0.4581272.11518680.html.plaintext.txt	0	proliferation apoptosis alters epithelial cell migration small intestine cftr null mice ann marie gallagher roberta
0.4581272.11518680.html.plaintext.txt	1	department molecular experimental medicine scripps research institute la jolla california 92037
0.4581272.11518680.html.plaintext.txt	2	abstract top abstract introduction methods results discussion references
0.4581272.11518680.html.plaintext.txt	3	expression mutated cystic fibrosis transmembrane conductance regulator cftr shown enhance proliferation within cf airways cells expressing mutated cftr shown less susceptible apoptosis
0.4581272.11518680.html.plaintext.txt	4	cftr expressed epithelial cells lining gastrointestinal tract cf mouse models characterized gastrointestinal obstruction hypothesized cftr null mice would increased epithelial cell proliferation reduced apoptosis within small intestine
0.4581272.11518680.html.plaintext.txt	5	rate intestinal epithelial cell migration crypt villus increased cftr null mice relative mice expressing wild type cftr
0.4581272.11518680.html.plaintext.txt	6	difference migration could explained increase epithelial cell proliferation difference apoptosis within crypts lieberkuhn
0.4581272.11518680.html.plaintext.txt	7	addition using two independent sets cf cell lines found epithelial cell susceptibility apoptosis unrelated presence functional cftr
0.4581272.11518680.html.plaintext.txt	8	thus increased proliferation alterations apoptosis within epithelial cells might contribute pathophysiology cf
0.4581272.11518680.html.plaintext.txt	9	cystic fibrosis transmembrane conductance regulator animal model pathophysiology
0.4581272.11518680.html.plaintext.txt	10	introduction top abstract introduction methods results discussion references
0.4581272.11518680.html.plaintext.txt	11	cystic fibrosis transmembrane conductance regulator cftr chloride channel mutated cf
0.4581272.11518680.html.plaintext.txt	12	mutation cftr results decrease epithelial cell chloride permeability
0.4581272.11518680.html.plaintext.txt	13	although defect affects exocrine tissues humans manifests primarily airways intestine
0.4581272.11518680.html.plaintext.txt	14	cf characterized reduced chloride fluid secretion results accumulation mucus within bronchioles meconium ileus cf newborns intestinal obstructions older cf patients
0.4581272.11518680.html.plaintext.txt	15	mouse models cf cftr deleted insertional deletional mutagenesis intestinal pathophysiology characterized mucus accumulation crypts lieberkuhn goblet cell hyperplasia intestinal obstruction
0.4581272.11518680.html.plaintext.txt	16	addition cftr expressed epithelial cells lining gastrointestinal tract reduction expression along crypt villus axis 7 26
0.4581272.11518680.html.plaintext.txt	17	previously gottlieb dosanjh 9 showed cultured c127 mouse mammary epithelial cells stably transfected f508 mutated cftr remained viable less susceptible apoptosis induced cycloheximide etoposide cells expressing wild type cftr
0.4581272.11518680.html.plaintext.txt	18	programmed cell death apoptosis physiologically relevant process occurs regenerating tissues lung intestine
0.4581272.11518680.html.plaintext.txt	19	cell turnover balance proliferation elimination cell proliferation shown greater airway epithelia nasal polyps cf patients tissue non cf patients 12 15
0.4581272.11518680.html.plaintext.txt	20	although phenomenon traditionally attributed inflammation possibility proliferative differences might due differential expression cftr addressed
0.4581272.11518680.html.plaintext.txt	21	mouse models cf cftr develop intestinal obstructions 10 cftr expressed epithelial cells lining gastrointestinal tract hypothesized cftr mouse intestine would show evidence altered apoptosis andor enhanced proliferation relative mice expressing wild type cftr
0.4581272.11518680.html.plaintext.txt	22	hypothesis tested vivo using knockout mouse model cf
0.4581272.11518680.html.plaintext.txt	23	mice expressing mutant cftr found greater rate migration epithelial cells crypt villus axis within small intestine
0.4581272.11518680.html.plaintext.txt	24	increased rate could attributed increase proliferative capacity cells within crypts lieberkuhn differences apoptosis
0.4581272.11518680.html.plaintext.txt	25	current results contradict previous findings 9 differences apoptosis cells transfected f508 cftr wild type cftr studies extended examine apoptosis two independent cell culture models cf
0.4581272.11518680.html.plaintext.txt	26	methods top abstract introduction methods results discussion references
0.4581272.11518680.html.plaintext.txt	27	mouse model cf generated dr
0.4581272.11518680.html.plaintext.txt	28	beverly koller university north carolina used studies 3
0.4581272.11518680.html.plaintext.txt	29	model cftrtm1unc cftr gene disrupted gene targeting mouse models cf animals develop intestinal obstructions typically die within weeks birth
0.4581272.11518680.html.plaintext.txt	30	however replacing drinking water colyte schwarz pharma milwaukee wi commercially available electrolyte solution containing 6 polyethylene glycol mice remain alive past 18 mo age 10
0.4581272.11518680.html.plaintext.txt	31	animals maintained within custom breeding colony scripps research institute animals receiving colyte place drinking water
0.4581272.11518680.html.plaintext.txt	32	time weaning genotypes mice determined isolation tail dna pcr amplification cftr alleles described previously koller et al
0.4581272.11518680.html.plaintext.txt	33	animal studies adhered approved institutional animal protocols american association accreditation laboratory animal care guidelines
0.4581272.11518680.html.plaintext.txt	34	bromodeoxyuridine brdu sigma chemical st
0.4581272.11518680.html.plaintext.txt	35	louis mo suspended pbs 20 mgml administered via intraperitoneal injection 150 microgg body wt
0.4581272.11518680.html.plaintext.txt	36	mice killed halothane overdose 2 48 h brdu injection
0.4581272.11518680.html.plaintext.txt	37	small intestine isolated excised rinsed pbs splayed open along length rinsed twice remove contents
0.4581272.11518680.html.plaintext.txt	38	splayed intestine fixed z fix 10 buffered formalin containing zinc anatech battle creek mi coiled proximal distal end form swiss roll dehydrated embedded paraffin tissue sectioning
0.4581272.11518680.html.plaintext.txt	39	tissue sections swiss rolls allow examination entire length intestine single section
0.4581272.11518680.html.plaintext.txt	40	brdu incorporation swiss rolls analyzed immunohistochemistry
0.4581272.11518680.html.plaintext.txt	41	briefly 3 microm thick tissue sections cleared paraffin rehydrated graded alcohols
0.4581272.11518680.html.plaintext.txt	42	endogenous peroxidase activity blocked 0
0.4581272.11518680.html.plaintext.txt	43	3 hydrogen peroxide methanol 15 min room temperature
0.4581272.11518680.html.plaintext.txt	44	1 n hcl 15 min 37 degrees c tissue treated 2 n hcl 30 min 37 degrees c rinsed 0
0.4581272.11518680.html.plaintext.txt	45	tissue sections incubated anti brdu sigma chemical 1500 20 normal goat serum 90 min 37 degrees c
0.4581272.11518680.html.plaintext.txt	46	incubation biotinylated goat anti mouse igg 12000 pbs containing 1 mgml igg free bsa caltag burlingame ca 60 min room temperature followed enzymatic labeling horseradish peroxidase conjugated streptavidin 11000 pbsbsa 30 min room temperature caltag
0.4581272.11518680.html.plaintext.txt	47	01 h2o2 used color development
0.4581272.11518680.html.plaintext.txt	48	tissues counterstained gills hematoxylin fisher scientific pittsburgh pa dehydrated graded alcohols placed coverslip permount fisher scientific
0.4581272.11518680.html.plaintext.txt	49	epithelial cell migration evaluated cftr cftr mice measuring distance base intestinal crypts distal paneth cell along epithelial cells brdu positive nuclei within crypt villus structure
0.4581272.11518680.html.plaintext.txt	50	investigator blinded animal identification time brdu injection
0.4581272.11518680.html.plaintext.txt	51	use x 20 objective nikon te300 microscope spot diagnostics instruments digital camera sterling heights mi 5 24 crypt villus structures captured animal analyzed using metamorph imaging software universal imaging west chester pa
0.4581272.11518680.html.plaintext.txt	52	three individual time courses brdu migration performed total 20 animals 3 animalsgenotype 2 24 h 4 micegenotype 48 h
0.4581272.11518680.html.plaintext.txt	53	anova used assess whether genotypic difference migration rate two tailed test utilized determine difference distance migration 48 h brdu injection
0.4581272.11518680.html.plaintext.txt	54	spontaneous induced epithelial cell apoptosis
0.4581272.11518680.html.plaintext.txt	55	situ terminal deoxynucleotidyltransferase dutp nick end labeling tunel found unreliable method detecting apoptosis gastrointestinal tract 21
0.4581272.11518680.html.plaintext.txt	56	therefore method previously described potten 21 apoptosis quantified calculating percentage cells condensed andor fragmented nuclei within first 10 cells following paneth cells crypts lieberkuhn used quantify apoptosis small intestine cftr mice
0.4581272.11518680.html.plaintext.txt	57	crypts scored investigator blinded identity animals met following criteria 1 paneth cells could viewed 2 crypt lumen could seen 3 minimum 10 nonoverlapping epithelial cells crypt column could distinguished
0.4581272.11518680.html.plaintext.txt	58	levels spontaneous apoptosis evaluated control animals
0.4581272.11518680.html.plaintext.txt	59	whole body cesium gamma irradiation used induce apoptosis small intestine cftr mice attempt uncover genotypic differences susceptibility apoptosis
0.4581272.11518680.html.plaintext.txt	60	initial dose response curve using cftr mice revealed significant epithelial cell apoptosis could seen 3 h whole body cesium gamma irradiation 100 rads
0.4581272.11518680.html.plaintext.txt	61	higher doses gamma irradiation result detection apoptotic cells
0.4581272.11518680.html.plaintext.txt	62	therefore subsequent experiments performed dose 100 rads animals killed 3 h gamma irradiation
0.4581272.11518680.html.plaintext.txt	63	following fixation sectioning described intestinal tissue deparaffinized stained hematoxylin placed coverslip permount
0.4581272.11518680.html.plaintext.txt	64	average number apoptotic nuclei determined minimum 50 cryptsanimal 18 cftr mice 8 control 10 irradiated 14 mice 5 control 9 irradiated expressed percentage first 10 crypt cells
0.4581272.11518680.html.plaintext.txt	65	anova used test whether irradiation increased intestinal cell apoptosis two tailed tests used determine statistical significance irradiation within genotype
0.4581272.11518680.html.plaintext.txt	66	intestinal epithelial cell proliferation
0.4581272.11518680.html.plaintext.txt	67	immunohistochemical detection proliferating cell nuclear antigen pcna evaluated within crypts control nonirradiated brdu cftr mice investigator blinded animal identity
0.4581272.11518680.html.plaintext.txt	68	tissues acquired processed described paraffin embedded swiss rolls dewaxed rehydrated graded alcohols
0.4581272.11518680.html.plaintext.txt	69	tissues incubated target retrieval solution dako carpinteria ca 95 degrees c 20 min room temperature additional 20 min
0.4581272.11518680.html.plaintext.txt	70	endogenous peroxidase activity blocked 0
0.4581272.11518680.html.plaintext.txt	71	3 hydrogen peroxide methanol incubation anti pcna clone pc10 dako 90 min 37 degrees c 20 normal goat serum
0.4581272.11518680.html.plaintext.txt	72	rinsing pbs tissue incubated biotinylated goat anti mouse igg caltag suspended 12000 pbs containing 1 mgml igg free bsa
0.4581272.11518680.html.plaintext.txt	73	30 min incubation horseradish peroxidase conjugated streptavidin caltag color developed sigmafast diaminobenzidine 0
0.4581272.11518680.html.plaintext.txt	74	2 mgml urea h2o2 counterstained hematoxylin dehydrated alcohols placed coverslip permount
0.4581272.11518680.html.plaintext.txt	75	proliferation evaluated determining average number pcna positive cells present within first 10 cells following paneth cells minimum 25 cryptsanimal
0.4581272.11518680.html.plaintext.txt	76	twelve animals 17 used determine genotypic difference epithelial cell proliferation
0.4581272.11518680.html.plaintext.txt	77	two tailed test used determine statistical significance
0.4581272.11518680.html.plaintext.txt	78	c127 mouse mammary epithelial cells stably transfected wild type cftr cftr deletion phenylalanine position 508 c127 f508 obtained dr
0.4581272.11518680.html.plaintext.txt	79	denning howard hughes medical institute university iowa college medicine 4
0.4581272.11518680.html.plaintext.txt	80	cells grown dmem gibco brl rockville md supplemented 10 fbs hyclone logan ut penicillin streptomycin fungizone sigma chemical passaged 15 two times per week
0.4581272.11518680.html.plaintext.txt	81	cell lines grown presence geneticin 500 microgml gibco brl
0.4581272.11518680.html.plaintext.txt	82	cft1 cell lines derived tracheal epithelial cells isolated 24 year old cf patient homozygous f508 mutation obtained j
0.4581272.11518680.html.plaintext.txt	83	yankaskas university north carolina
0.4581272.11518680.html.plaintext.txt	84	parental cell line cft1 c2 used establish three cell lines immortalized human papilloma virus
0.4581272.11518680.html.plaintext.txt	85	cft1 lcfsn cells overexpress wild type cftr introduced retroviral vector 20
0.4581272.11518680.html.plaintext.txt	86	cft1 f508 cells express additional copy cftr f508 mutation cft1 lc3 retroviral vector control cell line overexpressing galactosidase gene
0.4581272.11518680.html.plaintext.txt	87	cells grown hams f 12 fisher scientific supplemented insulin 10 microgml hydrocortisone 1 microm endothelial cell growth supplement ecgs 3
0.4581272.11518680.html.plaintext.txt	88	75 microgml epidermal growth factor 25 ngml t3 30 nm transferrin 5 microgml cholera toxin 10 ngml hormones obtained sigma chemical
0.4581272.11518680.html.plaintext.txt	89	cells except cft1 c2 cells grown presence geneticin 500 microgml passaged 13 two times per week
0.4581272.11518680.html.plaintext.txt	90	membrane destabilization detected yopro 1 uptake
0.4581272.11518680.html.plaintext.txt	91	cells plated 10000 cellswell 96 well tissue culture plates
0.4581272.11518680.html.plaintext.txt	92	24 h medium aspirated replaced 100 microl sterile pbs
0.4581272.11518680.html.plaintext.txt	93	cells ultraviolet uv irradiated 0 8000 jm2 using fisher scientific uv crosslinker pbs replaced fresh medium cells incubated 37 degrees c 5 co2
0.4581272.11518680.html.plaintext.txt	94	16 h 25 microm yopro 1 10 microl added well incubated 37 degrees c 10 min
0.4581272.11518680.html.plaintext.txt	95	yopro 1 taken cells unstable membrane binds double strand dna therefore apoptotic necrotic cells labeled yopro 1 13
0.4581272.11518680.html.plaintext.txt	96	use fluorescence plate reader bio tek instruments winooski vt yopro 1 found excited 530 nm emissions detected 480 nm
0.4581272.11518680.html.plaintext.txt	97	cells lysed 10 microl lysis buffer 125 mm edta 2
0.4581272.11518680.html.plaintext.txt	98	5 nonidet p 40 incubated 37 degrees c 5 co2 30 min fluorescence evaluated determine total number cells per well
0.4581272.11518680.html.plaintext.txt	99	ratio first fluorescence apoptotic necrotic cells second fluorescence total cells taken evaluate percent death plotted uv dose
0.4581272.11518680.html.plaintext.txt	100	nuclear condensation fragmentation
0.4581272.11518680.html.plaintext.txt	101	cells plated 30000 cellschamber four well chamber slides
0.4581272.11518680.html.plaintext.txt	102	one cell type plated per chamber slide cells plated first fourth chambers
0.4581272.11518680.html.plaintext.txt	103	allowing cells adhere reach 80 confluence medium aspirated replaced 500 microl sterile pbs
0.4581272.11518680.html.plaintext.txt	104	one chamber containing control cells covered opaque material prevent irradiation chamber slide irradiated 2000 jm2
0.4581272.11518680.html.plaintext.txt	105	position control irradiated cells randomized ensure analysis done blinded conditions
0.4581272.11518680.html.plaintext.txt	106	pbs aspirated replaced fresh medium
0.4581272.11518680.html.plaintext.txt	107	cells incubated 37 degrees c 5 co2 6 h 37 formaldehyde added chamber final concentration 3
0.4581272.11518680.html.plaintext.txt	108	fixation slides centrifuged 1200 rpm 15 min ensure minimal loss cells fixation procedure
0.4581272.11518680.html.plaintext.txt	109	cells fixed additional 15 min rinsed pbs allowed air dry
0.4581272.11518680.html.plaintext.txt	110	time analysis 30 microm hoechst
0.4581272.11518680.html.plaintext.txt	111	33342 pbs added chamber slides coverslipped minimum 300 cellschamber analyzed nuclear condensation fragmentation fluorescence microscopy
0.4581272.11518680.html.plaintext.txt	112	percentage fragmented condensed nuclei three separate experiments obtained experimenter blinded cell type irradiation dose
0.4581272.11518680.html.plaintext.txt	113	confirm mutated cftr responsible resistance apoptosis c127 f508 cells infected cftr adenovirus attempt restore susceptibility death cells
0.4581272.11518680.html.plaintext.txt	114	c127 f508 cells plated 5000 cellswell 96 well tissue culture plate allowed adhere overnight
0.4581272.11518680.html.plaintext.txt	115	preliminary studies galactosidase adenovirus ad2cmvgal 4 gift genzyme framingham ma showed cells fairly resistant infection adenovirus required 20000 infective unitscell 95 infectivity
0.4581272.11518680.html.plaintext.txt	116	cells infected 20000 infective units cftr adenovirus ad2cftr 16 gift genzyme suspended dmem containing 2 heat inactivated fbs 60 min room temperature followed 48 h 37 degrees c 5 co2
0.4581272.11518680.html.plaintext.txt	117	infection cells uv irradiated evaluated yopro 1 described determine susceptibility death
0.4581272.11518680.html.plaintext.txt	118	galactosidase adenovirus infected uninfected cells used negative controls
0.4581272.11518680.html.plaintext.txt	119	results top abstract introduction methods results discussion references
0.4581272.11518680.html.plaintext.txt	120	mouse models cf consistent susceptibility gastrointestinal obstruction therefore studies designed determine whether nonfunctional cftr alters kinetics epithelial cell migration within gastrointestinal tract ultimately might underlie pathophysiology within intestine
0.4581272.11518680.html.plaintext.txt	121	rate migration brdu labeled cells crypt villus axis faster cftr mice cftr littermates p 0
0.4581272.11518680.html.plaintext.txt	122	48 h distance epithelial cells cftr mice migrated significantly greater distance migration cftr mouse intestine p 0
0.4581272.11518680.html.plaintext.txt	123	epithelial cell migration crypts lieberkuhn intestinal villi net result proliferation apoptosis within crypts components evaluated separately see either altered result expression mutant cftr
0.4581272.11518680.html.plaintext.txt	124	increase epithelial cell migration might occur apoptosis reduced andor proliferation within crypts lieberkuhn increased
0.4581272.11518680.html.plaintext.txt	125	view larger version 12k fig
0.4581272.11518680.html.plaintext.txt	126	intestinal epithelial cell migration cystic fibrosis transmembrane conductance regulator cftr cftr mice
0.4581272.11518680.html.plaintext.txt	127	cftr mice given intraperitoneal injection bromodeoxyuridine brdu killed 2 48 h brdu injection
0.4581272.11518680.html.plaintext.txt	128	cells incorporated brdu localized immunohistochemically distance base crypt lieberkuhn brdu positive cell determined 20 animals 3 animalsgenotype evaluated 2 24 h 4 animalsgenotype examined 48 h
0.4581272.11518680.html.plaintext.txt	129	brdu labeled epithelial cells cftr mice migrate intestinal villi faster rate cells cftr mice
0.4581272.11518680.html.plaintext.txt	130	point represents mean plus minus se distal brdu positive cell animals group
0.4581272.11518680.html.plaintext.txt	131	48 h brdu migration distance migration significantly different 2 genotypes p 0
0.4581272.11518680.html.plaintext.txt	132	levels spontaneous apoptosis different cftr genotypes cftr mice exhibiting 5
0.4581272.11518680.html.plaintext.txt	133	6 apoptosis within crypts cftr cftr mice presenting 6 plus minus 2
0.4581272.11518680.html.plaintext.txt	134	1 apoptosis respectively fig
0.4581272.11518680.html.plaintext.txt	135	determine whether low levels spontaneous apoptosis seen within crypts masks difference susceptibility apoptosis intestinal apoptosis induced whole body cesium gamma irradiation
0.4581272.11518680.html.plaintext.txt	136	irradiation significantly increased apoptosis genotypes p 0
0.4581272.11518680.html.plaintext.txt	137	001 uncover differences susceptibility apoptosis genotypes fig
0.4581272.11518680.html.plaintext.txt	138	epithelial cells villus tips show nuclear fragmentation condensation additionally detection apoptosis gastrointestinal tract tunel highly variable 19
0.4581272.11518680.html.plaintext.txt	139	therefore apoptosis villus tips could examined study
0.4581272.11518680.html.plaintext.txt	140	view larger version 21k fig
0.4581272.11518680.html.plaintext.txt	141	irradiation induced crypt cell apoptosis cftr mice
0.4581272.11518680.html.plaintext.txt	142	cftr mice subjected whole body cesium gamma irradiation killed 3 h irradiation
0.4581272.11518680.html.plaintext.txt	143	apoptosis evaluated first 10 cells following paneth cells 50 crypts lieberkuhn per animal
0.4581272.11518680.html.plaintext.txt	144	animals per group noted bar
0.4581272.11518680.html.plaintext.txt	145	values means plus minus sd
0.4581272.11518680.html.plaintext.txt	146	gamma irradiation 100 rad induced 10 fold increases apoptosis within epithelial cells crypts lieberkuhn cftr cftr cftr mice p 0
0.4581272.11518680.html.plaintext.txt	147	genotypic differences susceptibility apoptosis
0.4581272.11518680.html.plaintext.txt	148	determine whether difference epithelial cell migration result differences crypt cell proliferation epithelial cells within crypts lieberkuhn evaluated expression pcna
0.4581272.11518680.html.plaintext.txt	149	significantly greater percentage epithelial cells cftr mice 49
0.4581272.11518680.html.plaintext.txt	150	6 express pcna animals expressing least one copy functional gene cftr 36
0.4581272.11518680.html.plaintext.txt	151	view larger version 11k fig
0.4581272.11518680.html.plaintext.txt	152	intestinal epithelial cell proliferation cftr mice
0.4581272.11518680.html.plaintext.txt	153	proliferating cell nuclear antigen pcna detected immunohistochemistry first 10 cells following paneth cells 25 crypts lieberkuhn 7 cftr mice 5 cftr mice
0.4581272.11518680.html.plaintext.txt	154	pcna positive cells per crypt revealed significantly proliferative capacity crypts lieberkuhn cftr mice 49
0.4581272.11518680.html.plaintext.txt	155	significant difference p 0
0.4581272.11518680.html.plaintext.txt	156	results animal studies contradict previous cell culture findings presented gottlieb dosanjh 9 cells expressing mutated cftr resistant apoptosis cells expressing wild type cftr
0.4581272.11518680.html.plaintext.txt	157	therefore experiments designed determine whether cell culture results misleading
0.4581272.11518680.html.plaintext.txt	158	mouse mammary epithelial cells expressing mutated cftr c127 f508 resistant death induced 1000 2000 jm2 uv irradiation cells expressing wild type cftr fig
0.4581272.11518680.html.plaintext.txt	159	uv irradiation doses 4000 jm2 similar percentage cell death seen cell types
0.4581272.11518680.html.plaintext.txt	160	consistent previous findings 9 c127 f508 cells resistant c127 wild type cells induction apoptosis etoposide cycloheximide
0.4581272.11518680.html.plaintext.txt	161	view larger version 20k fig
0.4581272.11518680.html.plaintext.txt	162	dose response curve ultraviolet uv induced cell death c127 cells expressing wild type cftr c127 wt c127 f508 cells
0.4581272.11518680.html.plaintext.txt	163	c127 cells uv irradiated doses 0 8000 jm2 evaluated cell death 16 h irradiation uptake dna binding fluorochrome yopro 1
0.4581272.11518680.html.plaintext.txt	164	cells unstable plasma membrane take yopro 1 therefore ratio fluorescence emissions cell lysis allows determination cell death
0.4581272.11518680.html.plaintext.txt	165	c127 wt susceptible uv irradiation induced death cells expressing f508 mutated cftr
0.4581272.11518680.html.plaintext.txt	166	001 produces significant genotypic differences death
0.4581272.11518680.html.plaintext.txt	167	irradiation doses 4000 jm2 results similar cell death two cell lines
0.4581272.11518680.html.plaintext.txt	168	values means plus minus sd 2 6 experimentsdose minimum triplicates dose experiment
0.4581272.11518680.html.plaintext.txt	169	determine whether difference susceptibility uv irradiation seen c127 cell lines result differences expression functional cftr c127 f508 cells infected adenovirus expressing wild type cftr induction apoptosis
0.4581272.11518680.html.plaintext.txt	170	although cells overexpressing mutant cftr may low level cftr activity 2 expression wild type cftr c127 f508 cells increase susceptibility cells death relative cells infected galactosidase adenovirus uninfected cells fig
0.4581272.11518680.html.plaintext.txt	171	data suggest expression functional cftr make c127 cells susceptible apoptosis cells expressing mutated cftr
0.4581272.11518680.html.plaintext.txt	172	instead data suggest observed difference apoptosis unrelated cftr instead may property acquired clonal selection process
0.4581272.11518680.html.plaintext.txt	173	view larger version 32k fig
0.4581272.11518680.html.plaintext.txt	174	dose effect uv irradiation cell death adenovirus infected c127 f508 cells
0.4581272.11518680.html.plaintext.txt	175	c127 f508 cells infected adenovirus construct containing wild type cftr wt cftr galactosidase gene b gal uninfected
0.4581272.11518680.html.plaintext.txt	176	48 h infection apoptosis induced 2000 jm2 uv irradiation
0.4581272.11518680.html.plaintext.txt	177	sixteen hours irradiation cells evaluated cell death uptake yopro 1
0.4581272.11518680.html.plaintext.txt	178	expression wild type cftr alter susceptibility death uv irradiation relative uninfected control cells
0.4581272.11518680.html.plaintext.txt	179	galactosidase expression made cells sensitive uv irradiation
0.4581272.11518680.html.plaintext.txt	180	data reflect 2 experiments performed quadruplicate range data reflected error bars
0.4581272.11518680.html.plaintext.txt	181	assess whether original data misleading second set cell lines tested determine susceptibility apoptosis based expression functional mutated cftr
0.4581272.11518680.html.plaintext.txt	182	cft1 cell lines 16 h uv irradiation cell death increased dose dependent manner similar extent across cell lines fig
0.4581272.11518680.html.plaintext.txt	183	similar data obtained 6 h uv irradiation using nuclear condensation fragmentation markers apoptosis fig
0.4581272.11518680.html.plaintext.txt	184	addition uv irradiation cft1 cell lines resulted similar time course dna degradation data shown dna laddering present 3 h uv irradiation four cell lines
0.4581272.11518680.html.plaintext.txt	185	furthermore cleavage caspase 3 pharmingen la jolla ca caspase 9 new england biolabs beverly ma uv irradiation different across cell lines data shown
0.4581272.11518680.html.plaintext.txt	186	thus current data c127 cft1 cell lines suggest cftr play role apoptosis
0.4581272.11518680.html.plaintext.txt	187	view larger version 36k fig
0.4581272.11518680.html.plaintext.txt	188	dose response curve uv induced cell death cft1 cell lines
0.4581272.11518680.html.plaintext.txt	189	cft1 cells uv irradiated doses 0 8000 jm2 evaluated cell death described fig
0.4581272.11518680.html.plaintext.txt	190	differences seen across cell lines
0.4581272.11518680.html.plaintext.txt	191	cells expressing wild type cftr lcfsn equally susceptible death uv irradiation cells parental cell line c2 cells expressing additional copies f508 mutation df508 cells expressing galactosidase vector control lc3
0.4581272.11518680.html.plaintext.txt	192	data reflect 2 experiments performed quadruplicate error bars reflecting range data
0.4581272.11518680.html.plaintext.txt	193	view larger version 30k fig
0.4581272.11518680.html.plaintext.txt	194	effect uv irradiation nuclear condensation fragmentation cft1 cells
0.4581272.11518680.html.plaintext.txt	195	cft1 cells uv irradiated 0 2000 jm2 fixed 6 h evaluated nuclear condensation fragmentation fluorescence microscopy staining nuclei 30 microm hoechst
0.4581272.11518680.html.plaintext.txt	196	examples typical nuclear condensation fragmentation cell line
0.4581272.11518680.html.plaintext.txt	197	b means plus minus sd apoptosis seen 3 separate experiments minimum 300 cells counted per cell type per experiment
0.4581272.11518680.html.plaintext.txt	198	amount apoptosis seen cell line similar independent expression wild type mutated cftr
0.4581272.11518680.html.plaintext.txt	199	discussion top abstract introduction methods results discussion references
0.4581272.11518680.html.plaintext.txt	200	many cf patients mouse models cf common pathology susceptibility gastrointestinal obstruction
0.4581272.11518680.html.plaintext.txt	201	normal intestine epithelial cells line villi absorptive surfaces
0.4581272.11518680.html.plaintext.txt	202	cells continuously regenerated proliferation crypts lieberkuhn differentiation migration villi
0.4581272.11518680.html.plaintext.txt	203	tips villi cells undergo apoptosis shed lumen 11 24
0.4581272.11518680.html.plaintext.txt	204	18 shown proliferation apoptosis occur stem cells within crypts apoptosis within crypts likely important part homeostatic process tissue maintenance
0.4581272.11518680.html.plaintext.txt	205	normal conditions stem cell proliferation epithelial sloughing equilibrium
0.4581272.11518680.html.plaintext.txt	206	shown current study epithelial cells cftr mice migrate crypt villus axis greater rate animals expressing functional cftr
0.4581272.11518680.html.plaintext.txt	207	epithelial cells cftr mice migrated 27 farther 48 h cftr mice
0.4581272.11518680.html.plaintext.txt	208	difference rate due differences proliferation apoptosis within crypts lieberkuhn 12 cells proliferative capacity cftr mice cftr mice
0.4581272.11518680.html.plaintext.txt	209	villus length different genotypes data shown increased number cells proliferating within crypt migrating villi would lead increase mass cells sloughed gastrointestinal tract
0.4581272.11518680.html.plaintext.txt	210	increased proliferative capacity within cftr null mice may attributed cellular defect within cells result nonfunctional cftr although mechanism might happen unknown
0.4581272.11518680.html.plaintext.txt	211	potentially differences intracellular ph might account enhanced proliferation cftr cells
0.4581272.11518680.html.plaintext.txt	212	cytosolic ph thought one factors control rate proliferation 8 cytoplasmic alkalinization constituting signal mitogenesis 1 22 27
0.4581272.11518680.html.plaintext.txt	213	addition cells higher intracellular ph likely g2 m phases cell cycle whereas cells lower ph likely g1 19
0.4581272.11518680.html.plaintext.txt	214	cells expressing mutated cftr reported 5 6 elevated cytosolic ph overexpression wild type cftr mutant cftr results growth arrest 23
0.4581272.11518680.html.plaintext.txt	215	thus mutation cftr may result elevated intracellular ph stimulates cell undergo proliferation readily thus increase rate epithelial cells crypts lieberkuhn proliferate migrate intestinal villi
0.4581272.11518680.html.plaintext.txt	216	mouse models cf show evidence inflammation intestinal obstructions 10 thus possibility stimulus enhanced proliferation within intestine cftr mice might due differences inflammation cannot ruled
0.4581272.11518680.html.plaintext.txt	217	proliferation nasal polyps 12 16 epithelium bronchial airways 15 shown increased cf patients attributed airway inflammation
0.4581272.11518680.html.plaintext.txt	218	chronic inflammation shown present cf intestine increased luminal content immune cell constituents secretory immunoglobulins cytokines 25
0.4581272.11518680.html.plaintext.txt	219	therefore inflammation within gastrointestinal tract potentially stimulus enhanced proliferation
0.4581272.11518680.html.plaintext.txt	220	initial studies gottlieb dosanjh 9 showed decreased susceptibility apoptosis cells expressing mutated cftr relative cells expressing wild type cftr
0.4581272.11518680.html.plaintext.txt	221	initial study cycloheximide etoposide used induce apoptosis
0.4581272.11518680.html.plaintext.txt	222	cftr anion channel mutated allow chloride transported across plasma membrane
0.4581272.11518680.html.plaintext.txt	223	transport problem one concern use drug chemical induce apoptosis difference ability cells transport drug chemical across cell membrane
0.4581272.11518680.html.plaintext.txt	224	avoid potential problem current studies uv irradiation utilized apoptotic stimulus
0.4581272.11518680.html.plaintext.txt	225	cells expressing mutated cftr resistant apoptosis induced uv irradiation cells expressing wild type cftr accordance findings gottlieb dosanjh 9
0.4581272.11518680.html.plaintext.txt	226	however one control lacking original set experiments introduction wild type cftr resistant cell lines restore susceptibility apoptosis
0.4581272.11518680.html.plaintext.txt	227	current study infection c127 f08 cells adenovirus expressing wild type cftr failed restore susceptibility apoptosis
0.4581272.11518680.html.plaintext.txt	228	galactosidase adenovirus infected cells found susceptible death uninfected infected cftr cells
0.4581272.11518680.html.plaintext.txt	229	reason behind increased propensity toward death known
0.4581272.11518680.html.plaintext.txt	230	galactosidase construct used experiments nuclear targeted protein location expression may make cells susceptible dna damaging effect uv irradiation
0.4581272.11518680.html.plaintext.txt	231	confirm findings c127 cells independent set cell lines used determine whether expression mutated wild type cftr results differences susceptibility apoptosis
0.4581272.11518680.html.plaintext.txt	232	cells mutated cftr found different sensitivity uv irradiation cells expressing wild type cftr evaluated membrane destabilization detected uptake yopro 1 nuclear condensation fragmentation dna degradation caspase cleavage
0.4581272.11518680.html.plaintext.txt	233	thus taken together data suggest cftr play role cells susceptibility apoptosis
0.4581272.11518680.html.plaintext.txt	234	cftr null mice epithelial cell kinetics within gastrointestinal tract differ mice expressing least one copy functional cftr
0.4581272.11518680.html.plaintext.txt	235	altered proliferation within crypts lieberkuhn accompanied changes apoptosis results increased rate cell migration villus
0.4581272.11518680.html.plaintext.txt	236	increased number cells reaching intestinal lumen might contribute viscosity luminal contents increase likelihood intestinal blockage one pathophysiological hallmarks cf
0.4581272.11518680.html.plaintext.txt	237	epithelial cell proliferation turnover increased parallel cf lung pancreas might contribute viscosity bronchial pancreatic secretions exacerbate symptoms cf
0.4581272.11518680.html.plaintext.txt	238	research supported postdoctoral fellowship cystic fibrosis foundation
0.4581272.11518680.html.plaintext.txt	239	gallagher grant cystic fibrosis foundation r
0.4581272.11518680.html.plaintext.txt	240	gottlieb award pew foundation scholars program biomedical sciences r
0.4581272.11518680.html.plaintext.txt	241	address reprint requests correspondence r
0.4581272.11518680.html.plaintext.txt	242	gottlieb scripps research institute 10550 n
0.4581272.11518680.html.plaintext.txt	243	mem220 la jolla ca 92037 e mail robbiegatscripps
0.4581272.11518680.html.plaintext.txt	244	costs publication article defrayed part payment page charges
0.4581272.11518680.html.plaintext.txt	245	article must therefore hereby marked advertisement accordance 18 u
0.4581272.11518680.html.plaintext.txt	246	section 1734 solely indicate fact
0.4581272.11518680.html.plaintext.txt	247	received 5 january 2001 accepted final form 4 may 2001
0.4581272.11518680.html.plaintext.txt	248	references top abstract introduction methods results discussion references
0.4581272.11518680.html.plaintext.txt	249	extracellular na initiation dna synthesis role intracellular ph k
0.4581272.11518680.html.plaintext.txt	250	j cell biol 98 1082 1089 1984abstract
0.4581272.11518680.html.plaintext.txt	251	cheng sh fang sl zabner j marshall j piraino schiavi sc jefferson dm welsh mj smith ae
0.4581272.11518680.html.plaintext.txt	252	functional activation cystic fibrosis trafficking mutant f508 cftr overexpression
0.4581272.11518680.html.plaintext.txt	253	j physiol lung cell mol physiol 268 l615 l624 1995abstractfree full text
0.4581272.11518680.html.plaintext.txt	254	clarke ll grubb br gabriel se smithies o koller bh boucher rc
0.4581272.11518680.html.plaintext.txt	255	defective epithelial chloride transport gene targeted mouse model cystic fibrosis
0.4581272.11518680.html.plaintext.txt	256	science 257 1125 1128 1992isimedline
0.4581272.11518680.html.plaintext.txt	257	denning gm anderson mp amara jf marshall j smith ae welsh mj
0.4581272.11518680.html.plaintext.txt	258	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.4581272.11518680.html.plaintext.txt	259	nature 358 761 764 1992isimedline
0.4581272.11518680.html.plaintext.txt	260	high intracellular ph lowered retrovirus mediated cftr gene transfer
0.4581272.11518680.html.plaintext.txt	261	biochem biophys res commun 180 342 348 1991isimedline
0.4581272.11518680.html.plaintext.txt	262	altered sulfate transport via anion exchange cfpac corrected retrovirus mediated cftr gene transfer
0.4581272.11518680.html.plaintext.txt	263	j physiol cell physiol 263 c176 c186 1992abstractfree full text
0.4581272.11518680.html.plaintext.txt	264	french pj van doorninck jh peters rh verbeek e ameen na marino cr de jonge hr bijman j scholte bj
0.4581272.11518680.html.plaintext.txt	265	delta f508 mutation mouse cystic fibrosis transmembrane conductance regulator results temperature sensitive processing defect vivo
0.4581272.11518680.html.plaintext.txt	266	j clin invest 98 1304 1312 1996abstractfree full text
0.4581272.11518680.html.plaintext.txt	267	gerson df kiefer h eufe w
0.4581272.11518680.html.plaintext.txt	268	intracellular ph mitogen stimulated lymphocytes
0.4581272.11518680.html.plaintext.txt	269	science 216 1009 1010 1982isimedline
0.4581272.11518680.html.plaintext.txt	270	mutant cystic fibrosis transmembrane conductance regulator inhibits acidification apoptosis c127 cells possible relevance cystic fibrosis
0.4581272.11518680.html.plaintext.txt	271	proc natl acad sci usa 93 3587 3591 1996abstractfree full text
0.4581272.11518680.html.plaintext.txt	272	intestinal physiology pathology gene targeted mouse models cystic fibrosis
0.4581272.11518680.html.plaintext.txt	273	j physiol gastrointest liver physiol 273 g258 g266 1997abstractfree full text
0.4581272.11518680.html.plaintext.txt	274	hall pa coates pj ansari b hopwood d
0.4581272.11518680.html.plaintext.txt	275	regulation cell number mammalian gastrointestinal tract importance apoptosis
0.4581272.11518680.html.plaintext.txt	276	j cell sci 107 3569 3577 1994abstractfree full text
0.4581272.11518680.html.plaintext.txt	277	hassid degaute mp dawance rombaut k nagy n choufani g decaestecker c danguy salmon kiss r
0.4581272.11518680.html.plaintext.txt	278	determination proliferative activity nasal polyps
0.4581272.11518680.html.plaintext.txt	279	j clin pathol 50 923 928 1997abstract
0.4581272.11518680.html.plaintext.txt	280	idziorek estaquier j de bels f ameisen jc
0.4581272.11518680.html.plaintext.txt	281	yopro 1 permits cytofluorometric analysis programmed cell death apoptosis without interfering cell viability
0.4581272.11518680.html.plaintext.txt	282	j immunol methods 185 249 258 1995isimedline
0.4581272.11518680.html.plaintext.txt	283	koller bh kim hs latour brigman k boucher rcj scambler p wainwright b smithies o
0.4581272.11518680.html.plaintext.txt	284	toward animal model cystic fibrosis targeted interruption exon 10 cystic fibrosis transmembrane regulator gene embryonic stem cells
0.4581272.11518680.html.plaintext.txt	285	proc natl acad sci usa 88 10730 10734 1991abstract
0.4581272.11518680.html.plaintext.txt	286	leigh mw kylander je yankaskas jr boucher rc
0.4581272.11518680.html.plaintext.txt	287	cell proliferation bronchial epithelium submucosal glands cystic fibrosis patients
0.4581272.11518680.html.plaintext.txt	288	j respir cell mol biol 12 605 612 1995abstract
0.4581272.11518680.html.plaintext.txt	289	lesprit e escudier e roger g pruliere v lenoir g reinert p coste
0.4581272.11518680.html.plaintext.txt	290	characterization inflammatory reaction upper airways cystic fibrosis patients
0.4581272.11518680.html.plaintext.txt	291	histol histopathol 15 395 402 2000isimedline
0.4581272.11518680.html.plaintext.txt	292	apoptosis interleukin 2 dependent cytotoxic lymphocyte cell line associated intracellular acidification
0.4581272.11518680.html.plaintext.txt	293	j biol chem 270 3203 3211 1995abstractfree full text
0.4581272.11518680.html.plaintext.txt	294	martin k kirkwood tb potten cs
0.4581272.11518680.html.plaintext.txt	295	age changes stem cells murine small intestinal crypts
0.4581272.11518680.html.plaintext.txt	296	exp cell res 241 316 323 1998isimedline
0.4581272.11518680.html.plaintext.txt	297	musgrove e seaman m hedley d
0.4581272.11518680.html.plaintext.txt	298	relationship cytoplasmic ph proliferation exponential growth cellular quiescence
0.4581272.11518680.html.plaintext.txt	299	exp cell res 172 65 75 1987isimedline
0.4581272.11518680.html.plaintext.txt	300	olsen jc johnson lg stutts mj sarkadi b yankaskas jr swanstrom r boucher rc
0.4581272.11518680.html.plaintext.txt	301	correction apical membrane chloride permeability defect polarized cystic fibrosis airway epithelia following retroviral mediated gene transfer
0.4581272.11518680.html.plaintext.txt	302	hum gene ther 3 253 266 1992isimedline
0.4581272.11518680.html.plaintext.txt	303	epithelial cell growth differentiation
0.4581272.11518680.html.plaintext.txt	304	j physiol gastrointest liver physiol 273 g253 g257 1997free full text
0.4581272.11518680.html.plaintext.txt	305	early signals mitogenic response
0.4581272.11518680.html.plaintext.txt	306	science 234 161 166 1986isimedline
0.4581272.11518680.html.plaintext.txt	307	schiavi sc abdelkader n reber pennington narayana r mcpherson jm smith ae hoppe iv h cheng sh
0.4581272.11518680.html.plaintext.txt	308	biosynthetic growth abnormalities associated high level expression cftr heterologous cells
0.4581272.11518680.html.plaintext.txt	309	j physiol cell physiol 270 c341 c351 1996abstractfree full text
0.4581272.11518680.html.plaintext.txt	310	shibahara sato n waguri iwanaga nakahara fukutomi h uchiyama y
0.4581272.11518680.html.plaintext.txt	311	fate effete epithelial cells villus tips human small intestine
0.4581272.11518680.html.plaintext.txt	312	arch histol cytol 58 205 219 1995isimedline
0.4581272.11518680.html.plaintext.txt	313	smyth rl croft nm ohea u marshall tg ferguson
0.4581272.11518680.html.plaintext.txt	314	intestinal inflammation cystic fibrosis
0.4581272.11518680.html.plaintext.txt	315	arch dis child 82 394 399 2000abstractfree full text
0.4581272.11518680.html.plaintext.txt	316	vivo cell specific expression cystic fibrosis transmembrane conductance regulator
0.4581272.11518680.html.plaintext.txt	317	nature 353 434 437 1991isimedline
0.4581272.11518680.html.plaintext.txt	318	vicentini lm villereal ml
0.4581272.11518680.html.plaintext.txt	319	inositol phosphates turnover cytosolic ca2 ph putative signals control cell growth
0.4581272.11518680.html.plaintext.txt	320	life sci 38 2269 2276 1986isimedline
0.4581272.11518680.html.plaintext.txt	321	j physiol gastrointest liver physiol 2813g681 g687 0193 185701 5
0.4581272.11518680.html.plaintext.txt	322	00 copyright 2001 american physiological society
0.41414222.16239222.html.plaintext.txt	0	cystic fibrosis transmembrane conductance regulator regulated direct interaction protein phosphatase 2a william r
0.41414222.16239222.html.plaintext.txt	1	thelin mehmet kesimer robert tarran silvia m
0.41414222.16239222.html.plaintext.txt	2	department cell developmental biology department biochemistry biophysics cystic fibrosispulmonary research treatment center university north carolina chapel hill chapel hill north carolina 27599
0.41414222.16239222.html.plaintext.txt	3	received publication july 6 2005 revised form september 23 2005
0.41414222.16239222.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references cystic fibrosis transmembrane conductance regulator cftr camp activated chloride channel expressed apical surface epithelia
0.41414222.16239222.html.plaintext.txt	5	although regulation cftr protein kinases well documented channel deactivation phosphatases well understood
0.41414222.16239222.html.plaintext.txt	6	find serinethreonine phosphatase pp2a physically associate cftr cooh terminus
0.41414222.16239222.html.plaintext.txt	7	pp2a heterotrimeric phosphatase composed catalytic subunit two divergent regulatory subunits b
0.41414222.16239222.html.plaintext.txt	8	cellular localization substrate specificity pp2a determined unique combination b regulatory subunits give rise least 75 different enzymes
0.41414222.16239222.html.plaintext.txt	9	mass spectrometry identified exact pp2a regulatory subunits associated cftr b find b subunit binds cftr directly
0.41414222.16239222.html.plaintext.txt	10	pp2a subunits localize apical surface airway epithelia pp2a phosphatase activity co purifies cftr calu 3 cells
0.41414222.16239222.html.plaintext.txt	11	functional assays inhibitors pp2a block rundown basal cftr currents increase channel activity excised patches airway epithelia intact mouse jejunum
0.41414222.16239222.html.plaintext.txt	12	moreover pp2a inhibition well differentiated human bronchial epithelial cells results cftr dependent increase airway surface liquid
0.41414222.16239222.html.plaintext.txt	13	data demonstrate pp2a relevant cftr phosphatase epithelial tissues
0.41414222.16239222.html.plaintext.txt	14	results may help reconcile differences phosphatase mediated channel regulation observed different tissues cells
0.41414222.16239222.html.plaintext.txt	15	furthermore pp2a may clinically relevant drug target cf considered future studies
0.41414222.16239222.html.plaintext.txt	16	introduction top abstract introduction experimental procedures results discussion references cystic fibrosis cf2 autosomal lethal disease characterized abnormal ion transport epithelial tissues
0.41414222.16239222.html.plaintext.txt	17	cf caused mutations cystic fibrosis transmembrane conductance regulator cftr apical membrane chloride channel
0.41414222.16239222.html.plaintext.txt	18	regulation cftr camp dependent protein kinase pka protein kinases extensively documented
0.41414222.16239222.html.plaintext.txt	19	pka phosphorylate cftr regulatory domain r domain least 11 serine residues 1 3
0.41414222.16239222.html.plaintext.txt	20	vivo pka phosphorylation increases cftr open probability number channels plasma membrane 4 5
0.41414222.16239222.html.plaintext.txt	21	work laboratory others demonstrated pka regulatory proteins compartmentalized close proximity cftr
0.41414222.16239222.html.plaintext.txt	22	cellular machinery capable generating camp including adenosine receptor membrane bound adenylate cyclase present cftr apical membrane patches 6
0.41414222.16239222.html.plaintext.txt	23	kinase anchoring proteins akaps target pka protein complexes cftr 7 9 disruption pkaakap interaction abolishes ability pka activate cftr response physiologic stimuli 9
0.41414222.16239222.html.plaintext.txt	24	addition phosphodiesterase pde4d also present cftr patch preparations forms camp diffusion barrier apical plasma membrane 10
0.41414222.16239222.html.plaintext.txt	25	cftr regulatory molecules including protein kinase c amp activated protein kinase found protein complexes associated directly cftr 11 12
0.41414222.16239222.html.plaintext.txt	26	less known ability serinethreonine phosphatases regulate cftr activity compartmentalized cftr
0.41414222.16239222.html.plaintext.txt	27	work many laboratories suggests multiple phosphatases including pp2a pp2b pp2c alkaline phosphatase involved deactivation cftr 13 17
0.41414222.16239222.html.plaintext.txt	28	vitro pp2a pp2c effective dephosphorylating purified cftr recombinant r domain
0.41414222.16239222.html.plaintext.txt	29	furthermore exogenous pp2a pp2c inactivate cftr excised membrane patches 13 18
0.41414222.16239222.html.plaintext.txt	30	human sweat ducts cardiac myocytes 3t3 fibroblasts hi 5 insect cells inhibitors pp2a increase cftr channel activity 14 16 18 19
0.41414222.16239222.html.plaintext.txt	31	likewise pp2b inhibitors stimulate cftr nih 3t3 fibroblasts 17
0.41414222.16239222.html.plaintext.txt	32	however contribution pp2a pp2b cftr deactivation may vary different cell types 15 20
0.41414222.16239222.html.plaintext.txt	33	baby hamster kidney cells pp2c co immunoprecipitates exogenously expressed cftr 20
0.41414222.16239222.html.plaintext.txt	34	additionally pp2c overexpression fischer rat thyroid cells decreases cftr chloride conductance 15
0.41414222.16239222.html.plaintext.txt	35	however ability endogenous pp2c regulate cftr native epithelial tissues unclear since pp2c inhibitors identified
0.41414222.16239222.html.plaintext.txt	36	date single phosphatase demonstrated necessary sufficient completely regulate cftr channel activity suggesting cftr dephosphorylated multiple phosphatases
0.41414222.16239222.html.plaintext.txt	37	present evidence direct interaction cftr serinethreonine phosphatase pp2a
0.41414222.16239222.html.plaintext.txt	38	interaction involves cooh terminus cftr pp2a b regulatory subunit
0.41414222.16239222.html.plaintext.txt	39	pp2a localizes apical cell surface negatively regulates cftr channel activity calu 3 cells intact mouse jejunum
0.41414222.16239222.html.plaintext.txt	40	furthermore inhibition pp2a increases airway surface liquid primary human bronchial epithelial hbe cells mechanism requiring cftr channel activity
0.41414222.16239222.html.plaintext.txt	41	conclude pp2a indeed relevant cftr phosphatase epithelial tissues
0.41414222.16239222.html.plaintext.txt	42	experimental procedures top abstract introduction experimental procedures results discussion references cell culture immunofluorescence calu 3 cells maintained described previously 21
0.41414222.16239222.html.plaintext.txt	43	human airway epithelial cells obtained freshly excised bronchial specimens normal subjects protease digestion seeded directly primary cultures 12 mm transwell col membranes col costar modified begm media ali conditions studied fully differentiated 3 5 weeks
0.41414222.16239222.html.plaintext.txt	44	cultures transepithelial resistances rt 300 ohms cm2 studied
0.41414222.16239222.html.plaintext.txt	45	immunofluorescence confocal microscopy performed described previously using anti pp2a subunit antibodies 22
0.41414222.16239222.html.plaintext.txt	46	monoclonal anti catalytic subunit monoclonal anti regulatory subunit polyclonal anti b subunit acquired upstate20biotechnologyupstate biotechnology inc
0.41414222.16239222.html.plaintext.txt	47	affinity purification cftr interacting proteins peptides corresponding residues 1375 1401 1411 1441 1451 1476 1471 1480 human cftr synthesized n terminal biotin tag genemed synthesis resuspended 50 mm tris cl ph 7
0.41414222.16239222.html.plaintext.txt	48	20 nmol peptides immobilized 100 microl streptavidin agarose sigma incubated calu 3 cell lysates
0.41414222.16239222.html.plaintext.txt	49	lysates prepared incubating twenty 100 mm dishes calu 3 cells binding buffer 50 mm tris cl 150 mm nacl 0
0.41414222.16239222.html.plaintext.txt	50	2 chaps protease roche applied science phosphatase sigma inhibitor mixtures 4 degrees c 1 h
0.41414222.16239222.html.plaintext.txt	51	following ultracentrifugation soluble fraction precleared empty streptavidin beads incubated cftr peptides conjugated streptavidin beads 1 h
0.41414222.16239222.html.plaintext.txt	52	bound fractions washed extensively binding buffer eluted 5 formic acid lyophilized
0.41414222.16239222.html.plaintext.txt	53	prior ms analysis protein samples reduced alkylated digested proteomics grade trypsin sigma
0.41414222.16239222.html.plaintext.txt	54	peptides analyzed liquid chromatography msms q tof micro waters manchester uk
0.41414222.16239222.html.plaintext.txt	55	data acquired using masslynx 4
0.41414222.16239222.html.plaintext.txt	56	0 software processed using proteinlynx module
0.41414222.16239222.html.plaintext.txt	57	processed data searched updated ncbinr sprot data bases using mascot search engine
0.41414222.16239222.html.plaintext.txt	58	mascot probability based mowse individual ion scores 46 accepted indicating identity extensive homology p 0
0.41414222.16239222.html.plaintext.txt	59	msms spectrum scores 20 45 examined individually acceptance criteria parent fragment ion masses within calibrated tolerance limits spectrum contained extended series consecutive y b ions
0.41414222.16239222.html.plaintext.txt	60	small scale experiments analyzed western blot performed using lysates two 100 mm dishes calu 3 cells 2 nmol cftr peptide
0.41414222.16239222.html.plaintext.txt	61	vitro binding assays binding assays performed described previously several exceptions 21 23
0.41414222.16239222.html.plaintext.txt	62	briefly cdna sequence human pp2a b subunit amplified pcr cloned bamhi xhoi sites pet 28c novagen madison wi
0.41414222.16239222.html.plaintext.txt	63	recombinant b subunit produced either rabbit reticulocyte lysates promega madison wi bl21 escherichia coli stratagene la jolla ca
0.41414222.16239222.html.plaintext.txt	64	reticulocyte lysates pp2a b subunit purified using ni2 nitrilotriacetic acid beads qiagen binding buffer 50 mm tris cl ph 7
0.41414222.16239222.html.plaintext.txt	65	remove reticulocyte proteins co purify b subunit beads washed three times binding buffer plus 2 m urea followed three washes binding buffer
0.41414222.16239222.html.plaintext.txt	66	b subunit eluted binding buffer plus 10 mm edta
0.41414222.16239222.html.plaintext.txt	67	bacterially expression b subunit performed previously described 24
0.41414222.16239222.html.plaintext.txt	68	purified pp2a core dimer consisting catalytic regulatory subunit obtained promega madison wi
0.41414222.16239222.html.plaintext.txt	69	purified proteins incubated indicated cftr peptides immobilized streptavidin beads binding buffer plus 0
0.41414222.16239222.html.plaintext.txt	70	2 bovine serum albumin 1 h 4 degrees c
0.41414222.16239222.html.plaintext.txt	71	following extensive washing bound proteins eluted resolved sds page analyzed western blot phosphorimaging analysis
0.41414222.16239222.html.plaintext.txt	72	co immunoprecipitation phosphatase assays calu 3 cells scraped hypotonic lysis buffer 150 mm tris cl 10 mm nacl protease inhibitors physically disrupted dounce homogenization ice
0.41414222.16239222.html.plaintext.txt	73	lysates centrifuged 500 x g 10 min remove nuclei unbroken cells
0.41414222.16239222.html.plaintext.txt	74	supernatant subsequently centrifuged 100000 x g 1 h pellet cell membranes
0.41414222.16239222.html.plaintext.txt	75	membranes resuspended binding buffer 1 h ice
0.41414222.16239222.html.plaintext.txt	76	cftr immunoprecipitated using cftr 596 antibodies gift dr
0.41414222.16239222.html.plaintext.txt	77	riordan university north carolina chapel hill nc isotype matched control antibodies covalently conjugated protein g dynabeads
0.41414222.16239222.html.plaintext.txt	78	bound proteins washed extensively analyzed western blot using specific antibodies pp2a subunits phosphatase activity using pp2a immunoprecipitation phosphatase assay kit upstate20biotechnologyupstate biotechnology
0.41414222.16239222.html.plaintext.txt	79	cftr currents outside membrane patches calu 3 cells procedures essentially described previously 6
0.41414222.16239222.html.plaintext.txt	80	briefly cftr cl channel activity recorded membrane potential 30 mv 6 8 megaohm resistance open pipette
0.41414222.16239222.html.plaintext.txt	81	pipette bath solutions described previously 6
0.41414222.16239222.html.plaintext.txt	82	cftr channel activity recorded digitally pclamp software 300 following patch excision
0.41414222.16239222.html.plaintext.txt	83	pp2a inhibitors protein kinase inhibitor included pipette solution indicated
0.41414222.16239222.html.plaintext.txt	84	cftr currents mouse jejunum details approach described previously 25 26
0.41414222.16239222.html.plaintext.txt	85	briefly sections midportion mouse jejunum studied short circuit current isc conditions 90 min recording
0.41414222.16239222.html.plaintext.txt	86	constant voltage pulse 1 5 mv 1 duration applied tissue every minute physiologic instruments san diego ca
0.41414222.16239222.html.plaintext.txt	87	potential difference resistance calculated ohms law changes isc response voltage pulse
0.41414222.16239222.html.plaintext.txt	88	tissues treated 100 microm endothall vehicle
0.41414222.16239222.html.plaintext.txt	89	confocal microscopy measurement periciliary liquid pcl technique described detail 27
0.41414222.16239222.html.plaintext.txt	90	briefly phosphate buffered saline 20 microl containing 2 mgml texas red dextran 10 kda molecular probes inc
0.41414222.16239222.html.plaintext.txt	91	eugene benzamil 10 4 m added cultured bronchial epithelium excess aspirated bring pcl height 7 microm
0.41414222.16239222.html.plaintext.txt	92	cftr specific inhibitor cftrinh172 also included noted concentration 10 5 m
0.41414222.16239222.html.plaintext.txt	93	measure average height pcl five predetermined points one central four 2 mm edge culture xz scanned previously described 27
0.41414222.16239222.html.plaintext.txt	94	studies perfluorocarbon added mucosally prevent evaporation pcl culture placed stage confocal microscope serosal reservoir 80 microl tes buffered ringer
0.41414222.16239222.html.plaintext.txt	95	okadaic acid added apical surface dry powder perfluorocarbon 5 microg okadaic acid25 ml perfluorocarboncm2 culture
0.41414222.16239222.html.plaintext.txt	96	perfluorocarbon effect pcl height ion transport previously described 27
0.41414222.16239222.html.plaintext.txt	97	results top abstract introduction experimental procedures results discussion references pp2a physically associates cooh terminus cftr cooh terminus cftr mediates protein protein interactions pdz proteins 7 28 30 adaptor protein ap 2 31 amp kinase 12 regulate cell surface stability membrane trafficking channel activity
0.41414222.16239222.html.plaintext.txt	98	present study asked whether highly conserved cftr cooh terminus interact additional proteins regulate channel function
0.41414222.16239222.html.plaintext.txt	99	chose focus last 25 amino acids cftr encompassing residues 1451 1476 precede include pdz binding motif
0.41414222.16239222.html.plaintext.txt	100	previous studies suggest region important cftr trafficking channel activity 32 however protein interactions reported
0.41414222.16239222.html.plaintext.txt	101	immobilized biotinylated cftr 1451 1476 peptides streptavidin agarose beads incubated peptides cell lysates prepared calu 3 cells eluted bound proteins formic acid
0.41414222.16239222.html.plaintext.txt	102	using nanoliquid chromatography msms identified serinethreonine protein phosphatase pp2a associated cftr 1451 1476
0.41414222.16239222.html.plaintext.txt	103	pp2a dephosphorylates cftr vitro decreases channel activity multiple cell systems 14 16 18 19
0.41414222.16239222.html.plaintext.txt	104	33 also identified interaction regulatory domain cftr pp2a suggesting pp2a anchoring cftr may involve multiple contacts
0.41414222.16239222.html.plaintext.txt	105	view larger version 31k figure 1
0.41414222.16239222.html.plaintext.txt	106	ms analysis pp2a subunits associated cftr cooh terminus
0.41414222.16239222.html.plaintext.txt	107	table pp2a subunit peptides identified msms analysis calu 3 cell proteins associated cftr 1451 1476
0.41414222.16239222.html.plaintext.txt	108	b example msms spectrum used specifically identify b subunit
0.41414222.16239222.html.plaintext.txt	109	y ions corresponding amino acids labeled spectrum
0.41414222.16239222.html.plaintext.txt	110	pp2a major cellular phosphatase regulates many protein targets
0.41414222.16239222.html.plaintext.txt	111	pp2a functions heterotrimeric complex composed catalytic subunit two regulatory subunits b 34
0.41414222.16239222.html.plaintext.txt	112	specificity pp2a determined unique combination regulatory subunits associated catalytic subunit
0.41414222.16239222.html.plaintext.txt	113	regulatory subunit encoded one two genes 86 identical
0.41414222.16239222.html.plaintext.txt	114	regulatory subunit tightly associated catalytic subunit functions scaffold recruit b regulatory subunit
0.41414222.16239222.html.plaintext.txt	115	b regulatory subunit highly divergent comparison pp2a subunits
0.41414222.16239222.html.plaintext.txt	116	b regulatory subunit divided b b b b families encoded least 14 different genes produce many five splice variants
0.41414222.16239222.html.plaintext.txt	117	diversity regulatory subunits gives rise 75 distinct pp2a enzymes
0.41414222.16239222.html.plaintext.txt	118	mass spectrometry observe peptides three pp2a subunits fig
0.41414222.16239222.html.plaintext.txt	119	importantly msms spectra provide amino acid sequence information allowed us precisely identify pp2a regulatory subunits associated cftr 1451 1476 b fig
0.41414222.16239222.html.plaintext.txt	120	western blot confirmed pp2a catalytic regulatory b regulatory subunits associate cftr 1451 1476 cftr c terminal peptides fig
0.41414222.16239222.html.plaintext.txt	121	furthermore pp2a subunits also co precipitate endogenous cftr calu 3 cell membranes fig
0.41414222.16239222.html.plaintext.txt	122	2b consistent interaction vivo
0.41414222.16239222.html.plaintext.txt	123	pp2a b subunit structurally unrelated b family co purify cftr 1451 1476 co immunoprecipitate endogenous cftr
0.41414222.16239222.html.plaintext.txt	124	addition asked whether pp2a phosphatase activity purified full length cftr
0.41414222.16239222.html.plaintext.txt	125	cftr immunoprecipitates assayed pp2a using colorimetric phosphatase assay
0.41414222.16239222.html.plaintext.txt	126	find pp2a like activity specifically co precipitates cftr igg control fig
0.41414222.16239222.html.plaintext.txt	127	characteristic pp2a phosphatase activity inhibited 1 microm okadaic acid 1 microm endothall potent inhibitors pp2a ic50 0
0.41414222.16239222.html.plaintext.txt	128	although okadaic acid endothall also inhibit pp1 ic50 10 nm 5 microm respectively previous studies found evidence support ability pp1 physically associate cftr dephosphorylate cftr vitro regulate channel activity 13 18 20
0.41414222.16239222.html.plaintext.txt	129	although pp2c shown associated cftr baby hamster kidney cells assay buffer contain mg2 required pp2c activity
0.41414222.16239222.html.plaintext.txt	130	taken together data suggest phosphatase activity associated cftr pp2a
0.41414222.16239222.html.plaintext.txt	131	view larger version 35k figure 2
0.41414222.16239222.html.plaintext.txt	132	pp2a heterotrimer co purifies cftr
0.41414222.16239222.html.plaintext.txt	133	biotinylated cftr peptides immobilized streptavidin beads incubated calu 3 cell lysates
0.41414222.16239222.html.plaintext.txt	134	bound proteins resolved sds page analyzed western blot using antibodies pp2a catalytic regulatory b regulatory b regulatory subunits
0.41414222.16239222.html.plaintext.txt	135	b c calu 3 cell lysates incubated either anti cftr monoclonal antibodies isotype matched mouse igg covalently coupled protein g dynabeads
0.41414222.16239222.html.plaintext.txt	136	beads extensively washed analyzed western blot using specific pp2a subunit antibodies b assayed serinethreonine phosphatase activity using upstate20biotechnologyupstate biotechnology phosphatase assay kit c
0.41414222.16239222.html.plaintext.txt	137	determine contribution pp2a total phosphatase activity pp2a inhibitors okadaic acid endothall added phosphatase assay n 4 condition
0.41414222.16239222.html.plaintext.txt	138	data represent mean values n 5 plus minus
0.41414222.16239222.html.plaintext.txt	139	ip immunoprecipitation ib immunoblotting
0.41414222.16239222.html.plaintext.txt	140	pp2a b subunit binds directly cooh terminus cftr clear multiple phosphatases regulate cftr channel activity
0.41414222.16239222.html.plaintext.txt	141	however degree pp2a contributes regulation varies different functional assays cell systems
0.41414222.16239222.html.plaintext.txt	142	given diversity pp2a enzymes intrigued possibility b regulatory subunit may part account differences
0.41414222.16239222.html.plaintext.txt	143	therefore asked whether pp2a b subunit could interact directly cftr
0.41414222.16239222.html.plaintext.txt	144	find pp2a b subunit expressed purified reticulocyte lysates binds cftr 1451 1476 cftr c terminal peptides fig
0.41414222.16239222.html.plaintext.txt	145	nherf 1 previously shown interact extreme cooh terminus cftr enriched cftr 1471 1480 peptide demonstrating specificity assay fig
0.41414222.16239222.html.plaintext.txt	146	although find catalytic subunit associated purified b subunit reticulocyte lysates data shown cannot rule possibility subunits present low levels may influencing binding cftr 1451 1476
0.41414222.16239222.html.plaintext.txt	147	using bacterially expressed purified b subunit observe direct dose dependent binding cftr 1451 1476 fig
0.41414222.16239222.html.plaintext.txt	148	furthermore also find core pp2a dimer composed catalytic regulatory subunit bind cftr 1451 1476 unless b subunit present fig
0.41414222.16239222.html.plaintext.txt	149	whereas clear whether b subunit alone necessary sufficient targeting pp2a cftr data suggest b subunit may play critical role binding specificity
0.41414222.16239222.html.plaintext.txt	150	pp2a localizes apical cell surface airway epithelia pp2a physiologically relevant cftr phosphatase reasoned subcellular localization partially overlap cftr
0.41414222.16239222.html.plaintext.txt	151	given large number pp2a substrates expect ubiquitously expressed catalytic tightly coupled regulatory subunits broad cellular distribution
0.41414222.16239222.html.plaintext.txt	152	however specific b regulatory subunits target pp2a enzyme distinct subcellular compartments restricted localization
0.41414222.16239222.html.plaintext.txt	153	using pan b antibody recognizes five gene products examined localization pp2a human airway
0.41414222.16239222.html.plaintext.txt	154	b subunits exhibit broad subcellular distribution human airway fig
0.41414222.16239222.html.plaintext.txt	155	find b staining strongly localizes apical membrane ciliated cells superficial epithelia gland ducts consistent localization cftr tissues
0.41414222.16239222.html.plaintext.txt	156	although cannot unambiguously attribute apical localization b subunit likely staining reflects distribution one combination cytosolic b subunits b b b b 35
0.41414222.16239222.html.plaintext.txt	157	addition observe staining perinuclear membranes nuclear speckles consistent observation b b localize nucleus 35 36
0.41414222.16239222.html.plaintext.txt	158	view larger version 20k figure 3
0.41414222.16239222.html.plaintext.txt	159	b subunit directly interacts cftr 1451 1476
0.41414222.16239222.html.plaintext.txt	160	indicated cftr cooh terminal peptides immobilized incubated radiolabeled b subunit nherf 1
0.41414222.16239222.html.plaintext.txt	161	bound fraction separated sds page analyzed phosphorimaging analysis
0.41414222.16239222.html.plaintext.txt	162	b 2 microm cftr 1411 1441 cftr 1451 1476 immbolized incubated bacterially expressed b subunit indicated concentrations
0.41414222.16239222.html.plaintext.txt	163	bound proteins washed analyzed western blot using pan b antibody
0.41414222.16239222.html.plaintext.txt	164	c immobilized cftr 1411 1441 cftr 1451 1476 incubated purified pp2a core dimer 0
0.41414222.16239222.html.plaintext.txt	165	05 units without b 1 microg
0.41414222.16239222.html.plaintext.txt	166	samples analyzed western blot using pp2a subunit antibodies
0.41414222.16239222.html.plaintext.txt	167	view larger version 99k figure 4
0.41414222.16239222.html.plaintext.txt	168	pp2a b regulatory subunit localizes apical compartment ciliated airway cells
0.41414222.16239222.html.plaintext.txt	169	shown representative images pp2a b regulatory subunit localization gland ducts superficial epithelium human airway
0.41414222.16239222.html.plaintext.txt	170	confocal images acquired four channels independent laser sources left differential interference contrast dic nuclear staining 46 diamidino 2 phenylindole blue center actin cytoskeleton rhodamine phalloidin red right pp2a b subunit family green
0.41414222.16239222.html.plaintext.txt	171	arrowheads indicate regions apical staining
0.41414222.16239222.html.plaintext.txt	172	bottom panel shows igg controls sections superficial epithelium
0.41414222.16239222.html.plaintext.txt	173	expected pp2a catalytic regulatory subunits broadly localized airway epithelia data shown clearly localized apical cell surface ciliated cells
0.41414222.16239222.html.plaintext.txt	174	antibodies directed catalytic regulatory subunits detect gene products subunit
0.41414222.16239222.html.plaintext.txt	175	thus antibodies label every pp2a molecule expect give broad distribution cell types
0.41414222.16239222.html.plaintext.txt	176	whereas pan b antibody detects five distinct gene products still represents one four families highly divergent pp2a b regulatory subunit
0.41414222.16239222.html.plaintext.txt	177	accordingly staining pattern b subunit exhibits restricted distribution including apical cell surface
0.41414222.16239222.html.plaintext.txt	178	localization data support biochemical evidence vivo interaction cftr pp2a
0.41414222.16239222.html.plaintext.txt	179	furthermore pp2a subunits concentrated apical cell surface suggesting potential role regulating channel activity cftr plasma membrane
0.41414222.16239222.html.plaintext.txt	180	pp2a inhibition prevents cftr rundown excised patches previous work results others consistent membrane localization camp signaling machinery regulates cftr
0.41414222.16239222.html.plaintext.txt	181	excised membrane patches endogenous pka activity activates cftr exogenous camp added excess membrane associated adenylate cyclase activated receptors 6 9
0.41414222.16239222.html.plaintext.txt	182	patch preparations cftr channel activity reflects phosphorylation status channel regulated balance pka endogenous phosphatases 6 18 37
0.41414222.16239222.html.plaintext.txt	183	consequently cftr channel gating increased conditions pka activity elevated increased camp inhibition phosphodiesterases 1 10
0.41414222.16239222.html.plaintext.txt	184	hypothesize rundown cftr activity following excision results shift balance endogenous pka phosphatase activities
0.41414222.16239222.html.plaintext.txt	185	based biochemical analyses demonstrating physical association cftr pp2a tested hypothesis examining cftr rundown excised patches control conditions presence pp2a inhibitors
0.41414222.16239222.html.plaintext.txt	186	compared average pipette current first 30 outside recordings average pipette current measured 270 300 performed previous studies 38
0.41414222.16239222.html.plaintext.txt	187	control conditions pipette solution contained atp gtp conditions allow cftr gating reflect activity endogenous pka 6
0.41414222.16239222.html.plaintext.txt	188	furthermore current flow patch mediated cl traversing cftr since channel events observed pipette current near zero protein kinase inhibitor 100 nm pipette 0
0.41414222.16239222.html.plaintext.txt	189	conditions cftr activity declines variably 5 min 0
0.41414222.16239222.html.plaintext.txt	190	however presence pp2a inhibitors okadaic acid endothall pipette prevented channel rundown 0
0.41414222.16239222.html.plaintext.txt	191	88 respectively n 10 treatment fig
0.41414222.16239222.html.plaintext.txt	192	although endothall okadaic acid inhibit pp2a potently also inhibit phosphatases pp1 pp4 pp5 39 40
0.41414222.16239222.html.plaintext.txt	193	therefore also tested specific inhibitor i2pp2a inhibit pp1 pp2b pp2c 41 42
0.41414222.16239222.html.plaintext.txt	194	similar endothall okadaic acid i2pp2a 1
0.41414222.16239222.html.plaintext.txt	195	7 microm also prevented cftr channel rundown 1
0.41414222.16239222.html.plaintext.txt	196	view larger version 32k figure 5
0.41414222.16239222.html.plaintext.txt	197	pp2a inhibitors functionally regulate cftr
0.41414222.16239222.html.plaintext.txt	198	b basal cftr currents measured apical patches generated calu 3 cells outside configuration
0.41414222.16239222.html.plaintext.txt	199	patches recorded control conditions outlined experimental procedures
0.41414222.16239222.html.plaintext.txt	200	indicated patches prepared presence okadaic acid oa 3 nm endothall 1 microm i2pp2a 1
0.41414222.16239222.html.plaintext.txt	201	representative traces condition shown
0.41414222.16239222.html.plaintext.txt	202	endothall i2pp2a traces expanded x axis clearly show discrete single channel events
0.41414222.16239222.html.plaintext.txt	203	b summary patch clamp data calu 3 cells
0.41414222.16239222.html.plaintext.txt	204	isc values treatment compared isc 0 test p 0
0.41414222.16239222.html.plaintext.txt	205	005 compared isc control samples test p 0
0.41414222.16239222.html.plaintext.txt	206	017 bonferronis post hoc relative control p 0
0.41414222.16239222.html.plaintext.txt	207	c cftr currents measured intact mouse jejunum ussing chambers described previously
0.41414222.16239222.html.plaintext.txt	208	tissues treated endothall 100 microm vehicle duration recording
0.41414222.16239222.html.plaintext.txt	209	isc represented change cftr chloride currents time 0 versus 90 min
0.41414222.16239222.html.plaintext.txt	210	data represent mean values n 4 plus minus
0.41414222.16239222.html.plaintext.txt	211	view larger version 14k figure 6
0.41414222.16239222.html.plaintext.txt	212	pp2a inhibition increases pcl height primary human airway cultures
0.41414222.16239222.html.plaintext.txt	213	pcl height assessed primary cultures human bronchial epithelia cells treated vehicle phosphate buffered saline okadaic acid oa5 microg25 ml perfluorocarboncm2 culture presence absence cftr inhibitor 172 10 5 m 10 min
0.41414222.16239222.html.plaintext.txt	214	pcl labeled texas red dextran height measured confocal microscopy
0.41414222.16239222.html.plaintext.txt	215	representative images taken time 0 10 min condition shown
0.41414222.16239222.html.plaintext.txt	216	b summary confocal data represented percentage change pcl height time 0 versus 10 min indicated treatments
0.41414222.16239222.html.plaintext.txt	217	data represent mean values n 6 conditions exception n 7 okadaic acid plus minus
0.41414222.16239222.html.plaintext.txt	218	treatments compared controls mann whitney u test p 0
0.41414222.16239222.html.plaintext.txt	219	pp2a inhibitors prevent cftr rundown intact epithelium consistent observation cftr pp2a physically interact effect pp2a inhibitors cftr excised patches suggests pp2a present patches therefore compartmentalized close proximity cftr
0.41414222.16239222.html.plaintext.txt	220	furthermore inhibitor data demonstrate endogenous pp2a regulate cftr channel activity
0.41414222.16239222.html.plaintext.txt	221	results strongly suggest pp2a functions relevant cftr phosphatase epithelial tissues
0.41414222.16239222.html.plaintext.txt	222	also tested whether pp2a inhibitors altered basal cftr activity intact epithelium
0.41414222.16239222.html.plaintext.txt	223	measured basal short circuit chloride currents freshly excised sections mouse jejunum ussing chamber experiments
0.41414222.16239222.html.plaintext.txt	224	previous studies demonstrated cftr constitutes major chloride channel preparations since jejunum cftr mice exhibit significant chloride conductance 43
0.41414222.16239222.html.plaintext.txt	225	find course control experiments basal cftr activity declined time isc 9
0.41414222.16239222.html.plaintext.txt	226	agreement patch clamp data find pp2a inhibitor endothall 100 microm prevented rundown cftr activity resulting increased chloride conductance course 90 min recording isc 12
0.41414222.16239222.html.plaintext.txt	227	inhibition pp2a increases airway surface liquid height airway epithelial cells regulate composition thin layer pcl critical innate host defense
0.41414222.16239222.html.plaintext.txt	228	cf lung disease pcl volume depleted reflecting imbalance solute transport across epithelium 44 47
0.41414222.16239222.html.plaintext.txt	229	ultimately pcl depletion results defective mucociliary clearance supports bacterial colonization exposes individuals life threatening infections 27 44 48
0.41414222.16239222.html.plaintext.txt	230	previous studies demonstrated cftr mediates majority pcl secretion plays fundamental role maintaining basal pcl volume 36 49
0.41414222.16239222.html.plaintext.txt	231	therefore asked whether inhibition pp2a would increase cftr activity thereby increase pcl levels primary hbe cultures
0.41414222.16239222.html.plaintext.txt	232	pcl labeled florescent dextran previously described 27
0.41414222.16239222.html.plaintext.txt	233	pcl height measured immediately 10 min indicated treatments
0.41414222.16239222.html.plaintext.txt	234	vehicle treatment significantly change pcl height fig
0.41414222.16239222.html.plaintext.txt	235	however cultures treated okadaic acid exhibited 30 increase pcl height pcl 2
0.41414222.16239222.html.plaintext.txt	236	pp2a inhibition likely influence activities many cellular proteins asked whether cftr required increase pcl
0.41414222.16239222.html.plaintext.txt	237	consistent previous data demonstrating importance cftr pcl secretion find cftr inhibitor cftrinh172 causes pcl height decrease 30 pcl 3
0.41414222.16239222.html.plaintext.txt	238	furthermore presence cftrinh172 okadaic acid similar cftrinh172 alone pcl 2
0.41414222.16239222.html.plaintext.txt	239	thus inhibition pp2a okadaic acid increases pcl height mechanism requires cftr
0.41414222.16239222.html.plaintext.txt	240	results consistent biochemical electrophysiological studies demonstrating cftr physically functionally associated pp2a epithelial tissues
0.41414222.16239222.html.plaintext.txt	241	discussion top abstract introduction experimental procedures results discussion references compartmentalization signaling machinery downstream effectors ensures specificity fidelity signal transduction response extracellular stimuli
0.41414222.16239222.html.plaintext.txt	242	previously demonstrated cftr localized close proximity regulatory proteins vivo including adenosine receptor adenylate cyclases pka phosphodiesterases 6 9 10
0.41414222.16239222.html.plaintext.txt	243	addition many signaling proteins regulate cftr activity including pka 7 9 protein kinase c 11 pp2c 20 amp kinase 12 shown organized multi protein complexes directly associated cftr
0.41414222.16239222.html.plaintext.txt	244	data present study add model demonstrating phosphatase pp2a physically functionally linked cftr
0.41414222.16239222.html.plaintext.txt	245	regulation cftr phosphatases extensively studied
0.41414222.16239222.html.plaintext.txt	246	whereas clear work many laboratories multiple phosphatases affect cftr channel activity specificity regulation poorly understood
0.41414222.16239222.html.plaintext.txt	247	identified pp2a biochemical screen proteins associate residues 1451 1476 cftr cooh terminus
0.41414222.16239222.html.plaintext.txt	248	power approach illustrated fact unambiguously identified exact pp2a regulatory subunits associated cftr mass spectrometry b
0.41414222.16239222.html.plaintext.txt	249	date least 21 distinct pp2a regulatory subunits identified 2 regulatory 19 b regulatory subunits review see ref
0.41414222.16239222.html.plaintext.txt	250	importantly unique combination regulatory subunits governs enzymatic activity substrate specificity localization pp2a enzymes 35 51
0.41414222.16239222.html.plaintext.txt	251	thus identification exact subunits associated cftr provides insight specificity cftr channel regulation phosphatases
0.41414222.16239222.html.plaintext.txt	252	using purified proteins find divergent b subunit interacts directly cftr 1451 1476 required binding catalytic regulatory subunits
0.41414222.16239222.html.plaintext.txt	253	data suggest b subunit may target pp2a enzyme cftr
0.41414222.16239222.html.plaintext.txt	254	intriguing speculate expression b subunit may account differences ability pp2a regulate cftr channel activity different cell types tissues
0.41414222.16239222.html.plaintext.txt	255	many cftr phosphatase studies utilized heterologous expression systems chinese hamster ovary cells 13 baby hamster kidney cells 20 hi 5 insect cells 19 may may express relevant cftr phosphatases subunits 13 19 20
0.41414222.16239222.html.plaintext.txt	256	unable ask whether pp2a b subunit expressed cell types reverse transcription pcr since insufficient sequence information available time
0.41414222.16239222.html.plaintext.txt	257	however expression specific pp2a subunits cells important consideration future experiments
0.41414222.16239222.html.plaintext.txt	258	33 reported interaction cftr pp2a involves direct binding ubiquitously expressed pp2a regulatory subunit cftr regulatory domain
0.41414222.16239222.html.plaintext.txt	259	demonstrate specificity cftra interaction vastiau et al
0.41414222.16239222.html.plaintext.txt	260	33 showed overexpressed heat repeats 1 10 cause decrease cftr rundown presumably due disruption acftr interaction
0.41414222.16239222.html.plaintext.txt	261	however pp2a b subunits also bind heat repeats 1 10 subunit would dislodged phosphatase complex 52 53
0.41414222.16239222.html.plaintext.txt	262	thus assays observed decrease cftr rundown could attributed disruption interaction cftr pp2a b regulatory subunits
0.41414222.16239222.html.plaintext.txt	263	nonetheless anchoring pp2a cftr chloride channel may involve multiple sites interaction mediated pp2a b subunits
0.41414222.16239222.html.plaintext.txt	264	previous studies demonstrated clear role pp2a deactivation rundown cftr native sweat ducts cardiac myocytes baby hamster kidney cells 3t3 fibroblasts hi 5 cells 14 16 18 19
0.41414222.16239222.html.plaintext.txt	265	however importance pp2a cftr regulation epithelial tissues seems variable
0.41414222.16239222.html.plaintext.txt	266	thus chose study physical functional association cftr pp2a airway epithelia
0.41414222.16239222.html.plaintext.txt	267	indeed found cftr pp2a interacted calu 3 cells pp2a catalytic regulatory b regulatory subunits specifically co precipitate endogenous cftr fig
0.41414222.16239222.html.plaintext.txt	268	additionally examined localization pp2a subunits human airway
0.41414222.16239222.html.plaintext.txt	269	fact pp2a regulates cftr channel activity epithelial tissues would expect phosphatase present apical cell surface consistent localization cftr
0.41414222.16239222.html.plaintext.txt	270	ubiquitously expressed pp2a catalytic subunit regulatory subunit diffuse staining pattern clearly included apical membrane superficial epithelium data shown
0.41414222.16239222.html.plaintext.txt	271	alternatively staining pan b regulatory subunit antibody showed restricted distribution including strong staining apical plasma membrane fig
0.41414222.16239222.html.plaintext.txt	272	thus pp2a subunits associated cftr present apical cell surface cftr functions
0.41414222.16239222.html.plaintext.txt	273	since available b antibodies detect family members cannot rule possibility b subunits b may also associate cftr localize apical surface airway epithelia
0.41414222.16239222.html.plaintext.txt	274	54 identified interaction chk2 pp2a b subunit found highly similar b family members b b b b also able bind chk2 vitro
0.41414222.16239222.html.plaintext.txt	275	consequently pp2a b regulatory subunits may interact cftr
0.41414222.16239222.html.plaintext.txt	276	however find association cftr structurally unrelated b regulatory family member b pr55a pull fig
0.41414222.16239222.html.plaintext.txt	277	2a immunoprecipitation fig
0.41414222.16239222.html.plaintext.txt	278	thus pp2a molecules associated cftr least appear specific b family
0.41414222.16239222.html.plaintext.txt	279	found cftr pp2a functionally associated airway intestinal epithelial cells
0.41414222.16239222.html.plaintext.txt	280	presence pp2a inhibitors cftr rundown blocked outside membrane patches calu 3 cells intact mouse jejunum fig
0.41414222.16239222.html.plaintext.txt	281	consistent biochemical observations presence pp2a membrane patches containing cftr strongly suggests proteins closely compartmentalized
0.41414222.16239222.html.plaintext.txt	282	furthermore data suggest pp2a relevant cftr phosphatase epithelial tissues agreement vastiau et al
0.41414222.16239222.html.plaintext.txt	283	33 found addition okadaic acid caco 2 epithelial cells delayed channel rundown following forskolin treatment
0.41414222.16239222.html.plaintext.txt	284	t84 airway epithelial cells pp2a inhibitors block rundown cftr following maximal activation forskolin 15 20
0.41414222.16239222.html.plaintext.txt	285	major difference data data studies chose measure effect pp2a inhibitors basal cftr currents opposed cftr currents following maximal activation forskolin pka
0.41414222.16239222.html.plaintext.txt	286	possible endogenous pp2a plays role regulating basal cftr currents phosphatases contribute deactivation hyperphosphorylated cftr
0.41414222.16239222.html.plaintext.txt	287	future studies needed address relative contribution different phosphatases regulation cftr channel activity epithelial tissues
0.41414222.16239222.html.plaintext.txt	288	airways mucus layer provides defensive barrier traps clears bacteria noxious particles airways 44 47
0.41414222.16239222.html.plaintext.txt	289	underlying pcl provides low viscosity fluid facilitates ciliary beating mucus clearance 12 55 56
0.41414222.16239222.html.plaintext.txt	290	based inhibitor studies cftr demonstrated play central role maintenance basal pcl height 36 49
0.41414222.16239222.html.plaintext.txt	291	furthermore loss cftr function results decreased pcl height increased viscosity
0.41414222.16239222.html.plaintext.txt	292	fact pp2a relevant cftr phosphatase airway epithelia reasoned inhibition pp2a increase cftr chloride conductance ultimately increase pcl height primary hbe cultures
0.41414222.16239222.html.plaintext.txt	293	find inhibition pp2a addition okadaic acid primary hbe cultures produces 30 increase pcl height consistent increase cftr activity fig
0.41414222.16239222.html.plaintext.txt	294	additionally cftr channel activity blocked cftrinh172 okadaic acid significant effect pcl
0.41414222.16239222.html.plaintext.txt	295	thus okadaic acid treatment increases pcl height cftr dependent mechanism consistent hypothesis cftr compartmentalized regulated pp2a epithelial tissues
0.41414222.16239222.html.plaintext.txt	296	addition regulating channel activity dephosphorylating cftr pp2a may also important mediating signaling trafficking events cftr
0.41414222.16239222.html.plaintext.txt	297	example amp activated protein kinase directly binds cftr negatively regulates channel activity also directly interact pp2a via regulatory subunit 12 56
0.41414222.16239222.html.plaintext.txt	298	moreover direct interaction cftr amp activated protein kinase mapped cftr residues 1420 1457 adjacent residues observe pp2a binding residues 1451 1476 12
0.41414222.16239222.html.plaintext.txt	299	interesting speculate pp2a amp activated protein kinase may function stabilize others interactions cftr may compete binding cftr cooh terminus
0.41414222.16239222.html.plaintext.txt	300	summary establish cftr physically functionally associated pp2a
0.41414222.16239222.html.plaintext.txt	301	data demonstrate pp2a directly interacts cftr via b regulatory subunit
0.41414222.16239222.html.plaintext.txt	302	furthermore provide first evidence pp2a regulates cftr airway epithelia major tissue affected cf
0.41414222.16239222.html.plaintext.txt	303	finally demonstrate inhibition pp2a well differentiated hbe cultures increases pcl height
0.41414222.16239222.html.plaintext.txt	304	decreased pcl underlies basic defect airway clearance observed cf patients data suggest pp2a may useful therapeutic target cf
0.41414222.16239222.html.plaintext.txt	305	footnotes work supported american heart association grant 0315363u w
0.41414222.16239222.html.plaintext.txt	306	cystic fibrosis foundation national institutes health grants hl34422 m
0.41414222.16239222.html.plaintext.txt	307	costs publication article defrayed part payment page charges
0.41414222.16239222.html.plaintext.txt	308	article must therefore hereby marked advertisement accordance 18 u
0.41414222.16239222.html.plaintext.txt	309	section 1734 solely indicate fact
0.41414222.16239222.html.plaintext.txt	310	1 correspondence addressed dept
0.41414222.16239222.html.plaintext.txt	311	cell developmental biology university north carolina chapel hill 506 taylor hall chapel hill nc 27599
0.41414222.16239222.html.plaintext.txt	312	919 966 9792 fax 919 966 1856 e mail milgatmed
0.41414222.16239222.html.plaintext.txt	313	2 abbreviations used cf cystic fibrosis cftr cystic fibrosis transmembrane conductance regulator pka camp dependent protein kinase akap kinase anchoring protein hbe human bronchial epithelial ms mass spectrometry tes 2 2 hydroxy 11 bishydroxymethylethylaminoethanesulfonic acid pcl periciliary liquid
0.41414222.16239222.html.plaintext.txt	314	acknowledgments thank
0.41414222.16239222.html.plaintext.txt	315	rogers excellent technical assistance
0.41414222.16239222.html.plaintext.txt	316	references top abstract introduction experimental procedures results discussion references cheng
0.41414222.16239222.html.plaintext.txt	317	1991 cell 66 1027 1036crossrefmedline order article via infotrieve seibert f
0.41414222.16239222.html.plaintext.txt	318	270 2158 2162abstractfree full text chang x
0.41414222.16239222.html.plaintext.txt	319	268 11304 11311abstractfree full text gadsby d
0.41414222.16239222.html.plaintext.txt	320	1 77 107abstractfree full text ameen n
0.41414222.16239222.html.plaintext.txt	321	98 14120 14125abstractfree full text sun f
0.41414222.16239222.html.plaintext.txt	322	275 29539 29546abstractfree full text sun f
0.41414222.16239222.html.plaintext.txt	323	275 14360 14366abstractfree full text huang p
0.41414222.16239222.html.plaintext.txt	324	280 7997 8003abstractfree full text liedtke c
0.41414222.16239222.html.plaintext.txt	325	277 22925 22933abstractfree full text hallows k
0.41414222.16239222.html.plaintext.txt	326	105 1711 1721abstractfree full text luo j
0.41414222.16239222.html.plaintext.txt	327	274 c1397 c1410medline order article via infotrieve hwang
0.41414222.16239222.html.plaintext.txt	328	101 629 650abstract travis
0.41414222.16239222.html.plaintext.txt	329	94 11055 11060abstractfree full text reddy m
0.41414222.16239222.html.plaintext.txt	330	270 c474 c480medline order article via infotrieve fischer h
0.41414222.16239222.html.plaintext.txt	331	436 175 181crossrefmedline order article via infotrieve berger h
0.41414222.16239222.html.plaintext.txt	332	268 2037 2047abstractfree full text yang
0.41414222.16239222.html.plaintext.txt	333	272 c142 c155medline order article via infotrieve zhu
0.41414222.16239222.html.plaintext.txt	334	274 29102 29107abstractfree full text mohler p
0.41414222.16239222.html.plaintext.txt	335	147 879 890abstractfree full text kreda
0.41414222.16239222.html.plaintext.txt	336	cell 16 2154 2167abstractfree full text scott r
0.41414222.16239222.html.plaintext.txt	337	277 22934 22941abstractfree full text smith f
0.41414222.16239222.html.plaintext.txt	338	274 19894 19900abstractfree full text grubb b
0.41414222.16239222.html.plaintext.txt	339	268 g505 g513medline order article via infotrieve grubb b
0.41414222.16239222.html.plaintext.txt	340	70 525 535medline order article via infotrieve tarran r
0.41414222.16239222.html.plaintext.txt	341	cell 8 149 158crossrefmedline order article via infotrieve cheng j
0.41414222.16239222.html.plaintext.txt	342	277 3520 3529abstractfree full text short d
0.41414222.16239222.html.plaintext.txt	343	273 19797 19801abstractfree full text wang
0.41414222.16239222.html.plaintext.txt	344	2000 cell 103 169 179crossrefmedline order article via infotrieve weixel k
0.41414222.16239222.html.plaintext.txt	345	275 3655 3660abstractfree full text ostedgaard l
0.41414222.16239222.html.plaintext.txt	346	100 1937 1942abstractfree full text vastiau
0.41414222.16239222.html.plaintext.txt	347	579 3392 3396crossrefmedline order article via infotrieve janssens v
0.41414222.16239222.html.plaintext.txt	348	353 417 439crossrefmedline order article via infotrieve mccright b
0.41414222.16239222.html.plaintext.txt	349	271 22081 22089abstractfree full text tarran r
0.41414222.16239222.html.plaintext.txt	350	280 35751 35759abstractfree full text tabcharani j
0.41414222.16239222.html.plaintext.txt	351	1991 nature 352 628 631crossrefmedline order article via infotrieve berger h
0.41414222.16239222.html.plaintext.txt	352	88 1422 1431medline order article via infotrieve brewis n
0.41414222.16239222.html.plaintext.txt	353	12 987 996abstract becker w
0.41414222.16239222.html.plaintext.txt	354	269 22586 22592abstractfree full text li m
0.41414222.16239222.html.plaintext.txt	355	1995 biochemistry 34 1988 1996crossrefmedline order article via infotrieve li m
0.41414222.16239222.html.plaintext.txt	356	271 11059 11062abstractfree full text clarke l
0.41414222.16239222.html.plaintext.txt	357	1992 science 257 1125 1128medline order article via infotrieve guggino w
0.41414222.16239222.html.plaintext.txt	358	7 888 889crossrefmedline order article via infotrieve verkman
0.41414222.16239222.html.plaintext.txt	359	109 571 577free full text wine j
0.41414222.16239222.html.plaintext.txt	360	103 309 312free full text matsui h
0.41414222.16239222.html.plaintext.txt	361	102 1125 1131abstractfree full text tarran r
0.41414222.16239222.html.plaintext.txt	362	120 407 418abstractfree full text ma
0.41414222.16239222.html.plaintext.txt	363	110 1651 1658abstractfree full text tehrani m
0.41414222.16239222.html.plaintext.txt	364	271 5164 5170abstractfree full text ruediger r
0.41414222.16239222.html.plaintext.txt	365	68 123 129abstract ruediger r
0.41414222.16239222.html.plaintext.txt	366	12 4872 4882abstract dozier c
0.41414222.16239222.html.plaintext.txt	367	cell 96 509 517crossrefmedline order article via infotrieve matsui h
0.41414222.16239222.html.plaintext.txt	368	1998 cell 95 1005 1015crossrefmedline order article via infotrieve gimeno alcaniz j
0.41414222.16239222.html.plaintext.txt	369	333 201 209crossrefmedline order article via infotrieve article abstract full text pdf versions article 2805041512 recent m507308200v1 purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles thelin w
0.41414222.16239222.html.plaintext.txt	370	pubmed pubmed citation articles thelin w
0.41414222.16239222.html.plaintext.txt	371	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright 2005 american society biochemistry molecular biology
0.43387523.10893256.html.plaintext.txt	0	role cytoplasmic segments sec61 ribosome binding translocation promoting activities sec61 complex david radena weiqun songa reid gilmorea department biochemistry molecular biology university massachusetts medical school worcester massachusetts 01655 0103
0.43387523.10893256.html.plaintext.txt	1	correspondence reid gilmore department biochemistry molecular biology university massachusetts medical school 55 lake avenue north worcester ma 01655 0103
0.43387523.10893256.html.plaintext.txt	2	tel508 856 5894 fax508 856 6231 e mailreid
0.43387523.10893256.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	4	sec61 complex performs dual function protein translocation across rer serving high affinity ribosome receptor translocation channel
0.43387523.10893256.html.plaintext.txt	5	define regions sec61 complex involved ribosome binding translocation promotion ribosome stripped microsomes subjected limited digestions using proteases different cleavage specificities
0.43387523.10893256.html.plaintext.txt	6	protein immunoblot analysis using antibodies specific nh2 cooh terminus sec61 used map location proteolysis cleavage sites
0.43387523.10893256.html.plaintext.txt	7	observed striking correlation loss binding activity nontranslating ribosomes digestion cooh terminal tail cytoplasmic loop 8 sec61
0.43387523.10893256.html.plaintext.txt	8	proteolyzed microsomes assayed srp independent translocation activity determine whether high affinity binding ribosome sec61 complex prerequisite nascent chain transport
0.43387523.10893256.html.plaintext.txt	9	microsomes bind nontranslating ribosomes physiological ionic strength remain active srp independent translocation indicating ribosome binding translocation promotion activities sec61 complex strictly correlate
0.43387523.10893256.html.plaintext.txt	10	translocation promoting activity severely inhibited cleavage cytosolic loop 6 indicating segment critical determinant function sec61 complex
0.43387523.10893256.html.plaintext.txt	11	key words endoplasmic reticulum protein targeting protein translocation translocon structure protein topology
0.43387523.10893256.html.plaintext.txt	12	introduction top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	13	proteins translocated across integrated er cotranslationally recognized 54 kd subunit signal recognition particle srp1 nh2 terminal signal sequence emerges exit site large ribosomal subunit review see walter johnson 1994
0.43387523.10893256.html.plaintext.txt	14	targeting srp ribosome nascent chain complex rer mediated interaction srp srp receptor sr heterodimeric gtpase localized rer
0.43387523.10893256.html.plaintext.txt	15	gtpase cycle involving srp54 sr initiates release signal sequence srp results attachment ribosome nascent chain complex rnc translocation channel connolly gilmore 1989 rapiejko gilmore 1997
0.43387523.10893256.html.plaintext.txt	16	nascent polypeptide subsequently transported across er membrane protein lined aqueous pore membrane gilmore blobel 1985 simon blobel 1991 crowley et al
0.43387523.10893256.html.plaintext.txt	17	central core protein translocation channel sec61 complex heterotrimeric integral membrane protein consisting sec61 sec61ss sec61 gorlich et al
0.43387523.10893256.html.plaintext.txt	18	1992 gorlich rapoport 1993
0.43387523.10893256.html.plaintext.txt	19	sec61 complex oligomerizes within plane membrane form quasi pentagonal 85 100 ring surrounding 20 40 pore hanein et al
0.43387523.10893256.html.plaintext.txt	20	nascent polypeptides thought traverse membrane via central pore sec61 oligomer proteins undergoing transport continuous contact sec61 ribosome nascent chain complex engages translocation channel mothes et al
0.43387523.10893256.html.plaintext.txt	21	10 transmembrane tm segments saccharomyces cerevisiae sec61 tm2 tm7 targets photoreactive cross linking agents nascent prepro factor chain targeted yeast sec complex plath et al
0.43387523.10893256.html.plaintext.txt	22	addition serving conduit nascent polypeptide transport across rer sec61 complex functions high affinity ribosome receptor gorlich et al
0.43387523.10893256.html.plaintext.txt	23	ultrastructural studies complexes
0.43387523.10893256.html.plaintext.txt	24	cerevisiae ribosome sec61 complex revealed exit site nascent polypeptide large ribosomal subunit aligned translocation channel single point contact sec61 oligomer ribosome beckmann et al
0.43387523.10893256.html.plaintext.txt	25	known segments sec61 responsible high affinity binding ribosome translocation channel certain sec61ss sec61 contribute affinity ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	26	ribosome nascent chain complexes bind unoccupied sec61 complexes srp independent reaction thought driven affinity ribosome sec61 complex jungnickel rapoport 1995 lauring et al
0.43387523.10893256.html.plaintext.txt	27	1995a raden gilmore 1998
0.43387523.10893256.html.plaintext.txt	28	artificial targeting reaction readily observed elongation arrested rncs incubated ribosome stripped microsomes contain excess sec61 complexes relative added rncs 80s ribosomes
0.43387523.10893256.html.plaintext.txt	29	although srp independent binding rncs sec61 complex signal sequence dependent lauring et al
0.43387523.10893256.html.plaintext.txt	30	1995b subsequent transport polypeptides targeted mechanism greatly facilitated recognition signal sequence sec61 jungnickel rapoport 1995
0.43387523.10893256.html.plaintext.txt	31	signal sequence recognition activity sec61 complex may provide proofreading mechanism enhance fidelity protein translocation across rer
0.43387523.10893256.html.plaintext.txt	32	used limited proteolysis sever cytoplasmically exposed segments rer membrane proteins
0.43387523.10893256.html.plaintext.txt	33	protease digested microsomes assayed srp independent translocation activity ability bind nontranslating ribosomes ribosome nascent chain complexes determine cytoplasmic segments sec61 complex contribute various functions sec61 complex
0.43387523.10893256.html.plaintext.txt	34	obtained evidence srp independent translocation obligatorily dependent upon high affinity binding ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	35	cytoplasmic segments sec61 complex important high affinity ribosome binding map cooh terminal cytoplasmic segments sec61
0.43387523.10893256.html.plaintext.txt	36	materials methods top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	37	preparation rough microsomes rm srp sr fragment protease digested pk rm rough microsomes rm srp isolated canine pancreas described walter et al
0.43387523.10893256.html.plaintext.txt	38	52 kd sr fragment prepared described previously nicchitta blobel 1989
0.43387523.10893256.html.plaintext.txt	39	puromycin high salt extracted rough microsomes pk rm prepared rm described previously raden gilmore 1998 except pk rm washed centrifugation rather twice 50 mm triethanolamine acetate ph 7
0.43387523.10893256.html.plaintext.txt	40	5 tea 600 mm potassium acetate 12 mm magnesium acetate 1 mm dtt 1 mm edta
0.43387523.10893256.html.plaintext.txt	41	pk rm resuspended membrane buffer 50 mm tea 250 mm sucrose 1 mm dtt concentration 2 eq microl eq defined walter et al
0.43387523.10893256.html.plaintext.txt	42	aliquots pk rm 500 microl digested concentration 2 eq microl 1 h
0.43387523.10893256.html.plaintext.txt	43	trypsin 0 30 microgml chymotrypsin 0 200 microgml digestions done ice terminated 1 mm pmsf followed 15 min incubation ice adjustment 10 microgml aprotinin
0.43387523.10893256.html.plaintext.txt	44	digestion endoproteinase glu c 200 microgml 1 h 37 degrees c terminated 1 mm 34 dichloroisocoumarin
0.43387523.10893256.html.plaintext.txt	45	thermolysin digestions 0 50 microgml done presence 1 mm cacl2 either 25 degrees c ice terminated addition 2 mm edta
0.43387523.10893256.html.plaintext.txt	46	protease digested pk rm adjusted 550 mm potassium acetate centrifuged 30 min 100000 g beckman type 50 rotor
0.43387523.10893256.html.plaintext.txt	47	membranes resuspended concentration 0
0.43387523.10893256.html.plaintext.txt	48	1 eq microl membrane buffer centrifuged 30 min 100000 g beckman type 50 rotor
0.43387523.10893256.html.plaintext.txt	49	repeating preceding resuspension centrifugation steps protease digested pk rm adjusted concentration 1 eq microl membrane buffer stored 80 degrees c
0.43387523.10893256.html.plaintext.txt	50	isolation ribosomes 125i labeling ribosomes ribosomes isolated wheat germ cytosol raden gilmore 1998 canine rm collins gilmore 1991 described previously
0.43387523.10893256.html.plaintext.txt	51	canine ribosomes resuspended tkmd 50 mm tea 150 mm potassium acetate 5 mm magnesium acetate 1 mm dtt applied 13 ml 10 30 sucrose gradient tkmd centrifuged 4 h 200000 gav sw40 rotor
0.43387523.10893256.html.plaintext.txt	52	ribosomes collected using density gradient fractionator isco quantified using extinction coefficient 260 nm e 6
0.43387523.10893256.html.plaintext.txt	53	canine ribosomes labeled iodine 125 incubating 26 pmol ribosomes 450 microci 125i bolton hunter reagent amersham pharmacia biotech 2 h ice
0.43387523.10893256.html.plaintext.txt	54	radiolabeling terminated adjusting sample 10 mm tris cl ph 7
0.43387523.10893256.html.plaintext.txt	55	125i labeled ribosomes separated unincorporated radiolabel centrifugation 5 20 sucrose gradient 50 mm tris cl ph 7
0.43387523.10893256.html.plaintext.txt	56	5 mm mgcl2 sw40 rotor 3 h 200000 gav
0.43387523.10893256.html.plaintext.txt	57	glycerol gradient centrifugation superose 12 chromatography 20 eq protease digested pk rm mixed 180 microl detergent high salt buffer obtain following final conditions 20 mm tris cl ph 7
0.43387523.10893256.html.plaintext.txt	58	4 500 mm nacl 1 mm mgcl2 1 mm mncl2 1 mm dtt 1x pic protease inhibitor cocktail defined walter et al
0.43387523.10893256.html.plaintext.txt	59	20 min incubation ice detergent extracts clarified centrifugation 5 min 30 psi airfuge
0.43387523.10893256.html.plaintext.txt	60	150 microl sample clarified detergent extract applied 5 ml 8 30 glycerol gradient 20 mm tris cl ph 7
0.43387523.10893256.html.plaintext.txt	61	4 500 mm nacl 1 mm mgcl2 1 mm mncl2 1 mm dtt 1x pic 0
0.43387523.10893256.html.plaintext.txt	62	125 digitonin 25 microgml egg yolk phosphatidylcholine
0.43387523.10893256.html.plaintext.txt	63	gradients centrifuged 18 h 85000 gav sw50
0.43387523.10893256.html.plaintext.txt	64	1 rotor separated 13 15 fractions using density gradient fractionator isco
0.43387523.10893256.html.plaintext.txt	65	clarified detergent extracts applied 23
0.43387523.10893256.html.plaintext.txt	66	6 ml superose 12 column equilibrated 20 mm tris cl ph 7
0.43387523.10893256.html.plaintext.txt	67	4 150 mm nacl 1 mm mgcl2 1 mm mncl2 1 mm dtt 1x pic 0
0.43387523.10893256.html.plaintext.txt	68	125 digitonin 25 microgml egg yolk phosphatidylcholine
0.43387523.10893256.html.plaintext.txt	69	5 ml collected column eluted equilibration buffer
0.43387523.10893256.html.plaintext.txt	70	ribosome binding assays protease digested pk rm ribosome binding assays performed mixing constant amount 125i labeled ribosomes typically 0
0.43387523.10893256.html.plaintext.txt	71	7 pmol unlabeled canine ribosomes
0.43387523.10893256.html.plaintext.txt	72	ribosomes incubated tx pk rm cx pk rm vx pk rm thx pk rm 20 min ice tkmd
0.43387523.10893256.html.plaintext.txt	73	30 microl sample applied 1
0.43387523.10893256.html.plaintext.txt	74	3 ml sepharose cl 2b column equilibrated tkmd
0.43387523.10893256.html.plaintext.txt	75	column eluted 270 microl tkmd followed 1
0.43387523.10893256.html.plaintext.txt	76	5 ml 50 mm tea 500 mm potassium acetate 5 mm magnesium acetate 1 mm dtt
0.43387523.10893256.html.plaintext.txt	77	ionic strength elution buffer raised reduce nonspecific absorption unbound ribosomes sepharose beads
0.43387523.10893256.html.plaintext.txt	78	100 microl fractions eluate collected amount 125i labeled ribosomes fraction determined using beckman counter
0.43387523.10893256.html.plaintext.txt	79	elution positions membrane bound ribosomes 0
0.43387523.10893256.html.plaintext.txt	80	5 ml determined control experiments wherein 125i labeled ribosomes fractionated incubation presence absence pk rm
0.43387523.10893256.html.plaintext.txt	81	binding data fit following equation using nonlinear least squares program rb bm rfkd rf rb rf concentrations bound free ribosomes respectively bm number binding sites kd dissociation constant
0.43387523.10893256.html.plaintext.txt	82	srp dependent srp independent translocation assays full length mrna encoding preprolactin ppl truncated mrnas encoding nh2 terminal 86 residues preprolactin ppl86 nh2 terminal 77 residues firefly luciferase ffluc77 isolated preparative scale transcriptions described previously rapiejko gilmore 1994
0.43387523.10893256.html.plaintext.txt	83	srp dependent translocation preprolactin assayed using 25 microl reticulocyte lysate translations contained 35smethionine endogenous srp 1
0.43387523.10893256.html.plaintext.txt	84	2 eq protease digested pk rm 200 fmol sr 52 kd fragment
0.43387523.10893256.html.plaintext.txt	85	translocated prolactin resolved preprolactin page sds
0.43387523.10893256.html.plaintext.txt	86	assay srp independent translocation truncated ppl86 mrna transcript translated 25 degrees c 15 min wheat germ system contained 35smethionine described previously gilmore et al
0.43387523.10893256.html.plaintext.txt	87	protein synthesis blocked adding cycloheximide final concentration 250 microm
0.43387523.10893256.html.plaintext.txt	88	translation products 10 microl unless stated otherwise incubated protease digested pk rm 10 eq unless specified otherwise 5 min 25 degrees c
0.43387523.10893256.html.plaintext.txt	89	translocation ppl86 induced releasing peptidyl trna ribosome incubation 25 mm edta 10 min 25 degrees c connolly et al
0.43387523.10893256.html.plaintext.txt	90	1989 raden gilmore 1998
0.43387523.10893256.html.plaintext.txt	91	assays prepared sds page previously described connolly et al
0.43387523.10893256.html.plaintext.txt	92	1989 subjected electrophoresis using tris tricine gels schagger von jagow 1987
0.43387523.10893256.html.plaintext.txt	93	percent translocation ppl86 calculated quantification pl56 ppl86 using following formula percent translocation 100 x 1
0.43387523.10893256.html.plaintext.txt	94	33 corrects loss nh2 terminal methionine residue ppl86 upon signal sequence cleavage
0.43387523.10893256.html.plaintext.txt	95	binding rncs bearing 35s labeled ppl86 protease digested pk rm assayed centrifugal flotation discontinuous sucrose gradients previously described lauring et al
0.43387523.10893256.html.plaintext.txt	96	1995b gel filtration chromatography sepharose cl 2b columns described separate membrane bound rncs unbound rncs
0.43387523.10893256.html.plaintext.txt	97	percentage rncs membrane bound quantified phosphorimager ppl86 fraction resolved sds page using tris tricine gels
0.43387523.10893256.html.plaintext.txt	98	insertion ppl86 sec61 translocation channel assayed resistance 1 h digestion ice 400 microgml proteinase k previously described connolly et al
0.43387523.10893256.html.plaintext.txt	99	protein immunoblots procedure protein immunoblots using enhanced chemiluminescence described raden gilmore 1998
0.43387523.10893256.html.plaintext.txt	100	multiple film exposures obtained insure ecl signal linear respect quantity antigen
0.43387523.10893256.html.plaintext.txt	101	western blots quantified fluor multi imager bio rad laboratories multi analyst software
0.43387523.10893256.html.plaintext.txt	102	mouse mabs specific ribophorin srss provided dr
0.43387523.10893256.html.plaintext.txt	103	gert kreibich nyu school medicine new york ny dr
0.43387523.10893256.html.plaintext.txt	104	peter walter university california san francisco san francisco ca respectively
0.43387523.10893256.html.plaintext.txt	105	rabbit antisera raised nh2 terminus sec61 sec61ss provided dr
0.43387523.10893256.html.plaintext.txt	106	christopher nicchitta duke university medical center durham nc dr
0.43387523.10893256.html.plaintext.txt	107	tom rapoport harvard university cambridge ma respectively
0.43387523.10893256.html.plaintext.txt	108	antibody raised rabbits cooh terminus sec61 keqsevgsmgallf using standard procedures
0.43387523.10893256.html.plaintext.txt	109	results top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	110	sensitivity sec61 proteolysis sec61 integrated er topology places four loops l2 l4 l6 l8 plus nh2 cooh terminal tails cytoplasmic face membrane fig 1
0.43387523.10893256.html.plaintext.txt	111	ss subunits sec61 complex integrated single tm spans located near cooh terminus
0.43387523.10893256.html.plaintext.txt	112	membrane bound ribosomes effectively block access proteases sec61 lesser extent sec61ss kalies et al
0.43387523.10893256.html.plaintext.txt	113	ribosome stripped microsomes pk rm digested proteases sever cytoplasmic segments sec61 complex
0.43387523.10893256.html.plaintext.txt	114	trypsin chymotrypsin endoproteinase glu c thermolysin digested pk rm designated respectively tx pk rm cx pk rm vx pk rm thx pk rm subscript x denotes concentration protease microgml used digestion
0.43387523.10893256.html.plaintext.txt	115	protein immunoblot analysis using antibodies specific nh2 cooh terminal tails sec61 used determine cytoplasmic segments sec61 accessible proteases
0.43387523.10893256.html.plaintext.txt	116	protease cleavage sites sec61 mapped cytoplasmic loops 6 8 comparison cooh terminal sec61 truncation products song et al
0.43387523.10893256.html.plaintext.txt	117	amino acid sequences cytoplasmic segments sec61 complex shown fig 1 b together potential cleavage sites trypsin chymotrypsin endoproteinase glu c
0.43387523.10893256.html.plaintext.txt	118	although cytoplasmic segment sec61 contains predicted cleavage sites least two proteases tested observed remarkable difference sensitivity regions protease digestion fig 1 b
0.43387523.10893256.html.plaintext.txt	119	loop 8 cooh terminus protease sensitive regions sec61 followed loop 6
0.43387523.10893256.html.plaintext.txt	120	nh2 terminal tail proposed amphipathic helix aligned membrane surface wilkinson et al
0.43387523.10893256.html.plaintext.txt	121	1996 far less sensitive digestion
0.43387523.10893256.html.plaintext.txt	122	loops 2 4 completely resistant proteases conditions tested
0.43387523.10893256.html.plaintext.txt	123	view larger version 25k figure 1
0.43387523.10893256.html.plaintext.txt	124	predicted membrane topology sec61 complex
0.43387523.10893256.html.plaintext.txt	125	topology diagrams sec61 sec61ss sec61 adapted shown previous publications gorlich et al
0.43387523.10893256.html.plaintext.txt	126	diagrams show relative predicted sizes cytosolic lumenal tails loops
0.43387523.10893256.html.plaintext.txt	127	sec61 segments used antigens production anti nh2 anti cooh terminal antibodies labeled
0.43387523.10893256.html.plaintext.txt	128	b amino acid sequences nh2 cooh terminal domains cytosolic loops sec61 sec61ss sec61 shown
0.43387523.10893256.html.plaintext.txt	129	potential protease cleavage sites indicated bold trypsin italics endoproteinase glu c underlining chymotrypsin
0.43387523.10893256.html.plaintext.txt	130	digestion sec61 sec61ss sec61 pk rm proteases summarized chart right
0.43387523.10893256.html.plaintext.txt	131	trypsin chymotrypsin subscript indicates minimum concentration protease tested yielded 50 digestion given segment see materials methods protease concentrations
0.43387523.10893256.html.plaintext.txt	132	additional symbols designate following lack detectable cleavage less 50 cleavage plus minus 50 cleavage digestion completion
0.43387523.10893256.html.plaintext.txt	133	oligomeric stability protease digested sec61 complex visualized electron microscopy purified sec61 complex forms oligomers composed three four sec61 heterotrimers hanein et al
0.43387523.10893256.html.plaintext.txt	134	assaying protease digested pk rm sec61 dependent translocation ribosome binding activities important determine whether oligomeric state channel altered protease digestion
0.43387523.10893256.html.plaintext.txt	135	sedimentation velocity measurements protein detergent complexes used distinguish monomeric oligomeric forms integral membrane proteins copeland et al
0.43387523.10893256.html.plaintext.txt	136	1986 doms helenius 1986 hebert carruthers 1991
0.43387523.10893256.html.plaintext.txt	137	undigested protease digested pk rm solubilized nonionic detergent digitonin sedimentation velocity intact protease digested sec61 complexes could compared using digitonin high salt glycerol gradients fig 2
0.43387523.10893256.html.plaintext.txt	138	undigested t0 pk rm membranes analyzed protein immunoblot analysis showed sec61 resolved srss e subunit 100 kd srp receptor ribophorin f subunit oligosaccharyltransferase ost
0.43387523.10893256.html.plaintext.txt	139	expected sec61ss b sec61 shown cosedimented sec61
0.43387523.10893256.html.plaintext.txt	140	ost serves useful internal sedimentation marker peak 9 11 11s corresponding protein molecular mass 300 kd kelleher gilmore 1997
0.43387523.10893256.html.plaintext.txt	141	less rapid sedimentation sec61 fractions 6 9 relative ost would consistent sec61 oligomer composed three four 70 kd sec61 heterotrimers
0.43387523.10893256.html.plaintext.txt	142	sec61 subunits severed loop 8 l8ntf loop 6 l6ntf cosedimented precisely intact sec61 t1 pk rm analyzed fig 2 c
0.43387523.10893256.html.plaintext.txt	143	sedimentation rate sec61 also altered quantitative cleavage sec61 loops 6 8 cooh terminus trypsin d
0.43387523.10893256.html.plaintext.txt	144	intact sec61 complex solubilized triton x 100 resolved digitonin high salt glycerol gradient sec61ss h sedimented far less rapidly well resolved sec61 g
0.43387523.10893256.html.plaintext.txt	145	resolution sec61 sec61ss consistent triton x 100 induced dissociation sec61 oligomer individual subunits
0.43387523.10893256.html.plaintext.txt	146	sec61 accounts 75 protein molecular mass sec61 complex triton x 100 treated sec61 subunit provides approximate sedimentation marker sec61 heterotrimer
0.43387523.10893256.html.plaintext.txt	147	aliquots intact protease digested sec61 complexes mixed glycerol gradient centrifugation fig 2 b
0.43387523.10893256.html.plaintext.txt	148	intact sec61 subunits derived undigested pk rm cosedimented nh2 terminal 22 kd fragment derived c50 pk rm th25 pk rm b
0.43387523.10893256.html.plaintext.txt	149	observed protease digested sec61 complexes well resolved triton x 100 treated sec61 c
0.43387523.10893256.html.plaintext.txt	150	view larger version 17k figure 2
0.43387523.10893256.html.plaintext.txt	151	oligomeric structure protease digested sec61 complex
0.43387523.10893256.html.plaintext.txt	152	glycerol gradient centrifugation digitonin high salt extracts tx pk rm f triton x 100 high salt extracts t0 pk rm g h
0.43387523.10893256.html.plaintext.txt	153	following samples analyzed b e h t0 pk rm c t1 pk rm d t20 pk rm
0.43387523.10893256.html.plaintext.txt	154	b glycerol gradient centrifugation detergent high salt extracts following samples t0 pk rm mixed c50 pk rm b t0 pk rm mixed th25 pk rm c t0 pk rm
0.43387523.10893256.html.plaintext.txt	155	protease digested pk rm solubilized digitonin high salt buffer b triton x 100 high salt buffer c
0.43387523.10893256.html.plaintext.txt	156	b detergent extracts analyzed digitonin high salt glycerol gradients
0.43387523.10893256.html.plaintext.txt	157	c superose 12 chromatography digitonin high salt extracts tx pk rm
0.43387523.10893256.html.plaintext.txt	158	following samples analyzed t0 pk rm b t1 pk rm c t7 pk rm d t20 pk rm
0.43387523.10893256.html.plaintext.txt	159	aliquots solubilized tx pk rm l c fraction glycerol gradients b selected fractions superose 12 columns c analyzed protein immunoblots using antibodies nh2 terminus sec61 samples except b e f h sec61ss b h srss e ribophorin f
0.43387523.10893256.html.plaintext.txt	160	l8ntf l6ntf designate nh2 terminal fragments sec61 severed cytoplasmic loops 8 6 respectively
0.43387523.10893256.html.plaintext.txt	161	dissociation translocation channel sec61 heterotrimers would result simultaneous decrease mass alteration shape
0.43387523.10893256.html.plaintext.txt	162	insure compensatory shape change mask conversion oligomeric ring heterotrimers analyzed intact protease digested sec61 complexes gel filtration chromatography digitonin high salt buffer fig 2 c
0.43387523.10893256.html.plaintext.txt	163	detergent solubilized sec61 complexes undigested membranes sample eluted fractions nh2 terminal fragments sec61 derived trypsin digestion loops 6 8 samples b d indicating stokes radius particle altered
0.43387523.10893256.html.plaintext.txt	164	taken together glycerol gradient centrifugation data gel filtration chromatography experiments demonstrate sec61 oligomer dissociate heterotrimers isolated subunits sec61 severed cytoplasmic loops 6 8 cooh terminus
0.43387523.10893256.html.plaintext.txt	165	ribosome binding abrogated proteolysis sec61 defined segments sec61 complex susceptible protease digestion shown sec61 oligomers remain intact assayed protease digested pk rm ribosome binding activity investigate role cytoplasmic domains sec61 complex
0.43387523.10893256.html.plaintext.txt	166	ribosome binding protease digested pk rm assayed incubating membranes fixed amount 125i labeled ribosomes increasing amounts unlabeled ribosomes fig 3
0.43387523.10893256.html.plaintext.txt	167	physiological ionic strength buffer 150 mm potassium acetates used assays minimize nonspecific binding ribosomes rer membrane proteins kalies et al
0.43387523.10893256.html.plaintext.txt	168	nonlinear least squares analysis binding data indicated undigested pk rm bind 0
0.43387523.10893256.html.plaintext.txt	169	36 pmol ribosomeseq binding affinity kd 18 nm value comparable previous reports kalies et al
0.43387523.10893256.html.plaintext.txt	170	ribosome binding data c0 pk rm c1 pk rm c5 pk rm c30 pk rm graphically displayed scatchard plots fig 3
0.43387523.10893256.html.plaintext.txt	171	notably number ribosome binding sites per eq cx pk rm x intercept value substantially reduced proteolysis microsomes
0.43387523.10893256.html.plaintext.txt	172	slope scatchard plot negative reciprocal binding affinity kd
0.43387523.10893256.html.plaintext.txt	173	observation scatchard plots linear rather curved indicates proteolysis sec61 complex lead mixed population high affinity low affinity ribosome binding sites
0.43387523.10893256.html.plaintext.txt	174	roughly parallel slopes scatchard plots reveals residual binding sites present protease digested pk rm binding affinity significantly lower less twofold sites detected undigested pk rm
0.43387523.10893256.html.plaintext.txt	175	compared number ribosome binding siteseq protease digested pk rm percentage intact sec61 chymotrypsin digested pk rm fig 3 b
0.43387523.10893256.html.plaintext.txt	176	inhibition ribosome binding activity chymotrypsin digestion correlated quite well digestion sec61
0.43387523.10893256.html.plaintext.txt	177	reduction ribosome binding activity observed c1 pk rm particular interest low concentrations chymotrypsin sever sec61 uniquely within cytoplasmic loop 8 yielding nh2 terminal fragment l8ntf cooh terminal fragment l8ctf fig 3 c
0.43387523.10893256.html.plaintext.txt	178	extensive digestion pk rm e
0.43387523.10893256.html.plaintext.txt	179	c30 pk rm cleaves sec61 within loops 6 8 causes loss cooh terminal immunoreactivity
0.43387523.10893256.html.plaintext.txt	180	view larger version 33k figure 3
0.43387523.10893256.html.plaintext.txt	181	ribosome binding trypsin chymotrypsin digested pk rm
0.43387523.10893256.html.plaintext.txt	182	b d aliquots 5 eq cx pk rm tx pk rm incubated 0
0.43387523.10893256.html.plaintext.txt	183	18 pmol 125i labeled canine ribosomes 0
0.43387523.10893256.html.plaintext.txt	184	5 pmol unlabeled ribosomes 50 mm tea 150 mm potassium acetate 5 mm magnesium acetate 1 mm dtt tkmd
0.43387523.10893256.html.plaintext.txt	185	membrane bound ribosomes separated unbound ribosomes gel filtration chromatography described materials methods
0.43387523.10893256.html.plaintext.txt	186	ribosome binding affinity number ribosome binding sites per eq protease digested pk rm calculated described materials methods
0.43387523.10893256.html.plaintext.txt	187	results displayed scatchard plots c0 pk rm squares c1 pk rm circles c5 pk rm triangles c30 pk rm open squares
0.43387523.10893256.html.plaintext.txt	188	ribosome binding activities cx pk rm b tx pk rm d expressed percentage triangles displayed undigested pk rm 360 fmoleq
0.43387523.10893256.html.plaintext.txt	189	percentage intact sec61 squares tx pk rm cx pk rm quantified scanning protein immunoblots
0.43387523.10893256.html.plaintext.txt	190	aliquots tx pk rm shown cx pk rm c subjected protein immunoblot analysis using antibodies specific nh2 terminus cooh terminus sec61 respectively designated sec61n sec61c
0.43387523.10893256.html.plaintext.txt	191	l8ntf l6ntf designate nh2 terminal fragments sec61 severed cytoplasmic loops 8 6 respectively l8ctf designates cooh terminal fragment sec61 severed loop 8
0.43387523.10893256.html.plaintext.txt	192	number ribosome binding sites reduced fourfold 55 sec61 digested t1 pk rm fig 3 d
0.43387523.10893256.html.plaintext.txt	193	conceivably dramatic effect trypsin digestion ribosome binding activity sec61 complex could explained liberation cytoplasmic sec61 segments crucial ribosome binding
0.43387523.10893256.html.plaintext.txt	194	one limitation mapping protease cleavage sites protein immunoblot analysis cannot determine whether sec61 subunits single multiple cleavage sites within loops 6 8
0.43387523.10893256.html.plaintext.txt	195	two cleavages within single loop would release soluble tryptic peptide
0.43387523.10893256.html.plaintext.txt	196	v200 pk rm bind ribosomes shown
0.43387523.10893256.html.plaintext.txt	197	previous studies predated identification sec61 complex ribosome receptor shown trypsin digestion ribosome stripped microsomes inhibits subsequent rebinding 80s ribosomes borgese et al
0.43387523.10893256.html.plaintext.txt	198	earlier studies ribosome binding membranes assayed low ionic strength conditions permit ribosome binding p180 protein savitz meyer 1990 savitz meyer 1993 well sec61 complex kalies et al
0.43387523.10893256.html.plaintext.txt	199	p180 sensitive trypsin digestion kalies et al
0.43387523.10893256.html.plaintext.txt	200	1994 reasoned tx pk rm could assayed ribosome binding activity hypotonic buffers 50 mm tris cl ph 7
0.43387523.10893256.html.plaintext.txt	201	5 25 mm kcl 5 mm mgcl2 without interference p180
0.43387523.10893256.html.plaintext.txt	202	t5 pk rm lack intact sec61 bind ribosomes hypotonic buffer shown
0.43387523.10893256.html.plaintext.txt	203	latter result confirms previous reports concerning trypsin sensitivity ribosome binding sites mammalian rer borgese et al
0.43387523.10893256.html.plaintext.txt	204	rnc interactions protease digested sec61 complexes two distinct interactions thought responsible attachment rnc rer adelman et al
0.43387523.10893256.html.plaintext.txt	205	1973 gilmore blobel 1985
0.43387523.10893256.html.plaintext.txt	206	one interaction ionic strength sensitive binding ribosome sec61 complex kalies et al
0.43387523.10893256.html.plaintext.txt	207	1994 assayed preceding experiments
0.43387523.10893256.html.plaintext.txt	208	unlike nontranslating ribosomes readily detached microsomes 0
0.43387523.10893256.html.plaintext.txt	209	5 m potassium acetate rncs remain tightly bound membrane high salt gilmore blobel 1985
0.43387523.10893256.html.plaintext.txt	210	ionic strength insensitive interaction rnc membrane dependent upon presence nascent polypeptide occurs upon signal sequence insertion translocation channel jungnickel rapoport 1995
0.43387523.10893256.html.plaintext.txt	211	determine whether rnc binding protease digested pk rm reduced took advantage observation rncs bind vacant translocation channels srp independent reaction jungnickel rapoport 1995 lauring et al
0.43387523.10893256.html.plaintext.txt	212	1995a raden gilmore 1998
0.43387523.10893256.html.plaintext.txt	213	substrate rnc binding experiments prepared translating truncated mrna encoding nh2 terminal 86 residues preprolactin ppl86 wheat germ system absence srp
0.43387523.10893256.html.plaintext.txt	214	rncs bound translocation channels separated unbound rncs centrifugal flotation sucrose density gradient either low 150 mm potassium acetate high salt 500 mm potassium acetate lauring et al
0.43387523.10893256.html.plaintext.txt	215	membrane bound rncs recovered interface low density top middle fractions m whereas unbound rncs remain high density bottom b fraction fig 4 t0 pk rm
0.43387523.10893256.html.plaintext.txt	216	trypsin digested pk rm assayed using low salt sucrose gradient rncs remain membrane vesicles instead recovered exclusively bottom fraction fig 4
0.43387523.10893256.html.plaintext.txt	217	clearly interaction rnc sec61 channel unstable sec61 subunits severed
0.43387523.10893256.html.plaintext.txt	218	view larger version 26k figure 4
0.43387523.10893256.html.plaintext.txt	219	proteolysis induced changes ribosome membrane junction
0.43387523.10893256.html.plaintext.txt	220	ppl86 ffluc77 mrnas translated absence srp assemble rncs
0.43387523.10893256.html.plaintext.txt	221	translation products incubated tx pk rm cx pk rm
0.43387523.10893256.html.plaintext.txt	222	individual assays chilled ice binding rncs protease digested pk rm assayed follows
0.43387523.10893256.html.plaintext.txt	223	binding rncs tx pk rm assayed adjusting samples 2
0.43387523.10893256.html.plaintext.txt	224	1 m sucrose applying bottom layer three step discontinuous sucrose gradient see materials methods
0.43387523.10893256.html.plaintext.txt	225	centrifugation membrane bound ppl86 recovered top middle m fractions whereas unbound ppl86 remained bottom b fraction
0.43387523.10893256.html.plaintext.txt	226	b membrane bound rncs separated unbound rncs gel filtration chromatography columns equilibrated tkmd
0.43387523.10893256.html.plaintext.txt	227	percentage ppl86 coeluted microsomes quantified sds page
0.43387523.10893256.html.plaintext.txt	228	c membrane bound rncs separated unbound rncs gel filtration chromatography columns equilibrated tkmd l tkmd adjusted 500 mm potassium acetate h
0.43387523.10893256.html.plaintext.txt	229	eluate fractions containing ppl86 ffluc77 rncs spotted onto whatmann 3mm filter paper precipitated cold 10 tca boiled 5 tca scintillation counting
0.43387523.10893256.html.plaintext.txt	230	b c percentage rncs elute void volume column absence pk rm 7 rncs subtracted background
0.43387523.10893256.html.plaintext.txt	231	d samples digested proteinase k ice described materials methods
0.43387523.10893256.html.plaintext.txt	232	protease resistant ppl86 expressed percentage ppl86 undigested control samples
0.43387523.10893256.html.plaintext.txt	233	chromatography sepharose cl 2b gel filtration column used second method separate membrane bound unbound rncs
0.43387523.10893256.html.plaintext.txt	234	60 ppl86 rncs coeluted undigested t0 pk rm void volume gel filtration column equilibrated 150 mm potassium acetate fig 4 b
0.43387523.10893256.html.plaintext.txt	235	c5 pk rm shown threefold reduction binding nontranslating ribosomes displayed twofold decrease rnc binding
0.43387523.10893256.html.plaintext.txt	236	c30 pk rm t10 pk rm 10 fold greater defect ribosome binding fig 3 bound 2
0.43387523.10893256.html.plaintext.txt	237	7 fold 5 fold less rncs undigested pk rm
0.43387523.10893256.html.plaintext.txt	238	rncs bind intact sec61 complexes resist extraction 0
0.43387523.10893256.html.plaintext.txt	239	5 m potassium acetate consistent nascent chain insertion translocation channel fig 4 c
0.43387523.10893256.html.plaintext.txt	240	majority 80 ppl86 rncs bind protease digested pk rm c30 pk rm also insensitive high salt extraction fig 4 c
0.43387523.10893256.html.plaintext.txt	241	determine whether binding rncs sec61 complex signal sequence independent incubated intact protease digested microsomes t10 pk rm c30 pk rm rncs assembled translation truncated firefly luciferase mrna ffluc77
0.43387523.10893256.html.plaintext.txt	242	reported previously lauring et al
0.43387523.10893256.html.plaintext.txt	243	1995b translocation channels pk rm bind rncs lack signal sequence fig 4 c
0.43387523.10893256.html.plaintext.txt	244	binding ffluc77 rncs protease digested pk rm either scarcely background t10 pk rm 3
0.43387523.10893256.html.plaintext.txt	245	5 fold reduced c30 pk rm relative intact microsomes fig 4 c
0.43387523.10893256.html.plaintext.txt	246	nascent polypeptide inserted translocation channel resides environment inaccessible proteases connolly et al
0.43387523.10893256.html.plaintext.txt	247	intimate contact cytosolic domains sec61 complex ribosome thought responsible maintaining tight seal ribosome membrane surface translocation proteins across rer crowley et al
0.43387523.10893256.html.plaintext.txt	248	interaction protease digested translocation channel rnc analyzed testing whether nascent polypeptide sensitive proteolysis fig 4 d
0.43387523.10893256.html.plaintext.txt	249	nascent ppl86 quantitatively digested proteinase k absence microsomes
0.43387523.10893256.html.plaintext.txt	250	experiment shown 28 nascent ppl86 chains protected proteinase k digestion assayed t0 pk rm
0.43387523.10893256.html.plaintext.txt	251	percentage protease inaccessible ppl86 similar typical efficiency 35 50 srp independent translocation reactions see fig 5
0.43387523.10893256.html.plaintext.txt	252	far smaller proportion 1 6 nascent polypeptides protected proteinase k upon attachment rncs trypsin digested sec61 complexes fig 4 d
0.43387523.10893256.html.plaintext.txt	253	conclude ribosome sec61 junction substantially altered loops 6 8 sec61 severed
0.43387523.10893256.html.plaintext.txt	254	view larger version 44k figure 5
0.43387523.10893256.html.plaintext.txt	255	srp independent translocation activity protease digested pk rm
0.43387523.10893256.html.plaintext.txt	256	tx pk rm cx pk rm v200 pk rm assayed srp independent translocation ppl86 described materials methods
0.43387523.10893256.html.plaintext.txt	257	b assays contained 10 microl translation products 10 eq tx pk rm v200 pk rm cx pk rm b
0.43387523.10893256.html.plaintext.txt	258	percent translocation solid bars calculated quantifying ppl86 pl56 resolution page sds expressed relative observed undigested membranes t0 pk rm c0 pk rm
0.43387523.10893256.html.plaintext.txt	259	ribosome binding activity shaded bars tx pk rm cx pk rm v200 pk rm taken fig 3
0.43387523.10893256.html.plaintext.txt	260	c aliquots 10 microl ppl86 translation products incubated 0 1 3 10 eq t0 pk rm filled squares t1 pk rm triangles t10 pk rm circles t30 pk rm open squares
0.43387523.10893256.html.plaintext.txt	261	d competition wheat germ 80s ribosomes rncs binding intact protease digested translocation channels
0.43387523.10893256.html.plaintext.txt	262	5 pmol 80s ribosomes 250 fmol ppl86 rncs mixed 0 22
0.43387523.10893256.html.plaintext.txt	263	5 pmol purified 80s ribosomes t0 pk rm triangles t3 pk rm squares
0.43387523.10893256.html.plaintext.txt	264	5 pmol corresponds 1x competing ribosomes
0.43387523.10893256.html.plaintext.txt	265	assays contained 5 eq t0 pk rm 1
0.43387523.10893256.html.plaintext.txt	266	5 pmol sec61 oligomers 15 eq t3 pk rm 4
0.43387523.10893256.html.plaintext.txt	267	greater amounts t3 pk rm assayed obtain comparable extents translocation absence competing ribosomes
0.43387523.10893256.html.plaintext.txt	268	srp independent translocation across protease digested pk rm based upon results described anticipated extensively digested pk rm would inactive srp independent translocation assay whereas microsomes retained significant ribosome binding activity e
0.43387523.10893256.html.plaintext.txt	269	t1 pk rm c5 pk rm would show srp independent translocation defects proportional fold reduction ribosome binding rnc binding activities
0.43387523.10893256.html.plaintext.txt	270	simplify interpretation srp independent translocation assays used tram protein independent substrate ppl86 experiments gorlich rapoport 1993
0.43387523.10893256.html.plaintext.txt	271	ribosome ppl86 complexes incubated protease digested pk rm 5 min allow rnc binding sec61 complex
0.43387523.10893256.html.plaintext.txt	272	rncs engaged translocation channel detected releasing nascent polypeptide edta permits translocation ppl86 er lumen processed pl56 cleavage signal sequence
0.43387523.10893256.html.plaintext.txt	273	protease digested pk rm assayed srp independent translocation activity
0.43387523.10893256.html.plaintext.txt	274	representative assays using 10 eq protease digested pk rm 3 pmol sec61 oligomers 10 microl wheat germ translation products 4
0.43387523.10893256.html.plaintext.txt	275	5 pmol ribosomes 250 fmol ppl86 rncs shown fig 5 b
0.43387523.10893256.html.plaintext.txt	276	surprisingly trypsin endoproteinase glu c digestion sec61 reduced srp independent translocation ppl86 twofold fig 5 solid bars
0.43387523.10893256.html.plaintext.txt	277	even striking chymotrypsin digestion sec61 caused 20 reduction srp independent translocation activity fig 5 b solid bars
0.43387523.10893256.html.plaintext.txt	278	binding nontranslating ribosomes protease digested membranes severely inhibited srp independent translocation activity fig 5a fig b shaded bars
0.43387523.10893256.html.plaintext.txt	279	control experiments demonstrated processed pl56 sequestered within microsomal vesicles
0.43387523.10893256.html.plaintext.txt	280	trypsin digested membranes t1 pk rm t10 pk rm t30 pk rm assayed srp independent translocation activity conditions 80s ribosomes present excess relative rnc binding sites undigested pk rm fig 5 c
0.43387523.10893256.html.plaintext.txt	281	translocation ppl86 across protease severed sec61 channels proportional quantity added microsomes
0.43387523.10893256.html.plaintext.txt	282	limiting amounts protease digested pk rm assayed 1 eq extensively digested pk rm t10 pk rm t30 pk rm threefold less active undigested pk rm srp independent translocation ppl86
0.43387523.10893256.html.plaintext.txt	283	thus even rncs excess relative tx pk rm fold reduction translocation activity considerably less observed reduction ribosome binding rnc binding activities
0.43387523.10893256.html.plaintext.txt	284	next used sensitive competition assay determine whether protease digested sec61 complexes retain residual binding determinants 80s ribosomes detected using classical ribosome binding assay shown fig 3
0.43387523.10893256.html.plaintext.txt	285	nontranslating 80s ribosomes compete rncs binding sec61 complex hence act competitive inhibitors srp independent targeting pathway lauring et al
0.43387523.10893256.html.plaintext.txt	286	1998 raden gilmore 1998
0.43387523.10893256.html.plaintext.txt	287	reasoned t3 pk rm retain 5 high affinity ribosome binding sites detectable intact pk rm fig 3 d might less sensitive inhibition 80s ribosomes assayed srp independent translocation activity
0.43387523.10893256.html.plaintext.txt	288	allow direct comparison effect competing ribosomes competition assays adjusted obtain comparable translocation activity absence competitor
0.43387523.10893256.html.plaintext.txt	289	observed previously addition 80s ribosomes caused concentration dependent decrease srp independent translocation across undigested pk rm fig 5 d triangles
0.43387523.10893256.html.plaintext.txt	290	protease digested t3pk rm assayed observed 80s ribosomes twofold less effective inhibitors srp independent translocation across t3 pk rm fig 5 d squares
0.43387523.10893256.html.plaintext.txt	291	nonetheless 80s ribosomes interfere rnc binding sec61 complex suggesting protease severed sec61 complexes retain residual affinity nontranslating ribosomes
0.43387523.10893256.html.plaintext.txt	292	thermolysin dissection sec61 given dramatic reduction ribosome binding activity caused cleavage sec61 multiple sites incubated pk rm thermolysin ice 25 degrees c achieve selective digestion sec61 fig 6
0.43387523.10893256.html.plaintext.txt	293	protein immunoblots using nh2 terminal specific antibody sec61 revealed proteolytic fragments 25 degrees c digestions similar obtained chymotrypsin compare fig 6 fig 3 c
0.43387523.10893256.html.plaintext.txt	294	proteolysis within loops 8 6 yielded 30 22 kd immunoreactive fragments sec61 respectively
0.43387523.10893256.html.plaintext.txt	295	rapid loss sec61 immunoreactivity observed blots probed cooh terminal specific antibody fig 6
0.43387523.10893256.html.plaintext.txt	296	smaller immunoreactive fragments sec61 detected either antibody
0.43387523.10893256.html.plaintext.txt	297	proteolysis within 14 residue cooh terminal tail abolish immunoreactivity without substantially altering gel mobility sec61
0.43387523.10893256.html.plaintext.txt	298	thermolysin digestions performed ice nh2 terminal antibody revealed limited digestion sec61 within loop 8
0.43387523.10893256.html.plaintext.txt	299	selective cleavage cooh terminal tail readily apparent shown loss cooh terminal immunoreactivity th20 pk rm th50 pk rm fig 6
0.43387523.10893256.html.plaintext.txt	300	control immunoblots using antibody ribophorin fig 6 showed differences sec61 cooh terminal immunoreactivity could explained differential recovery protease digested membranes preparative procedures
0.43387523.10893256.html.plaintext.txt	301	quantification protein immunoblots disclosed percentage intact sec61 recognized cooh terminal antibody intact sized sec61 recognized nh2 terminal antibody fig 6 b
0.43387523.10893256.html.plaintext.txt	302	difference nh2 cooh terminal values indicates percentage sec61 selectively cleaved cooh terminal tail
0.43387523.10893256.html.plaintext.txt	303	view larger version 41k figure 6
0.43387523.10893256.html.plaintext.txt	304	ribosome binding activity thermolysin digested pk rm
0.43387523.10893256.html.plaintext.txt	305	pk rm digested 25 degrees c ice thermolysin described materials methods
0.43387523.10893256.html.plaintext.txt	306	aliquots protease digested pk rm analyzed protein immunoblots probed antibodies sec61 ribophorin
0.43387523.10893256.html.plaintext.txt	307	antibodies specific nh2 terminus cooh terminus sec61 designated sec61 n sec61 c respectively
0.43387523.10893256.html.plaintext.txt	308	l8ntf l6ntf designate nh2 terminal fragments sec61 severed cytoplasmic loops 8 6 respectively
0.43387523.10893256.html.plaintext.txt	309	b protein immunoblots shown quantified calculate percentage intact sized sec61 recognized antibodies nh2 terminus shaded bars intact sec61 recognized antibody cooh terminus hatched bars
0.43387523.10893256.html.plaintext.txt	310	binding 80s ribosomes thx pk rm assayed described materials methods expressed percentage solid bars displayed undigested pk rm 360 fmoleq
0.43387523.10893256.html.plaintext.txt	311	thermolysin digested pk rm assayed ribosome binding activity fig 6 b
0.43387523.10893256.html.plaintext.txt	312	quantity ribosome binding sites solid bars compared amount intact sec61 recognized nh2 terminal shaded bars cooh terminal diagonal bars antibodies
0.43387523.10893256.html.plaintext.txt	313	comparison ribosome binding activities th2 pk rm th20 pk rm th50 pk rm revealed critical importance loop 8 cooh terminal tail sec61
0.43387523.10893256.html.plaintext.txt	314	loss ribosome binding activity three membrane preparations cannot ascribed digestion loop 6 remained intact instead must dependent upon digestion either loop 8 cooh terminus segments
0.43387523.10893256.html.plaintext.txt	315	importance cooh terminal tail sec61 evident upon comparison th2 pk rm th50 pk rm
0.43387523.10893256.html.plaintext.txt	316	although extent digestion within loop 8 comparable th50 pk rm lack cooh terminal tail sec61 display threefold fewer ribosome binding sites
0.43387523.10893256.html.plaintext.txt	317	latter result demonstrates intact sec61 cooh terminus important interaction 80s ribosome translocation channel
0.43387523.10893256.html.plaintext.txt	318	thermolysin digested membranes assayed srp dependent translocation activity using tram independent substrate preprolactin gorlich rapoport 1993 voigt et al
0.43387523.10893256.html.plaintext.txt	319	assay srp dependent translocation activity preprolactin mrna translated reticulocyte lysate system presence thermolysin digested pk rm
0.43387523.10893256.html.plaintext.txt	320	assays supplemented 52 kd sr fragment reconstitute srp receptor activity protein immunoblots shown thx pk rm lack intact sr shown
0.43387523.10893256.html.plaintext.txt	321	translocation preprolactin across membrane accompanied signal sequence cleavage yield processed prolactin
0.43387523.10893256.html.plaintext.txt	322	quantification results bottom shows srp dependent translocation activity correlated quite well ribosome binding activity
0.43387523.10893256.html.plaintext.txt	323	translocation preprolactin abolished sec61 severed cytoplasmic loop 6 e
0.43387523.10893256.html.plaintext.txt	324	th25 pk rm strongly inhibited sec61 cleaved loop 8 fig 7
0.43387523.10893256.html.plaintext.txt	325	similar results obtained assayed srp dependent integration op156 ribosome tethered nascent chain derived bovine opsin data shown
0.43387523.10893256.html.plaintext.txt	326	view larger version 33k figure 7
0.43387523.10893256.html.plaintext.txt	327	translocation activity thermolysin digested pk rm
0.43387523.10893256.html.plaintext.txt	328	thx pk rm assayed srp dependent translocation preprolactin
0.43387523.10893256.html.plaintext.txt	329	reticulocyte lysate translations programmed preprolactin mrna transcript supplemented 1
0.43387523.10893256.html.plaintext.txt	330	2 eq thx pk rm 200 fmol 52 kd fragment sr
0.43387523.10893256.html.plaintext.txt	331	preprolactin ppl prolactin pl resolved sds page
0.43387523.10893256.html.plaintext.txt	332	srp dependent translocation preprolactin across thx pk rm shaded bars ribosome binding thx pk rm solid bars expressed relative obtained undigested pk rm
0.43387523.10893256.html.plaintext.txt	333	b thx pk rm assayed srp independent translocation ppl86
0.43387523.10893256.html.plaintext.txt	334	ppl86 resolved pl56 signal sequence ss sds page
0.43387523.10893256.html.plaintext.txt	335	srp independent translocation ppl86 across thx pk rm shaded bars ribosome binding thx pk rm solid bars expressed relative obtained undigested pk rm
0.43387523.10893256.html.plaintext.txt	336	thermolysin digested pk rm also assayed srp independent translocation activity fig 7 b
0.43387523.10893256.html.plaintext.txt	337	quantification data revealed ribosome binding srp independent translocation promotion activities sec61 complex strictly linked
0.43387523.10893256.html.plaintext.txt	338	cooh terminal tail sec61 dispensable srp independent translocation activity
0.43387523.10893256.html.plaintext.txt	339	severe reduction srp independent translocation ppl86 observed sec61 cleaved loops 6 8
0.43387523.10893256.html.plaintext.txt	340	discussion top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	341	proteolysis sec61 topology sec61 mammalian er membrane initially deduced using hydropathy algorithms gorlich et al
0.43387523.10893256.html.plaintext.txt	342	1992 comparison experimentally derived topology model homologous escherichia coli secy protein akiyama ito 1987
0.43387523.10893256.html.plaintext.txt	343	good agreement predicted topology canine sec61 experimentally verified topology model
0.43387523.10893256.html.plaintext.txt	344	cerevisiae sec61p wilkinson et al
0.43387523.10893256.html.plaintext.txt	345	1996 lends considerable credence model depicted fig 1
0.43387523.10893256.html.plaintext.txt	346	proteolysis using enzymes different cleavage specificities used identify surface exposed loops cytoplasmic face sec61
0.43387523.10893256.html.plaintext.txt	347	based upon presence potential cleavage sites trypsin chymotrypsin endoproteinase glu c four loops two termini conceivable cytoplasmic segment sec61 would susceptible cleavage three proteases exception loop 6 lacks predicted cleavage site endoproteinase glu c
0.43387523.10893256.html.plaintext.txt	348	instead observed cooh terminal half sec61 much sensitive proteolysis nh2 terminal tail whereas loops 2 4 digested protease tested
0.43387523.10893256.html.plaintext.txt	349	although lack digestion within loop 4 explained short length segment loop 2 comparable length loop 6 size alone cannot explanation
0.43387523.10893256.html.plaintext.txt	350	relative insensitivity nh2 terminus consistent hypothesis segment canine sec61 embedded membrane surface amphipathic helix proposed
0.43387523.10893256.html.plaintext.txt	351	cerevisiae sec61p wilkinson et al
0.43387523.10893256.html.plaintext.txt	352	however cannot exclude possibility nh2 terminus sec61 protected another mechanism
0.43387523.10893256.html.plaintext.txt	353	selective digestion cooh terminal tail thermolysin ice indicates segment sec61 highly exposed surface sec61 oligomer
0.43387523.10893256.html.plaintext.txt	354	proteolysis sec61 cause translocation channel dissociate sec61 heterotrimers fragments thereof
0.43387523.10893256.html.plaintext.txt	355	maintenance oligomeric structure unexpected hydrophobic interactions tm spans sec61 sec61ss sec61 presumably responsible stability oligomer
0.43387523.10893256.html.plaintext.txt	356	established oligomeric structure sec61 complex compromised proteolytic digestion cytoplasmic loops assayed protease digested pk rm ribosome binding activity srp independent translocation ppl86 srp dependent translocation preprolactin
0.43387523.10893256.html.plaintext.txt	357	binding nontranslating ribosomes sec61 complex several rer membrane proteins sec61 complex p180 p34 bind ribosomes hypotonic solution reconstituted proteoliposomes ichimura et al
0.43387523.10893256.html.plaintext.txt	358	1992 savitz meyer 1993 kalies et al
0.43387523.10893256.html.plaintext.txt	359	however sec61 complex proteoliposomes retain high affinity ribosomes physiological ionic strength buffer kalies et al
0.43387523.10893256.html.plaintext.txt	360	furthermore well established sec61 complex also ribosome binding site protein translocation reaction gorlich rapoport 1993 kalies et al
0.43387523.10893256.html.plaintext.txt	361	analyzing ribosome binding protease digested pk rm physiological ionic strength buffer assay specifically monitored proteolysis sec61 complex altered binding nontranslating ribosomes translocation channel
0.43387523.10893256.html.plaintext.txt	362	results support hypothesis ribosome binding activity sec61 complex ascribed sec61
0.43387523.10893256.html.plaintext.txt	363	50 sec61 remained intact protease digested membranes lacked detectable ribosome binding e
0.43387523.10893256.html.plaintext.txt	364	t5 pk rm v200 pk rm demonstrating sec61 sufficient ribosome binding activity
0.43387523.10893256.html.plaintext.txt	365	extreme sensitivity sec61ss thermolysin digestion shown yielded th2 pk rm lack intact sec61ss yet retain considerable ribosome binding activity
0.43387523.10893256.html.plaintext.txt	366	1994 also concluded sec61ss dispensable ribosome binding sec61 complex
0.43387523.10893256.html.plaintext.txt	367	however cannot exclude possibility sec61ss sec61 help stabilize association ribosome sec61
0.43387523.10893256.html.plaintext.txt	368	ultrastructural evidence indicates ribosome tethered sec61 complex via single visible junction beckmann et al
0.43387523.10893256.html.plaintext.txt	369	1997 would logical suggest exposed surface sec61 ribosome binding site
0.43387523.10893256.html.plaintext.txt	370	support hypothesis protease accessible regions sec61 might correspond ribosome binding site observed sec61 complexes lack intact sec61 subunits bind nontranslating ribosomes
0.43387523.10893256.html.plaintext.txt	371	comparison 12 eukaryotic sec61 sequences reveals loops 6 8 highly conserved particularly respect location number charged amino acids
0.43387523.10893256.html.plaintext.txt	372	cooh terminus sec61 one least conserved cytoplasmic segments sec61 complex important role cooh terminus sec61 ribosome binding unexpected
0.43387523.10893256.html.plaintext.txt	373	results obtained c1 pk rm th2 pk rm strongly support hypothesis loop 8 required ribosome binding sec61 complex
0.43387523.10893256.html.plaintext.txt	374	selective cleavage cooh terminal tail sec61 thermolysin ice th50 pk rm showed segment sec61 crucial binding nontranslating ribosome translocation channel
0.43387523.10893256.html.plaintext.txt	375	assuming proteolysis translocation channel results random digestion sec61 subunits tetramer sec61 heterotrimers partially digested membranes contain mixture translocation channels zero four intact sec61 subunits
0.43387523.10893256.html.plaintext.txt	376	one unexpected result observation ribosome binding protease digested pk rm requires one intact sec61 subunit per translocation channel
0.43387523.10893256.html.plaintext.txt	377	consider example membranes retain 50 intact sec61 e
0.43387523.10893256.html.plaintext.txt	378	random 50 digestion tetrameric translocation channels would yield binomial distribution channels contain zero four intact sec61 subunits 6
0.43387523.10893256.html.plaintext.txt	379	25 zero intact 25 one intact 37
0.43387523.10893256.html.plaintext.txt	380	5 two intact 25 three intact 6
0.43387523.10893256.html.plaintext.txt	381	number ribosome binding sites detect c1 pk rm th2 pk rm 40 50 present pk rm much greater 6 complexes retain four intact sec61 subunits much less 94 complexes retain least one intact sec61 subunit
0.43387523.10893256.html.plaintext.txt	382	instead results best explained model requires multivalent contact ribosome two three sec61 subunits per sec61 oligomer
0.43387523.10893256.html.plaintext.txt	383	regard demonstration sec61 oligomer remains intact following proteolysis critical observation
0.43387523.10893256.html.plaintext.txt	384	based upon minimal protein bridge tethers ribosome yeast sec61 oligomer beckmann et al
0.43387523.10893256.html.plaintext.txt	385	1997 one might predicted three sec61 subunits tetrameric translocation channel could proteolyzed without reducing ribosome binding activity
0.43387523.10893256.html.plaintext.txt	386	interpretation apparent paradox physiological salt insensitive binding ribosome canine sec61 complex requires one secondary contact points observed three dimensional reconstructions
0.43387523.10893256.html.plaintext.txt	387	cerevisiae ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	388	signal sequence contributes specificity affinity rnc attachment three independent methods used analyze rnc binding provided evidence protease severed sec61 complexes bind rncs reduced capacity reduced affinity relative intact sec61 complexes
0.43387523.10893256.html.plaintext.txt	389	nonetheless rnc binding sec61 complex cannot directly equated high affinity ribosome binding activity
0.43387523.10893256.html.plaintext.txt	390	attachment ppl86 rncs sec61 complexes lack high affinity ribosome binding activity readily explained hypothesis signal sequence nascent polypeptide second ligand contributes significantly specificity affinity interaction rnc sec61 complex
0.43387523.10893256.html.plaintext.txt	391	rncs lack signal sequence e
0.43387523.10893256.html.plaintext.txt	392	ffluc77 bind poorly protease digested sec61 complexes
0.43387523.10893256.html.plaintext.txt	393	rationalize conclusion previous data showing 80s ribosomes compete rncs srp independent binding translocation channel noted previously raden gilmore 1998 80s ribosomes compete 11 basis rncs binding sec61 complex
0.43387523.10893256.html.plaintext.txt	394	hypothesize signal sequence substantially enhances affinity rnc translocation channel reducing dissociation rate ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	395	ribosome competition experiments conducted using protease digested pk rm observed free ribosomes twofold less effective competitors rnc binding consistent view affinity ribosome sec61 complex reduced proteolysis
0.43387523.10893256.html.plaintext.txt	396	photo cross linking studies indicate signal sequence nascent polypeptide inserted yeast sec61 complex contacts tm spans 2 7 plath et al
0.43387523.10893256.html.plaintext.txt	397	results strongly suggest signal sequence insertion occurs region sec61 inaccessible proteases hence distinct cytoplasmic loops contact ribosome
0.43387523.10893256.html.plaintext.txt	398	srp independent translocation polypeptides protease digested sec61 complexes srp independent translocation sec61 complex thought accurately mimic rnc binding nascent chain insertion transport phases translocation reaction
0.43387523.10893256.html.plaintext.txt	399	rncs targeted srp independent pathway binding rnc sec61 complex signal sequence independent lauring et al
0.43387523.10893256.html.plaintext.txt	400	1995a competitively inhibited presence nontranslating 80s ribosomes lauring et al
0.43387523.10893256.html.plaintext.txt	401	1998 raden gilmore 1998
0.43387523.10893256.html.plaintext.txt	402	srp independent translocation assays described used rnc preparations contained nascent chain associated complex nac
0.43387523.10893256.html.plaintext.txt	403	nac ribosome associated protein proposed negative regulator rnc binding sec61 complex lauring et al
0.43387523.10893256.html.plaintext.txt	404	however conclusion challenged endogenous nac wheat germ reticulocyte lysate cytosol prevent rnc binding sec61 complex neuhof et al
0.43387523.10893256.html.plaintext.txt	405	1998 raden gilmore 1998 therefore removal nac necessary
0.43387523.10893256.html.plaintext.txt	406	assayed srp independent translocation across protease digested pk rm made several unexpected observations
0.43387523.10893256.html.plaintext.txt	407	protease digested pk rm lack binding sites nontranslating ribosomes remain competent srp independent translocation ppl86
0.43387523.10893256.html.plaintext.txt	408	results indicate functional interaction nascent polypeptide translocation channel strictly dependent upon initial high affinity binding ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	409	definitive resolution ribosome binding translocation promotion activities sec61 complex obtained limited digestion sec61 thermolysin
0.43387523.10893256.html.plaintext.txt	410	cleavage cooh terminus sec61 drastically reduced ribosome binding activity relatively modest effect upon srp independent translocation ppl86
0.43387523.10893256.html.plaintext.txt	411	interaction rnc sec61 complex progresses several distinct stages nascent polypeptide increases length crowley et al
0.43387523.10893256.html.plaintext.txt	412	1994 jungnickel rapoport 1995 nicchitta zheng 1997
0.43387523.10893256.html.plaintext.txt	413	rncs bearing preprolactin chains shorter 70 residues attached salt sensitive manner even though nascent polypeptide contact sec61
0.43387523.10893256.html.plaintext.txt	414	salt resistant rnc attachment occurs upon elongation signal sequence inserted protease inaccessible environment translocation channel connolly et al
0.43387523.10893256.html.plaintext.txt	415	1989 jungnickel rapoport 1995 nicchitta zheng 1997
0.43387523.10893256.html.plaintext.txt	416	gating lumenal end translocation channel also occurs stage nascent chain elongation transport crowley et al
0.43387523.10893256.html.plaintext.txt	417	although ppl86 nascent chain sufficient length support stable interaction rnc sec61 complex observed interaction rnc translocation channel substantially weakened proteolysis sec61
0.43387523.10893256.html.plaintext.txt	418	rncs bearing ppl86 remain attached protease digested pk rm sucrose flotation gradients physiological ionic strength buffer fig 4
0.43387523.10893256.html.plaintext.txt	419	gel filtration chromatography avoids exposure sample 2 m sucrose high centrifugal fields provided evidence rncs bound protease digested pk rm fig 4b fig c
0.43387523.10893256.html.plaintext.txt	420	evidence rnc sec61 interaction altered provided finding junction ribosome membrane sufficiently tight prevent access macromolecular probe proteinase k nascent polypeptide
0.43387523.10893256.html.plaintext.txt	421	regions sec61 implicated rnc binding protein translocation protease digested pk rm described also assayed srp dependent translocation activity using procedure shown fig 7 song et al
0.43387523.10893256.html.plaintext.txt	422	shown th25 pk rm digestion sec61 either cytoplasmic loop 6 loop 8 leads complete block srp dependent translocation pathway
0.43387523.10893256.html.plaintext.txt	423	restrictive block srp dependent targeting pathway readily explained accumulation upstream translocation intermediate precedes transfer rnc srp54 sec61 song et al
0.43387523.10893256.html.plaintext.txt	424	srp independent pathway severely inhibited proteolysis sec61 cleavage within loops 6 8 reduced rnc binding nascent chain translocation
0.43387523.10893256.html.plaintext.txt	425	although moderate reduction srp independent translocation activity probably reflects reduced affinity translocation channel ribosome results strongly suggest translocation promoting function sec61 complex resides protease inaccessible region sec61
0.43387523.10893256.html.plaintext.txt	426	molecular genetic dissection sec61p suggested intact cytoplasmic loop 6 crucial vivo function sec61 complex wilkinson et al
0.43387523.10893256.html.plaintext.txt	427	complementary nh2 cooh terminal segments sec61p tested ability suppress sec61 null allele
0.43387523.10893256.html.plaintext.txt	428	exception nh2 terminal segments truncated within loops 6 7 coexpression complementary fragment yielded functional sec61p
0.43387523.10893256.html.plaintext.txt	429	thus intact loop 6 sec61 appears crucial translocation proteins across er
0.43387523.10893256.html.plaintext.txt	430	results indicate loop 8 cooh terminus required high affinity binding ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	431	propose two segments cooperate form ribosome binding platform responsible primary secondary contacts translocation channel ribosome
0.43387523.10893256.html.plaintext.txt	432	whereas detailed description ribosome binding site sec61 require ultrastructural molecular genetic analysis results described show cooh terminal half sec61 focus scrutiny
0.43387523.10893256.html.plaintext.txt	433	1 abbreviations used paper cx pk rm chymotrypsin digested pk rm ecl enhanced chemiluminescence nac nascent chain associated complex ost oligosaccharyltransferase pic protease inhibitor cocktail pk rm puromycin high salt washed rm rm rough microsomes rnc ribosome nascent chain complex sr signal recognition particle receptor srp signal recognition particle tea triethanolamine acetate ph 7
0.43387523.10893256.html.plaintext.txt	434	5 tm transmembrane tx pk rm trypsin digested pk rm thx pk rm thermolysin digested pk rm vx pk rm endoproteinase glu c digested pk rm
0.43387523.10893256.html.plaintext.txt	435	acknowledgements top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	436	thank gert kreibich chistopher nicchitta tom rapoport peter walter providing antibodies ribophorin sec61 sec61ss srss respectively
0.43387523.10893256.html.plaintext.txt	437	thank kennan kellaris georgetown university washington dc raising antisera cooh terminus sec61 postdoctoral fellow lab
0.43387523.10893256.html.plaintext.txt	438	work supported national institutes health grant phs gm 35687
0.43387523.10893256.html.plaintext.txt	439	submitted 12 november 1999 revised 31 may 2000 accepted 31 may 2000
0.43387523.10893256.html.plaintext.txt	440	references top abstract introduction materials methods results discussion acknowledgements references
0.43387523.10893256.html.plaintext.txt	441	ribosome membrane interaction
0.43387523.10893256.html.plaintext.txt	442	nondestructive disassembly rat liver rough microsomes ribosomal membrane components
0.43387523.10893256.html.plaintext.txt	443	56206 229abstractfree full text
0.43387523.10893256.html.plaintext.txt	444	topology analysis secy protein integral membrane protein involved protein export escherichia coli
0.43387523.10893256.html.plaintext.txt	445	alignment conduits nascent polypeptide chain ribosome sec61 complex
0.43387523.10893256.html.plaintext.txt	446	2782123 2126abstractfree full text
0.43387523.10893256.html.plaintext.txt	447	ribosome binding endoplasmic reticulum 180 kd protein identified cross linking membrane bound ribosomes required ribosome binding activity
0.43387523.10893256.html.plaintext.txt	448	access proteinase k partially translocated nascent polypeptides intact detergent solubilized membranes
0.43387523.10893256.html.plaintext.txt	449	assembly influenza hemagglutinin trimers role intracellular transport
0.43387523.10893256.html.plaintext.txt	450	characterization secretory protein translocation ribosome membrane interaction endoplasmic reticulum
0.43387523.10893256.html.plaintext.txt	451	isolation properties 34 kd membrane protein may essential ribosome binding rat liver rough microsomes
0.43387523.10893256.html.plaintext.txt	452	binding ribosomes rough endoplasmic reticulum mediated sec61p complex
0.43387523.10893256.html.plaintext.txt	453	dad1 defender apoptotic cell death subunit mammalian oligosaccharyltransferase
0.43387523.10893256.html.plaintext.txt	454	944994 4999abstractfree full text
0.43387523.10893256.html.plaintext.txt	455	intrinsic ability ribosomes bind endoplasmic reticulum membranes regulated signal recognition particle nascent polypeptide associated complex
0.43387523.10893256.html.plaintext.txt	456	nascent polypeptide associated complex protein prevents mistargeting nascent chains endoplasmic reticulum
0.43387523.10893256.html.plaintext.txt	457	systematic probing environment translocating secretory protein translocation er membrane
0.43387523.10893256.html.plaintext.txt	458	binding signal recognition particle gives ribosomenascent chain complexes competitive advantage endoplasmic reticulum membrane interaction
0.43387523.10893256.html.plaintext.txt	459	9103 115abstractfree full text
0.43387523.10893256.html.plaintext.txt	460	nascent secretory chain binding translocation distinct processes differentiation chemical alkylation
0.43387523.10893256.html.plaintext.txt	461	regulation ribosome membrane junction early stages presecretory protein translocation across endoplasmic reticulum
0.43387523.10893256.html.plaintext.txt	462	1391697 1708abstractfree full text
0.43387523.10893256.html.plaintext.txt	463	signal recognition particle dependent targeting ribosomes rough endoplasmic reticulum absence presence nascent polypeptide associated complex
0.43387523.10893256.html.plaintext.txt	464	9117 130abstractfree full text
0.43387523.10893256.html.plaintext.txt	465	signal sequence recognition targeting ribosomes endoplasmic reticulum signal recognition particle require gtp
0.43387523.10893256.html.plaintext.txt	466	180 kd ribosome receptor essential ribosome binding protein translocation
0.43387523.10893256.html.plaintext.txt	467	signal sequence dependent function tram protein early phases protein transport across endoplasmic reticulum
0.43387523.10893256.html.plaintext.txt	468	signal sequence recognition protein targeting endoplasmic reticulum membrane
0.43387523.10893256.html.plaintext.txt	469	translocation proteins across endoplasmic reticulum
0.43387523.10893256.html.plaintext.txt	470	signal recognition protein srp binds vitro assembled polysomes synthesizing secretory protein
0.43387523.10893256.html.plaintext.txt	471	determination transmembrane topology yeast sec61p essential component er translocation complex
0.43387523.10893256.html.plaintext.txt	472	27125590 25597abstractfree full text
0.43387523.10893256.html.plaintext.txt	473	molecular architecture er translocase probed chemical crosslinking sss1p complementary fragments sec61p
0.43387523.10893256.html.plaintext.txt	474	164549 4559abstractfree full text
0.42564055.9688615.html.plaintext.txt	0	activation f508 cftr epithelial monolayer zsuzsa bebok1 charles j
0.42564055.9688615.html.plaintext.txt	1	venglarik12 zita panczel3 tamas jilling4 kevin l
0.42564055.9688615.html.plaintext.txt	2	1 gregory fleming james cystic fibrosis research center departments 2 physiology biophysics 5 medicine university alabama birmingham birmingham alabama 35294 3 university medical school pecs pecs h 7624 hungary 4 department pediatrics northwestern university medical school evanston illinois 60201
0.42564055.9688615.html.plaintext.txt	3	abstract top abstract introduction methods results discussion references
0.42564055.9688615.html.plaintext.txt	4	f508 mutation leads retention cystic fibrosis transmembrane conductance regulator cftr endoplasmic reticulum rapid degradation proteasome proteolytic systems
0.42564055.9688615.html.plaintext.txt	5	stably transfected llc pk1 porcine kidney epithelial cells f508 cftr conforms paradigm present plasma membrane
0.42564055.9688615.html.plaintext.txt	6	llc pk1 cells human nasal polyp cells derived f508 homozygous patient grown plastic dishes treated epithelial differentiating agent dmso 2 4 days llc pk1 cells grown polarized monolayers permeable supports plasma membrane f508 cftr significantly increased
0.42564055.9688615.html.plaintext.txt	7	moreover confluent llc pk1 cells expressing f508 cftr treated dmso mounted ussing chamber increase camp activated short circuit current
0.42564055.9688615.html.plaintext.txt	8	00025 compared untreated controls observed
0.42564055.9688615.html.plaintext.txt	9	plasma membrane cftr detected dmso treatment nonepithelial cells mouse l cells expressing f508 cftr
0.42564055.9688615.html.plaintext.txt	10	experiments describe way augment f508 cftr maturation epithelial cells appears act novel mechanism allows insertion functional f508 cftr plasma membranes transporting cell monolayers
0.42564055.9688615.html.plaintext.txt	11	results raise possibility increased epithelial differentiation might increase delivery f508 cftr endoplasmic reticulum golgi f508 protein shielded degradative pathways proteasome allowed mature
0.42564055.9688615.html.plaintext.txt	12	short circuit current dimethyl sulfoxide cystic fibrosis transmembrane conductance regulator cell differentiation
0.42564055.9688615.html.plaintext.txt	13	introduction top abstract introduction methods results discussion references
0.42564055.9688615.html.plaintext.txt	14	approximately 90 cystic fibrosis cf patients possess least one cystic fibrosis transmembrane conductance regulator cftr allele lacks phenylalanine residue cftr position 508 f508
0.42564055.9688615.html.plaintext.txt	15	4 indicated f508 mutation causes retention cftr endoplasmic reticulum er failure insert protein plasma membrane
0.42564055.9688615.html.plaintext.txt	16	butyrate epithelial differentiating agent shown augment f508 maturation nonpolarized cells grown plastic 3
0.42564055.9688615.html.plaintext.txt	17	another report suggested possibility butyrate increases ion transport cf nasal epithelia although augmentation f508 maturation directly shown 36
0.42564055.9688615.html.plaintext.txt	18	improvements f508 cftr due butyrate attributed differentiating effects per se increased cftr mrna protein levels
0.42564055.9688615.html.plaintext.txt	19	f508 folding defect also temperature sensitive influenced high concentrations glycerol 7 37
0.42564055.9688615.html.plaintext.txt	20	cftr normally functions cl channel context polarized epithelial monolayers
0.42564055.9688615.html.plaintext.txt	21	however interventions activate maturation cl secretion f508 cftr physiologically important systems polarized epithelial cell monolayers difficult establish
0.42564055.9688615.html.plaintext.txt	22	effort many laboratories directed toward development channel openers f508 cftr
0.42564055.9688615.html.plaintext.txt	23	strategy depends least e
0.42564055.9688615.html.plaintext.txt	24	small amounts f508 protein plasma membrane 19
0.42564055.9688615.html.plaintext.txt	25	studies f508 processing focused undifferentiated cells less information available concerning cftr maturation polarized epithelia
0.42564055.9688615.html.plaintext.txt	26	previous observations laboratories suggest measurable amounts f508 protein might present highly differentiated f508 human nasal epithelial cells 9 cf sweat ducts situ 35 nasal airways f508 cftr mice 22
0.42564055.9688615.html.plaintext.txt	27	present experiments adapted llc pk1 renal epithelial cells transfected cftr cdnas measurement transepithelial cl transport
0.42564055.9688615.html.plaintext.txt	28	cell line readily forms polarized cell monolayers 30 34 39 may advantages primary cf airway epithelial cells
0.42564055.9688615.html.plaintext.txt	29	since lung nasal tissue f508 patients limited less frequently available use screening drugs effects cftr
0.42564055.9688615.html.plaintext.txt	30	although kidney derived llc pk1 cell line endogenously express wild type f508 cftr processing wild type mutant cftr cell type carefully studied found closely resemble behavior epithelial cells endogenously express cftr 28
0.42564055.9688615.html.plaintext.txt	31	moreover kidney derived epithelia useful model system characterizing effects due epithelial differentiation
0.42564055.9688615.html.plaintext.txt	32	example madin darby canine kidney cells grown filters used study distribution membrane proteins polarized cells 1 mechanisms underlying distribution 12 29
0.42564055.9688615.html.plaintext.txt	33	llc pk1 cells used explore specific markers differentiation 27 ion conductance membrane voltage 24 chemical induction differentiation 26 differentiation dependent expression na glucose cotransporter 8
0.42564055.9688615.html.plaintext.txt	34	also studied effect dmso human nasal epithelial cells derived f508 homozygous patients mouse l cells expressing f508 wild type cftr 46
0.42564055.9688615.html.plaintext.txt	35	studies found growth epithelial cells conditions designed induce differentiated phenotype treatment epithelial differentiating agent dmso growth cells monolayers permeable supports led improvements f508 cftr processing
0.42564055.9688615.html.plaintext.txt	36	butyrate 5 mm 24 h glycerol 10 48 h growth 27 degrees c 48 h detectable effect f508 maturation epithelial cell monolayers
0.42564055.9688615.html.plaintext.txt	37	methods top abstract introduction methods results discussion references
0.42564055.9688615.html.plaintext.txt	38	parental llc pk1 cells cultured m199 media supplemented 5 fetal bovine serum fbs
0.42564055.9688615.html.plaintext.txt	39	llc pk1 cells stable expression wild type f508 cftr generous gift
0.42564055.9688615.html.plaintext.txt	40	28 cultured dmem medium supplemented 10 fbs 500 microgml g418 sigma
0.42564055.9688615.html.plaintext.txt	41	dmso sigma diluted medium
0.42564055.9688615.html.plaintext.txt	42	cells treated dmso 2 volvol 4 days confluency
0.42564055.9688615.html.plaintext.txt	43	cd2 added induce cftr expression metallothionein promoter 5 microm experiments controls
0.42564055.9688615.html.plaintext.txt	44	mouse fibroblast cells expressing f508 wild type cftr 46 cultured dmem medium supplemented 10 fbs
0.42564055.9688615.html.plaintext.txt	45	human nasal polyp cells isolated cultured according earlier described protocol 47
0.42564055.9688615.html.plaintext.txt	46	llc pk1 cells grown plastic washed three times pbs ph 7
0.42564055.9688615.html.plaintext.txt	47	1 mm cacl2 ice lysed buffer containing 150 mm nacl 20 mm hepes 1 mm edta 1 np 40 100 microgml aprotinin 100 microgml leupeptin 2 mm phenylmethylsulfonyl fluoride
0.42564055.9688615.html.plaintext.txt	48	lysate supernatant 300 microg protein immunoprecipitated 4 degrees c 2 h using anti cftr cooh terminal monoclonal antibody genzyme protein g agarose beads boehringer mannheim
0.42564055.9688615.html.plaintext.txt	49	immunoprecipitated proteins phosphorylated vitro described previously 4 33 separated 7 polyacrylamide gel
0.42564055.9688615.html.plaintext.txt	50	gels placed phosphoscreen analyzed phosphorimager molecular dynamics
0.42564055.9688615.html.plaintext.txt	51	images characterized iplab spectrum signal analytics
0.42564055.9688615.html.plaintext.txt	52	rt pcr carried using promega polyattract series 9600 mrna isolation cdna synthesis system according manufacturers protocol
0.42564055.9688615.html.plaintext.txt	53	briefly mrna extracted control dmso treated samples 1 x 105 cells 50 mrna sample used synthesize cdna
0.42564055.9688615.html.plaintext.txt	54	remainder sample identically treated without rt control exclude dna contamination
0.42564055.9688615.html.plaintext.txt	55	samples homogenized diluted 40 microl prewarmed 70 degrees c manufacturers hybridization buffer mrna purified oligodt matrix
0.42564055.9688615.html.plaintext.txt	56	samples washed 10 microl samples processed cdna adding 5 microl reverse transcriptase
0.42564055.9688615.html.plaintext.txt	57	ensure pcr yield experiments roughly dependent amount mrna starting material pbluescript containing cftr gift j
0.42564055.9688615.html.plaintext.txt	58	rommens transcribed vitro t7 polymerase mrna added cell lysates parental llc pk1 cells known concentrations
0.42564055.9688615.html.plaintext.txt	59	first strand cftr cdna synthesized exactly studied parallel cdna cells expressing wild type f508 cftr
0.42564055.9688615.html.plaintext.txt	60	studies cdna synthesis stopped 30 min incubating samples 95 degrees c 5 min
0.42564055.9688615.html.plaintext.txt	61	control experiments rt omitted cdna synthesis step led detectable pcr product conditions
0.42564055.9688615.html.plaintext.txt	62	quantitation densitometry using iplab spectrum signal analytics
0.42564055.9688615.html.plaintext.txt	63	cftr detection confocal immunofluorescence microscopy using anti first nucleotide binding domain nbd1 rabbit polyclonal antibody
0.42564055.9688615.html.plaintext.txt	64	coverslips washed three times pbs containing 1 mm ca2 0
0.42564055.9688615.html.plaintext.txt	65	5 mm mg2 fixed 20 degrees c methanol 20 min air dried room temperature
0.42564055.9688615.html.plaintext.txt	66	cells rehydrated pbs 5 min
0.42564055.9688615.html.plaintext.txt	67	nonspecific protein binding sites blocked incubating 1 wt vol porcine globulin pbs 30 min room temperature
0.42564055.9688615.html.plaintext.txt	68	primary antibody polyclonal rabbit antibody raised cftr nbd1 17 33 applied incubated room temperature 40 min
0.42564055.9688615.html.plaintext.txt	69	subsequent washing 5 x 3 min washes pbs cells incubated tetramethylrhodamine isothiocyanate tritc labeled anti rabbit igg antibody 40 min washed mounted visualized described
0.42564055.9688615.html.plaintext.txt	70	controls first antibody replaced nonimmune rabbit serum negative cases
0.42564055.9688615.html.plaintext.txt	71	cells viewed olympus ix70 inverted epifluorescence microscope 623 nm light excitation using uplanapo x 100 uapo340 x 40 objectives
0.42564055.9688615.html.plaintext.txt	72	digital confocal images captured using photometrics sensys digital camera iplab spectrum software power microtome signal analytics
0.42564055.9688615.html.plaintext.txt	73	detection tight junction formation confocal immunofluorescence microscopy using anti zonula occludens 1 rabbit polyclonal antibody
0.42564055.9688615.html.plaintext.txt	74	coverslips washed three times pbs supplemented 1 mm ca2 0
0.42564055.9688615.html.plaintext.txt	75	5 mm mg2 fixed 4 formaldehyde pbs 30 min room temperature
0.42564055.9688615.html.plaintext.txt	76	nonspecific protein binding sites blocked incubating 1 wt vol porcine globulin sigma pbs 30 min room temperature
0.42564055.9688615.html.plaintext.txt	77	rabbit polyclonal antibody anti zonula occludens 1 zo 1 igg zymed laboratories 15 applied incubated room temperature 60 min
0.42564055.9688615.html.plaintext.txt	78	subsequent washing 5 x 3 min washes pbs cells incubated tritc labeled anti rabbit igg antibody dakopatts 40 min room temperature washed pbs mounted using vectashield vector labs mounting medium
0.42564055.9688615.html.plaintext.txt	79	controls first antibody replaced nonimmune rabbit serum negative cases
0.42564055.9688615.html.plaintext.txt	80	dmso treatment 2 4 days
0.42564055.9688615.html.plaintext.txt	81	identification f508 cftr single channel activity plasma membranes llc pk1 cells following dmso treatment
0.42564055.9688615.html.plaintext.txt	82	dmso treated cells grown plastic studied cell attached configuration patch clamp technique
0.42564055.9688615.html.plaintext.txt	83	bath pipette solutions electronics pipette fabrication details regarding patch clamp technique described previously 43
0.42564055.9688615.html.plaintext.txt	84	pipette solution contained impermeant cation
0.42564055.9688615.html.plaintext.txt	85	n methyl d glutamine inward current could due cl flow pipette
0.42564055.9688615.html.plaintext.txt	86	cftr channels activated excision 250 uml protein kinase pka plus 200 microm atp bath
0.42564055.9688615.html.plaintext.txt	87	transepithelial transport f508 cftr
0.42564055.9688615.html.plaintext.txt	88	llc pk1 cell monolayers grown confluency permeable supports millipore anotec least 5 days treated 2 dmso 3 6 additional days
0.42564055.9688615.html.plaintext.txt	89	filters mounted ussing chamber short circuit current isc measurement carried described ref
0.42564055.9688615.html.plaintext.txt	90	bumetanide added 100 microm mucosal serosal surfaces
0.42564055.9688615.html.plaintext.txt	91	nacl ringer solution contained mm 145 na 5 k 124
0.42564055.9688615.html.plaintext.txt	92	8 mm cl replaced impermeant anion gluconate
0.42564055.9688615.html.plaintext.txt	93	results top abstract introduction methods results discussion references
0.42564055.9688615.html.plaintext.txt	94	dmso treatment llc pk1 cells expressing f508 cftr
0.42564055.9688615.html.plaintext.txt	95	dmso like butyrate displays potent activity epithelial differentiating agent 14 23 31 40
0.42564055.9688615.html.plaintext.txt	96	drugs cause changes display plasma membrane glycoproteins epithelial cells although two compounds believed act independent mechanisms 14 23 31 40
0.42564055.9688615.html.plaintext.txt	97	dose time dependencies dmso treatment 0 2 5 10 dmso 1 6 12 h 1 3 4 5 days evaluated systematically llc pk1 cells express recombinant f508 cftr
0.42564055.9688615.html.plaintext.txt	98	found treatment 4 days 2 dmso led maximal effects f508 maturation transepithelial cl transport cells
0.42564055.9688615.html.plaintext.txt	99	2 dmso schedule visible effect cell viability quantitative assay cell growth celltiter 96 promega well known differentiating effects dmso slow cell proliferation decreased cell proliferation llc pk1 cells 15
0.42564055.9688615.html.plaintext.txt	100	therefore settled schedule future studies
0.42564055.9688615.html.plaintext.txt	101	studied llc pk1 cells expressing wild type f508 cftr parental non cftr expressing llc pk1 cell line 28
0.42564055.9688615.html.plaintext.txt	102	dmso treatment leads mature band c form f508 cftr
0.42564055.9688615.html.plaintext.txt	103	incomplete processing cftr identified absence mature fully glycosylated band c form protein 4
0.42564055.9688615.html.plaintext.txt	104	lower molecular weight forms cftr e
0.42564055.9688615.html.plaintext.txt	105	band b represent high mannose endoglycosidase h sensitive forms protein established cotranslationally er
0.42564055.9688615.html.plaintext.txt	106	maturation cftr core complex glycosylation reflects transition protein er golgi attachment carbohydrates trimming accomplished cftr proceeds trans golgi network
0.42564055.9688615.html.plaintext.txt	107	immunoprecipitation cftr 4 day pretreatment dmso shown fig
0.42564055.9688615.html.plaintext.txt	108	result shows appearance mature fully glycosylated cftr dmso treatment f508 cells
0.42564055.9688615.html.plaintext.txt	109	result supports notion f508 maturation augmented dmso
0.42564055.9688615.html.plaintext.txt	110	figure 1 also indicates small increase total cftr protein llc pk1 cells dmso treatment
0.42564055.9688615.html.plaintext.txt	111	determine whether increase due effects steady state levels mrna performed semiquantitative rt pcr total cellular mrna
0.42564055.9688615.html.plaintext.txt	112	dmso appear cause increases cftr mrna levels judged rt pcr assay fig
0.42564055.9688615.html.plaintext.txt	113	unlike previous reports concerning butyrate treatment 3 experiment suggests increased f508 cftr mrna account modest increase total f508 protein dmso treatment increase band c
0.42564055.9688615.html.plaintext.txt	114	results also suggest dmso promotes f508 maturation mechanism different observed butyrate
0.42564055.9688615.html.plaintext.txt	115	view larger version 32k fig
0.42564055.9688615.html.plaintext.txt	116	immunoprecipitation vitro phosphorylation cystic fibrosis transmembrane conductance regulator cftr
0.42564055.9688615.html.plaintext.txt	117	location 170 kda band c fully processed form cftr shown
0.42564055.9688615.html.plaintext.txt	118	lower molecular weight form band b also shown
0.42564055.9688615.html.plaintext.txt	119	band b represents endoglycosidase h sensitive endoplasmic reticulum localized form protein whereas band c complex glycosylated form taken cftr beyond entry golgi
0.42564055.9688615.html.plaintext.txt	120	total cftr obtained 106 cells 300 microg total cell lysate protein shown lane
0.42564055.9688615.html.plaintext.txt	121	b densitometric measurement cftr vitro phosphorylation
0.42564055.9688615.html.plaintext.txt	122	percentage fully processed band c cftr compared total cftr shown
0.42564055.9688615.html.plaintext.txt	123	approximately 10 total f508 cftr became fully glycosylated dmso treatment
0.42564055.9688615.html.plaintext.txt	124	cells experiments grown plastic dishes
0.42564055.9688615.html.plaintext.txt	125	quantitation phosphor imaging
0.42564055.9688615.html.plaintext.txt	126	view larger version 25k fig
0.42564055.9688615.html.plaintext.txt	127	cftr mrna levels dmso treatment
0.42564055.9688615.html.plaintext.txt	128	polya mrna isolated 5 x 105 cells used synthesize first strand cdna amplify segment human cftr first nucleotide binding domain nbd1 ref
0.42564055.9688615.html.plaintext.txt	129	16 size 500 bp indicated arrow
0.42564055.9688615.html.plaintext.txt	130	pcr products predicted size obtained cases
0.42564055.9688615.html.plaintext.txt	131	lane m displays molecular size standard
0.42564055.9688615.html.plaintext.txt	132	b evidence increased cftr mrna observed dmso treatment conditions shown fig
0.42564055.9688615.html.plaintext.txt	133	known amounts vitro transcribed cftr mrna reaction mixture 5 2 1 0 pgml led roughly linear pcr yield conditions shown
0.42564055.9688615.html.plaintext.txt	134	quantitation densitometry using iplab spectrum signal analytics
0.42564055.9688615.html.plaintext.txt	135	f508 cftr localization plasma membrane
0.42564055.9688615.html.plaintext.txt	136	used digital confocal fluorescent microscopy cftr localization detected polyclonal rabbit antibody raised cftr nbd1
0.42564055.9688615.html.plaintext.txt	137	antibody used experiments validated previously ability immunoprecipitate either truncated cftr full length cftr immunolocalize cftr cells overexpressing protein correctly identify presence absence cftr vivo salivary gland sections cftr wild type knockout mice strain 5 16 17 33
0.42564055.9688615.html.plaintext.txt	138	llc pk1 cells expressing wild type cftr protein localized mainly perinuclear er compartment region plasma membrane fig
0.42564055.9688615.html.plaintext.txt	139	dmso treatment slightly increased membrane staining wild type cftr
0.42564055.9688615.html.plaintext.txt	140	contrast f508 cftr detected perinuclear er compartment llc pk1 cells significant membrane staining
0.42564055.9688615.html.plaintext.txt	141	dmso treatment staining region cell membrane similar observed wild type cftr expressing cells could detected
0.42564055.9688615.html.plaintext.txt	142	f508 cftr localizes perinuclear er region f508 homozygous human nasal epithelial cells fig
0.42564055.9688615.html.plaintext.txt	143	treatment cells dmso 2 4 days resulted diffuse cytoplasmic staining included staining cells plasma membranes
0.42564055.9688615.html.plaintext.txt	144	contrast dmso treatment significant effect f508 cftr staining mouse fibroblast cells mouse l cells fig
0.42564055.9688615.html.plaintext.txt	145	studies suggest specificity effects dmso f508 cftr processing occurs epithelial cells fibroblast cells
0.42564055.9688615.html.plaintext.txt	146	view larger version 57k fig
0.42564055.9688615.html.plaintext.txt	147	immunofluorescent detection wild type f508 cftr recombinant llc pk1 cells
0.42564055.9688615.html.plaintext.txt	148	b cftr staining f508 homozygous human nasal epithelial cells primary culture
0.42564055.9688615.html.plaintext.txt	149	c cftr immunostaining mouse l cells
0.42564055.9688615.html.plaintext.txt	150	polyclonal rabbit antibody directed nbd1 used detect cftr
0.42564055.9688615.html.plaintext.txt	151	c confocal images shown cells condition
0.42564055.9688615.html.plaintext.txt	152	dmso treatment 2 4 days
0.42564055.9688615.html.plaintext.txt	153	controls 1 first antibody replaced nonimmune rabbit serum 2 parental non cftr expressing llc pk1 l cells studied negative cases
0.42564055.9688615.html.plaintext.txt	154	identification f508 channels plasma membranes llc pk1 cells
0.42564055.9688615.html.plaintext.txt	155	also examined f508 cftr activity plasma membranes llc pk1 cells following dmso treatment fig
0.42564055.9688615.html.plaintext.txt	156	4 using patch clamp techniques
0.42564055.9688615.html.plaintext.txt	157	cells grown plastic studied cell attached excised inside configurations
0.42564055.9688615.html.plaintext.txt	158	pipette solution contained impermeant cation
0.42564055.9688615.html.plaintext.txt	159	n methyl d glucamine inward current could due cl flow
0.42564055.9688615.html.plaintext.txt	160	holding potential approximately 60 mv
0.42564055.9688615.html.plaintext.txt	161	current voltage relationship typical tracing shown fig
0.42564055.9688615.html.plaintext.txt	162	4 consistent channel activity previously described f508 cftr 6 21 32
0.42564055.9688615.html.plaintext.txt	163	conductance channel 8 10 ps channel activated excision 250 uml pka plus 200 microm atp bath expected functional cftr protein
0.42564055.9688615.html.plaintext.txt	164	observed cftr channels 2 27 seals f508 llc pk1 cells 12 48 seals cells treated dmso
0.42564055.9688615.html.plaintext.txt	165	wild type cftr observed 8 25 seals
0.42564055.9688615.html.plaintext.txt	166	open probability f508 channels studied stimulation pka atp
0.42564055.9688615.html.plaintext.txt	167	representative tracing shown fig
0.42564055.9688615.html.plaintext.txt	168	4 open probability activation 2 98 closed open probability activation 97 3 closed
0.42564055.9688615.html.plaintext.txt	169	wild type cftr also exhibited strong activation cells attached open probability 98 following pka stimulation
0.42564055.9688615.html.plaintext.txt	170	view larger version 18k fig
0.42564055.9688615.html.plaintext.txt	171	single f508 cftr channels plasma membrane llc pk1 cells dmso treatment
0.42564055.9688615.html.plaintext.txt	172	cells studied cell attached excised inside io configuration
0.42564055.9688615.html.plaintext.txt	173	single channels properties similar described previously f508 cftr observed see text
0.42564055.9688615.html.plaintext.txt	174	b current voltage relationship
0.42564055.9688615.html.plaintext.txt	175	transepithelial cl transport mediated f508 cftr following dmso treatment
0.42564055.9688615.html.plaintext.txt	176	extend findings concerning f508 cftr llc pk1 cells grown plastic dishes also grew cells permeable supports form epithelial monolayers
0.42564055.9688615.html.plaintext.txt	177	llc pk1 cells exhibit differentiated phenotype conditions indicated tight junction formation epithelial resistance measurements capability perform vectoral ion transport 11 30 38 39
0.42564055.9688615.html.plaintext.txt	178	conditions f508 llc pk1 cells low detectable cl transport absent parental non cftr expressing cells p 0
0.42564055.9688615.html.plaintext.txt	179	resistance cell monolayers 100 cm2
0.42564055.9688615.html.plaintext.txt	180	3 day dmso treatment f508 cftr expressing cells led forskolin activated currents direction cl secretion greatly increased compared untreated f508 llc pk1 cells p 0
0.42564055.9688615.html.plaintext.txt	181	transport absent parental llc pk1 cells without dmso treatment indicating specificity f508 cftr expression
0.42564055.9688615.html.plaintext.txt	182	cl omitted solutions bathing monolayers isc detectable either wild type f508 cftr expressing cells treatment conditions indicating isc observed presence cl due vectoral cl transport
0.42564055.9688615.html.plaintext.txt	183	studies wild type cftr expressing cells shown comparison
0.42564055.9688615.html.plaintext.txt	184	modest increases monolayer resistance e
0.42564055.9688615.html.plaintext.txt	185	15 20 noted paired experiments result dmso treatment finding suggests enhancement tight junction formation cells grown permeable supports presence dmso
0.42564055.9688615.html.plaintext.txt	186	summary studies shown fig
0.42564055.9688615.html.plaintext.txt	187	view larger version 45k fig
0.42564055.9688615.html.plaintext.txt	188	short circuit current isc measurements llc pk1 cells
0.42564055.9688615.html.plaintext.txt	189	representative tracings shown without dmso treatment
0.42564055.9688615.html.plaintext.txt	190	f508 llc pk1 cell monolayers bathed nacl ringer solution exhibited rapid forskolin activated isc direction cl secretion specifically following dmso treatment f508 dmso
0.42564055.9688615.html.plaintext.txt	191	isc disappeared either cl f508 dmso 6 mm cl ringer bath bilaterally f508 cftr parental dmso omitted
0.42564055.9688615.html.plaintext.txt	192	comparison cells expressing wild type wt cftr shown
0.42564055.9688615.html.plaintext.txt	193	effects bumetanide blocker inhibits transepithelial cl transport inhibiting basolateral na k 2cl cotransporter also shown
0.42564055.9688615.html.plaintext.txt	194	resistance 100 cm2 experiment
0.42564055.9688615.html.plaintext.txt	195	mock treated cells f508 top right represent vehicle treatment without dmso
0.42564055.9688615.html.plaintext.txt	196	aperture area studies 0
0.42564055.9688615.html.plaintext.txt	197	view larger version 14k fig
0.42564055.9688615.html.plaintext.txt	198	summary isc activation f508 cftr
0.42564055.9688615.html.plaintext.txt	199	maximal isc stimulation forskolin f508 cftr parental llc pk1 cells conditions symmetrical nacl ringer solution shown
0.42564055.9688615.html.plaintext.txt	200	statistics students test compared parental llc pk1 without dmso third bar left n 12 paired experiments condition
0.42564055.9688615.html.plaintext.txt	201	isc studies alternative activators f508 cftr maturation llc pk1 cells
0.42564055.9688615.html.plaintext.txt	202	performed sorts experiments shown f508 llc pk1 cells following incubation 10 glycerol 48 h 5 mm butyrate 24 h longer incubations led substantial toxicity growth 27 degrees c 48 h
0.42564055.9688615.html.plaintext.txt	203	interventions shown augment f508 processing certain cell types grown plastic 3 7 37
0.42564055.9688615.html.plaintext.txt	204	saw evidence approaches either isc activation band c cftr
0.42564055.9688615.html.plaintext.txt	205	results significant suggest dmso acts potentiate f508 cftr maturation mechanism 1 different observed glycerol butyrate 2 potent obtained glycerol butyrate least llc pk1 model 3 allows insertion f508 cftr plasma membrane transporting cellular monolayer vitro
0.42564055.9688615.html.plaintext.txt	206	dmso treatment leads differentiated phenotype recombinant llc pk1 cells
0.42564055.9688615.html.plaintext.txt	207	determine whether dmso altered phenotype llc pk1 cells probed cells grown plastic antibody zo 1 constituent epithelial tight junctions 15 41
0.42564055.9688615.html.plaintext.txt	208	organization assembly tight junctions additional useful measurement polarity differentiation epithelial cell monolayers
0.42564055.9688615.html.plaintext.txt	209	well organized tight junctions occurring ordered distribution indicate higher level polarity differentiation whereas tight junction antigens absent poorly developed distributed throughout cytoplasm plasma membrane may indicative less differentiated phenotype
0.42564055.9688615.html.plaintext.txt	210	7 4 day treatment 2 dmso led qualitative increases tight junction organization llc pk1 cells detected zo 1 staining regions cell cell contact
0.42564055.9688615.html.plaintext.txt	211	view larger version 48k fig
0.42564055.9688615.html.plaintext.txt	212	tight junction formation llc pk1 cells dmso treatment
0.42564055.9688615.html.plaintext.txt	213	confocal immunofluorescence microscopy cells without dmso treatment
0.42564055.9688615.html.plaintext.txt	214	increases organization tight junction antigen zonula occludens 1 zo 1 observed result dmso treatment
0.42564055.9688615.html.plaintext.txt	215	discussion top abstract introduction methods results discussion references
0.42564055.9688615.html.plaintext.txt	216	llc pk1 cells grown plastic f508 cftr absent plasma membrane fig
0.42564055.9688615.html.plaintext.txt	217	3 detected cell surface cells grown monolayer permeable support fig
0.42564055.9688615.html.plaintext.txt	218	maturation f508 cftr augmented treatment nontoxic concentrations differentiation agent known increase epithelial cell polarity dmso 14 23 31 40
0.42564055.9688615.html.plaintext.txt	219	vitro model described cell monolayers opposed previous studies nonpolarized cells grown plastic might useful development procedures augment f508 cftr maturation study openers f508 cftr cl channels present plasma membrane
0.42564055.9688615.html.plaintext.txt	220	tested possibility dmso like butyrate increases f508 cftr mrna levels fig
0.42564055.9688615.html.plaintext.txt	221	saw evidence increased cftr mrna either wild type f508 llc pk1 cells dmso treatment conditions partially corrected f508 protein processing
0.42564055.9688615.html.plaintext.txt	222	moreover butyrate treatment f508 cells 5 mm caused improvement cl transport ussing chamber protocol
0.42564055.9688615.html.plaintext.txt	223	results suggest dmso augments maturation f508 cftr mechanism different known effects butyrate
0.42564055.9688615.html.plaintext.txt	224	dmso also recently suggested act chemical chaperone correct folding biogenesis pathogenic prion protein vitro w
0.42564055.9688615.html.plaintext.txt	225	welch personal communication
0.42564055.9688615.html.plaintext.txt	226	although possible dmso effects cftr folding direct evidence experiments dmso reach cytoplasmic levels alter kinetics efficiency aspects cftr folding living cells augment f508 cftr processing
0.42564055.9688615.html.plaintext.txt	227	therefore although effect cftr folding remains important consideration experiments studies necessary test direct role dmso chemical chaperone cftr
0.42564055.9688615.html.plaintext.txt	228	experiments interventions increase epithelial cell polarity differentiation also conferred increases f508 cftr maturation
0.42564055.9688615.html.plaintext.txt	229	growth epithelial cells permeable supports well established method augmenting epithelial cell differentiation described previously leading dome formation differentiated phenotype many cell types 13 18 25
0.42564055.9688615.html.plaintext.txt	230	llc pk1 cells previously reported switch undifferentiated differentiated phenotype grown filters 48
0.42564055.9688615.html.plaintext.txt	231	method therefore selected one way increase cell polarity experiments
0.42564055.9688615.html.plaintext.txt	232	showed growth permeable supports also led functionally detectable f508 cftr plasma membrane isc measurements fig
0.42564055.9688615.html.plaintext.txt	233	dmso treatment another well described method augmenting cell differentiation epithelial cells derived different tissues 14 23 31 40
0.42564055.9688615.html.plaintext.txt	234	accordingly tested influence dmso f508 cftr maturational processing
0.42564055.9688615.html.plaintext.txt	235	dmso treatment caused increased resistance llc pk1 monolayers presumably basis greater organization tight junctions treatment led increases f508 cftr activity cell surface figs
0.42564055.9688615.html.plaintext.txt	236	moreover observed organization tight junctions llc pk1 cells increased conditions led f508 maturation figs
0.42564055.9688615.html.plaintext.txt	237	finally vectoral chloride transport fig
0.42564055.9688615.html.plaintext.txt	238	5 detectable polarized epithelial monolayer observed studies anion transport
0.42564055.9688615.html.plaintext.txt	239	together experiments indicate differentiated phenotype also confers increase f508 cftr maturation
0.42564055.9688615.html.plaintext.txt	240	effect dmso f508 cftr processing also observed primary human nasal polyp cells nonepithelial cells mouse fibroblast l cells fig
0.42564055.9688615.html.plaintext.txt	241	experiments cell types suggest usefulness approach activating f508 processing human epithelial cells
0.42564055.9688615.html.plaintext.txt	242	transmembrane proteins often distributed throughout plasma membrane cells undifferentiated
0.42564055.9688615.html.plaintext.txt	243	onset differentiation development adherens junctions tight junctions cell matrix interactions structural polarity established
0.42564055.9688615.html.plaintext.txt	244	process proteins target apical membrane appears occur default mechanism 10
0.42564055.9688615.html.plaintext.txt	245	results may indicate cellular polarity helps establish part default pathway
0.42564055.9688615.html.plaintext.txt	246	possibility f508 cftr enters apical targeting pathway specifically increase cellular differentiation suggested results figs
0.42564055.9688615.html.plaintext.txt	247	contributors f508 maturation including stabilization folded structure f508 protein change f508 cftr interactions cellular chaperones decrease rate degradation f508 cftr er allow time reach golgi among alternative explanations findings shown
0.42564055.9688615.html.plaintext.txt	248	summary er epithelial cells hostile environment insofar cftr concerned
0.42564055.9688615.html.plaintext.txt	249	wild type f508 molecules even folded functional cl channels polyubiquitinated degraded short order half time 30 min proteasome possibly proteolytic pathways 20 44
0.42564055.9688615.html.plaintext.txt	250	cftr escapes er enters golgi may reach safe haven half time increases 12 h post er form
0.42564055.9688615.html.plaintext.txt	251	data suggest dmso treatment llc pk1 cells increased amount post er complex glycosylated membrane localized f508 cftr observed
0.42564055.9688615.html.plaintext.txt	252	neither block ubiquitination proteasome inhibition reported enhance f508 maturation less likely effects observed caused blockade proteasome ubiquitination
0.42564055.9688615.html.plaintext.txt	253	results raise possibility induction polarity llc pk1 cells might increase transition f508 cftr er trans golgi network figs
0.42564055.9688615.html.plaintext.txt	254	f508 cftr quality control mechanism becomes leaky differentiated cells compared undifferentiated state findings could important implications concerning vivo processing f508 cftr occurs well organized cells within tissues characterized tight junctions polarity
0.42564055.9688615.html.plaintext.txt	255	experiments needed test possibility well test effects dmso treatment f508 cf mice
0.42564055.9688615.html.plaintext.txt	256	gadi jan tidwell kynda roberts bonnie parrott help preparation manuscript eddie walthall technical assistance drs
0.42564055.9688615.html.plaintext.txt	257	vytas bankaitis douglas cyr useful discussions
0.42564055.9688615.html.plaintext.txt	258	work supported national institutes health cystic fibrosis foundation
0.42564055.9688615.html.plaintext.txt	259	address reprint requests e
0.42564055.9688615.html.plaintext.txt	260	sorscher gregory fleming james cystic fibrosis research center univ
0.42564055.9688615.html.plaintext.txt	261	alabama birmingham 1918 univ
0.42564055.9688615.html.plaintext.txt	262	boulevard bhsb 798 birmingham al 35294 0005
0.42564055.9688615.html.plaintext.txt	263	received 25 april 1997 accepted final form 27 april 1998
0.42564055.9688615.html.plaintext.txt	264	references top abstract introduction methods results discussion references
0.42564055.9688615.html.plaintext.txt	265	polarized expression gaba transporters madin darby canine kidney cells cultured hippocampal neurons
0.42564055.9688615.html.plaintext.txt	266	271 6917 6924 1996abstractfree full text
0.42564055.9688615.html.plaintext.txt	267	chemical chaperones correct mutant phenotype f508 cystic fibrosis transmembrane conductance regulator protein
0.42564055.9688615.html.plaintext.txt	268	cell stress chaperones 1 117 125 1996
0.42564055.9688615.html.plaintext.txt	269	functional activation cystic fibrosis trafficking mutant f508 cftr overexpression
0.42564055.9688615.html.plaintext.txt	270	12 l615 l624 1995abstractfree full text
0.42564055.9688615.html.plaintext.txt	271	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.42564055.9688615.html.plaintext.txt	272	cell 63 827 834 1990medline
0.42564055.9688615.html.plaintext.txt	273	analysis cftr truncation mutations r553x g542x mammalian cell lines xenopus oocytes human subjects abstract
0.42564055.9688615.html.plaintext.txt	274	altered chloride ion channel kinetics associated delta f508 cystic fibrosis mutation
0.42564055.9688615.html.plaintext.txt	275	nature 354 526 528 1991medline
0.42564055.9688615.html.plaintext.txt	276	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.42564055.9688615.html.plaintext.txt	277	nature 358 761 764 1992medline
0.42564055.9688615.html.plaintext.txt	278	pleiotropic upregulation na dependent cotransporters retinoic acid opossum kidney cells
0.42564055.9688615.html.plaintext.txt	279	42 f438 f444 1997abstractfree full text
0.42564055.9688615.html.plaintext.txt	280	cftr differentiation markers expression non cf delta f508 homozygous cf nasal epithelium
0.42564055.9688615.html.plaintext.txt	281	apical basal lateral cues epithelial polarization
0.42564055.9688615.html.plaintext.txt	282	basolateral localization export activity human multidrug resistance associated protein polarized pig kidney cells
0.42564055.9688615.html.plaintext.txt	283	97 1211 1218 1996abstractfree full text
0.42564055.9688615.html.plaintext.txt	284	polarized gp2 secretion mdck cells via gpi targeting apical membrane restricted proteolysis
0.42564055.9688615.html.plaintext.txt	285	33 g176 g183 1996abstractfree full text
0.42564055.9688615.html.plaintext.txt	286	human uterine cervical epithelial cells grown permeable supporta new model study differentiation
0.42564055.9688615.html.plaintext.txt	287	differentiation 56 107 118 1994medline
0.42564055.9688615.html.plaintext.txt	288	different propensity spontaneous differentiation cell clones isolated human ovarian surface epithelial cell line hoc 7
0.42564055.9688615.html.plaintext.txt	289	differentiation 53 45 50 1993medline
0.42564055.9688615.html.plaintext.txt	290	gap junctions cell polarity connexin32 connexin43 expressed polarized thyroid epithelial cells assemble separate gap junctions located distinct regions lateral plasma membrane domain
0.42564055.9688615.html.plaintext.txt	291	108 2609 2617 1995abstractfree full text
0.42564055.9688615.html.plaintext.txt	292	recombinant synthesis purification nucleotide binding characteristics first nucleotide binding domain cystic fibrosis gene product
0.42564055.9688615.html.plaintext.txt	293	267 6455 6458 1992abstractfree full text
0.42564055.9688615.html.plaintext.txt	294	severe phenotype mice termination mutation exon 2 cystic fibrosis gene
0.42564055.9688615.html.plaintext.txt	295	colonic crypt derived epithelia express induced ion transport differentiation monolayer cultures permeable matrix substrata
0.42564055.9688615.html.plaintext.txt	296	genistein potentiates wild type f508 cftr channel activity
0.42564055.9688615.html.plaintext.txt	297	42 c988 c998 1997abstractfree full text
0.42564055.9688615.html.plaintext.txt	298	multiple proteolytic systems including proteasome contribute cftr processing
0.42564055.9688615.html.plaintext.txt	299	cell 83 129 135 1995medline
0.42564055.9688615.html.plaintext.txt	300	biogenesis traffic function cystic fibrosis transmembrane conductance regulator
0.42564055.9688615.html.plaintext.txt	301	vivo activation cystic fibrosis transmembrane conductance regulator mutant deltaf508 murine nasal epithelium
0.42564055.9688615.html.plaintext.txt	302	usa 94 2604 2608 1997abstractfree full text
0.42564055.9688615.html.plaintext.txt	303	effect sodium butyrate dimethylsulfoxide biochemical properties human colon cancer cells
0.42564055.9688615.html.plaintext.txt	304	cancer 45 1185 1192 1980medline
0.42564055.9688615.html.plaintext.txt	305	effects cell differentiation ion conductances membrane voltage llc pk1 cells
0.42564055.9688615.html.plaintext.txt	306	culture dependent expression na conductances airway epithelial cells
0.42564055.9688615.html.plaintext.txt	307	chemical inducers differentiation long term renal cell line
0.42564055.9688615.html.plaintext.txt	308	expression differentiated functions kidney epithelial cell lines
0.42564055.9688615.html.plaintext.txt	309	stoichiometry recombinant cystic fibrosis transmembrane conductance regulator epithelial cells functional reconstitution cells vitro
0.42564055.9688615.html.plaintext.txt	310	269 2987 2995 1994abstractfree full text
0.42564055.9688615.html.plaintext.txt	311	hierarchy mechanisms involved generating nak atpase polarity mdck epithelial cells
0.42564055.9688615.html.plaintext.txt	312	130 1105 1115 1995abstract
0.42564055.9688615.html.plaintext.txt	313	chronic exposure llc pk1 epithelia phorbol ester tpa produces polyp like foci leaky tight junctions altered protein kinase c alpha expression localization
0.42564055.9688615.html.plaintext.txt	314	biochemical morphological differentiation human colonic epithelial cell line sw620 presence dimethylsulfoxide
0.42564055.9688615.html.plaintext.txt	315	mutant delta f508 cystic fibrosis transmembrane conductance regulator cl channel functional retained endoplasmic reticulum mammalian cells
0.42564055.9688615.html.plaintext.txt	316	270 12347 12350 1995abstractfree full text
0.42564055.9688615.html.plaintext.txt	317	one step affinity isolation recombinant protein using baculovirusinsect cell expression system
0.42564055.9688615.html.plaintext.txt	318	morphology differentiation maturation llc pk1 epithelia
0.42564055.9688615.html.plaintext.txt	319	cystic fibrosis affects specific cell type sweat gland secretory coil
0.42564055.9688615.html.plaintext.txt	320	42 c426 c433 1997abstractfree full text
0.42564055.9688615.html.plaintext.txt	321	pilot clinical trial oral sodium 4 phenyl butyrate buphenyl f508 homozygous cystic fibrosis patients partial restoration nasal epithelial cftr function
0.42564055.9688615.html.plaintext.txt	322	157 484 490 1998abstractfree full text
0.42564055.9688615.html.plaintext.txt	323	glycerol reverses misfolding phenotype common cystic fibrosis mutation
0.42564055.9688615.html.plaintext.txt	324	271 635 638 1996abstractfree full text
0.42564055.9688615.html.plaintext.txt	325	differentiation dependent expression naglucose cotransporter sglt1 llc pk1 cells role protein kinase c activation ongoing transcription
0.42564055.9688615.html.plaintext.txt	326	usa 91 11919 11923 1994abstractfree full text
0.42564055.9688615.html.plaintext.txt	327	characterization llc pk1 kidney epithelial cells vitro model studying renal tubular reabsorption protein drugs
0.42564055.9688615.html.plaintext.txt	328	differential effects sodium butyrate dimethyl sulfoxide retinoic acid membrane associated antigen enzymes glycoproteins human rectal adenocarcinomea cells
0.42564055.9688615.html.plaintext.txt	329	met proto oncogene mesenchymal epithelial cell conversion
0.42564055.9688615.html.plaintext.txt	330	science 263 98 101 1994medline
0.42564055.9688615.html.plaintext.txt	331	cholinergic regulation na absorption turtle colon role basolateral k conductance
0.42564055.9688615.html.plaintext.txt	332	20 c563 c570 1986abstractfree full text
0.42564055.9688615.html.plaintext.txt	333	atp alters current fluctuations cystic fibrosis transmembrane conductance regulator evidence three state activation mechanism
0.42564055.9688615.html.plaintext.txt	334	degradation cftr ubiquitin proteasome pathway
0.42564055.9688615.html.plaintext.txt	335	cell 83 121 127 1995medline
0.42564055.9688615.html.plaintext.txt	336	influence molecular chemical chaperones protein folding
0.42564055.9688615.html.plaintext.txt	337	cell stress chaperones 1 109 115 1996 3 september 1996 p
0.42564055.9688615.html.plaintext.txt	338	molecular basis defective anion transport l cells expressing recombinant forms cftr
0.42564055.9688615.html.plaintext.txt	339	culture human nasal epithelial cells collagen matrix supports
0.42564055.9688615.html.plaintext.txt	340	comparison bioelectric properties normal cystic fibrosis epithelia
0.42564055.9688615.html.plaintext.txt	341	apical trehalase expression associated cell patterning inducer treatment llc pk1 monolayers
0.42564055.9688615.html.plaintext.txt	342	j physiol cell physiol 2752c599 c607 0002 951398 5
0.42564055.9688615.html.plaintext.txt	343	00 copyright 1998 american physiological society
0.42448953.11812794.html.plaintext.txt	0	principal role proteasome endoplasmic reticulum associated degradation misfolded intracellular cystic fibrosis transmembrane conductance regulator marina
0.42448953.11812794.html.plaintext.txt	1	department biological sciences stanford university stanford california 94305 5020
0.42448953.11812794.html.plaintext.txt	2	received publication december 14 2001 revised form january 16 2002
0.42448953.11812794.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.42448953.11812794.html.plaintext.txt	4	endoplasmic reticulum associated degradation misfolded cystic fibrosis transmembrane conductance regulator cftr protein known involve ubiquitin proteasome system
0.42448953.11812794.html.plaintext.txt	5	addition atp independent proteolytic system suggested operate parallel pathway become regulated proteasomes inhibited jensen
0.42448953.11812794.html.plaintext.txt	6	study use two independent techniques pulse chase labeling noninvasive fluorescence cell based assay investigate proteolytic pathways underlying degradation misfolded cftr
0.42448953.11812794.html.plaintext.txt	7	report inhibitors proteasome significant effect preventing degradation cftr whereas cell permeable inhibitors lysosomal degradation autophagy several classes protease measurable effect cftr degradation used either alone combination specific proteasome inhibitor carbobenzoxy l leucyl leucyl l leucinal mg132
0.42448953.11812794.html.plaintext.txt	8	results suggest ubiquitin proteasome mediated degradation dominant pathway disposal misfolded cftr mammalian cells provide new mechanistic insight endoplasmic reticulum associated degradation
0.42448953.11812794.html.plaintext.txt	9	introduction top abstract introduction experimental procedures results discussion references
0.42448953.11812794.html.plaintext.txt	10	endoplasmic reticulum er1 site synthesis membrane secretory proteins site conformational maturation assembly correctly folded functional molecules
0.42448953.11812794.html.plaintext.txt	11	quality control refers system monitors folding assembly proteins er ensuring correctly folded proteins mature later compartments secretory pathway 1 2
0.42448953.11812794.html.plaintext.txt	12	nascent proteins fail fold assemble er degraded process known er associated degradation erad 3
0.42448953.11812794.html.plaintext.txt	13	studies mammalian cells yeast led formulation general model erad substrates degraded cytoplasmic proteasomes following retrotranslocation
0.42448953.11812794.html.plaintext.txt	14	dislocation across er membrane process requires sec61 translocon functional ubiquitylation machinery cytosolic face er membrane 4 6
0.42448953.11812794.html.plaintext.txt	15	dislocation erad substrates across er membrane kinetically coupled degradation proteasomes many cases cytosolic intermediates degradation hard detect 7 8
0.42448953.11812794.html.plaintext.txt	16	although central role proteasomes erad widely accepted number studies suggested nonproteasomal proteolytic systems may also contribute elimination misfolded proteins er 9 12
0.42448953.11812794.html.plaintext.txt	17	polytopic membrane protein cystic fibrosis transmembrane conductance regulator cftr chloride channel expressed apical surface polarized epithelial cells one first integral membrane proteins demonstrated substrate ubiquitin proteasome system 9 13
0.42448953.11812794.html.plaintext.txt	18	mutations cftr gene cause recessively inherited fatal disease cystic fibrosis
0.42448953.11812794.html.plaintext.txt	19	although nearly 1000 mutations linked cystic fibrosis majority caucasian cystic fibrosis patients least one copy f508 mutation temperature sensitive allele unable fold correctly physiological temperature
0.42448953.11812794.html.plaintext.txt	20	consequence f508 cftr f508 deployed plasma membrane instead rapidly degraded without processed golgi apparatus 14 15
0.42448953.11812794.html.plaintext.txt	21	several lines evidence support role ubiquitin proteasome pathway f508 turnover
0.42448953.11812794.html.plaintext.txt	22	first cftr undergoes co translational posttranslational ubiquitylation expressed cell free system 16 17
0.42448953.11812794.html.plaintext.txt	23	second inhibition proteasome function chemical inhibitors dominant negative form ubiquitin leads accumulation multiubiquitylated undegraded forms cftr f508 13
0.42448953.11812794.html.plaintext.txt	24	third degradation f508 cell free system sensitive inhibitors 19 20 subunits proteasome 17 18
0.42448953.11812794.html.plaintext.txt	25	curiously despite compelling evidence support role proteasomes degradation misfolded cftr effect proteasome inhibition disappearance f508 pulse chase studies minimal 9 13
0.42448953.11812794.html.plaintext.txt	26	observation led investigators conclude proteolytic systems primarily responsible erad misfolded cftr molecules 9
0.42448953.11812794.html.plaintext.txt	27	however proteases proteolytic systems convincingly demonstrated contribute degradation cftr erad substrates
0.42448953.11812794.html.plaintext.txt	28	therefore intracellular fate f508 identity proteases participate degradation remain unresolved
0.42448953.11812794.html.plaintext.txt	29	study used reporter gfp f508 consisting fusion gfp f508 19 assess participation proteasomes proteolytic systems f508 degradation
0.42448953.11812794.html.plaintext.txt	30	data establish proteolytic activities proteasome responsible vast majority intracellular degradation misfolded cftr molecules
0.42448953.11812794.html.plaintext.txt	31	experimental procedures top abstract introduction experimental procedures results discussion references
0.42448953.11812794.html.plaintext.txt	32	reagents chemicals exception proteasome inhibitors obtained sigma chemical co
0.42448953.11812794.html.plaintext.txt	33	epoxomicin carbobenzoxy l leucyl leucyl l leucinal mg132 obtained calbiochem
0.42448953.11812794.html.plaintext.txt	34	yu102 generously provided dr
0.42448953.11812794.html.plaintext.txt	35	graig crews yale university new haven ct
0.42448953.11812794.html.plaintext.txt	36	polyclonal anti gfp antibody kind gift dr
0.42448953.11812794.html.plaintext.txt	37	michael rexach stanford university
0.42448953.11812794.html.plaintext.txt	38	constructs cell lines pgfp cftr pegfp c1 vector clontech obtained dr
0.42448953.11812794.html.plaintext.txt	39	stanton dartmouth medical school hanover nh subsequently subcloned pcdna3
0.42448953.11812794.html.plaintext.txt	40	1 vector invitrogen using nhei ecorv
0.42448953.11812794.html.plaintext.txt	41	f508 mutation introduced replacing pml1 blp1 cassette within cftr sequence
0.42448953.11812794.html.plaintext.txt	42	selection stable cho cell lines gfp f508pcdna3 plasmid linearized transfected cho cells calcium phosphate precipitation
0.42448953.11812794.html.plaintext.txt	43	cells subjected selection g418 containing medium
0.42448953.11812794.html.plaintext.txt	44	stable transfectants expanded culture enriched gfp f508 expressing cells fluorescence activated cell sorting highly fluorescent cells overnight incubation cells proteasome inhibitor n acetyl l leucinyl l leucinyl l norleucinal
0.42448953.11812794.html.plaintext.txt	45	cells cloned 96 well dishes density 1 cellwell
0.42448953.11812794.html.plaintext.txt	46	clonal cell lines expanded analyzed full length gfp f508 expression immunoblotting single clone clone 2 selected study
0.42448953.11812794.html.plaintext.txt	47	generation human embryonic kidney hek293 cells stably expressing gfpu described elsewhere 20
0.42448953.11812794.html.plaintext.txt	48	35s labeling immunoprecipitation cho clone 2 cells plated 10 x 10 cm dishes treated 5 mm butyrate overnight increase gfp f508 expression
0.42448953.11812794.html.plaintext.txt	49	next day cells starved cysteinemethionine free media 30 min labeled 35scysteinemethionine specific activity 1 mciml 30 min presence 5 mm butyrate
0.42448953.11812794.html.plaintext.txt	50	two 10 cm dishes harvested immediately pulse 0 h whereas remaining dishes chased presence protein synthesis inhibitor emetine 75 microm emetine mg132 25 microm together
0.42448953.11812794.html.plaintext.txt	51	specified time intervals cells solubilized buffer 10 mm tris ph 7
0.42448953.11812794.html.plaintext.txt	52	5 5 mm edta 150 mm nacl 1 np 40 0
0.42448953.11812794.html.plaintext.txt	53	05 deoxycholate containing completetm protease inhibitor mixture roche diagnostics gmbh 30 min
0.42448953.11812794.html.plaintext.txt	54	cell lysates precleared protein sepharose beads incubated anti gfp antibody protein sepharose
0.42448953.11812794.html.plaintext.txt	55	immunoprecipitates washed extensively buffer fractionated 4 15 gradient sds page bio rad
0.42448953.11812794.html.plaintext.txt	56	quantitation radioactive bands done using phosphorimager si imagequant software molecular dynamics
0.42448953.11812794.html.plaintext.txt	57	fluorescence activated cell sorting assay analysis gfp f508 cftr fluorescence flow cytometry performed using coulter epics xl mcl flow cytometer expo v
0.42448953.11812794.html.plaintext.txt	58	cells typically incubated 5 mm butyrate overnight increase gfp f508 cftr expression 10 microgml n acetyl l leucinyl l leucinyl l norleucinal 3 h increase gfpu steady state level
0.42448953.11812794.html.plaintext.txt	59	addition emetine without protease inhibitors cultures incubated different time intervals analysis
0.42448953.11812794.html.plaintext.txt	60	data 10000 cells collected mean fluorescence cell population used measure gfp f508 levels treatment
0.42448953.11812794.html.plaintext.txt	61	2 cells expressing gfp f508 hek293 cells expressing gfpu atp depleted incubating cells glucose free medium dulbeccos modified eagles medium invitrogen containing metabolic inhibitors cyanide 5 mm 2 deoxy d glucose 5 mm described previously 21
0.42448953.11812794.html.plaintext.txt	62	procedure reduces atp content 10 baseline value within 10 min sustains low level atp content 22
0.42448953.11812794.html.plaintext.txt	63	based determination initial fluorescence measurement atp depleted cells 0 h taken 10 min exposure cells metabolic inhibitors
0.42448953.11812794.html.plaintext.txt	64	results top abstract introduction experimental procedures results discussion references
0.42448953.11812794.html.plaintext.txt	65	effect proteasome inhibitors gfp f508 degradation metabolic pulse chase analysis validate use gfp f508 model f508 degradation performed pulse chase analysis clonal cho cell line cl
0.42448953.11812794.html.plaintext.txt	66	2 stably expressing fusion protein
0.42448953.11812794.html.plaintext.txt	67	2 cells selected low basal expression levels avoid accumulation gfp f508 detergent insoluble aggresomes highly refractory degradation 23
0.42448953.11812794.html.plaintext.txt	68	use cells treated transcriptional activator sodium butyrate increase gfp f508 expression
0.42448953.11812794.html.plaintext.txt	69	conditions aggregation gfp f508 undetectable either immunoblot fluorescence microscopy data shown
0.42448953.11812794.html.plaintext.txt	70	immunoprecipitation metabolically labeled cell lysates anti gfp antibody revealed major mr 170000 band corresponding core glycosylated gfp f508 high molecular weight hmw species migrating near top gel fig
0.42448953.11812794.html.plaintext.txt	71	chase mr 170000 band disappeared first order kinetics t12 50 min consistent previous determinations f508 9 24 25 gfp f508 half life 23
0.42448953.11812794.html.plaintext.txt	72	presence mg132 specific proteasome inhibitor 26 half life species modestly extended t12 1
0.42448953.11812794.html.plaintext.txt	73	minor band migrating mr 50000 probably corresponds amino terminal fragment gfp 508 fusion protein comprising mr 20000 cftr addition gfp moiety reacted antibody gfp antibody raised carboxyl terminus cftr data shown
0.42448953.11812794.html.plaintext.txt	74	disappearance mr 50000 fragment paralleled mr 170000 band t12 1
0.42448953.11812794.html.plaintext.txt	75	1 h also modestly inhibited mg132 t12 1
0.42448953.11812794.html.plaintext.txt	76	hmw forms gfp f508 detected immediately pulse top band fig
0.42448953.11812794.html.plaintext.txt	77	complexes disappeared rapidly chase conducted absence proteasome inhibitor t12 0
0.42448953.11812794.html.plaintext.txt	78	9 h contrast core glycosylated protein mr 50000 fragment strongly stabilized presence mg132 t12 6
0.42448953.11812794.html.plaintext.txt	79	view larger version 59k fig
0.42448953.11812794.html.plaintext.txt	80	pulse chase analysis gfp f508 cftr degradation
0.42448953.11812794.html.plaintext.txt	81	butyrate treated cho cells labeled 35scysteinemethionine chased indicated time intervals presence absence mg132 25 microm
0.42448953.11812794.html.plaintext.txt	82	cells solubilized lysates immunoprecipitated anti gfp antibody described experimental procedures
0.42448953.11812794.html.plaintext.txt	83	b quantitation individual bands total radioactivity lane performed using imagequant software
0.42448953.11812794.html.plaintext.txt	84	filled symbols represent cells chased without mg132 open symbols represent cells chased presence 25 microm mg132
0.42448953.11812794.html.plaintext.txt	85	insets show semilog plots data
0.42448953.11812794.html.plaintext.txt	86	insets solid broken lines represent cells chased without mg132 respectively
0.42448953.11812794.html.plaintext.txt	87	hmw complexes could represent either polyubiquitylated forms monomeric gfp f508 16 17 detergent insoluble aggregates cftr 23
0.42448953.11812794.html.plaintext.txt	88	distinguish possibilities sought determine whether hmw material accumulated chase presence mg132 could degraded washout inhibitor
0.42448953.11812794.html.plaintext.txt	89	results data shown indicate hmw material soluble nonionic detergent competent degradation strongly suggesting increase molecular weight due covalent modification ub observed previously cftr cell free extracts 17
0.42448953.11812794.html.plaintext.txt	90	quantification pulse chase data indicates mg132 marginally effective stabilizing mr 170000 f508 band
0.42448953.11812794.html.plaintext.txt	91	even total amount gfp immunoreactive material considered sum electrophoretic species fig
0.42448953.11812794.html.plaintext.txt	92	1b bottom right panel 40 initial amount gfp f508 stable end 4 h chase despite proteasome inhibition
0.42448953.11812794.html.plaintext.txt	93	observation suggests several plausible explanations
0.42448953.11812794.html.plaintext.txt	94	first suggested jensen et al
0.42448953.11812794.html.plaintext.txt	95	9 addition proteasomes proteolytic systems could also contribute f508 erad
0.42448953.11812794.html.plaintext.txt	96	alternatively possible proteolytic activities within proteasome remain uninhibited presence mg132 continue degrade substrate
0.42448953.11812794.html.plaintext.txt	97	finally immunoprecipitation radiolabeled material detergent extracts pulse labeled cells may underestimate amount stable f508 protein becomes insoluble epitope used immunoprecipitation becomes inaccessible increased molecular weight due polyubiquitylation andor aggregation protein prevents well resolved sds page
0.42448953.11812794.html.plaintext.txt	98	reasoned noninvasive method monitoring fluorescence gfp f508 intact cells using fluorescence activated cell sorting analysis may accurate way measure protein stability rely upon efficient recovery radiolabeled protein cells upon detection resolvable electrophoretic species
0.42448953.11812794.html.plaintext.txt	99	would turn allow us better evaluate effect protease inhibitors prevention cftr degradation
0.42448953.11812794.html.plaintext.txt	100	fluorescence based determination gfp f508 degradation circumvent limitations pulse chase approach developed fluorescence based assay measure degradation gfp f508
0.42448953.11812794.html.plaintext.txt	101	inhibition gfp f508 synthesis butyrate treated cells emetine inhibitor translational elongation caused rapid decrease mean fluorescence measured flow cytometry fig
0.42448953.11812794.html.plaintext.txt	102	similar results obtained translation inhibitors including cycloheximide puromycin data shown
0.42448953.11812794.html.plaintext.txt	103	emetine affect degradation kinetics cftr f508 13
0.42448953.11812794.html.plaintext.txt	104	decrease gfp f508 fluorescence fitted first order exponential t12 60 min good agreement gfp f508 half life measured pulse chase experiments fig
0.42448953.11812794.html.plaintext.txt	105	control experiment cho cells expressing gfp alone incubated emetine 10 h without loss total fluorescence data shown consistent gfp stable protein 20 indicating emetine treatment cause detectable cell lysis course experiment
0.42448953.11812794.html.plaintext.txt	106	together results suggest decline fluorescence cl
0.42448953.11812794.html.plaintext.txt	107	2 cells upon exposure protein synthesis inhibitor faithfully reflects degradation f508 constitutes valid convenient method characterization degradation process
0.42448953.11812794.html.plaintext.txt	108	view larger version 17k fig
0.42448953.11812794.html.plaintext.txt	109	fluorescence based measurement f508 cftr degradation rate
0.42448953.11812794.html.plaintext.txt	110	butyrate treated cells incubated 75 microm emetine indicated time intervals cellular fluorescence measured flow cytometry
0.42448953.11812794.html.plaintext.txt	111	mean fluorescence 10000 cells determined time point represented percentage initial fluorescence
0.42448953.11812794.html.plaintext.txt	112	inset shows semilog plot fluorescence decline versus time emetine half time fluorescence decline calculated
0.42448953.11812794.html.plaintext.txt	113	inhibition gfp f508 degradation proteasome inhibitors assess effect inhibition different proteolytic systems degradation mutant cftr using fluorescence assay evaluated effect panel protease inhibitors decline gfp f508 fluorescence butyrate treated cl
0.42448953.11812794.html.plaintext.txt	114	2 cells presence emetine fig
0.42448953.11812794.html.plaintext.txt	115	among inhibitors tested known inhibit proteasome n acetyl l leucinyl l leucinyl l norleucinal clasto lactacystin lactone mg132 significantly slowed degradation gfp f508
0.42448953.11812794.html.plaintext.txt	116	contrast inhibitors serine cysteine proteases tpck n tosyl lys chloromethyl ketone phenylmethylsulfonyl fluoride calpains edta lysosomal cathepsins 2s3s trans epoxysuccinyl l leucylamido 3 methylbutane ethyl ester chloroquine nh4cl autophagy 3 methyladenine wortmannin measurable effect degradation process either alone fig
0.42448953.11812794.html.plaintext.txt	117	3a combination mg132 25 microm data shown
0.42448953.11812794.html.plaintext.txt	118	data confirm central role proteasomes degradation f508 suggest major proteolytic systems contribute significantly process
0.42448953.11812794.html.plaintext.txt	119	view larger version 28k fig
0.42448953.11812794.html.plaintext.txt	120	effect protease inhibitors gfp f508 fluorescence
0.42448953.11812794.html.plaintext.txt	121	2 cells treated 5 mm butyrate overnight incubated 4 h emetine alone 75 microm emetine one following protease inhibitors n acetyl l leucinyl l leucinyl l norleucinal alln 10 microgml 2s3s trans epoxysuccinyl l leucylamido 3 methylbutane ethyl ester est 10 microm lactone 25 microm edta 2 mm chloroquine 150 microm nh4cl 10 mm mg132 25 microm n tosyl lys chloromethyl ketone tlck 2 microgml 3 methyladenine 3 ma 10 mm tpck 2 microgml wortmannin 100 nm
0.42448953.11812794.html.plaintext.txt	122	fluorescence end 4 h expressed percentage initial fluorescence 0 subtraction background fluorescence cho cell autofluorescence
0.42448953.11812794.html.plaintext.txt	123	b cho clone 2 cells expressing gfp f508 solid line hek293 cells expressing gfpu broken line incubated 75 microm emetine respectively 75 microm emetine 25 microm mg132 respectively indicated time intervals
0.42448953.11812794.html.plaintext.txt	124	mean cellular fluorescence expressed percentage initial fluorescence 0 h subtraction background fluorescence
0.42448953.11812794.html.plaintext.txt	125	presence mg132 25 microm fluorescence gfp f508 first increased reaching almost 120 initial fluorescence 1 h emetine chase fig
0.42448953.11812794.html.plaintext.txt	126	increase probably reflects slow fluorogenesis gfp moiety t12 30 90 min 27 28 absence cftr degradation
0.42448953.11812794.html.plaintext.txt	127	indeed transient increase fluorescence also observed gfpu gfp molecule targeted ubiquitin proteasome system degradation via short carboxyl terminal degron 20 fig
0.42448953.11812794.html.plaintext.txt	128	however contrast gfpu completely stabilized 25 microm mg132 fluorescence gfp f508 started decline first hour dropped 70 initial fluorescence 4 h emetine chase
0.42448953.11812794.html.plaintext.txt	129	half time decline gfp f508 fluorescence presence mg132 25 microm 6
0.42448953.11812794.html.plaintext.txt	130	8 h indicating proteasome inhibition results substantial stabilization gfp f508
0.42448953.11812794.html.plaintext.txt	131	determine whether continued decline gfp f508 fluorescence presence mg132 due degradation proteasome examined effect increased inhibitor concentration fluorescence remaining 4 h chase point fig
0.42448953.11812794.html.plaintext.txt	132	data suggest gfp f508 degradation inhibited mg132 biphasically high affinity component ic50 10 microm low affinity component able saturate even concentrations high 300 microm
0.42448953.11812794.html.plaintext.txt	133	view larger version 17k fig
0.42448953.11812794.html.plaintext.txt	134	dose dependence proteasome inhibitors fluorescence assay
0.42448953.11812794.html.plaintext.txt	135	fluorescence butyrate treated cho cl
0.42448953.11812794.html.plaintext.txt	136	2 cells measured 4 h addition emetine indicated concentrations mg132 expressed percentage initial fluorescence 0 h
0.42448953.11812794.html.plaintext.txt	137	values represent average three experiments
0.42448953.11812794.html.plaintext.txt	138	2 cells incubated emetine alone emetine plus following concentrations epoxomicin 1 microm 5 microm 10 microm 20 microm 50 microm
0.42448953.11812794.html.plaintext.txt	139	inset rate constants gfp f508 degradation calculated plotted function epoxomicin concentration
0.42448953.11812794.html.plaintext.txt	140	2 cells incubated increasing concentrations epoxomicin absence presence 500 microm yu102
0.42448953.11812794.html.plaintext.txt	141	values represent average three separate experiments
0.42448953.11812794.html.plaintext.txt	142	investigate role proteasomes gfp f508 degradation performed titration epoxomicin highly specific potent proteasome inhibitor 29
0.42448953.11812794.html.plaintext.txt	143	like mg132 epoxomicin inhibited gfp f508 fluorescence decay biphasically high affinity component ic50 1 microm low affinity component fig
0.42448953.11812794.html.plaintext.txt	144	although epoxomicin inhibit three characterized activities proteasomes 66 500 fold effective inhibiting chymotrypsin like ct l activity trypsin like peptidyl glutamyl hydrolyzing activities respectively 30
0.42448953.11812794.html.plaintext.txt	145	investigate whether low affinity component mg132 epoxomicin titrations due non ct l activities performed titration epoxomicin presence 500 microm yu102 epoxyketone inhibitor selective peptidyl glutamyl hydrolyzing activity proteasome 30
0.42448953.11812794.html.plaintext.txt	146	treatment resulted small 10 15 significant increase degree inhibition gfp f508 fluorescence decay epoxomicin concentrations fig
0.42448953.11812794.html.plaintext.txt	147	results suggest ct l peptidyl glutamyl hydrolyzing activities proteasome may contribute independently degradation gfp f508
0.42448953.11812794.html.plaintext.txt	148	hallmark proteolysis ub proteasome system dependence atp hydrolysis
0.42448953.11812794.html.plaintext.txt	149	atp required least two steps ub dependent degradation activation ub substrate unfolding 31 32
0.42448953.11812794.html.plaintext.txt	150	however previous studies suggested fraction cftr degradation insensitive proteasome inhibitors independent atp 9
0.42448953.11812794.html.plaintext.txt	151	assess dependence gfp f508 degradation atp assayed gfp f508 fluorescence atp depleted cl
0.42448953.11812794.html.plaintext.txt	152	data demonstrate gfp f508 degradation absolutely dependent presence cellular atp
0.42448953.11812794.html.plaintext.txt	153	degradation gfpu similarly dependent upon atp fig
0.42448953.11812794.html.plaintext.txt	154	view larger version 16k fig
0.42448953.11812794.html.plaintext.txt	155	effect atp depletion gfp f508 gfpu degradation
0.42448953.11812794.html.plaintext.txt	156	2 cells expressing gfp f508 hek293 cells expressing gfpu b subjected emetine chase 4 h either high glucose medium glucose free medium containing 5 mm cyanide 5 mm 2 deoxy d glucose
0.42448953.11812794.html.plaintext.txt	157	data point represents average three separate experiments
0.42448953.11812794.html.plaintext.txt	158	discussion top abstract introduction experimental procedures results discussion references
0.42448953.11812794.html.plaintext.txt	159	er associated degradation central element quality control pathways ensure correctly folded assembled proteins deployed secretory pathway eukaryotic cells
0.42448953.11812794.html.plaintext.txt	160	although many studies confirmed primary role ub proteasome system erad apparently minimal effect highly potent proteasome inhibitors degradation cftr remained enigma suggested atp independent proteolytic systems also contribute erad
0.42448953.11812794.html.plaintext.txt	161	study used fluorescent substrate re evaluate role ups erad
0.42448953.11812794.html.plaintext.txt	162	data establish primacy ups degradation er associated misfolded cftr suggest different proteolytic functionalities proteasome associated three active subunits may operate independently degradation erad substrate gfp f508 apparently degradation cytoplasmic substrate gfpu
0.42448953.11812794.html.plaintext.txt	163	three lines evidence support conclusion ups principal pathway degradation misfolded cftr
0.42448953.11812794.html.plaintext.txt	164	first proteasome inhibitors inhibitors serine cysteine proteases inhibitors lysosomal autophagic pathways strongly stabilize gfp f508 fluorescence
0.42448953.11812794.html.plaintext.txt	165	second gfp f508 degradation inhibited mg132 epoxomicin dose dependent fashion biphasic apparent ic50 values expected range ct l non ct l activities 30
0.42448953.11812794.html.plaintext.txt	166	third gfp f508 degradation strictly dependent atp hallmark ups mediated proteolysis 31 32
0.42448953.11812794.html.plaintext.txt	167	possibility proteases initiate clipping cftr molecule situated er membrane followed proteasome mediated proteolysis also unlikely simultaneous addition protease proteasome inhibitors protect cftr degradation
0.42448953.11812794.html.plaintext.txt	168	although results rule participation cftr degradation protease classes cell permeable inhibitors available
0.42448953.11812794.html.plaintext.txt	169	aspartic proteases aminopeptidases forth substrate specific proteases e
0.42448953.11812794.html.plaintext.txt	170	colligin specific inhibitor procollagen degradation 33 data establish inhibition proteolytic activities proteasome alone sufficient prevent degradation majority f508 molecules living cells
0.42448953.11812794.html.plaintext.txt	171	previous studies using metabolic pulse chase labeling immunoprecipitation proteasome inhibitors including mg132 lactacystin modest effect inhibiting decay electrophoretic species corresponding core glycosylated f508 degradation 9 13
0.42448953.11812794.html.plaintext.txt	172	present work show least part radiolabel lost core glycosylated gfp f508 could recovered high molecular weight material
0.42448953.11812794.html.plaintext.txt	173	hmw material remains competent degradation data suggest absence proteasome function significant fraction radiolabeled gfp f508 molecules converted multiubiquitylated forms
0.42448953.11812794.html.plaintext.txt	174	accumulation hmw forms presence proteasome inhibition observed erad substrates subunit cell receptor 7 34 soluble proteins igg light chains 8 tend accumulate core glycosylated detergent soluble monomers er proteasome inhibition
0.42448953.11812794.html.plaintext.txt	175	likely difference consequence topology cftr mass protein accessible cytoplasmic face er hence components ubiquitin conjugation system
0.42448953.11812794.html.plaintext.txt	176	recent study reported inhibition proteasome function leads accumulation substantial fraction cftr reconstituted cell free extracts high molecular weight multiubiquitylated protein 17
0.42448953.11812794.html.plaintext.txt	177	studies proteasome inhibitor combination thereof able completely suppress decay gfp f508 fluorescence
0.42448953.11812794.html.plaintext.txt	178	unlikely apparent degradation 20 30 decrease fluorescence 4 h chase presence proteasome inhibitors result cell death due toxic effects simultaneous exposure emetine proteasome inhibitor 98 cells able exclude propidium iodide staining end 4 h chase
0.42448953.11812794.html.plaintext.txt	179	alternatively decrease gfp f508 fluorescence could principle due self quenching gfp fluorescence closely packed aggregates gfp f508 known form upon chronic exposure proteasome inhibitors 23
0.42448953.11812794.html.plaintext.txt	180	self quenching form fluorescence resonance energy transfer fluorescence resonance energy transfer homotransfer
0.42448953.11812794.html.plaintext.txt	181	observe heterotransfer compatible fluorescence resonance energy transfer heterotransfer pair cfp f508 yfp f508 even conditions designed maximize aggregation2 unlikely homotransfer adjacent gfp f508 molecules could account observed decrease fluorescence
0.42448953.11812794.html.plaintext.txt	182	also formally possible small decrease gfp f508 fluorescence could due partial unfolding gfp moiety atpase activity 19 proteasome cap without actual degradation cftr
0.42448953.11812794.html.plaintext.txt	183	however simplest explanation may none proteasome inhibitors used alone combination able fully inhibit three proteasomal subunits
0.42448953.11812794.html.plaintext.txt	184	explanation consistent conversion similar fraction 30 labeled gfp f508 high molecular weight multiubiquitin conjugates presence mg132 pulse labeling experiments fig
0.42448953.11812794.html.plaintext.txt	185	1 cell free experiments oberdorf et al
0.42448953.11812794.html.plaintext.txt	186	likely therefore proteolytic activities proteasome associated individual subunits act strictly cooperative fashion erad
0.42448953.11812794.html.plaintext.txt	187	findings gfp f508 vivo consistent oberdorf et al
0.42448953.11812794.html.plaintext.txt	188	18 found complete inhibition 5 subunit associated ct l activity led 40 reduction cell free cftr degradation myung et al
0.42448953.11812794.html.plaintext.txt	189	30 reported recently selective peptidyl glutamyl hydrolyzing inhibition insufficient inhibit protein degradation vivo
0.42448953.11812794.html.plaintext.txt	190	data strongly indicate catalytic sites proteasome function independently
0.42448953.11812794.html.plaintext.txt	191	clear studies degradation gfpu small soluble substrate ups completely inhibited mg132 whereas degradation gfp f508
0.42448953.11812794.html.plaintext.txt	192	perhaps discrepancy reflection functional differences mechanisms proteasomes engage substrates delivered cytosol dislocated across er membrane
0.42448953.11812794.html.plaintext.txt	193	thank neil bence providing hek293 cells expressing gfpu karim helmy help epoxomicin atp depletion experiments
0.42448953.11812794.html.plaintext.txt	194	craig crews kind gift yu102
0.42448953.11812794.html.plaintext.txt	195	also thank members kopito laboratory helpful comments
0.42448953.11812794.html.plaintext.txt	196	work supported part national institutes health grant r01 dk43994 r
0.42448953.11812794.html.plaintext.txt	197	costs publication article defrayed part payment page charges
0.42448953.11812794.html.plaintext.txt	198	article must therefore hereby marked advertisement accordance 18 u
0.42448953.11812794.html.plaintext.txt	199	section 1734 solely indicate fact
0.42448953.11812794.html.plaintext.txt	200	supported part postdoctoral training grant national institutes health
0.42448953.11812794.html.plaintext.txt	201	correspondence addressed dept
0.42448953.11812794.html.plaintext.txt	202	biological sciences stanford university 371 serra mall stanford ca 94305 5020
0.42448953.11812794.html.plaintext.txt	203	650 723 7581 fax 650 723 8475 e mail kopitostanford
0.42448953.11812794.html.plaintext.txt	204	published jbc papers press january 25 2002 doi 10
0.42448953.11812794.html.plaintext.txt	205	abbreviations used er endoplasmic reticulum erad endoplasmic reticulum associated degradation ups ubiquitin proteasome system tpck tosylphenylalanyl chloromethyl ketone cho chinese hamster ovary cftr cystic fibrosis transmembrane conductance regulator gfp green fluorescent protein cl
0.42448953.11812794.html.plaintext.txt	206	2 clone 2 hmw high molecular weight ub ubiquitin ct l chymotrypsin like
0.42448953.11812794.html.plaintext.txt	207	references top abstract introduction experimental procedures results discussion references 1
0.42448953.11812794.html.plaintext.txt	208	356 147 150crossrefmedline order article via infotrieve 2
0.42448953.11812794.html.plaintext.txt	209	13 431 437crossrefmedline order article via infotrieve 3
0.42448953.11812794.html.plaintext.txt	210	10 507 513crossrefmedline order article via infotrieve 4
0.42448953.11812794.html.plaintext.txt	211	1997 cell 88 427 430medline order article via infotrieve 5
0.42448953.11812794.html.plaintext.txt	212	26 125 130crossrefmedline order article via infotrieve 6
0.42448953.11812794.html.plaintext.txt	213	2000 cell 102 709 712medline order article via infotrieve 7
0.42448953.11812794.html.plaintext.txt	214	274 36852 36858abstractfree full text 8
0.42448953.11812794.html.plaintext.txt	215	163 11 14abstractfree full text 9
0.42448953.11812794.html.plaintext.txt	216	1995 cell 83 129 135medline order article via infotrieve 10
0.42448953.11812794.html.plaintext.txt	217	18 779 789abstractfree full text 11
0.42448953.11812794.html.plaintext.txt	218	353 493 501crossrefmedline order article via infotrieve 12
0.42448953.11812794.html.plaintext.txt	219	276 41444 41454abstractfree full text 13
0.42448953.11812794.html.plaintext.txt	220	1995 cell 83 121 127medline order article via infotrieve 14
0.42448953.11812794.html.plaintext.txt	221	79 s167 s173medline order article via infotrieve 15
0.42448953.11812794.html.plaintext.txt	222	2000 traffic 1 852 870crossrefmedline order article via infotrieve 16
0.42448953.11812794.html.plaintext.txt	223	273 7189 7192abstractfree full text 17
0.42448953.11812794.html.plaintext.txt	224	274 2616 2624abstractfree full text 18
0.42448953.11812794.html.plaintext.txt	225	2001 biochemistry 40 13397 13405crossrefmedline order article via infotrieve 19
0.42448953.11812794.html.plaintext.txt	226	273 21759 21768abstractfree full text 20
0.42448953.11812794.html.plaintext.txt	227	2001 science 292 1552 1555abstractfree full text 21
0.42448953.11812794.html.plaintext.txt	228	cell physiol 281 c1667 c1675abstractfree full text 22
0.42448953.11812794.html.plaintext.txt	229	270 f1057 f1065abstractfree full text 23
0.42448953.11812794.html.plaintext.txt	230	143 1883 1898abstractfree full text 24
0.42448953.11812794.html.plaintext.txt	231	269 25710 25718abstractfree full text 25
0.42448953.11812794.html.plaintext.txt	232	1994 cell 78 761 771medline order article via infotrieve 27
0.42448953.11812794.html.plaintext.txt	233	14 315 319medline order article via infotrieve 28
0.42448953.11812794.html.plaintext.txt	234	17 691 695crossrefmedline order article via infotrieve 29
0.42448953.11812794.html.plaintext.txt	235	96 10403 10408abstractfree full text 30
0.42448953.11812794.html.plaintext.txt	236	cell 7 411 420medline order article via infotrieve 31
0.42448953.11812794.html.plaintext.txt	237	67 425 479crossrefmedline order article via infotrieve 32
0.42448953.11812794.html.plaintext.txt	238	17 7151 7160free full text 33
0.42448953.11812794.html.plaintext.txt	239	314 23 30crossrefmedline order article via infotrieve 34
0.42448953.11812794.html.plaintext.txt	240	272 20800 20804abstractfree full text
0.42448953.11812794.html.plaintext.txt	241	copyright 2002 american society biochemistry molecular biology inc
0.44094175.11877404.html.plaintext.txt	0	diffusional mobility cystic fibrosis transmembrane conductance regulator mutant f508 cftr endoplasmic reticulum measured photobleaching gfp cftr chimeras peter m
0.44094175.11877404.html.plaintext.txt	1	departments medicine physiology cardiovascular research institute university california san francisco california 94143 0521 dartmouth medical school hanover new hampshire 03755 3835
0.44094175.11877404.html.plaintext.txt	2	received publication december 25 2001 revised form february 26 2002
0.44094175.11877404.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.44094175.11877404.html.plaintext.txt	4	mutations cystic fibrosis transmembrane conductance regulator protein cftr cause cystic fibrosis
0.44094175.11877404.html.plaintext.txt	5	common disease causing mutation f508 retained endoplasmic reticulum er unable function plasma membrane chloride channel
0.44094175.11877404.html.plaintext.txt	6	investigate whether er retention f508 cftr caused immobilization andor aggregation measured diffusional mobility green fluorescent protein gfp chimeras wild type wt cftr f508 cftr fluorescence recovery photobleaching
0.44094175.11877404.html.plaintext.txt	7	gfp labeled f508 cftr localized er wt cftr plasma membrane intracellular membranes transfected cos7 chinese hamster ovary k1 cells
0.44094175.11877404.html.plaintext.txt	8	chimeras localized er brefeldin treatment
0.44094175.11877404.html.plaintext.txt	9	spot photobleaching showed cftr diffusion diffusion coefficient 109 cm2s significantly slowed f508 mutation nearly wt cftr f508 cftr diffused throughout er without restriction
0.44094175.11877404.html.plaintext.txt	10	stabilization molecular chaperone interactions atp depletion produced remarkable f508 cftr immobilization 50 slowed diffusion 6
0.44094175.11877404.html.plaintext.txt	11	5 x 1010 cm2s little effect wt cftr
0.44094175.11877404.html.plaintext.txt	12	fluorescence depletion experiments revealed immobilized f508 cftr atp depleted cells remained er pattern
0.44094175.11877404.html.plaintext.txt	13	mobility wt cftr f508 cftr reduced maneuvers alter cftr processing interactions molecular chaperones including tunicamycin geldanamycin lactacystin
0.44094175.11877404.html.plaintext.txt	14	photobleaching fluorescent er lipid dioc43 showed neither er restructuring fragmentation maneuvers responsible slowing immobilization cftr
0.44094175.11877404.html.plaintext.txt	15	results suggest er retention f508 cftr due restricted er mobility b majority f508 cftr aggregated bound slowly moving membrane proteins c f508 cftr may interact greater extent molecular chaperones wt cftr
0.44094175.11877404.html.plaintext.txt	16	introduction top abstract introduction experimental procedures results discussion references
0.44094175.11877404.html.plaintext.txt	17	cystic fibrosis transmembrane conductance regulator protein cftr1 mediates transepithelial chloride transport across epithelial cells airways intestine pancreas sweat gland
0.44094175.11877404.html.plaintext.txt	18	mutations cftr cause lethal genetic disease cystic fibrosis produces chronic lung infection progressively impaired pulmonary function pancreatic insufficiency
0.44094175.11877404.html.plaintext.txt	19	common cftr mutant f508 cftr retained endoplasmic reticulum er consequently unable function plasma membrane chloride channel 1
0.44094175.11877404.html.plaintext.txt	20	electrophysiological studies indicate er retained f508 cftr least partially functional excised er membranes 2
0.44094175.11877404.html.plaintext.txt	21	growth f508 cftr expressing cells non physiological conditions low temperature ref
0.44094175.11877404.html.plaintext.txt	22	3 chemical chaperones ref
0.44094175.11877404.html.plaintext.txt	23	4 indicates certain conditions f508 cftr transported plasma membrane restore cell chloride permeability
0.44094175.11877404.html.plaintext.txt	24	cftr biosynthesis inefficient process
0.44094175.11877404.html.plaintext.txt	25	newly synthesized wild type wt cftr f508 cftr folded er membrane become core glycosylated 5 6
0.44094175.11877404.html.plaintext.txt	26	20 30 newly synthesized wt cftr transported golgi complex glycosylation occurs remaining protein ubiquinated degraded proteasome 7 8
0.44094175.11877404.html.plaintext.txt	27	wild type cftr exists initially protease susceptible form t12 30 min becomes stable upon transport er golgi t12 24 h whereas f508 cftr rapidly degraded t12 30 min 5 6
0.44094175.11877404.html.plaintext.txt	28	inhibition proteasome function results formation aggresomes detergent insoluble perinuclear protein aggregates common many degenerative diseases 9 11
0.44094175.11877404.html.plaintext.txt	29	cftr folding er appears facilitated interactions cellular quality control machinery
0.44094175.11877404.html.plaintext.txt	30	wild type cftr f508 cftr shown interact molecular chaperones hsc70 hdj2 hsp70 hsp90 calnexin bip grp94 12 15
0.44094175.11877404.html.plaintext.txt	31	recent data suggest hsc70 co chaperone chip c terminus hsc70 interacting protein targets immature cftr proteasome mediated degradation 16
0.44094175.11877404.html.plaintext.txt	32	biochemical data indicate calnexin hsp70 bind f508 cftr avidly wt cftr 12 13
0.44094175.11877404.html.plaintext.txt	33	differential processing f508 cftr wt cftr however probably accounted gross structural differences
0.44094175.11877404.html.plaintext.txt	34	proteolytic cleavage experiments suggested conformation f508 cftr similar early relatively unstable form wt cftr 17
0.44094175.11877404.html.plaintext.txt	35	vitro folding studies isolated nucleotide binding domain 1 containing phenylalanine 508 residue support view f508 mutation affect structure 18 19 may affect folding kinetics
0.44094175.11877404.html.plaintext.txt	36	used fluorescence recovery photobleaching measure diffusional mobility wt cftr f508 cftr er investigate whether f508 cftr immobilization interaction chaperones responsible er retention
0.44094175.11877404.html.plaintext.txt	37	several mechanisms proposed explain failure f508 cftr exported er immobilization f508 cftr potentially association chaperones self aggregation efficient f508 cftr recycling golgi andor failure er export machinery recognize f508 cftr
0.44094175.11877404.html.plaintext.txt	38	photobleaching measurements done cells expressing green fluorescent protein gfp chimeras wt cftr f508 cftr series maneuvers used probe interactions cftr processing machinery
0.44094175.11877404.html.plaintext.txt	39	shown previously gfp fusion n terminus cftr effect cftr localization processing function 9 20 22
0.44094175.11877404.html.plaintext.txt	40	used photobleaching previously quantify aqueous phase rheology cellular organellar compartments 23 25 investigate protein protein interactions aquaporin aqp water channels er plasma membranes 26 27
0.44094175.11877404.html.plaintext.txt	41	find er retention f508 cftr due immobilization aggregation binding slow moving membrane components however greater fraction f508 cftr wild type cftr interacted molecular chaperones atp depletion inhibition cftr processing proteasome inhibitor resulted cftr aggregation immobilization
0.44094175.11877404.html.plaintext.txt	42	experimental procedures top abstract introduction experimental procedures results discussion references
0.44094175.11877404.html.plaintext.txt	43	cell culture plasmids transfection treatments cos7 atcc crl 1651 cho k1 atcc ccl 61 cells obtained university california san francisco cell culture facility cultured dmeh 21 hams f12 media respectively supplemented 10 fetal bovine serum 100 unitsml penicillin 100 microgml streptomycin 37 degrees c 5 co295 air atmosphere
0.44094175.11877404.html.plaintext.txt	44	cells grown 18 mm diameter glass coverslips 12 well plates
0.44094175.11877404.html.plaintext.txt	45	cells transiently transfected plasmid dna using 6 microl lipofectamine invitrogen 1 microg plasmid dna according manufacturers instructions
0.44094175.11877404.html.plaintext.txt	46	cdna encoding wt cftr fused downstream enhanced gfp clontech described previously f508 mutation introduced site directed mutagenesis 20 22
0.44094175.11877404.html.plaintext.txt	47	glycosylation null mutant gfp wt cftr asparagine residues replaced glutamines positions 894 900 also generated site directed mutagenesis
0.44094175.11877404.html.plaintext.txt	48	gfp expression er lumen gfp sequence flanked n terminal preprolactin leader sequence c terminal kdel motif 25
0.44094175.11877404.html.plaintext.txt	49	gfp expression cytoplasm coding region pegfp clontech ligated pcdna3
0.44094175.11877404.html.plaintext.txt	50	photobleaching experiments performed 2 3 days transfection cftr transfected cells 1 2 days transfection cytoplasmic er targeted unconjugated gfp
0.44094175.11877404.html.plaintext.txt	51	experiments gfp cftr transfected cells treated brefeldin bfa 16 24 h incubation 5 microgml 37 degrees c co2 incubator
0.44094175.11877404.html.plaintext.txt	52	atp depletion cells incubated phosphate buffered saline containing 6 mm 2 deoxyglucose 0
0.44094175.11877404.html.plaintext.txt	53	02 sodium azide 37 degrees c 30 min 1 h
0.44094175.11877404.html.plaintext.txt	54	geldanamycin calbiochem used 0
0.44094175.11877404.html.plaintext.txt	55	1 microgml 90 min 14 tunicamycin calbiochem 5 microgml 20 h
0.44094175.11877404.html.plaintext.txt	56	clasto lactacystin lactone active form lactacystin sigma used 6 microm 1
0.44094175.11877404.html.plaintext.txt	57	heat shock experiments cells incubated 42 degrees c 1 h followed 16 20 h recovery 37 degrees c
0.44094175.11877404.html.plaintext.txt	58	paraformaldehyde gfp cftr immobilization used 4 30 min phosphate buffered saline 23 degrees c
0.44094175.11877404.html.plaintext.txt	59	er membranes untransfected cells subjected various treatments fluorescently labeled 33 dibutyloxacarbocyanine iodide dioc43 molecular probes incubation 10 min 10 microm dye phosphate buffered saline 37 degrees c
0.44094175.11877404.html.plaintext.txt	60	experiments transfected cells identified green fluorescence prior dioc43 labeling cells photobleached
0.44094175.11877404.html.plaintext.txt	61	relatively small amount gfp little effect recovery much brighter rapidly diffusing dioc43
0.44094175.11877404.html.plaintext.txt	62	fluorescence recovery photobleaching spot photobleaching argon ion laser beam 488 nm innova 70 4 coherent modulated acousto optic modulator first order beam directed onto cells oil immersion nikon fluor objective lens x 40 numerical aperture n
0.44094175.11877404.html.plaintext.txt	63	4 using inverted epifluorescence microscope
0.44094175.11877404.html.plaintext.txt	64	visualize cells select cellular regions bleached full field epi illumination accomplished using expanded zero order laser beam directed onto objective lens fiber optic
0.44094175.11877404.html.plaintext.txt	65	beam reflected onto objective dichroic mirror 510 nm emitted fluorescence filtered serial 530 plus minus 15 nm bandpass 515 nm longpass filters
0.44094175.11877404.html.plaintext.txt	66	emitted fluorescence detected photomultiplier digitized 14 bit analog digital converter
0.44094175.11877404.html.plaintext.txt	67	photomultiplier transiently gated bleach pulse
0.44094175.11877404.html.plaintext.txt	68	fluorescence sampled 200 ms bleach pulse rates 1 mhz
0.44094175.11877404.html.plaintext.txt	69	measurement slow recoveries electronic shutter used collect fluorescence 1 hz averaging 10000 acquisitions shutter open time 20 ms
0.44094175.11877404.html.plaintext.txt	70	photobleaching experiments image detection leitz upright microscope cooled ccd camera detector photometrics used record full field epifluorescence images
0.44094175.11877404.html.plaintext.txt	71	electronically shuttered bleach beam argon laser 488 nm directed onto sample using nikon x 25 long working distance air objective
0.44094175.11877404.html.plaintext.txt	72	cells viewed using oil immersion x 60 objective n
0.44094175.11877404.html.plaintext.txt	73	4 gfp filter set hq filters chroma
0.44094175.11877404.html.plaintext.txt	74	software written labview national instruments coordinate bleach pulse illumination camera shutters image acquisition
0.44094175.11877404.html.plaintext.txt	75	fluorescence loss photobleaching flip experiments performed using apparatus repeated laser photobleaching performed specified delays bleach pulses
0.44094175.11877404.html.plaintext.txt	76	photobleaching experiments done 37 degrees c
0.44094175.11877404.html.plaintext.txt	77	cultured cells mounted custom built perfusion chambers designed fit pdmi 2 microincubator harvard apparatus controlled tc 201a temperature regulator harvard apparatus
0.44094175.11877404.html.plaintext.txt	78	objective lens temperature also maintained 37 degrees c using lens thermoregulator bioptechs inc
0.44094175.11877404.html.plaintext.txt	79	maneuvers gfp cftr expressing cells single recovery curves 5 12 different cells averaged generate single averaged recovery curve repeated 4 10 times using different coverslips
0.44094175.11877404.html.plaintext.txt	80	cytoplasmic gfp er targeted gfp expressing cells averaged recovery curve generated 10 individual recoveries different cell
0.44094175.11877404.html.plaintext.txt	81	dioc43 measurements averaged recovery curves generated average 5 8 cells
0.44094175.11877404.html.plaintext.txt	82	results reported means plus minus
0.44094175.11877404.html.plaintext.txt	83	number different coverslips representative averaged recovery curves single coverslips shown figures reader evaluate curve shape signal noise ratio
0.44094175.11877404.html.plaintext.txt	84	statistical analysis performed analysis variance control conditions values p 0
0.44094175.11877404.html.plaintext.txt	85	analysis photobleaching recovery data spot photobleaching recovery curves analyzed described levin et al
0.44094175.11877404.html.plaintext.txt	86	briefly recovery half times t12 time fluorescence recover 50 due diffusion determined fluorescence recovery curves ft non linear regression
0.44094175.11877404.html.plaintext.txt	87	fluorescence recovery curves taken combination reversible determined fixed cell analysis irreversible due diffusion processes ft a1ftreversible a2ftirreversible a1 a2 1
0.44094175.11877404.html.plaintext.txt	88	diffusion mediated recovery fitted using semiempirical equation ftirreversible f0 f0 rfinf f0tt121 tt12 f0 prebleach fluorescence finf fluorescence infinite time r fractional fluorescence recovery
0.44094175.11877404.html.plaintext.txt	89	absolute diffusion coefficients calculated t12 using mathematical model er diffusion 25 28
0.44094175.11877404.html.plaintext.txt	90	results top abstract introduction experimental procedures results discussion references
0.44094175.11877404.html.plaintext.txt	91	diffusion wt cftr f508 cftr er living cells determined using gfp fluorescent reporter fig
0.44094175.11877404.html.plaintext.txt	92	transfection cos7 cho cells gfp wt cftr chimera showed gfp localization plasma membrane intracellular membranes including golgi er exclusively er bfa treatment fig
0.44094175.11877404.html.plaintext.txt	93	gfp f508 cftr chimera seen er like pattern without bfa treatment fig
0.44094175.11877404.html.plaintext.txt	94	similar patterns er staining observed cos7 cho cells transfected er localized aqueous phase gfp stained fluorescent er lipid probe dioc43 shown
0.44094175.11877404.html.plaintext.txt	95	view larger version 36k fig
0.44094175.11877404.html.plaintext.txt	96	gfp cftr expression transiently transfected cos7 cho cells
0.44094175.11877404.html.plaintext.txt	97	gfp cftr construct showing cftr fused downstream gfp reporter
0.44094175.11877404.html.plaintext.txt	98	b fluorescence micrographs transiently transfected cos7 cho cells expressing gfp wt cftr without left right bfa treatment
0.44094175.11877404.html.plaintext.txt	99	c fluorescence micrographs cells expressing gfp f508 cftr
0.44094175.11877404.html.plaintext.txt	100	photobleaching experiments image detection done evaluate gross mobility gfp cftr chimeras bfa treated cos7 fig
0.44094175.11877404.html.plaintext.txt	101	large region cell 5 microm diameter marked cross hairs bleached laser pulse fluorescence recovery recorded serial imaging
0.44094175.11877404.html.plaintext.txt	102	case darkened region seen immediately postbleach 0
0.44094175.11877404.html.plaintext.txt	103	recovery bleached region diffusive nature edges bleach spot inward appears nearly complete
0.44094175.11877404.html.plaintext.txt	104	kinetics fluorescence recovery qualitatively similar cells expressing wt cftr f508 cftr cell types
0.44094175.11877404.html.plaintext.txt	105	case fluorescence recovery 80 complete determined ratio fluorescence intensity bleach spot whole cell immediately versus 4 min bleach
0.44094175.11877404.html.plaintext.txt	106	quantitative spot photobleaching done brighter cos7 cells
0.44094175.11877404.html.plaintext.txt	107	view larger version 78k fig
0.44094175.11877404.html.plaintext.txt	108	photobleaching gfp cftr chimeras transiently transfected cos7 cho b cells
0.44094175.11877404.html.plaintext.txt	109	photobleaching image detection cells expressing gfp labeled wt cftr f508 cftr bfa treatment
0.44094175.11877404.html.plaintext.txt	110	images shown bleaching bleach spot indicated white cross hairs indicated times bleach pulse
0.44094175.11877404.html.plaintext.txt	111	experiments done 37 degrees c
0.44094175.11877404.html.plaintext.txt	112	image series one set experiments representative 4 8
0.44094175.11877404.html.plaintext.txt	113	3a shows spot photobleaching gfp labeled wt cftr top f508 cftr bottom using x 60 oil immersion objective produce small spot 1
0.44094175.11877404.html.plaintext.txt	114	2 microm diameter gfp fluorescence bleached 50 initial value
0.44094175.11877404.html.plaintext.txt	115	distinguish processes produce irreversible photobleaching authentic gfp diffusion produce reversible photobleaching triplet state relaxation photophysical phenomena fluorescence recovery measured fixed cells fig
0.44094175.11877404.html.plaintext.txt	116	3b using different spot sizes fig
0.44094175.11877404.html.plaintext.txt	117	found prior photobleaching studies 26 27 fluorescence recovery remaining fixation represents reversible diffusion independent photobleaching fixation abolishes diffusion
0.44094175.11877404.html.plaintext.txt	118	3b top curve shows small component 5 10 reversible photobleaching 1 exponential time constant
0.44094175.11877404.html.plaintext.txt	119	similar recoveries found photobleaching conditions unconjugated gfp cytoplasm middle curve aqueous phase unconjugated gfp er lumen bottom curve
0.44094175.11877404.html.plaintext.txt	120	expected reversible fluorescence recovery recovery rates depend spot size shown
0.44094175.11877404.html.plaintext.txt	121	3c shows unfixed cells fluorescence recovery spot size dependent expected diffusive processes recovery time larger spot increases approximately square spot diameter
0.44094175.11877404.html.plaintext.txt	122	using regression procedure determine t12 irreversible fluorescence recovery see experimental procedures t12 values gfp wt cftr 1040 plus minus 60 ms 100 x 3
0.44094175.11877404.html.plaintext.txt	123	2 40 x n 4 10 sets measurements
0.44094175.11877404.html.plaintext.txt	124	t12 values gfp f508 cftr bfa treated cells 1170 plus minus 120 ms 100 x 3
0.44094175.11877404.html.plaintext.txt	125	relative t12 expected diffusive process
0.44094175.11877404.html.plaintext.txt	126	view larger version 19k fig
0.44094175.11877404.html.plaintext.txt	127	quantitative spot photobleaching diffusion gfp labeled wt cftr f508 cftr er
0.44094175.11877404.html.plaintext.txt	128	spot photobleaching cells expressing wt cftr top f508 cftr bottom measured using x 60 oil immersion objective
0.44094175.11877404.html.plaintext.txt	129	bleach time 200 500 micros
0.44094175.11877404.html.plaintext.txt	130	curve average 10 fluorescence recovery experiments done different cell
0.44094175.11877404.html.plaintext.txt	131	b spot photobleaching paraformaldehyde fixed cells expressing gfp labeled wt cftr top cytoplasmic unconjugated gfp middle er lumen aqueous phase gfp bottom
0.44094175.11877404.html.plaintext.txt	132	measurements done x 60 objective
0.44094175.11877404.html.plaintext.txt	133	c spot photobleaching gfp labeled wt cftr measured using indicated objectives
0.44094175.11877404.html.plaintext.txt	134	bleach time adjusted give 40 50 bleach
0.44094175.11877404.html.plaintext.txt	135	d spot photobleaching soluble gfp er lumen top
0.44094175.11877404.html.plaintext.txt	136	summary absolute diffusion coefficients d middle percentage fluorescence recoveries bottom gfp cftr chimeras
0.44094175.11877404.html.plaintext.txt	137	n 5 10 sets experiments p 0
0.44094175.11877404.html.plaintext.txt	138	determine absolute diffusion coefficients comparative photobleaching measurements done gfp labeled cftr chimeras fig
0.44094175.11877404.html.plaintext.txt	139	3a soluble gfp er lumen
0.44094175.11877404.html.plaintext.txt	140	series experiments shown fig
0.44094175.11877404.html.plaintext.txt	141	3a t12 measured using x 60 objective 3
0.44094175.11877404.html.plaintext.txt	142	6 f508 cftr bfa n 5 10 sets experiments
0.44094175.11877404.html.plaintext.txt	143	3d top shows substantially faster fluorescence recovery soluble gfp er lumen cos7 cells t12 60 plus minus 4 ms n 12
0.44094175.11877404.html.plaintext.txt	144	value similar measured cho k1 cells identical conditions t12 65 plus minus 4 ms n 6 shown
0.44094175.11877404.html.plaintext.txt	145	absolute diffusion coefficient luminal gfp cos7 cells computed using simple model correct er geometric effects 28 6
0.44094175.11877404.html.plaintext.txt	146	5 x 108 cm2s similar previously measured cho cells 25 llc pk1 cells 27
0.44094175.11877404.html.plaintext.txt	147	3d middle summarizes diffusion coefficients gfp chimeras
0.44094175.11877404.html.plaintext.txt	148	significant effect f508 mutation cftr diffusion andor bfa treatment f508 cftr mobility
0.44094175.11877404.html.plaintext.txt	149	3d bottom summarizes percentage mobile gfp determined completeness fluorescence recovery long times
0.44094175.11877404.html.plaintext.txt	150	gfp wt cftr fluorescence recovered almost completely 92 plus minus 2 n 10 whereas gfp f508 cftr recovery bfa treated untreated cells slightly though significantly smaller 85 plus minus 2 82 plus minus 1
0.44094175.11877404.html.plaintext.txt	151	investigate interactions wt cftr f508 cftr elements er quality control machinery used series maneuvers modulate molecular chaperone interactions
0.44094175.11877404.html.plaintext.txt	152	4a shows wt cftr mobility atp depletion maneuver increases interactions cftr chaperones er produced 30 min incubation 6 mm 2 deoxyglucose 0
0.44094175.11877404.html.plaintext.txt	153	diffusion coefficient gfp wt cftr similar control conditions 10
0.44094175.11877404.html.plaintext.txt	154	9 x 1010 cm2s n 7 percentage recovery reduced significantly 80 plus minus 2
0.44094175.11877404.html.plaintext.txt	155	diffusion coefficient gfp f508 cftr reduced significantly 30 min atp depletion 6
0.44094175.11877404.html.plaintext.txt	156	4a bottom curve substantially gfp f508 cftr became immobilized mobile percentage 55 plus minus 5
0.44094175.11877404.html.plaintext.txt	157	atp depletion 60 min effect
0.44094175.11877404.html.plaintext.txt	158	table summarizes averaged diffusion coefficients percentages mobile gfp
0.44094175.11877404.html.plaintext.txt	159	investigate whether reduced f508 cftr mobility atp depleted cells related restructuring fragmentation er mobility fluorescent er membrane marker dioc43 measured
0.44094175.11877404.html.plaintext.txt	160	4b shows diffusion dioc43 essentially complete diffusion coefficient 2
0.44094175.11877404.html.plaintext.txt	161	dioc43 diffusion unaffected bfa treatment 2
0.44094175.11877404.html.plaintext.txt	162	1 x 108 cm2s n 5 middle curve atp depletion 2
0.44094175.11877404.html.plaintext.txt	163	3 x 108 cm2s n 4 bottom curve
0.44094175.11877404.html.plaintext.txt	164	photobleaching transfected cells expressing gfp labeled wild type cftr f508 cftr subsequently labeled dioc43 situ showed expression gfp cftr chimeras affect er structure fluidity shown
0.44094175.11877404.html.plaintext.txt	165	image photobleaching experiments similar shown fig
0.44094175.11877404.html.plaintext.txt	166	2 also performed dioc43 labeled cells shown demonstrated atp depletion alter er continuity gross structure
0.44094175.11877404.html.plaintext.txt	167	view larger version 70k fig
0.44094175.11877404.html.plaintext.txt	168	slowed gfp f508 cftr diffusion atp depletion
0.44094175.11877404.html.plaintext.txt	169	photobleaching cellular atp depletion produced 30 min incubation 6 mm 2 deoxyglucose 0
0.44094175.11877404.html.plaintext.txt	170	02 sodium azide x 60 objective
0.44094175.11877404.html.plaintext.txt	171	b photobleaching er lipid probe dioc43 control bfa treated atp depleted cells x 100 objective
0.44094175.11877404.html.plaintext.txt	172	c fluorescence depletion experiments gfp wt cftr control conditions top gfp f508 cftr atp depletion bottom
0.44094175.11877404.html.plaintext.txt	173	images shown bleaching bleach spot indicated white cross hairs indicated number bleach pulses
0.44094175.11877404.html.plaintext.txt	174	view table table diffusion coefficients d mobilities wt f508 cftr data mean plus minus
0.44094175.11877404.html.plaintext.txt	175	n 4 10 sets measurements measurement average 5 12 recovery curves different cells indicated maneuvers see experimental procedures
0.44094175.11877404.html.plaintext.txt	176	identify cellular location immobilized gfp f508 cftr atp depleted cells fluorescence loss photobleaching flip experiments performed fig
0.44094175.11877404.html.plaintext.txt	177	fixed spot cell repetitively bleached delays bleach pulse permit diffusion unbleached gfp labeled cftr location bleach spot
0.44094175.11877404.html.plaintext.txt	178	conditions gfp wt cftr freely diffused throughout er 10 cell fluorescence remaining 35 bleach pulses top
0.44094175.11877404.html.plaintext.txt	179	contrast substantial amount fluorescence remained bleaching gfp f508 cftr atp depleted cells bottom remaining fluorescence er pattern
0.44094175.11877404.html.plaintext.txt	180	findings suggest atp depletion alter er continuity gross structure immobilization f508 cftr atp depleted cells results interactions er proteins
0.44094175.11877404.html.plaintext.txt	181	additional maneuvers carried modulate putative cftr interactions molecular chaperones elements protein processing degradation fig
0.44094175.11877404.html.plaintext.txt	182	heat shock nonspecifically regulates expression molecular chaperones produced small reductions diffusion coefficients percentage mobilities wt cftr f508 cftr fig
0.44094175.11877404.html.plaintext.txt	183	proteasome inhibition lactacystin resulted mild slowing immobilization wt cftr f508 cftr 6 h incubation second curves complete immobilization 14 h third curves
0.44094175.11877404.html.plaintext.txt	184	gfp seen er pattern 6 h concentrated aggresomes 14 h shown
0.44094175.11877404.html.plaintext.txt	185	ansamysin compound geldanamycin disrupts associations hsp90 caused comparable slowing wt cftr f508 cftr somewhat greater immobilization f508 cftr fourth curves
0.44094175.11877404.html.plaintext.txt	186	last role glycosylation investigated incubation tunicamycin inhibit addition oligosaccharide chains using glycosylation null mutant wt cftr asparagines 894 900 replaced glutamines
0.44094175.11877404.html.plaintext.txt	187	somewhat immobilization f508 cftr wt cftr found tunicamycin fifth curves
0.44094175.11877404.html.plaintext.txt	188	although glycosylation null mutant wt cftr expressed poorly substantial proportion fluorescence associated aggresomes mobility er associated cftr could measured cells found similar produced tunicamycin sixth curve
0.44094175.11877404.html.plaintext.txt	189	view larger version 22k fig
0.44094175.11877404.html.plaintext.txt	190	effect putative modulators molecular chaperone interactions er mobility gfp wt cftr gfp f508 cftr
0.44094175.11877404.html.plaintext.txt	191	photobleaching experiments done cells expressing wt cftr f508 cftr b using x 60 objective fig
0.44094175.11877404.html.plaintext.txt	192	recovery curves average 5 12 individual measurements single cell
0.44094175.11877404.html.plaintext.txt	193	maneuvers described experimental procedures include heat shock 1 h incubation 42 degrees c followed 16 20 h recovery 37 degrees c lactacystin 6 microm 6 14 h geldanamycin 0
0.44094175.11877404.html.plaintext.txt	194	1 microgml 90 min tunicamycin 5 microgml 20 h glycosylation null mutant gfp wt cftr
0.44094175.11877404.html.plaintext.txt	195	curves shown fitted absolute diffusion coefficient cm2s x 1010 percentage recoveries following 9
0.44094175.11877404.html.plaintext.txt	196	2 83 heat shock f508 cftr 6
0.44094175.11877404.html.plaintext.txt	197	2 81 lactacystin 6 h wt 5
0.44094175.11877404.html.plaintext.txt	198	7 lactacystin 6 h f508 cftr 7
0.44094175.11877404.html.plaintext.txt	199	0 63 geldanamycin f508 cftr 6
0.44094175.11877404.html.plaintext.txt	200	2 61 tunicamycin f508 cftr 6
0.44094175.11877404.html.plaintext.txt	201	see table summary fitted mobilities diffusion coefficients
0.44094175.11877404.html.plaintext.txt	202	done atp depletion experiments diffusion er marker dioc43 measured transfected cells establish er restructuring fragmentation responsible reduced cftr mobility
0.44094175.11877404.html.plaintext.txt	203	diffusion dioc43 cells heat shocked treated lactacystin geldanamycin tunicamycin essentially complete 96 mobile similar measured control cells diffusion coefficients 2
0.44094175.11877404.html.plaintext.txt	204	7 x 108 cm2s n 4 treatment data shown
0.44094175.11877404.html.plaintext.txt	205	discussion top abstract introduction experimental procedures results discussion references
0.44094175.11877404.html.plaintext.txt	206	study shown although f508 cftr retained er diffuses comparable rate wt cftr bfa treated cells
0.44094175.11877404.html.plaintext.txt	207	similar observations made t126m mutant aqp2 water channel partially misfolded similarly retained er ref
0.44094175.11877404.html.plaintext.txt	208	27 temperature sensitive folding mutant vesicular stomatitis virus g protein 29
0.44094175.11877404.html.plaintext.txt	209	therefore slowed restricted f508 cftr mobility er cannot account failure exported
0.44094175.11877404.html.plaintext.txt	210	efficient recycling golgi failure recognized er export machinery remain possible explanations er localization f508 cftr
0.44094175.11877404.html.plaintext.txt	211	observation small amounts f508 cftr post er membranes suggests efficient recycling may responsible retention f508 cftr er 30
0.44094175.11877404.html.plaintext.txt	212	small immobile pool f508 cftr substantial immobilization atp depletion suggest greater fraction f508 cftr interacts molecular chaperones wt cftr
0.44094175.11877404.html.plaintext.txt	213	approximately 50 f508 cftr immobile atp depletion minor effects mobility wt cftr
0.44094175.11877404.html.plaintext.txt	214	simplest interpretation finding atp depletion stabilizes protein interactions molecular chaperones able reveal f508 cftr interactions observable normal conditions
0.44094175.11877404.html.plaintext.txt	215	discussed introduction f508 cftr structure thought similar early intermediate wt cftr biochemical evidence supports f508 cftr associations molecular chaperones
0.44094175.11877404.html.plaintext.txt	216	additional maneuvers performed investigate specific interactions wt cftr f508 cftr cellular protein processing machinery
0.44094175.11877404.html.plaintext.txt	217	inhibition n linked glycosylation tunicamycin resulted significant slowing immobilization wt cftr f508 cftr similar findings vsvg glycoprotein 29
0.44094175.11877404.html.plaintext.txt	218	similar results found glycosylation null wt cftr mutant poorly expressed plasma membrane determined biotinylation studies shown
0.44094175.11877404.html.plaintext.txt	219	protein glycosylation facilitate folding sorting quality control 31
0.44094175.11877404.html.plaintext.txt	220	data thus consistent role glycosylation cftr folding
0.44094175.11877404.html.plaintext.txt	221	proteasome inhibition causes accumulation deglycosylated wt cftr f508 cftr detergent insoluble high molecular weight aggregates 9 32
0.44094175.11877404.html.plaintext.txt	222	consistent observations bebok et al
0.44094175.11877404.html.plaintext.txt	223	32 demonstrated association sec61 translocation system cftr enhanced proteasome inhibition
0.44094175.11877404.html.plaintext.txt	224	prolonged 14 h incubation lactacystin wt cftr f508 cftr found aggresomes 9 10
0.44094175.11877404.html.plaintext.txt	225	aggresomes vimentin enclosed pericentriolar electron dense structures contain aggregates misfolded often ubiquinated proteins associated molecular chaperones proteasomes
0.44094175.11877404.html.plaintext.txt	226	expected gfp cftr chimeras completely immobile aggresomes
0.44094175.11877404.html.plaintext.txt	227	inhibition interaction hsp90 cftr geldanamycin also slowed diffusion wt cftr f508 cftr greater immobilization f508 cftr
0.44094175.11877404.html.plaintext.txt	228	geldanamycin shown disrupt interactions hsp90 cftr increasing degradation rates wt cftr f508 cftr 14
0.44094175.11877404.html.plaintext.txt	229	hsp90 thus proposed potential role protecting cftr rapid degradation
0.44094175.11877404.html.plaintext.txt	230	relative immobilization wt cftr f508 cftr geldanamycin treatment supports role hsp90 cftr processing
0.44094175.11877404.html.plaintext.txt	231	suggested vsvg nehls et al
0.44094175.11877404.html.plaintext.txt	232	29 believe physical state wt cftr f508 cftr perturbation cftr processing tunicamycin geldanamycin may different produced atp depletion
0.44094175.11877404.html.plaintext.txt	233	slowing immobilization cftr atp depletion may represent cftr interactions molecular chaperones existing large complexes 33 whereas immobilization tunicamycin geldanamycin molecular deglycosylation may represent cftr self aggregation
0.44094175.11877404.html.plaintext.txt	234	logarithmic relationship molecular radius diffusion rate protein bilayer substantial aggregates 10 100 units must formed significantly slow diffusion
0.44094175.11877404.html.plaintext.txt	235	similar responses wt cftr f508 cftr pharmacological maneuvers consistent intrinsically inefficient folding wt cftr compared p glycoprotein another member abc cassette family poorly folded
0.44094175.11877404.html.plaintext.txt	236	diffusion coefficient cftr diffusional mobility er 10 x 1010 cm2s within range er membrane proteins studied
0.44094175.11877404.html.plaintext.txt	237	membrane water channel aqp2 retained er bfa er retained mutant aqp2 t126m diffusion coefficients 2
0.44094175.11877404.html.plaintext.txt	238	cytochrome p450 2c2 intrinsic er protein diffusion coefficient 5
0.44094175.11877404.html.plaintext.txt	239	vsvg native misfolded states two er resident transmembrane proteins lamin b receptor subunit signal recognition particle receptor diffusion coefficients 26 50 x 1010 cm2s depending upon temperature 29
0.44094175.11877404.html.plaintext.txt	240	two golgi resident transmembrane proteins galactosyltransferase kdel receptor retained er bfa diffusion coefficients 21 48 x 1010 cm2s depending upon cell type temperature 29 35
0.44094175.11877404.html.plaintext.txt	241	diffusion coefficient er retained mhc class 1 molecule h2ld 20 46 x 1010 cm2s tap1 transporter associated antigen presentation 1 12 x 1010 cm2s 36
0.44094175.11877404.html.plaintext.txt	242	variation diffusion coefficients probably reflects different protein sizes interactions er cytoplasmic proteins er composition different cells
0.44094175.11877404.html.plaintext.txt	243	summary photobleaching data provide following evidence er retention f508 cftr due restricted er mobility b majority f508 cftr aggregated bound slowly moving membrane proteins c f508 cftr may interact greater extent molecular chaperones wt cftr
0.44094175.11877404.html.plaintext.txt	244	measurements er membrane protein diffusion provide unique vivo approach study protein protein associations complements classical biochemical 2 hybrid methods
0.44094175.11877404.html.plaintext.txt	245	thank katherin karlson assistance generation glycosylation null mutant egfp cftr
0.44094175.11877404.html.plaintext.txt	246	study supported national institutes health grants eb00415 dk43840 hl59198 dk35124 ey13574 hl60288 research development program grant r613 cystic fibrosis foundation
0.44094175.11877404.html.plaintext.txt	247	v national institutes health grants dk45881 dk34533 research development program grant cystic fibrosis foundation b
0.44094175.11877404.html.plaintext.txt	248	costs publication article defrayed part payment page charges
0.44094175.11877404.html.plaintext.txt	249	article must therefore hereby marked advertisement accordance 18 u
0.44094175.11877404.html.plaintext.txt	250	section 1734 solely indicate fact
0.44094175.11877404.html.plaintext.txt	251	correspondence addressed 1246 health sciences east tower cardiovascular research inst
0.44094175.11877404.html.plaintext.txt	252	university california san francisco san francisco ca 94143 0521
0.44094175.11877404.html.plaintext.txt	253	415 476 8530 fax 415 665 3847 e mail verkmanitsa
0.44094175.11877404.html.plaintext.txt	254	published jbc papers press february 27 2002 doi10
0.44094175.11877404.html.plaintext.txt	255	abbreviations used cftr cystic fibrosis transmembrane conductance regulator er endoplasmic reticulum gfp green fluorescent protein wt wild type cho chinese hamster ovary bfa brefeldin n
0.44094175.11877404.html.plaintext.txt	256	numerical aperture vsvg vesicular stomatitis virus g protein aqp aquaporin dioc43 33 dibutyloxacarbocyanine iodide flip fluorescence loss photobleaching
0.44094175.11877404.html.plaintext.txt	257	references top abstract introduction experimental procedures results discussion references 1
0.44094175.11877404.html.plaintext.txt	258	1990 cell 63 827 834medline order article via infotrieve 2
0.44094175.11877404.html.plaintext.txt	259	270 12347 12350abstractfree full text 3
0.44094175.11877404.html.plaintext.txt	260	1992 nature 358 761 764crossrefmedline order article via infotrieve 4
0.44094175.11877404.html.plaintext.txt	261	1996 cell stress chaperones 1 117 125medline order article via infotrieve 5
0.44094175.11877404.html.plaintext.txt	262	269 25710 25718abstractfree full text 6
0.44094175.11877404.html.plaintext.txt	263	1995 cell 83 121 127medline order article via infotrieve 8
0.44094175.11877404.html.plaintext.txt	264	1995 cell 83 129 135medline order article via infotrieve 9
0.44094175.11877404.html.plaintext.txt	265	143 1883 1893abstractfree full text 10
0.44094175.11877404.html.plaintext.txt	266	145 481 490abstractfree full text 11
0.44094175.11877404.html.plaintext.txt	267	10 524 530crossrefmedline order article via infotrieve 12
0.44094175.11877404.html.plaintext.txt	268	269 12784 12788abstractfree full text 14
0.44094175.11877404.html.plaintext.txt	269	17 6879 6887abstractfree full text 15
0.44094175.11877404.html.plaintext.txt	270	18 1492 1505abstractfree full text 16
0.44094175.11877404.html.plaintext.txt	271	3 100 10522crossrefmedline order article via infotrieve 17
0.44094175.11877404.html.plaintext.txt	272	5 180 183medline order article via infotrieve 18
0.44094175.11877404.html.plaintext.txt	273	271 7261 7264abstractfree full text 19
0.44094175.11877404.html.plaintext.txt	274	272 15739 15744abstractfree full text 20
0.44094175.11877404.html.plaintext.txt	275	273 21759 21768abstractfree full text 21
0.44094175.11877404.html.plaintext.txt	276	281 c1889 c1897abstractfree full text 23
0.44094175.11877404.html.plaintext.txt	277	138 131 142abstractfree full text 24
0.44094175.11877404.html.plaintext.txt	278	140 821 829abstractfree full text 25
0.44094175.11877404.html.plaintext.txt	279	76 2843 2851abstractfree full text 26
0.44094175.11877404.html.plaintext.txt	280	78 1024 1035abstractfree full text 27
0.44094175.11877404.html.plaintext.txt	281	276 21331 21336abstractfree full text 28
0.44094175.11877404.html.plaintext.txt	282	2 288 295crossrefmedline order article via infotrieve 30
0.44094175.11877404.html.plaintext.txt	283	2000 traffic 1 852 870crossrefmedline order article via infotrieve 31
0.44094175.11877404.html.plaintext.txt	284	2001 science 291 2364 2369abstractfree full text 32
0.44094175.11877404.html.plaintext.txt	285	273 29873 29878abstractfree full text 33
0.44094175.11877404.html.plaintext.txt	286	136 555 565abstractfree full text 34
0.44094175.11877404.html.plaintext.txt	287	95 14793 14798abstractfree full text 35
0.44094175.11877404.html.plaintext.txt	288	1996 science 273 797 801abstract 36
0.44094175.11877404.html.plaintext.txt	289	1999 immunity 11 231 240medline order article via infotrieve
0.44094175.11877404.html.plaintext.txt	290	copyright 2002 american society biochemistry molecular biology inc
0.4315326.10660517.html.plaintext.txt	0	minireview cystic fibrosis transmembrane conductance regulator structure function epithelial chloride channel myles h
0.4315326.10660517.html.plaintext.txt	1	center molecular recognition departments physiology cellular biophysics medicine columbia university new york new york 10032
0.4315326.10660517.html.plaintext.txt	2	introduction top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	3	synthesis degradation conclusions references
0.4315326.10660517.html.plaintext.txt	4	cystic fibrosis transmembrane conductance regulator cftr1 forms cl channel essential component epithelial cl transport systems many organs including intestines pancreas lungs sweat glands kidneys
0.4315326.10660517.html.plaintext.txt	5	cl secretory intestinal epithelium cl enters cells na k 2cl cotransporter basolateral membrane exits cftr apical membrane water follows osmotically 1
0.4315326.10660517.html.plaintext.txt	6	absorptive epithelia use similar transporters channels polarized distribution apical basolateral membranes usually reversed
0.4315326.10660517.html.plaintext.txt	7	major determinant transepithelial cl transport rate level activation cftr 2 3 depends extent phosphorylated
0.4315326.10660517.html.plaintext.txt	8	determined relative activities kinases phosphatases activities often hormonally regulated 1
0.4315326.10660517.html.plaintext.txt	9	defects gene encoding cftr reduce either cl transport capacity level cell surface expression cause cystic fibrosis cf 4 6 well form male sterility due congenital bilateral absence vas deferens 7
0.4315326.10660517.html.plaintext.txt	10	cf common lethal genetic disease caucasians 30000 cf patients united states
0.4315326.10660517.html.plaintext.txt	11	contrast intestinal epithelial cells overstimulation cftr activation protein kinases bacterial enterotoxins causes secretory diarrhea 1 8
0.4315326.10660517.html.plaintext.txt	12	secretory diarrhea second largest cause infant mortality developing world causing 3 million deaths per year children age 5
0.4315326.10660517.html.plaintext.txt	13	thus although cftr named association cf cause disease relationship secretory diarrhea widespread public health problem
0.4315326.10660517.html.plaintext.txt	14	cloning cftr 1989 9 facilitated studies structure function regulation biogenesis degradation reviewed article
0.4315326.10660517.html.plaintext.txt	15	issues reviewed elsewhere discussed include mechanisms mutations cftr cause cf 5 6 possible role cftr regulating ph within intracellular organelles 10
0.4315326.10660517.html.plaintext.txt	16	structural basis channel function top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	17	synthesis degradation conclusions references
0.4315326.10660517.html.plaintext.txt	18	cftr member atp binding cassette abc membrane transporter gene superfamily includes eukaryotic bacterial proteins multiple drug resistance protein mdr sulfonylurea receptor transporter antigen presentation bacterial periplasmic permeases 9 11
0.4315326.10660517.html.plaintext.txt	19	ion channel makes cftr unique gene superfamily members atp driven membrane transporters
0.4315326.10660517.html.plaintext.txt	20	cftr contains 1480 amino acids consists two homologous halves fig
0.4315326.10660517.html.plaintext.txt	21	half contains six membrane spanning segments nucleotide binding domain nbd
0.4315326.10660517.html.plaintext.txt	22	two halves cftr linked cytoplasmic regulatory domain r domain contains number consensus phosphorylation sites 9
0.4315326.10660517.html.plaintext.txt	23	proposed transmembrane topology fig
0.4315326.10660517.html.plaintext.txt	24	1 supported experimental evidence 9 12 13 77 protein cytoplasm 19 membrane spanning segments 4 extracellular loops except m1 m2 m7 m8 loops short
0.4315326.10660517.html.plaintext.txt	25	m7 m8 loop contains two n linked glycosylation sites used vivo 12 13
0.4315326.10660517.html.plaintext.txt	26	covalent linkage two halves required assembly function
0.4315326.10660517.html.plaintext.txt	27	expressed separate proteins cells halves assembled functional channels could co immunoprecipitated
0.4315326.10660517.html.plaintext.txt	28	assembly required interactions within membrane spanning domains 13 14
0.4315326.10660517.html.plaintext.txt	29	view larger version 16k fig
0.4315326.10660517.html.plaintext.txt	30	transmembrane topology cftr
0.4315326.10660517.html.plaintext.txt	31	gray balloons m7 m8 loop indicate n linked glycosylation sites
0.4315326.10660517.html.plaintext.txt	32	cftr inferred monomer following solubilization either ionic nonionic detergents biochemically distinct forms cftr expressed cells could co immunoprecipitated 15
0.4315326.10660517.html.plaintext.txt	33	contrast two studies concluded cftr homodimer situ based size cftr particles freeze fracture electron micrographs 16 functional effects coexpressing mutants distinct functional properties 17
0.4315326.10660517.html.plaintext.txt	34	homologous mdr transporter however dimers seen cryoelectron microscopic images 18
0.4315326.10660517.html.plaintext.txt	35	channel lining residues channel lining formed least part residues among 12 membrane spanning segments
0.4315326.10660517.html.plaintext.txt	36	major determinants channels functional properties likely among channel lining residues
0.4315326.10660517.html.plaintext.txt	37	water accessible residues inferred line channel identified m1 m3 m6 segments using substituted cysteine accessibility method 19 21
0.4315326.10660517.html.plaintext.txt	38	segments secondary structure inferred largely helical based patterns formed channel lining residues 19 21
0.4315326.10660517.html.plaintext.txt	39	support helical secondary structure membrane spanning segments provided studies synthetic peptides sequences corresponded m1 m6 segments
0.4315326.10660517.html.plaintext.txt	40	peptides largely helical liposomes detergent micelles 22 23
0.4315326.10660517.html.plaintext.txt	41	minimum channel diameter inferred 5
0.4315326.10660517.html.plaintext.txt	42	3 based size largest permeant anion 24
0.4315326.10660517.html.plaintext.txt	43	studies using patches larger numbers channels showed anions large lactobionate 10 13 diameter slightly permeable
0.4315326.10660517.html.plaintext.txt	44	thus least transiently diameter channel must 10 13 25
0.4315326.10660517.html.plaintext.txt	45	presence cytoplasmic atp large anions permeable cytoplasmic side 25
0.4315326.10660517.html.plaintext.txt	46	molecular basis asymmetric permeation large anions unknown
0.4315326.10660517.html.plaintext.txt	47	asymmetry conduction small anions channel linear current voltage relationship cl solutions 13
0.4315326.10660517.html.plaintext.txt	48	although studies suggested atp permeable cftr reviewed ref
0.4315326.10660517.html.plaintext.txt	49	26 convincingly demonstrated measurable electrogenic atp flux cftr 27 29
0.4315326.10660517.html.plaintext.txt	50	mechanism charge selectivity ability discriminate cl cations essential role cftr epithelial cl transport
0.4315326.10660517.html.plaintext.txt	51	extent anion selectivity measured cl na permeability ratio 30 ranges 10 300 31 32
0.4315326.10660517.html.plaintext.txt	52	showed charge selectivity filter discriminates anions cations located cytoplasmic end channel anions cations enter extracellular end channel 33
0.4315326.10660517.html.plaintext.txt	53	arg 352 cytoplasmic end m6 major determinant charge selectivity
0.4315326.10660517.html.plaintext.txt	54	removal positive charge position reduced cl na permeability ratio approximately 10 fold 34
0.4315326.10660517.html.plaintext.txt	55	hypothesized positive charge arg 352 creates electrostatic barrier cation permeation
0.4315326.10660517.html.plaintext.txt	56	near arg 352 channel must narrow enough electrostatic barrier extends across channel lumen 34
0.4315326.10660517.html.plaintext.txt	57	halide selectivity multiple ion occupancy channel displays modest selectivity halides
0.4315326.10660517.html.plaintext.txt	58	halide permeability sequence 1
0.4315326.10660517.html.plaintext.txt	59	2 indicative weak interactions permeating anions channel binding sites 30 32
0.4315326.10660517.html.plaintext.txt	60	multiple anions simultaneously occupy channel thereby resulting anomalous mole fraction effects single channel conductance mixtures cl scn
0.4315326.10660517.html.plaintext.txt	61	effects eliminated m6 mutant r347d arg 347 therefore hypothesized near anion binding site 35
0.4315326.10660517.html.plaintext.txt	62	arg 347 however shown form salt bridge asp 924 36
0.4315326.10660517.html.plaintext.txt	63	therefore possible rather arg 347 binding site structural perturbation caused loss salt bridge disrupted anion binding site elsewhere 30
0.4315326.10660517.html.plaintext.txt	64	channel inhibitors cftr inhibitors none high affinity specificity 13
0.4315326.10660517.html.plaintext.txt	65	affinity channel blocker diphenylamine 2 carboxylate reduced mutating two water accessible residues m6
0.4315326.10660517.html.plaintext.txt	66	mutations aligned m12 residues increased diphenylamine 2 carboxylate affinity suggesting channel lined residues halves cftr 37
0.4315326.10660517.html.plaintext.txt	67	contrast actions cl channels transporters disulfonic stilbenes dids inhibit applied cytoplasmic side 38
0.4315326.10660517.html.plaintext.txt	68	cytoplasmic application large anions also caused flickery block cftr
0.4315326.10660517.html.plaintext.txt	69	evidence channel asymmetric contains anion binding site cytoplasmic vestibule 39
0.4315326.10660517.html.plaintext.txt	70	residues forming cytoplasmic vestibule remain identified cytoplasmic loops probably contribute vestibule none cf related loop mutations affected ion conduction 40
0.4315326.10660517.html.plaintext.txt	71	picture emerging channel large extracellular vestibule extends plain membrane accessible anions cations extracellular side fig
0.4315326.10660517.html.plaintext.txt	72	channel narrows toward cytoplasmic end charge selectivity filter located
0.4315326.10660517.html.plaintext.txt	73	finally short cytoplasmic vestibule contains anion binding site
0.4315326.10660517.html.plaintext.txt	74	channel lining formed part residues m1 m3 m6 m12 segments
0.4315326.10660517.html.plaintext.txt	75	little known whether eight membrane spanning segments contribute channel lining
0.4315326.10660517.html.plaintext.txt	76	location gate blocks ion conduction channel closed state unknown
0.4315326.10660517.html.plaintext.txt	77	gate however controlled conformational changes cytoplasmic domains
0.4315326.10660517.html.plaintext.txt	78	view larger version 41k fig
0.4315326.10660517.html.plaintext.txt	79	schematic illustrating structure cftr relationships domains associated proteins channel
0.4315326.10660517.html.plaintext.txt	80	membrane spanning domains red water filled transmembrane channel blue nbd 1 yellow nbd 2 orange bound atp white ovals r domain green n c termini indicated black lines associated proteins syntaxin 1a syn 1a nah exchanger regulatory factorezrin binding protein 50 nherfebp 50 purple
0.4315326.10660517.html.plaintext.txt	81	note position arg 352 major determinant charge selectivity narrow point channel
0.4315326.10660517.html.plaintext.txt	82	cl ions probably interact nbds r domain pass channel
0.4315326.10660517.html.plaintext.txt	83	cytoplasmic vestibule binding site large anions see channel lining residues
0.4315326.10660517.html.plaintext.txt	84	interactions pp2c channels transporters shown see interactions proteins
0.4315326.10660517.html.plaintext.txt	85	regulation cftr channel gating top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	86	synthesis degradation conclusions references
0.4315326.10660517.html.plaintext.txt	87	two separate processes control gating cftr 1 phosphorylation 2 binding hydrolysis atp
0.4315326.10660517.html.plaintext.txt	88	phosphorylation necessary activation sufficient
0.4315326.10660517.html.plaintext.txt	89	phosphorylation gating closed open states controlled atp hydrolysis 12 13 41
0.4315326.10660517.html.plaintext.txt	90	phosphorylation prerequisite channel activation r domain contains multiple consensus phosphorylation sites camp dependent protein kinase pka protein kinase c pkc type ii cgmp dependent protein kinase 9 12 13 41 42
0.4315326.10660517.html.plaintext.txt	91	extensive phosphorylation greater channel open probability 41 43
0.4315326.10660517.html.plaintext.txt	92	appears extensive redundancy regulatory pka phosphorylation sites
0.4315326.10660517.html.plaintext.txt	93	five sites phosphorylated vivo removal sites 10 dibasic pka sites reduced eliminate pka activation 44
0.4315326.10660517.html.plaintext.txt	94	cftr still phosphorylated removal 10 dibasic sites indicating phosphorylation non dibasic pka sites sufficient channel activation one site identified 12 13 41
0.4315326.10660517.html.plaintext.txt	95	pkc phosphorylation may prerequisite activation pka 45
0.4315326.10660517.html.plaintext.txt	96	finally although genistein tyrosine kinase inhibitor activates cftr occurs direct interaction cftr involve tyrosine kinase reviewed ref
0.4315326.10660517.html.plaintext.txt	97	phosphorylation cftr deactivated protein phosphatases 41
0.4315326.10660517.html.plaintext.txt	98	dephosphorylation largely mediated protein phosphatases pp2c pp2a 46 47
0.4315326.10660517.html.plaintext.txt	99	pp2c closely linked cftr membrane could co immunoprecipitated cftr well cross linked cftr bifunctional cross linkers whereas pp1 pp2a pp2b could 48
0.4315326.10660517.html.plaintext.txt	100	channel gating requires atp hydrolysis following phosphorylation opening closing channel controlled atp binding hydrolysis 12 13 41
0.4315326.10660517.html.plaintext.txt	101	non hydrolyzable atp analogs support channel opening 49
0.4315326.10660517.html.plaintext.txt	102	purified phosphorylated reconstituted cftr binds atp km 0
0.4315326.10660517.html.plaintext.txt	103	3 mm hydrolyzes atp rate 1 molecules 50 similar rate channel gating
0.4315326.10660517.html.plaintext.txt	104	atp hydrolysis occurs nbds contain highly conserved walker b motifs found atpases 9 13 41 49
0.4315326.10660517.html.plaintext.txt	105	construct lacking r domain cftr r require phosphorylation open close presence atp 13
0.4315326.10660517.html.plaintext.txt	106	adding soluble phosphorylated r domain peptide cftr r enhanced atp sensitivity resulting increased channel open probability 51 52
0.4315326.10660517.html.plaintext.txt	107	thus r domain interacts nbds regulates atp affinity
0.4315326.10660517.html.plaintext.txt	108	structure bacterial nbd homologous bacterial periplasmic permeases nbds transmembrane domains usually separate gene products assemble biosynthesis 11 53
0.4315326.10660517.html.plaintext.txt	109	histidine periplasmic permease contains two copies nbd protein hisp copy single nucleotide binding site
0.4315326.10660517.html.plaintext.txt	110	x ray crystal structure hisp determined 54
0.4315326.10660517.html.plaintext.txt	111	sequence conservation bacterial eukaryotic nbds implies structures similar aligned residues perform similar functions hisp cftr
0.4315326.10660517.html.plaintext.txt	112	hisp novel structure 54
0.4315326.10660517.html.plaintext.txt	113	contains small regions structural similarity reca f1 atpase subunits
0.4315326.10660517.html.plaintext.txt	114	hisp shaped like letter l fig
0.4315326.10660517.html.plaintext.txt	115	one arm arm l contains atp binding site including walker b motifs
0.4315326.10660517.html.plaintext.txt	116	interactions walker residues atp via hydrogen bonds backbone amides atp phosphates
0.4315326.10660517.html.plaintext.txt	117	aspartate c terminus walker b motif aligned cftr residues asp 572 asp 1370 nbd 1 2 respectively inferred bind mg2 ion required hydrolysis
0.4315326.10660517.html.plaintext.txt	118	cftr residues gln 493 ser 573 nbd 1 gln 1291 glu 1371 nbd 2 align catalytically important residues hisp hydrogen bond water molecule turn hydrogen bonds phosphate
0.4315326.10660517.html.plaintext.txt	119	water molecule thought attack atp hydrogen bond lies parallel p o bond broken atp hydrolysis 54
0.4315326.10660517.html.plaintext.txt	120	adenine base forms hydrophobic interaction single aromatic residue perhaps explaining lack specificity among nucleotide triphosphates gate cftr 49
0.4315326.10660517.html.plaintext.txt	121	arm hisp structure arm ii contains lsggq motif forms foundation around arm ii built
0.4315326.10660517.html.plaintext.txt	122	arm ii inferred interact membrane spanning domains 54
0.4315326.10660517.html.plaintext.txt	123	residue aligned phe 508 cftr site common cf associated mutation lies exposed surface helix arm ii
0.4315326.10660517.html.plaintext.txt	124	channel gating sites atp hydrolysis current hypothesis atp hydrolysis nbd 1 opens channel atp hydrolysis nbd 2 closes channel terminate burst consistent functional effects mutations nbds 13 41
0.4315326.10660517.html.plaintext.txt	125	mutations nbd 2 walker motifs decrease atp hydrolysis rate slow channel closing 55 58
0.4315326.10660517.html.plaintext.txt	126	similar mutations nbd 1 reduce channel opening
0.4315326.10660517.html.plaintext.txt	127	nbd 1 mutations also altered channel closing rates suggesting functional interactions nbds 55 57
0.4315326.10660517.html.plaintext.txt	128	crystal structure solution hisp forms dimer interface located along edge arm 54
0.4315326.10660517.html.plaintext.txt	129	thus direct contacts nbds may structural basis functional interaction
0.4315326.10660517.html.plaintext.txt	130	mixtures atp non hydrolyzable analogs lock channels open state
0.4315326.10660517.html.plaintext.txt	131	presumably atp hydrolysis nbd 1 opens channels binding non hydrolyzable analog nbd 2 prevents closing 13 41
0.4315326.10660517.html.plaintext.txt	132	gating behavior cftr described several kinetic models
0.4315326.10660517.html.plaintext.txt	133	cyclic models essentially irreversible steps corresponding atp hydrolysis steps provide best descriptions channel gating reviewed refs
0.4315326.10660517.html.plaintext.txt	134	interactions proteins top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	135	synthesis degradation conclusions references
0.4315326.10660517.html.plaintext.txt	136	addition function cl channel cftr acts regulator channels transporters 26
0.4315326.10660517.html.plaintext.txt	137	cftr mediates camp regulation amiloride sensitive na channels 60 outward rectifying cl channels 61 62 clhco3 exchanger 63 romk k channel 26
0.4315326.10660517.html.plaintext.txt	138	whether regulatory functions result direct interactions cftr channels transporters indirect interactions via proteins remains determined
0.4315326.10660517.html.plaintext.txt	139	direct interactions cftr shown several proteins
0.4315326.10660517.html.plaintext.txt	140	syntaxin 1a interacts cytoplasmic n terminal domain cftr inhibits channel activity 64
0.4315326.10660517.html.plaintext.txt	141	family pdz binding domain proteins including nah exchanger regulatory factor 65 ezrin binding protein 50 66 bind c terminus d st x l fig
0.4315326.10660517.html.plaintext.txt	142	proteins presumably couple cftr cytoskeleton may involved apical membrane localization
0.4315326.10660517.html.plaintext.txt	143	finally mentioned cftr closely associated protein phosphatase 2c 48
0.4315326.10660517.html.plaintext.txt	144	synthesis degradation top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	145	synthesis degradation conclusions references
0.4315326.10660517.html.plaintext.txt	146	attention focused synthesis degradation cftr many mutations cause cf f508 lead misfolding cftr endoplasmic reticulum er subsequent degradation cftr reviewed refs
0.4315326.10660517.html.plaintext.txt	147	synthesis wild type cftr inefficient
0.4315326.10660517.html.plaintext.txt	148	30 newly synthesized cftr develops endoglycosidase h resistant mature glycosylation suggestive translocation er golgi complex 68 69
0.4315326.10660517.html.plaintext.txt	149	contrast 100 homologous mdr matures 70
0.4315326.10660517.html.plaintext.txt	150	cftr molecules fail mature polyubiquitinated degraded via cytoplasmic proteasome dependent pathway 71 72
0.4315326.10660517.html.plaintext.txt	151	er cftr transiently associates several chaperones including cytoplasmic hsp70 hsp90 er membrane chaperone calnexin 67 73
0.4315326.10660517.html.plaintext.txt	152	molecular basis inefficient processing cftr protein synthetic pathway remains elucidated
0.4315326.10660517.html.plaintext.txt	153	conclusions top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	154	synthesis degradation conclusions references
0.4315326.10660517.html.plaintext.txt	155	cftr important role epithelial cl transport cl channel regulator channels transporters
0.4315326.10660517.html.plaintext.txt	156	studies channel begun provide picture structure regulation
0.4315326.10660517.html.plaintext.txt	157	understanding cftr interacts channels transporter provide insights cellular regulation epithelial transport pathophysiology results defects cftr overstimulation bacterial toxins
0.4315326.10660517.html.plaintext.txt	158	one hopes studies provide basis design identification specific high affinity cftr inhibitors would useful basic studies role cftr epithelial cl transport potentially therapy secretory diarrhea major cause morbidity infant mortality developing world
0.4315326.10660517.html.plaintext.txt	159	jonathan javitch comments manuscript
0.4315326.10660517.html.plaintext.txt	160	minireview reprinted 2000 minireview compendium available december 2000
0.4315326.10660517.html.plaintext.txt	161	work supported part national institutes health grant dk51794 established scientist award new york city affiliate american heart association
0.4315326.10660517.html.plaintext.txt	162	correspondence addressed center molecular recognition depts
0.4315326.10660517.html.plaintext.txt	163	physiology cellular biophysics medicine columbia university 630 w
0.4315326.10660517.html.plaintext.txt	164	212 305 3974 fax 212 305 5594 e mail ma14columbia
0.4315326.10660517.html.plaintext.txt	165	abbreviations used cftr cystic fibrosis transmembrane conductance regulator cf cystic fibrosis dids 44 diisothiocyanostilbene 22 disulfonic acid mdr multiple drug resistance protein nbd nucleotide binding domain pka camp dependent protein kinase pkc protein kinase c er endoplasmic reticulum
0.4315326.10660517.html.plaintext.txt	166	references top introduction structural basis channel
0.4315326.10660517.html.plaintext.txt	167	synthesis degradation conclusions references 1
0.4315326.10660517.html.plaintext.txt	168	55 631 655crossrefmedline order article via infotrieve 2
0.4315326.10660517.html.plaintext.txt	169	1994 science 266 107 109medline order article via infotrieve 3
0.4315326.10660517.html.plaintext.txt	170	1993 cell 73 1251 1254medline order article via infotrieve 5
0.4315326.10660517.html.plaintext.txt	171	79 s215 s255medline order article via infotrieve 6
0.4315326.10660517.html.plaintext.txt	172	103 309 312free full text 7
0.4315326.10660517.html.plaintext.txt	173	44 61 78medline order article via infotrieve 9
0.4315326.10660517.html.plaintext.txt	174	1989 science 254 1066 1073 10
0.4315326.10660517.html.plaintext.txt	175	7 504 508crossrefmedline order article via infotrieve 11
0.4315326.10660517.html.plaintext.txt	176	55 609 630crossrefmedline order article via infotrieve 13
0.4315326.10660517.html.plaintext.txt	177	79 s23 s45medline order article via infotrieve 14
0.4315326.10660517.html.plaintext.txt	178	1997 biochemistry 36 1287 1294crossrefmedline order article via infotrieve 15
0.4315326.10660517.html.plaintext.txt	179	269 2987 2995abstractfree full text 16
0.4315326.10660517.html.plaintext.txt	180	95 11235 11240abstractfree full text 17
0.4315326.10660517.html.plaintext.txt	181	274 7627 7630abstractfree full text 18
0.4315326.10660517.html.plaintext.txt	182	272 10685 10694abstractfree full text 19
0.4315326.10660517.html.plaintext.txt	183	269 14865 14868abstractfree full text 20
0.4315326.10660517.html.plaintext.txt	184	1998 biochemistry 37 12233 12240crossrefmedline order article via infotrieve 22
0.4315326.10660517.html.plaintext.txt	185	431 29 33crossrefmedline order article via infotrieve 23
0.4315326.10660517.html.plaintext.txt	186	1998 biochemistry 37 844 853crossrefmedline order article via infotrieve 24
0.4315326.10660517.html.plaintext.txt	187	110 355 364abstractfree full text 25
0.4315326.10660517.html.plaintext.txt	188	111 601 614abstractfree full text 26
0.4315326.10660517.html.plaintext.txt	189	79 s145 s166medline order article via infotrieve 27
0.4315326.10660517.html.plaintext.txt	190	151 139 148crossrefmedline order article via infotrieve 28
0.4315326.10660517.html.plaintext.txt	191	271 11623 11626abstractfree full text 29
0.4315326.10660517.html.plaintext.txt	192	1996 science 271 1876 1879abstract 30
0.4315326.10660517.html.plaintext.txt	193	79 s47 s75medline order article via infotrieve 31
0.4315326.10660517.html.plaintext.txt	194	1991 science 253 202 205medline order article via infotrieve 32
0.4315326.10660517.html.plaintext.txt	195	110 341 354abstractfree full text 33
0.4315326.10660517.html.plaintext.txt	196	109 289 300abstractfree full text 34
0.4315326.10660517.html.plaintext.txt	197	1999 biochemistry 38 5528 5537crossrefmedline order article via infotrieve 35
0.4315326.10660517.html.plaintext.txt	198	1993 nature 366 79 82crossrefmedline order article via infotrieve 36
0.4315326.10660517.html.plaintext.txt	199	274 5429 5435abstractfree full text 37
0.4315326.10660517.html.plaintext.txt	200	1994 neuron 13 623 634medline order article via infotrieve 38
0.4315326.10660517.html.plaintext.txt	201	271 c628 c634abstractfree full text 40
0.4315326.10660517.html.plaintext.txt	202	1997 biochemistry 36 11966 11974crossrefmedline order article via infotrieve 41
0.4315326.10660517.html.plaintext.txt	203	79 s77 s107medline order article via infotrieve 42
0.4315326.10660517.html.plaintext.txt	204	22 307 312crossrefmedline order article via infotrieve 43
0.4315326.10660517.html.plaintext.txt	205	268 11304 11311abstractfree full text 45
0.4315326.10660517.html.plaintext.txt	206	272 4978 4984abstractfree full text 46
0.4315326.10660517.html.plaintext.txt	207	268 2037 2047abstractfree full text 47
0.4315326.10660517.html.plaintext.txt	208	274 c1397 c1410abstractfree full text 48
0.4315326.10660517.html.plaintext.txt	209	274 29102 29107abstractfree full text 49
0.4315326.10660517.html.plaintext.txt	210	1991 cell 67 775 784medline order article via infotrieve 50
0.4315326.10660517.html.plaintext.txt	211	271 28463 28468abstractfree full text 51
0.4315326.10660517.html.plaintext.txt	212	272 28133 28141abstractfree full text 52
0.4315326.10660517.html.plaintext.txt	213	1997 nature 389 294 296crossrefmedline order article via infotrieve 53
0.4315326.10660517.html.plaintext.txt	214	65 1 47medline order article via infotrieve 54
0.4315326.10660517.html.plaintext.txt	215	1998 nature 396 703 707crossrefmedline order article via infotrieve 55
0.4315326.10660517.html.plaintext.txt	216	270 1711 1717abstractfree full text 56
0.4315326.10660517.html.plaintext.txt	217	1995 cell 82 231 239medline order article via infotrieve 57
0.4315326.10660517.html.plaintext.txt	218	113 541 554abstractfree full text 59
0.4315326.10660517.html.plaintext.txt	219	114 49 53abstractfree full text 60
0.4315326.10660517.html.plaintext.txt	220	1995 science 269 847 850medline order article via infotrieve 61
0.4315326.10660517.html.plaintext.txt	221	1992 nature 358 581 584crossrefmedline order article via infotrieve 62
0.4315326.10660517.html.plaintext.txt	222	1993 nature 363 263 266crossrefmedline order article via infotrieve 63
0.4315326.10660517.html.plaintext.txt	223	274 14670 14677abstractfree full text 64
0.4315326.10660517.html.plaintext.txt	224	1997 nature 390 302 305crossrefmedline order article via infotrieve 65
0.4315326.10660517.html.plaintext.txt	225	95 8496 8501abstractfree full text 66
0.4315326.10660517.html.plaintext.txt	226	273 19797 19801abstractfree full text 67
0.4315326.10660517.html.plaintext.txt	227	79 s167 s173medline order article via infotrieve 68
0.4315326.10660517.html.plaintext.txt	228	269 25710 25718abstractfree full text 70
0.4315326.10660517.html.plaintext.txt	229	272 709 712abstractfree full text 71
0.4315326.10660517.html.plaintext.txt	230	1995 cell 83 129 135medline order article via infotrieve 72
0.4315326.10660517.html.plaintext.txt	231	1995 cell 83 121 127medline order article via infotrieve 73
0.4315326.10660517.html.plaintext.txt	232	17 6879 6887abstractfree full text
0.4315326.10660517.html.plaintext.txt	233	copyright 2000 american society biochemistry molecular biology inc
0.43467933.10919864.html.plaintext.txt	0	severed molecules functionally define boundaries cystic fibrosis transmembrane conductance regulators nh2 terminal nucleotide binding domain kim w
0.43467933.10919864.html.plaintext.txt	1	chana laszlo csanadya donna seto younga angus c
0.43467933.10919864.html.plaintext.txt	2	gadsbya laboratory cardiacmembrane physiology rockefeller university new york new york 10021 b laboratory molecular cellular neuroscience rockefeller university new york new york 10021
0.43467933.10919864.html.plaintext.txt	3	gadsby laboratory cardiacmembrane physiology rockefeller university 1230 york avenue new york ny 10021 6399
0.43467933.10919864.html.plaintext.txt	4	fax212 327 7589 e mailgadsbyatrockvax
0.43467933.10919864.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	6	cystic fibrosis transmembrane conductance regulator cl channel belongs family atp binding cassette proteins
0.43467933.10919864.html.plaintext.txt	7	cftr polypeptide comprises two transmembrane domains two nucleotide binding domains nbd1 nbd2 regulatory r domain
0.43467933.10919864.html.plaintext.txt	8	gating channel controlled kinase mediated phosphorylation r domain atp binding likely hydrolysis nbds
0.43467933.10919864.html.plaintext.txt	9	exon 13 cftr gene encodes amino acids aas 590 830 originally ascribed r domain
0.43467933.10919864.html.plaintext.txt	10	study cftr channels severed near likely nh2 cooh terminal boundaries nbd1
0.43467933.10919864.html.plaintext.txt	11	cftr channel activity assayed using two microelectrode voltage clamp excised patch recordings provided sensitive measure successful assembly pair channel segments sever point systematically shifted along primary sequence
0.43467933.10919864.html.plaintext.txt	12	substantial channel activity taken indication nbd1 functionally intact
0.43467933.10919864.html.plaintext.txt	13	approach revealed cooh terminus nbd1 extends beyond aa 590 lies aas 622 634 nh2 terminus nbd1 lies aas 432 449
0.43467933.10919864.html.plaintext.txt	14	facilitate biochemical studies expressed proteins flag epitope added nh2 termini full length cftr cftr segments truncated normal cooh terminus aa 1480
0.43467933.10919864.html.plaintext.txt	15	functionally identified nbd1 boundaries supported western blotting coimmunoprecipitation deglycosylation studies showed nh2 terminal segment representing aas 3 622 flag3 622 3 633 flag3 633 could physically associate cooh terminal fragment representing aas 634 1480 634 1480 however latter fragment glycosylated mature form presence flag3 633
0.43467933.10919864.html.plaintext.txt	16	similarly 433 1480 could physically associate flag3 432 glycosylated mature form however 449 1480 protein seemed unstable could hardly detected even expressed flag3 432
0.43467933.10919864.html.plaintext.txt	17	excised patch recordings functional severed cftr channels displayed hallmark characteristics cftr including requirement phosphorylation exposure mgatp gating ability locked open pyrophosphate amp pnp small single channel conductances high apparent affinity channel opening mgatp
0.43467933.10919864.html.plaintext.txt	18	definitions boundaries nbd1 domain cftr supported comparison solved nbd structures hisp rbsa
0.43467933.10919864.html.plaintext.txt	19	key words adenosine triphosphate binding cassette transporter domain structure chloride channel gating kinetics coimmunoprecipitation
0.43467933.10919864.html.plaintext.txt	20	introduction top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	21	cystic fibrosis transmembrane conductance regulator 170 kd protein product gene mutated cystic fibrosis patients riordan et al
0.43467933.10919864.html.plaintext.txt	22	topological organization cftr predicted nucleotide sequence gene cloned riordan et al
0.43467933.10919864.html.plaintext.txt	23	1989 largely stood test time
0.43467933.10919864.html.plaintext.txt	24	cftr comprises two approximately homologous halves incorporating putative hexa helical transmembrane domain followed linear sequence cytoplasmic nucleotide binding domain nbd
0.43467933.10919864.html.plaintext.txt	25	1 two halves linked charged cytoplasmic 200 residue regulatory r domain contains multiple sites phosphorylation protein kinase protein kinase c riordan et al
0.43467933.10919864.html.plaintext.txt	26	apart large linker domain cftrs overall predicted domain structure identifies member large family atp binding cassette abc membrane transporters e
0.43467933.10919864.html.plaintext.txt	27	several well known eukaryotic abc proteins p glycoprotein pgp multi drug resistance related protein mrp associated multi drug resistance tumor cells ste6 mating factor transporter yeast
0.43467933.10919864.html.plaintext.txt	28	examples membrane spanning domains two nbds encoded single large gene
0.43467933.10919864.html.plaintext.txt	29	much larger number prokaryotic abc transporters nbds frequently expressed individual genes hisp nbd histidine permease e
0.43467933.10919864.html.plaintext.txt	30	1998 two nbds may fused single gene product rbsa nbds ribose transporter e
0.43467933.10919864.html.plaintext.txt	31	1998 transmembrane domains may expressed yet genes
0.43467933.10919864.html.plaintext.txt	32	one implication post translational assembly functional transporters bacteria separate gene products many cases single domains must possess information needed fold correctly interact complementary domains make fully functioning transporter
0.43467933.10919864.html.plaintext.txt	33	unlike abc protein cftr functions chloride channel reviewed sheppard welsh 1999
0.43467933.10919864.html.plaintext.txt	34	r domain multiple phosphorylation sites also unique cftr dephosphorylated state prevents opening cftr cl channels
0.43467933.10919864.html.plaintext.txt	35	even phosphorylated pka however cftr channel cannot open exposed atp another hydrolyzable nucleoside triphosphate
0.43467933.10919864.html.plaintext.txt	36	regulation opening closing cftr channels phosphorylation r domain nucleotide binding hydrolysis nbds extremely complex yet fully understood
0.43467933.10919864.html.plaintext.txt	37	one suggestion atp hydrolysis nbd1 results channel opening binding atp nbd2 stabilizes open channel conformation e
0.43467933.10919864.html.plaintext.txt	38	csanady gadsby 1999 gadsby nairn 1999
0.43467933.10919864.html.plaintext.txt	39	recently however basis direct comparisons atp hydrolysis gating measurements wild type mutant cftr suggested atp hydrolysis might strictly coupled channel opening ramjeesingh et al
0.43467933.10919864.html.plaintext.txt	40	still remains clear interactions two nbds nbds r domain play important roles gating cftr channels reviewed csanady gadsby 1999 gadsby nairn 1999 sheppard welsh 1999
0.43467933.10919864.html.plaintext.txt	41	dissection roles would greatly benefit structural information domains presently lacking
0.43467933.10919864.html.plaintext.txt	42	nevertheless peptide models r domain picciotto et al
0.43467933.10919864.html.plaintext.txt	43	1992 dulhanty riordan 1994 nh2 terminal nbd nbd1 hartman et al
0.43467933.10919864.html.plaintext.txt	44	1992 ko pedersen 1995 yike et al
0.43467933.10919864.html.plaintext.txt	45	1998 cooh terminal nbd nbd2 randak et al
0.43467933.10919864.html.plaintext.txt	46	1997 expressed partly characterized
0.43467933.10919864.html.plaintext.txt	47	valid concern several constructs sparse knowledge location domain boundaries
0.43467933.10919864.html.plaintext.txt	48	first step towards addressing concern attempted define boundaries nbd1 cftr exploiting functional approach
0.43467933.10919864.html.plaintext.txt	49	already shown cftr channel protein severed near cooh terminal end r domain two halves coexpressed form functional complex ostedgaard et al
0.43467933.10919864.html.plaintext.txt	50	therefore given modular design abc transporters general reasoned judicious cuts links flanking nbd1 ought tolerated
0.43467933.10919864.html.plaintext.txt	51	indeed cuts three four domains ste6 abrogate function berkower et al
0.43467933.10919864.html.plaintext.txt	52	describe search boundaries nbd1 coexpressing contiguous near contiguous segments cftr xenopus oocytes assessing function two microelectrode voltage clamp excised patch recordings
0.43467933.10919864.html.plaintext.txt	53	expression physical association cftr protein segments assayed using immunoblots coimmunoprecipitation
0.43467933.10919864.html.plaintext.txt	54	using approach find nh2 terminus nbd1 lies amino acids aa 432 449 cooh terminus lies aas 622 634
0.43467933.10919864.html.plaintext.txt	55	moreover regions spanning aas 415 432 634 667 omitted without severely impairing cftr channel function
0.43467933.10919864.html.plaintext.txt	56	materials methods top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	57	molecular biology pgemhe wt constructed subcloning cftr cdna fragment excised pbq4
0.43467933.10919864.html.plaintext.txt	58	johanna rommens hospital sick children toronto ontario canada smai xhoi biolabs inc
0.43467933.10919864.html.plaintext.txt	59	flag epitope m dykddddk followed leucine added nh2 terminus cftr fragment containing amino acids 3 835 running two consecutive pcr reactions using geneamp pcr system 2400 perkinelmer
0.43467933.10919864.html.plaintext.txt	60	first pcr reaction flagfw1 5 tacaaagacgacgacgacaagcttaggtcgcctctggaaaaggc 835rv 5 ccgctcgagcta atcaaaaaagcactcctttaagtc used pgemhe wt template
0.43467933.10919864.html.plaintext.txt	61	second pcr reaction flagfw2 5 tcc cccgggccgccatggattacaaagacgacgacgacaag 835rv used purified pcr product obtained first reaction template
0.43467933.10919864.html.plaintext.txt	62	pcr product second reaction subcloned smai xhoi sites pgemhe make pgemhe flag3 835
0.43467933.10919864.html.plaintext.txt	63	pgemhe flag3 589 made pcr using t7 fw primer 5 taatacgactcactatagggcgaatt specific reverse oligonucleotide primer 589rv 5 ccgctcgagctagctttcaaatatttctttttc pgemhe flag3 835 template followed subcloning pgemhe
0.43467933.10919864.html.plaintext.txt	64	pgemhe flag3 611 pgemhe flag3 622 pgemhe flag3 633 pgemhe flag3 432 pgemhe flag3 414 similarly constructed using t7 fw corresponding specific reverse primers
0.43467933.10919864.html.plaintext.txt	65	pgemhe 590 1480 made pcr using 590fw 5 tcccccgggccgccatgtgtgtctgtaaactga tggctaacaaaa sp6 rv 5 cgccaagctatttaggtgacactatag pgemhe wt template followed subcloning
0.43467933.10919864.html.plaintext.txt	66	pgemhe 449 1480 pgemhe 433 1480 pgemhe 634 1480 pgemhe 668 1480 similarly constructed using specific forward primers
0.43467933.10919864.html.plaintext.txt	67	pgemhe flagwt constructed subcloning bspeixhoi fragment pgemhe wt encodes part tm6 domains follow bspei xhoi sites pgemhe flag3 835
0.43467933.10919864.html.plaintext.txt	68	pgemhe 1 432 pgemhe 1 633 constructed pcr reactions using pgemhe wt template
0.43467933.10919864.html.plaintext.txt	69	pcr reactions used pfu polymerase stratagene low number 15 20 pcr cycles constructs confirmed automated sequencing
0.43467933.10919864.html.plaintext.txt	70	coding sequence every engineered cftr segment began kozak consensus sequence ccgccatg includes methionine start codon
0.43467933.10919864.html.plaintext.txt	71	plasmid dnas linearized nhei crnas produced vitro transcription using t7 mmessage mmachine kit ambion run denaturing gels check size quality
0.43467933.10919864.html.plaintext.txt	72	rna concentration estimated comparison known amount 0
0.43467933.10919864.html.plaintext.txt	73	isolation injection xenopus oocytes stage v vi oocytes isolated adult female xenopus laevis nasco partial ovariectomy tricaine 1 solution anaesthesia defolliculated treatment room temperature 21 23 degrees c 2 h 2 mgml collagenase type ii worthington biochemicals type gibco brl nominally ca2 free oocyte ringers solution containing mm 82
0.43467933.10919864.html.plaintext.txt	74	5 nacl 2 kcl 1 mgcl2 5 hepes ph 7
0.43467933.10919864.html.plaintext.txt	75	defolliculated oocytes rinsed extensively ca2 free ringers three five washes 50 ml incubated 18 degrees c several hours ringers 1
0.43467933.10919864.html.plaintext.txt	76	8 mm ca2 50 microgml gentamycin gibco brl pressure injected nanojet drummond scientific crnas
0.43467933.10919864.html.plaintext.txt	77	injection pipettes pulled pp83 narishige glass capillaries 3 000 203 gx drummond scientific tips broken internal diameter 10 20 microm
0.43467933.10919864.html.plaintext.txt	78	usually unless otherwise specified 2
0.43467933.10919864.html.plaintext.txt	79	5 ng crna premixed coexpression constant total volume 50 nl injected per oocyte
0.43467933.10919864.html.plaintext.txt	80	injected oocytes incubated 18 degrees c 2 3 d used recording preparation membranes
0.43467933.10919864.html.plaintext.txt	81	electrophysiology two microelectrode voltage clamp measurements oocytes plexiglass recording chamber volume 150 microl continuously superfused 2 mlmin 22 degrees c gravity fed solutions selected manual valves hamilton
0.43467933.10919864.html.plaintext.txt	82	dead volume 100 microl solutions completely exchanged 8
0.43467933.10919864.html.plaintext.txt	83	standard bath solution ca2 free ringers solution
0.43467933.10919864.html.plaintext.txt	84	chamber connected virtual ground circuitry agagcl electrodes 2
0.43467933.10919864.html.plaintext.txt	85	currents measured voltage clamp amplifier oc 725a oocyte clamp warner instrument corp
0.43467933.10919864.html.plaintext.txt	86	filtered 50 hz eight pole bessel filter frequency devices inc
0.43467933.10919864.html.plaintext.txt	87	digitized online 100 hz using digidata 1200 board axon instruments inc
0.43467933.10919864.html.plaintext.txt	88	2 software axon instruments inc
0.43467933.10919864.html.plaintext.txt	89	microelectrodes pulled glass capillaries 3 000 210 g drummond scientific filled 3 m kcl resistances 0
0.43467933.10919864.html.plaintext.txt	90	voltage steps applied via amplifiers toggle switch duration 0
0.43467933.10919864.html.plaintext.txt	91	5 1 using pclamp software
0.43467933.10919864.html.plaintext.txt	92	steady state currents averaged 200 ms near ends 1 voltage steps plotted voltage
0.43467933.10919864.html.plaintext.txt	93	conductance calculated linear fits steady currents 60 20 mv
0.43467933.10919864.html.plaintext.txt	94	average values least five oocytes
0.43467933.10919864.html.plaintext.txt	95	patch clamp recording oocytes shrunk 2 min standard bath solution containing mm 138 nmg 2 mg sulfamate 5 hepes 0
0.43467933.10919864.html.plaintext.txt	96	5 egta 134 sulfamic acid ph 7
0.43467933.10919864.html.plaintext.txt	97	1 sulfamic acid supplemented 100 mm nacl
0.43467933.10919864.html.plaintext.txt	98	vitelline membranes removed manually oocytes transferred recording chamber containing standard bath solution
0.43467933.10919864.html.plaintext.txt	99	patch pipettes pulled borosilicate glass n 51a drummond scientific using vertical pipette puller fire polished tip diameter 1 2 microm 4 7 m
0.43467933.10919864.html.plaintext.txt	100	pipette solution contained mm 138 nmg 2 mgcl2 5 hepes 136 hcl ph 7
0.43467933.10919864.html.plaintext.txt	101	200 300 g seals obtained gentle suction
0.43467933.10919864.html.plaintext.txt	102	patches excised transferred flow chamber cytoplasmic surface continuously superfused 21 23 degrees c standard bath solution containing various test substances
0.43467933.10919864.html.plaintext.txt	103	switching solutions implemented computer driven electric valves general valve corp
0.43467933.10919864.html.plaintext.txt	104	dead volume 20 microl flow rate 0
0.43467933.10919864.html.plaintext.txt	105	5 mlmin complete solution exchange took 2 4
0.43467933.10919864.html.plaintext.txt	106	solution exchange rate verified end recording applying brief pulse 2 mm ca sulfamate observing rate decay endogenous ca2 activated cl channel current upon ca2 removal
0.43467933.10919864.html.plaintext.txt	107	bath electrode agagcl pellet 100 mm kcl connected flow chamber agar bridge 4 agar 100 mm kcl
0.43467933.10919864.html.plaintext.txt	108	outward unitary currents cftr channels recorded pipette potential 40 mv vm 40 mv via axopatch 200a amplifier axon instruments inc
0.43467933.10919864.html.plaintext.txt	109	filtered 100 hz eight pole bessel filter frequency devices inc
0.43467933.10919864.html.plaintext.txt	110	digitized online 1 khz using itc 16 board instrutech recorded disk pulse software heka elektronik
0.43467933.10919864.html.plaintext.txt	111	cftr channels activated 300 nm catalytic subunit protein kinase purified bovine heart kaczmarek et al
0.43467933.10919864.html.plaintext.txt	112	1980 measurements steady state macroscopic cftr current various pka csanady et al
0.43467933.10919864.html.plaintext.txt	113	1998 showed even 300 nm less saturating due highly active membrane associated phosphatases
0.43467933.10919864.html.plaintext.txt	114	mgatp sigma aldrich added 400 mm stock solution ph 7
0.43467933.10919864.html.plaintext.txt	115	end experiment channels counted locking open state 2 mm nmg pyrophosphate ppi fluka presence 100 microm mgatp 300 nm pka supplemented 2 mm mg sulfamate example see fig 8
0.43467933.10919864.html.plaintext.txt	116	li4 amppnp sigma aldrich added 400 mm stock solution
0.43467933.10919864.html.plaintext.txt	117	view larger version 14k figure 1
0.43467933.10919864.html.plaintext.txt	118	c representative current recordings oocytes held initial resting membrane potential ca2 free oocyte ringers solution
0.43467933.10919864.html.plaintext.txt	119	oocytes injected water b 6 ng wt cftr rna c 2
0.43467933.10919864.html.plaintext.txt	120	horizontal bars mark periods exposure 50 microm forskolin plus 1 mm ibmx
0.43467933.10919864.html.plaintext.txt	121	basal activated conductances monitored applying plus minus 60 mv voltage steps 1 long
0.43467933.10919864.html.plaintext.txt	122	magnitudes basal activated conductances rates activation similar oocytes injected 2
0.43467933.10919864.html.plaintext.txt	123	d v relationships obtained times f c empty symbols resting basal filled symbols activated
0.43467933.10919864.html.plaintext.txt	124	steady current levels averaged 200 ms near end 1 voltage steps 100 80 mv 20 mv increments plotted voltage
0.43467933.10919864.html.plaintext.txt	125	view larger version 30k figure 2
0.43467933.10919864.html.plaintext.txt	126	defining cooh terminal boundary nbd1 coexpressing severed cftr segments
0.43467933.10919864.html.plaintext.txt	127	bars show mean plus minus sem basal activated conductances 50 microm forskolin plus 1 mm ibmx oocytes injected crnas 2
0.43467933.10919864.html.plaintext.txt	128	5 ng per construct various cftr segments cartooned left nh2 terminal flag epitope black zigzag transmembrane domains blue cyan nbd1 red r domain green nbd2 yellow
0.43467933.10919864.html.plaintext.txt	129	conductances calculated linear fits steady state v data 60 20 mv average values five oocytes
0.43467933.10919864.html.plaintext.txt	130	cooh terminus lies residues 622 634
0.43467933.10919864.html.plaintext.txt	131	view larger version 27k figure 3
0.43467933.10919864.html.plaintext.txt	132	defining nh2 terminal boundary nbd1 coexpressing severed cftr channel segments
0.43467933.10919864.html.plaintext.txt	133	methods symbols fig 2
0.43467933.10919864.html.plaintext.txt	134	nh2 terminus found lie residues 432 449
0.43467933.10919864.html.plaintext.txt	135	view larger version 26k figure 4
0.43467933.10919864.html.plaintext.txt	136	negligible basal activated conductances oocytes injected 2
0.43467933.10919864.html.plaintext.txt	137	5 ng crna encoding indicated single truncated cftr channel segments
0.43467933.10919864.html.plaintext.txt	138	methods symbols fig 2
0.43467933.10919864.html.plaintext.txt	139	view larger version 36k figure 5
0.43467933.10919864.html.plaintext.txt	140	protein expression cftr constructs severed near cooh terminus nbd1
0.43467933.10919864.html.plaintext.txt	141	b immunoblots membrane proteins oocytes expressing individual cftr segments pairs segments indicated resolved sds page transferred blotted anti r domain antibody anti flag m2 antibody b
0.43467933.10919864.html.plaintext.txt	142	c coexpressed constructs flag3 633 plus 634 1480 digested n glycosidase f left endoglycosidase h right products identified anti r domain antibody
0.43467933.10919864.html.plaintext.txt	143	arrows c mark fully glycosylated 150 kd fat arrow core glycosylated 95 kd thin arrow deglycosylated 90 kd thin arrow forms 634 1480 protein
0.43467933.10919864.html.plaintext.txt	144	view larger version 32k figure 6
0.43467933.10919864.html.plaintext.txt	145	protein expression cftr constructs severed near nh2 terminus nbd1
0.43467933.10919864.html.plaintext.txt	146	immunoblot membrane proteins oocytes expressing individual cftr segments pairs segments indicated blotted anti r domain antibody
0.43467933.10919864.html.plaintext.txt	147	b coexpressed constructs flag3 432433 1480 digested n glycosidase f left endoglycosidase h right products identified anti r domain antibody
0.43467933.10919864.html.plaintext.txt	148	arrows b mark fully glycosylated 160 kd fat arrow core glycosylated 125 kd thin arrow deglycosylated 120 kd thin arrow forms 433 1480 protein
0.43467933.10919864.html.plaintext.txt	149	partially degraded form 70 kd
0.43467933.10919864.html.plaintext.txt	150	view larger version 52k figure 7
0.43467933.10919864.html.plaintext.txt	151	coimmunoprecipitation severed cftr constructs
0.43467933.10919864.html.plaintext.txt	152	digitonin solubilized membrane proteins immunoprecipitated anti flag m2 affinity beads eluted resolved sds page 7
0.43467933.10919864.html.plaintext.txt	153	5 10 gradient gels blotted anti r domain antibody top anti nh2 terminus antibody bottom
0.43467933.10919864.html.plaintext.txt	154	constructs severed near cooh terminus nbd1 uninjected lane 1 flag3 622634 1480 lane 2 flag3 633634 1480 lane 3 arrows fig 5
0.43467933.10919864.html.plaintext.txt	155	b constructs severed near nh2 terminus nbd1 flag3 432449 1480 lane 1 flag3 432433 1480 lane 2 arrows fig 6
0.43467933.10919864.html.plaintext.txt	156	view larger version 45k figure 8
0.43467933.10919864.html.plaintext.txt	157	representative excised patch current recordings showing wt 1 432433 1480 1 633634 1480 flag wt flag3 432433 1480 flag3 633634 1480 cftr channels
0.43467933.10919864.html.plaintext.txt	158	constructs displayed hallmark characteristics wt cftr including requirement phosphorylation pka 300 nm exposure mgatp 1 mm wt 2 mm others channel activity slow burst kinetics locking open state mixture atp 0
0.43467933.10919864.html.plaintext.txt	159	kinetic analysis digitized 100 hz bandwidth 1 khz sampling rate baseline corrected currents records containing one seven channels idealized using conventional half amplitude threshold crossing
0.43467933.10919864.html.plaintext.txt	160	desired parameters mean burst interburst durations intact severed cftr constructs determined follows
0.43467933.10919864.html.plaintext.txt	161	first gating transitions modeled simple closed open scheme brief flickery closures attributed pore blockage events e
0.43467933.10919864.html.plaintext.txt	162	ishihara welsh 1997 resulting three state closed open blocked scheme scheme 1
0.43467933.10919864.html.plaintext.txt	163	record best set rate constants rco roc rob rbo extracted simultaneous maximum likelihood fit dwell time histograms obtained conductance levels described csanady 2000
0.43467933.10919864.html.plaintext.txt	164	finally mean interburst durations calculated using relationship ib 1rco mean burst durations given b 1roc1 robrbo
0.43467933.10919864.html.plaintext.txt	165	control similar burst type gating c o b scheme arises alternative linear three state model closed closed open c c o events list sometimes also fitted assuming c c o scheme yielded new set rate constants identical mean burst interburst durations record every case
0.43467933.10919864.html.plaintext.txt	166	open probabilities po calculated directly events lists time average idealized current divided channel number estimated patch described measured single channel current amplitude
0.43467933.10919864.html.plaintext.txt	167	macroscopic currents patches containing 20 1000 cftr channels digitally refiltered 10 hz using gaussian filter sampled 50 hz
0.43467933.10919864.html.plaintext.txt	168	average steady state current towards end 10 30 test applications 50 microm mgatp normalized mean steady currents 2 mm mgatp test ratios used estimate apparent affinities atp
0.43467933.10919864.html.plaintext.txt	169	single channel conductances estimated amplitude histograms excised patch currents recorded holding potentials 80 40 0 40 80 mv symmetrical 140 mm cl
0.43467933.10919864.html.plaintext.txt	170	distances adjacent peaks fits sums gaussians plotted voltage straight lines fitted yield conductances
0.43467933.10919864.html.plaintext.txt	171	results presented mean plus minus sem five experiments kinetic data three experiments apparent affinities single channel conductances
0.43467933.10919864.html.plaintext.txt	172	statistical significances evaluated students test
0.43467933.10919864.html.plaintext.txt	173	preparation oocyte membranes oocytes injected crna incubated 48 h frozen liquid nitrogen stored 80 degrees c
0.43467933.10919864.html.plaintext.txt	174	aliquots 150 frozen oocytes homogenized 4 degrees c 1 ml lysis buffer containing mm 10 hepes ph 7
0.43467933.10919864.html.plaintext.txt	175	5 naoh 6 edta 50 nacl 1 mgml bsa 1 pmsf protease inhibitor cocktail calbiochem final concentrations 1 mm aebsf hcl 300 nm aprotinin 2 microm e 64 2 microm leupeptin hemisulfate suspensions centrifuged 3000 g 10 min
0.43467933.10919864.html.plaintext.txt	176	supernatants kept centrifuged 3000 g 10 min
0.43467933.10919864.html.plaintext.txt	177	2 ml lysis buffer added resulting supernatants centrifugation 173600 g 1 h
0.43467933.10919864.html.plaintext.txt	178	pellets washed 3 ml modified lysis buffer 10 glycerol instead bsa 0
0.43467933.10919864.html.plaintext.txt	179	5 mm pmsf centrifugation repeated pelleted membranes resuspended 0
0.43467933.10919864.html.plaintext.txt	180	2 ml modified lysis buffer stored 80 degrees c
0.43467933.10919864.html.plaintext.txt	181	western blotting coimmunoprecipitation membrane proteins 75 microg total membrane protein per lane resolved 7
0.43467933.10919864.html.plaintext.txt	182	5 sds page blotted onto nitrocellulose membranes using semi dry transfer cell bio rad laboratories
0.43467933.10919864.html.plaintext.txt	183	protein bands containing r domain detected anti r domain ab picciotto et al
0.43467933.10919864.html.plaintext.txt	184	1992 horseradish perozidase conjugated goat anti rabbit igg secondary ab
0.43467933.10919864.html.plaintext.txt	185	nh2 terminal fragments detected either using anti flag m2 monoclonal ab sigma aldrich hp conjugated goat anti mouse igg secondary ab coimmunoprecipitation experiments using anti nh2 terminal ab a2 kindly provided dr
0.43467933.10919864.html.plaintext.txt	186	skach oregon health sciences university portland hp conjugated goat anti rabbit igg secondary ab
0.43467933.10919864.html.plaintext.txt	187	protein bands visualized ecl western blotting kit amersham pharmacia biotech
0.43467933.10919864.html.plaintext.txt	188	coimmunoprecipitation procedure modified ostedgaard et al
0.43467933.10919864.html.plaintext.txt	189	450 microg total membrane protein sample solubilized 1 h 1 ml solubilization buffer 1
0.43467933.10919864.html.plaintext.txt	190	25 digitonin 150 mm nacl 50 mm trishcl ph 7
0.43467933.10919864.html.plaintext.txt	191	5 suspensions centrifuged 173600 g 1 h
0.43467933.10919864.html.plaintext.txt	192	supernatant soluble proteins mixed 200 microl anti flag m2 affinity gel sigma aldrich prewashed solubilization buffer mixtures rocked overnight centrifuged 26000 g 5 min
0.43467933.10919864.html.plaintext.txt	193	pellets containing anti flag m2 affinity gel bound proteins washed three times solubilization buffer three times high salt buffer 500 mm nacl 50 mm trishcl ph 7
0.43467933.10919864.html.plaintext.txt	194	5 twice 50 mm tris ph 7
0.43467933.10919864.html.plaintext.txt	195	coimmunoprecipitated proteins eluted 150 microl laemmli buffer
0.43467933.10919864.html.plaintext.txt	196	deglycosylation protein determination oocyte membrane protein samples 75 microg treated n glycosidase f endoglycosidase h 1 h 37 degrees c following suppliers protocol boehringer
0.43467933.10919864.html.plaintext.txt	197	protein concentrations measured bicinchonic acid pierce chemical co
0.43467933.10919864.html.plaintext.txt	198	results top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	199	wild type cftr channels display basal activity resting xenopus oocytes xenopus oocytes proven convenient expression system functional biochemical analysis variety ion channels including cftr e
0.43467933.10919864.html.plaintext.txt	200	1999 adopted study
0.43467933.10919864.html.plaintext.txt	201	fig 1a c shows typical recordings membrane current oocytes held near resting potentials 2 d injecting water b wt cftr crna c mixture two crnas encoding contiguous cftr segments flag3 633 634 1480
0.43467933.10919864.html.plaintext.txt	202	membrane conductance monitored every minute plus minus 60 mv steps away holding potential yielded negligibly small currents plus minus 0
0.43467933.10919864.html.plaintext.txt	203	1 microa less times control h2o injected oocytes also uninjected oocytes
0.43467933.10919864.html.plaintext.txt	204	contrast voltage steps elicited clearly discernible currents approximately plus minus 1 microa unstimulated oocytes expressing wt cftr reflecting mean basal conductance 10 plus minus 1 micros approximately plus minus 10 microa mean activated conductance 173 plus minus 4 micros within 2 min stimulating camppka pathway oocytes exposing 50 microm forskolin plus 1 mm ibmx fig 1 table 1
0.43467933.10919864.html.plaintext.txt	205	steady current levels near ends 1 voltage pulses potentials 100 80 mv shown steady state current voltage plots fig 1 d
0.43467933.10919864.html.plaintext.txt	206	oocytes expressing wt cftr v relationships approximately linear showed roughly reversal potential stimulation pka fig 1 d c d
0.43467933.10919864.html.plaintext.txt	207	oocytes expressing wt cftr uninjected oocytes subsequent injection pka inhibitor rpcamps estimated final concentration 1 mm diminished basal conductance matched h2o injected uninjected oocytes csanady l
0.43467933.10919864.html.plaintext.txt	208	gadsby manuscript submitted publication
0.43467933.10919864.html.plaintext.txt	209	indicates basal conductance reflected activity wt cftr channels phosphorylated basally active pka phosphatases must also constitutively active oocytes dephosphorylate cftr channels abolish basal activity introduction rpcamps
0.43467933.10919864.html.plaintext.txt	210	accordingly forskolin ibmx induced increase membrane conductance oocytes expressing cftr presumably reflected activation cftr pka mediated phosphorylation e
0.43467933.10919864.html.plaintext.txt	211	1993 possibly also direct stimulation cftr ibmx al nakkash hwang 1999
0.43467933.10919864.html.plaintext.txt	212	conductances oocytes expressing various cftr constructs
0.43467933.10919864.html.plaintext.txt	213	defining cooh terminal boundary nbd1 assessing function coexpressed severed cftr segments location boundary nbd1 r domain cftr presently unclear
0.43467933.10919864.html.plaintext.txt	214	initial suggestion exon 13 cftr comprising aas 590 830 encoded r domain hence exon 1213 junction marked boundary nbd1 r domain riordan et al
0.43467933.10919864.html.plaintext.txt	215	might reasonably expected functional cftr channels could reconstituted coexpression two contiguous segments cftr severed residues 589 590
0.43467933.10919864.html.plaintext.txt	216	nh2 terminal flag epitope incorporated facilitate immunoprecipitation detection expressed proteins see
0.43467933.10919864.html.plaintext.txt	217	injection oocytes mixture two crnas encoding two segments resulted conductances negligible basal 2 plus minus 1 micros activated 2 plus minus 1 micros conditions control uninjected oocytes fig 2 table 1
0.43467933.10919864.html.plaintext.txt	218	assumption nbd1 likely stretches beyond aa 589 compare annereau et al
0.43467933.10919864.html.plaintext.txt	219	1997 series constructs made cooh terminus flag3 589 incrementally extended
0.43467933.10919864.html.plaintext.txt	220	constructs turn coexpressed 590 1480 segment basal activated conductances measured assess channel function fig 2
0.43467933.10919864.html.plaintext.txt	221	conductances mimicked uninjected oocytes flag tagged cftr segment extended aa 633
0.43467933.10919864.html.plaintext.txt	222	thus basal activated conductances 2 plus minus 1 3 plus minus 1 micros oocytes injected flag3 622 plus 590 1480 jumped 8 plus minus 1 91 plus minus 7 micros oocytes coexpressing flag3 633 plus 590 1480
0.43467933.10919864.html.plaintext.txt	223	however basal activated conductances produced flag3 633 plus 590 1480 constructs smaller attained wt cftr fig 2
0.43467933.10919864.html.plaintext.txt	224	speculating shortfall might attributable repetition residues 590 633 upon coexpression flag3 633 plus 590 1480 removed overlapping residues coexpressing flag3 633 segment 634 1480 found basal activated conductances 17 plus minus 1 182 plus minus 4 micros respectively comparable oocytes expressing wt cftr fig 1 b d 2 table 1
0.43467933.10919864.html.plaintext.txt	225	results show robust cftr channel function obtained cooh terminus segment flag3 589 extended aa 633 aa 622 construct coexpressed appropriate complementary segment suggesting cooh terminus nbd1 lies aas 622 634
0.43467933.10919864.html.plaintext.txt	226	words could lie aa 623 624 625 etc
0.43467933.10919864.html.plaintext.txt	227	could extend far aa 633
0.43467933.10919864.html.plaintext.txt	228	alternative possibility crucial part nbd1 extends beyond aa 633 nevertheless associate flag3 633 segment form complete nbd1 domain rendered unlikely finding strong cftr channel activity reconstituted coexpression flag3 633 668 1480 despite omission 34 residue segment aas 634 667 basal activated conductances 16 plus minus 1 175 plus minus 7 micros respectively fig 2 table 1 similar wt cftr
0.43467933.10919864.html.plaintext.txt	229	hand oocytes coexpressing flag3 622 plus 634 1480 cftr channels must lack aas 623 633 displayed negligible basal activated conductances like uninjected oocytes
0.43467933.10919864.html.plaintext.txt	230	defining nh2 terminal boundary nbd1 used similar strategy incrementally extend nh2 terminus segment 590 1480 attempt build complete nbd1
0.43467933.10919864.html.plaintext.txt	231	upon coexpression flag3 589 extended segment 449 1480 yielded conductances indistinguishable uninjected oocytes extended segment 433 1480 gave substantial activated 129 plus minus 12 micros conductance though still smaller wt cftr injected oocytes fig 3
0.43467933.10919864.html.plaintext.txt	232	however omission overlapping section residues 433 589 coexpression flag3 432 plus 433 1480 resulted somewhat larger basal 6 plus minus 1 micros activated 157 plus minus 5 micros conductances approached oocytes expressing wt cftr channels
0.43467933.10919864.html.plaintext.txt	233	fact coexpression flag3 432 plus 449 1480 yielded functional channels confirms segment 433 448 essential part nbd1
0.43467933.10919864.html.plaintext.txt	234	contrast coexpression flag3 414 plus 433 1480 effectively deleted 18 residue segment aas 415 432 nevertheless resulted oocytes displayed basal activated conductances 7 plus minus 1 195 plus minus 5 micros respectively comparable oocytes expressing intact cftr fig 2 table 1
0.43467933.10919864.html.plaintext.txt	235	data suggest nh2 terminal boundary nbd1 lies aas 432 449
0.43467933.10919864.html.plaintext.txt	236	control test individual segment cftr used investigate functional boundaries nbd1 expressed oocytes basal activated conductances measured usual manner
0.43467933.10919864.html.plaintext.txt	237	cases resulting conductances similar uninjected oocytes fig 4 confirming none truncated cftr fragments readily forms viable channels expressed alone xenopus oocytes
0.43467933.10919864.html.plaintext.txt	238	expression maturation severed cftr segments western blots proteins resolved whole oocyte membrane preparations used evaluate expression intact truncated cftr proteins
0.43467933.10919864.html.plaintext.txt	239	expected r domain antibody recognize flag3 622 flag3 633 segments fig 5 lanes 1 2 detect single sharp band 95 kd fig 5 lane 3 thin arrow segment 634 1480 expressed alone
0.43467933.10919864.html.plaintext.txt	240	however additional broad band 150 kd appeared 634 1480 coexpressed flag3 633 fig 5 lane 5 fat arrow implying segment 634 1480 glycosylated
0.43467933.10919864.html.plaintext.txt	241	accordingly 95 kd band could digested perceptibly smaller band 90 kd fig 5 c thin arrows either endoglycosidase h n glycosidase f whereas broad 150 kd fig 5 c fat arrow band insensitive endoglycosidase h largely digested 90 kd band treatment n glycosidase f fig 5 c
0.43467933.10919864.html.plaintext.txt	242	endoglycosidase h may expected remove glycosyl moieties proteins yet modified early golgi enzyme mannosidase ii whereas n glycosidase f removes asparagine linked glycosyl groups results argue 90 kd band corresponds deglycosylated form segment 634 1480 95 150 kd bands correspond core glycosylated fully glycosylated forms respectively
0.43467933.10919864.html.plaintext.txt	243	turn suggests segment 634 1480 merely core glycosylated expressed alone fig 5 lane 3 could fully glycosylated coexpressed contiguous segment flag3 633 fig 5 lane 5
0.43467933.10919864.html.plaintext.txt	244	together several fold increase density 634 1480 signal presence flag3 633 compare lanes 3 5 findings indicate maturation stabilization segment 634 1480 promoted coexpression appropriate complementary segment flag3 633
0.43467933.10919864.html.plaintext.txt	245	interestingly however 150 kd band detected segment 634 1480 coexpressed flag3 622 fig 5 lane 4
0.43467933.10919864.html.plaintext.txt	246	despite fact flag3 633 flag3 622 segments detected anti flag m2 antibody single narrow bands fig 5 b expressed similar levels almost level whether expressed alone coexpressed 634 1480
0.43467933.10919864.html.plaintext.txt	247	thus although removal eleven residues aas 623 633 flag3 633 affect stability resulting segment flag3 622 fig 5 b lanes 2 5 vs
0.43467933.10919864.html.plaintext.txt	248	1 4 deletion abrogated ability segment promote glycosylation coexpressed fragment 634 1480 fig 5 lane 5 vs
0.43467933.10919864.html.plaintext.txt	249	data indicate completion cooh terminus segment flag3 622 aas 623 633 required productive interaction segment 634 1480 turn seems essential maturation resulting complex
0.43467933.10919864.html.plaintext.txt	250	consistent conclusion functional measurements using two electrode voltage clamp cooh terminus nbd1 lies residues 622 634
0.43467933.10919864.html.plaintext.txt	251	similarly r domain antibody detect flag3 432 segment lacks r domain fig 6 lane 1 recognized segment 433 1480 expressed alone gave sharp band 125 kd fig 6 lane 2 thin arrow
0.43467933.10919864.html.plaintext.txt	252	coexpression 433 1480 flag3 432 fig 6 lane 5 yielded band thin arrow together additional broader band fat arrow 160 kd together weak degradation bands 70 75 kd consistent glycosylation segment 433 1480
0.43467933.10919864.html.plaintext.txt	253	indeed treatment either endoglycosidase h n glycosidase f lower 125 kd mr band migrated slightly smaller fragment 120 kd fig 6 b thin arrows
0.43467933.10919864.html.plaintext.txt	254	hand higher 160 kd fig 6 b fat arrow mr band insensitive endoglycosidase h converted 120 kd band n glycosidase f
0.43467933.10919864.html.plaintext.txt	255	seems 120 kd band represents unglycosylated form segment 433 1480 125 160 kd bands represent core glycosylated fully glycosylated forms
0.43467933.10919864.html.plaintext.txt	256	however hardly protein detected range 45 180 kd r domain antibody segment 449 1480 expressed alone fig 6 lane 3
0.43467933.10919864.html.plaintext.txt	257	even coexpressed flag3 432 segment relatively weak band 70 kd could detected presumably representing degraded form 449 1480 protein fig 6 lane 4
0.43467933.10919864.html.plaintext.txt	258	appears stability 449 1480 protein slightly increased presence flag3 432 although glycosylated form 449 1480 observed
0.43467933.10919864.html.plaintext.txt	259	thus deletion aas 433 448 433 1480 yielded segment seemed highly unstable even coexpressed complementary segment cftr
0.43467933.10919864.html.plaintext.txt	260	biochemical findings support conclusion electrophysiological assays function nh2 terminus nbd1 lies residues 432 449
0.43467933.10919864.html.plaintext.txt	261	physical association complementary fragments starts endoplasmic reticulum coimmunoprecipitation tests made using anti flag m2 affinity beads evaluate physical association flag tagged nh2 terminal segments cftr complementary cooh terminal segments membrane extracts oocytes coinjected crnas encoding severed cftr molecules
0.43467933.10919864.html.plaintext.txt	262	segments flag3 622 flag3 633 detected antibody epitope near cftrs nh2 terminus fig 7 bottom lanes 2 3 able coimmunoprecipitate core glycosylated 95 kd thin arrow form segment 634 1480 top lanes 2 3
0.43467933.10919864.html.plaintext.txt	263	however fully glycosylated 150 kd fat arrow form 634 1480 coimmunoprecipitated flag3 633 fig 7 top lane 3 flag3 622 lane 2
0.43467933.10919864.html.plaintext.txt	264	immunoprecipitation via flag tag appears flag3 622 flag3 633 segments associate core glycosylated segment 634 1480 fig 7 top lanes 2 3 thin arrow presumably endoplasmic reticulum er flag3 633 plus 634 1480 complex proceeds golgi compartment eventually cell surface membrane mature fully glycosylated channel
0.43467933.10919864.html.plaintext.txt	265	flag3 622 plus 634 1480 complex fig 7 lane 2 hand appear leave er
0.43467933.10919864.html.plaintext.txt	266	correspondingly immunoprecipitation segment flag3 432 detected anti nh2 terminal antibody fig 7 b bottom lanes 1 2 resulted coimmunoprecipitation core glycosylated thin arrow fully glycosylated fat arrow forms segment 433 1480 top lane 2 little protein corresponding segment 449 1480 top lane 1
0.43467933.10919864.html.plaintext.txt	267	latter result corroborates conclusion western blot fig 6 segment 449 1480 appears rapidly degraded oocyte
0.43467933.10919864.html.plaintext.txt	268	coimmunoprecipitation using anti flag beads immature mature forms 433 1480 fig 7 b top lane 2 thin fat arrows however demonstrates segments flag3 432 433 1480 physically associate association takes place er latest early golgi compartment
0.43467933.10919864.html.plaintext.txt	269	data indicate complementary pairs cftr segments constitute functional channels whether severed intact nbd1 begin association er proceeding golgi cell membrane whereas segment pairs comprise intact nbd1 fail exit er
0.43467933.10919864.html.plaintext.txt	270	nh2 terminal flag epitope lowers po cftr channels slowing opening forskolin activates cftr channels indirectly via pathway involves adenylyl cyclase pka holoenzyme oocyte activation appears subject saturation csanady l
0.43467933.10919864.html.plaintext.txt	271	gadsby manuscript submitted publication
0.43467933.10919864.html.plaintext.txt	272	moreover ibmx millimolar concentrations likely directly stimulates cftr channel activity al nakkash hwang 1999
0.43467933.10919864.html.plaintext.txt	273	facts make two microelectrode recordings coarse assays function cftr channels whether intact severed expressed oocytes
0.43467933.10919864.html.plaintext.txt	274	therefore directly activated channels applying catalytic subunit pka cytoplasmic surface inside patches excised oocytes evaluated behavior detail
0.43467933.10919864.html.plaintext.txt	275	also nh2 terminal cftr segments described far tagged flag m2 epitope characterized unitary currents three representative channel types wt cftr cftr severed nbd1 cftr severed nbd1 case without flag tag e
0.43467933.10919864.html.plaintext.txt	276	representative recordings fig 8 show wt flag wt cftr channels share several accepted hallmark characteristics single channel conductance requirement atp prior phosphorylation pka channel activity relatively slow channel gating interburst burst durations order seconds locking channels open state ppi amppnp data shown
0.43467933.10919864.html.plaintext.txt	277	however kinetic analysis revealed po flag wt 13 wt fig 9 table 2
0.43467933.10919864.html.plaintext.txt	278	reduction po due change mean burst duration
0.43467933.10919864.html.plaintext.txt	279	closing rate rather reflected approximately threefold prolongation mean interburst duration
0.43467933.10919864.html.plaintext.txt	280	approximately threefold lower opening rate flag wt compared wt channels fig 9
0.43467933.10919864.html.plaintext.txt	281	comparable results obtained severed cftr channels flag3 432 plus 433 1480 flag3 633 plus 634 1480 compared flag less counterparts fig 9
0.43467933.10919864.html.plaintext.txt	282	evident recordings fig 8 constructs displayed general channel characteristics listed wt cftr channels
0.43467933.10919864.html.plaintext.txt	283	despite broad similarity severed cftr channels containing nh2 terminal flag showed interburst durations two threefold longer corresponding flag less severed cftr channels fig 9 table 2
0.43467933.10919864.html.plaintext.txt	284	therefore flag epitope added nh2 terminus cftr significantly reduces channel po selectively slowing channel opening
0.43467933.10919864.html.plaintext.txt	285	view larger version 25k figure 9
0.43467933.10919864.html.plaintext.txt	286	kinetic analysis wt 1 432433 1480 1 633634 1480 flag wt flag3 432433 1480 flag3 633634 1480 channels
0.43467933.10919864.html.plaintext.txt	287	kinetic parameters extracted records filtered 100 hz sampled 1 khz patches containing one seven channels exposed 2 mm mgatp 300 nm pka
0.43467933.10919864.html.plaintext.txt	288	mean burst durations constructs severed nbd1 r domain 1 633634 1480 flag3 633634 1480 significantly shorter wt flag wt
0.43467933.10919864.html.plaintext.txt	289	constructs containing flag epitope flag wt flag3 432 433 1480 flag3 633634 1480 showed significantly prolonged interburst durations hence significantly reduced po compared wt
0.43467933.10919864.html.plaintext.txt	290	gating kinetics intact severed cftr channels
0.43467933.10919864.html.plaintext.txt	291	severing cftr nbd1 r domain lowers po speeding channel closing interesting question whether severing cftr either nbd1 affects channel gating
0.43467933.10919864.html.plaintext.txt	292	results kinetic analysis fig 9 table 2 demonstrate severed channels formed segments 1 432 plus 433 1480 po mean burst duration mean interburst duration significantly different wt cftr channels
0.43467933.10919864.html.plaintext.txt	293	furthermore similarity influenced addition flag epitope since severed channels formed flag3 432 plus 433 1480 segments showed po burst interburst durations closely similar flag wt channels fig 9 table 2
0.43467933.10919864.html.plaintext.txt	294	however severed channels formed cftr segments 1 633 plus 634 1480 smaller po wt 1 432 plus 433 1480 channels attributable reduced burst duration
0.43467933.10919864.html.plaintext.txt	295	increased closing rate
0.43467933.10919864.html.plaintext.txt	296	effect severing cftr channels nbd1 independent presence absence flag epitope mean burst duration channels comprising segments flag3 633 plus 634 1480 significantly shorter either flag wt flag3 432 plus 433 1480 channels fig 9 table 2
0.43467933.10919864.html.plaintext.txt	297	findings indicate severing cftr nbd1 measurable effect channel po gating kinetics whereas severing cftr nbd1 r domain leads reduction po due increase channel closing rate
0.43467933.10919864.html.plaintext.txt	298	neither adding flag epitope severing cftr nbd1 affects single channel conductance apparent affinity atp verify neither incorporating flag epitope severing cftr nbd1 causes major structural alteration channel pore measured single channel conductances wt flag wt cftr channels severed channels formed segments 1 432 plus 433 1480 flag3 432 plus 433 1480 1 633 plus 634 1480 flag3 633 plus 634 1480 excised patches exposed symmetrical 140 mm cl solutions
0.43467933.10919864.html.plaintext.txt	299	conditions illustrated wt 1 432 plus 433 1480 channels channel type characterized ohmic single channel conductance average magnitude 7 ps significant difference conductance wt cftr channels constructs p 0
0.43467933.10919864.html.plaintext.txt	300	argues severing cftr adding nh2 terminal flag grossly alter pore architecture
0.43467933.10919864.html.plaintext.txt	301	view larger version 26k figure 10
0.43467933.10919864.html.plaintext.txt	302	single channel conductances wt 1 432433 1480 1 633634 1480 flagwt flag3 432433 1480 flag3 633634 1480 channels symmetrical 140 mm cl
0.43467933.10919864.html.plaintext.txt	303	b segments representative cftr channel current records illustrated wt 1 432433 1480 holding potentials 80 40 0 40 80 mv used create amplitude histograms fitted sums gaussians right
0.43467933.10919864.html.plaintext.txt	304	distances adjacent peaks plotted potential gave linear v plots
0.43467933.10919864.html.plaintext.txt	305	c fitted slopes gave conductances 6
0.43467933.10919864.html.plaintext.txt	306	1 flag3 633634 1480 none differed significantly wt p 0
0.43467933.10919864.html.plaintext.txt	307	assuming step binding atp one nbds rate limits channel opening see csanady gadsby 1999 gadsby nairn 1999 zeltwanger et al
0.43467933.10919864.html.plaintext.txt	308	1999 two possible explanations observation opening rate hence po decreased flag tagged cftr channels
0.43467933.10919864.html.plaintext.txt	309	decrease could result reduction either binding affinity atp site rate step binding step related hydrolysis transmission gating conformational change pore
0.43467933.10919864.html.plaintext.txt	310	distinguish two possibilities cftr construct measured macroscopic currents large patches containing many channels compared current magnitude test exposure 50 microm mgatp obtained 2 mm mgatp test fig 11
0.43467933.10919864.html.plaintext.txt	311	ratio currents i50 micromi2mm provides rough measure apparent affinity atp constructs 2 mm mgatp proved saturating concentration thus i1mmi2mm ratios 1
0.43467933.10919864.html.plaintext.txt	312	03 flag3 432433 1480 1
0.43467933.10919864.html.plaintext.txt	313	representative macroscopic current records constructs bar graph summary fig 11 show i50 micromi2mm ratios similar close 0
0.43467933.10919864.html.plaintext.txt	314	5 indicating k12atp activation po since time averaged number active channels may assumed constant bracketed measurements 50 microm constructs
0.43467933.10919864.html.plaintext.txt	315	hence observed reduction po addition flag epitope nh2 terminus cftr fig 9 likely reflect slowing rate limiting step atp binding
0.43467933.10919864.html.plaintext.txt	316	view larger version 26k figure 11
0.43467933.10919864.html.plaintext.txt	317	apparent affinities activation channel po mgatp
0.43467933.10919864.html.plaintext.txt	318	representative macropatch currents shown wt flag wt 1 633634 1480 flag3 633634 1480 b 1 432433 1480 flag3 432433 1480 c flag3 414433 1480 d channels
0.43467933.10919864.html.plaintext.txt	319	prephosphorylation pka removal pka atp channels closed 50 microm atp applied 10 30 bracketed exposures 2 mm atp
0.43467933.10919864.html.plaintext.txt	320	e ratios mean steady currents i50 micromi2mm 0
0.43467933.10919864.html.plaintext.txt	321	none constructs differed significantly wt p 0
0.43467933.10919864.html.plaintext.txt	322	deletion aas 415 432 cftr alter apparent affinity atp demonstration effective deletion aas 415 432 coexpression segments flag3 414 433 1480 impairs cftr channel activity little fig 3 ramifications understanding relationship structure channels function
0.43467933.10919864.html.plaintext.txt	323	residues 415 432 cftr align fig 12 comprising first ss strand recently solved high resolution structures hisp nbd histidine permease salmonella typhimurium hung et al
0.43467933.10919864.html.plaintext.txt	324	1998 nh2 terminal nbd rbsa incorporates two nbds ribose transporter escherichia coli armstrong et al
0.43467933.10919864.html.plaintext.txt	325	although sequences three nbds nbd1 cftr nh2 terminal nbd rbsa hisp share order 20 identity largely restricted highly conserved abc signature sequence walker b sequences walker et al
0.43467933.10919864.html.plaintext.txt	326	1982 latter contribute active site yet separated 140 residues hisp large distance strongly constrains alignments different nbd sequences hung et al
0.43467933.10919864.html.plaintext.txt	327	moreover despite small degree identity catalytic site architectures hisp rbsa closely similar resemble open cup formed broken ss barrel within nucleotide binds hung et al
0.43467933.10919864.html.plaintext.txt	328	crystal structures conserved aromatic residue tyr16 hisp phe14 rbsa located end first ss strand fig 12 makes extensive hydrophobic contact adenine base bound nucleotide least hisp seems crucial nucleotide binding shyamala et al
0.43467933.10919864.html.plaintext.txt	329	depending alignment corresponding residue nbd1 cftr likely leu435 fig 12 compare hung et al
0.43467933.10919864.html.plaintext.txt	330	insofar structure nbd1 cftr resembles hisp rbsa deletion aas 415 432 may expected remove entire first ss strand turn proximity phe433 leu435 would anticipated influence nucleotide binding
0.43467933.10919864.html.plaintext.txt	331	see whether deletion affects apparent affinity atp activation channel po measured ratio i50 micromi2mm flag3 414433 1480 cftr channels macropatches fig 11
0.43467933.10919864.html.plaintext.txt	332	ratio found close 0
0.43467933.10919864.html.plaintext.txt	333	5 flag3 414433 1480 channels value observed wt well cftr constructs tested fig 11
0.43467933.10919864.html.plaintext.txt	334	since one experiment i1mmi2mm 1
0.43467933.10919864.html.plaintext.txt	335	02 macropatch flag3 414433 1480 channels may conclude k12 atp 50 microm channels also
0.43467933.10919864.html.plaintext.txt	336	view larger version 22k figure 12
0.43467933.10919864.html.plaintext.txt	337	alignment cftrs nbd1 hisp
0.43467933.10919864.html.plaintext.txt	338	psi blast aligned cftr residues 422 637 corresponding residues hisp
0.43467933.10919864.html.plaintext.txt	339	secondary structure elements shown ss strands magenta arrows helices orange boxes correspond solved crystal structure hisp hung et al
0.43467933.10919864.html.plaintext.txt	340	cftr residue numbers centered corresponding letters
0.43467933.10919864.html.plaintext.txt	341	teal boxes identify three consensus sequences conserved abc proteins
0.43467933.10919864.html.plaintext.txt	342	red boxes cftr sequence identify nontolerated green boxes tolerated cut sites
0.43467933.10919864.html.plaintext.txt	343	cuts occurred two highlighted residues case
0.43467933.10919864.html.plaintext.txt	344	gray boxes identify sections flanking nbd1 sequence could omitted without destroying channel function
0.43467933.10919864.html.plaintext.txt	345	discussion top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	346	work demonstrated physical functional association complementary segments cftr severed nbd1 results split channels microscopic properties closely similar intact wt cftr
0.43467933.10919864.html.plaintext.txt	347	systematically shifting sever point able define domain boundaries nbd1 within 10 15 amino acids
0.43467933.10919864.html.plaintext.txt	348	newly defined boundaries important ramifications structural functional studies cftrs nbds whether isolated polypeptides native state incorporated full length cftr
0.43467933.10919864.html.plaintext.txt	349	severed membrane transport protein may nevertheless function demonstrated previously
0.43467933.10919864.html.plaintext.txt	350	coli cells expressing putative hexahelical halves lac permease severed within central cytoplasmic loop transport lactose one third rate cells expressing intact permease transport seen cells expressing either half alone bibi kaback 1990
0.43467933.10919864.html.plaintext.txt	351	similarly coexpression xenopus oocytes three complementary segments severed within cytoplasmic extracellular loops comprising full length human erythrocyte anion exchanger band 3 ae1 resulted cl influx levels comparable observed expression intact wt band 3 groves et al
0.43467933.10919864.html.plaintext.txt	352	although domain organization band 3 yet known remarkable protein backbone cut least four sever points least two simultaneously little detectable loss cl transport function
0.43467933.10919864.html.plaintext.txt	353	perhaps less surprising known multidomain protein like voltage gated na channel four repeats six putative membrane spanning helices still function single cut two repeats least two three linking loops stuhmer et al
0.43467933.10919864.html.plaintext.txt	354	eukaryotic abc transporters also multidomain proteins homologous internal repeats consequence evolution prokaryotic ancestors individual domains often expressed separate genes e
0.43467933.10919864.html.plaintext.txt	355	surprising abc molecules yeast factor transporter ste6 also function coexpressed two separate halves berkower michaelis 1991 coimmunoprecipitation experiments demonstrate two halves physically interact berkower et al
0.43467933.10919864.html.plaintext.txt	356	representatives two families multidrug resistance abc proteins pgp loo clarke 1994 mrp gao et al
0.43467933.10919864.html.plaintext.txt	357	1996 also shown survive cut half nbd1 second transmembrane domain retain least partial function severed mrp transported substrate least third well intact mrp fraction possibly simply reflecting efficiency simultaneous transfection insect cells used gao et al
0.43467933.10919864.html.plaintext.txt	358	1996 whereas severed pgp supported substrate induced atpase activity half intact pgp showed sign drug transport nih 3t3 cells possibly due defective trafficking cell membrane loo clarke 1994
0.43467933.10919864.html.plaintext.txt	359	physical functional association nh2 cooh terminal halves cftr residues 1 835 837 1480 cut r domain demonstrated ostedgaard et al
0.43467933.10919864.html.plaintext.txt	360	1997 found severed construct supported intracellular camp activated anion fluxes assayed measurements spq fluorescence comparable wt cftr
0.43467933.10919864.html.plaintext.txt	361	assaying function severed molecules define domain boundaries approach well suited multidomain single gene eukaryotic abc transporters individual domains may correspond product single ancestral gene may therefore reasonably expected capable folding separately
0.43467933.10919864.html.plaintext.txt	362	indeed already several examples putative links domains eukaryotic abc proteins severed without destroying molecules overall function described
0.43467933.10919864.html.plaintext.txt	363	general severing backbone protein detectably impair function reasonable conclude covalent linkage point required assayed function
0.43467933.10919864.html.plaintext.txt	364	may concluded either cut occurs functional domains sever point lies within domain native fold function nevertheless retained shiba schimmel 1992 betton hofnung 1994
0.43467933.10919864.html.plaintext.txt	365	however latter possibility becomes far less likely function remains intact substantial deletion introduced one side sever point
0.43467933.10919864.html.plaintext.txt	366	precisely finding effectively deleted 18 residue segment 415 432 coexpressing flag3 414 plus 433 1480 fig 3 nh2 proximal side nbd1 34 residue segment 634 667 coexpressing flag3 633 plus 668 1480 fig 2 cooh proximal side nbd1 fig 12 gray
0.43467933.10919864.html.plaintext.txt	367	contrast could detect neither function mature protein simply introduced single cut fig 12 red 16 11 residues away deletions respectively direction conserved core domain
0.43467933.10919864.html.plaintext.txt	368	therefore domain boundaries nbd1 cftr defined assays microscopic function used confidently assigned lie within residues 433 448 623 633 nh2 cooh termini nbd1 respectively
0.43467933.10919864.html.plaintext.txt	369	present work made detailed single channel measurements show individual severed cftr channels cut 1 432 plus 433 1480 1 633 plus 634 1480 nbd1 unitary conductance wt cftr channels fig 10 almost identical microscopic gating characteristics presence pka catalytic subunit fig 9
0.43467933.10919864.html.plaintext.txt	370	severed constructs opening rate wt channels apparent affinity activation channel po mgatp locked open ppi fig 8 amppnp
0.43467933.10919864.html.plaintext.txt	371	closing rate channels cut nbd1 differed wt 40 faster indicating bursting state somewhat destabilized cut due slight acceleration rate limiting step channel closing likely reflecting speeding slowest step atp hydrolysis cycle nbd2 csanady et al
0.43467933.10919864.html.plaintext.txt	372	thus conclude normal gating function nbd1 others infer control channel opening reviews see e
0.43467933.10919864.html.plaintext.txt	373	csanady gadsby 1999 gadsby nairn 1999 depend covalent linkage either first transmembrane domain r domain since maximal opening rates intact channels channels cut nbd1 fig 9
0.43467933.10919864.html.plaintext.txt	374	channel opening require segments 415 432 fig 3 fig 11 634 667 fig 2
0.43467933.10919864.html.plaintext.txt	375	hand found consistent significant effect incorporating eight residue flag tag nh2 terminus cftr reproducibly slowed channel opening approximately two threefold resulting approximately two threefold reduction po severed intact constructs without affecting mean burst duration conductance locking channels
0.43467933.10919864.html.plaintext.txt	376	notable attaching 238 residue green fluorescent protein gfp nh2 terminus cftr found affect neither single channel conductance assayed bilayers macroscopic whole cell conductance transfected nih 3t3 cells moyer et al
0.43467933.10919864.html.plaintext.txt	377	remains unclear whether channel po affected large gfp tag bilayer experiments address channel number gating kinetics comparison made levels cftr protein expressed cells transfected wt cftr transfected gfp cftr
0.43467933.10919864.html.plaintext.txt	378	interestingly interaction acidic region cftrs nh2 terminal cytoplasmic tail r domain recently demonstrated stabilized open state channel naren et al
0.43467933.10919864.html.plaintext.txt	379	1999 disrupting interaction mutating acidic residues resulted shorter bursts
0.43467933.10919864.html.plaintext.txt	380	yet clear whether finding relates observation incorporation largely acidic flag nh2 terminus cftr stabilized channel closed state intact severed channels
0.43467933.10919864.html.plaintext.txt	381	found however effect also mediated via r domain since addition nh2 terminal flag alter opening rate severed cftr channels entire r domain aas 634 836 missing csanady l
0.43467933.10919864.html.plaintext.txt	382	gadsby manuscript submitted publication
0.43467933.10919864.html.plaintext.txt	383	none half molecule constructs gave measurable basal activated cl conductance two microelectrode recordings macroscopic currents regardless whether oocytes expressing nh2 terminal half construct flag3 835 illustrated without flag3 633 fig 4 r domain cooh terminal half cftr construct 634 1480 fig 4 without construct 837 1480 illustrated r domain
0.43467933.10919864.html.plaintext.txt	384	however record patches excised oocytes cannot rule possibility extremely low density channels might formed certain half molecules
0.43467933.10919864.html.plaintext.txt	385	macroscopic current results contrast recent report expression cooh terminal half cftr either without r domain gave macroscopic intracellular camp activated whole cell currents injected oocytes transfected ib3 cells well unitary currents activated pka atp patches excised ib3 cells devidas et al
0.43467933.10919864.html.plaintext.txt	386	although major procedural difference injection 50 ng crna per construct experiments vs
0.43467933.10919864.html.plaintext.txt	387	5 ng seems unlikely protein expression correspondingly high activated conductance wt cftr 10 micros devidas et al
0.43467933.10919864.html.plaintext.txt	388	1998 20 fold smaller average present experiments fig 1 fig 2 fig 3 table 1
0.43467933.10919864.html.plaintext.txt	389	1994 observe channel currents patches excised hela cells expressing nh2 terminal half cftr truncated r domain segment 1 835 though channel formation far less efficient wt cftr presumably accounts fact change spq fluorescence could detected cells challenged camp elevating cocktail ostedgaard et al
0.43467933.10919864.html.plaintext.txt	390	boundaries cftrs nbd1 functionally defined compare crystal structures hisp rbsa nbds whose close similarity supports considered reasonable models structure abc nbds including cftr although safe boundaries cftrs nbd1 433 633 circumscribe 200 residues whereas crystallized nbds hisp rbsa included 259 241 residues respectively still compare reasonably well alignments e
0.43467933.10919864.html.plaintext.txt	391	1998 indicate nbd1 cftr lacks stretch 20 30 amino acids present nbds
0.43467933.10919864.html.plaintext.txt	392	moreover safe sever points rationalized basis alignments
0.43467933.10919864.html.plaintext.txt	393	thus phe433 would predicted occur near end first ss strand fig 12 distance phosphate bound atp although nearby leu435 phe433 implicated binding nucleotide base see hung et al
0.43467933.10919864.html.plaintext.txt	394	1998 leu633 would expected occur final ss strand nbd structure pair final helices arranged slightly differently hisp rbsa
0.43467933.10919864.html.plaintext.txt	395	contrast nontolerated sever point glu449 occurs highly conserved glycine hisp rbsa begins ss strand center ss sheet forms major wall active site severing might anticipated disrupt structure
0.43467933.10919864.html.plaintext.txt	396	cooh terminus gly622 predicted lie loop connecting last two antiparallel ss strands large ss sheet severing might perturb stabilizing interactions two strands
0.43467933.10919864.html.plaintext.txt	397	overall structures hisp rbsa afford reasonable interpretations results nbd1 cftr supports notion nbds abc transporters likely share general fold
0.43467933.10919864.html.plaintext.txt	398	findings importance design peptide models cftrs nbds imply instance cftr nbd1 constructs truncated near residue 589 would structurally incomplete hence functionally disadvantaged see hartman et al
0.43467933.10919864.html.plaintext.txt	399	1992 ko pedersen 1995 ko et al
0.43467933.10919864.html.plaintext.txt	400	1998 might cftr nbd2 constructs truncated leu1399 corresponding nbd1 leu602 randak et al
0.43467933.10919864.html.plaintext.txt	401	finding severed cftr channels lacking residues 415 432
0.43467933.10919864.html.plaintext.txt	402	coexpressed flag3 414 plus 433 1480 opened mgatp apparent affinity seen wt cftr channels k12 50 microm fig 11 intriguing
0.43467933.10919864.html.plaintext.txt	403	number observations suggested binding atp nbd1 possibly hydrolysis atp responsible cftr channel opening reviewed csanady gadsby 1999 gadsby nairn 1999
0.43467933.10919864.html.plaintext.txt	404	example cftr 1 835 channels truncated r domain hence lacking nbd2 opened mgatp micromolar apparent affinity sheppard et al
0.43467933.10919864.html.plaintext.txt	405	1994 cftr 1 1218 channels also lacking nbd2 yield large currents whole oocytes robust channel gating excised patches chan et al
0.43467933.10919864.html.plaintext.txt	406	moreover mutant k1250a cftr channels atp hydrolysis nbd2 severely impaired ramjeesingh et al
0.43467933.10919864.html.plaintext.txt	407	1999 show brief wt like openings low micromolar atp extremely long openings higher atp reflect binding nbd2 atp cannot hydrolyzed zeltwanger et al
0.43467933.10919864.html.plaintext.txt	408	1999 results imply brief openings low atp involve nbd1
0.43467933.10919864.html.plaintext.txt	409	nevertheless possible binding site responsible channel opening formed entirely nbd1
0.43467933.10919864.html.plaintext.txt	410	relatively high affinity action mgatp open cftr channels indeed occur nbd1 even flag3 414 plus 433 1480 channels findings prompt new series questions
0.43467933.10919864.html.plaintext.txt	411	thus despite overall similarity organization nbds abc transporters perhaps detailed structure nucleotide binding pocket nbd1 cftr differs hisp rbsa perhaps detailed structures similar expectations consequences deleting ss strand formed residues 415 432 unwarranted alternatively perhaps substantial contributions binding energy mgatp nbd1 made regions cftr polypeptide nbd2 e
0.43467933.10919864.html.plaintext.txt	412	jones george 1999 cytoplasmic loops transmembrane domains e
0.43467933.10919864.html.plaintext.txt	413	1997 point mutations residues believed lie near catalytic sites cftrs nbds chosen basis hisp rbsa structures soon help resolve questions compare vergani et al
0.43467933.10919864.html.plaintext.txt	414	1 abbreviations used paper aa amino acid abc atp binding cassette er endoplasmic reticulum mrp multi drug resistance related protein nbd nucleotide binding domain pgp p glycoprotein ppi pyrophosphate r domain regulatory domain
0.43467933.10919864.html.plaintext.txt	415	acknowledgements top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	416	thank roberto sanchez andrej sali help alignments structural modeling david kopsco atsuko horiuchi technical assistance kate hall peter hoff paola vergani help manuscript figures
0.43467933.10919864.html.plaintext.txt	417	csanady william obaker graduate fellow rockefeller university
0.43467933.10919864.html.plaintext.txt	418	work supported national institutes health grant dk 51767
0.43467933.10919864.html.plaintext.txt	419	luis reuss served guest editor
0.43467933.10919864.html.plaintext.txt	420	submitted 25 february 2000 revised 5 may 2000 accepted 5 june 2000
0.43467933.10919864.html.plaintext.txt	421	references top abstract introduction materials methods results discussion acknowledgements references
0.43467933.10919864.html.plaintext.txt	422	activation wild type deltaf508 cftr phosphodiesterase inhibitors camp dependent independent mechanisms
0.43467933.10919864.html.plaintext.txt	423	novel model first nucleotide binding domain cystic fibrosis transmembrane conductance regulator
0.43467933.10919864.html.plaintext.txt	424	febs lett 407303 308medline
0.43467933.10919864.html.plaintext.txt	425	5 structure n terminal atp binding cassette ribose abc transporter
0.43467933.10919864.html.plaintext.txt	426	cl channel activity xenopus oocytes expressing cystic fibrosis gene
0.43467933.10919864.html.plaintext.txt	427	26619142 19145abstractfree full text
0.43467933.10919864.html.plaintext.txt	428	mutational analysis yeast factor transporter ste6 member atp binding cassette abc protein superfamily
0.43467933.10919864.html.plaintext.txt	429	functional physical interactions partial molecules ste6 yeast atp binding cassette protein
0.43467933.10919864.html.plaintext.txt	430	chem 27122983 22989abstractfree full text
0.43467933.10919864.html.plaintext.txt	431	vivo expression lacy gene two segments leads functional lac permease
0.43467933.10919864.html.plaintext.txt	432	vivo assembly active maltose binding protein independently exported protein fragments
0.43467933.10919864.html.plaintext.txt	433	deletion analysis cftr channel r domain using severed molecules
0.43467933.10919864.html.plaintext.txt	434	cystic fibrosis transmembrane conductance regulator cftr nucleotide binding domain 1 nbd 1 cftr truncated within nbd 1 target epithelial plasma membrane increase anion permeability
0.43467933.10919864.html.plaintext.txt	435	rapid kinetic analysis multi channel records simultaneous fit dwell time histograms
0.43467933.10919864.html.plaintext.txt	436	j 78785 799abstractfree full text
0.43467933.10919864.html.plaintext.txt	437	r domain serine 768 negative regulator cftr chloride channel gating
0.43467933.10919864.html.plaintext.txt	438	cftr channel gating incremental progress irreversible steps
0.43467933.10919864.html.plaintext.txt	439	physiol 11449 53abstractfree full text
0.43467933.10919864.html.plaintext.txt	440	second half cystic fibrosis transmembrane conductance regulator forms functional chloride channel
0.43467933.10919864.html.plaintext.txt	441	chem 27329373 29380abstractfree full text
0.43467933.10919864.html.plaintext.txt	442	phosphorylation camp dependent protein kinase causes conformational change r domain cystic fibrosis transmembrane conductance regulator
0.43467933.10919864.html.plaintext.txt	443	biochemistry 334072 4079medline
0.43467933.10919864.html.plaintext.txt	444	control cftr channel gating phosphorylation nucleotide hydrolysis
0.43467933.10919864.html.plaintext.txt	445	reconstitution atp dependent leukotriene c4 transport co expression half molecules human multidrug resistance protein insect cells
0.43467933.10919864.html.plaintext.txt	446	chem 27127782 27787abstractfree full text
0.43467933.10919864.html.plaintext.txt	447	functional reassembly anion transport domain human red cell band 3 ae1 multiple non complementary fragments
0.43467933.10919864.html.plaintext.txt	448	febs lett 433223 227medline
0.43467933.10919864.html.plaintext.txt	449	recombinant synthesis purification nucleotide binding characteristics first nucleotide binding domain cystic fibrosis gene product
0.43467933.10919864.html.plaintext.txt	450	chem 2676455 6458abstractfree full text
0.43467933.10919864.html.plaintext.txt	451	abc transporters microorganisms man
0.43467933.10919864.html.plaintext.txt	452	crystal structure atp binding subunit abc transporter
0.43467933.10919864.html.plaintext.txt	453	block mops reveals conformation change cftr pore produced atp hydrolysis
0.43467933.10919864.html.plaintext.txt	454	cell physiol 273c1278 c1289abstractfree full text
0.43467933.10919864.html.plaintext.txt	455	subunit interactions abc transporters towards functional architecture
0.43467933.10919864.html.plaintext.txt	456	microinjection catalytic subunit cyclic amp dependent protein kinase enhances calcium action potentials bag cell neurons cell culture
0.43467933.10919864.html.plaintext.txt	457	cystic fibrosis transmembrane conductance regulator first nucleotide binding fold targets membrane retention atp binding function
0.43467933.10919864.html.plaintext.txt	458	first nucleotide binding fold cystic fibrosis transmembrane conductance regulator function active atpase
0.43467933.10919864.html.plaintext.txt	459	chem 27022093 22096abstractfree full text
0.43467933.10919864.html.plaintext.txt	460	subunit stoichiometry mammalian k channel determined construction multimeric cdnas
0.43467933.10919864.html.plaintext.txt	461	reconstitution drug stimulated atpase activity following co expression half human p glycoprotein separate polypeptides
0.43467933.10919864.html.plaintext.txt	462	chem 2697750 7755abstractfree full text
0.43467933.10919864.html.plaintext.txt	463	subunit interactions abc transporters conserved sequence hydrophobic membrane proteins periplasmic permeases defines important site interaction atpase subunits
0.43467933.10919864.html.plaintext.txt	464	j 163066 3077abstractfree full text
0.43467933.10919864.html.plaintext.txt	465	membrane trafficking cystic fibrosis gene product cystic fibrosis transmembrane conductance regulator tagged green fluorescent protein madin darby canine kidney cells
0.43467933.10919864.html.plaintext.txt	466	chem 27321759 21768abstractfree full text
0.43467933.10919864.html.plaintext.txt	467	cftr chloride channel regulation interdomain interaction
0.43467933.10919864.html.plaintext.txt	468	286544 548abstractfree full text
0.43467933.10919864.html.plaintext.txt	469	association domains within cystic fibrosis transmembrane conductance regulator
0.43467933.10919864.html.plaintext.txt	470	biochemistry 361287 1294medline
0.43467933.10919864.html.plaintext.txt	471	phosphorylation cystic fibrosis transmembrane conductance regulator
0.43467933.10919864.html.plaintext.txt	472	26712742 12752abstractfree full text
0.43467933.10919864.html.plaintext.txt	473	walker mutations reveal loose relationship catalytic channel gating activities purified cftr cystic fibrosis transmembrane conductance regulator
0.43467933.10919864.html.plaintext.txt	474	biochemistry 381463 1468medline
0.43467933.10919864.html.plaintext.txt	475	recombinant polypeptide model second predicted nucleotide binding fold cystic fibrosis transmembrane conductance regulator gtp binding protein
0.43467933.10919864.html.plaintext.txt	476	recombinant polypeptide model second nucleotide binding fold cystic fibrosis transmembrane conductance regulator functions active atpase gtpase adenylate kinase
0.43467933.10919864.html.plaintext.txt	477	febs lett 410180 186medline
0.43467933.10919864.html.plaintext.txt	478	identification cystic fibrosis gene cloning characterization complementary dna
0.43467933.10919864.html.plaintext.txt	479	amino terminal portion cftr forms regulated cl channel
0.43467933.10919864.html.plaintext.txt	480	structure function cftr chloride channel
0.43467933.10919864.html.plaintext.txt	481	functional assembly randomly cleaved protein
0.43467933.10919864.html.plaintext.txt	482	structure function analysis histidine permease comparison cystic fibrosis mutations
0.43467933.10919864.html.plaintext.txt	483	chem 26618714 18719abstractfree full text
0.43467933.10919864.html.plaintext.txt	484	functional roles nucleotide binding folds activation cystic fibrosis transmembrane conductance regulator
0.43467933.10919864.html.plaintext.txt	485	structural parts involved activation inactivation sodium channel
0.43467933.10919864.html.plaintext.txt	486	mutations near predicted catalytic site nbd1 affect cftr cl channel function surprisingly little
0.43467933.10919864.html.plaintext.txt	487	distantly related sequences ss subunits atp synthase myosin kinases atp requiring enzymes common nucleotide binding fold
0.43467933.10919864.html.plaintext.txt	488	cftr nucleotide binding folds regulate accessibility stability active state
0.43467933.10919864.html.plaintext.txt	489	recombinant peptide model first nucleotide binding fold cystic fibrosis transmembrane conductance regulator comparison wild type delta f508 mutant forms
0.43467933.10919864.html.plaintext.txt	490	sci 589 97abstractfree full text
0.43467933.10919864.html.plaintext.txt	491	gating cystic fibrosis transmembrane conductance regulator chloride channels adenosine triphosphate hydrolysis
0.43467933.10919864.html.plaintext.txt	492	physiol 113541 554abstractfree full text
0.43596935.7499295.html.plaintext.txt	0	1995 american society biochemistry molecular biology inc
0.43596935.7499295.html.plaintext.txt	1	intracellular loop transmembrane segments iv v cystic fibrosis transmembrane conductance regulator involved regulation chloride channel conductance state
0.43596935.7499295.html.plaintext.txt	2	received publication august 1 1995 revised form september 21 1995
0.43596935.7499295.html.plaintext.txt	3	drumm 2 jianjie ma 1 pamela b
0.43596935.7499295.html.plaintext.txt	4	1departments physiology biophysics 2pediatrics case western reserve university school medicine cleveland ohio 44106 abstract introduction experimental procedures results discussion footnotes acknowledgements references
0.43596935.7499295.html.plaintext.txt	5	cystic fibrosis transmembrane conductance regulator cftr contains two membrane spanning domains consists six transmembrane segments joined three extracellular two intracellular loops different length
0.43596935.7499295.html.plaintext.txt	6	examine role intracellular loops cftr channel function studied deletion mutant cftr 19 cftr 19 amino acids removed intracellular loop joining transmembrane segments iv v
0.43596935.7499295.html.plaintext.txt	7	mutant protein expressed human embryonic kidney cell line 293 hek
0.43596935.7499295.html.plaintext.txt	8	fully mature glycosylated cftr 170 kda immunoprecipitated cells transfected wild type cftr cdna cells transfected mutant gene expressed core glycosylated form 140 kda
0.43596935.7499295.html.plaintext.txt	9	chloride efflux rate measured 6 methoxyl n 3 sulfopropyl quinolinium spq fluorescence cells expressing wild type cftr increased 600 response forskolin
0.43596935.7499295.html.plaintext.txt	10	contrast 19 cftr expressing cells significant response forskolin
0.43596935.7499295.html.plaintext.txt	11	western blotting performed subcellular membrane fractions showed 19 cftr located fractions f508 cftr processing mutant cftr
0.43596935.7499295.html.plaintext.txt	12	results suggest 19 cftr located intracellular membranes without reaching cell surface
0.43596935.7499295.html.plaintext.txt	13	upon reconstitution lipid bilayer membranes 19 cftr formed functional cl channel gating properties nearly identical wild type cftr channel
0.43596935.7499295.html.plaintext.txt	14	however 19 cftr channels exhibited frequent transitions 6 picosiemens subconductance state whereas wild type cftr channels rarely exist subconductance state
0.43596935.7499295.html.plaintext.txt	15	data suggest intracellular loop involved stabilizing full conductance state cftr cl channel
0.43596935.7499295.html.plaintext.txt	16	cystic fibrosis transmembrane conductance regulator cftr consists five distinct regions two putative membrane spanning domains two nucleotide binding folds regulatory domain1
0.43596935.7499295.html.plaintext.txt	17	cftr forms cl channel linear conductance2 3 regulated camp dependent protein kinase phosphorylation 2 4 5 6 multiple sites regulatory domain binding hydrolysis atp nucleotide binding folds 7 8 9 10
0.43596935.7499295.html.plaintext.txt	18	structure function five domains cftr extensively studied11 12 13 14
0.43596935.7499295.html.plaintext.txt	19	contrast little known role intracellular loops contribution function cftr cl channel
0.43596935.7499295.html.plaintext.txt	20	intracellular loops channel proteins appear participate channel function
0.43596935.7499295.html.plaintext.txt	21	instance mutations second intracellular loop shaker k channel affect channel inactivation15
0.43596935.7499295.html.plaintext.txt	22	deletion portion putative cytosolic loops two transmembrane repeats na channel slows rate channel inactivation16
0.43596935.7499295.html.plaintext.txt	23	investigate role intracellular loops cftr cl channel function studied deletion mutant cftr 19 cftr 19 amino acids removed intracellular loop joining transmembrane segments iv v first membrane spanning domain
0.43596935.7499295.html.plaintext.txt	24	largest hydrophilic loop first membrane spanning domain one third residues loop charged
0.43596935.7499295.html.plaintext.txt	25	features make loop candidate electrostatic allosteric interactions cytosolic domains cftr nucleotide binding folds regulatory domain intracellular loops cellular proteins contribute channel function
0.43596935.7499295.html.plaintext.txt	26	subcloning cftr genethe wild type f508 cftr cdnas 17 subcloned epstein barr virus based episomal eukaryotic expression vector pcep4 invitrogen san diego ca nhei xhoi restriction sites
0.43596935.7499295.html.plaintext.txt	27	mutant gene lacks 57 nucleotides nucleotides 930 987 shuttled pbluescript pcep4 substituting corresponding fragment pcep4wt wt wild type mutant one kpni aflii restriction sites
0.43596935.7499295.html.plaintext.txt	28	mutant clone pcep419 confirmed restriction enzyme digestion dna sequencing shuttled fragment nucleotides 874 1040
0.43596935.7499295.html.plaintext.txt	29	cell culturea human embryonic kidney cell line 293 ebna invitrogen used transfection expression wild type mutant cftr proteins
0.43596935.7499295.html.plaintext.txt	30	cell line contains pcmv ebna vector constitutively expresses epstein barr virus ebna 1 gene product increases transfection efficiency epstein barr virus based vectors
0.43596935.7499295.html.plaintext.txt	31	cell line exhibited high transfection efficiency 80 lipofectin reagent life technologies inc
0.43596935.7499295.html.plaintext.txt	32	following manufacturers instructions
0.43596935.7499295.html.plaintext.txt	33	cells maintained dulbeccos modified eagles medium biofluids inc
0.43596935.7499295.html.plaintext.txt	34	rockville md containing 10 fetal bovine serum life technologies inc
0.43596935.7499295.html.plaintext.txt	35	geneticin g418 sulfate 250 microgml life technologies inc
0.43596935.7499295.html.plaintext.txt	36	added cell culture medium continuous selection cells containing pcmv ebna vector
0.43596935.7499295.html.plaintext.txt	37	parent cell line grown confluence 37 degrees c incubator 5 co passed 15 2 days gene transfer
0.43596935.7499295.html.plaintext.txt	38	pcep4wt pcep4f508 pcep419 introduced cells using lipofectin reagent
0.43596935.7499295.html.plaintext.txt	39	two days transfection cells passed selected hygromycin resistance medium containing hygromycin b boehringer mannheim germany 260 microgml
0.43596935.7499295.html.plaintext.txt	40	3 weeks selection cells used immunoprecipitation western blot assay spq assay isolation microsomal vesicles reconstitution studies lipid bilayers
0.43596935.7499295.html.plaintext.txt	41	immunoprecipitationwestern blot assay cftr293 hek cells transfected pcep4wt pcep4deltaf508 pcep419 cultured confluence 162 cm flasks costar cambridge ma
0.43596935.7499295.html.plaintext.txt	42	cells washed three times ice cold phosphate buffered saline 137 mm nacl 10 mm nahpo 2
0.43596935.7499295.html.plaintext.txt	43	8 mm khpo 5 microm diisopropyl fluorophosphate ph 7
0.43596935.7499295.html.plaintext.txt	44	4 lysed 1 ml ice cold radioimmune precipitation assay solution 150 mm nacl 50 mm tris cl ph 8
0.43596935.7499295.html.plaintext.txt	45	0 1 triton x 100 1 sodium deoxycholate 0
0.43596935.7499295.html.plaintext.txt	46	1 sds presence protease inhibitors 10 microgml aprotinin 10 microgml pepstatin 5 microm diisopropyl fluorophosphate spun 48000 g 1 h 4 degrees c
0.43596935.7499295.html.plaintext.txt	47	mouse anti human cftr monoclonal antibody specific regulatory domain cftr monoclonal antibody 13 1 2 microg genzyme corp
0.43596935.7499295.html.plaintext.txt	48	cambridge ma added 350 microl cell lysis supernatant solution incubated ice 90 min
0.43596935.7499295.html.plaintext.txt	49	antibody complexes precipitated 20 microl protein g agarose beads boehringer incubation 4 degrees c 30 min rocker
0.43596935.7499295.html.plaintext.txt	50	beads washed radioimmune precipitation assay solution three times bound proteins solubilized 20 microl gel sample buffer 200 mm tris cl ph 6
0.43596935.7499295.html.plaintext.txt	51	7 9 sds 6 mercaptoethanol 15 glycerol 0
0.43596935.7499295.html.plaintext.txt	52	01 bromphenol blue loaded onto 5 sds polyacrylamide gel
0.43596935.7499295.html.plaintext.txt	53	proteins transferred polyvinylidene difluoride membrane bio rad probed monoclonal antibody 13 1 0
0.43596935.7499295.html.plaintext.txt	54	secondary peroxidase conjugated affinity purified goat antibody mouse igg organon teknika corp
0.43596935.7499295.html.plaintext.txt	55	west chester pa added allow visualization cftr antibody complex
0.43596935.7499295.html.plaintext.txt	56	proteins detected chemiluminescence according manufacturers recommendations ecl kit amersham corp
0.43596935.7499295.html.plaintext.txt	57	spq assay cl transportcells transferred glass coverslips cultured 2 3 days loaded spq fluorescent dye hypotonic loading described previously18
0.43596935.7499295.html.plaintext.txt	58	briefly cells incubated room temperature 4 min 11 mixture cl buffer 126 mm nacl 5 mm kcl 1
0.43596935.7499295.html.plaintext.txt	59	2 distilled ho containing 5 mm spq
0.43596935.7499295.html.plaintext.txt	60	glass coverslip mounted chamber stage heated 37 degrees c arranged continuous flow warmed buffer solutions studied one one using upright zeiss epifluorescence microscope
0.43596935.7499295.html.plaintext.txt	61	fluorescence excited 355 nm omega optical inc
0.43596935.7499295.html.plaintext.txt	62	brattleboro vt 75 watt xenon lamp
0.43596935.7499295.html.plaintext.txt	63	excitation light reflected 400 nm fused silica dichroic mirror omega optical inc
0.43596935.7499295.html.plaintext.txt	64	illuminated cells 20 objective numerical aperature 0
0.43596935.7499295.html.plaintext.txt	65	emitted light filtered 450 nm lens detected microchannel plate image intensifier model ks 1381 series ccd 200 solid state video camera video scope international ltd
0.43596935.7499295.html.plaintext.txt	66	images quantified model mvp frame grabber board matrox quebec canada mounted internally host 386 computer processed image 1 fl software universal imaging corp
0.43596935.7499295.html.plaintext.txt	67	26 represents average 16 images
0.43596935.7499295.html.plaintext.txt	68	successive images recorded rate 1 every 5
0.43596935.7499295.html.plaintext.txt	69	blank field obtained closing camera shutter used background image subtracted prior acquisition images
0.43596935.7499295.html.plaintext.txt	70	spq fluorescence calibrated measuring fluorescence absence chloride maximum fluorescence presence solution quenched spq fluorescence 150 mm kscn 10 microm valinomycin
0.43596935.7499295.html.plaintext.txt	71	photobleaching corrected subtracting straight line connects two points beginning experiment kscn valinomycin application
0.43596935.7499295.html.plaintext.txt	72	results expressed rates relative fluorescence unitsminute
0.43596935.7499295.html.plaintext.txt	73	rates calculated fitting single exponential equation initial portion single curve correction photobleaching
0.43596935.7499295.html.plaintext.txt	74	cells exhibited 15 photobleaching dye leakage used analysis
0.43596935.7499295.html.plaintext.txt	75	subcellular fractionation membrane vesiclesthe protocol used modified version gunderson kopito 19 see fig
0.43596935.7499295.html.plaintext.txt	76	briefly 12 75 cm flasks 293 hek cells transfected pcep4wt pcep4f508 pcep419 vector harvested scraping flask bottom following three washes ice cold phosphate buffered saline
0.43596935.7499295.html.plaintext.txt	77	cell pellet 600 g 5 min 4 degrees c resuspended incubation 10 min ice cold hypotonic lysis buffer 10 mm hepes ph 7
0.43596935.7499295.html.plaintext.txt	78	2 1 mm edta 5 microm diisopropyl fluorophosphate 10 microgml pepstatin 10 microgml aprotinin 9
0.43596935.7499295.html.plaintext.txt	79	6 mgml benzamidine prior lysis 10 strokes tight fitting dounce homogenizer followed 15 strokes addition equal volume sucrose buffer 500 mm sucrose 1 mm edta 10 mm hepes ph 7
0.43596935.7499295.html.plaintext.txt	80	microsomes collected centrifugation post mitochondrial supernatant 6000 g 20 min 4 degrees c 100000 g 45 min resuspended either 600 microl isotonic buffer 250 mm sucrose 1 mm edta 10 mm hepes ph 7
0.43596935.7499295.html.plaintext.txt	81	2 prephosphorylation buffer 250 mm sucrose 10 mm hepes ph 7
0.43596935.7499295.html.plaintext.txt	82	2 5 mm atp 5 mm mgcl 100 unitsml camp dependent protein kinase catalytic subunit
0.43596935.7499295.html.plaintext.txt	83	separation plasma intracellular membranes carried discontinuous sucrose gradient 10000 g 6 h 4 degrees c swinging bucket rotor sw 28
0.43596935.7499295.html.plaintext.txt	84	fraction v collected interface two sucrose gradients
0.43596935.7499295.html.plaintext.txt	85	subsequently abbreviated fractionation scheme used separated f508 cftr wild type intracellular membrane plasma membrane
0.43596935.7499295.html.plaintext.txt	86	experiment cells washed lysed buffer except diisopropyl fluorophosphate included
0.43596935.7499295.html.plaintext.txt	87	post mitochondrial supernatant spun 12000 g 30 min give intracellular membrane fig
0.43596935.7499295.html.plaintext.txt	88	5c im supernatant spun 100000 g 45 min give plasma membrane pm
0.43596935.7499295.html.plaintext.txt	89	figure 5 subcellular fractionation western blotting cftr
0.43596935.7499295.html.plaintext.txt	90	discontinuous sucrose gradient five densities 28 33 36 38
0.43596935.7499295.html.plaintext.txt	91	7 used separate plasma membrane intracellular membranes
0.43596935.7499295.html.plaintext.txt	92	b shown top gradient lane 2833 lane ii 3336 lane iii 3638
0.43596935.7499295.html.plaintext.txt	93	7 lane v pellet lane vi
0.43596935.7499295.html.plaintext.txt	94	50 microg total protein fraction subjected 5 sds polyacrylamide gel electrophoresis cftr protein detected described experimental procedures
0.43596935.7499295.html.plaintext.txt	95	protein markers labeled middle
0.43596935.7499295.html.plaintext.txt	96	c plasma pm intracellular membrane im fractions f508 cftr 19 cftr expressing cells grown 37 degrees c run 5 sds polyacrylamide gel detected described b
0.43596935.7499295.html.plaintext.txt	97	protein markers labeled left
0.43596935.7499295.html.plaintext.txt	98	arrowhead wild type wt cftr protein 170 kda arrowhead b f508 cftr protein 140 kda arrowhead c 19 cftr protein 140 kda
0.43596935.7499295.html.plaintext.txt	99	detection cftr western blottingthe membrane fractions collected procedure washed resuspended isotonic buffer
0.43596935.7499295.html.plaintext.txt	100	50 microg protein fraction denatured 6 gel sample buffer 300 mm tris cl ph 6
0.43596935.7499295.html.plaintext.txt	101	8 600 mm dithiothreitol 12 sds 0
0.43596935.7499295.html.plaintext.txt	102	6 bromphenol blue loaded onto 5 sds polyacrylamide gel
0.43596935.7499295.html.plaintext.txt	103	proteins transferred polyvinylidene difluoride membrane detected described immunoprecipitationwestern blot assay cftr
0.43596935.7499295.html.plaintext.txt	104	reconstitution cftr cl channellipid bilayer membranes formed across aperture 200 microm diameter lipid mixture phosphatidylethanolaminephosphatidylserinecholesterol ratio 661 lipids dissolved decane concentration 40 mgml20
0.43596935.7499295.html.plaintext.txt	105	recording solutions contained following cis side solution intracellular 200 mm kcl 2 mm mgatp 10 mm hepestris ph 7
0.43596935.7499295.html.plaintext.txt	106	4 trans side solution extracellular 50 mm kcl 10 mm hepestris ph 7
0.43596935.7499295.html.plaintext.txt	107	microsomal vesicles 3 6 microl containing wild type 19 cftr protein added cis side solution
0.43596935.7499295.html.plaintext.txt	108	50 unitsml camp dependent protein kinase catalytic subunit promega madison wi always present cis side solution
0.43596935.7499295.html.plaintext.txt	109	single channel currents recorded axopatch 200a patch clamp unit axon instruments inc
0.43596935.7499295.html.plaintext.txt	110	data acquisition pulse generation performed 486 computer 1200 digidata ad da convertor axon instruments inc
0.43596935.7499295.html.plaintext.txt	111	currents sampled 1 2
0.43596935.7499295.html.plaintext.txt	112	5 mspoint filtered 100 hz
0.43596935.7499295.html.plaintext.txt	113	single channel data analyses performed pclamp software axon instruments inc
0.43596935.7499295.html.plaintext.txt	114	subcloning cftr mutant gene eukaryotic expression vectorthe cftr mutant studied paper spontaneous deletion mutation cftr cdna 57 nucleotides corresponding 19 amino acids mieniqsvkaycweeamek residues 266 284 deleted
0.43596935.7499295.html.plaintext.txt	115	residues located intracellular loop joining transmembrane segments iv v first membrane spanning domain fig
0.43596935.7499295.html.plaintext.txt	116	mutant gene shuttled pbluescript pcep4 eukaryotic cell expression
0.43596935.7499295.html.plaintext.txt	117	pcep4 vector contains cytomegalovirus promoter drives transcription cloned gene
0.43596935.7499295.html.plaintext.txt	118	figure 1 predicted topology cftr
0.43596935.7499295.html.plaintext.txt	119	predicted membrane topology cftr shown deleted 19 amino acids indicated
0.43596935.7499295.html.plaintext.txt	120	l loop tm transmembrane segment nbf nucleotide binding fold r regulatory
0.43596935.7499295.html.plaintext.txt	121	expression wild type mutant cftr proteinsthe cftr protein expressed eukaryotic cells transfecting pcep4wt pcep4f508 pcep419 293 hek cells using lipofectin reagent21
0.43596935.7499295.html.plaintext.txt	122	confirm cftr expression immunoprecipitationwestern blot assay performed transfected cells
0.43596935.7499295.html.plaintext.txt	123	cells transfected pcep4wt expressed readily detectable amount fully glycosylated form cftr protein molecular mass 170 kda untransfected cells fig
0.43596935.7499295.html.plaintext.txt	124	cells transfected either pcep4f508 pcep419 showed dominant band 140 kda fig
0.43596935.7499295.html.plaintext.txt	125	2 probably corresponds core glycosylated form cftr
0.43596935.7499295.html.plaintext.txt	126	consistent studies22 23 f508 cftr incompletely glycosylated 37 degrees c displayed increased glycosylation culture temperature lowered 26 degrees c fig
0.43596935.7499295.html.plaintext.txt	127	however incubation pcep419 transfected cells 26 degrees c 2 days increase amount 19 cftr protein fully glycosylated form fig
0.43596935.7499295.html.plaintext.txt	128	amount 140 kda protein associated f508 cftr 19 cftr increased significantly following lower temperature incubation fig
0.43596935.7499295.html.plaintext.txt	129	2 lanes 5 7 probably due slower degradation abnormal protein intracellular organelles
0.43596935.7499295.html.plaintext.txt	130	figure 2 immunoprecipitation western blotting cftr
0.43596935.7499295.html.plaintext.txt	131	293 hek cells transfected pcep4wt pcep4f508 pcep419 immunoprecipitated blotted described experimental procedures
0.43596935.7499295.html.plaintext.txt	132	similar number cells lysed cell line
0.43596935.7499295.html.plaintext.txt	133	proteins visualized exposing blot kodak x omat ar film 3 min
0.43596935.7499295.html.plaintext.txt	134	lane 1 untransfected 293 hek cells lanes 2 3 wild type cftr expressing cells lanes 4 5 f508 cftr expressing cells lanes 6 7 19 cftr expressing cells
0.43596935.7499295.html.plaintext.txt	135	lanes labeled 26 degrees c contained cells cultured 8090 confluence 37 degrees c 5 co followed incubation 26 degrees c 6 co 2 days
0.43596935.7499295.html.plaintext.txt	136	spq assay cl transportthe immunoprecipitationwestern blot assay detected fully glycosylated 19 cftr protein
0.43596935.7499295.html.plaintext.txt	137	however studies shown cftr mutants produce fully glycosylated form quantities small detected assay nevertheless result functional channels cell surface23 24
0.43596935.7499295.html.plaintext.txt	138	test surface function 19 cftr spq assay performed pcep419 transfected cells using pcep4wt transfected cells positive control untransfected cells negative control
0.43596935.7499295.html.plaintext.txt	139	representative traces chloride movement five six cells cell line absence presence 10 microm forskolin depicted fig
0.43596935.7499295.html.plaintext.txt	140	decrease spq fluorescence indicates cl influx increase fluorescence indicates cl efflux
0.43596935.7499295.html.plaintext.txt	141	forskolin failed elicit increase rate cl efflux untransfected 293 hek cells fig
0.43596935.7499295.html.plaintext.txt	142	wild type cftr transfected cells hand exhibited significant increase rate cl efflux upon forskolin stimulation fig
0.43596935.7499295.html.plaintext.txt	143	cells transfected 19 cftr stimulation rate cl efflux forskolin statistically different untransfected cells fig
0.43596935.7499295.html.plaintext.txt	144	data multiple experiments summarized fig
0.43596935.7499295.html.plaintext.txt	145	incubation 19 cftr expressing cells 26 degrees c 15 48 h increase rate cl efflux following forskolin stimulation fig
0.43596935.7499295.html.plaintext.txt	146	result consistent immunoprecipitationwestern blot studies fig
0.43596935.7499295.html.plaintext.txt	147	2 indicate little 19 cftr reaches golgi apparatus final glycosylation presumably transport plasma membrane
0.43596935.7499295.html.plaintext.txt	148	figure 3 spq assay cl transport
0.43596935.7499295.html.plaintext.txt	149	cells loaded spq preincubated nitrate solution 126 mm nano 5 mm kno 1
0.43596935.7499295.html.plaintext.txt	150	2 ice 15 min allow depletion intracellular chloride
0.43596935.7499295.html.plaintext.txt	151	beginning experiment cells first perfused nitrate solution fluorescence stable 1 min
0.43596935.7499295.html.plaintext.txt	152	perfusion solution switched cl containing solution
0.43596935.7499295.html.plaintext.txt	153	spq fluorescence quenched cl entered cell
0.43596935.7499295.html.plaintext.txt	154	fluorescence reached steady state perfusion switched nitrate solution fluorescence came back base line
0.43596935.7499295.html.plaintext.txt	155	cycle repeated 10 microm forskolin fsk added cl nitrate solution
0.43596935.7499295.html.plaintext.txt	156	conclusion experiment cells perfused kscn 150 mm plus valinomycin val 10 microm solution quench fluorescence
0.43596935.7499295.html.plaintext.txt	157	trace represents fluorescence single cell beginning end
0.43596935.7499295.html.plaintext.txt	158	untransfected 293 hek cells b wild type wt cftr transfected cells c 19 cftr transfected cells
0.43596935.7499295.html.plaintext.txt	159	fluorescence five six cells plotted three cases
0.43596935.7499295.html.plaintext.txt	160	figure 4 forskolin stimulation rate cl efflux
0.43596935.7499295.html.plaintext.txt	161	cl efflux rate calculated described experimental procedures plotted relative fluorescence unitsminute
0.43596935.7499295.html.plaintext.txt	162	open bars indicate rate basal cl efflux hatched bars indicate rate cl efflux upon forskolin fsk 10 microm stimulation
0.43596935.7499295.html.plaintext.txt	163	percentage forskolin stimulated cl efflux basal cl efflux also plotted b
0.43596935.7499295.html.plaintext.txt	164	untransfected cells control forskolin stimulated efflux rate 157 plus minus 7 base line 198 cells 37 degrees c n 7
0.43596935.7499295.html.plaintext.txt	165	wild type wt cftr transfected cells forskolin stimulated efflux rate 618 plus minus 37 base line 297 cells 37 degrees c n 8
0.43596935.7499295.html.plaintext.txt	166	19 cftr expressing cells forskolin stimulated efflux rate 178 plus minus 15 base line 170 cells 37 degrees c n 10 statistically different control
0.43596935.7499295.html.plaintext.txt	167	data labeled 26 degrees c wild type cftr 453 plus minus 144 forskolin stimulation 40 cells n 3 19 cftr 90 plus minus 10 forskolin stimulation 65 cells n 4 obtained cells incubated 26 degrees c 15 48 h experiment
0.43596935.7499295.html.plaintext.txt	168	localization 19 cftr proteinsubcellular membrane fractionation performed 293 hek cells transfected cftr cdna localize 19 cftr protein
0.43596935.7499295.html.plaintext.txt	169	intracellular membranes separated plasma membrane using discontinuous sucrose density gradient fig
0.43596935.7499295.html.plaintext.txt	170	wild type cftr used marker plasma membrane f508 cftr known cftr processing mutant marker intracellular membranes
0.43596935.7499295.html.plaintext.txt	171	western blotting showed wild type cftr protein 170 kda detected mainly fractions ii iii f508 cftr protein 140 kda detected mainly fraction iv sucrose density gradient fig
0.43596935.7499295.html.plaintext.txt	172	intracellular membrane fractions isolated 19 cftr expressing cells contained 140 kda cftr protein colocalized f508 cftr protein fig
0.43596935.7499295.html.plaintext.txt	173	together immunoprecipitationwestern blot spq assays data suggest 19 cftr processing mutant
0.43596935.7499295.html.plaintext.txt	174	functional characterization wild type 19 cftr cl channelsto study function 19 cftr microsomal vesicles contain mixtures plasma membrane endoplasmic reticulum golgi membranes incorporated planar lipid bilayers
0.43596935.7499295.html.plaintext.txt	175	function compared wild type cftr incorporated planar lipid bilayers plasma membrane vesicles
0.43596935.7499295.html.plaintext.txt	176	consistent previous studies19 wild type cftr showed camp dependent protein kinase phosphorylation dependent cl channel linear conductance 8
0.43596935.7499295.html.plaintext.txt	177	extrapolated reversal potential 22
0.43596935.7499295.html.plaintext.txt	178	4 mv kcl gradient 200 mm cis 50 mm trans consistent chloride selective channel
0.43596935.7499295.html.plaintext.txt	179	without camp dependent protein kinase 8 ps cl channel never observed vesicles isolated 293 hek cells n 30 without n 20 transfection cftr cdna
0.43596935.7499295.html.plaintext.txt	180	figure 6 reconstitution cftr cl channel lipid bilayer membranes
0.43596935.7499295.html.plaintext.txt	181	represented traces selected single channel currents given test potential wild type cftr channel 19 cftr channel b
0.43596935.7499295.html.plaintext.txt	182	wild type 19 cftr channels exhibited linear current voltage relationship slope conductance 8
0.43596935.7499295.html.plaintext.txt	183	6 ps extrapolated reversal potential 22
0.43596935.7499295.html.plaintext.txt	184	wild type cftr n 76 19 cftr n 14
0.43596935.7499295.html.plaintext.txt	185	reconstituted cftr channels slow kinetics gating
0.43596935.7499295.html.plaintext.txt	186	open lifetime histogram contained least two exponentials mean open lifetimes 23
0.43596935.7499295.html.plaintext.txt	187	relative occurrence yy y 0
0.43596935.7499295.html.plaintext.txt	188	average open probability p 0
0.43596935.7499295.html.plaintext.txt	189	separate studies found wild type cftr channel contained two distinct subconductance states conductances 6 ps o2 2
0.43596935.7499295.html.plaintext.txt	190	7 ps addition full conductance state 8 ps o1
0.43596935.7499295.html.plaintext.txt	191	occurrence o2 however low wild type cftr accounted 10 open events see fig
0.43596935.7499295.html.plaintext.txt	192	figure 7 open time histograms 80 mv
0.43596935.7499295.html.plaintext.txt	193	open events calculated 80 mv wild type wt 19 b cftr channels
0.43596935.7499295.html.plaintext.txt	194	histograms constructed total 4040 open events obtained three separate experiments wild type cftr 4843 open events obtained four separate experiments 19 cftr
0.43596935.7499295.html.plaintext.txt	195	solid lines represent best fit according following equation y y exp y exp 23
0.43596935.7499295.html.plaintext.txt	196	figure 10 open current histogram 80 mv
0.43596935.7499295.html.plaintext.txt	197	current amplitudes individual open events calculated 50 threshold detection method using pclamp software
0.43596935.7499295.html.plaintext.txt	198	currents sorted resolution 0
0.43596935.7499295.html.plaintext.txt	199	histogram contained three separate experiments wild type wt cftr channel b contained four separate experiments 19 cftr channel
0.43596935.7499295.html.plaintext.txt	200	solid lines represent best fit sum two gaussian distribution functions y wcjs34842 exp x micro wcjs34842 exp x micro w 5
0.43596935.7499295.html.plaintext.txt	201	19 cftr incorporated lipid bilayer membrane functional cl channel activity identified
0.43596935.7499295.html.plaintext.txt	202	full conductance state o1 19 cftr cl channel identical wild type cftr channel fig
0.43596935.7499295.html.plaintext.txt	203	similar wild type cftr channel 19 cftr channel average open probability 0
0.43596935.7499295.html.plaintext.txt	204	043 mean open lifetimes 30
0.43596935.7499295.html.plaintext.txt	205	relative occurrence yy y 0
0.43596935.7499295.html.plaintext.txt	206	thus gating 19 cftr channel significantly different wild type cftr channel time resolution 100 hz cutoff frequency bilayer system
0.43596935.7499295.html.plaintext.txt	207	figure 8 subconductance states 19 cftr
0.43596935.7499295.html.plaintext.txt	208	consecutive traces wild type wt cftr 19 cftr measured test potential 80 mv
0.43596935.7499295.html.plaintext.txt	209	cases bilayer contained three active cftr channels
0.43596935.7499295.html.plaintext.txt	210	o1 corresponds full open state 8 ps o2 corresponds subconductance state channel 6 ps
0.43596935.7499295.html.plaintext.txt	211	significant difference 19 cftr wild type cftr found distribution channel subconductance states
0.43596935.7499295.html.plaintext.txt	212	unlike wild type cftr channel 19 cftr channel displayed prominent subconductance state o2 fig
0.43596935.7499295.html.plaintext.txt	213	9shows amplitude histogram two separate experiments wild type 19 cftr channels
0.43596935.7499295.html.plaintext.txt	214	histograms different particularly first open level
0.43596935.7499295.html.plaintext.txt	215	frequent occurrence subconductance state resulted asymmetric distribution first open level 19 cftr channel indicated o1 o2
0.43596935.7499295.html.plaintext.txt	216	similar phenomena observed 13 experiments 19 cftr channels
0.43596935.7499295.html.plaintext.txt	217	relative paucity instances two channels recordings especially 19 mutant records two channels clearly present e
0.43596935.7499295.html.plaintext.txt	218	reasons unclear detailed analysis beyond scope paper
0.43596935.7499295.html.plaintext.txt	219	figure 9 amplitude histogram cftr channel
0.43596935.7499295.html.plaintext.txt	220	histogram constructed 16 episodes data shown fig
0.43596935.7499295.html.plaintext.txt	221	acquisition points included
0.43596935.7499295.html.plaintext.txt	222	three open levels wild type wt cftr could fitted gaussian distributions first open level amplitude 0
0.43596935.7499295.html.plaintext.txt	223	first open level 19 cftr channels could fitted two gaussian distribution functions amplitudes 0
0.43596935.7499295.html.plaintext.txt	224	10shows amplitude histograms open channel current pooled multiple experiments single cftr channel incorporated bilayer membrane
0.43596935.7499295.html.plaintext.txt	225	clearly 19 cftr channel contained openings o2 state wild type cftr channel fig
0.43596935.7499295.html.plaintext.txt	226	histograms could fitted sum two gaussian distribution functions mean currents 0
0.43596935.7499295.html.plaintext.txt	227	relative occurrence o2 state estimated 9 wild type cftr channel 23 19 cftr channel
0.43596935.7499295.html.plaintext.txt	228	study examined function cftr deletion mutant 19 cftr
0.43596935.7499295.html.plaintext.txt	229	deletion mutation results incomplete glycosylation intracellular retention cftr based following observations
0.43596935.7499295.html.plaintext.txt	230	immunoprecipitationwestern blot assay identified core glycosylated form 19 cftr 140 kda different fully mature glycosylated protein 170 kda ii subcellular fractionation showed 19 cftr protein localized predominantly intracellular membranes iii spq assay cells expressing 19 cftr showed forskolin stimulated cl transport
0.43596935.7499295.html.plaintext.txt	231	however processing mutant maintained functional cl channel activity presumably intracellular organelles reconstituted lipid bilayer membranes
0.43596935.7499295.html.plaintext.txt	232	notable difference wild type 19 cftr channels lies distribution conductance states
0.43596935.7499295.html.plaintext.txt	233	deletion mutation caused frequent occurrence subconductance state within cl channel
0.43596935.7499295.html.plaintext.txt	234	common disease causing mutation cftr deletion single phenylalanine residue position 508 f508 cftr
0.43596935.7499295.html.plaintext.txt	235	f508 cftr protein retained endoplasmic reticulum fails reach intended site action plasma membrane
0.43596935.7499295.html.plaintext.txt	236	regard processing 37 degrees c 19 cftr appears similar f508 cftr
0.43596935.7499295.html.plaintext.txt	237	however f508 cftr appears fully mature glycosylated form traffic plasma membrane following incubation lower temperature 26 30 degrees c fig
0.43596935.7499295.html.plaintext.txt	238	unlike f508 cftr misprocessing 19 cftr temperature insensitive protein remained core glycosylated state intracellular organelles even 26 degrees c
0.43596935.7499295.html.plaintext.txt	239	f508 cftr proteins plasma membrane give rise functional cl channels similar wild type cftr terms open probability 26 conductance state24 26
0.43596935.7499295.html.plaintext.txt	240	cardiac specific isoform cftr lacks 30 amino acids intracellular loop transmembrane segments ii iii
0.43596935.7499295.html.plaintext.txt	241	caused alternative splicing exon 5 cftr mrna27
0.43596935.7499295.html.plaintext.txt	242	cardiac cftr functions camp dependent protein kinase regulated cl channel conduction properties similar epithelial cftr9 28
0.43596935.7499295.html.plaintext.txt	243	however expressed hela cells human cftr lacking exon 5 failed generate camp mediated chloride transport spq assay apparently due defective intracellular processing29
0.43596935.7499295.html.plaintext.txt	244	strategy applied study cftr channel function used study even misprocessed mislocalized channels therefore ought applicable study effects deleting exon 5 cftr channel function well
0.43596935.7499295.html.plaintext.txt	245	19 amino acids deleted 19 cftr span major part intracellular loop joining transmembrane segments iv v
0.43596935.7499295.html.plaintext.txt	246	segment highly hydrophilic one third residues charged two lysines four glutamates
0.43596935.7499295.html.plaintext.txt	247	several factors could account subconductance state associated 19 cftr channel
0.43596935.7499295.html.plaintext.txt	248	one possibility retention 19 cftr protein intracellular membranes alters function cl channel
0.43596935.7499295.html.plaintext.txt	249	maturation cftr endoplasmic reticulum golgi apparatus plasma membrane involves several processing post translational modifications e
0.43596935.7499295.html.plaintext.txt	250	endoplasmic reticulum membrane contains proteins including various types chaperons could interact cftr alter function cl channel
0.43596935.7499295.html.plaintext.txt	251	however gating kinetics open probability 19 cftr channel intracellular membrane similar wild type cftr channel plasma membrane deletion 19 amino acids alter essential function cftr cl channel
0.43596935.7499295.html.plaintext.txt	252	moreover wild type cftr channel occasionally enters o2 subconductance state characteristic 19 cftr channel
0.43596935.7499295.html.plaintext.txt	253	observations suggest subconductance state associated 19 cftr cl channel probably intrinsic property cftr protein deletion affects cftr way favor o2 conductance state
0.43596935.7499295.html.plaintext.txt	254	second possibility loop interacts domains nucleotide binding folds regulatory domain intracellular loops cftr cellular proteins involved conductance state transition
0.43596935.7499295.html.plaintext.txt	255	deletion part loop might affect channel structure allosterically changing inter intramolecular interactions thus induce quasi stable open configuration addition full open state
0.43596935.7499295.html.plaintext.txt	256	understanding distribution subconductance states associated single cl channel provide valuable information structure function relationships cftr cl channel
0.43596935.7499295.html.plaintext.txt	257	approach reported allows functional characterization cftr intracellular membranes besides endoplasmic reticulum membrane25
0.43596935.7499295.html.plaintext.txt	258	preparing vesicles intracellular membranes separated plasma membrane principle one study processing mutant lipid bilayer system
0.43596935.7499295.html.plaintext.txt	259	experiments necessary test role specific amino acids intracellular loops e
0.43596935.7499295.html.plaintext.txt	260	positively negatively charged hydrophobic amino acids regulation conductance state cftr cl channel
0.43596935.7499295.html.plaintext.txt	261	work supported research development program grant cystic fibrosis foundation grants p30 dk27651 ro1hldk49003 national institutes health
0.43596935.7499295.html.plaintext.txt	262	costs publication article defrayed part payment page charges
0.43596935.7499295.html.plaintext.txt	263	article must therefore hereby marked advertisement accordance 18 u
0.43596935.7499295.html.plaintext.txt	264	section 1734 solely indicate fact
0.43596935.7499295.html.plaintext.txt	265	correspondence addressed depts
0.43596935.7499295.html.plaintext.txt	266	physiology biophysics pediatrics case western reserve university school medicine brb 2109 adelbert rd
0.43596935.7499295.html.plaintext.txt	267	216 368 4370 fax 216 368 4223
0.43596935.7499295.html.plaintext.txt	268	abbreviations used cftr cystic fibrosis transmembrane conductance regulator ps picosiemens spq 6 methoxyl n 3 sulfopropyl quinolinium
0.43596935.7499295.html.plaintext.txt	269	perez help spq assay graphics drs
0.43596935.7499295.html.plaintext.txt	270	zhao help membrane preparations y
0.43596935.7499295.html.plaintext.txt	271	hervey help immunoprecipitation assay
0.43596935.7499295.html.plaintext.txt	272	1989 science 245 1066 1073 medline order article via infotrieve anderson m
0.43596935.7499295.html.plaintext.txt	273	1991 science 253 202 207 medline order article via infotrieve bear c
0.43596935.7499295.html.plaintext.txt	274	1992 cell 68 809 818 medline order article via infotrieve cheng
0.43596935.7499295.html.plaintext.txt	275	1991 cell 66 1027 1036 medline order article via infotrieve rich d
0.43596935.7499295.html.plaintext.txt	276	268 20259 20267 abstractfree full text chang x
0.43596935.7499295.html.plaintext.txt	277	268 11304 11311 abstractfree full text anderson m
0.43596935.7499295.html.plaintext.txt	278	1991 cell 67 775 784 medline order article via infotrieve quinton p
0.43596935.7499295.html.plaintext.txt	279	1992 nature 360 79 81 crossrefmedline order article via infotrieve nagel g
0.43596935.7499295.html.plaintext.txt	280	1992 nature 360 81 84 crossrefmedline order article via infotrieve baukrowitz
0.43596935.7499295.html.plaintext.txt	281	1994 neuron 12 473 482 medline order article via infotrieve tsui l
0.43596935.7499295.html.plaintext.txt	282	8 392 398 medline order article via infotrieve welsh m
0.43596935.7499295.html.plaintext.txt	283	1993 cell 73 1251 1254 medline order article via infotrieve riordan j
0.43596935.7499295.html.plaintext.txt	284	55 609 630 crossrefmedline order article via infotrieve gadsby d
0.43596935.7499295.html.plaintext.txt	285	19 513 518 crossrefmedline order article via infotrieve isacoff e
0.43596935.7499295.html.plaintext.txt	286	1991 nature 353 86 90 crossrefmedline order article via infotrieve stuhmer w
0.43596935.7499295.html.plaintext.txt	287	1989 nature 339 597 603 crossrefmedline order article via infotrieve drumm m
0.43596935.7499295.html.plaintext.txt	288	1991 science 254 1797 1799 medline order article via infotrieve chao
0.43596935.7499295.html.plaintext.txt	289	56 1071 1081 abstract gunderson k
0.43596935.7499295.html.plaintext.txt	290	269 19349 19353 abstractfree full text ma j
0.43596935.7499295.html.plaintext.txt	291	67 626 633 abstract felgner p
0.43596935.7499295.html.plaintext.txt	292	84 7413 7417 abstract denning d
0.43596935.7499295.html.plaintext.txt	293	1992 nature 358 761 764 crossrefmedline order article via infotrieve lukacs g
0.43596935.7499295.html.plaintext.txt	294	268 21592 21598 abstractfree full text dalemans w
0.43596935.7499295.html.plaintext.txt	295	1991 nature 354 526 528 crossrefmedline order article via infotrieve pasyk e
0.43596935.7499295.html.plaintext.txt	296	270 12347 12350 abstractfree full text li c
0.43596935.7499295.html.plaintext.txt	297	1993 nature genetics 3 311 316 medline order article via infotrieve horowitz b
0.43596935.7499295.html.plaintext.txt	298	1993 nature genetics 4 426 431 medline order article via infotrieve 1995 american society biochemistry molecular biology inc
0.44482413.11707463.html.plaintext.txt	0	golgi associated pdz domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression jie cheng bryan d
0.44482413.11707463.html.plaintext.txt	1	moyer michal milewski johannes loffing masahiro ikeda john e
0.44482413.11707463.html.plaintext.txt	2	department physiology institute genetic medicine johns hopkins university school medicine baltimore maryland 21205 department physiology dartmouth medical school dartmouth college hanover new hampshire 03755 institute anatomy university zurich ch 8057 zurich switzerland
0.44482413.11707463.html.plaintext.txt	3	received publication october 23 2001 revised form november 12 2001
0.44482413.11707463.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references
0.44482413.11707463.html.plaintext.txt	5	identified novel cystic fibrosis transmembrane conductance regulator cftr associating pdz domain containing protein cal cftr associated ligand containing two predicted coiled coiled domains one pdz domain
0.44482413.11707463.html.plaintext.txt	6	pdz domain cal binds c terminus cftr
0.44482413.11707463.html.plaintext.txt	7	although cal predicted transmembrane domains cal associated membranes mediated region containing coiled coil domains
0.44482413.11707463.html.plaintext.txt	8	cal located primarily golgi apparatus co localizing trans golgi markers sensitive brefeldin treatment
0.44482413.11707463.html.plaintext.txt	9	immunoprecipitation experiments suggest cal exists multimer
0.44482413.11707463.html.plaintext.txt	10	overexpression cal reduces cftr chloride currents mammalian cells decreases expression rate insertion half life cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	11	nah exchanger regulatory factor nhe rf subplasma membrane pdz domain protein restores cell surface expression cftr chloride currents
0.44482413.11707463.html.plaintext.txt	12	addition nhe rf inhibits binding cal cftr
0.44482413.11707463.html.plaintext.txt	13	cal modulates surface expression cftr
0.44482413.11707463.html.plaintext.txt	14	cal favors retention cftr within cell whereas nhe rf favors surface expression competing cal binding cftr
0.44482413.11707463.html.plaintext.txt	15	thus regulation cftr plasma membrane involves dynamic interaction least two pdz domain proteins
0.44482413.11707463.html.plaintext.txt	16	introduction top abstract introduction experimental procedures results discussion references
0.44482413.11707463.html.plaintext.txt	17	cystic fibrosis genetic disorder caused mutations cystic fibrosis transmembrane conductance regulator cftr1 1 3
0.44482413.11707463.html.plaintext.txt	18	cftr camp regulated chloride channel channel regulator 4 mediates salt water balance number tissues including airways intestines pancreatic sweat ducts kidney tubules 5
0.44482413.11707463.html.plaintext.txt	19	many polarized epithelial tissues cftr functions apical cell membrane sweat duct cftr localized apical basolateral cell membranes
0.44482413.11707463.html.plaintext.txt	20	common mutation cftr f508 degraded endoplasmic reticulum er associated processes many studies focused trafficking cftr compartment 6
0.44482413.11707463.html.plaintext.txt	21	much less attention devoted cftr processed post er pathways
0.44482413.11707463.html.plaintext.txt	22	reported previously polarization cftr apical membrane human airway kidney epithelial cells altered cftr mutants lacking c terminal domain 7 8
0.44482413.11707463.html.plaintext.txt	23	data suggested c terminal domain plays role either trafficking andor stability within plasma membrane
0.44482413.11707463.html.plaintext.txt	24	last three amino acids cftr thr arg leu comprise consensus sequence known bind pdz domain proteins family proteins containing 80 90 amino acid motif binds c terminus variety ion channels receptors 9 11
0.44482413.11707463.html.plaintext.txt	25	least two pdz domain containing proteins nah exchanger regulatory factor nhe rf also called ebp50 cftr associated protein cap70 known bind terminal amino acids cftr 12 13
0.44482413.11707463.html.plaintext.txt	26	nhe rf submembranous phosphoprotein regulates apical membrane nah exchanger nhe3 14
0.44482413.11707463.html.plaintext.txt	27	nhe rf associates ezrin binds regulatory subunit pka 15 hypothesized nhe rf anchors cftr cytoskeleton subapical compartment targeting protein kinase near cftr 12
0.44482413.11707463.html.plaintext.txt	28	e3karp nhe rf related protein also shown interact cftr 16 17
0.44482413.11707463.html.plaintext.txt	29	cap70 subapical protein four pdz domains binds least two cftr molecules simultaneously via pdz3 pdz4 18
0.44482413.11707463.html.plaintext.txt	30	cap70 nhe rf enhance cftr cl channel activity excised patches probably cross linking cftr dimers 18 19
0.44482413.11707463.html.plaintext.txt	31	nhe rf e3karp cap70 localized subplasma membrane regions reflecting proposed roles anchoring andor regulating cftr
0.44482413.11707463.html.plaintext.txt	32	although growing evidence functional interaction cftr pdz domain proteins plasma membrane little known whether pdz domain proteins play role intracellular trafficking cftr along er golgi plasma membrane
0.44482413.11707463.html.plaintext.txt	33	post er secretory pathway involved trafficking wild type mutant cftr plasma membrane poorly characterized
0.44482413.11707463.html.plaintext.txt	34	recent study demonstrated cftr unusually low distribution cis golgi compartments compared membrane proteins 20 raising possibility cftr may utilize novel modes anterograde retrograde trafficking mechanisms
0.44482413.11707463.html.plaintext.txt	35	learn role c terminus cftr processing trafficking used yeast two hybrid assay identify proteins bind cftr
0.44482413.11707463.html.plaintext.txt	36	identified novel pdz domain protein cal interacts cftr post er secretory pathway
0.44482413.11707463.html.plaintext.txt	37	pdz domain cal binds directly c terminus cftr
0.44482413.11707463.html.plaintext.txt	38	native cftr cal localize golgi markers lung tissue vivo
0.44482413.11707463.html.plaintext.txt	39	overexpression cal suppresses cftr expression cell surface reduces cftr currents xenopus oocytes mammalian cells
0.44482413.11707463.html.plaintext.txt	40	suppression overcome nhe rf
0.44482413.11707463.html.plaintext.txt	41	data demonstrate cal modulates surface expression cftr
0.44482413.11707463.html.plaintext.txt	42	although nhe rf alone enhance surface expression cftr competes cal binding cftr indirectly enhances expression plasma membrane
0.44482413.11707463.html.plaintext.txt	43	thus expression cftr plasma membrane involves dynamic interaction least two pdz domain proteins
0.44482413.11707463.html.plaintext.txt	44	experimental procedures top abstract introduction experimental procedures results discussion references
0.44482413.11707463.html.plaintext.txt	45	two hybrid screening cloning cal yeast two hybrid screening used identify proteins interact c terminus cftr 21
0.44482413.11707463.html.plaintext.txt	46	bait consisted c terminal 51 amino acids rat cftr aa 1428 1478 rcftr amplified pcr rat lung matchmaker cdna library clontech palo alto ca
0.44482413.11707463.html.plaintext.txt	47	pcr products subcloned bamhipsti sites pas2 1 vector frame gal4 dna binding domain
0.44482413.11707463.html.plaintext.txt	48	approximately 1 x 107 recombinants rat lung matchmaker cdna library fused gal4 activation domain clontech screened interaction bait protein y190 yeast cells triple minus plates supplemented 35 mm 3 amino 124 triazole 3 leu trp 3
0.44482413.11707463.html.plaintext.txt	49	rat cal rcal fragment identified yeast two hybrid screening used screen human lung cdna library clontech obtain full length human cal hcal
0.44482413.11707463.html.plaintext.txt	50	cloned inserts sequenced directions automated fluorescent sequencing johns hopkins university biosynthesis sequencing facility
0.44482413.11707463.html.plaintext.txt	51	partial rat cal truncated extreme n terminus also obtained hybridization screening rat hippocampus library gift drs
0.44482413.11707463.html.plaintext.txt	52	yeast two hybrid assay rcftrc4 aa 1428 1474 rcftrc7 aa 1428 1471 subcloned bamhipsti sites pas2 1 vector frame gal4 dna binding domain clontech
0.44482413.11707463.html.plaintext.txt	53	rcftrc4 rcftrc7 empty pas2 1 vector co transformed rcal pgad10 vector y190 cells
0.44482413.11707463.html.plaintext.txt	54	interactions monitored lacz expression filter lifted transformed cells counting viable colonies triple minus plates leu trp 35 mm 3
0.44482413.11707463.html.plaintext.txt	55	cell culture transfection human embryonic kidney cell line hek 293 colorectal carcinoma t84 cells obtained american type tissue culture manassas va maintained dmemf 12 11 l glutamine penicillin streptomycin 10 fcs
0.44482413.11707463.html.plaintext.txt	56	african green monkey kidney cell cos 7 madin darby canine kidney ii cells mdck obtained american type tissue culture maintained dmem l glutamine penicillin streptomycin 10 fcs
0.44482413.11707463.html.plaintext.txt	57	human bronchial epithelial cells 16hbe14o gift dr
0.44482413.11707463.html.plaintext.txt	58	dieter gruenert maintained minimal essential medium l glutamine penicillin streptomycin 10 fcs
0.44482413.11707463.html.plaintext.txt	59	cystic fibrosis bronchial epithelial cells ib3 1 22 maintained lhc 8 basal medium l glutamine penicillin streptomycin 5 fcs
0.44482413.11707463.html.plaintext.txt	60	lhc 8 basal medium purchased biofluids
0.44482413.11707463.html.plaintext.txt	61	media components purchased invitrogen carlsbad ca
0.44482413.11707463.html.plaintext.txt	62	l glutamine 2 mm penicillin 100 unitsml streptomycin 100 microgml used
0.44482413.11707463.html.plaintext.txt	63	cos 7 ib3 1 mdck 16hbe14o cells transfected using lipofectamine lipofectamine 2000 invitrogen according manufacturers instructions
0.44482413.11707463.html.plaintext.txt	64	antibody production glutathione transferase gst fusion protein c terminal polypeptide aa 216 454 human cal prepared using gst gene fusion system amersham biosciences inc
0.44482413.11707463.html.plaintext.txt	65	precision protease cleaved cal c terminal polypeptide sent commercial producer covance princeton nj prepare rabbit polyclonal antibodies
0.44482413.11707463.html.plaintext.txt	66	plasmid construction ha myc tagged constructs made pcr amplification subcloning salinoti sites ha tagged prk5 vector prk5 ha myc tagged prk5 vector prk5 myc respectively gifts drs
0.44482413.11707463.html.plaintext.txt	67	huganir johns hopkins university
0.44482413.11707463.html.plaintext.txt	68	resulting constructs contain ha myc tag n terminus fusion proteins fig
0.44482413.11707463.html.plaintext.txt	69	gfp tagged constructs made pcr amplification subcloning salinoti sites pegfp n1 vector clontech
0.44482413.11707463.html.plaintext.txt	70	resulting constructs contain egfp tag c terminus fusion proteins fig
0.44482413.11707463.html.plaintext.txt	71	constructs sequence verified
0.44482413.11707463.html.plaintext.txt	72	plasmid constructs used ha nhe rf 13 gfp cftr gfp cftrtrl 7 full length vesicular stomatitis virus glycoprotein vsvg protein cloned pcdna3
0.44482413.11707463.html.plaintext.txt	73	northern blotting multiple human tissue polya rna blots mtb1 mtb2 clontech containing 16 human tissue polya rnas hybridized full length hcal probes stringent conditions according manufacturers directions
0.44482413.11707463.html.plaintext.txt	74	immunoprecipitation immunoblotting cells harvested processed described previously 23
0.44482413.11707463.html.plaintext.txt	75	briefly cells solubilized lysates spun 14000 x g 15 min pellet insoluble material
0.44482413.11707463.html.plaintext.txt	76	supernatants immunoprecipitated 1 microg monoclonal myc antibody ha antibody roche molecular biochemicals indianapolis il r domain cftr antibody genzyme cambridge ma polyclonal gfp antibody clontech cal antibody followed protein g agarose beads r domain cftr antibody protein agarose beads antibodies
0.44482413.11707463.html.plaintext.txt	77	eluted proteins subjected sds page western blot followed enhanced chemiluminescence ecl amersham biosciences inc
0.44482413.11707463.html.plaintext.txt	78	gfp cftr detected monoclonal gfp antibody 11000 roche molecular biochemicals
0.44482413.11707463.html.plaintext.txt	79	ha cal ha nhe rf ha tagged molecules detected monoclonal ha antibody 12000 roche molecular biochemicals
0.44482413.11707463.html.plaintext.txt	80	endogenous cal detected cal antibodies
0.44482413.11707463.html.plaintext.txt	81	endogenous cftr detected immunoprecipitation r domain cftr antibody genzyme followed protein kinase phosphorylation described previously 24
0.44482413.11707463.html.plaintext.txt	82	pull assay biotinylated peptides first incubated immobilized neutravidin beads pierce catalog number 53151 nonidet p 40 lysis buffer 4 degrees c 2 h
0.44482413.11707463.html.plaintext.txt	83	beads washed three times nonidet p 40 lysis buffer
0.44482413.11707463.html.plaintext.txt	84	500 microg cell lysate total volume 500 microl added 25 microg immobilized neutravidin beads tumbled 4 degrees c 2 h
0.44482413.11707463.html.plaintext.txt	85	samples washed three times nonidet p 40 lysis buffer
0.44482413.11707463.html.plaintext.txt	86	bound proteins eluted 2 x laemmli sample buffer supplemented 100 microm dtt 42 degrees c 30 min
0.44482413.11707463.html.plaintext.txt	87	eluted proteins subjected sds page western blot
0.44482413.11707463.html.plaintext.txt	88	biotinylated peptides used cftrct biotin sgsgskpqiaalleeteeevqdtrl cftrct2 biotin teeevqdtrl jn33 biotin mnrvieedgtsa c terminus human frizzled 3
0.44482413.11707463.html.plaintext.txt	89	surface biotinylation biotinylated cftr plasma membrane precipitated described detail previously modifications 23
0.44482413.11707463.html.plaintext.txt	90	lysates incubated immobilized neutravidin beads pierce catalog number 53151 bound proteins eluted 2 x laemmli sample buffer supplemented 100 microm dtt 42 degrees c 30 min
0.44482413.11707463.html.plaintext.txt	91	eluted proteins subjected sds page western blot
0.44482413.11707463.html.plaintext.txt	92	gfp cftr detected monoclonal gfp antibody 11000 roche molecular biochemicals
0.44482413.11707463.html.plaintext.txt	93	vsvg surface biotinylation cos 7 cells transfected full length vsvg
0.44482413.11707463.html.plaintext.txt	94	vsvg detected rabbit anti vsvg polyclonal antibody 25
0.44482413.11707463.html.plaintext.txt	95	pulse chase cell surface biotinylation two days transfection cos 7 cells washed twice methioninecysteine free dmem incubated 60 min methioninecysteine free dmem
0.44482413.11707463.html.plaintext.txt	96	cells incubated methioninecysteine free dmem containing tran35s label 250 microciml 30 min
0.44482413.11707463.html.plaintext.txt	97	subsequently cells washed extensively dmem containing 10 mm non labeled methionine 10 mm unlabeled cysteine chased solution 0 30 60 90 120 min
0.44482413.11707463.html.plaintext.txt	98	biotinylated cftr plasma membrane immunoprecipitated described previously 23
0.44482413.11707463.html.plaintext.txt	99	radiolabeled cftr analyzed using phosphorimager molecular dynamics sunnyvale ca
0.44482413.11707463.html.plaintext.txt	100	examine effect cal overexpression half life cftr plasma membrane cells incubated methioninecysteine free dmem containing tran35s label 250 microciml 3 h
0.44482413.11707463.html.plaintext.txt	101	cells washed extensively dmem containing 10 mm non labeled methionine 10 mm unlabeled cysteine containing penicillinstreptomycin 10 fbs chased solution 0 12 24 32 h
0.44482413.11707463.html.plaintext.txt	102	plasma membrane proteins biotinylated 0 12 24 32 h biotinylated cftr immunoprecipitated using gfp monoclonal antibody
0.44482413.11707463.html.plaintext.txt	103	radiolabeled cftr analyzed using phosphorimager
0.44482413.11707463.html.plaintext.txt	104	subcellular fractionation subcellular fractionation experiments cells trypsinized collected centrifugation
0.44482413.11707463.html.plaintext.txt	105	pellet resuspended incubated ice cold swelling buffer 1 mm dtt 1 mm mgcl2 1 mm egta complete protease inhibitor mixture roche molecular biochemicals 5 min
0.44482413.11707463.html.plaintext.txt	106	cells collected centrifugation resuspended buffer containing 0
0.44482413.11707463.html.plaintext.txt	107	25 m sucrose 3 mm imidazole ph 7
0.44482413.11707463.html.plaintext.txt	108	4 complete protease inhibitor mixture
0.44482413.11707463.html.plaintext.txt	109	lysate obtained homogenizing 10 strokes dounce homogenizer
0.44482413.11707463.html.plaintext.txt	110	pre clarification centrifugation 100 x g 4 degrees c 5 min lysate spun ultracentrifuge 100000 x g 45 min 4 degrees c centrifuge tl 100 using tla 100
0.44482413.11707463.html.plaintext.txt	111	2 rotor beckman coulter
0.44482413.11707463.html.plaintext.txt	112	tubulin monoclonal antibody obtained amersham biosciences inc
0.44482413.11707463.html.plaintext.txt	113	confocal microscopy cultured cells plated glass coverslips 1 day post transfection examined 2 days post transfection
0.44482413.11707463.html.plaintext.txt	114	cells fixed 4 paraformaldehyde permeabilized 0
0.44482413.11707463.html.plaintext.txt	115	nonspecific binding sites blocked 5 normal goat serum ngs
0.44482413.11707463.html.plaintext.txt	116	cells stained anti ha monoclonal antibody 12000 roche molecular biochemicals adaptin 110 sigma chemical co
0.44482413.11707463.html.plaintext.txt	117	louis mo 5 ngs washed 1 bovine serum albumin incubated goat anti mouse cy3 secondary antibodies 1 ngs
0.44482413.11707463.html.plaintext.txt	118	cases cells counter stained 46 diamidino 2 phenyl indole 200 microgml sigma visualize nuclei
0.44482413.11707463.html.plaintext.txt	119	specimens mounted viewed lsm 410 confocal microscope zeiss
0.44482413.11707463.html.plaintext.txt	120	immunofluorescence rat tracheae performed exactly described 26
0.44482413.11707463.html.plaintext.txt	121	sections frozen tracheae 6 microm thick incubated following antibodies rabbit anti cal 1500 mouse anti cop 150 sigma mouse anti 58k 150 sigma mouse anti tgn38 150 oncogene cambridge ma
0.44482413.11707463.html.plaintext.txt	122	whole cell patch clamp recordings whole cell recordings performed room temperature cos 7 cells grown glass coverslips 1 2 days post transfection
0.44482413.11707463.html.plaintext.txt	123	5 mgml sodium butyrate 16 h day experiments described 23
0.44482413.11707463.html.plaintext.txt	124	transfected cells expressing gfp cftr identified fluorescence microscope te200 nikon
0.44482413.11707463.html.plaintext.txt	125	coverslips perfused extracellular solution containing mm 140 nacl 5 kcl 2 mgcl2 1 cacl2 10 glucose 20 sucrose 0
0.44482413.11707463.html.plaintext.txt	126	sucrose dids used prevent activation endogenous chloride currents
0.44482413.11707463.html.plaintext.txt	127	pipette resistance pipette solution ps containing mm 150 cscl 1 mgcl2 2 na2atp 1 egta 10 hepes ph 7
0.44482413.11707463.html.plaintext.txt	128	4 tris ranged 5 8 m
0.44482413.11707463.html.plaintext.txt	129	input capacitance ranged 11 64 picofarads
0.44482413.11707463.html.plaintext.txt	130	pclamp8 software axon instruments used sample analyze data
0.44482413.11707463.html.plaintext.txt	131	current voltage v relationships obtained 100 ms voltage step holding potential 0 mv
0.44482413.11707463.html.plaintext.txt	132	junction potentials extracellular solution ps measured using 3 m kcl bridge 2 mv
0.44482413.11707463.html.plaintext.txt	133	therefore correction potentials made
0.44482413.11707463.html.plaintext.txt	134	extracellular membrane permeant camp analogue 8 chlorophenyl thio camp cpt camp 250 microm applied using nearby pipette 30 35 microm diameter
0.44482413.11707463.html.plaintext.txt	135	results top abstract introduction experimental procedures results discussion references
0.44482413.11707463.html.plaintext.txt	136	identification tissue distribution cal identify pdz domain proteins interact cftr performed yeast two hybrid screen using last 51 amino acids c terminus rat cftr 21
0.44482413.11707463.html.plaintext.txt	137	approximately 1 x 107 recombinants lung cdna library fused gal4 dna activation domain screened
0.44482413.11707463.html.plaintext.txt	138	novel protein designated cal cftr associated ligand identified screening
0.44482413.11707463.html.plaintext.txt	139	fifty six clones isolated encoded overlapping partial sequences cal
0.44482413.11707463.html.plaintext.txt	140	contained consensus sequence complete pdz domain
0.44482413.11707463.html.plaintext.txt	141	interaction cftr cal confirmed re transforming cloned cdna yeast
0.44482413.11707463.html.plaintext.txt	142	interaction bait dependent occur vector alone
0.44482413.11707463.html.plaintext.txt	143	interaction also dependent upon terminal amino acids cftr occur cftr c terminal constructs missing terminal 4 7 amino acids data shown
0.44482413.11707463.html.plaintext.txt	144	obtain full length cal screened human lung cdna library clontech rat cal cdna
0.44482413.11707463.html.plaintext.txt	145	seven independent overlapping clones identified
0.44482413.11707463.html.plaintext.txt	146	largest fragment contained 1362 bp open reading frame preceded 132 bp upstream frame stop codon
0.44482413.11707463.html.plaintext.txt	147	start codon consistent kozak consensus sequence 27 identified
0.44482413.11707463.html.plaintext.txt	148	translation reading frame predicts 454 amino acid polypeptide estimated molecular mass 50 kda fig
0.44482413.11707463.html.plaintext.txt	149	hydropathy analysis detect putative membrane spanning regions 28
0.44482413.11707463.html.plaintext.txt	150	targeting signal sequence detected
0.44482413.11707463.html.plaintext.txt	151	carboxyl half cal identical amino half aberrant clone homo sapiens rna ros1 oncogene 29
0.44482413.11707463.html.plaintext.txt	152	aberrant clone likely results rearrangement cal human ros1 oncogene
0.44482413.11707463.html.plaintext.txt	153	cal mapped chromosome 6q21a aligning finished human genomic sequence pac 94g16 genbanktm 30
0.44482413.11707463.html.plaintext.txt	154	rat cal cdna highly homologous human cal 91 identity 94 conserved obtained hybridization screen fig
0.44482413.11707463.html.plaintext.txt	155	human cal also highly homologous 56 identity 71 homology protein identified caenorhabditis elegans genome project zk849
0.44482413.11707463.html.plaintext.txt	156	2 suggesting evolutionarily conserved function fig
0.44482413.11707463.html.plaintext.txt	157	1a well recently described protein 31
0.44482413.11707463.html.plaintext.txt	158	addition pdz domain cal predicted two coiled coil domains
0.44482413.11707463.html.plaintext.txt	159	coiled coil domains also involved protein protein interactions 32
0.44482413.11707463.html.plaintext.txt	160	co existence coiled coil domains pdz domain suggests cal potentially interact multiple proteins
0.44482413.11707463.html.plaintext.txt	161	view larger version 90k fig
0.44482413.11707463.html.plaintext.txt	162	protein sequences protein domains tissue distribution cal
0.44482413.11707463.html.plaintext.txt	163	conceptual translation human cal cdna hcal accession number af450008 partial rat cal cdna rcal putative c
0.44482413.11707463.html.plaintext.txt	164	2 genbanktm accession number t28036
0.44482413.11707463.html.plaintext.txt	165	box depicts pdz domain aa 280 363
0.44482413.11707463.html.plaintext.txt	166	underlined coiled coil domains aa 77 132 143 198
0.44482413.11707463.html.plaintext.txt	167	b tissue distribution cal mrna
0.44482413.11707463.html.plaintext.txt	168	multiple human tissue polya rna blots probed cal stringent conditions
0.44482413.11707463.html.plaintext.txt	169	major transcript 5 kb detected tissues
0.44482413.11707463.html.plaintext.txt	170	5 2 kb detected number tissues
0.44482413.11707463.html.plaintext.txt	171	full length cal consists n terminal domain n coiled coil domain cc green pdz domain pdz red c terminal domain c
0.44482413.11707463.html.plaintext.txt	172	b ha tagged pdz domain cal aa 216 404
0.44482413.11707463.html.plaintext.txt	173	c myc tagged n terminal half cal including n terminal coiled coil domains aa 1 279
0.44482413.11707463.html.plaintext.txt	174	d myc tagged c terminal half cal including c terminal pdz domains aa 216 454
0.44482413.11707463.html.plaintext.txt	175	e gfp tagged n terminal domain cal aa 1 76
0.44482413.11707463.html.plaintext.txt	176	f gfp tagged n terminal coiled coil domains cal aa 1 279
0.44482413.11707463.html.plaintext.txt	177	g gfp tagged pdz domain c terminal cal aa 216 454
0.44482413.11707463.html.plaintext.txt	178	blue filled circles indicate positions epitope tags
0.44482413.11707463.html.plaintext.txt	179	northern blot analysis detected cal human tissues examined including cftr expressing tissues lung pancreas fig
0.44482413.11707463.html.plaintext.txt	180	major transcript 5 kb addition tissues less abundant transcripts different sizes e
0.44482413.11707463.html.plaintext.txt	181	ubiquitous expression pattern evolutionarily conserved protein sequence cal suggest essential housekeeping role interaction cftr membrane proteins similar pdz binding motifs
0.44482413.11707463.html.plaintext.txt	182	native properties cal study cal vivo generated rabbit polyclonal antibody raised c terminal domain human cal see experimental procedures
0.44482413.11707463.html.plaintext.txt	183	consistent wide pattern expression cal mrna cal protein endogenously expressed several cell lines including human bronchial epithelial cells 16hbe14o fig
0.44482413.11707463.html.plaintext.txt	184	2a colonic carcinoma t84 cell line see related data fig
0.44482413.11707463.html.plaintext.txt	185	3d cystic fibrosis bronchial epithelial cell line ib3 1 data shown
0.44482413.11707463.html.plaintext.txt	186	western blots 16hbe14o cells display native cal two molecular masses 50 kda 100 kda bands fig
0.44482413.11707463.html.plaintext.txt	187	2a lysate analyzed non reducing conditions single 50 kda band fig
0.44482413.11707463.html.plaintext.txt	188	2a dtt analyzed reducing conditions
0.44482413.11707463.html.plaintext.txt	189	raises possibility cal form homo multimer
0.44482413.11707463.html.plaintext.txt	190	test cotransfected hek293 cells ha tagged full length cal ha cal one following myc tagged cal constructs full length myc cal construct containing c terminal portion including pdz domain myc cal pdz c construct containing n terminal amino acids including coiled coil domains minus pdz domain myc cal n cc
0.44482413.11707463.html.plaintext.txt	191	cells containing myc tagged full length cal first lane n terminal portion cal third lane possible immunoprecipitate ha tagged full length cal anti myc antibodies fig
0.44482413.11707463.html.plaintext.txt	192	myc labeled c terminal portion capable precipitating ha tagged full length cal second lane
0.44482413.11707463.html.plaintext.txt	193	data demonstrate cal forms homo multimer self association domain lies n terminal half cal
0.44482413.11707463.html.plaintext.txt	194	view larger version 31k fig
0.44482413.11707463.html.plaintext.txt	195	native properties cal
0.44482413.11707463.html.plaintext.txt	196	expression cal cultured cells
0.44482413.11707463.html.plaintext.txt	197	total lysate 16hbe14ocells boiled 5 min laemmli sample buffer see experimental procedures minus 5 lysate non reducing condition plus 5 reducing condition
0.44482413.11707463.html.plaintext.txt	198	right lane contains total lysate cells incubated 37 degrees c 15 min laemmli buffer containing 50 mm dtt dtt reducing condition
0.44482413.11707463.html.plaintext.txt	199	cal detected western blot using rabbit polyclonal cal antibody
0.44482413.11707463.html.plaintext.txt	200	b crude membrane pellet soluble fractions soluble 16hbe14o cells separated sds page detected cal polyclonal antibody upper panel tubulin monoclonal antibody lower panel
0.44482413.11707463.html.plaintext.txt	201	cal associated primarily membrane fraction
0.44482413.11707463.html.plaintext.txt	202	c co immunoprecipitation ha cal three constructs myc tagged cal
0.44482413.11707463.html.plaintext.txt	203	hek293 cells co transfected ha cal left right myc cal containing full length cal myc cal pdz c containing pdz c terminal domains myc cal n cc containing n terminal coiled coil domains empty vector prk5
0.44482413.11707463.html.plaintext.txt	204	cell lysates immunoprecipitated myc monoclonal antibody followed western blot using ha monoclonal antibody
0.44482413.11707463.html.plaintext.txt	205	d gfp tagged cal constructs indicated transfected hek293 cells
0.44482413.11707463.html.plaintext.txt	206	crude membrane fraction p soluble fraction isolated see experimental procedures separated sds page detected gfp monoclonal antibody
0.44482413.11707463.html.plaintext.txt	207	predicted molecular masses follows gfp cal n 37 kda gfp cal n cc 57 kda gfp cal pdz c 53 kda gfp cal fl 80 kda gfp alone 27 kda
0.44482413.11707463.html.plaintext.txt	208	view larger version 39k fig
0.44482413.11707463.html.plaintext.txt	209	biochemical characterization cal cftr interaction
0.44482413.11707463.html.plaintext.txt	210	co immunoprecipitation full length cal cftr
0.44482413.11707463.html.plaintext.txt	211	cos 7 cells transfected indicated
0.44482413.11707463.html.plaintext.txt	212	top two panels cell lysates immunoprecipitated gfp antibody
0.44482413.11707463.html.plaintext.txt	213	cal cftr detected ha gfp antibodies respectively
0.44482413.11707463.html.plaintext.txt	214	bottom two panels cell lysates loaded onto sds page directly cal cftr detected ha gfp antibodies respectively
0.44482413.11707463.html.plaintext.txt	215	lane 1 mock transfected cells
0.44482413.11707463.html.plaintext.txt	216	lane 3 ha cal gfp cftr trl
0.44482413.11707463.html.plaintext.txt	217	b co immunoprecipitation cal pdz domain c terminus cftr
0.44482413.11707463.html.plaintext.txt	218	cos 7 cells transfected indicated plasmids
0.44482413.11707463.html.plaintext.txt	219	lanes 2 3 immunoprecipitation myc antibody
0.44482413.11707463.html.plaintext.txt	220	cell lysates immunoprecipitated materials detected western blotting ha monoclonal antibody
0.44482413.11707463.html.plaintext.txt	221	c interaction c terminus cftr native cal
0.44482413.11707463.html.plaintext.txt	222	total lysates 16hbe14o cells incubated two biotinylated c terminal cftr peptides sgsgskpqiaalleeteeevqdtrl lane 1 teeevqdtrl lane 2 control biotinylated peptide jn33 lane 3
0.44482413.11707463.html.plaintext.txt	223	jn33 peptide comprises biotinylated c terminus human frizzled 3 biotin mnrvieedgtsa
0.44482413.11707463.html.plaintext.txt	224	jn33 used control nonspecific binding
0.44482413.11707463.html.plaintext.txt	225	bound fractions precipitated neutravidin beads analyzed western blot using cal antibody
0.44482413.11707463.html.plaintext.txt	226	d co immunoprecipitation native cal cftr t84 cells
0.44482413.11707463.html.plaintext.txt	227	total lysates t84 cells immunoprecipitated cftr antisera genzyme r domain monoclonal antibodies cftr 160 kda lane 1 protein beads lane 2 cal antisera lane 3
0.44482413.11707463.html.plaintext.txt	228	top panel western blot using cal antibody
0.44482413.11707463.html.plaintext.txt	229	bottom panel autoradiography radiolabeled cftr see experimental procedures
0.44482413.11707463.html.plaintext.txt	230	determine cal membrane associated cytosolic protein 16hbe14o cells fractionated centrifugation pellet soluble fractions
0.44482413.11707463.html.plaintext.txt	231	cal found pellet soluble fractions fig
0.44482413.11707463.html.plaintext.txt	232	2b suggesting cal could associate membrane fraction
0.44482413.11707463.html.plaintext.txt	233	isolate sequences responsible membrane association transfected various truncation constructs gfp tagged cal hek293 cells assayed subcellular fractionation
0.44482413.11707463.html.plaintext.txt	234	gfp change cal membrane association fig
0.44482413.11707463.html.plaintext.txt	235	cal containing n terminal domain lacking coiled coil pdz domains cal n mostly within soluble fraction pellet fig
0.44482413.11707463.html.plaintext.txt	236	cal containing n terminal coiled coil domains lacking pdz domain cal n cc found pelleted fraction fig
0.44482413.11707463.html.plaintext.txt	237	cal containing pdz c terminal domains cal pdz c soluble fig
0.44482413.11707463.html.plaintext.txt	238	although cal predicted transmembrane sequences coiled coil domains conferred membrane association presumably binding resident golgi coiled coil proteins
0.44482413.11707463.html.plaintext.txt	239	cal binds cftr test whether full length cal cftr interact animal cells cos 7 cells transiently transfected n terminal tagged full length ha cal gfp cftr fig
0.44482413.11707463.html.plaintext.txt	240	gfp cftr single channel whole cell current properties indistinguishable wild type cftr 23
0.44482413.11707463.html.plaintext.txt	241	3 ha cal gfp cftr co immunoprecipitated gfp polyclonal antibody fig
0.44482413.11707463.html.plaintext.txt	242	removal last 3 amino acid residues full length cftr gfp cftrtrl substantially reduced ability truncated cftr interact cal fig
0.44482413.11707463.html.plaintext.txt	243	3a lane 3 suggesting importance extreme c terminal pdz binding motif
0.44482413.11707463.html.plaintext.txt	244	faint band lane 3 suggests weak binding sites cal may exist cftr
0.44482413.11707463.html.plaintext.txt	245	test whether pdz interacting domain cftr important cal cftr interaction conducted studies using c terminus cftr pdz domain cal fig
0.44482413.11707463.html.plaintext.txt	246	cos 7 cells transfected ha tagged pdz domain cal ha cal pdz aa 216 404 myc tagged c terminus cftr myc cftr c aa 1387 1480
0.44482413.11707463.html.plaintext.txt	247	ha cal pdz co immunoprecipitated myc cftr c using anti myc antibody fig
0.44482413.11707463.html.plaintext.txt	248	control ha cal pdz immunoprecipitated myc antibody absence myc cftr c fig
0.44482413.11707463.html.plaintext.txt	249	truncation c terminal cftr residues trl abolishes binding fig
0.44482413.11707463.html.plaintext.txt	250	3a binding occur portions containing pdz domain cal c terminus cftr fig
0.44482413.11707463.html.plaintext.txt	251	3b pdz domain mediated interaction necessary sufficient cal cftr interaction
0.44482413.11707463.html.plaintext.txt	252	confirm c terminus cftr involved interaction immobilized biotinylated peptides corresponding c terminal 8 24 residues cftr neutravidin beads incubated peptides whole cell lysates prepared 16hbe14o cells
0.44482413.11707463.html.plaintext.txt	253	bound fractions examined western blot using cal antisera
0.44482413.11707463.html.plaintext.txt	254	endogenous cal bound immobilized cftr peptides fig
0.44482413.11707463.html.plaintext.txt	255	3c lanes 1 2 control peptide fig
0.44482413.11707463.html.plaintext.txt	256	last 8 residues cftr bind cal interaction likely direct mediated proteins
0.44482413.11707463.html.plaintext.txt	257	test whether cal present complex cftr vivo cftr immunoprecipitated t84 cell lysates using r domain antibody genzyme precipitated fraction analyzed western blotting using cal antibody
0.44482413.11707463.html.plaintext.txt	258	cal found cftr immunoprecipitated fraction fig
0.44482413.11707463.html.plaintext.txt	259	3d lane 1 control fraction fig
0.44482413.11707463.html.plaintext.txt	260	reciprocal experiment cal antisera also precipitated cftr fig
0.44482413.11707463.html.plaintext.txt	261	taken together data suggest cftr cal associate vivo
0.44482413.11707463.html.plaintext.txt	262	golgi localization cal next examined expression native cal indirect immunofluorescence staining rabbit anti cal antibodies
0.44482413.11707463.html.plaintext.txt	263	rat trachea cal immunostaining seen surface epithelium submucosal glands fig
0.44482413.11707463.html.plaintext.txt	264	staining bright acini ducts d submucosal glands fig
0.44482413.11707463.html.plaintext.txt	265	cal predominantly localized intracellular compartments acinar cells weakly expressed cytoplasm fig
0.44482413.11707463.html.plaintext.txt	266	conditions pre immune serum shows significant staining fig
0.44482413.11707463.html.plaintext.txt	267	examine subcellular localization cal acinar cells double labeled cal antibodies golgi markers
0.44482413.11707463.html.plaintext.txt	268	4 d f cal colocalized trans golgi network marker tgn38
0.44482413.11707463.html.plaintext.txt	269	cal partially colocalizes cop medial cis golgi marker fig
0.44482413.11707463.html.plaintext.txt	270	4 g 58k marker er golgi intermediate compartment ergic fig
0.44482413.11707463.html.plaintext.txt	271	similar staining pattern observed rat kidney cells data shown
0.44482413.11707463.html.plaintext.txt	272	view larger version 33k fig
0.44482413.11707463.html.plaintext.txt	273	immunohistochemical detection cal rat trachea
0.44482413.11707463.html.plaintext.txt	274	overview cross section rat trachea showing surface epithelium 1 lamina propria 2 submucosa 3
0.44482413.11707463.html.plaintext.txt	275	cal immunostaining bright acini ducts d submucosal glands
0.44482413.11707463.html.plaintext.txt	276	b higher magnification two acini shows cal localized intracellular tubular compartments acinar cells
0.44482413.11707463.html.plaintext.txt	277	intracellular staining seen consecutive cryosection c incubated pre immune serum pis
0.44482413.11707463.html.plaintext.txt	278	acinar lumen b c indicated asterisks
0.44482413.11707463.html.plaintext.txt	279	d l high power magnifications showing co immunostainings antibodies directed cal tgn38 d f cal cop g cal 58k j l
0.44482413.11707463.html.plaintext.txt	280	co localization visualized image overlay yellow
0.44482413.11707463.html.plaintext.txt	281	bars 50 microm c 20 microm l 3 microm
0.44482413.11707463.html.plaintext.txt	282	investigate subcellular localization cal examined transiently transfected ha tagged cal using monoclonal ha
0.44482413.11707463.html.plaintext.txt	283	ib3 mdck cells cal detected monoclonal antibody ha epitope tag appeared predominantly juxtanuclear region single spot overlapped expression trans golgi network tgn marker adaptin figs
0.44482413.11707463.html.plaintext.txt	284	weak expression observed cytoplasm
0.44482413.11707463.html.plaintext.txt	285	treatment bfa known redistribute golgi coat proteins cytosol 33
0.44482413.11707463.html.plaintext.txt	286	ib3 cells bfa treatments 15 min caused redistribution adaptin cal cytoplasm fig
0.44482413.11707463.html.plaintext.txt	287	bfa also caused redistribution cal cytoplasm 16hbe14o fig
0.44482413.11707463.html.plaintext.txt	288	endogenous cal found subcellular localization detected anti cal antibody data shown
0.44482413.11707463.html.plaintext.txt	289	view larger version 24k fig
0.44482413.11707463.html.plaintext.txt	290	subcellular localization cal
0.44482413.11707463.html.plaintext.txt	291	ib3 1 cells transfected ha cal grown collagen coated glass coverslips
0.44482413.11707463.html.plaintext.txt	292	cal detected monoclonal antibody ha epitope green tgn marker adaptin monoclonal antibody adaptin red
0.44482413.11707463.html.plaintext.txt	293	co localization visualized image overlay yellow
0.44482413.11707463.html.plaintext.txt	294	top panel cells treated bfa
0.44482413.11707463.html.plaintext.txt	295	bottom panel cells treated bfa 10 microgml 15 min 37 degrees c
0.44482413.11707463.html.plaintext.txt	296	b mdck ii cells transfected ha cal grown plastic
0.44482413.11707463.html.plaintext.txt	297	cal green adaptin red detected described
0.44482413.11707463.html.plaintext.txt	298	co localization visualized image overlay yellow
0.44482413.11707463.html.plaintext.txt	299	c 16hbe14o cells transfected ha cal grown vitrogen
0.44482413.11707463.html.plaintext.txt	300	cal detected monoclonal antibody ha epitope green epithelial tight junction marker zo 1 detected monoclonal antibody zo 1 red
0.44482413.11707463.html.plaintext.txt	301	cal reduces cftr cl current elucidate functional consequence cal cftr interaction examined co expression cal affects cftr mediated cl conductance cos 7 cells
0.44482413.11707463.html.plaintext.txt	302	6 shows whole cell recordings summary data measured using whole cell patch clamp technique
0.44482413.11707463.html.plaintext.txt	303	cftr expressing cells identified using gfp fluorescence
0.44482413.11707463.html.plaintext.txt	304	6 b produced camp activated cl currents typical shown previously cftr 23
0.44482413.11707463.html.plaintext.txt	305	cftr cl currents observed non transfected mock transfected cells data shown
0.44482413.11707463.html.plaintext.txt	306	co transfection cftr cal resulted greatly reduced currents despite expression cftr fig
0.44482413.11707463.html.plaintext.txt	307	parallel experiments presence gfp cftr ha cal verified prove green fluorescing cells co transfected cftr cal
0.44482413.11707463.html.plaintext.txt	308	test outcome cftr cal mrna injected xenopus oocytes
0.44482413.11707463.html.plaintext.txt	309	absence cal expression cftr mrna resulted camp activated currents typical cftr
0.44482413.11707463.html.plaintext.txt	310	currents present non injected oocytes
0.44482413.11707463.html.plaintext.txt	311	co expression cal clearly inhibited cftr mediated camp activated cl currents data shown
0.44482413.11707463.html.plaintext.txt	312	data show cal inhibits cftr currents mammalian xenopus oocyte expression systems
0.44482413.11707463.html.plaintext.txt	313	view larger version 22k fig
0.44482413.11707463.html.plaintext.txt	314	cal affects cftr cl currents
0.44482413.11707463.html.plaintext.txt	315	cos 7 cells transfected 1 microg gfp cftr b 1 microg gfp cftr 3 microg ha cal c d 1 microg gfp cftr 3 microg ha cal 1 microg ha nhe rf e f
0.44482413.11707463.html.plaintext.txt	316	currents measured whole cell patch clamp
0.44482413.11707463.html.plaintext.txt	317	typical recordings application cpt camp 250 microm evoked chloride currents c e relationships steady state current membrane voltage shown b d f
0.44482413.11707463.html.plaintext.txt	318	cell held 0 mv 100 ms voltage steps applied 100 100 mv increments 20 mv
0.44482413.11707463.html.plaintext.txt	319	open solid circles indicate basal cpt camp stimulated current respectively
0.44482413.11707463.html.plaintext.txt	320	cpt camp induced current responses observed mock transfected cells data shown
0.44482413.11707463.html.plaintext.txt	321	bar graph g shows maximum deviations current basal level stimulation 250 microm cpt camp 1 min
0.44482413.11707463.html.plaintext.txt	322	values presented mean plus minus
0.44482413.11707463.html.plaintext.txt	323	01 versus cftr cal dunnetts method
0.44482413.11707463.html.plaintext.txt	324	numbers experiments given parentheses
0.44482413.11707463.html.plaintext.txt	325	cal alters surface expression cftr inhibition whole cell currents cal could caused either direct inhibition cl channel activity reduction cftr channel number cell surface investigated effect cal cftr protein expression cell surface
0.44482413.11707463.html.plaintext.txt	326	first co expressed ha cal gfp cftr cos 7 cells examined cal affects plasma membrane expression cftr
0.44482413.11707463.html.plaintext.txt	327	ha cal alone detected primarily golgi apparatus expression cytosol near plasma membrane fig
0.44482413.11707463.html.plaintext.txt	328	wild type gfp cftr alone found plasma membrane er fig
0.44482413.11707463.html.plaintext.txt	329	cells co expressing ha cal gfp cftr cftr disappeared cell membrane clustered intracellular location fig
0.44482413.11707463.html.plaintext.txt	330	moreover cal colocalized cftr intracellular location fig
0.44482413.11707463.html.plaintext.txt	331	view larger version 14k fig
0.44482413.11707463.html.plaintext.txt	332	immunochemical characterization cftr cal interaction
0.44482413.11707463.html.plaintext.txt	333	cos 7 cells transfected ha cal alone gfp cftr alone b co transfected cal gfp cftr c d e cal detected monoclonal antibody ha epitope red
0.44482413.11707463.html.plaintext.txt	334	cftr detected gfp fluorescence green
0.44482413.11707463.html.plaintext.txt	335	co localization visualized image overlay yellow
0.44482413.11707463.html.plaintext.txt	336	co expression cal cftr results redistribution complete colocalization protein clusters
0.44482413.11707463.html.plaintext.txt	337	next tested whether cell surface expression gfp cftr cos 7 assessed surface biotinylation altered co expression ha cal
0.44482413.11707463.html.plaintext.txt	338	approximately 10 cftr expressed cell surface 40 48 h post transfection
0.44482413.11707463.html.plaintext.txt	339	overexpression ha cal reduced expression gfp cftr cell surface fig
0.44482413.11707463.html.plaintext.txt	340	reduction becomes pronounced increasing amounts ha cal fig
0.44482413.11707463.html.plaintext.txt	341	contrast overexpression ha cal effect plasma membrane expression gfp cftrtrl data shown
0.44482413.11707463.html.plaintext.txt	342	test whether overexpression cal causes generalized suppression membrane protein trafficking co transfected cos 7 cells ha cal vesicular stomatitis virus glycoprotein vsvg known traffic plasma membrane cis medial trans golgi 34
0.44482413.11707463.html.plaintext.txt	343	8c effect vsvg surface expression
0.44482413.11707463.html.plaintext.txt	344	likewise cal effect p glycoprotein surface expression like cftr apical membrane protein data shown
0.44482413.11707463.html.plaintext.txt	345	taken together data show inhibition surface expression cftr cal cause nonspecific effect protein overexpression
0.44482413.11707463.html.plaintext.txt	346	data demonstrate cal selectively inhibits cell surface expression cftr
0.44482413.11707463.html.plaintext.txt	347	view larger version 52k fig
0.44482413.11707463.html.plaintext.txt	348	cal affects cell surface cftr expression
0.44482413.11707463.html.plaintext.txt	349	cos 7 cells co transfected 3 microg gfp cftr various amounts ha cal ha nhe rf empty vector prk5
0.44482413.11707463.html.plaintext.txt	350	cell surface membrane proteins biotinylated analyzed western blot using gfp monoclonal antibody top panel
0.44482413.11707463.html.plaintext.txt	351	total lysates analyzed using ha monoclonal antibody middle panel gfp monoclonal antibody bottom panel
0.44482413.11707463.html.plaintext.txt	352	b luminescent image analysis cell surface gfp cftr expression
0.44482413.11707463.html.plaintext.txt	353	values percentage cell surface cftr total cell lysate
0.44482413.11707463.html.plaintext.txt	354	data averages three independent experiments
0.44482413.11707463.html.plaintext.txt	355	c cell surface vsvg expression
0.44482413.11707463.html.plaintext.txt	356	cos 7 cells co transfected 3 microg vsvg various amounts ha cal
0.44482413.11707463.html.plaintext.txt	357	cell surface proteins analyzed using vsvg monoclonal antibody top panel
0.44482413.11707463.html.plaintext.txt	358	total lysates analyzed western blot using ha monoclonal antibody middle panel vsvg monoclonal antibody bottom panel
0.44482413.11707463.html.plaintext.txt	359	d co immunoprecipitation cftr cal nhe rf
0.44482413.11707463.html.plaintext.txt	360	cos 7 cells transfected gfp cftr 3 microg ha cal 6 microg ha nhe rf 3 microg indicated
0.44482413.11707463.html.plaintext.txt	361	lysates immunoprecipitated gfp polyclonal antibodies analyzed using ha monoclonal antibody top panel
0.44482413.11707463.html.plaintext.txt	362	cell lysates analyzed using ha monoclonal antibody bottom panel
0.44482413.11707463.html.plaintext.txt	363	ip immunoprecipitation wb western blot
0.44482413.11707463.html.plaintext.txt	364	cal alters insertion cftr half life cftr plasma membrane characterize mechanism cal suppresses surface expression cftr conducted two sets experiments
0.44482413.11707463.html.plaintext.txt	365	first measured rate appearance cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	366	cos 7 cells transfected gfp cftr ha cal
0.44482413.11707463.html.plaintext.txt	367	two days later cells labeled 35s cysmet 30 min chased 0 120 min plasma membrane cftr detected cell surface biotinylation
0.44482413.11707463.html.plaintext.txt	368	cal inhibits expression cftr plasma membrane least part decreasing rate appearance cftr plasma membrane fig
0.44482413.11707463.html.plaintext.txt	369	second examined effect cal half life cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	370	cos 7 cells transfected gfp cftr ha cal
0.44482413.11707463.html.plaintext.txt	371	two days later cells labeled 35s cysmet 3 h chased 0 32 h plasma membrane cftr detected cell surface biotinylation
0.44482413.11707463.html.plaintext.txt	372	cal also decreased half life cftr plasma membrane fig
0.44482413.11707463.html.plaintext.txt	373	data suggest cal may interact components near cell surface determining expression cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	374	view larger version 33k fig
0.44482413.11707463.html.plaintext.txt	375	cal affects insertion cftr plasma membrane well half life plasma membrane
0.44482413.11707463.html.plaintext.txt	376	rate cftr appearance plasma membrane
0.44482413.11707463.html.plaintext.txt	377	cos 7 cells transfected gfp cftr 3 microg gfp cftr 3 microg ha cal 3 microg
0.44482413.11707463.html.plaintext.txt	378	two days later cells labeled 35s cysmet 30 min chased 0 120 min
0.44482413.11707463.html.plaintext.txt	379	figure presents rate appearance 35s labeled cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	380	data relative amount cftr plasma membrane 0 cftr cells averages two independent experiments
0.44482413.11707463.html.plaintext.txt	381	b half life cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	382	cos 7 cells transfected gfp cftr 3 microg gfp cftr 3 microg ha cal 3 microg
0.44482413.11707463.html.plaintext.txt	383	two days later plasma membrane proteins biotinylated 0 cells placed back incubator 12 24 32 h
0.44482413.11707463.html.plaintext.txt	384	proteins analyzed western blot using gfp monoclonal antibody
0.44482413.11707463.html.plaintext.txt	385	roles cal pdz domain proteins determining cell surface cftr expression nhe rf subplasma membrane pdz domain protein may anchor cftr cytoskeleton
0.44482413.11707463.html.plaintext.txt	386	understand pdz domain proteins may work together regulating cftr trafficking membrane organization examined effect overexpressing nhe rf alone co expressing nhe rf cal cftr cell surface expression
0.44482413.11707463.html.plaintext.txt	387	overexpression ha nhe rf change plasma membrane expression gfp cftr fig
0.44482413.11707463.html.plaintext.txt	388	co expression ha nhe rf ha cal however restored cell surface gfp cftr expression fig
0.44482413.11707463.html.plaintext.txt	389	whereas cal overexpression inhibited cftr currents fig
0.44482413.11707463.html.plaintext.txt	390	6 c d g restored nhe rf expressed along cal cftr fig
0.44482413.11707463.html.plaintext.txt	391	addition nhe rf alone cftr affect cftr currents fig
0.44482413.11707463.html.plaintext.txt	392	shown nhe rf certain conditions enhance open probability cftr excised patches stimulation diminished expression nhe rf high 19
0.44482413.11707463.html.plaintext.txt	393	6 gfp tagged cftr ha tagged nhe rf cotransfected ratio 11 weight
0.44482413.11707463.html.plaintext.txt	394	also co transfected gfp cftr nhe rf ratio 13 weight observed results data shown
0.44482413.11707463.html.plaintext.txt	395	clearly effect nhe rf restoring cftr currents cells overexpressing cal parallels restoration cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	396	cal nhe rf bind pdz binding motif c terminus cftr tested whether nhe rf competes cal binding cftr
0.44482413.11707463.html.plaintext.txt	397	co transfected ha tagged cal nhe rf together gfp cftr cos7 cells immunoprecipitated gfp cftr
0.44482413.11707463.html.plaintext.txt	398	indeed binding cal cftr substantially reduced co expression nhe rf fig
0.44482413.11707463.html.plaintext.txt	399	densitometry analysis indicated co expression nhe rf reduced binding cal cftr 70
0.44482413.11707463.html.plaintext.txt	400	ratio cal nhe rf 14
0.44482413.11707463.html.plaintext.txt	401	3 lysate cells co express two proteins lane 3 bottom panel
0.44482413.11707463.html.plaintext.txt	402	data suggest nhe rf reverses inhibitory effect cal competing cal binding cftr
0.44482413.11707463.html.plaintext.txt	403	discussion top abstract introduction experimental procedures results discussion references
0.44482413.11707463.html.plaintext.txt	404	identified golgi cftr interacting protein cal plays role regulating plasma membrane expression cftr
0.44482413.11707463.html.plaintext.txt	405	cal first pdz domain protein identified regulates trafficking cftr
0.44482413.11707463.html.plaintext.txt	406	biochemical evidence suggests cal exist multimer mediated domains n terminal region
0.44482413.11707463.html.plaintext.txt	407	cal form clusters cftr within cell overexpressed suggesting multimers cal may tether one cftr within cell mechanism regulate export plasma membrane
0.44482413.11707463.html.plaintext.txt	408	consistent data overexpression cal suppresses cftr expression cell surface
0.44482413.11707463.html.plaintext.txt	409	contrast effect cftr cal affect vsvg surface expression see fig
0.44482413.11707463.html.plaintext.txt	410	8c p glycoprotein expression proteins sort plasma membrane c terminal pdz interacting domains
0.44482413.11707463.html.plaintext.txt	411	cal also affect surface expression cftrtrl eliminating possibility inhibition surface expression due simply nonspecific effect protein overexpression
0.44482413.11707463.html.plaintext.txt	412	thus role cal restricted proteins cftr c terminal pdz domains capable binding cal
0.44482413.11707463.html.plaintext.txt	413	given wide distribution cal many tissues likely cal regulate surface expression molecules cftr long c terminal domain capable binding cal
0.44482413.11707463.html.plaintext.txt	414	although cal located primarily located within golgi also found plasma membrane may also function fig
0.44482413.11707463.html.plaintext.txt	415	cal contains two putative coiled coil domains play role membrane association
0.44482413.11707463.html.plaintext.txt	416	coiled coil domains found snare proteins large number golgi resident proteins
0.44482413.11707463.html.plaintext.txt	417	recently shown cal bind q snare protein syntaxin 6 protein whose primary function unknown 31
0.44482413.11707463.html.plaintext.txt	418	likely coiled coil domains cal may mediate interactions multiple golgi proteins
0.44482413.11707463.html.plaintext.txt	419	cal overexpression also reduces rate appearance cftr plasma membrane suggesting cal may reduce anterograde trafficking cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	420	cal also reduces half life cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	421	least two possible scenarios explain cal may interact cftr
0.44482413.11707463.html.plaintext.txt	422	first cal may part anterograde trafficking complex controls cftr movement er golgi plasma membrane
0.44482413.11707463.html.plaintext.txt	423	cal two coiled coil domains may tether cftr golgi requisite step moving cftr cell surface
0.44482413.11707463.html.plaintext.txt	424	overexpression cal may disrupt stoichiometry anterograde trafficking complex favor retention cal cftr complex golgi
0.44482413.11707463.html.plaintext.txt	425	second cal may also regulate retrograde trafficking cftr golgi er perhaps promote recycling cftr er degradation
0.44482413.11707463.html.plaintext.txt	426	thus cal like pdz protein grasp 5565 may play role vesicle budding cargo selection er golgi golgi membrane transport 35 36
0.44482413.11707463.html.plaintext.txt	427	8a overexpression cal enhances er localized immature core glycosylated form cftr band b localized er
0.44482413.11707463.html.plaintext.txt	428	role cal tether cftr golgi promotes cftr trafficking plasma membrane clearly majority cal located within golgi yet also found near plasma membrane fig
0.44482413.11707463.html.plaintext.txt	429	also membrane biotinylated cftr co immunoprecipitated cal data shown indicating cal cftr complexes travel plasma membrane
0.44482413.11707463.html.plaintext.txt	430	unlike cal pdz domain proteins nhe rf e3karp associated plasma membrane 12 suggesting play key role function cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	431	data show cal overexpressed cftr trafficking plasma membrane reduced suppression reversed nhe rf
0.44482413.11707463.html.plaintext.txt	432	hypothesize cal abundant golgi binding cftr cal may favored
0.44482413.11707463.html.plaintext.txt	433	cal cftr complex traffics plasma membrane nhe rf abundant cftr may bind nhe rf tethers cftr actin based cytoskeleton
0.44482413.11707463.html.plaintext.txt	434	tethering cftr plasma membrane increases half life cftr plasma membrane resulting apical polarization cftr
0.44482413.11707463.html.plaintext.txt	435	2 overexpression cal increases expression golgi plasma membrane data shown shifting stoichiometry interaction cftr nhe rf toward cal decreasing half life cftr plasma membrane
0.44482413.11707463.html.plaintext.txt	436	data answer critical question one pdz domain protein interacts cftr
0.44482413.11707463.html.plaintext.txt	437	least cal nhe rf show concentrated different locations within cell transiently interact likely within plasma membrane regulate surface expression cftr
0.44482413.11707463.html.plaintext.txt	438	thus regulation two pdz domain proteins may allow precise regulation cftr surface expression
0.44482413.11707463.html.plaintext.txt	439	membrane proteins found bind multiple pdz domain proteins
0.44482413.11707463.html.plaintext.txt	440	example c termini glur23 subunits ampa receptors bind gripabp contains 7 pdz domains 37 pick1 contains single pdz domain well domain interacts protein kinase c 38
0.44482413.11707463.html.plaintext.txt	441	phosphorylation c terminus glur2 protein kinase c prevents binding grip pick1 may contribute protein kinase c induced rapid internalization surface glur2 subunits 39
0.44482413.11707463.html.plaintext.txt	442	likewise c terminus 1 adrenergic receptor binds pair pdz proteins psd 95 magi 2 40 41
0.44482413.11707463.html.plaintext.txt	443	although agonist induced internalization 1 adrenergic receptor attenuated psd 95 co expression markedly increased co expression magi 2 41
0.44482413.11707463.html.plaintext.txt	444	reports well present findings support notion multiple pdz domain proteins interact short c terminus membrane protein regulate function
0.44482413.11707463.html.plaintext.txt	445	precise mechanism cal may hand cftr nhe rf remains unknown
0.44482413.11707463.html.plaintext.txt	446	clear whether driven strictly mass balance affinity combination two
0.44482413.11707463.html.plaintext.txt	447	co expression system nhe rf expression 4
0.44482413.11707463.html.plaintext.txt	448	conditions nhe rf may sufficiently compete cal cftr binding strictly mass action
0.44482413.11707463.html.plaintext.txt	449	immunofluorescence localization studies suggested cftr present apical membrane subapical vesicles 42
0.44482413.11707463.html.plaintext.txt	450	findings confirmed cryoimmunogold electron microscopy 43
0.44482413.11707463.html.plaintext.txt	451	translocation cftr intracellular pool plasma membrane may regulated protein kinase observed investigators 44 45 others 23 46
0.44482413.11707463.html.plaintext.txt	452	possible cal may pass cftr nhe rf subapical vesicles
0.44482413.11707463.html.plaintext.txt	453	important determine endogenous levels cal nhe rf cftr binding proteins locations well relative affinity cftr native tissues express cftr
0.44482413.11707463.html.plaintext.txt	454	likely data together regulation protein kinase andor physiological pathophysiological stimuli provide comprehensive understanding cftr trafficking regulation different native tissues
0.44482413.11707463.html.plaintext.txt	455	summary identified novel cftr interacting protein cal plays role surface expression cftr
0.44482413.11707463.html.plaintext.txt	456	recent evidence suggests f508 cftr escapes er early secretory pathway
0.44482413.11707463.html.plaintext.txt	457	understanding role interacting proteins cal cftr trafficking may prove useful devising strategies increase plasma membrane expression f508 cftr
0.44482413.11707463.html.plaintext.txt	458	wide tissue distribution cal suggests may important trafficking ion channels receptors c terminal sequences similar cftr
0.44482413.11707463.html.plaintext.txt	459	hubbard peying fong critical reading manuscript
0.44482413.11707463.html.plaintext.txt	460	work supported cystic fibrosis foundation research development programs w
0.44482413.11707463.html.plaintext.txt	461	national institutes health grants dk 48977 w
0.44482413.11707463.html.plaintext.txt	462	costs publication article defrayed part payment page charges
0.44482413.11707463.html.plaintext.txt	463	article must therefore hereby marked advertisement accordance 18 u
0.44482413.11707463.html.plaintext.txt	464	section 1734 solely indicate fact
0.44482413.11707463.html.plaintext.txt	465	nucleotide sequences reported paper submitted genbanktmebi data bank accession numbers af450008
0.44482413.11707463.html.plaintext.txt	466	correspondence addressed dept
0.44482413.11707463.html.plaintext.txt	467	physiology johns hopkins university school medicine baltimore md 21205
0.44482413.11707463.html.plaintext.txt	468	410 955 7166 fax 410 955 0461 e mail wgugginobs
0.44482413.11707463.html.plaintext.txt	469	published jbc papers press november 13 2001 doi 10
0.44482413.11707463.html.plaintext.txt	470	stanton unpublished observations
0.44482413.11707463.html.plaintext.txt	471	abbreviations used cftr cystic fibrosis transmembrane conductance regulator cal cftr associated ligand nhe rf nah exchanger regulatory factor vsvg vesicular stomatitis virus glycoprotein pdz psd 95dlgzo 1 gfp green fluorescence protein ha hemagglutinin gst glutathione transferase bfa brefeldin cpt camp 8 chlorophenyl thio camp dtt dithiothreitol mercaptoethanol ez link sulfo nhs ss biotin sulfosuccinimidyl 2 biotin amidoethyl 13 dithiopropionate tbs tris buffered saline pbs phosphate buffered saline er endoplasmic reticulum aa amino acids 3 3 amino 124 triazole dmem dulbeccos modified eagles medium fcs fetal calf serum mdck madin darby canine kidney cells ngs normal goat serum ps pipette solution tgn trans golgi network ergic er golgi intermediate compartment dids 44 diisothiocyanatostilbene 22 disulfonic acid
0.44482413.11707463.html.plaintext.txt	472	references top abstract introduction experimental procedures results discussion references 1
0.44482413.11707463.html.plaintext.txt	473	1989 science 245 1066 1073medline order article via infotrieve 2
0.44482413.11707463.html.plaintext.txt	474	1989 science 245 1059 1065medline order article via infotrieve 3
0.44482413.11707463.html.plaintext.txt	475	79 s23 s45medline order article via infotrieve 4
0.44482413.11707463.html.plaintext.txt	476	79 s145 s166medline order article via infotrieve 5
0.44482413.11707463.html.plaintext.txt	477	1999 cell 96 607 610medline order article via infotrieve 6
0.44482413.11707463.html.plaintext.txt	478	79 s167 s173medline order article via infotrieve 7
0.44482413.11707463.html.plaintext.txt	479	104 1353 1361abstractfree full text 8
0.44482413.11707463.html.plaintext.txt	480	275 27069 27074abstractfree full text 9
0.44482413.11707463.html.plaintext.txt	481	1998 cell 94 691 694medline order article via infotrieve 10
0.44482413.11707463.html.plaintext.txt	482	97 11135 11136free full text 11
0.44482413.11707463.html.plaintext.txt	483	24 1 29crossrefmedline order article via infotrieve 12
0.44482413.11707463.html.plaintext.txt	484	273 19797 19801abstractfree full text 13
0.44482413.11707463.html.plaintext.txt	485	427 103 108crossrefmedline order article via infotrieve 14
0.44482413.11707463.html.plaintext.txt	486	95 2143 2149medline order article via infotrieve 15
0.44482413.11707463.html.plaintext.txt	487	16 35 43abstractfree full text 16
0.44482413.11707463.html.plaintext.txt	488	275 14360 14366abstractfree full text 17
0.44482413.11707463.html.plaintext.txt	489	275 29539 29546abstractfree full text 18
0.44482413.11707463.html.plaintext.txt	490	2000 cell 103 169 179medline order article via infotrieve 19
0.44482413.11707463.html.plaintext.txt	491	98 1300 1305abstractfree full text 20
0.44482413.11707463.html.plaintext.txt	492	2000 traffic 1 852 870crossrefmedline order article via infotrieve 21
0.44482413.11707463.html.plaintext.txt	493	1989 nature 340 245 246crossrefmedline order article via infotrieve 22
0.44482413.11707463.html.plaintext.txt	494	4 313 319medline order article via infotrieve 23
0.44482413.11707463.html.plaintext.txt	495	273 21759 21768abstractfree full text 24
0.44482413.11707463.html.plaintext.txt	496	1990 cell 63 827 834medline order article via infotrieve 25
0.44482413.11707463.html.plaintext.txt	497	cell physiol 279 c1016 c1023abstractfree full text 27
0.44482413.11707463.html.plaintext.txt	498	genome 7 563 574crossrefmedline order article via infotrieve 28
0.44482413.11707463.html.plaintext.txt	499	157 105 132medline order article via infotrieve 29
0.44482413.11707463.html.plaintext.txt	500	25 3389 3402abstractfree full text 31
0.44482413.11707463.html.plaintext.txt	501	276 29456 29465abstractfree full text 32
0.44482413.11707463.html.plaintext.txt	502	1991 science 252 1162 1164medline order article via infotrieve 33
0.44482413.11707463.html.plaintext.txt	503	263 18545 18552abstractfree full text 34
0.44482413.11707463.html.plaintext.txt	504	18 4949 4960abstractfree full text 36
0.44482413.11707463.html.plaintext.txt	505	19 6427 6439abstractfree full text 37
0.44482413.11707463.html.plaintext.txt	506	1997 nature 386 279 284crossrefmedline order article via infotrieve 38
0.44482413.11707463.html.plaintext.txt	507	1999 neuron 22 179 187medline order article via infotrieve 39
0.44482413.11707463.html.plaintext.txt	508	20 7258 7267abstractfree full text 40
0.44482413.11707463.html.plaintext.txt	509	276 41310 41317abstractfree full text 41
0.44482413.11707463.html.plaintext.txt	510	275 38659 38666abstractfree full text 42
0.44482413.11707463.html.plaintext.txt	511	267 c1 c24abstractfree full text 43
0.44482413.11707463.html.plaintext.txt	512	114 219 228medline order article via infotrieve 44
0.44482413.11707463.html.plaintext.txt	513	271 4381 4387abstractfree full text 45
0.44482413.11707463.html.plaintext.txt	514	109 1325 1334abstractfree full text 46
0.44482413.11707463.html.plaintext.txt	515	264 c491 c498abstractfree full text
0.44482413.11707463.html.plaintext.txt	516	copyright 2002 american society biochemistry molecular biology inc
0.4183819.11087715.html.plaintext.txt	0	characterization oligosaccharide structures associated cystic fibrosis transmembrane conductance regulator catherine r
0.4183819.11087715.html.plaintext.txt	1	lachapelle john marshall elizabeth
0.4183819.11087715.html.plaintext.txt	2	genzyme corporation 31 new york avenue framingham ma 01701 9322 usa
0.4183819.11087715.html.plaintext.txt	3	received april 26 2000 revised june 26 2000 accepted june 26 2000
0.4183819.11087715.html.plaintext.txt	4	abstract top abstract introduction results discussion material methods acknowledgments abbreviations references cystic fibrosis transmembrane conductance regulator cftr plasma membrane associated glycoprotein
0.4183819.11087715.html.plaintext.txt	5	protein exist three different molecular weight forms approximately 127 131 160 kda representing either nonglycosylated core glycosylated fully mature complex glycosylated cftr respectively
0.4183819.11087715.html.plaintext.txt	6	common mutation cystic fibrosis cf results synthesis variant f508 cftr incompletely glycosylated defective trafficking cell surface
0.4183819.11087715.html.plaintext.txt	7	study analyzed oligosaccharide structures associated different forms recombinant cftr expressing purifying channel protein either mammalian chinese hamster ovary cho insect sf9 cells
0.4183819.11087715.html.plaintext.txt	8	using glycosidases face analysis fluorophore assisted carbohydrate electrophoresis determined purified cho cftr contained polylactosaminoglycan pl sequences sf9 cftr oligomannosidic saccharides fucosylation innermost glcnac
0.4183819.11087715.html.plaintext.txt	9	presence pl sequences recombinant cho cftr consistent normal feature mammalian processing since endogenous cftr isolated t84 cells displayed similar pattern glycosylation
0.4183819.11087715.html.plaintext.txt	10	present study also reports use face qualitative analysis small amounts glycoprotein oligosaccharides released enzymatically
0.4183819.11087715.html.plaintext.txt	11	key words cftrface analysis polylactosaminoglycansoligomannosidic saccharides
0.4183819.11087715.html.plaintext.txt	12	introduction top abstract introduction results discussion material methods acknowledgments abbreviations references cystic fibrosis cf caused mutations gene encoding cystic fibrosis transmembrane conductance regulator cftr boat et al
0.4183819.11087715.html.plaintext.txt	13	patients cf marked dysfunctional epithelia due absence functional cftr chloride cl channels apical plasma membranes affected cells
0.4183819.11087715.html.plaintext.txt	14	studies shown cftr membrane associated glycoprotein whose cl channel activity regulated protein kinase mediated phosphorylation cheng et al
0.4183819.11087715.html.plaintext.txt	15	electrophoretic analysis indicated cftr exist three different molecular weight forms approximately 127 kda 131 kda 160 kda referred bands b c respectively gregory et al
0.4183819.11087715.html.plaintext.txt	16	bands b c represent different glycoforms cftr band representing nonglycosylated cftr band b representing core glycosylated cftr band c representing mature cftr complex glycosylation cheng et al
0.4183819.11087715.html.plaintext.txt	17	posttranslational modifications cftr may represent important marker protein processing cheng et al
0.4183819.11087715.html.plaintext.txt	18	presence core glycosylated band b cftr example indicates processing protein endoplasmic reticulum er mature band c cftr complex glycosylation representative processing golgi cheng et al
0.4183819.11087715.html.plaintext.txt	19	significance cftr glycosylation understood best however studying mutant f508 cftr
0.4183819.11087715.html.plaintext.txt	20	deletion phenylalanine residue position 508 f508 cftr common cause cystic fibrosis boat et al
0.4183819.11087715.html.plaintext.txt	21	37 degrees c mutant f508 cftr synthesized predominantly bands b suggesting variant protein unable traffic normally golgi apparatus cheng et al
0.4183819.11087715.html.plaintext.txt	22	reason cftr chloride channels detected
0.4183819.11087715.html.plaintext.txt	23	however processing recombinant f508 cftr revert towards wild type cftr incubation temperature cells reduced 26 degrees c denning et al
0.4183819.11087715.html.plaintext.txt	24	lower temperature cftr becomes fully processed presented plasma membrane evidenced appearance small amounts mature band c cftr detection camp regulated cl channel activity cell surface denning et al
0.4183819.11087715.html.plaintext.txt	25	studies relationship glycosylation function cftr suggest addition carbohydrate cftr necessary prerequisite protein target plasma membrane function camp stimulated cl channel gregory et al
0.4183819.11087715.html.plaintext.txt	26	1993 however determining oligosaccharide structures associated cftr contribute better understanding structure complex transmembrane protein influence f508 cftr cell membrane glycoproteins
0.4183819.11087715.html.plaintext.txt	27	study analyzed pattern glycosylation different forms cftr oriordan et al
0.4183819.11087715.html.plaintext.txt	28	1995 expressing channel protein either mammalian insect cells
0.4183819.11087715.html.plaintext.txt	29	show pattern glycosylation recombinant cftr expressed mammalian cell systems representative occurs endogenous cftr cftr expressed insect cells fully processed
0.4183819.11087715.html.plaintext.txt	30	results top abstract introduction results discussion material methods acknowledgments abbreviations references different glycosylation forms cftr expressed mammalian insect cells two types mammalian cells cho chinese hamster ovary c127 mouse mammary adenocarcinoma insect cell line sf9 used overexpression human cftr marshall et al
0.4183819.11087715.html.plaintext.txt	31	different glycosylation forms cftr bands b c expressed varying levels depending cell type used
0.4183819.11087715.html.plaintext.txt	32	cftr prepared lysates recombinant c127 cho cells predominantly fully mature band c form 160 kda minor component band b figure 1a lane 2 figure 1b lane 3
0.4183819.11087715.html.plaintext.txt	33	however cftr prepared recombinant sf9 insect cells appeared predominantly 131 kda polypeptide figure 1b lane 2 similar size band b form observed mammalian cells figure 1a lane 2
0.4183819.11087715.html.plaintext.txt	34	expected since proteins expressed sf9 cells reported harbor solely oligomannosidic glycosylation vialard et al
0.4183819.11087715.html.plaintext.txt	35	studies oligosaccharide structures wild type cftr performed using cftr purified sources
0.4183819.11087715.html.plaintext.txt	36	view larger version 26k fig
0.4183819.11087715.html.plaintext.txt	37	expression cftr different cell types
0.4183819.11087715.html.plaintext.txt	38	autoradiographs immunoprecipitated cftr transfected c127 cells b cho sf9 cells
0.4183819.11087715.html.plaintext.txt	39	cftr labeled phosphorylation 32p atp catalytic subunit camp dependent pka electrophoresed 6 sds polyacrylamide gels
0.4183819.11087715.html.plaintext.txt	40	bands b c represent core glycosylated fully glycosylated cftr respectively
0.4183819.11087715.html.plaintext.txt	41	lane 1 mock transfected c127 cells lane 2 c127 cells transfected wild type cftr lane 3 c127 cells transfected f508 cftr
0.4183819.11087715.html.plaintext.txt	42	b lane 1 uninfected sf9 cells lane 2 sf9 cells infected wild type cftr baculovirus lane 3 cho cells transfected wild type cftr lane 4 parental cho cells
0.4183819.11087715.html.plaintext.txt	43	fractionation bands b c forms cftr lectin affinity chromatography since bands b c forms cftr differed carbohydrate content could fractionated purified lectin affinity chromatography
0.4183819.11087715.html.plaintext.txt	44	lectin wheat germ agglutinin specifically recognizes n acetylglucosamine residues nagata burger 1974 present complex carbohydrate glycoproteins therefore could used separate band c cftr contains complex carbohydrate structures band b cftr contains oligomannose structures
0.4183819.11087715.html.plaintext.txt	45	shown figure 2 chromatography t84 cell lysates wheat germ agglutinin sepharose resulted retention band c band b form cftr
0.4183819.11087715.html.plaintext.txt	46	bound band c form cftr could recovered resin highly purified form elution buffer containing 0
0.4183819.11087715.html.plaintext.txt	47	5 m n acetylglucosamine figure 2 lanes 3 4
0.4183819.11087715.html.plaintext.txt	48	similarly insect sf9 derived cftr synthesized predominantly band b species cftr failed bind wheat germ agglutinin sepharose data shown
0.4183819.11087715.html.plaintext.txt	49	results consistent band b cftr containing core glycosylation band c cftr containing carbohydrates complex type cheng et al
0.4183819.11087715.html.plaintext.txt	50	view larger version 52k fig
0.4183819.11087715.html.plaintext.txt	51	affinity chromatography cho cftr using wheat germ agglutinin
0.4183819.11087715.html.plaintext.txt	52	t84 cells expressing cftr lysed 1 chapso applied onto wheat germ lectin sepharose
0.4183819.11087715.html.plaintext.txt	53	bound proteins eluted resin 0
0.4183819.11087715.html.plaintext.txt	54	column fractions immunoprecipitated mab 13 1 phosphorylated presence 32p atp catalytic subunit protein kinase
0.4183819.11087715.html.plaintext.txt	55	lane 1 represents load lane 2 flow lanes 3 4 represent band c cftr specifically eluted 0
0.4183819.11087715.html.plaintext.txt	56	characterization cho cftr using glycosidases n glycanase endo ss galactosidase digestion purified band c cftr 160 kda cho cells n glycanase cleaves n linked oligosaccharides oligosaccharide structure asparagine residue resulted reduction size protein observed band cftr 127 kda indicating mature band c cftr modified n linked glycosylation figure 3 lane 2
0.4183819.11087715.html.plaintext.txt	57	cftr membrane glycoprotein also determined whether harbored polylactosamine carbohydrate structures known associated class glycoproteins gahmberg et al
0.4183819.11087715.html.plaintext.txt	58	indeed digestion purified band c cftr endo ss galactosidase hydrolyzes polylactosamine containing structures reduced size 131 kda figure 3 lane 3 arguing presence structures cftr
0.4183819.11087715.html.plaintext.txt	59	additional digestion endo ss galactosidase treated band c n glycanase resulted reduction size band figure 3 lane 4
0.4183819.11087715.html.plaintext.txt	60	view larger version 36k fig
0.4183819.11087715.html.plaintext.txt	61	endo ss galactosidase n glycanase digestion cho cftr
0.4183819.11087715.html.plaintext.txt	62	purified band c cftr cho cells lane 1 digested n glycanase lane 2 endo ss galactosidase alone lane 3 endo ss galactosidase followed n glycanase lane 4
0.4183819.11087715.html.plaintext.txt	63	samples separated 6 sds polyacrylamide gels followed coomassie blue staining
0.4183819.11087715.html.plaintext.txt	64	characterization cho cftr using lectin blots characterization structure n linked oligosaccharides present band c cftr purified cho cells performed using lectin blots
0.4183819.11087715.html.plaintext.txt	65	two lectins used dsa datura stramonium agglutinin maa maackia amurensis agglutinin
0.4183819.11087715.html.plaintext.txt	66	dsa known bind unbranched yamashita et al
0.4183819.11087715.html.plaintext.txt	67	1987 branched polylactosamine sequences fukuda fukuda 1984 oligosaccharides containing outer mannose residue substituted gal ss 14 glcnac c 2 c 6 positions cummings et al
0.4183819.11087715.html.plaintext.txt	68	1982 cummings kornfeld 1984 merkle cummings 1987
0.4183819.11087715.html.plaintext.txt	69	lectin maa recognizes sialic acid linked either 2 3 2 6 galactose haseley et al
0.4183819.11087715.html.plaintext.txt	70	since cho cells unable effect 2 6 sialylation carr et al
0.4183819.11087715.html.plaintext.txt	71	1989 predicted cho cftr sialylated would 2 3 type
0.4183819.11087715.html.plaintext.txt	72	indeed confirmed band c cftr isolated cho cells failed react sna sambucus nigra agglutinin lectin recognizes specifically 2 6 sialic acids haseley et al
0.4183819.11087715.html.plaintext.txt	73	figure 4 shows band c cftr reacted strongly lectin dsa weakly maa
0.4183819.11087715.html.plaintext.txt	74	however following treatment endo ss galactosidase marked decrease reactivity digested cftr lectins figure 4
0.4183819.11087715.html.plaintext.txt	75	observation treatment cftr endo ss galactosidase greatly reduced ability bind dsa coupled demonstration band c cftr sensitive endo ss galactosidase digestion indicate mature cho cftr comprised predominantly polylactosamine structures
0.4183819.11087715.html.plaintext.txt	76	cftr also reacted albeit weakly maa suggests presence sialic acid residues polylactosamine chains
0.4183819.11087715.html.plaintext.txt	77	view larger version 44k fig
0.4183819.11087715.html.plaintext.txt	78	endo ss galactosidase treatment cftr followed lectin blotting
0.4183819.11087715.html.plaintext.txt	79	immunoaffinity purified band c cftr cho cells treated endo ss galactosidase described materials methods transferred nitrocellulose probed using either lectin dsa datura stramonium agglutinin maa mackia amurensis agglutinin
0.4183819.11087715.html.plaintext.txt	80	position cftr indicated
0.4183819.11087715.html.plaintext.txt	81	refers cftr treated endo ss galactosidase untreated samples
0.4183819.11087715.html.plaintext.txt	82	face analysis oligosaccharides released following digestion band c cftr glycosidases structure oligosaccharides released n glycanase endo ss galactosidase digestion band c cftr isolated cho cells assessed relatively simple rapid method called face fluorophore assisted carbohydrate electrophoresis friedman higgins 1994
0.4183819.11087715.html.plaintext.txt	83	face 8 aminonaphthalene 136 trisulfonic acid ants covalently linked high efficiency reductive amination reducing end oligosaccharides jackson 1990
0.4183819.11087715.html.plaintext.txt	84	resulting ants oligosaccharide conjugates fluorescence emission properties conjugates electrophoretically resolved high density polyacrylamide gels detectable low picomole levels
0.4183819.11087715.html.plaintext.txt	85	case neutral oligosaccharides ants labeling also confers charge labeled conjugate
0.4183819.11087715.html.plaintext.txt	86	figure 5 shows fluorescent band patterns ants labeled oligosaccharides released band c cftr following digestion either n glycanase figure 5a endo ss galactosidase figure 5b
0.4183819.11087715.html.plaintext.txt	87	oligosaccharides released cftr treatment n glycanase alone co migrated trisialo triantennary asialo tetraantennary oligosaccharide standards
0.4183819.11087715.html.plaintext.txt	88	n glycanase released oligosaccharides neuraminidase treated band c cftr slower mobility migrated asialo biantennary asialo tetraantennary oligosaccharide standards data shown
0.4183819.11087715.html.plaintext.txt	89	slower mobility due removal sialic acid neuraminidase affects charge released oligosaccharides
0.4183819.11087715.html.plaintext.txt	90	data suggests oligosaccharide structures present mature cftr larger tetra antennary type
0.4183819.11087715.html.plaintext.txt	91	analyze nature oligosaccharide chains face analysis also performed oligosaccharides released endo ss galactosidase treatment band c cftr
0.4183819.11087715.html.plaintext.txt	92	predicted molecular size oligosaccharides released endo ss galactosidase digestion low molecular weight figure 5b consistent release sialylated lactosamines figure 5b
0.4183819.11087715.html.plaintext.txt	93	view larger version 33k fig
0.4183819.11087715.html.plaintext.txt	94	face analysis oligosaccharides released band c cho cftr
0.4183819.11087715.html.plaintext.txt	95	immunoaffinity purified band c cftr cho cells separated 4 20 gradient polyacrylamide gel transferred onto immobilon stained using amido black
0.4183819.11087715.html.plaintext.txt	96	cftr protein bands excised immobilon treated either n glycanase endo ss galactosidase b
0.4183819.11087715.html.plaintext.txt	97	oligosaccharides released labeled using ants analyzed high density polyacrylamide gel
0.4183819.11087715.html.plaintext.txt	98	lanes 1 standards 2 control enzyme alone 3 oligosaccharides released glycosidase digestion
0.4183819.11087715.html.plaintext.txt	99	structural representations oligosaccharide standards glycosylation pattern cftr produced insect sf9 cells shown insect glycoproteins like cell systems first synthesized attached high mannose oligosaccharide asn glcnac2 man9 glc3 hsieh robbins 1984
0.4183819.11087715.html.plaintext.txt	100	oligosaccharide structures sensitive endoglycosidase h removes sugars high mannose glycoprotein leaving one molecule n acetylglucosamine attached asparagine
0.4183819.11087715.html.plaintext.txt	101	analyses n glycans isolated endogenous recombinant glycoproteins expressed insect cells revealed innermost n acetylglucosamine subject fucosylation jarvis summers 1989 kuroda et al
0.4183819.11087715.html.plaintext.txt	102	case n linked glycans processing lead formation proteins trimannosyl core asn glcnac2 man3
0.4183819.11087715.html.plaintext.txt	103	conflicting reports whether insect cells necessary enzymes processing high mannose carbohydrates complex type oligosaccharides
0.4183819.11087715.html.plaintext.txt	104	case cftr example expression insect sf9 cells results expression endoglycosidase h sensitive band b data shown
0.4183819.11087715.html.plaintext.txt	105	characterize glycosylation analyzed oligosaccharides released endoglycosidase h n glycanase digestion sf9 cftr using face
0.4183819.11087715.html.plaintext.txt	106	figure 6 lane 2 shows pattern ants labeled oligosaccharides released upon digestion sf9 cftr endoglycosidase h
0.4183819.11087715.html.plaintext.txt	107	oligosaccharides released co migrated oligomannose standards figure 6 table ib confirming sf9 cftr contained endoglycosidase h sensitive oligomannose glycosylation
0.4183819.11087715.html.plaintext.txt	108	oligosaccharides released endo h migrate faster indicated standards since endo h leaves glcnac residue attached asparagine glycoprotein
0.4183819.11087715.html.plaintext.txt	109	interestingly insect cftr digested n glycanase releases complex high mannose oligosaccharide structures main oligosaccharide released electrophoretic mobility slightly slower man3 consistent presence fucosylated man3 figure 6 lane 1
0.4183819.11087715.html.plaintext.txt	110	structure likely fucosylated 1 6 linkage since 1 3 fucosylation inhibits n glycanase tretter et al
0.4183819.11087715.html.plaintext.txt	111	endo h cannot release either 1 3 1 6 fucosylated structures trimble maley 1984 explains several bands visible endo h lane one band predominates n glycanase lane
0.4183819.11087715.html.plaintext.txt	112	pattern glycosylation similar reported kuroda et al
0.4183819.11087715.html.plaintext.txt	113	1990 influenza virus hemagglutinin expressed insect cells
0.4183819.11087715.html.plaintext.txt	114	result also consistent fact fucosylation insect oligosaccharides occurs innermost n acetylglucosamine released n glycanase treatment remains attached peptide endoglycosidase h digestion
0.4183819.11087715.html.plaintext.txt	115	view larger version 49k fig
0.4183819.11087715.html.plaintext.txt	116	face analysis oligosaccharides released sf9 cftr
0.4183819.11087715.html.plaintext.txt	117	oligosaccharides released either endoglycosidase h n glycanase digestion sf9 cftr ants labeled analyzed polyacrylamide gel electrophoresis
0.4183819.11087715.html.plaintext.txt	118	lane 1 contains ants labeled oligosaccharides released n glycanase digestion sf9 cftr lane 2 ants labeled oligosaccharides released endoglycosidase h digestion sf9 cftr lane 3 glucose polymer standards
0.4183819.11087715.html.plaintext.txt	119	migration oligosaccharide standards man3 man9 man3f also indicated
0.4183819.11087715.html.plaintext.txt	120	comparison recombinant nonrecombinant forms cftr would therefore appear distinct differences pattern glycosylation cftr depending cell system used express protein
0.4183819.11087715.html.plaintext.txt	121	mature cftr cho cells example showed unusual polylactosamine structures contrast oligomannose glycosylation observed sf9 cftr
0.4183819.11087715.html.plaintext.txt	122	examine whether presence polylactosamine glycosylation feature recombinant cftr expressed cho cells truly represent type glycosylation occurs endogenous cftr non recombinant cftr expressed t84 cells characterized
0.4183819.11087715.html.plaintext.txt	123	address issue cftr t84 cho sf9 cells digested n glycanase figure 7
0.4183819.11087715.html.plaintext.txt	124	digestion band c cftr isolated t84 cells n glycanase generated protein apparent molecular weight 127 kda band
0.4183819.11087715.html.plaintext.txt	125	thus mature cftr expressed t84 cells digested n glycanase comigrated product n glycanase digestion mature cftr cho cells figure 7
0.4183819.11087715.html.plaintext.txt	126	large reduction molecular weight n glycanase digestion t84 cftr suggests t84 cftr also likely contained polylactosamine glycosylation
0.4183819.11087715.html.plaintext.txt	127	furthermore t84 cftr showed molecular weight shift cho cftr upon digestion endo ss galactosidase figure 8
0.4183819.11087715.html.plaintext.txt	128	suggests type glycosylation observed recombinant cho cftr probably representative type glycosylation occurs nonrecombinant forms cftr
0.4183819.11087715.html.plaintext.txt	129	view larger version 70k fig
0.4183819.11087715.html.plaintext.txt	130	comparison cftr expressed sf9 cho t84 cells
0.4183819.11087715.html.plaintext.txt	131	cell lysates prepared cho t84 sf9 cells immunoprecipitated mab 24 1 anti cftr carboxy terminus antibody
0.4183819.11087715.html.plaintext.txt	132	immunoprecipitates cftr digested glycosidases n glycanase endo ss galactosidase phosphorylated using 32p atp catalytic subunit protein kinase
0.4183819.11087715.html.plaintext.txt	133	labeled digested immunoprecipitates cftr subsequently analyzed 6 sds polyacrylamide gel
0.4183819.11087715.html.plaintext.txt	134	view larger version 45k fig
0.4183819.11087715.html.plaintext.txt	135	endo ss galactosidase digestion cftr t84 cho cells
0.4183819.11087715.html.plaintext.txt	136	band c cftr cho t84 cells immunoprecipitated mab 24 1 anti cftr carboxy terminus antibody digested endo ss galactosidase phosphorylated using 32p atp catalytic subunit protein kinase
0.4183819.11087715.html.plaintext.txt	137	labeled digested immunoprecipitates cftr resolved 6 sds polyacrylamide gel
0.4183819.11087715.html.plaintext.txt	138	discussion top abstract introduction results discussion material methods acknowledgments abbreviations references shown mature band c form cftr expressed cho cells unique pattern glycosylation consisting complex structures n acetyllactosamine repeating units
0.4183819.11087715.html.plaintext.txt	139	evidenced sensitivity digestion n glycanase endo ss galactosidase binding characteristics dsa lectin electrophorectic mobility using face
0.4183819.11087715.html.plaintext.txt	140	occurrence glycoforms necessarily result expression cftr recombinant cell per se since endogenous cftr t84 cells shown similar characteristics
0.4183819.11087715.html.plaintext.txt	141	polylactosaminoglycans pl heterogeneous oligosaccharides distinct common complex type asparagine linked oligosaccharides side chains galss1 4glcnacss1 3 repeats susceptible endo ss galactosidase scudder et al
0.4183819.11087715.html.plaintext.txt	142	importance pl sequences mature fully processed cftr yet unclear
0.4183819.11087715.html.plaintext.txt	143	anion exchanger band 3 major glycoprotein erythrocytes reportedly also contains similar pl structures fukuda 1985 feizi 1985
0.4183819.11087715.html.plaintext.txt	144	speculated beppu 1992 igg autoantibody band 3 human erythrocyte membrane anti band 3 plays role removing senescent damaged erythrocytes circulation recognizing sialylated poly n lactosaminyl sugar chains
0.4183819.11087715.html.plaintext.txt	145	suggested functions poly n lactosaminyl structures band 3 include shielding potential antigenic sites external loops protection protein proteolytic degradation casey 1992
0.4183819.11087715.html.plaintext.txt	146	likewise could presence poly n lactosamine structures cftr may help reduce antigenicity protein maintain channel active form membrane improving stability preventing degraded proteases
0.4183819.11087715.html.plaintext.txt	147	role oligosaccharide chain activity transport proteins extensively studied
0.4183819.11087715.html.plaintext.txt	148	however pl associated structures reported influence processing proper trafficking targeting plasma membrane proteins sites action wang et al
0.4183819.11087715.html.plaintext.txt	149	interestingly effect lowering temperature two important enzymes responsible synthesis pl sequences namely ss1 3 n acetylglucosaminyltransferase ss1 4 galactosyltransferase documented
0.4183819.11087715.html.plaintext.txt	150	shown lamps lysosomal associated membrane glycoproteins expressed hl 60 cells lower temperatures 21 degrees c processed acquire poly n acetyllactosamines lamps produced 37 degrees c wang et al
0.4183819.11087715.html.plaintext.txt	151	attributed longer association lamps golgi compartments ss1 3 n acetylglucosaminyltransferase ss1 4 galactosyltransferase enzymes normally resident
0.4183819.11087715.html.plaintext.txt	152	perhaps observation lowering temperature incubation f508 cftr expressing cells facilitates processing mutant protein band c denning et al
0.4183819.11087715.html.plaintext.txt	153	1992 may due part longer association variant protein golgi complex thereby allowing acquire extended pl structures
0.4183819.11087715.html.plaintext.txt	154	baculovirus expression cftr sf9 insect cell system resulted expression predominantly protein band comigrated band b cftr
0.4183819.11087715.html.plaintext.txt	155	expression band b like cftr sf9 cells consistent earlier reports indicating oligomannose structures contained recombinant proteins expressed insect cell line wojchowski et al
0.4183819.11087715.html.plaintext.txt	156	1987 greenfield 1988 luckow summers 1988 little processing original high mannose oligosaccharide core occurs cells
0.4183819.11087715.html.plaintext.txt	157	using face showed sf9 cftr modified fucosylation innermost n acetylglucosamine residue
0.4183819.11087715.html.plaintext.txt	158	confirms presence fucosyltransferase gene insect cells first reported davidson castellino 1991 demonstrated presence fucose recombinant human plasminogen r hpg expressed sf21 insect cells
0.4183819.11087715.html.plaintext.txt	159	investigators also first demonstrate addition complex carbohydrate structures proteins expressed insect cells could occur specifically dependent infective process employed
0.4183819.11087715.html.plaintext.txt	160	present study cftr expressed sf9 insect cell system oligomannose structures however may possible manipulate nature cftr glycosylation cells altering infective process thus generating fully processed cftr representative endogenously expressed cftr cftr expressed recombinant mammalian cells
0.4183819.11087715.html.plaintext.txt	161	presently unclear whether different glycoforms cftr exhibit different activities
0.4183819.11087715.html.plaintext.txt	162	studies suggested carbohydrate moiety dispensable cftr cl channel activity morris 1993
0.4183819.11087715.html.plaintext.txt	163	mutant cftr altered unable undergo n glycosylation shown retain camp stimulated cl channel activity gregory et al
0.4183819.11087715.html.plaintext.txt	164	similarly sf9 cftr lacks complex oligosaccharide structures also exhibited functional cftr channel activity bear et al
0.4183819.11087715.html.plaintext.txt	165	however studies suggested state glycosylation cftr may affect stability plasma membrane luckas et al
0.4183819.11087715.html.plaintext.txt	166	clearly effect carbohydrate addition structure function cftr requires investigation
0.4183819.11087715.html.plaintext.txt	167	turn may implications development relevant therapies treatment cf patients harboring common form disease
0.4183819.11087715.html.plaintext.txt	168	material methods top abstract introduction results discussion material methods acknowledgments abbreviations references materials face reagents equipment supplied glyko novato ca n glycanase endo ss galactosidase neuraminidase lectin link kit supplied genzyme cambridge ma dig glycan differentiation kit supplied boehringer mannheim wheat germ agglutinin sepharose supplied sigma st
0.4183819.11087715.html.plaintext.txt	169	cell cultures human colon carcinoma cell line t84 obtained american type culture collection atcc ccl 248
0.4183819.11087715.html.plaintext.txt	170	established c127 mouse mammary epitheloid cells cho chinese hamster ovary cells stably transfected human cftr cdna generated maintained described previously marshall et al
0.4183819.11087715.html.plaintext.txt	171	growth infection sf9 cells recombinant cftr expressing viruses also described previously oriordan et al
0.4183819.11087715.html.plaintext.txt	172	purification recombinant cftr cho cells carbohydrate analysis cho cftr immunoaffinity purified using monoclonal antibody mab 13 1 cross linked hydrazide resin essentially described oriordan et al
0.4183819.11087715.html.plaintext.txt	173	briefly cftr solubilized membranes using 1
0.4183819.11087715.html.plaintext.txt	174	5 lyso pc solubilized material incubated resin overnight 4 degrees c
0.4183819.11087715.html.plaintext.txt	175	following extensive washing wash buffer 150 mm nacl 50 mm tris hcl ph 8
0.4183819.11087715.html.plaintext.txt	176	0 1 mm edta 1 sodium cholate remove nonspecifically bound proteins cftr eluted resin using 150 mm naoh 10 glycerol 1 mm edta ph 11
0.4183819.11087715.html.plaintext.txt	177	5 sodium cholate neutralized 0
0.4183819.11087715.html.plaintext.txt	178	treatment endo ss galactosidase n glycanase approximately 100 g immunoaffinity purified cftr neutralized elution buffer 150 mm naoh 10 glycerol 1 mm edta ph 11
0.4183819.11087715.html.plaintext.txt	179	5 sodium cholate buffer neutralized 0
0.4183819.11087715.html.plaintext.txt	180	01 units endo ss galactosidase enzyme 6 h room temperature
0.4183819.11087715.html.plaintext.txt	181	reaction stopped addition sds page sample buffer followed electrophoresis 4 20 gradient gel
0.4183819.11087715.html.plaintext.txt	182	alternatively samples analyzed face reaction stopped evaporating samples dryness using speed vacuum
0.4183819.11087715.html.plaintext.txt	183	n glycanase digestion cftr first denatured adding sodium dodecyl sulfate sds 0
0.4183819.11087715.html.plaintext.txt	184	1 ss mercaptoethanol 50 mm incubating 37 degrees c 5 min
0.4183819.11087715.html.plaintext.txt	185	8 reaction initiated adding 40 units n glycanase genzyme incubating 2 h 37 degrees c
0.4183819.11087715.html.plaintext.txt	186	reactions done neutralized elution buffer described
0.4183819.11087715.html.plaintext.txt	187	reactions stopped evaporation dryness using speed vacuum
0.4183819.11087715.html.plaintext.txt	188	fluorophore assisted carbohydrate electrophoresis face face analysis applied previously described friedman higgins 1994
0.4183819.11087715.html.plaintext.txt	189	carbohydrate moiety cho cftr prepared face analysis first running 100 200 microg immunoaffinity purified material 4 20 sds page gel followed transfer pvdf membrane 10 mm caps 10 methanol ph 11
0.4183819.11087715.html.plaintext.txt	190	conditions electrophoresis described oriordan et al
0.4183819.11087715.html.plaintext.txt	191	1 amido black 20 ethanol background destained 20 ethanol
0.4183819.11087715.html.plaintext.txt	192	destaining membrane kept 50 mm nahpo4 ph 7
0.4183819.11087715.html.plaintext.txt	193	cftr band excised cut small pieces careful let membrane dry
0.4183819.11087715.html.plaintext.txt	194	pieces placed microfuge tube covered approximately 100 200 microl 50 mm nahpo4 ph 7
0.4183819.11087715.html.plaintext.txt	195	carbohydrates removed cftr using n glycanase described
0.4183819.11087715.html.plaintext.txt	196	instances cftr digested neuraminidase prior n glycanase digestion
0.4183819.11087715.html.plaintext.txt	197	briefly membranes rinsed 50 mm nahpo4 ph 5
0.4183819.11087715.html.plaintext.txt	198	5 covered 200 microl 50 mm nahpo4 ph 5
0.4183819.11087715.html.plaintext.txt	199	1 units neuraminidase added reaction allowed proceed overnight room temperature
0.4183819.11087715.html.plaintext.txt	200	fluorescence labeling carbohydrate residues carried 18 h using reagents protocol supplied glyko novato ca
0.4183819.11087715.html.plaintext.txt	201	electrophoresis reagents equipment also supplied glyko
0.4183819.11087715.html.plaintext.txt	202	lectin blots sds page analysis immunoaffinity purified cftr electrophoresed standard conditions transferred nitrocellulose paper described oriordan et al
0.4183819.11087715.html.plaintext.txt	203	dig glycan differentiation kit boehringer mannheim lectin link kit genzyme corp
0.4183819.11087715.html.plaintext.txt	204	lectin blotting performed according manufacturers directions
0.4183819.11087715.html.plaintext.txt	205	immunoprecipitation protein phosphorylation using protein kinase t84 cell lysates prepared treating cells lysis buffer 50 mm tris hcl ph 7
0.4183819.11087715.html.plaintext.txt	206	5 150 mm nacl 1 np 40 1 mm pmsf 5 mm aprotinin
0.4183819.11087715.html.plaintext.txt	207	incubation ice 30 min unlysed cells removed centrifugation 14000g
0.4183819.11087715.html.plaintext.txt	208	cftr immunoprecipitated monoclonal antibody mab 13 1 gregory et al
0.4183819.11087715.html.plaintext.txt	209	1991 immunoprecipitates incubated protein kinase 20 ng 32patp 10 mci final volume 50 microl kinase buffer 50 mm tris hcl ph 7
0.4183819.11087715.html.plaintext.txt	210	5 10 mm mgcl2 100 mgml bovine serum albumin 30 degrees c 50 min
0.4183819.11087715.html.plaintext.txt	211	samples heated 5 min 37 degrees c electrophoresis
0.4183819.11087715.html.plaintext.txt	212	glycosidase digestion immunoprecipitates performed overnight digestion presence enzyme 10 mm sodium phosphate buffer ph 6
0.4183819.11087715.html.plaintext.txt	213	digestion performed prior phosphorylation assay
0.4183819.11087715.html.plaintext.txt	214	wheat germ agglutinin chromatography wheat germ agglutinin sepharose equilibrated phosphate buffered saline
0.4183819.11087715.html.plaintext.txt	215	t84 cell lysates prepared described applied equilibrated wheat germ agglutinin sepharose
0.4183819.11087715.html.plaintext.txt	216	flow fraction collected column washed pbs elution 0
0.4183819.11087715.html.plaintext.txt	217	flow fraction n acetylglucosamine eluate assayed cftr immunoprecipitation monoclonal antibody mab 13 1
0.4183819.11087715.html.plaintext.txt	218	immunoprecipitates incubated protein kinase 32patp 10 mci described labeled proteins analyzed sds page
0.4183819.11087715.html.plaintext.txt	219	acknowledgments top abstract introduction results discussion material methods acknowledgments abbreviations references thank drs
0.4183819.11087715.html.plaintext.txt	220	wadsworth helen romanczuk critical review manuscript
0.4183819.11087715.html.plaintext.txt	221	abbreviations top abstract introduction results discussion material methods acknowledgments abbreviations references ants 8 aminonaphthalene 136 trisulfonic acid caps 3 cyclohexylamino propane sulfonic acid chapso 3 3 cholamidopropyldimethylammonio 2 hydroxy 1 propanesulfonate cho chinese hamster ovary cftr cystic fibrosis transmembrane conductance regulator cf cystic fibrosis face fluorophore assisted carbohydrate electrophoresis page polyacrylamide gel electrophoresis pc phosphatidylcholine pmsf phenylmethylsulfonylfluoride pl polylactosaminoglycans sa sialic acid
0.4183819.11087715.html.plaintext.txt	222	footnotes 1 correspondence addressed
0.4183819.11087715.html.plaintext.txt	223	references top abstract introduction results discussion material methods acknowledgments abbreviations references altmannf
0.4183819.11087715.html.plaintext.txt	224	1993 processing asparagine linked oligosaccharides n acetylglucosaminyltransferase ii activities cultured lepidopteran cells
0.4183819.11087715.html.plaintext.txt	225	1992 purification functional reconstitution cystic fibrosis transmembrane conductance regulator cftr
0.4183819.11087715.html.plaintext.txt	226	1992 antigenic determinants senescent antigen human erythrocytes located sialylated carbohydrate chains band 3 glycoprotein
0.4183819.11087715.html.plaintext.txt	227	metabolic basis inherited diseases
0.4183819.11087715.html.plaintext.txt	228	1989 protein carbohydrate structural analysis recombinant soluble cd4 receptor mass spectrometry
0.4183819.11087715.html.plaintext.txt	229	1992 enzymatic deglycosylation human band 3 anion transport protein erythrocyte membrane
0.4183819.11087715.html.plaintext.txt	230	effect protein structure transport properties
0.4183819.11087715.html.plaintext.txt	231	1991 carbohydrate variant recombinant beta subunit human choriogonadotrophin expressed baculovirus expression system
0.4183819.11087715.html.plaintext.txt	232	1990 defective intracellular transport processing cftr molecular basis cystic fibrosis
0.4183819.11087715.html.plaintext.txt	233	1984 distribution repeating gal ss 14 glcnac ss 1 3 sequences asparagine linked oligosaccharides mouse lymphoma cell lines bw5147 phar 2
0.4183819.11087715.html.plaintext.txt	234	1982 mouse lymphoma cell line resistant leukoagglutinating lectin phaseolus vulgaris deficient udp glcnac d mannoside ss 16 n acetylglucosaminyltransferase
0.4183819.11087715.html.plaintext.txt	235	1991 asparagine linked oligosaccharide processing lepidopteran insect cells
0.4183819.11087715.html.plaintext.txt	236	temporal dependence nature oligosaccharides assembled asparagine 289 recombinant human plasminogen produced baculovirus vector infected spodoptera frugiperda iplb sf 21ae cells
0.4183819.11087715.html.plaintext.txt	237	biochemistry 30 6165 6174
0.4183819.11087715.html.plaintext.txt	238	1992 processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.4183819.11087715.html.plaintext.txt	239	1985 demonstration monoclonal antibodies carbohydrate structures glycoproteins glycolipids onco developmental antigens
0.4183819.11087715.html.plaintext.txt	240	1994 method monitoring glycosylation recombinant glycoproteins conditioned medium using fluorophore assisted carbohydrate electrophoresis
0.4183819.11087715.html.plaintext.txt	241	1985 cell surface glycoconjugates onco differentiation markers hematopoietic cells biochim
0.4183819.11087715.html.plaintext.txt	242	biology glycoproteins
0.4183819.11087715.html.plaintext.txt	243	plenum publishing new york pp
0.4183819.11087715.html.plaintext.txt	244	1976 absence major sialoglycoprotein membrane human en erythrocytes increased glycosylation band 3
0.4183819.11087715.html.plaintext.txt	245	1988 expression human egf receptor ligand stimulatable kinase activity insect cells using baculovirus vector
0.4183819.11087715.html.plaintext.txt	246	1990 expression characterization cystic fibrosis transmembrane conductance regulator
0.4183819.11087715.html.plaintext.txt	247	1991 maturation function cystic fibrosis transmembrane conductance regulator variants bearing mutations putative nucleotide binding domains 1 2
0.4183819.11087715.html.plaintext.txt	248	1999 characterization carbohydrate binding specificty kinetic parameters lectins using surface plasmon resonance
0.4183819.11087715.html.plaintext.txt	249	1984 regulation asparagine linked oligosaccharide processing
0.4183819.11087715.html.plaintext.txt	250	oligosaccharide processing aedes alboptictus mosquito cells
0.4183819.11087715.html.plaintext.txt	251	1990 use polyacrylamide gel electrophoresis high resolution separation reducing saccharides labeled fluorophore 8 aminonaphthalene 136 trisulphonic acid
0.4183819.11087715.html.plaintext.txt	252	detection picomolar quantities imaging system based cooled charge coupled device
0.4183819.11087715.html.plaintext.txt	253	1989 glycosylation secretion human tissue plasminogen activator recombinant baculovirus infected insect cells
0.4183819.11087715.html.plaintext.txt	254	1992 mislocalisation f508 cftr cystic fibrosis sweat gland
0.4183819.11087715.html.plaintext.txt	255	1990 oligosaccharides influenza virus hemagglutinin expressed insect cells baculovirus vector
0.4183819.11087715.html.plaintext.txt	256	virology 174 418 429isimedline
0.4183819.11087715.html.plaintext.txt	257	1993 delta f508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.4183819.11087715.html.plaintext.txt	258	determination functional half lives transfected cells
0.4183819.11087715.html.plaintext.txt	259	1988 signals important high level expression foreign genes autographa californica nuclear polyhedrosis virus expression vectors
0.4183819.11087715.html.plaintext.txt	260	1994 stoichiometry recombinant cystic fibrosis transmembrane conductance regulator epithelial cells functional reconstitution cells vitro
0.4183819.11087715.html.plaintext.txt	261	1987 lectin affinity chromatography glycopeptides
0.4183819.11087715.html.plaintext.txt	262	1993 glycosylation status endogenous cftr affect camp stimulated cl secretion epithelial cells
0.4183819.11087715.html.plaintext.txt	263	molecular characteristics specificity sugar binding
0.4183819.11087715.html.plaintext.txt	264	1995 purification characterization recombinant cystic fibrosis transmembrane conductance regulator chinese hamster ovary insect cells
0.4183819.11087715.html.plaintext.txt	265	1983 isolation characterization endo ss galactosidase bacteroides fragilis
0.4183819.11087715.html.plaintext.txt	266	1989 carbohydrate structures human tissue plasminogen activator expressed chinese hamster ovary cells
0.4183819.11087715.html.plaintext.txt	267	1992 1 6 1 3 difucosylation asparagine bound n acetylglucosamine honeybee venom phospholipase a2
0.4183819.11087715.html.plaintext.txt	268	1992 distinct n glycan fucosylation potentials three lepidopteran cell lines
0.4183819.11087715.html.plaintext.txt	269	1991 peptide n4 n acetyl ss glucosaminyl asparagine amidase f cannot release glycans fucose attached 1 3 asparagine linked n acetylglucosamine residue
0.4183819.11087715.html.plaintext.txt	270	1984 optimizing hydrolysis n linked high mannose oligosaccharides endo ss n acetylglucosaminidase h
0.4183819.11087715.html.plaintext.txt	271	1990 synthesis membrane fusion hemagglutinin proteins measles virus using novel baculovirus vector containing beta galactosidase gene
0.4183819.11087715.html.plaintext.txt	272	1991 poly n acetyllactosamines attached lysosomal membrane glycoproteins increased prolonged association golgi complex
0.4183819.11087715.html.plaintext.txt	273	1991 characterization oligosaccharide structures chimeric respiratory syncytial virus protein expressed insect cell line sf9
0.4183819.11087715.html.plaintext.txt	274	biochemistry 30 2863 2868
0.4183819.11087715.html.plaintext.txt	275	1996 turnover cystic fibrosis transmembrane conductance regulator cftr slow degradation wild type delta f508 cftr surface membrane preparations immortalized airway epithelial cells
0.4183819.11087715.html.plaintext.txt	276	1991 characterization oligosaccharides drosophila melanogaster glycoproteins
0.4183819.11087715.html.plaintext.txt	277	1987 active human erythropoietin expressed insect cells using baculovirus vector role n linked oligosaccharide
0.4183819.11087715.html.plaintext.txt	278	1987 carbohydrate binding properties complex type oligosaccharides immobilized datura stramonium lectin
0.4739439.9002671.html.plaintext.txt	0	functional human cftr produced stable chinese hamster ovary cell lines derived using yeast artificial chromosomes functional human cftr produced stable chinese hamster ovary cell lines derived using yeast artificial chromosomes peter j
0.4739439.9002671.html.plaintext.txt	1	guggino4 yuan jiang2 melissa
0.4739439.9002671.html.plaintext.txt	2	1laboratories gene transfer 2cancer genetics national center human genome research national institutes health bethesda maryland 20892 usa departments 3pediatrics anesthesia critical care medicine 4physiology johns hopkins medical institutions baltimore maryland 21287 usa
0.4739439.9002671.html.plaintext.txt	3	received july 29 1996 revised accepted november 5 1996
0.4739439.9002671.html.plaintext.txt	4	cystic fibrosis transmembrane conductance regulator gene cftr encodes transmembrane protein cftr functions part cyclic adenosine monophosphate camp regulated chloride channel
0.4739439.9002671.html.plaintext.txt	5	cftr expression controlled temporally cell specifically mechanisms poorly understood
0.4739439.9002671.html.plaintext.txt	6	insight cftr regulation could facilitated successful introduction entire 230 kb human cftr adjacent sequences mammalian cells
0.4739439.9002671.html.plaintext.txt	7	end introduced two different cftr containing yeast artificial chromosomes yacs 320 620 kb chinese hamster ovary k1 cho cells
0.4739439.9002671.html.plaintext.txt	8	clonal cell lines containing human cftr identified pcr genetic functional analyses one clone containing yac described
0.4739439.9002671.html.plaintext.txt	9	integration human cftr containing yacs cho genome unique site cell line demonstrated fluorescence situ hybridization fish
0.4739439.9002671.html.plaintext.txt	10	southern blot analysis suggested order one copy human cftr integrated per cho cell genome
0.4739439.9002671.html.plaintext.txt	11	fiber fish restriction analysis suggested cftr remained grossly intact
0.4739439.9002671.html.plaintext.txt	12	northern analysis showed full length human cftr mrna
0.4739439.9002671.html.plaintext.txt	13	immunoprecipitation followed phosphorylation protein kinase demonstrated mature glycosylated cftr
0.4739439.9002671.html.plaintext.txt	14	finally chloride secretion response camp indicated functional nature human cftr
0.4739439.9002671.html.plaintext.txt	15	study provides several novel results including functional human cftrcan expressed yacs ii cho cells permissive environment expression human cftr iii level human cftr expression cho cells unexpectedly high given lack endogenous cftr production iv suggestion fiber fish cftr integrity correlates functional gene expression
0.4739439.9002671.html.plaintext.txt	16	yacs cell lines derived useful tools study cftr expression
0.4739439.9002671.html.plaintext.txt	17	cystic fibrosis cf common fatal autosomal recessive disorder caucasian population 1
0.4739439.9002671.html.plaintext.txt	18	caused mutations cystic fibrosis transmembrane conductance regulator gene cftr leading loss cyclic adenosine monophosphate camp stimulated chloride efflux epithelial cells 2 4
0.4739439.9002671.html.plaintext.txt	19	cftr 230 kb gene encoding 1480 amino acid transmembrane protein functions chloride channel several regulatory properties 5 6
0.4739439.9002671.html.plaintext.txt	20	600 mutations cftr identified individuals cf 7
0.4739439.9002671.html.plaintext.txt	21	common mutation deletion 3 bp leading loss phenylalanine residue position 508 found nearly 70 cf alleles 8
0.4739439.9002671.html.plaintext.txt	22	cftr expressed primarily exocrine epithelia lung gastrointestinal tract pancreas sweat glands 9 11
0.4739439.9002671.html.plaintext.txt	23	expression generally low tissues although specific epithelial cell types serous cells submucosal glands lung relatively high level expression 12
0.4739439.9002671.html.plaintext.txt	24	mechanisms govern level cell specific regulation cftr expression explored remain poorly understood
0.4739439.9002671.html.plaintext.txt	25	putative promoter region lies within 3800 bp start site cftr transcription supports low level expression reporter genes vitro 13 16
0.4739439.9002671.html.plaintext.txt	26	cftr expression induced camp 17 suppressed phorbol ester 18 19
0.4739439.9002671.html.plaintext.txt	27	20 demonstrated induction cftr expression protein kinase mediated 8 bp camp responsive element upstream cftr
0.4739439.9002671.html.plaintext.txt	28	21 analyzed function inverted ccaat element 132 119 upstream cftr detail
0.4739439.9002671.html.plaintext.txt	29	showed transcription factor binding element confers basal camp induced cftr expression
0.4739439.9002671.html.plaintext.txt	30	level cftr expression also appears related state cellular differentiation 22
0.4739439.9002671.html.plaintext.txt	31	additional regulatory elements shown lie within 5 flanking region well within first cftr intron 23
0.4739439.9002671.html.plaintext.txt	32	dnase hypersensitivity sites demonstrated within 120 kb upstream cftr correlation cell type specific cftr expression observed 24
0.4739439.9002671.html.plaintext.txt	33	taken together studies provide little insight exact mechanisms determine level specificity cftr expression
0.4739439.9002671.html.plaintext.txt	34	one novel approach study cftr expression introduce entire 230 kb gene flanking sequences mammalian cells
0.4739439.9002671.html.plaintext.txt	35	obstacles approach include obtaining appropriate vector containing full length human cftr without deletions mutations rearrangements ii maintaining integrity cftr vector propagation iii transferring cftr intact appropriate mammalian cells
0.4739439.9002671.html.plaintext.txt	36	yeast artificial chromosomes yacs provide potential vectors study
0.4739439.9002671.html.plaintext.txt	37	yacs containing human cftr generated soon gene identified 25 26
0.4739439.9002671.html.plaintext.txt	38	although genetic structure yacs studied functionality cftr contained within established
0.4739439.9002671.html.plaintext.txt	39	goal present study determine two different yacs containing full length human cftr 45 335 kb adjacent upstream sequence produce functional human cystic fibrosis transmembrane conductance regulator protein cftr mammalian cells
0.4739439.9002671.html.plaintext.txt	40	analyses follow demonstrate functionality human cftr contained within yac
0.4739439.9002671.html.plaintext.txt	41	results human cftr containing yacs used generate stable chinese hamster ovary cell lines
0.4739439.9002671.html.plaintext.txt	42	yac used study contains full length human cftr fig
0.4739439.9002671.html.plaintext.txt	43	neomycin resistance gene neor introduced right arm yac extent human sequence surrounding cftr determined restriction analysis
0.4739439.9002671.html.plaintext.txt	44	smaller yac ycftr325 neo 320 kb contains 45 kb flanking sequence upstream cftr transcriptional unit 30 kb 3 flanking dna
0.4739439.9002671.html.plaintext.txt	45	larger yac ycftr8 neo 620 kb contains 335 kb 5 flanking 40 kb 3 flanking dna
0.4739439.9002671.html.plaintext.txt	46	map two yacs used study
0.4739439.9002671.html.plaintext.txt	47	ycftr325 neo 320 kb contains 45 kb 5 flanking 30 kb 3 flanking dna
0.4739439.9002671.html.plaintext.txt	48	ycftr8 neo 620 kb contains 335 kb 5 flanking 40 kb 3 flanking dna
0.4739439.9002671.html.plaintext.txt	49	cftr transcription start site indicated arrow
0.4739439.9002671.html.plaintext.txt	50	nrui sites human dna well two sites right yac arm indicated n
0.4739439.9002671.html.plaintext.txt	51	separate experiments chinese hamster ovary k1 cho cells fused yeast spheroplasts containing one two yacs
0.4739439.9002671.html.plaintext.txt	52	cho cells incorporated neor identified clonal growth presence g418
0.4739439.9002671.html.plaintext.txt	53	approximately 50 colonies cho cells yac transfer present 2 weeks g418 selection
0.4739439.9002671.html.plaintext.txt	54	twenty clones derived using smaller yac 27 clones derived using larger yac randomly selected sub cultured
0.4739439.9002671.html.plaintext.txt	55	fourteen clones containing smaller yac seven containing larger yac randomly selected analyzed determine contained human cftr described
0.4739439.9002671.html.plaintext.txt	56	screening cho cell clones human cftr performed polymerase chain reaction pcr analysis genomic dna using two sets intron primers one spanning exon 2 exon 6a
0.4739439.9002671.html.plaintext.txt	57	primers chosen toward 5 end gene since neor located beyond 3 end cftr
0.4739439.9002671.html.plaintext.txt	58	seven 14 clones derived using smaller yac six seven clones derived larger yac positive cftr exons 2 6a
0.4739439.9002671.html.plaintext.txt	59	control cho cell dna negative identical reaction conditions
0.4739439.9002671.html.plaintext.txt	60	clones positive exons analyzed cftr mrna reverse transcription rt pcr using primers spanning exon 7 exon 9
0.4739439.9002671.html.plaintext.txt	61	three seven clones derived using smaller yac four six clones derived using larger yac positive
0.4739439.9002671.html.plaintext.txt	62	control cho cell rna negative identical reaction conditions data shown
0.4739439.9002671.html.plaintext.txt	63	based screening candidates chosen study
0.4739439.9002671.html.plaintext.txt	64	detailed genetic functional analyses two clones highest level cftr mrna described
0.4739439.9002671.html.plaintext.txt	65	cell line designated cs2c5 derived using ycftr325 neo cs1f2 derived using ycftr8 neo
0.4739439.9002671.html.plaintext.txt	66	single site integration identified cell line
0.4739439.9002671.html.plaintext.txt	67	fluorescence situ hybridization fish performed metaphase nuclei cs2c5 cs1f2 determine site cftr integration fig
0.4739439.9002671.html.plaintext.txt	68	using yac derived y37ab12 25 containing entire cftr probe human cftr localized single locus clone
0.4739439.9002671.html.plaintext.txt	69	human cftr integrated cho chromosome band 4p21 23 cs2c5 cell line cho chromosome band 5q27 cs1f2 cell line
0.4739439.9002671.html.plaintext.txt	70	fish metaphase nuclei hybridized cftr containing yac probe derived y37ab12 labeled spectrumorange
0.4739439.9002671.html.plaintext.txt	71	chromosomes counter stained dapi
0.4739439.9002671.html.plaintext.txt	72	ycftr325 neo integrated cho chromosome band 4p21 23 cell line cs2c5
0.4739439.9002671.html.plaintext.txt	73	b ycftr8 neo integrated cho chromosome band 5q27 cell line cs1f2
0.4739439.9002671.html.plaintext.txt	74	hybridization seen control cho cells data shown
0.4739439.9002671.html.plaintext.txt	75	southern analysis performed determine copy number human cftr incorporated cho cell clone fig
0.4739439.9002671.html.plaintext.txt	76	genomic dna cs2c5 cs1f2 control cho cells ht 1080 pseudodiploid human fibrosarcoma cell line atcc ccl 121 digested ecori hybridized cdna fragment containing part cftr 3 untranslated region within exon 24
0.4739439.9002671.html.plaintext.txt	77	2 kb single band seen cs2c5 cs1f2 ht 1080 control cho
0.4739439.9002671.html.plaintext.txt	78	cftr copy number assessed comparing clones ht 1080
0.4739439.9002671.html.plaintext.txt	79	intensity bands 10 mug cs2c5 cs1f2 dna similar obtained 5 mug ht 1080 dna
0.4739439.9002671.html.plaintext.txt	80	data suggest order one copy cftr integrated cho genome cell line
0.4739439.9002671.html.plaintext.txt	81	similar results shown cs2c5 cs1f2 compared cfpac 1 cells hyperdiploid human pancreatic adenocarcinoma cell line atcc crl 1918
0.4739439.9002671.html.plaintext.txt	82	southern analysis genomic dna human genomic dna cs2c5 cs1f2 cho cells digested ecori hybridized cdna probe containing cftr 3 untranslated region within exon 24
0.4739439.9002671.html.plaintext.txt	83	lane 1 10 mug dna cs2c5
0.4739439.9002671.html.plaintext.txt	84	lane 2 10 mug dna cs1f2
0.4739439.9002671.html.plaintext.txt	85	lane 3 10 mug dna control cho cells
0.4739439.9002671.html.plaintext.txt	86	lane 4 5 mug dna human ht 1080 cells
0.4739439.9002671.html.plaintext.txt	87	lane 5 10 mug dna human ht 1080 cells
0.4739439.9002671.html.plaintext.txt	88	lane 6 5 mug dna human cfpac 1 cells
0.4739439.9002671.html.plaintext.txt	89	lane 7 10 mug dna human cfpac 1
0.4739439.9002671.html.plaintext.txt	90	lane 8 10 mug dna ycftr325 neo
0.4739439.9002671.html.plaintext.txt	91	lane 9 10 mug dna ycftr8 neo
0.4739439.9002671.html.plaintext.txt	92	size markers indicated kb
0.4739439.9002671.html.plaintext.txt	93	human cftr integrated intact
0.4739439.9002671.html.plaintext.txt	94	integrity human cftr present cho cell clones assessed fiber fish fig
0.4739439.9002671.html.plaintext.txt	95	dna strands cftr containing clones cho cells normal human peripheral blood lymphocytes pbl analyzed
0.4739439.9002671.html.plaintext.txt	96	probes used delineate human cftr included human cftr containing yac used fish fig
0.4739439.9002671.html.plaintext.txt	97	2 cosmids cw44 27 containing exon 1 cf24 gift jeff touchman eric green nih bethesda md containing exons 20 24
0.4739439.9002671.html.plaintext.txt	98	rhodamine labeled cosmids delineate ends cftr coding region fluorescein labeled yac probe extends 45 kb upstream 30 kb downstream 230 kb gene
0.4739439.9002671.html.plaintext.txt	99	expected hybridization pattern seen pbl well dna fibers obtained cs2c5 cs1f2 cells
0.4739439.9002671.html.plaintext.txt	100	dna fibers control cho cells hybridize cftr probes
0.4739439.9002671.html.plaintext.txt	101	data confirm presence human cftr clones suggest gene grossly intact
0.4739439.9002671.html.plaintext.txt	102	fiber fish dna strands pbl cs2c5 cs1f2 cells
0.4739439.9002671.html.plaintext.txt	103	diagram three probes used inthese experiments representing expected lengths fully stretched b form dna magnification used panels
0.4739439.9002671.html.plaintext.txt	104	cftr containing yac probe obtained y37ab12 labeled fluorescein
0.4739439.9002671.html.plaintext.txt	105	cosmids containing exons 1 cw44 20 24 cf24 labeled rhodamine
0.4739439.9002671.html.plaintext.txt	106	technique allow definitive orientation fiber direction
0.4739439.9002671.html.plaintext.txt	107	b fiber fish dna strands derived pbl hybridized three cftr probes
0.4739439.9002671.html.plaintext.txt	108	c fiber fish dna strands obtained cell line cs2c5
0.4739439.9002671.html.plaintext.txt	109	d fiber fish dna strands obtained cell line cs1f2
0.4739439.9002671.html.plaintext.txt	110	hybridization seen control cho cells data shown
0.4739439.9002671.html.plaintext.txt	111	southern analysis genomic dna human genomic dna cs2c5 cs1f2 cho cells digested ecori hybridized full length cftr cdna probe
0.4739439.9002671.html.plaintext.txt	112	lane 4 dna human ht 1080 cells
0.4739439.9002671.html.plaintext.txt	113	southern blot hybridization genomic dna cs2c5 cs1f2 control cho human ht 1080 cells performed assess integrity integrated cftr fig
0.4739439.9002671.html.plaintext.txt	114	dna digested ecori separated 0
0.4739439.9002671.html.plaintext.txt	115	8 agarose gel hybridized probe comprising full length human cftr cdna hybridize ecori fragments contain cftr exons
0.4739439.9002671.html.plaintext.txt	116	data shows two clones similar hybridization patterns bands nearly identical pattern seen control human dna
0.4739439.9002671.html.plaintext.txt	117	genomic dnas yeast containing yac also similar hybridization pattern clones human genomic dna although faintest bands yeast difficult visualize mammalian cells
0.4739439.9002671.html.plaintext.txt	118	data suggests high degree integrity majority integrated human cftr cho cell lines 230 kb coding sequence consistent observation full length cftr mrna functional protein
0.4739439.9002671.html.plaintext.txt	119	human cftr mrna protein expressed cho cell lines
0.4739439.9002671.html.plaintext.txt	120	presence human cftr mrna determined northern analysis fig
0.4739439.9002671.html.plaintext.txt	121	5 kb mrna transcript observed cs2c5 cs1f2 cells
0.4739439.9002671.html.plaintext.txt	122	transcript similar size cftr mrna produced t84 cells served positive control cftr expression 13
0.4739439.9002671.html.plaintext.txt	123	corresponding transcript detected control cho cells normal human airway epithelial cells data shown
0.4739439.9002671.html.plaintext.txt	124	results demonstrate cs2c5 cs1f2 produce sufficient amount full length human cftr mrna detected rt pcr northern analysis
0.4739439.9002671.html.plaintext.txt	125	presence human cftr determined immunoprecipitation cell lysates antibody c terminus cftr phosphorylation gamma 32padenosine triphosphate atp analysis sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page fig
0.4739439.9002671.html.plaintext.txt	126	clones produced mature glycosylated cftr could phosphorylated vitro
0.4739439.9002671.html.plaintext.txt	127	similar cftr profile seen t84 cells
0.4739439.9002671.html.plaintext.txt	128	corresponding band observed control cho cell lysate
0.4739439.9002671.html.plaintext.txt	129	appearance mature human cftr cs2c5 cs1f2 cells demonstrates cho cells possess cellular machinery transcribe cftr introduced yac translate appropriately process protein
0.4739439.9002671.html.plaintext.txt	130	northern analysis total rna cs2c5 cs1f2 control cho cells hybridized cftr cdna probe
0.4739439.9002671.html.plaintext.txt	131	5 kb cftr mrna band indicated arrow
0.4739439.9002671.html.plaintext.txt	132	lane 1 20 mug rna cs2c5 cells
0.4739439.9002671.html.plaintext.txt	133	lane 2 20 mug rna cs1f2 cells
0.4739439.9002671.html.plaintext.txt	134	lane 3 20 mug rna control cho cells
0.4739439.9002671.html.plaintext.txt	135	lane 4 2 mug rna t84 cells
0.4739439.9002671.html.plaintext.txt	136	sds page cell lysates immunoprecipitated antibody cftr phosphorylated gamma 32patp
0.4739439.9002671.html.plaintext.txt	137	mature cftr indicated arrow
0.4739439.9002671.html.plaintext.txt	138	lane 1 control cho cell lysate
0.4739439.9002671.html.plaintext.txt	139	autoradiograph exposure times 50 h lanes 1 3 10 h lane 4
0.4739439.9002671.html.plaintext.txt	140	human cftr functional cho cell lines
0.4739439.9002671.html.plaintext.txt	141	function human cftr produced cho cell lines cs2c5 cs1f2 assessed camp stimulated 36cl efflux fig
0.4739439.9002671.html.plaintext.txt	142	camp stimulation provided addition forskolin non hydrolyzable analogues camp period equilibration
0.4739439.9002671.html.plaintext.txt	143	significant rise 36cl efflux observed 30 60 camp stimulation clones p 0
0.4739439.9002671.html.plaintext.txt	144	level 36cl efflux response camp early passage cs2c5 cs1f2 cells similar observed t84 cells p 0
0.4739439.9002671.html.plaintext.txt	145	analogous camp stimulated 36cl efflux control cho cells another clonal cho cell line s1 derived using 140 kb yac containing neor human dna unrelated cftr
0.4739439.9002671.html.plaintext.txt	146	absence endogenous cftr activity cho cells release 36cl cell layer clones response camp indicates presence functional human cftr produced introduced yacs
0.4739439.9002671.html.plaintext.txt	147	36cl efflux cells stimulated forskolin non hydrolyzable camp analogues camp cocktail
0.4739439.9002671.html.plaintext.txt	148	data expressed percent 36cl efflux per min
0.4739439.9002671.html.plaintext.txt	149	cs2c5 cells early 8th 9th circle n 12 later passages 11th 12th n 12
0.4739439.9002671.html.plaintext.txt	150	b cs1f2 cells early 8th 9th circle n 12 later passages 11th 12th n 12
0.4739439.9002671.html.plaintext.txt	151	c control cho cells squf n 23 s1 cells containing yac neor without cftr squ n 23 d 84 cells utrif n 12
0.4739439.9002671.html.plaintext.txt	152	level efflux compared 1 min control time point camp added p 0
0.4739439.9002671.html.plaintext.txt	153	study describes generation two clonal cho cell lines cs2c5 cs1f2 containing full length human cftr
0.4739439.9002671.html.plaintext.txt	154	cell lines derived fusion cho cells yeast spheroplasts containing two different yacs include human cftr 75 375 kb adjacent sequences
0.4739439.9002671.html.plaintext.txt	155	fluorescence situ hybridization performed metaphase nuclei indicate site yac integration
0.4739439.9002671.html.plaintext.txt	156	single site integration different cho chromosome found cell line
0.4739439.9002671.html.plaintext.txt	157	southern analysis suggested clone likely contains order one copy human cftr per cho cell genome
0.4739439.9002671.html.plaintext.txt	158	fiber fish suggested gross structural integrity transferred cftr cell lines
0.4739439.9002671.html.plaintext.txt	159	integrity integrated cftr indicated restriction analysis genomic dna
0.4739439.9002671.html.plaintext.txt	160	results suggested majority human cftr grossly intact correlated functionalcftr production potentially extending application fiber fish beyond current status genetic mapping tool 28 29
0.4739439.9002671.html.plaintext.txt	161	fiber fish also suggested flanking sequences common yacs present cell lines
0.4739439.9002671.html.plaintext.txt	162	finally sequence tagged site sl12 located extreme 5 end ycftr8 neo 26 detected dna cs1f2 cells suggesting larger yac incorporated entirety cho genome data shown
0.4739439.9002671.html.plaintext.txt	163	parental yacs used experiments constructed several years ago 25 26
0.4739439.9002671.html.plaintext.txt	164	although human cftr contained yacs shown grossly intact even transfer chinese hamster fibroblasts 30 functionality cftr established
0.4739439.9002671.html.plaintext.txt	165	present study demonstrates production full length cftr mrna functional protein cs2c5 cs1f2
0.4739439.9002671.html.plaintext.txt	166	human cftr production cell lines implies regulatory elements needed gene expression contained within yacs
0.4739439.9002671.html.plaintext.txt	167	ability cells produce mature functional protein cell surface 15 passages demonstrated camp stimulated 36cl efflux
0.4739439.9002671.html.plaintext.txt	168	cs2c5 cs1f2 distinctive clonal lines generated study cftr mrna detected rt pcr northern analysis
0.4739439.9002671.html.plaintext.txt	169	none cell lines created study analyzed northern analysis comparable mrna transcripts
0.4739439.9002671.html.plaintext.txt	170	rate 36cl efflux observed cs2c5 cs1f2 early passages similar seen t84 cells despite fact lower cftr mrna protein levels t84 cells
0.4739439.9002671.html.plaintext.txt	171	data supports previous studies camp mediated chloride efflux sensitive indicator functional protein without direct correlation level cftr expression 31
0.4739439.9002671.html.plaintext.txt	172	ordinarily yac gene transfer carried mammalian cell line gene interest endogenously expressed placing yac environment likely permissive human promoter 32 35
0.4739439.9002671.html.plaintext.txt	173	contrast present study demonstrates yac mediated gene transfer cells lacking endogenous cftr production 36 37
0.4739439.9002671.html.plaintext.txt	174	unclear human cftr appears functionally expressed endogenous transferred genes could potentially interact basal transcription factors
0.4739439.9002671.html.plaintext.txt	175	several aspects yac integration may support expression transferred human cftr cho cell clones
0.4739439.9002671.html.plaintext.txt	176	example suggested transferred yacs may retain chromatin structure favors expression 38
0.4739439.9002671.html.plaintext.txt	177	cftr expression yacs may favored requirement nearby neor expressed order cells survive forcing adjacent chromatin remain open
0.4739439.9002671.html.plaintext.txt	178	addition human hamster genes could different affinities dna binding proteins
0.4739439.9002671.html.plaintext.txt	179	alternative explanation hamster cftr mutated cannot produce functional cftr
0.4739439.9002671.html.plaintext.txt	180	better understand differential expression hamster human genes would useful directly compare structure two genes
0.4739439.9002671.html.plaintext.txt	181	however work remains done hamster cftr yet extensively characterized
0.4739439.9002671.html.plaintext.txt	182	present studies full length human cftr probes clearly cross hybridize control cho cells suggesting little homology hamster human cftr perhaps gene absent control cho line
0.4739439.9002671.html.plaintext.txt	183	etiology unexpectedly high level human cftr expression cho cell lines also unclear
0.4739439.9002671.html.plaintext.txt	184	clonal cell line produces mrna protein easily detectable levels
0.4739439.9002671.html.plaintext.txt	185	fish southern analysis suggest level expression likely consequence cftr integrated unique locus cell line copy number order one per cho genome
0.4739439.9002671.html.plaintext.txt	186	contrast techniques employed present study applied evaluate cftr expression normal diploid human epithelial cells difficult detect cftr mrna 10 protein
0.4739439.9002671.html.plaintext.txt	187	cheng genzyme framingham ma pers
0.4739439.9002671.html.plaintext.txt	188	level cftr expression could related number factors including regulatory sequences within yac vector distance gene lies yac ends integration site host genome 32 38
0.4739439.9002671.html.plaintext.txt	189	another potential positive influence cftr promoter function sv40 enhancer supports neor expression
0.4739439.9002671.html.plaintext.txt	190	sv40 enhancer shown augment cftr promoter function reporter gene constructs 15
0.4739439.9002671.html.plaintext.txt	191	addition factors liberation gene negative regulatory element possibly downstream region included either yac could result higher expected expression
0.4739439.9002671.html.plaintext.txt	192	cftr containing yacs additional flanking sequences available 26 could used address issue
0.4739439.9002671.html.plaintext.txt	193	similar levels human cftr expression cs2c5 cs1f2 cells suggest expression independent site integration
0.4739439.9002671.html.plaintext.txt	194	position independent expression necessarily expected cell lines created yac transfer
0.4739439.9002671.html.plaintext.txt	195	postulated buffer dna sequence might insulate gene interest positional effects site integration 32
0.4739439.9002671.html.plaintext.txt	196	extensive amount sequence upstream cftr yacs could potentially act buffer might account similar level expression seen two different clones
0.4739439.9002671.html.plaintext.txt	197	detailed analysis clones derived yac would necessary determine factors contribute level human cftr expression
0.4739439.9002671.html.plaintext.txt	198	study demonstrates cftr contained within yacs used study free gross rearrangements functional
0.4739439.9002671.html.plaintext.txt	199	furthermore expression introduced gene indicates sufficient sequence present promote human cftr expression
0.4739439.9002671.html.plaintext.txt	200	although first study investigating function full length human cftr contained within yacs limited number studies documented functional protein production human genes transferred mammalian cells yac vectors 34 38 42
0.4739439.9002671.html.plaintext.txt	201	cell lines often appropriate regulation transferred genes used study various aspects gene expression 38 39
0.4739439.9002671.html.plaintext.txt	202	cftr containing yacs cell lines described paper offer several advantages model systems study cftr expression
0.4739439.9002671.html.plaintext.txt	203	analysis role intron sequences flanking sequences contained within cftr containing yacs may help elucidate regulation cftr expression ways possible cell lines created cdna constructs 36 43
0.4739439.9002671.html.plaintext.txt	204	addition cells study growth disadvantage compared parental cho cells
0.4739439.9002671.html.plaintext.txt	205	finally yacs manipulated yeast generate mutations cftr modified include reporter genes place human sequences
0.4739439.9002671.html.plaintext.txt	206	thus yacs cell lines derived useful tools study cftr gene expression
0.4739439.9002671.html.plaintext.txt	207	materials methods cell culture
0.4739439.9002671.html.plaintext.txt	208	chinese hamster ovary k 1 cells originally roger tilley houston tx human t84 cfpac 1 ht 1080 cells american type culture collection atcc rockville md grown dulbeccos modified eagles medium biofluids rockville md supplemented 10 fetal bovine serum biofluids 100 uml penicillin gibcobrl gaithersburg md 100 mugml streptomycin gibcobrl 0
0.4739439.9002671.html.plaintext.txt	209	25 mugml amphotericin b gibcobrl dmem humidified incubator containing 5 co2 37oc
0.4739439.9002671.html.plaintext.txt	210	yeast artificial chromosome modification gene transfer
0.4739439.9002671.html.plaintext.txt	211	two yacs previously shown carry cftr y37ab12 310 kb 25 ycf 187 r 610 kb 26 kar crossed saccharomyces cerevisiae strain yph925 previously described 44
0.4739439.9002671.html.plaintext.txt	212	resultant clones retrofitted using plasmid pran4 atcc carries ade2 gene selection yeast neor expressed sv40 promoter selection mammalian cells 45
0.4739439.9002671.html.plaintext.txt	213	pfge southern blot analysis used verify retrofitted yac clones contained neor appropriate sizes
0.4739439.9002671.html.plaintext.txt	214	resulting yacs 320 620 kb size designated ycftr325 neo ycftr8 neo respectively
0.4739439.9002671.html.plaintext.txt	215	restriction enzyme digestion yacs used map human genomic dna flanking 230 kb cftr
0.4739439.9002671.html.plaintext.txt	216	spheroplast fusion carried according huxley et al
0.4739439.9002671.html.plaintext.txt	217	40 minor modifications
0.4739439.9002671.html.plaintext.txt	218	spheroplasts fused rapidly dividing cho cellsby dropwise addition 0
0.4739439.9002671.html.plaintext.txt	219	5 ml polyethylene glycol 1500 boehringer mannheim indianapolis containing 50 mul dimethyl sulfoxide 5 mm cacl2
0.4739439.9002671.html.plaintext.txt	220	mixture allowed stand room temperature 1 2 min time 5 ml dulbeccos modified eagles medium added
0.4739439.9002671.html.plaintext.txt	221	resulting cell suspension mixed inversion centrifuged 700 g 5 min
0.4739439.9002671.html.plaintext.txt	222	cell pellet resuspended dmem divided four 10 cm tissue culture plates
0.4739439.9002671.html.plaintext.txt	223	forty eight hours later medium removed replaced dmem supplemented 400 mug activityml g418 gibcobrl
0.4739439.9002671.html.plaintext.txt	224	medium changed three times weekly
0.4739439.9002671.html.plaintext.txt	225	2 weeks individual colonies observed isolated using cloning cylinders trypsinized placed 48 well plates containing dmem supplemented 400 mug activityml g418
0.4739439.9002671.html.plaintext.txt	226	cells reached confluence passed sequentially 3 cm 10 cm plates
0.4739439.9002671.html.plaintext.txt	227	s1 cell line derived similar fashion using 140 kb yac containing neor human dna unrelated cftr
0.4739439.9002671.html.plaintext.txt	228	genomic dna extracted cs2c5 cs1f2 ht 1080 control cho cells using standard techniques
0.4739439.9002671.html.plaintext.txt	229	genomic dna screened pcr using intron primers surrounding exons 2 6a described zielenski et al
0.4739439.9002671.html.plaintext.txt	230	southern analysis performed genomic dna digested ecori new england biolabs beverly ma 3 h 37oc
0.4739439.9002671.html.plaintext.txt	231	digested dna run 0
0.4739439.9002671.html.plaintext.txt	232	8 wv agarose gel blotted onto nytran plus keene nh
0.4739439.9002671.html.plaintext.txt	233	copy number experiments dna hybridized 685 bp cdna fragment containing part cftr 3 untranslated region within exon 24 integrity experiments dna hybridized full length cftr cdna probe derived ptg5955 47
0.4739439.9002671.html.plaintext.txt	234	probes labeled alpha 32pdctp sp
0.4739439.9002671.html.plaintext.txt	235	3000 mcimmole amersham arlington heights il using rediprime system amersham according manufacturers specifications
0.4739439.9002671.html.plaintext.txt	236	yeast genomic dna prepared using puregene dna isolation kit gentra systems research triangle park nc according manufacturers specifications
0.4739439.9002671.html.plaintext.txt	237	total rna extracted cs2c5 cs1f2 control cho t84 cell lines using trizol gibcobrl according manufacturers instructions
0.4739439.9002671.html.plaintext.txt	238	screening rna performed rt pcr
0.4739439.9002671.html.plaintext.txt	239	rna treated rnase free dnase promega madison wi 45 min 37oc incubated superscript ii gibcobrl 1 h 42oc using random primers promega
0.4739439.9002671.html.plaintext.txt	240	aliquot resulting cdna underwent 40 cycles pcr using following conditions 94oc 30 55oc 60 72oc 60
0.4739439.9002671.html.plaintext.txt	241	following primers spanning exons 7 9 used 5 tgtgcttccctatgcactaat 3 forward 5 ttaatatctttcaggacaggag 3reverse
0.4739439.9002671.html.plaintext.txt	242	northern analysis performed 20 mug total rna derived cs2c5 cs1f2 control cho cells 2 mug total rna derived t84 cells
0.4739439.9002671.html.plaintext.txt	243	rna separated using 1
0.4739439.9002671.html.plaintext.txt	244	2 agarose wv 1 formaldehyde vv denaturing gel transferred nytran hybridized cftr cdna probe derived ptg5955 47 labeled alpha 32pdctp using rediprime system according manufacturers specifications
0.4739439.9002671.html.plaintext.txt	245	fluorescence situ hybridization
0.4739439.9002671.html.plaintext.txt	246	cftr containing yac probe derived y37ab12 25 prepared degenerate oligonucleotide priming pfge purified yac dna use fish fiber fish analyses
0.4739439.9002671.html.plaintext.txt	247	used metaphase fish probe labeled spectrumorange conjugated dutp
0.4739439.9002671.html.plaintext.txt	248	used fiber fish probe labeled digoxigenin 11 dutp boehringer mannheim detected fluorescein conjugated anti digoxigenin antibody oncor gaithersburg md
0.4739439.9002671.html.plaintext.txt	249	cosmid probes fiber fish labeled random priming biotin dutp using bio prime kit visualized rhodamine conjugated avidin
0.4739439.9002671.html.plaintext.txt	250	metaphase fish carried according pinkel et al
0.4739439.9002671.html.plaintext.txt	251	48 minor modifications
0.4739439.9002671.html.plaintext.txt	252	metaphase spreadswere prepared cells 70 80 confluent
0.4739439.9002671.html.plaintext.txt	253	10 cm plate cells incubated sequentially 200 mug ethidium bromide gibcobrl 37oc 1 h 1 mug colcemid gibcobrl additional 40 min 37oc
0.4739439.9002671.html.plaintext.txt	254	cells harvested cell scraper washed three times pbs incubated 75 mm kcl 30 min 37oc
0.4739439.9002671.html.plaintext.txt	255	one ml methanolacetic acid 31 vv added cells centrifuged 200 g 5 min room temperature
0.4739439.9002671.html.plaintext.txt	256	pellet washed least four times 5 ml methanolacetic acid 31 vv
0.4739439.9002671.html.plaintext.txt	257	final wash pellet resuspended 1 ml methanolacetic acid 31 vv dropped onto glass slide air dried 3 days prior use
0.4739439.9002671.html.plaintext.txt	258	slides containing metaphase nuclei incubated 37oc 2 ssc least 1 h dehydrated ethanol series 70 100 air dried denatured 70oc 2 min dehydrated ice cold ethanol series air dried
0.4739439.9002671.html.plaintext.txt	259	cftr containing yac probe described added hybridization buffer 0
0.4739439.9002671.html.plaintext.txt	260	5 mm tris hcl 50 formamide vv 10 dextran sulfate vv denatured 70oc 5 min
0.4739439.9002671.html.plaintext.txt	261	twenty mul denatured probe added slide covered glass cover slip sealed rubber cement
0.4739439.9002671.html.plaintext.txt	262	slides placed humidified chamber incubated overnight 37oc
0.4739439.9002671.html.plaintext.txt	263	coverslip removed slides washed successively 50 formamide vv 2 ssc 20 min 45oc 1 ssc 10 min 45oc 0
0.4739439.9002671.html.plaintext.txt	264	slides placed 1 phosphate buffered detergent pbd oncor least 10 min room temperature dried 2 sheets 3 mm whatman filter paper
0.4739439.9002671.html.plaintext.txt	265	fifteen mul anti fade mounting medium containing 46 diamidino 2 phenylindole dapi oncor added slide covered glass cover slip
0.4739439.9002671.html.plaintext.txt	266	fluorescence signals detected using zeiss axiophot microscope carl zeiss thornwood ny captured photometrics ch230 camera equipped metachrome ii extended uv ccd array ip lab spectrum software signal analytics vienna va
0.4739439.9002671.html.plaintext.txt	267	images transferred power macintosh 8100100 composite images generated using adobe photoshop
0.4739439.9002671.html.plaintext.txt	268	dna fibers prepared fiber fish using method heiskanen et al
0.4739439.9002671.html.plaintext.txt	269	49 minor modifications
0.4739439.9002671.html.plaintext.txt	270	mechanical stretching fibers carried first melting small slice dna containing agarose plug 10 20 mul
0.4739439.9002671.html.plaintext.txt	271	plug placed 20 mul water slide allowed melt 2 min thermal block maintained 85oc
0.4739439.9002671.html.plaintext.txt	272	water added compensate evaporation period
0.4739439.9002671.html.plaintext.txt	273	stretching accomplished pulling edge second microscope slide across dna
0.4739439.9002671.html.plaintext.txt	274	moisture evident air drying slide immersed 10 mm tris hcl 1 mm edta ph 8
0.4739439.9002671.html.plaintext.txt	275	0 70oc 2 min remove residual agar non adherent dna
0.4739439.9002671.html.plaintext.txt	276	slide allowed air dry cool 1 min
0.4739439.9002671.html.plaintext.txt	277	dehydrated ethanol series 70 85 100 retain fibers subsequent processing reduce non specific binding
0.4739439.9002671.html.plaintext.txt	278	probe hybridization washing detection carried described heiskanen et al
0.4739439.9002671.html.plaintext.txt	279	immunoprecipitation phosphorylation cftr vitro catalytic subunit protein kinase performed described cheng et al
0.4739439.9002671.html.plaintext.txt	280	50 minor modifications
0.4739439.9002671.html.plaintext.txt	281	brief cftr immunoprecipitated cell lysates using mouse monoclonal antibody c terminus genzyme cambridge ma incubated 50 ng protein kinase catalytic subunit sigma st
0.4739439.9002671.html.plaintext.txt	282	louis mo 10 muci gamma 32patp sp
0.4739439.9002671.html.plaintext.txt	283	5000 mcimmole amersham 50 mul 50mm tris hcl ph7
0.4739439.9002671.html.plaintext.txt	284	5 10 mm mgcl2 100 mugml bovine serum albumin pentax fraction v miles kankakee il 30oc 60 min
0.4739439.9002671.html.plaintext.txt	285	reaction stopped addition 0
0.4739439.9002671.html.plaintext.txt	286	5 ml ripa buffer 50 mm tris hcl ph 7
0.4739439.9002671.html.plaintext.txt	287	15 m nacl 1 triton x 100 vv 1 sodium deoxycholate wv 0
0.4739439.9002671.html.plaintext.txt	288	samples washed twice ripa buffer run 6 sds polyacrylamide gel
0.4739439.9002671.html.plaintext.txt	289	control cho t84 s1 early passage 8th 9th later passage 14th 15th cs2c5 cs1f2 cells assayed 36cl efflux response camp 37oc 51
0.4739439.9002671.html.plaintext.txt	290	confluent cells assayed 6 well plates
0.4739439.9002671.html.plaintext.txt	291	media removed cell layers washed three times dulbeccos pbs without calcium magnesium gibcobrl 1
0.4739439.9002671.html.plaintext.txt	292	5 ml ringers saline containing 2
0.4739439.9002671.html.plaintext.txt	293	3 mcig amersham placed cells
0.4739439.9002671.html.plaintext.txt	294	following 2 3 h incubation cells washed four times 0
0.4739439.9002671.html.plaintext.txt	295	75 ml ringers saline remove excess radioactivity
0.4739439.9002671.html.plaintext.txt	296	control period 1 min cell layer washed 0
0.4739439.9002671.html.plaintext.txt	297	75 ml ringers saline 15 intervals determine cells baseline level 36cl efflux
0.4739439.9002671.html.plaintext.txt	298	chloride efflux stimulated addition 0
0.4739439.9002671.html.plaintext.txt	299	75 ml ringers saline containing camp cocktail 2
0.4739439.9002671.html.plaintext.txt	300	5 mum forskolin sigma 250 mm 8 bromo adenosine 35 cyclic monophosphate sigma 250 mm 8 4 chlorophenylthio adenosine 35 cyclic monophosphate sigma 0
0.4739439.9002671.html.plaintext.txt	301	5 2 3 4 min baseline 36cl efflux determined
0.4739439.9002671.html.plaintext.txt	302	cells lysed 0
0.4739439.9002671.html.plaintext.txt	303	5 n naoh determine amount 36cl remaining cell layer
0.4739439.9002671.html.plaintext.txt	304	samples mixed 5 ml cytoscint icn costa mesa ca counted beckman model ls 1801 liquid scintillation counter
0.4739439.9002671.html.plaintext.txt	305	data normalized per min basis
0.4739439.9002671.html.plaintext.txt	306	increase 36cl efflux associated camp stimulation compared baseline efflux 1 min paired test
0.4739439.9002671.html.plaintext.txt	307	thank jeffrey trent min chen contributions work sheila compton vincent coviello amalia dutra technical assistance paul liu francis collins helpful discussion critical reading manuscript daryl leja graphics expertise
0.4739439.9002671.html.plaintext.txt	308	ycf 187 r cf24 sl12 generously provided jeff touchman eric green
0.4739439.9002671.html.plaintext.txt	309	cho cells generously provided robert nussbaum
0.4739439.9002671.html.plaintext.txt	310	cw44 generously provided lap chee tsui johanna rommens university toronto
0.4739439.9002671.html.plaintext.txt	311	ptg5955 generously provided transgene strasbourg france
0.4739439.9002671.html.plaintext.txt	312	work supported part nih grants dk 48977 hl 47122 north american cystic fibrosis foundation cff research development program es wg
0.4739439.9002671.html.plaintext.txt	313	kh nihcff post doctoral fellow
0.4739439.9002671.html.plaintext.txt	314	atp adenosine triphosphate cho chinese hamster ovary camp cyclic adenosine monophosphate cf cystic fibrosis cftr cystic fibrosis transmembrane conductance regulator cftr cystic fibrosis transmembrane conductance regulator gene fiber fish fiber fluorescence situ hybridization fish fluorescence situ hybridization pbl peripheral blood lymphocytes pfge pulsed field gel electrophoresis neor neomycin resistance gene sds sodium dodecyl sulfate sds page sodium dodecyl sulfate polyacrylamide gel electrophoresis yac yeast artificial chromosome
0.4739439.9002671.html.plaintext.txt	315	metabolic molecular bases inherited disease
0.4739439.9002671.html.plaintext.txt	316	1986 chloride potassium channels cystic fibrosis airway epithelia
0.4739439.9002671.html.plaintext.txt	317	1986 cystic fibrosis beta adrenergic response airway epithelial cell cultures
0.4739439.9002671.html.plaintext.txt	318	1986 altered regulation airway epithelial cell chloride channels cystic fibrosis
0.4739439.9002671.html.plaintext.txt	319	1995 cftr camp dependent regulator sodium channels
0.4739439.9002671.html.plaintext.txt	320	1995 cftr regulates outwardly rectifying chloride channels autocrine mechanism involving atp
0.4739439.9002671.html.plaintext.txt	321	7 cystic fibrosis mutation database
0.4739439.9002671.html.plaintext.txt	322	1989 identification cystic fibrosis gene genetic anaylsis
0.4739439.9002671.html.plaintext.txt	323	1993 cftr expression regulated cycle seminiferous epithelium oestrous cycle rodents
0.4739439.9002671.html.plaintext.txt	324	1991 expression cystic fibrosis transmembrane conductance regulator gene respiratory tract normal individuals individuals cystic fibrosis
0.4739439.9002671.html.plaintext.txt	325	1989 identification cystic fibrosis gene cloning characterization complementary dna
0.4739439.9002671.html.plaintext.txt	326	1992 submucosal glands predominant site cftr expression human bronchus
0.4739439.9002671.html.plaintext.txt	327	1991 cystic fibrosis gene housekeeping type promoter expressed low levels cells epithelial origin
0.4739439.9002671.html.plaintext.txt	328	1993 characterization cystic fibrosis transmembrane conductance regulator promoter region
0.4739439.9002671.html.plaintext.txt	329	1991 characterization promoter region cystic fibrosis transmembrane conductance regulator gene
0.4739439.9002671.html.plaintext.txt	330	1994 analysis mouse rat cftr promoter regions
0.4739439.9002671.html.plaintext.txt	331	1992 induction expression cystic fibrosis transmembrane conductance regulator
0.4739439.9002671.html.plaintext.txt	332	1991 regulation cystic fibrosis gene mrna transcript levels induction cystic fibrosis secretory phenotype epithelial cells phorbol ester
0.4739439.9002671.html.plaintext.txt	333	1993 mechanism inhibition camp dependent epithelial chloride secretion phorbol esters
0.4739439.9002671.html.plaintext.txt	334	1995 basal expression cystic fibrosis transmembrane conductance regulator gene dependent protein kinase activity
0.4739439.9002671.html.plaintext.txt	335	1995 transcription cystic fibrosis transmembrane conductance regulator requires ccaat like element basal camp mediated regulation
0.4739439.9002671.html.plaintext.txt	336	1992 cellular differentiation required camp ca2 dependent cl secretion colonic epithelial cells expressing high levels cystic fibrosis transmembrane conductance regulator
0.4739439.9002671.html.plaintext.txt	337	1996 regulatory element intron 1 cystic fibrosis transmembrane conductance regulator gene
0.4739439.9002671.html.plaintext.txt	338	1995 charcterization dnase hypersensitive sites 120kb 5 cftr gene
0.4739439.9002671.html.plaintext.txt	339	1991 yeast artificial chromosome contig encompassing cystic fibrosis locus
0.4739439.9002671.html.plaintext.txt	340	1990 chromosomal region cystic fibrosis gene yeast artificial chromosomes model human genome mapping
0.4739439.9002671.html.plaintext.txt	341	1989 identification cystic fibrosis gene chromosome walking jumping
0.4739439.9002671.html.plaintext.txt	342	1995 high resolution dna fiber fish genomic dna mapping colour bar coding large genes
0.4739439.9002671.html.plaintext.txt	343	1995 high resolution dna fiber fish yeast artifical chromosomes direct visualization dna replication
0.4739439.9002671.html.plaintext.txt	344	1992 targeted integration neomycin yeast artificial chromosomes yacs transfection mammalian cells
0.4739439.9002671.html.plaintext.txt	345	1994 increasing expression normal human cftr cdna cystic fibrosis epithelial cells results progressive increase level cftr protein expression limit level camp stimulated chloride secretion
0.4739439.9002671.html.plaintext.txt	346	1993 transgenic mice containing human heavy chain immunoglobulin gene fragment yeast artificial chromosome
0.4739439.9002671.html.plaintext.txt	347	1992 molecular complementation collagen mutation mammalian cells using yeast artificial chromosomes
0.4739439.9002671.html.plaintext.txt	348	1990 human glucose 6 phosphate dehydrogenase gene carried yeast artificial chromosome encodes active enzyme activity monkey cells
0.4739439.9002671.html.plaintext.txt	349	1991 phosphorylation regulated cl channel cho cells stably expressing cystic fibrosis gene
0.4739439.9002671.html.plaintext.txt	350	1992 small linear chloride channels endogenous nonepithelial cells
0.4739439.9002671.html.plaintext.txt	351	1995 functional expression yeast artificial chromosome human multidrug resistance genes mouse cells
0.4739439.9002671.html.plaintext.txt	352	1993 use yeast artificial chromosomes yacs studying control gene expression correct regulation gene human beta globin locus yac following transfer mouse erythroleukemia cell lines
0.4739439.9002671.html.plaintext.txt	353	1991 human hprt gene yeast artificial chromosome functional transferred mouse cells cell fusion
0.4739439.9002671.html.plaintext.txt	354	1994 sublocalization human interferon gamma receptor accessory factor gene characterization accessory factor activity yeast artificial chromosome fragmentation
0.4739439.9002671.html.plaintext.txt	355	1994 epitope carcinoembryonic antigen defined clinically relevant antibody pr1a3
0.4739439.9002671.html.plaintext.txt	356	1991 generation camp activated chloride currents expression cftr
0.4739439.9002671.html.plaintext.txt	357	1993 targeted recombination based cloning manipulation large dna segments yeast
0.4739439.9002671.html.plaintext.txt	358	methods companion methods enzymology 5 161 175
0.4739439.9002671.html.plaintext.txt	359	1993 new vector transfer yeast artificial chromosomes mammalian cells
0.4739439.9002671.html.plaintext.txt	360	1991 genomic dna sequence cystic fibrosis transmembrane conductance regulator cftr gene
0.4739439.9002671.html.plaintext.txt	361	1992 vivo transfer human cystic fibrosis transmembrane conductance regulator gene airway epithelium
0.4739439.9002671.html.plaintext.txt	362	1986 cytogenetic analysis using quanitative high sensitivity fluoresence hybridization
0.4739439.9002671.html.plaintext.txt	363	1994 high resolution mapping using fluorescence situ hybridization extended dna fibers prepared agarose embedded cells
0.4739439.9002671.html.plaintext.txt	364	1990 defective intracellular transport processing cftr molecular basis cystic fibrosis
0.4739439.9002671.html.plaintext.txt	365	1995 two cystic fibrosis transmembrane conductance regulator mutations different effects pulmonary phenotype regulation outwardly rectfied chloride currents
0.4739439.9002671.html.plaintext.txt	366	correspondence addressed
0.4739439.9002671.html.plaintext.txt	367	page maintained oup admin
0.4739439.9002671.html.plaintext.txt	368	last updated sun jan 12 133616 gmt 1997
0.4739439.9002671.html.plaintext.txt	369	part oup journals world wide web service
0.4739439.9002671.html.plaintext.txt	370	copyright oxford university press 1996
0.4726967.12039948.html.plaintext.txt	0	cysteine string protein interacts modulates maturation cystic fibrosis transmembrane conductance regulator hui zhang kathryn w
0.4726967.12039948.html.plaintext.txt	1	peters fei sun christopher r
0.4726967.12039948.html.plaintext.txt	2	marino jochen lang robert d
0.4726967.12039948.html.plaintext.txt	3	department cell biology physiology university pittsburgh school medicine pittsburgh pennsylvania 15261 department medicine university tennessee memphis tennessee 38163 institut europeen de chimie et biologie pessac f 33607 france physiological laboratory university liverpool liverpool l69 3bx united kingdom
0.4726967.12039948.html.plaintext.txt	4	received publication december 7 2001 revised form may 1 2002
0.4726967.12039948.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references
0.4726967.12039948.html.plaintext.txt	6	cystic fibrosis transmembrane conductance regulator cftr camp regulated chloride channel whose phosphorylation regulates channel gating trafficking plasma membrane
0.4726967.12039948.html.plaintext.txt	7	cysteine string proteins csps j domain containing membrane associated proteins functionally implicated regulated exocytosis
0.4726967.12039948.html.plaintext.txt	8	therefore evaluated possibility csp involved regulated cftr trafficking
0.4726967.12039948.html.plaintext.txt	9	found csp expressed mammalian epithelial cell lines several express cftr
0.4726967.12039948.html.plaintext.txt	10	calu 3 airway cells immunofluorescence colocalized csp calnexin endoplasmic reticulum cftr apical membrane domain
0.4726967.12039948.html.plaintext.txt	11	cftr coprecipitated csp calu 3 cell lysates
0.4726967.12039948.html.plaintext.txt	12	csp associated core glycosylated immature fully glycosylated mature cftrs bands b c however relation endogenous levels b c bands expressed calu 3 cells csp interaction band b predominated
0.4726967.12039948.html.plaintext.txt	13	vitro protein binding assays detected physical interactions mammalian csp isoforms cftr r domain n terminus submicromolar affinities
0.4726967.12039948.html.plaintext.txt	14	xenopus oocytes expressing cftr csp overexpression decreased chloride current membrane capacitance increases evoked camp stimulation decreased levels cftr protein detected immunoblot
0.4726967.12039948.html.plaintext.txt	15	mammalian cells steady state expression cftr band c eliminated pulse chase studies showed csp coexpression blocked conversion immature mature cftr stabilized band b
0.4726967.12039948.html.plaintext.txt	16	results demonstrate primary role csp cftr protein maturation
0.4726967.12039948.html.plaintext.txt	17	physical interaction hsc70 binding protein immature cftr localization endoplasmic reticulum decrease production mature cftr observed csp overexpression reflect role csp cftr biogenesis
0.4726967.12039948.html.plaintext.txt	18	documented role csp regulated exocytosis interaction mature cftr coexpression cftr apical membrane domain epithelial cells may reflect also role csp regulated cftr trafficking plasma membrane
0.4726967.12039948.html.plaintext.txt	19	introduction top abstract introduction experimental procedures results discussion references
0.4726967.12039948.html.plaintext.txt	20	cystic fibrosis transmembrane conductance regulator cftr1 responsible camp activated chloride conductance epithelial cell apical membranes 1
0.4726967.12039948.html.plaintext.txt	21	mutations cftr gene cause cystic fibrosis whereas hyperactivity transport pathway produces secretory diarrhea
0.4726967.12039948.html.plaintext.txt	22	folding cftr energetically complex misfolding degradation protein features common cftr mutation f508 2 3
0.4726967.12039948.html.plaintext.txt	23	addition f508 cftr unable undergo atp dependent conformational changes er required proper folding
0.4726967.12039948.html.plaintext.txt	24	cftr folding retarded er protein becomes target proteolysis er associated degradation mechanisms police protein secretory pathway misfolded incompletely complexed proteins 4
0.4726967.12039948.html.plaintext.txt	25	degradation involves ubiquitination aberrant protein delivery proteasome 5 6
0.4726967.12039948.html.plaintext.txt	26	nearly f508 cftr produced cell destroyed manner complex folding pattern much wild type protein also degraded
0.4726967.12039948.html.plaintext.txt	27	mechanisms govern cftr foldingdegradation processes facilitated chaperone co chaperone protein interactions discussed
0.4726967.12039948.html.plaintext.txt	28	primary step cftr activation involves campprotein kinase mediated phosphorylation central regulatory r domain permits channel gate also alters pathways cftr trafficking plasma membrane 7
0.4726967.12039948.html.plaintext.txt	29	recent years protein interactions several cftr domains implicated channel function trafficking
0.4726967.12039948.html.plaintext.txt	30	n terminal cytosolic tail cftr site syntaxin 1a binding 8 syntaxin 1a overexpression thought inhibit cftr currents reducing channel gating 9 interfering regulated cftr trafficking plasma membrane 10
0.4726967.12039948.html.plaintext.txt	31	motif promoting cftr endocytosis identified c terminus region interacts physically plasma membrane endocytic adapter ap 2 complex 11 12
0.4726967.12039948.html.plaintext.txt	32	c terminus cftr corresponds pdz psd 95disc largezo 1 binding motif interacts ezrin radixin moesin binding phosphoprotein 50 e3karp bring ezrin proximity cftr 13 14
0.4726967.12039948.html.plaintext.txt	33	ezrin anchor protein kinase position physiologically appropriate cftr phosphorylation 15 16 ezrin interactions cytoskeleton permit retention cftr apical membrane mechanism establish polarity epithelial cells 17
0.4726967.12039948.html.plaintext.txt	34	report interaction cftr another multidomain protein cysteine string protein csp
0.4726967.12039948.html.plaintext.txt	35	csps first discovered drosophila torpedo 18 19 expression documented variety tissues several mammalian species 20 21
0.4726967.12039948.html.plaintext.txt	36	csp null mutants drosophila produce temperature sensitive block synaptic transmission followed paralysis premature death
0.4726967.12039948.html.plaintext.txt	37	findings demonstrate crucial role csp neurosecretion 22
0.4726967.12039948.html.plaintext.txt	38	neurons csp associated predominantly synaptic vesicles 19 secretory cells found large dense core secretory granules 23 24
0.4726967.12039948.html.plaintext.txt	39	studies membrane dye labeling 25 neurotransmitter release 26 27 indicated csp knockouts exhibit defective neurotransmitter exocytosis presynaptic endocytosis vesicle recycling appear intact
0.4726967.12039948.html.plaintext.txt	40	studies neuroendocrine 28 endocrine cells 24 confirmed altered csp expression elicits impaired secretory phenotype
0.4726967.12039948.html.plaintext.txt	41	csps contain n terminal j domain central cysteine rich string region phylogenetically variable c terminal domain
0.4726967.12039948.html.plaintext.txt	42	j domains csps structurally conserved among different species region provides fingerprint csp member dnajhsp40 heat shock protein chaperone family
0.4726967.12039948.html.plaintext.txt	43	observed chaperone proteins 29 hpd motif csp j domain mediates binding activation hsc70 chaperone atpases influence protein conformationbinding
0.4726967.12039948.html.plaintext.txt	44	structural predictions indicate c terminus csp1 may form coiled coil region structure may important view emerging evidence csp interact proteins involved exocytosis vesicle associated membrane protein syntaxins 1a 4 21 30 31
0.4726967.12039948.html.plaintext.txt	45	thus prior results suggest csp could link functions snare complex hsc70
0.4726967.12039948.html.plaintext.txt	46	concept assembly core fusion complex requires chaperone activity raised previously 21 however explicit roles csp hsc70 assembly disassembly snare components yet known
0.4726967.12039948.html.plaintext.txt	47	c terminus csp contains primary structural difference exists mammalian isoforms full length csp1 c terminal truncated variant csp2 32 33
0.4726967.12039948.html.plaintext.txt	48	csp expression epithelial cells characterized previously
0.4726967.12039948.html.plaintext.txt	49	found various mammalian epithelial cell lines express two csp isoforms expression csp1 predominated csp2
0.4726967.12039948.html.plaintext.txt	50	calu 3 airway epithelial cells csp partially colocalized cftr er apical plasma membrane domains
0.4726967.12039948.html.plaintext.txt	51	csp coprecipitated cftr calu 3 cell lysates bound selectively n terminus r domain cftr high affinity
0.4726967.12039948.html.plaintext.txt	52	coexpression csp isoforms cftr inhibited functional responses associated camp stimulation exogenous csp expression decreased production mature cftr
0.4726967.12039948.html.plaintext.txt	53	findings suggest csp cftr binding partner influence biogenesis trafficking cftr
0.4726967.12039948.html.plaintext.txt	54	experimental procedures top abstract introduction experimental procedures results discussion references
0.4726967.12039948.html.plaintext.txt	55	materials reagents protein ag agarose beads taq polymerase purchased invitrogen
0.4726967.12039948.html.plaintext.txt	56	glutathione sepharose 4b purchased amersham biosciences
0.4726967.12039948.html.plaintext.txt	57	dna restriction endonucleases new england biolabs
0.4726967.12039948.html.plaintext.txt	58	dna purification kits obtained qiagen
0.4726967.12039948.html.plaintext.txt	59	csp1 csp2 cdnas subcloned pcdna3 n terminal myc tag 34
0.4726967.12039948.html.plaintext.txt	60	mouse hippocampus neuronal cell sy5s lysate employed csp protein positive control kindly provided dr
0.4726967.12039948.html.plaintext.txt	61	chaohua yan childrens hospital pittsburgh
0.4726967.12039948.html.plaintext.txt	62	protein kinase reagent grade chemicals purchased sigma
0.4726967.12039948.html.plaintext.txt	63	antibodies anti csp serum raised rabbits recombinant bovine csp1 32
0.4726967.12039948.html.plaintext.txt	64	monoclonal anti gst anti golgi 58k antibodies purchased sigma
0.4726967.12039948.html.plaintext.txt	65	anti cftr polyclonal antibodies r3195 generated affinity purified described 35
0.4726967.12039948.html.plaintext.txt	66	anti cftr mab3484 mab3482 anti csp monoclonal antibodies obtained chemicon
0.4726967.12039948.html.plaintext.txt	67	horseradish peroxidase conjugated anti rabbit igg anti mouse igg obtained sigma
0.4726967.12039948.html.plaintext.txt	68	monoclonal anti calnexin antibodies obtained affinity bioreagents
0.4726967.12039948.html.plaintext.txt	69	cell culture calu 3 t84 cells cultured described sun et al
0.4726967.12039948.html.plaintext.txt	70	cfpac 1 cells grown iscoves essential medium biofluids containing 5 fetal bovine serum 4 mm l glutamine penicillin streptomycin invitrogen
0.4726967.12039948.html.plaintext.txt	71	madin darby canine kidney hek293 cells cultured dulbeccos modified eagles medium sigma 10 fetal bovine serum 4 mm l glutamine penicillin streptomycin
0.4726967.12039948.html.plaintext.txt	72	xenopus kidney derived a6 epithelial cells cultured described previously 36
0.4726967.12039948.html.plaintext.txt	73	reverse transcription pcr total rnas prepared indicated cell lines use trizol buffer invitrogen cdnas synthesized using reverse transcriptase dt15 primer
0.4726967.12039948.html.plaintext.txt	74	pcrs performed described 24
0.4726967.12039948.html.plaintext.txt	75	following primers used 5 attaggatccatggcagaccagagacagc sense human csp bamhi restriction site underlined 5 acgaattcttagttgaacccgtcagtgtg antisense human csp ecori restriction site underlined 5 attaggatccatggcagatcagcggcagc sense xenopus csp 5 acgaattctcagttgaatccatcggtgtg antisense xenopus csp
0.4726967.12039948.html.plaintext.txt	76	pcr products calu 3 a6 cells cloned pcrii vector using topo cloning reaction transformation kit invitrogen sequencing
0.4726967.12039948.html.plaintext.txt	77	western blotting crude membranes various epithelial cell lines oocytes prepared described lang et al
0.4726967.12039948.html.plaintext.txt	78	prepare crude membrane extracts epithelial cells detached incubation 5 min 37 degrees c 1 x trypsin two washes ice cold phosphate buffered saline cells resuspended ice cold homogenization buffer 5 mm hepes ph 7
0.4726967.12039948.html.plaintext.txt	79	4 250 mm sucrose 1 mm egta 10 microgml leupeptin 2 microgml aprotinin sonicated centrifuged 100000 x g 60 min
0.4726967.12039948.html.plaintext.txt	80	crude membranes recovered incubated 0
0.4726967.12039948.html.plaintext.txt	81	5 triton x 100 4 degrees c 1 h centrifuged 16000 x g 1 h
0.4726967.12039948.html.plaintext.txt	82	supernatant collected stored analysis
0.4726967.12039948.html.plaintext.txt	83	50 microg membrane extract separated 12 sds page minigels transferred polyvinylidene difluoride membranes
0.4726967.12039948.html.plaintext.txt	84	blots probed 12000 dilution csp cftr antiserum
0.4726967.12039948.html.plaintext.txt	85	vesicular stomatitis virus glycoprotein vsv g detection blots probed polyclonal antibody 15000 dilution
0.4726967.12039948.html.plaintext.txt	86	immunofluorescence calu 3 cell labeling performed described previously 14
0.4726967.12039948.html.plaintext.txt	87	cells seeded filters costar transwell 2 3 weeks use
0.4726967.12039948.html.plaintext.txt	88	washing away apical secretions cells fixed 4 paraformaldehyde permeabilized 0
0.4726967.12039948.html.plaintext.txt	89	filters mounted glass coverslips images obtained using leica tcs nt confocal microscope described 14
0.4726967.12039948.html.plaintext.txt	90	plasmid constructs gst fusion protein expression wild type csp1 csp2 subcloned pgex 6p 1
0.4726967.12039948.html.plaintext.txt	91	cdnas encoding gst cftr r domain gst r gst cftr n terminus gst n gst cftr c terminus gst c described previously 15
0.4726967.12039948.html.plaintext.txt	92	gst cftr n random constructed gst n except one nucleotide shift reading frame yields different amino acid composition net charge size comparable cftr n
0.4726967.12039948.html.plaintext.txt	93	purification dialysis gst fusion proteins performed described sun et al
0.4726967.12039948.html.plaintext.txt	94	pull assays coimmunoprecipitation 10 microg gst fusion protein incubated 20 microl preequilibrated glutathione sepharose 4b beads 200 microl dignam d buffer containing 0
0.4726967.12039948.html.plaintext.txt	95	1 bovine serum albumin 4 degrees c 1 h 38
0.4726967.12039948.html.plaintext.txt	96	calu 3 membrane fractions added incubation continued additional 2 h 4 degrees c
0.4726967.12039948.html.plaintext.txt	97	five washes dignam d buffer samples resuspended 30 microl 2 x sds sample buffer boiled 2 min resolved 12 sds page probed anti csp antibodies 12000
0.4726967.12039948.html.plaintext.txt	98	coimmunoprecipitation performed described sun et al
0.4726967.12039948.html.plaintext.txt	99	10 protein extract employed immunoprecipitation loaded subsequent immunoblot
0.4726967.12039948.html.plaintext.txt	100	vitro binding competition assays vitro binding assays performed described sun et al
0.4726967.12039948.html.plaintext.txt	101	15 vitro competition assays performed described sun et al
0.4726967.12039948.html.plaintext.txt	102	briefly 10 microg gst cftr r gst cftr n fusion protein immobilized glutathione beads incubated 106 cpm 35s labeled csp1 csp2 presence indicated concentrations unlabeled csp1 csp2
0.4726967.12039948.html.plaintext.txt	103	five washes samples resuspended sds sample buffer signals visualized autoradiography
0.4726967.12039948.html.plaintext.txt	104	transient transfections hek293 cells grown 60 mm dishes transiently transfected using lipofectamine invitrogen indicated pcdna3 pcdna3
0.4726967.12039948.html.plaintext.txt	105	1 expression plasmids 4 microg cdnadish
0.4726967.12039948.html.plaintext.txt	106	24 h cells rinsed phosphate buffered saline either prepared pulse chase assays lysed ripa buffer 50 mm tris hcl ph 7
0.4726967.12039948.html.plaintext.txt	107	4 150 mm nacl 1 triton x 100 1 sodium deoxycholate 0
0.4726967.12039948.html.plaintext.txt	108	1 sds nonidet p 40 lysis buffer 0
0.4726967.12039948.html.plaintext.txt	109	09 nonidet 40 50 mm tris hcl ph 7
0.4726967.12039948.html.plaintext.txt	110	4 150 mm nacl 10 mm namoo4
0.4726967.12039948.html.plaintext.txt	111	samples incubated 2 h appropriate lysis buffer centrifuged 16000 x g 30 min 4 degrees c
0.4726967.12039948.html.plaintext.txt	112	cell extracts utilized immunoblot analysis see figure legends
0.4726967.12039948.html.plaintext.txt	113	pulse chase assays metabolic labeling immunoprecipitation cftr performed using methods described previously 39 40 modifications
0.4726967.12039948.html.plaintext.txt	114	transfected hek293 cells starved methionine cysteine free dulbeccos modified eagles medium 30 min metabolically labeled redivue pro mix l 35s 140 microciml amersham biosciences 30 min 37 degrees c
0.4726967.12039948.html.plaintext.txt	115	cells washed twice phosphate buffered saline lysed immediately incubated complete dulbeccos modified eagles medium indicated chase periods
0.4726967.12039948.html.plaintext.txt	116	cell lysates precleared protein agarose immunoprecipitation performed described 40 using m3a7 anti cftr kindly supplied dr
0.4726967.12039948.html.plaintext.txt	117	immunoprecipitates analyzed using 7 sds page autoradiography
0.4726967.12039948.html.plaintext.txt	118	electrophysiology cftr csp1 csp2 crnas synthesized using mmessage mmachine kit ambion linearized plasmids
0.4726967.12039948.html.plaintext.txt	119	quality synthesized crna determined spectrophotometry agarose gel electrophoresis
0.4726967.12039948.html.plaintext.txt	120	oocyte preparation crna injections carried described takahashi et al
0.4726967.12039948.html.plaintext.txt	121	expression proceeded 2 6 days current capacitance recordings performed described 10 41
0.4726967.12039948.html.plaintext.txt	122	data provided mean plus minus
0.4726967.12039948.html.plaintext.txt	123	results top abstract introduction experimental procedures results discussion references
0.4726967.12039948.html.plaintext.txt	124	csp expressed epithelial cells immunoblotting performed determine whether csp expressed several epithelial cell lines
0.4726967.12039948.html.plaintext.txt	125	crude membrane extracts mammalian cells hek293 madin darby canine kidney type 2 cfpac 1 calu 3 t84 xenopus a6 cell line resolved 12 sds page probed anti csp antiserum distinguish csp isoforms 32
0.4726967.12039948.html.plaintext.txt	126	positive control membranes sy5y human neuronal hippocampal cell line applied gel
0.4726967.12039948.html.plaintext.txt	127	1a mammalian epithelial cells examined expressed two csp isoforms
0.4726967.12039948.html.plaintext.txt	128	1a appropriate size csp1 33 35 kda whereas lower bands mammalian cells correspond size expected csp2 26 28 kda isoform uniformly less abundant
0.4726967.12039948.html.plaintext.txt	129	contrast a6 cells expressed one csp isoform
0.4726967.12039948.html.plaintext.txt	130	closely related csp1 csp2 33 although molecular size slightly smaller csp1 mammalian cells
0.4726967.12039948.html.plaintext.txt	131	csp antiserum also recognized vitro synthesized csp1 csp2 data shown
0.4726967.12039948.html.plaintext.txt	132	view larger version 46k fig
0.4726967.12039948.html.plaintext.txt	133	csps expressed various epithelial cell lines
0.4726967.12039948.html.plaintext.txt	134	panel homogenates 15 microg protein indicated cell lines probed csp antiserum
0.4726967.12039948.html.plaintext.txt	135	panel b reverse transcription pcr performed described experimental procedures
0.4726967.12039948.html.plaintext.txt	136	cdna added pcr designated control
0.4726967.12039948.html.plaintext.txt	137	confirm expression csp isoforms cells reverse transcription pcr employed results shown fig
0.4726967.12039948.html.plaintext.txt	138	sizes pcr products expected cdnas encoding csp1 csp2
0.4726967.12039948.html.plaintext.txt	139	products derived contaminating dna primers employed span csp exons
0.4726967.12039948.html.plaintext.txt	140	csp2 protein truncated relative csp1 insertion stop codon containing rna splice fragment 32 accounts smaller size csp2 protein larger cdna pcr product fig
0.4726967.12039948.html.plaintext.txt	141	although pcr results quantitative csp amplicon ratios different cell lines generally agreed pattern isoform expression observed immunoblot
0.4726967.12039948.html.plaintext.txt	142	protein analysis csp isoforms expressed lower levels t84 cells
0.4726967.12039948.html.plaintext.txt	143	one isoform csp detected a6 cells accord protein data fig
0.4726967.12039948.html.plaintext.txt	144	1a information data base
0.4726967.12039948.html.plaintext.txt	145	sequencing pcr products confirmed expression csp1 2 calu 3 cells single isoform 33 reported xenopus a6 epithelia data shown
0.4726967.12039948.html.plaintext.txt	146	csps partially colocalized cftr er apical membranes non epithelial cells csps membrane associated localized predominantly large dense core vesicles synaptic like microvesicles 22 24 42 43
0.4726967.12039948.html.plaintext.txt	147	small fraction csp located plasma membranes neurons neuroendocrine endocrine cells
0.4726967.12039948.html.plaintext.txt	148	large dense core vesicles present epithelial cells defined secretory products e
0.4726967.12039948.html.plaintext.txt	149	pancreatic acinar cells csp distribution epithelial cells defined previously
0.4726967.12039948.html.plaintext.txt	150	examine subcellular distribution csps airway epithelial cells immunofluorescent staining performed polarized calu 3 cells visualized using confocal microscopy
0.4726967.12039948.html.plaintext.txt	151	sections taken various cell depths fig
0.4726967.12039948.html.plaintext.txt	152	2 d showed predominantly punctate vesicular distribution pattern csp green fluorescence
0.4726967.12039948.html.plaintext.txt	153	csp cftr red fluorescence colocalized apical sections indicated yellow staining pattern fig
0.4726967.12039948.html.plaintext.txt	154	2e fraction csp colocalized cftr apical region cells apex cells showed little apparent colocalization
0.4726967.12039948.html.plaintext.txt	155	although csp colocalized cftr apical membrane compartments significant fractions proteins showed apparent overlap immunofluorescence steady state cellular distributions fig
0.4726967.12039948.html.plaintext.txt	156	partly presence csp appear large secretory granules lack cftr 44
0.4726967.12039948.html.plaintext.txt	157	granules likely contain secretory products characteristic airway submucosal gland serous cells calu 3 cells express e
0.4726967.12039948.html.plaintext.txt	158	mucins microbial defense substances protease inhibitors 45
0.4726967.12039948.html.plaintext.txt	159	cftr detected membranes fig
0.4726967.12039948.html.plaintext.txt	160	2 contrast localization cftr found mucin granules canine gallbladder cells 46
0.4726967.12039948.html.plaintext.txt	161	observation suggests csp may play cftr independent role secretory granule exocytosis calu 3 cells possibility require study
0.4726967.12039948.html.plaintext.txt	162	view larger version 70k fig
0.4726967.12039948.html.plaintext.txt	163	colocalization csp cftr calnexin calu 3 cells
0.4726967.12039948.html.plaintext.txt	164	calu 3 cells labeled polyclonal csp antiserum monoclonal cftr r domain calnexin antibodies
0.4726967.12039948.html.plaintext.txt	165	labeling detected alexa488 green indicating csp alexa568 red indicating cftr panels e calnexin panel f
0.4726967.12039948.html.plaintext.txt	166	serial images xy plane collected every 0
0.4726967.12039948.html.plaintext.txt	167	5 microm specimen depth xy images panels d taken cell apex base separated 2
0.4726967.12039948.html.plaintext.txt	168	panel e shows xz scan region indicated panel
0.4726967.12039948.html.plaintext.txt	169	images collected confocal microscopy analyzed using metamorph universal imaging software
0.4726967.12039948.html.plaintext.txt	170	2f taken nuclear level shows csp green partially colocalized calnexin red er marker
0.4726967.12039948.html.plaintext.txt	171	preliminary analysis calu 3 cells sucrose density gradient centrifugation consistent also colocalization proteins csp found fractions containing er marker calnexin
0.4726967.12039948.html.plaintext.txt	172	2 results suggest fraction csp colocalized cftr er apical membrane domain calu 3 epithelia
0.4726967.12039948.html.plaintext.txt	173	interaction cftr csp determine whether physical interaction csp cftr could detected vivo performed coimmunoprecipitation experiments fig
0.4726967.12039948.html.plaintext.txt	174	studies initial precipitation performed either csp antiserum antibodies first nucleotide binding domain nbd1 cftr
0.4726967.12039948.html.plaintext.txt	175	3a lane 3 csp antibody coimmunoprecipitated mature glycosylated cftr band c upper well immature core glycosylated cftr band b lower calu 3 cell extracts
0.4726967.12039948.html.plaintext.txt	176	negative control cftr precipitated nonimmune igg lane 2
0.4726967.12039948.html.plaintext.txt	177	control coimmunoprecipitation performed direct cftr immunoblotting calu 3 membrane preparations fig
0.4726967.12039948.html.plaintext.txt	178	cftr bands present ratio b c bands found csp immunoprecipitation differs constitutively expressed
0.4726967.12039948.html.plaintext.txt	179	together results cellular localization experiments immunoprecipitation results suggest steady state csp interacts immature core glycosylated form cftr er mature fully glycosylated cftr apical membrane domain
0.4726967.12039948.html.plaintext.txt	180	3b cftr nbd1 antibody coprecipitated csp calu 3 membranes see positive control calu 3 cell lysate lane 1
0.4726967.12039948.html.plaintext.txt	181	n terminal cftr antibody precipitate significant csp data shown
0.4726967.12039948.html.plaintext.txt	182	lower band denoted csp panel b likely represents deacylated csp produced coimmunoprecipitation conditions include overnight incubation detergent noted others 47
0.4726967.12039948.html.plaintext.txt	183	lower band observed conditions used immunoblotting fig
0.4726967.12039948.html.plaintext.txt	184	negative control csp coprecipitate gst antibody fig
0.4726967.12039948.html.plaintext.txt	185	absence csp coprecipitation anti cftr n could represent problem antibody affinity may reflect impaired antibody access epitope n terminus cftr
0.4726967.12039948.html.plaintext.txt	186	view larger version 28k fig
0.4726967.12039948.html.plaintext.txt	187	coimmunoprecipitation csp cftr
0.4726967.12039948.html.plaintext.txt	188	calu 3 membrane extract mixed csp cftr antibody precipitated described experimental procedures
0.4726967.12039948.html.plaintext.txt	189	immunoblots probed anti cftr 12000 panel anti csp antibodies 12000 panel b
0.4726967.12039948.html.plaintext.txt	190	calu 3 cell membrane extract loaded positive control panels b lanes 1
0.4726967.12039948.html.plaintext.txt	191	antibodies used immunoprecipitation nonimmune igg anti csp panel lanes 2 3 anti gst anti cftr nbd1 panel b lanes 2 3
0.4726967.12039948.html.plaintext.txt	192	lower band denoted csp panel b likely represents deacylated csp produced coimmunoprecipitation conditions include overnight incubation detergent
0.4726967.12039948.html.plaintext.txt	193	outcome noted others 43 47
0.4726967.12039948.html.plaintext.txt	194	hc indicates antibody heavy chain
0.4726967.12039948.html.plaintext.txt	195	csp interacts r domain n terminus cftr results coimmunoprecipitation experiments indicate cftr csp interact vivo
0.4726967.12039948.html.plaintext.txt	196	evaluate cftr domain interactions csp performed pull experiments gst gst cftr fusion proteins bound glutathione sepharose beads incubated calu 3 cftr expressing hek293 membrane extracts
0.4726967.12039948.html.plaintext.txt	197	protein complexes washed resolved sds page immunoblotting performed using csp antibodies
0.4726967.12039948.html.plaintext.txt	198	verify comparable amounts gst gst fusion proteins applied assays western blots subsequently stained coomassie blue
0.4726967.12039948.html.plaintext.txt	199	similar amounts fusion proteins present illustrated fig
0.4726967.12039948.html.plaintext.txt	200	4b cftr r domain n terminus showed significant interactions csp
0.4726967.12039948.html.plaintext.txt	201	weak interaction cftr c csp detected observed consistently
0.4726967.12039948.html.plaintext.txt	202	binding detected csp gst gst cftr n random gst syntaxin 1a pull assays
0.4726967.12039948.html.plaintext.txt	203	interaction csp cftr n consistent finding coimmunoprecipitation studies suggests interaction cftr n could masked csp binding
0.4726967.12039948.html.plaintext.txt	204	view larger version 18k fig
0.4726967.12039948.html.plaintext.txt	205	csp interacts r domain n terminus cftr
0.4726967.12039948.html.plaintext.txt	206	bead immobilized gst cftr fusion proteins incubated calu 3 membrane extracts
0.4726967.12039948.html.plaintext.txt	207	washing samples resolved 12 sds page
0.4726967.12039948.html.plaintext.txt	208	coomassie blue staining used determine protein loading panel membranes blotted csp antiserum panel b
0.4726967.12039948.html.plaintext.txt	209	gst cftr fusion proteins lane 1 gst lane 2 gst r lane 3 gst c lane 4 gst n lane 5 gst n random lane 6 gst syntaxin 1a
0.4726967.12039948.html.plaintext.txt	210	indicated two csp isoforms identified various mammalian species 21 csp2 truncated 31 amino acids c terminus relative csp1
0.4726967.12039948.html.plaintext.txt	211	csp isoforms interact cftr cftr domains calu 3 cells figs
0.4726967.12039948.html.plaintext.txt	212	3 4 cannot determined lack isoform specific csp antibodies
0.4726967.12039948.html.plaintext.txt	213	csp1 may physiologically significant isoform predominant expression presence csp1 species fig
0.4726967.12039948.html.plaintext.txt	214	characterizing cftr csp interactions evaluated influence csp1 csp2 however discussion following refer cftr interactions csp without attempting discriminate whether mediated specific csp isoform
0.4726967.12039948.html.plaintext.txt	215	relative affinities csp cftr domains determine relative binding properties csp1 2 cftr performed binding assays vitro synthesized 35s labeled csp1 csp2
0.4726967.12039948.html.plaintext.txt	216	csp interactions documented using autoradiography fig
0.4726967.12039948.html.plaintext.txt	217	5a liquid scintillation counting fig
0.4726967.12039948.html.plaintext.txt	218	indicated data assays interaction csp1 cftr r domain lane 2 stronger cftr n lane 4 consistent calu 3 cell pull experiments fig
0.4726967.12039948.html.plaintext.txt	219	present experiments weak interaction cftr nbd1 csp1 lane 5 also detected relative gst negative control lane 1
0.4726967.12039948.html.plaintext.txt	220	data cftr c lane 3 different gst control
0.4726967.12039948.html.plaintext.txt	221	unlike csp1 csp2 showed similar levels binding cftr r cftr n
0.4726967.12039948.html.plaintext.txt	222	like csp1 csp2 showed significant low level binding cftr nbd1 relative gst control
0.4726967.12039948.html.plaintext.txt	223	lower panel provides pooled data three independent experiments
0.4726967.12039948.html.plaintext.txt	224	view larger version 37k fig
0.4726967.12039948.html.plaintext.txt	225	quantitative csp interactions cftr r domain n terminus
0.4726967.12039948.html.plaintext.txt	226	immobilized gst cftr fusion proteins incubated 35s csp1 35s csp2 washed samples resolved 15 sds page
0.4726967.12039948.html.plaintext.txt	227	csp binding detected autoradiography panel liquid scintillation counting panel b
0.4726967.12039948.html.plaintext.txt	228	mean data three independent experiments shown
0.4726967.12039948.html.plaintext.txt	229	asterisks indicate significant difference gst control
0.4726967.12039948.html.plaintext.txt	230	lane 1 gst lane 2 gst r lane 3 gst c lane 4 gst n lane 5 gst nbd1 s1 s2 1 microl 35s csp1 35s csp2 loaded positive control
0.4726967.12039948.html.plaintext.txt	231	higher molecular mass bands thought represent csp dimers observed previously 47
0.4726967.12039948.html.plaintext.txt	232	determine relative binding affinities csps cftr r domain n terminus performed vitro competitive binding assays described experimental procedures
0.4726967.12039948.html.plaintext.txt	233	pull experiments 35s labeled csp1 2 mixed various amounts unlabeled csp mixing immobilized cftr domains
0.4726967.12039948.html.plaintext.txt	234	6a unlabeled csp1 competed labeled csp1 binding cftr r 1 microm unlabeled csp1 eliminated 51 35s csp1 binding
0.4726967.12039948.html.plaintext.txt	235	results imply affinity csp1 binding cftr r 1 microm
0.4726967.12039948.html.plaintext.txt	236	qualitatively similar results obtained csp1 binding cftr n terminus case apparent binding affinity 10 nm
0.4726967.12039948.html.plaintext.txt	237	6a association labeled csp2 either cftr n terminus r domain essentially eliminated presence 1 microm cold csp2 data shown
0.4726967.12039948.html.plaintext.txt	238	results indicate csp1 csp2 show saturable binding r domain n terminus cftr affinities interactions submicromolar range
0.4726967.12039948.html.plaintext.txt	239	whether differences apparent binding affinity detected experiments e
0.4726967.12039948.html.plaintext.txt	240	csp1 interactions r n physiological significance require detailed knowledge functional consequences
0.4726967.12039948.html.plaintext.txt	241	view larger version 24k fig
0.4726967.12039948.html.plaintext.txt	242	affinity csp binding cftr r cftr n
0.4726967.12039948.html.plaintext.txt	243	panels b immobilized gst cftr fusion proteins incubated 35s csp1 presence absence five concentrations unlabeled csp1 binding detected autoradiography upper panels densitometric quantification autoradiography lower panels
0.4726967.12039948.html.plaintext.txt	244	lane b 35s csp1 omitted negative control lane c equivalent amount 35s csp1 added positive control
0.4726967.12039948.html.plaintext.txt	245	csp coexpression inhibits cftr chloride currents multiple domain interactions observed csp binding cftr well colocalization proteins er apical membrane domain suggest functional interactions proteins could extensive
0.4726967.12039948.html.plaintext.txt	246	initiate studies coexpressed cftr either csp1 csp2 xenopus oocytes determined cftr dependent current capacitance changes evoked camp stimulation
0.4726967.12039948.html.plaintext.txt	247	prior studies cftr expressing oocytes indicate camp induced membrane current im caused chloride flow cftr corresponding increase membrane capacitance cm monitors changes cell surface area associated regulated insertion cftr plasma membrane 10 41
0.4726967.12039948.html.plaintext.txt	248	relation initial rationale studies monitored cm csp known function regulated exocytosis systems 21
0.4726967.12039948.html.plaintext.txt	249	control oocytes injected cftr crna showed changes im cm response camp stimulation observed previously 41
0.4726967.12039948.html.plaintext.txt	250	expression csp without cftr also yielded im cm responses camp data shown
0.4726967.12039948.html.plaintext.txt	251	steady state data eight experiments cftr expressing oocytes provided fig
0.4726967.12039948.html.plaintext.txt	252	coexpression csp1 csp2 cftr decreased im cm responses result cftr stimulation
0.4726967.12039948.html.plaintext.txt	253	although either csp isoform reduced functional expression cftr csp2 potent inhibitor im cm 90 inhibition relative csp1 50 inhibition
0.4726967.12039948.html.plaintext.txt	254	7 documents expression myc tagged csp isoforms time recording
0.4726967.12039948.html.plaintext.txt	255	band lane 1 observed oocytes expressing cftr alone corresponds single known endogenous xenopus csp consistent a6 cell line data shown fig
0.4726967.12039948.html.plaintext.txt	256	exogenous expression myc tagged csp1 2 shown lanes 2 3 upper panel
0.4726967.12039948.html.plaintext.txt	257	know whether endogenous xenopus csp closely resembles mammalian csp1 42 contributes differences extent inhibition isoforms whether different potencies relate structural features
0.4726967.12039948.html.plaintext.txt	258	view larger version 27k fig
0.4726967.12039948.html.plaintext.txt	259	csp coexpression inhibits cftr im cm
0.4726967.12039948.html.plaintext.txt	260	lower panel im solid bars basal stimulated cm values horizontal vertical lined bars respectively oocytes expressing cftr cftr plus indicated csp isoform
0.4726967.12039948.html.plaintext.txt	261	stimulation elicited bath addition 10 microm forskolin 1 mm isobutylmethylxanthine
0.4726967.12039948.html.plaintext.txt	262	steady state data three independent experiments shown
0.4726967.12039948.html.plaintext.txt	263	numbers observations cftr 36 cftr csp1 14 cftr csp2 28
0.4726967.12039948.html.plaintext.txt	264	im cm inhibition csp coexpression significant p 0
0.4726967.12039948.html.plaintext.txt	265	upper panel oocyte expression endogenous xenopus csp lanes myc csp1 lane 2 myc csp2 lane 3 parallel experiments
0.4726967.12039948.html.plaintext.txt	266	crna injectedoocyte cftr 1 ng csp isoforms 5 ng
0.4726967.12039948.html.plaintext.txt	267	csp inhibits functional cftr responses decreasing steady state cftr expression determine whether observed inhibition cftr current capacitance changes result csp induced change cftr expression levels immunoprecipitated cftr oocytes expressing cftr alone cftr plus csp1 csp2 csp2 double mutant h43qe93v
0.4726967.12039948.html.plaintext.txt	268	cftr precipitated oocyte membrane extracts resolved sds page immunoblotted see experimental procedures
0.4726967.12039948.html.plaintext.txt	269	cftr currents recorded populations oocytes time harvest also provided
0.4726967.12039948.html.plaintext.txt	270	8 upper panel coexpression csp1 csp2 produced significant decreases level cftr expression 52 36 control level densitometry lanes 3 4 respectively
0.4726967.12039948.html.plaintext.txt	271	negative control cftr detected noninjected oocytes lane 1
0.4726967.12039948.html.plaintext.txt	272	positive control blotted cftr expressed transiently hek293 cells lane 6
0.4726967.12039948.html.plaintext.txt	273	apparent molecular masses cftr b c bands expressed oocytes similar observed hek cells longer exposure demonstrated migration hek cell band b location observed oocytes
0.4726967.12039948.html.plaintext.txt	274	increase cftr expression observed csp2 double mutant result currents greater cftr control
0.4726967.12039948.html.plaintext.txt	275	degree cftr expression increase observed experiments present mammalian cells see
0.4726967.12039948.html.plaintext.txt	276	basis stimulatory effect csp2 double mutant pursued
0.4726967.12039948.html.plaintext.txt	277	double mutant mutation sites 43 conserved site j domain csp essential hsc70 binding atp hydrolysis 48 glu 93 located csp linker region shown previously abrogate inhibitory effect csp overexpression insulin release pancreatic cells 24
0.4726967.12039948.html.plaintext.txt	278	results indicate effects exogenously expressed csp cftr activity specific known csp functional domains suggest inhibition cftr functional response due primarily csp induced reduction cftr protein expression
0.4726967.12039948.html.plaintext.txt	279	view larger version 48k fig
0.4726967.12039948.html.plaintext.txt	280	csp coexpression reduces oocyte cftr protein levels
0.4726967.12039948.html.plaintext.txt	281	crnas encoding cftr 1 ng csp isoforms 5 ng injected xenopus oocytes indicated
0.4726967.12039948.html.plaintext.txt	282	upper panel results cftr immunoprecipitation
0.4726967.12039948.html.plaintext.txt	283	immunoprecipitation performed anti cftr monoclonal m3a7 immunoblot probed anti cftr polyclonal r3195 antibodies
0.4726967.12039948.html.plaintext.txt	284	lane 1 uninjected control lane 2 cftr alone lane 3 cftr plus csp1 lane 4 cftr plus csp2 lane 5 cftr plus csp2 double mutant lane 6 hek293 cells transiently expressing cftr used positive control
0.4726967.12039948.html.plaintext.txt	285	lower panel camp stimulated chloride currents recorded oocyte populations used immunoprecipitations
0.4726967.12039948.html.plaintext.txt	286	data five pooled oocytes immunoprecipitation 50 microg proteinlane four five oocytes icl condition
0.4726967.12039948.html.plaintext.txt	287	recordingsimmunoprecipitations performed 4 days injection
0.4726967.12039948.html.plaintext.txt	288	csp coexpression inhibits cftr biogenesis influence csp coexpression steady state levels cftr expressed mammalian cells determined cotransfecting hek293 cells plasmids encoding csp cftr
0.4726967.12039948.html.plaintext.txt	289	cftr levels determined immunoblot 24 h
0.4726967.12039948.html.plaintext.txt	290	csp cdnas used transfection included n terminal myc tag permitting exogenous csp expression detected using anti myc antibody lower panel fig
0.4726967.12039948.html.plaintext.txt	291	shown top panel fig
0.4726967.12039948.html.plaintext.txt	292	9a coexpression either csp1 csp2 cftr lanes 3 4 eliminated expression mature glycosylated cftr band c produced accumulation immature cftr band b
0.4726967.12039948.html.plaintext.txt	293	finding suggests csp overexpression interferes processing cftr mature form stabilizes immature form cftr
0.4726967.12039948.html.plaintext.txt	294	effect exogenous csp cftr biogenesis specific csp2 double mutant h43ve93q eliminated inhibitory effect cftr maturation lane 5
0.4726967.12039948.html.plaintext.txt	295	experiments similar result obtained csp2 single mutant h43q implying functional j domain critical inhibitory effect csp overexpression
0.4726967.12039948.html.plaintext.txt	296	enhancement cftr protein level csp2 double mutant found oocytes observed mammalian cells
0.4726967.12039948.html.plaintext.txt	297	view larger version 34k fig
0.4726967.12039948.html.plaintext.txt	298	effect csp cftr biogenesis
0.4726967.12039948.html.plaintext.txt	299	panel hek293 cells transfected cftr lane 2 cftr plus myc csp1 lane 3 cftr plus myc csp2 lane 4 cftr plus myc csp2 double mutant lane 5
0.4726967.12039948.html.plaintext.txt	300	lane 1 nontransfected control
0.4726967.12039948.html.plaintext.txt	301	24 h 50 microg cell extract resolved 7 15 mini sds page blots probed polyclonal anti cftr r3195 12000 monoclonal anti hsc70 12000 monoclonal anti c myc 9e10 12000 sigma antibodies
0.4726967.12039948.html.plaintext.txt	302	b c indicate positions immature mature cftr respectively
0.4726967.12039948.html.plaintext.txt	303	panel b hek293 cells transfected vsv g lane 1 vsv g plus csp1 lane 2 blots probed anti vsv g polyclonal 15000
0.4726967.12039948.html.plaintext.txt	304	experiments otherwise performed panel
0.4726967.12039948.html.plaintext.txt	305	csp hsc70 binding protein examined levels hsc70 immunoblot conditions
0.4726967.12039948.html.plaintext.txt	306	shown middle panel fig
0.4726967.12039948.html.plaintext.txt	307	9a effect csp1 2 cftr expression associated change hsc70 expression levels hsc70 binding protein expressed
0.4726967.12039948.html.plaintext.txt	308	thus failure cells express mature cftr caused change expression important cftr chaperone
0.4726967.12039948.html.plaintext.txt	309	addition specificity csp effect cftr biogenesis determined coexpressing csp vsv g
0.4726967.12039948.html.plaintext.txt	310	csp coexpression affect production mature vsv g experiments performed manner similar cftr fig
0.4726967.12039948.html.plaintext.txt	311	result suggests effect expressed csp specific maturation cftr
0.4726967.12039948.html.plaintext.txt	312	effect csp steady state expression mature cftr supported results pulse chase assays
0.4726967.12039948.html.plaintext.txt	313	10 csp1 coexpression hek293 cells blocked conversion immature cftr mature cftr
0.4726967.12039948.html.plaintext.txt	314	prior studies 5 30 wild type cftr matures fully glycosylated band c protein lower panels however band c detected csp coexpressing cells
0.4726967.12039948.html.plaintext.txt	315	addition half life immature cftr prolonged consistent accumulation band b observed steady state data fig
0.4726967.12039948.html.plaintext.txt	316	similar effects biogenesis mature cftr resulted coexpression csp2 data shown
0.4726967.12039948.html.plaintext.txt	317	csp coexpression rise band b production chase periods 30 60 min probably attributed lack cold methionine cysteine chase media nevertheless experiments cftr alone performed identically
0.4726967.12039948.html.plaintext.txt	318	results indicate csp interferes cftr biogenesis csp overexpressed
0.4726967.12039948.html.plaintext.txt	319	implications findings physiological role csp production cftr discussed
0.4726967.12039948.html.plaintext.txt	320	view larger version 51k fig
0.4726967.12039948.html.plaintext.txt	321	pulse chase analysis cftr biogenesis hek293 cells performed described experimental procedures
0.4726967.12039948.html.plaintext.txt	322	ttf indicates transient transfection conditions
0.4726967.12039948.html.plaintext.txt	323	35s labeled cftr immunoprecipitated using 3 microg monoclonal cftr antibody m3a7
0.4726967.12039948.html.plaintext.txt	324	samples resolved sds page cftr revealed autoradiography
0.4726967.12039948.html.plaintext.txt	325	intensities cftr c b forms indicated times quantified densitometry expressed percentage cftr b form chase time 0 taken 100
0.4726967.12039948.html.plaintext.txt	326	discussion top abstract introduction experimental procedures results discussion references
0.4726967.12039948.html.plaintext.txt	327	results study show csp expressed variety epithelial cell lines several models cftr mediated chloride secretion
0.4726967.12039948.html.plaintext.txt	328	cells expressed predominantly csp1 observed previously neurons secretory cells 21 e
0.4726967.12039948.html.plaintext.txt	329	immunofluorescent labeling showed membrane limited distribution csp er apical membrane compartments
0.4726967.12039948.html.plaintext.txt	330	significant amounts cftr coprecipitated csp calu 3 cell lysates protein binding assays csp associated cftr r domain n terminus
0.4726967.12039948.html.plaintext.txt	331	overexpression csp decreased cftr biogenesis correspondingly reduced functional response cftr camp stimulation
0.4726967.12039948.html.plaintext.txt	332	results indicate csp interacts physically functionally cftr epithelial cells
0.4726967.12039948.html.plaintext.txt	333	first report action csp protein maturation discussed
0.4726967.12039948.html.plaintext.txt	334	role csp regulated exocytosis csp expected influence cftr directly virtue localization cytosolic surfaces intracellular membranes contain cftr
0.4726967.12039948.html.plaintext.txt	335	defining feature csps central cysteine rich string domain palmitoylation multiple sites permits csp associate membrane lipid 49
0.4726967.12039948.html.plaintext.txt	336	immunofluorescence demonstrated csp distributed membrane limited compartments including apical membrane domain calu 3 cells fig
0.4726967.12039948.html.plaintext.txt	337	csps discovered drosophila cellular distribution knockout studies role proteins neurotransmitter secretion became apparent 18
0.4726967.12039948.html.plaintext.txt	338	studies neuroendocrine 28 endocrine cells 24 confirmed role csp regulated exocytosis
0.4726967.12039948.html.plaintext.txt	339	several studies implicated regulated exocytic event control plasma membrane cftr channel density 50
0.4726967.12039948.html.plaintext.txt	340	xenopus oocytes expressing cftr camp stimulation enhances chloride current elicits increases membrane capacitance cell surface cftr labeling consistent camp regulated insertion cftr plasma membrane 10 41 51
0.4726967.12039948.html.plaintext.txt	341	adenovirus transduced madin darby canine kidney cells cftr distributed intracellular plasma membrane compartments basal conditions recruited plasma membrane camp stimulation 52
0.4726967.12039948.html.plaintext.txt	342	partial colocalization csp cftr apical membrane domain calu 3 cells fig
0.4726967.12039948.html.plaintext.txt	343	2e interaction mature band c cftr fig
0.4726967.12039948.html.plaintext.txt	344	3a consistent concept protein may participate post golgi cftr trafficking events
0.4726967.12039948.html.plaintext.txt	345	interesting determine whether csp interacts cftr regulated trafficking compartment location would consonant documented role csp regulated exocytosis
0.4726967.12039948.html.plaintext.txt	346	perform studies however necessary obviate influence csp cftr maturation
0.4726967.12039948.html.plaintext.txt	347	role csp cftr biogenesis found csp localized airway epithelial cells compartment marked er resident protein calnexin
0.4726967.12039948.html.plaintext.txt	348	coimmunoprecipitation experiments showed core glycosylated immature cftr associated csp mature fully glycosylated protein particularly proportion steady state expression levels mature immature forms cftr
0.4726967.12039948.html.plaintext.txt	349	addition csp coexpression reduced production mature cftr effect csp appears require functional j domain
0.4726967.12039948.html.plaintext.txt	350	results imply csp cftr interact cftr biogenesis er
0.4726967.12039948.html.plaintext.txt	351	member dnaj family proteins csp could play role cftr processing via association hsc70
0.4726967.12039948.html.plaintext.txt	352	dnaj proteins serve co chaperones recruit hsc70 atpases specific substrates activate atpase activity chaperone modulate protein conformation folding protein protein interactions 4 29
0.4726967.12039948.html.plaintext.txt	353	hsc70 long recognized cftr chaperone coprecipitates cftr presence atp 39
0.4726967.12039948.html.plaintext.txt	354	hsc70 shown assist preventing aggregation nbd1 domain common cftr folding mutant f508 located 4 53 54
0.4726967.12039948.html.plaintext.txt	355	normally wild type cftr released chaperones achieves native conformation hsc70 thought remain attached misfolded cftr recruit ubiquitin ligase chip facilitate proteosome mediated cftr degradation 40 55
0.4726967.12039948.html.plaintext.txt	356	csp j domain protein interacts hsc70 enhances atpase activity 56
0.4726967.12039948.html.plaintext.txt	357	interaction csp hsc70 cftr likely affect cftr processing one two ways
0.4726967.12039948.html.plaintext.txt	358	first csp may cftr co chaperone stabilizes intermediate forms cftr promote folding maturation
0.4726967.12039948.html.plaintext.txt	359	model suggests csp contributes positively cftr maturation similar hsc70 co chaperone hdj 2 53
0.4726967.12039948.html.plaintext.txt	360	second csp interactions nonfolded cftr intermediates may contribute degradation nascent cftr
0.4726967.12039948.html.plaintext.txt	361	model suggests csp may contribute cftr degradation similar hsc70 interacting protein chip see
0.4726967.12039948.html.plaintext.txt	362	either model could explain csp overexpression reduces steady state expression levels mature cftr mammalian cells oocytes therefore camp stimulated cftr currents figs
0.4726967.12039948.html.plaintext.txt	363	first model csp overexpression causes prolonged association hsc70 cftr target cftr degradation 55
0.4726967.12039948.html.plaintext.txt	364	hsc70 shown promote ubiquitination degradation several cellular proteins 57
0.4726967.12039948.html.plaintext.txt	365	example overexpression hsc70 leads ubiquitination degradation apolipoprotein b 58
0.4726967.12039948.html.plaintext.txt	366	thus prolonged csp mediated association cftr hsc70 csp overexpression could lead cftr degradation despite possibility physiological role csp facilitate cftr biogenesis
0.4726967.12039948.html.plaintext.txt	367	second model trivial augmenting level protein involved cftr degradation would reduce cftr expression
0.4726967.12039948.html.plaintext.txt	368	illustrative model hsc70 binding protein chip ubiquitin ligase whose overexpression promotes proteasome mediated cftr degradation 40
0.4726967.12039948.html.plaintext.txt	369	chip appears recognize slowly folding misfolded forms cftr promotes destruction binding cftr associated hsc70
0.4726967.12039948.html.plaintext.txt	370	chip targets cftr ubiquitin conjugating enzymes
0.4726967.12039948.html.plaintext.txt	371	finding proteosome inhibitors fail promote trafficking class ii cftr mutants suggests mechanisms exist irreversible targeting protein intracellular degradation processes cellular destruction
0.4726967.12039948.html.plaintext.txt	372	chip appears component pathway principle csp could function manner well
0.4726967.12039948.html.plaintext.txt	373	several findings favor co chaperone model
0.4726967.12039948.html.plaintext.txt	374	first predominant interaction csp cftr band b calu 3 cells fig
0.4726967.12039948.html.plaintext.txt	375	3 suggests physiological role csp maturation cftr majority cftr expressed cells fully glycosylated mature form
0.4726967.12039948.html.plaintext.txt	376	second direct interaction csp cftr subdomains absence hsc70 figs
0.4726967.12039948.html.plaintext.txt	377	4 5 suggests csp may localize hsc70 specific sites facilitate cftr folding
0.4726967.12039948.html.plaintext.txt	378	contrast chip 40 csp require hsc70 interaction cftr
0.4726967.12039948.html.plaintext.txt	379	third csp overexpression stabilized cftr band b contrary result expected protein promotes degradation
0.4726967.12039948.html.plaintext.txt	380	finally previous data indicate positive role csp protein folding processes also favoring first model csp interaction
0.4726967.12039948.html.plaintext.txt	381	true dnaj proteins csp bind unfolded proteins prevent aggregation 49
0.4726967.12039948.html.plaintext.txt	382	activity synergistic similar action hsc70
0.4726967.12039948.html.plaintext.txt	383	together findings suggest csp may serve co chaperone cftr biogenesis
0.4726967.12039948.html.plaintext.txt	384	csp interactions n terminus r domain regard protein interactions could regulate cftr biogenesis interesting csp capacity bind r domain cftr n terminus
0.4726967.12039948.html.plaintext.txt	385	previous studies implicate n terminus site important normal processing cftr suggest interactions r domain cftr subdomains may facilitate biogenesis 3
0.4726967.12039948.html.plaintext.txt	386	n terminal truncations cftr poorly processed little truncated protein able traffic plasma membrane
0.4726967.12039948.html.plaintext.txt	387	addition several n terminal disease mutations processing mutants
0.4726967.12039948.html.plaintext.txt	388	several studies indicate pivotal point cftr synthesis generation r domain
0.4726967.12039948.html.plaintext.txt	389	synthesis r domain cftr unstable associated chaperones prevent nbd aggregation 53 54
0.4726967.12039948.html.plaintext.txt	390	r domain formed chaperone protein associations cftr decrease nascent protein becomes stable
0.4726967.12039948.html.plaintext.txt	391	studies indicate mutations near n terminus cftr lead ultimately protein degradation recognized er associated degradation machinery r domain synthesized 3
0.4726967.12039948.html.plaintext.txt	392	implies degradation processes recognize structural interfaces cftr subdomains
0.4726967.12039948.html.plaintext.txt	393	interdomain effects may mediated specific co chaperones interact several cftr subdomains facilitate access hsc70 intermediates folding pathway csp candidate interactions
0.4726967.12039948.html.plaintext.txt	394	finally discussion focused primarily cftr biogenesis er however possible also physiological action csp involves trafficking immature cftr post er compartments
0.4726967.12039948.html.plaintext.txt	395	example csp cftr could interact transition cftr er golgi intermediate compartment proximal golgi regions prior cftr glycosylation
0.4726967.12039948.html.plaintext.txt	396	mechanistic involvement csp trafficking processes may parallel action regulated exocytic events see discussion presumably exploiting interaction hsc70 facilitate trafficking protein interactions
0.4726967.12039948.html.plaintext.txt	397	addition nonconventional pathway cftr trafficking proposed recently 59 60 involving direct transit er trans golgi network perhaps via endosomal compartment
0.4726967.12039948.html.plaintext.txt	398	csp could involved trafficking steps however significance role cftr maturation cell type dependent presence pathway epithelial cells yet demonstrated
0.4726967.12039948.html.plaintext.txt	399	studies necessary evaluate possibilities
0.4726967.12039948.html.plaintext.txt	400	formerly csp implicated important component regulated exocytic machinery plasma membrane rationale examining csp actions relation regulated cftr trafficking
0.4726967.12039948.html.plaintext.txt	401	however principal findings present study demonstrate primary role csp cftr protein maturation
0.4726967.12039948.html.plaintext.txt	402	although csp interact process vsv g maturation interesting determine whether additional proteins whose biogenesis involves interactions csp
0.4726967.12039948.html.plaintext.txt	403	wrigley excellent technical assistance john r
0.4726967.12039948.html.plaintext.txt	404	riordan antibody mark silvis neil
0.4726967.12039948.html.plaintext.txt	405	bradbury meir aridor help pulse chase studies simon c
0.4726967.12039948.html.plaintext.txt	406	watkins assistance image analysis jeffrey l
0.4726967.12039948.html.plaintext.txt	407	brodsky meir aridor comments manuscript
0.4726967.12039948.html.plaintext.txt	408	work supported national institutes health grant dk56490 cystic fibrosis foundation grants frizze97ro 99go grant wellcome trust
0.4726967.12039948.html.plaintext.txt	409	costs publication article defrayed part payment page charges
0.4726967.12039948.html.plaintext.txt	410	article must therefore hereby marked advertisement accordance 18 u
0.4726967.12039948.html.plaintext.txt	411	section 1734 solely indicate fact
0.4726967.12039948.html.plaintext.txt	412	correspondence addressed dept
0.4726967.12039948.html.plaintext.txt	413	cell biology physiology university pittsburgh school medicine s362 bst 3500 terrace st
0.4726967.12039948.html.plaintext.txt	414	412 648 9498 e mail frizzellpitt
0.4726967.12039948.html.plaintext.txt	415	published jbc papers press may 30 2002 doi 10
0.4726967.12039948.html.plaintext.txt	416	abbreviations used cftr cystic fibrosis transmembrane conductance regulator cm capacitance current csp cysteine string protein er endoplasmic reticulum gst glutathione transferase gst c gst cftr c terminus gst n gst cftr n terminus gst r gst cftr r domain hek human embryonic kidney hsc heat shock cognate im camp induced membrane current nbd nucleotide binding domain r domain regulatory domain snare soluble nsf attachment protein receptor vsv g vesicular stomatitis virus glycoprotein chip c terminus hsc70 interacting protein
0.4726967.12039948.html.plaintext.txt	417	references top abstract introduction experimental procedures results discussion references 1
0.4726967.12039948.html.plaintext.txt	418	1 s215 s255medline order article via infotrieve 2
0.4726967.12039948.html.plaintext.txt	419	57 825 831crossrefmedline order article via infotrieve 4
0.4726967.12039948.html.plaintext.txt	420	281 l39 l42free full text 5
0.4726967.12039948.html.plaintext.txt	421	1995 cell 83 129 135medline order article via infotrieve 6
0.4726967.12039948.html.plaintext.txt	422	1995 cell 83 121 127medline order article via infotrieve 7
0.4726967.12039948.html.plaintext.txt	423	1992 science 256 530 532medline order article via infotrieve 8
0.4726967.12039948.html.plaintext.txt	424	95 10972 10977abstractfree full text 9
0.4726967.12039948.html.plaintext.txt	425	105 377 386abstractfree full text 10
0.4726967.12039948.html.plaintext.txt	426	277 c174 c180medline order article via infotrieve 11
0.4726967.12039948.html.plaintext.txt	427	274 3602 3609abstractfree full text 12
0.4726967.12039948.html.plaintext.txt	428	275 3655 3660abstractfree full text 13
0.4726967.12039948.html.plaintext.txt	429	273 19797 19801abstractfree full text 14
0.4726967.12039948.html.plaintext.txt	430	275 14360 14366abstractfree full text 15
0.4726967.12039948.html.plaintext.txt	431	275 29539 29546abstractfree full text 16
0.4726967.12039948.html.plaintext.txt	432	278 c417 c422abstractfree full text 17
0.4726967.12039948.html.plaintext.txt	433	275 27069 27074abstractfree full text 18
0.4726967.12039948.html.plaintext.txt	434	7 15 29medline order article via infotrieve 19
0.4726967.12039948.html.plaintext.txt	435	1994 science 263 981 982medline order article via infotrieve 20
0.4726967.12039948.html.plaintext.txt	436	391 269 272crossrefmedline order article via infotrieve 21
0.4726967.12039948.html.plaintext.txt	437	74 1781 1789crossrefmedline order article via infotrieve 22
0.4726967.12039948.html.plaintext.txt	438	1994 science 263 977 980medline order article via infotrieve 23
0.4726967.12039948.html.plaintext.txt	439	17 5048 5058abstractfree full text 24
0.4726967.12039948.html.plaintext.txt	440	437 267 272crossrefmedline order article via infotrieve 25
0.4726967.12039948.html.plaintext.txt	441	18 956 964abstractfree full text 26
0.4726967.12039948.html.plaintext.txt	442	1994 neuron 13 899 907medline order article via infotrieve 27
0.4726967.12039948.html.plaintext.txt	443	82 50 59abstractfree full text 28
0.4726967.12039948.html.plaintext.txt	444	co2 ulinktypedoi crossrefmedline order article via infotrieve 29
0.4726967.12039948.html.plaintext.txt	445	79 425 449abstractfree full text 30
0.4726967.12039948.html.plaintext.txt	446	273 13488 13492abstractfree full text 31
0.4726967.12039948.html.plaintext.txt	447	19 10270 10279abstractfree full text 32
0.4726967.12039948.html.plaintext.txt	448	271 7320 7323abstractfree full text 33
0.4726967.12039948.html.plaintext.txt	449	acta 1401 239 241medline order article via infotrieve 34
0.4726967.12039948.html.plaintext.txt	450	112 1345 1351abstractfree full text 35
0.4726967.12039948.html.plaintext.txt	451	98 1304 1312abstractfree full text 36
0.4726967.12039948.html.plaintext.txt	452	275 39886 39893abstractfree full text 37
0.4726967.12039948.html.plaintext.txt	453	16 5837 5846abstractfree full text 38
0.4726967.12039948.html.plaintext.txt	454	274 20812 20817abstractfree full text 39
0.4726967.12039948.html.plaintext.txt	455	3 100 105crossrefmedline order article via infotrieve 41
0.4726967.12039948.html.plaintext.txt	456	271 c1 c8abstractfree full text 42
0.4726967.12039948.html.plaintext.txt	457	436 85 91crossrefmedline order article via infotrieve 43
0.4726967.12039948.html.plaintext.txt	458	271 19514 19517abstractfree full text 44
0.4726967.12039948.html.plaintext.txt	459	13 245 261medline order article via infotrieve 45
0.4726967.12039948.html.plaintext.txt	460	9 547 556medline order article via infotrieve 46
0.4726967.12039948.html.plaintext.txt	461	2000 glycobiology 10 149 157abstractfree full text 47
0.4726967.12039948.html.plaintext.txt	462	58 2037 2040medline order article via infotrieve 48
0.4726967.12039948.html.plaintext.txt	463	272 31420 31426abstractfree full text 49
0.4726967.12039948.html.plaintext.txt	464	335 205 209medline order article via infotrieve 50
0.4726967.12039948.html.plaintext.txt	465	438 561 569crossrefmedline order article via infotrieve 52
0.4726967.12039948.html.plaintext.txt	466	18 1492 1505abstractfree full text 54
0.4726967.12039948.html.plaintext.txt	467	272 25421 25424abstractfree full text 55
0.4726967.12039948.html.plaintext.txt	468	271 25989 25993abstractfree full text 57
0.4726967.12039948.html.plaintext.txt	469	272 9002 9010abstractfree full text 58
0.4726967.12039948.html.plaintext.txt	470	276 24891 24900abstractfree full text 59
0.4726967.12039948.html.plaintext.txt	471	2000 traffic 1 852 870crossrefmedline order article via infotrieve 60
0.4726967.12039948.html.plaintext.txt	472	277 11401 11409abstractfree full text
0.4726967.12039948.html.plaintext.txt	473	copyright 2002 american society biochemistry molecular biology inc
0.4141868.9736778.html.plaintext.txt	0	characterization 19 disease associated missense mutations regulatory domain cystic fibrosis transmembrane conductance regulator
0.4141868.9736778.html.plaintext.txt	1	anne vankeerberghen lin wei1 martine jaspers jean jacques cassiman bernd nilius harry cuppens
0.4141868.9736778.html.plaintext.txt	2	centre human genetics 1department physiology university leuven b 3000 leuven belgium
0.4141868.9736778.html.plaintext.txt	3	received may 14 1998 revised accepted july 17 1998
0.4141868.9736778.html.plaintext.txt	4	order gain better insight structure function regulatory domain rd cystic fibrosis transmembrane conductance regulator cftr protein 19 rd missense mutations identified patients functionally characterized
0.4141868.9736778.html.plaintext.txt	5	nine i601f l610s a613t d614g i618t l619s h620p g628r l633p resulted aberrant processing
0.4141868.9736778.html.plaintext.txt	6	small number functional cftr proteins therefore appear cell membrane cells expressing mutants
0.4141868.9736778.html.plaintext.txt	7	mutations clustered n terminal part rd suggesting subdomain folding pattern sensitive amino acid changes
0.4141868.9736778.html.plaintext.txt	8	mutations caused aberrant processing characterized electrophysiological level
0.4141868.9736778.html.plaintext.txt	9	first studied whole cell level xenopus laevis oocytes
0.4141868.9736778.html.plaintext.txt	10	mutants induced whole cell current significantly different wild type cftr subsequently analysed single channel level cos1 cells transiently expressing different mutant wild type proteins
0.4141868.9736778.html.plaintext.txt	11	three mutant chloride channels g622d r792g e822k cftr characterized significantly lower intrinsic chloride channel activities compared wild type cftr
0.4141868.9736778.html.plaintext.txt	12	two mutations h620q a800g resulted increased intrinsic chloride transport activities
0.4141868.9736778.html.plaintext.txt	13	finally t665s e826k cftr single channel properties significantly different wild type cftr
0.4141868.9736778.html.plaintext.txt	14	cystic fibrosis cf caused mutations cystic fibrosis transmembrane conductance regulator cftr gene common lethal autosomal recessive disorder caucasian population
0.4141868.9736778.html.plaintext.txt	15	disease characterized abnormal salt transport across apical border epithelial cells 1
0.4141868.9736778.html.plaintext.txt	16	cftr protein 2 4 transmembrane protein consisting two repeated motifs composed transmembrane domain nucleotide binding domain nbd separated highly charged regulatory domain rd
0.4141868.9736778.html.plaintext.txt	17	rd consists alternating clusters positively negatively charged amino acids harbours multiple consensus sequences phosphorylation protein kinase pka protein kinase c pkc 3
0.4141868.9736778.html.plaintext.txt	18	reconstitution cftr protein proteoliposomes proved forms linear low conductance chloride channel 5
0.4141868.9736778.html.plaintext.txt	19	activation cftr complex occurs different steps
0.4141868.9736778.html.plaintext.txt	20	first rd phosphorylated camp dependent pka
0.4141868.9736778.html.plaintext.txt	21	step enhanced pre stimulation pkc 6
0.4141868.9736778.html.plaintext.txt	22	second step atp binds hydrolysed first nbd thereby opening channel allowing chloride ions flow electrochemical gradient
0.4141868.9736778.html.plaintext.txt	23	third step atp hydrolysis nbd2 closes channel 7
0.4141868.9736778.html.plaintext.txt	24	long rd phosphorylated atp re open channel
0.4141868.9736778.html.plaintext.txt	25	dephosphorylation rd phosphatases 8 results final closure channel
0.4141868.9736778.html.plaintext.txt	26	precise mechanisms rd regulates anion flow far understood
0.4141868.9736778.html.plaintext.txt	27	although rd contains nine consensus sites pka redundant phosphorylation single site sufficient channel activation 9
0.4141868.9736778.html.plaintext.txt	28	given fact activation cftr occur pka phosphorylation degeneration phosphorylation sites puzzling
0.4141868.9736778.html.plaintext.txt	29	hand channel locked activated state mutagenesis ser asp moieties pka consensus sites 10
0.4141868.9736778.html.plaintext.txt	30	observation indicates negative charges introduced pka phosphorylation important channel activation
0.4141868.9736778.html.plaintext.txt	31	deleting part rd amino acids 708 835 also yield cftr channel escapes pka regulation constitutively active 11
0.4141868.9736778.html.plaintext.txt	32	therefore hypothesized rd closes chloride channel pore repulsed pore negative charges introduced
0.4141868.9736778.html.plaintext.txt	33	although deltar cftr proteins constitutively active open probability po one third found wild type cftr
0.4141868.9736778.html.plaintext.txt	34	moreover addition unphosphorylated rd deltar cftr effect channel activity addition phosphorylated rd doubles po
0.4141868.9736778.html.plaintext.txt	35	increase activity apparently results higher rate channel opening higher sensitivity nbd1 atp
0.4141868.9736778.html.plaintext.txt	36	based findings hypothesized phosphorylation rd changes sensitivity nbd1 atp 1213
0.4141868.9736778.html.plaintext.txt	37	given crucial role rd regulation channel activities thorough knowledge structure function warranted
0.4141868.9736778.html.plaintext.txt	38	regard known rd missense mutations found patients could provide important information metabolism function rd
0.4141868.9736778.html.plaintext.txt	39	investigations 19 missense mutations show mutations affect protein maturation others lead decreased function gain function still others appear effect assay systems used
0.4141868.9736778.html.plaintext.txt	40	results cross species analysis rd
0.4141868.9736778.html.plaintext.txt	41	exon 13 sequences cftr nine different organisms aligned fig
0.4141868.9736778.html.plaintext.txt	42	1 high conservation n terminal part rd1 amino acid 650 observed
0.4141868.9736778.html.plaintext.txt	43	c terminal two thirds rd2 pka phosphorylation sites conserved located subdomain
0.4141868.9736778.html.plaintext.txt	44	rd highly charged part due presence pka consensus sequences highly basic
0.4141868.9736778.html.plaintext.txt	45	two acidic amino acid stretches found
0.4141868.9736778.html.plaintext.txt	46	first one amino acids 725 730 located first half rd2 although region poorly conserved negative charge found species studied
0.4141868.9736778.html.plaintext.txt	47	second acid region amino acids 822 828 located end rd completely conserved
0.4141868.9736778.html.plaintext.txt	48	alignment exon 13 sequences derived different species
0.4141868.9736778.html.plaintext.txt	49	exon 13 derived spiny dogfish squalus acanthias genbank accession
0.4141868.9736778.html.plaintext.txt	50	116141 african clawed frog xenopus laevis genbank accession nos 64623 1617482 cow bos taurus genbank accession
0.4141868.9736778.html.plaintext.txt	51	461719 sheep ovis aries genbank accession
0.4141868.9736778.html.plaintext.txt	52	862652 human homo sapiens genbank accession
0.4141868.9736778.html.plaintext.txt	53	625338 european rabbit oryctolagus cuniculuc genbank accession
0.4141868.9736778.html.plaintext.txt	54	1100985 norway rat rattus norvegicus genbank accession
0.4141868.9736778.html.plaintext.txt	55	382755 house mouse mus musculus genbank accession
0.4141868.9736778.html.plaintext.txt	56	192567 aligned using genalign multiple sequence alignment program intelligenetics software
0.4141868.9736778.html.plaintext.txt	57	mutations detected patients i601f l610s a613t d614g i618t l619s h620p h620q d622g g628r l633p t665s f693l k698r v754m r766m r792g a800g i807m e822k e826k indicated bold underlined pka phosphorylation sites arrow two acidic domains boxed
0.4141868.9736778.html.plaintext.txt	58	21 rd missense mutations three k698r r766m r792g located pka recognition consensus sites
0.4141868.9736778.html.plaintext.txt	59	r766m r792g disrupted pka recognition site might therefore interfere cftr regulation
0.4141868.9736778.html.plaintext.txt	60	different rd mutations affected almost except d648v v754m a800g amino acid moieties absolutely highly conserved
0.4141868.9736778.html.plaintext.txt	61	high conservation mutated amino acids highlights importance structure function
0.4141868.9736778.html.plaintext.txt	62	six 21 disease mutations affected charge amino acid residue two even resulted amino acid opposite charge
0.4141868.9736778.html.plaintext.txt	63	latter two located highly conserved c terminal acidic domain
0.4141868.9736778.html.plaintext.txt	64	effect rd mutations cftr processing
0.4141868.9736778.html.plaintext.txt	65	beginning study 19 different rd mutations table 1 described patients
0.4141868.9736778.html.plaintext.txt	66	since found f693l mutation polymorphism 1415 i807m polymorphism associated congenital bilateral absence vas deferens cbavd unpublished data
0.4141868.9736778.html.plaintext.txt	67	two additional disease mutations characterized functional level study identified k698r v754m 15
0.4141868.9736778.html.plaintext.txt	68	nature rd mutations cause cftr dysfunction however unknown
0.4141868.9736778.html.plaintext.txt	69	known cftr mutations like f508 cause misfolding protein endoplasmic reticulum er resulting retention degradation quality control system operates cell compartment 16
0.4141868.9736778.html.plaintext.txt	70	therefore first determined maturation pattern different mutant cftr proteins listed table 1
0.4141868.9736778.html.plaintext.txt	71	different mutations introduced wild type cftr cdna inserted eukaryotic expression vector pcdna3 mutant constructs transfected cos1 cells
0.4141868.9736778.html.plaintext.txt	72	corresponding proteins analysed means pulse chase experiments
0.4141868.9736778.html.plaintext.txt	73	cftr translation products enter er become glycosylated addition two high mannose glycosyl groups fourth extracellular loop
0.4141868.9736778.html.plaintext.txt	74	event gives rise appearance 150 kda protein prominent form wild type cftr 30 min chase fig
0.4141868.9736778.html.plaintext.txt	75	protein leaves er enters golgi apparatus glycosyl groups become modified complex sugar groups gives rise protein lower mobility 190 kda seen lanes 2 3 figure 2
0.4141868.9736778.html.plaintext.txt	76	190 kda protein move plasma membrane contribute chloride channel activity
0.4141868.9736778.html.plaintext.txt	77	maturation pattern found wild type cftr also mutants table 2 i807m cftr fig
0.4141868.9736778.html.plaintext.txt	78	mutants however presented abnormal maturation pattern seen l610s d614g cftr fig
0.4141868.9736778.html.plaintext.txt	79	mutant proteins yielded 150 kda form even 210 min chase indicating gave rise misfolded proteins retained degraded er
0.4141868.9736778.html.plaintext.txt	80	order confirm 150 kda form indeed er form 190 kda form complex glycosylated one two enzymatic digestions performed results shown
0.4141868.9736778.html.plaintext.txt	81	immunopurified proteins incubated endoglycosidase h enzyme recognizes cleaves high mannose residues 150 kda forms maturing non maturing mutants digested
0.4141868.9736778.html.plaintext.txt	82	n glycosidase f enzyme recognizes degrades high mannose complex glycosyl groups degraded 150 kda well 190 kda form
0.4141868.9736778.html.plaintext.txt	83	mutations gave rise protein able proceed 190 kda form i601f l610s a613t d614g i618t l619s h620p g628r l633p table 2 therefore class two mutations 17 disease phenotype caused absence sufficient cftr protein cell surface
0.4141868.9736778.html.plaintext.txt	84	primers used mutagenesis primer sequence i601f a1933t 5prime cta aca aaa cta ggt ttt tgg tca ctt c 3prime l610s t1961c 5prime cta aaa tgg aac att caa aga aag ctg 3prime a613t g1969a 5prime cat tta aag aaa act gac aaa ata tta 3prime d614g a1973g 5prime cat tta aag aaa gct ggc aaa ata tta 3prime i618t t1985c 5prime gac aaa ata tta act ttg cat gaa gg 3prime l619s t1988c 5prime gac aaa ata tta att tcg cat gaa ggt 3prime h620p a1991c 5prime caa aat att aat ttt gcc tga agg tag c 3prime h620q t1992g 5prime aat att aat ttt gca gga agg tag cag 3prime g622d g1997a 5prime ttg cat gaa gat agc agc tat ttt tat g 3prime g628r g2014c 5prime gca gct att ttt atc gga cat ttt c 3prime l633p t2030c 5prime cat ttt cag aac ccc aaa atc tac agc 3prime d648v a2075t 5prime ctc atg gga tgt gtt tct ttc gac c 3prime t665s a2125t 5prime caa tcc taa ctg agt cct tac acc g 3prime f693l t2209c 5prime cag act gga gag ctt ggg gaa aaa ag 3prime r766m g2429t 5prime gca cga agg atg cag tct gtc ctg 3prime r792g c2506g 5prime cag cat cca cag gaa aag tgt cac tg 3prime a800g c2531g 5prime ctg gcc cct cag gga aac ttg act g 3prime i807m a2553g 5prime ctg aac tgg ata tgt att caa gaa gg 3prime e822k g2596a 5prime ggc ttg gaa ata agt aaa gaa att aac g 3prime e826k g2608a 5prime gaa gaa att aac aaa gaa gac tta aag 3prime selection primer bstbi 5prime ctc tgg ggt ccg gaa tga ccg ac 3prime two primers used mutagenesis reaction
0.4141868.9736778.html.plaintext.txt	85	first mutagenesis primer contains mutation introduced cftr coding region
0.4141868.9736778.html.plaintext.txt	86	first column lists amino acid change introduced mutation nucleotide change given parentheses amino acid nucleotide assignment according ref
0.4141868.9736778.html.plaintext.txt	87	selection primer destroys recognition site bstbi
0.4141868.9736778.html.plaintext.txt	88	primer used selection mutant constructs mutagenesis protocol constructs lost restriction enzyme recognition site cut bstbi contain introduced cftr mutation
0.4141868.9736778.html.plaintext.txt	89	whole cell currents xenopus oocytes expressing wild type mutant cftr
0.4141868.9736778.html.plaintext.txt	90	since studied mutations identified patients expected interfere normal cftr chloride channel function
0.4141868.9736778.html.plaintext.txt	91	mutations caused arrest protein maturation therefore analysed electrophysiological level
0.4141868.9736778.html.plaintext.txt	92	end cftr rna maturing mutants prepared vitro transcription injected xenopus laevis oocytes
0.4141868.9736778.html.plaintext.txt	93	basal camp induced whole cell chloride currents measured using two electrode voltage clamp technique
0.4141868.9736778.html.plaintext.txt	94	results shown figure 3
0.4141868.9736778.html.plaintext.txt	95	four mutations t665s r792g e822k e826k caused significant reduction camp induced chloride current
0.4141868.9736778.html.plaintext.txt	96	interestingly two mutations h620q a800g gave rise chloride channels significantly higher chloride transport activities
0.4141868.9736778.html.plaintext.txt	97	remainder g622d d648v f693l r766m i807m significantly affect chloride transport ability compared wild type cftr channels
0.4141868.9736778.html.plaintext.txt	98	maturation pattern rd mutations associated phenotype found patients indicated genotype mutation associated cf pancreas status given mutation form b form c form clinical data genotype phenotype reference i601f i601fg542x ps m
0.4141868.9736778.html.plaintext.txt	99	schwarz personal communication l610s unknown unknown a613t unknown unknown d614g d614gunknown pi 14 i618t i618tdf508 ps g
0.4141868.9736778.html.plaintext.txt	100	cutting personal communication l619s l619sunknown pi b
0.4141868.9736778.html.plaintext.txt	101	tummler personal communication h620p h620pr1158x ps m
0.4141868.9736778.html.plaintext.txt	102	schwarz personal communication h620q h620qdf508 pi
0.4141868.9736778.html.plaintext.txt	103	dork personal communication g622d g622dunknown oligospermia j
0.4141868.9736778.html.plaintext.txt	104	zielenski personal communication g628r unknown unknown l633p l633p3659delc m
0.4141868.9736778.html.plaintext.txt	105	schwarz personal communication d648v d648v384910kb ct pi c
0.4141868.9736778.html.plaintext.txt	106	ferec personal communication t665s unknown unknown f693l f693lw1282x healthy c
0.4141868.9736778.html.plaintext.txt	107	ferec cf genetic analysis consortium r766m r766mr792g cbavd d
0.4141868.9736778.html.plaintext.txt	108	glavac personal communication r792g r766mr792g cbavd d
0.4141868.9736778.html.plaintext.txt	109	glavac personal communication a800g a800gunknown cbavd 34 i807m i807munknown cbavd observation e822k e822kunknown pi 35 e826k e826kunknown thoracic sarcoidosis c
0.4141868.9736778.html.plaintext.txt	110	bombieri personal communication protein matures form protein reach respective maturation step
0.4141868.9736778.html.plaintext.txt	111	single channel measurements wild type mutant cftr chloride channels
0.4141868.9736778.html.plaintext.txt	112	pulse chase immunoprecipitation cftr cos1 cells transiently expressing wild type l610s d614g i807m cftr
0.4141868.9736778.html.plaintext.txt	113	proteins labelled 35smethionine 35scysteine chased indicated time periods cftr proteins immunoprecipitated antibody directed c terminal part cftr
0.4141868.9736778.html.plaintext.txt	114	immunopurified proteins separated 4 12 sds gel visualized autoradiography
0.4141868.9736778.html.plaintext.txt	115	core glycosylated 150 kda mature 190 kda forms indicated
0.4141868.9736778.html.plaintext.txt	116	whole cell chloride currents measured xenopus laevis oocytes expressing wild type mutant cftr proteins
0.4141868.9736778.html.plaintext.txt	117	xenopus laevis oocytes injected vitro transcribed wild type mutant cftr rna basal black bar camp induced white bar chloride currents measured two electrode voltage clamp technique 72 h later
0.4141868.9736778.html.plaintext.txt	118	mutants showed significantly different camp dependent chloride current p 0
0.4141868.9736778.html.plaintext.txt	119	05 compared wild type cftr marked asterisk number cells analysed indicated
0.4141868.9736778.html.plaintext.txt	120	altered chloride transport activities either caused difference number functional cftr proteins incorporated apical cell membrane andor differences conductive andor gating properties channels
0.4141868.9736778.html.plaintext.txt	121	mutants affected whole cell currents therefore studied single channel level
0.4141868.9736778.html.plaintext.txt	122	different wild type mutant cftr cdnas incorporated bicistronic vector transfection cos1 cells bicistronic transcript cftr green fluorescent protein gfp formed
0.4141868.9736778.html.plaintext.txt	123	cos1 cells expressing gfp therefore also cftr used single channel measurements
0.4141868.9736778.html.plaintext.txt	124	current measured addition forskolin ibmx extracellular side cell
0.4141868.9736778.html.plaintext.txt	125	examples tracings wild type h620q cftr proteins shown figure 4a
0.4141868.9736778.html.plaintext.txt	126	4b mutant cftr chloride channels showed linear v relationships single channel conductances different wild type fig
0.4141868.9736778.html.plaintext.txt	127	po different cftr variants determined fig
0.4141868.9736778.html.plaintext.txt	128	single channel activities correlated well whole cell currents measured oocytes majority cftr proteins studied
0.4141868.9736778.html.plaintext.txt	129	g622d r792g e822k gave rise cftr chloride channel significantly lower po wild type cftr h620q a800g cftr resulted channels significantly higher po
0.4141868.9736778.html.plaintext.txt	130	activation single channels expressing wild type mutant cftr h620q
0.4141868.9736778.html.plaintext.txt	131	single channel current tracings wild type h620q cftr addition activation cocktail 1 microm ibmx 0
0.4141868.9736778.html.plaintext.txt	132	1 microm forskolin external site membrane patch
0.4141868.9736778.html.plaintext.txt	133	0 closed state 1 3 open channel events
0.4141868.9736778.html.plaintext.txt	134	b corresponding current voltage v relationship obtained wild type cftr
0.4141868.9736778.html.plaintext.txt	135	c single channel conductances wild type mutant cftr channels calculated current measured 60 mv theoretical reversal potential 0 mv
0.4141868.9736778.html.plaintext.txt	136	number cells analysed identical figure 5
0.4141868.9736778.html.plaintext.txt	137	measurements done cell attached configuration using symmetrical chloride conditions cos cells transiently expressing wild type mutant cftr
0.4141868.9736778.html.plaintext.txt	138	synopsis changes open probabilities po wild type mutant cftr chloride channels expressed cos1 cells
0.4141868.9736778.html.plaintext.txt	139	cos1 cells transfected bicistronic construct gfp cdna wild type mutant cftr cdnas
0.4141868.9736778.html.plaintext.txt	140	cells expressing gfp selected used single channel measurements
0.4141868.9736778.html.plaintext.txt	141	number channels estimated overlapping sweep events
0.4141868.9736778.html.plaintext.txt	142	mutant cftr chloride channels characterized po value significantly different wild type cftr marked asterisk p 0
0.4141868.9736778.html.plaintext.txt	143	05 number cells patched indicated
0.4141868.9736778.html.plaintext.txt	144	since discovery cftr gene 21 rd missense mutations identified patients
0.4141868.9736778.html.plaintext.txt	145	studied effect 19 mutations table 1 maturation electrophysiological properties cftr
0.4141868.9736778.html.plaintext.txt	146	nine mutations caused aberrant processing i601f l610s a613t d614g i618t l619s h620p g628r l633p
0.4141868.9736778.html.plaintext.txt	147	striking observation mutations caused processing defect clustered n terminal part amino acids 601 619 rd showed normal maturation pattern clustered c terminal end amino acids 648 826
0.4141868.9736778.html.plaintext.txt	148	effects caused different types mutations introduced since similar amino acid changes found subdomains
0.4141868.9736778.html.plaintext.txt	149	region linking two parts effect mutation depends amino acid change introduced
0.4141868.9736778.html.plaintext.txt	150	illustrated amino acid 620 two different mutations detected cf patients
0.4141868.9736778.html.plaintext.txt	151	his620 changed gln effect maturation observed
0.4141868.9736778.html.plaintext.txt	152	his620 changed pro amino acid dramatically affects secondary structure protein therefore possibly correct folding non maturing protein obtained
0.4141868.9736778.html.plaintext.txt	153	noted however effects mutations involving pro dramatic located second subdomain cftr since recombinant protein three wild type pro residues mutated still formed mature 190 kda form 18
0.4141868.9736778.html.plaintext.txt	154	rd initially assigned portion cftr protein encoded exon 13
0.4141868.9736778.html.plaintext.txt	155	accumulating evidence however indicates rd divided two subdomains
0.4141868.9736778.html.plaintext.txt	156	cross species analysis revealed n terminal part domain highly conserved amino acid level evolution shark human c terminal two thirds phosphorylation sites conserved 19
0.4141868.9736778.html.plaintext.txt	157	moreover rd phosphorylation sites exclusively located second part
0.4141868.9736778.html.plaintext.txt	158	new model nbd1 recently obtained computational modelling based x ray structure bovine mitochondrial f1 atpase
0.4141868.9736778.html.plaintext.txt	159	according model amino acids 453 650 far attributed exon 13 rd fact predicted part nbd1 20
0.4141868.9736778.html.plaintext.txt	160	found missense mutations located part rd fail mature characteristic majority nbd1 mutations 21
0.4141868.9736778.html.plaintext.txt	161	mutations affect maturation h620q g622d d648v t665s f693l r766m r792g a800g i807m e822k e826k subsequently analysed electrophysiological level
0.4141868.9736778.html.plaintext.txt	162	three g622d r792g e822k gave rise chloride channels significantly lower po wild type channel
0.4141868.9736778.html.plaintext.txt	163	one mutations r792g disrupts consensus recognition site pka
0.4141868.9736778.html.plaintext.txt	164	since shown site phosphorylated vivo pka 9 one strongest stimulatory sites cftr activation 22 elimination pka recognition sequence might result chloride channel aberrant regulation consequence lower activity
0.4141868.9736778.html.plaintext.txt	165	strikingly two mutations h620q a800g showed significantly increased po compared wild type cftr
0.4141868.9736778.html.plaintext.txt	166	far p574h mutation located nbd1 shown give rise protein higher intrinsic chloride transport properties
0.4141868.9736778.html.plaintext.txt	167	mutant however mature 2324
0.4141868.9736778.html.plaintext.txt	168	hyperactive disease causing mutations described h620q a800g mature
0.4141868.9736778.html.plaintext.txt	169	remaining mutations d648v t665s f693l r766m i807m e826k caused significant alterations intrinsic chloride channel activity
0.4141868.9736778.html.plaintext.txt	170	f693l turned polymorphism 15 thereby explaining normal function
0.4141868.9736778.html.plaintext.txt	171	apart chloride channel cftr also regulator channels
0.4141868.9736778.html.plaintext.txt	172	found cftr negative regulator amiloride sensitive epithelial sodium channels 25 28 positive regulator outwardly rectifying chloride channels 2930 potassium channels 31 atp channel associated cftr 32
0.4141868.9736778.html.plaintext.txt	173	therefore mutant proteins wild type increased channel activity may cause cf phenotype due abnormal regulatory properties
0.4141868.9736778.html.plaintext.txt	174	view fact rd quite unique cftr compared atp binding cassette proteins interaction rd atp channel shown domain becomes prime candidate play crucial role regulatory activities cftr
0.4141868.9736778.html.plaintext.txt	175	recently shown polymorphic alleles like found m470v locus also affect cftr properties maturational electrophysiological levels 33
0.4141868.9736778.html.plaintext.txt	176	normal hyperfunctional mutations could therefore cause cftr malfunctioning present particular haplotype background
0.4141868.9736778.html.plaintext.txt	177	since haplotypes known mutations studied functional effect might masked
0.4141868.9736778.html.plaintext.txt	178	hand cannot excluded patients carried yet undetected second mutation cftr allele
0.4141868.9736778.html.plaintext.txt	179	result studied exon 13 mutation would polymorphism
0.4141868.9736778.html.plaintext.txt	180	conclusion based maturation studies cftr rd subdivided two subdomains n terminal one third exon 13 sensitive missense mutations c terminal part exon 13 shows less stringent structural requirements
0.4141868.9736778.html.plaintext.txt	181	mutations however defect maturation could detected
0.4141868.9736778.html.plaintext.txt	182	moreover gave rise chloride channels intrinsic activities similar even higher wild type cftr
0.4141868.9736778.html.plaintext.txt	183	experiments required clarify mechanism latter mutations cause disease
0.4141868.9736778.html.plaintext.txt	184	materials methods construction rd mutants
0.4141868.9736778.html.plaintext.txt	185	xhoi kpni fragment containing cftr coding region isolated prokaryotic vector ptg5960 transgene sa strasbourg france inserted eukaryotic expression vector pcdna3 invitrogen leek netherlands
0.4141868.9736778.html.plaintext.txt	186	order remove potential atg start codon derived multiple cloning site ptg5960 construct digested kpni ecorv resulting linear plasmid blunt end ligated t4 dna polymerase treatment
0.4141868.9736778.html.plaintext.txt	187	cftr coding region present resulting construct characterized dideoxy sequencing one polymorphism v470 identified
0.4141868.9736778.html.plaintext.txt	188	sequence also contained three neutral amino acid changes t930c a933g t936c introduced order inactivate cryptic prokaryotic promoter 36
0.4141868.9736778.html.plaintext.txt	189	rd missense mutations reported may 23 1996 cystic fibrosis genetic analysis consortium table 1 introduced using transformer site directed mutagenesis kit clontech laboratories palo alto ca
0.4141868.9736778.html.plaintext.txt	190	primers used mutagenesis listed table 1
0.4141868.9736778.html.plaintext.txt	191	complete cftr coding region 20 mutants sequenced mutations desired ones found
0.4141868.9736778.html.plaintext.txt	192	single channel measurements different mutant wild type cftr cdnas transferred bicistronic gfp expression vector pcineoires gfp 37
0.4141868.9736778.html.plaintext.txt	193	purpose wild type cftr cdna derived pcdna3 cftr ligated t4 dna polymerase treated xhoi saci fragment pcineoires gfp
0.4141868.9736778.html.plaintext.txt	194	latter first linearized nhei blunt ended t4 dna polymerase dephosphorylated bovine alkaline phosphatase
0.4141868.9736778.html.plaintext.txt	195	rd flanking sequences subsequently removed pcineowtcftr ires gfp complete digestion xbai partial digestion bstxi replaced corresponding mutant cftr fragments obtained complete digestion different mutant pcdna3 cftr constructs xbai bstxi
0.4141868.9736778.html.plaintext.txt	196	expression pulse chase immunoprecipitation cftr
0.4141868.9736778.html.plaintext.txt	197	twenty micrograms plasmid dna electroporated biorad gene pulser bio rad hercules ca 1
0.4141868.9736778.html.plaintext.txt	198	transfected cells cultured 48 72 h 37 degrees c dmem f12 life technologies inchinnan uk supplemented 10 fetal bovine serum hyclone laboratories logan ut subsequently selected 480 mgl g418 disulphate duchefa haarlem netherlands
0.4141868.9736778.html.plaintext.txt	199	2 weeks selection cells starved 30 min rpmi 1640 medium life technologies inchinnan uk without methionine cysteine labelled 30 min pulse rpmi 1640 supplemented 100 microciml 35smethionine 35scysteine icn pharmaceuticals costa mesa ca finally chased different time periods dmem f12 supplemented 10 fetal bovine serum
0.4141868.9736778.html.plaintext.txt	200	cells scraped subsequently lysed sonication ice cold ippa buffer 20 mm tris 150 mm nacl 1 na desoxycholate 1 triton x 100 0
0.4141868.9736778.html.plaintext.txt	201	4 supplemented protease inhibitors 20 microgml soybean trypsin inhibitor 1 microgml leupeptin 1 microgml antipain 1 microgml pepstatin 1 microgml chymostatin 1 mm phenylmethylsulfonyl fluoride
0.4141868.9736778.html.plaintext.txt	202	lysate precleared protein sepharose cl 4b beads pharmacia biotech uppsala sweden cftr proteins affinity purified incubation 1 h anti cftr monoclonal antibody directed c terminal part cftr genzyme diagnostics cambridge ma
0.4141868.9736778.html.plaintext.txt	203	immunocomplexes purified protein sepharose cl 4b beads addition loading buffer 1 beta mercaptoethanol 16 mm tris hcl ph 6
0.4141868.9736778.html.plaintext.txt	204	8 4 sds bromophenol blue 10 glycerol loaded 4 12 sds gel novex san diego ca
0.4141868.9736778.html.plaintext.txt	205	drying gel exposed 70 degrees c light sensitive film 3 4 h
0.4141868.9736778.html.plaintext.txt	206	digestions glycosidases carried cftr proteins immunoprecipitated purified protein sepharose cl 4b beads
0.4141868.9736778.html.plaintext.txt	207	endoglycosidase h digestion performed overnight 37 degrees c 2
0.4141868.9736778.html.plaintext.txt	208	5 mu endoglycosidase h boehringer mannheim mannheim germany 0
0.4141868.9736778.html.plaintext.txt	209	05 m citrate buffer containing 0
0.4141868.9736778.html.plaintext.txt	210	order obtain complete deglycosylation cftr proteins incubated 15 min room temperature 0
0.4141868.9736778.html.plaintext.txt	211	3 sds followed overnight incubation 37 degrees c 0
0.4141868.9736778.html.plaintext.txt	212	25 u n glycosidase f boehringer mannheim n glycosidase f buffer 50 mm tris 25 mm edta 1 triton x 100 ph 8
0.4141868.9736778.html.plaintext.txt	213	different cftr constructs vitro transcribed using t7 ribomax large scale rna production system promega madison wi according protocol manufacturer
0.4141868.9736778.html.plaintext.txt	214	quality rna determined means formaldehyde agarose 1 gel electrophoresis
0.4141868.9736778.html.plaintext.txt	215	female toads xenopus laevis anaesthetized ice cold water containing 2 gl 3 aminobenzoic acid ethylester sigma aldrich bornem belgium oocytes subsequently collected via abdominal excision
0.4141868.9736778.html.plaintext.txt	216	oocytes incubated calcium free solution containing 2 mgml collagenase boehringer mannheim 1 h
0.4141868.9736778.html.plaintext.txt	217	oocytes injected 50 nl vitro transcribed rna 5 microg microl
0.4141868.9736778.html.plaintext.txt	218	two electrode voltage clamp assays
0.4141868.9736778.html.plaintext.txt	219	three days rna injection oocytes mounted perfusion chamber impaled two electrodes voltage clamped
0.4141868.9736778.html.plaintext.txt	220	order block endogenous ca2 activated chloride currents perfusion solution 96 mm nacl 5 mm hepes 2 mm kcl 1
0.4141868.9736778.html.plaintext.txt	221	8 mm cacl2 1 mm mgcl2 ph 7
0.4141868.9736778.html.plaintext.txt	222	4 contained 100 microm niflumic acid
0.4141868.9736778.html.plaintext.txt	223	cftr currents activated addition 10 microm forskolin 1 mm ibmx
0.4141868.9736778.html.plaintext.txt	224	data analysed students test
0.4141868.9736778.html.plaintext.txt	225	data reported means plus minus sem
0.4141868.9736778.html.plaintext.txt	226	chloride currents activated non infected oocytes water injected oocytes oocytes injected rna derived vitro transcribed pcdna3
0.4141868.9736778.html.plaintext.txt	227	cos1 cells transfected different pcineogfp cftr constructs 37 36 h later seeded glass coverslips
0.4141868.9736778.html.plaintext.txt	228	coverslips mounted patch clamp set epc 7 amplifier list darmstadt germany containing zeiss axiovert 100 microscope xenon light source epifluorescence optics zeiss xbo 75 zeiss epi unit fluorescence condenser 48 72 h transfection
0.4141868.9736778.html.plaintext.txt	229	band pass filter zeiss bp 450 490 used excitation gfp
0.4141868.9736778.html.plaintext.txt	230	excitation via dichroic mirror zeiss ft 510
0.4141868.9736778.html.plaintext.txt	231	light emitted gfp expressing cells passed 520 nm long pass filter zeiss lp 520 visually detected
0.4141868.9736778.html.plaintext.txt	232	cells emitting green fluorescent light excitation consequently expressing gfp cftr proteins used single channel measurements
0.4141868.9736778.html.plaintext.txt	233	electrophysiological measurements performed room temperature cell attached configuration pipette resistance 10 momega currents digitized 1 khz filtered 500 hz
0.4141868.9736778.html.plaintext.txt	234	data collected continuously axo tape v
0.4141868.9736778.html.plaintext.txt	235	02 software package axon instruments forster city ca analysed ascd software program 38
0.4141868.9736778.html.plaintext.txt	236	one patch per cell studied therefore number patches equal number cells studied
0.4141868.9736778.html.plaintext.txt	237	pipette bath solutions contained 140 mm n methyl d glucamine chloride 10 mm naf 10 mm hepes 2 mm mgcl2 5 mm cscl 1 mm mg atp 1 mm egta ph 7
0.4141868.9736778.html.plaintext.txt	238	channels activated addition 1 microm ibmx 0
0.4141868.9736778.html.plaintext.txt	239	1 microm forskolin bath external solution
0.4141868.9736778.html.plaintext.txt	240	open probability po calculated po iimiddotn averaged current whole stimulation period single channel current obtained amplitude histograms n number channels estimated overlapping events
0.4141868.9736778.html.plaintext.txt	241	data analysed students test
0.4141868.9736778.html.plaintext.txt	242	data reported means plus minus sem
0.4141868.9736778.html.plaintext.txt	243	would like thank jan eggermont kindly provided pcineoires gfp transgene sa strasbourg france generously provided ptg5960 vector
0.4141868.9736778.html.plaintext.txt	244	also grateful thilo dork burkhard tummler damjan glavac claude ferec cristina bombieri julian zielenski garry cutting martin schwarz information concerning phenotypes associated different mutations studied
0.4141868.9736778.html.plaintext.txt	245	anne vankeerberghen fellow het vlaams instituut voor de bevordering van het wetenschappelijk technologisch onderzoek de industrie harry cuppens postdoctoraal navorser van het onderzoeksfonds ku leuven
0.4141868.9736778.html.plaintext.txt	246	investigations also supported alphonse jean forton grant koning boudewijn stichting grant g
0.4141868.9736778.html.plaintext.txt	247	95 thefonds voor wetenschappelijk onderzoek b
0.4141868.9736778.html.plaintext.txt	248	cbavd congenital bilateral absence vas deferens cf cystic fibrosis cftr cystic fibrosis transmembrane conductance regulator er endoplasmic reticulum gfp green flourescent protein nbd nucleotide binding domain rd regulatory domain pka protein kinase pkc protein kinase c po open probability
0.4141868.9736778.html.plaintext.txt	249	eds metabolic molecular bases inherited disease cystic fibrosis
0.4141868.9736778.html.plaintext.txt	250	1989 identification cystic fibrosis gene chromosome walking jumping
0.4141868.9736778.html.plaintext.txt	251	1989 identification cystic fibrosis gene cloning characterization complementary dna
0.4141868.9736778.html.plaintext.txt	252	1989 identification cystic fibrosis gene genetic analysis
0.4141868.9736778.html.plaintext.txt	253	1992 purification functional reconstitution cystic fibrosis transmembrane conductance regulator cftr
0.4141868.9736778.html.plaintext.txt	254	1991 phosphorylation regulated cl channel cho cells stably expressing cystic fibrosis gene
0.4141868.9736778.html.plaintext.txt	255	1995 two nucleotide binding domains cystic fibrosis transmembrane conductance regulator cftr distinct functions controlling channel activity
0.4141868.9736778.html.plaintext.txt	256	1993 regulation cystic fibrosis transmembrane conductance regulator cl channel specific protein kinases protein phosphatases
0.4141868.9736778.html.plaintext.txt	257	1991 phosphorylation r domain camp dependent protein kinase regulates cftr chloride channel
0.4141868.9736778.html.plaintext.txt	258	1993 regulation cystic fibrosis transmembrane conductance regulator cl channel negative charge r domain
0.4141868.9736778.html.plaintext.txt	259	1991 effect deleting r domain cftr generated chloride channels
0.4141868.9736778.html.plaintext.txt	260	1997 function r domain cystic fibrosis transmembrane conductance regulator chloride channel
0.4141868.9736778.html.plaintext.txt	261	1997 stimulation cftr activity phosphorylated r domain
0.4141868.9736778.html.plaintext.txt	262	1993 identification three novel cystic fibrosis mutations sample italian cystic fibrosis patients
0.4141868.9736778.html.plaintext.txt	263	cf genetic analysis consortium httpwww
0.4141868.9736778.html.plaintext.txt	264	1990 defective intracellular transport processing cftr molecular basis cystic fibrosis
0.4141868.9736778.html.plaintext.txt	265	1993 molecular mechanisms cftr chloride channel dysfunction cystic fibrosis
0.4141868.9736778.html.plaintext.txt	266	1997 structure function regulatory r domain cftr
0.4141868.9736778.html.plaintext.txt	267	1994 two domain model r domain cystic fibrosis transmembrane conductance regulator based sequence similarities
0.4141868.9736778.html.plaintext.txt	268	1997 novel model first nucleotide binding domain cystic fibrosis transmembrane conductance regulator
0.4141868.9736778.html.plaintext.txt	269	1991 maturation function cystic fibrosis transmembrane conductance regulator variants bearing mutations putative nucleotide binding domains 1 2
0.4141868.9736778.html.plaintext.txt	270	1997 cftr activation additive effects stimulatory inhibitory phosphorylation sites r domain
0.4141868.9736778.html.plaintext.txt	271	1995 mechanism dysfunction two nucleotide binding domain mutations cystic fibrosis transmembrane conductance regulator associated pancreatic sufficiency
0.4141868.9736778.html.plaintext.txt	272	1995 change gating mode leading increased intrinsic cl channel activity compensates defective processing cystic fibrosis mutant corresponding mild form disease
0.4141868.9736778.html.plaintext.txt	273	1995 cftr camp dependent regulator sodium channels
0.4141868.9736778.html.plaintext.txt	274	1996 wild type f508 cftr inhibits na conductance coexpressed xenopus oocytes
0.4141868.9736778.html.plaintext.txt	275	1996 regulation epithelial sodium channels cystic fibrosis transmembrane conductance regulator
0.4141868.9736778.html.plaintext.txt	276	1997 cystic fibrosis transmembrane conductance regulator inverts protein kinase mediated regulation epithelial sodium channel single channel kinetics
0.4141868.9736778.html.plaintext.txt	277	1993 cftr outwardly rectifying channels distinct proteins regulatory relationship
0.4141868.9736778.html.plaintext.txt	278	1995 cftr regulates outwardly rectifying chloride channels autocrine mechanism involving atp
0.4141868.9736778.html.plaintext.txt	279	1996 camp stimulation cftr expressing xenopus oocytes activates chromanol inhibitable k conductance
0.4141868.9736778.html.plaintext.txt	280	1998 cftr cl channel cftr associated atp channel distinct pores regulated common gates
0.4141868.9736778.html.plaintext.txt	281	1998 polyvariant mutant cystic fibrosis transmembrane conductance regulator genes
0.4141868.9736778.html.plaintext.txt	282	1995 congenital bilateral absence vas deferens primary form cystic fibrosis analysis cftr gene 67 patients
0.4141868.9736778.html.plaintext.txt	283	1993 detection 94 cystic fibrosis mutations sample belgian population identification four novel mutations
0.4141868.9736778.html.plaintext.txt	284	1990 expression characterization cystic fibrosis transmembrane conductance regulator
0.4141868.9736778.html.plaintext.txt	285	1997 use bicistronic gfp expression vector characterise ion channels transfection mammalian cells
0.4141868.9736778.html.plaintext.txt	286	1989 kinetic properties cardiac type calcium channel guinea pig
0.4141868.9736778.html.plaintext.txt	287	correspondence addressed
0.4141868.9736778.html.plaintext.txt	288	tel 32 16 34 60 70 fax 32 16 34 59 97 email harry
0.4141868.9736778.html.plaintext.txt	289	page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoup
0.4141868.9736778.html.plaintext.txt	290	uk u d last modification 12 sep 1998 copyright oxford university press 1998
0.4846223.7493947.html.plaintext.txt	0	1995 american society biochemistry molecular biology inc
0.4846223.7493947.html.plaintext.txt	1	interaction cystic fibrosis transmembrane conductance regulator outwardly rectified chloride channels
0.4846223.7493947.html.plaintext.txt	2	received publication july 24 1995 revised form september 29 1995
0.4846223.7493947.html.plaintext.txt	3	biljana jovov 1 iskander
0.4846223.7493947.html.plaintext.txt	4	1department physiology biophysics university alabama birmingham birmingham alabama 35294 2department molecular cellular physiology university cincinnati cincinnati ohio 45267 0576 abstract introduction experimental procedures results discussion footnotes acknowledgements references
0.4846223.7493947.html.plaintext.txt	5	previously described protocol simultaneous isolation reconstitution protein kinase pka sensitive outwardly rectified chloride channel orcc cystic fibrosis transmembrane conductance regulator cftr bovine tracheal epithelium
0.4846223.7493947.html.plaintext.txt	6	immunoprecipitation cftr preparation prevented pka activation orcc suggesting cftr regulated orcc regulatory relationship preserved throughout purification procedure
0.4846223.7493947.html.plaintext.txt	7	report purification cftr bovine tracheal epithelia purification cftr conduction mutant g551d cftr retrovirally transduced mouse l cells using combination alkali stripping triton x extraction immunoaffinity chromatography
0.4846223.7493947.html.plaintext.txt	8	immunopurified cftr proteins reconstituted absence presence orcc
0.4846223.7493947.html.plaintext.txt	9	test hypothesis functional cftr support activation orcc pka atp used inhibitory anti cftr peptide antibody g551d cftr
0.4846223.7493947.html.plaintext.txt	10	anti cftr peptide antibodies present prior addition pka atp activation orcc cftr prevented
0.4846223.7493947.html.plaintext.txt	11	antibody added activation orcc cftr cl channels pka atp cftr cl channel inhibited
0.4846223.7493947.html.plaintext.txt	12	orcc g551d cftr co incorporated planar bilayers orcc recorded channel could activated addition pka atp
0.4846223.7493947.html.plaintext.txt	13	thus functional cftr required activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	14	also tested hypothesis pka activation orcc dependent extracellular presence atp
0.4846223.7493947.html.plaintext.txt	15	added atp presumed extracellular side lipid bilayer conditions possible activate orcc
0.4846223.7493947.html.plaintext.txt	16	presence inhibitory anti cftr antibody g551d cftr
0.4846223.7493947.html.plaintext.txt	17	cases orcc regained pka sensitivity
0.4846223.7493947.html.plaintext.txt	18	moreover addition hexokinase glucose extracellular side prevented activation orccs pka atp presence cftr
0.4846223.7493947.html.plaintext.txt	19	experiments confirm presence cftr well presence atp extracellular side required activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	20	cystic fibrosis transmembrane conductance regulator cftr outwardly rectified chloride channels orcc contribute camp activated chloride conductance normal cystic fibrosis cf airway cells 1 2
0.4846223.7493947.html.plaintext.txt	21	orccs present apical membranes cf airway epithelia cannot activated protein kinase pka atp3 4 5
0.4846223.7493947.html.plaintext.txt	22	cftr channels regulated pka atp inhibited channel blocker diphenylamine 2 carboxylate dpc 44 diisothiocyanostilbene 22 disulfonic acid dids6 7 whereas orccs dids sensitive
0.4846223.7493947.html.plaintext.txt	23	although cftr orcc channels distinct proteins linked unknown regulatory pathways
0.4846223.7493947.html.plaintext.txt	24	different mechanisms cftr might regulate orcc envisioned
0.4846223.7493947.html.plaintext.txt	25	example cftr could interact directly orcc protein apical membrane regulation could consequence channel function cftr
0.4846223.7493947.html.plaintext.txt	26	shown cftr act atp cl channel6
0.4846223.7493947.html.plaintext.txt	27	recently gugginos group 7 demonstrated atp transported cftr acts autocrine stimulator orcc
0.4846223.7493947.html.plaintext.txt	28	proposed mechanism regulation via p receptor either direct coupling orcc g protein coupled signaling pathway stimulates orcc
0.4846223.7493947.html.plaintext.txt	29	increasing evidence suggests heterogeneity molecular pathogenesis cf
0.4846223.7493947.html.plaintext.txt	30	mutations deletion phenylalanine position 508 phe 508 cftr cause cftr processed improperly within epithelial cells disease may result mutant protein fails traffic apical cell membrane
0.4846223.7493947.html.plaintext.txt	31	mutations relatively common glycine aspartic acid replacement cftr position 551 g551d 3 mutations appear processed targeted normally plasma membrane lack responsiveness stimulation camp8
0.4846223.7493947.html.plaintext.txt	32	known different mutational forms cftr affect regulation orcc pka
0.4846223.7493947.html.plaintext.txt	33	amino acid sequence analysis suggests cftr composed two motifs containing membrane spanning domain msd nucleotide binding domain nbd linked regulatory r domain9
0.4846223.7493947.html.plaintext.txt	34	recently welsh colleagues 10 demonstrated amino terminal portion cftr includes msd1 nbd1 r domain forms regulated cl channel
0.4846223.7493947.html.plaintext.txt	35	shown previously even smaller part cftr namely nbd1 amino acids 426 588 form anion channel reconstituted planar lipid bilayers11
0.4846223.7493947.html.plaintext.txt	36	known portions cftr molecule also transport atp sufficient replace intact cftr regulation orcc
0.4846223.7493947.html.plaintext.txt	37	recently reported simultaneous isolation functional reconstitution orcc cftr bovine tracheal epithelia12
0.4846223.7493947.html.plaintext.txt	38	regulatory relationship channel proteins preserved throughout purification procedure demonstrated activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	39	immunoprecipitation cftr preparation prevented activation orcc pka atp suggesting presence cftr required pka dependent activation orcc
0.4846223.7493947.html.plaintext.txt	40	however experiments distinguish functional cftr essential conferring pka sensitivity orcc physical interaction cftr required
0.4846223.7493947.html.plaintext.txt	41	thus tested hypothesis functional form cftr required pka activation orcc
0.4846223.7493947.html.plaintext.txt	42	order achieve goal used inhibitory anti cftr peptide antibody 13 14 15 block cftr transport function replaced functional cftr nonfunctional mutant form cftr namely g551d cftr8
0.4846223.7493947.html.plaintext.txt	43	results indicate cftr functional orcc activated pka atp
0.4846223.7493947.html.plaintext.txt	44	results also consistent hypothesis schwiebert et al
0.4846223.7493947.html.plaintext.txt	45	7 transport atp cftr extracellular side cells necessary pka activation orcc
0.4846223.7493947.html.plaintext.txt	46	materials patp obtained dupont nen
0.4846223.7493947.html.plaintext.txt	47	hydrazide derivatized acti disk obtained fmc corp
0.4846223.7493947.html.plaintext.txt	48	peroxide free triton x 100 bio beads sm2 purchased bio rad
0.4846223.7493947.html.plaintext.txt	49	phospholipids obtained avanti polar lipids birmingham al
0.4846223.7493947.html.plaintext.txt	50	reagents analytical grade purchased sigma bio rad fisher
0.4846223.7493947.html.plaintext.txt	51	tracheal apical membrane preparationbovine tracheal apical membrane vesicles prepared differential centrifugation using procedure first described langridge smith et al
0.4846223.7493947.html.plaintext.txt	52	16 modified described previously14
0.4846223.7493947.html.plaintext.txt	53	aliquots prepared vesicles average protein concentration 5 mgml stored liquid nitrogen use
0.4846223.7493947.html.plaintext.txt	54	extraction peripheral proteins native membrane vesicles achieved incubation vesicles 30 min kcl buffer 100 mm kcl 5 mm trishepes 0
0.4846223.7493947.html.plaintext.txt	55	alkaline stripped vesicles recovered centrifugation 35000 g 35 min solubilized triton x 100 0
0.4846223.7493947.html.plaintext.txt	56	8 presence kcl buffer ph 7
0.4846223.7493947.html.plaintext.txt	57	quantitation solubilized protein performed using bca method
0.4846223.7493947.html.plaintext.txt	58	immunopurification orcc cftr clchannel proteins p38 antibodiesimmunopurification orcc cftr performed described previously12
0.4846223.7493947.html.plaintext.txt	59	polyclonal rabbit antibody p38 generated 38 kda component anion channel protein covalently linked hydrazide activated disk
0.4846223.7493947.html.plaintext.txt	60	equivalent amount non immune rabbit igg linked another hydrazide activated disk
0.4846223.7493947.html.plaintext.txt	61	solubilized prewashed apical membrane vesicles diluted 40 ml buffer recirculated first non immune disk immune disk 1 h disk allow unspecific specific binding proteins
0.4846223.7493947.html.plaintext.txt	62	disks extensively washed naclphosphate buffer elution 100 mm glycine ph 3
0.4846223.7493947.html.plaintext.txt	63	successive 2 ml fractions collected immediately neutralized 40 microl 1 m tris
0.4846223.7493947.html.plaintext.txt	64	first 15 fractions pooled concentrated 500 microl used reconstitution liposomes biochemical characterization
0.4846223.7493947.html.plaintext.txt	65	immunopurification vitro phosphorylation normal mutant form g551d cftrimmunopurification cftr bovine tracheal apical vesicles wild type cftr l cell lysate g551d cftr performed using polyclonal anti cftr antibodies raised purified fusion protein corresponding first nbd1 amino acids 426 588 cftr18
0.4846223.7493947.html.plaintext.txt	66	l cell lysates prepared described previously16
0.4846223.7493947.html.plaintext.txt	67	essentially immunopurification procedure described p38 antibodies followed except solubilized proteins precleared non immune igg prior recirculation disks ph elution buffer 2
0.4846223.7493947.html.plaintext.txt	68	subsequent labeling analysis eluted proteins patp done described previously 12
0.4846223.7493947.html.plaintext.txt	69	complete solubilized material 30 40 microg proteins immunopurified proteins approximately 100 200 ng washed reaction buffer 50 mm tris ph 7
0.4846223.7493947.html.plaintext.txt	70	5 10 mm mgcl concentrated 40 microl
0.4846223.7493947.html.plaintext.txt	71	pka 300 ng 2 nmol patp 3000 cimmol added mixture incubated 60 min 30 degrees c
0.4846223.7493947.html.plaintext.txt	72	reaction stopped adding sds sample buffer containing 10 mm dithiothreitol
0.4846223.7493947.html.plaintext.txt	73	samples run 6 acrylamide gels dried gels analyzed autoradiography
0.4846223.7493947.html.plaintext.txt	74	immunoprecipitation cftr p38 immunopurified bovine tracheal proteinsimmunoprecipitation cftr p38 immunopurified bovine tracheal proteins performed described previously 19 using polyclonal anti cftr antibodies
0.4846223.7493947.html.plaintext.txt	75	precipitation performed radioimmune precipitation buffer contained 50 mm tris ph 7
0.4846223.7493947.html.plaintext.txt	76	5 550 mm nacl 1 triton x 100 1 sodium deoxycholate 0
0.4846223.7493947.html.plaintext.txt	77	1 sds ensure dissociation cftr proteins
0.4846223.7493947.html.plaintext.txt	78	tissue cultureretrovirus transduced l cells containing g551d cftr 8 kind gift dr
0.4846223.7493947.html.plaintext.txt	79	raymond frizzell university alabama birmingham murine fibroblast cell line grown dulbeccos modified eagles medium life technologies inc
0.4846223.7493947.html.plaintext.txt	80	supplemented 10 heat inactivated fetal bovine serum 100 unitsml penicillin 100 microgml streptomycin
0.4846223.7493947.html.plaintext.txt	81	production anti cftrantibodynew zealand white rabbits immunized purified nbd1 amino acids 426 588 fusion protein emulsified freunds adjuvant complete initial immunization incomplete thereafter ratio 11
0.4846223.7493947.html.plaintext.txt	82	animal received 400 500 microg purified protein
0.4846223.7493947.html.plaintext.txt	83	animals bled marginal ear vein 2 week intervals initial four bleeds
0.4846223.7493947.html.plaintext.txt	84	serum antibody titer monitor enzyme linked immunosorbent assay described previously17 using purified fusion protein antigen
0.4846223.7493947.html.plaintext.txt	85	subsequently animals bled boosted required
0.4846223.7493947.html.plaintext.txt	86	production anti cftrantibodyanti cftr antibody produced described in13
0.4846223.7493947.html.plaintext.txt	87	new zealand white rabbits immunized synthetic peptide corresponding amino acids 505 511 cftr
0.4846223.7493947.html.plaintext.txt	88	site directed antibody affinity purified immune serum using synthetic 505 511 peptide coupled cnbr activated sepharose
0.4846223.7493947.html.plaintext.txt	89	whole cell patch clamp studies shown antibody neutralizes cftr function13
0.4846223.7493947.html.plaintext.txt	90	polyacrylamide gelsprotein separation polyacrylamide gels performed using method laemmli20
0.4846223.7493947.html.plaintext.txt	91	apparent m unknown proteins determined appropriately constructed log mversus relative mobility r curves
0.4846223.7493947.html.plaintext.txt	92	planar lipid bilayer experimentsimmunopurified cl channel proteins reconstituted liposomes described previously21
0.4846223.7493947.html.plaintext.txt	93	briefly concentrated protein samples 100 200 ng mixed phospholipid mixture phosphatidylethanolamine phosphatidylserine phosphatidylcholine ratio 503020 www presence 400 mm kcl 0
0.4846223.7493947.html.plaintext.txt	94	5 mm mgcl 5 mm trishcl ph 7
0.4846223.7493947.html.plaintext.txt	95	4 final volume 600 microl
0.4846223.7493947.html.plaintext.txt	96	residual triton x 100 removed incubating samples 150 mg bio beads sm 2 first room temperature 45 min overnight 4 degrees c
0.4846223.7493947.html.plaintext.txt	97	proteoliposomes separated beads using 1 ml syringe fitted 27 gauge needle
0.4846223.7493947.html.plaintext.txt	98	liposomes contained co reconstituted orcc g551d cftr produced mixing equal amount 100 200 ng immunopurified orcc protein immunopurified g551d cftr protein following procedure reconstitution single immunopurified material
0.4846223.7493947.html.plaintext.txt	99	planar lipid bilayers composed mixture diphytanoyl phosphatidylethanolamine diphytanoyl phosphatidylserine oxidized cholesterol 212 www ratio final concentration 25 mgml n octane painted fire polished glass capillary 200 microm hole drilled polystyrene chamber described previously22
0.4846223.7493947.html.plaintext.txt	100	bilayer formation monitored increase membrane capacitance final value 300 400 picofarads
0.4846223.7493947.html.plaintext.txt	101	liposomes containing anion channel proteins incorporated bilayers bathed symmetrical solutions 100 mm kcl 10 mm mops adjusted ph 7
0.4846223.7493947.html.plaintext.txt	102	channel incorporation indicated appearance quantal step increases current applied voltage
0.4846223.7493947.html.plaintext.txt	103	current measurements performed high gain amplifier circuit based design described previously23
0.4846223.7493947.html.plaintext.txt	104	single channel records analyzed pclamp version 5
0.4846223.7493947.html.plaintext.txt	105	steady state single channel current voltage iv curves measured channel incorporation applying known voltage measuring individual channel current
0.4846223.7493947.html.plaintext.txt	106	single channel open probability p calculated p ni unitary current mean current n total number active channels
0.4846223.7493947.html.plaintext.txt	107	n estimated points current amplitude histograms produced pclamp software
0.4846223.7493947.html.plaintext.txt	108	dashed line figures represents zero current level close state
0.4846223.7493947.html.plaintext.txt	109	bilayer experiments repeated minimum four times specified set experimental conditions
0.4846223.7493947.html.plaintext.txt	110	immunopurification bovine cftr tracheal epithelia recombinant g551d cftr l cell lysatepreviously reported immunopurification procedure simultaneous isolation orcc cftr bovine tracheal epithelia
0.4846223.7493947.html.plaintext.txt	111	incorporation isolated proteins demonstrated channel proteins well regulatory relationship well preserved 12
0.4846223.7493947.html.plaintext.txt	112	delineate mechanism interaction orcc cftr immunopurified reconstituted two different forms cftr
0.4846223.7493947.html.plaintext.txt	113	immunopurification procedure essentially previously described simultaneous isolation orcc cftr except anti cftr antibody used
0.4846223.7493947.html.plaintext.txt	114	mild conditions immunopurification helped preserve functional protein reconstitution
0.4846223.7493947.html.plaintext.txt	115	cell lysate l cells expressing g551d served source nonfunctional mutated form cftr
0.4846223.7493947.html.plaintext.txt	116	vitro phosphorylation immunopurified material revealed dominant 170 kda phosphoprotein isolated either bovine tracheal epithelia fig
0.4846223.7493947.html.plaintext.txt	117	1a lane 2 n 3 l cell lysate fig
0.4846223.7493947.html.plaintext.txt	118	shown previously g551d form cftr different wild type cftr respect glycosylation8
0.4846223.7493947.html.plaintext.txt	119	results indicate anti cftr antibodies suitable immunopurification g551d cftr l cell lysates g551d cftr vitro phosphorylated
0.4846223.7493947.html.plaintext.txt	120	figure 1 autoradiograph vitro phosphorylated immunopurified bovine cftr g551d cftr
0.4846223.7493947.html.plaintext.txt	121	phosphorylation reaction mixture consisted protein sample dissolved 40 microl buffer 50 mm tris ph 7
0.4846223.7493947.html.plaintext.txt	122	5 10 mm mgcl 300 ng catalytic subunit protein kinase 2 nmol patp
0.4846223.7493947.html.plaintext.txt	123	reaction carried 30 degrees c 60 min
0.4846223.7493947.html.plaintext.txt	124	lane 1 total vitro phosphorylated proteins solubilized tracheal apical membrane vesicles
0.4846223.7493947.html.plaintext.txt	125	lane 2 phosphoprotein eluted immune acti disk polyclonal anti cftr antibody
0.4846223.7493947.html.plaintext.txt	126	170 kda phosphoprotein present
0.4846223.7493947.html.plaintext.txt	127	lane 3 phosphoproteins eluted non immune igg bound acti disk
0.4846223.7493947.html.plaintext.txt	128	b g551d cftr mouse l cells
0.4846223.7493947.html.plaintext.txt	129	lane 1 total vitro phosphorylated proteins l cell lysate
0.4846223.7493947.html.plaintext.txt	130	lane 2 phosphoprotein eluted immune igg bound acti disk polyclonal anti cftr antibody
0.4846223.7493947.html.plaintext.txt	131	170 kda phosphoprotein present
0.4846223.7493947.html.plaintext.txt	132	lane 3 phosphoproteins eluted non immune igg bound acti disk
0.4846223.7493947.html.plaintext.txt	133	reconstitution bovine tracheal cftr g551d cftrequal amounts immunopurified tracheal cftr g551d cftr reconstituted proteoliposomes incorporated planar lipid bilayers
0.4846223.7493947.html.plaintext.txt	134	2a shows typical current traces channel activity bovine tracheal cftr incorporation activation pka atp
0.4846223.7493947.html.plaintext.txt	135	channel activity observed whatsoever incorporation performed absence pka atp bathing solution
0.4846223.7493947.html.plaintext.txt	136	incorporations random therefore pka atp present compartments bilayer chamber prior incorporation
0.4846223.7493947.html.plaintext.txt	137	wild type cftr containing vesicles used small 16 picosiemens linear anion selective channel recorded
0.4846223.7493947.html.plaintext.txt	138	identity incorporated channel confirmed insensitivity 100 microm dids sensitivity dpc block anti cftr antibodies fig
0.4846223.7493947.html.plaintext.txt	139	moreover channel cl permselectivity 41
0.4846223.7493947.html.plaintext.txt	140	anti cftr antibodies added one side bilayer containing incorporated cftr final concentration 25 50 ngml inhibited bovine cftr channel activity presence pka atp
0.4846223.7493947.html.plaintext.txt	141	however due random orientation channel bilayer experiments 1128 antibodies inhibit cftr added one side system
0.4846223.7493947.html.plaintext.txt	142	experiments addition antibodies opposite side successfully inhibited channel activity
0.4846223.7493947.html.plaintext.txt	143	addition anti cftr antibody antibody used purification cftr either sides bilayer effect activity incorporated bovine cftr fig
0.4846223.7493947.html.plaintext.txt	144	incorporation g551d cftr treatment pka atp result appearance channel activity n 15
0.4846223.7493947.html.plaintext.txt	145	figure 2 single channel activity immunopurified bovine cftr reconstituted planar lipid bilayer
0.4846223.7493947.html.plaintext.txt	146	control single channel recordings performed holding potentials 80 mv presence 100 microm atp catalytic subunit pka 1
0.4846223.7493947.html.plaintext.txt	147	anti cftr antibodies 200 microgml added sides bilayer followed addition 100 microm dids compartments bilayer chamber
0.4846223.7493947.html.plaintext.txt	148	addition 100 microm dids separate experiment n 13 either side channel containing bilayer prior addition anti cftr antibodies effect channel activity
0.4846223.7493947.html.plaintext.txt	149	experiment shown representative 18 total 33 300 microm dpc completely blocked channel activity added one side bilayer usually trans
0.4846223.7493947.html.plaintext.txt	150	15 experiments dpc ineffective added one side bilayer
0.4846223.7493947.html.plaintext.txt	151	thus addition 300 microm dpc made opposite side resulted abolished channel activity
0.4846223.7493947.html.plaintext.txt	152	experiment shown anti cftr antibodies 50 ngml added one side bilayer usually cis
0.4846223.7493947.html.plaintext.txt	153	likewise dpc inhibition experiments channel activity remained unaffected 11 experiments total 28 antibodies added opposite side subsequent inhibition
0.4846223.7493947.html.plaintext.txt	154	effect inhibitory anti cftrantibodies activation orcc pka atpwe next examined whether inhibitory anti cftr antibodies could prevent activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	155	experiments used immunopurified material obtained using p38 antibodies contained cftr co purified orcc
0.4846223.7493947.html.plaintext.txt	156	current rectification orcc allowed us determine sidedness incorporated channels
0.4846223.7493947.html.plaintext.txt	157	moreover incorporation proteins negatively charged bilayers held 80 mv permitted us perform oriented reconstitutions
0.4846223.7493947.html.plaintext.txt	158	cytoplasmic pka sensitive portion channels faced cis compartment extracellular portion faced trans compartment 90 successful incorporations orcc cftr assessed pka activation
0.4846223.7493947.html.plaintext.txt	159	another observation allowed us determine whether cftr co reconstituted bilayer membrane prior pka activation
0.4846223.7493947.html.plaintext.txt	160	current voltage iv curves orcc presence nonphosphorylated cftr slightly less rectified negative voltage quadrant compared cftr absent fig
0.4846223.7493947.html.plaintext.txt	161	distinction important experiments pka atp failed activate orcc incorporated bilayer membrane 3 72 using criterion described concluded cftr present bilayer
0.4846223.7493947.html.plaintext.txt	162	furthermore three experiments cftr channel activity also observed subsequent addition pka atp either side bilayer
0.4846223.7493947.html.plaintext.txt	163	figure 5 single channel current voltage relationships immunopurified reconstituted orcc presence absence wild type cftr g551d cftr activation pka atp planar lipid bilayer
0.4846223.7493947.html.plaintext.txt	164	conditions defined symbol legends graph
0.4846223.7493947.html.plaintext.txt	165	symbols indicate mean values error bars indicate plus minus
0.4846223.7493947.html.plaintext.txt	166	least four separate experiments condition
0.4846223.7493947.html.plaintext.txt	167	found anti cftr antibodies effect base line orcc activity confirming specificity toward cftr
0.4846223.7493947.html.plaintext.txt	168	inhibitory anti cftr antibodies added presumptive cytoplasmic bathing solutions pka atp activation incorporated channels cftr cl channel activity inhibited orcc remained activated p 0
0.4846223.7493947.html.plaintext.txt	169	amplitude histograms channel recordings made presence pka atp fig
0.4846223.7493947.html.plaintext.txt	170	3b showed least three cftr cl channels accompanied one orcc channel one orcc active bilayer inhibition cftr using anti cftr antibodies
0.4846223.7493947.html.plaintext.txt	171	however would premature draw conclusions exact molar ratio orcc cftr necessary interaction bilayer experiments comparable experiments two five cftr channels per single orcc observed
0.4846223.7493947.html.plaintext.txt	172	contrast results obtained anti cftr antibodies added pka atp activation incorporated channels addition inhibitory anti cftr antibodies prior addition pka atp prevented activation cftr orcc pka atp n 11 fig
0.4846223.7493947.html.plaintext.txt	173	figure 3 effect anti cftr antibody pka atp activated orcc cftr planar lipid bilayer
0.4846223.7493947.html.plaintext.txt	174	traces shown representative 21 experiments
0.4846223.7493947.html.plaintext.txt	175	holding potential doses pka atp anti cftr antibodies described fig
0.4846223.7493947.html.plaintext.txt	176	control refers channel activity symmetrical bathing solutions containing 100 mm kcl 10 mm mops ph 7
0.4846223.7493947.html.plaintext.txt	177	additions made sequentially shown figure
0.4846223.7493947.html.plaintext.txt	178	b point amplitude histograms traces shown
0.4846223.7493947.html.plaintext.txt	179	histograms generated pclamp software record 5 min length
0.4846223.7493947.html.plaintext.txt	180	figure 4 effect anti cftr antibody activation orcc cftr pka atp planar lipid bilayer
0.4846223.7493947.html.plaintext.txt	181	traces shown representative 11 experiments
0.4846223.7493947.html.plaintext.txt	182	holding potential doses pka atp anti cftr antibodies described fig
0.4846223.7493947.html.plaintext.txt	183	control refers channel activity symmetrical bathing solutions containing 100 mm kcl 10 mm mops ph 7
0.4846223.7493947.html.plaintext.txt	184	additions made sequentially shown figure
0.4846223.7493947.html.plaintext.txt	185	b point amplitude histogram traces shown
0.4846223.7493947.html.plaintext.txt	186	histograms generated pclamp software recordings 5 min length
0.4846223.7493947.html.plaintext.txt	187	anti cftr antibodies affect rectification properties orcc although using antibodies block cftr channel activity able determine precisely iv curves phosphorylated orcc
0.4846223.7493947.html.plaintext.txt	188	notably rectification orcc upon pka induced phosphorylation change
0.4846223.7493947.html.plaintext.txt	189	slope conductance orcc positive voltages altered conditions
0.4846223.7493947.html.plaintext.txt	190	results support hypothesis active form cftr required activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	191	effect replacement functional cftr nonfunctional g551d cftr activation orcc pka atpto test hypothesis functional form cftr required activation orcc pka atp co reconstituted immunopurified orcc nonfunctional g551d cftr
0.4846223.7493947.html.plaintext.txt	192	separation orcc co purified orcc cftr achieved immunodepletion cftr preparation
0.4846223.7493947.html.plaintext.txt	193	removal cftr confirmed absence 170 kda phosphoprotein lack activation pka atp reconstituted orcc incorporated planar lipid bilayers described earlier 12
0.4846223.7493947.html.plaintext.txt	194	g551d cftr immunopurified described methods co reconstituted preparation containing orcc devoid cftr
0.4846223.7493947.html.plaintext.txt	195	replacement normal cftr g551d cftr used autoradiographydensitometry estimate intensity vitro phosphorylated cftr 170 kda band replaced normal cftr similar amount g551d cftr g551d cftr also vitro phosphorylated
0.4846223.7493947.html.plaintext.txt	196	conditions following incorporation bilayer orcc recorded change open probability upon addition pka atp one either cis trans side bilayer p 0
0.4846223.7493947.html.plaintext.txt	197	05 n 9 presence pka atp
0.4846223.7493947.html.plaintext.txt	198	detailed analysis electrical properties orcc revealed change rectification properties presence g551d cftr negative potential quadrant similar described orcc presence normal cftr see fig
0.4846223.7493947.html.plaintext.txt	199	three separate experiments liposomes containing g551d cftr fused bilayer already containing orcc cftr
0.4846223.7493947.html.plaintext.txt	200	presence g551d cftr like incorporation wild type cftr produced change rectification properties orcc
0.4846223.7493947.html.plaintext.txt	201	2 experiments total 26 performed orcc incorporated liposomes presumably containing orcc g551d cftr displayed properties identical orcc incorporated cftr immunodepleted preparations
0.4846223.7493947.html.plaintext.txt	202	observations allowed us conclude change rectification indicative presence g551d cftr bilayer containing orcc
0.4846223.7493947.html.plaintext.txt	203	nonetheless orcc activated pka atp experiments n 9 thus supporting hypothesis conductive form cftr required activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	204	however three experiments pka atp added sides bilayer containing orcc g551d cftr activity orcc increased 2 fold 0
0.4846223.7493947.html.plaintext.txt	205	effect extracellular atp activation orcc pka atpit shown cftr cl atp channel6
0.4846223.7493947.html.plaintext.txt	206	test transport atp cftr required activation orcc added atp scavenging system hexokinase 0
0.4846223.7493947.html.plaintext.txt	207	5 unitml glucose5 mm presumptive extracellular side bilayer containing incorporated orcc cftr cl channels
0.4846223.7493947.html.plaintext.txt	208	presence hexokinase glucose presumptive extracellular side influence activation cftr channel pka atp added opposite side bilayer prevent pka mediated activation orcc n 12
0.4846223.7493947.html.plaintext.txt	209	results contrast pka mediated activation orcc cftr seen absence hexokinase glucose cf
0.4846223.7493947.html.plaintext.txt	210	aforementioned results suggested atp secretion cftr may required pka induced activation orcc
0.4846223.7493947.html.plaintext.txt	211	addition atp presumptive extracellular side effect channel activity incorporated orcc cftr
0.4846223.7493947.html.plaintext.txt	212	transport atp cftr requirement pka mediated activation orcc possible activate orcc addition atp extracellular solution pka atp cytoplasmic side system
0.4846223.7493947.html.plaintext.txt	213	however orcc alone incorporated bilayer channel could activated addition 100 microm atp outside pka atp inside pka atp bathing solutions see fig
0.4846223.7493947.html.plaintext.txt	214	results suggest transport atp cftr role cftr plays regulation orcc
0.4846223.7493947.html.plaintext.txt	215	figure 7 channel activity orcc g551d cftr planar lipid bilayers effects extracellular atp intracellular pka atp
0.4846223.7493947.html.plaintext.txt	216	traces shown representative 11 experiments
0.4846223.7493947.html.plaintext.txt	217	holding potential doses pka atp anti cftr antibodies described fig
0.4846223.7493947.html.plaintext.txt	218	control refers channel activity symmetrical bathing solutions containing 100 mm kcl 10 mm mops ph 7
0.4846223.7493947.html.plaintext.txt	219	additions made sequentially shown figure
0.4846223.7493947.html.plaintext.txt	220	therefore examined presence atp presumptive extracellular side bilayer containing orcc nonfunctional cftr
0.4846223.7493947.html.plaintext.txt	221	either blocked inhibitory antibody nonfunctional g551d cftr could restore pka sensitivity orcc
0.4846223.7493947.html.plaintext.txt	222	conditions namely presence inhibitory antibodies fig
0.4846223.7493947.html.plaintext.txt	223	7 orcc regained pka sensitivity 100 microm atp added extracellular bathing medium
0.4846223.7493947.html.plaintext.txt	224	findings also confirmed hypothesis transport atp role cftr plays regulation orcc
0.4846223.7493947.html.plaintext.txt	225	results also indicate g551d cftr like wild type cftr incorporated membrane specific orientation presence orcc
0.4846223.7493947.html.plaintext.txt	226	figure 6 channel activity orcc cftr planar lipid bilayers presence anti cftr antibody effects extracellular atp intracellular pka atp
0.4846223.7493947.html.plaintext.txt	227	traces shown representative 14 experiments
0.4846223.7493947.html.plaintext.txt	228	holding potential doses pka atp anti cftr antibodies described fig
0.4846223.7493947.html.plaintext.txt	229	control refers channel activity symmetrical bathing solutions containing 100 mm kcl 10 mm mops ph 7
0.4846223.7493947.html.plaintext.txt	230	additions made sequentially shown figure
0.4846223.7493947.html.plaintext.txt	231	also tested whether portion cftr namely nbd1 domain could interact orcc presence extracellular atp sufficient pka mediated activation orcc
0.4846223.7493947.html.plaintext.txt	232	however four separate experiments found nbd1 could substitute full sized cftr regulation orcc pka atp added either sides membrane
0.4846223.7493947.html.plaintext.txt	233	results demonstrate immunopurified functionally reconstituted planar lipid bilayers bovine cftr nonconductive g551d cftr transduced l cells
0.4846223.7493947.html.plaintext.txt	234	similar immunopurification procedure isolation reconstitution recombinant functionally competent cftr chinese hamster ovary sf9 cells reported recently24
0.4846223.7493947.html.plaintext.txt	235	reconstituted proteins used purified functionally reconstituted orcc described previously delineation mechanism interaction cftr orcc
0.4846223.7493947.html.plaintext.txt	236	immunopurified reconstituted bovine cftr cl channel ion selectivity inhibitor specificity inhibition anti cftr antibodies reported previously patch clamp studies reconstituted recombinant cftr7 13 25
0.4846223.7493947.html.plaintext.txt	237	main difference previously reported characteristics cftr cl channel bovine cftr cl channel single channel conductance
0.4846223.7493947.html.plaintext.txt	238	experiments conductance bovine cftr 16 picosiemens somewhat larger previously reported 8 13 picosiemens
0.4846223.7493947.html.plaintext.txt	239	conductance cftr channel hands regardless antibody used purification presence absence orcc reconstituted material
0.4846223.7493947.html.plaintext.txt	240	reason discrepancy apparent
0.4846223.7493947.html.plaintext.txt	241	study demonstrated transport function cftr intact could activation orcc pka atp occur
0.4846223.7493947.html.plaintext.txt	242	results also support gugginos 7 hypothesis one function cftr activation orcc transport atp extracellular side cell membrane
0.4846223.7493947.html.plaintext.txt	243	hypothesis consistent findings reisin et al
0.4846223.7493947.html.plaintext.txt	244	6 demonstrated directly atp traverse cftr channel
0.4846223.7493947.html.plaintext.txt	245	cannot present exclude co purification purinergic receptor procedures
0.4846223.7493947.html.plaintext.txt	246	however unlikely receptor coupled mechanism would active bilayer system absence necessary signaling molecules
0.4846223.7493947.html.plaintext.txt	247	however failure orcc activated pka atp presence external atp supports idea purinergic receptor mediated pathway co purify preparation
0.4846223.7493947.html.plaintext.txt	248	second finding revealed study nonconductive form cftr g551d able support activation orcc pka atp present extracellular side incorporated channels
0.4846223.7493947.html.plaintext.txt	249	shown previously portion cftr includes msd1 nbd1 r domain even smaller parts cftr nbd1 amino acids 426 588 form cl channels10 11
0.4846223.7493947.html.plaintext.txt	250	tested whether nbd1 could substitute cftr regulation orcc pka atp
0.4846223.7493947.html.plaintext.txt	251	conditions used studies nbd1 form channel bilayer therefore able substitute cftr
0.4846223.7493947.html.plaintext.txt	252	furthermore recombinant nbd1 purified prokaryotic cells unable support activation pka orcc presence exogenously added extracellular atp
0.4846223.7493947.html.plaintext.txt	253	taken together results suggest minimal size requirement cftr necessary subserve regulatory role pka related activation orcc
0.4846223.7493947.html.plaintext.txt	254	summary immunopurified functionally reconstituted cftr bovine trachea nonconductive g551d cftr transduced l cells
0.4846223.7493947.html.plaintext.txt	255	combination previously co purified orcc cftr bovine tracheal epithelia inhibitory anti cftr antibodies able explore regulatory relationship orcc cftr
0.4846223.7493947.html.plaintext.txt	256	shown functional cftr required activation orcc pka atp
0.4846223.7493947.html.plaintext.txt	257	cftr apparently required transport atp cytoplasm extracellular bathing solution interact external domain orcc
0.4846223.7493947.html.plaintext.txt	258	observation orcc cannot activated extracellular atp pka atp added cytoplasmic side absence cftr molecule also suggests addition transport atp function cftr direct interaction cftr orcc essential confer pka sensitivity orcc
0.4846223.7493947.html.plaintext.txt	259	work supported part national institutes health grant dk48764
0.4846223.7493947.html.plaintext.txt	260	costs publication article defrayed part payment page charges
0.4846223.7493947.html.plaintext.txt	261	article must therefore hereby marked advertisement accordance 18 u
0.4846223.7493947.html.plaintext.txt	262	section 1734 solely indicate fact
0.4846223.7493947.html.plaintext.txt	263	supported fellowship cff981 provided cystic fibrosis foundation
0.4846223.7493947.html.plaintext.txt	264	correspondence addressed university alabama birmingham dept
0.4846223.7493947.html.plaintext.txt	265	physiology biophysics 1918 university blvd
0.4846223.7493947.html.plaintext.txt	266	706 bhsb birmingham al 35294 0005
0.4846223.7493947.html.plaintext.txt	267	abbreviations used cftr cystic fibrosis transmembrane conductance regulator orcc outwardly rectified chloride channel pka protein kinase dpc diphenylamine 2 carboxylate dids 44 diisothiocyanostilbene 22 disulfonic acid msd membrane spanning domain nbd nucleotide binding domain mops 4 morpholinepropanesulfonic acid
0.4846223.7493947.html.plaintext.txt	268	tamas jilling help production cftr antibodies
0.4846223.7493947.html.plaintext.txt	269	thank deborah keeton excellent technical assistance charlae starr prompt secretarial help
0.4846223.7493947.html.plaintext.txt	270	greatly appreciate gift purified catalytic subunit protein kinase dr
0.4846223.7493947.html.plaintext.txt	271	1992 nature 358 581 584 crossrefmedline order article via infotrieve gabriel
0.4846223.7493947.html.plaintext.txt	272	1993 nature 363 263 266 crossrefmedline order article via infotrieve hwang c
0.4846223.7493947.html.plaintext.txt	273	1989 science 244 1351 1353 medline order article via infotrieve quinton p
0.4846223.7493947.html.plaintext.txt	274	1983 nature 301 421 422 medline order article via infotrieve anderson p
0.4846223.7493947.html.plaintext.txt	275	1991 science 251 269 682 reisin
0.4846223.7493947.html.plaintext.txt	276	269 20584 20591 abstractfree full text schwiebert e
0.4846223.7493947.html.plaintext.txt	277	81 1063 1073 medline order article via infotrieve yang y
0.4846223.7493947.html.plaintext.txt	278	2 1253 1261 abstract fuller c
0.4846223.7493947.html.plaintext.txt	279	1994 cell 76 1091 1098 medline order article via infotrieve arisipe n
0.4846223.7493947.html.plaintext.txt	280	89 1539 1543 abstract jovov b
0.4846223.7493947.html.plaintext.txt	281	270 1521 1528 abstractfree full text chan h
0.4846223.7493947.html.plaintext.txt	282	267 8411 8416 abstractfree full text tien x
0.4846223.7493947.html.plaintext.txt	283	269 51 54 abstractfree full text nelson d
0.4846223.7493947.html.plaintext.txt	284	acta 731 318 328 medline order article via infotrieve ran
0.4846223.7493947.html.plaintext.txt	285	266 4782 4788 abstractfree full text hartman j
0.4846223.7493947.html.plaintext.txt	286	1970 nature 227 680 685 medline order article via infotrieve ran
0.4846223.7493947.html.plaintext.txt	287	267 20630 20637 abstractfree full text ismailov
0.4846223.7493947.html.plaintext.txt	288	269 10235 10247 abstractfree full text alvarez o
0.4846223.7493947.html.plaintext.txt	289	270 17033 17043 abstractfree full text bear c
0.4846223.7493947.html.plaintext.txt	290	1992 cell 68 809 818 medline order article via infotrieve 1995 american society biochemistry molecular biology inc
0.49234396.11404248.html.plaintext.txt	0	editorial focus activation nf b airway epithelial cells dependent cftr trafficking cl channel function adam j
0.49234396.11404248.html.plaintext.txt	1	weber grace soong ruth bryan shahryar saba alice prince
0.49234396.11404248.html.plaintext.txt	2	college physicians surgeons columbia university new york new york 10032
0.49234396.11404248.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references
0.49234396.11404248.html.plaintext.txt	4	polymorphonuclear leukocyte dominated airway inflammation major component cystic fibrosis cf lung disease may associated cf transmembrane conductance regulator cftr dysfunction well infection
0.49234396.11404248.html.plaintext.txt	5	mutant f508 cftr mistrafficked accumulates endoplasmic reticulum er may cause cell stress activation nuclear factor nf b
0.49234396.11404248.html.plaintext.txt	6	g551d mutants also lack cl channel function cftr trafficked normally
0.49234396.11404248.html.plaintext.txt	7	compared effects cftr mutations endogenous activation nf b reporter construct
0.49234396.11404248.html.plaintext.txt	8	transfected chinese hamster ovary cells mistrafficked f508 allele caused sevenfold activation nf b compared wild type cftr g551d mutant p 0
0.49234396.11404248.html.plaintext.txt	9	nf b also activated 9hteopcep r cells 16hbepcftr antisense cell lines lack cftr cl channel function accumulate mutant protein er
0.49234396.11404248.html.plaintext.txt	10	endogenous activation nf b associated elevated interleukin 8 expression
0.49234396.11404248.html.plaintext.txt	11	impaired cftr cl channel activity well cell stress due accumulation mistrafficked cftr er contributes endogenous activation nf b cells cftr mutation
0.49234396.11404248.html.plaintext.txt	12	nuclear factor b cystic fibrosis transmembrane conductance regulator chloride channel inflammatory response intracellular calcium mitogen activated protein kinase
0.49234396.11404248.html.plaintext.txt	13	introduction top abstract introduction materials methods results discussion references
0.49234396.11404248.html.plaintext.txt	14	cystic fibrosis cf transmembrane conductance regulator cftr mutations many effects physiology respiratory epithelial cells addition expected effects cl transport
0.49234396.11404248.html.plaintext.txt	15	one major clinical manifestations cftr mutations excessive airway inflammation 14 17 implying cftr affects immune function airway epithelial cells particularly expression nuclear factor nf b dependent proinflammatory chemokines cytokines
0.49234396.11404248.html.plaintext.txt	16	several lines experimental evidence suggest cftr dysfunction influences exogenous activation epithelial immune function 8 30
0.49234396.11404248.html.plaintext.txt	17	bacteria persist respiratory tract cf patients due decreased antimicrobial activity cf airway surface fluid impair bacterial clearance due mucus plugging 25
0.49234396.11404248.html.plaintext.txt	18	cells cftr mutations increased numbers asialoglycolipid receptors common bacterial pathogens 24
0.49234396.11404248.html.plaintext.txt	19	ligation receptors activates nf b dependent epithelial interleukin il 8 production recruit polymorphonuclear leukocytes pmns circulation airways 8
0.49234396.11404248.html.plaintext.txt	20	epithelial expression il 8 bacterial stimulation increased cells cftr dysfunction finding demonstrated matched cf corrected cell lines 5 9 27 30 cftr deficient cftr mice compared normal control mice 29
0.49234396.11404248.html.plaintext.txt	21	cftr dysfunction might affect endogenous expression nf b dependent genes less well documented
0.49234396.11404248.html.plaintext.txt	22	nf b transcription factor required expression many genes important inflammation
0.49234396.11404248.html.plaintext.txt	23	complexed cell cytoplasm ib selectively phosphorylated ubiquitinated degraded proteasome response stimuli 2
0.49234396.11404248.html.plaintext.txt	24	signal dependent signal independent ib phosphorylation 20 distinction may relevant endogenous activity nf b opposed activation response superficial stimulus bacterial attachment surface receptors
0.49234396.11404248.html.plaintext.txt	25	ligation superficial asialo gm1 receptors epithelial surfaces bacterial adhesins stimulates ca2 dependent kinase activity mitogen activated protein kinase phosphorylation nf b activation 23a
0.49234396.11404248.html.plaintext.txt	26	nf b translocation may regulated intracellular factors lead different pattern ib phosphorylation elicited extracellular stimuli 4
0.49234396.11404248.html.plaintext.txt	27	proposed abnormal trafficking f508 cftr accumulation endoplasmic reticulum er provides sufficient intracellular stress cause nf b activation 2
0.49234396.11404248.html.plaintext.txt	28	common cftr mutation responsible cf 70 patients deletion phenylalanine residue f508 nucleotide binding domain
0.49234396.11404248.html.plaintext.txt	29	f508 mutant cftr fails transport cl response camp accumulates er due abnormal maturation folding 1 7 32
0.49234396.11404248.html.plaintext.txt	30	experimental data generated adenovirus mutants targeted retention er pahl colleagues 18 19 proposed homozygous f508 mutations cftr would similarly cause ca2 release activation nf b resultant transcription proinflammatory cytokines chemokines
0.49234396.11404248.html.plaintext.txt	31	comparison endogenous activation nf b ib3 cells w1282xf508 trafficking mutant similar homozygous f508 mutation corrected c 38 cells express functional truncated form cftr consistent hypothesis
0.49234396.11404248.html.plaintext.txt	32	transcriptionally active p65 component nf b found nuclei unstimulated cf cells corrected cells immunofluorescence labeling confirmed gel shift assays 8
0.49234396.11404248.html.plaintext.txt	33	manipulations increase cftr trafficking apical surface cell growth low temperature addition glycerol decreased amount p65 found ib3 cell nuclei
0.49234396.11404248.html.plaintext.txt	34	although observations consistent hypothesis abnormal cftr proteins cause endogenous activation nf b differentiate two possible mechanisms cell stress associated cftr mistrafficking leads changes intracellular ca2 concentration ca2i stimulation nf b translocation cftr cl channel dysfunction associated endogenous activation nf b
0.49234396.11404248.html.plaintext.txt	35	types cftr mutations cause cf like physiology
0.49234396.11404248.html.plaintext.txt	36	lack cl secretion response camp without causing trafficking abnormalities resulting accumulation mutant proteins er 7
0.49234396.11404248.html.plaintext.txt	37	analysis activation nf b cell lines would provide opportunity determine whether cl channel dysfunction alone associated regulation nf b
0.49234396.11404248.html.plaintext.txt	38	g551d cftr mutant conserved glycine atp binding cassette mutated lacks cl channel function protein properly folded trafficked 12
0.49234396.11404248.html.plaintext.txt	39	patients g551d mutation clinical disease indistinguishable caused common f508 mutation 10
0.49234396.11404248.html.plaintext.txt	40	9hteo human tracheal epithelial cell line transfected plasmid directing constitutive expression cftr regulatory r domain also fails transport cl response camp expressing low levels wild type cftr message detected rt pcr 21
0.49234396.11404248.html.plaintext.txt	41	9hteopcep r cells readily activated pseudomonas aeruginosa express significantly il 8 control cells containing empty vector 5
0.49234396.11404248.html.plaintext.txt	42	impact impaired cftr cl channel activity normal interaction ibs nf b known
0.49234396.11404248.html.plaintext.txt	43	recently constructed 16hbe cell lines expressing plasmid encoded cftr sense antisense orientation also provide opportunity test impact cftr cl channel function activation nf b airway cells without confounding issues mistrafficked cftr protein 23
0.49234396.11404248.html.plaintext.txt	44	experiments detailed report several matched cell lines cftr dysfunction due lack cl channel function cftr misfolding mistrafficking tested endogenous activation nf b basal il 8 expression
0.49234396.11404248.html.plaintext.txt	45	although cftr mistrafficking typical common f508 mutation associated cell stress may responsible increased expression proinflammatory cytokines chemokines associated cf cells sought establish whether cftr cl channel function well effects cftr mistrafficking contributes endogenous activation nf b excessive inflammation characterizes cf airway pathology
0.49234396.11404248.html.plaintext.txt	46	materials methods top abstract introduction materials methods results discussion references
0.49234396.11404248.html.plaintext.txt	47	9hteo cells human tracheal epithelial cell line 11 grown dmem supplemented 10 fcs stably transfected either pcep vector control pcep r providing constitutive expression r domain cftr resulting typical cf like physiology
0.49234396.11404248.html.plaintext.txt	48	failure cl secretion response camp 21 altered superficial sialylation 5
0.49234396.11404248.html.plaintext.txt	49	ib3 cells f508w1282x human bronchial epithelial cell line c 38 cells corrected cells normal physiology express episomal truncated form cftr 33 obtained p
0.49234396.11404248.html.plaintext.txt	50	zeitlin johns hopkins university baltimore md grown lhc 8 medium biofluids rockville md plus 10 fcs
0.49234396.11404248.html.plaintext.txt	51	ib3 cells used studies contain empty vector
0.49234396.11404248.html.plaintext.txt	52	16hbe cells transfected plasmids expressing first 131 nucleotides cftr either sense antisense orientation grown mem plus 10 fcs plus l glutamine previously described 23
0.49234396.11404248.html.plaintext.txt	53	cells expressing antisense plasmid failed respond camp agonists cl secretion
0.49234396.11404248.html.plaintext.txt	54	stably transfected chinese hamster ovary cho k1 cells express f508 cftr g551d cftr obtained j
0.49234396.11404248.html.plaintext.txt	55	riordan mayo clinic scottsdale scottsdale az grown mem plus 200 microm methotrexate plus 8 fcs
0.49234396.11404248.html.plaintext.txt	56	cho k1 cells obtained american type culture collection atcc lipofected pcep plasmid constructs expressing either wild type cftr g551d cftr f508 cftr vector alone provided m
0.49234396.11404248.html.plaintext.txt	57	drumm case western reserve university cleveland oh
0.49234396.11404248.html.plaintext.txt	58	cho cells grown mem plus 10 fcs
0.49234396.11404248.html.plaintext.txt	59	cftr expression cells verified immunodetection cooh terminus specific mouse monoclonal anti cftr antibody genzyme minneapolis mn
0.49234396.11404248.html.plaintext.txt	60	total rna isolated confluent monolayers ib3 c 38 cells grown 10 cm plates rneasy mini kit rt performed omniscript rt qiagen valencia ca
0.49234396.11404248.html.plaintext.txt	61	pcr primers human il 8 5 tactccaaacctttccaaccc 3 5 aacttctccacaaccctctg 3
0.49234396.11404248.html.plaintext.txt	62	cells stimulated addition 0
0.49234396.11404248.html.plaintext.txt	63	aeruginosa pao1 5 x 109 colony stimulating unitsml scraped agar plate resuspended cell culture medium
0.49234396.11404248.html.plaintext.txt	64	il 8 epithelial cell culture supernatants measured elisa r d systems minneapolis mn
0.49234396.11404248.html.plaintext.txt	65	cells weaned serum 18 h supernatants harvested 18 h later il 8 elisa
0.49234396.11404248.html.plaintext.txt	66	duplicate wells treated trypan blue assess epithelial viability assay 75
0.49234396.11404248.html.plaintext.txt	67	il 8 data point determined quintuplicate means plus minus sd calculated
0.49234396.11404248.html.plaintext.txt	68	significance evaluated one way anova dunnetts posttest graphpad instat version 3
0.49234396.11404248.html.plaintext.txt	69	00 graphpad software san diego ca test null hypothesis difference amount il 8 produced epithelial cells different cftr function
0.49234396.11404248.html.plaintext.txt	70	activation nf b detected luciferase reporter constructs
0.49234396.11404248.html.plaintext.txt	71	cells grown six well plates 80 90 confluence washed pbs replated serum antibiotic free medium
0.49234396.11404248.html.plaintext.txt	72	cells transiently transfected lipofectamine 2000 reagent life technologies gaithersburg md 1 microg plasmid dna pnf b luc stratagene la jolla ca constitutively active prl tk promega madison wi control transfection efficiency incubated 37 degrees c 5 co2 18 h
0.49234396.11404248.html.plaintext.txt	73	lipofection cho cells done additional 3 microg pcep cftr vector dna
0.49234396.11404248.html.plaintext.txt	74	cells washed lysed harvested passive lysis buffer promega
0.49234396.11404248.html.plaintext.txt	75	luciferase assays performed reagents protocol dual luciferase reporter assay system promega analyzed luminometer
0.49234396.11404248.html.plaintext.txt	76	standardization transfection efficiency data plotted means quadruplicate samples representative least three independent experiments
0.49234396.11404248.html.plaintext.txt	77	statistical analysis performed unpaired test experiments involving epithelial cells one way anova analyze results obtained cho cells accommodate larger sample size
0.49234396.11404248.html.plaintext.txt	78	relative levels ca2i estimated fluo 3 loaded ib3 c 38 cells fluorescence imaging
0.49234396.11404248.html.plaintext.txt	79	monolayers c 38 ib3 cells grown 2 days lab tekii chambered slides nalge nunc international naperville il lhc 8 medium biofluids supplemented 10 fcs
0.49234396.11404248.html.plaintext.txt	80	monolayers washed dye loaded fluo 3 bio rad hercules ca 0
0.49234396.11404248.html.plaintext.txt	81	5 h room temperature dark modified ringer solution 145 mm nacl 5 mm kcl 1 mm na2hpo4 2 mm cacl2 10 mm glucose 20 mm hepes 1 mm mgso4 ph 7
0.49234396.11404248.html.plaintext.txt	82	cells rinsed ringer solution incubated 30 min allow continued cleavage acetoxymethyl ester
0.49234396.11404248.html.plaintext.txt	83	monolayers imaged zeiss axiovert microscope x 40 magnification inovision software
0.49234396.11404248.html.plaintext.txt	84	images taken 10 intervals addition stimuli image average eight scans
0.49234396.11404248.html.plaintext.txt	85	final measurements taken addition ionophore 4 bromo 23187 bio rad allow correction differences dye loading
0.49234396.11404248.html.plaintext.txt	86	images analyzed scion image software scion frederick md
0.49234396.11404248.html.plaintext.txt	87	significance determined unpaired test compare mean relative fluorescence two populations epithelial cells
0.49234396.11404248.html.plaintext.txt	88	airway epithelial cells grown near confluence lab tekii eight chambered glass slides nalge nunc international
0.49234396.11404248.html.plaintext.txt	89	washed pbs fixed 4 paraformaldehyde pbs 20 min room temperature washed three times pbs blocked 10 goat serum ca2mg2 pbs 1 h room temperature
0.49234396.11404248.html.plaintext.txt	90	blocking cells washed three times pbs incubated 1100 dilution rabbit polyclonal antibody p65 santa cruz biotechnology santa cruz ca 1 h room temperature washed incubated goat anti rabbit igg conjugated tetramethylrhodamine b isothiocyanate tritc 150 zymed south san francisco ca pbs plus 0
0.49234396.11404248.html.plaintext.txt	91	1 bsa plus equal volume bis benzimide 50 microgml 1 h room temperature
0.49234396.11404248.html.plaintext.txt	92	cells imaged zeiss axiovert s100 microscope hamamatsu orca ii digital camera inovision software
0.49234396.11404248.html.plaintext.txt	93	560d15 400df15 band pass filters used tritc bis benzimide imaging respectively
0.49234396.11404248.html.plaintext.txt	94	emission data collected triple pass filter wavelengths 460 nm bis benzimide 602 nm tritc
0.49234396.11404248.html.plaintext.txt	95	results top abstract introduction materials methods results discussion references
0.49234396.11404248.html.plaintext.txt	96	activation nf b epithelial cells cftr dysfunction
0.49234396.11404248.html.plaintext.txt	97	determine whether lack cftr associated cl channel function affects basal activation nf b airway epithelial cells two cell lines defective cftr function without mutations associated mistrafficking studied
0.49234396.11404248.html.plaintext.txt	98	9hteopcep cells 9hteopcep r cells constitutive overexpression cftr r domain fail transport cl response camp transfected nf b luciferase reporter construct
0.49234396.11404248.html.plaintext.txt	99	5 fold greater activation nf b 9hteopcep cells expressing vector control fig
0.49234396.11404248.html.plaintext.txt	100	similarly 16hbe cells expressing cftr antisense previously shown lack cftr dependent cl channel activity fivefold greater activation nf b reporter cells expressing cftr sense orientation p 0
0.49234396.11404248.html.plaintext.txt	101	view larger version 15k fig
0.49234396.11404248.html.plaintext.txt	102	nuclear factor nf b activation airway epithelial cells defective cystic fibrosis cf transmembrane conductance regulator cftr cl channel function
0.49234396.11404248.html.plaintext.txt	103	relative activation nf b luciferase reporter construct 16hbe cells expressing cftr sense antisense construct 9hteopcep 9hteopcep r cells shown n 12 experiments
0.49234396.11404248.html.plaintext.txt	104	nuclear p65 rel cells cftr dysfunction detected immunofluorescence
0.49234396.11404248.html.plaintext.txt	105	presence p65 rel component nf b cell nucleus generally indicative nf b activation gene transcription
0.49234396.11404248.html.plaintext.txt	106	verify activation nf b detected reporter constructs indicative nuclear localization p65 component cell lines permeabilized treated antibody p65 detected goat anti human igg conjugated tritc bis benzimide stain nuclei
0.49234396.11404248.html.plaintext.txt	107	control cells normal cftr function either 9hteopcep 16hbecftr sense predominantly cytosolic p65 fluorescence fig
0.49234396.11404248.html.plaintext.txt	108	contrast within fields 9hteocep r 16hbecftr antisense cells significantly cells nuclear p65 tritc fluorescence colocalizing blue bis benzimide nuclear stain
0.49234396.11404248.html.plaintext.txt	109	view larger version 127k fig
0.49234396.11404248.html.plaintext.txt	110	fluorescence imaging airway epithelial cells localize nf b p65
0.49234396.11404248.html.plaintext.txt	111	digital images permeabilized cells analyzed inovision software localize anti p65 nf b tetramethylrhodamine isothiocyanate tritc bis benzimide nuclear fluorescence
0.49234396.11404248.html.plaintext.txt	112	activation nf b cho cells expressing wild type mutant cftr
0.49234396.11404248.html.plaintext.txt	113	cho cells transiently transfected pcep empty vector pcep vector expressing wild type cftr low levels basal nf b activation cells transfected plasmid expressing mutant g551d cftr fig
0.49234396.11404248.html.plaintext.txt	114	contrast threefold increase luciferase activity associated cho cells expressing mutant f508 cftr p 0
0.49234396.11404248.html.plaintext.txt	115	001 f508 compared pcep vector control
0.49234396.11404248.html.plaintext.txt	116	experiments done stably transfected cho cells yielded similar results fig
0.49234396.11404248.html.plaintext.txt	117	3c expression f508 cftr associated sevenfold increase reporter activation compared cho cells expressing g551d mutation p 0
0.49234396.11404248.html.plaintext.txt	118	001 cho cells transfected reporter construct alone p 0
0.49234396.11404248.html.plaintext.txt	119	relative expression cftr cho cells roughly equivalent fig
0.49234396.11404248.html.plaintext.txt	120	cho cells expression f508 cftr mutation sufficient activate nf b whereas presence comparable amounts mutant g551d cftr
0.49234396.11404248.html.plaintext.txt	121	view larger version 21k fig
0.49234396.11404248.html.plaintext.txt	122	nf b activation chinese hamster ovary cho cells transiently transfected cftr
0.49234396.11404248.html.plaintext.txt	123	relative activation nf b luciferase reporter construct cho cells without cftr transiently transfected pcep vector wild type wt cftr g551d cftr f508 cftr cloned pcep n 12 experiments
0.49234396.11404248.html.plaintext.txt	124	b immunodetection cftr transiently transfected cho cells lane control cho cells lane b pcep wild type cftr lane c pcep g551d cftr lane d pcep f508 cftr
0.49234396.11404248.html.plaintext.txt	125	c nf b activation stably transfected cho cells n 12 experiments
0.49234396.11404248.html.plaintext.txt	126	d immunodetection cftr stably transfected cho cells
0.49234396.11404248.html.plaintext.txt	127	lane without cftr control lane b g551d cftr lane c f508 cftr
0.49234396.11404248.html.plaintext.txt	128	il 8 expression increased cell lines cftr dysfunction
0.49234396.11404248.html.plaintext.txt	129	nuclear localization nf b associated transcription several genes il 8 major pmn chemokine important inflammation
0.49234396.11404248.html.plaintext.txt	130	increased expression il 8 frequently reported characteristic cf cells bacterial stimulation well basal conditions 8
0.49234396.11404248.html.plaintext.txt	131	determine whether activation nf b seen epithelial cell lines dysfunctional cftr associated il 8 response il 8 expression assessed rt pcr fig
0.49234396.11404248.html.plaintext.txt	132	unstimulated cells produce sufficient amounts il 8 serum free medium detect standard elisa
0.49234396.11404248.html.plaintext.txt	133	increased il 8 mrna expression detected ib3 cells compared endogenous levels c 38 cells cell lines increased il 8 mrna expression response bacterial stimulation included positive control
0.49234396.11404248.html.plaintext.txt	134	view larger version 32k fig
0.49234396.11404248.html.plaintext.txt	135	interleukin il 8 mrna expression ib3 c 38 cells
0.49234396.11404248.html.plaintext.txt	136	expression il 8 mrna analyzed pcr reverse transcription compared actin control
0.49234396.11404248.html.plaintext.txt	137	lane ib3 cells lane b ib3 cells stimulated pseudomonas aeruginosa lane c c 38 cells lane d c 38 cells stimulated p
0.49234396.11404248.html.plaintext.txt	138	il 8 production could reliably measured elisa 9hteo 16hbe cell culture supernatants accumulated 18 h weaned serum
0.49234396.11404248.html.plaintext.txt	139	9hteopcep r cells produced il 8 expressing vector control p 0
0.49234396.11404248.html.plaintext.txt	140	001 lack cftr expression 16hbe cells expressing cftr antisense also associated increased il 8 expression p 0
0.49234396.11404248.html.plaintext.txt	141	thus cell lines defective cftr cl channel activity regardless nature cftr defect increased il 8 production compared corresponding cell line normal cftr activity
0.49234396.11404248.html.plaintext.txt	142	view larger version 15k fig
0.49234396.11404248.html.plaintext.txt	143	il 8 expression cells cftr cl channel dysfunction
0.49234396.11404248.html.plaintext.txt	144	relative amounts il 8 epithelial cell culture supernatants detected elisa
0.49234396.11404248.html.plaintext.txt	145	purposes comparison amount expressed control cell lines 16hbecftr sense 21 microg microg protein 9hteopcep 3
0.49234396.11404248.html.plaintext.txt	146	75 ng microg protein considered 100 n 5 experiments
0.49234396.11404248.html.plaintext.txt	147	ca2i cells er overload
0.49234396.11404248.html.plaintext.txt	148	epithelial cells mistrafficked cftr er overload postulated increased release ca2 er stores consequence response could activate ca2 dependent kinase activity
0.49234396.11404248.html.plaintext.txt	149	relative ca2i estimated subconfluent ib3 c 38 cells loaded fluorescent indicator fluo 3 fig
0.49234396.11404248.html.plaintext.txt	150	populations different cell types compared consistent trend increased ca2i associated ib3 cells relative basal fluorescence ranging 0
0.49234396.11404248.html.plaintext.txt	151	85 compared population c 38 cells basal ca2i range 0
0.49234396.11404248.html.plaintext.txt	152	comparing relative fluorescence 10 individual cells single time point 30 ib3 cells relative mean fluorescence 0
0.49234396.11404248.html.plaintext.txt	153	cell types responded addition p
0.49234396.11404248.html.plaintext.txt	154	aeruginosa increased ca2i
0.49234396.11404248.html.plaintext.txt	155	view larger version 19k fig
0.49234396.11404248.html.plaintext.txt	156	relative intracellular ca2 concentration ca2i ib3 c 38 cells
0.49234396.11404248.html.plaintext.txt	157	tracing represents relative level ca2i individual cell normalized maximal level obtained addition ionophore
0.49234396.11404248.html.plaintext.txt	158	relative response addition 109 colony forming unitsml pao1 indicated
0.49234396.11404248.html.plaintext.txt	159	relative mean ca2i 30 unstimulated ib3 cells 0
0.49234396.11404248.html.plaintext.txt	160	758 significantly higher c 38 cells 0
0.49234396.11404248.html.plaintext.txt	161	discussion top abstract introduction materials methods results discussion references
0.49234396.11404248.html.plaintext.txt	162	airway inflammation major factor pathogenesis cf pulmonary disease
0.49234396.11404248.html.plaintext.txt	163	clinical studies clearly established direct correlation infection il 8 secretion accumulation pmns toxic products cf lung 14 17
0.49234396.11404248.html.plaintext.txt	164	bacterial stimulation cells cftr mutations activates significantly greater cytokine expression matched cells normal cftr function 5 8 29 30
0.49234396.11404248.html.plaintext.txt	165	several reports 8 28 suggest cells cftr dysfunction endogenously upregulated expression proinflammatory cytokines chemokines
0.49234396.11404248.html.plaintext.txt	166	young infants cf even without detectable evidence prior infection pmns increased amounts il 8 airways 14 proinflammatory cytokine expression increased cells cultured directly uninfected cf tissues 28
0.49234396.11404248.html.plaintext.txt	167	findings consistent vitro studies demonstrating endogenous activation nf b cf corrected cell lines
0.49234396.11404248.html.plaintext.txt	168	indicated data report lack cftr cl channel function physiological consequences mistrafficked mutant cftr appear contribute endogenous activation nf b cf airway cells manifested increased expression il 8 cells even absence bacterial stimulation
0.49234396.11404248.html.plaintext.txt	169	evidence endogenous activation nf b cells cftr dysfunction due several different mechanisms
0.49234396.11404248.html.plaintext.txt	170	previous studies ib3 cells express w1282xf508 mutation associated mistrafficked cftr accumulates er found significant amounts p65 component nf b nuclei basal conditions nuclear nf b corrected c 38 cells 8
0.49234396.11404248.html.plaintext.txt	171	translocation nf b associated many types stimuli additional consequences accumulated mutant cftr er also demonstrated mutant cell line
0.49234396.11404248.html.plaintext.txt	172	ib3 cells found higher basal ca2i predicted consequence er stress 2 18
0.49234396.11404248.html.plaintext.txt	173	presence nuclear nf b ib3 cells could correlated increased il 8 expression estimated rt pcr compared control c 38 cell line
0.49234396.11404248.html.plaintext.txt	174	concentration il 8 tissue culture supernatant minimal cells 18 h incubation serum free medium however relative amount il 8 message consistent previous report dimango et al
0.49234396.11404248.html.plaintext.txt	175	investigators found increased endogenous levels il 8 associated cftr mutations 30
0.49234396.11404248.html.plaintext.txt	176	cell culture conditions effects fcs handling monolayers affect translocation nf b endogenous expression il 8
0.49234396.11404248.html.plaintext.txt	177	thus seems relevant demonstrate presence nuclear p65 appears associated expected biological response namely il 8 expression
0.49234396.11404248.html.plaintext.txt	178	activation nf b dependent pathways necessarily increased ib3 compared c 38 cells
0.49234396.11404248.html.plaintext.txt	179	stimulation nf b translocation associated antiapoptotic effect many cell lines including respiratory epithelial cells
0.49234396.11404248.html.plaintext.txt	180	rates apoptosis increased proteasome inhibitors inhibit ib degradation block nf b translocation 31
0.49234396.11404248.html.plaintext.txt	181	study published recently 23 rates ib3 c 38 cell apoptosis equivalent control conditions bacterial stimulation despite observed differences endogenous nuclear nf b
0.49234396.11404248.html.plaintext.txt	182	thus association cftr dysfunction activation nf b transcription nf b dependent genes somewhat selective global response
0.49234396.11404248.html.plaintext.txt	183	consequences cftr mistrafficking activation nf b demonstrated cho cells normally express cftr
0.49234396.11404248.html.plaintext.txt	184	presence mistrafficked mutant f508 cftr significant stimulus nf b activation cho cells
0.49234396.11404248.html.plaintext.txt	185	g551d cftr function appropriately cl channel trafficked normally apical surface respiratory epithelial cell 10 stimulate nf b
0.49234396.11404248.html.plaintext.txt	186	expression normal cftr plasmid construct cause nf b activation cho cells transfection empty vector luciferase reporter construct
0.49234396.11404248.html.plaintext.txt	187	although g551d f508 cftr mutations associated clinical disease lack cl secretion response camp 10 major difference mutants mistrafficking accumulation f508 cftr within er
0.49234396.11404248.html.plaintext.txt	188	thus appears consequences mistrafficking f508 sufficient activate nf b cho cells
0.49234396.11404248.html.plaintext.txt	189	epithelial cells unlike cho cells appears requirement normal cftr function regulating nf b dependent gene transcription
0.49234396.11404248.html.plaintext.txt	190	homozygous f508 compound f508w1282x mutation could activate nf b two independent mechanisms cell stress associated mistrafficking effects directly due lack cftr cl channel activity
0.49234396.11404248.html.plaintext.txt	191	cell lines lack cftr cl function due either overproduction cftr r domain expression cftr antisense activated nf b significant amounts endogenous il 8 production compared corresponding control cell lines
0.49234396.11404248.html.plaintext.txt	192	amount il 8 endogenously expressed cell lines greater ib3 c38 cells could quantified standard elisa assay
0.49234396.11404248.html.plaintext.txt	193	presence p65 component nf b nuclei undisturbed cells grown coverslips well relative activation nf b reporter construct compared appropriate controls indicates activated state unlikely artifact either cell transformation manipulations occurring cell culture
0.49234396.11404248.html.plaintext.txt	194	neither 9hteopcep r 16hbecftr antisense cells excessive cftr accumulation er lack cftr cl channel function epithelial cells appears responsible observed increase nf b activation il 8 expression
0.49234396.11404248.html.plaintext.txt	195	exactly cftr dysfunction contributes activation nuclear localization nf b unclear
0.49234396.11404248.html.plaintext.txt	196	multiple mechanisms nf b activation divided signal dependent signal independent pathways 20
0.49234396.11404248.html.plaintext.txt	197	airway epithelial cells bacterial attachment asialo gm1 activates ca2 dependent signaling pathway results nf b activation il 8 transcription cascade includes phosphorylation p38 extracellular signal regulated kinase families mitogen activated protein kinases 23a
0.49234396.11404248.html.plaintext.txt	198	signal independent pathway perhaps involving ib nf b regulation directly may affected mistrafficked cftr
0.49234396.11404248.html.plaintext.txt	199	ib shown increased ib3 cells basal conditions hypophosphorylated enabling nuclear nf b bound ib complexes direct transcription 30
0.49234396.11404248.html.plaintext.txt	200	hypophosphorylated ib may involved either signal dependent persistent activation nf b 26
0.49234396.11404248.html.plaintext.txt	201	diminished levels cytosolic ib associated cf f508f508 bronchial gland cells primary culture correlated presence nuclear nf b rel 27
0.49234396.11404248.html.plaintext.txt	202	possible cftr function perhaps affecting ph specific intracellular compartments 3 affects relevant kinase phosphatase activity
0.49234396.11404248.html.plaintext.txt	203	abnormalities signal transducer activator transduction 1 phosphorylation 9hteopcep r cells described recently 13 indicating cftr may role multiple signaling pathways
0.49234396.11404248.html.plaintext.txt	204	observations reflect complexities cftr involvement normal physiology epithelial cell
0.49234396.11404248.html.plaintext.txt	205	strategies gene therapy correct cftr cl channel function alone ameliorate effects mutant cftr mistrafficking majority airway epithelial cells may sufficient control inflammatory component cf lung disease
0.49234396.11404248.html.plaintext.txt	206	consequences cftr dysfunction activating translocation nf b stimulating expression proinflammatory cytokines important understanding many roles cftr normal cell physiology also clinically relevant
0.49234396.11404248.html.plaintext.txt	207	majority cf patients common f508 cftr alleles multiple reasons increased expression inflammatory mediators airways
0.49234396.11404248.html.plaintext.txt	208	effects cftr mistrafficking er stress lack cftr cl channel function exogenous stimulation due airway infection act increase epithelial nf b translocation expression proinflammatory genes
0.49234396.11404248.html.plaintext.txt	209	epithelial immune activation provide multiple targets therapy
0.49234396.11404248.html.plaintext.txt	210	may possible devise therapy modulate endogenous upregulation nf b dependent gene transcription without compromising epithelial barrier function host inflammatory response exogenous airway pathogens
0.49234396.11404248.html.plaintext.txt	211	expert technical assistance provided robert adamo
0.49234396.11404248.html.plaintext.txt	212	work supported national heart lung blood institute grants hl 56194
0.49234396.11404248.html.plaintext.txt	213	prince p50 hl 60293 p
0.49234396.11404248.html.plaintext.txt	214	davis case western reserve university cleveland oh
0.49234396.11404248.html.plaintext.txt	215	imaging studies performed optical microscopy facility herbert irving cancer center columbia university new york ny supported national center research resources grant 1 s10 rr 10506
0.49234396.11404248.html.plaintext.txt	216	original submission response special call papers cftr trafficking signaling respiratory epithelium
0.49234396.11404248.html.plaintext.txt	217	address reprint requests correspondence
0.49234396.11404248.html.plaintext.txt	218	new york ny 10032 e mail asp7atcolumbia
0.49234396.11404248.html.plaintext.txt	219	costs publication article defrayed part payment page charges
0.49234396.11404248.html.plaintext.txt	220	article must therefore hereby marked advertisement accordance 18 u
0.49234396.11404248.html.plaintext.txt	221	section 1734 solely indicate fact
0.49234396.11404248.html.plaintext.txt	222	received 2 october 2000 accepted final form 29 january 2001
0.49234396.11404248.html.plaintext.txt	223	references top abstract introduction materials methods results discussion references
0.49234396.11404248.html.plaintext.txt	224	cystic fibrosis transmembrane conductance regulator
0.49234396.11404248.html.plaintext.txt	225	j biol chem 275 3729 3732 2000free full text
0.49234396.11404248.html.plaintext.txt	226	baeuerle pa baltimore d
0.49234396.11404248.html.plaintext.txt	227	barasch j kiss b prince saiman l gruenert d al awqati q
0.49234396.11404248.html.plaintext.txt	228	defective acidification intracellular organelles cystic fibrosis
0.49234396.11404248.html.plaintext.txt	229	nature 352 70 73 1991isimedline
0.49234396.11404248.html.plaintext.txt	230	baumann b kistler b kirillov bergman y wirth
0.49234396.11404248.html.plaintext.txt	231	mutant plasmacytoma cell line s107 allows identification distinct pathways leading nf b activation
0.49234396.11404248.html.plaintext.txt	232	j biol chem 273 11448 11453 1998abstractfree full text
0.49234396.11404248.html.plaintext.txt	233	bryan r kube d perez davis pb prince
0.49234396.11404248.html.plaintext.txt	234	overproduction cftr r domain leads increased levels asialogm1 increased p
0.49234396.11404248.html.plaintext.txt	235	aeruginosa binding epithelial cells
0.49234396.11404248.html.plaintext.txt	236	j respir cell mol biol 19 269 277 1998abstractfree full text
0.49234396.11404248.html.plaintext.txt	237	carter ab knudtson kl monick mm hunninghake gw
0.49234396.11404248.html.plaintext.txt	238	p38 mitogen activated protein kinase required nf b dependent gene expression
0.49234396.11404248.html.plaintext.txt	239	j biol chem 274 30858 30863 1999abstractfree full text
0.49234396.11404248.html.plaintext.txt	240	cheng sh gregory rj marshall j paul souza dw white ga oriordan cr smith ae
0.49234396.11404248.html.plaintext.txt	241	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.49234396.11404248.html.plaintext.txt	242	cell 63 827 834 1990isimedline
0.49234396.11404248.html.plaintext.txt	243	dimango e ratner aj bryan r tabibi prince
0.49234396.11404248.html.plaintext.txt	244	activation nf b adherent p
0.49234396.11404248.html.plaintext.txt	245	aeruginosa normal cystic fibrosis respiratory epithelial cells
0.49234396.11404248.html.plaintext.txt	246	j clin invest 101 2598 2605 1998abstractfree full text
0.49234396.11404248.html.plaintext.txt	247	dimango e zar hj bryan r prince
0.49234396.11404248.html.plaintext.txt	248	diverse pseudomonas aeruginosa gene products stimulate respiratory epithelial cells produce interleukin 8
0.49234396.11404248.html.plaintext.txt	249	j clin invest 96 2204 2210 1995isimedline
0.49234396.11404248.html.plaintext.txt	250	fulmer sb schwiebert em morales mm guggino wb cutting gr
0.49234396.11404248.html.plaintext.txt	251	two cystic fibrosis transmembrane conductance regulator mutations different effects pulmonary phenotype regulation outwardly rectified chloride currents
0.49234396.11404248.html.plaintext.txt	252	proc natl acad sci usa 92 6832 6836 1995abstract
0.49234396.11404248.html.plaintext.txt	253	gruenert dc basbaum cb welsh mj li m finkbeiner e nadel ja
0.49234396.11404248.html.plaintext.txt	254	characterization human epithelial cells transformed origin defective simian virus 40
0.49234396.11404248.html.plaintext.txt	255	proc natl acad sci usa 85 5951 5955 1988abstract
0.49234396.11404248.html.plaintext.txt	256	biogenesis traffic function cystic fibrosis transmembrane conductance regulator
0.49234396.11404248.html.plaintext.txt	257	int rev cytol 172 192 241 1997
0.49234396.11404248.html.plaintext.txt	258	vivo alterations ifn regulatory factor 1 pias1 protein levels cystic fibrosis epithelium
0.49234396.11404248.html.plaintext.txt	259	j clin invest 106 403 410 2000abstractfree full text
0.49234396.11404248.html.plaintext.txt	260	khan tz gillespie mmk parson pe waegener js riches dwh accurso fj
0.49234396.11404248.html.plaintext.txt	261	airway inflammation infants cystic fibrosis occur absence detectable endotoxin bronchoalveolar lavage fluid
0.49234396.11404248.html.plaintext.txt	262	j respir crit care med 151 1075 1082 1995abstract
0.49234396.11404248.html.plaintext.txt	263	konstan mw hilliard ka norvell tm berger m
0.49234396.11404248.html.plaintext.txt	264	bronchoalveolar lavage findings cystic fibrosis patients stable clinically mild lung disease suggest ongoing infection inflammation
0.49234396.11404248.html.plaintext.txt	265	j respir crit care med 150 448 454 1994abstract
0.49234396.11404248.html.plaintext.txt	266	muhlebach ms stewart pw leigh mw noah tl
0.49234396.11404248.html.plaintext.txt	267	quantification inflammatory responses bacteria young cystic fibrosis control patients
0.49234396.11404248.html.plaintext.txt	268	j respir crit care med 160 186 191 1999abstractfree full text
0.49234396.11404248.html.plaintext.txt	269	noah tl black hr cheng pw wood re leigh mw
0.49234396.11404248.html.plaintext.txt	270	nasal bronchoalveolar lavage fluid cytokines early cystic fibrosis
0.49234396.11404248.html.plaintext.txt	271	j infect dis 175 638 647 1997isimedline
0.49234396.11404248.html.plaintext.txt	272	activation nf b er stress requires ca2 reactive oxygen intermediates messengers
0.49234396.11404248.html.plaintext.txt	273	febs lett 392 129 136 1996isimedline
0.49234396.11404248.html.plaintext.txt	274	pahl hl sester m burgert hg baeurle pa
0.49234396.11404248.html.plaintext.txt	275	activation transcription factor nf b adenovirus e319k protein requires er retention
0.49234396.11404248.html.plaintext.txt	276	j cell biol 132 511 522 1996abstract
0.49234396.11404248.html.plaintext.txt	277	signal dependent independent degradation free nf b bound ib
0.49234396.11404248.html.plaintext.txt	278	j biol chem 275 21278 21286 2000abstractfree full text
0.49234396.11404248.html.plaintext.txt	279	perez risma k eckman e davis p
0.49234396.11404248.html.plaintext.txt	280	overexpression r domain eliminates camp stimulated cl secretion 9hteo cells culture
0.49234396.11404248.html.plaintext.txt	281	j physiol lung cell mol physiol 271 l85 l92 1996abstractfree full text
0.49234396.11404248.html.plaintext.txt	282	rajan cacalano g bryan r ratner aj sontich cu van heerckeren davis pb prince
0.49234396.11404248.html.plaintext.txt	283	psuedomonas aeruginosa induction apoptosis respiratory epithelial cells analysis effects cystic fibrosis transmembrane conductance regulator dysfunction bacterial virulence factors
0.49234396.11404248.html.plaintext.txt	284	j respir cell mol biol 23 304 312 2000abstractfree full text
0.49234396.11404248.html.plaintext.txt	285	ratner aj bryan r weber nguyen barnes d pitt gelber se cheung prince
0.49234396.11404248.html.plaintext.txt	286	cystic fibrosis pathogens activate ca2 dependent mapk signaling pathways airway epithelial cells
0.49234396.11404248.html.plaintext.txt	287	aeruginosa pili bind asialogm1 increased surface cystic fibrosis epithelial cells
0.49234396.11404248.html.plaintext.txt	288	j clin invest 92 1875 1880 1993isimedline
0.49234396.11404248.html.plaintext.txt	289	smith jj travis sm greenberg ep welsh mj
0.49234396.11404248.html.plaintext.txt	290	cystic fibrosis airway epithelia fail kill bacteria abnormal airway surface fluid
0.49234396.11404248.html.plaintext.txt	291	cell 85 229 236 1996isimedline
0.49234396.11404248.html.plaintext.txt	292	suyang h phillips r douglas ghosh
0.49234396.11404248.html.plaintext.txt	293	role unphosphorylated newly synthesized ib persistent activation nf b
0.49234396.11404248.html.plaintext.txt	294	mol cell biol 16 5444 5449 1996abstract
0.49234396.11404248.html.plaintext.txt	295	tabary o escotte couetil jp hubert d dusser d puchelle e jacquot j
0.49234396.11404248.html.plaintext.txt	296	genistein inhibits constitutive inducible nf kappab activation decreases il 8 production human cystic fibrosis bronchial gland cells
0.49234396.11404248.html.plaintext.txt	297	j pathol 155 473 481 1999abstractfree full text
0.49234396.11404248.html.plaintext.txt	298	tirouvanziam r de bentzmann hubeau c hinnrasky j jacquot j peault b puchelle e
0.49234396.11404248.html.plaintext.txt	299	inflammation infection naive human cystic fibrosis airway grafts
0.49234396.11404248.html.plaintext.txt	300	j respir cell mol biol 23 121 127 2000abstractfree full text
0.49234396.11404248.html.plaintext.txt	301	van heeckeren walenga r konstan mw bonfield davis pb ferkol
0.49234396.11404248.html.plaintext.txt	302	excessive inflammatory response cystic fibrosis mice bronchopulmonary infection pseudomonas aeruginosa
0.49234396.11404248.html.plaintext.txt	303	j clin invest 100 2810 2815 1997abstractfree full text
0.49234396.11404248.html.plaintext.txt	304	venkatakrishnan stecenko king g blackwell tr brigham k christman jw blackwell ts
0.49234396.11404248.html.plaintext.txt	305	exaggerated activation nuclear factor b altered ib processing cystic fibrosis bronchial epithelial cells
0.49234396.11404248.html.plaintext.txt	306	j respir cell mol biol 23 396 403 2000abstractfree full text
0.49234396.11404248.html.plaintext.txt	307	wang cy mayo mw korneluk rg goeddel dv baldwin
0.49234396.11404248.html.plaintext.txt	308	nf b antiapoptosis induction traf1 traf2 c iap1 c iap2 suppress caspase 8 activation
0.49234396.11404248.html.plaintext.txt	309	science 281 1680 1683 1998abstractfree full text
0.49234396.11404248.html.plaintext.txt	310	molecular mechanisms cftr chloride channel dysfunction cystic fibrosis
0.49234396.11404248.html.plaintext.txt	311	cell 73 1251 1254 1993isimedline
0.49234396.11404248.html.plaintext.txt	312	zeitlin pl lu l cutting g stetten g kieffer ka craig r guggino wb
0.49234396.11404248.html.plaintext.txt	313	cystic fibrosis bronchial epithelial cell line immortalization adeno 12 sv40 infection
0.49234396.11404248.html.plaintext.txt	314	j respir cell mol biol 4 313 319 1991isimedline
0.49234396.11404248.html.plaintext.txt	315	j physiol lung cell mol physiol 2811l71 l78 1040 060501 5
0.49234396.11404248.html.plaintext.txt	316	00 copyright 2001 american physiological society
0.41338694.15591098.html.plaintext.txt	0	erythrocytes humans cystic fibrosis fail stimulate nitric oxide synthesis isolated rabbit lungs griffith liang2 alan h
0.41338694.15591098.html.plaintext.txt	1	departments 1pharmacological physiological science 2internal medicine saint louis university school medicine st
0.41338694.15591098.html.plaintext.txt	2	submitted 9 august 2004 accepted final form 2 december 2004
0.41338694.15591098.html.plaintext.txt	3	abstract top abstract materials methods results discussion grants references erythrocytes red blood cells either rabbits healthy humans required demonstrate participation nitric oxide regulation pulmonary vascular resistance isolated rabbit lung
0.41338694.15591098.html.plaintext.txt	4	property erythrocyte responsible stimulation synthesis reported ability release atp response physiological stimuli including deformation
0.41338694.15591098.html.plaintext.txt	5	moreover signal transduction pathway relates mechanical deformation erythrocytes atp release described cystic fibrosis cf transmembrane conductance regulator cftr component
0.41338694.15591098.html.plaintext.txt	6	erythrocytes individuals cf release atp response deformation
0.41338694.15591098.html.plaintext.txt	7	investigated hypothesis contrast healthy humans erythrocytes humans cf fail stimulate endogenous synthesis isolated rabbit lung
0.41338694.15591098.html.plaintext.txt	8	report cftr component membranes rabbit human erythrocytes
0.41338694.15591098.html.plaintext.txt	9	addition synthase inhibitor n nitro l arginine methyl ester l name 100 microm produced increases vascular resistance isolated rabbit lungs perfused physiological salt solution pss containing erythrocytes healthy humans l name without effect lungs perfused pss alone pss containing erythrocytes cf patients
0.41338694.15591098.html.plaintext.txt	10	results provide support hypothesis cf defect atp release erythrocytes could lead decreased endogenous pulmonary synthesis contribute pulmonary hypertension
0.41338694.15591098.html.plaintext.txt	11	adenosine triphosphate red blood cells pulmonary circulation
0.41338694.15591098.html.plaintext.txt	12	well established endothelium derived relaxing factor nitric oxide produced endothelial cells released relaxes vascular smooth muscle 10 14 19
0.41338694.15591098.html.plaintext.txt	13	physiologically alteration shear applied endothelium blood vessels suggested major stimulus release 3 22
0.41338694.15591098.html.plaintext.txt	14	however pulmonary circulation reappraisal viewpoint required reported isolated rabbit 31 rat 36 38 lungs perfused physiological salt solution pss alterations shear stress alone evoke release
0.41338694.15591098.html.plaintext.txt	15	contrast lungs species perfused either blood 36 pss containing washed erythrocytes 30 38 inhibition endogenous synthesis produced shift slope pressure flow relationship consistent decrease vascular caliber
0.41338694.15591098.html.plaintext.txt	16	determinant vascular resistance
0.41338694.15591098.html.plaintext.txt	17	ability erythrocyte stimulate synthesis pulmonary circulation rabbit rat reported independent effects viscosity pressure 31 36
0.41338694.15591098.html.plaintext.txt	18	property erythrocyte associated stimulation endogenous synthesis shown release atp 26 28 30
0.41338694.15591098.html.plaintext.txt	19	support hypothesis erythrocyte derived atp stimulus endogenous synthesis lung addition atp perfusate isolated rabbit lungs produces vasodilation large part dependent stimulation endogenous synthesis 30
0.41338694.15591098.html.plaintext.txt	20	importantly addition rabbit erythrocytes human erythrocytes reported release atp response physiological stimuli mechanical deformation stimulate endogenous synthesis isolated perfused rabbit lung 26
0.41338694.15591098.html.plaintext.txt	21	recently signal transduction pathway relates mechanical deformation atp release human rabbit erythrocytes described 17 18 27 29
0.41338694.15591098.html.plaintext.txt	22	pathway includes heterotrimeric g proteins gs 17 gi 18 adenylyl cyclase 29 pka 29 cystic fibrosis transmembrane conductance regulator cftr 27
0.41338694.15591098.html.plaintext.txt	23	activity cftr shown required deformation induced atp release erythrocytes rabbits humans 27
0.41338694.15591098.html.plaintext.txt	24	thus erythrocytes humans cystic fibrosis condition cftr activity absent markedly reduced rabbit erythrocytes incubated inhibitors cftr activity failed release atp response mechanical deformation 27
0.41338694.15591098.html.plaintext.txt	25	demonstrate cftr expressed membrane rabbit human erythrocytes contrast healthy humans erythrocytes humans cystic fibrosis fail stimulate endogenous synthesis isolated rabbit pulmonary circulation
0.41338694.15591098.html.plaintext.txt	26	materials methods top abstract materials methods results discussion grants references isolation rabbit human erythrocytes
0.41338694.15591098.html.plaintext.txt	27	rabbit erythrocytes obtained new zealand white rabbits male 2 3 kg body wt
0.41338694.15591098.html.plaintext.txt	28	animals anesthetized ketamine 12
0.41338694.15591098.html.plaintext.txt	29	5 mlkg im xylazine 1 mgkg im followed pentobarbital sodium 10 mgkg iv
0.41338694.15591098.html.plaintext.txt	30	tracheal intubation animals mechanically ventilated room air tidal volume 10 mlkg rate 20 25 breathsmin
0.41338694.15591098.html.plaintext.txt	31	catheter placed carotid artery administration heparin 500 units phlebotomy
0.41338694.15591098.html.plaintext.txt	32	ten minutes heparin animals exsanguinated
0.41338694.15591098.html.plaintext.txt	33	human erythrocytes obtained venipuncture performed antecubital vein without use tourniquet
0.41338694.15591098.html.plaintext.txt	34	sixty milliliters blood collected syringe containing 50 units heparin
0.41338694.15591098.html.plaintext.txt	35	protocols removal blood rabbits humans approved institutional animal care use committee institutional review board saint louis university respectively
0.41338694.15591098.html.plaintext.txt	36	rabbit human blood centrifuged 500 g 10 min 4 degrees c
0.41338694.15591098.html.plaintext.txt	37	plasma buffy coat uppermost erythrocytes removed aspiration discarded
0.41338694.15591098.html.plaintext.txt	38	remaining erythrocytes washed three times buffer solution containing 140
0.41338694.15591098.html.plaintext.txt	39	5 bsa fraction v icn biomedicals aurora oh final ph 7
0.41338694.15591098.html.plaintext.txt	40	hematocrit washed erythrocytes determined using autocrit ultra 3 centrifuge becton dickinson bedford ma
0.41338694.15591098.html.plaintext.txt	41	preparation erythrocyte membranes
0.41338694.15591098.html.plaintext.txt	42	washed rabbit human erythrocytes diluted 1100 ice cold lysis buffer 5 mm tris hcl 2 mm edta ph 7
0.41338694.15591098.html.plaintext.txt	43	4 stirred 4 degrees c 20 min
0.41338694.15591098.html.plaintext.txt	44	resulting mixture centrifuged 23000 g 15 min 4 degrees c
0.41338694.15591098.html.plaintext.txt	45	supernatant removed discarded
0.41338694.15591098.html.plaintext.txt	46	membranes resuspended cold lysis buffer centrifuged second time
0.41338694.15591098.html.plaintext.txt	47	pellets pooled resuspended ice cold lysis buffer centrifuged 23000 g 15 min 4 degrees c final time
0.41338694.15591098.html.plaintext.txt	48	supernatant discarded protein concentration determined bca protein assay pierce rockford il
0.41338694.15591098.html.plaintext.txt	49	aliquots frozen 80 degrees c
0.41338694.15591098.html.plaintext.txt	50	immediately electrophoresis membranes thawed ice sonicated briefly w 220f sonicator heat systems ultrasonics farmingdale ny vortexed 5 microl 10 sds per 200 ml sample heated 95 degrees c 90
0.41338694.15591098.html.plaintext.txt	51	preparation t84 human colon carcinoma cells
0.41338694.15591098.html.plaintext.txt	52	t84 cells american type culture collection express large amounts cftr 4 33 grown confluence 11 mixture dmem ham f12 medium 70 mm culture dish
0.41338694.15591098.html.plaintext.txt	53	dishes washed 5 min pbs ph 7
0.41338694.15591098.html.plaintext.txt	54	4 containing cocktail protease inhibitors complete roche diagnostics mannheim germany
0.41338694.15591098.html.plaintext.txt	55	cells removed mechanical scraping centrifuged 8000 g 90
0.41338694.15591098.html.plaintext.txt	56	resulting cell pellet resolubilized ice cold 250 mm sucrose 1 mm edta 20 mm imidazole ph 7
0.41338694.15591098.html.plaintext.txt	57	2 protease inhibitor cocktail
0.41338694.15591098.html.plaintext.txt	58	10 min incubation ice suspension briefly sonicated centrifuged 16000 g 30 4 degrees c
0.41338694.15591098.html.plaintext.txt	59	supernatant 200 ml vortexed 10 sds 5 ml heated 95 degrees c 90
0.41338694.15591098.html.plaintext.txt	60	samples stored 80 degrees c western blot analysis
0.41338694.15591098.html.plaintext.txt	61	membrane proteins mixed sample buffer 1
0.41338694.15591098.html.plaintext.txt	62	5 sds 6 volvol glycerol 0
0.41338694.15591098.html.plaintext.txt	63	6 dithiothreitol 10 mm tris ph 6
0.41338694.15591098.html.plaintext.txt	64	01 bromophenol blue heated 95 degrees c 2 min resolved electrophoresis 5 sds polyacrylamide precast gels bio rad hercules ca
0.41338694.15591098.html.plaintext.txt	65	electrophoresis proteins transferred polyvinylidene difluoride pvdf membrane millipore bedford ma transfer buffer 25 mm tris base 192 mm glycine 10 methanol
0.41338694.15591098.html.plaintext.txt	66	pvdf membranes blocked 1 h buffer solution containing 5 nonfat dry milk 10 mm sodium phosphate 150 mm nacl 0
0.41338694.15591098.html.plaintext.txt	67	pvdf membranes immunoblotted overnight mouse monoclonal anti cftr antibody r d systems wash buffer solution containing 1 nonfat dry milk 10 mm sodium phosphate 150 mm nacl 0
0.41338694.15591098.html.plaintext.txt	68	pvdf membranes washed three times 10 mm sodium phosphate 150 mm nacl 0
0.41338694.15591098.html.plaintext.txt	69	4 immunoblotted anti mouse igg secondary antibody conjugated horseradish peroxidase amersham piscataway nj
0.41338694.15591098.html.plaintext.txt	70	membranes washed protein visualized using enhanced chemiluminescence amersham
0.41338694.15591098.html.plaintext.txt	71	rabbits anesthetized ventilated exsanguinated described
0.41338694.15591098.html.plaintext.txt	72	heart lungs removed en block continuous ventilation
0.41338694.15591098.html.plaintext.txt	73	catheter placed main pulmonary artery right ventricle second catheter placed left atrium
0.41338694.15591098.html.plaintext.txt	74	heart lungs suspended humidified chamber maintained 37 degrees c ventilated gas containing 15 o2 6 co2 balance n2
0.41338694.15591098.html.plaintext.txt	75	residual blood present lungs removed perfusion 200 ml pss 118
0.41338694.15591098.html.plaintext.txt	76	1 mm glucose 5 hetastarch baxter healthcare deerfield il without recirculation
0.41338694.15591098.html.plaintext.txt	77	lungs perfused pss 80 mlmin recirculating volume 100 ml
0.41338694.15591098.html.plaintext.txt	78	pulmonary arterial pressure ppa left atrial pressure pla airway pressure paw recorded continuously
0.41338694.15591098.html.plaintext.txt	79	pla set pressure 2 3 mmhg screw clamp lungs perfused zone iii conditions ppa pla paw
0.41338694.15591098.html.plaintext.txt	80	pulmonary microvascular pressure pmv determined double occlusion method 15
0.41338694.15591098.html.plaintext.txt	81	arterial venous cannulae simultaneously occluded electronically controlled solenoid pinch valves cause minimal fluid displacement
0.41338694.15591098.html.plaintext.txt	82	occlusions maintained 3 5 resulting equilibration pressures pulmonary arterial venous catheters recorded estimate pmv
0.41338694.15591098.html.plaintext.txt	83	samples perfusate analyzed ph po2 pco2 control experimental conditions phox blood gas analyzer nova biomedical waltham ma
0.41338694.15591098.html.plaintext.txt	84	minimum 15 min perfusion 80 mlmin pressure flow relationship determined measuring vascular pressures ppa pmv flow rates 50 100 200 300 mlmin
0.41338694.15591098.html.plaintext.txt	85	within 20 change flow rate pla adjusted 2 3 mmhg pmv determined
0.41338694.15591098.html.plaintext.txt	86	finally flow rate returned 80 mlmin recovery
0.41338694.15591098.html.plaintext.txt	87	n nitro l arginine methyl ester l name calbiochem added perfusate achieve final concentration either 30 100 300 microm
0.41338694.15591098.html.plaintext.txt	88	30 min second pressure flow relationship determined
0.41338694.15591098.html.plaintext.txt	89	separate studies isolated lungs perfused either pss alone pss washed erythrocytes obtained healthy humans humans cystic fibrosis added
0.41338694.15591098.html.plaintext.txt	90	erythrocytes obtained day use added perfusate within 15 min washed
0.41338694.15591098.html.plaintext.txt	91	statistical significance experimental periods determined anova
0.41338694.15591098.html.plaintext.txt	92	event f ratio indicated changes occurred least significant difference test used identify individual differences
0.41338694.15591098.html.plaintext.txt	93	slope pressure flow relationships determined least squares linear regression analysis
0.41338694.15591098.html.plaintext.txt	94	05 less considered statistically significant
0.41338694.15591098.html.plaintext.txt	95	results reported means plus minus se
0.41338694.15591098.html.plaintext.txt	96	results top abstract materials methods results discussion grants references identification cftr erythrocyte membranes
0.41338694.15591098.html.plaintext.txt	97	cftr component signal transduction pathway atp release rabbit human erythrocytes must present cell membranes
0.41338694.15591098.html.plaintext.txt	98	membranes prepared human colon carcinoma cell line shown express cftr t84 cells used positive control 4 33
0.41338694.15591098.html.plaintext.txt	99	membranes human rabbit erythrocytes found contain cftr protein examined western blot analysis fig
0.41338694.15591098.html.plaintext.txt	100	view larger version 80k fig
0.41338694.15591098.html.plaintext.txt	101	identification cystic fibrosis transmembrane conductance regulator cftr protein membranes humans rabbit erythrocytes 84 colon carcinoma cells
0.41338694.15591098.html.plaintext.txt	102	cell membranes prepared described protein resolved using 5 sds page gel
0.41338694.15591098.html.plaintext.txt	103	protein transferred polyvinylidene difluoride membrane incubated mouse monoclonal anti cftr antibody
0.41338694.15591098.html.plaintext.txt	104	lane 1 rabbit erythrocyte membranes 15 microg protein representative 3 studies lane 2 84 cell membranes 15 microg protein representative 3 studies lane 3 human erythrocyte membranes 50 microg protein representative 5 studies
0.41338694.15591098.html.plaintext.txt	105	effect l name pressure flow relationships isolated rabbit lungs perfused pss absence erythrocytes
0.41338694.15591098.html.plaintext.txt	106	pressure flow relationship determined isolated rabbit lungs perfused pss absence presence l name concentrations either 30 100 300 microm
0.41338694.15591098.html.plaintext.txt	107	absence erythrocytes l name effect pressure flow relationship fig
0.41338694.15591098.html.plaintext.txt	108	view larger version 24k fig
0.41338694.15591098.html.plaintext.txt	109	effect n nitro l arginine methyl ester l name perfusate concentrations either 30 100 300 microm relationship flow rate pressure gradient across pulmonary circulation pulmonary artial pressure ppa left arterial pressure pla lungs perfused physiological salt solution pss absence erythrocytes n 3 groups
0.41338694.15591098.html.plaintext.txt	110	b effect l name pressure gradient across pulmonary circulation ppa pla lungs perfused pss containing erythrocytes healthy humans n 5 humans cystic fibrosis n 4
0.41338694.15591098.html.plaintext.txt	111	05 compared groups
0.41338694.15591098.html.plaintext.txt	112	values means plus minus se
0.41338694.15591098.html.plaintext.txt	113	perfusion isolated rabbit lungs pss containing washed human erythrocytes
0.41338694.15591098.html.plaintext.txt	114	initial ph gas tensions hematocrit studies lungs perfused pss containing erythrocytes healthy human erythrocytes humans cystic fibrosis depicted table 1
0.41338694.15591098.html.plaintext.txt	115	humans cystic fibrosis identified homozygous f508 genotype treated medications including inhaled agonists ipratropium bromide corticosteroids antibiotics dnase inhibitors mast cell degranulation well oral pancreatic enzyme replacement antibiotics proton pump inhibitors vitamins
0.41338694.15591098.html.plaintext.txt	116	addition washed human erythrocytes perfusate isolated rabbit lungs result increased airway pressure weight gain course experiment
0.41338694.15591098.html.plaintext.txt	117	perfusate ph gas tensions isolated perfused rabbit lungs perfused pss containing rbcs healthy humans humans cystic fibrosis
0.41338694.15591098.html.plaintext.txt	118	effect l name pressure flow relationships isolated rabbit lungs perfused pss containing erythrocytes healthy humans
0.41338694.15591098.html.plaintext.txt	119	control conditions perfusion 80 mlmin addition l name perfusate resulted increase perfusion pressure fig
0.41338694.15591098.html.plaintext.txt	120	moreover addition l name resulted shift pressure flow relationship pressure difference across pulmonary circulation ppa pla increased flow rate studied fig
0.41338694.15591098.html.plaintext.txt	121	importantly slope relationship increased l name p 0
0.41338694.15591098.html.plaintext.txt	122	01 consistent interpretation conditions inhibition endogenous synthesis associated increase ohmic resistance 15
0.41338694.15591098.html.plaintext.txt	123	finally site increased resistance examined determination effect l name changes upstream ppa pmv downstream pmv pla vascular resistance
0.41338694.15591098.html.plaintext.txt	124	increases vascular resistance confined upstream vascular segment fig
0.41338694.15591098.html.plaintext.txt	125	view larger version 15k fig
0.41338694.15591098.html.plaintext.txt	126	effect l name 100 microm relationship flow rate pressure gradient across pulmonary circulation ppa pla lungs perfused pss containing washed erythrocytes healthy humans n 5
0.41338694.15591098.html.plaintext.txt	127	05 compared control pre l name values
0.41338694.15591098.html.plaintext.txt	128	values means plus minus se
0.41338694.15591098.html.plaintext.txt	129	view larger version 15k fig
0.41338694.15591098.html.plaintext.txt	130	effect l name 100 microm relationship flow rate pressure gradient across upstream arterial segment pulmonary circulation ppa pulmonary microvascular pressure pmv pressure gradient across downstream venous segment pulmonary circulation b pmv pla lungs perfused pss containing washed erythrocytes healthy humans n 5
0.41338694.15591098.html.plaintext.txt	131	05 compared control pre l name values
0.41338694.15591098.html.plaintext.txt	132	values means plus minus se
0.41338694.15591098.html.plaintext.txt	133	effect l name pressure flow relationships isolated rabbit lungs perfused pss containing erythrocytes humans cystic fibrosis
0.41338694.15591098.html.plaintext.txt	134	isolated rabbit lungs perfused pss containing erythrocytes humans cystic fibrosis l name administration result change perfusion pressure control conditions fig
0.41338694.15591098.html.plaintext.txt	135	moreover presence erythrocytes l name effect pressure flow relationships fig
0.41338694.15591098.html.plaintext.txt	136	view larger version 13k fig
0.41338694.15591098.html.plaintext.txt	137	effect l name 100 microm relationship flow rate pressure gradient across pulmonary circulation ppa pla lungs perfused pss containing washed erythrocytes humans cystic fibrosis n 4
0.41338694.15591098.html.plaintext.txt	138	values means plus minus se
0.41338694.15591098.html.plaintext.txt	139	discussion top abstract materials methods results discussion grants references reported previously erythrocytes either rabbits 31 rats 36 38 healthy humans 26 required demonstration flow induced synthesis isolated perfused lungs
0.41338694.15591098.html.plaintext.txt	140	observations coupled findings physiological stimuli mechanical deformation 18 26 27 29 stimulate atp release erythrocytes atp stimulus endogenous synthesis isolated rabbit lung 30 suggest novel mechanism control pulmonary vascular caliber
0.41338694.15591098.html.plaintext.txt	141	construct erythrocyte deformed increments velocity blood flow vessel andor reductions vascular caliber releases atp stimulates endothelial synthesis resulting relaxation vascular smooth muscle thereby increase vascular caliber
0.41338694.15591098.html.plaintext.txt	142	vasodilation would result decrease pulmonary vascular resistance well decrease stimulus additional erythrocyte deformation atp release
0.41338694.15591098.html.plaintext.txt	143	basis scheme erythrocyte derived atp would contribute low vascular pressure healthy lung via stimulation endogenous synthesis
0.41338694.15591098.html.plaintext.txt	144	recently signal transduction pathway relates mechanical deformation atp release erythrocytes rabbits humans described
0.41338694.15591098.html.plaintext.txt	145	components pathway include heterotrimeric g proteins gs 17 gi 18 adenylyl cyclase 29 pka 29 cftr 27
0.41338694.15591098.html.plaintext.txt	146	role cftr pathway suggested reports member atp binding cassette could facilitate movement atp cells either acting atp conduit 21 22 regulating another channel atp release 20 23
0.41338694.15591098.html.plaintext.txt	147	finding cftr activity lost markedly diminished humans cystic fibrosis 5 6 provided unique opportunity investigation role cftr release atp erythrocytes response physiological stimulus mechanical deformation
0.41338694.15591098.html.plaintext.txt	148	reported previously erythrocytes patients cystic fibrosis well rabbit erythrocytes incubated two chemically dissimilar inhibitors cftr namely glibenclamide 24 25 niflumic acid 7 failed release atp response mechanical deformation 27
0.41338694.15591098.html.plaintext.txt	149	necessary step establishing cftr component signal transduction pathway atp release erythrocytes demonstration presence erythrocyte membranes
0.41338694.15591098.html.plaintext.txt	150	recently shown cftr protein present erythrocyte membranes healthy humans humans cystic fibrosis 1 32
0.41338694.15591098.html.plaintext.txt	151	addition reported human erythroblasts contain cftr mrna 37
0.41338694.15591098.html.plaintext.txt	152	however must noted neither cftr protein human erythrocytes mrna human erythroid progenitor cells detected another study 13
0.41338694.15591098.html.plaintext.txt	153	present work confirm finding cftr protein component human erythrocyte membranes fig
0.41338694.15591098.html.plaintext.txt	154	addition show membranes rabbit erythrocytes also possess cftr fig
0.41338694.15591098.html.plaintext.txt	155	thus cftr necessary component proposed signal transduction pathway atp release erythrocytes present membranes rabbit human erythrocytes cells release atp response mechanical deformation 26 27 29
0.41338694.15591098.html.plaintext.txt	156	although cftr activity required deformation induced atp release erythrocytes humans 27 loss cftr activity may different effect basal atp release cells
0.41338694.15591098.html.plaintext.txt	157	reported concentration atp increased blood cftr knockout mice well humans cystic fibrosis compared either wild type controls healthy humans respectively 1
0.41338694.15591098.html.plaintext.txt	158	important note studies atp release studied quiescent conditions
0.41338694.15591098.html.plaintext.txt	159	erythrocytes subjected mechanical deformation
0.41338694.15591098.html.plaintext.txt	160	thus possible although cftr required deformation induced atp release erythrocytes another member atp binding cassette multidrug resistance associated protein 1 involved basal atp release cells 1
0.41338694.15591098.html.plaintext.txt	161	hypothesis atp released erythrocytes healthy humans response deformation stimulates endogenous synthesis isolated rabbit lung supported previous studies
0.41338694.15591098.html.plaintext.txt	162	erythrocytes healthy humans release atp response mechanical deformation would encountered pass pulmonary circulation
0.41338694.15591098.html.plaintext.txt	163	amount atp released response deformation shown stimulus dependent 26 27 29
0.41338694.15591098.html.plaintext.txt	164	addition inclusion human erythrocytes perfusate isolated rabbit lungs resulted stimulation endogenous synthesis 26
0.41338694.15591098.html.plaintext.txt	165	finally addition atp perfusate isolated rabbit lungs resulted concentration dependent decreases total pulmonary vascular resistance inhibited pretreatment synthase inhibitor l name 30
0.41338694.15591098.html.plaintext.txt	166	view findings cftr expressed human erythrocyte membranes component signal transduction pathway relates erythrocyte deformation atp release 27 atp release erythrocytes stimulus endogenous synthesis rabbit pulmonary circulation 30 hypothesized erythrocytes humans cystic fibrosis condition activity cftr defective would fail stimulate synthesis isolated perfused rabbit lung
0.41338694.15591098.html.plaintext.txt	167	presence washed erythrocytes healthy humans administration synthase inhibitor l name perfusate isolated lungs resulted shift pressure flow relationship manner consistent increase ohmic resistance fig
0.41338694.15591098.html.plaintext.txt	168	increase vascular resistance confined upstream vascular segment ppa pmv function flow rate fig
0.41338694.15591098.html.plaintext.txt	169	contrast presence erythrocytes patients cystic fibrosis l name without effect pressure flow relationship
0.41338694.15591098.html.plaintext.txt	170	determinant pulmonary vascular resistance fig
0.41338694.15591098.html.plaintext.txt	171	several studies suggest endogenous synthesis lung may decreased humans cystic fibrosis
0.41338694.15591098.html.plaintext.txt	172	reported amounts detected exhaled gas decreased humans cystic fibrosis compared healthy humans 2 15 35
0.41338694.15591098.html.plaintext.txt	173	must recognized source measured exhaled gas unknown could derive endothelium blood vessels airways resident cells
0.41338694.15591098.html.plaintext.txt	174	however reported exhaled reduced neonates cystic fibrosis development detectable respiratory symptoms suggesting decrease exhaled result increased mucus accumulation andor inflammation 9
0.41338694.15591098.html.plaintext.txt	175	thus decrease measurable exhaled gas cystic fibrosis patients compared healthy controls could reflect part failure erythrocyte derived atp stimulate endogenous synthesis
0.41338694.15591098.html.plaintext.txt	176	importantly reported isolated blood vessels obtained lungs humans cystic fibrosis precontracted phenylephrine relaxed response application adp first degradation product atp 8
0.41338694.15591098.html.plaintext.txt	177	response shown endothelium dependent although nature endothelium derived relaxing factor determined
0.41338694.15591098.html.plaintext.txt	178	thus reasonable hypothesize erythrocyte derived atp released pulmonary circulation humans cystic fibrosis endogenous synthesis could stimulated
0.41338694.15591098.html.plaintext.txt	179	failure deformation induced atp release erythrocytes thereby loss physiological stimulus endogenous synthesis could expected lead ultimately development pulmonary hypertension
0.41338694.15591098.html.plaintext.txt	180	pulmonary hypertension seen humans cystic fibrosis however condition often attributed destructive lung disease subsequent loss pulmonary capillaries andor hypoxic pulmonary vasoconstriction 11 34
0.41338694.15591098.html.plaintext.txt	181	results presented suggest defect atp release erythrocytes cystic fibrosis patients traverse pulmonary circulation could additional factor leading development pulmonary hypertension individuals
0.41338694.15591098.html.plaintext.txt	182	summary demonstrate cftr component erythrocyte membrane rabbits humans
0.41338694.15591098.html.plaintext.txt	183	erythrocytes humans protein functional stimulate endogenous synthesis isolated rabbit lung
0.41338694.15591098.html.plaintext.txt	184	contrast erythrocytes humans cystic fibrosis condition cftr activity impaired stimulate synthesis model
0.41338694.15591098.html.plaintext.txt	185	findings provide support hypothesis erythrocyte derived atp released response physiological stimulus mechanical deformation could serve aid maintenance normal pulmonary vascular resistance via stimulation endogenous synthesis
0.41338694.15591098.html.plaintext.txt	186	grants top abstract materials methods results discussion grants references study supported national heart lung blood institute grants hl 51298 hl 52675 hl 39226
0.41338694.15591098.html.plaintext.txt	187	acknowledgments authors thank elizabeth bowles technical assistance j
0.41338694.15591098.html.plaintext.txt	188	footnotes address reprint requests correspondence r
0.41338694.15591098.html.plaintext.txt	189	pharmacological physiological science saint louis univ
0.41338694.15591098.html.plaintext.txt	190	louis mo 63104 e mail spragueratslu
0.41338694.15591098.html.plaintext.txt	191	costs publication article defrayed part payment page charges
0.41338694.15591098.html.plaintext.txt	192	article must therefore hereby marked advertisement accordance 18 u
0.41338694.15591098.html.plaintext.txt	193	section 1734 solely indicate fact
0.41338694.15591098.html.plaintext.txt	194	references top abstract materials methods results discussion grants references abraham eh sterling km kim rj salikhova ay huffman hb crockett ma johnston n parker hw boyle jr hartov demidenko e efird j kahn j grubman sa jefferson dm robson sc thakar jh lorico rappa g sartorelli ac okunieff p
0.41338694.15591098.html.plaintext.txt	195	erythrocyte membrane atp binding cassette abc proteins mrp1 cftr well cd39 ecto apyrase involved rbc atp transport elevated plasma atp cystic fibrosis
0.41338694.15591098.html.plaintext.txt	196	blood cells mol dis 27 165 180 2001
0.41338694.15591098.html.plaintext.txt	197	crossrefisimedline balfour lynn im laverty dinwiddie r
0.41338694.15591098.html.plaintext.txt	198	reduced upper airway nitric oxide cystic fibrosis
0.41338694.15591098.html.plaintext.txt	199	arch dis child 75 319 322 1996
0.41338694.15591098.html.plaintext.txt	200	abstract buga gm gold fukuto jm ignarro lj
0.41338694.15591098.html.plaintext.txt	201	shear stress induced release nitric oxide endothelial cells grown beads
0.41338694.15591098.html.plaintext.txt	202	hypertension 17 187 193 1991
0.41338694.15591098.html.plaintext.txt	203	abstract cafferata eg gonzalez guerrico pivetta oh santa coloma ta
0.41338694.15591098.html.plaintext.txt	204	identification differential display mrna specifically induced 12 o tetradecanoylphorbol 13 acetate tpa 84 human colon carcinoma cells
0.41338694.15591098.html.plaintext.txt	205	cell mol biol 42 797 804 1996
0.41338694.15591098.html.plaintext.txt	206	isimedline cheng sh gregory rj marshall j paul souza dw white ga o riordan cr smith ae
0.41338694.15591098.html.plaintext.txt	207	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.41338694.15591098.html.plaintext.txt	208	crossrefisimedline davis pb drumm m konstan mw
0.41338694.15591098.html.plaintext.txt	209	j respir crit care med 154 1229 1256 1996
0.41338694.15591098.html.plaintext.txt	210	isimedline devor dc schultz bd
0.41338694.15591098.html.plaintext.txt	211	ibuprofen inhibits cystic fibrosis transmembrane conductance regulator mediated cl secretion
0.41338694.15591098.html.plaintext.txt	212	j clin invest 102 679 687 1998
0.41338694.15591098.html.plaintext.txt	213	abstractfree full text dinh xuan higenbottam tw pepke zaba j celland c wallwork j
0.41338694.15591098.html.plaintext.txt	214	reduced endothelium dependent relaxation cystic fibrosis pulmonary arteries
0.41338694.15591098.html.plaintext.txt	215	eur j pharmacol 163 401 403 1989
0.41338694.15591098.html.plaintext.txt	216	crossrefisimedline elphick demoncheaux eag ritson higgenbottam tw everard ml
0.41338694.15591098.html.plaintext.txt	217	exhaled nitric oxide reduced infants cystic fibrosis
0.41338694.15591098.html.plaintext.txt	218	abstractfree full text furchgott rf zawadzki jv
0.41338694.15591098.html.plaintext.txt	219	obligatory role endothelial cells relaxation arterial smooth muscle acetylcholine
0.41338694.15591098.html.plaintext.txt	220	crossrefisimedline goldring rm fishman ap turino gm cohen hi denning cr andersen dh
0.41338694.15591098.html.plaintext.txt	221	pulmonary hypertension cor pulmonale cystic fibrosis pancreas
0.41338694.15591098.html.plaintext.txt	222	j pediatr 65 501 523 1964
0.41338694.15591098.html.plaintext.txt	223	isimedline hanrahan jw mathews cj grygorczyk r tabcharani ja grzelczak z chang xb riordan jr
0.41338694.15591098.html.plaintext.txt	224	regulation cftr chloride channel humans sharks
0.41338694.15591098.html.plaintext.txt	225	j exp zool 275 283 291 1996
0.41338694.15591098.html.plaintext.txt	226	abstractfree full text ignarro lj buga g chaudhuri g
0.41338694.15591098.html.plaintext.txt	227	edrf generation release perfused bovine pulmonary artery vein
0.41338694.15591098.html.plaintext.txt	228	eur j pharmacol 149 79 88 1988
0.41338694.15591098.html.plaintext.txt	229	crossrefisimedline linehan jh dawson ca rickaby da
0.41338694.15591098.html.plaintext.txt	230	distribution vascular resistance compliance dog lung lobe
0.41338694.15591098.html.plaintext.txt	231	j appl physiol 53 158 168 1982
0.41338694.15591098.html.plaintext.txt	232	abstractfree full text lundberg jon nordvall sl weitzberg e kollberg h alving k
0.41338694.15591098.html.plaintext.txt	233	exhaled nitric oxide paediatric asthma cystic fibrosis
0.41338694.15591098.html.plaintext.txt	234	arch dis child 75 323 326 1996
0.41338694.15591098.html.plaintext.txt	235	abstract olearczyk jj stephenson ah lonigro aj sprague rs
0.41338694.15591098.html.plaintext.txt	236	receptor mediated activation heterotrimeric g protein gs results atp release erythrocytes
0.41338694.15591098.html.plaintext.txt	237	med sci monit 7 669 674 2001
0.41338694.15591098.html.plaintext.txt	238	medline olearczyk jj stephenson ah lonigro aj sprague rs
0.41338694.15591098.html.plaintext.txt	239	heterotrimeric g protein gi involved signal transduction pathway atp release erythrocytes
0.41338694.15591098.html.plaintext.txt	240	j physiol heart circ physiol 286 h940 h945 2004
0.41338694.15591098.html.plaintext.txt	241	abstractfree full text palmer r ferrige mj moncada
0.41338694.15591098.html.plaintext.txt	242	nitric oxide release accounts biological activity endothelium derived relaxing factor
0.41338694.15591098.html.plaintext.txt	243	crossrefisimedline reddy mm quinton pm haws c wine jj grygorczyk r tabcharani ja hanrahan jw gunderson kl kopito rr
0.41338694.15591098.html.plaintext.txt	244	failure cystic fibrosis transmembrane conductance regulator conduct atp
0.41338694.15591098.html.plaintext.txt	245	science 271 1876 1879 1996
0.41338694.15591098.html.plaintext.txt	246	abstract reisin il prat ag abraham eh amara jf gregory rj ausiello da cantiello hf
0.41338694.15591098.html.plaintext.txt	247	cystic fibrosis transmembrane conductance regulator dual atp chloride channel
0.41338694.15591098.html.plaintext.txt	248	j biol chem 269 20584 20591 1994
0.41338694.15591098.html.plaintext.txt	249	abstractfree full text rubanyi gm romero jc vanhoutte pm
0.41338694.15591098.html.plaintext.txt	250	flow induced release endothelium derived relaxing factor
0.41338694.15591098.html.plaintext.txt	251	j physiol heart circ physiol 250 h1145 h1149 1986
0.41338694.15591098.html.plaintext.txt	252	abstractfree full text schwiebert em egan hwang th fulmer sb allen ss cutting gr guggino w
0.41338694.15591098.html.plaintext.txt	253	cftr regulated outward rectifying chloride channels autocrine mechanism involving atp
0.41338694.15591098.html.plaintext.txt	254	crossrefisimedline sheppard dn welsh mj
0.41338694.15591098.html.plaintext.txt	255	effect atp sensitive k channel regulators cystic fibrosis transmembrane conductance regulator chloride currents
0.41338694.15591098.html.plaintext.txt	256	j gen physiol 100 573 591 1992
0.41338694.15591098.html.plaintext.txt	257	abstract sheppard dn welsh mj
0.41338694.15591098.html.plaintext.txt	258	inhibition cystic fibrosis transmembrane conductance regulator atp sensitive k channel regulators
0.41338694.15591098.html.plaintext.txt	259	ann ny acad sci 707 275 284 1993
0.41338694.15591098.html.plaintext.txt	260	isimedline sprague rs ellsworth stephenson ah lonigro aj
0.41338694.15591098.html.plaintext.txt	261	atp red blood cell link local control pulmonary circulation
0.41338694.15591098.html.plaintext.txt	262	j physiol heart circ physiol 271 h2717 h2722 1996
0.41338694.15591098.html.plaintext.txt	263	abstractfree full text sprague rs ellsworth ml stephenson ah kleinhenz lonigro aj
0.41338694.15591098.html.plaintext.txt	264	deformation induced atp release red blood cells requires cystic fibrosis transmembrane conductance regulator activity
0.41338694.15591098.html.plaintext.txt	265	j physiol heart circ physiol 275 h1726 h1732 1998
0.41338694.15591098.html.plaintext.txt	266	abstractfree full text sprague rs ellsworth stephenson ah lonigro aj
0.41338694.15591098.html.plaintext.txt	267	increases perfusate flow rate stimulate atp release form red blood cells isolated rabbit lungs
0.41338694.15591098.html.plaintext.txt	268	exp clin cardiol 3 73 77 1998
0.41338694.15591098.html.plaintext.txt	269	sprague rs ellsworth ml stephenson ah lonigro aj
0.41338694.15591098.html.plaintext.txt	270	participation camp signal transduction pathway relating erythrocyte deformation atp release
0.41338694.15591098.html.plaintext.txt	271	j physiol cell physiol 281 c1158 c1164 2001
0.41338694.15591098.html.plaintext.txt	272	abstractfree full text sprague rs olearczyk jj spence dm stephenson ah sprung rw lonigro aj
0.41338694.15591098.html.plaintext.txt	273	extracellular atp signaling rabbit lung erythrocytes determinants vascular resistance
0.41338694.15591098.html.plaintext.txt	274	j physiol heart circ physiol 285 h693 h700 2003
0.41338694.15591098.html.plaintext.txt	275	abstractfree full text sprague rs stephenson ah dimmitt ra weintraub nl branch ca mcmurdo l lonigro aj
0.41338694.15591098.html.plaintext.txt	276	effect l name pressure flow relationships isolated rabbit lungs role red blood cells
0.41338694.15591098.html.plaintext.txt	277	j physiol heart circ physiol 269 h1941 h1948 1995
0.41338694.15591098.html.plaintext.txt	278	abstractfree full text sterling km jr shah kim rj johnson nif salikhova ay abraham eh
0.41338694.15591098.html.plaintext.txt	279	cystic fibrosis transmembrane conductance regulator human mouse red blood cell membranes interaction ecto apyrase
0.41338694.15591098.html.plaintext.txt	280	j cell biochem 91 1174 1182 2004
0.41338694.15591098.html.plaintext.txt	281	crossrefisimedline strong tv boehm k collins fs
0.41338694.15591098.html.plaintext.txt	282	localization cystic fibrosis transmembrane conductance regulator mrna human gastrointestinal tract situ hybridization
0.41338694.15591098.html.plaintext.txt	283	j clin invest 93 347 354 1994
0.41338694.15591098.html.plaintext.txt	284	pulmonary hypertension cystic fibrosis
0.41338694.15591098.html.plaintext.txt	285	arch pathol 92 409 414 1971
0.41338694.15591098.html.plaintext.txt	286	isimedline thomas sr kharitonov sa scott sf hodson barnes pj
0.41338694.15591098.html.plaintext.txt	287	nasal exhaled nitric oxide reduced adult patients cystic fibrosis correlate cystic fibrosis genotype
0.41338694.15591098.html.plaintext.txt	288	abstractfree full text uncles dr daughterty mo frank du roos cm rich gf
0.41338694.15591098.html.plaintext.txt	289	nitric oxide modulation pulmonary vascular resistance red blood cell dependent isolated rat lungs
0.41338694.15591098.html.plaintext.txt	290	anesth analg 83 1212 1217 1996
0.41338694.15591098.html.plaintext.txt	291	abstract verloo p kocken chm van der wel tilly bc hogema bm sinaasappel m thomas aw de jonge hr
0.41338694.15591098.html.plaintext.txt	292	plasmodium falciparum activated chloride channels defective erythrocytes cystic fibrosis patients
0.41338694.15591098.html.plaintext.txt	293	j biol chem 279 10316 10332 2004
0.41338694.15591098.html.plaintext.txt	294	abstractfree full text wilson khimenko p moore tm taylor ae
0.41338694.15591098.html.plaintext.txt	295	perfusate viscosity hematocrit determine pulmonary vascular responsiveness synthase inhibitors
0.41338694.15591098.html.plaintext.txt	296	j physiol heart circ physiol 270 h1757 h1765 1996
0.44555384.15039462.html.plaintext.txt	0	syntaxin 8 impairs trafficking cystic fibrosis transmembrane conductance regulator cftr inhibits channel activity frederic bilan1 vincent thoreau1 magali nacfer1 renaud derand2 caroline norez2 anne cantereau2 martine garcia3 frederic becq2 alain kitzis1
0.44555384.15039462.html.plaintext.txt	1	1 laboratoire de genetique cellulaire et moleculaire upres ea 2622 chu de poitiers bp 577 86021 poitiers cedex france 2 laboratoire de biomembranes et signalisation cellulaire cnrs umr 6558 universite de poitiers france 3 laboratoire dimmunologie et interactions moleculaires upres ea 2224 universite de poitiers france
0.44555384.15039462.html.plaintext.txt	2	author correspondence e mail
0.44555384.15039462.html.plaintext.txt	3	summary top summary introduction materials methods results discussion references cystic fibrosis transmembrane conductance regulator cftr cyclic amp dependent chloride channel mediates electrolyte transport across luminal surface epithelial cells
0.44555384.15039462.html.plaintext.txt	4	paper describe cftr regulation syntaxin 8 snare protein target soluble n ethylmaleimide sensitive factor attachment protein receptor involved snare endosomal complex
0.44555384.15039462.html.plaintext.txt	5	syntaxin family members key molecules implicated diverse vesicle docking membrane fusion events
0.44555384.15039462.html.plaintext.txt	6	found syntaxin 8 physically interacts cftr recombinant syntaxin 8 binds cftr vitro proteins co immunoprecipitate ht29 cells
0.44555384.15039462.html.plaintext.txt	7	syntaxin 8 regulates cftr mediated currents chinese hamster ovary cho cells stably expressing cftr syntaxin 8
0.44555384.15039462.html.plaintext.txt	8	iodide efflux whole cell patch clamp experiments cells indicate strong inhibition cftr chloride current syntaxin 8 overexpression
0.44555384.15039462.html.plaintext.txt	9	cellular level observed syntaxin 8 overexpression disturbs cftr trafficking
0.44555384.15039462.html.plaintext.txt	10	confocal microscopy shows dramatic decrease green fluorescent protein tagged cftr plasma membrane staining syntaxin 8 coexpressed cos 7 cells
0.44555384.15039462.html.plaintext.txt	11	using antibodies lamp 1 tfr rab11 determined immunofluorescence assays proteins mainly accumulated recycling endosomes
0.44555384.15039462.html.plaintext.txt	12	results evidence syntaxin 8 contributes regulation cftr trafficking chloride channel activity snare machinery
0.44555384.15039462.html.plaintext.txt	13	key words cftr syntaxin 8 snare recycling endosome trafficking
0.44555384.15039462.html.plaintext.txt	14	introduction top summary introduction materials methods results discussion references cystic fibrosis broadest autosomal recessive disorder among caucasian populations
0.44555384.15039462.html.plaintext.txt	15	characterized mutations cftr cystic fibrosis transmembrane conductance regulator gene encodes camp activated chloride channel expressed apical membrane epithelial cells rommens et al
0.44555384.15039462.html.plaintext.txt	16	cftr protein atp binding cassette abc transporter specific cytoplasmic regulator domain r whose phosphorylation protein kinase pka activates cftr chloride conductance reviewed ostedgaard et al
0.44555384.15039462.html.plaintext.txt	17	cystic fibrosis patients dysfunction chloride channel activity cftr alone seems insufficient elicit deep disorders ionic equilibrium observed surface epithelial tissues
0.44555384.15039462.html.plaintext.txt	18	indeed cftr expression linked regulation numerous ionic channels assumed cftr key member complex network ionic channels gabriel et al
0.44555384.15039462.html.plaintext.txt	19	2000 cytoplasmic proteins epithelia
0.44555384.15039462.html.plaintext.txt	20	example cftr interacts several proteins containing pdz psd 95dlgzo 1 domains
0.44555384.15039462.html.plaintext.txt	21	proteins localized subplasma membrane region short et al
0.44555384.15039462.html.plaintext.txt	22	2001 one found golgi apparatus cheng et al
0.44555384.15039462.html.plaintext.txt	23	interactions also detected cftr proteins involved intracellular vesicle trafficking
0.44555384.15039462.html.plaintext.txt	24	notably c terminus cftr binds endocytic clathrin adaptator complex ap 2 weixel bradbury 2000 presumably internalization cftr plasma membrane
0.44555384.15039462.html.plaintext.txt	25	several studies focusing relationships cftr proteins snare soluble n ethylmaleimide sensitive factor attachment protein receptor family
0.44555384.15039462.html.plaintext.txt	26	proteins involved membrane fusion events happening different steps vesicle trafficking eukaryotic cells reviewed chen scheller 2001
0.44555384.15039462.html.plaintext.txt	27	syntaxins belong subfamily snares whose c terminal half contains snare homology domain weimbs et al
0.44555384.15039462.html.plaintext.txt	28	1997 followed short hydrophobic tail anchors protein resident membrane
0.44555384.15039462.html.plaintext.txt	29	region syntaxins upstream transmembrane domain protrudes cytoplasmic side vesicle plasma membrane
0.44555384.15039462.html.plaintext.txt	30	remarkably direct interaction snare homology domain syntaxin 1a n terminal cytoplasmic tail cftr thought responsible inhibiting cftr chloride channel activity naren et al
0.44555384.15039462.html.plaintext.txt	31	previously described cloning human syntaxin 8 cdna stx8 gene using r domain cftr bait two hybrid screening human fetal lung library thoreau et al
0.44555384.15039462.html.plaintext.txt	32	subsequently syntaxin 8 localized different endosomal compartments involved trafficking early endosome ee late endosome le homotypic fusion events le prekeris et al
0.44555384.15039462.html.plaintext.txt	33	present study establish syntaxin 8 overexpression inhibits cftr channel activity trafficking plasma membrane
0.44555384.15039462.html.plaintext.txt	34	direct regulation also suggested show evidence existence physical interaction cftr syntaxin 8 either directly within protein complex
0.44555384.15039462.html.plaintext.txt	35	thus propose syntaxin 8 member cftr interaction network
0.44555384.15039462.html.plaintext.txt	36	results strengthen idea snare machinery directly regulates cftr trafficking activity
0.44555384.15039462.html.plaintext.txt	37	materials methods top summary introduction materials methods results discussion references constructs antibodies cdnas encoding human syntaxin 8 syntaxin 1a syntaxin 3 obtained rt pcr total rna isolated human colonic epithelial cell line ht29 cl19a
0.44555384.15039462.html.plaintext.txt	38	full length stx8 cdna cloned ecori bamhi sites mammalian expression vector pcdna3
0.44555384.15039462.html.plaintext.txt	39	full length stx1a stx3 cdnas cloned noti xhoi sites pcdna3
0.44555384.15039462.html.plaintext.txt	40	using directed mutagenesis quikchangetm site directed mutagenesis kit stratagene constructed cytosoluble syntaxin 8 stop codon position 211 noted syn8tm protein lacks hydrophobic transmembrane anchor
0.44555384.15039462.html.plaintext.txt	41	three different recombinant syntaxin 8 gst glutathione transferase fusion generated inserting pcr fragments bamhi sali sites bacterial expression vector pgex 5x 3 pharmacia syn8tm
0.44555384.15039462.html.plaintext.txt	42	syn8 aa 1 209 syn8 aa 1 99 syn8 aa 99 209
0.44555384.15039462.html.plaintext.txt	43	gst syn1atm bacterial expression vector gift
0.44555384.15039462.html.plaintext.txt	44	naren university alabama birmingham al
0.44555384.15039462.html.plaintext.txt	45	gst vamp8tm aa 1 74 gst syn7tm aa 1 236 bacterial expression vectors obtained w
0.44555384.15039462.html.plaintext.txt	46	antonin max planck institute biophysical chemistry gottingen germany
0.44555384.15039462.html.plaintext.txt	47	gst vti1btm vector aa 1 207 gift g
0.44555384.15039462.html.plaintext.txt	48	von mollard georg august universitat gottingen germany
0.44555384.15039462.html.plaintext.txt	49	expression cftr tagged gfp green fluorescent protein analyzed using ps65tegfp c1wt cftr construct gift k
0.44555384.15039462.html.plaintext.txt	50	karlson dartmouth college hanover nh
0.44555384.15039462.html.plaintext.txt	51	following antibodies used study rabbit polyclonal antibody syntaxin 3 gift
0.44555384.15039462.html.plaintext.txt	52	1997 monoclonal antibody syntaxin 1a clone 78
0.44555384.15039462.html.plaintext.txt	53	3 synaptic systems germany monoclonal antibody syntaxin 8 clone 48 transduction laboratories antibodies cftr monoclonal antibody clone m3a7 epitope amino acid 1370 1380 chemicon international used immunoblotting monoclonal antibody clone 24 1 epitope amino acid 1377 1480 r d systems used immunoprecipitation antibody gfp monoclonal antibody clone gep 20 sigma aldrich
0.44555384.15039462.html.plaintext.txt	54	immunofluorescence experiments anti syntaxin 8 antibody prepared immunization rabbit bacterially expressed gst syn8tm
0.44555384.15039462.html.plaintext.txt	55	polyclonal antibody affinity purified rabbit antiserum using cnbr activated sepharose beads amersham pharmacia biotech
0.44555384.15039462.html.plaintext.txt	56	monoclonal anti tfr antibody purchased sigma aldrich clone df1513 monoclonal anti lamp 1 obtained pharmingen rabbit polyclonal anti rab11 antibody gift b
0.44555384.15039462.html.plaintext.txt	57	2000 rabbit polyclonal anti ncx2 provided intermediary c
0.44555384.15039462.html.plaintext.txt	58	cognard lbsc poitiers france
0.44555384.15039462.html.plaintext.txt	59	fluorescent secondary antibodies obtained jackson immunoresearch laboratories
0.44555384.15039462.html.plaintext.txt	60	secondary antibody western blot obtained amersham pharmacia biotech horseradish peroxidase conjugated goat anti mouse igg
0.44555384.15039462.html.plaintext.txt	61	cell culture cell lines cultured 37 degrees c 5 co2 medium containing 100 iuml penicillin panpharma sa france 100 microgml streptomycin solvay pharma france
0.44555384.15039462.html.plaintext.txt	62	cho cells transfected cftr cdna cho cftr established j
0.44555384.15039462.html.plaintext.txt	63	1991 grown mem medium glutamax life technologies containing 100 microm methotrexate sigma aldrich supplemented 7 fetal calf serum life technologies
0.44555384.15039462.html.plaintext.txt	64	cos 7 ht29 cl19a cells cultured dmem glutamax supplemented 10 fetal calf serum
0.44555384.15039462.html.plaintext.txt	65	transfection cho cftr cells transfected 1 microg pcdna3
0.44555384.15039462.html.plaintext.txt	66	1zeo plasmids encoding syntaxins using 3 microl fugene6tm transfection reagent roche diagnostics corp
0.44555384.15039462.html.plaintext.txt	67	according manufacturers protocol
0.44555384.15039462.html.plaintext.txt	68	24 48 hours incubation 40 microgml zeocin invitrogen added culture medium
0.44555384.15039462.html.plaintext.txt	69	resistant cells cultured 20 microgml zeocin tested western blot immunofluorescence
0.44555384.15039462.html.plaintext.txt	70	isolate clones overexpressing syn8 syn8tm cells diluted cultured 24 well plates
0.44555384.15039462.html.plaintext.txt	71	electroporation cos 7 cells 2x106 cells 90 confluence trypsinized resuspended 800 microl pbs 10 microg plasmid
0.44555384.15039462.html.plaintext.txt	72	5 minutes incubation ice cells transferred electroporation cuvette 4 mm electrode gap equibio ltd electroporated one shock 300 v 450 microf using easyject plus multipurpose electroporation system equibio ltd
0.44555384.15039462.html.plaintext.txt	73	cells incubated ice 10 minutes 10 ml culture medium plated glass coverslips grown 48 hours treated subsequently immunofluorescence analysis
0.44555384.15039462.html.plaintext.txt	74	iodide efflux experiments cftr chloride channel activity assayed measuring rate iodide 125i efflux transfected cho cells previously described derand et al
0.44555384.15039462.html.plaintext.txt	75	experiments performed 37 degrees c
0.44555384.15039462.html.plaintext.txt	76	loss intracellular 125i determined removing medium efflux buffer every 1 minute 10 minutes
0.44555384.15039462.html.plaintext.txt	77	fraction initial intracellular 125i lost interval time determined time dependent rates 125i efflux calculated ln125it1 125it2t1 t2 125it intracellular 125i time t1 t2 successive time points venglarik et al
0.44555384.15039462.html.plaintext.txt	78	patch clamp experiments whole cell chloride currents recorded cho cells room temperature list epc 7 patch clamp amplifier
0.44555384.15039462.html.plaintext.txt	79	v relationships built clamping membrane potential 40 mv pulses 100 mv 100 mv 20 mv increments
0.44555384.15039462.html.plaintext.txt	80	mediums generating chloride gradient 151 mm external concentration 28 mm internal concentration used
0.44555384.15039462.html.plaintext.txt	81	pipette solution contained 113 mm l aspartic acid 113 mm csoh 27 mm cscl 1 mm nacl 1 mm mgcl2 1 mm egta 10 mm tes 285 mosm ph 7
0.44555384.15039462.html.plaintext.txt	82	mgatp 3 mm added patch clamp experiments started
0.44555384.15039462.html.plaintext.txt	83	external solution consisted 145 mm nacl 4 mm cscl 1 mm cacl2 5 mm glucose 10 mm tes 340 mosm ph 7
0.44555384.15039462.html.plaintext.txt	84	results analyzed pclamp6 package software pclamp axon instruments
0.44555384.15039462.html.plaintext.txt	85	cells stimulated forskolin sigma aldrich cftr activator mpb 91 5 butyl 6 hydroxy 10 chlorobenzocquinolizinium synthesized previously described derand et al
0.44555384.15039462.html.plaintext.txt	86	statistics results expressed means plus minus
0.44555384.15039462.html.plaintext.txt	87	compare sets data used either analysis variance anova students test
0.44555384.15039462.html.plaintext.txt	88	differences considered statistically significant p 0
0.44555384.15039462.html.plaintext.txt	89	statistical tests performed using graphpad prism version 3
0.44555384.15039462.html.plaintext.txt	90	0 windows graphpad software
0.44555384.15039462.html.plaintext.txt	91	immunofluorescence cells grown glass coverslips washed pbs pbs buffer supplemented 1 mm cacl2 1 mm mgcl2 fixed 10 minutes 3 paraformaldehyde pbs permeabilized 10 minutes saponin buffer 0
0.44555384.15039462.html.plaintext.txt	92	cells incubated pbs containing 0
0.44555384.15039462.html.plaintext.txt	93	5 bsa 45 minutes room temperature block unspecific antigen sites
0.44555384.15039462.html.plaintext.txt	94	coverslips labeled 1 hour primary antibody 1100 blocking buffer
0.44555384.15039462.html.plaintext.txt	95	cells washed three times pbs containing 0
0.44555384.15039462.html.plaintext.txt	96	5 bsa labeled conjugated antibody 1100 1 hour
0.44555384.15039462.html.plaintext.txt	97	coverslips mounted vectashield fluorescence medium h1000 vector lab
0.44555384.15039462.html.plaintext.txt	98	confocal imaging labeled samples examined confocal laser scanning microscopy using biorad mrc 1024
0.44555384.15039462.html.plaintext.txt	99	confocal unit attached inverted microscope olympus ix70
0.44555384.15039462.html.plaintext.txt	100	maximal resolution obtained olympus plan apo x60 water 1
0.44555384.15039462.html.plaintext.txt	101	3 numerical aperture objective lens
0.44555384.15039462.html.plaintext.txt	102	fluorescence signal collection image construction scaling performed control software lasersharp 3
0.44555384.15039462.html.plaintext.txt	103	colocalization study cftr syntaxin 8 endosomal markers bleed avoided acquisition red green far red fluorescence images collected sequentially merged rgb colored image
0.44555384.15039462.html.plaintext.txt	104	2 software permitted analysis degree colocalization focal plane
0.44555384.15039462.html.plaintext.txt	105	pair color combinations two dimensional fluorogram displayed intensity distribution different colored pixels within merged image scattergram
0.44555384.15039462.html.plaintext.txt	106	possible select subset pixels scattergram significant intensity colors shown colored rectangle visualize cell image localization selected pixels
0.44555384.15039462.html.plaintext.txt	107	sds page immunoblot cells homogenized several passes 23 gauge syringe needle ripa buffer 50 mm tris hcl ph 7
0.44555384.15039462.html.plaintext.txt	108	5 1 mm edta 100 mm nacl 1 triton x 100 containing protease inhibitors 20 microm leupeptin 0
0.44555384.15039462.html.plaintext.txt	109	8 microm aprotinin 10 microm pepstatin 1
0.44555384.15039462.html.plaintext.txt	110	25 mm phenylmethylsulfonyl fluoride
0.44555384.15039462.html.plaintext.txt	111	cell lysates incubated ice 30 minutes clarified centrifugation 15000 g 5 minutes 4 degrees c
0.44555384.15039462.html.plaintext.txt	112	total proteins quantified using bca protein assay reagent pierce 10 50 microg proteins loaded onto sds page apparatus
0.44555384.15039462.html.plaintext.txt	113	sds page performed according laemmli favre laemmli favre 1973
0.44555384.15039462.html.plaintext.txt	114	extracts separated 15 polyacrylamide gels study syntaxin 8 7 cftr
0.44555384.15039462.html.plaintext.txt	115	western blots proteins transferred gels 0
0.44555384.15039462.html.plaintext.txt	116	20 microm pore nitrocellulose membrane sartorius germany using miniprotean iii electroblotter biorad laboratories
0.44555384.15039462.html.plaintext.txt	117	immunoblots washed pbs containing 0
0.44555384.15039462.html.plaintext.txt	118	1 tween 20 pbs tween probed overnight 4 degrees c primary antibody pbs tween
0.44555384.15039462.html.plaintext.txt	119	membranes washed incubated 1 hour 4 degrees c secondary antibody
0.44555384.15039462.html.plaintext.txt	120	bound antibodies detected using enhanced luminol oxidizing reagents specified manufacturer ecl amersham pharmacia biotech
0.44555384.15039462.html.plaintext.txt	121	immunoprecipitation cell lysates prepared described 1 ml lysis buffer per 100 mm culture dish
0.44555384.15039462.html.plaintext.txt	122	experiments 3 ml cell lysate supplemented 9 ml net buffer 50 mm tris hcl ph 7
0.44555384.15039462.html.plaintext.txt	123	05 nonidet p 40 incubated overnight 4 degrees c 2 microg cftr syn8 antibodies
0.44555384.15039462.html.plaintext.txt	124	precipitate immune complexes incubation 3 microg protein g sepharose amersham pharmacia biotech conducted 1 hour 4 degrees c
0.44555384.15039462.html.plaintext.txt	125	bead bound complexes washed three times cold net buffer denatured laemmli buffer 15 minutes room temperature
0.44555384.15039462.html.plaintext.txt	126	samples separated sds page analyzed western blot
0.44555384.15039462.html.plaintext.txt	127	pull assays gst fusion proteins produced e
0.44555384.15039462.html.plaintext.txt	128	cells transformed pgex amersham pharmacia biotech constructs grown lysed according manufacturers protocol
0.44555384.15039462.html.plaintext.txt	129	recombinant proteins contained lysates purified incubation 30 minutes 4 degrees c 500 microl glutathione sepharose beads amersham pharmacia biotech followed three washes pbs 1 triton x 100
0.44555384.15039462.html.plaintext.txt	130	gst fusion protein yield controlled sds page followed coomassie blue gel staining
0.44555384.15039462.html.plaintext.txt	131	8x106 cos 7 cells stably transfected gfp cftr lysed described
0.44555384.15039462.html.plaintext.txt	132	lysates mixed 200 microg recombinant proteins bound glutathione sepharose beads
0.44555384.15039462.html.plaintext.txt	133	incubation conducted overnight 4 degrees c
0.44555384.15039462.html.plaintext.txt	134	bead bound complexes washed three times lysis buffer denatured laemmli buffer 15 minutes room temperature loaded 7 sds page analyzed western blot using gfp antibody
0.44555384.15039462.html.plaintext.txt	135	results top summary introduction materials methods results discussion references inhibition cftr channel activity syntaxin 8 overexpression cho cells first part study addressed functional interactions syntaxin 8 cftr
0.44555384.15039462.html.plaintext.txt	136	cho cftr cells transfected plasmid pcdna3
0.44555384.15039462.html.plaintext.txt	137	transfection 50 cells found overexpress syntaxin 8 determined immunofluorescence analysis data shown
0.44555384.15039462.html.plaintext.txt	138	step observed iodide efflux experiments significant inhibition 40 cftr channel activity cho cftrsyn8 cells compared control cho cftr cells data shown
0.44555384.15039462.html.plaintext.txt	139	experiments selected one clone named cho 2t doubly transfected highly overexpressing syntaxin 8 fig
0.44555384.15039462.html.plaintext.txt	140	view larger version 46k fig
0.44555384.15039462.html.plaintext.txt	141	syntaxin 8 cftr expression cho cftr cell line cho 2t clone
0.44555384.15039462.html.plaintext.txt	142	monoclonal antibody raised syntaxin 8 used study syntaxin 8 expression levels localization cho cells expressing either cftr cho cftr cftr syntaxin 8 cho 2t
0.44555384.15039462.html.plaintext.txt	143	specific labeling visualized using tritc conjugated secondary antibody
0.44555384.15039462.html.plaintext.txt	144	b equal amounts protein 10 microg subjected sds page followed immunoblotting
0.44555384.15039462.html.plaintext.txt	145	syntaxin 8 overexpression confirmed cho 2t clone
0.44555384.15039462.html.plaintext.txt	146	c cell lysates containing equal amount protein subjected immunoprecipitation cftr antibody
0.44555384.15039462.html.plaintext.txt	147	presence cftr cho cftr cho 2t cells revealed immunoblotting
0.44555384.15039462.html.plaintext.txt	148	immunostaining endogenous syntaxin 8 cho cftr cells presented vesicle like pattern
0.44555384.15039462.html.plaintext.txt	149	intensity staining increased stx8 cdna transfection
0.44555384.15039462.html.plaintext.txt	150	moreover strong perinuclear staining appeared doubly transfected cho 2t clone fig
0.44555384.15039462.html.plaintext.txt	151	overexpression syntaxin 8 also assessed immunoblot fig
0.44555384.15039462.html.plaintext.txt	152	verify cftr expression cho 2t clone affected compared cho cftr cells controlled cftr mrna level quantitative rt pcr found significant difference two cell lines data shown
0.44555384.15039462.html.plaintext.txt	153	moreover performed immunoprecipitation assess presence cftr protein cell line fig
0.44555384.15039462.html.plaintext.txt	154	cftr could immunoprecipitated comparable efficiency cho cftr cho 2t cell lysates
0.44555384.15039462.html.plaintext.txt	155	anti cftr immunoblotting revealed characteristic mature band c immature band b cftr cho cell lines
0.44555384.15039462.html.plaintext.txt	156	consequences syntaxin 8 overexpression cftr channel activity studied using iodide efflux whole cell patch clamp experiments cho cftr cho 2t cells
0.44555384.15039462.html.plaintext.txt	157	control experiments performed cho cftr cells transfected pcdna3
0.44555384.15039462.html.plaintext.txt	158	resulting data exhibited significant difference cftr channel activity mock transfected control cho cftr cells data shown
0.44555384.15039462.html.plaintext.txt	159	2 shows results iodide efflux experiments
0.44555384.15039462.html.plaintext.txt	160	control cho cftr cells cftr activity stimulated 2
0.44555384.15039462.html.plaintext.txt	161	5 microm 5 microm forskolin fig
0.44555384.15039462.html.plaintext.txt	162	2abd cftr channel activator mpb 91 fig
0.44555384.15039462.html.plaintext.txt	163	5 microm forskolin 5 microm forskolin 250 microm mpb 91 respectively
0.44555384.15039462.html.plaintext.txt	164	cho 2t cells corresponding peak rates reduced p 0
0.44555384.15039462.html.plaintext.txt	165	021 n8 respectively shown fig
0.44555384.15039462.html.plaintext.txt	166	results summarized fig
0.44555384.15039462.html.plaintext.txt	167	2d showed expression syntaxin 8 altered activation process cftr 100 plus minus 7
0.44555384.15039462.html.plaintext.txt	168	18 n8 100 plus minus 13
0.44555384.15039462.html.plaintext.txt	169	64 n8 respectively expressed percentage cftr maximal activity
0.44555384.15039462.html.plaintext.txt	170	view larger version 25k fig
0.44555384.15039462.html.plaintext.txt	171	analysis iodide efflux assay cftr chloride channel activity presence syntaxin 8
0.44555384.15039462.html.plaintext.txt	172	c iodide effluxes measured using cho cftr cells cftr syn8 transfected cho 2t cells
0.44555384.15039462.html.plaintext.txt	173	5 microm forskolin 5 microm forskolin b 250 microm mpb 91 c interval time indicated bar top panel
0.44555384.15039462.html.plaintext.txt	174	d summary data collected 8 16 different experiments using cho cftr cells empty columns cho 2t cells filled columns
0.44555384.15039462.html.plaintext.txt	175	data expressed percentage maximal activity presence corresponding agent cho cftr cells
0.44555384.15039462.html.plaintext.txt	176	determine whether cytosolic domain 90 entire protein syntaxin 8 could modulate cftr channel activity used soluble form protein deleted transmembrane domain noted syn8tm
0.44555384.15039462.html.plaintext.txt	177	cho cftr cells transfected appropriate vector described
0.44555384.15039462.html.plaintext.txt	178	one clone isolated characterized immunofluorescence
0.44555384.15039462.html.plaintext.txt	179	clone exhibited diffuse cytosolic nuclear staining fig
0.44555384.15039462.html.plaintext.txt	180	3ab representative syn8tm overexpression pattern observed noncloned cells data shown
0.44555384.15039462.html.plaintext.txt	181	staining clearly distinct endogenous syntaxin 8 expression profile presented organized vesicular like structure cho cftr cells fig
0.44555384.15039462.html.plaintext.txt	182	iodide efflux experiments fig
0.44555384.15039462.html.plaintext.txt	183	3b using 5 microm forskolin 250 microm mpb 91 stimulations activated cftr channel significant difference control cho cftr 100 plus minus 8
0.44555384.15039462.html.plaintext.txt	184	027 n4 100 plus minus 11
0.44555384.15039462.html.plaintext.txt	185	67 n4 respectively expressed percentage cftr maximal activity syn8tm expressing cloned cells 95
0.44555384.15039462.html.plaintext.txt	186	5 n4 respectively expressed percentage cftr activity
0.44555384.15039462.html.plaintext.txt	187	similar results obtained noncloned cho cftr cells overexpressing syn8tm data shown
0.44555384.15039462.html.plaintext.txt	188	view larger version 43k fig
0.44555384.15039462.html.plaintext.txt	189	analysis cftr channel activity presence different syntaxins
0.44555384.15039462.html.plaintext.txt	190	expression profile analysis different syntaxins nt plasmid transfection cho cftr cells syn8tm syn1a syn3
0.44555384.15039462.html.plaintext.txt	191	b summary data collected four independent iodide efflux experiments using cho cftr cells empty columns chocftrsyn8tm clone filled columns
0.44555384.15039462.html.plaintext.txt	192	c summary data obtained 12 16 independent iodide efflux experiments using cho cftr cho cftrsyn3 cho cftrsyn1a stimulated 5 microm forskolin
0.44555384.15039462.html.plaintext.txt	193	data expressed percentage cftr maximal activity
0.44555384.15039462.html.plaintext.txt	194	stage agreed cftr inhibition due overexpression snare proteins
0.44555384.15039462.html.plaintext.txt	195	syntaxin 3 unlike syntaxin 1a known physically interact cftr naren et al
0.44555384.15039462.html.plaintext.txt	196	assayed cftr channel modulation overexpression syntaxins cho cftr model
0.44555384.15039462.html.plaintext.txt	197	stably transfected cells characterized fluorescent immunostaining fig
0.44555384.15039462.html.plaintext.txt	198	noticed syntaxin 1a well syntaxin 3 antibodies unable detect endogenous proteins fig
0.44555384.15039462.html.plaintext.txt	199	expected cells overexpressing syntaxin 1a syntaxin 3 presented plasma membrane localization fig
0.44555384.15039462.html.plaintext.txt	200	3adf proteins predominant perinuclear staining observed case syntaxin 1a fig
0.44555384.15039462.html.plaintext.txt	201	case 40 cells exhibited high level expression data shown
0.44555384.15039462.html.plaintext.txt	202	measured cftr response iodide efflux experiments 5 microm forskolin stimulation found significant difference control syn3 transfected cho cftr cells whereas syntaxin 1a overexpression induced 40 inhibition cftr channel activity 100 plus minus 3
0.44555384.15039462.html.plaintext.txt	203	63 n12 respectively expressed percentage cftr maximal activity fig
0.44555384.15039462.html.plaintext.txt	204	confirm iodide efflux results performed whole cell patch clamp recordings compared properties cftr chloride currents presence absence syntaxin 8
0.44555384.15039462.html.plaintext.txt	205	control cho cftr cells activity cftr cl current stimulated 5 microm forskolin current measured 60 mv 25
0.44555384.15039462.html.plaintext.txt	206	expression syntaxin 8 cho 2t cells resulted dramatic reduction cftr chloride current current density measured 60 mv 4
0.44555384.15039462.html.plaintext.txt	207	77 papf n7 concentration fig
0.44555384.15039462.html.plaintext.txt	208	4b d 5 microm 10 microm forskolin respectively
0.44555384.15039462.html.plaintext.txt	209	observations confirmed flux study showed chloride channel activity cftr strongly affected syntaxin 8
0.44555384.15039462.html.plaintext.txt	210	view larger version 22k fig
0.44555384.15039462.html.plaintext.txt	211	analysis patch clamp assay cftr chloride channel activity presence syntaxin 8
0.44555384.15039462.html.plaintext.txt	212	typical whole cell currents recorded cho cftr cell syn8 cftr transfected cho 2t cell b absence presence 5 microm forskolin bath
0.44555384.15039462.html.plaintext.txt	213	cells capacitances 30 ps 27 ps b respectively
0.44555384.15039462.html.plaintext.txt	214	c averaged current voltage relationships 12 cho cftr cells seven cho 2t cells presence 5 microm forskolin
0.44555384.15039462.html.plaintext.txt	215	d histograms showing current densities measured 60 mv different experimental conditions indicated bottom column
0.44555384.15039462.html.plaintext.txt	216	number experiments indicated graph
0.44555384.15039462.html.plaintext.txt	217	gfp tagged cftr trafficking impaired syntaxin 8 overexpression cos 7 cells understand syntaxin 8 overexpression induces inhibition cftr chloride current investigated impact syntaxin 8 cytosoluble syntaxin 8 expression cellular distribution gfp tagged cftr cos 7 cells
0.44555384.15039462.html.plaintext.txt	218	gfp cftr known functional gfp tag affect trafficking localization moyer et al
0.44555384.15039462.html.plaintext.txt	219	moreover observed cos 7 cells two cystic fibrosis widespread mutants gfp f508delcftr gfp g551dcftr exhibited pharmacological response trafficking consistent physiological data data shown
0.44555384.15039462.html.plaintext.txt	220	immunofluorescence study showed cases endogenous overexpressed syntaxin 8 concentrated structure close nuclear envelope cytoplasm punctuated staining indicated presence syntaxin 8 vesicle like structures
0.44555384.15039462.html.plaintext.txt	221	following experiments chosen photomultiplier sensitivity allowing us visualize overexpressed syntaxin 8 without fluorescence saturation
0.44555384.15039462.html.plaintext.txt	222	sensitivity endogenous syntaxin 8 detected
0.44555384.15039462.html.plaintext.txt	223	cells overexpressing gfp cftr exhibited strong plasma membrane staining weaker intracellular staining fig
0.44555384.15039462.html.plaintext.txt	224	cos 7 cells cotransfected syntaxin 8 gfp cftr observed strong decrease disappearance gfp cftr plasma membrane staining fig
0.44555384.15039462.html.plaintext.txt	225	gfp cftr appeared cytosolic punctuated pattern shown fig
0.44555384.15039462.html.plaintext.txt	226	5b observation different z positions
0.44555384.15039462.html.plaintext.txt	227	moreover cotransfection empty pcdna3
0.44555384.15039462.html.plaintext.txt	228	1zeo vector affect gfp cftr localization plasma membrane data shown
0.44555384.15039462.html.plaintext.txt	229	view larger version 144k fig
0.44555384.15039462.html.plaintext.txt	230	impact syntaxin 8 overexpression gfp cftr cellular localization cos 7 cells
0.44555384.15039462.html.plaintext.txt	231	c thick optical sections acquired 2 0
0.44555384.15039462.html.plaintext.txt	232	8 microm steps top bottom
0.44555384.15039462.html.plaintext.txt	233	d f projections entire z series
0.44555384.15039462.html.plaintext.txt	234	cells transfected gfp cftr alone ad cotransfected gfp cftr syn8 cotransfected gfp cftr cytosoluble form syntaxin 8 syn8tm cf
0.44555384.15039462.html.plaintext.txt	235	green fluorescence resulting gfp cftr expression shows strong continuous localization gfp cftr concentrated plasma membrane control cells ad
0.44555384.15039462.html.plaintext.txt	236	doubly transfected cells overexpression syn8 revealed red fluorescence associated strong reduction gfp cftr plasma membrane localization partial colocalization visualized juxtanuclear region revealed yellow fluorescence
0.44555384.15039462.html.plaintext.txt	237	contrast experiments using syn8tm exhibit large cytosolic staining syntaxin 8 soluble form plasma membrane staining gfp cftr cf
0.44555384.15039462.html.plaintext.txt	238	g control experiments studying ncx2 localization wild type syn8 transfected cos 7 cells
0.44555384.15039462.html.plaintext.txt	239	arrowheads indicate plasma membrane localization ncx2 cases
0.44555384.15039462.html.plaintext.txt	240	image representative six independent experiments
0.44555384.15039462.html.plaintext.txt	241	control experiments using syn8tm exhibited large cytosolic staining clearly differed wild type syntaxin 8 immunostaining pattern
0.44555384.15039462.html.plaintext.txt	242	cells overexpressing syn8tm presented plasma membrane staining gfp cftr focal planes fig
0.44555384.15039462.html.plaintext.txt	243	5c projection xy sections fig
0.44555384.15039462.html.plaintext.txt	244	5f intensity level comparable gfp cftr overexpressing cells
0.44555384.15039462.html.plaintext.txt	245	result evidenced double transfection affect expression level exogenous proteins syn8tm gfp cftr compared cells transfected one cdnas
0.44555384.15039462.html.plaintext.txt	246	thus could discount possibility syntaxin 8 inhibitory effect cftr trafficking simply due excess protein biosynthesis cell
0.44555384.15039462.html.plaintext.txt	247	cells overexpressing wild type syntaxin 8 exhibited colocalization gfp cftr juxtanuclear region fig
0.44555384.15039462.html.plaintext.txt	248	however accumulation gfp cftr syntaxin 8 region seem linked coexpression proteins gfp cftr syntaxin 8 alone also strong staining organelle near nucleus
0.44555384.15039462.html.plaintext.txt	249	cytoplasm syntaxin 8 often appeared dot like structures corresponding presumably endosomelysosome structures whereas gfp cftr appeared homogenous entire cytosol
0.44555384.15039462.html.plaintext.txt	250	apart juxtanuclear organelles wild type syntaxin 8 gfp cftr seem colocalized distal part cytosol
0.44555384.15039462.html.plaintext.txt	251	contrast syn8tm immunostaining pattern colocalized gfp cftr juxtanuclear area also large part cytosol
0.44555384.15039462.html.plaintext.txt	252	colocalization two proteins also observed plasma membrane several focal planes fig
0.44555384.15039462.html.plaintext.txt	253	view larger version 71k fig
0.44555384.15039462.html.plaintext.txt	254	syntaxin 8 must anchored membrane inhibit gfp cftr plasma membrane localization
0.44555384.15039462.html.plaintext.txt	255	compared intracellular localization proteins cos 7 cells cotransfected gfp cftr syn8 gfp cftr syn8tm b
0.44555384.15039462.html.plaintext.txt	256	overexpressed aa syntaxin 8 shows predominantly perinuclear staining also appears cytoplasm punctuated pattern
0.44555384.15039462.html.plaintext.txt	257	gfp cftr presents plasma membrane localization ab accumulated colocalizes syntaxin 8 perinuclear region arrows
0.44555384.15039462.html.plaintext.txt	258	b soluble syntaxin 8 syn8tm displays continuous staining within cell predominantly accumulated compartments gfp cftr present notably plasma membrane
0.44555384.15039462.html.plaintext.txt	259	results showed overexpressing wild type syntaxin 8 anchored vesicle membrane disturbed cftr trafficking whereas cytosoluble syntaxin 8 little effect cftr plasma membrane localization
0.44555384.15039462.html.plaintext.txt	260	control analyzed distribution plasma membrane naca2 exchanger isoform ncx2 li et al
0.44555384.15039462.html.plaintext.txt	261	1994 known interact snare proteins
0.44555384.15039462.html.plaintext.txt	262	expected surface localization ncx2 cos 7 cells affected syntaxin 8 overexpression fig
0.44555384.15039462.html.plaintext.txt	263	gfp cftr syntaxin 8 colocalize accumulated recycling endosomes re cos 7 transfected cells identify subcellular compartments gfp cftr syntaxin 8 colocalize performed immunofluorescence studies three well characterized markers endosomal lysosomal compartments wild type doubly transfected cos 7 cells
0.44555384.15039462.html.plaintext.txt	264	expected cells overexpressing gfp cftr syntaxin 8 exhibited strong staining proteins juxtanuclear area compartment two proteins highly colocalize fig
0.44555384.15039462.html.plaintext.txt	265	fluorogram showed syntaxin 8 cftr fluorescent plots placed bisector line fig
0.44555384.15039462.html.plaintext.txt	266	indicated high degree colocalization proteins
0.44555384.15039462.html.plaintext.txt	267	immunostaining experiment highest intensity merged fluorescence corresponded juxtanuclear region data shown
0.44555384.15039462.html.plaintext.txt	268	syntaxin 8 immunostaining whether using rabbit polyclonal antibody fig
0.44555384.15039462.html.plaintext.txt	269	7aaba mouse monoclonal antibody fig
0.44555384.15039462.html.plaintext.txt	270	7ca gave classical tubularvesicular like pattern
0.44555384.15039462.html.plaintext.txt	271	gfp cftr described localized plasma membrane punctuated tubular like structures cytosol strong signal seen juxtanuclear area fig
0.44555384.15039462.html.plaintext.txt	272	lamp 1 lelysosomal marker staining observed strong vesicular perinuclear pattern fig
0.44555384.15039462.html.plaintext.txt	273	7ac distribution colocalize syn8 gfp cftr cellular staining fig
0.44555384.15039462.html.plaintext.txt	274	data confirmed fluorograms showing lamp 1 fluorescence distribution clearly separated cftr syn8 fluorescences fig
0.44555384.15039462.html.plaintext.txt	275	contrast tfr immunostaining endocytosis recycling pathway revealed dot like vesicular pattern extensive cytosol lamp 1 staining fig
0.44555384.15039462.html.plaintext.txt	276	intracellular distribution tfr cftr one hand noted tfrcftr tfr syn8 hand noted tfrsyn8 mostly distinct compartments within cell fig
0.44555384.15039462.html.plaintext.txt	277	results supported data fluorograms showed two distinct fluorescences case
0.44555384.15039462.html.plaintext.txt	278	several plots high intensity overlapping fluorescence suggested colocalization tfr cftr one hand tfr syn8 vesicular structures near nucleus fig
0.44555384.15039462.html.plaintext.txt	279	compared tfrcftr tfrsyn8 vesicular pattern region insert observed many similarities suggesting tfr cftr syn8 present vesicles
0.44555384.15039462.html.plaintext.txt	280	juxtanuclear colocalization cftr syn8 partially matched tfr localization could identify vesicles recycling post golgi endosomes
0.44555384.15039462.html.plaintext.txt	281	test hypothesis used rabbit polyclonal antibody rab11 protein found associated trans golgi network tgn membranes post golgi vesicles recycling endosomes urbe et al
0.44555384.15039462.html.plaintext.txt	282	cos 7 cells endogenous rab11 displayed punctuated vesicular pattern scattered throughout cytoplasm seemed accumulate tubulo vesicular structure near nucleus fig
0.44555384.15039462.html.plaintext.txt	283	wild type cells partial colocalization found rab11 tfr stainings fig
0.44555384.15039462.html.plaintext.txt	284	7db overlap detected rab11 lamp 1 stainings fig
0.44555384.15039462.html.plaintext.txt	285	finally cos 7 cells transfected gfp cftr syn8 rab11 immunostaining profile matched exactly cftr syn8 stainings fig
0.44555384.15039462.html.plaintext.txt	286	results sustained fluorogram data showing rab11syn8 rab11cftr fluorescent plots bisector line fig
0.44555384.15039462.html.plaintext.txt	287	clearly showed proteins localization
0.44555384.15039462.html.plaintext.txt	288	conclusion syntaxin 8 inhibits cftr trafficking cos 7 transfected cells cftr appears restricted compartment including least recycling endosomes possibly post golgi vesicles
0.44555384.15039462.html.plaintext.txt	289	view larger version 63k fig
0.44555384.15039462.html.plaintext.txt	290	gfp cftr syntaxin 8 colocalize least recycling endosome complexes doubly transfected cos 7 cells
0.44555384.15039462.html.plaintext.txt	291	experiment except d cos 7 cells cotransfected gfp cftr syn8 costained anti syntaxin 8 antibody anti lamp 1 anti tfr b anti rab11 c antibodies
0.44555384.15039462.html.plaintext.txt	292	cell images present projection entire z series sections acquired fluorescent confocal microscopy
0.44555384.15039462.html.plaintext.txt	293	fluorograms obtained described materials methods
0.44555384.15039462.html.plaintext.txt	294	experiment protein colocalizations analyzed three fluorograms
0.44555384.15039462.html.plaintext.txt	295	syntaxin 8 c gfp cftr b c exhibit perinuclear staining expected
0.44555384.15039462.html.plaintext.txt	296	two proteins colocalize perinuclear region shown merged images d c fluorograms e c
0.44555384.15039462.html.plaintext.txt	297	lamp 1 immunostaining pattern ac exhibits colocalization gfp cftr syntaxin 8 merged image ad fluorograms afg whereas immunostaining profile obtained tfr bc presents partial colocalization merged picture bd fluorograms bfg
0.44555384.15039462.html.plaintext.txt	298	analyze colocalization compartments selected plots high fluorescence intensity placed fluorogram bisector line square bfg generate images showing colocalization patterns cftr tfr bf syn8 tfr bg
0.44555384.15039462.html.plaintext.txt	299	vesicular pattern obtained case similar shows colocalization three proteins within vesicles
0.44555384.15039462.html.plaintext.txt	300	contrast rab11 immunostaining cc closely matches perinuclear region cftr syntaxin 8 stainings cd
0.44555384.15039462.html.plaintext.txt	301	high degree colocalization sustained fluorogram data cfg displaying rab11cftr rab11syn8 fluorescent plots placed bisector line
0.44555384.15039462.html.plaintext.txt	302	control studied endogenous localization rab11 lamp 1 rab11 tfr wild type cos 7 cells
0.44555384.15039462.html.plaintext.txt	303	expected overlap found lamp 1 rab11 stainings da whereas partial colocalization observed perinuclear region rab11 tfr db
0.44555384.15039462.html.plaintext.txt	304	analysis representative three independent experiments
0.44555384.15039462.html.plaintext.txt	305	syntaxin 8 physically interacts cftr test physical interaction syntaxin 8 cftr performed immunoprecipitation experiments cho 2t ht29 cl19a cell lines expressing syntaxin 8 cftr
0.44555384.15039462.html.plaintext.txt	306	using lysates cell lines purified syntaxin 8 cftr complexes using monoclonal syntaxin 8 cftr antibodies respectively
0.44555384.15039462.html.plaintext.txt	307	expected syntaxin 8 cftr immunoprecipitated high efficiency fig
0.44555384.15039462.html.plaintext.txt	308	syntaxin 8 complexes anti cftr western blot revealed presence mature band c immature band b forms cftr cell line fig
0.44555384.15039462.html.plaintext.txt	309	reversibly cftr complexes anti syntaxin 8 western blot revealed significant amount protein fig
0.44555384.15039462.html.plaintext.txt	310	notably existence interaction untransfected ht29 cl19a cells suggests physiological relevance result
0.44555384.15039462.html.plaintext.txt	311	view larger version 39k fig
0.44555384.15039462.html.plaintext.txt	312	cftr syntaxin 8 belong protein complex
0.44555384.15039462.html.plaintext.txt	313	co immunoprecipitation cftr syn8 cho 2t ht29 cl19a cell lysates
0.44555384.15039462.html.plaintext.txt	314	immunoprecipitated proteins revealed western blot antibodies cftr
0.44555384.15039462.html.plaintext.txt	315	bands b c represent immature mature forms cftr respectively
0.44555384.15039462.html.plaintext.txt	316	cftr antibody nonimmune mouse igg used positive negative immunoprecipitation controls respectively
0.44555384.15039462.html.plaintext.txt	317	b co immunoprecipitation syn8 cftr cho 2t ht29 cl19a cell lysates
0.44555384.15039462.html.plaintext.txt	318	immunoprecipitated proteins revealed western blot antibodies syn8
0.44555384.15039462.html.plaintext.txt	319	cho 2t ht29 cells lysates used positive control western blot
0.44555384.15039462.html.plaintext.txt	320	syn 8 antibody nonimmune mouse igg used positive negative immunoprecipitation controls respectively
0.44555384.15039462.html.plaintext.txt	321	also investigated interaction cftr syntaxin 8 vitro affinity binding assay using four recombinant gst fusion proteins positive control cytosolic domain syntaxin 1a syn1atm cytosolic domain syntaxin 8 syn8tm two truncated domains syntaxin 8 syn81 99 syn899 209
0.44555384.15039462.html.plaintext.txt	322	recombinant gst protein used negative control
0.44555384.15039462.html.plaintext.txt	323	bead bound recombinant proteins incubated cos 7gfp cftr cell lysate retained proteins analyzed western blot using anti gfp antibody fig
0.44555384.15039462.html.plaintext.txt	324	cos 7gfp cftr cell lysate used gfp cftr control
0.44555384.15039462.html.plaintext.txt	325	n terminal tagging cftr gfp affect vitro binding syntaxin 1a shown interact n terminus cftr naren et al
0.44555384.15039462.html.plaintext.txt	326	gfp cftr pulled syntaxin 8 either full length cytosolic domain syntaxin 8 truncated domain predominantly n terminal half upstream snare domain
0.44555384.15039462.html.plaintext.txt	327	however interaction far weaker compared gfp cftr binding syntaxin 1a
0.44555384.15039462.html.plaintext.txt	328	nevertheless results significant cftr retained gst alone
0.44555384.15039462.html.plaintext.txt	329	pull experiments revealed weak physical interaction syntaxin 8 cftr hypothesized intermediary proteins could involved cftrsyntaxin 8 complexes
0.44555384.15039462.html.plaintext.txt	330	best candidates components endosomal snare complex vamp8 vti1b syntaxin 7
0.44555384.15039462.html.plaintext.txt	331	similarly produced recombinant snare proteins test interaction cftr
0.44555384.15039462.html.plaintext.txt	332	gfp cftr pulled either vamp8 vti1b syntaxin 7 fig
0.44555384.15039462.html.plaintext.txt	333	data suggested endosomal snare proteins vamp8 vti1b bound cftr vitro comparable efficiency syntaxin 1a fig
0.44555384.15039462.html.plaintext.txt	334	view larger version 48k fig
0.44555384.15039462.html.plaintext.txt	335	vitro interactions cftr endosomal snare proteins
0.44555384.15039462.html.plaintext.txt	336	vitro binding gfp cftr different recombinant cytosolic domains syntaxin 8 gst syn8tm gst syn81 99 gst syn899 209
0.44555384.15039462.html.plaintext.txt	337	b vitro binding gfp cftr different recombinant endosomal snare proteins gst syn7tm gst vamp8tm gst vti1btm
0.44555384.15039462.html.plaintext.txt	338	ab glutathione sepharose immobilized gst gst fusion proteins incubated cos 7gfp cftr cell extracts
0.44555384.15039462.html.plaintext.txt	339	bound proteins studied anti gfp immunoblot
0.44555384.15039462.html.plaintext.txt	340	cos 7gfp cftr lysate used gfp cftr control gst syn1atm gst alone used respectively positive negative pull controls
0.44555384.15039462.html.plaintext.txt	341	discussion top summary introduction materials methods results discussion references previously described molecular cloning human syntaxin 8 cdna two hybrid system using r domain cftr bait screen human fetal lung cdna library thoreau et al
0.44555384.15039462.html.plaintext.txt	342	present report establish functional relevance interaction two proteins
0.44555384.15039462.html.plaintext.txt	343	regulation cftr channel activity syntaxin 8 observed syntaxin 8 overexpression responsible strong inhibition cftr channel activated either camp pathway forskolin stimulation camp independent pathway cftr activator mpb 91 derand et al
0.44555384.15039462.html.plaintext.txt	344	regulation ionic channels snare proteins already described
0.44555384.15039462.html.plaintext.txt	345	example physical interactions assessed syntaxin 1a pq type calcium channels n type calcium channels bezprozvanny et al
0.44555384.15039462.html.plaintext.txt	346	2000 amiloride sensitive epithelial sodium channels saxena et al
0.44555384.15039462.html.plaintext.txt	347	interestingly syntaxin 1a inhibits cftr chloride current direct protein protein interaction snare homology domain syntaxin 1a n terminal cytoplasmic tail cftr naren et al
0.44555384.15039462.html.plaintext.txt	348	another study peters et al
0.44555384.15039462.html.plaintext.txt	349	1999 camp induced delivery plasma membrane cftr present peripheral vesicles inhibited syntaxin 1a xenopus oocytes
0.44555384.15039462.html.plaintext.txt	350	case syntaxin 1a electrophysiological data indeed showed inhibition cftr activity due syntaxin 8 overexpression
0.44555384.15039462.html.plaintext.txt	351	regulation protein specific performed experiment syntaxin 3 snare protein bind cftr obtained normal cftr activation
0.44555384.15039462.html.plaintext.txt	352	moreover cftr modulation required syntaxin 8 anchored membrane showed soluble form effect cftr activity
0.44555384.15039462.html.plaintext.txt	353	thus cftr may directly regulated protein protein interaction alternatively syntaxin 8 overexpression may disturb vesicular transport machinery
0.44555384.15039462.html.plaintext.txt	354	could affect cftr recycling cellular targeting towards plasma membrane consequently inhibit chloride channel activity measured cell level
0.44555384.15039462.html.plaintext.txt	355	physical interactions syntaxin 8 cftr shown direct protein protein interaction given cftr pulled using immobilized gst syntaxin 8 recombinant proteins
0.44555384.15039462.html.plaintext.txt	356	moreover cftr syntaxin 8 could co immunoprecipitated cho 2t ht29 cl19a cell extracts
0.44555384.15039462.html.plaintext.txt	357	data suggest syntaxin 8 interacts cftr either directly component cftr containing complex
0.44555384.15039462.html.plaintext.txt	358	however interaction different one observed syntaxin 1a cftr
0.44555384.15039462.html.plaintext.txt	359	recombinant gst syntaxin 1a binds cftr high affinity naren et al
0.44555384.15039462.html.plaintext.txt	360	1997 whereas interaction syntaxin 8 cftr appears weaker
0.44555384.15039462.html.plaintext.txt	361	moreover unlike syntaxin 1a snare domain interacts cftr moiety syntaxin 8 binds cftr
0.44555384.15039462.html.plaintext.txt	362	despite fact necessary test vitro binding different domains cftr syntaxin 8 ascertain direct physical interaction immunoprecipitation results confirm syntaxin 8 cftr part complex
0.44555384.15039462.html.plaintext.txt	363	precipitated proteins efficiency cho transfected cells ht29 cl19a cells endogenously expressing cftr syntaxin 8 conclude interaction induced solely overexpression
0.44555384.15039462.html.plaintext.txt	364	affinity syntaxin 8 cftr weak syntaxin 8 may major partner cftr
0.44555384.15039462.html.plaintext.txt	365	tierce proteins may necessary establish protein complex containing syntaxin 8 cftr
0.44555384.15039462.html.plaintext.txt	366	hypothesis consistent pull immunoprecipitation experiments could explain small amount cftr retained gst syntaxin 8
0.44555384.15039462.html.plaintext.txt	367	possible candidates partner different components heterotetrameric endosomal snare core complex vti1b syntaxin 7 vamp8 antonin et al
0.44555384.15039462.html.plaintext.txt	368	pull experiments suggest vamp8 vti1b strongly directly interact cftr could partner proteins involved cftrsyntaxin 8 multimeric protein complex
0.44555384.15039462.html.plaintext.txt	369	result strengthens idea entire snare complex could regulate ion channel deliveryinsertion retrieval recycling plasma membrane
0.44555384.15039462.html.plaintext.txt	370	syntaxin 8 involved cftr trafficking syntaxin 8 physical binding functional regulation cftr prompted us investigate cellular level effect syntaxin 8 overexpression cftr localization
0.44555384.15039462.html.plaintext.txt	371	gfp fluorescence analysis cos 7gfp cftr cells showed strong plasma membrane staining characteristic mature cftr cellular localization
0.44555384.15039462.html.plaintext.txt	372	however syntaxin 8 cotransfected gfp cftr dramatic decrease disappearance cftr plasma membrane staining observed proteins colocalized perinuclear region
0.44555384.15039462.html.plaintext.txt	373	syntaxin 8 impact cftr trafficking apply channel overexpressed syntaxin 8 plasma membrane localization endogenous naca2 exchanger affected
0.44555384.15039462.html.plaintext.txt	374	moreover coexpression gfp cftr syn8tm cytosoluble form syntaxin 8 depleted transmembrane domain led normal trafficking gfp cftr plasma membrane
0.44555384.15039462.html.plaintext.txt	375	furthermore plasma membrane colocalization syn8tm gfp cftr observed interestingly syn8tm seen plasma membrane cftr present
0.44555384.15039462.html.plaintext.txt	376	generally syn8tm located mainly cellular structures gfp cftr abundant
0.44555384.15039462.html.plaintext.txt	377	syntaxin 8 soluble may physically bind cftr follow trafficking syntaxin 8 anchored vesicle membrane binds cftr cellular compartment syntaxin 8 assumes function
0.44555384.15039462.html.plaintext.txt	378	syn8tm little effect cftr trafficking inhibition cftr trafficking syntaxin 8 overexpression could related excess protein synthesis endoplasmic reticulum
0.44555384.15039462.html.plaintext.txt	379	moreover syntaxin 8 must anchored vesicle membranes impair cftr trafficking means snare function syntaxin 8 engaged
0.44555384.15039462.html.plaintext.txt	380	results reinforce physiological relevance putative regulator role syntaxin 8 cftr channel activity
0.44555384.15039462.html.plaintext.txt	381	syntaxin 8 involved cftr recycling pathway precise identification colocalization region cftr syntaxin 8 determined using fluorescent confocal microscopy three well characterized antibodies lamp 1 lelysosomal marker protein tfr transferrin receptor eere marker protein rab11 stains re tgn membranes
0.44555384.15039462.html.plaintext.txt	382	results exhibited colocalization lamp 1 staining juxtanuclear compartment cftr syntaxin 8 accumulated
0.44555384.15039462.html.plaintext.txt	383	tfr vesicular pattern partially matched region cftr syntaxin 8 tfr seemed located together thin perinuclear vesicles
0.44555384.15039462.html.plaintext.txt	384	contrast rab11 staining highly similar syntaxin 8 cftr juxtanuclear staining observed high degree colocalization fluorograms merged image
0.44555384.15039462.html.plaintext.txt	385	results indicate syntaxin 8 overexpressed gfp cftr proteins mainly localized compartment could identified recycling endosomes andor tgn membranes
0.44555384.15039462.html.plaintext.txt	386	colocalized cftr syntaxin 8 tfr rab11 proteins favour recycling endosome hypothesis
0.44555384.15039462.html.plaintext.txt	387	syntaxin 8 snare protein belongs least endosomal snare complex antonin et al
0.44555384.15039462.html.plaintext.txt	388	2000 consequently involved endosomal pathway like syntaxins 7 11 1213 prekeris et al
0.44555384.15039462.html.plaintext.txt	389	cellular localization determined mainly early endosome syntaxin 8 also detected late endosome lysosome organelles
0.44555384.15039462.html.plaintext.txt	390	early endosome dynamic compartment displaying highly complex pleiomorphic organization contains clearly two functionally distinct subcompartments without real physical boundaries plasma membrane proteins recycled via recycling endosomes degraded via endosomal carrier vesiclesmultivesicular bodies degradation pathway reviewed gruenberg 2001
0.44555384.15039462.html.plaintext.txt	391	cases syntaxin 8 also observed plasma membrane subramaniam et al
0.44555384.15039462.html.plaintext.txt	392	2000 kasai akagawa 2001 suggesting vesicular cycling syntaxin 8
0.44555384.15039462.html.plaintext.txt	393	mechanism cftr recycling still poorly understood cftr previously detected recycling endosomes using fluorescence microscopy human bronchial epithelial cells poschet et al
0.44555384.15039462.html.plaintext.txt	394	thus physical binding cftr syntaxin 8 may occur recycling endosomes cellular compartment required cftr recycling pathway syntaxin 8 probably assembled snare proteins
0.44555384.15039462.html.plaintext.txt	395	endosomal snare complex implicated vesicular trafficking function
0.44555384.15039462.html.plaintext.txt	396	syntaxin 8 overexpression likely disrupt vesicular transport step involved previously observed several snare proteins dascher balch 1996 low et al
0.44555384.15039462.html.plaintext.txt	397	could explain cftr accumulation recycling endosomes experiments
0.44555384.15039462.html.plaintext.txt	398	results show syntaxin 8 appears important regulatory protein directly implicated cftr recycling pathway
0.44555384.15039462.html.plaintext.txt	399	conclusion snare proteins particularly syntaxin 8 participate actively cftr trafficking recycling andor direct regulation cftr activity
0.44555384.15039462.html.plaintext.txt	400	describe relationship cftr syntaxin 8 recycling endosome
0.44555384.15039462.html.plaintext.txt	401	recent paper showed cystic fibrosis cells dysfunction recycling endosome pathway may many repercussions endocytic plasma membrane processes poschet et al
0.44555384.15039462.html.plaintext.txt	402	elucidating recycling pathway cftr could important understanding physiopathology cystic fibrosis
0.44555384.15039462.html.plaintext.txt	403	acknowledgments thank following people gift reagents j
0.44555384.15039462.html.plaintext.txt	404	stanton gfp cftr construct
0.44555384.15039462.html.plaintext.txt	405	naren gst syn1atm construct w
0.44555384.15039462.html.plaintext.txt	406	von mollard endosomal snare constructs y
0.44555384.15039462.html.plaintext.txt	407	salamero rab11 antibody helpful discussions
0.44555384.15039462.html.plaintext.txt	408	work supported vaincre la mucoviscidose region poitou charentes
0.44555384.15039462.html.plaintext.txt	409	footnotes authors contributed equally work
0.44555384.15039462.html.plaintext.txt	410	references top summary introduction materials methods results discussion references
0.44555384.15039462.html.plaintext.txt	411	snare complex mediating fusion late endosomes defines conserved properties snare structure function
0.44555384.15039462.html.plaintext.txt	412	crystal structure endosomal snare complex reveals common structural principles snares
0.44555384.15039462.html.plaintext.txt	413	functional impact syntaxin gating n type q type calcium channels
0.44555384.15039462.html.plaintext.txt	414	snare mediated membrane fusion
0.44555384.15039462.html.plaintext.txt	415	golgi associated pdz domain protein modulates cystic fibrosis transmembrane conductance regulator plasma membrane expression
0.44555384.15039462.html.plaintext.txt	416	cftr chloride channels regulated snap 23syntaxin 1a complex
0.44555384.15039462.html.plaintext.txt	417	mammalian sly1 regulates syntaxin 5 function endoplasmic reticulum golgi transport
0.44555384.15039462.html.plaintext.txt	418	human syntaxin 3 localized apically human intestinal cells
0.44555384.15039462.html.plaintext.txt	419	activation g551d cftr channel mpb 91 regulation atpase activity phosphorylation
0.44555384.15039462.html.plaintext.txt	420	correction delf508 cftr activity benzocquinolizinium compounds facilitation processing cystic fibrosis airway cells
0.44555384.15039462.html.plaintext.txt	421	cftr outward rectifying chloride channels distinct proteins regulatory relationship
0.44555384.15039462.html.plaintext.txt	422	endocytic pathway mosaic domains
0.44555384.15039462.html.plaintext.txt	423	g protein modulation n type calcium channels facilitated physical interactions syntaxin 1a gss
0.44555384.15039462.html.plaintext.txt	424	cytosolic termini ss enac subunits involved functional interactions cystic fibrosis transmembrane conductance regulator epithelial sodium channel
0.44555384.15039462.html.plaintext.txt	425	roles cytoplasmic transmembrane domains syntaxins intracellular localization trafficking
0.44555384.15039462.html.plaintext.txt	426	maturation head bacteriophage t4
0.44555384.15039462.html.plaintext.txt	427	cloning ncx2 isoform plasma membrane na ca2 exchanger
0.44555384.15039462.html.plaintext.txt	428	snare machinery involved apical plasma membrane trafficking mdck cells
0.44555384.15039462.html.plaintext.txt	429	membrane trafficking cystic fibrosis gene product cystic fibrosis transmembrane conductance regulator tagged green fluorescent protein madin darby canine kidney cells
0.44555384.15039462.html.plaintext.txt	430	syntaxin 7 localized late endosome compartments associates vamp8 required late endosome lysosome fusion
0.44555384.15039462.html.plaintext.txt	431	regulation cftr chloride channels syntaxin munc 18 isoforms
0.44555384.15039462.html.plaintext.txt	432	syntaxin 1a inhibits cftr chloride channels means domain specific protein protein interactions
0.44555384.15039462.html.plaintext.txt	433	syntaxin 1a expressed airway epithelial cells modulates cftr cl currents
0.44555384.15039462.html.plaintext.txt	434	regulation cystic fibrosis transmembrane conductance regulator cl channel r domain
0.44555384.15039462.html.plaintext.txt	435	syntaxin 1a inhibits regulated cftr trafficking xenopus oocytes
0.44555384.15039462.html.plaintext.txt	436	hyperacidification cellulobrevin endocytic compartments defective endosomal recycling cystic fibrosis respiratory epithelial cells
0.44555384.15039462.html.plaintext.txt	437	syntaxin 13 mediates cycling plasma membrane proteins via tubulovesicular recycling endosomes
0.44555384.15039462.html.plaintext.txt	438	differential roles syntaxin 7 syntaxin 8 endosomal trafficking
0.44555384.15039462.html.plaintext.txt	439	regulation cystic fibrosis transmembrane conductance regulator single channel gating bivalent pdz domain mediated interaction
0.44555384.15039462.html.plaintext.txt	440	identification cystic fibrosis gene cloning characterization complementary dna
0.44555384.15039462.html.plaintext.txt	441	identification cystic fibrosis gene chromosome walking jumping
0.44555384.15039462.html.plaintext.txt	442	interaction syntaxins amiloride sensitive epithelial sodium channel
0.44555384.15039462.html.plaintext.txt	443	calcium dependent interaction n type calcium channels synaptic core complex
0.44555384.15039462.html.plaintext.txt	444	apical pdz protein anchors cystic fibrosis transmembrane conductance regulator cytoskeleton
0.44555384.15039462.html.plaintext.txt	445	cftr camp dependent regulator sodium channels
0.44555384.15039462.html.plaintext.txt	446	preferential association syntaxin 8 early endosome
0.44555384.15039462.html.plaintext.txt	447	cftr cl channel cftr associated atp channel distinct pores regulated common gates
0.44555384.15039462.html.plaintext.txt	448	phosphorylation regulated cl channel cho cells stably expressing cystic fibrosis gene
0.44555384.15039462.html.plaintext.txt	449	syntaxin 12 member syntaxin family localized endosome
0.44555384.15039462.html.plaintext.txt	450	molecular cloning expression analysis chromosomal localization human syntaxin 8 stx8
0.44555384.15039462.html.plaintext.txt	451	rab11 regulates recycling pericentriolar recycling endosome
0.44555384.15039462.html.plaintext.txt	452	rab11 small gtpase associated constitutive regulated secretory pathways pc12 cells
0.44555384.15039462.html.plaintext.txt	453	syntaxin 11 associated snap 23 late endosomes trans golgi network
0.44555384.15039462.html.plaintext.txt	454	simple assay agonist regulated cl k conductances salt secreting epithelial cells
0.44555384.15039462.html.plaintext.txt	455	peptide binding consensus nhe rf pdz1 domain matches c terminal sequence cystic fibrosis transmembrane conductance regulator cftr
0.44555384.15039462.html.plaintext.txt	456	accessory protein facilitated cftr cftr interaction molecular mechanism potentiate chloride channel activity
0.44555384.15039462.html.plaintext.txt	457	conserved domain present different families vesicular fusion proteins new superfamily
0.44555384.15039462.html.plaintext.txt	458	carboxyl terminus cystic fibrosis transmembrane conductance regulator binds ap 2 clathrin adaptators
0.44555384.15039462.html.plaintext.txt	459	rab11 regulates compartmentalization early endosomes required efficient transport early endosomes trans golgi network
0.44555384.15039462.html.plaintext.txt	460	syntaxin 7 novel syntaxin member associated early endosomal compartments
0.563135.15003935.html.plaintext.txt	0	cystic fibrosis gene therapy lung inflammation better worse lisa m
0.563135.15003935.html.plaintext.txt	1	department physiology biophysics university alabama birmingham birmingham alabama 35294 0005
0.563135.15003935.html.plaintext.txt	2	study van heeckeren colleagues one current articles focus ref
0.563135.15003935.html.plaintext.txt	3	l717 issue addresses question whether adenoviral delivery cystic fibrosis transmembrane conductance regulator cftr cystic fibrosis airways attenuates inflammation mortality associated chronic bacterial infection
0.563135.15003935.html.plaintext.txt	4	intriguing question adenoviral vectors invoke substantial immune response prohibits repeated administration lung 2
0.563135.15003935.html.plaintext.txt	5	article van heeckeren coworkers report within infected cystic fibrosis lung cftr expression andor adenoviral vector induced inflammation yields significant survival advantage
0.563135.15003935.html.plaintext.txt	6	promising observation may profound implications utility adenoviral vectors gene therapy treatment cystic fibrosis
0.563135.15003935.html.plaintext.txt	7	cftr mutations cystic fibrosis lung pathophysiology
0.563135.15003935.html.plaintext.txt	8	cystic fibrosis common autosomal recessive disorder caucasian population frequency 1 2500 live births
0.563135.15003935.html.plaintext.txt	9	caused defective function cftr gene product 14 encodes 170 180 kda protein functions camp regulated chloride channel
0.563135.15003935.html.plaintext.txt	10	cftr protein expressed normally tissues affected cystic fibrosis including airway submucosal glands airway epithelial cells
0.563135.15003935.html.plaintext.txt	11	cystic fibrosis respiratory disease phenotype includes thick mucus secretion bacterial colonization lung select bacterial pathogens including pseudomonas aeruginosa 13
0.563135.15003935.html.plaintext.txt	12	aeruginosa infections compounded inability clear organism result profound neutrophil migration airways secretion variety inflammatory mediators including neutrophil elastase reactive oxygen species inflammatory cytokines cause irreversible damage airways gas exchange components
0.563135.15003935.html.plaintext.txt	13	cystic fibrosis adenoviral vector mediated gene therapy
0.563135.15003935.html.plaintext.txt	14	correction defective cftr gene vivo long holy grail cystic fibrosis research community
0.563135.15003935.html.plaintext.txt	15	use adenoviral vectors pursuit problematic reviewed ref
0.563135.15003935.html.plaintext.txt	16	early clinical trials administration adenoviral vectors encoding cftr demonstrated great promise transient correction chloride transport defects
0.563135.15003935.html.plaintext.txt	17	subsequent studies however failed repeat initial finding moreover revealed adenoviral vector mediated delivery cftr cystic fibrosis airways limited local immune response associated multiple vector administrations
0.563135.15003935.html.plaintext.txt	18	similarly van heeckeren colleagues 19 reported previously p
0.563135.15003935.html.plaintext.txt	19	aeruginosa induced bronchopulmonary inflammation also limited efficacy adenoviral vector mediated gene transfer
0.563135.15003935.html.plaintext.txt	20	despite limitation several studies suggest extent cftr correction required normal lung phenotype may quite low 2 thereby validating use adenoviral vectors cystic fibrosis gene therapy
0.563135.15003935.html.plaintext.txt	21	current study van heeckeren et al
0.563135.15003935.html.plaintext.txt	22	20 impact adenoviral vector mediated gene therapy examined context cystic fibrosis lung chronically infected bacteria 19
0.563135.15003935.html.plaintext.txt	23	ambitious study van heeckeren coworkers 20 authors determined whether cftr delivery improved outcome cystic fibrosis murine model infected p
0.563135.15003935.html.plaintext.txt	24	specifically authors reported gut corrected cystic fibrosis mice treated adenoviral vector encoding cftr inoculated p
0.563135.15003935.html.plaintext.txt	25	aeruginosa laden agarose beads exhibited significantly greater cumulative 10 day survival compared sucrose controls survival empty vector controls however significantly different
0.563135.15003935.html.plaintext.txt	26	importantly authors observed differences mice receiving cftr vector controls regard extent lung inflammation
0.563135.15003935.html.plaintext.txt	27	data authors concluded observed survival advantage mice receiving adenoviral delivery cftr cystic fibrosis lung may due cftr expression andor proinflammatory effects adenoviral vector
0.563135.15003935.html.plaintext.txt	28	adenoviral vector induced inflammation
0.563135.15003935.html.plaintext.txt	29	cumulative 10 day survival significantly different mice receiving cftr encoding vectors vs
0.563135.15003935.html.plaintext.txt	30	empty vector controls likely cftr expression plays small role response
0.563135.15003935.html.plaintext.txt	31	authors note 20 possible administration adenoviral vector may induced protective immune response improved cumulative survival
0.563135.15003935.html.plaintext.txt	32	support possibility authors observed persistent lung lymphocytosis response adenoviral vector administration response enhanced upon challenge p
0.563135.15003935.html.plaintext.txt	33	aeruginosa laden agarose beads
0.563135.15003935.html.plaintext.txt	34	interestingly authors observe increased bacterial killing mice treated either cftr encoding adenoviral vector empty vector control
0.563135.15003935.html.plaintext.txt	35	early studies markham coworkers 8 12 suggest cell mediated immune responses protective p
0.563135.15003935.html.plaintext.txt	36	example authors shown adoptive transfer cells mice immunized p
0.563135.15003935.html.plaintext.txt	37	aeruginosa granulocytopenic mice resulted nearly 100 survival upon challenge p
0.563135.15003935.html.plaintext.txt	38	similar findings reported others 3
0.563135.15003935.html.plaintext.txt	39	despite reports exact nature cell mediated immunity p
0.563135.15003935.html.plaintext.txt	40	aeruginosa infections remains unclear
0.563135.15003935.html.plaintext.txt	41	hoiby colleagues reported rat model p
0.563135.15003935.html.plaintext.txt	42	aeruginosa pnuemonia 4 cystic fibrosis patients 11 chronic p
0.563135.15003935.html.plaintext.txt	43	aeruginosa infection induces helper type 2 th2 like response
0.563135.15003935.html.plaintext.txt	44	th2 responses characterized production il 4 il 5 important generation humoral immunity
0.563135.15003935.html.plaintext.txt	45	results supported observation chronic p
0.563135.15003935.html.plaintext.txt	46	aeruginosa lung infection severe th2 responding mouse strain balbc 10
0.563135.15003935.html.plaintext.txt	47	regard protective cell immunity hoiby coworkers 4 5 9 demonstrated induction th1 dominated cytokine response improves outcome chronic p
0.563135.15003935.html.plaintext.txt	48	th1 responses characterized production ifn instrumental generation cell mediated immunity
0.563135.15003935.html.plaintext.txt	49	interestingly previous studies shown adenoviral vector administration trigger th1 response lungs mice 18 21 humans 1
0.563135.15003935.html.plaintext.txt	50	light findings tempting conclude improved cumulative survival observed van heeckeren study 20 function adenovirus induced th1 response however conclusion may simplistic
0.563135.15003935.html.plaintext.txt	51	several recent studies call question beneficial nature th1 response p
0.563135.15003935.html.plaintext.txt	52	reports examining role virulence factor alginate 17 quorum sensing molecule n 3 oxododecanoylhomoserine lactone 16 p
0.563135.15003935.html.plaintext.txt	53	aeruginosa pathogenicity indicate factors induces th1 predominated immune response may contribute p
0.563135.15003935.html.plaintext.txt	54	moreover schultz colleagues 15 reported recently rat model p
0.563135.15003935.html.plaintext.txt	55	aeruginosa pneumonia endogenous ifn impairs bacterial clearance host defense
0.563135.15003935.html.plaintext.txt	56	clearly differences strain p
0.563135.15003935.html.plaintext.txt	57	mucoid type infection acute vs
0.563135.15003935.html.plaintext.txt	58	chronic route administration model system analysis must taken account considering role th1th2 responses p
0.563135.15003935.html.plaintext.txt	59	despite ongoing debate cell responses p
0.563135.15003935.html.plaintext.txt	60	aeruginosa infections noted studies performed non cystic fibrosis model systems
0.563135.15003935.html.plaintext.txt	61	recent evidence indicates cell responses may dysregulated cystic fibrosis 6 7 studies need performed context cystic fibrosis lung
0.563135.15003935.html.plaintext.txt	62	underscored van heeckeren study 20 suggests adenoviral vector induced inflammation may promote survival cystic fibrosis mice chronic p
0.563135.15003935.html.plaintext.txt	63	well conceived studies study precipitates number unanswered questions
0.563135.15003935.html.plaintext.txt	64	example absence p
0.563135.15003935.html.plaintext.txt	65	aeruginosa infection nature inflammatory response differ mice receiving adenoviral vector encoding cftr vs
0.563135.15003935.html.plaintext.txt	66	empty vector controls cftr play role cell immune responses triggered p
0.563135.15003935.html.plaintext.txt	67	aeruginosa infection hyperimmune response cystic fibrosis lung contribute adenoviral vector p
0.563135.15003935.html.plaintext.txt	68	aeruginosa mediated inflammation future studies examining immune responses triggered upon adenoviral vector administration p
0.563135.15003935.html.plaintext.txt	69	aeruginosa infected cystic fibrosis airways provide new important information regarding utility adenoviral vectors cystic fibrosis related gene therapy
0.563135.15003935.html.plaintext.txt	70	work supported grant cystic fibrosis foundation l
0.563135.15003935.html.plaintext.txt	71	footnotes address reprint requests correspondence l
0.563135.15003935.html.plaintext.txt	72	physiology biophysics univ
0.563135.15003935.html.plaintext.txt	73	alabama birmingham mclm 966 1918 univ
0.563135.15003935.html.plaintext.txt	74	birmingham al 35294 0005 e mail lschwiebatuab
0.563135.15003935.html.plaintext.txt	75	references top references chirmule n propert kj magosin sa qian y qian r wilson jm
0.563135.15003935.html.plaintext.txt	76	immune responses adenovirus adeno associated virus humans
0.563135.15003935.html.plaintext.txt	77	crossrefisimedline driskell ra engelhardt jf
0.563135.15003935.html.plaintext.txt	78	current status gene therapy inherited lung diseases
0.563135.15003935.html.plaintext.txt	79	annu rev physiol 65 585 612 2003
0.563135.15003935.html.plaintext.txt	80	crossrefisimedline dunkley ml clancy rl cripps aw
0.563135.15003935.html.plaintext.txt	81	role cd4 cells orally immunized rats enhanced clearance pseudomonas aeruginosa lung
0.563135.15003935.html.plaintext.txt	82	isimedline johansen hk hougen hp cryz sj rygaard j hoiby n
0.563135.15003935.html.plaintext.txt	83	vaccination promotes th1 like inflammation survival chronic pseudomonas aeruginosa pneumonia rats
0.563135.15003935.html.plaintext.txt	84	j respir crit care med 152 1337 1346 1995
0.563135.15003935.html.plaintext.txt	85	abstract johansen hk hougen hp rygaard j hoiby n
0.563135.15003935.html.plaintext.txt	86	interferon treatment decreases inflammatory response chronic pseudomonas aeruginosa pneumonia rats
0.563135.15003935.html.plaintext.txt	87	clin exp immunol 103 212 218 1996
0.563135.15003935.html.plaintext.txt	88	crossrefisimedline knutsen ap slavin rg roodman st mueller kr marino nl
0.563135.15003935.html.plaintext.txt	89	decreased helper cell function patients cystic fibrosis
0.563135.15003935.html.plaintext.txt	90	int arch allergy appl immunol 85 847 850 1988
0.563135.15003935.html.plaintext.txt	91	lahat n rivlin j iancu tc
0.563135.15003935.html.plaintext.txt	92	functional immunoregulatory cell function patients cystic fibrosis
0.563135.15003935.html.plaintext.txt	93	j clin immunol 9 287 295 1989
0.563135.15003935.html.plaintext.txt	94	isimedline markham rb powderly wg
0.563135.15003935.html.plaintext.txt	95	exposure mice live pseudomonas aeruginosa generates protective cell mediated immunity absence antibody response
0.563135.15003935.html.plaintext.txt	96	j immunol 140 2039 2045 1988
0.563135.15003935.html.plaintext.txt	97	abstractfree full text moser c jensen po kobayashi o hougen hp song z rygaard j kharazmi hoiby n
0.563135.15003935.html.plaintext.txt	98	improved outcome chronic pseudomonas aeruginosa lung infection associated induction th1 dominated cytokine response
0.563135.15003935.html.plaintext.txt	99	clin exp immunol 127 206 213 2002
0.563135.15003935.html.plaintext.txt	100	crossrefisimedline moser c johansen hk song z hougen hp rygaard j hoiby n
0.563135.15003935.html.plaintext.txt	101	chronic pseudomonas aeruginosa lung infection severe th2 responding balbc mice compared th1 responding c3hhen mice
0.563135.15003935.html.plaintext.txt	102	isimedline moser c kjaergaard pressler kharazmi koch c hoiby n
0.563135.15003935.html.plaintext.txt	103	immune response chronic pseudomonas aeruginosa lung infection cystic fibrosis patients predominantly th2 type
0.563135.15003935.html.plaintext.txt	104	crossrefisimedline powderly wg pier gb markham rb
0.563135.15003935.html.plaintext.txt	105	lymphocyte mediated protection pseudomonas aeruginosa infection granulocytopenic mice
0.563135.15003935.html.plaintext.txt	106	j clin invest 78 375 380 1986
0.563135.15003935.html.plaintext.txt	107	isimedline ratjen f doring g
0.563135.15003935.html.plaintext.txt	108	crossrefisimedline riordan jr rommens jm kerem b alon n rozmahel r grzelczak z zielenski j lok plavsic n chou jl
0.563135.15003935.html.plaintext.txt	109	identification cystic fibrosis gene cloning characterization complementary dna
0.563135.15003935.html.plaintext.txt	110	science 245 september 1989 p
0.563135.15003935.html.plaintext.txt	111	isimedline schultz mj rijneveld aw speelman p van deventer sj van der poll
0.563135.15003935.html.plaintext.txt	112	endogenous interferon impairs bacterial clearance lungs pseudomonas aeruginosa pneumonia
0.563135.15003935.html.plaintext.txt	113	eur cytokine netw 12 39 44 2001
0.563135.15003935.html.plaintext.txt	114	isimedline smith rs harris sg phipps r iglewski b
0.563135.15003935.html.plaintext.txt	115	pseudomonas aeruginosa quorum sensing molecule n 3 oxododecanoylhomoserine lactone contributes virulence induces inflammation vivo
0.563135.15003935.html.plaintext.txt	116	j bacteriol 184 1132 1139 2002
0.563135.15003935.html.plaintext.txt	117	abstractfree full text song z wu h ciofu o kong kf hoiby n rygaard j kharazmi mathee k
0.563135.15003935.html.plaintext.txt	118	pseudomonas aeruginosa alginate refractory th1 immune response impedes host immune clearance mouse model acute lung infection
0.563135.15003935.html.plaintext.txt	119	j med microbiol 52 731 740 2003
0.563135.15003935.html.plaintext.txt	120	abstractfree full text van ginkel fw mcghee jr chongguang l simecka jw yamamoto m frizzell ra sorscher ej kiyono h pascual dw
0.563135.15003935.html.plaintext.txt	121	adenoviral gene delivery elicits distinct pulmonary associated helper cell responses vector transgene
0.563135.15003935.html.plaintext.txt	122	abstract van heeckeren ferkol tosi m
0.563135.15003935.html.plaintext.txt	123	effects bronchopulmonary inflammation induced pseudomonas aeruginosa adenovirus mediated gene transfer airway epithelial cells mice
0.563135.15003935.html.plaintext.txt	124	crossrefisimedline van heeckeren scaria schluchter md ferkol tw wadsworth davis pb
0.563135.15003935.html.plaintext.txt	125	delivery cftr adenoviral vector cystic fibrosis mouse lung model chronic pseudomonas aeruginosa lung infection
0.563135.15003935.html.plaintext.txt	126	j physiol lung cell mol physiol 286 l717 l726 2004
0.563135.15003935.html.plaintext.txt	127	yang y li q ertl hc wilson jm
0.563135.15003935.html.plaintext.txt	128	cellular humoral immune responses viral antigens create barriers lung directed gene therapy recombinant adenoviruses
0.563135.15003935.html.plaintext.txt	129	abstract article full text pdf alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager search citing articles isi web science 3 google scholar articles schwiebert l
0.563135.15003935.html.plaintext.txt	130	articles citing article pubmed pubmed citation articles schwiebert l
0.563135.15003935.html.plaintext.txt	131	home help feedback subscriptions archive search table contents visit aps journals online copyright 2004 american physiological society
0.5180734.12839834.html.plaintext.txt	0	rme 1 regulates recycling cystic fibrosis transmembrane conductance regulator john
0.5180734.12839834.html.plaintext.txt	1	picciano1 nadia ameen12 barth d
0.5180734.12839834.html.plaintext.txt	2	1cystic fibrosis research centre department cell biology physiology 2childrens hospital university pittsburgh school medicine pittsburgh pennsylvania 15261 3department molecular biology biochemistry rutgers piscataway new jersey 08854
0.5180734.12839834.html.plaintext.txt	3	submitted 9 april 2003 accepted final form 18 june 2003
0.5180734.12839834.html.plaintext.txt	4	abstract top abstract methods materials results discussion references endocytic motifs carboxyl terminus cystic fibrosis transmembrane conductance regulator cftr direct internalization plasma membrane clathrin mediated endocytosis
0.5180734.12839834.html.plaintext.txt	5	however fate internalized cftr remained unknown
0.5180734.12839834.html.plaintext.txt	6	internalized membrane proteins either targeted degradation recycled back plasma membrane
0.5180734.12839834.html.plaintext.txt	7	using cell surface biotinylation antibody uptake studies show cftr undergoes constitutive endocytosis recycling back plasma membrane
0.5180734.12839834.html.plaintext.txt	8	expression dominant negative rme 1 protein regulates exit endosomal recycling compartment cftr expressing cells results expansion recycling compartments
0.5180734.12839834.html.plaintext.txt	9	transferrin marker endosomal recycling compartment cftr accumulate enlarged recycling endosomes
0.5180734.12839834.html.plaintext.txt	10	accumulation leads loss cell surface cftr prevented recycled back cell surface
0.5180734.12839834.html.plaintext.txt	11	contrast traffic low density lipoprotein ldl unaffected expression dominant negative rme 1
0.5180734.12839834.html.plaintext.txt	12	addition chimeras containing extracellular domain transferrin receptor carboxyl terminal tail cftr also enter rme 1 regulated recycling compartments accumulate compartments containing dominant negative rme 1 suggesting addition endocytic signals carboxyl terminal tail cftr also contains intracellular traffic information
0.5180734.12839834.html.plaintext.txt	13	cystic fibrosis transmembrane conductance regulator rme 1 endocytosis recycling channel
0.5180734.12839834.html.plaintext.txt	14	cystic fibrosis cf common lethal genetic disease caucasians results mutations cystic fibrosis transmembrane conductance regulator cftr member abc superfamily transport proteins 28
0.5180734.12839834.html.plaintext.txt	15	cftr camp activated anion channel channel regulator functions apical membrane polarized epithelia regulate secretion respiratory gastrointestinal tracts 37
0.5180734.12839834.html.plaintext.txt	16	previous studies shown cftr stable component plasma membrane rather efficiently endocytosed cell surface 18 27 35 clathrin coated pits 4 5
0.5180734.12839834.html.plaintext.txt	17	furthermore entry cftr clathrin dependent endocytic pathway mediated binding tyrosine based endocytic motif carboxyl terminus cftr 27 35 medium subunit ap2 clathrin adaptor complex 36
0.5180734.12839834.html.plaintext.txt	18	addition endocytic motifs cftr also interacts pdz domain containing proteins 29 32 amp kinase 10 carboxyl terminus syntax ins amino terminus 24 25
0.5180734.12839834.html.plaintext.txt	19	interactions modulate cell surface expression cftr clear 2 22 although morphological biochemical functional data indicate cftr present cell surface intracellular compartments heterologous expression systems epithelial cells natively express cftr 1 3 33
0.5180734.12839834.html.plaintext.txt	20	although much known mechanisms cftr internalization fate internalized cftr less well documented
0.5180734.12839834.html.plaintext.txt	21	previous studies suggested internalized cftr recycled 31 pathway compartments cftr traverses undergo recycling known
0.5180734.12839834.html.plaintext.txt	22	endocytosed material directed initially sorting endosomal compartment directed one two destinations
0.5180734.12839834.html.plaintext.txt	23	molecules low density lipoprotein ldl retained sorting endosome matures andor fuses late endosomes 6
0.5180734.12839834.html.plaintext.txt	24	molecules destined recycled back cell surface initially targeted endosomal recycling compartment erc 9 23
0.5180734.12839834.html.plaintext.txt	25	erc extensively characterized basis studies transferrin receptor recycling 39 insulin regulated recycling glut 4 14 data concerning entry ion channels cftr compartment recycling back cell surface
0.5180734.12839834.html.plaintext.txt	26	rme 1 epsin homology eh domain containing protein 8 recently identified key element controlling exit erc 15
0.5180734.12839834.html.plaintext.txt	27	dominant negative rme 1 rme 1 g429r expressed mammalian cells effect endocytosis integral membrane proteins transferrin receptor dramatically inhibits recycling transferrin receptor back cell surface trapping receptor erc 15
0.5180734.12839834.html.plaintext.txt	28	endocytosed proteins ldl targeted lysosomes enter erc unaffected
0.5180734.12839834.html.plaintext.txt	29	examined fate endocytosed cftr using dominant negative rme 1 tool probing transport cftr erc
0.5180734.12839834.html.plaintext.txt	30	methods materials top abstract methods materials results discussion references plasmids
0.5180734.12839834.html.plaintext.txt	31	transferrin receptorcftr chimera entire cytoplasmic domain transferrin receptor replaced amino acids 1391 1476 cftr generous gift dr
0.5180734.12839834.html.plaintext.txt	32	jim collawn university alabama birmingham 27
0.5180734.12839834.html.plaintext.txt	33	tfrcftr subcloned mammalian expression vector pcmv4 stratagene using cla1 orientation confirmed sequence analysis
0.5180734.12839834.html.plaintext.txt	34	isogenic 293 cells stably expressing wild type cftr generated previously described 30 maintained dmem supplemented 10 fbs hygromycin 150 microgml
0.5180734.12839834.html.plaintext.txt	35	two hundred ninety three cells expressing cftr transfected transiently lipofectamine gibco brl 60 confluence analyzed 48 72 h
0.5180734.12839834.html.plaintext.txt	36	trvb1 chinese hamster ovarian cho cell line fails express transferrin receptors generously provided dr
0.5180734.12839834.html.plaintext.txt	37	tim mcgraw cornell university ithaca ny 20
0.5180734.12839834.html.plaintext.txt	38	trvb1 cells transiently transfected transferrin receptorcftr chimera using lipofectamine gibco brl 24 h later g429r green fluorescent protein gfp tagged rme 1
0.5180734.12839834.html.plaintext.txt	39	experiments performed 48 h later
0.5180734.12839834.html.plaintext.txt	40	monitor recycling cftr used modified cell surface biotinylation assay 7 31 34
0.5180734.12839834.html.plaintext.txt	41	briefly plasma membranes biotinylated 4 degrees c using cleavable reagent sulpho nhs ss biotin pierce rockford il warmed 37 degrees c load endocytic vesicles biotinylated proteins including cftr
0.5180734.12839834.html.plaintext.txt	42	remaining cell surface biotin removed using mesna previously described 34
0.5180734.12839834.html.plaintext.txt	43	subsequently cells either lysed rewarmed 37 degrees c allow internalized biotinylated cftr recycle cell surface
0.5180734.12839834.html.plaintext.txt	44	cells cooled 4 degrees c disulphide bonds recycled cell surface proteins reduced mesna cells lysed
0.5180734.12839834.html.plaintext.txt	45	biotinylated proteins isolated streptavidin agarose beads eluted sds sample buffer resolved 7
0.5180734.12839834.html.plaintext.txt	46	biotinylated cftr detected western blot analysis described
0.5180734.12839834.html.plaintext.txt	47	fluorescent labeling indirect immunofluorescence
0.5180734.12839834.html.plaintext.txt	48	cftr expressing 293 cells grown polylysine coated glass coverslips
0.5180734.12839834.html.plaintext.txt	49	two three days posttransfection without gfp tagged dominant negative rme 1 cells rinsed ice cold pbs supplemented 2 mm cacl2 1 mm mgcl2 pbs cm
0.5180734.12839834.html.plaintext.txt	50	cells fixed 2 paraformalde hyde0
0.5180734.12839834.html.plaintext.txt	51	1 triton x 100 exposed antibodies cftr m3a7 l12b4 upstate waltham
0.5180734.12839834.html.plaintext.txt	52	antibody binding visualized using cy3 conjugated goat anti mouse secondary antibodies molecular probes eugene
0.5180734.12839834.html.plaintext.txt	53	antibodies rme generous gift dr
0.5180734.12839834.html.plaintext.txt	54	robinson university cambridge cambridge uk
0.5180734.12839834.html.plaintext.txt	55	label cells transferrin cells incubated 10 microgml cy3 transferrin
0.5180734.12839834.html.plaintext.txt	56	dildl ldl labeled 33 dioctadecyclindocarbocyanine molecular probes
0.5180734.12839834.html.plaintext.txt	57	confocal images obtained zeiss 510 meta confocal scanning microscope
0.5180734.12839834.html.plaintext.txt	58	staining cftr performed essentially described 1
0.5180734.12839834.html.plaintext.txt	59	briefly 293 cells fixed 2 paraformaldehyde pbs 2 h room temperature pelleted embedded 3 liquid gelatin placed ice 10 min
0.5180734.12839834.html.plaintext.txt	60	1 m pbs overnight 4 degrees c
0.5180734.12839834.html.plaintext.txt	61	pellet frozen onto ultracryotome stubs liquid nitrogen stored liquid nitrogen use
0.5180734.12839834.html.plaintext.txt	62	ultra thin sections 70 100 nm cut using reichert ultracut u ultramicrotome fc4s cryoattachment
0.5180734.12839834.html.plaintext.txt	63	sections picked onto drop 2
0.5180734.12839834.html.plaintext.txt	64	3 m sucrose mounted formvar coated copper grids
0.5180734.12839834.html.plaintext.txt	65	briefly sections washed pbs nonspecific binding blocked pbs containing 0
0.5180734.12839834.html.plaintext.txt	66	5 bovine serum albumin bsa 0
0.5180734.12839834.html.plaintext.txt	67	15 glycine pbs containing 0
0.5180734.12839834.html.plaintext.txt	68	5 bsa followed 30 min incubation 5 normal goat serum
0.5180734.12839834.html.plaintext.txt	69	sections incubated primary antibodies 150 1 h labeled colloidal gold 125 room temperature 1 h amersham piscataway nj
0.5180734.12839834.html.plaintext.txt	70	sections washed pbs containing 0
0.5180734.12839834.html.plaintext.txt	71	5 bsa pbs fixed 2
0.5180734.12839834.html.plaintext.txt	72	sections post stained 4 uranyl acetate embedded 1
0.5180734.12839834.html.plaintext.txt	73	labeling observed jeol jem 1210 electron microscope peabody 80 kv
0.5180734.12839834.html.plaintext.txt	74	cells washed ice cold pbs lysed tgh buffer 1 volvol triton x 100 10 volvol glycerol 25 mm hepes na ph 7
0.5180734.12839834.html.plaintext.txt	75	4 containing protease inhibitors complete edta free protease inhibitors roche 20 min ice
0.5180734.12839834.html.plaintext.txt	76	nuclei unbroken cells removed centrifugation 15000 g 5 min 4 degrees c
0.5180734.12839834.html.plaintext.txt	77	soluble proteins resolved 7
0.5180734.12839834.html.plaintext.txt	78	5 sds page gel transferred nitrocellulose membrane
0.5180734.12839834.html.plaintext.txt	79	block membranes probed antibodies cftr m3a7 upstate transferrin receptor bd pharmingen visualized enhanced chemiluminescence pico west described 36
0.5180734.12839834.html.plaintext.txt	80	immunomagnetic isolation cftr containing vesicles
0.5180734.12839834.html.plaintext.txt	81	cftr expressing 293 cells transfected g429r rme 1 washed pbs homogenized passing cells 20 times 25 gauge needle buffer 250 mm sucrose containing 50 mm na hepes ph 7
0.5180734.12839834.html.plaintext.txt	82	postnuclear supernatants obtained centrifugation incubated overnight 4 degrees c 1 microgml m3a7 lb12b4 anti cftr antibodies
0.5180734.12839834.html.plaintext.txt	83	washed paramagnetic beads 25 microl coated sheep anti mouse antibodies dynal biotech added 90 min incubation 4 degrees c
0.5180734.12839834.html.plaintext.txt	84	vesicles washed isolated using standard magnetic separation protocols subjected immunoblot analysis using antibodies described text
0.5180734.12839834.html.plaintext.txt	85	results top abstract methods materials results discussion references cftr undergoes constitutive recycling
0.5180734.12839834.html.plaintext.txt	86	investigate endocytic recycling cftr initially confirmed cftr undergoes constitutive internalization
0.5180734.12839834.html.plaintext.txt	87	1a observed linear increase endocytic internalization cftr 0 8 min
0.5180734.12839834.html.plaintext.txt	88	6 8 min amount apparent cftr internalization increase cftr rapidly recycled back cell surface fig
0.5180734.12839834.html.plaintext.txt	89	observed linear increase endocytic recycling cftr back cell surface 0 5 min
0.5180734.12839834.html.plaintext.txt	90	thereafter amount apparent cftr recycling back cell surface failed increase presumably due rapid reinternalization cftr plasma membrane fig
0.5180734.12839834.html.plaintext.txt	91	view larger version 13k fig
0.5180734.12839834.html.plaintext.txt	92	cystic fibrosis transmembrane conductance regulator cftr undergoes constitutive endocytosis recycling
0.5180734.12839834.html.plaintext.txt	93	endocytosis recycling b cftr monitored described materials methods
0.5180734.12839834.html.plaintext.txt	94	results expressed means plus minus se least 3 separate experiments
0.5180734.12839834.html.plaintext.txt	95	rme 1 identifies recycling compartment 293 cells
0.5180734.12839834.html.plaintext.txt	96	characterize endocytic recycling cftr investigated whether internalized cftr entered compartments whose turnover regulated rme 1
0.5180734.12839834.html.plaintext.txt	97	anti rme 1 antibodies labeled three structures within cftr expressing 293 cells fig
0.5180734.12839834.html.plaintext.txt	98	2a compartment within perinuclear region intracellular vesicles plasma membrane see fig
0.5180734.12839834.html.plaintext.txt	99	2a inset consistent localization rme 1 cho cells 15
0.5180734.12839834.html.plaintext.txt	100	colocalization rme 1 endoplasmic reticulum markers fig
0.5180734.12839834.html.plaintext.txt	101	2 c lysosomal markers fig
0.5180734.12839834.html.plaintext.txt	102	2 g early endosome markers fig
0.5180734.12839834.html.plaintext.txt	103	minor component apparent overlap observed golgi compartments fig
0.5180734.12839834.html.plaintext.txt	104	however signals largely separable minor overlap probably represents lack special resolution optical slice
0.5180734.12839834.html.plaintext.txt	105	view larger version 84k fig
0.5180734.12839834.html.plaintext.txt	106	distribution endogenous rme 1 293 cells
0.5180734.12839834.html.plaintext.txt	107	cells fixed stained polyclonal antibodies rme 1 followed secondary antibodies conjugated alexa 488 monoclonal antibodies endoplasmic reticulum er markers bip c golgi markers golgin 97 d f lysosomal markers lamp 1 g early endosome markers eea1 j l followed secondary antibodies conjugated cy3
0.5180734.12839834.html.plaintext.txt	108	mitochondria initially labeled live cells using mito tracker molecular probes followed fixation staining rme 1 m o
0.5180734.12839834.html.plaintext.txt	109	expression g429r rme 1 slows transferrin recycling
0.5180734.12839834.html.plaintext.txt	110	confirm g429r rme 1 inhibited exit endosomal recycling compartments 293 cells transiently expressed gfp tagged g429r rme 1 cells stably expressing wild type cftr
0.5180734.12839834.html.plaintext.txt	111	endosomal recycling compartments identified incubating cells 60 min 37 degrees c continued presence cy3 labeled transferrin
0.5180734.12839834.html.plaintext.txt	112	3a transferrin positive compartments seen discrete perinuclear vesicles throughout cytoplasm cell
0.5180734.12839834.html.plaintext.txt	113	experiments performed using cells transiently transfected g429r rme 1 transferrin observed large perinuclear compartments fig
0.5180734.12839834.html.plaintext.txt	114	compartments colocalized gfp tagged g429r rme 1 fig
0.5180734.12839834.html.plaintext.txt	115	3 c d consistent effects g429r rme 1 affecting exit entry erc
0.5180734.12839834.html.plaintext.txt	116	nontransfected cells incubated similar conditions dildl showed uptake labeled ldl large cytoplasmic vesicles fig
0.5180734.12839834.html.plaintext.txt	117	3e presumably late endosomeslysosomes
0.5180734.12839834.html.plaintext.txt	118	transient expression g429r rme 1 fig
0.5180734.12839834.html.plaintext.txt	119	3 g h affect localization dildl fig
0.5180734.12839834.html.plaintext.txt	120	3 f h showed little colocalization gfp tagged g429r rme 1 fig
0.5180734.12839834.html.plaintext.txt	121	results consistent premise g429r rme 1 effect endocytic uptake traffic late endosomeslysosomes affects exit recycling compartments
0.5180734.12839834.html.plaintext.txt	122	view larger version 39k fig
0.5180734.12839834.html.plaintext.txt	123	expression g429r rme 1 affects subcellular localization transferrin low density lipoprotein ldl
0.5180734.12839834.html.plaintext.txt	124	cells stably expressing wild type rme 1 incubated 1 h continued presence cy3 labeled transferrin ldl labeled 33 dioctadecyclindocarbocyanine dildl e
0.5180734.12839834.html.plaintext.txt	125	expression g429r rme 1 caused redistribution transferrin large cytosolic vesicles b colocalized gfp tagged g429r rme 1 c
0.5180734.12839834.html.plaintext.txt	126	merge transferrin g429r signal shows almost complete overlap d
0.5180734.12839834.html.plaintext.txt	127	expression g429r rme 1 affect delivery dildl late endosomes lysosomes f colocalization gfp tagged rme 1 g dildl seen shown lack colocalization merge h
0.5180734.12839834.html.plaintext.txt	128	cftr targeted rme 1 positive compartments
0.5180734.12839834.html.plaintext.txt	129	shown internalized cftr recycles efficiently back plasma membrane determined whether recycling involved trafficking cftr erc similar fashion molecules transferrin
0.5180734.12839834.html.plaintext.txt	130	untransfected cells cftr seen associated plasma membrane fig
0.5180734.12839834.html.plaintext.txt	131	4a consistent previously published data
0.5180734.12839834.html.plaintext.txt	132	however upon expression g429r rme 1 plasma membrane associated staining cftr markedly decreased concomitant increase intracellular cftr localization fig
0.5180734.12839834.html.plaintext.txt	133	moreover intracellular cftr found colocalize mostly recycling compartment determined colocalization rme 1 fig
0.5180734.12839834.html.plaintext.txt	134	neighboring cells failed take plasmid g429r rme 1 retained cell surface staining cftr
0.5180734.12839834.html.plaintext.txt	135	view larger version 20k fig
0.5180734.12839834.html.plaintext.txt	136	expression g429r rme 1 affects cellular localization cftr
0.5180734.12839834.html.plaintext.txt	137	cftr293 cells transiently transfected gfp tagged g429r rme 1
0.5180734.12839834.html.plaintext.txt	138	cells subsequently fixed stained cftr using cy3 conjugated secondary antibodies
0.5180734.12839834.html.plaintext.txt	139	untransfected cells cftr clearly seen plasma membrane
0.5180734.12839834.html.plaintext.txt	140	transfected cells b d cftr moved intracellular compartment completely overlapped gfp tagged g429r rme 1 c d
0.5180734.12839834.html.plaintext.txt	141	inset d shows higher magnification colocalized signal
0.5180734.12839834.html.plaintext.txt	142	confirm cftr indeed trapped erc presence g429r rme 1 performed immunogold electron microscopy cells expressing cftr
0.5180734.12839834.html.plaintext.txt	143	studies revealed presence transferrin receptor marker erc fig
0.5180734.12839834.html.plaintext.txt	144	5 cftr within vesicle
0.5180734.12839834.html.plaintext.txt	145	cftr also colocalized gold labeled anti gfp antibodies data shown
0.5180734.12839834.html.plaintext.txt	146	view larger version 154k fig
0.5180734.12839834.html.plaintext.txt	147	immunogold localization cftr endosomal recycling compartment erc
0.5180734.12839834.html.plaintext.txt	148	cells expressing cftr g429r rme 1 fixed processed immunogold electron microscopy described materials methods
0.5180734.12839834.html.plaintext.txt	149	cftr arrows identified 5 nm gold particles transferrin receptor arrowhead 15 nm gold particles
0.5180734.12839834.html.plaintext.txt	150	confirm redistribution cftr cell surface location intracellular compartment cell surface biotinylation experiments performed
0.5180734.12839834.html.plaintext.txt	151	presence band c cftr fig
0.5180734.12839834.html.plaintext.txt	152	6 b seen untransfected cells cells transfected wild type rme 1 cells transfected g429r rme 1 arguing role rme 1 biosynthetic pathway
0.5180734.12839834.html.plaintext.txt	153	slight reduction amount cell surface cftr presence wild type rme 1 expression g429r rme 1 caused marked reduction amount cell surface cftr fig
0.5180734.12839834.html.plaintext.txt	154	6 b consistent redirection cftr intracellular compartments
0.5180734.12839834.html.plaintext.txt	155	reduction cell surface cftr presence g429r rme 1 due global reduction cftr expression amount total cftr cells expressing g429r rme 1 significantly lower untransfected cells fig
0.5180734.12839834.html.plaintext.txt	156	view larger version 28k fig
0.5180734.12839834.html.plaintext.txt	157	expression rme 1 g429r wild type rme 1 causes loss cell surface cftr
0.5180734.12839834.html.plaintext.txt	158	untransfected cftr293 cells cells transfected wild type rme 1 g429r rme 1 subjected cell surface biotinylation described materials meth ods
0.5180734.12839834.html.plaintext.txt	159	streptavidin precipitation subsequent immunoblot analysis revealed presence band c cftr untransfected cells cells transfected wild type rme 1 markedly reduced cells transfected g429r rme 1
0.5180734.12839834.html.plaintext.txt	160	shown b results densitometric scans data shown
0.5180734.12839834.html.plaintext.txt	161	analysis total cell lysate cftr presence absence g429r rme 1 c d revealed little difference total cftr
0.5180734.12839834.html.plaintext.txt	162	results means plus minus se 3 separate experiments
0.5180734.12839834.html.plaintext.txt	163	immunomagnetic isolation cftr containing vesicles
0.5180734.12839834.html.plaintext.txt	164	immunofluorescence microscopy revealed presence cftr trapped erc presence g429r rme 1
0.5180734.12839834.html.plaintext.txt	165	alternative strategy show g429r rme 1 causes trapping cftr erc vesicles cftr293 cells transfected g429r rme 1 subject immunomagnetic isolation using anti cftr antibodies fig
0.5180734.12839834.html.plaintext.txt	166	cftr erc oriented cytosolic domains cftr facing outside vesicle immunoprecipitated cftr containing vesicles cells using antibodies directed amino carboxyl termini cftr
0.5180734.12839834.html.plaintext.txt	167	immunoblot analysis isolated vesicles revealed presence band c cftr
0.5180734.12839834.html.plaintext.txt	168	rme 1 transferrin receptor also identified within cftr containing vesicles
0.5180734.12839834.html.plaintext.txt	169	contrast markers early endosomes eea1 lysosomes lamp1 showed little signal
0.5180734.12839834.html.plaintext.txt	170	view larger version 35k fig
0.5180734.12839834.html.plaintext.txt	171	g429r rme 1 localizes cftr erc early endosomes lysosomes
0.5180734.12839834.html.plaintext.txt	172	cftr containing vesicles subjected immunomagnetic isolation
0.5180734.12839834.html.plaintext.txt	173	subsequent immunoblot analysis following antibodies employed
0.5180734.12839834.html.plaintext.txt	174	robinson transferrin receptor tfr 85 kda transduction labsbd pharmingen cftr 180 kda upstate biotech eea1180 kda lamp 1 transduction labsbd pharmingen
0.5180734.12839834.html.plaintext.txt	175	carboxyl terminal domain cftr contains erc targeting information
0.5180734.12839834.html.plaintext.txt	176	show cftr enters erc clathrin coated endocytic pathway monitored traffic internalized cftr
0.5180734.12839834.html.plaintext.txt	177	steady state level cell surface cftr presence g429r rme 1 extremely low high affinity extracellular antibodies ligands cftr decided utilize cftrtransferrin receptor chimera transiently coexpressed g429r rme 1
0.5180734.12839834.html.plaintext.txt	178	trvb1 cells lacking endogenous transferrin receptors transiently transfected cftr transferrin receptor tfr chimera cytoplasmic domain transferrin receptor replaced carboxyl terminal domain cftr
0.5180734.12839834.html.plaintext.txt	179	twenty four hours transfection cells also transfected g429r rme 1
0.5180734.12839834.html.plaintext.txt	180	traffic cftrtfr chimera monitored using cy3 conjugated transferrin
0.5180734.12839834.html.plaintext.txt	181	cells containing cftrtfr fig
0.5180734.12839834.html.plaintext.txt	182	8 b cftrtfr g429r rme 1 fig
0.5180734.12839834.html.plaintext.txt	183	8 c f incubated 1 h continued presence cy3 transferrin fig
0.5180734.12839834.html.plaintext.txt	184	cy3 transferrin efficiently taken sets cells
0.5180734.12839834.html.plaintext.txt	185	hour pulse labeled transferrin cells subject hour chase absence labeled transferrin 100 fold excess unlabeled transferrin
0.5180734.12839834.html.plaintext.txt	186	cells expressing cftrtfr alone fig
0.5180734.12839834.html.plaintext.txt	187	8b showed loss cell associated signal transferrin efficiently recycled back cell surface released medium
0.5180734.12839834.html.plaintext.txt	188	contrast cells expressing cftrtfr g429r rme 1 fig
0.5180734.12839834.html.plaintext.txt	189	8d failed recycle internalized transferrin back cell surface
0.5180734.12839834.html.plaintext.txt	190	structures within transferrin remained colocalized gfp tagged g429r rme 1 fig
0.5180734.12839834.html.plaintext.txt	191	view larger version 58k fig
0.5180734.12839834.html.plaintext.txt	192	carboxyl terminus cftr target erc
0.5180734.12839834.html.plaintext.txt	193	trvb1 cells expressing cftrtfr chimeras presence wild type rme 1 labeled 1 h presence cy3 transferrin followed 1 h chase presence 100 fold excess unlabeled transferrin b
0.5180734.12839834.html.plaintext.txt	194	similar experiments performed cells expressing gfp tagged g429r rme 1 cells incubated 1 h presence cy3 transferrin c followed 1 h chase presence 100 fold excess unlabeled transferrin d
0.5180734.12839834.html.plaintext.txt	195	cells expressing gfp tagged g429r rme 1 corresponding gfp signal shown green e f
0.5180734.12839834.html.plaintext.txt	196	discussion top abstract methods materials results discussion references clearly established signals carboxyl terminal domain cftr direct entrance clathrin mediated endocytic pathway 4 12 18 27 35 36
0.5180734.12839834.html.plaintext.txt	197	interest observations endocytic internalization kinetics cftr rapid 12 18 27 34 internalized cftr appears fully functional 5 17
0.5180734.12839834.html.plaintext.txt	198	observations suggest possibility internalized cftr may constitutively recycled back cell surface
0.5180734.12839834.html.plaintext.txt	199	indeed given rapid internalization kinetics cftr biosynthetic kinetics would equally rapid maintain steady state cell surface cftr
0.5180734.12839834.html.plaintext.txt	200	however treatment cftr expressing cho cells either cycloheximide brefeldin cause diminution forskolin stimulated cftr function 24 h 16 arguing internalized cftr may recycled rather degraded
0.5180734.12839834.html.plaintext.txt	201	studies swiatecka urban et al
0.5180734.12839834.html.plaintext.txt	202	31 argued recycling cftr may important establishing apical polarity epithelial cells
0.5180734.12839834.html.plaintext.txt	203	although exit material erc reinsertion plasma membrane thought constitutive pathway traffic nonetheless requires cellular machinery
0.5180734.12839834.html.plaintext.txt	204	role rme 1 regulating aspects endocyticrecycling pathway established using dominant negative mutants cho cells c
0.5180734.12839834.html.plaintext.txt	205	rme 1 effect initial clathrin mediated endocytic events rme 1 function necessary proteins exit erc travel back plasma membrane
0.5180734.12839834.html.plaintext.txt	206	contrast rme 1 plays role traffic proteins ldl late endosomelysosome pathway
0.5180734.12839834.html.plaintext.txt	207	although one rme family member c
0.5180734.12839834.html.plaintext.txt	208	elegans four related genes humans 8 21 26
0.5180734.12839834.html.plaintext.txt	209	yet tissue distribution expression overlap cftr different rme 1 genes known
0.5180734.12839834.html.plaintext.txt	210	show internalized cftr enters endocytic recycling compartment traffic back cell surface identical fashion well described marker endosomal recycling transferrin receptor
0.5180734.12839834.html.plaintext.txt	211	expression dominant negative rme 1 effect endocytosis shown uptake ldl transferrin cftrtransferrin chimeras consistent previously published data 8 15
0.5180734.12839834.html.plaintext.txt	212	contrast traffic ldl late endosomeslysosomes unaffected dominant negative rme 1 shows colocalization gfp tagged g429r rme 1 transferrin marker recycling compartment shows almost complete overlap gfp tagged g429r rme 1
0.5180734.12839834.html.plaintext.txt	213	cftr localization dominant negative rme 1 expressing cells shows overlap transferrin gfp arguing internalized cftr enters recycling compartment transferrin access
0.5180734.12839834.html.plaintext.txt	214	observation expression dominant negative rme 1 caused marked redistribution cftr away plasma membrane trapped erc argues rapid endocytic rate cftr
0.5180734.12839834.html.plaintext.txt	215	indeed several groups shown cftr efficiently endocytosed cell surface 12 18 27 34
0.5180734.12839834.html.plaintext.txt	216	moreover redistribution cftr presence g429r rme 1 argues maintenance steady state cell surface levels cftr primarily due recycling internalized cftr rather insertion newly synthesized cftr
0.5180734.12839834.html.plaintext.txt	217	lack high affinity antibodies extracellular domains cftr low level expression cell surface cftr presence g429r rme 1 precluded monitoring cftr cell surface erc
0.5180734.12839834.html.plaintext.txt	218	confirm entry cftr erc endocytic pathway monitored access transferrin receptorcftr chimeras erc
0.5180734.12839834.html.plaintext.txt	219	transferrin receptor constructs lack cytoplasmic tail internalized inefficiently 13 27
0.5180734.12839834.html.plaintext.txt	220	addition carboxyl tail cftr tail less transferrin receptors restores efficient internalization receptor labeled transferrin reporters 27
0.5180734.12839834.html.plaintext.txt	221	transfection cells transferrin receptorcftr chimeras dominant negative rme 1 shows labeled transferrin trapped within erc arguing entry erc endocytic rather biosynthetic pathway
0.5180734.12839834.html.plaintext.txt	222	moreover argues carboxyl tail cftr contain signals direct traffic cftr away recycling pathways lysosomal degradative compartments
0.5180734.12839834.html.plaintext.txt	223	many endocytosed membrane proteins thought recycle cell surface via juxtanuclear recycling compartment 23 true proteins
0.5180734.12839834.html.plaintext.txt	224	example kir channels potassium channel family involved regulating membrane excitability 38 recycle cell surface rme 1 regulated compartments 19
0.5180734.12839834.html.plaintext.txt	225	thus clear different ion channels traffic recycle diverse compartments
0.5180734.12839834.html.plaintext.txt	226	many laboratories commercial academic currently attempting acquire pharmacological compounds increase efficiency mutant cftr molecules fold exit endoplasmic reticulum get inserted plasma membrane
0.5180734.12839834.html.plaintext.txt	227	observation even wild type cftr rapidly removed cell surface argues necessity understand recycling processes potential increase rate cftr exits recycling compartment gets reinserted back plasma membrane
0.5180734.12839834.html.plaintext.txt	228	particularly true f508 cftr common mutation cftr even corrected growth cells reduced temperatures significantly shorter half life plasma membrane wild type cftr 11
0.5180734.12839834.html.plaintext.txt	229	thus clear understanding molecular events governing recycling cftr provide inside ways augment overall residence time pharmacologically corrected mutant cftr molecules cell surface
0.5180734.12839834.html.plaintext.txt	230	disclosures work supported cystic fibrosis foundation national institute diabetes digestive kidney diseases grants dk 57583 p50 dk 56490 component 2 n
0.5180734.12839834.html.plaintext.txt	231	acknowledgments thank stuart shand university pittsburgh centre biological imaging performing confocal immunofluorescence microscopy
0.5180734.12839834.html.plaintext.txt	232	footnotes address reprint requests correspondence n
0.5180734.12839834.html.plaintext.txt	233	bradbury s306 bst south dept
0.5180734.12839834.html.plaintext.txt	234	cell biology physiology univ
0.5180734.12839834.html.plaintext.txt	235	pittsburgh school medicine 3500 terrace st
0.5180734.12839834.html.plaintext.txt	236	pittsburgh pa 15261 e mail nabradatpitt
0.5180734.12839834.html.plaintext.txt	237	costs publication article defrayed part payment page charges
0.5180734.12839834.html.plaintext.txt	238	article must therefore hereby marked advertisement accordance 18 u
0.5180734.12839834.html.plaintext.txt	239	section 1734 solely indicate fact
0.5180734.12839834.html.plaintext.txt	240	references top abstract methods materials results discussion references 1
0.5180734.12839834.html.plaintext.txt	241	ameen na van donselaar e posthuman g de jonge h mclaughlin g geuze hj marino cr peters pj
0.5180734.12839834.html.plaintext.txt	242	subcellular distribution cftr rat intestine supports physiologic role cftr regulation vesicle traffic
0.5180734.12839834.html.plaintext.txt	243	histochem cell biol 114 219 228 2000
0.5180734.12839834.html.plaintext.txt	244	benharouga m sharma m j haardt m dryzmala l popov m schwappach b grinstein du k lukacs gl
0.5180734.12839834.html.plaintext.txt	245	role c terminus nah exchanger regulatory factor nherf functional expression cftr non polarized cells epithelia
0.5180734.12839834.html.plaintext.txt	246	j biol chem 278 22079 22089 2003
0.5180734.12839834.html.plaintext.txt	247	intracellular cftr localization function
0.5180734.12839834.html.plaintext.txt	248	physiol rev 79 s175 s191 1999
0.5180734.12839834.html.plaintext.txt	249	bradbury na clark ja watkins sc widnell cc smith hsi bridges rj
0.5180734.12839834.html.plaintext.txt	250	characterization internalization pathways cystic fibrosis transmembrane conductance regulator
0.5180734.12839834.html.plaintext.txt	251	j physiol lung cell mol physiol 276 l659 l668 1999
0.5180734.12839834.html.plaintext.txt	252	bradbury na cohn ja venglarik cj bridges rj
0.5180734.12839834.html.plaintext.txt	253	biochemical biophysical identification cystic fibrosis transmembrane conductance regulator chloride channels components endocytic clathrin coated vesicles
0.5180734.12839834.html.plaintext.txt	254	j biol chem 269 8296 8302 1994
0.5180734.12839834.html.plaintext.txt	255	dunn kw mcgraw te maxfield fr
0.5180734.12839834.html.plaintext.txt	256	iterative fractionation recycling receptors lysosomally destined ligands early sorting endosome
0.5180734.12839834.html.plaintext.txt	257	j cell biol 109 3303 3314 1989
0.5180734.12839834.html.plaintext.txt	258	insulin responsive aminopeptidase trafficking 3t3 l1 adipocytes
0.5180734.12839834.html.plaintext.txt	259	j biol chem 275 2560 2567 2000
0.5180734.12839834.html.plaintext.txt	260	grant b zhang y paupard mc lin sx hall dh hirsh d
0.5180734.12839834.html.plaintext.txt	261	evidence rme 1 conserved c
0.5180734.12839834.html.plaintext.txt	262	elegans eh domain protein functions endocytic recycling
0.5180734.12839834.html.plaintext.txt	263	nat cell biol 3 573 579 2001
0.5180734.12839834.html.plaintext.txt	264	membrane transport endocytic pathway
0.5180734.12839834.html.plaintext.txt	265	curr opin cell biol 7 552 563 1995
0.5180734.12839834.html.plaintext.txt	266	hallows kr raghuram v kemp witters la foskett jk
0.5180734.12839834.html.plaintext.txt	267	inhibition cystic fibrosis transmembrane conductance regulator novel interaction metabolic sensor amp activated protein kinase
0.5180734.12839834.html.plaintext.txt	268	j clin invest 105 1711 1721 2000
0.5180734.12839834.html.plaintext.txt	269	heda gd tanwani m marino cr
0.5180734.12839834.html.plaintext.txt	270	delta f508 mutation shortens biochemical half life plasma membrane cftr polarized epithelial cells
0.5180734.12839834.html.plaintext.txt	271	j physiol cell physiol 280 c166 c174 2001
0.5180734.12839834.html.plaintext.txt	272	multiple endocytic signals c terminal tail cystic fibrosis transmembrane conductance regulator
0.5180734.12839834.html.plaintext.txt	273	jing sq spencer miller k hopkins c trowbridge
0.5180734.12839834.html.plaintext.txt	274	role human transferrin receptor cytoplasmic domain endocytosis localization specific signal sequence internalization
0.5180734.12839834.html.plaintext.txt	275	j cell biol 110 283 294 1990
0.5180734.12839834.html.plaintext.txt	276	johnson ao subtil petrush r kobylarz k keller sr mcgraw te
0.5180734.12839834.html.plaintext.txt	277	identification insulin responsive slow endocytic recycling mechanism chinese hamster ovary cells
0.5180734.12839834.html.plaintext.txt	278	j biol chem 273 17968 17977 1998
0.5180734.12839834.html.plaintext.txt	279	lin sx grant b hirsh d maxfield fr
0.5180734.12839834.html.plaintext.txt	280	rme 1 regulates distribution function endocytic recycling compartment mammalian cells
0.5180734.12839834.html.plaintext.txt	281	nat cell biol 3 567 572 2001
0.5180734.12839834.html.plaintext.txt	282	lukacs gl chang xb bear ce kartner n mohamed riordan jr grinstein
0.5180734.12839834.html.plaintext.txt	283	f508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.5180734.12839834.html.plaintext.txt	284	j biol chem 268 21592 21598 1993
0.5180734.12839834.html.plaintext.txt	285	lukacs gl chang xb kartner n rotstein od riordan jr grinstein
0.5180734.12839834.html.plaintext.txt	286	cystic fibrosis transmembrane regulator present functional endosomes
0.5180734.12839834.html.plaintext.txt	287	role determinant endosomal ph
0.5180734.12839834.html.plaintext.txt	288	j biol chem 267 14568 14572 1992
0.5180734.12839834.html.plaintext.txt	289	lukacs gl segal g kartner n grinstein zhang f
0.5180734.12839834.html.plaintext.txt	290	constitutive internalization cystic fibrosis transmembrane conductance regulator occurs via clathrin dependent endocytosis regulated protein phosphorylation
0.5180734.12839834.html.plaintext.txt	291	ma d zerangue n raab graham k fried sr jan yn jan ly
0.5180734.12839834.html.plaintext.txt	292	diverse trafficking patters due multiple traffic motifs g protein activated inwardly rectifying potassium channels brain heart
0.5180734.12839834.html.plaintext.txt	293	martys j shevell mcgraw te
0.5180734.12839834.html.plaintext.txt	294	studies transferrin recycling reconstituted streptolysin o permeabilized chinese hamster ovary cells
0.5180734.12839834.html.plaintext.txt	295	j biol chem 270 25976 25984 1995
0.5180734.12839834.html.plaintext.txt	296	mintz l galperin e pasmanik chor m tulzinsky bromberg y kozac ca joyner fein horowitz m
0.5180734.12839834.html.plaintext.txt	297	ehd1 eh domain containing protein specific expression pattern
0.5180734.12839834.html.plaintext.txt	298	moyer bd denton j karlson kh reynolds d wang mickle je milewski m cutting gr guggino wb li m stanton ba
0.5180734.12839834.html.plaintext.txt	299	pdz interaction domain cftr apical membrane polarization signal
0.5180734.12839834.html.plaintext.txt	300	j clin invest 104 1353 1361 1999
0.5180734.12839834.html.plaintext.txt	301	mukherjee ghosh rn maxfield fr
0.5180734.12839834.html.plaintext.txt	302	naren ap nelson dj xie w jovov b pevsner j bennett mk benos dj quick mw kirk kl
0.5180734.12839834.html.plaintext.txt	303	regulation cftr chloride channels syntaxin munc18 isoforms
0.5180734.12839834.html.plaintext.txt	304	peters kw qi j watkins sc frizzell ra
0.5180734.12839834.html.plaintext.txt	305	syntaxin 1a inhibits regulated cftr trafficking xenopus oocytes
0.5180734.12839834.html.plaintext.txt	306	j physiol cell physiol 277 c174 c180 1999
0.5180734.12839834.html.plaintext.txt	307	pohl u smith js tachibana ueki k lee hk ramaswany wu o mohrenweiser hw jenkins rb luois dn
0.5180734.12839834.html.plaintext.txt	308	ehd2 ehd3 ehd4 encode novel members highly conserved family eh domain containing proteins
0.5180734.12839834.html.plaintext.txt	309	prince ls peter k hatton sr zaliauskiene l cotlin lf clancy jp marchase rb collawn jf
0.5180734.12839834.html.plaintext.txt	310	efficient endocytosis cystic fibrosis transmembrane conductance regulator requires tyrosine based signal
0.5180734.12839834.html.plaintext.txt	311	j biol chem 274 3602 3609 1999
0.5180734.12839834.html.plaintext.txt	312	riordan jr rommens jm kerem b alon n rozmahel r grzelczak z zielenski j lok plavsic n chou j drumm ml iannuzzi mc collins fs tsui l c
0.5180734.12839834.html.plaintext.txt	313	identification cystic fibrosis gene cloning characterization complementary dna
0.5180734.12839834.html.plaintext.txt	314	short db trotter kw reczek d kreda sm bretscher boucher rc stutts mj milgram sl
0.5180734.12839834.html.plaintext.txt	315	apical pdz protein anchors cystic fibrosis transmembrane conductance regulator cytoskeleton
0.5180734.12839834.html.plaintext.txt	316	j biol chem 273 19797 19801 1998
0.5180734.12839834.html.plaintext.txt	317	silvis mr picciano ja bertrand c weixel k bridges rj bradbury na
0.5180734.12839834.html.plaintext.txt	318	mutation cystic fibrosis transmembrane conductance regulator generates novel internalization sequence enhances endocytic rates
0.5180734.12839834.html.plaintext.txt	319	j biol chem 278 11554 11560 2003
0.5180734.12839834.html.plaintext.txt	320	swiatecka urban duhaime m coutermarsh b karlson kh collawn jf milewski m cutting gr guggino wb langford g stanton ba
0.5180734.12839834.html.plaintext.txt	321	pdz domain interaction controls endocytic recycling cystic fibrosis transmembrane conductance regulator
0.5180734.12839834.html.plaintext.txt	322	j biol chem 277 40099 40105 2002
0.5180734.12839834.html.plaintext.txt	323	wang raab rw schatz pj guggino wb li m
0.5180734.12839834.html.plaintext.txt	324	peptide binding consensus nhe rf pdz1 domain matches c terminal sequence cystic fibrosis transmembrane conductance regulator cftr
0.5180734.12839834.html.plaintext.txt	325	webster p vanacore l nairn ac marino cr
0.5180734.12839834.html.plaintext.txt	326	subcellular localization cftr endosomes ductal epithelium
0.5180734.12839834.html.plaintext.txt	327	j physiol cell physiol 267 c340 c348 1994
0.5180734.12839834.html.plaintext.txt	328	analysis cftr endocytosis cell surface biotinylation
0.5180734.12839834.html.plaintext.txt	329	carboxyl terminus cystic fibrosis transmembrane conductance regulator binds ap 2 clathrin adaptors
0.5180734.12839834.html.plaintext.txt	330	j biol chem 275 3655 3660 2000
0.5180734.12839834.html.plaintext.txt	331	mu 2 binding directs cystic fibrosis transmembrane conductance regulator clathrin mediated endocytic pathway
0.5180734.12839834.html.plaintext.txt	332	j biol chem 276 46251 46259 2001
0.5180734.12839834.html.plaintext.txt	333	welsh mj ramsey bw accurso f cutting gr
0.5180734.12839834.html.plaintext.txt	334	metabolic molecular bases inherited diseases edited scriver cr beaudet al sly ws valle d
0.5180734.12839834.html.plaintext.txt	335	new york mcgraw hill 2001 p
0.5180734.12839834.html.plaintext.txt	336	yamada m inanobe kurachi y
0.5180734.12839834.html.plaintext.txt	337	g protein regulation potassium ion channels
0.5180734.12839834.html.plaintext.txt	338	pharmacol rev 50 723 757 1998
0.5180734.12839834.html.plaintext.txt	339	yamashiro dj tycko b fluss sr maxfield fr
0.5180734.12839834.html.plaintext.txt	340	segregation transferrin mildly acidic ph 6
0.5180734.12839834.html.plaintext.txt	341	5 para golgi compartment recycling pathway
0.44344512.11054417.html.plaintext.txt	0	newly synthesized human opioid receptors retained endoplasmic reticulum retrotranslocated cytosol deglycosylated ubiquitinated degraded proteasome ulla e
0.44344512.11054417.html.plaintext.txt	1	petaja repo mireille hogue andre laperriere suparna bhalla philippe walker michel bouvier
0.44344512.11054417.html.plaintext.txt	2	departement de biochimie universite de montreal montreal quebec h3c 3j7 canada astrazeneca research development montreal st
0.44344512.11054417.html.plaintext.txt	3	laurent quebec h4s 1z9 canada department anatomy cell biology university oulu fin 90014 oulu finland
0.44344512.11054417.html.plaintext.txt	4	received publication august 7 2000 revised form october 25 2000
0.44344512.11054417.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references
0.44344512.11054417.html.plaintext.txt	6	previously shown fraction newly synthesized human opioid receptors able leave endoplasmic reticulum er reach cell surface petaja repo u
0.44344512.11054417.html.plaintext.txt	7	present study investigated fate receptors retained intracellularly
0.44344512.11054417.html.plaintext.txt	8	pulse chase experiments revealed disappearance receptor precursor form mr 45000 two smaller species mr 42000 39000 inhibited proteasome blocker lactacystin
0.44344512.11054417.html.plaintext.txt	9	treatment also promoted accumulation mature receptor form mr 55000 indicating er quality control actively routes significant proportion rescuable receptors proteasome degradation
0.44344512.11054417.html.plaintext.txt	10	addition degradation intermediates included full length deglycosylated mr 39000 ubiquitinated forms receptor found accumulate cytosol upon inhibition proteasome function
0.44344512.11054417.html.plaintext.txt	11	finally coimmunoprecipitation experiments subunit sec61 translocon complex revealed receptor precursor deglycosylated degradation intermediates interact translocon
0.44344512.11054417.html.plaintext.txt	12	taken together results support model misfolded incompletely folded receptors transported cytoplasmic side er membrane via sec61 translocon deglycosylated conjugated ubiquitin prior degradation cytoplasmic 26 proteasomes
0.44344512.11054417.html.plaintext.txt	13	introduction top abstract introduction experimental procedures results discussion references
0.44344512.11054417.html.plaintext.txt	14	endoplasmic reticulum er1 quality control scrutinizes newly synthesized proteins entering secretory pathway ensures correctly folded case multimeric proteins fully assembled complexes deployed distal cellular compartments 1
0.44344512.11054417.html.plaintext.txt	15	fail fulfill criteria retained er subsequently degraded
0.44344512.11054417.html.plaintext.txt	16	even minor changes protein primary structure cause retention er
0.44344512.11054417.html.plaintext.txt	17	exemplified many diseases including cystic fibrosis cases 1 antitrypsin deficiency familial hypercholesterolemia characterized er storage phenotype 2
0.44344512.11054417.html.plaintext.txt	18	although less thoroughly characterized numerous naturally occurring mutations leading er retention g protein coupled receptors gpcrs also evoked cause inherited diseases
0.44344512.11054417.html.plaintext.txt	19	example er retained mutants rhodopsin luteinizing hormone receptor v2 vasopressin receptor implicated forms retinitis pigmentosa male pseudohermaphroditism nephrogenic diabetes insipidus respectively 3 6
0.44344512.11054417.html.plaintext.txt	20	emerging evidence indicates degradation aberrant er proteins mediated cytosolic multiprotease complex 26 proteasome
0.44344512.11054417.html.plaintext.txt	21	indeed increasing number misfolded unassembled yeast eukaryotic integral membrane secreted proteins shown substrates disposal mechanism 7 26
0.44344512.11054417.html.plaintext.txt	22	however proteasome mediated degradation restricted misfolded unassembled proteins evidenced observation resident er proteins substrates degradation pathway response cellular signals 27 29
0.44344512.11054417.html.plaintext.txt	23	thus hypothesized degradation pathway might role regulating steady state levels normal wild type proteins traversing secretory pathway described many cytosolic nuclear regulatory molecules review see refs
0.44344512.11054417.html.plaintext.txt	24	reported examples pointing phenomenon however scarce exceptions apolipoprotein b100 32 33 apolipoproteina 34 tyrosinase 35
0.44344512.11054417.html.plaintext.txt	25	recent report schubert co workers 36 showed least 30 newly synthesized proteins might degraded proteasomes
0.44344512.11054417.html.plaintext.txt	26	whether degraded proteins represent defective ribosomal products resulting errors translation suggested might also include correctly translated incompletely folded proteins remains determined
0.44344512.11054417.html.plaintext.txt	27	proteasome mediated ubiquitin dependent degradation cytosolic nuclear proteins well described phenomenon review see refs
0.44344512.11054417.html.plaintext.txt	28	30 31 detailed mechanisms involved er associated proteasomal degradation remain unclear
0.44344512.11054417.html.plaintext.txt	29	recent findings led emergence models suggesting misfolded incompletely folded er proteins retrotranslocated cytosolic side er membrane sec61 translocon complex conjugated ubiquitin hydrolysis 26 proteasomes review see refs
0.44344512.11054417.html.plaintext.txt	30	previously shown human opioid receptor hor example integral membrane proteins partially retained er possibly due difficulties folding process 40
0.44344512.11054417.html.plaintext.txt	31	another example cystic fibrosis transmembrane conductance regulator cftr review see ref
0.44344512.11054417.html.plaintext.txt	32	40 25 newly synthesized wild type hor cftr molecules respectively able leave er reach cell surface
0.44344512.11054417.html.plaintext.txt	33	thus set determine whether er retained hors targeted degradation 26 proteasomes delineate mechanisms involved process
0.44344512.11054417.html.plaintext.txt	34	results presented indicate receptors transported back cytosol process involves sec61 translocon deglycosylated degraded proteasomes
0.44344512.11054417.html.plaintext.txt	35	furthermore inhibition proteasomal pathway led accumulation ubiquitinated receptor forms pointing fact polyubiquitination may targeting signal disposal misfolded incompletely folded hor molecules
0.44344512.11054417.html.plaintext.txt	36	experimental procedures top abstract introduction experimental procedures results discussion references
0.44344512.11054417.html.plaintext.txt	37	materials expre35s35s protein labeling mix 1175 cimmol 9 3hbremazocine 26
0.44344512.11054417.html.plaintext.txt	38	6 cimmol purchased perkinelmer life sciences
0.44344512.11054417.html.plaintext.txt	39	recombinant peptide n glycosidase f pngase f flavobacterium meningosepticum purified escherichia coli ec 3
0.44344512.11054417.html.plaintext.txt	40	52 roche molecular biochemicals
0.44344512.11054417.html.plaintext.txt	41	proteasome inhibitors lactacystin z leu leu leu cho mg 132 z ile gluotbu ala leu cho psi obtained calbiochem
0.44344512.11054417.html.plaintext.txt	42	cell culture reagents either life technologies inc
0.44344512.11054417.html.plaintext.txt	43	anti flag m2 monoclonal antibody anti flag m2 affinity resin flag peptide products sigma
0.44344512.11054417.html.plaintext.txt	44	anti calnexin spa 860 anti heat shock protein 70 hsp70 spa 820 anti ubiquitin spa 200 antibodies stressgen biotechnologies corp
0.44344512.11054417.html.plaintext.txt	45	protein g sepharose amersham pharmacia biotech
0.44344512.11054417.html.plaintext.txt	46	anti sec61 antibody generous gift dr
0.44344512.11054417.html.plaintext.txt	47	rapoport harvard medical school boston ma
0.44344512.11054417.html.plaintext.txt	48	reagents analytical grade obtained various commercial suppliers
0.44344512.11054417.html.plaintext.txt	49	cell culture cells cultured either 25 cm2 75 cm2 culture flasks grown 80 90 confluence 37 degrees c humidified atmosphere 5 co2
0.44344512.11054417.html.plaintext.txt	50	human embryonic kidney 293s hek 293s cells stably expressing hor tagged c terminus flag epitope dykddddk 40 maintained dulbeccos modified eagles medium dmem containing 10 vv fetal calf serum 1000 unitsml penicillin 1 mgml streptomycin 1
0.44344512.11054417.html.plaintext.txt	51	5 microgml fungizone complete dmem 400 microgml geneticin
0.44344512.11054417.html.plaintext.txt	52	clone expressing 10 pmol receptormg membrane protein chosen study
0.44344512.11054417.html.plaintext.txt	53	metabolic labeling 35smethioninecysteine 35smethioninecysteine labeling cells first preincubated methionine cysteine free dmem 60 min 37 degrees c labeling performed fresh medium containing 150 microciml 35smethioninecysteine
0.44344512.11054417.html.plaintext.txt	54	incubation 60 min 37 degrees c pulse terminated washing cells twice chase medium complete dmem supplemented 5 mm methionine chased different periods time specified figures
0.44344512.11054417.html.plaintext.txt	55	labeling performed presence proteasome inhibitors reagents added 3 h pulse labeling final concentration 10 microm lactacystin 25 microm mg 132 psi
0.44344512.11054417.html.plaintext.txt	56	labeling cells washed harvested phosphate buffered saline unless otherwise indicated quick frozen liquid nitrogen stored 80 degrees c
0.44344512.11054417.html.plaintext.txt	57	immunoprecipitations total cellular lysates prepared buffer 0
0.44344512.11054417.html.plaintext.txt	58	5 n dodecyl d maltoside ddm wv 25 mm tris hcl ph 7
0.44344512.11054417.html.plaintext.txt	59	4 140 mm nacl 2 mm edta 5 microgml leupeptin 5 microgml soybean trypsin inhibitor sti 10 microgml benzamidine 2 microgml aprotinin 0
0.44344512.11054417.html.plaintext.txt	60	5 mm phenylmethylsulfonyl fluoride pmsf 2 mm 110 phenanthroline
0.44344512.11054417.html.plaintext.txt	61	insoluble material removed centrifugation 5000 x g 30 min bovine serum albumin added final concentration 0
0.44344512.11054417.html.plaintext.txt	62	receptor immunoprecipitated using anti flag m2 affinity resin described 40
0.44344512.11054417.html.plaintext.txt	63	sec61 immunoprecipitation ddm replaced digitonin nacl edta 110 phenanthroline omitted buffer
0.44344512.11054417.html.plaintext.txt	64	ubiquitin immunoprecipitation n ethylmaleimide nem included buffers distinguish high molecular weight ubiquitinated receptor forms putative aggregated receptors
0.44344512.11054417.html.plaintext.txt	65	immunoprecipitation calnexin hsp70 sec61 ubiquitin samples precleared 60 min 15 microl protein g sepharose
0.44344512.11054417.html.plaintext.txt	66	appropriate antibody dilutions 1200 10 microgml 1100 1100 respectively 15 microl protein g sepharose added incubated overnight 4 degrees c gentle agitation
0.44344512.11054417.html.plaintext.txt	67	following washing resin described 40 bound antigens eluted sds sample buffer 62
0.44344512.11054417.html.plaintext.txt	68	8 2 wv sds 10 vv glycerol 0
0.44344512.11054417.html.plaintext.txt	69	001 wv bromphenol blue 95 degrees c 5 min
0.44344512.11054417.html.plaintext.txt	70	two consecutive immunoprecipitation steps performed antigens eluted 1 wv sds 25 mm tris hcl ph 7
0.44344512.11054417.html.plaintext.txt	71	4 95 degrees c 5 min eluates diluted 10 fold buffer prior next immunoprecipitation
0.44344512.11054417.html.plaintext.txt	72	cell fractionation cells harvested homogenized buffer b 25 mm tris hcl ph 7
0.44344512.11054417.html.plaintext.txt	73	4 140 mm nacl 2 mm edta 5 microgml leupeptin 5 microgml sti 10 microgml benzamidine 2 microgml aprotinin 0
0.44344512.11054417.html.plaintext.txt	74	5 mm pmsf 2 mm 110 phenanthroline dounce homogenizer fig
0.44344512.11054417.html.plaintext.txt	75	3 d e 4b cells homogenized freezing thawing cell suspension passing 10 times 26 gauge needle
0.44344512.11054417.html.plaintext.txt	76	fractionation performed described 42
0.44344512.11054417.html.plaintext.txt	77	briefly homogenates first centrifuged 1000 x g 10 min pellet unbroken cells nuclei
0.44344512.11054417.html.plaintext.txt	78	supernatant centrifuged 10000 x g 30 min pellet crude membranes supernatant centrifuged 100000 x g 60 min clarify cytosolic fraction
0.44344512.11054417.html.plaintext.txt	79	ddm added soluble fraction final concentration 0
0.44344512.11054417.html.plaintext.txt	80	5 wv decrease nonspecific binding proteins either anti flag m2 affinity resin protein g sepharose
0.44344512.11054417.html.plaintext.txt	81	pellets washed buffer b solubilized buffer insoluble material removed centrifugation 100000 x g 60 min
0.44344512.11054417.html.plaintext.txt	82	immunoprecipitations soluble fraction solubilized membranes carried described
0.44344512.11054417.html.plaintext.txt	83	deglycosylation immunoprecipitated hors immunoprecipitated receptors deglycosylated following elution anti flag m2 affinity resin 1 wv sds 50 mm sodium phosphate ph 7
0.44344512.11054417.html.plaintext.txt	84	enzyme reaction eluates diluted 10 fold 0
0.44344512.11054417.html.plaintext.txt	85	5 wv ddm 50 mm sodium phosphate ph 7
0.44344512.11054417.html.plaintext.txt	86	5 mm pmsf 2 mm 110 phenanthroline 5 microgml leupeptin 5 microgml sti 10 microgml benzamidine 1 2 mercaptoethanol
0.44344512.11054417.html.plaintext.txt	87	pngase f added final concentration 0
0.44344512.11054417.html.plaintext.txt	88	01 10 unitsml samples incubated 37 degrees c 16 h reaction terminated addition sds sample buffer
0.44344512.11054417.html.plaintext.txt	89	sds polyacrylamide gel electrophoresis sds page sds page performed described 43 using 4 stacking gels 10 separating gels
0.44344512.11054417.html.plaintext.txt	90	samples heated 95 degrees c 2 min presence 50 mm dithiothreitol run bio rad mini protein ii apparatus
0.44344512.11054417.html.plaintext.txt	91	molecular weight markers bio rad detected staining coomassie brilliant blue bio rad used calibrate gels
0.44344512.11054417.html.plaintext.txt	92	detection radioactivity gels treated en3hance perkinelmer life sciences according manufacturers instructions dried exposed 80 degrees c 1 15 days using biomax mr film intensifying screens eastman kodak co
0.44344512.11054417.html.plaintext.txt	93	relative intensities labeled bands fluorographs analyzed densitometric scanning agfa arcus ii laser scanner data quantified using nih image program version 1
0.44344512.11054417.html.plaintext.txt	94	61 subtracting local background lane
0.44344512.11054417.html.plaintext.txt	95	miscellaneous procedures total protein measured using bio rad dc assay kit bovine serum albumin standard
0.44344512.11054417.html.plaintext.txt	96	binding assays carried using 3hbremazocine essentially described 40
0.44344512.11054417.html.plaintext.txt	97	results top abstract introduction experimental procedures results discussion references
0.44344512.11054417.html.plaintext.txt	98	degradation er retained newly synthesized hors mediated proteasomal pathway previously shown large fraction newly synthesized hors hek 293s cells remains pre golgi compartment core glycosylated mr 45000 precursors transported cell surface 40
0.44344512.11054417.html.plaintext.txt	99	set investigate fate intracellularly retained receptors
0.44344512.11054417.html.plaintext.txt	100	determine whether proteasomes involved degradation receptor forms cells incubated lactacystin specific inhibitor 26 proteasome 44 45
0.44344512.11054417.html.plaintext.txt	101	hek 293s cells stably expressing receptor carrying c terminal flag epitope hek 293s hor flag cells metabolically labeled 35smethioninecysteine chase medium containing excess unlabeled methionine cell lysates prepared receptors isolated immunoprecipitation fig
0.44344512.11054417.html.plaintext.txt	102	major band mr 45000 two minor ones mr 42000 39000 apparent untreated cells end pulse fig
0.44344512.11054417.html.plaintext.txt	103	subsequent chase label incorporated bands decreased slower diffusely migrating band mr 55000 appeared representing fully mature receptor 40
0.44344512.11054417.html.plaintext.txt	104	cells treated lactacystin increase labeling receptor species detected fig
0.44344512.11054417.html.plaintext.txt	105	furthermore proteasome inhibition significantly retarded disappearance mr 45000 42000 39000 receptor species half life last one dramatically affected table
0.44344512.11054417.html.plaintext.txt	106	similar findings obtained using two proteasome inhibitors peptide aldehydes mg 132 psi 45 data shown
0.44344512.11054417.html.plaintext.txt	107	taken together results suggest active role proteasomes elimination newly synthesized hors
0.44344512.11054417.html.plaintext.txt	108	fact lactacystin promoted increase receptor labeling even within shorter pulse period 15 min suggests targeting degradation begins early either cotranslationally immediately receptor synthesis complete
0.44344512.11054417.html.plaintext.txt	109	inhibition rapid degradation likely responsible increase amount mature receptors observed pulse chase labeling experiments compare lanes 4 5 fig
0.44344512.11054417.html.plaintext.txt	110	increase accompanied 38 increase number 3hbremazocine binding sites detected
0.44344512.11054417.html.plaintext.txt	111	findings due presence flag epitope tag c terminus receptor since results also obtained using receptor harboring tag n terminus data shown
0.44344512.11054417.html.plaintext.txt	112	unfortunately lack high affinity selective antibody hor makes impossible carry experiments native untagged receptor
0.44344512.11054417.html.plaintext.txt	113	view larger version 39k fig
0.44344512.11054417.html.plaintext.txt	114	hor synthesis maturation untreated lactacystin treated hek 293s cells
0.44344512.11054417.html.plaintext.txt	115	hek 293s hor flag cells untreated treated 10 microm lactacystin b 3 h pulse labeled 60 min 35smethioninecysteine chased indicated times absence continued presence proteasome inhibitor b
0.44344512.11054417.html.plaintext.txt	116	cellular lysates prepared solubilized receptors isolated two step immunoprecipitation using anti flag m2 antibody described experimental procedures
0.44344512.11054417.html.plaintext.txt	117	samples analyzed sds page fluorography dried gels exposed x ray films
0.44344512.11054417.html.plaintext.txt	118	fluorographs shown representative four independent experiments
0.44344512.11054417.html.plaintext.txt	119	arrows indicate molecular weights different receptor forms
0.44344512.11054417.html.plaintext.txt	120	markers used calibrate gels indicated top myosin galactosidase phosphorylase b bovine serum albumin ovalbumin carbonic anhydrase
0.44344512.11054417.html.plaintext.txt	121	view table table half lives hor species absence presence lactacystin relative intensities labeled receptor species quantified fluorographs pulse chase experiments example presented fig 1 densitometric scanning
0.44344512.11054417.html.plaintext.txt	122	half lives different receptor species determined using graphpad prism program version 2
0.44344512.11054417.html.plaintext.txt	123	01 data represent mean plus minus
0.44344512.11054417.html.plaintext.txt	124	four independent experiments
0.44344512.11054417.html.plaintext.txt	125	statistical significance differences assessed using two tailed students test
0.44344512.11054417.html.plaintext.txt	126	mr 42000 39000 hor species represent receptors carrying one n linked oligosaccharides respectively reported previously n linked oligosaccharides newly synthesized glycoproteins removed proteasomal degradation 13 17 26 35 42 46
0.44344512.11054417.html.plaintext.txt	127	therefore assessed whether smaller molecular weight receptor species mr 42000 39000 represent deglycosylated receptors rather proteolytic fragments
0.44344512.11054417.html.plaintext.txt	128	purpose immunoprecipitated 35smethioninecysteine pulse labeled samples subjected enzymatic deglycosylation using pngase f remove two n linked glycans receptor 40
0.44344512.11054417.html.plaintext.txt	129	2 lane 5 complete deglycosylation mr 45000 receptor precursor led appearance single species migrating mr 39000
0.44344512.11054417.html.plaintext.txt	130	fact mr 42000 species found intermediate stepwise deglycosylation receptor precursor suggests species represents receptor carrying one n linked glycan
0.44344512.11054417.html.plaintext.txt	131	mobility mr 39000 species stabilized lactacystin treated cells indistinguishable pngase f digested core glycosylated mr 45000 receptor form fig
0.44344512.11054417.html.plaintext.txt	132	2 compare lanes 5 7 confirming fact species represents intact receptor polypeptide n linked glycans
0.44344512.11054417.html.plaintext.txt	133	protein translocation er membrane core glycosylation believed occur cotranslationally mammalian cells 47
0.44344512.11054417.html.plaintext.txt	134	thus likely mr 39000 receptor species represents previously core glycosylated receptor deglycosylated intermediate degradation pathway
0.44344512.11054417.html.plaintext.txt	135	view larger version 34k fig
0.44344512.11054417.html.plaintext.txt	136	deglycosylation metabolically labeled hor pngase f
0.44344512.11054417.html.plaintext.txt	137	hek 293s hor flag cells pulse labeled 60 min 35smethioninecysteine absence presence lactacystin indicated
0.44344512.11054417.html.plaintext.txt	138	receptors isolated cellular lysates immunoprecipitation described fig
0.44344512.11054417.html.plaintext.txt	139	immunoprecipitates incubated 16 h 37 degrees c increasing concentrations 0
0.44344512.11054417.html.plaintext.txt	140	01 1 unitml pngase f described experimental procedures
0.44344512.11054417.html.plaintext.txt	141	enzyme free controls lanes 1 6 contained buffer
0.44344512.11054417.html.plaintext.txt	142	reactions stopped adding sds sample buffer followed sds page fluorography
0.44344512.11054417.html.plaintext.txt	143	mr 39000 hor species dislocates er membrane accumulates cytosol verify nature subcellular localization mr 39000 hor species fractionation cellular homogenates performed metabolic labeling fig
0.44344512.11054417.html.plaintext.txt	144	receptors immunoprecipitated four fractions 1000 x g pellet containing cellular debris nuclei trapped soluble proteins 10000 x g pellet containing crude membranes 100000 x g pellet containing residual microsomal membranes 100000 x g supernatant containing cytosolic proteins
0.44344512.11054417.html.plaintext.txt	145	control er membrane protein calnexin cytosolic protein hsp70 immunoprecipitated aliquots four fractions
0.44344512.11054417.html.plaintext.txt	146	calnexin detected membrane fraction fig
0.44344512.11054417.html.plaintext.txt	147	3b lanes 3 4 cytosolic one lanes 7 8 whereas opposite true hsp70 fig
0.44344512.11054417.html.plaintext.txt	148	expected proteins also detected 1000 x g pellet fig
0.44344512.11054417.html.plaintext.txt	149	3a addition found membrane fraction mr 39000 receptor species recovered cytosolic fraction lactacystin treated lane 8 untreated cells lane 7
0.44344512.11054417.html.plaintext.txt	150	agreement notion represents intermediate degradation pathway would normally broken cytosolic proteasomes
0.44344512.11054417.html.plaintext.txt	151	higher molecular weight bands forming regularly spaced ladder smallest apparent molecular weight 45000 also found cytosolic fraction lactacystin treated cells fig
0.44344512.11054417.html.plaintext.txt	152	mr 45000 species represent core glycosylated receptor precursor seen fig
0.44344512.11054417.html.plaintext.txt	153	3a lanes 1 4 pngase f able decrease molecular weight fig
0.44344512.11054417.html.plaintext.txt	154	likely ladder accompanying high molecular weight smear comprise polyubiquitinated forms mr 39000 receptor see
0.44344512.11054417.html.plaintext.txt	155	view larger version 40k fig
0.44344512.11054417.html.plaintext.txt	156	subcellular fractionation metabolically labeled hek 293s hor flag cells
0.44344512.11054417.html.plaintext.txt	157	hek 293s hor flag cells pulse labeled 60 min 35smethioninecysteine presence absence lactacystin indicated either harvested immediately d chased indicated times continued presence proteasome inhibitor e
0.44344512.11054417.html.plaintext.txt	158	total cellular homogenates fractionated differential centrifugation described experimental procedures
0.44344512.11054417.html.plaintext.txt	159	hor d e calnexin b hsp70 c immunoprecipitated fractions obtained using appropriate antibodies
0.44344512.11054417.html.plaintext.txt	160	immunoprecipitates either analyzed directly sds page fluorography c e deglycosylated pngase f prior sds page d
0.44344512.11054417.html.plaintext.txt	161	arrows indicate migration different receptor species calnexin hsp70
0.44344512.11054417.html.plaintext.txt	162	results shown representative four c two d e independent experiments
0.44344512.11054417.html.plaintext.txt	163	fact inhibition proteasomal degradation significantly increased amount mr 39000 hor species cytosolic fraction fig
0.44344512.11054417.html.plaintext.txt	164	3a lanes 7 8 suggests species may dislocate er membrane accumulate cytosol prior proteasomal degradation
0.44344512.11054417.html.plaintext.txt	165	test hypothesis receptors immunoprecipitated soluble fraction pulse chase labeling lactacystin treated cells
0.44344512.11054417.html.plaintext.txt	166	3e small amount mr 39000 receptor species present cytosol end pulse
0.44344512.11054417.html.plaintext.txt	167	however amount detected clearly increased chase indicating mr 39000 species originates pool newly synthesized receptors retained er failure inefficiency translocation machinery
0.44344512.11054417.html.plaintext.txt	168	thus species likely results deglycosylation mr 45000 receptor precursor destined degradation eventually dislocates er membrane
0.44344512.11054417.html.plaintext.txt	169	removal n linked glycans likely occurs prior retrotranslocation cytosol since deglycosylated hor species found cytosolic membrane fractions fig
0.44344512.11054417.html.plaintext.txt	170	3a lanes 8 4 respectively
0.44344512.11054417.html.plaintext.txt	171	inhibition proteasomal degradation leads accumulation polyubiquitinated hors directly test hypothesis hor modified ubiquitination cellular lysates 35smethioninecysteine pulse labeled cells subjected sequential immunoprecipitation
0.44344512.11054417.html.plaintext.txt	172	first hors immunoprecipitated anti flag m2 antibody purified material denatured sds
0.44344512.11054417.html.plaintext.txt	173	proteins reimmunoprecipitated using anti ubiquitin antibody
0.44344512.11054417.html.plaintext.txt	174	immunoprecipitation steps fig
0.44344512.11054417.html.plaintext.txt	175	4 b carried presence nem prevent inappropriate aggregation proteins
0.44344512.11054417.html.plaintext.txt	176	lactacystin treated cells immunoprecipitated material migrated high molecular weight smear extended upwards toward top gel fig
0.44344512.11054417.html.plaintext.txt	177	4a lane 4 feature characteristic ubiquitinated proteins 8 10 17 20 22 33 35 48 49
0.44344512.11054417.html.plaintext.txt	178	smear probably due variable number ubiquitin molecules added individual receptor molecules process polyubiquitination
0.44344512.11054417.html.plaintext.txt	179	ubiquitinated proteins barely detectable absence lactacystin fig
0.44344512.11054417.html.plaintext.txt	180	4a lane 3 indicating normally efficiently disposed proteasomes
0.44344512.11054417.html.plaintext.txt	181	view larger version 41k fig
0.44344512.11054417.html.plaintext.txt	182	immunoprecipitation ubiquitinated hor species metabolically labeled hek 293s hor flag cells
0.44344512.11054417.html.plaintext.txt	183	hek 293s hor flag cells pulse labeled 60 min 35smethioninecysteine absence presence lactacystin indicated cellular lysates prepared membrane b lanes 1 3 7 8 soluble fractions b lanes 4 6 isolated
0.44344512.11054417.html.plaintext.txt	184	total pool receptors lanes 1 2 b lanes 1 4 ubiquitinated receptor forms lanes 3 4 b lanes 2 3 5 8 isolated sequential immunoprecipitation using anti flag m2 anti ubiquitin antibodies indicated
0.44344512.11054417.html.plaintext.txt	185	immunoprecipitates subjected sds page fluorography
0.44344512.11054417.html.plaintext.txt	186	lanes 7 8 b represent longer exposures lanes 2 3 respectively
0.44344512.11054417.html.plaintext.txt	187	results shown representative three independent experiments
0.44344512.11054417.html.plaintext.txt	188	assess whether ubiquitinated hor species associated er membranes represent dislocated cytosolic receptors 35smethioninecysteine labeled receptors subjected sequential immunoprecipitation following fractionation lactacystin treated cells
0.44344512.11054417.html.plaintext.txt	189	4b presence ubiquitinated receptors cytosolic fraction could easily detected following re immunoprecipitation purified hors anti ubiquitin antibody lane 5
0.44344512.11054417.html.plaintext.txt	190	although hardly ubiquitinated material could seen membrane fraction lane 2 longer exposure revealed ubiquitinated receptors also associated fraction lane 7
0.44344512.11054417.html.plaintext.txt	191	results suggest ubiquitinated receptors accumulate cytosol receptor dislocates er membrane addition ubiquitin molecules receptor begins prior dislocation
0.44344512.11054417.html.plaintext.txt	192	verify receptor ubiquitinated coimmunoprecipitate ubiquitinated proteins anti ubiquitin antibody immunoprecipitates purified second time anti flag m2 antibody following sds denaturation
0.44344512.11054417.html.plaintext.txt	193	expected ubiquitinated receptor diffusely migrating material recovered fig
0.44344512.11054417.html.plaintext.txt	194	distinct higher molecular weight species detected fig
0.44344512.11054417.html.plaintext.txt	195	4 panels lane 2 b lane 4 panels lane 4 b lane 5 likely represent labeled proteins interact newly synthesized receptor sds resistant manner receptor oligomers resistant nem
0.44344512.11054417.html.plaintext.txt	196	polyubiquitination receptor result presence flag epitope tag c terminus since n terminally tagged receptor form also found ubiquitinated data shown
0.44344512.11054417.html.plaintext.txt	197	observation significant proportion soluble receptors migrates nonubiquitinated mr 39000 species fig
0.44344512.11054417.html.plaintext.txt	198	4b lane 4 consistent previous observations 8 17 35 48
0.44344512.11054417.html.plaintext.txt	199	nonubiquitinated species probably results constant deubiquitination ubiquitin isopeptidases 50
0.44344512.11054417.html.plaintext.txt	200	unlikely form could result lactacystin mediated interference cotranslational protein translocation er membrane since species accumulates cytosol chase period metabolic labeling experiment shown fig
0.44344512.11054417.html.plaintext.txt	201	er retained newly synthesized hors retrotranslocated cytosol via sec61 complex cellular fractionation experiments clearly showed er retained newly synthesized hors dislocate er membrane cytosol figs
0.44344512.11054417.html.plaintext.txt	202	assess whether dislocation involves retrotranslocation sec61 translocon reported membrane proteins degraded proteasomes 13 17 21 coimmunoprecipitation experiments subunit sec61 complex performed
0.44344512.11054417.html.plaintext.txt	203	cells treated lactacystin pulse labeled 35smethioninecysteine chased 60 min
0.44344512.11054417.html.plaintext.txt	204	5a lanes 5 6 re immunoprecipitation sec61 immunoprecipitates anti flag m2 antibody recovered mr 45000 42000 39000 receptor species suggesting interact translocon
0.44344512.11054417.html.plaintext.txt	205	interaction shown specific species absent anti sec61 antibody replaced preimmune serum first immunoprecipitation step fig
0.44344512.11054417.html.plaintext.txt	206	5a lanes 3 4 anti flag m2 affinity resin replaced anti mouse igg agarose second step data shown
0.44344512.11054417.html.plaintext.txt	207	although three receptor species found coimmunoprecipitate subunit sec61 complex untreated lactacystin treated cells treatment proteasome inhibitor increased amount mr 39000 species became prevalent fig
0.44344512.11054417.html.plaintext.txt	208	sensitivity mr 45000 mr 42000 receptors pngase f fig
0.44344512.11054417.html.plaintext.txt	209	5b lanes 3 4 confirmed identity precursor deglycosylation intermediate respectively
0.44344512.11054417.html.plaintext.txt	210	cells chased 60 min lysates prepared receptor species interact translocon likely transit exit er rather translocated membrane
0.44344512.11054417.html.plaintext.txt	211	fact fully deglycosylated mr 39000 receptor well glycosylated mr 42000 45000 species associate sec61 complex confirms deglycosylation occurs complete retrotranslocation receptor cytosol
0.44344512.11054417.html.plaintext.txt	212	view larger version 34k fig
0.44344512.11054417.html.plaintext.txt	213	immunoprecipitation sec61 complex associated hor species metabolically labeled hek 293s hor flag cells
0.44344512.11054417.html.plaintext.txt	214	hek 293s hor flag cells pulse labeled 60 min 35smethioninecysteine chased 60 min presence absence lactacystin indicated
0.44344512.11054417.html.plaintext.txt	215	total pool receptors lanes 1 2 b lanes 1 3 interacting sec61 complex lanes 5 6 b lanes 2 4 isolated total lysates sequential coimmunoprecipitation using anti flag m2 anti sec61 antibodies indicated immunoprecipitates subjected sds page fluorography either directly pngase f digestion b
0.44344512.11054417.html.plaintext.txt	216	results shown representative three independent experiments
0.44344512.11054417.html.plaintext.txt	217	discussion top abstract introduction experimental procedures results discussion references
0.44344512.11054417.html.plaintext.txt	218	results present study indicate core glycosylated hor precursors competent enter maturation pathway transported cytosol process involves sec61 translocon removal n linked oligosaccharides addition ubiquitin molecules
0.44344512.11054417.html.plaintext.txt	219	process leads targeting significant proportion newly synthesized receptors degradation 26 proteasomes
0.44344512.11054417.html.plaintext.txt	220	hor thus appears protein due inherent difficulties acquiring native conformation efficiently disposed er quality control
0.44344512.11054417.html.plaintext.txt	221	elimination could result either high level irreversible misfolding limitations folding kinetics
0.44344512.11054417.html.plaintext.txt	222	proteasomal blockade found enhance er export maturation receptor kinetic limitations leading premature degradation folding intermediates likely contribute observed phenomenon
0.44344512.11054417.html.plaintext.txt	223	irrespective nature receptor forms targeted degradation irreversibly misfolded folding intermediates present results show er quality control eliminate high proportion wild type proteins
0.44344512.11054417.html.plaintext.txt	224	seem unique hor since schubert colleagues 36 recently suggested least 30 newly synthesized proteins degraded proteasomes 36
0.44344512.11054417.html.plaintext.txt	225	hypothesized degradation referred defective ribosomal products could serve important adaptation early antigen presentation viral infection 36 51
0.44344512.11054417.html.plaintext.txt	226	whether high rate degradation newly synthesized hors also serves biological purpose remains determined
0.44344512.11054417.html.plaintext.txt	227	alternatively process could merely reflect exceedingly stringent control system monitoring rapid error prone protein synthesis machinery
0.44344512.11054417.html.plaintext.txt	228	expression relatively high level 10 pmolmg protein clone used needed perform type studies presented one cannot entirely exclude overexpression part responsible proteasomal mediated degradation observed
0.44344512.11054417.html.plaintext.txt	229	however feel unlikely since identical data obtained using clone expressing smaller number receptors 4 pmolmg protein data shown
0.44344512.11054417.html.plaintext.txt	230	additionally fact several endogenously expressed er proteins shown targeted proteasomal degradation regulated manner 27 29 reinforces idea proteolytic pathway general mechanism used regulate protein biosynthesis
0.44344512.11054417.html.plaintext.txt	231	several lines evidence demonstrate role cytoplasmic proteasomes high degradation rate newly synthesized hors
0.44344512.11054417.html.plaintext.txt	232	first turnover rate core glycosylated mr 45000 precursor well two smaller receptor species mr 42000 39000 reduced considerably cells treated proteasomal inhibitors lactacystin mg 132 psi
0.44344512.11054417.html.plaintext.txt	233	second amount fully mature receptor increased upon proteasomal inhibition
0.44344512.11054417.html.plaintext.txt	234	finally mr 39000 receptor polyubiquitinated forms accumulated cytoplasm following proteasomal blockade
0.44344512.11054417.html.plaintext.txt	235	given mr 39000 receptor species contains full length receptor polypeptide data support hypothesis integral membrane proteins released completely er membrane prior proteasomal degradation rather cleaved partially within membrane 13 15 17 42
0.44344512.11054417.html.plaintext.txt	236	association hor precursor two full length deglycosylated intermediates sec61 translocon supports recently proposed model suggesting retrotranslocation misfolded incompletely folded er proteins cytoplasm mediated sec61 complex 13 17 21 46 52 53 multimeric protein complex also responsible cotranslational translocation proteins er 54
0.44344512.11054417.html.plaintext.txt	237	like hor major histocompatibility class molecule f508 mutant cftr found interact sec61 translocon transit er leads degradation proteasomes 13 17
0.44344512.11054417.html.plaintext.txt	238	hypothesized dislocation integral membrane proteins may involve reverse process membrane integration involving lateral opening translocon toward lipid bilayer 39 54
0.44344512.11054417.html.plaintext.txt	239	however misfolded incompletely folded proteins recognized delivered dislocation machinery unknown
0.44344512.11054417.html.plaintext.txt	240	similarly precise mechanism proteasomal substrates extracted lipid bilayer well origin driving force retrotranslocation still unresolved issues
0.44344512.11054417.html.plaintext.txt	241	finding mr 39000 hor degradation intermediate accumulates cytosol following lactacystin treatment suggests proteasomal function obligatory dislocation membrane proteins er membrane
0.44344512.11054417.html.plaintext.txt	242	however rule possibility normal conditions
0.44344512.11054417.html.plaintext.txt	243	proteasomes impaired dislocation degradation misfolded incompletely folded proteins may tightly coupled events
0.44344512.11054417.html.plaintext.txt	244	fact three observations present study suggest coupling proteasome function dislocation proteins er membrane
0.44344512.11054417.html.plaintext.txt	245	inhibition proteasome found 1 increase amount reduce turnover rate membrane bound mr 42000 45000 forms receptor 2 increase total amount receptor coimmunoprecipitated subunit sec61 complex 3 increase relative proportion translocon associated mr 39000 degradation intermediate ultimately dislocates er membrane cytosol
0.44344512.11054417.html.plaintext.txt	246	thus although proteasomal function obligatory dislocation impairment appears lead attenuation process prolongation association translocon
0.44344512.11054417.html.plaintext.txt	247	results consistent findings showing mutant 21 chimeric 55 transmembrane proteins stabilized within er membrane yeast mutants expressing functionally impaired proteasomes
0.44344512.11054417.html.plaintext.txt	248	coupling dislocation degradation could achieved direct transfer protein substrates proteasomes
0.44344512.11054417.html.plaintext.txt	249	indeed although proteasomes mainly detected cytosol nucleus found associated er membranes 56
0.44344512.11054417.html.plaintext.txt	250	coupling membrane dissociation proteolysis would clearly increase efficiency proteolysis direct transfer unfolded retrotranslocated proteins proteasome would eliminate need additional unfolding substrate prerequisite proteasomal degradation 31
0.44344512.11054417.html.plaintext.txt	251	time proteasome via regulatory subcomplex pa700 could provide driving force retrotranslocation 31
0.44344512.11054417.html.plaintext.txt	252	coupling would also effective way prevent cytoplasmic aggregation dislocated membrane proteins
0.44344512.11054417.html.plaintext.txt	253	context noteworthy proteasomal blockade shown promote formation high molecular weight insoluble aggregates 8 16
0.44344512.11054417.html.plaintext.txt	254	example wild type f508 mutant forms cftr shown accumulate together cytosolic chaperones specific pericentriolar structure called aggresome 57 58
0.44344512.11054417.html.plaintext.txt	255	inhibition proteasomal degradation resulted accumulation polyubiquitinated forms hor cytosol suggesting modification may target misfolded incompletely folded receptors proteasome
0.44344512.11054417.html.plaintext.txt	256	based finding small amount ubiquitinated receptor forms detected membrane fraction also envisioned polyubiquitination could provide direct signal proteasome recruitment er membrane
0.44344512.11054417.html.plaintext.txt	257	however unclear whether ubiquitination prerequisite rapid breakdown receptor shown many integral membrane secretory proteins degraded proteasomes
0.44344512.11054417.html.plaintext.txt	258	example many misfolded unassembled er proteins shown stabilized mutant ubiquitin activating 8 46 48 ubiquitin conjugating enzymes 9 10 18 20 21 59 dominant negative ubiquitin mutants prevent polyubiquitination substrate proteins 8 10 18 21 48 60
0.44344512.11054417.html.plaintext.txt	259	considering enzymes could responsible ubiquitination hor still membrane bound noteworthy two yeast ubiquitin conjugating enzymes ubc6p ubc7p implicated ubiquitination degradation er proteins 9 10 18 20 21 28 59
0.44344512.11054417.html.plaintext.txt	260	enzymes localized er thus possibly enabling ubiquitination misfolded incompletely folded proteins prior dislocation membrane
0.44344512.11054417.html.plaintext.txt	261	ubc6p integral membrane protein anchored membrane via c terminal hydrophobic sequence 61 whereas ubc7p docked onto membrane protein cue1p 59
0.44344512.11054417.html.plaintext.txt	262	recent report several mammalian homologs ubc6p identified 62
0.44344512.11054417.html.plaintext.txt	263	whether enzymes actually involved ubiquitination degradation er proteins remains determined
0.44344512.11054417.html.plaintext.txt	264	proteasomal degradation hor preceded removal two n linked oligosaccharides mr 45000 receptor precursor
0.44344512.11054417.html.plaintext.txt	265	agreement previous reports glycoproteins proteasomal degradation described 13 17 26 35 42 46
0.44344512.11054417.html.plaintext.txt	266	although pngase type activity detected cytosolic microsomal membrane fractions mammalian tissues 63 64 enzymes mediating deglycosylation misfolded incompletely folded proteins well precise location remained elusive
0.44344512.11054417.html.plaintext.txt	267	however recent cloning cytosolic yeast pngase 65 may pointing first candidate involved deglycosylation proteasomal substrates
0.44344512.11054417.html.plaintext.txt	268	case data suggest deglycosylation hor occurs prior dislocation er membrane translocon
0.44344512.11054417.html.plaintext.txt	269	indeed neither mr 45000 receptor precursor partially deglycosylated mr 42000 form found cytosolic fraction
0.44344512.11054417.html.plaintext.txt	270	furthermore fully deglycosylated mr 39000 degradation intermediate found coimmunoprecipitate subunit sec61 complex
0.44344512.11054417.html.plaintext.txt	271	whether degradation pathway uncovered hor present study unique characteristic receptor represents general mechanism regulating maturation cell surface expression gpcrs remains open question
0.44344512.11054417.html.plaintext.txt	272	indeed little known processes involved foldingmaturationdegradation gpcrs
0.44344512.11054417.html.plaintext.txt	273	inhibition proteasome function found lead increase 2 adrenergic receptor expression hek 293 cells 66 three gpcrs rhodopsin 67 yeast mating factor receptors 68 69 previously shown ubiquitinated
0.44344512.11054417.html.plaintext.txt	274	rhodopsin specific role yet attributed modification whereas ubiquitination proposed internalization signal activated mating factor receptor leading lysosomalvacuolar degradation 68 70 72
0.44344512.11054417.html.plaintext.txt	275	interestingly monoubiquitination rather polyubiquitination normally associated proteasome degradation pathway appears sufficient promote internalization 70 72
0.44344512.11054417.html.plaintext.txt	276	interesting determine whether ubiquitination hor mammalian gpcrs addition role proteasome mediated degradation er retained receptors also implicated internalization lysosomal degradation
0.44344512.11054417.html.plaintext.txt	277	dual role ubiquitination proposed number yeast mammalian membrane proteins 38 documented yet mammalian gpcrs
0.44344512.11054417.html.plaintext.txt	278	results present study support notion cytosolic proteasomal disposal mechanism involved elimination newly synthesized hors resulting ultimately degradation even salvageable folding intermediates
0.44344512.11054417.html.plaintext.txt	279	raises several important questions
0.44344512.11054417.html.plaintext.txt	280	example becomes important determine mechanisms stringent er monitoring system discriminates conformational variants receptor sorts either degradation allows transport downstream within secretory pathway
0.44344512.11054417.html.plaintext.txt	281	future studies also needed identify pathways components facilitate folding receptor determine whether control dynamic regulatory processes
0.44344512.11054417.html.plaintext.txt	282	although inhibiting proteasomal function favored er export maturation receptor large proportion newly synthesized receptors still remained entrapped within er
0.44344512.11054417.html.plaintext.txt	283	whether approaches acting earlier pathway steps could effective enhancing receptor folding still remains investigated
0.44344512.11054417.html.plaintext.txt	284	rapoport harvard medical school boston providing us anti sec61 antibody
0.44344512.11054417.html.plaintext.txt	285	thierry groblewski critical reading manuscript
0.44344512.11054417.html.plaintext.txt	286	work supported part grants medical research council canada m
0.44344512.11054417.html.plaintext.txt	287	ella georg ehrnrooth foundation helsinki university pharmacy oulu university scholarship foundation u
0.44344512.11054417.html.plaintext.txt	288	costs publication article defrayed part payment page charges
0.44344512.11054417.html.plaintext.txt	289	article must therefore hereby marked advertisement accordance 18 u
0.44344512.11054417.html.plaintext.txt	290	section 1734 solely indicate fact
0.44344512.11054417.html.plaintext.txt	291	correspondence may addressed dept
0.44344512.11054417.html.plaintext.txt	292	anatomy cell biology university oulu p
0.44344512.11054417.html.plaintext.txt	293	box 5000 fin 90014 oulu finland
0.44344512.11054417.html.plaintext.txt	294	scientist medical research council canada
0.44344512.11054417.html.plaintext.txt	295	correspondence may addressed dept
0.44344512.11054417.html.plaintext.txt	296	de biochimie faculte de medicine universite de montreal p
0.44344512.11054417.html.plaintext.txt	297	box 6128 succursale centre ville montreal quebec h3c 3j7 canada
0.44344512.11054417.html.plaintext.txt	298	published jbc papers press october 27 2000 doi 10
0.44344512.11054417.html.plaintext.txt	299	abbreviations used er endoplasmic reticulum cftr cystic fibrosis transmembrane conductance regulator ddm n dodecyl d maltoside dmem dulbeccos modified eagles medium gpcr g protein coupled receptor hor human opioid receptor hek 293s human embryonic kidney 293s hsp70 heat shock protein 70 mg 132 z leu leu leu cho nem n ethylmaleimide page polyacrylamide gel electrophoresis pmsf phenylmethylsulfonyl fluoride pngase f peptide n glycosidase f psi z ile gluotbu ala leu cho sti soybean trypsin inhibitor
0.44344512.11054417.html.plaintext.txt	300	references top abstract introduction experimental procedures results discussion references 1
0.44344512.11054417.html.plaintext.txt	301	1999 science 286 1882 1888abstractfree full text 2
0.44344512.11054417.html.plaintext.txt	302	19 173 202abstractfree full text 3
0.44344512.11054417.html.plaintext.txt	303	65 949 958crossrefmedline order article via infotrieve 5
0.44344512.11054417.html.plaintext.txt	304	76 326 337crossrefmedline order article via infotrieve 6
0.44344512.11054417.html.plaintext.txt	305	105 887 895abstractfree full text 7
0.44344512.11054417.html.plaintext.txt	306	1995 cell 83 129 135medline order article via infotrieve 8
0.44344512.11054417.html.plaintext.txt	307	1995 cell 83 121 127medline order article via infotrieve 9
0.44344512.11054417.html.plaintext.txt	308	1996 science 273 1725 1728abstractfree full text 11
0.44344512.11054417.html.plaintext.txt	309	271 22791 22795abstractfree full text 12
0.44344512.11054417.html.plaintext.txt	310	93 13797 13801abstractfree full text 13
0.44344512.11054417.html.plaintext.txt	311	1996 nature 384 432 438crossrefmedline order article via infotrieve 14
0.44344512.11054417.html.plaintext.txt	312	94 1896 1901abstractfree full text 15
0.44344512.11054417.html.plaintext.txt	313	1997 immunity 7 113 122medline order article via infotrieve 16
0.44344512.11054417.html.plaintext.txt	314	272 20800 20804abstractfree full text 17
0.44344512.11054417.html.plaintext.txt	315	273 29873 29878abstractfree full text 18
0.44344512.11054417.html.plaintext.txt	316	12 315 323abstractfree full text 19
0.44344512.11054417.html.plaintext.txt	317	273 11183 11188abstractfree full text 20
0.44344512.11054417.html.plaintext.txt	318	cell 9 2767 2784abstractfree full text 21
0.44344512.11054417.html.plaintext.txt	319	273 32848 32856abstractfree full text 22
0.44344512.11054417.html.plaintext.txt	320	187 835 846abstractfree full text 23
0.44344512.11054417.html.plaintext.txt	321	274 27392 27398abstractfree full text 24
0.44344512.11054417.html.plaintext.txt	322	cell 11 217 226abstractfree full text 25
0.44344512.11054417.html.plaintext.txt	323	19 550 561abstractfree full text 26
0.44344512.11054417.html.plaintext.txt	324	14 769 778abstractfree full text 27
0.44344512.11054417.html.plaintext.txt	325	271 25630 25638abstractfree full text 28
0.44344512.11054417.html.plaintext.txt	326	94 12944 12948abstractfree full text 29
0.44344512.11054417.html.plaintext.txt	327	272 9771 9778abstractfree full text 30
0.44344512.11054417.html.plaintext.txt	328	67 425 479crossrefmedline order article via infotrieve 31
0.44344512.11054417.html.plaintext.txt	329	68 1015 1068crossrefmedline order article via infotrieve 32
0.44344512.11054417.html.plaintext.txt	330	272 20427 20434abstractfree full text 33
0.44344512.11054417.html.plaintext.txt	331	1996 biochemistry 35 13843 13848crossrefmedline order article via infotrieve 34
0.44344512.11054417.html.plaintext.txt	332	40 275 286abstractfree full text 35
0.44344512.11054417.html.plaintext.txt	333	94 6210 6215abstractfree full text 36
0.44344512.11054417.html.plaintext.txt	334	2000 nature 404 770 774crossrefmedline order article via infotrieve 37
0.44344512.11054417.html.plaintext.txt	335	1997 cell 88 427 430medline order article via infotrieve 38
0.44344512.11054417.html.plaintext.txt	336	14 19 57crossrefmedline order article via infotrieve 39
0.44344512.11054417.html.plaintext.txt	337	112 4185 4191abstractfree full text 40
0.44344512.11054417.html.plaintext.txt	338	275 13727 13736abstractfree full text 41
0.44344512.11054417.html.plaintext.txt	339	79 s167 s173medline order article via infotrieve 42
0.44344512.11054417.html.plaintext.txt	340	1996 cell 84 769 779medline order article via infotrieve 43
0.44344512.11054417.html.plaintext.txt	341	1970 nature 227 680 685medline order article via infotrieve 44
0.44344512.11054417.html.plaintext.txt	342	1995 science 268 726 731medline order article via infotrieve 45
0.44344512.11054417.html.plaintext.txt	343	8 397 403crossrefmedline order article via infotrieve 46
0.44344512.11054417.html.plaintext.txt	344	273 9734 9743abstractfree full text 47
0.44344512.11054417.html.plaintext.txt	345	54 631 664crossrefmedline order article via infotrieve 48
0.44344512.11054417.html.plaintext.txt	346	274 36852 36858abstractfree full text 49
0.44344512.11054417.html.plaintext.txt	347	274 2616 2624abstractfree full text 50
0.44344512.11054417.html.plaintext.txt	348	30 405 439crossrefmedline order article via infotrieve 51
0.44344512.11054417.html.plaintext.txt	349	2000 nature 404 774 778crossrefmedline order article via infotrieve 52
0.44344512.11054417.html.plaintext.txt	350	16 4540 4548abstractfree full text 53
0.44344512.11054417.html.plaintext.txt	351	1997 nature 388 891 895crossrefmedline order article via infotrieve 54
0.44344512.11054417.html.plaintext.txt	352	1998 cell 92 381 390medline order article via infotrieve 55
0.44344512.11054417.html.plaintext.txt	353	17 3251 3257abstractfree full text 56
0.44344512.11054417.html.plaintext.txt	354	10 110 114crossrefmedline order article via infotrieve 57
0.44344512.11054417.html.plaintext.txt	355	143 1883 1898abstractfree full text 58
0.44344512.11054417.html.plaintext.txt	356	145 481 490abstractfree full text 59
0.44344512.11054417.html.plaintext.txt	357	1997 science 278 1806 1809abstractfree full text 60
0.44344512.11054417.html.plaintext.txt	358	278 g39 g48abstractfree full text 61
0.44344512.11054417.html.plaintext.txt	359	1993 nature 365 176 179crossrefmedline order article via infotrieve 62
0.44344512.11054417.html.plaintext.txt	360	269 474 480crossrefmedline order article via infotrieve 63
0.44344512.11054417.html.plaintext.txt	361	94 6244 6249abstractfree full text 64
0.44344512.11054417.html.plaintext.txt	362	322 655 661medline order article via infotrieve 65
0.44344512.11054417.html.plaintext.txt	363	149 1039 1051abstractfree full text 66
0.44344512.11054417.html.plaintext.txt	364	274 28900 28908abstractfree full text 67
0.44344512.11054417.html.plaintext.txt	365	271 14473 14484abstractfree full text 68
0.44344512.11054417.html.plaintext.txt	366	1996 cell 84 277 287medline order article via infotrieve 69
0.44344512.11054417.html.plaintext.txt	367	1 193 202medline order article via infotrieve 71
0.44344512.11054417.html.plaintext.txt	368	141 349 358abstractfree full text 72
0.44344512.11054417.html.plaintext.txt	369	19 187 198abstractfree full text
0.44344512.11054417.html.plaintext.txt	370	copyright 2001 american society biochemistry molecular biology inc
0.48486084.10409120.html.plaintext.txt	0	rapid communication syntaxin 1a inhibits regulated cftr trafficking xenopus oocytes kathryn w
0.48486084.10409120.html.plaintext.txt	1	department cell biology physiology university pittsburgh school medicine pittsburgh pennsylvania 15261
0.48486084.10409120.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references
0.48486084.10409120.html.plaintext.txt	3	cystic fibrosis transmembrane conductance regulator cftr epithelial cell cl channel whose gating activity membrane trafficking controlled campprotein kinase pka mediated phosphorylation
0.48486084.10409120.html.plaintext.txt	4	cftr cl currents regulated also syntaxin 1a
0.48486084.10409120.html.plaintext.txt	5	nature 390 302 305 1997 protein best known role membrane trafficking neurosecretion
0.48486084.10409120.html.plaintext.txt	6	examine mechanism syntaxin 1a inhibition expressed proteins xenopus oocytes monitored agonist induced changes plasma membrane capacitance cell surface fluorescence cftr contains external epitope tag
0.48486084.10409120.html.plaintext.txt	7	camp stimulation elicited large increases membrane capacitance cell surface labeling flag tagged cftr
0.48486084.10409120.html.plaintext.txt	8	coexpression cftr syntaxin 1a syntaxin 3 inhibited camp induced increases membrane capacitance plasma membrane cftr content
0.48486084.10409120.html.plaintext.txt	9	injection botulinum toxinc1 rapidly reversed syntaxins effects current capacitance indicating cannot explained effect cftr synthesis
0.48486084.10409120.html.plaintext.txt	10	functional expression integral membrane proteins including na coupled glucose transporter hsglt1 inwardly rectified k channel hik1 p2y2 nucleotide receptor viral hemagglutinin protein affected syntaxin 1a coexpression
0.48486084.10409120.html.plaintext.txt	11	findings indicate acute regulation number cftr cl channels plasma membrane one mechanism camppka regulates cl currents
0.48486084.10409120.html.plaintext.txt	12	inhibition plasma membrane cftr content syntaxin 1a consistent concept syntaxin components snare machinery involved regulated trafficking cftr
0.48486084.10409120.html.plaintext.txt	13	membrane traffic snare proteins immunofluorescence capacitance cystic fibrosis transmembrane conductance regulator
0.48486084.10409120.html.plaintext.txt	14	introduction top abstract introduction materials methods results discussion references
0.48486084.10409120.html.plaintext.txt	15	cystic fibrosis caused mutations gene encoding cystic fibrosis transmembrane conductance regulator cftr accounts camp stimulated cl conductance apical membranes many secretory absorptive epithelial cells 22
0.48486084.10409120.html.plaintext.txt	16	biochemical electrophysiological studies demonstrated cftr cl channel activity requires protein kinase pka mediated phosphorylation r domain 18 31 binding hydrolysis atp one nucleotide binding domains 1 23 26
0.48486084.10409120.html.plaintext.txt	17	addition facilitating cftr cl channel gating camppka stimulation cftr expressing cells evokes changes membrane trafficking
0.48486084.10409120.html.plaintext.txt	18	camp stimulates exocytosis inhibits endocytosis regulated trafficking events require expression wild type cftr 5
0.48486084.10409120.html.plaintext.txt	19	close correlation observed cftr dependent increases cl current membrane capacitance suggests cftr resides membrane vesicles whose trafficking influenced camp dependent agonists 25 30
0.48486084.10409120.html.plaintext.txt	20	accordingly cl current stimulation camppka may arise increases channel open probability po andor increases number n active cftr cl channels residing plasma membrane
0.48486084.10409120.html.plaintext.txt	21	results recent studies implicated role membrane traffic regulatory proteins control cftr cl currents
0.48486084.10409120.html.plaintext.txt	22	20 showed syntaxin 1a expressed colonic secretory epithelial cells detected interaction cftr syntaxin 1a using vitro protein binding assays 21
0.48486084.10409120.html.plaintext.txt	23	coexpression syntaxin 1a cftr xenopus oocytes inhibited camp stimulated cl currents inhibition could reversed syntaxin binding protein munc 18
0.48486084.10409120.html.plaintext.txt	24	proposed syntaxin 1a munc 18 regulate cftr thus cl secretion apical membranes secretory epithelial cells
0.48486084.10409120.html.plaintext.txt	25	using measurements plasma membrane capacitance cell surface expression cftr demonstrate syntaxin 1a expression interferes camppka regulated cftr trafficking
0.48486084.10409120.html.plaintext.txt	26	used epitope tagged cftr show camp stimulation elicits increase plasma membrane cftr content paralleled camp induced increase plasma membrane capacitance
0.48486084.10409120.html.plaintext.txt	27	syntaxin 1a coexpression selectively inhibited camp induced increase membrane capacitance reduced amount cftr detected plasma membrane
0.48486084.10409120.html.plaintext.txt	28	syntaxin induced reduction n consistent role protein component membrane fusion machinery
0.48486084.10409120.html.plaintext.txt	29	materials methods top abstract introduction materials methods results discussion references
0.48486084.10409120.html.plaintext.txt	30	oocyte isolations rna injections performed described previously 8 11
0.48486084.10409120.html.plaintext.txt	31	xenopus laevis obtained xenopus 1 ann arbor mi
0.48486084.10409120.html.plaintext.txt	32	oocytes isolated surgically follicular cells removed 60 90 min collagenase incubation 2 mgml type 2 worthington
0.48486084.10409120.html.plaintext.txt	33	stage 5 6 oocytes maintained modified barths solution overnight injection 50 nl vol crna cftr syntaxin 1a syntaxin 3
0.48486084.10409120.html.plaintext.txt	34	noninjected oocytes served controls
0.48486084.10409120.html.plaintext.txt	35	expression allowed proceed 18 degrees c 1 3 days current recordings immunofluorescence measurements performed
0.48486084.10409120.html.plaintext.txt	36	nd 96 solution utilized current measurements contained mm 96 nacl l kcl 1
0.48486084.10409120.html.plaintext.txt	37	recordings cftr dependent cl current icl membrane capacitance cm changes performed described ref
0.48486084.10409120.html.plaintext.txt	38	briefly cells impaled two 3 m kcl filled electrodes connected geneclamp 500 amplifier axon instruments foster city ca via ag agcl pellet electrodes referenced bath ag agcl pellet
0.48486084.10409120.html.plaintext.txt	39	membrane potentials allowed stabilize current capacitance recordings
0.48486084.10409120.html.plaintext.txt	40	voltage clamp controlled adda interface board axolab 1100 using pc running software generated laboratory
0.48486084.10409120.html.plaintext.txt	41	membrane capacitance calculated time course current decay 10 mv hyperpolarizing voltage pulse
0.48486084.10409120.html.plaintext.txt	42	decay time constant derived single exponential fit pulse currents cm calculated line described 30
0.48486084.10409120.html.plaintext.txt	43	steady state membrane currents recorded 60 mv inward currents reflect cl flow cftr stimulation camp shown prior studies 8 11
0.48486084.10409120.html.plaintext.txt	44	values icl cm obtained 2 intervals steady state values given figures
0.48486084.10409120.html.plaintext.txt	45	used immunofluorescence techniques monitor expression cftr oocyte plasma membrane
0.48486084.10409120.html.plaintext.txt	46	cells injected crna encoding epitope tagged cftr contains flag epitope dykdddk inserted predicted fourth extracellular loop cftr amino acid position 901 designated m2 901cftr
0.48486084.10409120.html.plaintext.txt	47	prior studies shown flag tagged cftr behaves identically wild type counterpart macroscopic current stimulation 13 single channel measurements detect difference channel gating pkaatp regulation relative wild type cftr 24
0.48486084.10409120.html.plaintext.txt	48	m2 901cftr expressing oocytes subjected staining protocol quantitate cftr protein expression cell surface using monoclonal m2 antibody kodak
0.48486084.10409120.html.plaintext.txt	49	oocytes cooled rapidly 0 4 degrees c incubated m2 antibody overnight temperature 11250 dilution
0.48486084.10409120.html.plaintext.txt	50	washed 5 fcs nd 96 oocytes incubated 4 degrees c fluorescein conjugated goat anti mouse igg 1100 dilution washed five times
0.48486084.10409120.html.plaintext.txt	51	protocol avoids permeabilization fixation conditions might expose intracellular flag cftr m2 antibody
0.48486084.10409120.html.plaintext.txt	52	thus staining conditions epitope position selected permit detection m2 901cftr localized plasma membrane epitope exposed cell surface
0.48486084.10409120.html.plaintext.txt	53	experiments cftr cl currents recorded m2 901cftr expressing oocytes implementing staining protocol
0.48486084.10409120.html.plaintext.txt	54	permitted cftr cl currents cell surface expression determined cells
0.48486084.10409120.html.plaintext.txt	55	experiments oocytes fixed permeabilized assess total flag cftr labeling using ice cold caltag reagents proprietary
0.48486084.10409120.html.plaintext.txt	56	cells immersed 200 microl medium 15 min washed 5 bsa c aurionnd 96 placed 200 microl medium b 30 min
0.48486084.10409120.html.plaintext.txt	57	three washes bsa cnd 96 subjected staining protocol described
0.48486084.10409120.html.plaintext.txt	58	individual oocytes scanned molecular dynamics multiprobe 2001 laser confocal microscope x 10 magnification using 10 microm optical sections
0.48486084.10409120.html.plaintext.txt	59	sections scanned 512 x 512 pixels 488 nm laser 510 nm primary beam splitter 510 nm secondary beam splitter
0.48486084.10409120.html.plaintext.txt	60	control uninjected oocytes scanned set fluorescence background laser intensity voltage set accordingly
0.48486084.10409120.html.plaintext.txt	61	image planes throughout depth specimen collected
0.48486084.10409120.html.plaintext.txt	62	quantitative measure protein expression surface oocyte derived maximal intensity rendered image
0.48486084.10409120.html.plaintext.txt	63	periphery image delineated mean pixel intensity calculated
0.48486084.10409120.html.plaintext.txt	64	crnas transcribed vitro using message machine kit ambion linearized plasmids
0.48486084.10409120.html.plaintext.txt	65	rat syntaxin cdnas kindly provided laboratory dr
0.48486084.10409120.html.plaintext.txt	66	richard scheller stanford university stanford ca
0.48486084.10409120.html.plaintext.txt	67	expression confirmed immunoprecipitation 35 kda proteins oocytes expressing syntaxin 1a syntaxin 3 data shown
0.48486084.10409120.html.plaintext.txt	68	plasmids encoding control proteins see fig
0.48486084.10409120.html.plaintext.txt	69	5 gifts laboratories drs
0.48486084.10409120.html.plaintext.txt	70	ernst wright university california los angeles ca john edelman vollum institute david julius university california san francisco ca
0.48486084.10409120.html.plaintext.txt	71	botulinum toxinc1 botc1 obtained wako chemical industries japan injected 25 nl pbs
0.48486084.10409120.html.plaintext.txt	72	results expressed means plus minus se
0.48486084.10409120.html.plaintext.txt	73	results top abstract introduction materials methods results discussion references
0.48486084.10409120.html.plaintext.txt	74	camp increases plasma membrane cftr
0.48486084.10409120.html.plaintext.txt	75	figure 1 shows composite images intact nonpermeabilized oocytes expressing epitope tagged m2 901cftr fig
0.48486084.10409120.html.plaintext.txt	76	representative image control noninjected oocyte displayed fig
0.48486084.10409120.html.plaintext.txt	77	cftr currents cell surface fluorescence determined 2 3 days crna injection
0.48486084.10409120.html.plaintext.txt	78	noninjected oocytes background fluorescence low fig
0.48486084.10409120.html.plaintext.txt	79	oocytes expressing m2 901cftr nonstimulated conditions showed low levels surface staining slightly background suggesting low level cftr expression plasma membrane absence agonist stimulation fig
0.48486084.10409120.html.plaintext.txt	80	m2 901cftr oocytes stimulated forskolinibmx 15 min showed large significant increase surface fluorescence fig
0.48486084.10409120.html.plaintext.txt	81	low fluorescence intensity detected absence agonist suggests staining protocol permit access m2 antibody intracellular epitope
0.48486084.10409120.html.plaintext.txt	82	assays performed permeabilized oocytes addition forskolinibmx influence fluorescence intensity using labeling conditions cftr basal 25
0.48486084.10409120.html.plaintext.txt	83	result indicates recognition flag epitope m2 antibody require cftr stimulation
0.48486084.10409120.html.plaintext.txt	84	view larger version 82k fig
0.48486084.10409120.html.plaintext.txt	85	effect camp stimulation cell surface cystic fibrosis transmembrane conductance regulator cftr
0.48486084.10409120.html.plaintext.txt	86	confocal images fluorescence intensities oocytes injected m2 901cftr crna 1 ng water obtained described materials methods
0.48486084.10409120.html.plaintext.txt	87	noninjected control scale bar 200 microm
0.48486084.10409120.html.plaintext.txt	88	b nonstimulated oocyte expressing m2 901cftr
0.48486084.10409120.html.plaintext.txt	89	c m2 901cftr expressing oocyte stimulated 10 microm forskolin 1 mm ibmx 15 min
0.48486084.10409120.html.plaintext.txt	90	d mean fluorescence intensity current 60 mv results 3 experiments 8 oocytes treated b c
0.48486084.10409120.html.plaintext.txt	91	intensity values corrected background fluorescence intensity 18 plus minus 2 recorded noninjected oocytes n 5
0.48486084.10409120.html.plaintext.txt	92	average data three experiments nonpermeabilized oocytes provided fig
0.48486084.10409120.html.plaintext.txt	93	also shown results parallel measurements steady state current obtained addition forskolinibmx values consistent magnitude cftr current stimulation observed prior studies 8 11
0.48486084.10409120.html.plaintext.txt	94	immunofluorescence data indicate increase cl current paralleled increase plasma membrane cftr
0.48486084.10409120.html.plaintext.txt	95	oocytes stimulation group staining protocol initiated 15 min addition forskolinibmx time cl currents rise plateau level
0.48486084.10409120.html.plaintext.txt	96	thus detection m2 epitope cell surface occurs within time frame required camp induced increases cl current membrane capacitance 30
0.48486084.10409120.html.plaintext.txt	97	findings consistent idea camppka stimulation induces insertion cftr containing vesicles plasma membrane
0.48486084.10409120.html.plaintext.txt	98	syntaxin 1a inhibits camppka induced increases plasma membrane capacitance cftr
0.48486084.10409120.html.plaintext.txt	99	effects icl cm syntaxin coexpression cftr illustrated fig
0.48486084.10409120.html.plaintext.txt	100	syntaxin 1a coexpressed cftr cl current stimulation camp inhibited reported naren et al
0.48486084.10409120.html.plaintext.txt	101	parallel syntaxin induced reduction cl current camp stimulation membrane capacitance also markedly inhibited
0.48486084.10409120.html.plaintext.txt	102	inhibition changes icl icl cm cm selective syntaxin 1a
0.48486084.10409120.html.plaintext.txt	103	coexpression syntaxin 3 cftr affect parameters significantly suggesting effects syntaxin isoform specific
0.48486084.10409120.html.plaintext.txt	104	finding also eliminates translational competition cftr syntaxin crnas explanation inhibitory effect syntaxin 1a agonist induced icl cm
0.48486084.10409120.html.plaintext.txt	105	view larger version 23k fig
0.48486084.10409120.html.plaintext.txt	106	effect syntaxin coexpression current icl 60 mv capacitance cm responses camp stimulation
0.48486084.10409120.html.plaintext.txt	107	oocytes injected crna cftr 1 ng andor syntaxin 1a 3 syn1a syn3 respectively 5 ng
0.48486084.10409120.html.plaintext.txt	108	steady state values icl cm obtained stimulation 10 microm forskolin 1 mm ibmx n 5 group
0.48486084.10409120.html.plaintext.txt	109	similar levels inhibition current capacitance obtained syntaxin 1a doses ranging 1 20 ng cftr constant 1 ng data shown
0.48486084.10409120.html.plaintext.txt	110	effect syntaxin 1a coexpression cftr detected oocyte surface camppka stimulation illustrated fig
0.48486084.10409120.html.plaintext.txt	111	1c images collected oocytes stimulated maximally effective concentrations forskolin ibmx see legend fig
0.48486084.10409120.html.plaintext.txt	112	noninjected control oocyte illustrates background level cell surface staining presence agonists fig
0.48486084.10409120.html.plaintext.txt	113	low fluorescence intensity indicates camp stimulation increase background fluorescence absence cftr expression compare fig
0.48486084.10409120.html.plaintext.txt	114	camp stimulation m2 901cftr readily detected surface membrane fig
0.48486084.10409120.html.plaintext.txt	115	3b coexpression syntaxin 1a markedly reduced plasma membrane cftr camp stimulation fig
0.48486084.10409120.html.plaintext.txt	116	result consistent syntaxin 1a induced decrease camp dependent cm shown fig
0.48486084.10409120.html.plaintext.txt	117	membrane capacitance current responses syntaxin 3 coexpression effect cell surface cftr staining data shown
0.48486084.10409120.html.plaintext.txt	118	quantitation results four experiments fig
0.48486084.10409120.html.plaintext.txt	119	3d shows cftr surface expression correlates magnitude currents recorded oocytes antibody labeling
0.48486084.10409120.html.plaintext.txt	120	syntaxin 1a coexpression cell surface cftr fluorescence intensity fell nearly level water injected controls
0.48486084.10409120.html.plaintext.txt	121	thus insertion cftr plasma membrane required activation cftr cl currents recorded cells stimulation syntaxin 1a reduces cftr cl currents decreasing amount cftr plasma membrane stimulation
0.48486084.10409120.html.plaintext.txt	122	view larger version 62k fig
0.48486084.10409120.html.plaintext.txt	123	effect syntaxin 1a cell surface cftr camp stimulation
0.48486084.10409120.html.plaintext.txt	124	oocyte injections rna m2 901cftr crna b 1 ng m2 901cftr syntaxin 1a crna c 5 ng
0.48486084.10409120.html.plaintext.txt	125	oocytes exposed 10 microm forskolin 1 mm ibmx 15 min labeling
0.48486084.10409120.html.plaintext.txt	126	small adherent air bubbles produced nonstained areas b areas 5 oocyte image area
0.48486084.10409120.html.plaintext.txt	127	d mean current 60 mv fluorescence intensity measured sequentially oocytes
0.48486084.10409120.html.plaintext.txt	128	results 4 experiments 16 oocytes treated b c
0.48486084.10409120.html.plaintext.txt	129	values corrected background intensity 23 plus minus 2 water injected controls n 10
0.48486084.10409120.html.plaintext.txt	130	effects botc1 cftr icl cm without syntaxin 1a coexpression shown fig
0.48486084.10409120.html.plaintext.txt	131	injected botc1 60 min recording current capacitance responses forskolinibmx
0.48486084.10409120.html.plaintext.txt	132	botc1 acutely reversed syntaxin 1a inhibition icl cm presumably due cleavage syntaxin 1a
0.48486084.10409120.html.plaintext.txt	133	toxin interfere icl cm responses oocytes injected cftr alone
0.48486084.10409120.html.plaintext.txt	134	relatively rapid reversal cftr function argues effect syntaxin level cftr protein expression explanation inhibitory effect cftr current capacitance
0.48486084.10409120.html.plaintext.txt	135	comparison half time inhibition cftr currents oocytes brefeldin 6 h data shown
0.48486084.10409120.html.plaintext.txt	136	finding indicates steady state rates cftr production degradation cells sufficiently rapid protein synthesis account botc1 reversal syntaxins effects cftr
0.48486084.10409120.html.plaintext.txt	137	view larger version 28k fig
0.48486084.10409120.html.plaintext.txt	138	effect botulinum toxin c1 botc1 current icl capacitance cm responses camp stimulation
0.48486084.10409120.html.plaintext.txt	139	oocytes injected 1 ng botc1 60 min recording
0.48486084.10409120.html.plaintext.txt	140	2 results 3 experiments least 8 oocytesgroup
0.48486084.10409120.html.plaintext.txt	141	finally examined influence syntaxin coexpression activities several plasma membrane transport receptor proteins
0.48486084.10409120.html.plaintext.txt	142	control experiments performed examine possibility syntaxin 1a may block functional expression cftr generally interfering migration proteins biosynthetic pathway leading plasma membrane
0.48486084.10409120.html.plaintext.txt	143	crna amounts selected based prior reports using constructs see references currents obtained similar magnitude
0.48486084.10409120.html.plaintext.txt	144	coexpression syntaxin 1a na dependent glucose transporter sglt1 12 atp sensitive ca activated k channel ik1 14 p2y2 purinergic receptor 17 effect currents associated activation proteins fig
0.48486084.10409120.html.plaintext.txt	145	5 see legend activation conditions
0.48486084.10409120.html.plaintext.txt	146	addition syntaxin 1a inhibit plasma membrane expression viral hemagglutinin ha protein oocyte surface detected immunofluorescence using techniques similar used detection cell surface m2 901cftr background subtracted ha fluorescence intensities ha alone 24
0.48486084.10409120.html.plaintext.txt	147	1 n 6 ha syntaxin 1a 29
0.48486084.10409120.html.plaintext.txt	148	0 n 5 crnas 5 ng ha 10 ng syntaxin 1a
0.48486084.10409120.html.plaintext.txt	149	data show syntaxin 1a impair ha protein expression even crna dose ratio favor syntaxin 1a
0.48486084.10409120.html.plaintext.txt	150	addition relative protein expression level hik1 judged current comparable obtained cftr compare figs
0.48486084.10409120.html.plaintext.txt	151	single channel current amplitude po hik1 greater cftr 12 similar macroscopic current requires expression less protein
0.48486084.10409120.html.plaintext.txt	152	despite hik1 currents inhibited syntaxin 1a even five times dose required maximal inhibition cftr see legends figs
0.48486084.10409120.html.plaintext.txt	153	accordingly syntaxin 1a simply disrupting expression targeting integral plasma membrane proteins rather inhibitory effect specific cftr
0.48486084.10409120.html.plaintext.txt	154	view larger version 22k fig
0.48486084.10409120.html.plaintext.txt	155	effect syntaxin coexpression activity plasma membrane proteins
0.48486084.10409120.html.plaintext.txt	156	numbers parentheses indicate crna amounts injectedoocyte
0.48486084.10409120.html.plaintext.txt	157	na coupled glucose transporter hsglt1 50 ng syntaxin 1a 5 ng
0.48486084.10409120.html.plaintext.txt	158	inward na current 100 mv evoked addition 5 mm methyl d glycoside bath
0.48486084.10409120.html.plaintext.txt	159	b inward rectifier k channel hik1 50 ng syntaxins 1a 3 10 ng
0.48486084.10409120.html.plaintext.txt	160	inward k current 100 mv evoked bath addition 1 microm ionomycin
0.48486084.10409120.html.plaintext.txt	161	c current voltage relationship endogenous cl current elicited p2y2 nucleotide receptor 5 ng activation bath addition 100 microm utp syntaxin 1a 5 ng
0.48486084.10409120.html.plaintext.txt	162	see text citations details
0.48486084.10409120.html.plaintext.txt	163	discussion top abstract introduction materials methods results discussion references
0.48486084.10409120.html.plaintext.txt	164	previous study 30 showed camp stimulation increased cl current membrane capacitance cftr expressing xenopus oocytes
0.48486084.10409120.html.plaintext.txt	165	effects reversible agonist washout required cftr expression
0.48486084.10409120.html.plaintext.txt	166	changes icl cm closely correlated one another agonist dose cftr expression level varied cftr mutants different icl responses expressed
0.48486084.10409120.html.plaintext.txt	167	increase cell surface area detected cm confirmed morphometry oocyte surface cells used electrical recordings 30
0.48486084.10409120.html.plaintext.txt	168	close correlation icl cm suggests cftr activation camppka elicits reversible stimulation membrane vesicle insertion plasma membrane process implicated variety cftr expressing cells 4
0.48486084.10409120.html.plaintext.txt	169	results obtained oocytes expressing epitope tagged cftr verify concept
0.48486084.10409120.html.plaintext.txt	170	incorporation extracellular flag epitope permits detection cftr protein surface nonpermeabilized cells 13
0.48486084.10409120.html.plaintext.txt	171	approach obviates problems resolving protein localization plasma membrane since standard immunofluorescence techniques sufficient resolution distinguish protein 100 nm submembrane vesicles plasma membrane
0.48486084.10409120.html.plaintext.txt	172	cftr bearing flag tag fourth extracellular loop detected appreciably surface oocytes basal nonstimulated conditions cftr cl currents near zero fig
0.48486084.10409120.html.plaintext.txt	173	camp stimulation increased plasma membrane cftr sevenfold within time frame associated stimulation icl cm 15 min figs
0.48486084.10409120.html.plaintext.txt	174	control experiments indicated m2 antibody staining noninjected oocytes affected camp stimulation
0.48486084.10409120.html.plaintext.txt	175	surface labeling signal cftr stimulation dependent
0.48486084.10409120.html.plaintext.txt	176	correlations camp stimulated cftr current capacitance cell surface labeling show cftr insertion exocytosis important event stimulation plasma membrane cl conductance cells camp
0.48486084.10409120.html.plaintext.txt	177	oocyte proven useful model studies transporter related membrane trafficking events
0.48486084.10409120.html.plaintext.txt	178	previous studies include relocation aminobutyric acid transporters plasma membrane response protein kinase c activation 7 regulation cell surface expression several na dependent cotransport processes protein kinases c 12
0.48486084.10409120.html.plaintext.txt	179	addition influence mutations amiloride sensitive na channel enac produce hypertension prolonging plasma membrane residency time enac characterized mechanistically using oocyte expression system 28
0.48486084.10409120.html.plaintext.txt	180	biochemical events control membrane insertion retrieval processes plasma membrane thought conform principles first identified vesicle transit among compartments protein biosynthetic pathway 2 29
0.48486084.10409120.html.plaintext.txt	181	interactions among proteins comprise soluble n ethylmaleimide sensitive factor attachment protein target receptor snare protein complex control targeting docking fusion retrieval membrane vesicles contain secretory products integral membrane proteins like cftr become constituents plasma membrane
0.48486084.10409120.html.plaintext.txt	182	physiological importance snare proteins exemplified highly regulated process neurosecretion understanding actions proteins membrane trafficking events epithelial cells relatively meager
0.48486084.10409120.html.plaintext.txt	183	findings implicate role syntaxin regulated cftr trafficking
0.48486084.10409120.html.plaintext.txt	184	coexpression cftr syntaxin 1a reduced camp dependent membrane insertion event detected increase membrane capacitance fig
0.48486084.10409120.html.plaintext.txt	185	syntaxin also blocked increase plasma membrane cftr occurs stimulation activity camppka fig
0.48486084.10409120.html.plaintext.txt	186	cftr detected significant levels plasma membrane basal conditions fig
0.48486084.10409120.html.plaintext.txt	187	1 present appreciably cell surface camp stimulation cells coexpressing syntaxin 1a
0.48486084.10409120.html.plaintext.txt	188	effects specific cftr opposed integral membrane proteins examined selective syntaxin isoform could explained effect syntaxin cftr synthesis
0.48486084.10409120.html.plaintext.txt	189	taken together findings indicate syntaxin 1a interferes camppka stimulated trafficking cftr cell surface
0.48486084.10409120.html.plaintext.txt	190	mechanism effect results naren et al
0.48486084.10409120.html.plaintext.txt	191	20 21 suggest cftr cl currents inhibited due physical interaction proteins
0.48486084.10409120.html.plaintext.txt	192	protein protein interaction observed also n type ca channels syntaxin 1a 27 may contribute syntaxin associated downregulation ca currents 3 32
0.48486084.10409120.html.plaintext.txt	193	assuming physical interaction occurs syntaxin 1a cftr vivo expressed syntaxin 1a may prevent cftr insertion plasma membrane binding cftr contained vesicles would normally fuse plasma membrane
0.48486084.10409120.html.plaintext.txt	194	second cftr syntaxin 1a complex may retrieved rapidly plasma membrane endocytosis
0.48486084.10409120.html.plaintext.txt	195	measurements detect net membrane area cm steady state plasma membrane cftr distinguish whether effect syntaxin insertion retrieval cftr
0.48486084.10409120.html.plaintext.txt	196	possible also overexpressed syntaxin associates primarily cftr snare components block membrane fusion process
0.48486084.10409120.html.plaintext.txt	197	according view syntaxin 1a overexpression would disrupt stoichiometric interactions among snare proteins required plasma membrane fusion cftr containing vesicles
0.48486084.10409120.html.plaintext.txt	198	effect expressed syntaxin observed previously
0.48486084.10409120.html.plaintext.txt	199	example exogenous expression golgi snare syntaxin 5 inhibited protein traffic endoplasmic reticulum golgi step syntaxin isoform functions 9
0.48486084.10409120.html.plaintext.txt	200	likewise expression syntaxin 1a 1b blocked glucose stimulated insulin secretion pancreatic cells 19
0.48486084.10409120.html.plaintext.txt	201	mdck cells syntaxin 3 apically localized exogenous expression selectively inhibited apical targeting apical recycling immunoglobulin receptor 16
0.48486084.10409120.html.plaintext.txt	202	findings suggest overexpression specific syntaxin isoform disrupts pathway isoform normally plays role membrane trafficking events
0.48486084.10409120.html.plaintext.txt	203	true results suggest endogenous snare proteins including xenopus syntaxin 1a ortholog responsible camp regulated plasma membrane cftr insertion oocytes
0.48486084.10409120.html.plaintext.txt	204	expression core components snare machinery observed cortical granules sea urchin oocytes 6
0.48486084.10409120.html.plaintext.txt	205	accordingly snare fusion machinery would employed mediate membrane insertion cftr interaction cftr snare proteins could explain expression cftr alone confer camp dependent membrane trafficking events cells none present cftr expression 5 30
0.48486084.10409120.html.plaintext.txt	206	requirement specific snare components process could also account apparent failure certain cell types support regulated cftr trafficking events 10 15
0.48486084.10409120.html.plaintext.txt	207	demonstration syntaxin 1a expressed colonic secretory cells 1 consistent concept protein together components snare machinery mediates camppka regulated insertion cftr apical membranes cells
0.48486084.10409120.html.plaintext.txt	208	although findings suggest snare machinery plays important role regulated trafficking cftr plasma membrane rule direct regulation cftrs gating po could result physical interaction syntaxin
0.48486084.10409120.html.plaintext.txt	209	accordingly syntaxin could directly regulate cftr cl currents perhaps relation snare protein mediated membrane trafficking reactions control amount cftr present plasma membrane
0.48486084.10409120.html.plaintext.txt	210	qi contributed equally work
0.48486084.10409120.html.plaintext.txt	211	thank megan weiss technical assistance patricia connelly help manuscript laboratory richard scheller syntaxin cdnas
0.48486084.10409120.html.plaintext.txt	212	research supported national institute diabetes digestive kidney diseases grant dk 50829 cystic fibrosis foundation grants 97ro 96po
0.48486084.10409120.html.plaintext.txt	213	costs publication article defrayed part payment page charges
0.48486084.10409120.html.plaintext.txt	214	article must therefore hereby marked advertisement accordance 18 u
0.48486084.10409120.html.plaintext.txt	215	1734 solely indicate fact
0.48486084.10409120.html.plaintext.txt	216	address reprint requests correspondence r
0.48486084.10409120.html.plaintext.txt	217	cell biology physiology s362 bst 3500 terrace st
0.48486084.10409120.html.plaintext.txt	218	pittsburgh school medicine pittsburgh pa 15261 e mail frizzellatpitt
0.48486084.10409120.html.plaintext.txt	219	received 19 february 1999 accepted final form 5 april 1999
0.48486084.10409120.html.plaintext.txt	220	references top abstract introduction materials methods results discussion references
0.48486084.10409120.html.plaintext.txt	221	coupling atp hydrolysis channel gating purified reconstituted cftr
0.48486084.10409120.html.plaintext.txt	222	molecular machinery secretion conserved yeast neurons
0.48486084.10409120.html.plaintext.txt	223	usa 90 2559 2563 1993abstract
0.48486084.10409120.html.plaintext.txt	224	functional impact syntaxin gating n type q type calcium channels
0.48486084.10409120.html.plaintext.txt	225	nature 378 623 626 1995medline
0.48486084.10409120.html.plaintext.txt	226	intracellular cftr localization function
0.48486084.10409120.html.plaintext.txt	227	regulation plasma membrane recycling cftr
0.48486084.10409120.html.plaintext.txt	228	science 256 530 532 1992medline
0.48486084.10409120.html.plaintext.txt	229	members snare hypothesis associated cortical granule exocytosis sea urchin egg
0.48486084.10409120.html.plaintext.txt	230	protein kinase c modulates activity cloned aminobutyric acid transporter expressed xenopus oocytes via regulated subcellular redistribution transporter
0.48486084.10409120.html.plaintext.txt	231	269 14759 14767 1994abstractfree full text
0.48486084.10409120.html.plaintext.txt	232	camp stimulated ion currents xenopus oocytes expressing cftr crna
0.48486084.10409120.html.plaintext.txt	233	31 c783 c788 1992abstractfree full text
0.48486084.10409120.html.plaintext.txt	234	mammalian sly1 regulates syntaxin 5 function endoplasmic reticulum golgi transport
0.48486084.10409120.html.plaintext.txt	235	271 15866 15869 1996abstractfree full text
0.48486084.10409120.html.plaintext.txt	236	plasma membrane recycling cftr expressing cho cells
0.48486084.10409120.html.plaintext.txt	237	cl conductance expressed f508 mutant cftrs activated near wild type levels xenopus oocytes
0.48486084.10409120.html.plaintext.txt	238	science 254 1797 1799 1991medline
0.48486084.10409120.html.plaintext.txt	239	regulation naglucose cotransporter expression protein kinases xenopus laevis oocytes
0.48486084.10409120.html.plaintext.txt	240	271 14740 14746 1996abstractfree full text
0.48486084.10409120.html.plaintext.txt	241	epitope tagging permits cell surface detection functional cftr
0.48486084.10409120.html.plaintext.txt	242	38 c1565 c1576 1995abstractfree full text
0.48486084.10409120.html.plaintext.txt	243	human intermediate conductance calcium activated potassium channel
0.48486084.10409120.html.plaintext.txt	244	usa 94 11651 11656 1997abstractfree full text
0.48486084.10409120.html.plaintext.txt	245	exocytosis involved activation cl secretion via cftr calu 3 airway epithelial cells
0.48486084.10409120.html.plaintext.txt	246	44 c913 c920 1998abstractfree full text
0.48486084.10409120.html.plaintext.txt	247	snare machinery involved apical plasma membrane trafficking mdck cells
0.48486084.10409120.html.plaintext.txt	248	141 1503 1513 1998abstractfree full text
0.48486084.10409120.html.plaintext.txt	249	expression cloning atp receptor mouse neuroblastoma cells
0.48486084.10409120.html.plaintext.txt	250	usa 90 5113 5117 1993abstract
0.48486084.10409120.html.plaintext.txt	251	dibasic protein kinase sites regulate bursting rate nucleotide sensitivity cystic fibrosis transmembrane conductance regulator chloride channel
0.48486084.10409120.html.plaintext.txt	252	508 365 377 1998abstractfree full text
0.48486084.10409120.html.plaintext.txt	253	expression functional role syntaxin 1hpc 1 pancreatic beta cells
0.48486084.10409120.html.plaintext.txt	254	syntaxin 1a 1b plays negative role regulatory insulin release pathway
0.48486084.10409120.html.plaintext.txt	255	271 1160 1165 1996abstractfree full text
0.48486084.10409120.html.plaintext.txt	256	regulation cftr chloride channels syntaxin munc 18 isoforms
0.48486084.10409120.html.plaintext.txt	257	nature 390 302 305 1997medline
0.48486084.10409120.html.plaintext.txt	258	syntaxin 1a inhibits cftr chloride channels means domain specific protein protein interactions
0.48486084.10409120.html.plaintext.txt	259	usa 95 10972 10977 1998abstractfree full text
0.48486084.10409120.html.plaintext.txt	260	role cftr airway disease
0.48486084.10409120.html.plaintext.txt	261	regulation cftr cl channel gating adp atp analogues
0.48486084.10409120.html.plaintext.txt	262	flag epitope positioned external loop preserves normal biophysical properties cftr
0.48486084.10409120.html.plaintext.txt	263	42 c2080 c2089 1997abstractfree full text
0.48486084.10409120.html.plaintext.txt	264	heterotrimeric g proteins vesicle trafficking cftr cl channels
0.48486084.10409120.html.plaintext.txt	265	36 c272 c281 1994abstractfree full text
0.48486084.10409120.html.plaintext.txt	266	atp hydrolysis cycles mechanism p glycoprotein cftr
0.48486084.10409120.html.plaintext.txt	267	calcium dependent interaction n type calcium channels synaptic core complex
0.48486084.10409120.html.plaintext.txt	268	nature 379 451 454 1996medline
0.48486084.10409120.html.plaintext.txt	269	activity epithelial sodium channel regulated clathrin medicated endocytosis
0.48486084.10409120.html.plaintext.txt	270	272 25537 25541 1997abstractfree full text
0.48486084.10409120.html.plaintext.txt	271	synaptic vesicle cycle cascade protein protein interactions
0.48486084.10409120.html.plaintext.txt	272	nature 375 645 653 1995medline
0.48486084.10409120.html.plaintext.txt	273	cftr dependent membrane insertion linked stimulation cftr chloride conductance
0.48486084.10409120.html.plaintext.txt	274	40 c1887 c1894 1996abstractfree full text
0.48486084.10409120.html.plaintext.txt	275	stimulation cftr activity phosphorylated r domain
0.48486084.10409120.html.plaintext.txt	276	nature 389 294 296 1997medline
0.48486084.10409120.html.plaintext.txt	277	functional interaction syntaxin snap 25 voltage sensitive l n type ca2 channels
0.48486084.10409120.html.plaintext.txt	278	j physiol cell physiol 2771c174 c180 0002 951399 5
0.48486084.10409120.html.plaintext.txt	279	00 copyright 1999 american physiological society
0.41072902.15479737.html.plaintext.txt	0	rockefeller university press 0021 9525 8
0.41072902.15479737.html.plaintext.txt	1	00 jcb volume 167 number 1 65 74 article abstract pdf full text supplemental material index correction v167p567 alert article cited citation map services alert new content jcb download citation manager cited online articles google scholar articles wang x
0.41072902.15479737.html.plaintext.txt	2	articles citing article pubmed pubmed citation articles wang x
0.41072902.15479737.html.plaintext.txt	3	related collections related article article
0.41072902.15479737.html.plaintext.txt	4	copii dependent export cystic fibrosis transmembrane conductance regulator er uses di acidic exit code xiaodong wang1 jeanne matteson1 yu an12 bryan moyer1 jin san yoo1 sergei bannykh1 ian
0.41072902.15479737.html.plaintext.txt	5	1 department cell biology scripps research institute la jolla ca 92037 2 department molecular biology scripps research institute la jolla ca 92037 3 institute childhood neglected diseases scripps research institute la jolla ca 92037 4 mayo foundation
0.41072902.15479737.html.plaintext.txt	6	johnson medical research center mayo clinic scottsdale az 85259
0.41072902.15479737.html.plaintext.txt	7	abstract top abstract introduction results discussion materials methods references cystic fibrosis cf childhood hereditary disease common mutant form cf transmembrane conductance regulator cftr f508 fails exit endoplasmic reticulum er
0.41072902.15479737.html.plaintext.txt	8	export wild type cftr er requires coat complex ii copii machinery sensitive sar1 mutants disrupt normal coat assembly disassembly
0.41072902.15479737.html.plaintext.txt	9	contrast copii used deliver cftr er associated degradation
0.41072902.15479737.html.plaintext.txt	10	find exit wild type cftr er blocked mutation consensus di acidic er exit motif present first nucleotide binding domain
0.41072902.15479737.html.plaintext.txt	11	mutation code disrupts interaction copii coat selection complex sec23sec24
0.41072902.15479737.html.plaintext.txt	12	propose di acidic exit code plays key role linking cftr copii coat machinery primary defect responsible cf f508 expressing patients
0.41072902.15479737.html.plaintext.txt	13	matteson contributed equally paper
0.41072902.15479737.html.plaintext.txt	14	abbreviations used paper bfa brefeldin bhk baby hamster kidney cf cystic fibrosis cftr cf transmembrane conductance regulator copii coat complex ii endo h endoglycosidase h erad er associated degradation gap guanine nucleotide activating protein nbd1 nucleotide binding domain 1 vsv g vesicular stomatitis virus glycoprotein
0.41072902.15479737.html.plaintext.txt	15	introduction top abstract introduction results discussion materials methods references cystic fibrosis cf transmembrane conductance regulator cftr camp regulated chloride channel found apical membrane polarized epithelia lining many tissues including intestine pancreas lung reviews see kopito 1999 riordan 1999 bertrand frizzell 2003
0.41072902.15479737.html.plaintext.txt	16	although 1000 mutations identified cftr gene f508 accounts nearly 70 cf alleles
0.41072902.15479737.html.plaintext.txt	17	homozygous individuals f508 cftr mutation leads severe forms cf
0.41072902.15479737.html.plaintext.txt	18	cftr contains 12 transmembrane domains three cytosolic oriented domains nucleotide binding domain 1 nbd1 r nbd2 involved channel gating
0.41072902.15479737.html.plaintext.txt	19	current evidence suggests deletion phe508 nbd1 prevents proper folding trafficking cftr er plasma membrane kopito 1999 riordan 1999 bertrand frizzell 2003
0.41072902.15479737.html.plaintext.txt	20	f508 cftr temperature sensitive mutant transfer permissive temperature 27 30 degrees c results partial export er denning et al
0.41072902.15479737.html.plaintext.txt	21	misfolded f508 cftr fails exit er eliminated er associated degradation erad pathway xiong et al
0.41072902.15479737.html.plaintext.txt	22	export er appears involve specific exit codes couple cargo common cytosolic budding machinery barlowe 2003
0.41072902.15479737.html.plaintext.txt	23	conserved di acidic exit code found cytosolic tail many type transmembrane proteins first identified mammalian cells nishimura balch 1997 nishimura et al
0.41072902.15479737.html.plaintext.txt	24	2000 subsequently yeast votsmeier gallwitz 2001 malkus et al
0.41072902.15479737.html.plaintext.txt	25	di acidic code directs selective balch et al
0.41072902.15479737.html.plaintext.txt	26	1994 efficient nishimura balch 1997 nishimura et al
0.41072902.15479737.html.plaintext.txt	27	1999 er export promoting interaction cargo coat complex ii copii budding machinery
0.41072902.15479737.html.plaintext.txt	28	copii review see antonny schekman 2001 consists sar1 gtpase cargo selection protein complex sec2324 sar1 specific guanine nucleotide activating protein gap aridor et al
0.41072902.15479737.html.plaintext.txt	29	2002 coat polymer assembly factor sec1331 pryer et al
0.41072902.15479737.html.plaintext.txt	30	sar1 gtpase recruited activated er localized transmembrane protein sec12 guanine nucleotide exchange factor specific sar1 barlowe schekman 1993 weissman et al
0.41072902.15479737.html.plaintext.txt	31	sar1 activation essential recruitment sec2324 complex er membrane select cargo initiate copii coat assembly
0.41072902.15479737.html.plaintext.txt	32	assembly disassembly copii coat rigorously controlled vivo vitro use biochemically characterized sar1 mutants
0.41072902.15479737.html.plaintext.txt	33	sar1t39n referred sar1 gdp restricted gdp bound state biochemically functions competitive inhibitor wild type sar1 recruitment thereby preventing sec2324 attachment er membrane coat assembly kuge et al
0.41072902.15479737.html.plaintext.txt	34	sar1h79g referred sar1 gtp reduced rate gap stimulated hydrolysis remaining gtp bound state activation
0.41072902.15479737.html.plaintext.txt	35	although efficiently recruited er membrane promotes cargo recruitment assembly coat polymers inability undergo hydrolysis interferes subsequent copii coat disassembly resulting inhibition er golgi transport kuge et al
0.41072902.15479737.html.plaintext.txt	36	addition demonstrated protein kinase inhibitor h89 blocks recruitment copii coat components prevents vesicle formation er aridor balch 2000
0.41072902.15479737.html.plaintext.txt	37	probes provide powerful approaches dissect role copii function transport cargo secretory pathway
0.41072902.15479737.html.plaintext.txt	38	develop therapeutic means stimulate f508 cftr trafficking er cell surface necessary understand mechanisms pathways regulate export er
0.41072902.15479737.html.plaintext.txt	39	previously shown cftr exits er copii dependent fashion yoo et al
0.41072902.15479737.html.plaintext.txt	40	recent paper fu sztul 2003 proposed copii also regulates delivery wild type cftr erad pathway yeast saccharomyces cerevisiae xiong et al
0.41072902.15479737.html.plaintext.txt	41	examined detail contribution copii export cftr golgi potential contribution erad pathway mammalian cells
0.41072902.15479737.html.plaintext.txt	42	results demonstrate although copii essential export wild type cftr er found evidence copii contributes targeting either wild type cftr f508 cftr mutant erad pathway
0.41072902.15479737.html.plaintext.txt	43	intriguingly report export cftr highly sensitive mutation highly conserved consensus di acidic exit code nishimura balch 1997 found nbd1 domain cftr
0.41072902.15479737.html.plaintext.txt	44	find coupling sec2324 cargo selection complex di acidic code critical diverting cftr erad pathway
0.41072902.15479737.html.plaintext.txt	45	propose di acidic exit code plays key role linking cftr copii coat machinery primary defect leading disease f508 expressing patients
0.41072902.15479737.html.plaintext.txt	46	results top abstract introduction results discussion materials methods references degradation wild type cftr copii independent follow export cftr er baby hamster kidney bhk cells transfected cftr using vaccinia transient expression system pulse labeled 35smethionine cftr transport golgi detected processing band b n linked core oligosaccharide form band c complex form golgi associated glycosyltransferases reduced migration sds page yoo et al
0.41072902.15479737.html.plaintext.txt	47	tissue culture cell lines engineered express cftr wild type cftr inefficiently exported resulting processing 20 30 er associated band b golgi post golgi mature band c form fig
0.41072902.15479737.html.plaintext.txt	48	1 inset bottom left panel riordan 1999
0.41072902.15479737.html.plaintext.txt	49	cftr failing exit er degraded erad indicated loss band b fig
0.41072902.15479737.html.plaintext.txt	50	1 inset top panel xiong et al
0.41072902.15479737.html.plaintext.txt	51	view larger version 43k figure 1
0.41072902.15479737.html.plaintext.txt	52	export cftr er copii dependent
0.41072902.15479737.html.plaintext.txt	53	bhk cells transfected pcdna3
0.41072902.15479737.html.plaintext.txt	54	1 plasmids containing either wild type cftr f508 cftr cotransfected pcdna3
0.41072902.15479737.html.plaintext.txt	55	1 containing indicated sar1 mutants described previously yoo et al
0.41072902.15479737.html.plaintext.txt	56	30 min pulse 35smet cftr immunoprecipitated indicated chase time quantitated using molecular dynamics phosphoimager described previously yoo et al
0.41072902.15479737.html.plaintext.txt	57	expression levels sar1 mutants 5 10 fold endogenous monitored immunoblotting specific antibody described previously yoo et al
0.41072902.15479737.html.plaintext.txt	58	b top panels quantitation cftr band b er form reported percentage total b plus c 0 time point
0.41072902.15479737.html.plaintext.txt	59	b bottom panels quantitation cftr band c glycosylated form reported percentage total b plus c 0 time point
0.41072902.15479737.html.plaintext.txt	60	insets b show representative autoradiographs containing band b c arrows
0.41072902.15479737.html.plaintext.txt	61	top right panel significant increase amount band b remaining six independent experiments cells transfected sar1 gtp compared sar1 gdp 3 h shown p 0
0.41072902.15479737.html.plaintext.txt	62	dashed horizontal line indicates level band b remaining wild type mock control
0.41072902.15479737.html.plaintext.txt	63	bottom right panel cb ratios shown 3 h time point
0.41072902.15479737.html.plaintext.txt	64	results b typical least three independent experiments
0.41072902.15479737.html.plaintext.txt	65	previously reported yoo et al
0.41072902.15479737.html.plaintext.txt	66	2002 golgi processing band b band c inhibited cotransfection sar1 gtp mutant overexpressed 5 10 fold demonstrating cftr exits er copii dependent pathway fig
0.41072902.15479737.html.plaintext.txt	67	inhibition clearly evident ratio band c band b cb ratio
0.41072902.15479737.html.plaintext.txt	68	compared mock control cb value 1
0.41072902.15479737.html.plaintext.txt	69	8 3 h time point cb ratio presence sar1 gtp 0
0.41072902.15479737.html.plaintext.txt	70	pursue possibility copii required er export erad examined effect sar1 gdp mutant restricted gdp bound form cftr glycosylation proteolysis
0.41072902.15479737.html.plaintext.txt	71	sar1 gdp competitive inhibitor recruitment wild type sar1 sec12 guanine nucleotide exchange factor weissman et al
0.41072902.15479737.html.plaintext.txt	72	2001 sar1 activation essential recruitment cargo selection sec2324 complex er membrane kuge et al
0.41072902.15479737.html.plaintext.txt	73	2001 sar1 gdp competes wild type sar1 competitively reduce efficiency copii recruitment coat assembly
0.41072902.15479737.html.plaintext.txt	74	although cotransfection wild type cftr sar1 gdp 5 10 fold overexpression kuge et al
0.41072902.15479737.html.plaintext.txt	75	2002 strongly inhibited export measured processing band b band c fig
0.41072902.15479737.html.plaintext.txt	76	1 inset bottom panels cb ratio 0
0.41072902.15479737.html.plaintext.txt	77	7 wild type cftr continued degraded efficiently presence mutant fig
0.41072902.15479737.html.plaintext.txt	78	identical results observed early late time points transfection unpublished data indicating potential accumulation cargo er presence sar1 gdp unlikely influence effect sar1 gdp cftr trafficking degradation
0.41072902.15479737.html.plaintext.txt	79	contrast sar1 gdp sar1 gtp dominant negative mutant promotes cargo collection stable copii coated intermediates
0.41072902.15479737.html.plaintext.txt	80	consequence targeting fusion intermediates golgi blocked kuge et al
0.41072902.15479737.html.plaintext.txt	81	interestingly cotransfection wild type cftr sar1 gtp significantly p 0
0.41072902.15479737.html.plaintext.txt	82	05 protected immature band b wild type cftr degradation erad pathway compared degradation rate observed presence sar1 gdp mutant fig
0.41072902.15479737.html.plaintext.txt	83	result raises possibility recruitment cftr assembling copii polymer er exit sites prevents access erad
0.41072902.15479737.html.plaintext.txt	84	also examined effects sar1 gdp sar1 gtp restricted mutants f508 cftr stability given protein exported er therefore completely degraded erad fig
0.41072902.15479737.html.plaintext.txt	85	cotransfection f508 cftr sar1 gtp restricted mutant promote processing band b c fig
0.41072902.15479737.html.plaintext.txt	86	1 b inset bottom panel affect kinetics degradation erad fig
0.41072902.15479737.html.plaintext.txt	87	identical result observed sar1 gdp restricted mutants fig
0.41072902.15479737.html.plaintext.txt	88	results consistent idea failure export er reflects inability f508 link copii
0.41072902.15479737.html.plaintext.txt	89	provide additional evidence role sar1 selection wild type cftr export took advantage protein kinase inhibitor h89 previously shown inhibit sar1 recruitment copii coat assembly aridor balch 2000
0.41072902.15479737.html.plaintext.txt	90	addition h89 cells stably expressing cftr strongly reduced export 90 fig
0.41072902.15479737.html.plaintext.txt	91	erad continues efficiently suggesting copii recruitment required targeting degradation h89 like sar1 gdp uncouples cargo copii coat machinery aridor balch 2000
0.41072902.15479737.html.plaintext.txt	92	view larger version 21k figure 2
0.41072902.15479737.html.plaintext.txt	93	export cftr er degradation inhibited kinase inhibitor h89
0.41072902.15479737.html.plaintext.txt	94	bhk cells stably expressing either wild type cftr f508 cftr labeled 35smet 30 min described previously yoo et al
0.41072902.15479737.html.plaintext.txt	95	labeling cells chased indicated time absence presence 50 microm h89 processing cftr band b er form mature band c quantitated described previously yoo et al
0.41072902.15479737.html.plaintext.txt	96	results typical two independent experiments
0.41072902.15479737.html.plaintext.txt	97	conclude conditions enhance copii assembly er membrane stabilize wild type cftr erad
0.41072902.15479737.html.plaintext.txt	98	contrast conditions interfere copii recruitment prevent export wild type cftr little effect delivery either wild type cftr f508 cftr erad pathway
0.41072902.15479737.html.plaintext.txt	99	thus erad pathway functions largely independently copii machinery
0.41072902.15479737.html.plaintext.txt	100	export erad reversibly sensitive novel sar1 temperature sensitive sar1ts mutant ensure aforementioned results sar1 mutants consequence targeting either wild type mutant cftr nonphysiological pathway reflect indirect effects cargo er cftr export stability developed temperature sensitive variant sar1
0.41072902.15479737.html.plaintext.txt	101	mutant dominant negative permissive temperature 32 degrees c folded properly
0.41072902.15479737.html.plaintext.txt	102	loses dominant negative activity transferred restrictive temperature 40 degrees c misfolds
0.41072902.15479737.html.plaintext.txt	103	cotransfected type 1 transmembrane protein vesicular stomatitis virus glycoprotein vsv g 32 degrees c sar1ts shows strong inhibition processing vsv g endoglycosidase h endo h sensitive er form endo h resistant golgi form fig
0.41072902.15479737.html.plaintext.txt	104	3 indicative er golgi transport block
0.41072902.15479737.html.plaintext.txt	105	contrast 40 degrees c condition promotes destabilization mutant protein inhibition export lost fig
0.41072902.15479737.html.plaintext.txt	106	thus sar1ts shows thermoreversible temperature sensitive er export block
0.41072902.15479737.html.plaintext.txt	107	view larger version 24k figure 3
0.41072902.15479737.html.plaintext.txt	108	er export reversibly sensitive novel sar1 temperature sensitive sar1ts mutant
0.41072902.15479737.html.plaintext.txt	109	bhk cells cotransfected pcdna3
0.41072902.15479737.html.plaintext.txt	110	1 containing either vsv g vsv g indicated sar1 mutant
0.41072902.15479737.html.plaintext.txt	111	effect sar1 gtp control sar1ts processing vsv g endoglycosidase h sensitive endo hs er form endo h resistant endo hr golgi form 5 min pulse 35smet 32 degrees c followed 30 min chase indicated temperature determined described previously yoo et al
0.41072902.15479737.html.plaintext.txt	112	b bhk cells cotransfected pcdna3
0.41072902.15479737.html.plaintext.txt	113	1 containing wild type cftr either vector mock indicated cotransfected pcdna3
0.41072902.15479737.html.plaintext.txt	114	transport processing cftr band b c followed indicated temperature described fig
0.41072902.15479737.html.plaintext.txt	115	cb ratios sar1ts mutant 32 40 degrees c shown 3 h time point
0.41072902.15479737.html.plaintext.txt	116	asterisk top panel b indicates cftr exported inefficiently er band c weakly processed early golgi oligosaccharide forms
0.41072902.15479737.html.plaintext.txt	117	white lines indicate intervening lanes spliced
0.41072902.15479737.html.plaintext.txt	118	results typical three independent experiments
0.41072902.15479737.html.plaintext.txt	119	transient coexpression sar1ts wild type cftr 32 degrees c significantly inhibited export wild type cftr compared mock control measured processing band b band c forms fig
0.41072902.15479737.html.plaintext.txt	120	3 b bottom right panel cb ratio 0
0.41072902.15479737.html.plaintext.txt	121	sar1ts apparent effect stabilizing wild type cftr degradation 32 degrees c fig
0.41072902.15479737.html.plaintext.txt	122	3 b top panel consistent interpretation sar1ts interferes copii coat assembly affect erad pathways
0.41072902.15479737.html.plaintext.txt	123	moreover cotransfection f508 cftr sar1ts effect either f508 cftr export degradation compared controls expressing f508 alone either 32 40 degrees c temperatures unpublished data
0.41072902.15479737.html.plaintext.txt	124	importantly used two stage incubation protocol examine ability cftr exported er accumulation presence sar1ts mutant 32 degrees c
0.41072902.15479737.html.plaintext.txt	125	cells transfected 14 h 32 degrees c prevent cftr export labeled 30 min 32 degrees c stage 1
0.41072902.15479737.html.plaintext.txt	126	subsequently cells transferred 40 degrees c stage 2 inactivate sar1ts
0.41072902.15479737.html.plaintext.txt	127	contrast incubation 32 degrees c fig
0.41072902.15479737.html.plaintext.txt	128	3 b bottom right panel cb ratio 0
0.41072902.15479737.html.plaintext.txt	129	5 3 h upon transfer 40 degrees c observed normal processing wild type cftr band b c fig
0.41072902.15479737.html.plaintext.txt	130	3 b bottom right panel cb ratio 4 3 h
0.41072902.15479737.html.plaintext.txt	131	thus reversible inhibition processing wild type cftr band c imposed incubation 32 degrees c presence sar1ts interferes normal physiological pathway required copii dependent export degradation
0.41072902.15479737.html.plaintext.txt	132	cftr uses di acidic exit code export er understand requirement copii export cftr er examined cftr sequence presence evolutionarily conserved tyrosine based di acidic code required export vsv g nishimura balch 1997 nishimura et al
0.41072902.15479737.html.plaintext.txt	133	2000 transmembrane proteins er mammalian cells bannykh balch 1998 bannykh et al
0.41072902.15479737.html.plaintext.txt	134	1998 yeast votsmeier gallwitz 2001 malkus et al
0.41072902.15479737.html.plaintext.txt	135	notably cftr contained ykdad motif residues 563 567 first nucleotide binding motif nbd1 evolutionarily conserved similar found vsv g yxdxe nishimura balch 1997 sevier et al
0.41072902.15479737.html.plaintext.txt	136	structure nbd1 domain cftr 1roz
0.41072902.15479737.html.plaintext.txt	137	pdb reveals ykdad motif located surface exposed loop linking nh2 terminal helical domain containing phe508 cooh terminal sheet domain lewis et al
0.41072902.15479737.html.plaintext.txt	138	strikingly transient expression cftr mutants either one daa cftr fig
0.41072902.15479737.html.plaintext.txt	139	4 b inset bottom panel aaa cftr unpublished data conserved asp residues mutated ala resulted complete inhibition export er measured inability band b processed band c morphological distribution consistent localization er bannykh et al
0.41072902.15479737.html.plaintext.txt	140	like f508 cftr cotransfection sar1 gtp failed promote export stabilize daa cftr erad suggesting mutation di acidic motif uncoupled cftr copii fig
0.41072902.15479737.html.plaintext.txt	141	also examined whether like f508 cftr daa cftr phenotype temperature sensitive examining rate export lowered temperature 30 degrees c
0.41072902.15479737.html.plaintext.txt	142	whereas transfer f508 cftr 30 degrees c resulted significant enhancement transport cell surface reflecting effect conformational stability nbd1 observed previously denning et al
0.41072902.15479737.html.plaintext.txt	143	1996 observe similar increase daa cftr export 30 degrees c unpublished data
0.41072902.15479737.html.plaintext.txt	144	results suggest daa mutation affect fold nbd1 similar fashion f508 mutation stabilized incubation reduced temperature
0.41072902.15479737.html.plaintext.txt	145	view larger version 51k figure 4
0.41072902.15479737.html.plaintext.txt	146	cftr uses di acidic code export er
0.41072902.15479737.html.plaintext.txt	147	location phe508 di acidic code nbd1 domain cftr lewis et al
0.41072902.15479737.html.plaintext.txt	148	shown blue phe508 shown red carbon backbone yellow side chains orientation residues asp565 asp567 di acidic code
0.41072902.15479737.html.plaintext.txt	149	b cells either transfected cotransfected indicated wild type mutant cftr sar1 gtp mutant indicated
0.41072902.15479737.html.plaintext.txt	150	processing band b band c quantitated described fig
0.41072902.15479737.html.plaintext.txt	151	c effect bfa stability wild type cftr f508 cftr daa cftr mutant er
0.41072902.15479737.html.plaintext.txt	152	white lines indicate intervening lanes spliced
0.41072902.15479737.html.plaintext.txt	153	cells pulse labeled 30 min 35smet 37 degrees c
0.41072902.15479737.html.plaintext.txt	154	10 microgml bfa added incubation continued 3 h 37 degrees c
0.41072902.15479737.html.plaintext.txt	155	lanes d g total cftr found band b pulse expressed value 100
0.41072902.15479737.html.plaintext.txt	156	lanes b e h fraction cftr found band b 3 h incubation absence bfa
0.41072902.15479737.html.plaintext.txt	157	lanes c f fraction cftr found band b 3 h incubation presence bfa
0.41072902.15479737.html.plaintext.txt	158	dashed bar lane b indicates total b c 3 h time point absence bfa
0.41072902.15479737.html.plaintext.txt	159	results typical least two independent experiments condition shown
0.41072902.15479737.html.plaintext.txt	160	characterize biochemical properties daa cftr mutant took advantage previous observation treatment cftr expressing cells brefeldin bfa reduces degradation wild type cftr f508 cftr ostedgaard et al
0.41072902.15479737.html.plaintext.txt	161	bfa triggers collapse golgi er preventing recruitment coat complex golgi membranes review see chardin mccormick 1999
0.41072902.15479737.html.plaintext.txt	162	contrast potent effect coat complex function golgi bfa effect copii function er export
0.41072902.15479737.html.plaintext.txt	163	consequence bfa treated cells er associated cargo collected export intermediates accumulate absence functional golgi compartments lippincott schwartz et al
0.41072902.15479737.html.plaintext.txt	164	expected addition bfa prevented processing wild type cftr band b c partially stabilized wild type cftr erad likely reflecting recruitment copii intermediates fig
0.41072902.15479737.html.plaintext.txt	165	contrast bfa prevent degradation either f508 daa cftr mutant fig
0.41072902.15479737.html.plaintext.txt	166	results consistent interpretation mutants fail couple copii machinery nishimura balch 1997 nishimura et al
0.41072902.15479737.html.plaintext.txt	167	1999 resulting delivery erad pathway
0.41072902.15479737.html.plaintext.txt	168	biochemical interaction cftr copii disrupted f508 daa mutations although results described previous section raise possibility cftr may exit er di acidic code remained shown wild type cftr engage copii machinery whether interaction copii disrupted f508 daa cftr mutations
0.41072902.15479737.html.plaintext.txt	169	purpose first examined ability cftr bind sec23sec24 cargo selection complex immunoprecipitates recovered detergent lysates hek293 cell lines stably expressing either wild type cftr f508 cftr
0.41072902.15479737.html.plaintext.txt	170	5 cells expressing wild type cftr protein largely band c mature form 5 band b er form expected result given wild type cftr accumulates post golgi compartments
0.41072902.15479737.html.plaintext.txt	171	contrast f508 cftr expressing hek293 cells form band b reflecting er localization level expression reflecting continuous degradation erad fig
0.41072902.15479737.html.plaintext.txt	172	despite large difference steady state level cftr wild type f508 expressing cells quantitated recovery sec24 respect total amount wild type cftr f508 cftr band b using immunoblotting observed f508 cftr bound 25 observed wild type cftr fig
0.41072902.15479737.html.plaintext.txt	173	sec24 recovered hek293 cells express cftr unpublished data
0.41072902.15479737.html.plaintext.txt	174	immunoprecipitations performed ice likely temperature sensitive phenotype f508 cftr resulted partial folding transfer ice accounting observed level recovery sec24
0.41072902.15479737.html.plaintext.txt	175	although band b er form would expected form cftr would bind er specific copii coat machinery examined whether immunoprecipitation sec24 would recover band c cell surface form
0.41072902.15479737.html.plaintext.txt	176	despite large excess band c cell fig
0.41072902.15479737.html.plaintext.txt	177	5 immunoprecipitation sec24 followed immunoblotting cftr recovered band b forms either wild type f508 fig
0.41072902.15479737.html.plaintext.txt	178	view larger version 30k figure 5
0.41072902.15479737.html.plaintext.txt	179	wild type cftr daa cftr binds copii
0.41072902.15479737.html.plaintext.txt	180	hek293 stably expressing wild type f508 lysed presence 1 triton x 100 sec23sec24 complex recovered immunoprecipitation cftr specific mab quantitated described materials methods
0.41072902.15479737.html.plaintext.txt	181	cftr bands b c sec24 detected immunoblotting specific antibody described materials methods
0.41072902.15479737.html.plaintext.txt	182	b except amount cftr recovered immunoprecipitation sec24 specific polyclonal antibody quantitated described materials methods using immunoblotting
0.41072902.15479737.html.plaintext.txt	183	hek293 cells expressing cftr used control
0.41072902.15479737.html.plaintext.txt	184	cftr bands b c detected immunoblotting specific antibody
0.41072902.15479737.html.plaintext.txt	185	c hek293 cells transfected pcdna3
0.41072902.15479737.html.plaintext.txt	186	1 plasmids containing either wild type cftr daa cftr described previously yoo et al
0.41072902.15479737.html.plaintext.txt	187	cells lysed presence 1 triton x 100 amount sec23sec24 complex recovered bound band b cftr expressed sec24band b ratio quantitated described materials methods
0.41072902.15479737.html.plaintext.txt	188	cftr bands b c sec24 detected immunoblotting specific antibodies
0.41072902.15479737.html.plaintext.txt	189	d hek293 stably expressing wild type f508 incubated 37 degrees c wild type indicated time 30 degrees c f508 lysed presence 1 triton x 100 amount sec23sec24 complex recovered bound cftr immunoprecipitation cftr specific antibody quantitated described materials methods
0.41072902.15479737.html.plaintext.txt	190	error bars indicates sd samples generated time point triplicate
0.41072902.15479737.html.plaintext.txt	191	test ability daa cftr mutant bind sec23sec24 transfected hek293 cells wild type cftr daa cftr using vaccinia expression system
0.41072902.15479737.html.plaintext.txt	192	strikingly observed band b daa cftr mutant bound 5 recovered immunoprecipitates wild type cftr fig
0.41072902.15479737.html.plaintext.txt	193	results support conclusion marked inefficiency daa cftr exit er consequence inability couple cargo selection complex sec23sec24
0.41072902.15479737.html.plaintext.txt	194	correlate effects di acidic code daa cftr mutant copii binding effects phe508 ability f508 cftr exit er transfer 30 degrees c performed temperature shift experiment
0.41072902.15479737.html.plaintext.txt	195	5 d increasing incubation time 30 degrees c f508 showed strong increase interaction sec24 approaching value observed wild type cftr 37 degrees c steady state
0.41072902.15479737.html.plaintext.txt	196	results suggest reduced temperature promotes maturation cftr presentation exit code interaction copii coat machinery export er
0.41072902.15479737.html.plaintext.txt	197	discussion top abstract introduction results discussion materials methods references copii dependent export cftr using sar1 mutants well characterized biochemical properties found export wild type cftr dependent copii coat assembly mammalian cells
0.41072902.15479737.html.plaintext.txt	198	would expected result wild type cftr f508 cftr acquires normal protein fold necessary cargo selection copii
0.41072902.15479737.html.plaintext.txt	199	several lines evidence support conclusion
0.41072902.15479737.html.plaintext.txt	200	first sar1 gtp mutant stabilizes coat assembly markedly reduces rate erad capture copii transport intermediates accumulate presence activated sar1 aridor et al
0.41072902.15479737.html.plaintext.txt	201	second sar1 gdp mutant prevents copii coat recruitment inhibited export wild type cftr stabilize er band b form
0.41072902.15479737.html.plaintext.txt	202	unlikely effects gdp mutant cftr export influenced build cargo er transient expression protocol observed inhibition transport earliest time points transfection inhibitory properties sar1 gdp mutant begin take effect
0.41072902.15479737.html.plaintext.txt	203	conclusion supported ability h89 rapidly efficiently uncouple cftr export cells stably expressing wild type cftr
0.41072902.15479737.html.plaintext.txt	204	furthermore two stage assay using sar1ts mutant found accumulation cftr er 32 degrees c effect export inactivation sar1ts 40 degrees c
0.41072902.15479737.html.plaintext.txt	205	detect significant effects sar1 gdp uncouples cftr copii degradation cftr suggest export erad pathways operate independently
0.41072902.15479737.html.plaintext.txt	206	copii participate erad recent paper fu sztul 2003 suggested targeting cftr erad pathway
0.41072902.15479737.html.plaintext.txt	207	cerevisiae requires copii absence copii function cftr accumulates er like subcompartment rather degraded kiser et al
0.41072902.15479737.html.plaintext.txt	208	2001 fu sztul 2003 sullivan et al
0.41072902.15479737.html.plaintext.txt	209	contrast found copii participate erad either wild type cftr f508 cftr mammalian cells
0.41072902.15479737.html.plaintext.txt	210	reasons discrepancy apparent
0.41072902.15479737.html.plaintext.txt	211	first cftr exit er yeast condition limiting interpretation results kiser et al
0.41072902.15479737.html.plaintext.txt	212	2001 fu sztul 2003 sullivan et al
0.41072902.15479737.html.plaintext.txt	213	second experiments used overexpression gfp tagged variant cftr gfp cftr
0.41072902.15479737.html.plaintext.txt	214	similar gfp cftr construct expressed mammalian cells markedly reduced rate export accumulates er tubular elements 30 degrees c comparable experiments yeast cells incubated 24 degrees c significantly overlaps calnexin fig
0.41072902.15479737.html.plaintext.txt	215	overlap consistent fact folding nascent cftr er likely involve calnexin pind et al
0.41072902.15479737.html.plaintext.txt	216	however upon transfer 37 degrees c gfp cftr efficiently exported cell surface mammalian cells fig
0.41072902.15479737.html.plaintext.txt	217	thus mammalian cells gfp cftr accumulate transiently bona fide er like tubular network reduced temperature unlikely specialized copii regulated degradative subcompartment suggested yeast export blocked temperatures fu sztul 2003 sullivan et al
0.41072902.15479737.html.plaintext.txt	218	third concern experiments relied temperature sensitive copii mutants prevent degradation leading interpretation copii required erad
0.41072902.15479737.html.plaintext.txt	219	experiments required prolonged incubation yeast restrictive temperature 40 degrees c assess effect mutant copii component erad
0.41072902.15479737.html.plaintext.txt	220	well established elevated temperature 40 degrees mammalian cells markedly stabilizes approximately twofold wild type cftr f508 cftr erad response induction heat shock folding chaperones strickland et al
0.41072902.15479737.html.plaintext.txt	221	1999 choo kang zeitlin 2001 farinha et al
0.41072902.15479737.html.plaintext.txt	222	thus twofold effect temperature sensitive sec12 variant preventing cftr degradation yeast largely explained twofold difference stability observed upon shift permissive restrictive temperature control incubations absence sec12ts fu sztul 2003
0.41072902.15479737.html.plaintext.txt	223	fourth unlike sar1 gdp gtp mutants biochemical properties sec13 sec23 temperature sensitive mutants characterized
0.41072902.15479737.html.plaintext.txt	224	example sec13 sec23 temperature sensitive variants may inactivated shifting restrictive temperature suggested fu sztul 2003
0.41072902.15479737.html.plaintext.txt	225	rather may promote stable coat assembly leading partial segregation cftr erad observed copii coat polymer assembly promoted sar1 gtp mutant
0.41072902.15479737.html.plaintext.txt	226	conclude role copii direct cftr selection copii vesicles removing protein erad copii independent targeted pool
0.41072902.15479737.html.plaintext.txt	227	di acidic code mediates cftr export important finding provides new insight role copii export cftr er processing band b c sensitive mutation conserved di acidic code exit motif originally detected cytoplasmic tail vsv g nishimura balch 1997 nishimura et al
0.41072902.15479737.html.plaintext.txt	228	consistent finding natural variant cystic fibrosis mutation database httpwww
0.41072902.15479737.html.plaintext.txt	229	cacftr substitution g d position 565 565dad 565gad results severe deficiency phenotype although allele complex tzetis et al
0.41072902.15479737.html.plaintext.txt	230	requirement di acidic code cftr export consistent similar requirement di acidic motif export multi membrane spanning k channel ma et al
0.41072902.15479737.html.plaintext.txt	231	2001 ma jan 2002 yeast gap permease malkus et al
0.41072902.15479737.html.plaintext.txt	232	given transfer di acidic code er retained protein sufficient promote efficient export nishimura balch 1997 nishimura et al
0.41072902.15479737.html.plaintext.txt	233	1999 fact di acidic code recognizes sec24 subunit sec2324 complex miller et al
0.41072902.15479737.html.plaintext.txt	234	2002 evident di acidic motif may used cftr engage sec24
0.41072902.15479737.html.plaintext.txt	235	cftr coimmunoprecipitation results provide direct evidence dad motif nbd1 cftr serves functional er exit code loss code results impaired binding sec2324
0.41072902.15479737.html.plaintext.txt	236	case gap permease suggested di acidic code although necessary export sufficient miller et al
0.41072902.15479737.html.plaintext.txt	237	similar constraint may apply cftr protein complicated cytosolic folding pathway involving numerous chaperones cochaperones pind et al
0.41072902.15479737.html.plaintext.txt	238	1998 brodsky 2001 zhang et al
0.41072902.15479737.html.plaintext.txt	239	2002 may facilitate recognition sec23sec24 complex unpublished data
0.41072902.15479737.html.plaintext.txt	240	nbd1 domains large variety abc transporters similar structural organization schmitt tampe 2002
0.41072902.15479737.html.plaintext.txt	241	structural alignment nbd1 domain cftr lewis et al
0.41072902.15479737.html.plaintext.txt	242	2004 nbd1 domain abc transporter btucd reveals di acidic code found solvent exposed loop connecting nh2 terminal helical domain containing phe508 cooh terminal sheet domain fig
0.41072902.15479737.html.plaintext.txt	243	given structure sar1 sec2324 complex containing bound di acidic peptide available huang et al
0.41072902.15479737.html.plaintext.txt	244	2003 built homology model nbd1 cftr replacing similar structural fold nbd1 btucd fig
0.41072902.15479737.html.plaintext.txt	245	new structure btucd nbd1cftr combined structure sec2324 sar1 complex illustrate ability di acidic code loop nbd1cftr insert directly sec2324 di acidic code binding pocket fig
0.41072902.15479737.html.plaintext.txt	246	s2 three dimensional view available httpwww
0.41072902.15479737.html.plaintext.txt	247	docking reveals little steric interference residues within binding pocket residues defining tertiary structure btucd nbd1cftr sar1sec2423 complex
0.41072902.15479737.html.plaintext.txt	248	moreover orientation nh2 terminus sar1 fig
0.41072902.15479737.html.plaintext.txt	249	6 red ss strand residues 25 34 linked flexible nh2 terminal tail involved anchoring sar1 membrane fig
0.41072902.15479737.html.plaintext.txt	250	6 black dashed line observed crystal structure huang et al
0.41072902.15479737.html.plaintext.txt	251	2002 oriented correctly facilitate recruitment sec2324 activated sar1
0.41072902.15479737.html.plaintext.txt	252	apparent sar1 btucd nbd1cftr interact sec23sec24 independently shown holo cargo selection complex
0.41072902.15479737.html.plaintext.txt	253	thus general structural features cftr nbd1 domain presented within structure btucd consistent role di acidic code directing interaction copii exit er
0.41072902.15479737.html.plaintext.txt	254	view larger version 61k figure 6
0.41072902.15479737.html.plaintext.txt	255	cftr copii cargo selection complex
0.41072902.15479737.html.plaintext.txt	256	bottom structure cftr nbd1 1rox
0.41072902.15479737.html.plaintext.txt	257	pdb oriented show structural homology nbd1 structural domain bacterial abc transporter btucd 1l7v
0.41072902.15479737.html.plaintext.txt	258	cftr nbd1 phe508 shown blue residues asp565 asp567 di acidic code shown yellow
0.41072902.15479737.html.plaintext.txt	259	btucd cytosolic domains shown green putative transmembrane spanning domains shown red
0.41072902.15479737.html.plaintext.txt	260	short loop shown red btucd corresponds structurally di acidic code containing loop cftr nbd1
0.41072902.15479737.html.plaintext.txt	261	middle homology structure containing cftr nbd1 btucd btu nbd1cftr docked sar1sec2324 complex bi et al
0.41072902.15479737.html.plaintext.txt	262	2003 see materials methods
0.41072902.15479737.html.plaintext.txt	263	gray rectangle illustrates putative location membrane bilayer
0.41072902.15479737.html.plaintext.txt	264	top interaction cftr nbd1 di acidic code binding pocket sec2324 bi et al
0.41072902.15479737.html.plaintext.txt	265	shown blue arg230 235 559 561 basic residues defining di acidic code pocket sec24 bi et al
0.41072902.15479737.html.plaintext.txt	266	minor steric interference observed asp565 cftr nbd1 leu616 sec24 homology model
0.41072902.15479737.html.plaintext.txt	267	s2 three dimensional rendering interface cftr nbd1 sec2324 cargo complex
0.41072902.15479737.html.plaintext.txt	268	given likely importance aromatic side chain phe508 stabilizing conserved structural fold nh2 terminal helical domain nbd1 fig
0.41072902.15479737.html.plaintext.txt	269	6 blue residue deletion phe508 f508 cftr mutant may alter orientation di acidic motif containing loop thereby compromising interaction sec24
0.41072902.15479737.html.plaintext.txt	270	notion directly tested cftr coimmunoprecipitation experiments found binding band b f508 sec24 much lower wild type cftr
0.41072902.15479737.html.plaintext.txt	271	consistent interpretation f508 cftr sec24 interaction transport cell surface rescued promoting folding 30 degrees c
0.41072902.15479737.html.plaintext.txt	272	moreover export f508 cftr er also rescued cis additional point mutations nbd1 stabilize structural fold decarvalho et al
0.41072902.15479737.html.plaintext.txt	273	given 1000 mutants reported affect cftr export function leading varying degrees disease surprising residues flanking di acidic code also reported mutation database
0.41072902.15479737.html.plaintext.txt	274	structural considerations strongly suggest many flanking mutations unlike di acidic code found solvent exposed loop likely affect fold helical ss strands contribute structural organization nbd1 indirectly compromise presentation code unpublished data
0.41072902.15479737.html.plaintext.txt	275	propose inability f508 cftr mutant engage copii machinery sec24 primary basis common form cf
0.41072902.15479737.html.plaintext.txt	276	materials methods top abstract introduction results discussion materials methods references materials reagents vaccinia transient expression prepared described previously yoo et al
0.41072902.15479737.html.plaintext.txt	277	hek293 stably expressing wild type cftr f508 cftr obtained n
0.41072902.15479737.html.plaintext.txt	278	bradbury university pittsburgh school medicine pittsburgh pa
0.41072902.15479737.html.plaintext.txt	279	m3a7 antibody provided j
0.41072902.15479737.html.plaintext.txt	280	riordan mayo clinic scottsdale az
0.41072902.15479737.html.plaintext.txt	281	vaccinia transient expression vaccinia transient expression quantification performed exactly described previously yoo et al
0.41072902.15479737.html.plaintext.txt	282	sem determined using software program prism
0.41072902.15479737.html.plaintext.txt	283	immunoprecipitation cftr sec24 complex hek293 cells stably expressing wild type cftr f508 cftr vaccinia transfected hek293 cells transiently expressing wild type cftr daa cftr lysed ice triton x 100 lysis buffer 50 mm tris hcl ph 7
0.41072902.15479737.html.plaintext.txt	284	4 150 mm nacl 1 triton x 100 supplemented complete protease inhibitor cocktail tablets roche diagnostics gmbh
0.41072902.15479737.html.plaintext.txt	285	soluble fraction lysates incubated protein g beads coupled anti cftr antibody m3a7 anti sec24 polyclonal antibodies
0.41072902.15479737.html.plaintext.txt	286	immunocomplexes washed eluted 50 mm tris hcl ph 6
0.41072902.15479737.html.plaintext.txt	287	protein components complexes separated sds page
0.41072902.15479737.html.plaintext.txt	288	cftr sec24 detected immunoblot
0.41072902.15479737.html.plaintext.txt	289	cftr sec24 quantitated densitometry using molecular dynamics imaging system
0.41072902.15479737.html.plaintext.txt	290	brief cftr detected immunoblotting immunoblots exposed linear range quantitated measuring densities band b c
0.41072902.15479737.html.plaintext.txt	291	similar area immediately adjacent bands b c lane background subtracted b c value obtain indicated values shown results
0.41072902.15479737.html.plaintext.txt	292	structural alignment cftr nbd1 btucd sec2324 complex fitting cftr nbd1 btucd sec2324 performed follows
0.41072902.15479737.html.plaintext.txt	293	sec24nbd1 complex model built sec24dxe peptide complex 1pd1
0.41072902.15479737.html.plaintext.txt	294	pdb coordinates superimposing dxe peptide onto corresponding part nbd1
0.41072902.15479737.html.plaintext.txt	295	sec24nbd1sec23 complex model built sec24nbd1 model sec24sec23 complex 1m2v
0.41072902.15479737.html.plaintext.txt	296	pdb superimposing sec24 coordinates
0.41072902.15479737.html.plaintext.txt	297	sec24nbd1sec23sar1 complex model built sec24nbd1sec23 model sec23sar1 complex 1m2o
0.41072902.15479737.html.plaintext.txt	298	pdb superimposing sec23 coordinates
0.41072902.15479737.html.plaintext.txt	299	sec24nbd1sec23sar1btucd complex model built sec24nbd1sec23sar1 model btucd 1l7v
0.41072902.15479737.html.plaintext.txt	300	pdb superimposing cftr nbd1 btud coordinates
0.41072902.15479737.html.plaintext.txt	301	fitting performed using mclachlan algorithm mclachlan 1982 implemented program profit httpwww
0.41072902.15479737.html.plaintext.txt	302	online supplemental material fig
0.41072902.15479737.html.plaintext.txt	303	s1 shows gfp cftr accumulates er 28 degrees c
0.41072902.15479737.html.plaintext.txt	304	s2 three dimensional rendering cftr nbd1 di acidic code docked sar1sec2324 cargo selection complex
0.41072902.15479737.html.plaintext.txt	305	online supplemental material available httpwww
0.41072902.15479737.html.plaintext.txt	306	acknowledgments work supported national institutes health nih grant gm42336 w
0.41072902.15479737.html.plaintext.txt	307	balch individual national research service award nih post doctoral fellowship b
0.41072902.15479737.html.plaintext.txt	308	moyer cystic fibrosis foundation postdoctoral fellowship x
0.41072902.15479737.html.plaintext.txt	309	scripps research institute manuscript number 1234 cb
0.41072902.15479737.html.plaintext.txt	310	submitted 9 january 2004accepted 23 august 2004
0.41072902.15479737.html.plaintext.txt	311	references top abstract introduction results discussion materials methods references
0.41072902.15479737.html.plaintext.txt	312	self assembly minimal copii cages
0.41072902.15479737.html.plaintext.txt	313	dynamics copii coat gtp stable analogues
0.41072902.15479737.html.plaintext.txt	314	er export public transportation copii coach
0.41072902.15479737.html.plaintext.txt	315	kinase signaling initiates copii recruitment export mammalian endoplasmic reticulum
0.41072902.15479737.html.plaintext.txt	316	sequential coupling copii copi vesicle coats endoplasmic reticulum golgi transport
0.41072902.15479737.html.plaintext.txt	317	sar1 gtpase coordinates biosynthetic cargo selection endoplasmic reticulum export site assembly
0.41072902.15479737.html.plaintext.txt	318	cargo selection copii budding machinery export endoplasmic reticulum
0.41072902.15479737.html.plaintext.txt	319	vesicular stomatitis virus glycoprotein sorted concentrated export endoplasmic reticulum
0.41072902.15479737.html.plaintext.txt	320	selective transport cargo endoplasmic reticulum golgi compartments
0.41072902.15479737.html.plaintext.txt	321	traffic pattern cystic fibrosis transmembrane regulator early exocytic pathway
0.41072902.15479737.html.plaintext.txt	322	signals copii dependent export er whats ticket trends cell biol
0.41072902.15479737.html.plaintext.txt	323	sec12 encodes guanine nucleotide exchange factor essential transport vesicle budding er
0.41072902.15479737.html.plaintext.txt	324	role regulated cftr trafficking epithelial secretion
0.41072902.15479737.html.plaintext.txt	325	structure sec2324 sar1 pre budding complex copii vesicle coat
0.41072902.15479737.html.plaintext.txt	326	chaperoning maturation cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	327	brefeldin advantage uncompetitive
0.41072902.15479737.html.plaintext.txt	328	induction hsp70 promotes f508 cftr trafficking
0.41072902.15479737.html.plaintext.txt	329	mutations nucleotide binding domain 1 signature motif region rescue processing functional defects cystic fibrosis transmembrane conductance regulator f508
0.41072902.15479737.html.plaintext.txt	330	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.41072902.15479737.html.plaintext.txt	331	human dnaj homologue hdj 1heat shock protein hsp 40 co chaperone required vivo stabilization cystic fibrosis transmembrane conductance regulator hsp70
0.41072902.15479737.html.plaintext.txt	332	f508 mutation mouse cystic fibrosis transmembrane conductance regulator results temperature sensitive processing defect vivo
0.41072902.15479737.html.plaintext.txt	333	traffic independent function sar1pcopii machinery proteasomal sorting cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	334	principal role proteasome endoplasmic reticulum associated degradation misfolded intracellular cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	335	crystal structure sar1 gdp 1
0.41072902.15479737.html.plaintext.txt	336	7 resolution role nh2 terminus er export
0.41072902.15479737.html.plaintext.txt	337	expression degradation cystic fibrosis transmembrane conductance regulator saccharomyces cerevisiae
0.41072902.15479737.html.plaintext.txt	338	biosynthesis degradation cftr
0.41072902.15479737.html.plaintext.txt	339	sar1 promotes vesicle budding endoplasmic reticulum golgi compartments
0.41072902.15479737.html.plaintext.txt	340	role mammalian ubc6 homologues er associated protein degradation
0.41072902.15479737.html.plaintext.txt	341	structure nucleotide binding domain 1 cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	342	rapid redistribution golgi proteins er cells treated brefeldin evidence membrane cycling golgi er
0.41072902.15479737.html.plaintext.txt	343	perturbation hsp90 interaction nascent cftr prevents maturation accelerates degradation proteasome
0.41072902.15479737.html.plaintext.txt	344	conformational maturation cftr mutant counterpart f508 occurs endoplasmic reticulum requires atp
0.41072902.15479737.html.plaintext.txt	345	er transport signals trafficking potassium channels receptors
0.41072902.15479737.html.plaintext.txt	346	role er export signals controlling surface potassium channel numbers
0.41072902.15479737.html.plaintext.txt	347	concentrative sorting secretory cargo proteins copii coated vesicles
0.41072902.15479737.html.plaintext.txt	348	rapid comparison protein structures
0.41072902.15479737.html.plaintext.txt	349	hdj 2hsc70 chaperone pair facilitates early steps cftr biogenesis
0.41072902.15479737.html.plaintext.txt	350	cargo selection copii vesicles driven sec24p subunit
0.41072902.15479737.html.plaintext.txt	351	snare selectivity copii coat
0.41072902.15479737.html.plaintext.txt	352	di acidic signal required selective export endoplasmic reticulum
0.41072902.15479737.html.plaintext.txt	353	di acidic dxe code directs concentration cargo export endoplasmic reticulum
0.41072902.15479737.html.plaintext.txt	354	processing cftr bearing p574h mutation differs wild type f508 cftr
0.41072902.15479737.html.plaintext.txt	355	participation endoplasmic reticulum chaperone calnexin p88 ip90 biogenesis cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	356	cytosolic sec13p complex required vesicle formation endoplasmic reticulum vitro
0.41072902.15479737.html.plaintext.txt	357	cystic fibrosis disease misprocessing cystic fibrosis transmembrane conductance regulator glycoprotein
0.41072902.15479737.html.plaintext.txt	358	efficient export vesicular stomatitis virus g protein endoplasmic reticulum requires signal cytoplasmic tail includes tyrosine based di acidic motifs
0.41072902.15479737.html.plaintext.txt	359	structure mechanism abc transporters
0.41072902.15479737.html.plaintext.txt	360	molecular chaperone hsc70 assists vitro folding n terminal nucleotide binding domain cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	361	localization bip molecular chaperone respect endoplasmic reticulum foci containing cystic fibrosis transmembrane conductance regulator yeast
0.41072902.15479737.html.plaintext.txt	362	cftr gene mutations including three novel nucleotide substitutions haplotype background patients asthma disseminated bronchiectasis chronic obstructive pulmonary disease
0.41072902.15479737.html.plaintext.txt	363	acidic sequence putative yeast golgi membrane protein binds copii facilitates er export
0.41072902.15479737.html.plaintext.txt	364	intracellular turnover cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	365	inefficient processing rapid degradation wild type mutant proteins
0.41072902.15479737.html.plaintext.txt	366	mammalian guanine nucleotide exchange factor msec12 essential activation sar1 gtpase directing endoplasmic reticulum export
0.41072902.15479737.html.plaintext.txt	367	evidence endoplasmic reticulum er associated degradation cystic fibrosis transmembrane conductance regulator linked retrograde translocation er membrane
0.41072902.15479737.html.plaintext.txt	368	non conventional trafficking cystic fibrosis transmembrane conductance regulator early secretory pathway
0.41072902.15479737.html.plaintext.txt	369	cysteine string protein interacts modulates maturation cystic fibrosis transmembrane conductance regulator
0.41072902.15479737.html.plaintext.txt	370	export cystic fibrosis nicole lebrasseur j
0.44508743.14581585.html.plaintext.txt	0	voltage dependent gating cystic fibrosis transmembrane conductance regulator cl channel zhiwei cai toby
0.44508743.14581585.html.plaintext.txt	1	department physiology university bristol school medical sciences university walk bristol bs8 1td uk
0.44508743.14581585.html.plaintext.txt	2	sheppard department physiology school medical sciences university walk university bristol bristol bs8 1td uk
0.44508743.14581585.html.plaintext.txt	3	fax 44 117 928 8923 email d
0.44508743.14581585.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references excised inside membrane patches bathed symmetrical cl rich solutions current voltage v relationship macroscopic cystic fibrosis transmembrane conductance regulator cftr cl currents inwardly rectifies large positive voltages
0.44508743.14581585.html.plaintext.txt	5	investigate mechanism inward rectification studied cftr cl channels excised inside membrane patches cells expressing wild type human murine cftr using voltage ramp step protocols
0.44508743.14581585.html.plaintext.txt	6	using voltage ramp protocol magnitude human cftr cl current 100 mv 74 plus minus 2 n 10 100 mv
0.44508743.14581585.html.plaintext.txt	7	rectification macroscopic cftr cl current reproduced full ensemble currents generated averaging single channel currents elicited identical voltage ramp protocol
0.44508743.14581585.html.plaintext.txt	8	however using voltage step protocol single channel current amplitude human cftr 100 mv 88 plus minus 2 n 10 100 mv
0.44508743.14581585.html.plaintext.txt	9	based data hypothesized voltage might alter gating behavior human cftr
0.44508743.14581585.html.plaintext.txt	10	using linear three state kinetic schemes demonstrated voltage marked effects channel gating
0.44508743.14581585.html.plaintext.txt	11	membrane depolarization decreased duration bursts interburst interval increased duration gaps within bursts
0.44508743.14581585.html.plaintext.txt	12	however voltage dependencies different rate constants opposite directions voltage without large effect open probability po human cftr
0.44508743.14581585.html.plaintext.txt	13	contrast po murine cftr decreased markedly positive voltages suggesting rectification murine cftr stronger human cftr
0.44508743.14581585.html.plaintext.txt	14	conclude inward rectification cftr caused reduction changes gating kinetics
0.44508743.14581585.html.plaintext.txt	15	suggest inward rectification intrinsic property cftr cl channel result pore block
0.44508743.14581585.html.plaintext.txt	16	key words atp binding cassette transporter cystic fibrosis chloride ion channel channel gating voltage dependence
0.44508743.14581585.html.plaintext.txt	17	introduction top abstract introduction materials methods results discussion references cystic fibrosis transmembrane conductance regulator cftr riordan et al
0.44508743.14581585.html.plaintext.txt	18	1989 phosphorylation regulated cl channel plays central role transepithelial fluid electrolyte transport gadsby nairn 1999 sheppard welsh 1999
0.44508743.14581585.html.plaintext.txt	19	characteristic behavior cftr determined function different domains cftr assembled
0.44508743.14581585.html.plaintext.txt	20	include two membrane spanning domains msds composed six transmembrane segments two nucleotide binding domains nbds contain motifs interact atp unique r regulatory domain contains multiple consensus phosphorylation sites many charged amino acids
0.44508743.14581585.html.plaintext.txt	21	msds assemble form cl selective pore nbds r domain control cftr channel gating gadsby nairn 1999 sheppard welsh 1999
0.44508743.14581585.html.plaintext.txt	22	cell attached membrane patch recordings single channel current voltage v relationship cftr outwardly rectifies berger et al
0.44508743.14581585.html.plaintext.txt	23	1991 attributed outward rectification goldman type rectification caused cl concentration gradient
0.44508743.14581585.html.plaintext.txt	24	however subsequent studies offered alternative explanations
0.44508743.14581585.html.plaintext.txt	25	1993 proposed rectification function concentration permeability anions within cell
0.44508743.14581585.html.plaintext.txt	26	second fischer machen 1994 attributed rectification high frequency gating cftr cl channel negative voltages
0.44508743.14581585.html.plaintext.txt	27	third studies number investigators demonstrated large anions cause voltage dependent block cftr cl channel present intracellular solution mcdonough et al
0.44508743.14581585.html.plaintext.txt	28	1994 linsdell hanrahan 1996 sheppard robinson 1997 zhou et al
0.44508743.14581585.html.plaintext.txt	29	anions bind within deep wide vestibule intracellular end cftr pore prevent cl permeation linsdell hanrahan 1996 sheppard robinson 1997 hwang sheppard 1999 zhou et al
0.44508743.14581585.html.plaintext.txt	30	block cftr cl channel large intracellular anions reminiscent effect intracellular cations inward rectifier k channels kir channels hille 2001
0.44508743.14581585.html.plaintext.txt	31	inward rectification k channels caused voltage dependent block mg2 polyamines found cytoplasm cell vandenberg 1987 lopatin et al
0.44508743.14581585.html.plaintext.txt	32	thus first proposed tabcharani et al
0.44508743.14581585.html.plaintext.txt	33	1991 outward rectification cftr cl channels observed cell attached membrane patches likely caused voltage dependent block large anions found cytoplasm cell linsdell hanrahan 1998a 1999
0.44508743.14581585.html.plaintext.txt	34	inside membrane patches excised cells expressing wild type human cftr bathed symmetrical cl rich solutions single channel v relationship cftr linear e
0.44508743.14581585.html.plaintext.txt	35	however previously observed inward rectification wild type cftr cl currents excised membrane patches c127 cells expressing wild type human cftr lansdell et al
0.44508743.14581585.html.plaintext.txt	36	2000 cai sheppard 2002
0.44508743.14581585.html.plaintext.txt	37	negative voltages v relationship linear whereas positive voltages v relationship exhibited inward rectification marked voltages 50 mv lansdell et al
0.44508743.14581585.html.plaintext.txt	38	2000 cai sheppard 2002
0.44508743.14581585.html.plaintext.txt	39	using excised membrane patches baby hamster kidney bhk cells expressing wild type human cftr linsdell colleagues observed similar results studies linsdell hanrahan 1999 linsdell gong 2002 others e
0.44508743.14581585.html.plaintext.txt	40	1998 linsdell hanrahan 1998b
0.44508743.14581585.html.plaintext.txt	41	1996 reported inward rectification cftr cl channels reconstituted planar lipid bilayers
0.44508743.14581585.html.plaintext.txt	42	study investigate mechanism inward rectification cftr cl channel
0.44508743.14581585.html.plaintext.txt	43	employ voltage ramp step protocols study macroscopic single channel currents excised inside membrane patches cells expressing wild type human murine cftr kinetic modeling analyze channel gating
0.44508743.14581585.html.plaintext.txt	44	materials methods top abstract introduction materials methods results discussion references cells cell culture study used mouse mammary epithelial c127 cells stably expressing wild type human cftr chinese hamster ovary cho cells stably expressing wild type murine cftr
0.44508743.14581585.html.plaintext.txt	45	c127 cho cells gifts dr
0.44508743.14581585.html.plaintext.txt	46	oriordan genzyme framingham ma dr
0.44508743.14581585.html.plaintext.txt	47	wainwright university queensland brisbane australia respectively
0.44508743.14581585.html.plaintext.txt	48	cells cultured described previously sheppard robinson 1997 lansdell et al
0.44508743.14581585.html.plaintext.txt	49	experiments using excised inside membrane patches cells seeded onto glass coverslips used within 48 h
0.44508743.14581585.html.plaintext.txt	50	electrophysiology cftr cl channels recorded excised inside membrane patches using axopatch 200a patch clamp amplifier axon instruments inc
0.44508743.14581585.html.plaintext.txt	51	pclamp data acquisition analysis software version 6
0.44508743.14581585.html.plaintext.txt	52	described previously hamill et al
0.44508743.14581585.html.plaintext.txt	53	1981 sheppard robinson 1997
0.44508743.14581585.html.plaintext.txt	54	established sign convention used throughout currents produced positive charge moving intra extracellular solutions anions moving opposite direction shown positive currents
0.44508743.14581585.html.plaintext.txt	55	pipette extracellular bath intracellular solutions contained mm 140 nmdg 3 mgcl2 1 csegta 10 tes adjusted ph 7
0.44508743.14581585.html.plaintext.txt	56	3 hcl cl 147 mm free ca2 10 8 m
0.44508743.14581585.html.plaintext.txt	57	patch pipettes resistances 10 30 m filled solution
0.44508743.14581585.html.plaintext.txt	58	intracellular solution maintained 37 degrees c using temperature controlled microscope stage brook industries
0.44508743.14581585.html.plaintext.txt	59	excision inside membrane patches added catalytic subunit pka 75 nm atp 1 mm intracellular solution within 5 min patch excision activate cftr cl channels
0.44508743.14581585.html.plaintext.txt	60	prevent rundown cftr cl channels excised membrane patches added pka intracellular solutions
0.44508743.14581585.html.plaintext.txt	61	unless otherwise indicated membrane patches voltage clamped 50 mv
0.44508743.14581585.html.plaintext.txt	62	investigate voltage dependence cftr used either membrane patches containing large numbers active channels membrane patches containing five less active channels
0.44508743.14581585.html.plaintext.txt	63	number channels membrane patch determined maximum number simultaneous channel openings observed course experiment previously described lansdell et al
0.44508743.14581585.html.plaintext.txt	64	using multichannel patches generated macroscopic v relationships averaging currents generated 15 30 ramps voltage 2 duration holding voltage 50 mv
0.44508743.14581585.html.plaintext.txt	65	basal currents active cftr cl channels recorded absence pka 75 nm atp 1 mm subtracted recorded presence pka atp generate v relationship cftr cl currents
0.44508743.14581585.html.plaintext.txt	66	generate ensemble currents applied voltage protocol used multichannel patches membrane patches containing five less active channels 50 100 times
0.44508743.14581585.html.plaintext.txt	67	subtracted basal currents recorded absence pka 75 nm atp 1 mm currents recorded presence pka atp averaging subtracted currents generate ensemble current
0.44508743.14581585.html.plaintext.txt	68	single channel studies voltage dependence cftr voltage stepped 100 100 mv 20 mv increments 30 60 duration
0.44508743.14581585.html.plaintext.txt	69	alternatively voltage clamped single voltage 2 4 min periods acquire sufficient data analyses gating kinetics
0.44508743.14581585.html.plaintext.txt	70	cftr cl currents initially recorded digital audiotape using digital tape recorder model dtr 1204 biologic scientific instruments intracel ltd
0.44508743.14581585.html.plaintext.txt	71	playback records filtered eight pole bessel filter model 902lpf2 frequency devicestm scensys ltd
0.44508743.14581585.html.plaintext.txt	72	corner frequency 500 hz acquired using digidata 1200 interface axon instruments inc
0.44508743.14581585.html.plaintext.txt	73	pclamp software sampling rates either 1
0.44508743.14581585.html.plaintext.txt	74	0 khz voltage ramp protocols 5 khz single channel studies
0.44508743.14581585.html.plaintext.txt	75	determine whether sampling rate 1 khz suitable construction v relationships compared effects acquiring voltage ramp protocols sampling rates 1 5 khz
0.44508743.14581585.html.plaintext.txt	76	1 b demonstrates identical v relationships obtained using two different sampling rates
0.44508743.14581585.html.plaintext.txt	77	measure single channel current amplitude gaussian distributions fit current amplitude histograms
0.44508743.14581585.html.plaintext.txt	78	chord conductance calculated dividing unitary current difference applied voltage reversal potential
0.44508743.14581585.html.plaintext.txt	79	open probability po kinetic analyses lists open open closed times created using half amplitude crossing criterion event detection
0.44508743.14581585.html.plaintext.txt	80	transitions 1 ms duration excluded analyses
0.44508743.14581585.html.plaintext.txt	81	single channel open closed time histograms created using logarithmic x axes 10 bins decade 1
0.44508743.14581585.html.plaintext.txt	82	histograms fit one component exponential functions using maximum likelihood method
0.44508743.14581585.html.plaintext.txt	83	determine component function fitted best log likelihood ratio test used considered statistically significant value 2
0.44508743.14581585.html.plaintext.txt	84	burst analysis performed described carson et al
0.44508743.14581585.html.plaintext.txt	85	1995a using burst delimiter tc time separates interburst closures intraburst closures determined analyses closed time histograms fig
0.44508743.14581585.html.plaintext.txt	86	closures longer tc considered define interburst closures whereas closures shorter time considered gaps within bursts
0.44508743.14581585.html.plaintext.txt	87	mean interburst interval tibi calculated using equation
0.44508743.14581585.html.plaintext.txt	88	1where tb mean burst duration x open probability within burst
0.44508743.14581585.html.plaintext.txt	89	mean burst duration tmbd open probability within burst poburst determined directly experimental data using pclamp software
0.44508743.14581585.html.plaintext.txt	90	tmbd determined histograms burst duration data plotted logarithmic x axes 10 bins decade 1 poburst calculated using burst duration closed times within bursts data po calculated described previously lansdell et al
0.44508743.14581585.html.plaintext.txt	91	membrane patches contained single active channel used single channel kinetic analyses
0.44508743.14581585.html.plaintext.txt	92	modeling single channel kinetics perform maximum likelihood analysis develop kinetic models cftr channel gating used qub software suite www
0.44508743.14581585.html.plaintext.txt	93	1997 analyze data membrane patches contained single active channel described previously cai sheppard 2002
0.44508743.14581585.html.plaintext.txt	94	brief digitized current records generated pclamp software imported filtering baseline corrected program pre
0.44508743.14581585.html.plaintext.txt	95	using recursive viterbi algorithm program skm idealized currents produced
0.44508743.14581585.html.plaintext.txt	96	finally rate constants kinetic models calculated idealized current dwell time sequence using maximum likelihood approach program mil
0.44508743.14581585.html.plaintext.txt	97	consistency analyses using pclamp software transitions 1 ms excluded
0.44508743.14581585.html.plaintext.txt	98	investigate voltage dependence rate constants first calculated rate constants equivalent positive negative voltages individual membrane patches
0.44508743.14581585.html.plaintext.txt	99	rate constants voltage dependent relationship rate constant voltage described single exponential function
0.44508743.14581585.html.plaintext.txt	100	2where k unknown rate constant k0 rate constant unitary ligand concentration zero voltage p ligand concentration v voltage
0.44508743.14581585.html.plaintext.txt	101	3where zg equivalent gating charge defined product unit charge moved z times fraction electric field qe elementary charge kb boltzmanns constant absolute temperature
0.44508743.14581585.html.plaintext.txt	102	parameters k1 k0 intrinsic properties channel vary experimental conditions qin et al
0.44508743.14581585.html.plaintext.txt	103	determine k0 k1 simultaneously fitted combined sets data obtained equivalent positive negative voltages e
0.44508743.14581585.html.plaintext.txt	104	plus minus 75 mv membrane patch
0.44508743.14581585.html.plaintext.txt	105	ligand concentration p constant experimental conditions employed atpi 1 mm value p assumed 1
0.44508743.14581585.html.plaintext.txt	106	finally using values k0 k1 simulated effects voltage rate constants wide range voltages program sim qin et al
0.44508743.14581585.html.plaintext.txt	107	reagents catalytic subunit pka purchased promega uk
0.44508743.14581585.html.plaintext.txt	108	adp disodium salt atp disodium salt pyrophosphate tetrasodium salt tes obtained sigma aldrich
0.44508743.14581585.html.plaintext.txt	109	chemicals reagent grade
0.44508743.14581585.html.plaintext.txt	110	statistics results expressed means plus minus sem n observations
0.44508743.14581585.html.plaintext.txt	111	compare sets data used either one way analysis variance anova students paired test
0.44508743.14581585.html.plaintext.txt	112	differences considered statistically significant p 0
0.44508743.14581585.html.plaintext.txt	113	tests performed using sigmastattm version 2
0.44508743.14581585.html.plaintext.txt	114	online supplemental material investigate possibility inward rectification cftr cl currents caused component recording solutions examined effect cftr number factors bath pipette solutions
0.44508743.14581585.html.plaintext.txt	115	included nature biological buffer fig
0.44508743.14581585.html.plaintext.txt	116	s1 monovalent cation used recording solutions figs
0.44508743.14581585.html.plaintext.txt	117	supplemental figures text available httpwww
0.44508743.14581585.html.plaintext.txt	118	results top abstract introduction materials methods results discussion references voltage dependence cftr cl channel learn voltage regulates activity cftr studied cftr cl currents excised inside membrane patches c127 cells expressing wild type human cftr
0.44508743.14581585.html.plaintext.txt	119	bathed membrane patches symmetrical 147 mm cl solutions recorded membrane currents voltage range plus minus 100 mv using voltage ramp protocol
0.44508743.14581585.html.plaintext.txt	120	1 demonstrates basal conditions voltage ramp protocol evoked tiny membrane currents
0.44508743.14581585.html.plaintext.txt	121	however activation cftr cl currents camp dependent phosphorylation voltage ramp protocol elicited large membrane currents fig
0.44508743.14581585.html.plaintext.txt	122	identify membrane currents generated cftr subtracted membrane currents recorded basal conditions recorded following addition pka 75 nm atp 1 mm intracellular solution
0.44508743.14581585.html.plaintext.txt	123	1 b shows v relationship cftr cl currents
0.44508743.14581585.html.plaintext.txt	124	negative voltages v relationship linear whereas positive voltages v relationship exhibits weak inward rectification fig
0.44508743.14581585.html.plaintext.txt	125	inward rectification cftr cl currents clearly demonstrated fig
0.44508743.14581585.html.plaintext.txt	126	1 c data expressed percentage current value 100 mv
0.44508743.14581585.html.plaintext.txt	127	voltages 50 mv current values diverge noticeably v relationship ion channel obeys ohms law fig
0.44508743.14581585.html.plaintext.txt	128	data indicate cftr cl currents exhibit weak inward rectification bathed symmetrical cl rich solutions
0.44508743.14581585.html.plaintext.txt	129	view larger version 17k figure 1
0.44508743.14581585.html.plaintext.txt	130	v relationship cftr cl currents
0.44508743.14581585.html.plaintext.txt	131	current traces excised inside membrane patch c127 cell expressing wild type human cftr
0.44508743.14581585.html.plaintext.txt	132	recordings made absence middle presence bottom pka 75 nm atp 1 mm intracellular solution
0.44508743.14581585.html.plaintext.txt	133	basal recording current response single ramp voltage active cftr cl channels whereas recording presence pka atp average current 30 ramps voltage
0.44508743.14581585.html.plaintext.txt	134	holding voltage 50 mv membrane patch bathed symmetrical 147 mm nmdgcl solutions
0.44508743.14581585.html.plaintext.txt	135	voltage ramp protocol used shown currents acquired sampling rate 1 khz described materials methods
0.44508743.14581585.html.plaintext.txt	136	b v relationship constructed subtracting basal trace pka atp trace shown
0.44508743.14581585.html.plaintext.txt	137	inset shows v relationship data acquired sampling rate 5 khz abscissa 100 100 mv ordinate 30 30 pa
0.44508743.14581585.html.plaintext.txt	138	c v relationship cftr cl currents
0.44508743.14581585.html.plaintext.txt	139	data means plus minus sem n 10 voltage calculated expressing individual current values measured 100 100 mv 10 mv increments percentage current value 100 mv
0.44508743.14581585.html.plaintext.txt	140	error bars smaller symbol size
0.44508743.14581585.html.plaintext.txt	141	continuous line fit second order regression data
0.44508743.14581585.html.plaintext.txt	142	dotted line shows predicted ohmic v relationship
0.44508743.14581585.html.plaintext.txt	143	investigate inward rectification cftr studied single cl channels
0.44508743.14581585.html.plaintext.txt	144	reasoned v relationship individual cftr cl channels exhibits inward rectification summation single channel currents reproduce rectification macroscopic cftr cl currents
0.44508743.14581585.html.plaintext.txt	145	test hypothesis applied voltage protocol used study macroscopic cftr cl currents membrane patches containing five less active channels
0.44508743.14581585.html.plaintext.txt	146	2 shows activity single cftr cl channel evoked five ramps voltage 100 100 mv
0.44508743.14581585.html.plaintext.txt	147	visual inspection single channel records suggests current amplitude negative voltages larger positive voltages
0.44508743.14581585.html.plaintext.txt	148	consistent idea ensemble current generated averaging single channel currents elicited 70 voltage ramps inwardly rectifies fig
0.44508743.14581585.html.plaintext.txt	149	importantly extent inward rectification observed ensemble current agrees closely macroscopic cftr cl currents figs
0.44508743.14581585.html.plaintext.txt	150	example 100 mv magnitude macroscopic cftr cl current 74 plus minus 2 n 10 100 mv ensemble current 79 plus minus 3 n 5 100 mv p 0
0.44508743.14581585.html.plaintext.txt	151	data indicate voltage dependent changes single channel activity cftr account inward rectification macroscopic cftr cl currents
0.44508743.14581585.html.plaintext.txt	152	view larger version 27k figure 2
0.44508743.14581585.html.plaintext.txt	153	summation single channel currents reproduces rectification macroscopic cftr cl currents
0.44508743.14581585.html.plaintext.txt	154	representative recordings single cftr cl channel excised inside membrane patch elicited depolarizing voltage ramp 100 100 mv
0.44508743.14581585.html.plaintext.txt	155	atp 1 mm pka 75 nm continuously present intracellular solution
0.44508743.14581585.html.plaintext.txt	156	dotted line indicates zero current level
0.44508743.14581585.html.plaintext.txt	157	purpose illustration single channel records digitally refiltered 100 hz
0.44508743.14581585.html.plaintext.txt	158	b ensemble current obtained averaging 70 ramps voltage experiment shown
0.44508743.14581585.html.plaintext.txt	159	continuous line fit second order regression data
0.44508743.14581585.html.plaintext.txt	160	c v relationship expressed percentage current value 100 mv
0.44508743.14581585.html.plaintext.txt	161	data means plus minus sem n 5 voltage
0.44508743.14581585.html.plaintext.txt	162	effect voltage single channel activity cftr principal inward rectification cftr cl currents might caused voltage dependent change first number active channels second current flow open channels third channel gating hence po
0.44508743.14581585.html.plaintext.txt	163	discriminate different possibilities investigated effect voltage single channel activity cftr
0.44508743.14581585.html.plaintext.txt	164	3 compares activity single cftr cl channel phosphorylated pka atp 75 75 mv
0.44508743.14581585.html.plaintext.txt	165	single channel records suggest inward rectification caused decrease number active channels present positive voltages n 6 fig
0.44508743.14581585.html.plaintext.txt	166	contrary single channel data suggest inward rectification caused reduction changes gating behavior positive voltages fig
0.44508743.14581585.html.plaintext.txt	167	view larger version 55k figure 3
0.44508743.14581585.html.plaintext.txt	168	effect voltage single channel activity cftr
0.44508743.14581585.html.plaintext.txt	169	representative recordings single cftr cl channel 75 mv top 75 mv bottom
0.44508743.14581585.html.plaintext.txt	170	atp 1 mm pka 75 nm continuously present intracellular solution
0.44508743.14581585.html.plaintext.txt	171	dotted lines indicate closed channel state
0.44508743.14581585.html.plaintext.txt	172	downward upward deflections correspond channel openings 75 mv 75 mv respectively
0.44508743.14581585.html.plaintext.txt	173	purpose illustration single channel records filtered 500 hz digitized 1 khz
0.44508743.14581585.html.plaintext.txt	174	decrease positive voltages readily apparent visual inspection single channel records fig
0.44508743.14581585.html.plaintext.txt	175	however evident single channel current amplitude histograms v relationship cftr fig
0.44508743.14581585.html.plaintext.txt	176	4 shows histograms distribution current values plus minus 50 plus minus 75 mv
0.44508743.14581585.html.plaintext.txt	177	compared values negative voltages reduction 50 mv slight 75 mv small fig
0.44508743.14581585.html.plaintext.txt	178	nevertheless like macroscopic cftr cl currents single channel v relationship cftr weakly inwardly rectified positive voltages fig
0.44508743.14581585.html.plaintext.txt	179	consistent data chord conductance cftr decreased 11
0.44508743.14581585.html.plaintext.txt	180	3 ps 100 mv n 10 p 0
0.44508743.14581585.html.plaintext.txt	181	view larger version 31k figure 4
0.44508743.14581585.html.plaintext.txt	182	single channel conductance cftr
0.44508743.14581585.html.plaintext.txt	183	single channel current amplitude histograms single cftr cl channel indicated voltages recorded using conditions described fig
0.44508743.14581585.html.plaintext.txt	184	negative voltages top closed channel amplitude shown right whereas positive voltages bottom closed channel amplitude shown left
0.44508743.14581585.html.plaintext.txt	185	linear x axes 20 bins decade 1 used histograms continuous lines represent fit gaussian distributions data
0.44508743.14581585.html.plaintext.txt	186	vertical dashed lines indicate position open closed channel levels negative voltages
0.44508743.14581585.html.plaintext.txt	187	b single channel v relationship cftr
0.44508743.14581585.html.plaintext.txt	188	c relationship chord conductance voltage data shown b
0.44508743.14581585.html.plaintext.txt	189	chord conductance calculated described materials methods
0.44508743.14581585.html.plaintext.txt	190	comparison macroscopic single channel v relationships cftr figs
0.44508743.14581585.html.plaintext.txt	191	1 c 4 b suggests decrease positive voltages insufficient account rectification macroscopic cftr cl currents
0.44508743.14581585.html.plaintext.txt	192	example 100 mv single channel current amplitude 88 plus minus 2 100 mv n 10 whereas 100 mv macroscopic current 74 plus minus 2 100 mv n 10 p 0
0.44508743.14581585.html.plaintext.txt	193	agreement data fig
0.44508743.14581585.html.plaintext.txt	194	3 demonstrates pattern channel gating 75 mv differs strikingly observed 75 mv
0.44508743.14581585.html.plaintext.txt	195	negative voltages gating behavior cftr characterized bursts channel activity interrupted brief flickery closures separated longer closures bursts fig
0.44508743.14581585.html.plaintext.txt	196	contrast positive voltages duration bursts well long closed periods separating bursts decreased length fig
0.44508743.14581585.html.plaintext.txt	197	quantify changes gating behavior positive voltages used membrane patches contained single active channel
0.44508743.14581585.html.plaintext.txt	198	analyzed histograms open closed times plus minus 75 mv determine voltage alters distribution open closed times
0.44508743.14581585.html.plaintext.txt	199	75 75 mv open closed time histograms cftr best fitted one two component functions respectively fig
0.44508743.14581585.html.plaintext.txt	200	however positive voltages distribution open closed times altered several ways
0.44508743.14581585.html.plaintext.txt	201	first open time constant o1 decreased 52 fig
0.44508743.14581585.html.plaintext.txt	202	second fast closed time constant c1 describes flickery closures interrupt channel openings increased 79 share closed time distribution expanded slightly 61 66 fig
0.44508743.14581585.html.plaintext.txt	203	third slow closed time constant c2 describes long closures separate channel openings decreased 27 share closed time distribution contracted slightly 39 34 fig
0.44508743.14581585.html.plaintext.txt	204	consequence changes channel gating number events per minute 75 mv double 75 mv table
0.44508743.14581585.html.plaintext.txt	205	view larger version 34k figure 5
0.44508743.14581585.html.plaintext.txt	206	analysis dwell time histograms single cftr cl channel
0.44508743.14581585.html.plaintext.txt	207	b representative open closed time histograms single cftr cl channel recorded 75 75 mv respectively using conditions described fig
0.44508743.14581585.html.plaintext.txt	208	open time histograms continuous line fit one component exponential function
0.44508743.14581585.html.plaintext.txt	209	closed time histograms continuous line fit two component exponential function
0.44508743.14581585.html.plaintext.txt	210	dotted lines show individual components exponential functions
0.44508743.14581585.html.plaintext.txt	211	logarithmic x axes 10 bins decade 1 used open closed time histograms
0.44508743.14581585.html.plaintext.txt	212	c burst duration top interburst interval middle po bottom cftr indicated voltages
0.44508743.14581585.html.plaintext.txt	213	columns error bars indicate means plus minus sem n 10 voltage
0.44508743.14581585.html.plaintext.txt	214	po data filled circles connected lines represent individual experiments open circles means plus minus sem n 10
0.44508743.14581585.html.plaintext.txt	215	asterisks indicate values significantly different 75 mv data p 0
0.44508743.14581585.html.plaintext.txt	216	burst duration interburst interval calculated described materials methods
0.44508743.14581585.html.plaintext.txt	217	view table table effect voltage open closed time constants wild type cftr cl channels
0.44508743.14581585.html.plaintext.txt	218	investigate changes gating behavior positive voltages performed analysis bursts using burst delimiter tc determined nadir two populations channel closures fig
0.44508743.14581585.html.plaintext.txt	219	5 b table carson et al
0.44508743.14581585.html.plaintext.txt	220	32 ms n 10 whereas 75 mv tc 18
0.44508743.14581585.html.plaintext.txt	221	large difference fast slow time constants negative positive voltages suggests errors caused misclassification bursts rare
0.44508743.14581585.html.plaintext.txt	222	5 c demonstrates burst duration interburst interval significantly decreased 75 mv p 0
0.44508743.14581585.html.plaintext.txt	223	result po cftr 75 mv slightly decreased compared value 75 mv although difference statistically significant p 0
0.44508743.14581585.html.plaintext.txt	224	data suggest voltage alters gating behavior cftr cl channel without noticeably changing po
0.44508743.14581585.html.plaintext.txt	225	thus data suggest single channel behavior cftr accounts rectification cftr cl currents
0.44508743.14581585.html.plaintext.txt	226	cftr cl current determined product number cftr cl channels membrane patch n single channel current amplitude probability po single channel open icftr n x x po
0.44508743.14581585.html.plaintext.txt	227	set variables 100 100 mv data compare cftr cl current generated 100 100 mv
0.44508743.14581585.html.plaintext.txt	228	table ii presents values variable predicted cftr cl current determined calculating n x x po observed value cftr cl current
0.44508743.14581585.html.plaintext.txt	229	differences observed predicted values likely accounted using data plus minus 75 mv plus minus 100 mv calculate po subtraction basal currents
0.44508743.14581585.html.plaintext.txt	230	1 nevertheless predicted observed values agree closely
0.44508743.14581585.html.plaintext.txt	231	view table table ii comparison predicted cftr cl current n x x po measured cftr cl current 100 100 mv
0.44508743.14581585.html.plaintext.txt	232	voltage changes gating kinetics cftr understand better voltage changes pattern channel gating used maximum likelihood analysis kinetic modeling
0.44508743.14581585.html.plaintext.txt	233	using approach winter et al
0.44508743.14581585.html.plaintext.txt	234	1994 demonstrated gating kinetics single phosphorylated wild type cftr cl channels described equally well linear three state schemes shown figs
0.44508743.14581585.html.plaintext.txt	235	schemes c1 represents long duration closed state separating channel openings c2 brief flickery closures interrupt channel openings o open state
0.44508743.14581585.html.plaintext.txt	236	transitions three states described rate constants ss1 ss2 1 2
0.44508743.14581585.html.plaintext.txt	237	using c1c2o kinetic scheme intracellular atp regulates cftr transition c1 c2 atp concentration raised ss1 increases winter et al
0.44508743.14581585.html.plaintext.txt	238	contrast none transition rates altered significantly atp winter et al
0.44508743.14581585.html.plaintext.txt	239	similar analyses data support model atp dependent regulation cftr channel gating cai sheppard 2002
0.44508743.14581585.html.plaintext.txt	240	also suggest using c1oc2 kinetic scheme intracellular atp regulates cftr transition c1 o ss1 increasing elevated atp concentrations rate constants remain unchanged unpublished data
0.44508743.14581585.html.plaintext.txt	241	gating behavior cftr equally well described kinetic schemes c1c2o c1oc2 used schemes determine voltage regulates cftr channel gating
0.44508743.14581585.html.plaintext.txt	242	view larger version 24k figure 6
0.44508743.14581585.html.plaintext.txt	243	effect voltage rate constants c1c2o kinetic scheme
0.44508743.14581585.html.plaintext.txt	244	c1c2o kinetic scheme describes cftr channel gating winter et al
0.44508743.14581585.html.plaintext.txt	245	states c1 c2 o represent two closed states one open state respectively ss1 ss2 1 2 represent rate constants describing transitions states
0.44508743.14581585.html.plaintext.txt	246	states enclosed within dashed box represent bursting state
0.44508743.14581585.html.plaintext.txt	247	b rate constants indicated voltages determined maximum likelihood fit model shown
0.44508743.14581585.html.plaintext.txt	248	data means plus minus sem n 6 voltage
0.44508743.14581585.html.plaintext.txt	249	asterisks indicate values significantly different 75 mv data p 0
0.44508743.14581585.html.plaintext.txt	250	c relationship rate constants ss1 filled circles ss2 filled diamonds 1 open circles 2 open diamonds voltage c1c2o model
0.44508743.14581585.html.plaintext.txt	251	values means plus minus sem n 5 6 voltage
0.44508743.14581585.html.plaintext.txt	252	continuous lines represent fits single exponential function kk0pexp eq
0.44508743.14581585.html.plaintext.txt	253	2 described materials methods
0.44508743.14581585.html.plaintext.txt	254	6 b shows rate constants c1c2o kinetic scheme fig
0.44508743.14581585.html.plaintext.txt	255	1994 75 75 mv calculated using qub software suite www
0.44508743.14581585.html.plaintext.txt	256	compared 75 mv data 1 decreased 53 75 mv 2 increased 88 ss2 decreased 24 ss1 unchanged
0.44508743.14581585.html.plaintext.txt	257	duration bursts influenced first 1 rate constant determines velocity channel leaves bursting state second 2 ss2 rate constants control opening closing transitions within bursting state see eq
0.44508743.14581585.html.plaintext.txt	258	decrease 1 delays exit bursting state hence increases duration bursts 75 mv
0.44508743.14581585.html.plaintext.txt	259	contrast decrease ss2 particularly increase 2 act decrease duration bursts 75 mv
0.44508743.14581585.html.plaintext.txt	260	thus data suggest depolarized voltages produce reciprocal changes 1 rate constants within bursting state
0.44508743.14581585.html.plaintext.txt	261	2 ss2 tend offset
0.44508743.14581585.html.plaintext.txt	262	7 b shows rate constants c1oc2 kinetic scheme fig
0.44508743.14581585.html.plaintext.txt	263	compared 75 mv data 1 increased 27 75 mv ss1 increased 29 ss2 increased 118 2 decreased 34
0.44508743.14581585.html.plaintext.txt	264	c1c2o kinetic scheme duration bursts c1oc2 model influenced 1 2 ss2 see eq
0.44508743.14581585.html.plaintext.txt	265	however unlike c1c2o kinetic scheme changes 2 ss2 little effect burst duration 75 mv increase 1 accelerates rate exit bursting state hence decreases duration bursts 75 mv
0.44508743.14581585.html.plaintext.txt	266	similarly increase ss1 rate constant determines velocity channel enters bursting state causes reduction interburst interval 75 mv
0.44508743.14581585.html.plaintext.txt	267	view larger version 24k figure 7
0.44508743.14581585.html.plaintext.txt	268	effect voltage rate constants c1oc2 kinetic scheme
0.44508743.14581585.html.plaintext.txt	269	c1oc2 kinetic scheme describes cftr channel gating winter et al
0.44508743.14581585.html.plaintext.txt	270	b rate constants indicated voltages determined maximum likelihood fit model shown
0.44508743.14581585.html.plaintext.txt	271	c relationship rate constants ss1 filled circles ss2 filled diamonds 1 open circles voltage c1oc2 scheme
0.44508743.14581585.html.plaintext.txt	272	inset shows relationship rate constant 2 voltage scheme
0.44508743.14581585.html.plaintext.txt	273	investigate whether changes rate constants counteract used rate constants c1c2o c1oc2 kinetic schemes calculate values burst duration ii mean duration gaps within bursts iii interburst interval iv po compared values derived using pclamp software
0.44508743.14581585.html.plaintext.txt	274	first using kinetic scheme c1c2o mean burst duration given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	275	4 mean burst duration decreased 158 plus minus 17 ms n 6 75 mv 130 plus minus 18 ms n 6 75 mv decrease 18 p 0
0.44508743.14581585.html.plaintext.txt	276	using kinetic scheme c1oc2 mean burst duration given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	277	5 mean burst duration decreased 145 plus minus 18 ms n 6 75 mv 120 plus minus 16 ms n 6 75 mv reduction 17 p 0
0.44508743.14581585.html.plaintext.txt	278	data close agreement mean burst duration values determined using rate constant data c1c2o kinetic scheme pclamp software 19 decrease fig
0.44508743.14581585.html.plaintext.txt	279	indicate burst duration decreases positive voltages
0.44508743.14581585.html.plaintext.txt	280	second using kinetic scheme c1c2o mean duration gaps within bursts given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	281	6 mean duration gaps within bursts increased 1
0.44508743.14581585.html.plaintext.txt	282	17 ms n 6 75 mv increase 57 p 0
0.44508743.14581585.html.plaintext.txt	283	using kinetic scheme c1oc2 mean duration gaps within bursts given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	284	7 mean duration gaps within bursts increased 1
0.44508743.14581585.html.plaintext.txt	285	15 ms n 6 75 mv increase 52 p 0
0.44508743.14581585.html.plaintext.txt	286	data reasonable agreement values mean duration gaps within bursts calculated using rate constant data c1c2o kinetic scheme excellent agreement values determined using pclamp software 75 mv 2
0.44508743.14581585.html.plaintext.txt	287	25 ms n 10 52 increase p 0
0.44508743.14581585.html.plaintext.txt	288	indicate bursts become interrupted longer brief closures positive voltages
0.44508743.14581585.html.plaintext.txt	289	third using kinetic scheme c1c2o approximate value interburst interval determined using equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	290	8 interburst interval decreased 113 plus minus 18 ms n 6 75 mv 84 plus minus 11 ms n 6 75 mv decrease 26 p 0
0.44508743.14581585.html.plaintext.txt	291	using kinetic scheme c1oc2 interburst interval given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	292	9 interburst interval decreased 106 plus minus 18 ms n 6 75 mv 80 plus minus 11 ms n 6 75 mv reduction 25 p 0
0.44508743.14581585.html.plaintext.txt	293	data good agreement values interburst interval calculated using rate constant data c1c2o kinetic scheme reasonable agreement values determined using pclamp software 16 decrease fig
0.44508743.14581585.html.plaintext.txt	294	indicate interburst interval decreases positive voltages
0.44508743.14581585.html.plaintext.txt	295	fourth using kinetic scheme c1c2o po given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	296	10 po decreased slightly 0
0.44508743.14581585.html.plaintext.txt	297	04 n 6 75 mv decrease 2 p 0
0.44508743.14581585.html.plaintext.txt	298	using kinetic scheme c1oc2 po given equation sakmann trube 1984
0.44508743.14581585.html.plaintext.txt	299	11 po decreased marginally 0
0.44508743.14581585.html.plaintext.txt	300	04 n 6 75 mv reduction 2 p 0
0.44508743.14581585.html.plaintext.txt	301	data good agreement values po calculated using rate constant data c1c2o kinetic scheme good agreement values determined using pclamp software 5 decrease fig
0.44508743.14581585.html.plaintext.txt	302	however decrease po calculated using rate constant data statistically significant unlike calculated using pclamp software
0.44508743.14581585.html.plaintext.txt	303	attribute subtle effect voltage po changes mean burst duration interburst interval counterbalancing
0.44508743.14581585.html.plaintext.txt	304	understand better voltage dependence cftr channel gating calculated rate constants kinetic schemes 50 20 20 50 mv fitted data using single exponential function kk0pexp eq
0.44508743.14581585.html.plaintext.txt	305	determine whether rate constants changed voltage performed one way anovas
0.44508743.14581585.html.plaintext.txt	306	considering first c1c2o kinetic scheme test indicated ss1 ss2 change significantly voltage fig
0.44508743.14581585.html.plaintext.txt	307	2 contrast significant difference found voltage 2 1 fig
0.44508743.14581585.html.plaintext.txt	308	2 considering next c1oc2 kinetic scheme one way anovas indicated 1 ss2 change significantly voltage fig
0.44508743.14581585.html.plaintext.txt	309	contrast significant difference found voltage ss1 2 fig
0.44508743.14581585.html.plaintext.txt	310	thus kinetic schemes voltage profound effects gating behavior cftr cl channel
0.44508743.14581585.html.plaintext.txt	311	however kinetic schemes effects voltage rate constants tend oppose one another cftr cl currents exhibit weak voltage dependence
0.44508743.14581585.html.plaintext.txt	312	finally using data figs
0.44508743.14581585.html.plaintext.txt	313	6 c 7 c derived values equivalent gating charge rate constants two kinetic schemes tables iii iv
0.44508743.14581585.html.plaintext.txt	314	c1c2o kinetic scheme total equivalent gating charge cftr 0
0.44508743.14581585.html.plaintext.txt	315	32e table iii c1oc2 kinetic scheme 0
0.44508743.14581585.html.plaintext.txt	316	values gating charge threefold lower clc 0 voltage dependent cl channel torpedo electric organ hanke miller 1983 pusch et al
0.44508743.14581585.html.plaintext.txt	317	1995 chen miller 1996 fortyfold lower voltage gated na k ca2 channels hille 2001
0.44508743.14581585.html.plaintext.txt	318	view table table iii summary fits rate constants c1c2o kinetic scheme
0.44508743.14581585.html.plaintext.txt	319	view table table iv summary fits rate constants c1oc2 kinetic scheme
0.44508743.14581585.html.plaintext.txt	320	effect voltage regulation channel gating nbds following camp dependent phosphorylation gating behavior cftr controlled cycles atp binding hydrolysis nbds gadsby nairn 1999 sheppard welsh 1999
0.44508743.14581585.html.plaintext.txt	321	previous work indicates adp inhibits activity cftr antagonizing atp dependent channel opening prolong greatly duration long closures separating channel openings winter et al
0.44508743.14581585.html.plaintext.txt	322	conversely inorganic phosphate analogue pyrophosphate ppi stimulates activity cftr increasing frequency prolonging dramatically duration channel openings carson et al
0.44508743.14581585.html.plaintext.txt	323	especially interested effects ppi voltage dependence cftr channel gating ppi abolished asymmetric permeability cftr large organic anions linsdell hanrahan 1998b
0.44508743.14581585.html.plaintext.txt	324	speculated ppi might convert cftr inwardly rectifying channel linear channel
0.44508743.14581585.html.plaintext.txt	325	test hypothesis examined effect ppi inward rectification cftr cl currents using voltage ramp protocols
0.44508743.14581585.html.plaintext.txt	326	control tested effect adp without effect asymmetric permeability cftr large organic anions linsdell hanrahan 1998b
0.44508743.14581585.html.plaintext.txt	327	8 shows v relationships cftr cl currents recorded absence presence ppi 5 mm
0.44508743.14581585.html.plaintext.txt	328	ppi 5 mm increased cftr cl currents similar amounts negative positive voltages fig
0.44508743.14581585.html.plaintext.txt	329	8 b indicating ppi stimulation cftr voltage independent
0.44508743.14581585.html.plaintext.txt	330	9 b demonstrates cftr inhibition adp 1 mm voltage independent
0.44508743.14581585.html.plaintext.txt	331	consistent data neither ppi 5 mm adp 1 mm altered inward rectification cftr cl currents figs
0.44508743.14581585.html.plaintext.txt	332	view larger version 14k figure 8
0.44508743.14581585.html.plaintext.txt	333	pyrophosphate stimulation cftr cl currents voltage independent
0.44508743.14581585.html.plaintext.txt	334	v relationships cftr cl currents recorded absence presence pyrophosphate ppi 5 mm intracellular solution
0.44508743.14581585.html.plaintext.txt	335	b effect voltage fraction cftr cl current stimulated ppi 5 mm
0.44508743.14581585.html.plaintext.txt	336	values means plus minus sem n 4 voltage
0.44508743.14581585.html.plaintext.txt	337	continuous line fit first order regression data
0.44508743.14581585.html.plaintext.txt	338	c v relationships cftr cl currents recorded absence open circles presence filled circles ppi 5 mm expressed percentage current value 100 mv
0.44508743.14581585.html.plaintext.txt	339	data means plus minus sem n 4 voltage
0.44508743.14581585.html.plaintext.txt	340	view larger version 13k figure 9
0.44508743.14581585.html.plaintext.txt	341	adp inhibition cftr cl currents voltage independent
0.44508743.14581585.html.plaintext.txt	342	v relationships cftr cl currents recorded absence presence adp 1 mm intracellular solution
0.44508743.14581585.html.plaintext.txt	343	b effect voltage fraction cftr cl current inhibited adp 1 mm
0.44508743.14581585.html.plaintext.txt	344	c v relationships cftr cl currents recorded absence open circles presence filled circles adp 1 mm expressed percentage current value 100 mv
0.44508743.14581585.html.plaintext.txt	345	voltage dependence murine cftr cl channel previous work demonstrated wild type murine cftr cl channels reduced single channel conductance dramatically decreased po altered pattern channel gating compared wild type human cftr lansdell et al
0.44508743.14581585.html.plaintext.txt	346	explore voltage dependence cftr investigated effect voltage activity wild type murine cftr cl channels excised inside membrane patches
0.44508743.14581585.html.plaintext.txt	347	10 demonstrates 80 mv pattern gating murine cftr characterized transitions closed state two open states sustained openings subconductance state brief openings full open state lansdell et al
0.44508743.14581585.html.plaintext.txt	348	80 mv gating behavior cftr also characterized prolonged openings subconductance state brief openings full open state fig
0.44508743.14581585.html.plaintext.txt	349	however frequency duration openings full open state appeared reduced compared 80 mv fig
0.44508743.14581585.html.plaintext.txt	350	view larger version 36k figure 10
0.44508743.14581585.html.plaintext.txt	351	effect voltage murine cftr cl channel
0.44508743.14581585.html.plaintext.txt	352	recordings single murine cftr cl channel 80 mv top 80 mv bottom made using conditions described fig
0.44508743.14581585.html.plaintext.txt	353	b single channel v relationships human open circles murine filled circles cftr
0.44508743.14581585.html.plaintext.txt	354	data means plus minus sem n 8 10 voltage
0.44508743.14581585.html.plaintext.txt	355	c relationship chord conductance voltage data shown b
0.44508743.14581585.html.plaintext.txt	356	d effect voltage po human left ordinate murine right ordinate cftr
0.44508743.14581585.html.plaintext.txt	357	columns error bars indicate means plus minus sem human n 6 murine n 10
0.44508743.14581585.html.plaintext.txt	358	human cftr voltage 75 75 mv whereas murine voltage 80 80 mv
0.44508743.14581585.html.plaintext.txt	359	asterisks indicate values significantly different data negative voltages p 0
0.44508743.14581585.html.plaintext.txt	360	quantify voltage dependence murine cftr cl channel measured po full open state
0.44508743.14581585.html.plaintext.txt	361	investigate voltage dependence subconductance state tiny single channel current amplitude
0.44508743.14581585.html.plaintext.txt	362	10 b compares single channel v relationship murine cftr human cftr
0.44508743.14581585.html.plaintext.txt	363	murine cftr 100 mv 73 plus minus 4 n 7 100 mv human cftr 100 mv 88 plus minus 2 n 10 100 mv p 0
0.44508743.14581585.html.plaintext.txt	364	consistent data chord conductance murine cftr decreased 25 voltage range 100 100 mv whereas human cftr decreased 12 fig
0.44508743.14581585.html.plaintext.txt	365	moreover voltage tested chord conductance murine cftr reduced compared human cftr fig
0.44508743.14581585.html.plaintext.txt	366	10 d compares po human murine cftr negative positive voltages
0.44508743.14581585.html.plaintext.txt	367	data demonstrate two important differences human murine cftr first po full open state murine cftr much reduced compared human cftr fig
0.44508743.14581585.html.plaintext.txt	368	second po murine cftr greatly decreased positive voltages whereas human cftr little changed fig
0.44508743.14581585.html.plaintext.txt	369	murine cftr po value 80 mv decreased 49 plus minus 10 n 10 compared 80 mv p 0
0.44508743.14581585.html.plaintext.txt	370	contrast human cftr po value 75 mv decreased 5 plus minus 1 n 6 compared 75 mv p 0
0.44508743.14581585.html.plaintext.txt	371	thus single channel data suggest inward rectification murine cftr stronger human cftr cl channel
0.44508743.14581585.html.plaintext.txt	372	discussion top abstract introduction materials methods results discussion references goal study investigate inward rectification macroscopic cftr cl currents excised inside membrane patches
0.44508743.14581585.html.plaintext.txt	373	using three independent methods demonstrated cftr exhibits inward rectification bathed symmetrical cl rich solutions
0.44508743.14581585.html.plaintext.txt	374	data indicate inward rectification caused voltage dependent decrease single channel chord conductance changes kinetics channel gating large positive voltages
0.44508743.14581585.html.plaintext.txt	375	also suggest inward rectification murine cftr cl channel stronger human cftr
0.44508743.14581585.html.plaintext.txt	376	principal inward rectification cftr cl channel might either result channel block soluble factor intrinsic property cftr channel protein
0.44508743.14581585.html.plaintext.txt	377	studies ion channels provide strong support hypotheses
0.44508743.14581585.html.plaintext.txt	378	example inward rectification kir channels nmda receptors cyclic nucleotide gated channels caused voltage dependent block outward current flow extrinsic cations
0.44508743.14581585.html.plaintext.txt	379	case kir channels blocking cations intracellular mg2 polyamines vandenberg 1987 lopatin et al
0.44508743.14581585.html.plaintext.txt	380	1994 whereas nmda receptors cyclic nucleotide gated channels blocking cations extracellular ca2 mg2 nowak et al
0.44508743.14581585.html.plaintext.txt	381	1984 zimmerman baylor 1986
0.44508743.14581585.html.plaintext.txt	382	contrast inward rectification kat1 inward rectifier k channel plant arabidopsis thaliana results intrinsic gating mechanism zei aldrich 1998
0.44508743.14581585.html.plaintext.txt	383	like voltage gated k channels hille 2001 kat1 possesses voltage sensor s4 segment uses energy voltage control channel gating zei aldrich 1998
0.44508743.14581585.html.plaintext.txt	384	several lines evidence suggest channel block likely account inward rectification cftr cl channel excised inside membrane patches
0.44508743.14581585.html.plaintext.txt	385	first changes composition intra extracellular solutions abolish inward rectification data discussion see online supplemental material available httpwww
0.44508743.14581585.html.plaintext.txt	386	second inward rectification observed using cells expressing either native recombinant wild type human cftr e
0.44508743.14581585.html.plaintext.txt	387	quinton reddy 2000 lansdell et al
0.44508743.14581585.html.plaintext.txt	388	2000 linsdell gong 2002 study indicating inward rectification independent expression system used investigate cftr
0.44508743.14581585.html.plaintext.txt	389	third inward rectification cftr cl channels reconstituted planar lipid bilayers unaffected changes composition lipid bilayer zhao et al
0.44508743.14581585.html.plaintext.txt	390	1996 suggesting surface charge membrane lipid affect inward rectification
0.44508743.14581585.html.plaintext.txt	391	fourth effects voltage function murine cftr cl channel present study indicate inward rectification common characteristic human murine cftr
0.44508743.14581585.html.plaintext.txt	392	fifth mutation several residues within msds alters shape v relationship cftr
0.44508743.14581585.html.plaintext.txt	393	inward rectification cftr cl currents accentuated mutation r334 t338 t339 s341 sixth transmembrane segment m6 gong linsdell 2003 linsdell et al
0.44508743.14581585.html.plaintext.txt	394	2002 s1118 m11 zhang et al
0.44508743.14581585.html.plaintext.txt	395	2000 t1134 n1138 m12 gupta et al
0.44508743.14581585.html.plaintext.txt	396	contrast mutation v317 m5 zhang et al
0.44508743.14581585.html.plaintext.txt	397	2002 causes outward rectification cftr cl currents
0.44508743.14581585.html.plaintext.txt	398	based data speculate inward rectification intrinsic property cftr cl channel
0.44508743.14581585.html.plaintext.txt	399	adp ppi two agents interact nbds without effect inward rectification site directed mutations msds enhance inward rectification propose cftr pore determines property cftr cl channel
0.44508743.14581585.html.plaintext.txt	400	cftr pore responsible inward rectification architecture pore facilitate flow cl intra extracellular side membrane hinder cl flow opposite direction
0.44508743.14581585.html.plaintext.txt	401	transport ions maximal translocation rates ion channels evolved charged lined vestibules concentrate funnel ions toward selectivity filter green andersen 1991 dutzler et al
0.44508743.14581585.html.plaintext.txt	402	based considerations inward rectification current flow cftr pore might achieved asymmetries geometry intra extracellular vestibules differences distribution cl binding sites two vestibules combination factors
0.44508743.14581585.html.plaintext.txt	403	evidence asymmetries topology intra extracellular vestibules provided studies anion permeation channel block
0.44508743.14581585.html.plaintext.txt	404	anion permeation studies indicate narrowest part cftr pore 0
0.44508743.14581585.html.plaintext.txt	405	60 nm diameter cheung akabas 1996 linsdell et al
0.44508743.14581585.html.plaintext.txt	406	1997 widening certain circumstances diameter 1
0.44508743.14581585.html.plaintext.txt	407	3 nm linsdell hanrahan 1998b
0.44508743.14581585.html.plaintext.txt	408	constriction likely represents selectivity filter occurs region f337 t338 m6 mutation residues altered dramatically anion permeability sequence cftr whereas mutation residues m6 less marked effects anion permeation linsdell et al
0.44508743.14581585.html.plaintext.txt	409	1998 2000 mccarty zhang 2001 gong et al
0.44508743.14581585.html.plaintext.txt	410	2002 gupta linsdell 2003
0.44508743.14581585.html.plaintext.txt	411	intra extracellular sides constriction pore enlarges
0.44508743.14581585.html.plaintext.txt	412	voltage dependence channel block large organic anions suggests cftr pore contains wide intracellular vestibule funnels blocking anions deep pore bind occlude pore block cl permeation linsdell hanrahan 1996 sheppard robinson 1997 hwang sheppard 1999 zhou et al
0.44508743.14581585.html.plaintext.txt	413	less known topology extracellular end cftr pore
0.44508743.14581585.html.plaintext.txt	414	based ability methanethiosulphonate reagents extracellular solution react m6 residues toward cytosolic side membrane cheung akabas 1996 might also wide extracellular vestibule
0.44508743.14581585.html.plaintext.txt	415	however inability open channel blockers reach binding sites added extracellular solution short length extracellular loops 3 6 led mccarty 2000 propose cftr small extracellular vestibule
0.44508743.14581585.html.plaintext.txt	416	consistent idea linsdell hanrahan 1998ab demonstrated cftr exhibits asymmetric permeability large organic anions e
0.44508743.14581585.html.plaintext.txt	417	galacturonate glutathione lactobionate
0.44508743.14581585.html.plaintext.txt	418	normal gating cycle flow large organic anions cftr pore permitted intra extracellular direction linsdell hanrahan 1998ab
0.44508743.14581585.html.plaintext.txt	419	sixth transmembrane segment plays crucial role determining pore properties cftr sheppard welsh 1999 mccarty 2000 gong et al
0.44508743.14581585.html.plaintext.txt	420	within m6 residues r334 smith et al
0.44508743.14581585.html.plaintext.txt	421	2001 gong linsdell 2003 k335 anderson et al
0.44508743.14581585.html.plaintext.txt	422	2002 possibly r352 guinamard akabas 1999 gong et al
0.44508743.14581585.html.plaintext.txt	423	2002 contribute cl binding sites
0.44508743.14581585.html.plaintext.txt	424	assuming narrowest part cftr pore occurs region f337 t338 see linsdell et al
0.44508743.14581585.html.plaintext.txt	425	1998 2000 mccarty zhang 2001 gong et al
0.44508743.14581585.html.plaintext.txt	426	2002 gupta linsdell 2003 data suggest three cl binding sites s341 i344 r352 might located spacious intracellular vestibule whereas two cl binding sites r334 k335 might located confined extracellular vestibule
0.44508743.14581585.html.plaintext.txt	427	simple model suggests current flow cftr pore might inwardly rectify
0.44508743.14581585.html.plaintext.txt	428	however important caveat model present knowledge mechanism anion permeation cftr cl channel incomplete quite likely residues transmembrane segments contribute cl binding sites
0.44508743.14581585.html.plaintext.txt	429	nevertheless asymmetries size intra extracellular vestibules andor distribution cl binding sites within cftr pore plausible explanations inward rectification cftr cl currents
0.44508743.14581585.html.plaintext.txt	430	besides architecture cftr pore voltage dependent gating might make contribution observed inward rectification current flow cftr cl channel
0.44508743.14581585.html.plaintext.txt	431	work investigators demonstrate cftr channel gating exhibits voltage dependence despite lack marked effect voltage po
0.44508743.14581585.html.plaintext.txt	432	first using cell attached membrane patches nih 3t3 fibroblasts expressing wild type human cftr fischer machen 1994 demonstrated slow atp dependent gating voltage independent whereas fast flickery intraburst gating voltage dependent becoming dominant gating mode strong negative voltages
0.44508743.14581585.html.plaintext.txt	433	second using excised membrane patches xenopus oocytes expressing wild type human cftr zhang et al
0.44508743.14581585.html.plaintext.txt	434	2002 demonstrated burst duration increases negative voltages whereas interburst interval unaffected voltage
0.44508743.14581585.html.plaintext.txt	435	third investigate flickery closures interrupt bursts channel openings zhou et al
0.44508743.14581585.html.plaintext.txt	436	2001 analyzed gating kinetics cftr variant k1250a whose prolonged openings facilitate discrimination fast slow gating events
0.44508743.14581585.html.plaintext.txt	437	2001 found rate transition short lived closed state open state exhibits voltage dependence sensitive permeant anions extracellular solution suggesting brief flickery closures represent voltage dependent occupancy anion binding site within cftr pore unknown intracellular anions
0.44508743.14581585.html.plaintext.txt	438	elucidate effects voltage cftr channel gating adopted different strategy investigators
0.44508743.14581585.html.plaintext.txt	439	employed kinetic modeling analyze gating behavior single wild type human cftr cl channels excised membrane patches bathed symmetrical cl rich solutions 37 degrees c lightly filtered data
0.44508743.14581585.html.plaintext.txt	440	using approach determined effect voltage fast slow gating events
0.44508743.14581585.html.plaintext.txt	441	data indicate voltage significant effects cftr channel gating
0.44508743.14581585.html.plaintext.txt	442	membrane depolarization decreased duration bursts interburst interval increased duration gaps within bursts
0.44508743.14581585.html.plaintext.txt	443	however voltage dependencies different rate constants opposite directions po largely unaffected voltage
0.44508743.14581585.html.plaintext.txt	444	voltage independence po lack effect adp ppi inward rectification cftr cl currents argue changes cftr channel gating contribute rectification macroscopic cftr cl currents
0.44508743.14581585.html.plaintext.txt	445	however data suggest contrary
0.44508743.14581585.html.plaintext.txt	446	first predicted cftr cl current n x x po 100 mv accounted reductions po agrees closely measured cftr cl current voltage
0.44508743.14581585.html.plaintext.txt	447	second po murine cftr decreased markedly positive voltages
0.44508743.14581585.html.plaintext.txt	448	third comparison data smith et al
0.44508743.14581585.html.plaintext.txt	449	2001 gong linsdell 2003 suggests strong inward rectification cftr variant r334c accounted voltage dependent changes
0.44508743.14581585.html.plaintext.txt	450	based data argue voltage dependent changes cftr channel gating contribute inward rectification macroscopic cftr cl currents
0.44508743.14581585.html.plaintext.txt	451	data indicate total equivalent gating charge cftr 0
0.44508743.14581585.html.plaintext.txt	452	small size gating charge cftr consistent lack marked voltage dependence cftr channel gating
0.44508743.14581585.html.plaintext.txt	453	data suggest residues charged uncharged polar side chains move small distance within transmembrane electric field
0.44508743.14581585.html.plaintext.txt	454	residues might located either along full length cftr pore restricted specific region permeation pathway
0.44508743.14581585.html.plaintext.txt	455	alternatively linear three state kinetic schemes might simple describe voltage dependence cftr channel gating
0.44508743.14581585.html.plaintext.txt	456	total equivalent gating charge cftr comparable amount charge movement intrinsic voltage dependent cl channel clc 0 chen miller 1996 favor former idea
0.44508743.14581585.html.plaintext.txt	457	amino acid sequence clc 0 lacks motif equivalent s4 segment voltage sensor voltage gated cation channels hille 2001
0.44508743.14581585.html.plaintext.txt	458	instead permeant anions extracellular solution act source gating charge pusch et al
0.44508743.14581585.html.plaintext.txt	459	binding cl ions cl binding site located extracellular end clc 0 pore causes conformational change precedes channel opening inward cl flow chen miller 1996
0.44508743.14581585.html.plaintext.txt	460	bound cl ions traverse transmembrane electric field gating voltage cl concentration dependent pusch et al
0.44508743.14581585.html.plaintext.txt	461	excitingly structural basis gating mechanism elucidated following determination high resolution crystal structures bacterial clc proteins dutzler et al
0.44508743.14581585.html.plaintext.txt	462	bacterial clc channels cl binding site closest extracellular end selectivity filter gated carboxyl group glutamate e148 protrudes clc channel pore carboxyl group e148 bound cl binding site pore closed cl ion binds pore opens allow cl permeation dutzler et al
0.44508743.14581585.html.plaintext.txt	463	regulation clc channel gating localized motions amino acid side chain dutzler et al
0.44508743.14581585.html.plaintext.txt	464	2003 raises question whether similar mechanism might operate cftr cl channel
0.44508743.14581585.html.plaintext.txt	465	however anion permeation cftr pore tightly linked function nbds power channel gating
0.44508743.14581585.html.plaintext.txt	466	2003 recently demonstrated glutathione permeation cftr pore controlled atp binding rather atp binding hydrolysis case cl permeation
0.44508743.14581585.html.plaintext.txt	467	data suggest global conformation changes structure cftr protein control cl permeation local changes orientation amino acid side chains
0.44508743.14581585.html.plaintext.txt	468	idea correct would suggest cftr channel gating shares similarities activation gating k channels involves reorientation transmembrane helices jiang et al
0.44508743.14581585.html.plaintext.txt	469	future studies test possibility
0.44508743.14581585.html.plaintext.txt	470	footnotes online version paper contains supplemental material
0.44508743.14581585.html.plaintext.txt	471	abbreviations used paper cftr cystic fibrosis transmembrane conductance regulator m transmembrane segment msd membrane spanning domain nbd nucleotide binding domain ppi pyrophosphate
0.44508743.14581585.html.plaintext.txt	472	1 although small membrane currents evoked voltage ramp protocol basal conditions outwardly rectified
0.44508743.14581585.html.plaintext.txt	473	example 100 mv basal current 0
0.44508743.14581585.html.plaintext.txt	474	20 pa 100 mv basal current 2
0.44508743.14581585.html.plaintext.txt	475	basal currents subtracted recorded presence atp 1 mm pka 75 nm outward rectification basal current accounted 6 plus minus 2 n 10 inward rectification cftr cl current 100 mv
0.44508743.14581585.html.plaintext.txt	476	2 contrast analyses rate constant values plus minus 75 mv using students paired test analyses rate constant data range 75 75 mv using one way anovas failed achieve statistical significance
0.44508743.14581585.html.plaintext.txt	477	attribute difference fact paired data used analyses using students paired test pooled data used one way anovas
0.44508743.14581585.html.plaintext.txt	478	acknowledgments thank professor m
0.44508743.14581585.html.plaintext.txt	479	winter departmental colleagues especially dr
0.44508743.14581585.html.plaintext.txt	480	meech valuable discussions dr
0.44508743.14581585.html.plaintext.txt	481	oriordan genzyme framingham ma gift c127 cells expressing wild type human cftr dr
0.44508743.14581585.html.plaintext.txt	482	wainwright university queensland brisbane australia gift cho cells expressing wild type murine cftr dr
0.44508743.14581585.html.plaintext.txt	483	mendes universidade de lisboa lisboa portugal gift bhk cells expressing wild type human cftr
0.44508743.14581585.html.plaintext.txt	484	work supported cystic fibrosis trust national kidney research fund
0.44508743.14581585.html.plaintext.txt	485	submitted 13 august 2003 accepted 2 october 2003
0.44508743.14581585.html.plaintext.txt	486	references top abstract introduction materials methods results discussion references anderson m
0.44508743.14581585.html.plaintext.txt	487	demonstration cftr chloride channel alteration anion selectivity
0.44508743.14581585.html.plaintext.txt	488	identification regulation cystic fibrosis transmembrane conductance regulator generated chloride channel
0.44508743.14581585.html.plaintext.txt	489	phloxine b interacts cystic fibrosis transmembrane conductance regulator multiple sites modulate channel activity
0.44508743.14581585.html.plaintext.txt	490	abstractfree full text carson m
0.44508743.14581585.html.plaintext.txt	491	two nucleotide binding domains cystic fibrosis transmembrane conductance regulator cftr distinct functions controlling channel activity
0.44508743.14581585.html.plaintext.txt	492	abstractfree full text carson m
0.44508743.14581585.html.plaintext.txt	493	pyrophosphate stimulates wild type mutant cystic fibrosis transmembrane conductance regulator cl channels
0.44508743.14581585.html.plaintext.txt	494	abstractfree full text chen
0.44508743.14581585.html.plaintext.txt	495	nonequilibrium gating voltage dependence clc 0 cl channel
0.44508743.14581585.html.plaintext.txt	496	identification cystic fibrosis transmembrane conductance regulator channel lining residues flanking m6 membrane spanning segment
0.44508743.14581585.html.plaintext.txt	497	x ray structure clc chloride channel 3
0.44508743.14581585.html.plaintext.txt	498	0 reveals molecular basis anion selectivity
0.44508743.14581585.html.plaintext.txt	499	gating selectivity filter clc chloride channels
0.44508743.14581585.html.plaintext.txt	500	abstractfree full text fischer h
0.44508743.14581585.html.plaintext.txt	501	cftr displays voltage dependence two gating modes stimulation
0.44508743.14581585.html.plaintext.txt	502	control cystic fibrosis transmembrane conductance regulator channel gating phosphorylation nucleotide hydrolysis
0.44508743.14581585.html.plaintext.txt	503	molecular determinants aucn2 binding permeability within cystic fibrosis transmembrane conductance regulator cl channel pore
0.44508743.14581585.html.plaintext.txt	504	abstractfree full text gong x
0.44508743.14581585.html.plaintext.txt	505	molecular determinants role anion binding site external mouth cftr chloride channel pore
0.44508743.14581585.html.plaintext.txt	506	abstractfree full text green w
0.44508743.14581585.html.plaintext.txt	507	surface charges ion channel function
0.44508743.14581585.html.plaintext.txt	508	crossrefmedline guinamard r
0.44508743.14581585.html.plaintext.txt	509	arg352 major determinant charge selectivity cystic fibrosis transmembrane conductance regulator chloride channel
0.44508743.14581585.html.plaintext.txt	510	asymmetric structure cystic fibrosis transmembrane conductance regulator chloride channel pore suggested mutagenesis twelfth transmembrane region
0.44508743.14581585.html.plaintext.txt	511	extent selectivity filter conferred sixth transmembrane region cftr chloride channel pore
0.44508743.14581585.html.plaintext.txt	512	improved patch clamp techniques high resolution current recording cells cell free membrane patches
0.44508743.14581585.html.plaintext.txt	513	single chloride channels torpedo electroplax activation protons
0.44508743.14581585.html.plaintext.txt	514	ion channels excitable membranes
0.44508743.14581585.html.plaintext.txt	515	molecular pharmacology cftr cl channel
0.44508743.14581585.html.plaintext.txt	516	x ray structure voltage dependent k channel
0.44508743.14581585.html.plaintext.txt	517	cftr directly mediates nucleotide regulated glutathione flux
0.44508743.14581585.html.plaintext.txt	518	abstractfree full text lansdell k
0.44508743.14581585.html.plaintext.txt	519	comparison gating behaviour human murine cystic fibrosis transmembrane conductance regulator cl channels expressed mammalian cells
0.44508743.14581585.html.plaintext.txt	520	abstractfree full text lansdell k
0.44508743.14581585.html.plaintext.txt	521	regulation murine cystic fibrosis transmembrane conductance regulator cl channels expressed chinese hamster ovary cells
0.44508743.14581585.html.plaintext.txt	522	abstractfree full text lansdell k
0.44508743.14581585.html.plaintext.txt	523	two mechanisms genistein inhibition cystic fibrosis transmembrane conductance regulator cl channels expressed murine cell line
0.44508743.14581585.html.plaintext.txt	524	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	525	permeability wild type mutant cystic fibrosis transmembrane conductance regulator chloride channels polyatomic anions
0.44508743.14581585.html.plaintext.txt	526	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	527	non pore lining amino acid side chains influence anion selectivity human cftr cl channel expressed mammalian cell lines
0.44508743.14581585.html.plaintext.txt	528	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	529	molecular determinants anion selectivity cystic fibrosis transmembrane conductance regulator chloride channel pore
0.44508743.14581585.html.plaintext.txt	530	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	531	multiple inhibitory effects aucn2 ions cystic fibrosis transmembrane conductance regulator cl channel currents
0.44508743.14581585.html.plaintext.txt	532	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	533	disulphonic stilbene block cystic fibrosis transmembrane conductance regulator cl channels expressed mammalian cell line regulation critical pore residue
0.44508743.14581585.html.plaintext.txt	534	glutathione permeability cftr
0.44508743.14581585.html.plaintext.txt	535	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	536	adenosine triphosphate dependent asymmetry anion permeation cystic fibrosis transmembrane conductance regulator chloride channel
0.44508743.14581585.html.plaintext.txt	537	abstractfree full text linsdell p
0.44508743.14581585.html.plaintext.txt	538	substrates multidrug resistance associated proteins block cystic fibrosis transmembrane conductance regulator chloride channel
0.44508743.14581585.html.plaintext.txt	539	abstractfree full text lopatin
0.44508743.14581585.html.plaintext.txt	540	potassium channel block cytoplasmic polyamines mechanism intrinsic rectification
0.44508743.14581585.html.plaintext.txt	541	permeation cftr chloride channel
0.44508743.14581585.html.plaintext.txt	542	abstractfree full text mccarty n
0.44508743.14581585.html.plaintext.txt	543	identification region strong discrimination pore cftr
0.44508743.14581585.html.plaintext.txt	544	abstractfree full text mcdonough
0.44508743.14581585.html.plaintext.txt	545	novel pore lining residues cftr govern permeation open channel block
0.44508743.14581585.html.plaintext.txt	546	magnesium gates glutamate activated channels mouse central neurones
0.44508743.14581585.html.plaintext.txt	547	mechanism rectification isoproterenol activated chloride current guinea pig ventricular myocytes
0.44508743.14581585.html.plaintext.txt	548	gating voltage dependent chloride channel clc 0 permeant anion
0.44508743.14581585.html.plaintext.txt	549	maximum likelihood estimation aggregated markov processes
0.44508743.14581585.html.plaintext.txt	550	direct optimization approach hidden markov modeling single channel kinetics
0.44508743.14581585.html.plaintext.txt	551	abstractfree full text quinton p
0.44508743.14581585.html.plaintext.txt	552	cftr rectifying non rectifying anion channel j
0.44508743.14581585.html.plaintext.txt	553	identification cystic fibrosis gene cloning characterization complementary dna
0.44508743.14581585.html.plaintext.txt	554	voltage dependent inactivation inward rectifying single channel currents guinea pig heart cell membrane
0.44508743.14581585.html.plaintext.txt	555	mechanism glibenclamide inhibition cystic fibrosis transmembrane conductance regulator cl channels expressed murine cell line
0.44508743.14581585.html.plaintext.txt	556	structure function cystic fibrosis transmembrane conductance regulator chloride channel
0.44508743.14581585.html.plaintext.txt	557	cftr covalent noncovalent modification suggests role fixed charges anion conduction
0.44508743.14581585.html.plaintext.txt	558	abstractfree full text tabcharani j
0.44508743.14581585.html.plaintext.txt	559	phosphorylation regulated cl channel cho cells stably expressing cystic fibrosis gene
0.44508743.14581585.html.plaintext.txt	560	crossrefmedline vandenberg c
0.44508743.14581585.html.plaintext.txt	561	inward rectification potassium channel cardiac ventricular cells depends internal magnesium ions
0.44508743.14581585.html.plaintext.txt	562	effect atp concentration cftr cl channels kinetic analysis channel regulation
0.44508743.14581585.html.plaintext.txt	563	voltage dependent gating single wild type s4 mutant kat1 inward rectifier potassium channels
0.44508743.14581585.html.plaintext.txt	564	abstractfree full text zhang z
0.44508743.14581585.html.plaintext.txt	565	interaction permeation gating putative pore domain mutant cystic fibrosis transmembrane conductance regulator
0.44508743.14581585.html.plaintext.txt	566	abstractfree full text zhang z
0.44508743.14581585.html.plaintext.txt	567	voltage sensitive gating induced mutation fifth transmembrane domain cftr
0.44508743.14581585.html.plaintext.txt	568	abstractfree full text zhao j
0.44508743.14581585.html.plaintext.txt	569	rectification cystic fibrosis transmembrane conductance regulator chloride channel mediated extracellular divalent cations
0.44508743.14581585.html.plaintext.txt	570	voltage dependent flickery block open cystic fibrosis transmembrane conductance regulator cftr channel pore
0.44508743.14581585.html.plaintext.txt	571	abstractfree full text zhou z
0.44508743.14581585.html.plaintext.txt	572	probing open cftr pore organic anion blockers
0.44508743.14581585.html.plaintext.txt	573	abstractfree full text zimmerman
0.44508743.14581585.html.plaintext.txt	574	cyclic gmp sensitive conductance retinal rods consists aqueous pores
0.48690367.11121388.html.plaintext.txt	0	f508 mutation shortens biochemical half life plasma membrane cftr polarized epithelial cells ghanshyam d
0.48690367.11121388.html.plaintext.txt	1	heda12 mridul tanwani2 christopher r
0.48690367.11121388.html.plaintext.txt	2	1 research 3 medical services veterans affairs medical center departments 2 medicine 4 physiology biophysics university tennessee health sciences center memphis tennessee 38163
0.48690367.11121388.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references
0.48690367.11121388.html.plaintext.txt	4	although biosynthetic arrest f508 mutant cystic fibrosis transmembrane conductance regulator cftr partially reversed physical chemical means recent evidence suggests functional stability mutant protein reaching cell surface compromised
0.48690367.11121388.html.plaintext.txt	5	understand molecular basis observation current study directly measured half life f508 wild type cftr cell surface transfected llc pk1 cells
0.48690367.11121388.html.plaintext.txt	6	plasma membrane cftr expression time characterized biochemically functionally polarized epithelial cells
0.48690367.11121388.html.plaintext.txt	7	surface biotinylation streptavidin extraction quantitative immunoblot analysis determined biochemical half life plasma membrane f508 cftr 4 h whereas plasma membrane half life wild type cftr exceeded 48 h
0.48690367.11121388.html.plaintext.txt	8	difference biochemical stability correlated cftr mediated transport function
0.48690367.11121388.html.plaintext.txt	9	findings indicate f508 mutation decreases biochemical stability cftr cell surface
0.48690367.11121388.html.plaintext.txt	10	conclude f508 mutation triggers rapid internalization cftr andor preferential sorting pathway rapid degradation
0.48690367.11121388.html.plaintext.txt	11	cystic fibrosis regulation membrane protein endocytosis chloride channel cystic fibrosis transmembrane conductance regulator
0.48690367.11121388.html.plaintext.txt	12	introduction top abstract introduction materials methods results discussion references
0.48690367.11121388.html.plaintext.txt	13	cystic fibrosis cf caused gene mutation results deletion phenylalanine position 508 cftr cystic fibrosis transmembrane conductance regulator cftr protein 13
0.48690367.11121388.html.plaintext.txt	14	f508 deletion results misfolding nascent cftr molecule endoplasmic reticulum er leading retention er chaparone proteins subsequent ubiquitination premature degradation cytoplasmic proteosome complex reviewed ref
0.48690367.11121388.html.plaintext.txt	15	consequence little f508 cftr processed mature fully glycosylated form trafficked plasma membrane cftr normally functions camp activated chloride channel
0.48690367.11121388.html.plaintext.txt	16	f508 mutant retains intrinsic chloride transport function 8 18 interest approaches drive f508 cftr past er quality control system cell surface grown
0.48690367.11121388.html.plaintext.txt	17	several vitro studies shown surface expression f508 cftr upregulated chemical physical means
0.48690367.11121388.html.plaintext.txt	18	butyrate compounds shown create camp activated chloride currents cultured f508 cells presumably overwhelming er quality control system increase gene transcription 4 28
0.48690367.11121388.html.plaintext.txt	19	glycerol 30 low temperature 8 stabilize conformation newly synthesized f508 allowing bypass er quality control system reach biochemical maturity
0.48690367.11121388.html.plaintext.txt	20	treatments increase camp activated chloride transport detected mutant cells
0.48690367.11121388.html.plaintext.txt	21	findings suggest pharmacological agents downregulate er quality control system might useful correcting chloride transport defect f508 cells
0.48690367.11121388.html.plaintext.txt	22	approach clinically effective f508 protein must maintain degree biochemical stability reaching cell surface
0.48690367.11121388.html.plaintext.txt	23	little known however fate cftr protein reaches cell surface
0.48690367.11121388.html.plaintext.txt	24	initial work suggested f508 wild type cftr similar plasma membrane half lives 8 subsequent vitro study shown camp activated chloride currents nonpolarized f508 cells less stable wild type cells 23
0.48690367.11121388.html.plaintext.txt	25	plasma membrane expression cftr proteins directly examined study molecular basis observation known
0.48690367.11121388.html.plaintext.txt	26	functional instability f508 cells could due rapid inactivation f508 channels cell surface rapid internalization andor degradation mutant protein
0.48690367.11121388.html.plaintext.txt	27	functional inactivation supported data several studies show conduction properties f508 cftr differ wild type cftr 6 9 11
0.48690367.11121388.html.plaintext.txt	28	fact recent electrophysiological study since confirmed f508 cftr rapidly inactivated wild type cftr excised membrane patches 31
0.48690367.11121388.html.plaintext.txt	29	documented differences vesicle trafficking f508 wild type cftr 2 32 suggest potential role membrane trafficking regulation plasma membrane cftr function
0.48690367.11121388.html.plaintext.txt	30	however technical difficulties getting measurable quantities f508 protein cell surface hindered efforts compare plasma membrane f508 wild type cftr protein expression
0.48690367.11121388.html.plaintext.txt	31	current study overcame obstacle simultaneous treatment cells low temperature sodium butyrate act synergistically markedly upregulate surface cftr expression 12
0.48690367.11121388.html.plaintext.txt	32	readily detectable levels f508 cftr cell surface became possible test hypothesis f508 protein biochemically unstable wild type cftr
0.48690367.11121388.html.plaintext.txt	33	performed polarized epithelial cell line experiments presented confirm biochemical half life plasma membrane f508 cftr much shorter wild type cftr
0.48690367.11121388.html.plaintext.txt	34	differences biochemical half life correlate transport function suggesting rapid internalization andor degradation f508 cftr alone account rapid loss chloride transport function characteristic f508 cells
0.48690367.11121388.html.plaintext.txt	35	materials methods top abstract introduction materials methods results discussion references
0.48690367.11121388.html.plaintext.txt	36	pig kidney epithelial cells llc pk1 stably transfected human wild type f508 cftr cdna kindly provided dr
0.48690367.11121388.html.plaintext.txt	37	seng cheng genzyme boston ma
0.48690367.11121388.html.plaintext.txt	38	cells grown low glucose dmem supplemented 10 fbs 400 microgml genticin life technologies grand island ny 37 degrees c plastic dishes coated human placental type iv collagen sigma chemical st
0.48690367.11121388.html.plaintext.txt	39	125i efflux experiments cells grown clear transwell membrane inserts coated type iv collagen corning costar cambridge ma
0.48690367.11121388.html.plaintext.txt	40	immunocytochemical experiments cells grown collagen coated glass coverslips
0.48690367.11121388.html.plaintext.txt	41	upregulation surface cftr expression
0.48690367.11121388.html.plaintext.txt	42	transfected llc pk1 cells grown 70 confluence described treated 60 h 27 degrees c presence 5 mm sodium butyrate upregulate surface cftr expression 12
0.48690367.11121388.html.plaintext.txt	43	low temperature partially inhibits cell proliferation cell overgrowth occur 60 h treatment confluency rarely achieved
0.48690367.11121388.html.plaintext.txt	44	biochemical determination surface cftr expression time
0.48690367.11121388.html.plaintext.txt	45	upregulation surface cftr expression cells washed butyrate free media incubated 37 degrees c media containing 20 microgml cycloheximide inhibitor protein synthesis designated time intervals 48 h
0.48690367.11121388.html.plaintext.txt	46	cells washed ice cold pbs ph 7
0.48690367.11121388.html.plaintext.txt	47	1 mm cacl2 1 mm mgcl2 inhibit vesicle trafficking surface biotinylation performed described previously 19
0.48690367.11121388.html.plaintext.txt	48	briefly glycosidic moieties surface membrane proteins derivatized sodium periodate biotinylated using biotin lc hydrazide according company protocol pierce rockford il
0.48690367.11121388.html.plaintext.txt	49	efficiency surface biotinylation tested examining effect increasing biotin lc hydrazide exposure times surface cftr expression
0.48690367.11121388.html.plaintext.txt	50	time dependent increase surface cftr expression occurred prolonged reagent exposure data shown
0.48690367.11121388.html.plaintext.txt	51	surface biotinylation cells lysed 1 sds containing 0
0.48690367.11121388.html.plaintext.txt	52	2 mm phenylmethylsulfonyl fluoride 1 mm benzamidine sonicated shear dna molecules centrifuged 10000 g 10 min 4 degrees c remove cellular debris
0.48690367.11121388.html.plaintext.txt	53	clear supernatants normalized 50 microg total protein nutated 30 min excess streptavidin coated agarose sa beads uncoated control agarose cn beads sigma
0.48690367.11121388.html.plaintext.txt	54	incubation beads pelleted supernatants subjected 6
0.48690367.11121388.html.plaintext.txt	55	5 sds page followed transfer hybond p polyvinylidene difluoride membrane amersham sunnyvale ca
0.48690367.11121388.html.plaintext.txt	56	transfer blocked 5 nonfat dry milk 137 mm nacl 0
0.48690367.11121388.html.plaintext.txt	57	1 tween 20 20 mm tris hcl ph 7
0.48690367.11121388.html.plaintext.txt	58	6 immunoblotted 1100 dilution r3194 affinity purified polyclonal anti cftr antibody
0.48690367.11121388.html.plaintext.txt	59	specificity r3194 cftr characterized previously transgenic mice 37 cftr mock transfected hek 293 cells 17 cooh terminal cftr peptide competition experiments 37
0.48690367.11121388.html.plaintext.txt	60	cftr bands visualized enhanced chemifluorescence amersham quantified using storm 860 imaging system imagequant software molecular dynamics sunnyvale ca
0.48690367.11121388.html.plaintext.txt	61	use approach biotinylated surface proteins irreversibly extracted sa bead processing
0.48690367.11121388.html.plaintext.txt	62	efficiency extraction step examined stripping immunoblots reblotting streptavidin conjugated horseradish peroxidase followed sigma fast diaminobenzidine color development confirm absence biotinylated proteins sa bead processed samples see fig
0.48690367.11121388.html.plaintext.txt	63	thus post sa bead supernatants contain intracellular unbiotinylated proteins whereas cn bead supernatants contain cellular proteins biotinylated unbiotinylated
0.48690367.11121388.html.plaintext.txt	64	surface cftr expression determined subtracting intensity cftr signal sa bead extraction intensity total cftr signal cn bead processed samples
0.48690367.11121388.html.plaintext.txt	65	functional determination surface cftr expression time
0.48690367.11121388.html.plaintext.txt	66	chloride secretion determined isotopic efflux 125i preloaded cells previously described 33
0.48690367.11121388.html.plaintext.txt	67	briefly membrane inserts containing llc pk1 cells treated 20 microgml cycloheximide 37 degrees c excised cells washed efflux buffer 140 mm nacl 4
0.48690367.11121388.html.plaintext.txt	68	2 mm cacl2 10 mm glucose 10 mm hepes ph 7
0.48690367.11121388.html.plaintext.txt	69	cells loaded 125i incubation 3 microci 125i labeled na new england nuclear boston ma 1 h 37 degrees c
0.48690367.11121388.html.plaintext.txt	70	cell monolayers washed free excess 125i time dependent efflux isotope media measured stimulation camp agonists forskolin 10 microm isobutyl methylxanthine ibmx 1
0.48690367.11121388.html.plaintext.txt	71	cells solubilized 0
0.48690367.11121388.html.plaintext.txt	72	1 n naoh 125i radioactivity media samples final cell lysate determined counting gamma emissions packard minaxi gamma counter series 5000
0.48690367.11121388.html.plaintext.txt	73	rate coefficient iodide efflux r calculated using following formula r1 r2 percent counts remaining cell layer times t1 t2
0.48690367.11121388.html.plaintext.txt	74	data presented means plus minus se replicate experiments
0.48690367.11121388.html.plaintext.txt	75	differential inhibition 125i efflux dids diphenylamine 2 carboxylic acid used confirm camp stimulated efflux cells cftr mediated
0.48690367.11121388.html.plaintext.txt	76	immunocytochemical determination surface cftr expression
0.48690367.11121388.html.plaintext.txt	77	butyratelow temperature treated cells grown collagen coated coverslips fixed 1 h 4 paraformaldehyde permeabilized 0
0.48690367.11121388.html.plaintext.txt	78	free aldehyde residues quenched 30 min 50 mm nh4cl cells blocked 1 bsa prepared pbs
0.48690367.11121388.html.plaintext.txt	79	cells incubated overnight 4 degrees c r3194 polyclonal anti cftr andor monoclonal antibody 6h monoclonal subunit rat na k atpase generously provided michael j
0.48690367.11121388.html.plaintext.txt	80	caplan yale school medicine new haven ct
0.48690367.11121388.html.plaintext.txt	81	anti cftr labeling detected fitc conjugated goat anti rabbit fab2 fragments anti na k atpase labeling detected tetramethylrhodamine isothiocyanate conjugated goat anti mouse fab2 fragments jackson immunoresearch labs west grove pa
0.48690367.11121388.html.plaintext.txt	82	double label experiments primary antibodies applied simultaneously fluorescent conjugated secondary antibodies
0.48690367.11121388.html.plaintext.txt	83	fluorescent signals visualized axiophot fluorescent microscope zeiss digitally stored using photoshop 4
0.48690367.11121388.html.plaintext.txt	84	01 software adobe systems mountain view ca
0.48690367.11121388.html.plaintext.txt	85	photoshop used modify images adjust contrast improved signal definition
0.48690367.11121388.html.plaintext.txt	86	signal detected absence primary antibody indicating background labeling low experimental conditions employed data shown
0.48690367.11121388.html.plaintext.txt	87	results top abstract introduction materials methods results discussion references
0.48690367.11121388.html.plaintext.txt	88	natural cell type expresses f508 wild type cftr transfected cell lines served standard model system studying differences processing trafficking cftr
0.48690367.11121388.html.plaintext.txt	89	widely used cell lines cho 3t3 c127 hek however either unpolarized undetermined polarity
0.48690367.11121388.html.plaintext.txt	90	vesicle trafficking polarized unpolarized cells may differ sought examine cftr surface expression transfected mammalian cell line evidence cellular polarity
0.48690367.11121388.html.plaintext.txt	91	llc pk1 cells transformed epithelial cells proximal tubule pig kidney
0.48690367.11121388.html.plaintext.txt	92	morphological evidence polarity obtained electron microscopy demonstrated appearance apical tight junctions monolayers transfected cells fig
0.48690367.11121388.html.plaintext.txt	93	functional polarity demonstrated double label immunofluorescent microscopy experiments using apical basolateral membrane markers
0.48690367.11121388.html.plaintext.txt	94	1b na k atpase expression llc pk1 cells primarily surface basal location consistent known distribution along basolateral membrane polarized epithelial cells
0.48690367.11121388.html.plaintext.txt	95	although cftr surface intracellular signal high expressing cells surface signal apically distributed colocalize na k atpase
0.48690367.11121388.html.plaintext.txt	96	prominent intracellular cftr signal seen cells discussed greater detail
0.48690367.11121388.html.plaintext.txt	97	experiments indicate cftr transfected llc pk1 cells morphological functional features characteristic polarized epithelial cells
0.48690367.11121388.html.plaintext.txt	98	view larger version 95k fig
0.48690367.11121388.html.plaintext.txt	99	analysis llc pk1 cell polarity
0.48690367.11121388.html.plaintext.txt	100	wild type llc pk1 cells grown permeable supports polarity determined morphologically functionally
0.48690367.11121388.html.plaintext.txt	101	low left high right magnification electron micrographs showing tight junctions apical domain adjacent cells arrowheads
0.48690367.11121388.html.plaintext.txt	102	original magnifications x 12500 x 24000 respectively
0.48690367.11121388.html.plaintext.txt	103	b double label immunofluorescence micrographs cystic fibrosis transmembrane conductance regulator cftr green na k atpase red distribution llc pk1 cells
0.48690367.11121388.html.plaintext.txt	104	distribution membrane proteins captured apical subapical basal regions cells epifluorescence microscopy
0.48690367.11121388.html.plaintext.txt	105	cftr labeling seen throughout cell membrane labeling prominent apical subapical regions
0.48690367.11121388.html.plaintext.txt	106	na k atpase localized plasma membrane basal part cell
0.48690367.11121388.html.plaintext.txt	107	plasma membrane labeling pattern differs
0.48690367.11121388.html.plaintext.txt	108	direct biochemical study f508 expression plasma membrane sufficient quantities protein driven cell surface
0.48690367.11121388.html.plaintext.txt	109	accomplish cells treated 27 degrees c presence 5 mm sodium butyrate markedly upregulate surface cftr expression 12
0.48690367.11121388.html.plaintext.txt	110	previous time course experiments identified 60 h treatment optimal upregulation cftr expression 12
0.48690367.11121388.html.plaintext.txt	111	although wild type cells require butyrate low temperature treatment detection plasma membrane cftr chose control experiments treating cells identically
0.48690367.11121388.html.plaintext.txt	112	2 mature band c f508 cftr detected llc pk1 cells grown 37 degrees c presence absence sodium butyrate detected immunoblot analysis cells grown 27 degrees c alone
0.48690367.11121388.html.plaintext.txt	113	sodium butyrate low temperature treatments combined however marked increase total f508 cftr expression accompanied appearance mature fully glycosylated form band c
0.48690367.11121388.html.plaintext.txt	114	upregulation cftr expression experimental conditions even pronounced wild type llc pk1 cells
0.48690367.11121388.html.plaintext.txt	115	view larger version 39k fig
0.48690367.11121388.html.plaintext.txt	116	effect sodium butyrate sb temperature cftr protein expression
0.48690367.11121388.html.plaintext.txt	117	f508 wild type llc pk1 cells grown 70 confluence treated 60 h absence presence 5 mm sodium butyrate 37 27 degrees c
0.48690367.11121388.html.plaintext.txt	118	treatment cells harvested lysed normalized 50 microg total protein sds page immunoblotting anti cftr antibody r3194
0.48690367.11121388.html.plaintext.txt	119	arrows identify cftr bands b c
0.48690367.11121388.html.plaintext.txt	120	although mature band c cftr routinely used marker plasma membrane cftr expression 5 8 30 studies native 26 36 transfected 21 cells shown mature cftr resides cell surface
0.48690367.11121388.html.plaintext.txt	121	confirm f508 cftr driven surface llc pk1 cells butyrate low temperature treatment plasma membrane cftr expression measured biochemically functionally cytochemically
0.48690367.11121388.html.plaintext.txt	122	surface biotinylation streptavidin extraction used determine much f508 protein actually reached cell surface molecular forms cftr targeted
0.48690367.11121388.html.plaintext.txt	123	3 cftr treated f508 wild type llc pk1 cells reach cell surface
0.48690367.11121388.html.plaintext.txt	124	based replicate experiments n 5 35 cftr found reside cell surface 33
0.48690367.11121388.html.plaintext.txt	125	biotinylation experiments also demonstrated mature band c form cftr expressed plasma membrane
0.48690367.11121388.html.plaintext.txt	126	immature band b form unaffected streptavidin extraction indicating biotinylated therefore present cell surface
0.48690367.11121388.html.plaintext.txt	127	surface expression f508 cftr butyrate low temperature treatment subsequently confirmed cytochemically functionally fig
0.48690367.11121388.html.plaintext.txt	128	relative distribution cftr surface intracellular compartments including prominent intracellular signal correlated biotinylation data
0.48690367.11121388.html.plaintext.txt	129	functional evidence surface cftr expression cell lines obtained forskolinibmx stimulated 125i efflux assay fig
0.48690367.11121388.html.plaintext.txt	130	view larger version 70k fig
0.48690367.11121388.html.plaintext.txt	131	plasma membrane expression cftr
0.48690367.11121388.html.plaintext.txt	132	f508 wild type llc pk1 cells grown 70 confluence treated 5 mm sodium butyrate 27 degrees c 60 h upregulate plasma membrane cftr expression
0.48690367.11121388.html.plaintext.txt	133	cells surface biotinylated described materials methods
0.48690367.11121388.html.plaintext.txt	134	detergent lysates biotinylated cells normalized total protein 50 microg reacted streptavidin conjugated agarose beads sa remove surface biotinylated proteins plain agarose control cn beads remove protein
0.48690367.11121388.html.plaintext.txt	135	lysate proteins bead treatment separated sds page transferred polyvinylidene difluoride membranes
0.48690367.11121388.html.plaintext.txt	136	top transfer membrane immunoblotted r3194 detect cftr protein expression
0.48690367.11121388.html.plaintext.txt	137	cn lanes depict total cftr expression whereas sa lanes show unbiotinylated intracellular proteins samples
0.48690367.11121388.html.plaintext.txt	138	arrows identify cftr bands b c
0.48690367.11121388.html.plaintext.txt	139	bottom transfer membrane stripped antibodies reblotted streptavidin conjugated alkaline phosphatase followed diaminobenzidine reaction detect presence biotinylated proteins lane
0.48690367.11121388.html.plaintext.txt	140	absence biotinylated proteins sa lanes shows efficiency streptavidin bead extraction step
0.48690367.11121388.html.plaintext.txt	141	view larger version 67k fig
0.48690367.11121388.html.plaintext.txt	142	cytochemical functional detection plasma membrane cftr
0.48690367.11121388.html.plaintext.txt	143	expression f508 left wild type right cftr plasma membrane butyrate low temperature treatment determined immunofluorescence microscopy top 125i efflux assay bottom
0.48690367.11121388.html.plaintext.txt	144	arrows immunofluorescence micrographs denote plasma membrane cftr labeling
0.48690367.11121388.html.plaintext.txt	145	arrows 125i efflux graphs note time cells stimulated forskolinisobutyl methylxanthine ibmx
0.48690367.11121388.html.plaintext.txt	146	control condition cells grown 37 degrees c without butyrate treatment 27 degrees c sb
0.48690367.11121388.html.plaintext.txt	147	125i efflux values represent means plus minus se replicate experiments
0.48690367.11121388.html.plaintext.txt	148	use surface biotinylation procedure half life plasma membrane cftr f508 wild type cells examined next fig
0.48690367.11121388.html.plaintext.txt	149	experiments surface cftr expression upregulated pretreatment sodium butyrate low temperature
0.48690367.11121388.html.plaintext.txt	150	cells transferred physiological temperature 37 degrees c treated 48 h presence cycloheximide
0.48690367.11121388.html.plaintext.txt	151	cells surface biotinylated solubilized streptavidin extracted immunoblot analysis used quantify cftr protein expression
0.48690367.11121388.html.plaintext.txt	152	rapid fall immature band b cftr expression f508 cells due inhibition new protein synthesis cycloheximide combined er degradation conversion mature band c form
0.48690367.11121388.html.plaintext.txt	153	5 band b cftr also rapidly degraded wild type cells signal undetectable 4 h earliest time point examined
0.48690367.11121388.html.plaintext.txt	154	findings consistent observations ward kopito 34 demonstrated immature forms f508 wild type cftr similar rates degradation
0.48690367.11121388.html.plaintext.txt	155	view larger version 44k fig
0.48690367.11121388.html.plaintext.txt	156	biochemical half life plasma membrane cftr
0.48690367.11121388.html.plaintext.txt	157	f508 wild type llc pk1 cells pulsed butyrate low temperature chased 37 degrees c presence 20 microgml cycloheximide times indicated
0.48690367.11121388.html.plaintext.txt	158	completion chase cells transferred 4 degrees c surface proteins biotinylated solubilized processed either streptavidin sa control cn agarose beads
0.48690367.11121388.html.plaintext.txt	159	postbead lysates normalized 50 microg total protein immunoblotted r3194 anti cftr antibody
0.48690367.11121388.html.plaintext.txt	160	arrows identify cftr bands b c
0.48690367.11121388.html.plaintext.txt	161	f508 cells total band c cftr expression nearly eliminated 6 h
0.48690367.11121388.html.plaintext.txt	162	contrast total band c cftr expression wild type cells persisted 48 h
0.48690367.11121388.html.plaintext.txt	163	although band c cftr intracellular persistence streptavidin extractable pool long 48 h provides biochemical evidence presence plasma membrane cftr expression wild type cells least length time
0.48690367.11121388.html.plaintext.txt	164	relative distribution cftr intracellular plasma membrane compartments change appreciably time data shown plasma membrane half life protein estimated quantifying rate degradation total band c cftr
0.48690367.11121388.html.plaintext.txt	165	replicate experiments n 7 calculated biochemical half life plasma membrane cftr f508 cells 4 h whereas biochemical half life plasma membrane cftr wild type cells exceeded 48 h
0.48690367.11121388.html.plaintext.txt	166	rule possibility relatively long plasma membrane half life wild type cftr artifact overexpression biochemical functional studies repeated conditions comparable total cftr expression two cells lines
0.48690367.11121388.html.plaintext.txt	167	2 wild type cells treated sodium butyrate 37 degrees c cftr expression levels comparable found f508 cells treated sodium butyrate 27 degrees c
0.48690367.11121388.html.plaintext.txt	168	thus cells pretreated manner processed analyzed described previously
0.48690367.11121388.html.plaintext.txt	169	conditions comparable total cftr expression biochemical half life band c cftr wild type cells continued exceed 24 h
0.48690367.11121388.html.plaintext.txt	170	surface biotinylation experiments also confirmed presence plasma membrane cftr least length time fig
0.48690367.11121388.html.plaintext.txt	171	contrasts near absence detectable f508 protein 6 h chase
0.48690367.11121388.html.plaintext.txt	172	although able detect functional f508 cftr early time points qualitative 125i efflux assay functional cftr expression detected f508 cells 24 h chase contrasts sharply persistence functional cftr wild type cells time
0.48690367.11121388.html.plaintext.txt	173	similar kinetic studies performed transfected unpolarized c127 cells f508 expression exceeds wild type cftr butyrate low temperature treatment similar half life values f508 wild type cftr obtained data shown
0.48690367.11121388.html.plaintext.txt	174	thus several lines evidence indicate difference plasma membrane expression f508 wild type cftr reflects biology two protein species simply overexpression
0.48690367.11121388.html.plaintext.txt	175	view larger version 41k fig
0.48690367.11121388.html.plaintext.txt	176	half life plasma membrane cftr conditions comparable levels cftr expression
0.48690367.11121388.html.plaintext.txt	177	confirm long plasma membrane half life wild type cftr artifact overexpression experiment performed conditions comparable total cftr expression cell types
0.48690367.11121388.html.plaintext.txt	178	2 f508 cells treated 5 mm sodium butyrate 27 degrees c compared wild type cells treated 5 mm sodium butyrate 37 degrees c
0.48690367.11121388.html.plaintext.txt	179	treatment cells transferred 37 degrees c incubated presence 20 microgml cycloheximide times shown
0.48690367.11121388.html.plaintext.txt	180	top biochemical half life f508 wild type cftr surface biotinylation sa cn bead extraction immunoblotting r3194
0.48690367.11121388.html.plaintext.txt	181	bottom 125i efflux forskolinibmx stimulated cells baseline 24 h chase 37 degrees c
0.48690367.11121388.html.plaintext.txt	182	control condition cells grown 37 degrees c without butyrate treatment chase period
0.48690367.11121388.html.plaintext.txt	183	biochemical functional stability wild type cftr continues exceed 24 h even relative overexpression corrected
0.48690367.11121388.html.plaintext.txt	184	discussion top abstract introduction materials methods results discussion references
0.48690367.11121388.html.plaintext.txt	185	long term goals gene therapy realized strategies designed upregulate plasma membrane expression f508 cftr remain important potential therapeutic option cf 16 29
0.48690367.11121388.html.plaintext.txt	186	much emphasis placed biogenesis f508 cftr goal overcome biosynthetic arrest thereby increase delivery functional f508 cftr channels cell surface
0.48690367.11121388.html.plaintext.txt	187	effective correction cf defect however require stable expression f508 reaching plasma membrane one study shown functional half life plasma membrane f508 intact cells less wild type cftr 23
0.48690367.11121388.html.plaintext.txt	188	current study sought test hypothesis short functional half life f508 cells results rapid removal cftr channels cell surface
0.48690367.11121388.html.plaintext.txt	189	study biochemical stability plasma membrane f508 cftr sufficient quantities mutant protein needed driven cell surface
0.48690367.11121388.html.plaintext.txt	190	current study took advantage combination therapy sodium butyrate low temperature increase surface f508 protein expression levels sufficient direct measurement cftr protein half life quantitative immunoblot technique 12
0.48690367.11121388.html.plaintext.txt	191	thus experiments cells pretreated sodium butyrate low temperature upregulate cftr protein expression followed 37 degrees c examine plasma membrane half life cftr species
0.48690367.11121388.html.plaintext.txt	192	cell polarity affect membrane trafficking experiments performed polarized epithelial cell line llc pk1
0.48690367.11121388.html.plaintext.txt	193	butyrate low temperature treatment cftr cells intracellular
0.48690367.11121388.html.plaintext.txt	194	surface biotinylation experiments demonstrated mature fully glycosylated band c form cftr reached cell surface
0.48690367.11121388.html.plaintext.txt	195	evidence direct targeting immature electrophoretic bands b cftr plasma membrane found
0.48690367.11121388.html.plaintext.txt	196	quantitative analysis cftr distribution butyratelow temperature treated llc pk1 cells demonstrated 65 band c cftr remained intracellular
0.48690367.11121388.html.plaintext.txt	197	true f508 wild type cftr similar observations made cell systems 26 36
0.48690367.11121388.html.plaintext.txt	198	although changes band c cftr expression correlated changes plasma membrane cftr expression transfected llc pk1 cells may true cell types
0.48690367.11121388.html.plaintext.txt	199	thus surface protein labeling techniques remain accurate means measuring plasma membrane cftr expression
0.48690367.11121388.html.plaintext.txt	200	biochemical finding prominent intracellular compartment cftr confirmed immunocytochemically
0.48690367.11121388.html.plaintext.txt	201	butyratelow temperature treatment f508 wild type cells labeled similarly modest surface prominent intracellular signals
0.48690367.11121388.html.plaintext.txt	202	identity intracellular signal cell type remains unknown
0.48690367.11121388.html.plaintext.txt	203	wild type cells surface biotinylation demonstrated unbiotinylated cftr band c form therefore presumably post er compartment golgi endosomes transport vesicles etc
0.48690367.11121388.html.plaintext.txt	204	f508 cells unbiotinylated cftr band b form large er component intracellular signal would expected
0.48690367.11121388.html.plaintext.txt	205	identification sources intracellular cftr labeling cells however require much additional study
0.48690367.11121388.html.plaintext.txt	206	kinetics f508 wild type cftr degradation time examined physiological temperature conditions protein synthesis inhibition
0.48690367.11121388.html.plaintext.txt	207	rate cftr degradation quantified biochemically confirmed functional assay
0.48690367.11121388.html.plaintext.txt	208	replicate experiments indicate biochemical half life plasma membrane f508 cftr 4 h whereas biochemical half life plasma membrane wild type cftr exceeds 48 h
0.48690367.11121388.html.plaintext.txt	209	values correlate changes 125i efflux remarkably similar functional data generated lukacs et al
0.48690367.11121388.html.plaintext.txt	210	23 nonpolarized c127 cells
0.48690367.11121388.html.plaintext.txt	211	time dependent correlation rate plasma membrane cftr degradation loss camp stimulated 125i efflux indicates functional instability f508 cells theoretically attributed rapid degradation plasma membrane f508 cftr
0.48690367.11121388.html.plaintext.txt	212	data however exclude contributory role channel inactivation process
0.48690367.11121388.html.plaintext.txt	213	findings establish f508 mutation negative effect biochemical stability cftr cell surface
0.48690367.11121388.html.plaintext.txt	214	biochemical instability must due rapid internalization mutant protein andor selective targeting rapid degradation
0.48690367.11121388.html.plaintext.txt	215	cftr endocytosed clathrin coated vesicles 1 22 molecular signal cftr internalization may reside cytoplasmic tail 10 24 25
0.48690367.11121388.html.plaintext.txt	216	f508 mutation however first nucleotide binding domain distance cytoplasmic end molecule
0.48690367.11121388.html.plaintext.txt	217	thus cftr must another internalization signal f508 mutation must indirect effect cooh terminal signals
0.48690367.11121388.html.plaintext.txt	218	based understanding cftr folding biogenesis attractive hypothesize f508 mutation affects cftr folding manner cooh terminal internalization signal altered
0.48690367.11121388.html.plaintext.txt	219	fundamental question signal cooh terminal tyrosine based sequences implicated positioning membrane proteins coated pits 7 20 one recent study implicated phosphorylation tyrosine 1424 regulation cftr endocytosis 25
0.48690367.11121388.html.plaintext.txt	220	hand rate internalization ste6 yeast homolog cftr ste3p another yeast membrane protein regulated ubiquitination 14 27
0.48690367.11121388.html.plaintext.txt	221	ubiquitination major signal degradation wild type f508 cftr biogenesis 35 provocative speculate also involved plasma membrane cftr degradation
0.48690367.11121388.html.plaintext.txt	222	cftr biosynthesis ubiquitination targets immature forms f508 wild type cftr rapid proteosome degradation similar kinetics 34
0.48690367.11121388.html.plaintext.txt	223	pool wild type cftr however escapes fate becomes fully glycosylated reaches plasma membrane
0.48690367.11121388.html.plaintext.txt	224	ubiquitination also signal plasma membrane cftr degradation one would postulate wild type mutant proteins differentially ubiquitinated cell surface account different rates degradation
0.48690367.11121388.html.plaintext.txt	225	yeast data suggest proteasome complex final target ubiquitinated plasma membrane ste6 15 one must also consider possibility ubiquitination plasma membrane cftr serves different role e
0.48690367.11121388.html.plaintext.txt	226	signaling internalization andor sorting rather proteosome degradation
0.48690367.11121388.html.plaintext.txt	227	although provocative role ubiquitination downregulation surface cftr expression remains highly speculative time
0.48690367.11121388.html.plaintext.txt	228	alternatively mutant wild type cftr may similar rates internalization differentially sorted endocytic compartment f508 targeted rapid lysosomal degradation wild type cftr recycled back plasma membrane
0.48690367.11121388.html.plaintext.txt	229	case f508 mutation might affecting interaction cftr specific gtp binding rab proteins regulate vesicle trafficking reviewed ref
0.48690367.11121388.html.plaintext.txt	230	rab4 closely associated sorting endosomes understanding interactions f508 wild type cftr would particular interest
0.48690367.11121388.html.plaintext.txt	231	last one must consider effect phosphorylation cftr trafficking particularly light data showing rate endocytosis differs f508 wild type cells camp activation 2
0.48690367.11121388.html.plaintext.txt	232	although current study examine biochemical stability plasma membrane cftr stimulatory conditions basal phosphorylation state two cftr species may differ turn could expose different internalization signals
0.48690367.11121388.html.plaintext.txt	233	conclusion f508 mutation dramatically reduces residence time cftr cell surface
0.48690367.11121388.html.plaintext.txt	234	must due effect mutation rate cftr internalization andor intracellular targeting
0.48690367.11121388.html.plaintext.txt	235	although little known aspect cftr biology clear implications therapeutic strategies rely delivering f508 protein cell surface
0.48690367.11121388.html.plaintext.txt	236	frizzell helpful discussions acknowledge technical assistance virginia jeanes
0.48690367.11121388.html.plaintext.txt	237	work supported office research development medical research service department veterans affairs c
0.48690367.11121388.html.plaintext.txt	238	marino cystic fibrosis foundation c
0.48690367.11121388.html.plaintext.txt	239	address reprint requests correspondence c
0.48690367.11121388.html.plaintext.txt	240	marino medical service 111 va medical center 1030 jefferson ave
0.48690367.11121388.html.plaintext.txt	241	memphis tn 38104 e mail cmarinoatutmem
0.48690367.11121388.html.plaintext.txt	242	costs publication article defrayed part payment page charges
0.48690367.11121388.html.plaintext.txt	243	article must therefore hereby marked advertisement accordance 18 u
0.48690367.11121388.html.plaintext.txt	244	section 1734 solely indicate fact
0.48690367.11121388.html.plaintext.txt	245	received 24 may 2000 accepted final form 9 august 2000
0.48690367.11121388.html.plaintext.txt	246	references top abstract introduction materials methods results discussion references
0.48690367.11121388.html.plaintext.txt	247	bradbury na cohn ja venglarik cj bridges rj
0.48690367.11121388.html.plaintext.txt	248	biochemical biophysical identification cystic fibrosis transmembrane conductance regulator chloride channels components endocytic clathrin coated vesicles
0.48690367.11121388.html.plaintext.txt	249	j biol chem 269 8296 8304 1994abstractfree full text
0.48690367.11121388.html.plaintext.txt	250	bradbury na jilling berta g sorscher ej bridges rj kirk kl
0.48690367.11121388.html.plaintext.txt	251	regulation plasma membrane recycling cftr
0.48690367.11121388.html.plaintext.txt	252	science 256 530 532 1992isimedline
0.48690367.11121388.html.plaintext.txt	253	role arf rab gtpases membrane transport
0.48690367.11121388.html.plaintext.txt	254	curr opin cell biol 11 466 475 1999isimedline
0.48690367.11121388.html.plaintext.txt	255	cheng sh fang sl zabner j marshall j piraino schivi sc jefferson dm welsh mj smith ae
0.48690367.11121388.html.plaintext.txt	256	functional activation cystic fibrosis trafficking mutant f508 cftr overexpression
0.48690367.11121388.html.plaintext.txt	257	j physiol lung cell mol physiol 268 l615 l624 1995abstractfree full text
0.48690367.11121388.html.plaintext.txt	258	cheng sh gregory rj marshall j paul souza dw white ga oriordan cr smith ae
0.48690367.11121388.html.plaintext.txt	259	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.48690367.11121388.html.plaintext.txt	260	cell 63 827 834 1990isimedline
0.48690367.11121388.html.plaintext.txt	261	dalemans w barbry p champigny g jallat dott k dreyer d crystal rg pavirani lecocq j p lazdunski m
0.48690367.11121388.html.plaintext.txt	262	altered chloride ion channel kinetics associated f508 cystic fibrosis mutation
0.48690367.11121388.html.plaintext.txt	263	nature 354 526 528 1991isimedline
0.48690367.11121388.html.plaintext.txt	264	davis cg goldstein jl sudhof tc anderson rgw russell dw brown ms
0.48690367.11121388.html.plaintext.txt	265	acid dependent ligand dissociation recycling ldl receptor mediated growth factor homology region
0.48690367.11121388.html.plaintext.txt	266	nature 326 760 765 1987isimedline
0.48690367.11121388.html.plaintext.txt	267	denning gm anderson mp amara jf marshall j smith ae welsh mj
0.48690367.11121388.html.plaintext.txt	268	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.48690367.11121388.html.plaintext.txt	269	nature 358 761 764 1992isimedline
0.48690367.11121388.html.plaintext.txt	270	drumm ml wilkinson dj smit ls worrell rt strong tv frizzell ra dawson dc collins fs
0.48690367.11121388.html.plaintext.txt	271	chloride conductance expressed f508 mutant cftrs xenopus oocytes
0.48690367.11121388.html.plaintext.txt	272	science 254 1797 1799 1991isimedline
0.48690367.11121388.html.plaintext.txt	273	haardt mh benharouga m lechardeur d kartner n lukacs gl
0.48690367.11121388.html.plaintext.txt	274	c terminal truncations destabilize cystic fibrosis transmembrane conductance regulator without imparing biogenesis
0.48690367.11121388.html.plaintext.txt	275	j biol chem 274 21873 21877 1999abstractfree full text
0.48690367.11121388.html.plaintext.txt	276	haws cm nepomuceno ib krouse wakelee h law xia y nguyen h wine jj
0.48690367.11121388.html.plaintext.txt	277	f508 cftr channels kinetics activation forskolin potentiation xanthines
0.48690367.11121388.html.plaintext.txt	278	j physiol cell physiol 270 c1544 c1555 1996abstractfree full text
0.48690367.11121388.html.plaintext.txt	279	surface expression cystic fibrosis transmembrane conductance regulator mutant f508 markedly regulated combination treatment sodium butyrate low temperature
0.48690367.11121388.html.plaintext.txt	280	biochem biophys res commun 271 659 664 2000isimedline
0.48690367.11121388.html.plaintext.txt	281	kerem b rommens jm buchanan ja markiewicz d cox tk chakravarti buchwald m tsui l c
0.48690367.11121388.html.plaintext.txt	282	identification cystic fibrosis gene genetic analysis
0.48690367.11121388.html.plaintext.txt	283	science 245 1073 1080 1989isimedline
0.48690367.11121388.html.plaintext.txt	284	kolling r hollenberg cp
0.48690367.11121388.html.plaintext.txt	285	abc transporter ste6 accumulates plasma membrane ubiquitinated form endocytosis mutants
0.48690367.11121388.html.plaintext.txt	286	embo j 13 3261 3271 1994abstract
0.48690367.11121388.html.plaintext.txt	287	linker region abc transporter ste6 mediates ubiquitination fast turnover protein
0.48690367.11121388.html.plaintext.txt	288	embo j 16 2251 2261 1997abstractfree full text
0.48690367.11121388.html.plaintext.txt	289	biosynthesis degradation cftr
0.48690367.11121388.html.plaintext.txt	290	physiol rev 79 suppl 1 s167 s173 1999medline
0.48690367.11121388.html.plaintext.txt	291	lee mg whigley wc zeng w noel le marino cr thomas pj muallem
0.48690367.11121388.html.plaintext.txt	292	regulation clhco3 exchange cystic fibrosis transmembrane conductance regulator expressed nih 3t3 hek 293 cells
0.48690367.11121388.html.plaintext.txt	293	j biol chem 274 3414 3421 1999abstractfree full text
0.48690367.11121388.html.plaintext.txt	294	li c ramjeesingh m reyes e jensen chang x b rommens jm bear ce
0.48690367.11121388.html.plaintext.txt	295	cystic fibrosis mutation delta f508 influence chloride channel activity cftr
0.48690367.11121388.html.plaintext.txt	296	nat genet 3 311 316 1993isimedline
0.48690367.11121388.html.plaintext.txt	297	lisanti mp le bivic sargiacomo m rodriguez boulan e
0.48690367.11121388.html.plaintext.txt	298	steady state distribution biogenesis endogenous madin darby canine kidney glycoproteins evidence intracellular sorting polarized cell surface delivery
0.48690367.11121388.html.plaintext.txt	299	j cell biol 109 2117 2127 1989abstract
0.48690367.11121388.html.plaintext.txt	300	lobel p fujimoto k ye rd griffiths g kornfeld
0.48690367.11121388.html.plaintext.txt	301	mutations cytoplasmic domain 275 kd mannose 6 phosphate receptor differentially alter lysosomal enzyme sorting endocytosis
0.48690367.11121388.html.plaintext.txt	302	cell 57 787 796 1989isimedline
0.48690367.11121388.html.plaintext.txt	303	lukacs gl chang xb kartner n rotstein od riordan jr grinstein
0.48690367.11121388.html.plaintext.txt	304	cystic fibrosis transmembrane regulator present functional endosomes
0.48690367.11121388.html.plaintext.txt	305	role determinant endosomal ph
0.48690367.11121388.html.plaintext.txt	306	j biol chem 267 14568 14572 1992abstractfree full text
0.48690367.11121388.html.plaintext.txt	307	lukacs gl segal g kartner n grinstein zhang f
0.48690367.11121388.html.plaintext.txt	308	constitutive internalization cystic fibrosis transmembrane conductance regulator ocurs via clathrin dependent endocytosis regulated protein phosphorylation
0.48690367.11121388.html.plaintext.txt	309	biochem j 328 353 361 1997isimedline
0.48690367.11121388.html.plaintext.txt	310	lukacs gl xiu bao c bear c kartner n mohamed riordan jr grinstein
0.48690367.11121388.html.plaintext.txt	311	f508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.48690367.11121388.html.plaintext.txt	312	j biol chem 268 21592 21598 1993abstractfree full text
0.48690367.11121388.html.plaintext.txt	313	mukherjee ghosh rn maxfield fr
0.48690367.11121388.html.plaintext.txt	314	physiol rev 77 759 803 1997abstractfree full text
0.48690367.11121388.html.plaintext.txt	315	prince ls peter k hatton sr zaliauskiene l cotlin lf clancy jp marchase rb collawn jf
0.48690367.11121388.html.plaintext.txt	316	efficient endocytosis cystic fibrosis transmembrane conductance regulator requires tyrosine based signal
0.48690367.11121388.html.plaintext.txt	317	j biol chem 274 3602 3609 1999abstractfree full text
0.48690367.11121388.html.plaintext.txt	318	prince ls tousson marchase rb
0.48690367.11121388.html.plaintext.txt	319	cell surface labeling cftr t84 cells
0.48690367.11121388.html.plaintext.txt	320	j physiol cell physiol 264 c491 c498 1993abstractfree full text
0.48690367.11121388.html.plaintext.txt	321	ubiquitination yeast factor receptor
0.48690367.11121388.html.plaintext.txt	322	j cell biol 134 661 674 1996abstract
0.48690367.11121388.html.plaintext.txt	323	rubenstein rc egan zeitlin pl
0.48690367.11121388.html.plaintext.txt	324	vitro pharmacologic restoration cftr mediated chloride transport sodium 4 phenylbutyrate cystic fibrosis epithelial cells containing f508 cftr
0.48690367.11121388.html.plaintext.txt	325	j clin invest 100 2457 2465 1997abstractfree full text
0.48690367.11121388.html.plaintext.txt	326	rubenstein rc zeitlin pl
0.48690367.11121388.html.plaintext.txt	327	pilot clinical trial oral sodium 4 phenylbutyrate buphenyl deltaf508 homozygous cystic fibrosis patients partial restoration nasal epithelial cftr function
0.48690367.11121388.html.plaintext.txt	328	j respir crit care med 157 484 490 1998abstractfree full text
0.48690367.11121388.html.plaintext.txt	329	sato ward cl krouse wine jj kopito rr
0.48690367.11121388.html.plaintext.txt	330	glycerol reverses misfolding phenotype common cystic fibrosis mutation
0.48690367.11121388.html.plaintext.txt	331	j biol chem 271 635 638 1995abstractfree full text
0.48690367.11121388.html.plaintext.txt	332	schultz bd frizzell ra bridges rj
0.48690367.11121388.html.plaintext.txt	333	rescue dysfunctional deltaf508 cftr chloride channel activity ibmx
0.48690367.11121388.html.plaintext.txt	334	j membr biol 170 51 66 1999isimedline
0.48690367.11121388.html.plaintext.txt	335	schweibert em gesek r ercolani l wjasow c gruenert dc karlson k stanton ba
0.48690367.11121388.html.plaintext.txt	336	heterotrimeric g proteins vesicle trafficking cftr cl channels
0.48690367.11121388.html.plaintext.txt	337	j physiol cell physiol 267 c272 c281 1994abstractfree full text
0.48690367.11121388.html.plaintext.txt	338	venglarik cj bridges rj frizzell ra
0.48690367.11121388.html.plaintext.txt	339	simple assay agonist regulated cl k conductances salt secreting epithelial cells
0.48690367.11121388.html.plaintext.txt	340	j physiol cell physiol 259 c358 c364 1990abstractfree full text
0.48690367.11121388.html.plaintext.txt	341	intracellular turnover cystic fibrosis transmembrane conductance regulator
0.48690367.11121388.html.plaintext.txt	342	j biol chem 269 25710 25718 1994abstractfree full text
0.48690367.11121388.html.plaintext.txt	343	ward cl omura kopito rr
0.48690367.11121388.html.plaintext.txt	344	degradation cftr ubiquitin proteasome pathway
0.48690367.11121388.html.plaintext.txt	345	cell 83 121 127 1995isimedline
0.48690367.11121388.html.plaintext.txt	346	webster p vanacore l nairn ac marino cr
0.48690367.11121388.html.plaintext.txt	347	subcellular localization cftr endosomes ductal epithelium
0.48690367.11121388.html.plaintext.txt	348	j physiol cell physiol 267 c340 c348 1994abstractfree full text
0.48690367.11121388.html.plaintext.txt	349	zeng w lee mg yan m diaz j benjamin marino cr kopito rr freedman cotton cu muallem thomas p
0.48690367.11121388.html.plaintext.txt	350	immuno functional characterization cftr submandibular pancreatic acinar duct cells
0.48690367.11121388.html.plaintext.txt	351	j physiol cell physiol 273 c442 c455 1997abstractfree full text
0.48690367.11121388.html.plaintext.txt	352	j physiol cell physiol 2801c166 c174
0.43853024.9585408.html.plaintext.txt	0	subunit sec61 complex facilitates cotranslational protein transport interacts signal peptidase translocation
0.43853024.9585408.html.plaintext.txt	1	abteilung biochemie ii zentrum biochemie und molekulare zellbiologie georg august universitat 37073 gottingen germany harvard medical school department cell biology boston massachusetts 02115
0.43853024.9585408.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references
0.43853024.9585408.html.plaintext.txt	3	sec61 complex central component protein translocation apparatus er membrane
0.43853024.9585408.html.plaintext.txt	4	addressed role subunit sec61 cotranslational protein translocation
0.43853024.9585408.html.plaintext.txt	5	reconstituted system show sec61 complex lacking sec61 essentially inactive elongation membrane targeting nascent chain occur time
0.43853024.9585408.html.plaintext.txt	6	translocation process perturbed step nascent chain would inserted translocation channel
0.43853024.9585408.html.plaintext.txt	7	however sufficient time given interaction nascent polypeptide mutant sec61 complex translocation almost normal
0.43853024.9585408.html.plaintext.txt	8	thus sec61 kinetically facilitates cotranslational translocation essential
0.43853024.9585408.html.plaintext.txt	9	using chemical cross linking show sec61 interacts subunits sec61 complex also 25 kd subunit signal peptidase complex spc25 thus demonstrating first time tight interaction spc sec61 complex
0.43853024.9585408.html.plaintext.txt	10	interestingly cross links sec61 spc25 sec61 sec61 depend presence membrane bound ribosomes suggesting interactions induced translocation initiated
0.43853024.9585408.html.plaintext.txt	11	propose spc transiently recruited translocation site thus enhancing activity
0.43853024.9585408.html.plaintext.txt	12	introduction top abstract introduction materials methods results discussion references
0.43853024.9585408.html.plaintext.txt	13	higher eukaryotes proteins transported across er membrane cotranslational manner
0.43853024.9585408.html.plaintext.txt	14	translating ribosome binds tightly er membrane connolly et al
0.43853024.9585408.html.plaintext.txt	15	1994 growing nascent polypeptide chain transferred directly channel ribosome channel membrane blobel dobberstein 1975 connolly et al
0.43853024.9585408.html.plaintext.txt	16	1989 simon blobel 1991 gorlich et al
0.43853024.9585408.html.plaintext.txt	17	1992b gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	18	cotranslational translocation pathway mammals reproduced reconstituted proteoliposomes containing three membrane protein components srp receptor complex translocating chain associating membrane tram1 protein sec61 complex gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	19	signal recognition particle srp receptor required target ribosome nascent chain complex er membrane
0.43853024.9585408.html.plaintext.txt	20	function tram protein still unclear required translocation subset proteins gorlich et al
0.43853024.9585408.html.plaintext.txt	21	sec61 complex represents essential core translocation machinery er membrane
0.43853024.9585408.html.plaintext.txt	22	consists three subunits subunit sec61 spans membrane 10 times subunits sec61 sec61 respectively span membrane single time
0.43853024.9585408.html.plaintext.txt	23	sec61 complex evolutionarily highly conserved proposed carry least three different functions
0.43853024.9585408.html.plaintext.txt	24	first major constituent protein conducting membrane channel
0.43853024.9585408.html.plaintext.txt	25	cross linking experiments shown subunit continuous proximity nascent polypeptide chains passing membrane mothes et al
0.43853024.9585408.html.plaintext.txt	26	recent electron microscopic data demonstrate sec61 complex form cylindrical oligomers presumably represent channels hanein et al
0.43853024.9585408.html.plaintext.txt	27	second sec61 complex tightly associated membrane bound ribosomes likely ribosome receptor gorlich et al
0.43853024.9585408.html.plaintext.txt	28	1994 jungnickel rapoport 1995
0.43853024.9585408.html.plaintext.txt	29	third sec61 complex involved signal sequence recognition event takes place inside membrane jungnickel rapoport 1995
0.43853024.9585408.html.plaintext.txt	30	role sec61 complex subunits different functions yet clear
0.43853024.9585408.html.plaintext.txt	31	whereas presence multi spanning subunit channel forming protein complex may surprising role two small single spanning polypeptide chains remains mysterious
0.43853024.9585408.html.plaintext.txt	32	particular enigma subunit
0.43853024.9585408.html.plaintext.txt	33	saccharomyces cerevisiae simultaneous deletion subunits two homologous sec61 complexes sec61p ssh1p complex lethal cells show growth defect elevated temperatures finke et al
0.43853024.9585408.html.plaintext.txt	34	thus despite fact protein evolutionarily highly conserved appear absolutely required vivo
0.43853024.9585408.html.plaintext.txt	35	posttranslational protein transport across yeast er membranes vitro reduced completely prevented subunits lacking
0.43853024.9585408.html.plaintext.txt	36	point transport process inhibited whether subunits play role cotranslational mode protein transport yet investigated
0.43853024.9585408.html.plaintext.txt	37	function subunit sec61 complex may necessarily restricted actual translocation process
0.43853024.9585408.html.plaintext.txt	38	transport proteins across er membrane must intimately coupled modification folding seems possible subunit could involved interactions translocation channel modifying enzymes chaperones
0.43853024.9585408.html.plaintext.txt	39	physical association proteins channel may enhance efficiency function
0.43853024.9585408.html.plaintext.txt	40	good example signal peptidase abundant enzyme whose active site lumen er
0.43853024.9585408.html.plaintext.txt	41	although cleave signal peptide even completed polypeptide chains efficiency probably much higher act polypeptide chains emerging translocation channel lumen er
0.43853024.9585408.html.plaintext.txt	42	one may therefore predict physical association channel constituents
0.43853024.9585408.html.plaintext.txt	43	signal peptidase complex composed five membrane protein subunits evans et al
0.43853024.9585408.html.plaintext.txt	44	1986 two active site enzymatic activity one lumenal domain unknown function two 12 25 kd cytosolic domains
0.43853024.9585408.html.plaintext.txt	45	function latter particularly unclear cannot contribute enzymatic activity lumenal side membrane essential viability yeast cells lively walsh 1983 fang et al
0.43853024.9585408.html.plaintext.txt	46	1996 kalies hartmann 1996 mullins et al
0.43853024.9585408.html.plaintext.txt	47	would especially good candidates serve linkers translocation channel
0.43853024.9585408.html.plaintext.txt	48	present paper analyzed role subunit sec61 complex cotranslational translocation pathway mammals
0.43853024.9585408.html.plaintext.txt	49	using reconstituted system demonstrate subunit kinetically facilitates essential cotranslational translocation
0.43853024.9585408.html.plaintext.txt	50	protein play role interaction ribosome sec61 complex rather insertion nascent chain translocation site
0.43853024.9585408.html.plaintext.txt	51	using bifunctional cross linker also provide evidence interacts specifically 25 kd subunit signal peptidase complex spc25 thus demonstrating first time tight interactions spc sec61 complex
0.43853024.9585408.html.plaintext.txt	52	cross linking observed presence membrane bound ribosomes
0.43853024.9585408.html.plaintext.txt	53	data thus suggest upon ribosome binding sec61 complex interaction cytosolic domains sec61 spc25 serves recruit signal peptidase complex translocation site
0.43853024.9585408.html.plaintext.txt	54	together observation cross linking subunits sec61 complex also dependent translocation data provide first evidence structural changes translocation apparatus upon initiation cotranslational translocation
0.43853024.9585408.html.plaintext.txt	55	materials methods top abstract introduction materials methods results discussion references preparation reconstituted proteoliposomes
0.43853024.9585408.html.plaintext.txt	56	microsomes treated puromycin high salt pk rm gorlich rapoport 1993 solubilized concentration 2 eq microl sb 50 mm hepeskoh ph 7
0.43853024.9585408.html.plaintext.txt	57	6 15 glycerin 400 mm potassium acetate 10 mm magnesium acetate 10 microgml leupeptin 2 microgml pepstatin 5 microgml chymostatin protease inhibitors containing 1
0.43853024.9585408.html.plaintext.txt	58	5 decylsucrose 30 min ice
0.43853024.9585408.html.plaintext.txt	59	centrifugation 10 min 14000 rpm microfuge 0
0.43853024.9585408.html.plaintext.txt	60	7 deoxybigchap added supernatant
0.43853024.9585408.html.plaintext.txt	61	500 microl detergent extract mixed 100 microl immunoaffinity resin contained 0
0.43853024.9585408.html.plaintext.txt	62	2 mgml affinity purified antibodies directed nh2 terminus sec61 covalently coupled protein sepharose gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	63	column previously equilibrated sb containing 1
0.43853024.9585408.html.plaintext.txt	64	incubation done 18 h overhead shaker cold room
0.43853024.9585408.html.plaintext.txt	65	every 6 h resin replaced new one
0.43853024.9585408.html.plaintext.txt	66	non bound material collected proteoliposomes produced incubation sm2 biobeads 4 degrees c bio rad laboratories hercules ca gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	67	proteoliposomes containing purified sec61 complex prepared described previously kalies et al
0.43853024.9585408.html.plaintext.txt	68	signal peptidase complex spc purified reported gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	69	proteoliposomes produced mixing 20 microl spc preparation 200 eq 20 microl phospholipid mixture phosphatidylcholine phosphatidylethanolamine phosphatidylserine phosphatidylinositol ratio 10025312
0.43853024.9585408.html.plaintext.txt	70	5 total concentration 5 mgml
0.43853024.9585408.html.plaintext.txt	71	40 microg sm2 biobeads equilibrated sb added vesicles prepared described gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	72	binding ribosomes proteoliposomes
0.43853024.9585408.html.plaintext.txt	73	purification radioactive labeling binding ribosomes reconstituted proteoliposomes done described kalies et al
0.43853024.9585408.html.plaintext.txt	74	ribosome binding carried 26 degrees c
0.43853024.9585408.html.plaintext.txt	75	cross linking bis maleimidohexane
0.43853024.9585408.html.plaintext.txt	76	25 mm stock solution bis maleimidohexane bmh dimethylformamid prepared
0.43853024.9585408.html.plaintext.txt	77	microsomes proteoliposomes incubated increasing amounts bmh 30 min 0 degrees c cross link buffer containing 50 mm hepeskoh ph 7
0.43853024.9585408.html.plaintext.txt	78	6 100 mm kcl 5 mm mgcl2 250 mm sucrose protease inhibitors
0.43853024.9585408.html.plaintext.txt	79	reaction quenched addition 100 mm mercaptoethanol samples analyzed sds page immunoblotting using various antibodies
0.43853024.9585408.html.plaintext.txt	80	transcription translation translocation
0.43853024.9585408.html.plaintext.txt	81	transcripts coding preprolactin produced vitro transcription t7 rna polymerase plasmid pgembp1
0.43853024.9585408.html.plaintext.txt	82	full length transcripts plasmid cut psti case transcripts coding 86 mer pvuii
0.43853024.9585408.html.plaintext.txt	83	translation full length protein carried wheat germ system presence 40 nm srp 35smethionine membranes 26 degrees c 30 min
0.43853024.9585408.html.plaintext.txt	84	15 min 4 microm edeine added prevent initiation
0.43853024.9585408.html.plaintext.txt	85	parallel experiment translation started absence membranes 15 min 26 degrees c
0.43853024.9585408.html.plaintext.txt	86	4 microm edeine membranes added
0.43853024.9585408.html.plaintext.txt	87	samples incubated ice 10 min followed incubation 26 degrees c additional 15 min
0.43853024.9585408.html.plaintext.txt	88	half sample precipitated 15 tca
0.43853024.9585408.html.plaintext.txt	89	half treated 0
0.43853024.9585408.html.plaintext.txt	90	5 mgml proteinase k 30 min ice precipitation tca
0.43853024.9585408.html.plaintext.txt	91	pellets washed acetone dissolved sds sample buffer
0.43853024.9585408.html.plaintext.txt	92	sds page gels dried analyzed quantitative manner phosphorimager bas 1000 fuji tokyo japan
0.43853024.9585408.html.plaintext.txt	93	translation 86 mer preprolactin done reticulocyte lysate system presence 35smethionine 24 degrees c 20 min
0.43853024.9585408.html.plaintext.txt	94	mock translation mrna omitted
0.43853024.9585408.html.plaintext.txt	95	2 mm cycloheximide 5 eq membranes added 300 microl translation mix incubation continued 0 degrees c 10 min 25 degrees c 5 min
0.43853024.9585408.html.plaintext.txt	96	centrifugation microfuge 14000 rpm 5 min samples layered top sucrose cushion 400 microl 50 mm hepeskoh ph 7
0.43853024.9585408.html.plaintext.txt	97	6 100 mm kcl 5 mm mgcl2 500 mm sucrose centrifuged 75000 rpm 20 min rotor tla 100
0.43853024.9585408.html.plaintext.txt	98	finally pellets resuspended 65 microl cross link buffer
0.43853024.9585408.html.plaintext.txt	99	immunoblotting immunoprecipitation antibodies
0.43853024.9585408.html.plaintext.txt	100	immunoblotting carried described gorlich et al
0.43853024.9585408.html.plaintext.txt	101	immunoprecipitation samples denatured sds sample buffer omitting reducing reagents
0.43853024.9585408.html.plaintext.txt	102	samples mixed 10 vol sb containing 1 triton x 100 incubated 20 min ice
0.43853024.9585408.html.plaintext.txt	103	affinity purified antibodies sec61 coupled protein sepharose added
0.43853024.9585408.html.plaintext.txt	104	shaking cold room 3 h antibody resin washed 1 triton x 100 sb
0.43853024.9585408.html.plaintext.txt	105	finally material bound column analyzed sds page western blotting
0.43853024.9585408.html.plaintext.txt	106	polyclonal antibodies directed following synthetic peptides used nh2 terminus sec61 gorlich et al
0.43853024.9585408.html.plaintext.txt	107	1992b cooh terminus sec61 gorlich rapoport 1993 position 137 150 srp receptor docking protein cooh terminus tram protein gorlich et al
0.43853024.9585408.html.plaintext.txt	108	1992a nh2 terminus sec61 dqvmqfvepsrqc cooh terminus spc25 kalies hartmann 1996
0.43853024.9585408.html.plaintext.txt	109	results top abstract introduction materials methods results discussion references sec61 facilitates cotranslational protein translocation
0.43853024.9585408.html.plaintext.txt	110	used reconstituted proteoliposomes immunodepleted subunit sec61 complex investigate role protein cotranslational protein translocation
0.43853024.9585408.html.plaintext.txt	111	mammalian pk rm solubilized detergent mixture leads dissociation sec61 complex subunits
0.43853024.9585408.html.plaintext.txt	112	detergent extract incubated either antibodies directed sec61 immobilized protein sepharose generate mock depleted extract protein sepharose alone
0.43853024.9585408.html.plaintext.txt	113	efficiency immunodepletion tested western blotting using radioactively labeled secondary antibody phosphorimager
0.43853024.9585408.html.plaintext.txt	114	typical experiment depleted proteoliposomes contained 0
0.43853024.9585408.html.plaintext.txt	115	5 original amount sec61 whereas proteins tested remained almost unaffected fig
0.43853024.9585408.html.plaintext.txt	116	exception sec61 concentration reduced 50 70 worst case
0.43853024.9585408.html.plaintext.txt	117	apparently conditions used subunits totally dissociated
0.43853024.9585408.html.plaintext.txt	118	view larger version 38k fig
0.43853024.9585408.html.plaintext.txt	119	sec61 facilitates cotranslational protein translocation
0.43853024.9585408.html.plaintext.txt	120	produce proteoliposomes lacking sec61 ribosome free membranes pk rm solubilized conditions sec61 complex dissociates subunits
0.43853024.9585408.html.plaintext.txt	121	detergent extract immunodepleted antibody column directed sec61 incubated protein sepharose generate mock depleted extract
0.43853024.9585408.html.plaintext.txt	122	reconstitution proteoliposomes pk rm analyzed sds page western blotting using radioactively labeled secondary antibody phosphorimager system quantitation
0.43853024.9585408.html.plaintext.txt	123	b membranes proteoliposomes analyzed tested competence translocate polypeptides
0.43853024.9585408.html.plaintext.txt	124	preprolactin mrna translated wheat germ system presence srp microsomes proteoliposomes respectively 26 degrees c lanes 2 8
0.43853024.9585408.html.plaintext.txt	125	parallel experiment translation started absence microsomes
0.43853024.9585408.html.plaintext.txt	126	addition membranes proteoliposomes respectively targeting reaction carried 0 degrees c followed elongation 26 degrees c lanes 10 16
0.43853024.9585408.html.plaintext.txt	127	half sample treated proteinase k assay material translocated vesicles therefore protected added protease
0.43853024.9585408.html.plaintext.txt	128	dp subunit srp receptor ppl preprolactin pl prolactin
0.43853024.9585408.html.plaintext.txt	129	tested reconstituted proteoliposomes ability translocate proteins synthesized wheat germ translation system
0.43853024.9585408.html.plaintext.txt	130	microsomes pk rm served control
0.43853024.9585408.html.plaintext.txt	131	transcripts coding full length preprolactin translated 26 degrees c presence microsomes proteoliposomes concentration normalized sec61 content fig
0.43853024.9585408.html.plaintext.txt	132	pk rm mock depleted proteoliposomes translocation activity fig
0.43853024.9585408.html.plaintext.txt	133	1 b lanes 6 7 whereas depleted proteoliposomes totally inactive lane 8
0.43853024.9585408.html.plaintext.txt	134	absence sec61 processed prolactin produced fig
0.43853024.9585408.html.plaintext.txt	135	1 b lane 4 however accessible action proteinase k therefore presumably represents material generated signal peptidase incorporated reconstituted membrane inverse orientation
0.43853024.9585408.html.plaintext.txt	136	since sec61 essential yeast wondered mammalian sec61 complex lacking component may show vitro translocation activity less stringent conditions used
0.43853024.9585408.html.plaintext.txt	137	therefore performed translocation reaction time would allowed membrane binding ribosome nascent chain complex
0.43853024.9585408.html.plaintext.txt	138	translation full length transcript coding preprolactin initially carried presence srp absence membranes
0.43853024.9585408.html.plaintext.txt	139	leads translational arrest polypeptide chain reaches length 70 residues
0.43853024.9585408.html.plaintext.txt	140	membranes added 0 degrees c conditions allow efficient membrane binding ribosome nascent chain complexes chain elongation
0.43853024.9585408.html.plaintext.txt	141	samples warmed 26 degrees c continue translation concomitant translocation
0.43853024.9585408.html.plaintext.txt	142	protocol proteoliposomes lacking sec61 active translocation although activity lower factor three compared wild type complex fig
0.43853024.9585408.html.plaintext.txt	143	thus depleted proteoliposomes capable translocate polypeptides given enough time membrane targeting reaction
0.43853024.9585408.html.plaintext.txt	144	results also indicate sec61 complex lacking subunit irreversibly denatured prolonged immunodepletion procedure
0.43853024.9585408.html.plaintext.txt	145	data suggest ribosome nascent chain complex targeted membrane thus brought contact signal peptidase subsequent translocation step perturbed
0.43853024.9585408.html.plaintext.txt	146	also found fragment preprolactin 86 amino acids could efficiently targeted reconstituted proteoliposomes reached protease protected state even sec61 lacking data shown supporting conclusion insertion nascent chain sec61 depleted translocation site occur chain elongation going
0.43853024.9585408.html.plaintext.txt	147	noted absence membranes almost full length preprolactin could observed fig
0.43853024.9585408.html.plaintext.txt	148	1 b lanes 1 9 indicating conditions used srp produced tight translational arrest
0.43853024.9585408.html.plaintext.txt	149	microsomes two types proteoliposomes able release translational arrest fig
0.43853024.9585408.html.plaintext.txt	150	1 b lanes 2 4 10 12 indicating reaction dependent presence sec61
0.43853024.9585408.html.plaintext.txt	151	sec61 required ribosome binding
0.43853024.9585408.html.plaintext.txt	152	data suggested absence sec61 binding ribosome nascent chain complex er membrane less efficient
0.43853024.9585408.html.plaintext.txt	153	could due either defect interaction mutated sec61 complex ribosome perturbed insertion nascent chain translocation site
0.43853024.9585408.html.plaintext.txt	154	therefore analyzed whether subunit plays role ribosome binding
0.43853024.9585408.html.plaintext.txt	155	depleted mock depleted proteoliposomes incubated physiological salt concentrations radioactively labeled ribosomes increasing amounts unlabeled ribosomes lacking nascent polypeptide chains
0.43853024.9585408.html.plaintext.txt	156	conditions ribosomes interact mainly sec61 complex kalies et al
0.43853024.9585408.html.plaintext.txt	157	separate unbound bound fraction membranes floated sucrose gradient
0.43853024.9585408.html.plaintext.txt	158	scatchard plot analysis used estimate number binding sites apparent dissociation constants fig
0.43853024.9585408.html.plaintext.txt	159	depleted mock depleted proteoliposomes found bind ribosomes approximately binding constant
0.43853024.9585408.html.plaintext.txt	160	also number binding sites
0.43853024.9585408.html.plaintext.txt	161	measured parameters good agreement published data binding ribosomes pk rm proteoliposomes kalies et al
0.43853024.9585408.html.plaintext.txt	162	1994 although dissociation constants seem somewhat higher 26 degrees 0 degrees c
0.43853024.9585408.html.plaintext.txt	163	thus steps interaction srp membrane receptor binding ribosomes sec61 complex must responsible less efficient insertion nascent polypeptide chains proteoliposomes lacking sec61
0.43853024.9585408.html.plaintext.txt	164	view larger version 20k fig
0.43853024.9585408.html.plaintext.txt	165	binding ribosomes reconstituted proteoliposomes
0.43853024.9585408.html.plaintext.txt	166	sec61 mock depleted proteoliposomes incubated radioactively labeled ribosomes increasing amounts unlabeled ribosomes physiological salt concentrations 26 degrees c
0.43853024.9585408.html.plaintext.txt	167	separate bound unbound fraction samples submitted flotation sucrose gradient
0.43853024.9585408.html.plaintext.txt	168	number binding sites apparent dissociation constants estimated scatchard plot analysis
0.43853024.9585408.html.plaintext.txt	169	kd dissociation constant eq membrane equivalant walter blobel 1983
0.43853024.9585408.html.plaintext.txt	170	sec61 interacts 25 kd subunit signal peptidase complex
0.43853024.9585408.html.plaintext.txt	171	analyze function sec61 investigated molecular environment membrane chemical cross linking
0.43853024.9585408.html.plaintext.txt	172	rough microsomes rm treated increasing amounts bmh bifunctional cross linking reagent reacts sulfhydryl sh groups
0.43853024.9585408.html.plaintext.txt	173	proteins subsequently separated sds page analyzed immunoblotting antibodies sec61 fig
0.43853024.9585408.html.plaintext.txt	174	three cross linked products detected antibodies fig
0.43853024.9585408.html.plaintext.txt	175	apparent molecular weights cross linked proteins estimated 12 23 38 kd assuming apparent molecular weight sec61 13 kd
0.43853024.9585408.html.plaintext.txt	176	view larger version 36k fig
0.43853024.9585408.html.plaintext.txt	177	analysis environment sec61 chemical cross linking
0.43853024.9585408.html.plaintext.txt	178	rm treated increasing amounts bis maleimidohexane bmh subsequently analyzed sds page immunoblotting using antibodies directed subunit sec61 complex lanes 1 6
0.43853024.9585408.html.plaintext.txt	179	identify cross linked polypeptides rm treated bmh indicated
0.43853024.9585408.html.plaintext.txt	180	samples subsequently immunoprecipitated denaturing conditions anti sec61 column
0.43853024.9585408.html.plaintext.txt	181	precipitated material analyzed western blotting using antibodies directed sec61 lanes 7 10 sec61 lanes 11 14 25 kd subunit signal peptidase complex spc25 lanes 15 18 respectively
0.43853024.9585408.html.plaintext.txt	182	lanes 1 7 11 15 show results untreated rm
0.43853024.9585408.html.plaintext.txt	183	identify cross linked proteins microsomes treated two different concentrations bmh dissolved sds containing buffer dissociate noncovalent chemical bonds
0.43853024.9585408.html.plaintext.txt	184	extract subjected immunoprecipitation sec61 antibodies precipitated material analyzed western blotting using different antibodies
0.43853024.9585408.html.plaintext.txt	185	3 shows immunoblots antibodies directed sec61 fig
0.43853024.9585408.html.plaintext.txt	186	3 lanes 11 14 spc25 lanes 15 18
0.43853024.9585408.html.plaintext.txt	187	product containing 38 kd protein could immunoprecipitated sec61 antibodies fig
0.43853024.9585408.html.plaintext.txt	188	3 lane 10 recognized sec61 antibody lane 14 indicating generated cross linking subunits sec61 complex
0.43853024.9585408.html.plaintext.txt	189	product containing protein 23 kd could immunoprecipitated sec61 antibodies fig
0.43853024.9585408.html.plaintext.txt	190	3 lane 9 reacted antibodies spc25 lane 17 thus generated cross linking two proteins
0.43853024.9585408.html.plaintext.txt	191	neither sec61 spc25 coprecipitated sec61 bmh omitted fig
0.43853024.9585408.html.plaintext.txt	192	3 lanes 12 16 antibodies recognized single bands untreated rm lanes 11 15
0.43853024.9585408.html.plaintext.txt	193	product containing protein 12 kd react antibodies tested
0.43853024.9585408.html.plaintext.txt	194	considering size suspected may represent product generated cross linking two subunits sec61 complex
0.43853024.9585408.html.plaintext.txt	195	test assumption purified sec61 complex reconstituted proteoliposomes subjected cross linking bmh
0.43853024.9585408.html.plaintext.txt	196	analyzed sds page immunoblotting sec61 antibodies cross linked product containing 12 kd protein observed fig
0.43853024.9585408.html.plaintext.txt	197	4 lanes 10 12 indicating cross linking partner indeed constituent sec61 complex
0.43853024.9585408.html.plaintext.txt	198	smaller cross linked product fig
0.43853024.9585408.html.plaintext.txt	199	4 lanes 11 12 marked asterisk probably generated cross linking sec61 sec61 smallest subunit sec61 complex
0.43853024.9585408.html.plaintext.txt	200	appearance cross linked product native microsomes variable among different experiments
0.43853024.9585408.html.plaintext.txt	201	view larger version 50k fig
0.43853024.9585408.html.plaintext.txt	202	sec61 involved ribosome dependent structural changes translocation site
0.43853024.9585408.html.plaintext.txt	203	rough microsomes rm ribosome free membranes pk rm proteoliposomes produced unfractionated detergent extract pk rm total proteoliposomes containing purified sec61 complex sec61p purified signal peptidase complex spc respectively treated bmh indicated
0.43853024.9585408.html.plaintext.txt	204	sds page samples analyzed immunoblotting antibodies sec61 spc25 b
0.43853024.9585408.html.plaintext.txt	205	position probable cross link sec61 sec61 marked asterisk
0.43853024.9585408.html.plaintext.txt	206	ribosome dependent structural changes translocation site
0.43853024.9585408.html.plaintext.txt	207	concerned membrane bound ribosomes may prevent full access bifunctional cross linker sec61 subset interacting partners could detected
0.43853024.9585408.html.plaintext.txt	208	however surprise pk rm used cross linking experiments additional cross links observed sec61 sec61 sec61 spc25 could longer seen fig
0.43853024.9585408.html.plaintext.txt	209	treatment rm high salt puromycin alone change cross links data shown suggesting disappearance requires dissociation ribosomes subunits
0.43853024.9585408.html.plaintext.txt	210	agreement assumption proteoliposomes reconstituted crude detergent extract microsomes proteoliposomes containing purified sec61 complex lack membrane bound ribosomes also give cross links fig
0.43853024.9585408.html.plaintext.txt	211	similar conclusion could drawn cross linking reaction analyzed spc25 antibodies fig
0.43853024.9585408.html.plaintext.txt	212	rm two cross linked products seen one 36 kd spc25 sec61 another 46 kd fig
0.43853024.9585408.html.plaintext.txt	213	pk rm proteoliposomes reconstituted crude detergent extract adduct spc25 sec61 longer observed fig
0.43853024.9585408.html.plaintext.txt	214	4 b lanes 4 6 lanes 7 9 respectively whereas 46 kd cross linked product remained unchanged
0.43853024.9585408.html.plaintext.txt	215	latter also observed proteoliposomes containing purified signal peptidase complex fig
0.43853024.9585408.html.plaintext.txt	216	two spc subunits nonglycosylated spc25 glycoprotein spc2223 carry sh groups appropriate molecular weight produce 46 kd cross link spc25
0.43853024.9585408.html.plaintext.txt	217	molecular weight cross linked product change treatment n glycosidase f data shown conclude consists two spc25
0.43853024.9585408.html.plaintext.txt	218	exclude high salt treatment preparation pk rm responsible structural alterations identified ribosomes detached membrane independent method
0.43853024.9585408.html.plaintext.txt	219	reaction bmh performed presence 10 mm edta low salt conditions cross link sec61 sec61 sec61 spc25 could seen anymore fig
0.43853024.9585408.html.plaintext.txt	220	however homotypic cross link two sec61 remained unchanged indicating edta interfere reactivity bmh
0.43853024.9585408.html.plaintext.txt	221	noted extent cross linking intensity reduced varied different experiments
0.43853024.9585408.html.plaintext.txt	222	view larger version 60k fig
0.43853024.9585408.html.plaintext.txt	223	structural changes translocation site edta treated microsomes
0.43853024.9585408.html.plaintext.txt	224	rm incubated 10 mm edta bmh added indicated
0.43853024.9585408.html.plaintext.txt	225	samples analyzed sds page immunoblotting anti sec61 antibodies
0.43853024.9585408.html.plaintext.txt	226	ribosome dependent alteration cross link pattern real physiological significance possible reproduce cross link sec61 sec61 sec61 spc25 retargeting ribosomes carrying nascent polypeptide chains ribosome free membranes
0.43853024.9585408.html.plaintext.txt	227	ribosome nascent chain complexes produced vitro translation truncated mrna coding first 86 amino acids preprolactin 86 mer
0.43853024.9585408.html.plaintext.txt	228	ribosome free membranes pk rm added translation mix fig
0.43853024.9585408.html.plaintext.txt	229	controls pk rm rm incubated translation mix contain preprolactin mrna fig
0.43853024.9585408.html.plaintext.txt	230	isolation membranes aliquots sample treated different amounts bmh
0.43853024.9585408.html.plaintext.txt	231	samples analyzed western blotting sec61 antibodies using enhanced chemiluminescence detection system fig
0.43853024.9585408.html.plaintext.txt	232	6 quantitative immunoblotting using radioactively labeled secondary antibodies phosphorimager fig
0.43853024.9585408.html.plaintext.txt	233	6 b shows incubation pk rm ribosome nascent chain complexes led clear restimulation cross link intensity sec61 sec61 sec61 spc25
0.43853024.9585408.html.plaintext.txt	234	similar results obtained edta treated membranes analyzed data shown
0.43853024.9585408.html.plaintext.txt	235	view larger version 47k fig
0.43853024.9585408.html.plaintext.txt	236	structural changes translocation site induced targeting ribosomes carrying preprolactin 86 mer ppl 86mer
0.43853024.9585408.html.plaintext.txt	237	translation carried reticulocyte lysate system presence lanes 4 6 absence lanes 1 3 7 9 mrna coding ppl 86 mer
0.43853024.9585408.html.plaintext.txt	238	addition pk rm lanes 1 6 rough microsomes lanes 7 9 respectively targeting reaction carried 0 degrees c followed incubation 26 degrees c
0.43853024.9585408.html.plaintext.txt	239	membranes collected centrifugation sucrose cushion separated three aliquots treated bis maleimidohexane bmh indicated
0.43853024.9585408.html.plaintext.txt	240	samples analyzed immunoblotting antibodies sec61 using detection system enhanced chemiluminescence radioactively labeled secondary antibodies b respectively
0.43853024.9585408.html.plaintext.txt	241	unknown cross link marked asterisk observed experiments
0.43853024.9585408.html.plaintext.txt	242	b phosphorimager system used quantitation cross linking intensities
0.43853024.9585408.html.plaintext.txt	243	cross linking intensities obtained rm defined 100
0.43853024.9585408.html.plaintext.txt	244	taken together data provide evidence subunit sec61 complex involved ribosome dependent conformational changes translocation channel specifically interacts signal peptidase cotranslational translocation
0.43853024.9585408.html.plaintext.txt	245	discussion top abstract introduction materials methods results discussion references
0.43853024.9585408.html.plaintext.txt	246	paper studied role subunit sec61 complex cotranslational protein translocation mammalian er
0.43853024.9585408.html.plaintext.txt	247	found translocation competence reconstituted proteoliposomes immunodepleted sec61 greatly reduced tested conditions membrane targeting translation occur time
0.43853024.9585408.html.plaintext.txt	248	however ribosomes carrying short nascent chains first targeted membrane translation continued
0.43853024.9585408.html.plaintext.txt	249	enough time given membrane insertion depleted proteoliposomes marginally reduced activity
0.43853024.9585408.html.plaintext.txt	250	results explained assumption elongation nascent chain insertion translocation channel kinetically competing processes membrane insertion slow elongation nascent chain would continue cytosol folding would prevent later interaction signal sequence translocation apparatus
0.43853024.9585408.html.plaintext.txt	251	therefore infer subunit required rapid insertion ribosome bound nascent chain translocation sites er membrane
0.43853024.9585408.html.plaintext.txt	252	observation subunit essential agreement fact deletion two subunits yeast cells lethal leads growth phenotype elevated temperatures
0.43853024.9585408.html.plaintext.txt	253	since microsomes isolated mutant reduced activity posttranslational protein transport present results indicate subunit plays role pathways absolutely required either one
0.43853024.9585408.html.plaintext.txt	254	cotranslational translocation process known much detail able analyze effect sec61 depletion various steps
0.43853024.9585408.html.plaintext.txt	255	one first steps interaction ribosome nascent chain srp complex srp receptor membrane leads release translational arrest exerted srp
0.43853024.9585408.html.plaintext.txt	256	reaction perturbed depletion sec61 although previous data showed optimal release srp receptor sec61 complex required gorlich rapoport 1993
0.43853024.9585408.html.plaintext.txt	257	therefore conclude subunit essential activity sec61 complex
0.43853024.9585408.html.plaintext.txt	258	binding ribosomes er membrane also affected absence sec61
0.43853024.9585408.html.plaintext.txt	259	number binding sites dissociation constant remained unchanged almost identical values determined reconstituted purified wild type sec61 complex
0.43853024.9585408.html.plaintext.txt	260	results consistent observation proteolytic degradation cytosolic domain sec61 microsomes prevent binding ribosomes kalies et al
0.43853024.9585408.html.plaintext.txt	261	taken together results indicate even absence sec61 efficient release srp arrest binding ribosome nascent chain complex sec61 complex occur
0.43853024.9585408.html.plaintext.txt	262	conclusion supported observation membrane targeted nascent chains undergo signal peptide cleavage signal peptidase located wrong orientation reconstituted membrane
0.43853024.9585408.html.plaintext.txt	263	therefore appears step subsequent membrane targeting likely step nascent chain inserted sec61 channel perturbed absence subunit
0.43853024.9585408.html.plaintext.txt	264	structural changes sec61 channel may required opening crowley et al
0.43853024.9585408.html.plaintext.txt	265	1994 jungnickel rapoport 1995 may occur reduced rate
0.43853024.9585408.html.plaintext.txt	266	analyze function sec61 probed molecular environment er membranes cross linking
0.43853024.9585408.html.plaintext.txt	267	bifunctional cross linker used reacts specifically sh groups therefore expected give relative simple cross linking pattern
0.43853024.9585408.html.plaintext.txt	268	predicted rough microsomes sec61 found close proximity subunit sec61 complex
0.43853024.9585408.html.plaintext.txt	269	also found cross linked product consisting two sec61 molecules perhaps explained occurrence oligomers trimeric sec61 complex microsomes hanein et al
0.43853024.9585408.html.plaintext.txt	270	interestingly however specific cross linked product containing spc25 observed
0.43853024.9585408.html.plaintext.txt	271	conversely cross linking partners spc25 analyzed partner outside signal peptidase complex found sec61
0.43853024.9585408.html.plaintext.txt	272	remarkably 70 spc25 could cross linked sec61
0.43853024.9585408.html.plaintext.txt	273	therefore believe cross link two proteins indicates specific interaction
0.43853024.9585408.html.plaintext.txt	274	data provide first evidence signal peptidase physically contacts protein conducting channel membrane
0.43853024.9585408.html.plaintext.txt	275	cross linking sec61 spc25 likely occurred cytosolic domains since cysteine sec61 nh2 terminus two appropriately located cysteines exist nh2 terminal domain spc25 fig
0.43853024.9585408.html.plaintext.txt	276	7 previously shown cytosolic kalies hartmann 1996
0.43853024.9585408.html.plaintext.txt	277	spc25 almost amino acid residues lumen er active site signal peptidase resides fig
0.43853024.9585408.html.plaintext.txt	278	7 function therefore obscure
0.43853024.9585408.html.plaintext.txt	279	basis data propose involved interaction sec61 complex bring enzyme close translocating polypeptide substrate
0.43853024.9585408.html.plaintext.txt	280	however sequestration translocation site may absolutely essential function signal peptidase complex abundant probably reach substrates mere diffusion plane membrane explaining neither spc25 sec61 essential viability yeast cells
0.43853024.9585408.html.plaintext.txt	281	view larger version 20k fig
0.43853024.9585408.html.plaintext.txt	282	membrane topology signal peptidase complex sec61 complex
0.43853024.9585408.html.plaintext.txt	283	topologies subunits schematically illustrated
0.43853024.9585408.html.plaintext.txt	284	dark boxes indicate hydrophobic segments membrane spanning segments respectively
0.43853024.9585408.html.plaintext.txt	285	spc2223 drawn glycosylated form
0.43853024.9585408.html.plaintext.txt	286	position sh groups marked white circles
0.43853024.9585408.html.plaintext.txt	287	evidence conjecture sec61 may involved recruiting signal peptidase complex translocation site comes cross linking experiments ribosome stripped membranes used
0.43853024.9585408.html.plaintext.txt	288	membranes gave many cross link reduced cross links sec61 spc25
0.43853024.9585408.html.plaintext.txt	289	retargeting ribosome nascent chain complexes almost ribosome free membranes cross linking proteins increased suggesting interaction induced translocation initiated ribosome binding
0.43853024.9585408.html.plaintext.txt	290	cross linking sec61 sec61 also dependent presence membrane bound ribosomes
0.43853024.9585408.html.plaintext.txt	291	effects required dissociation ribosome merely release nascent chain ribosome since occurred puromycin high low salt concentrations
0.43853024.9585408.html.plaintext.txt	292	changes cross linking pattern upon ribosome removal retargeting ribosome nascent chain complexes could caused conformational alterations assembled complex dissociation assembly subcomplexes
0.43853024.9585408.html.plaintext.txt	293	case provide first evidence structural changes among known components translocation apparatus induced onset cotranslational translocation
0.43853024.9585408.html.plaintext.txt	294	received publication 11 april 1997 revised form 10 february 1998
0.43853024.9585408.html.plaintext.txt	295	work supported grant deutsche forschungsgemeinschaft
0.43853024.9585408.html.plaintext.txt	296	address correspondence dr
0.43853024.9585408.html.plaintext.txt	297	hartmann abteilung biochemie ii zentrum biochemie und molekulare zellbiologie georg august universitat gossler strasse 12 d 37073 gottingen germany
0.43853024.9585408.html.plaintext.txt	298	abbreviations used paper
0.43853024.9585408.html.plaintext.txt	299	bmh bis maleimidohexane pk rm puromycin high salt treated rough microsomes rm rough microsomes spc signal peptidase complex spc25 25 kd subunit signal peptidase complex srp signal recognition particle tram translocating chain associating membrane
0.43853024.9585408.html.plaintext.txt	300	references top abstract introduction materials methods results discussion references 1
0.43853024.9585408.html.plaintext.txt	301	alignment conduits nascent chain ribosome sec61 complex
0.43853024.9585408.html.plaintext.txt	302	278 2123 2126 abstractfree full text
0.43853024.9585408.html.plaintext.txt	303	transfer proteins across membranes
0.43853024.9585408.html.plaintext.txt	304	presence proteolytically processed unprocessed nascent immunoglobulin light chains membrane bound ribosomes murine myeloma
0.43853024.9585408.html.plaintext.txt	305	access proteinase k partially translocated nascent polypeptides intact detergent solubilized membranes
0.43853024.9585408.html.plaintext.txt	306	signal sequence moves ribosomal tunnel noncytoplasmic aqueous environment er membrane early translocation
0.43853024.9585408.html.plaintext.txt	307	secretory proteins move endoplasmic reticulum membrane via aqueous gated pore
0.43853024.9585408.html.plaintext.txt	308	purification microsomal signal peptidase complex
0.43853024.9585408.html.plaintext.txt	309	homologue mammalian spc12 important efficient signal peptidase activity saccharomyces cerevisiae
0.43853024.9585408.html.plaintext.txt	310	271 16460 16465 abstractfree full text
0.43853024.9585408.html.plaintext.txt	311	second trimeric complex containing homologs sec61 complex functions protein transport across er membrane
0.43853024.9585408.html.plaintext.txt	312	protein translocation proteoliposomes reconstituted purified components endoplasmic reticulum membrane
0.43853024.9585408.html.plaintext.txt	313	protein endoplasmic reticulum involved early polypeptide translocation
0.43853024.9585408.html.plaintext.txt	314	mammalian homolog sec61p secyp associated ribosomes nascent polypeptides translocation
0.43853024.9585408.html.plaintext.txt	315	oligomeric rings sec61p complex induced ligands required protein translocation
0.43853024.9585408.html.plaintext.txt	316	posttargeting signal sequence recognition event endoplasmic reticulum membrane
0.43853024.9585408.html.plaintext.txt	317	membrane topology 12 25 kda subunit mammalian signal peptidase complex
0.43853024.9585408.html.plaintext.txt	318	271 3925 3929 abstractfree full text
0.43853024.9585408.html.plaintext.txt	319	binding ribosomes rough endoplasmic reticulum mediated sec61p complex
0.43853024.9585408.html.plaintext.txt	320	hen oviduct signal peptidase integral membrane protein
0.43853024.9585408.html.plaintext.txt	321	258 9488 9495 abstractfree full text
0.43853024.9585408.html.plaintext.txt	322	systematic probing environment translocating secretory protein translocation er membrane
0.43853024.9585408.html.plaintext.txt	323	structurally related spc1p spc2p yeast signal peptidase complex functionally distinct
0.43853024.9585408.html.plaintext.txt	324	271 29094 29099 abstractfree full text
0.43853024.9585408.html.plaintext.txt	325	protein conducting channel endoplasmic reticulum
0.43853024.9585408.html.plaintext.txt	326	signal sequence dependent function tram protein early phases protein transport across endoplasmic reticulum membrane
0.43853024.9585408.html.plaintext.txt	327	preparation microsomal membranes cotranslational protein translocation
0.43853024.9585408.html.plaintext.txt	328	methods enzymol 96 84 93 copyright 1998 rockefeller university press
0.4319393.15066992.html.plaintext.txt	0	efficient intracellular processing endogenous cystic fibrosis transmembrane conductance regulator epithelial cell lines karoly varga asta jurkuvenaite john wakefield jeong
0.4319393.15066992.html.plaintext.txt	1	venglarik ashutosh niraj marina mazur eric j
0.4319393.15066992.html.plaintext.txt	2	departments cell biology medicine genetics gregory fleming james cystic fibrosis research center university alabama birmingham birmingham alabama 35294 tranzyme corporation birmingham alabama 35209
0.4319393.15066992.html.plaintext.txt	3	received publication february 11 2004 revised form march 22 2004
0.4319393.15066992.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references cystic fibrosis transmembrane conductance regulator cftr camp dependent protein kinase activated chloride channel resides apical surface epithelial cells
0.4319393.15066992.html.plaintext.txt	5	one unusual feature protein biogenesis 75 wild type cftr degraded endoplasmic reticulum er associated degradative erad pathway
0.4319393.15066992.html.plaintext.txt	6	examining biogenesis structural instability molecule technically challenging due limited amount cftr expressed epithelia
0.4319393.15066992.html.plaintext.txt	7	consequently investigators employed heterologous overexpression systems
0.4319393.15066992.html.plaintext.txt	8	based recent results epithelial specific factors regulate cftr biogenesis function hypothesized cftr biogenesis endogenous cftr expressing epithelial cells may efficient
0.4319393.15066992.html.plaintext.txt	9	test compared cftr biogenesis two epithelial cell lines endogenously expressing cftr calu 3 t84 two heterologous expression systems cos 7 hela
0.4319393.15066992.html.plaintext.txt	10	consistent previous reports 20 35 newly synthesized cftr converted maturely glycosylated cftr cos 7 hela cells respectively
0.4319393.15066992.html.plaintext.txt	11	contrast cftr maturation virtually 100 efficient calu 3 t84 cells
0.4319393.15066992.html.plaintext.txt	12	furthermore inhibition proteasome effect cftr biogenesis calu 3 cells whereas stabilized immature form cftr hela cells
0.4319393.15066992.html.plaintext.txt	13	quantitative reverse transcriptase pcr indicated cftr message levels 4 fold lower calu 3 hela cells yet steady state protein levels comparable
0.4319393.15066992.html.plaintext.txt	14	results question structural instability model wild type cftr indicate epithelial cells endogenously expressing cftr efficiently process protein post golgi compartments
0.4319393.15066992.html.plaintext.txt	15	introduction top abstract introduction materials methods results discussion references newly synthesized proteins entering secretory pathway carefully monitored er1 quality control machinery ensure correctly folded molecules exit continue journey cell surface
0.4319393.15066992.html.plaintext.txt	16	misfolded membrane secretory proteins promptly recognized degraded er associated degradation pathway erad reviewed 1 2
0.4319393.15066992.html.plaintext.txt	17	understanding process critical since number diseases including cystic fibrosis congenital hypothyrosis familial hypercholesterolemia caused protein folding defects often arise missense deletion mutations 3 4
0.4319393.15066992.html.plaintext.txt	18	despite fact many mutations result production proteins retain biological activity rapidly degraded erad preventing proper targeting proteins biologically relevant destinations reviewed ref
0.4319393.15066992.html.plaintext.txt	19	interestingly inefficient protein biogenesis appears occur even wild type proteins number examples include epithelial sodium channels 6 shaker type potassium channels 7 major histocompatibility complex class ii molecules 8 opioid receptor 9 10 erythropoietin receptor 11 erythrocyte anion exchanger 1 band 3 12 cftr 13
0.4319393.15066992.html.plaintext.txt	20	many proteins including cftr assembled cell membrane part multiprotein complex 14 15 suggesting molecular rationing components complexes might regulated biogenesis
0.4319393.15066992.html.plaintext.txt	21	cftr large transmembrane glycoprotein consisting two homologous halves containing six transmembrane segments tmd1 tmd2 nucleotide binding domain nbd1 nbd2 connected regulatory domain 16
0.4319393.15066992.html.plaintext.txt	22	1480 amino acid protein member traffic atpase atp binding cassette abc transporter family 17 functions camp regulated cl channel 18 19 regulates ion conductive pathways including epithelial cl na atp transport 20 22
0.4319393.15066992.html.plaintext.txt	23	common mutation cftr f508 results production protein fails exit er 13 rapidly degraded erad 23 25
0.4319393.15066992.html.plaintext.txt	24	interestingly even wild type protein substrate erad much 75 degraded proteasome biogenesis 13 24 25
0.4319393.15066992.html.plaintext.txt	25	since small fraction newly synthesized wild type cftr reaches cell surface performs biological function question often arisen cftr biogenesis inefficient
0.4319393.15066992.html.plaintext.txt	26	study tector hartl 26 suggested possibility transmembrane segment 6 tmd1 unstable due 3 charged residues within domain
0.4319393.15066992.html.plaintext.txt	27	substitution residues non charged amino acids resulted increase protein stability loss chloride transport 26 suggesting protein stability compromised biological function
0.4319393.15066992.html.plaintext.txt	28	hypothesis evaluated cells endogenously expressing cftr
0.4319393.15066992.html.plaintext.txt	29	suggested appropriate cellular context may necessary support proper membrane protein trafficking reviewed refs
0.4319393.15066992.html.plaintext.txt	30	addition possible altered protein trafficking may result use overexpression systems non physiological experimental conditions reviewed bertrand et al
0.4319393.15066992.html.plaintext.txt	31	given initial studies cftr biogenesis performed primarily transfected heterologous overexpression systems careful analysis endogenous cftr biogenesis early er post golgi pathways warranted
0.4319393.15066992.html.plaintext.txt	32	heterologous systems may lack cftr binding partners ebp50 syntaxin 1a cal 15 29 33 association proteins cftr may required proper maturation andor trafficking
0.4319393.15066992.html.plaintext.txt	33	present studies monitored maturation efficiency cftr two human epithelial cell lines endogenously expresses cftr calu 3 34 t84 cells 35
0.4319393.15066992.html.plaintext.txt	34	metabolic pulse chase analysis cftr cells grown nonpolarizing polarizing conditions indicated core glycosylated band b cftr efficiently 100 processed maturely glycosylated band c protein extremely stable
0.4319393.15066992.html.plaintext.txt	35	moreover quantitative cell surface biotinylation assays revealed cftr surface pool substantially elevated calu 3 cells compared heterologous expression systems
0.4319393.15066992.html.plaintext.txt	36	thus endogenous cftr maturation differs fundamentally patterns reported recombinant overexpression systems differences extend across multiple cellular compartments
0.4319393.15066992.html.plaintext.txt	37	findings cast doubt upon viewpoint wild type cftr protein maturation inefficient
0.4319393.15066992.html.plaintext.txt	38	materials methods top abstract introduction materials methods results discussion references cell lines culture conditions cos 7 calu 3 t84 cells obtained atcc www
0.4319393.15066992.html.plaintext.txt	39	org maintained cystic fibrosis research center university alabama birmingham
0.4319393.15066992.html.plaintext.txt	40	hela cells overexpressing wild type cftr transduced selected previously described 36 37 cultured dulbeccos modified eagles medium invitrogen 10 fbs 37 degrees c humidified incubator 5 co2
0.4319393.15066992.html.plaintext.txt	41	cell monolayers calu 3 cells seeded 6
0.4319393.15066992.html.plaintext.txt	42	5 12 mm diameter transwell filters corning costar corning ny
0.4319393.15066992.html.plaintext.txt	43	2 3 days medium containing 10 fbs exchanged 2 fbs containing media cells cultured additional 7 9 days liquid apical basolateral compartments
0.4319393.15066992.html.plaintext.txt	44	conditions cells formed monolayers trans epithelial resistances 800 cm2
0.4319393.15066992.html.plaintext.txt	45	transient transfection cos 7 cells cos 7 cells transiently transfected using lipofectamine plus reagent invitrogen according manufacturers protocol
0.4319393.15066992.html.plaintext.txt	46	transfected cells cultured 24 48 h analysis described previously 38
0.4319393.15066992.html.plaintext.txt	47	immunoprecipitation cftr cftr immunoprecipitated using 24 1 anti c terminal antibody atcc number hb 11947 38 phosphorylated 32patp perkinelmer life sciences camp dependent protein kinase promega
0.4319393.15066992.html.plaintext.txt	48	labeled cftr analyzed sds page autoradiography described previously 39
0.4319393.15066992.html.plaintext.txt	49	metabolic pulse chase one hour addition radiolabeled amino acids tissue culture medium replaced methioninecysteine free minimal essential medium
0.4319393.15066992.html.plaintext.txt	50	1 h methionine starvation 37 degrees c 300 microciml easytag protein labeling mixture 35smethioninecysteine perkinelmer life sciences added cells pulse labeled 30 min maturation studies 60 min protein half life analysis
0.4319393.15066992.html.plaintext.txt	51	radioactive medium exchanged cold complete medium cultured various chase periods
0.4319393.15066992.html.plaintext.txt	52	cells lysed time points indicated cftr immunoprecipitated using 24 1 monoclonal antibody protein ag agarose roche diagnostics
0.4319393.15066992.html.plaintext.txt	53	immunoprecipitated samples analyzed sds page 6 gels detected using autoradiography phosphorimager amersham biosciences
0.4319393.15066992.html.plaintext.txt	54	calculation protein half lives performed described straley et al
0.4319393.15066992.html.plaintext.txt	55	maturation efficiency measured comparing density labeled band b density fully glycosylated band c using iplab software scanalytics inc
0.4319393.15066992.html.plaintext.txt	56	cell surface biotinylation cell surface glycoproteins biotinylated described previously 38
0.4319393.15066992.html.plaintext.txt	57	total cftr biotinylated cftr immunoprecipitated vitro phosphorylated using 32patp perkinelmer life sciences pka catalytic subunit promega separated sds page detected using autoradiography phorphorimager analysis described previously 38
0.4319393.15066992.html.plaintext.txt	58	biotinylation efficiency tested comparing transferrin receptor 125i binding assay biotinylated fraction transferrin receptor
0.4319393.15066992.html.plaintext.txt	59	efficiency cell surface biotinylation experiments presented 75 plus minus 4
0.4319393.15066992.html.plaintext.txt	60	semiquantitative rt pcr total rna isolated filter using rneasy mini kit qiagen
0.4319393.15066992.html.plaintext.txt	61	rna concentration calculated based absorbance samples 260 nm
0.4319393.15066992.html.plaintext.txt	62	one tube rt pcr kit qiagen used amplify cftr mrna using 1 ng total rna templates
0.4319393.15066992.html.plaintext.txt	63	primers designed anneal two different exons exon 10 exon 11 prevent possible amplification genomic dna pre mrna
0.4319393.15066992.html.plaintext.txt	64	sequences primers 5 acttcacttctaatgatgat 3exon 10f1 5 aaaacatctaggtatccaa 3exon 11r
0.4319393.15066992.html.plaintext.txt	65	two primers specific gapdh used controls sample 42
0.4319393.15066992.html.plaintext.txt	66	rt pcr performed instructed manufacturer
0.4319393.15066992.html.plaintext.txt	67	number pcr cycles experiment experimentally determined 28 cycles allow semiquantification pcr products log linear phase amplification
0.4319393.15066992.html.plaintext.txt	68	rna samples isolated cftr negative hela cells used control assure specificity pcr product
0.4319393.15066992.html.plaintext.txt	69	specificity gapdh primers previously tested 42
0.4319393.15066992.html.plaintext.txt	70	controls template reverse transcriptase also included
0.4319393.15066992.html.plaintext.txt	71	experiments repeated two times
0.4319393.15066992.html.plaintext.txt	72	fluorescence based kinetic real time pcr isolated rna samples also analyzed fluorescence based kinetic real time pcr using abi prism 7900 sequence detection system described previously genes 43
0.4319393.15066992.html.plaintext.txt	73	one step rt pcr performed serial dilutions rna isolates using master mix reagent kit assay demand gene expression probes applied biosystems cftr assay id hs00357011m1
0.4319393.15066992.html.plaintext.txt	74	6 carboxylfluorescein chosen reporter dye 5 end probe minor groove binder quencher 3 end
0.4319393.15066992.html.plaintext.txt	75	5 nuclease activity taq dna polymerase cleaves probe generates fluorescent signal proportional amount starting target template
0.4319393.15066992.html.plaintext.txt	76	reporter signal divided fluorescence internal reference dye 5 carboxy x rhodamine normalize non pcr related fluorescence
0.4319393.15066992.html.plaintext.txt	77	taqman rt pcr reaction performed final volume 20 microl containing 0
0.4319393.15066992.html.plaintext.txt	78	5 microl rna 10 microl taqman one step rt pcr master mix applied biosystems 0
0.4319393.15066992.html.plaintext.txt	79	5 microl multiscribernase inhibitor 1 microl 20x primerprobe set cftr andor 18 rrna endogenous control
0.4319393.15066992.html.plaintext.txt	80	six 10 fold serial dilutions 100 10 6 rna samples isolated models cell lines amplified duplicates using cftr andor 18 endogenous control
0.4319393.15066992.html.plaintext.txt	81	data exported abi prism 7900sds software microsoft excel relative standard curves plotted
0.4319393.15066992.html.plaintext.txt	82	using excel trendline option line best fit plotted
0.4319393.15066992.html.plaintext.txt	83	data cell line analyzed based standard curves relative quantities extrapolated
0.4319393.15066992.html.plaintext.txt	84	cftr values normalized 18 dividing cftr values corresponding 18 values sample according applied biosystems relative quantification method
0.4319393.15066992.html.plaintext.txt	85	specificity quality primers assured abi
0.4319393.15066992.html.plaintext.txt	86	appropriate controls rna primers reverse transcriptase included set experiments
0.4319393.15066992.html.plaintext.txt	87	microscopy indirect immunofluorescence performed described previously 41
0.4319393.15066992.html.plaintext.txt	88	statistical analysis results expressed means plus minus
0.4319393.15066992.html.plaintext.txt	89	statistical significance among means determined using students test two samples
0.4319393.15066992.html.plaintext.txt	90	results top abstract introduction materials methods results discussion references calu 3 cells express high levels cftr compared heterologous expression systems compare cftr biogenesis heterologous versus endogenous expression systems first determined relative amounts cftr transiently transfected cos 7 cells hela cells stably expressing cftr cells endogenously express cftr calu 3 cells
0.4319393.15066992.html.plaintext.txt	91	cos 7 cells represent common cell type used extensively study cftr biogenesis 13 38 44 hela 45 calu 3 cells 15 41 46 47 selected based stable high expression levels wild type cftr
0.4319393.15066992.html.plaintext.txt	92	compare cftr expression levels model cell lines cftr immunoprecipitated 250 microg total cellular protein standardized conditions
0.4319393.15066992.html.plaintext.txt	93	relative amounts cftr expressed cell type calculated based densitometry shown fig
0.4319393.15066992.html.plaintext.txt	94	cos 7 cells cftr expression levels dependent upon transfection efficiency hela calu 3 cells expression levels consistently high
0.4319393.15066992.html.plaintext.txt	95	since relative expression level calu 3 cells similar hela cells stably expressing wild type cftr selected calu 3 cells initial analysis
0.4319393.15066992.html.plaintext.txt	96	view larger version 14k fig
0.4319393.15066992.html.plaintext.txt	97	steady state wild type cftr protein level high calu 3 cells
0.4319393.15066992.html.plaintext.txt	98	transfected cos 7 cells wild type cftr expression levels analyzed 48 h transfection
0.4319393.15066992.html.plaintext.txt	99	hela cells stably expressing cftr calu 3 cells endogenously expressing protein grown standard conditions tested 80 confluence
0.4319393.15066992.html.plaintext.txt	100	cftr immunoprecipitated 250 microg total protein cell type using anti cftr c terminal monoclonal antibody 24 1
0.4319393.15066992.html.plaintext.txt	101	immunoprecipitated cftr vitro phosphorylated protein kinase 32patp analyzed sds page autoradiography
0.4319393.15066992.html.plaintext.txt	102	representative gel four shown upper panel
0.4319393.15066992.html.plaintext.txt	103	relative amounts wild type cftr expressed cell lines calculated based densitometry lower panel
0.4319393.15066992.html.plaintext.txt	104	averages plus minus
0.4319393.15066992.html.plaintext.txt	105	calculated four independent experiments
0.4319393.15066992.html.plaintext.txt	106	b cftr mrna levels significantly lower calu 3 cells hela cells
0.4319393.15066992.html.plaintext.txt	107	cftr message levels hela calu 3 cells tested using semiquantitative rt pcr using gapdh control upper panel representative gel shown taqman quantitative pcr using 18 rrna control lower panel
0.4319393.15066992.html.plaintext.txt	108	results plotted cftr mrna levels relative 18 rrna mean
0.4319393.15066992.html.plaintext.txt	109	four separate samples amplified condition
0.4319393.15066992.html.plaintext.txt	110	contrast slightly lower cftr protein levels cftr message levels 4 fold higher hela cells
0.4319393.15066992.html.plaintext.txt	111	simplest explanation high cftr levels hela calu 3 cells similar cftr mrna levels protein synthetic rates stability
0.4319393.15066992.html.plaintext.txt	112	compare cftr mrna levels hela calu 3 cells developed semiquantitative rt pcr using gapdh internal control
0.4319393.15066992.html.plaintext.txt	113	1b gapdh message levels similar cftr message levels significantly higher hela cells calu 3 contrast rather similar protein levels fig
0.4319393.15066992.html.plaintext.txt	114	assess differences also performed taqman quantitative pcr fig
0.4319393.15066992.html.plaintext.txt	115	results real time experiments establish cftr message levels hela cells 3
0.4319393.15066992.html.plaintext.txt	116	5 fold higher calu 3 cells
0.4319393.15066992.html.plaintext.txt	117	findings imply high steady state levels cftr calu 3 cells must due increased translational rate increased maturation efficiency extended protein half life combination effects
0.4319393.15066992.html.plaintext.txt	118	cftr maturation protein stability enhanced calu 3 cells monitor cftr maturation efficiency protein half life calu 3 cells compare values previously reported results performed metabolic pulse chase experiments followed cftr maturation cos 7 hela calu 3 cells
0.4319393.15066992.html.plaintext.txt	119	experiments compared amount newly synthesized band b cftr conversion fully glycosylated band c cftr cell type
0.4319393.15066992.html.plaintext.txt	120	results indicate significantly cftr synthesized cos 7 hela cells calu 3 cells first described cheng et al
0.4319393.15066992.html.plaintext.txt	121	conversion immaturely glycosylated cftr maturely glycosylated form extremely inefficient 27 plus minus 7
0.4319393.15066992.html.plaintext.txt	122	n 7 maturation efficiency cos 7 cells 39 plus minus 5
0.4319393.15066992.html.plaintext.txt	123	contrast amount newly synthesized band b form cftr lowest calu 3 cells maturation efficiency 92
0.4319393.15066992.html.plaintext.txt	124	4 plus minus 8 n 11 4 h fig
0.4319393.15066992.html.plaintext.txt	125	results indicate although less cftr produced calu 3 cells protein processed much efficiently mature form
0.4319393.15066992.html.plaintext.txt	126	furthermore comparing total densities band b band c cftr 4 h chase indicated total densities remain constant
0.4319393.15066992.html.plaintext.txt	127	suggests early degradation newly synthesized band b converted band c maturation reaches maximum 4 h pulse
0.4319393.15066992.html.plaintext.txt	128	view larger version 25k fig
0.4319393.15066992.html.plaintext.txt	129	cftr maturation efficient calu 3 cells
0.4319393.15066992.html.plaintext.txt	130	cos 7 hela calu 3 cells pulse labeled 300 mciml 35s labeled amino acids easytag protein labeling mixture perkinelmer life sciences
0.4319393.15066992.html.plaintext.txt	131	pulse 35smethioninecysteine containing medium replaced complete medium
0.4319393.15066992.html.plaintext.txt	132	cells lysed time points specified cftr immunoprecipitated anti cftr 24 1 antibody
0.4319393.15066992.html.plaintext.txt	133	samples separated sds page 6 gels analyzed using phosphorimager amersham biosciences
0.4319393.15066992.html.plaintext.txt	134	cftr maturation efficiency measured comparing density labeled band b 100 30 min pulse density band c 4 h chase using iplab software
0.4319393.15066992.html.plaintext.txt	135	average maturation efficiencies end 4 h chase cell line tested
0.4319393.15066992.html.plaintext.txt	136	results plotted percent newly synthesized band b converted band c end 4 h chase average
0.4319393.15066992.html.plaintext.txt	137	b representative pulse chase experiments shown cell line left panels
0.4319393.15066992.html.plaintext.txt	138	arrows indicate core band b fully glycosylated band c cftr
0.4319393.15066992.html.plaintext.txt	139	average disappearance band b maturation andor degradation formation band c time point right panels
0.4319393.15066992.html.plaintext.txt	140	disappearance band b diamonds formation band c squares calculated based densitometry chase time point
0.4319393.15066992.html.plaintext.txt	141	results plotted percent band b density 0 time point average
0.4319393.15066992.html.plaintext.txt	142	test whether increased cftr maturation efficiency alone responsible high cftr levels calu 3 cells determined half life fully glycosylated cftr cell line
0.4319393.15066992.html.plaintext.txt	143	using extended chase period metabolic labeling experiments found cftr half lives 10
0.4319393.15066992.html.plaintext.txt	144	results indicate cftr stable calu 3 cells compared heterologous cells
0.4319393.15066992.html.plaintext.txt	145	therefore efficient cftr maturation elongated protein half lives contribute high steady state cftr levels cells
0.4319393.15066992.html.plaintext.txt	146	view larger version 31k fig
0.4319393.15066992.html.plaintext.txt	147	cftr half life longer calu 3 cells compared heterologous expression systems
0.4319393.15066992.html.plaintext.txt	148	cos 7 cells cftr half lives tested 24 h transfection hela calu 3 cells 24 h seeding
0.4319393.15066992.html.plaintext.txt	149	1 h pulse 35smethionine easytag protein labeling mixture indicated chase periods complete medium cells lysed radioimmune precipitation assay buffer cftr immunoprecipitated analyzed described
0.4319393.15066992.html.plaintext.txt	150	average cftr half lives monitored densitometry n number experiments
0.4319393.15066992.html.plaintext.txt	151	calculation protein half lives performed described straley et al
0.4319393.15066992.html.plaintext.txt	152	b representative gels cftr half life measurements shown cell types
0.4319393.15066992.html.plaintext.txt	153	erad cftr insignificant calu 3 cells early degradation wild type cftr proteasome described common feature cftr biogenesis 23 25 48
0.4319393.15066992.html.plaintext.txt	154	cftr maturation approaches 100 efficiency calu 3 cells hypothesized disappearance band b cftr cells clearly result maturation degradation proteasome
0.4319393.15066992.html.plaintext.txt	155	test possibility compared effects two proteasome inhibitors alln 50 microm 48 clasto lactacystin lactone 10 microm 49 half lives band b cftr hela calu 3 cells
0.4319393.15066992.html.plaintext.txt	156	4 50 microm alln caused significant increase half life band b cftr hela cells effect stability immature cftr calu 3 cells suggesting core glycosylated protein substrate erad calu 3 cells
0.4319393.15066992.html.plaintext.txt	157	similar results seen proteasome blocked using 10 microm clasto lactacystin lactone data shown
0.4319393.15066992.html.plaintext.txt	158	results support hypothesis calu 3 cells newly synthesized core glycosylated cftr processed fully glycosylated form therefore role proteasome early events cftr processing calu 3 cells
0.4319393.15066992.html.plaintext.txt	159	view larger version 46k fig
0.4319393.15066992.html.plaintext.txt	160	proteasome inhibition effect cftr processing calu 3 cells
0.4319393.15066992.html.plaintext.txt	161	metabolic pulse chase experiments performed described legend fig
0.4319393.15066992.html.plaintext.txt	162	2 calu 3 hela presence absence 50 microm alln
0.4319393.15066992.html.plaintext.txt	163	samples alln present medium entire experiment
0.4319393.15066992.html.plaintext.txt	164	representative gels shown left densities band b triangle diamond band c x square cftr chase time point plotted percent band b 0 time point
0.4319393.15066992.html.plaintext.txt	165	alln treatment resulted increase half life band b hela cells top right panel
0.4319393.15066992.html.plaintext.txt	166	representative two experiments shown
0.4319393.15066992.html.plaintext.txt	167	cell surface cftr expression elevated calu 3 cells test whether increased cftr stability translates higher percentage cftr cell surface performed quantitative cell surface biotinylation experiments compared biotinylated total pools cftr cell lines
0.4319393.15066992.html.plaintext.txt	168	5a indicate biotinylated cftr pool cos 7 cells 11 plus minus 2
0.4319393.15066992.html.plaintext.txt	169	5 calu 3 20 plus minus 4
0.4319393.15066992.html.plaintext.txt	170	since calu 3 cells grown plastic dishes standard tissue culture conditions tested whether growing cells semipermeable supports polarized monolayers affects cftr surface expression
0.4319393.15066992.html.plaintext.txt	171	growing cells 9 12 days 12 mm filters cells formed tight monolayers monitored measuring transepithelial resistance 800 cm2
0.4319393.15066992.html.plaintext.txt	172	conditions biotinylated cftr fraction 17 plus minus 5 similar non polarized cells
0.4319393.15066992.html.plaintext.txt	173	results demonstrate surface cftr pool calu 3 cells higher cell polarity affect relative surface pool
0.4319393.15066992.html.plaintext.txt	174	view larger version 27k fig
0.4319393.15066992.html.plaintext.txt	175	cftr distribution cos 7 hela calu 3 cells
0.4319393.15066992.html.plaintext.txt	176	relative surface pools cftr expressed cos 7 hela calu 3 cells determined using surface biotinylation assay 38
0.4319393.15066992.html.plaintext.txt	177	assays total cftr 50 lysates compared biotinylated fraction b
0.4319393.15066992.html.plaintext.txt	178	cells lysed radioimmune precipitation assay buffer cftr immunoprecipitated using anti cftr c terminal 24 1 monoclonal antibody
0.4319393.15066992.html.plaintext.txt	179	50 lysates cftr immunoprecipitated described eluted re captured using avidin sepharose beads biotinylated cftr b
0.4319393.15066992.html.plaintext.txt	180	total cftr biotinylated cftr b vitro phosphorylated protein kinase 32patp separated sds page analyzed phosphorimaging densitometry
0.4319393.15066992.html.plaintext.txt	181	representative gels seven experiments shown
0.4319393.15066992.html.plaintext.txt	182	average percentage biotinylated cftr cell type calculated based densitometry
0.4319393.15066992.html.plaintext.txt	183	b cftr distribution calu 3 monolayers
0.4319393.15066992.html.plaintext.txt	184	calu 3 cells grown permeable supports analyzed 10 12 days culture using indirect immunofluorescence
0.4319393.15066992.html.plaintext.txt	185	cftr labeled 24 1 monoclonal antibody anti mouse igg alexa fluor488 green
0.4319393.15066992.html.plaintext.txt	186	tight junctions stained using polyclonal rabbit anti zo1 antibody zymed laboratories inc
0.4319393.15066992.html.plaintext.txt	187	anti rabbit igg alexa fluor596 red
0.4319393.15066992.html.plaintext.txt	188	side view top view apical membrane domain shown
0.4319393.15066992.html.plaintext.txt	189	cftr green present apical membrane also intracellularly
0.4319393.15066992.html.plaintext.txt	190	tight junctions well developed represented organized red staining zo1
0.4319393.15066992.html.plaintext.txt	191	c cftr maturation efficiency calu 3 cells grown filters
0.4319393.15066992.html.plaintext.txt	192	calu 3 cells grown 12 mm filters metabolically labeled cftr maturation efficiency monitored described legend fig
0.4319393.15066992.html.plaintext.txt	193	conversion band b band c compared time points chase
0.4319393.15066992.html.plaintext.txt	194	results plotted percent band b 30 min highest density chase time
0.4319393.15066992.html.plaintext.txt	195	fact cftr surface expression elevated polarized cells somewhat surprising given ht29 cells colonic epithelial cell line cftr surface expression requires polarization colonocytes 50
0.4319393.15066992.html.plaintext.txt	196	confirm calu 3 cells formed polarized monolayers monitored expression zo 1 marker tight junctions red 51 cftr green localization calu 3 cells using immunocytochemistry fig
0.4319393.15066992.html.plaintext.txt	197	5b indicate calu 3 cells formed tight monolayers evidenced zo 1 staining red close apical surface cftr green found cell surface intracellular sites
0.4319393.15066992.html.plaintext.txt	198	next tested whether rate efficiency cftr maturation affected cell polarity
0.4319393.15066992.html.plaintext.txt	199	5c confirm similar conventional tissue culture conditions fig
0.4319393.15066992.html.plaintext.txt	200	2 b cftr maturation also efficient polarizing conditions 90
0.4319393.15066992.html.plaintext.txt	201	interestingly experiments calu 3 monolayers suggested amount radiolabeled cftr dramatically decreased compared non polarized conditions rates conversion newly synthesized band b cftr fully glycosylated band c cftr slower standard conditions
0.4319393.15066992.html.plaintext.txt	202	30 newly synthesized band b cftr converted fully glycosylated band c 2 h maturation completed 6 h chase
0.4319393.15066992.html.plaintext.txt	203	cftr maturation efficient t84 cells grown standard tissue culture conditions determine whether efficient cftr maturation special feature calu 3 cells present endogenous cftr expressing cell lines also tested t84 ht29 colonic epithelial cell lines endogenously expressing wild type cftr
0.4319393.15066992.html.plaintext.txt	204	6a indicates steady state cftr protein levels highest calu 3 cells
0.4319393.15066992.html.plaintext.txt	205	t84 ht29 cells cftr levels 3 10 fold lower calu 3 respectively fig
0.4319393.15066992.html.plaintext.txt	206	taqman rt pcr measurements demonstrated cftr message levels t84 cells 4 fold ht29 10 fold lower calu 3 cells grown conditions fig
0.4319393.15066992.html.plaintext.txt	207	low transcription consequent low translation cftr ht29 cells t84 cells synthesized sufficient amounts protein effectively follow maturation efficiency
0.4319393.15066992.html.plaintext.txt	208	6c although cftr synthetic levels quite low maturation efficiency early chase periods variable end 4th h chase maturation newly synthesized protein virtually 100 t84 cells
0.4319393.15066992.html.plaintext.txt	209	results indicate efficient processing endogenous wild type cftr unique feature calu 3 cells also exists colonic epithelial cell line
0.4319393.15066992.html.plaintext.txt	210	view larger version 28k fig
0.4319393.15066992.html.plaintext.txt	211	cftr expression maturation t84 cells
0.4319393.15066992.html.plaintext.txt	212	cftr protein mrna levels b compared calu 3 t84 ht29 cells described materials methods
0.4319393.15066992.html.plaintext.txt	213	cftr maturation efficiency monitored t84 cells described legend fig
0.4319393.15066992.html.plaintext.txt	214	representative gel n 3 shown c left panel
0.4319393.15066992.html.plaintext.txt	215	relative amount fully glycosylated cftr band c squares core glycosylated cftr band b diamonds plotted percent immature band b pulse right panel
0.4319393.15066992.html.plaintext.txt	216	discussion top abstract introduction materials methods results discussion references knowledge experiments shown represent first complete analysis wild type cftr biogenesis human epithelial cell lines endogenously expressing protein highlight following important points
0.4319393.15066992.html.plaintext.txt	217	first contrast heterologous cftr expressing cell lines cftr maturation efficient calu 3 t84 cells
0.4319393.15066992.html.plaintext.txt	218	second mature cftr stable large portion intracellular
0.4319393.15066992.html.plaintext.txt	219	third since cftr biogenesis efficient erad plays role degradation wild type protein
0.4319393.15066992.html.plaintext.txt	220	finally although cftr message levels low calu 3 cells compared transduced cells steady state protein levels comparable heterologous expression systems suggesting cftr biogenesis protein stability faithfully reproduced heterologous systems
0.4319393.15066992.html.plaintext.txt	221	studies indicate detailed analysis endogenous cftr expressing cell lines warranted
0.4319393.15066992.html.plaintext.txt	222	initial studies cftr biogenesis described complete early degradation f508 cftr inefficient maturation wild type protein 13 24 52
0.4319393.15066992.html.plaintext.txt	223	studies employed heterologous overexpression systems one exception 24
0.4319393.15066992.html.plaintext.txt	224	kopito colleagues 24 compared wild type cftr maturation efficiency stable hek cells ht29 t84 cells endogenously expressing wild type cftr
0.4319393.15066992.html.plaintext.txt	225	cells cftr expression levels 10 50 fold lower hek maturation efficiency cftr 25 2 h chase
0.4319393.15066992.html.plaintext.txt	226	studies cftr maturation calu 3 t84 cells reached maximum 100 4 h
0.4319393.15066992.html.plaintext.txt	227	analysis cftr maturation efficiency cos 7 hela cells suggested significant increase band c levels 2 4 h chase periods whereas calu 3 cells t84 cells cftr maturation completed end 4th h
0.4319393.15066992.html.plaintext.txt	228	slower cftr processing noted endogenously expressing cells even pronounced calu 3 cells grown polarized monolayers
0.4319393.15066992.html.plaintext.txt	229	comparison cell lines found cftr mrna protein levels 4 10 fold higher calu 3 cells t84 ht29 cells
0.4319393.15066992.html.plaintext.txt	230	able follow maturation protein ht29 cells analysis t84 revealed cftr maturation efficient complete end 4 h chase
0.4319393.15066992.html.plaintext.txt	231	rapid disappearance band b cftr t84 ht29 hek cells also described attributed degradation 24
0.4319393.15066992.html.plaintext.txt	232	however experiments completed role proteasome early cftr degradation described protein overexpression shown overload proteasome
0.4319393.15066992.html.plaintext.txt	233	subsequently demonstrated either inhibition proteasome 25 48 protein overproduction 53 could result delayed degradation
0.4319393.15066992.html.plaintext.txt	234	therefore clear disappearance band b could due degradation maturation
0.4319393.15066992.html.plaintext.txt	235	studies proteasome blockade revealed calu 3 cells disappearance band b due proteasomal degradation whereas hela cells partially
0.4319393.15066992.html.plaintext.txt	236	increased half life mature cftr calu 3 cells suggests epithelial factors stabilize cftr
0.4319393.15066992.html.plaintext.txt	237	finding supported studies showing cftr half life heterologous systems 8 12 h 38 52 whereas llc pk1 54 mdck cells 55 two kidney epithelial cells stably expressing wild type cftr half life significantly longer cells grown polarized conditions
0.4319393.15066992.html.plaintext.txt	238	increased stability mature wild type cftr epithelial cells also consistent previous findings growing mdck cells polarized monolayers results increased steady state cftr levels function
0.4319393.15066992.html.plaintext.txt	239	furthermore possible cell type specific differences wild type cftr biogenesis stability suggested findings cellular polarization calu 3 cells significant effect total cell surface cftr levels contrast previous findings mdck cells 56
0.4319393.15066992.html.plaintext.txt	240	morphological cell surface biotinylation studies indicate existence large intracellular cftr pool calu 3 cells
0.4319393.15066992.html.plaintext.txt	241	dynamics precise cellular localization pool remain unclear several studies 44 57 61 indicated cftr found endosomal recycling endosomal compartments
0.4319393.15066992.html.plaintext.txt	242	regulation surface localized cftr accomplished polarized epithelia whether physiological role intracellular pool remain open questions
0.4319393.15066992.html.plaintext.txt	243	factors allow efficient cftr maturation well responsible stabilizing mature protein calu 3 t84 cells identified
0.4319393.15066992.html.plaintext.txt	244	however dramatic progress made recently identifying tissue specific factors organize delivery function transport proteins appropriate membrane domains 27 62 64
0.4319393.15066992.html.plaintext.txt	245	results suggest cellular context molecular rationing transport components important proper function also intracellular trafficking 27 64
0.4319393.15066992.html.plaintext.txt	246	nevertheless normal epithelial cell function depends accurate delivery large number membrane components particular cell surface domain defects process often lead disease 3 4
0.4319393.15066992.html.plaintext.txt	247	therefore crucial understand different cell types organize biogenesis intracellular processing key molecules 27 28
0.4319393.15066992.html.plaintext.txt	248	since cftr plays central role regulation epithelial ion transport multiple organ systems understanding biogenesis cellular distribution stability epithelia may first step toward identifying molecular defects leading early degradation otherwise functional mutants f508 cftr
0.4319393.15066992.html.plaintext.txt	249	importance elucidating biogenesis intracellular journey wild type cftr also underscored two publications indicating f508 cftr found cell surface native epithelia 65 66
0.4319393.15066992.html.plaintext.txt	250	earlier reports raise possibility correct physiological milieu even mutant protein might traffic differently reported heterologous expression systems
0.4319393.15066992.html.plaintext.txt	251	furthermore number cftr associating proteins identified shown regulate either function 32 intracellular journey cftr 33
0.4319393.15066992.html.plaintext.txt	252	whether yet identified proteins effect biogenesis stability wild type protein native epithelia remains determined
0.4319393.15066992.html.plaintext.txt	253	although endogenous wild type cftr synthesis quite low many native tissues results suggest usefulness cell lines endogenously expressing cftr powerful tools investigating cell type specific differences cftr biogenesis function
0.4319393.15066992.html.plaintext.txt	254	footnotes work supported part fellowship research development program cystic fibrosis foundation cff k
0.4319393.15066992.html.plaintext.txt	255	american lung association grant z
0.4319393.15066992.html.plaintext.txt	256	national institutes health grant dk60065 j
0.4319393.15066992.html.plaintext.txt	257	grant research development program cff national institutes health e
0.4319393.15066992.html.plaintext.txt	258	costs publication article defrayed part payment page charges
0.4319393.15066992.html.plaintext.txt	259	article must therefore hereby marked advertisement accordance 18 u
0.4319393.15066992.html.plaintext.txt	260	section 1734 solely indicate fact
0.4319393.15066992.html.plaintext.txt	261	study represents collaborative effort bebok collawn laboratories investigators contributed equally supervision experiments
0.4319393.15066992.html.plaintext.txt	262	correspondence addressed dept
0.4319393.15066992.html.plaintext.txt	263	cell biology gregory fleming james cf research center university alabama birmingham mclm 760 1918 university blvd
0.4319393.15066992.html.plaintext.txt	264	205 975 5449 fax 205 934 7593 e mail bebokatuab
0.4319393.15066992.html.plaintext.txt	265	1 abbreviations used er endoplasmic reticulum erad er associated degradation cftr cystic fibrosis transmembrane conductance regulator rt reverse transcriptase gapdh glyceraldehyde 3 phosphate dehydrogenase alln n acetyl leucyl leucyl norleucinal mdck madin darby canine kidney
0.4319393.15066992.html.plaintext.txt	266	acknowledgments thank gregory fleming james cf research center support research
0.4319393.15066992.html.plaintext.txt	267	elizabeth sztul erik schwiebert critical reading manuscript helpful suggestions
0.4319393.15066992.html.plaintext.txt	268	references top abstract introduction materials methods results discussion references hampton r
0.4319393.15066992.html.plaintext.txt	269	14 476 482crossrefmedline order article via infotrieve goldberg
0.4319393.15066992.html.plaintext.txt	270	2003 nature 426 895 899crossrefmedline order article via infotrieve aridor m
0.4319393.15066992.html.plaintext.txt	271	2000 traffic 1 836 851crossrefmedline order article via infotrieve aridor m
0.4319393.15066992.html.plaintext.txt	272	2002 traffic 3 781 790crossrefmedline order article via infotrieve kim p
0.4319393.15066992.html.plaintext.txt	273	19 173 202abstractfree full text weisz o
0.4319393.15066992.html.plaintext.txt	274	275 39886 39893abstractfree full text liu
0.4319393.15066992.html.plaintext.txt	275	85 61 71abstractfree full text sant
0.4319393.15066992.html.plaintext.txt	276	174 799 808abstract petaja repo u
0.4319393.15066992.html.plaintext.txt	277	276 4416 4423abstractfree full text petaja repo u
0.4319393.15066992.html.plaintext.txt	278	275 13727 13736abstractfree full text yoshimura
0.4319393.15066992.html.plaintext.txt	279	1990 nature 348 647 649crossrefmedline order article via infotrieve li j
0.4319393.15066992.html.plaintext.txt	280	349 51 57crossrefmedline order article via infotrieve cheng
0.4319393.15066992.html.plaintext.txt	281	1990 cell 63 827 834medline order article via infotrieve sun f
0.4319393.15066992.html.plaintext.txt	282	275 14360 14366abstractfree full text sun f
0.4319393.15066992.html.plaintext.txt	283	275 29539 29546abstractfree full text riordan j
0.4319393.15066992.html.plaintext.txt	284	1989 science 245 1066 1073medline order article via infotrieve hyde
0.4319393.15066992.html.plaintext.txt	285	1990 nature 346 362 365crossrefmedline order article via infotrieve anderson m
0.4319393.15066992.html.plaintext.txt	286	1991 science 253 202 205medline order article via infotrieve anderson m
0.4319393.15066992.html.plaintext.txt	287	1992 science 257 1701 1704medline order article via infotrieve schwiebert e
0.4319393.15066992.html.plaintext.txt	288	276 c1 c8medline order article via infotrieve schwiebert e
0.4319393.15066992.html.plaintext.txt	289	1995 cell 81 1063 1073medline order article via infotrieve stutts m
0.4319393.15066992.html.plaintext.txt	290	1995 science 269 847 850medline order article via infotrieve bebok z
0.4319393.15066992.html.plaintext.txt	291	273 29873 29878abstractfree full text ward c
0.4319393.15066992.html.plaintext.txt	292	269 25710 25718abstractfree full text ward c
0.4319393.15066992.html.plaintext.txt	293	1995 cell 83 121 127medline order article via infotrieve tector m
0.4319393.15066992.html.plaintext.txt	294	18 6290 6298abstractfree full text brown d
0.4319393.15066992.html.plaintext.txt	295	273 19797 19801abstractfree full text peters k
0.4319393.15066992.html.plaintext.txt	296	277 c174 c180medline order article via infotrieve naren
0.4319393.15066992.html.plaintext.txt	297	15 57 61abstractfree full text naren
0.4319393.15066992.html.plaintext.txt	298	1997 nature 390 302 305crossrefmedline order article via infotrieve cheng j
0.4319393.15066992.html.plaintext.txt	299	277 3520 3529abstractfree full text shen b
0.4319393.15066992.html.plaintext.txt	300	266 l493 l501medline order article via infotrieve cohn j
0.4319393.15066992.html.plaintext.txt	301	2 47 55crossrefmedline order article via infotrieve kappes j
0.4319393.15066992.html.plaintext.txt	302	76 449 465medline order article via infotrieve peter k
0.4319393.15066992.html.plaintext.txt	303	277 49952 49957abstractfree full text bebok z
0.4319393.15066992.html.plaintext.txt	304	cell 9 1683 1694abstractfree full text bebok z
0.4319393.15066992.html.plaintext.txt	305	277 43041 43049abstractfree full text li j
0.4319393.15066992.html.plaintext.txt	306	274 10790 10794abstractfree full text haslett j
0.4319393.15066992.html.plaintext.txt	307	99 15000 15005abstractfree full text prince l
0.4319393.15066992.html.plaintext.txt	308	274 3602 3609abstractfree full text bebok z
0.4319393.15066992.html.plaintext.txt	309	275 c913 c920medline order article via infotrieve loffing j
0.4319393.15066992.html.plaintext.txt	310	277 l700 l708medline order article via infotrieve jensen
0.4319393.15066992.html.plaintext.txt	311	1995 cell 83 129 135medline order article via infotrieve dick l
0.4319393.15066992.html.plaintext.txt	312	271 7273 7276abstractfree full text morris
0.4319393.15066992.html.plaintext.txt	313	266 c254 c268medline order article via infotrieve coyne c
0.4319393.15066992.html.plaintext.txt	314	cell 13 3218 3234abstractfree full text lukacs g
0.4319393.15066992.html.plaintext.txt	315	13 6076 6086abstract johnston j
0.4319393.15066992.html.plaintext.txt	316	143 1883 1898abstractfree full text heda g
0.4319393.15066992.html.plaintext.txt	317	280 c166 c174 swiatecka urban
0.4319393.15066992.html.plaintext.txt	318	277 40099 40105abstractfree full text bebok z
0.4319393.15066992.html.plaintext.txt	319	278 11554 11560abstractfree full text bradbury n
0.4319393.15066992.html.plaintext.txt	320	276 l659 l668medline order article via infotrieve bradbury n
0.4319393.15066992.html.plaintext.txt	321	79 s175 s191medline order article via infotrieve ameen n
0.4319393.15066992.html.plaintext.txt	322	114 219 228medline order article via infotrieve prince l
0.4319393.15066992.html.plaintext.txt	323	91 5192 5196abstract madrid r
0.4319393.15066992.html.plaintext.txt	324	20 7008 7021abstractfree full text li g
0.4319393.15066992.html.plaintext.txt	325	278 19791 19797abstractfree full text krumins
0.4319393.15066992.html.plaintext.txt	326	279 2593 2599abstractfree full text kalin n
0.4319393.15066992.html.plaintext.txt	327	103 1379 1389abstractfree full text penque d
0.4319393.15066992.html.plaintext.txt	328	80 857 868medline order article via infotrieve
0.4228028.11741811.html.plaintext.txt	0	a2 adenosine receptors regulate cftr pka pla2 b
0.4228028.11741811.html.plaintext.txt	1	departments 1 human genetics 4 medicine 5 pediatrics university alabama birmingham birmingham 35233 2 gregory fleming james cystic fibrosis research center university alabama birmingham birmingham alabama 35294 3 department pediatrics university mississippi jackson mississippi 39216
0.4228028.11741811.html.plaintext.txt	2	abstract top abstract introduction methods results discussion references
0.4228028.11741811.html.plaintext.txt	3	investigated adenosine ado activation cystic fibrosis transmembrane conductance regulator cftr vitro vivo
0.4228028.11741811.html.plaintext.txt	4	a2b ado receptors identified calu 3 ib 3 1 cos 7 primary human airway cells
0.4228028.11741811.html.plaintext.txt	5	ado elevated camp calu 3 ib 3 1 cos 7 cells activated protein kinase dependent halide efflux calu 3 cells
0.4228028.11741811.html.plaintext.txt	6	ado promoted arachidonic acid release calu 3 cells phospholipase a2 pla2 inhibition blocked ado activated halide efflux calu 3 cos 7 cells expressing cftr
0.4228028.11741811.html.plaintext.txt	7	forskolin 2 adrenergic receptor stimulated efflux affected treatment
0.4228028.11741811.html.plaintext.txt	8	cytoplasmic pla2 cpla2 identified calu 3 ib 3 1 cos 7 cells cpla2 inhibition affect ado stimulated camp concentrations
0.4228028.11741811.html.plaintext.txt	9	cftr cftr mice ado stimulated nasal cl secretion cftr dependent sensitive a2 receptor pla2 blockade
0.4228028.11741811.html.plaintext.txt	10	cos 7 cells transiently expressing f508 cftr ado activated halide efflux
0.4228028.11741811.html.plaintext.txt	11	ado also activated g551d cftr dependent halide efflux combined arachidonic acid phosphodiesterase inhibition
0.4228028.11741811.html.plaintext.txt	12	conclusion pla2 protein kinase contribute a2 receptor activation cftr components signaling pathway augment wild type mutant cftr activity
0.4228028.11741811.html.plaintext.txt	13	cystic fibrosis transmembrane conductance regulator airway epithelia calu 3 cells chloride secretion nasal potential difference protein kinase phospholipase a2
0.4228028.11741811.html.plaintext.txt	14	introduction top abstract introduction methods results discussion references
0.4228028.11741811.html.plaintext.txt	15	cystic fibrosis transmembrane conductance regulator cftr camp regulated cl channel responsible regulating ion transport many tissues expressed including airways airway submucosal glands sweat glands gastrointestinal tract pancreatic bile ducts reproductive tract 58 74
0.4228028.11741811.html.plaintext.txt	16	defective cftr function disrupts ion transport believed contribute clinical sequelae characteristic cystic fibrosis cf 49 58 67 74
0.4228028.11741811.html.plaintext.txt	17	cftr regulation vivo accomplished atp binding hydrolysis nucleotide binding domain 1 2 regulation phosphorylation status regulatory domain 10 11 36
0.4228028.11741811.html.plaintext.txt	18	process complex depends camp production surface receptors couple adenylyl cyclase camp degradation phosphodiesterase pde activity 40 41 domain domain interactions within cftr 55 protein protein interactions cftr associated regulatory proteins 31 32 54 64 direct phosphorylation dephosphorylation regulatory domain protein kinase pka phosphatases 6 11 respectively
0.4228028.11741811.html.plaintext.txt	19	receptor based pathways signal camp therefore relatively accessible candidates promoting activation cftr vivo
0.4228028.11741811.html.plaintext.txt	20	established 2 adrenergic receptors commonly stimulated assays detect cftr dependent cl secretion measured changes nasal potential difference pd mice humans 44
0.4228028.11741811.html.plaintext.txt	21	adenosine ado cl secretagogue signals p1 purinergic receptors recent studies demonstrated a2b ado receptors ars tightly couple cftr pka
0.4228028.11741811.html.plaintext.txt	22	calu 3 cells part coupling due compartmentalized signaling cftr adenylyl cyclase pkaii kinase anchoring protein interactions 34 71
0.4228028.11741811.html.plaintext.txt	23	t84 cells also express a2b ars shown mediate neutrophil stimulated cl secretion 48 70
0.4228028.11741811.html.plaintext.txt	24	studies 2 4 also suggested role phospholipase a2 pla2 ado activated cl secretion t84 cells
0.4228028.11741811.html.plaintext.txt	25	nature role whether similar signaling contributes cftr activation cftr expressing cells tissues however unknown
0.4228028.11741811.html.plaintext.txt	26	report describe cftr regulation a2 ars vitro vivo evaluate contribution cytoplasmic pla2 cpla2 a2 receptor signaling airway cells murine airway
0.4228028.11741811.html.plaintext.txt	27	findings suggest a2 receptors maximize cftr activation signaling adenylyl cyclase pka cpla2 components receptor signaling pathways activate common disease causing cftr mutations
0.4228028.11741811.html.plaintext.txt	28	methods top abstract introduction methods results discussion references
0.4228028.11741811.html.plaintext.txt	29	cell lines purchased american type culture collection manassas va
0.4228028.11741811.html.plaintext.txt	30	cos 7 cells grown dmem plus 10 fetal bovine serum fbs 1 penicillin plus streptomycin
0.4228028.11741811.html.plaintext.txt	31	ib 3 1 cells grown lhc medium plus 3 fbs 1 penicillin plus streptomycin
0.4228028.11741811.html.plaintext.txt	32	calu 3 cells grown mem plus 10 fbs 1 penicillin plus streptomycin supplemented nonessential amino acids
0.4228028.11741811.html.plaintext.txt	33	study polarized calu 3 cells air liquid interface polyester transwell clear costar filters 0
0.4228028.11741811.html.plaintext.txt	34	4 microm pore diameter 6 mm insert diameter arachidonic acid aa release ussing chamber experiments 24 mm insert diameter immunocytochemistry experiments fisher scientific pittsburgh pa coated human placental collagen matrix becton dickinson franklin lakes nj concentration 5 microgcm2 overnight seeded 1 x 106 cellscm2
0.4228028.11741811.html.plaintext.txt	35	filters confluent 1 wk medium removed apical surface cells fed basolateral surface
0.4228028.11741811.html.plaintext.txt	36	48 h resistance checked 1000 2000 cm 6 mm filters 400 600 cm 24 mm filters 72 96 h cells studied described transepithelial short circuit currents
0.4228028.11741811.html.plaintext.txt	37	primary human nasal cells isolated grown explant cultures vectabond treated glass coverslips previously described 15 studied 1 wk seeded
0.4228028.11741811.html.plaintext.txt	38	cftr transiently expressed cos 7 cells vaccinia based expression system previously described 16 17
0.4228028.11741811.html.plaintext.txt	39	cells grown vectabond treated glass coverslips infected vaccinia containing t7 polymerase generous gift dr
0.4228028.11741811.html.plaintext.txt	40	moss national institutes health bethesda md multiplicity infection 10 30 min
0.4228028.11741811.html.plaintext.txt	41	wild type wt f508 g551d cftr control t7 promoter ptm 1 vector introduced cells complex n 1 23 dioleoyloxypropyl nnn trimethylammonium dotap propane 12 dioleoyl sn glycero 3 phosphoethanolamine dope 20 microg dotap dope 5 microg ptm 1 cftr5 x 105 cells 4 h
0.4228028.11741811.html.plaintext.txt	42	cftr plasmids ptm 1 vector generous gift dr
0.4228028.11741811.html.plaintext.txt	43	cheng genzyme cambridge ma
0.4228028.11741811.html.plaintext.txt	44	cells washed pbs returned dmem plus 10 fbs studied 18 24 h postinfection wt cftr g551d cftr grown 29 degrees c 48 h f508 cftr
0.4228028.11741811.html.plaintext.txt	45	fluorescence based halide efflux measurements
0.4228028.11741811.html.plaintext.txt	46	study cftr activation measured halide efflux cos 7 cells transiently expressing wt f508 g551d cftr calu 3 cells halide quenched dye 6 methoxy n 3 sulfopropylquinolinium spq molecular probes eugene previously described 16 17
0.4228028.11741811.html.plaintext.txt	47	briefly cos 7 cells seeded vectabond treated glass coverslips calu 3 cells seeded vectabond treated coverslips coated 5 microgcm2 human placental extracellular matrix
0.4228028.11741811.html.plaintext.txt	48	cells grown 80 confluent
0.4228028.11741811.html.plaintext.txt	49	immediately study cells hypotonically loaded 10 mm spq 10 min placed quenching nai buffer
0.4228028.11741811.html.plaintext.txt	50	cells placed specially designed perfusion chamber studied 23 degrees c
0.4228028.11741811.html.plaintext.txt	51	fluorescence individual cells measured zeiss inverted microscope excitation 340 nm emission 410 nm pti imaging system hamamatsu camera
0.4228028.11741811.html.plaintext.txt	52	baseline fluorescence measured isotonic nai buffer 16 17 cells perfused isotonic dequench buffer nano3 replaced nai indicated time point generally 200
0.4228028.11741811.html.plaintext.txt	53	perfusate switched dequench buffer plus agonist requenched end experiment
0.4228028.11741811.html.plaintext.txt	54	fluorescence normalized cell baseline value increases shown percent increase fluorescence basal quenched fluorescence
0.4228028.11741811.html.plaintext.txt	55	unless otherwise specified means plus minus se cells included curves shown
0.4228028.11741811.html.plaintext.txt	56	detect a2b ar cells lysed radioimmunoprecipitation assay buffer 150 mm nacl 1 nonidet p 40 0
0.4228028.11741811.html.plaintext.txt	57	1 sds 50 mm tris cl 10 mgml phenylmethylsulfonyl fluoride ph 8
0.4228028.11741811.html.plaintext.txt	58	cos 7 cells lysates immunoprecipitated isoform specific polyclonal rabbit anti a2b ar antibody alpha diagnostics san antonio tx raised 16 amino acid sequence corresponding third extracellular domain human brain a2b ar cdna previously described 17
0.4228028.11741811.html.plaintext.txt	59	briefly anti a2b ar antibody linked protein agarose beads incubated cell lysates 2 h
0.4228028.11741811.html.plaintext.txt	60	precleared cell lysates beads without primary antibody used negative control
0.4228028.11741811.html.plaintext.txt	61	beads washed three times pbs plus 0
0.4228028.11741811.html.plaintext.txt	62	1 tween immunoprecipitates released sample buffer incubated 37 degrees c 10 min
0.4228028.11741811.html.plaintext.txt	63	calu 3 ib 3 1 cells lysates western blotted without immunoprecipitation
0.4228028.11741811.html.plaintext.txt	64	proteins separated sds page precast 12 gels novex gels invitrogen carlsbad ca electrophoretically blotted onto polyvinylidene difluoride membranes
0.4228028.11741811.html.plaintext.txt	65	membranes blocked 1 bsa pbs 30 min washed three times pbs plus 0
0.4228028.11741811.html.plaintext.txt	66	1 tween probed anti a2b ar antibody 11000 dilution 2 h
0.4228028.11741811.html.plaintext.txt	67	negative control membranes blotted fivefold excess weight a2b ar specific neutralizing peptide added primary antibody alpha diagnostics
0.4228028.11741811.html.plaintext.txt	68	membranes washed three times incubated secondary antibody 11000 dilution goat anti rabbit antibody conjugated alkaline phosphatase southern biotechnology associates birmingham al 2 h
0.4228028.11741811.html.plaintext.txt	69	membranes washed three times developed 5 bromo 4 chloro 3 indolyl phosphate bcip 4 nitro blue tetrazolium chloride nbt carbonate buffer ph 9
0.4228028.11741811.html.plaintext.txt	70	similar techniques used identify cpla2 cell lysates using affinity purified mouse monoclonal igg2b antibody raised amino terminal domain human cpla2 cdna santa cruz biotechnology santa cruz ca
0.4228028.11741811.html.plaintext.txt	71	antibody used identify cpla2 protein cell lysate immunoprecipitates calu 3 ib 3 1 cells anti cpla2 linked precleared protein g beads roche diagnostics indianapolis cell lysates alone cos 7 cells
0.4228028.11741811.html.plaintext.txt	72	proteins separated sds page 8 precast gels blotted onto polyvinylidene difluoride membranes membranes blocked washed probed primary antibody 11000
0.4228028.11741811.html.plaintext.txt	73	secondary antibody goat anti mouse igg alkaline phosphatase conjugate 11000 dilution southern biotechnology associates blots developed nbt bcip
0.4228028.11741811.html.plaintext.txt	74	nasal explant cultures human surgical specimens grown vectabond treated coverslips coated 5 microgcm2 human placental extracellular matrix previously described 15
0.4228028.11741811.html.plaintext.txt	75	5 days age cells fixed 4 formaldehyde pbs 20 min ph 7
0.4228028.11741811.html.plaintext.txt	76	4 washed twice pbs permeabilized 0
0.4228028.11741811.html.plaintext.txt	77	05 surfactant triton x 100 pierce endogen rockford il
0.4228028.11741811.html.plaintext.txt	78	slides pretreated 1 bsa pbs block nonspecific protein binding sites
0.4228028.11741811.html.plaintext.txt	79	a2b ar antigen detected polyclonal rabbit anti a2b ar antibody 125 dilution 1 bsa 1 h
0.4228028.11741811.html.plaintext.txt	80	cells washed three times pbs 15 min incubated secondary antibody goat anti rabbit fitc conjugate 1100 dilution 1 bsa 1 h
0.4228028.11741811.html.plaintext.txt	81	cells mounted 46 diamidino 2 phenylindole vectashield mounting fluid vector laboratories
0.4228028.11741811.html.plaintext.txt	82	studies a2b ar localization polarized calu 3 cells a2b ar antigen identified filter fold technique previously described 7
0.4228028.11741811.html.plaintext.txt	83	briefly high resistance monolayers fixed 3 transmission electron microscopy grade formaldehyde touismis rockville md 45 min room temperature stained without detergent permeabilization
0.4228028.11741811.html.plaintext.txt	84	fixed monolayers washed three times pbs 15 min blocked nonimmune goat serum 30 min 125 dilution vector laboratories incubated primary rabbit anti a2b ar antibody 1100 dilution nonimmune goat serum 1 h room temperature
0.4228028.11741811.html.plaintext.txt	85	neutralizing peptide five times weight concentration primary antibody used negative control filters
0.4228028.11741811.html.plaintext.txt	86	goat anti rabbit alexa fluorochromes 180 dilution molecular probes used identify primary antibody
0.4228028.11741811.html.plaintext.txt	87	nuclei identified hoechst 33258 staining 20 microgml 4 min
0.4228028.11741811.html.plaintext.txt	88	filters folded apical side exposed mounted 0
0.4228028.11741811.html.plaintext.txt	89	1 p phenylenediamine sigma st
0.4228028.11741811.html.plaintext.txt	90	louis mo pbs glycerol 19 dilution
0.4228028.11741811.html.plaintext.txt	91	digital confocal images captured analyzed olympus ix70 inverted reflective fluorescent light microscope 623 nm excitation uplanapo x 100 u apo340 x 40 objectives photometric sensys digital camera iplab spectrum software supplemented power microtome extension software signalytics fairfax va
0.4228028.11741811.html.plaintext.txt	92	transepithelial short circuit currents
0.4228028.11741811.html.plaintext.txt	93	calu 3 cells grown monolayers air liquid interface mounted modified ussing chambers jims instruments iowa city ia initially bathed sides identical ringer solutions containing mm 115 nacl 25 nahco3 2
0.4228028.11741811.html.plaintext.txt	94	2 mgcl2 10 d glucose ph 7
0.4228028.11741811.html.plaintext.txt	95	bath solutions vigorously stirred gassed 5 co2
0.4228028.11741811.html.plaintext.txt	96	solutions chambers maintained 37 degrees c
0.4228028.11741811.html.plaintext.txt	97	short circuit current isc measurements obtained epithelial voltage clamp university iowa bioengineering iowa city ia
0.4228028.11741811.html.plaintext.txt	98	3 mv pulse 1 duration imposed every 100 monitor resistance calculated ohms law
0.4228028.11741811.html.plaintext.txt	99	measure stimulated isc mucosal bathing solution changed low cl solution containing mm 1
0.4228028.11741811.html.plaintext.txt	100	2 nacl 115 sodium gluconate components plus 100 microm amiloride
0.4228028.11741811.html.plaintext.txt	101	increasing concentrations ado added mucosal serosal bathing solutions 8 min observation ado concentration
0.4228028.11741811.html.plaintext.txt	102	cells stimulated 100 microm ado 200 microm glibenclamide added mucosal bathing solution effectively blocking stimulated isc 90
0.4228028.11741811.html.plaintext.txt	103	cftr cftr mice cftrunc mice c57bl6j genetic background studied conventional nasal pd protocol 29 69
0.4228028.11741811.html.plaintext.txt	104	cftr mice carried two copies human cftr cdna contains stop codon position 489 s489x
0.4228028.11741811.html.plaintext.txt	105	cftr mice included cftr cftr mice shown similar nasal ion transport characteristics 42
0.4228028.11741811.html.plaintext.txt	106	genotypes verified pcr dental enamel characteristics
0.4228028.11741811.html.plaintext.txt	107	male female mice 16 40 wk age studied
0.4228028.11741811.html.plaintext.txt	108	mice anesthetized cocktail consisting ketamine 100 mgml 82
0.4228028.11741811.html.plaintext.txt	109	5 microl acepromazine 10 mgml 30 microl xylazine 100 mgml 15 microl administered intraperitoneal injection 0
0.4228028.11741811.html.plaintext.txt	110	mouse tail gently abraded placed lactated ringer solution connected calomel cell high impedance voltage follower vf 1 world precision instruments sarasota fl
0.4228028.11741811.html.plaintext.txt	111	exploring bridge established connecting ag agcl electrode wire bridge syringe pumped solutions rate 180 microlh
0.4228028.11741811.html.plaintext.txt	112	5 min mice appropriately somnolent permit cannulation nostril pe 10 cannula pulled tip diameter 0
0.4228028.11741811.html.plaintext.txt	113	solutions perfused included ringer lactate plus amiloride 100 microm solution 1 low cl concentration cl solution containing 2
0.4228028.11741811.html.plaintext.txt	114	4 mm kh2po4 115 mm sodium gluconate 25 mm nahco3 1
0.4228028.11741811.html.plaintext.txt	115	24 mm calcium gluconate2 100 microm amiloride solution 2 solution 3 solution 2 plus agonist described text
0.4228028.11741811.html.plaintext.txt	116	superperfused condition studied 6 min total 18 min per protocol per mouse
0.4228028.11741811.html.plaintext.txt	117	calu 3 cells grown confluence 35 mm culture dishes coated 5 microgml human placental collagen high resistance monolayers air liquid interface washed pbs loaded 1 microciml 3haa overnight moravek biochemical la brea ca
0.4228028.11741811.html.plaintext.txt	118	plates filters washed five times pbs placed mem plus 10 fbs without 100 microm ado 750 microl volume 35 mm plates 150 microl apical volume 300 microl basolateral volume cells filters
0.4228028.11741811.html.plaintext.txt	119	aa release quantified 20 min cells plates 20 40 min cells filters
0.4228028.11741811.html.plaintext.txt	120	cells lysed 1 n naoh effluxed aa plate quantified scintillation counting normalized percent total number counts manner similar previously described 13
0.4228028.11741811.html.plaintext.txt	121	cellular camp measured elisa based detection kit previously described 17 cayman chemical ann arbor mi
0.4228028.11741811.html.plaintext.txt	122	briefly cells grown 35 mm dishes 7 x 106 cellsdish stimulated agonist 10 min cellular camp extracted ice cold ethanol
0.4228028.11741811.html.plaintext.txt	123	supernatants vacuum dried resuspended phosphate buffer camp levels quantified per manufacturers directions
0.4228028.11741811.html.plaintext.txt	124	experiments papaverine 100 microm nonspecific nonxanthine pde inhibitor included improve camp detection
0.4228028.11741811.html.plaintext.txt	125	xanthine based inhibitors avoided commonly interact ado receptors 39
0.4228028.11741811.html.plaintext.txt	126	ado hemisodium salt chlorpromazine cpz h 89 cl forskolin zaprinast aa purchased calbiochem san diego ca albuterol alb salbutamol theophylline 8 cyclopentyl 13 dipropylxanthine dpcpx 8 phenyltheophylline rolipram milrinone purchased sigma papaverine hcl purchased research biochemicals international natick ma
0.4228028.11741811.html.plaintext.txt	127	descriptive statistics means plus minus se tests statistical significance performed sigmastat software jandel ca
0.4228028.11741811.html.plaintext.txt	128	paired unpaired tests used samples continuous data camp levels aa levels stimulated pd measurements isc 2 analysis used compare number f508 cftr expressing cells responding different agonists ado forskolin dpcpx control
0.4228028.11741811.html.plaintext.txt	129	05 considered statistically significant
0.4228028.11741811.html.plaintext.txt	130	results top abstract introduction methods results discussion references
0.4228028.11741811.html.plaintext.txt	131	human airway cells express a2b ars
0.4228028.11741811.html.plaintext.txt	132	polyclonal anti a2b ar antibody calu 3 ib 3 1 cell lysates probed a2b receptor expression western blotting
0.4228028.11741811.html.plaintext.txt	133	positive control cos 7 cells laboratory previously demonstrated endogenously express a2b ars 17 also evaluated
0.4228028.11741811.html.plaintext.txt	134	figure 1 shows three cell types specific 40 kda band identified
0.4228028.11741811.html.plaintext.txt	135	using anti a2b ar antibody investigated a2b receptor localization primary human nasal airway cells fig
0.4228028.11741811.html.plaintext.txt	136	2a polarized calu 3 cells airway cell line serous phenotype high levels cftr expression fig
0.4228028.11741811.html.plaintext.txt	137	cell types antibody detected plasma membrane localized a2b ar
0.4228028.11741811.html.plaintext.txt	138	staining predominantly along apical surface calu 3 cells
0.4228028.11741811.html.plaintext.txt	139	functional studies ussing chambers demonstrated ado added either apical basolateral surface briskly activated isc fig
0.4228028.11741811.html.plaintext.txt	140	ado potent stimulus added apical membrane basolateral membrane isc stimulated either membrane sensitive apical glibenclamide blockade 90 inhibition stimulated isc produced 100 microm ado p 0
0.4228028.11741811.html.plaintext.txt	141	although range concentrations capable activating isc consistent a2 receptor stimulation experiments exclude possibility additional ar subtypes may contribute ado stimulated isc
0.4228028.11741811.html.plaintext.txt	142	hco transport addition cl transport may contribute isc calu 3 monolayers 22 66 functional studies cftr activity performed spq based halide efflux assay 15 17
0.4228028.11741811.html.plaintext.txt	143	view larger version 21k fig
0.4228028.11741811.html.plaintext.txt	144	identification a2b adenosine ado receptors ars
0.4228028.11741811.html.plaintext.txt	145	characteristic 40 kda band identified 3 cell types
0.4228028.11741811.html.plaintext.txt	146	negative controls precleared beads cell lysates cos 7 cell immunoprecipitates primary antibody conjugated beads addition neutralizing peptide western blotting calu 3 ib 3 1 cells 5 fold excess neutralizing peptide added incubation primary antibody
0.4228028.11741811.html.plaintext.txt	147	view larger version 39k fig
0.4228028.11741811.html.plaintext.txt	148	immunofluorescence primary human bronchial epithelial cells calu 3 cell monolayers studied immunofluorescence b respectively ussing chambers c
0.4228028.11741811.html.plaintext.txt	149	cells prepared studied described methods
0.4228028.11741811.html.plaintext.txt	150	left a2b ar antigen identified membrane staining pattern green
0.4228028.11741811.html.plaintext.txt	151	right negative control cultures 5 fold excess neutralizing peptide incubation primary antibody eliminated membrane staining
0.4228028.11741811.html.plaintext.txt	152	b top a2b ar antigen calu 3 monolayers green shows predominantly apical membrane staining
0.4228028.11741811.html.plaintext.txt	153	b bottom addition neutralizing peptide negative control cultures eliminated membrane staining
0.4228028.11741811.html.plaintext.txt	154	c effects apical basolateral addition ado short circuit current isc calu 3 cells
0.4228028.11741811.html.plaintext.txt	155	cells grown air liquid interface studied ussing chambers
0.4228028.11741811.html.plaintext.txt	156	c left representative isc tracings
0.4228028.11741811.html.plaintext.txt	157	top calu 3 cells initially cultured lactated ringer solution followed left right 1 mucosal low cl concentration cl buffer amiloride 100 microm 2 addition mucosal 1 microm ado 3 addition basolateral 1 microm ado 4 blockade mucosal 200 microm glibenclamide
0.4228028.11741811.html.plaintext.txt	158	bottom experiment except basolateral ado 1 microm 2 added mucosal ado 1 microm 3
0.4228028.11741811.html.plaintext.txt	159	right ado strong stimulus added either membrane
0.4228028.11741811.html.plaintext.txt	160	0 microm compared 10 microm
0.4228028.11741811.html.plaintext.txt	161	0 microm compared 10 microm p 0
0.4228028.11741811.html.plaintext.txt	162	001 10 microm compared 100 microm
0.4228028.11741811.html.plaintext.txt	163	apical stimulated isc greater basolateral stimulated isc 0
0.4228028.11741811.html.plaintext.txt	164	approximately 90 stimulated isc 100 microm either membrane blocked glibenclamide 200 microm added mucosal compartment data shown
0.4228028.11741811.html.plaintext.txt	165	ado stimulates pla2 adenylyl cyclase cftr activation
0.4228028.11741811.html.plaintext.txt	166	previous studies cftr regulation a2b receptors cos 7 cells laboratory 17 showed a2b receptor signaling potent stimulus accomplishing strong activation cftr despite modest effects cellular camp compared forskolin
0.4228028.11741811.html.plaintext.txt	167	results similar reported barrett colleagues 3 4 t84 cells
0.4228028.11741811.html.plaintext.txt	168	subsequent studies barrett bigby 2 ado activated isc t84 monolayers found associated aa mobilization sensitivity pla2 inhibition
0.4228028.11741811.html.plaintext.txt	169	determine whether pla2 signaling might contribute a2 receptor activation cftr airway cos 7 cells evaluated cells cpla2 expression cpla2 activity ado stimulation
0.4228028.11741811.html.plaintext.txt	170	figure 3 shows calu 3 ib 3 1 cos 7 cell lysates monoclonal anti cpla2 antibody detected 110 kda protein consistent cpla2
0.4228028.11741811.html.plaintext.txt	171	view larger version 12k fig
0.4228028.11741811.html.plaintext.txt	172	identification cytoplasmic phospholipase a2 cpla2 3 cell types
0.4228028.11741811.html.plaintext.txt	173	cell lysates immunoprecipitated anti cpla2 antibody calu 3 ib 3 1 cells separated sds page
0.4228028.11741811.html.plaintext.txt	174	cpla2 antigen 110 kda detected monoclonal anti cpla2 antibody arrow
0.4228028.11741811.html.plaintext.txt	175	control conditions precleared beads cell lysates without primary antibody calu 3 ib 3 1 cells
0.4228028.11741811.html.plaintext.txt	176	cos 7 cell lysates separated sds page western blotted anti cpla2 antibody
0.4228028.11741811.html.plaintext.txt	177	controls received primary antibody blotting
0.4228028.11741811.html.plaintext.txt	178	activated pla2 releases aa sn 2 position membrane phospholipids
0.4228028.11741811.html.plaintext.txt	179	determine whether ado activated pla2 stimulated release aa airway cells express a2b receptors cftr calu 3 cells grown plastic permeable supports air liquid interface loaded 3haa exposed ado 100 microm fig
0.4228028.11741811.html.plaintext.txt	180	ado stimulated aa release calu 3 cells grown either condition
0.4228028.11741811.html.plaintext.txt	181	aa release expressed percent counts released basolateral apical total counts p 0
0.4228028.11741811.html.plaintext.txt	182	aa released preferentially apical compartment detectable amount approximately 110 apical release released basolateral surface fig
0.4228028.11741811.html.plaintext.txt	183	studies effects cpla2 inhibition cpz pka inhibition h 89 cl ado stimulated aa release complicated mild approximately twofold increase nonspecific aa release calu 3 cells treatment either inhibitor
0.4228028.11741811.html.plaintext.txt	184	cell viability treatment either compound preserved however based cytotoxicity assay studies data shown spq retention response fig
0.4228028.11741811.html.plaintext.txt	185	view larger version 9k fig
0.4228028.11741811.html.plaintext.txt	186	ado stimulates arachidonic acid aa release calu 3 cells
0.4228028.11741811.html.plaintext.txt	187	cells loaded 3haa overnight washed 5 times studied
0.4228028.11741811.html.plaintext.txt	188	values means plus minus se
0.4228028.11741811.html.plaintext.txt	189	aa release cells grown 35 mm plastic dishes stimulated ado 100 microm 20 min compared cells unstimulated dishes n 10 dishescondition
0.4228028.11741811.html.plaintext.txt	190	b apical release aa calu 3 cells grown permeable supports air liquid interface stimulated 100 microm ado compared cells unstimulated filters n 6 filterscondition
0.4228028.11741811.html.plaintext.txt	191	cells stimulated two 20 min time points
0.4228028.11741811.html.plaintext.txt	192	release second 20 min shown
0.4228028.11741811.html.plaintext.txt	193	entire 40 min period ado stimulated aa release 20 unstimulated condition p 0
0.4228028.11741811.html.plaintext.txt	194	c basolateral release aa 20 min time point
0.4228028.11741811.html.plaintext.txt	195	counts released medium retained cells stimulated unstimulated conditions different cells grown dishes filters b c
0.4228028.11741811.html.plaintext.txt	196	08 ado stimulated compared control cells
0.4228028.11741811.html.plaintext.txt	197	06 entire 40 min time period
0.4228028.11741811.html.plaintext.txt	198	view larger version 35k fig
0.4228028.11741811.html.plaintext.txt	199	ado activation halide efflux cystic fibrosis transmembrane conductance regulator cftr expressing cos 7 cells b calu 3 cells c e
0.4228028.11741811.html.plaintext.txt	200	values means plus minus se increase fluorescence basal nai quenched fluorescence n 40 cellscondition
0.4228028.11741811.html.plaintext.txt	201	cos 7 cells expressing cftr stimulated ado arrows activation seen higher concentration
0.4228028.11741811.html.plaintext.txt	202	experiment performed presence 25 microm aa 200 shift cftr activation 0
0.4228028.11741811.html.plaintext.txt	203	treatment cells chlorpromazine cpz 50 microm 200 blocked cftr activation 2
0.4228028.11741811.html.plaintext.txt	204	aa 25 100 microm arrows failed activate halide efflux
0.4228028.11741811.html.plaintext.txt	205	b cos 7 cells expressing cftr stimulated forskolin forsk alone 20 microm arrow addition 25 microm aa 200 forskolin stimulation cftr 20 microm
0.4228028.11741811.html.plaintext.txt	206	treatment cpz 50 microm effect forskolin activation
0.4228028.11741811.html.plaintext.txt	207	t7 controls cftr stimulated aa 25 microm 200 forskolin 20 microm arrow failed activate halide efflux
0.4228028.11741811.html.plaintext.txt	208	c calu 3 cells stimulated ado 2 microm
0.4228028.11741811.html.plaintext.txt	209	treatment cpz 50 microm 200 h 89 5 microm 4 h blocked ado activated halide efflux
0.4228028.11741811.html.plaintext.txt	210	aa alone 100 microm arrow failed activate halide efflux
0.4228028.11741811.html.plaintext.txt	211	d calu 3 cells stimulated albuterol alb 0
0.4228028.11741811.html.plaintext.txt	212	2 microm activated halide efflux
0.4228028.11741811.html.plaintext.txt	213	treatment cpz 50 microm 200 effect alb activation whereas treatment h 89 cl 5 microm 4 h blocked activation halide efflux
0.4228028.11741811.html.plaintext.txt	214	e calu 3 cells treated cpz 50 microm 200
0.4228028.11741811.html.plaintext.txt	215	high concentration ado 100 microm partially overcame cpz blockade
0.4228028.11741811.html.plaintext.txt	216	view larger version 40k fig
0.4228028.11741811.html.plaintext.txt	217	ado stimulates camp production cos 7 ib 3 1 calu 3 cells
0.4228028.11741811.html.plaintext.txt	218	camp levels measured elisa described see methods
0.4228028.11741811.html.plaintext.txt	219	cells stimulated 10 min extraction n 4 12 culturescondition
0.4228028.11741811.html.plaintext.txt	220	concentrations 10 microm ado 50 microm cpz 100 microm aa
0.4228028.11741811.html.plaintext.txt	221	papaverine 100 microm included conditions enhance camp detection previously described 17
0.4228028.11741811.html.plaintext.txt	222	values means plus minus se condition
0.4228028.11741811.html.plaintext.txt	223	001 compared control 100 microm papaverine
0.4228028.11741811.html.plaintext.txt	224	d calu 3 cells camp dose response curve
0.4228028.11741811.html.plaintext.txt	225	0 10 microm stimulation camp production inhibited treatment 100 microm cpz
0.4228028.11741811.html.plaintext.txt	226	02 ado alone compared papaverine control 100 microm
0.4228028.11741811.html.plaintext.txt	227	01 ado cpz compared papaverine control
0.4228028.11741811.html.plaintext.txt	228	addition investigating cftr activity isc measurements studies performed spq established assay cftr activity specific assay halide transport
0.4228028.11741811.html.plaintext.txt	229	spq based studies also allowed comparison a2 receptor stimulated halide transport calu 3 cells cos 7 cells fail polarize
0.4228028.11741811.html.plaintext.txt	230	cells represent simple cell type used study a2b receptor regulation wt mutant cftrs express a2b receptors purinergic receptors commonly found airway cells complex epithelial cells 17
0.4228028.11741811.html.plaintext.txt	231	ado stimulated halide efflux cos 7 cells expressing cftr shown fig
0.4228028.11741811.html.plaintext.txt	232	ado alone activated halide efflux 2 microm 0
0.4228028.11741811.html.plaintext.txt	233	2 microm consistent signaling lower affinity a2 receptors rather a1 receptors fig
0.4228028.11741811.html.plaintext.txt	234	treatment cells pla2 inhibitor cpz 50 microm blocked ado activated efflux
0.4228028.11741811.html.plaintext.txt	235	contrast addition pla2 product aa 25 microm augmented ado stimulus shifting activation halide efflux 0
0.4228028.11741811.html.plaintext.txt	236	aa alone 25 100 microm however failed activate halide efflux cftr expressing cos 7 cells
0.4228028.11741811.html.plaintext.txt	237	results suggest cpla2 signaling part pathway a2 receptors activate cftr model system
0.4228028.11741811.html.plaintext.txt	238	cpla2 product aa used alone however insufficient unable substitute ado
0.4228028.11741811.html.plaintext.txt	239	results therefore suggest a2 receptors activate cftr additional signaling pathways need stimulated
0.4228028.11741811.html.plaintext.txt	240	5b forskolin activated halide efflux cos 7 cells cftr inhibited cpz
0.4228028.11741811.html.plaintext.txt	241	test whether observations applied airway cells express cftr a2b receptors halide efflux experiments performed calu 3 cells
0.4228028.11741811.html.plaintext.txt	242	ado activated halide efflux blocked cpz 50 microm whereas aa alone failed activate efflux
0.4228028.11741811.html.plaintext.txt	243	high concentrations ado 100 microm able partially overcome cpz blockade fig
0.4228028.11741811.html.plaintext.txt	244	ado response also blocked pka inhibitor h 89 cl 5 microm indicating ado also utilizes adenylyl cyclase camp activate halide efflux
0.4228028.11741811.html.plaintext.txt	245	control experiments 2 receptor activation halide efflux alb sensitive h 89 cl cpla2 inhibition cpz fig
0.4228028.11741811.html.plaintext.txt	246	results consistent cos 7 cells indicate distinct differences exist mechanisms a2 receptors 2 receptors activate cftr halide transport vitro systems
0.4228028.11741811.html.plaintext.txt	247	a2 ars traditionally couple adenylyl cyclase gs elevate cellular camp previously laboratory 17 shown a2b receptor stimulation cos 7 cells increases camp dose dependent manner 17
0.4228028.11741811.html.plaintext.txt	248	whether a2 receptor stimulation camp involves pla2 signaling however known
0.4228028.11741811.html.plaintext.txt	249	figure 6 shows cos 7 ib 3 1 calu 3 cells ado 10 microm increased camp
0.4228028.11741811.html.plaintext.txt	250	treatment cells pla2 inhibitor cpz 50 microm effect ado stimulated camp production three cell lines yet completely abolished ado activated halide efflux cos 7 calu 3 cells fig
0.4228028.11741811.html.plaintext.txt	251	production camp lower doses ado 0
0.4228028.11741811.html.plaintext.txt	252	1 1 microm also inhibited cpz treatment calu 3 cells fig
0.4228028.11741811.html.plaintext.txt	253	results confirm a2 receptors couple adenylyl cyclase elevate camp also show inhibitory effect cpz exerts ado stimulation cftr independent camp
0.4228028.11741811.html.plaintext.txt	254	rather results shown figs
0.4228028.11741811.html.plaintext.txt	255	4 6 suggest ado stimulation leads cpla2 pka activation pathway required stimulation cftr
0.4228028.11741811.html.plaintext.txt	256	aa alone 100 microm variable effects camp stimulating camp production airway cells p 0
0.4228028.11741811.html.plaintext.txt	257	001 calu 3 cells compared control conditions cos 7 cells
0.4228028.11741811.html.plaintext.txt	258	camp produced high dose aa appeared contribute little cftr activation
0.4228028.11741811.html.plaintext.txt	259	aa alone insufficient acutely activate halide efflux either calu 3 cells cos 7 cells expressing cftr fig
0.4228028.11741811.html.plaintext.txt	260	5 aa additive effect camp combined ado stimulation three cell types
0.4228028.11741811.html.plaintext.txt	261	contrast functional results shown fig
0.4228028.11741811.html.plaintext.txt	262	5a addition aa ado stimulation appeared augment cftr dependent halide efflux
0.4228028.11741811.html.plaintext.txt	263	ado activation cftr dependent cl transport vivo
0.4228028.11741811.html.plaintext.txt	264	results given ado stimulates pla2 adenylyl cyclase cftr activation provide framework investigate ado activated cl transport vivo
0.4228028.11741811.html.plaintext.txt	265	studies investigated ion transport across murine nasal mucosa using nasal pd well established bioelectric assay cftr activity vivo
0.4228028.11741811.html.plaintext.txt	266	figure 7 shows examples nasal pd tracings cftr fig
0.4228028.11741811.html.plaintext.txt	267	cftr mouse ado stimulated hyperpolarization fig
0.4228028.11741811.html.plaintext.txt	268	7a arrow 3 consistent cl conductance
0.4228028.11741811.html.plaintext.txt	269	cftr mouse depolarization continued perfusion low cl solution low cl solution plus ado 500 microm
0.4228028.11741811.html.plaintext.txt	270	figure 8a summarizes comparison ado 100 microm alb 100 microm isoproterenol iso 100 microm forskolin 10 microm stimulated cl secretion cftr mice
0.4228028.11741811.html.plaintext.txt	271	ado potent cl secretagogue producing polarization 10 12 mice studied p 0
0.4228028.11741811.html.plaintext.txt	272	005 compared agonist iso control mice
0.4228028.11741811.html.plaintext.txt	273	alb also strong agonist similar forskolin producing polarization six eight mice studied p 0
0.4228028.11741811.html.plaintext.txt	274	05 alb forskolin compared iso control animals
0.4228028.11741811.html.plaintext.txt	275	contrast iso less predictable producing hyperpolarization 5 14 mice
0.4228028.11741811.html.plaintext.txt	276	ar stimulation ado 500 microm 2 receptor stimulation specific 2 receptor agonist alb 500 microm failed activate cl conductance cftr mice fig
0.4228028.11741811.html.plaintext.txt	277	studies confirm receptors stimulate cftr dependent cl transport
0.4228028.11741811.html.plaintext.txt	278	ado stimulated cl conductance cftr mice sensitive a2 receptor blockade 8 phenyltheophylline p 0
0.4228028.11741811.html.plaintext.txt	279	02 indicating ado activates cl conductance a2 receptor signaling fig
0.4228028.11741811.html.plaintext.txt	280	view larger version 19k fig
0.4228028.11741811.html.plaintext.txt	281	examples nasal potential differences pds cftr cftr mice
0.4228028.11741811.html.plaintext.txt	282	mice underwent standard nasal pd protocol described methods
0.4228028.11741811.html.plaintext.txt	283	solution 1 lactated ringer 100 microm amiloride solution 2 low cl solution 100 microm amiloride solution 3 solution 2 agonist
0.4228028.11741811.html.plaintext.txt	284	upward deflections hyperpolarization lumen negative conventionally taken represent cl secretion
0.4228028.11741811.html.plaintext.txt	285	cftr mouse 100 microm ado included solution 3
0.4228028.11741811.html.plaintext.txt	286	b cftr mouse 500 microm ado included solution 3
0.4228028.11741811.html.plaintext.txt	287	depolarizing phenotype throughout entire protocol seen
0.4228028.11741811.html.plaintext.txt	288	view larger version 11k fig
0.4228028.11741811.html.plaintext.txt	289	stimulated cl transport cftr c cftr b mice
0.4228028.11741811.html.plaintext.txt	290	change pd switch solution 3 shown
0.4228028.11741811.html.plaintext.txt	291	cftr mice stimulated ado 100 microm n 12 alb 100 microm n 8 forsk 10 microm n 10 isoproterenol iso 100 microm n 14 low cl control agonist n 18 included solution 3 shown
0.4228028.11741811.html.plaintext.txt	292	005 ado compared iso control
0.4228028.11741811.html.plaintext.txt	293	025 forsk compared iso control p 0
0.4228028.11741811.html.plaintext.txt	294	05 alb compared iso control
0.4228028.11741811.html.plaintext.txt	295	b cftr mice stimulated ado 500 microm n 10 alb 500 microm n 10
0.4228028.11741811.html.plaintext.txt	296	depolarizing phenotype seen agonists similar cftr control mice low cl alone solution 3 n 14
0.4228028.11741811.html.plaintext.txt	297	c cftr mice stimulated 50 microm ado solution 3 n 8 50 microm ado solution 3 100 microm 8 phenyltheophylline 8 pt solutions 2 3 n 10
0.4228028.11741811.html.plaintext.txt	298	02 change pd stimulation solution 3 ado compared solution 2 agonist
0.4228028.11741811.html.plaintext.txt	299	next investigated contribution pla2 cl secretion across murine nasal mucosa
0.4228028.11741811.html.plaintext.txt	300	figure 9 shows effect pla2 inhibitor cpz 100 microm ado alb stimulated cl conductance
0.4228028.11741811.html.plaintext.txt	301	ado 500 microm strongly stimulated cl secretion blocked cpz treatment p 0
0.4228028.11741811.html.plaintext.txt	302	contrast alb 500 microm stimulated cl secretion affected cpz
0.4228028.11741811.html.plaintext.txt	303	costimulation ado alb 500 microm failed produce additive effects cl conductance indicating two signaling pathways converge cftr dependent cftr independent cl transport pathways data shown
0.4228028.11741811.html.plaintext.txt	304	results also confirm vitro observations demonstrated a2 receptor activation cftr vivo depends pla2 activity
0.4228028.11741811.html.plaintext.txt	305	view larger version 11k fig
0.4228028.11741811.html.plaintext.txt	306	cpla2 inhibition blocks ado stimulated cl transport
0.4228028.11741811.html.plaintext.txt	307	nasal pds performed cftr mice described fig
0.4228028.11741811.html.plaintext.txt	308	mice stimulated ado 500 microm alb 500 microm solution 3 presence absence cpz 100 microm included solutions 2 3
0.4228028.11741811.html.plaintext.txt	309	02 ado cpz compared ado alone alb alone alb cpz
0.4228028.11741811.html.plaintext.txt	310	a2b ars activate f508 cftr g551d cftr
0.4228028.11741811.html.plaintext.txt	311	results discussed ado activation cftr dependent cl transport vivo show ado a2 receptor signaling potently activate cftr dependent cl transport vitro vivo
0.4228028.11741811.html.plaintext.txt	312	determine whether a2b receptor signaling could used improve activity common disease causing cftr mutations transiently expressed f508 cftr class ii mutation g551d cftr class iii mutation cos 7 cells
0.4228028.11741811.html.plaintext.txt	313	figure 10 shows localization cell membrane growth 29 degrees c 48 h f508 cftr activated a2b receptor stimulation 10 microm ado fashion similar direct adenylyl cyclase activation forskolin 20 microm
0.4228028.11741811.html.plaintext.txt	314	halide efflux stronger produced stimulation dpcpx agent acutely stimulate f508 cftr dependent halide efflux f508 cftr expressing cells currently clinical trials activator f508 cftr cf patients 24 30 p 0
0.4228028.11741811.html.plaintext.txt	315	001 comparing proportion responding cells stimulated ado dpcpx
0.4228028.11741811.html.plaintext.txt	316	test ability a2b receptor stimulation activate f508 cftr prolonged treatment dpcpx
0.4228028.11741811.html.plaintext.txt	317	activation f508 cftr accomplished despite modest effects ado camp compared forskolin 17
0.4228028.11741811.html.plaintext.txt	318	view larger version 31k fig
0.4228028.11741811.html.plaintext.txt	319	a2b receptor activation halide efflux f508 cftr expressing cells
0.4228028.11741811.html.plaintext.txt	320	cos 7 cells expressing f508 cftr studied growth 29 degrees c 48 h
0.4228028.11741811.html.plaintext.txt	321	cells perfused nai quenching buffer 0 200 no3 dequenching buffer 200 500 no3 buffer agonist 500 arrow
0.4228028.11741811.html.plaintext.txt	322	screened cells per condition described methods
0.4228028.11741811.html.plaintext.txt	323	responding cells condition compared 2 test
0.4228028.11741811.html.plaintext.txt	324	values means plus minus se responding cells stimulated condition forsk 20 microm ado 10 microm means plus minus se nonresponding cells 8 cyclopentyl 13 dipropylxanthine dpcpx 30 nm stimulated cells no3 control cells
0.4228028.11741811.html.plaintext.txt	325	concentration dpcpx used previously shown maximally induce acute 36cl release f508 cftr expressing cells 24 30
0.4228028.11741811.html.plaintext.txt	326	001 ado forsk compared dpcpx no3 conditions
0.4228028.11741811.html.plaintext.txt	327	11 cos 7 cells expressing g551d cftr stimulated forskolin ado aa
0.4228028.11741811.html.plaintext.txt	328	series pde inhibitors also evaluated previous reports 62 63 77 suggested surface localized mutant cftrs might partially responsive stimulation certain pde inhibitors
0.4228028.11741811.html.plaintext.txt	329	isotype specific inhibitors rolipram pde 4 specific milrinone pde 3 specific zaprinast pde 5 6 specific used concentrations 20 fold inhibitor constant respective pdes 72
0.4228028.11741811.html.plaintext.txt	330	two nonspecific pde inhibitors papaverine theophylline studied 200 microm
0.4228028.11741811.html.plaintext.txt	331	pde inhibitors milrinone evaluated clinical trials ability activate cl conductance normal subjects cf patients carrying g551d cftr mutation 68
0.4228028.11741811.html.plaintext.txt	332	concentrations used none pde inhibitors alone consistently elevated camp cos 7 cells 10 min exposure data shown none stimuli including ado activated g551d cftr specific halide efflux fig
0.4228028.11741811.html.plaintext.txt	333	wt cftr expressing cells stimulated forskolin shown comparison
0.4228028.11741811.html.plaintext.txt	334	11b g551d cftr expressing cos 7 cells exposed combinations ado 200 microm aa 100 microm pde inhibitors
0.4228028.11741811.html.plaintext.txt	335	contrast results fig
0.4228028.11741811.html.plaintext.txt	336	11a a2b receptor stimulation combined aa pde inhibition strongly activated halide efflux fashion similar produced wt cftr expressing cells
0.4228028.11741811.html.plaintext.txt	337	together results shown figs
0.4228028.11741811.html.plaintext.txt	338	10 11 indicate activity two common disease associated cftr mutations increased dramatically a2b ar signaling
0.4228028.11741811.html.plaintext.txt	339	view larger version 32k fig
0.4228028.11741811.html.plaintext.txt	340	activation halide efflux g551d cftr expressing cells
0.4228028.11741811.html.plaintext.txt	341	g551d cftr expressing cells compared wild type wt cftr expressing cells
0.4228028.11741811.html.plaintext.txt	342	cos 7 cells transiently expressing wt g551d cftr studied 6 methoxy n 3 sulfopropylquinolinium spq described methods n 40 cellscondition
0.4228028.11741811.html.plaintext.txt	343	g551d cftr expressing cells failed activate halide efflux stimulated ado 200 microm papaverine pap 200 microm ado rolipram rol 20 microm combination forsk 20 microm arrow
0.4228028.11741811.html.plaintext.txt	344	wt cftr expressing cells stimulated forsk cftr forsk 20 microm shown comparison
0.4228028.11741811.html.plaintext.txt	345	b g551d cftr expressing cos 7 cells stimulated ado 200 microm aa 100 microm combined series phosphodiesterase inhibitors pdeis
0.4228028.11741811.html.plaintext.txt	346	cells perfused no3 buffer aa 200 ado pdei added arrows
0.4228028.11741811.html.plaintext.txt	347	isotype specific pdeis studied concentrations 20 fold inhibition constant respective pdes
0.4228028.11741811.html.plaintext.txt	348	cells also studied ado aa alone
0.4228028.11741811.html.plaintext.txt	349	values means plus minus se cells studied condition n 40
0.4228028.11741811.html.plaintext.txt	350	concentrations pdeis microm 20 milrinone mil 20 rol 200 pap 5 zap 200 theophylline theo
0.4228028.11741811.html.plaintext.txt	351	discussion top abstract introduction methods results discussion references
0.4228028.11741811.html.plaintext.txt	352	report investigated cellular pathways utilized ado activate cftr dependent ion transport
0.4228028.11741811.html.plaintext.txt	353	using series experimental systems including single cells polarized cell monolayers vivo measurements cftr cftr mice demonstrated ado a2 ars activates cftr dependent halide transport
0.4228028.11741811.html.plaintext.txt	354	receptors expressed human airway cells signal part camp pka
0.4228028.11741811.html.plaintext.txt	355	also demonstrated dependence signaling pathway pla2 activity vitro vivo
0.4228028.11741811.html.plaintext.txt	356	finally showed two common disease associated cftr mutations activated a2b receptors alone f508 cftr using messenger pathways stimulated a2b receptors g551d cftr
0.4228028.11741811.html.plaintext.txt	357	results help establish physiological role ado stimulated cl secretion vivo may identify new targets improving function mutant cftr molecules
0.4228028.11741811.html.plaintext.txt	358	ado ubiquitous signaling molecule serving protean functions ranging regulation neurotransmission cardiovascular tone inflammation many organ systems
0.4228028.11741811.html.plaintext.txt	359	results together investigators indicate important role ado regulator cftr
0.4228028.11741811.html.plaintext.txt	360	ado a2 receptors potent activators cl secretion primary human airway cell monolayers addition canine gerbil airway cells t84 intestinal cells 28 46 59 70
0.4228028.11741811.html.plaintext.txt	361	systems cl secretion accomplished setting low camp levels
0.4228028.11741811.html.plaintext.txt	362	part high efficiency due compartmentalization a2b receptors transduction proteins cftr 34 71
0.4228028.11741811.html.plaintext.txt	363	results suggest addition spatial compartmentalization efficient transduction a2 receptors cftr involves cpla2 activation aa signaling
0.4228028.11741811.html.plaintext.txt	364	a2 receptors including a2a a2b subtypes classically signal stimulation adenylyl cyclase camp ultimately pka 56
0.4228028.11741811.html.plaintext.txt	365	although a2a receptors appear hold strictly observation a2b receptors shown stimulate additional signaling pathways phospholipase c direct regulation calcium channels experience pla2 26
0.4228028.11741811.html.plaintext.txt	366	observations particular interest recent studies 27 demonstrated abnormal lipid profiles including elevated aa levels murine cf tissues
0.4228028.11741811.html.plaintext.txt	367	findings demonstrate lipid signaling may important regulation cftr activity ado vitro vivo
0.4228028.11741811.html.plaintext.txt	368	present results therefore set stage future studies designed test relationship membrane lipid composition a2 receptors cftr activity
0.4228028.11741811.html.plaintext.txt	369	two general classes pla2 enzymes cpla2 three subtypes secretory pla2 seven subtypes 33
0.4228028.11741811.html.plaintext.txt	370	expressed many tissues including lung leukocytes
0.4228028.11741811.html.plaintext.txt	371	cpla2 translocates cell membranes activation primarily releases aa membrane lipids
0.4228028.11741811.html.plaintext.txt	372	cpla2 shown play important immunologic role human airway epithelial cells governing aa release epithelia immunostimulation 76
0.4228028.11741811.html.plaintext.txt	373	studies 50 also observed dysregulation pla2 cf airway increased aa release seen bradykinin exposure f508 cftr expressing airway cells compared normal control cells
0.4228028.11741811.html.plaintext.txt	374	aa parent molecule two important inflammatory signaling cascades including 1 cyclooxygenase cox pathway leads production prostanoids thromboxanes 2 lipoxygenase pathway aa metabolized 5 hydroperoxyeicosatetraenoic acid 5 hydroxyeicosatetraenoic acid leukotrienes a4 e4
0.4228028.11741811.html.plaintext.txt	375	clinical studies suggest products aa metabolism including proinflammatory species direct relevance cf related inflammation
0.4228028.11741811.html.plaintext.txt	376	cox 1 inhibitor ibuprofen routinely used pediatric cf population reduce lung inflammation slow progression cf lung disease 45
0.4228028.11741811.html.plaintext.txt	377	glucocorticoids suppress cox 2 expression also studied cf clinical trials attenuating decline pulmonary function pediatric cf patients 25
0.4228028.11741811.html.plaintext.txt	378	relevance aa signaling pathways cftr activity ion transport however previously demonstrated
0.4228028.11741811.html.plaintext.txt	379	results suggest buildup aa may beneficial effects cftr activity context activation surface receptors
0.4228028.11741811.html.plaintext.txt	380	mechanism a2 receptors activate cftr dependent cl transport complex
0.4228028.11741811.html.plaintext.txt	381	cftr activation a2 receptors could blocked either pka cpla2 inhibition fig
0.4228028.11741811.html.plaintext.txt	382	production camp reduced pla2 inhibition three cell lines fig
0.4228028.11741811.html.plaintext.txt	383	although 10 min high dose 100 microm aa exposure could stimulate camp production two airway cell lines primarily calu 3 cells likely actions distal metabolites pgi pge2 pgf2 pgd 73 failed augment camp production ado acutely activate cftr used alone cos 7 calu 3 cells fig
0.4228028.11741811.html.plaintext.txt	384	results suggest additional effects aa cftr dependent halide transport influences total cellular camp
0.4228028.11741811.html.plaintext.txt	385	rather a2 receptors appear activate adenylyl cyclase cpla2 parallel signaling pathway contributing maximization cftr activity
0.4228028.11741811.html.plaintext.txt	386	pla2 signaling necessary activate cftr receptors however 2 adrenergic stimulation activated cftr dependent cl transport vitro vivo despite cpla2 inhibition figs
0.4228028.11741811.html.plaintext.txt	387	figure 12 summary model provides three possible mechanisms cpla2 aa could contribute a2 receptor activation cftr
0.4228028.11741811.html.plaintext.txt	388	possible ado andor aa exerts effects part activating k channels increasing driving force halide efflux
0.4228028.11741811.html.plaintext.txt	389	aa shown stimulatory inhibitory effects epithelial k channels modulation basolateral k channel activity strongly influence transepithelial cl transport 20 21
0.4228028.11741811.html.plaintext.txt	390	related experiments ado activated halide efflux cftr expressing cos 7 cells reduced two k channel blockers including barium tetraethylammonium 10 mm 18 19
0.4228028.11741811.html.plaintext.txt	391	results suggest stimulatory effects ado cftr seen studies independent k channel activation
0.4228028.11741811.html.plaintext.txt	392	observation aa augmented stimulation cftr ado forskolin figs
0.4228028.11741811.html.plaintext.txt	393	5 11 failed stimulate cftr alone vitro fig
0.4228028.11741811.html.plaintext.txt	394	5 suggests aa may exert permissive effect cftr activation
0.4228028.11741811.html.plaintext.txt	395	membrane derived fatty acids including aa metabolites demonstrated interact ion channels influence activation signaling molecules including nucleotide sensitivity atp activated k channels 5 65 light sensitive transient receptor potential transient receptor potential like channels 14 small cl channels rabbit parietal cells 61 nicotinic acetylcholine receptor 9 calcium channels part oscillating calcium currents 51
0.4228028.11741811.html.plaintext.txt	396	aa interact cftr alter cl channel activity
0.4228028.11741811.html.plaintext.txt	397	cytoplasmic aa produces flickery block cftr inside membrane patches heterologous expression 1 35 47
0.4228028.11741811.html.plaintext.txt	398	membrane lipids including aa differential effects function channels stimulating channel activity one surface inhibiting channel activity 52
0.4228028.11741811.html.plaintext.txt	399	speculate aa one metabolites may interact external portion channel unidentified regulatory factor secondarily influences cftr cl channel function
0.4228028.11741811.html.plaintext.txt	400	alternatively products aa metabolism could accelerate local camp production way increase cftr channel activity
0.4228028.11741811.html.plaintext.txt	401	process would difficult detect total cellular assays quantitate camp
0.4228028.11741811.html.plaintext.txt	402	effect would need quite dramatic however g551d cftr previously shown poorly responsive powerful phosphorylating stimuli appears activated costimulation aa fig
0.4228028.11741811.html.plaintext.txt	403	occurs despite detectable change camp combined ado fig
0.4228028.11741811.html.plaintext.txt	404	6a pronounced combined pde inhibition
0.4228028.11741811.html.plaintext.txt	405	single channel based studies necessary help clarify mechanism cpla2 aa promote cftr activity
0.4228028.11741811.html.plaintext.txt	406	finally results exclude possibility additional processes may involved cpz shown effects cell signaling pathways addition pla2 8 12 23 43 57
0.4228028.11741811.html.plaintext.txt	407	view larger version 16k fig
0.4228028.11741811.html.plaintext.txt	408	three potential mechanisms a2 receptors signal cftr activation
0.4228028.11741811.html.plaintext.txt	409	ado stimulates a2 adenosine receptors a2 ar activate cpla2 adenylyl cyclase
0.4228028.11741811.html.plaintext.txt	410	aa products aa metabolism combined camp helped maximize cftr transport cl
0.4228028.11741811.html.plaintext.txt	411	mechanism could involve effects electrochemical driving force ion transport cftr
0.4228028.11741811.html.plaintext.txt	412	activation k channels direct effects lipid species cftr associated factors direct effects possibly increasing rate camp production vicinity cftr accelerated camp production
0.4228028.11741811.html.plaintext.txt	413	cox cyclooxygenase lo lipoxygenase
0.4228028.11741811.html.plaintext.txt	414	7 9 indicate ado potent cl secretagogue vivo activating cftr dependent cl transport across murine nasal mucosa predictably iso studied 100 microm
0.4228028.11741811.html.plaintext.txt	415	relevance human nasal pd protocols typically use 2 receptor stimulation iso aid detection cftr dependent cl transport
0.4228028.11741811.html.plaintext.txt	416	results suggest comparisons two receptor pathways human subjects may improve sensitivity nasal pd could implications clinical studies use assay measure low level cftr function
0.4228028.11741811.html.plaintext.txt	417	importance pla2 signaling ado activation cl transport also demonstrated vivo ado alb stimulated cl conductance sensitive pla2 inhibition
0.4228028.11741811.html.plaintext.txt	418	a2 receptor signaling may also useful improving activity disease related cftr mutations
0.4228028.11741811.html.plaintext.txt	419	using vitro system demonstrated cftr mutations three subclasses classes ii iii iv activated a2b receptors 17 figs
0.4228028.11741811.html.plaintext.txt	420	although expression levels mutant cftrs far higher found vivo results shown figs
0.4228028.11741811.html.plaintext.txt	421	10 11 support notion mutant cftrs localized cell membrane activated endogenous receptor based signaling pathways
0.4228028.11741811.html.plaintext.txt	422	current approaches increase mutant cftr activity including improvement cftr biosynthesis e
0.4228028.11741811.html.plaintext.txt	423	suppression premature stop mutations aminoglycoside antibiotics 7 15 75 increase trafficking f508 cftr cell membrane e
0.4228028.11741811.html.plaintext.txt	424	treatment butyrate compounds 60 treatment surface mutant cftrs activating compounds e
0.4228028.11741811.html.plaintext.txt	425	genistein pde inhibitors 38 68 may complemented use a2 receptor signaling pathways
0.4228028.11741811.html.plaintext.txt	426	findings also suggest common mutant cftrs least partially responsive signaling pathway available cell membrane
0.4228028.11741811.html.plaintext.txt	427	summary studies demonstrate a2b ars expressed cf normal airway cells localizing predominantly apical membrane polarized calu 3 cells
0.4228028.11741811.html.plaintext.txt	428	a2 receptors mediate activation cftr dependent cl transport vitro vivo utilizing cpla2 aa addition camp pka
0.4228028.11741811.html.plaintext.txt	429	ado a2 ars compare favorably agents activators cftr dependent cl conductance stimulating cl secretion better 2 adrenergic receptor agonist iso mice activating f508 cftr similar forskolin vitro
0.4228028.11741811.html.plaintext.txt	430	studies therefore provide rationale investigation effects ado a2 receptor signaling measured cl secretion humans
0.4228028.11741811.html.plaintext.txt	431	thank university alabama birmingham uab adult pediatric ear nose throat departments providing remnant human tissue immunocytochemical studies dr
0.4228028.11741811.html.plaintext.txt	432	zsuzsa bebok department internal medicine uab cystic fibrosis research center albert tousson uab imaging facilities core providing guidance immunocytochemistry experiments dr
0.4228028.11741811.html.plaintext.txt	433	kevin kirk helpful discussions regarding manuscript
0.4228028.11741811.html.plaintext.txt	434	work supported cystic fibrosis foundation grants clancy96lo r464 national institutes health grants r01 hl 67088 01 p50 dk 53090 p30 dk 54781
0.4228028.11741811.html.plaintext.txt	435	clancy cystic fibrosis foundation leroy matthews award recipient
0.4228028.11741811.html.plaintext.txt	436	address reprint requests correspondence j
0.4228028.11741811.html.plaintext.txt	437	pediatrics gregory fleming james cystic fibrosis research center 1600 7th ave
0.4228028.11741811.html.plaintext.txt	438	620 acc birmingham al 35233 e mail jclancyatpeds
0.4228028.11741811.html.plaintext.txt	439	costs publication article defrayed part payment page charges
0.4228028.11741811.html.plaintext.txt	440	article must therefore hereby marked advertisement accordance 18 u
0.4228028.11741811.html.plaintext.txt	441	section 1734 solely indicate fact
0.4228028.11741811.html.plaintext.txt	442	received 10 may 2001 accepted final form 12 september 2001
0.4228028.11741811.html.plaintext.txt	443	references top abstract introduction methods results discussion references
0.4228028.11741811.html.plaintext.txt	444	fatty acids inhibit apical membrane chloride channels airway epithelia
0.4228028.11741811.html.plaintext.txt	445	proc natl acad sci usa 87 7334 7338 1990abstract
0.4228028.11741811.html.plaintext.txt	446	involvement arachidonic acid chloride secretory response intestinal epithelial cells
0.4228028.11741811.html.plaintext.txt	447	j physiol cell physiol 264 c446 c452 1993abstractfree full text
0.4228028.11741811.html.plaintext.txt	448	barrett ke cohn ja huott pa wasserman si dharmsathaphorn k
0.4228028.11741811.html.plaintext.txt	449	immune related intestinal chloride secretion
0.4228028.11741811.html.plaintext.txt	450	effect adenosine t84 cell line
0.4228028.11741811.html.plaintext.txt	451	j physiol cell physiol 258 c902 c912 1990abstractfree full text
0.4228028.11741811.html.plaintext.txt	452	barrett ke huott pa shah ss dharmsathaphorn k wasserman si
0.4228028.11741811.html.plaintext.txt	453	differing effects apical basolateral adenosine colonic epithelial cell line t84
0.4228028.11741811.html.plaintext.txt	454	j physiol cell physiol 256 c197 c203 1989abstractfree full text
0.4228028.11741811.html.plaintext.txt	455	baukrowitz schulte u oliver d herlitze krauter tucker sj ruppersberg jp fakler b
0.4228028.11741811.html.plaintext.txt	456	pip2 pip determinants atp inhibition katp channels
0.4228028.11741811.html.plaintext.txt	457	science 282 1141 1144 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	458	becq f jensen tj chang xb savoia rommens jm tsui lc buchwald m riordan jr hanrahan jw
0.4228028.11741811.html.plaintext.txt	459	phosphatase inhibitors activate normal defective cftr chloride channels
0.4228028.11741811.html.plaintext.txt	460	proc natl acad sci usa 91 9160 9164 1994abstractfree full text
0.4228028.11741811.html.plaintext.txt	461	bedwell dm kaenjak benos dj bebok z bubien jk hong j tousson clancy jp sorscher ej
0.4228028.11741811.html.plaintext.txt	462	suppression cftr premature stop mutation bronchial epithelial cell line
0.4228028.11741811.html.plaintext.txt	463	nat med 3 1280 1284 1997isimedline
0.4228028.11741811.html.plaintext.txt	464	bhattacharyya d sen pc
0.4228028.11741811.html.plaintext.txt	465	effect binding chlorpromazine chloroquine ion transporting atpases
0.4228028.11741811.html.plaintext.txt	466	mol cell biochem 198 179 185 1999isimedline
0.4228028.11741811.html.plaintext.txt	467	bouzat cb barrantes fj
0.4228028.11741811.html.plaintext.txt	468	effects long chain fatty acids channel activity nicotinic acetylcholine receptor
0.4228028.11741811.html.plaintext.txt	469	receptors channels 1 251 258 1993isimedline
0.4228028.11741811.html.plaintext.txt	470	carson mr travis sm welsh mj
0.4228028.11741811.html.plaintext.txt	471	two nucleotide binding domains cystic fibrosis transmembrane conductance regulator cftr distinct functions controlling channel activity
0.4228028.11741811.html.plaintext.txt	472	j biol chem 270 1711 1717 1995abstractfree full text
0.4228028.11741811.html.plaintext.txt	473	cheng sh rich dp marshall j gregory rj welsh mj smith ae
0.4228028.11741811.html.plaintext.txt	474	phosphorylation r domain camp dependent protein kinase regulates cftr chloride channel
0.4228028.11741811.html.plaintext.txt	475	cell 66 1027 1036 1991isimedline
0.4228028.11741811.html.plaintext.txt	476	choi sy kim yh lee yk kim kt
0.4228028.11741811.html.plaintext.txt	477	chlorpromazine inhibits store operated calcium entry subsequent noradrenaline secretion pc12 cells
0.4228028.11741811.html.plaintext.txt	478	br j pharmacol 132 411 418 2001abstractfree full text
0.4228028.11741811.html.plaintext.txt	479	choukroun gj marshansky v gustafson ce mckee m hajjar rj rosenzweig brown d bonventre jv
0.4228028.11741811.html.plaintext.txt	480	cytosolic phospholipase a2 regulates golgi structure modulates intracellular trafficking membrane proteins
0.4228028.11741811.html.plaintext.txt	481	j clin invest 106 983 993 2000abstractfree full text
0.4228028.11741811.html.plaintext.txt	482	chyb raghu p hardie rc
0.4228028.11741811.html.plaintext.txt	483	polyunsaturated fatty acids activate drosophila light sensitive channels trp trpl
0.4228028.11741811.html.plaintext.txt	484	nature 397 255 259 1999isimedline
0.4228028.11741811.html.plaintext.txt	485	clancy jp bebok z ruiz fe king c jones j walker l greer h hong js wing l macaluso m lyrene r sorscher ej
0.4228028.11741811.html.plaintext.txt	486	evidence systemic gentamicin suppresses premature stop mutations patients cystic fibrosis
0.4228028.11741811.html.plaintext.txt	487	j respir crit care med 1163 1682 1692 2001
0.4228028.11741811.html.plaintext.txt	488	clancy jp hong js bebok z king sa demolombe bedwell dm sorscher ej
0.4228028.11741811.html.plaintext.txt	489	cystic fibrosis transmembrane conductance regulator cftr nucleotide binding domain 1 nbd 1 cftr truncated within nbd 1 target epithelial plasma membrane increase anion permeability
0.4228028.11741811.html.plaintext.txt	490	biochemistry 37 15222 15230 1998isimedline
0.4228028.11741811.html.plaintext.txt	491	clancy jp ruiz fe sorscher ej
0.4228028.11741811.html.plaintext.txt	492	adenosine nucleotides activate wild type r117h cftr a2b receptor coupled pathway
0.4228028.11741811.html.plaintext.txt	493	j physiol cell physiol 276 c361 c369 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	494	cobb br bebok z hong j king c sorscher ej clancy jp
0.4228028.11741811.html.plaintext.txt	495	wildtype g551d cftr activation a2b adenosine receptors phosphodiesterase pde inhibitors camp cftr activity abstract
0.4228028.11741811.html.plaintext.txt	496	pediatr pulmonol suppl 19 171 1999
0.4228028.11741811.html.plaintext.txt	497	cobb br hong j clancy jp
0.4228028.11741811.html.plaintext.txt	498	pla2 signaling governs a2b adenosine receptor activation cftr abstract
0.4228028.11741811.html.plaintext.txt	499	pediatr pulmonol suppl 20 191 2000
0.4228028.11741811.html.plaintext.txt	500	modulation k channels arachidonic acid t84 cells
0.4228028.11741811.html.plaintext.txt	501	inhibition ca2 dependent k channel
0.4228028.11741811.html.plaintext.txt	502	j physiol cell physiol 274 c138 c148 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	503	modulation k channels arachidonic acid t84 cells
0.4228028.11741811.html.plaintext.txt	504	activation ca2 independent k channel
0.4228028.11741811.html.plaintext.txt	505	j physiol cell physiol 274 c149 c160 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	506	devor dc singh ak lambert lc deluca frizzell ra bridges rj
0.4228028.11741811.html.plaintext.txt	507	bicarbonate chloride secretion calu 3 human airway epithelial cells
0.4228028.11741811.html.plaintext.txt	508	j gen physiol 113 743 760 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	509	effects treatment haloperidol chlorpromazine clozapine protein kinase c pkc phosphoinositide specific phospholipase c pi plc activity mrna protein expression pkc plc isozymes rat brain
0.4228028.11741811.html.plaintext.txt	510	j pharmacol exp ther 291 688 704 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	511	eidelman o guay broder c van galen pj jacobson ka fox c turner rj cabantchik zi pollard hb
0.4228028.11741811.html.plaintext.txt	512	a1 adenosine receptor antagonists activate chloride efflux cystic fibrosis cells
0.4228028.11741811.html.plaintext.txt	513	proc natl acad sci usa 89 5562 5566 1992abstract
0.4228028.11741811.html.plaintext.txt	514	eigen h rosenstein bj fitzsimmons schidlow dv
0.4228028.11741811.html.plaintext.txt	515	multicenter study alternate day prednisone therapy patients cystic fibrosis
0.4228028.11741811.html.plaintext.txt	516	cystic fibrosis foundation prednisone trial group
0.4228028.11741811.html.plaintext.txt	517	j pediatr 126 515 523 1995isimedline
0.4228028.11741811.html.plaintext.txt	518	feoktistov polosa r holgate st biaggioni
0.4228028.11741811.html.plaintext.txt	519	adenosine a2b receptors novel therapeutic target asthma trends pharmacol sci 19 148 152 1998isimedline
0.4228028.11741811.html.plaintext.txt	520	freedman sd katz mh parker em laposata m urman alvarez jg
0.4228028.11741811.html.plaintext.txt	521	membrane lipid imbalance plays role phenotypic expression cystic fibrosis cftr mice
0.4228028.11741811.html.plaintext.txt	522	proc natl acad sci usa 96 13995 14000 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	523	furukawa m ikeda k oshima suzuki h yamaya m sasaki h takasaka
0.4228028.11741811.html.plaintext.txt	524	a2 adenosine receptors mongolian gerbil middle ear epithelium regulation cl secretion
0.4228028.11741811.html.plaintext.txt	525	acta physiol scand 163 103 112 1998isimedline
0.4228028.11741811.html.plaintext.txt	526	grubb br vick rn boucher rc
0.4228028.11741811.html.plaintext.txt	527	hyperabsorption na raised ca2 mediated cl secretion nasal epithelia cf mice
0.4228028.11741811.html.plaintext.txt	528	j physiol cell physiol 266 c1478 c1483 1994abstractfree full text
0.4228028.11741811.html.plaintext.txt	529	guay broder c jacobson ka barnoy cabantchik zi guggino wb zeitlin pl turner rj vergara l eidelman o pollard hb
0.4228028.11741811.html.plaintext.txt	530	a1 receptor antagonist 8 cyclopentyl 13 dipropylxanthine selectively activates chloride efflux human epithelial mouse fibroblast cell lines expressing cystic fibrosis transmembrane regulator delta f508 mutation
0.4228028.11741811.html.plaintext.txt	531	biochemistry 34 9079 9087 1995isimedline
0.4228028.11741811.html.plaintext.txt	532	hall ra ostedgaard ls premont rt blitzer jt rahman n welsh mj lefkowitz rj
0.4228028.11741811.html.plaintext.txt	533	c terminal motif found 2 adrenergic receptor p2y1 receptor cystic fibrosis transmembrane conductance regulator determines binding nah exchanger regulatory factor family pdz proteins
0.4228028.11741811.html.plaintext.txt	534	proc natl acad sci usa 95 8496 8501 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	535	hallows kr raghuram v kemp witters la foskett jk
0.4228028.11741811.html.plaintext.txt	536	inhibition cystic fibrosis transmembrane conductance regulator novel interaction metabolic sensor amp activated protein kinase
0.4228028.11741811.html.plaintext.txt	537	j clin invest 105 1711 1721 2000abstractfree full text
0.4228028.11741811.html.plaintext.txt	538	heller koch schmeck j van ackern k
0.4228028.11741811.html.plaintext.txt	539	lipid mediators inflammatory disorders
0.4228028.11741811.html.plaintext.txt	540	drugs 55 487 496 1998isimedline
0.4228028.11741811.html.plaintext.txt	541	huang p trotter k boucher rc milgram sl stutts mj
0.4228028.11741811.html.plaintext.txt	542	pka holoenzyme functionally coupled cftr akaps
0.4228028.11741811.html.plaintext.txt	543	j physiol cell physiol 278 c417 c422 2000abstractfree full text
0.4228028.11741811.html.plaintext.txt	544	hwang tc guggino se guggino wb
0.4228028.11741811.html.plaintext.txt	545	direct modulation secretory chloride channels arachidonic cis unsaturated fatty acids
0.4228028.11741811.html.plaintext.txt	546	proc natl acad sci usa 87 5706 5709 1990abstract
0.4228028.11741811.html.plaintext.txt	547	hwang tc nagel g nairn ac gadsby dc
0.4228028.11741811.html.plaintext.txt	548	regulation gating cystic fibrosis transmembrane conductance regulator cl channels phosphorylation atp hydrolysis
0.4228028.11741811.html.plaintext.txt	549	proc natl acad sci usa 91 4698 4702 1994abstract
0.4228028.11741811.html.plaintext.txt	550	illek b tam aw fischer h machen te
0.4228028.11741811.html.plaintext.txt	551	anion selectivity apical membrane conductance calu 3 human airway epithelium
0.4228028.11741811.html.plaintext.txt	552	pflugers arch 437 812 822 1999isimedline
0.4228028.11741811.html.plaintext.txt	553	illek b zhang l lewis nc moss rb dong jy fischer h
0.4228028.11741811.html.plaintext.txt	554	defective function cystic fibrosis causing missense mutation g551d recovered genistein
0.4228028.11741811.html.plaintext.txt	555	j physiol cell physiol 277 c833 c839 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	556	jacobson ka galen pjm adenosine receptors pharmacology structure activity relationships therapeutic potential
0.4228028.11741811.html.plaintext.txt	557	j med chem 35 407 422 1992isimedline
0.4228028.11741811.html.plaintext.txt	558	kelley tj al nakkash l cotton cu drumm ml
0.4228028.11741811.html.plaintext.txt	559	activation endogenous f508 cystic fibrosis transmembrane conductance regulator phosphodiesterase inhibition
0.4228028.11741811.html.plaintext.txt	560	j clin invest 98 513 520 1996abstractfree full text
0.4228028.11741811.html.plaintext.txt	561	kelley tj al nakkash l drumm ml
0.4228028.11741811.html.plaintext.txt	562	cftr mediated chloride permeability regulated type iii phosphodiesterases airway epithelial cells
0.4228028.11741811.html.plaintext.txt	563	j respir cell mol biol 13 657 664 1995abstract
0.4228028.11741811.html.plaintext.txt	564	kelley tj thomas k milgram lj drumm ml
0.4228028.11741811.html.plaintext.txt	565	vivo activation cystic fibrosis transmembrane conductance regulator mutant deltaf508 murine nasal epithelium
0.4228028.11741811.html.plaintext.txt	566	proc natl acad sci usa 94 2604 2608 1997abstractfree full text
0.4228028.11741811.html.plaintext.txt	567	khan sz dyer jl michelangeli f
0.4228028.11741811.html.plaintext.txt	568	inhibition type 1 inositol 145 trisphosphate sensitive ca2 channel calmodulin antagonists
0.4228028.11741811.html.plaintext.txt	569	cell signal 13 57 63 2001isimedline
0.4228028.11741811.html.plaintext.txt	570	knowles mr paradiso boucher rc
0.4228028.11741811.html.plaintext.txt	571	vivo nasal potential difference techniques protocols assessing efficacy gene transfer cystic fibrosis
0.4228028.11741811.html.plaintext.txt	572	hum gene ther 6 445 455 1995isimedline
0.4228028.11741811.html.plaintext.txt	573	konstan mw byard pj hoppel cl davis pb
0.4228028.11741811.html.plaintext.txt	574	effect high dose ibuprofen patients cystic fibrosis
0.4228028.11741811.html.plaintext.txt	575	n engl j med 332 848 854 1995abstractfree full text
0.4228028.11741811.html.plaintext.txt	576	lazarowski er mason sj clarke l harden tk boucher rc
0.4228028.11741811.html.plaintext.txt	577	adenosine receptors human airway epithelia relationship chloride secretion
0.4228028.11741811.html.plaintext.txt	578	br j pharmacol 106 774 782 1992abstract
0.4228028.11741811.html.plaintext.txt	579	inhibition cystic fibrosis transmembrane conductance regulator chloride channel currents arachidonic acid
0.4228028.11741811.html.plaintext.txt	580	j physiol pharmacol 78 490 499 2000isimedline
0.4228028.11741811.html.plaintext.txt	581	madara jl patapoff tw gillece castro b colgan sp parkos ca delp c mrsny rj
0.4228028.11741811.html.plaintext.txt	582	5 adenosine monophosphate neutrophil derived paracrine factor elicits chloride secretion t84 intestinal epithelial cell monolayers
0.4228028.11741811.html.plaintext.txt	583	j clin invest 91 2320 2325 1993isimedline
0.4228028.11741811.html.plaintext.txt	584	matsui h grubb br tarran r randell sh gatzy jt davis cw boucher rc
0.4228028.11741811.html.plaintext.txt	585	evidence periciliary liquid layer depletion abnormal ion composition pathogenesis cystic fibrosis airways disease
0.4228028.11741811.html.plaintext.txt	586	cell 95 1005 1015 1998isimedline
0.4228028.11741811.html.plaintext.txt	587	miele l cordella miele e xing m frizzell r mukherjee ab
0.4228028.11741811.html.plaintext.txt	588	cystic fibrosis gene mutation f508 associated intrinsic abnormality ca2 induced arachidonic acid release epithelial cells
0.4228028.11741811.html.plaintext.txt	589	dna cell biol 16 749 759 1997isimedline
0.4228028.11741811.html.plaintext.txt	590	mignen o shuttleworth tj
0.4228028.11741811.html.plaintext.txt	591	iarc novel arachidonate regulated noncapacitative ca2 entry channel
0.4228028.11741811.html.plaintext.txt	592	j biol chem 275 9114 9119 2000abstractfree full text
0.4228028.11741811.html.plaintext.txt	593	mochizuki oda n negishi m mori k ito
0.4228028.11741811.html.plaintext.txt	594	arachidonic acid activates cation channels bovine adrenal chromaffin cells
0.4228028.11741811.html.plaintext.txt	595	j neurochem 61 1882 1890 1993isimedline
0.4228028.11741811.html.plaintext.txt	596	moon singh m krouse wine jj
0.4228028.11741811.html.plaintext.txt	597	calcium stimulated cl secretion calu 3 human airway cells requires cftr
0.4228028.11741811.html.plaintext.txt	598	j physiol lung cell mol physiol 273 l1208 l1219 1997abstractfree full text
0.4228028.11741811.html.plaintext.txt	599	moyer bd denton j karlson kh reynolds d wang mickle je milewski m cutting gr guggino wb li m stanton ba
0.4228028.11741811.html.plaintext.txt	600	pdz interacting domain cftr apical membrane polarization signal
0.4228028.11741811.html.plaintext.txt	601	j clin invest 104 1353 1361 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	602	naren ap cormet boyaka e fu j villain m blalock je quick mw kirk kl
0.4228028.11741811.html.plaintext.txt	603	cftr chloride channel regulation interdomain interaction
0.4228028.11741811.html.plaintext.txt	604	science 286 544 548 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	605	adenosine receptor subtypes characterization therapeutic regulation
0.4228028.11741811.html.plaintext.txt	606	annu rev pharmacol toxicol 35 581 606 1995isimedline
0.4228028.11741811.html.plaintext.txt	607	park bae choi kang b kim k
0.4228028.11741811.html.plaintext.txt	608	inhibition nicotinic acetylcholine receptors calcium channels clozapine bovine adrenal chromaffin cells
0.4228028.11741811.html.plaintext.txt	609	biochem pharmacol 61 1011 1019 2001isimedline
0.4228028.11741811.html.plaintext.txt	610	pilewski j frizzell ra
0.4228028.11741811.html.plaintext.txt	611	role cftr airway disease
0.4228028.11741811.html.plaintext.txt	612	physiol rev 79 suppl 1 s215 s255 1999medline
0.4228028.11741811.html.plaintext.txt	613	pratt ad clancy g welsh mj
0.4228028.11741811.html.plaintext.txt	614	mucosal adenosine stimulates chloride secretion canine tracheal epithelium
0.4228028.11741811.html.plaintext.txt	615	j physiol cell physiol 251 c167 c174 1986abstractfree full text
0.4228028.11741811.html.plaintext.txt	616	rubenstein rc zeitlin pl
0.4228028.11741811.html.plaintext.txt	617	pilot clinical trial oral sodium 4 phenylbutyrate buphenyl f508 homozygous cystic fibrosis patients partial restoration nasal epithelial cftr function
0.4228028.11741811.html.plaintext.txt	618	j respir crit care med 157 484 490 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	619	sakai h okada y morii m takeguchi n
0.4228028.11741811.html.plaintext.txt	620	arachidonic acid prostaglandin e2 activate small conductance cl channels basolateral membrane rabbit parietal cells
0.4228028.11741811.html.plaintext.txt	621	j physiol lond 448 293 306 1992abstract
0.4228028.11741811.html.plaintext.txt	622	schultz bd frizzell ra bridges rj
0.4228028.11741811.html.plaintext.txt	623	rescue dysfunctional f508 cftr chloride channel activity ibmx
0.4228028.11741811.html.plaintext.txt	624	j membr biol 170 51 66 1999isimedline
0.4228028.11741811.html.plaintext.txt	625	schultz bd singh ak devor dc bridges rj
0.4228028.11741811.html.plaintext.txt	626	pharmacology cftr chloride channel activity
0.4228028.11741811.html.plaintext.txt	627	physiol rev 79 s109 s144 1999medline
0.4228028.11741811.html.plaintext.txt	628	short db trotter kw reczek d kreda sm bretscher boucher rc stutts mj milgram sl
0.4228028.11741811.html.plaintext.txt	629	apical pdz protein anchors cystic fibrosis transmembrane conductance regulator cytoskeleton
0.4228028.11741811.html.plaintext.txt	630	j biol chem 273 19797 19801 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	631	membrane phospholipid control nucleotide sensitivity katp channels
0.4228028.11741811.html.plaintext.txt	632	science 282 1138 1141 1998abstractfree full text
0.4228028.11741811.html.plaintext.txt	633	singh m krouse m moon wine jj
0.4228028.11741811.html.plaintext.txt	634	basal isc calu 3 human airway cells bicarbonate dependent cl secretion
0.4228028.11741811.html.plaintext.txt	635	j physiol lung cell mol physiol 272 l690 l698 1997abstractfree full text
0.4228028.11741811.html.plaintext.txt	636	smith jj travis sm greenberg ep welsh mj
0.4228028.11741811.html.plaintext.txt	637	cystic fibrosis airway epithelia fail kill bacteria abnormal airway surface fluid
0.4228028.11741811.html.plaintext.txt	638	cell 85 229 236 1996isimedline
0.4228028.11741811.html.plaintext.txt	639	smith sn middleton pg chadwick jaffe bush ka rolleston farley r delaney sj wainwright b geddes dm alton ew
0.4228028.11741811.html.plaintext.txt	640	vivo effects milrinone airways cystic fibrosis mice human subjects
0.4228028.11741811.html.plaintext.txt	641	j respir cell mol biol 20 129 134 1999abstractfree full text
0.4228028.11741811.html.plaintext.txt	642	snouwaert jn brigman kk latour malouf nn boucher rc smithies o koller bh
0.4228028.11741811.html.plaintext.txt	643	animal model cystic fibrosis made gene targeting
0.4228028.11741811.html.plaintext.txt	644	science 257 1083 1088 1992isimedline
0.4228028.11741811.html.plaintext.txt	645	strohmeier gr reppert sm lencer wi madara jl
0.4228028.11741811.html.plaintext.txt	646	a2b adenosine receptor mediates camp responses adenosine receptor agonists human intestinal epithelia
0.4228028.11741811.html.plaintext.txt	647	j biol chem 270 2387 2394 1995abstractfree full text
0.4228028.11741811.html.plaintext.txt	648	sun f hug mj bradbury na frizzell ra
0.4228028.11741811.html.plaintext.txt	649	protein kinase associates cystic fibrosis transmembrane conductance regulator via interaction ezrin
0.4228028.11741811.html.plaintext.txt	650	j biol chem 275 14360 14366 2000abstractfree full text
0.4228028.11741811.html.plaintext.txt	651	phosphodiesterase isozymes molecular targets novel antiasthma agents
0.4228028.11741811.html.plaintext.txt	652	j respir crit care med 157 351 370 1998free full text
0.4228028.11741811.html.plaintext.txt	653	versteeg hh van bergen en henegouwen pm van deventer sj peppelenbosch mp
0.4228028.11741811.html.plaintext.txt	654	cyclooxygenase dependent signaling molecular events consequences
0.4228028.11741811.html.plaintext.txt	655	febs lett 445 1 5 1999isimedline
0.4228028.11741811.html.plaintext.txt	656	welsh mj boat tf tsui l c beaudet al
0.4228028.11741811.html.plaintext.txt	657	metabolic basis inherited disease edited scriver cr beaudet al sly ws valle d
0.4228028.11741811.html.plaintext.txt	658	new york mcgraw hill 1995 p
0.4228028.11741811.html.plaintext.txt	659	wilschanski m famini c blau h rivlin j augarten avital kerem b kerem e
0.4228028.11741811.html.plaintext.txt	660	pilot study effect gentamicin nasal potential difference measurements cystic fibrosis patients carrying stop mutations
0.4228028.11741811.html.plaintext.txt	661	j respir crit care med 161 860 865 2000abstractfree full text
0.4228028.11741811.html.plaintext.txt	662	wu levine sj cowan m logun c angus cw shelhamer jh
0.4228028.11741811.html.plaintext.txt	663	antisense inhibition 85 kda cpla2 blocks arachidonic acid release airway epithelial cells
0.4228028.11741811.html.plaintext.txt	664	j physiol lung cell mol physiol 273 l331 l338 1997abstractfree full text
0.4228028.11741811.html.plaintext.txt	665	yang y devor dc engelhardt jf ernst sa strong tv collins fs cohn ja frizzell ra wilson jm
0.4228028.11741811.html.plaintext.txt	666	molecular basis defective anion transport l cells expressing recombinant forms cftr
0.4228028.11741811.html.plaintext.txt	667	hum mol genet 2 1253 1261 1993abstract
0.4228028.11741811.html.plaintext.txt	668	j physiol lung cell mol physiol 2821l12 l25 1040 060502 5
0.4228028.11741811.html.plaintext.txt	669	00 copyright 2002 american physiological society
0.41600177.11504857.html.plaintext.txt	0	combined analysis cystic fibrosis transmembrane conductance regulator implications structure disease models jian min chen chris cutler caroline jacques gilles buf erick denamur guillaume lecointre bernard mercier gordon cramb claude ferec
0.41600177.11504857.html.plaintext.txt	1	institut national de la sante et de la recherche medicale emi 01 15 etablissement francais du sang bretagne universite de bretagne occidentale centre hospitalier universitaire brest france school biology university saint andrews saint andrews fife scotland laboratoire de biochimie biologie moleculaire chu angers angers france observatoire oceanologique universite pierre et marie curiecentre national de la recherche scientifique banyuls sur mer france institut national de la sante et de la recherche medicale u458 hopital robert debre paris france service de systematique moleculaire museum national dhistoire naturelle paris france
0.41600177.11504857.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion conclusions acknowledgements references past decade nearly 1000 variants identified cystic fibrosis transmembrane conductance regulator cftr gene classic atypical cystic fibrosis cf patients worldwide enormous wealth information concerning structure function protein also accumulated
0.41600177.11504857.html.plaintext.txt	3	data evaluated together sequence comparison currently available cftr homologs likely refine global structure function relationship protein turn facilitate interpretation identified mutations gene
0.41600177.11504857.html.plaintext.txt	4	based combined analysis recently defined functional r domain cftr protein
0.41600177.11504857.html.plaintext.txt	5	first presenting two full length cdna sequences termed scftr scftr ii atlantic salmon salmo salar additional partial coding sequence eastern gray kangaroo macropus giganteus study went refine boundaries two nucleotide binding domains nbds cooh terminal tail c tail wherein nbd1 defined going p439 g646 nbd2 going a1225 e1417 c tail going e1418 l1480
0.41600177.11504857.html.plaintext.txt	6	approach also provided insights differential roles two halves cftr highlighted several well conserved motifs may involved inter intramolecular interactions
0.41600177.11504857.html.plaintext.txt	7	moreover serious concern certain fraction missense mutations identified cftr gene may functional consequences raised
0.41600177.11504857.html.plaintext.txt	8	finally phylogenetic analysis full length cftr amino acid sequences extended set exon 13 coding nucleotide sequences reinforced idea rabbit may represent better cf model mouse strengthened assertion long branch attraction artifact separates murine rodents rabbit guinea pig glires
0.41600177.11504857.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion conclusions acknowledgements references cystic fibrosis cf online mendelian inheritance man omim 219700 common lethal autosomal recessive disease caucasian population caused mutations cystic fibrosis transmembrane conductance regulator cftr omim 602421 gene kerem et al
0.41600177.11504857.html.plaintext.txt	10	encoded 1480 amino acid protein functions mainly chloride selective ion channel composed two structurally homologous halves half consisting membrane spanning domain msd nucleotide binding domain nbd two halves linked unique regulatory r domain
0.41600177.11504857.html.plaintext.txt	11	msds contribute formation chloride selective pore nbds bind hydrolyze atp regulate channel gating r domain phosphorylation controls channel activity reviews see gadsby nairn 1999 sheppard welsh 1999
0.41600177.11504857.html.plaintext.txt	12	addition increasing evidence cftr affect transport ions including hco 3 choi et al
0.41600177.11504857.html.plaintext.txt	13	cloning cftr riordan et al
0.41600177.11504857.html.plaintext.txt	14	1989 promoted extensive research activities two interrelated aspects first identification cftr mutations classic atypical cf patients second elucidation functional role cftr normal diseased states past decade
0.41600177.11504857.html.plaintext.txt	15	however screening cftr mutations become purely molecular pursuit currently nearly 1000 dna variants gene deposited cf mutation data base httpwww
0.41600177.11504857.html.plaintext.txt	16	cacftr principal challenge interpretation events terms likely medical consequences
0.41600177.11504857.html.plaintext.txt	17	especially case vast number missense mutations 40 rare even private
0.41600177.11504857.html.plaintext.txt	18	formidable nature situation lies large size complexity gene importantly complex multidomain structure protein
0.41600177.11504857.html.plaintext.txt	19	although functional analysis unfortunately still routinely available continue used bridge gap complemented strategies
0.41600177.11504857.html.plaintext.txt	20	regard impact comparative sequence analysis tremendous
0.41600177.11504857.html.plaintext.txt	21	even originally proposed cftr structure proved remarkably prescient largely based comparison human cftr number atp binding cassette abc family members riordan et al
0.41600177.11504857.html.plaintext.txt	22	furthermore cross species sequence comparisons small number cftr homologs available early 1990s highlighted identified mutations occurred evolutionary conserved residues diamond et al
0.41600177.11504857.html.plaintext.txt	23	1991 tucker tannahill higgins 1992
0.41600177.11504857.html.plaintext.txt	24	early necessarily limited analyses clearly demonstrated importance evolutionary information interpreting effects mutations also frequently taken account design functional studies
0.41600177.11504857.html.plaintext.txt	25	therefore large number missense mutations identified human cftr abundance structural functional analysis data accumulated past decade evaluated together context sequence comparison currently available cftr orthologs allow significantly improved refinement domain structure cftr
0.41600177.11504857.html.plaintext.txt	26	turn facilitate interpretation identified mutations
0.41600177.11504857.html.plaintext.txt	27	central thesis work represents attempt towards end already large number cftr orthologs expanded determination sequences two full length cftr orthologous isoforms single teleost fish species atlantic salmon salmo salar
0.41600177.11504857.html.plaintext.txt	28	availability newly expanded number cftr sequences also offered opportunity reevaluate use mouse models cf studies phylogenetic point view check whether paraphyly glires lagomorpha rodentia determined using cftr sequences reliable simply result long branch attraction artifact long rodent branch divergent outgroup xenopus vuillaumier et al
0.41600177.11504857.html.plaintext.txt	29	regard partial coding sequence eastern gray kangaroo macropus giganteus marsupial mammal whose divergence time placental mammals 120 myr also produced order determine whether outgroup long branch attraction artifact existed
0.41600177.11504857.html.plaintext.txt	30	materials methods top abstract introduction materials methods results discussion conclusions acknowledgements references cloning atlantic salmon
0.41600177.11504857.html.plaintext.txt	31	salar cftr cdnas gill tissues atlantic salmon adapted seawater least 2 weeks used mrna preparation
0.41600177.11504857.html.plaintext.txt	32	first strand cdna subsequently synthesized using moloney murine leukemia virus reverse transcriptase clontech palo alto calif
0.41600177.11504857.html.plaintext.txt	33	three steps taken isolate salmon cftr cdnas polymerase chain reaction pcr
0.41600177.11504857.html.plaintext.txt	34	first three pairs inosine containing degenerate oligonucleotide primers sense 5 tttc ggic cttic caic cagct actic ggic atg caag atg acg 3 antisense 5 agtc icaag icaag agta icaag agtc icgc agtc ct tt agta 3 sense 5 gcic ictic tatc aaag gatc gcic gatc cttic tatc ctt 3 antisense 5 tgg ttc ctct ttc cgc atgtct gac ati actc tt 3 sense 5 tatc tttc gaag acic tctic tttc catc aaag gc 3 antisense 5 aagag cac atic aagtc tgtc ttag tgic ccag 3 targeted highly conserved regions cftr gene based published cftr sequences synthesized used generate candidate pcr fragments
0.41600177.11504857.html.plaintext.txt	35	second specific cftr fragment obtained new specific primers designed pcr fragments amplified
0.41600177.11504857.html.plaintext.txt	36	efforts generated two sets three overlapping clones covering salmon cftr coding sequence
0.41600177.11504857.html.plaintext.txt	37	finally remaining translated 5 3 untranslated regions utrs two cdnas obtained using 53 rapid amplification cdna ends race kit boehringer mannheim mannheim germany similar marathon cdna cloning kit clontech utilizing isoform specific primers
0.41600177.11504857.html.plaintext.txt	38	cloning cftr exon 13 coding sequence eastern gray kangaroo m
0.41600177.11504857.html.plaintext.txt	39	giganteus determine possible presence long branch attraction artifact long rodent branch divergent outgroup xenopus vuillaumier et al
0.41600177.11504857.html.plaintext.txt	40	1997 also maximize refinement boundaries nbd1 r domain cloning coding sequence exon 13 largest exon cftr gene eastern gray kangaroo undertaken
0.41600177.11504857.html.plaintext.txt	41	pair degenerate oligonucleotide primers sense 5 tgt itct tgct aaa cttga atg gcti aagc aaa ac 3 antisense 5 ctct tcaga agtc tctc ttc agtt atat itc ttc 3 targeted highly conserved sequences published cftr homologs end exon 13 respectively synthesized
0.41600177.11504857.html.plaintext.txt	42	genomic dna used pcr amplification
0.41600177.11504857.html.plaintext.txt	43	dna sequencing pcr products purified centricon 100 millipore bedford mass
0.41600177.11504857.html.plaintext.txt	44	cloned pgem vector promega madison wis
0.41600177.11504857.html.plaintext.txt	45	double stranded dna sequenced using combination specific primers vector specific t7sp6 primers strands using abi prism bigdye terminator cycle sequencing kit pe applied biosystems foster city calif
0.41600177.11504857.html.plaintext.txt	46	multiple sequence alignments full length cftr sequences collated genbank swissprot
0.41600177.11504857.html.plaintext.txt	47	order refine boundaries nbd1 several partial sequences also collated
0.41600177.11504857.html.plaintext.txt	48	multiple sequence alignments first performed clustal w httpwww2
0.41600177.11504857.html.plaintext.txt	49	alignment corrected eye using must philippe 1993 order take account similarities chemical properties amino acid side chains
0.41600177.11504857.html.plaintext.txt	50	missense mutations single amino acid deletion mutations missense mutations single amino acid deletions cf mutation data base httpwww
0.41600177.11504857.html.plaintext.txt	51	phylogenetic analysis two cftr sequence data sets utilized phylogenetic analysis
0.41600177.11504857.html.plaintext.txt	52	one used 17 exon 13 coding nucleotide sequences provided 543 positions 343 informative parsimony
0.41600177.11504857.html.plaintext.txt	53	contained 16 full length cftr amino acid sequences 1544 positions among 771 informative parsimony
0.41600177.11504857.html.plaintext.txt	54	phylogenetic analysis performed principally using branch bound search paup swofford 1999
0.41600177.11504857.html.plaintext.txt	55	check impact suspected artifact tree reconstruction method trees also reconstructed using uncorrected distances corrected distances kimura 1983 neighbor joining approach saitou nei 1987 using must package philippe 1993
0.41600177.11504857.html.plaintext.txt	56	moreover absolute mutational saturation tested plotting pairwise observed differences pairwise inferred substitutions parsimonious tree using paup must
0.41600177.11504857.html.plaintext.txt	57	saturation detected either nucleotide amino acid data set
0.41600177.11504857.html.plaintext.txt	58	statistical robustness nodes 1000 bootstrap replicates generated bremer 1994 supports calculated using paup
0.41600177.11504857.html.plaintext.txt	59	results discussion top abstract introduction materials methods results discussion conclusions acknowledgements references isolation characterization two distinct cdnas encoding salmon cftr atlantic salmon interest two reasons
0.41600177.11504857.html.plaintext.txt	60	first salmon capable adapting rapidly freshwater seawater buf 1993 presumed unique phenomenon osmoregulation associated expression cftr homolog
0.41600177.11504857.html.plaintext.txt	61	second salmon distantly related humans already analyzed organisms including mice tata et al
0.41600177.11504857.html.plaintext.txt	62	1991 dogfish marshall et al
0.41600177.11504857.html.plaintext.txt	63	1991 rats fiedler nemecz shull 1992 frogs tucker tannahill higgins 1992 price et al
0.41600177.11504857.html.plaintext.txt	64	1996 sheep tebbutt et al
0.41600177.11504857.html.plaintext.txt	65	candidate pcr fragments generated salmon gill tissue using degenerate oligonucleotide primers
0.41600177.11504857.html.plaintext.txt	66	many rounds cloning sequencing sequence aligning particularly complicated unexpected presence two highly homologous clearly different sequences two cftr transcripts finally obtained
0.41600177.11504857.html.plaintext.txt	67	sequence accuracy two transcripts ensured isoform specific pcr amplifications using cdna samples prepared individual salmon
0.41600177.11504857.html.plaintext.txt	68	general properties two transcripts designated scftr genbank accession number af155237 scftr ii genbank accession number af161070 respectively summarized table 1
0.41600177.11504857.html.plaintext.txt	69	although guarantee 5 utr sequence complete 3 utr sequence considered complete due presence polya addition signal sequence 16 bp scftr 12 bp scftr ii upstream polya tail
0.41600177.11504857.html.plaintext.txt	70	view table table 1 comparison scftr scftr ii transcripts
0.41600177.11504857.html.plaintext.txt	71	possibility scftr scftr ii genes represented two unique isoforms rather allelic variants first indicated sequences
0.41600177.11504857.html.plaintext.txt	72	nucleotide level scftr scftr ii share level sequence identity high 93
0.41600177.11504857.html.plaintext.txt	73	2 coding region significantly lower homology 5 3 utrs
0.41600177.11504857.html.plaintext.txt	74	110 bp nucleotides immediately upstream translation start site 64
0.41600177.11504857.html.plaintext.txt	75	0 identical 3 utr 71
0.41600177.11504857.html.plaintext.txt	76	amino acid level significantly lower sequence identity observed r domain 85
0.41600177.11504857.html.plaintext.txt	77	0 domain structure accordance riordan et al
0.41600177.11504857.html.plaintext.txt	78	given wide support recent vivo expression data although scftr expression scftr ii expression shown increase gill following abrupt seawater exposure pattern temporal expression gene considerably different singer et al
0.41600177.11504857.html.plaintext.txt	79	moreover existence two different genes encoding product entirely surprising many fish species including salmonids hordvik 1998 undergone tetraploidization events evolutionary histories duplication certain hormone genes e
0.41600177.11504857.html.plaintext.txt	80	takeo yamashita 1999 ion water transporter genes cutler et al
0.41600177.11504857.html.plaintext.txt	81	2000 unpublished data certain fishes reported
0.41600177.11504857.html.plaintext.txt	82	furthermore also circumstantial evidence suggesting presence two cftr genes another teleost fish killifish two transcripts two polypeptides detected gill northern blotting singer et al
0.41600177.11504857.html.plaintext.txt	83	1998 western blotting mickle cutting 2000 respectively
0.41600177.11504857.html.plaintext.txt	84	observations taken together strongly suggest scftr scftr ii represent different isoforms presence duplicate cftr isoforms may general phenomenon teleost fish species
0.41600177.11504857.html.plaintext.txt	85	although phylogenetic analysis indicates duplication occurred general radiation teleost fish species 200 400 mya may associated whole genome duplication event meyer malaga trillo 1999 even salmonid acanthomorph divergence middle cretaceous 100 mya lecointre 1994 fig
0.41600177.11504857.html.plaintext.txt	86	view larger version 15k fig
0.41600177.11504857.html.plaintext.txt	87	parsimonious tree based full length cystic fibrosis transmembrane conductance regulator cftr amino acid sequences using branch bound search paup 4
0.41600177.11504857.html.plaintext.txt	88	sequence length utilized 1544 positions 971 variable 771 informative parsimony
0.41600177.11504857.html.plaintext.txt	89	tree length 2270 consistency index 0
0.41600177.11504857.html.plaintext.txt	90	branch lengths given using acctran optimization
0.41600177.11504857.html.plaintext.txt	91	numbers nodes bootstrap proportions obtained 1000 replicates
0.41600177.11504857.html.plaintext.txt	92	bremer 1994 indices 5 except rhesus monkey macaque clade whose bremer index 1
0.41600177.11504857.html.plaintext.txt	93	tree recovered neighbor joining method saitou nei 1987 using corrected distances kimura 1983
0.41600177.11504857.html.plaintext.txt	94	see table 2 cftr sequences except eel anguilla anguilla sequence unpublished data refer figure 2 sequence alignment embl accession number align000076
0.41600177.11504857.html.plaintext.txt	95	cloning process additional full length cftr sequences several species including killifish singer et al
0.41600177.11504857.html.plaintext.txt	96	1998 puffer fish davidson et al
0.41600177.11504857.html.plaintext.txt	97	2000 also reported summarized table 2
0.41600177.11504857.html.plaintext.txt	98	indicated figure 1 scftr scftr ii along killifish puffer fish sequences divergent cftr homologs far discovered
0.41600177.11504857.html.plaintext.txt	99	availability large number cftr homologs cover wide range vertebrate species representing evolutionary divergence 420 myr allowed important broad cross species sequence comparisons performed
0.41600177.11504857.html.plaintext.txt	100	view table table 2 cftr sequences used analysis
0.41600177.11504857.html.plaintext.txt	101	implications combined analysis global structure function relationship cftr alignment 15 full length cftr amino acid sequences presented figure 2 current available missense mutations single amino acid deletions positioned along aligned sequences
0.41600177.11504857.html.plaintext.txt	102	refine boundaries nbd1 new isolated partial exon 13 coding sequence eastern gray kangaroo genbank accession number af293978 several partial sequences also aligned
0.41600177.11504857.html.plaintext.txt	103	global survey figure 2 highlights two nbds well conserved divergent region r domain
0.41600177.11504857.html.plaintext.txt	104	also general correlation level sequence homology number mutations identified throughout entire cftr
0.41600177.11504857.html.plaintext.txt	105	moreover 11 common missense mutations single amino acid deletions
0.41600177.11504857.html.plaintext.txt	106	f508del g551d n1303k r117h r347p i507del g85e r560t a455e r334w s549n identified classic atypical cf patients worldwide httpwww
0.41600177.11504857.html.plaintext.txt	107	cacftr occur stringently conserved residues across 15 cftr sequences
0.41600177.11504857.html.plaintext.txt	108	observations strongly suggest combined analysis current available data conjunction comprehensive sequence comparison cftr homologs highly desirable
0.41600177.11504857.html.plaintext.txt	109	indeed based approach functional r domain recently defined chen scotet ferec 2000 see also fig
0.41600177.11504857.html.plaintext.txt	110	importantly definition agrees well derived concurrent functional approach csanady et al
0.41600177.11504857.html.plaintext.txt	111	2000 also appears concur regulatory role unique domain baldursson berger welsh 2000
0.41600177.11504857.html.plaintext.txt	112	extend study refine boundaries two nbds cooh terminal tail c tail provide insights global structure function relationship cftr exploiting approach
0.41600177.11504857.html.plaintext.txt	113	view larger version 134k fig
0.41600177.11504857.html.plaintext.txt	114	broad alignment cystic fibrosis transmembrane conductance regulator cftr amino acid sequences
0.41600177.11504857.html.plaintext.txt	115	dashes indicate gaps introduced maximize alignment
0.41600177.11504857.html.plaintext.txt	116	identical residues species bold letters
0.41600177.11504857.html.plaintext.txt	117	12 membrane spanning regions tm1tm12 sequentially underlined
0.41600177.11504857.html.plaintext.txt	118	particular nbd1 nbd2 indicated dotted lines r domain c tail represented continuous lines wherein upper lines correspond original definitions riordan et al
0.41600177.11504857.html.plaintext.txt	119	1989 lower ones correspond new definitions
0.41600177.11504857.html.plaintext.txt	120	currently identified missense mutations single amino acid deletions httpwww
0.41600177.11504857.html.plaintext.txt	121	cacftr positioned sequence accordingly
0.41600177.11504857.html.plaintext.txt	122	see table 2 cftr sequences used alignment
0.41600177.11504857.html.plaintext.txt	123	refinement boundaries nbd1 nbd1 originally defined going amino acid f433 amino acid i586 human cftr notation throughout text riordan et al
0.41600177.11504857.html.plaintext.txt	124	definition subsequently modified several structural models annereau et al
0.41600177.11504857.html.plaintext.txt	125	1997 hoedemaeker davidson rose 1998 whose common feature extended cooh terminus nbd1 beyond residue i586
0.41600177.11504857.html.plaintext.txt	126	complementary observations originally defined r domain also challenged chen scotet ferec 2000 references therein
0.41600177.11504857.html.plaintext.txt	127	particular boundaries nbd1 recently investigated carefully designed functional approach cftr channel constructs severed near likely nh2 cooh terminal boundaries nbd1 systematically along primary sequence successful assembly pair channel segments measured cftr channel activity chan et al
0.41600177.11504857.html.plaintext.txt	128	additional piece information precise boundaries nbd1 begun emerge tentatively defined going p439 g646 fig
0.41600177.11504857.html.plaintext.txt	129	new definition nh2 terminus nbd1 combines following considerations
0.41600177.11504857.html.plaintext.txt	130	principal evidence comes evolutionary data
0.41600177.11504857.html.plaintext.txt	131	illustrated figure 2 sharp increase sequence conservation beginning p439 comparison immediately preceding sequence
0.41600177.11504857.html.plaintext.txt	132	first six amino acids originally defined nbd1
0.41600177.11504857.html.plaintext.txt	133	f433 t438 quite divergent even extent deletions occurred several species upstream region divergent sequence track 20 amino acids
0.41600177.11504857.html.plaintext.txt	134	contrast downstream p439 stringently conserved three amino acid motif
0.41600177.11504857.html.plaintext.txt	135	p439 v440 l441 also nonstringently conserved residues k442 a457 changes mainly involving substitutions conservative amino acids region followed highly conserved walker motif gstgagkt amino acid 458 amino acid 465
0.41600177.11504857.html.plaintext.txt	136	similar transition divergence sequence conservation also present equivalent location aligned sequences abc transporter family members illustrated sequence comparison 17 bacterial membrane proteins form periplasmic permease gene family mimura holbrook ames 1991
0.41600177.11504857.html.plaintext.txt	137	second definition consistent structural models human cftr nh2 terminus nbd1 regarded t438 higgins 1992 l441 bianchet et al
0.41600177.11504857.html.plaintext.txt	138	1997 around v440 hoedemaeker davidson rose 1998 respectively
0.41600177.11504857.html.plaintext.txt	139	definition also appears correlate reasonably well three dimensional crystal structure hisp atp binding subunit bacterial histidine transporter p439 would predicted occur beginning second ss strand hisp hung et al
0.41600177.11504857.html.plaintext.txt	140	third definition falls within amino acids n432 e449 functionally defined nh2 terminus nbd1 chan et al
0.41600177.11504857.html.plaintext.txt	141	finally definition given support mutational pattern transitional region fig
0.41600177.11504857.html.plaintext.txt	142	however one may argue new definition nh2 terminus nbd1 might inappropriately excluded sequences aligned first ss strand hisp hung et al
0.41600177.11504857.html.plaintext.txt	143	particular relevance point residue f433 aromatic amino acid corresponds residue y16 hisp
0.41600177.11504857.html.plaintext.txt	144	structure hisp considered good model binding atp nbd aromatic y16 confirmed play critical role determined mutational studies shyamala et al
0.41600177.11504857.html.plaintext.txt	145	moreover structures two prokaryotic nbd proteins livf amino terminal nbd rbsa show similar binding interaction nbd atp side chain aromatic residue analogous y16 hisp interacts adenine ring atp stabilize nucleotide binding
0.41600177.11504857.html.plaintext.txt	146	furthermore aromatic residue 20 30 amino acids upstream start walker motif similar position relative y16 hisp conserved abc transporter nbds summarized berger welsh 2000
0.41600177.11504857.html.plaintext.txt	147	inference f433 human cftr may participate atp binding
0.41600177.11504857.html.plaintext.txt	148	however recent functional analysis refuted possibility highlighted unique structure cftr nbd compared nbd structures berger welsh 2000
0.41600177.11504857.html.plaintext.txt	149	undoubtedly finding adds weight newly defined nbd1
0.41600177.11504857.html.plaintext.txt	150	previously defined nh2 terminus r domain beginning c647 chen scotet ferec 2000
0.41600177.11504857.html.plaintext.txt	151	consequently g646 could considered cooh terminus nbd1
0.41600177.11504857.html.plaintext.txt	152	however concurrent functional approach defined cooh terminus nbd1 occurring g622 q634 chan et al
0.41600177.11504857.html.plaintext.txt	153	nevertheless g646 seems logical positioning true boundary linking nbd1 r domain cftr
0.41600177.11504857.html.plaintext.txt	154	addition previous arguments chen scotet ferec 2000 supporting evidence also exists
0.41600177.11504857.html.plaintext.txt	155	principal evidence comes evolutionary data
0.41600177.11504857.html.plaintext.txt	156	indicated figure 2 sequence s623 g646 well conserved f587 g622 latter common part extended nbd1 two studies chan et al
0.41600177.11504857.html.plaintext.txt	157	2000 chen scotet ferec 2000
0.41600177.11504857.html.plaintext.txt	158	perhaps important indication comes sequence alignment abc transporter nbds example hisp ends exactly residue g646 human cftr homolog see fig
0.41600177.11504857.html.plaintext.txt	159	moreover important note functional assembly paired cftr segments severed l633q634 good cleaved n432f433 chan et al
0.41600177.11504857.html.plaintext.txt	160	regard interesting compare paired cftr fragments cleaved newly defined nbd1r domain boundary
0.41600177.11504857.html.plaintext.txt	161	g646c647 cleaved l633q634
0.41600177.11504857.html.plaintext.txt	162	refinement boundaries nbd2 original location amino acid sequence nbd2 y1219 r1386 riordan et al
0.41600177.11504857.html.plaintext.txt	163	historically nbd2 received much less attention nbd1
0.41600177.11504857.html.plaintext.txt	164	boundaries nbd1 redefined nbd2 similarly refined
0.41600177.11504857.html.plaintext.txt	165	accordingly nh2 terminus nbd2 could defined going a1225 reference relative position highly conserved walker motif also correlates fairly well mutational pattern appearance missense mutations clustering around walker motif grtgsgks amino acid 1244 amino acid 1251 transitional region nbd2 fig
0.41600177.11504857.html.plaintext.txt	166	however cooh terminus nbd2 extended p1443 reference redefined nbd1 see also fig
0.41600177.11504857.html.plaintext.txt	167	1998 cooh terminal portion new nbd2 shows poor sequence conservation
0.41600177.11504857.html.plaintext.txt	168	yet surprising considered context abc transporter family example counterpart region 17 bacterial periplasmic permeases similarly divergent mimura holbrook ames 1991
0.41600177.11504857.html.plaintext.txt	169	thus seems clear cooh terminal portions nbds general less functionally restrained throughout abc transporter family although stark contrast nbd1 cftr cooh terminal portion highly conserved fig
0.41600177.11504857.html.plaintext.txt	170	clear whether sequence conservation related immediately following r domain unique cftr lends weight unique structure cftr nbd1
0.41600177.11504857.html.plaintext.txt	171	although p1443 could represent cooh terminus new nbd2 accepted without reservations
0.41600177.11504857.html.plaintext.txt	172	significant sequence divergence cooh terminal portion new nbd2 different structural requirements cftr nbd compared abc transporter nbds general berger welsh 2000 differential roles cftr nbd1 nbd2 particular discussed argue alternative definition
0.41600177.11504857.html.plaintext.txt	173	reassuring well evolutionary data clinical observations functional studies concur
0.41600177.11504857.html.plaintext.txt	174	initial location sequence divergence transitional region clearly situated e1418 fig
0.41600177.11504857.html.plaintext.txt	175	addition shortest truncation associated cf disease pancreatic insufficiency recurrent pulmonary infection terminates q1412 httpwww
0.41600177.11504857.html.plaintext.txt	176	furthermore review several functional studies clearly points fact cftr truncated ator upstream v1415 significantly affects biogenesis maturation stability protein molecules truncated downstream n1419 rich et al
0.41600177.11504857.html.plaintext.txt	177	1999 gentzsch riordan 2001
0.41600177.11504857.html.plaintext.txt	178	three lines observation together mutational pattern region strongly suggest residue e1417 confidently assigned cooh terminus nbd2
0.41600177.11504857.html.plaintext.txt	179	new definition also validated analysis redefined c tail cftr discussed
0.41600177.11504857.html.plaintext.txt	180	functional delineation c tail cooh terminus nbd2 could naturally anticipated nh2 boundary c tail appears best delineate functional role cftr
0.41600177.11504857.html.plaintext.txt	181	one hand newly defined c tail nonessential effects biogenesis processing stability cftr previously assigned original c tail relocated within newly defined nbd2
0.41600177.11504857.html.plaintext.txt	182	moreover even two trafficking signals thought reside newly defined c terminal tail y1424 dileucine pair l1430 l1431 demonstrated alter steady state amount nascent mature cftr recent functional studies gentzsch riordan 2001
0.41600177.11504857.html.plaintext.txt	183	hand newly defined c tail appear essential well conserved motif involving final three amino acids trl represents pdz interacting domain required polarization cftr apical plasma membrane epithelial cells moyer et al
0.41600177.11504857.html.plaintext.txt	184	even important note pdz binding motif alone sufficient polarized distribution cftr milewski et al
0.41600177.11504857.html.plaintext.txt	185	therefore c tail whole would play minor role pathogenesis cf disease
0.41600177.11504857.html.plaintext.txt	186	indeed neither s1455x mickle et al
0.41600177.11504857.html.plaintext.txt	187	cacftr caused severe cf phenotype
0.41600177.11504857.html.plaintext.txt	188	inference single missense mutations identified c tail may significant functional consequence
0.41600177.11504857.html.plaintext.txt	189	consistent hypothesis none three missense mutations identified region fig
0.41600177.11504857.html.plaintext.txt	190	2 confidently assigned causal cf disease example r1422w identified cf patient also carried mutations f508del d993y r1453w identified patient diffuse panbronchiolitis httpwww
0.41600177.11504857.html.plaintext.txt	191	finally attention may drawn well conserved negatively charged motif e1469 e1474 c tail
0.41600177.11504857.html.plaintext.txt	192	insights differential function nbd1 nbd2 two nbds functionally equivalent immediately noticed early 1990s
0.41600177.11504857.html.plaintext.txt	193	cf associated mutations found predominantly cftrs nbd1 opposed nbd2 also mutations homologous amino acid residues within nbd1 nbd2 resulted different effects cftr maturation function cheng et al
0.41600177.11504857.html.plaintext.txt	194	recently different roles nbd1 nbd2 cftr chloride channel regulation ion channels investigated variety approaches e
0.41600177.11504857.html.plaintext.txt	195	apart fact disease associated mutations nbd1 nbd2 half common missense mutations single amino acid deletions occur nbd1 figure 2 reveals additional interesting observation regarding mutational patterns well conserved motifs nbds
0.41600177.11504857.html.plaintext.txt	196	17 missense mutations clustered lsggq motif lsggq amino acids 548 552 walker b motif ravykdadlylld amino acids 560 572 nbd1 four missense mutations equivalent regions lshgh amino acids 1346 1350 rsvlskakillld amino acids 1358 1370 nbd2
0.41600177.11504857.html.plaintext.txt	197	conversely one missense mutation walker motif gstgagkt amino acids 458 465 nbd1 five mutations corresponding motif grtgsgks amino acids 1244 1251 nbd2
0.41600177.11504857.html.plaintext.txt	198	finding intriguing since one hand although walker walker b presumably involved atp binding hydrolysis exact mechanisms remain largely unknown
0.41600177.11504857.html.plaintext.txt	199	hand generally believed atp hydrolysis nbd1 nbd2 may drive channel opening closing respectively reviewed nagel 1999 recent biochemical analysis suggests opening closing may occur consequence nucleotide binding dissociation hydrolysis functional unit involving domains aleksandrov et al
0.41600177.11504857.html.plaintext.txt	200	therefore tempting ask whether distinct mutational patterns important motifs linked intrinsically functional differences walker walker b sites within two nbds
0.41600177.11504857.html.plaintext.txt	201	elucidation question would improve understanding basic physiology cftr well abc transporters
0.41600177.11504857.html.plaintext.txt	202	nevertheless observation gives support idea nbd1 nbd2 make different contributions gating cftr channels
0.41600177.11504857.html.plaintext.txt	203	insights differential role msd1 f81 v350 msd2 i860 s1150 msd predicted contain six transmembrane segments tms three extracellular loops ecls two intracellular loops icls
0.41600177.11504857.html.plaintext.txt	204	case two nbds functional differences also found two msds e
0.41600177.11504857.html.plaintext.txt	205	yue devidas guggino 2000
0.41600177.11504857.html.plaintext.txt	206	comparison stringently conserved residues tms two msds reveals tms msd1 generally conserved msd2 data shown see also fig
0.41600177.11504857.html.plaintext.txt	207	2 tm6 12 21 residues 57
0.41600177.11504857.html.plaintext.txt	208	1 tm12 11 22 residues 50
0.41600177.11504857.html.plaintext.txt	209	0 conserved motifs two msds respectively tm6 conserved
0.41600177.11504857.html.plaintext.txt	210	evolutionary conservation regions correlates perfectly analysis suggests 1 tm6 tm12 line cftr pore 2 tm6 main determinant pore properties cftr 3 msd1 msd2 contribute differently cftr pore properties sheppard welsh 1999
0.41600177.11504857.html.plaintext.txt	211	defining feature ion channels selectivity ability pass certain ions high rate time effectively excluding others
0.41600177.11504857.html.plaintext.txt	212	discrimination different cations certain cation channels known occur short region pore known selectivity filter existence discrete anion selectivity filter pores cl channels controversial linsdell evagelidis hanrahan 2000
0.41600177.11504857.html.plaintext.txt	213	nevertheless based mentioned evolutionary data selectivity filter cftr indeed exists would likely located highly conserved tm tm6
0.41600177.11504857.html.plaintext.txt	214	surprisingly anion selectivity br cl cftr pore found mainly determined first half protein yue devidas guggino 2000 mutations several residues tm6 including k335 anderson et al
0.41600177.11504857.html.plaintext.txt	215	1991 f337 linsdell evagelidis hanrahan 2000 t338 linsdell zheng hanrahan 1998 r347 cheung akabas 1997 shown significantly affect anion selectivity
0.41600177.11504857.html.plaintext.txt	216	moreover stringently conserved motif t351 r352 q353 immediately downstream tm6 also suggested loop back channel narrowing lumen thereby forming major resistance current flow anion selectivity filter cheung akabas 1997
0.41600177.11504857.html.plaintext.txt	217	assuming anion selectivity filter resides vicinity tm6 interesting note presence another highly conserved motif also vicinity q359 t360 w361 y362 d363
0.41600177.11504857.html.plaintext.txt	218	furthermore also similarly stringently conserved motif downstream tm12 msd2 l1156 m1157 r1158 s1159 v1160
0.41600177.11504857.html.plaintext.txt	219	inspection figure 2 also reveals four icls generally conserved tm ecl subdomains msds
0.41600177.11504857.html.plaintext.txt	220	date missense mutations identified icl 19 amino acid deletion concerning icl2 investigated functional analysis reviewed sheppard welsh 1999
0.41600177.11504857.html.plaintext.txt	221	studies strongly indicated icls critical correct protein processing
0.41600177.11504857.html.plaintext.txt	222	among four icls icl4 amino acid q1035 amino acid r1102 sequence homology high 72 across 15 cftr species turns conserved subdomain entire cftr sequence
0.41600177.11504857.html.plaintext.txt	223	stringent sequence conservation coupled cluster missense mutations identified subdomain among two homozygosities h1085r yoshimura et al
0.41600177.11504857.html.plaintext.txt	224	1999 r1066c casals et al
0.41600177.11504857.html.plaintext.txt	225	1997 cause severe cf phenotype undoubtedly underlies functional significance within cftr
0.41600177.11504857.html.plaintext.txt	226	large fraction analyzed icl4 missense mutations disrupted biosynthetic processing cftr universally case
0.41600177.11504857.html.plaintext.txt	227	importantly processed mutants discernible effect channels pore properties alter gating behavior response increasing concentrations atp stimulation response pyrophosphate cotten et al
0.41600177.11504857.html.plaintext.txt	228	thus icl4 probably three icls may actively participate interdomain interactions example may link nbds msds thereby coupling activity nbds gating channel
0.41600177.11504857.html.plaintext.txt	229	possible motifs implicated interdomain interaction nh2 terminal tail n tail m1 r80 r domain eliciting finding n tail controls cftr channel gating physical interaction r domain
0.41600177.11504857.html.plaintext.txt	230	surprisingly positive regulatory activity mapped cluster acidic residues d47 e51 e54 d58 within highly charged conserved motif d44 e60 fig
0.41600177.11504857.html.plaintext.txt	231	since effects n tail mutations steady state phosphorylation vitro vivo detected n tail likely modulates channel activity controlling access phosphorylated r domain inhibitory stimulatory sites within channel naren et al
0.41600177.11504857.html.plaintext.txt	232	fact cluster stringently conserved acidic residues n tail appears bind part r domain probably region involving amino acids 708 740 nearby surrounding sequences naren et al
0.41600177.11504857.html.plaintext.txt	233	illustrated figure 2 three highly conserved positively charged motifs k696 r697 k698 r709 k710 r764 r765 r766 region
0.41600177.11504857.html.plaintext.txt	234	although conservation motifs may explained fact potentially participate phosphorylation r domain possibility least serve counterparts acidic residues n tail cannot excluded particularly fact none appear phosphyorylated pka vivo taken account cheng et al
0.41600177.11504857.html.plaintext.txt	235	recently relatively small portion r domain residues 760 783 encompasses stringently conserved motif r765 r766 q767 s768 v769 l760 found critical prevention constitutive activity cftr baldursson et al
0.41600177.11504857.html.plaintext.txt	236	highlights functional importance motifs considered conserved even within evolutionarily divergent r domain sequences
0.41600177.11504857.html.plaintext.txt	237	future studies focusing motifs may result revelation novel molecular mechanisms
0.41600177.11504857.html.plaintext.txt	238	many missense mutations functional unlike splicing truncating mutations always difficult assign definitive role missense mutations especially detected single cases
0.41600177.11504857.html.plaintext.txt	239	functional analysis provides important data extrapolation clinical effects may straightforward
0.41600177.11504857.html.plaintext.txt	240	seen conflicting results often occur aspects cf research exemplified two different models salt water transport across epithelia reviewed wine 1999 well disparity among results intracellular localization f508del cftr reviewed drumm 1999
0.41600177.11504857.html.plaintext.txt	241	ongoing effort tackle issue e
0.41600177.11504857.html.plaintext.txt	242	cf european network second consensus meeting towards validation cftr gene expression functional assays estoril march 30 april 1 2001
0.41600177.11504857.html.plaintext.txt	243	believe combined analysis currently available data complement effort enhance understanding identified mutations particularly missense
0.41600177.11504857.html.plaintext.txt	244	taking advantage previously redefined r domain systemic evaluation missense mutations occurring region produced result mutations f693l v754m t760m identified likely represent neutral polymorphisms chen scotet ferec 2000
0.41600177.11504857.html.plaintext.txt	245	similarly missense mutations occurring evolutionarily divergent regions example n418s g424s q890r k1177r may also represent neutral polymorphisms
0.41600177.11504857.html.plaintext.txt	246	extreme example mutations i506m f508c occur stringently conserved residues functionally important nbd1 also confirmed nonfunctional variants kobayashi et al
0.41600177.11504857.html.plaintext.txt	247	1990 kalin dork tummler 1992 et al
0.41600177.11504857.html.plaintext.txt	248	assignment mutations two extreme cases would raise serious concern certain fraction identified missense mutations classic atypical cf patients may fact merely represent polymorphisms rather mutations associated disease
0.41600177.11504857.html.plaintext.txt	249	assumption correct unreasonable infer truly causal mutation event may remain unidentified certain fraction patients disease incorrectly assumed caused identified missense mutations
0.41600177.11504857.html.plaintext.txt	250	assumption supported following considerations
0.41600177.11504857.html.plaintext.txt	251	large size cftr gene makes difficult analyze entire coding sequence mention intronic sequence
0.41600177.11504857.html.plaintext.txt	252	consequently initial identification one dna variant may discourage screening efforts thereby ignoring second variant cis gene
0.41600177.11504857.html.plaintext.txt	253	even whole cftr gene analyzed certain variants large deletions within gene detected increasing rate httpwww
0.41600177.11504857.html.plaintext.txt	254	cacftr still readily detected common mutational screening techniques girodon boulandet cazeneuve goossens 2000
0.41600177.11504857.html.plaintext.txt	255	addition promoter sequence romey et al
0.41600177.11504857.html.plaintext.txt	256	1999 upstream regulatory region nuthall et al
0.41600177.11504857.html.plaintext.txt	257	1999 cftr gene may targets extended mutational screening
0.41600177.11504857.html.plaintext.txt	258	moreover mutations genes certain cf like disease subjects considered mekus et al
0.41600177.11504857.html.plaintext.txt	259	taken together likely certain fraction missense mutations identified cftr gene may ultimately confirmed nonpathological polymorphisms
0.41600177.11504857.html.plaintext.txt	260	even possible may turn modifiers another variant cftr gene even another gene
0.41600177.11504857.html.plaintext.txt	261	answer question significantly improve understanding disease well protein
0.41600177.11504857.html.plaintext.txt	262	nevertheless vast number missense mutations represents invaluable resource exploring subtlety cftr structure function relationship figure 2 could serve important complement ongoing mutation detection functional analysis efforts cf field
0.41600177.11504857.html.plaintext.txt	263	comprehensive phylogenetic analysis implications animal models cf additional dividend availability large number cftr sequences benefit concerning use animal models cf studies
0.41600177.11504857.html.plaintext.txt	264	previously suggested rabbit could better cf model current murine model mainly based 1 anatomical developmental data 2 comparison cftr promotor sequences partial coding sequences 3 phylogenetic analysis sequences vuillaumier et al
0.41600177.11504857.html.plaintext.txt	265	although sequence comparisons clearly showed higher similarity rabbit primate sequences murine primate sequences even rabbit murine sequences phylogenetic implications ambiguous
0.41600177.11504857.html.plaintext.txt	266	long branch attraction artifact felsenstein 1978 murine lineage toward outgroup suspected vuillaumier et al
0.41600177.11504857.html.plaintext.txt	267	classical artifact phylogenetics concerns tree reconstruction methods
0.41600177.11504857.html.plaintext.txt	268	occurs rates character change vary among lineages provoking trees grouping lineages sharing close rates whatever evolutionary relationships
0.41600177.11504857.html.plaintext.txt	269	solve ambiguity additional sequence data particularly species required successful analysis
0.41600177.11504857.html.plaintext.txt	270	full length cftr amino acid sequences analyzed study fig
0.41600177.11504857.html.plaintext.txt	271	1 murine lineage basal placental mammals strange result possibly due long branch attraction
0.41600177.11504857.html.plaintext.txt	272	moreover position rabbit ambiguous
0.41600177.11504857.html.plaintext.txt	273	parsimonious tree fig
0.41600177.11504857.html.plaintext.txt	274	1 neighbor joining tree corrected distances data shown rabbit sister group bovids primates clade
0.41600177.11504857.html.plaintext.txt	275	neighbor joining tree based uncorrected distances rabbit sister group primates previous report vuillaumier et al
0.41600177.11504857.html.plaintext.txt	276	extended set exon 13 coding sequences including nonplacental mammal kangaroo another nonmurid rodent guinea pig analyzed fig
0.41600177.11504857.html.plaintext.txt	277	3 guinea pig represented sister group rabbit corresponding glires node e murids still basal placental mammals
0.41600177.11504857.html.plaintext.txt	278	assuming rodents monophyletic group novacek wyss 1986 luckett hartenberger 1993 philippe 1997 appears murids artifactually basal placental tree sister group guinea pig within clade e
0.41600177.11504857.html.plaintext.txt	279	thus high level divergence mouse sequence makes mouse inappropriate model cf studies also provokes phylogenetic artifact
0.41600177.11504857.html.plaintext.txt	280	unfortunately addition kangaroo sequence correct artifact added taxon closer placental mammals frog order break long branch could reduced possibility murid long branch attraction
0.41600177.11504857.html.plaintext.txt	281	nevertheless conclusions phylogenetic analysis challenge proposition rabbit better cf model whose sequence closely related humans murine species
0.41600177.11504857.html.plaintext.txt	282	additionally guinea pig appears equally good model candidate
0.41600177.11504857.html.plaintext.txt	283	view larger version 16k fig
0.41600177.11504857.html.plaintext.txt	284	parsimonious tree nucleotide sequences encoding cftr exon 13 using branch bound search paup 4
0.41600177.11504857.html.plaintext.txt	285	sequence length 618 positions 75 positions removed corresponded two independent insertions teleost sequences yielding 543 positions 397 variable 343 informative parsimony
0.41600177.11504857.html.plaintext.txt	286	taking inserteddeleted regions account produces identical tree
0.41600177.11504857.html.plaintext.txt	287	tree length 1134 consistency index 0
0.41600177.11504857.html.plaintext.txt	288	branch lengths given using acctran optimization
0.41600177.11504857.html.plaintext.txt	289	numbers nodes bootstrap proportions obtained 1000 replicates
0.41600177.11504857.html.plaintext.txt	290	tree recovered neighbor joining method saitou nei 1987 except position puffer fish sister group killifish neighbor joining tree
0.41600177.11504857.html.plaintext.txt	291	exon 13 encoding amino acids analyzed data shown sequence variability phylogenetic information lost
0.41600177.11504857.html.plaintext.txt	292	consequently nodes c d e collapsed preventing conclusion interrelationships placental mammals amino acid data set
0.41600177.11504857.html.plaintext.txt	293	embl accession number sequence alignment align000079
0.41600177.11504857.html.plaintext.txt	294	conclusions top abstract introduction materials methods results discussion conclusions acknowledgements references summary expanded already large number cftr homologs determining additional sequences atlantic salmon eastern gray kangaroo
0.41600177.11504857.html.plaintext.txt	295	particularly cloned two distinct cftr sequences atlantic salmon first time two isoforms cftr ever reported single species
0.41600177.11504857.html.plaintext.txt	296	availability newly expanded set cftr homologs allowed comprehensive cross species sequence comparison phylogenetic analysis ever performed
0.41600177.11504857.html.plaintext.txt	297	combined analysis current mutational structural functional data conjunction sequence comparison yielded tantalizing insights global cftr structure function relationship comprehensive phylogenetic analysis reinforces idea rabbit may represent better cf model mouse strengthens assertion long branch attraction artifact separates murine rodents rabbit guinea pig glires
0.41600177.11504857.html.plaintext.txt	298	hopefully refined boundaries two nbds c tail proposed cf model animal provide framework future investigations stringently conserved motifs within cftr may represent good candidates targets identifying sites participating inter intramolecular interactions
0.41600177.11504857.html.plaintext.txt	299	knowledge help resolve diversity complexity cftr defects lead better treatment disease
0.41600177.11504857.html.plaintext.txt	300	view larger version 111k fig
0.41600177.11504857.html.plaintext.txt	301	view larger version 113k fig
0.41600177.11504857.html.plaintext.txt	302	view larger version 126k fig
0.41600177.11504857.html.plaintext.txt	303	view larger version 80k fig
0.41600177.11504857.html.plaintext.txt	304	view larger version 69k fig
0.41600177.11504857.html.plaintext.txt	305	view larger version 78k fig
0.41600177.11504857.html.plaintext.txt	306	acknowledgements top abstract introduction materials methods results discussion conclusions acknowledgements references thank isabelle quere technical assistance dr
0.41600177.11504857.html.plaintext.txt	307	rigoulet vincennes zoo paris kangaroo dna two anonymous referees helpful criticisms sylvain rivard reading revised manuscript
0.41600177.11504857.html.plaintext.txt	308	work supported institut national de la sante et de la recherche medicale france natural environment research council wellcome trust united kingdom
0.41600177.11504857.html.plaintext.txt	309	footnotes william jeffery reviewing editor
0.41600177.11504857.html.plaintext.txt	310	1 keywords cystic fibrosis transmembrane conductance regulator missense mutation structure disease models phylogeny atlantic salmon rabbit
0.41600177.11504857.html.plaintext.txt	311	2 address correspondence reprints claude ferec etablissement francais du sang bretagne universite de bretagne occidentale centre hospitalier universitaire 46 rue felix le dantec 29275 brest france
0.41600177.11504857.html.plaintext.txt	312	references top abstract introduction materials methods results discussion conclusions acknowledgements references
0.41600177.11504857.html.plaintext.txt	313	riordan 2001 differential interactions nucleotides two nucleotide binding domains cftr j
0.41600177.11504857.html.plaintext.txt	314	chem 27612918 12923abstractfree full text
0.41600177.11504857.html.plaintext.txt	315	welsh 1991 demonstration cftr chloride channel alteration anion selectivity science 253202 205isimedline
0.41600177.11504857.html.plaintext.txt	316	stoven 1997 novel model first nucleotide binding domain cystic fibrosis transmembrane conductance regulator febs lett 407303 308isimedline
0.41600177.11504857.html.plaintext.txt	317	welsh 2000 contribution r domain phosphoserines function cftr studied fischer rat thyroid epithelia
0.41600177.11504857.html.plaintext.txt	318	physiol 279l835 l841abstractfree full text
0.41600177.11504857.html.plaintext.txt	319	welsh 2001 cftr cl channels r domain deletions translocations show phosphorylation dependent independent activity j
0.41600177.11504857.html.plaintext.txt	320	chem 2761904 1910abstractfree full text
0.41600177.11504857.html.plaintext.txt	321	welsh 2000 differences cystic fibrosis transmembrane conductance regulator hisp interaction adenine ring atp j
0.41600177.11504857.html.plaintext.txt	322	chem 27529407 29412abstractfree full text
0.41600177.11504857.html.plaintext.txt	323	pedersen 1997 modeling nucleotide binding domains abc transporter proteins based f1 atpasereca topology structural model nucleotide binding domains cystic fibrosis transmembrane conductance regulator cftr j
0.41600177.11504857.html.plaintext.txt	324	biomembr 29503 524isimedline
0.41600177.11504857.html.plaintext.txt	325	1993 seawater adaptation strategies salmonids pp
0.41600177.11504857.html.plaintext.txt	326	aquaculture fundamental applied research
0.41600177.11504857.html.plaintext.txt	327	american geophysical union washington d
0.41600177.11504857.html.plaintext.txt	328	1994 branch support tree stability cladistics 10295 304isi
0.41600177.11504857.html.plaintext.txt	329	egan 2000 identification cystic fibrosis transmembrane conductance regulator domains important interactions romk2 j
0.41600177.11504857.html.plaintext.txt	330	chem 27516697 16701abstractfree full text
0.41600177.11504857.html.plaintext.txt	331	20 co authors 1997 missense mutation r1066c second transmembrane domain cftr causes severe cystic fibrosis phenotype study 19 heterozygous 2 homozygous patients hum
0.41600177.11504857.html.plaintext.txt	332	mutat 10387 392isimedline
0.41600177.11504857.html.plaintext.txt	333	gadsby 2000 severed molecules functionally define boundaries cystic fibrosis transmembrane conductance regulators nh2 terminal nucleotide binding domain j
0.41600177.11504857.html.plaintext.txt	334	physiol 116163 180abstractfree full text
0.41600177.11504857.html.plaintext.txt	335	ferec 2000 definition functional r domain cystic fibrosis transmembrane conductance regulator mol
0.41600177.11504857.html.plaintext.txt	336	metab 71245 249isimedline
0.41600177.11504857.html.plaintext.txt	337	smith 1990 defective intracellular transport processing cftr molecular basis cystic fibrosis cell 63827 834isimedline
0.41600177.11504857.html.plaintext.txt	338	smith 1991 phosphorylation r domain camp dependent protein kinase regulates cftr chloride channel cell 661027 1036isimedline
0.41600177.11504857.html.plaintext.txt	339	akabas 1997 locating anion selectivity filter cystic fibrosis transmembrane conductance regulator cftr chloride channel j
0.41600177.11504857.html.plaintext.txt	340	physiol 109289 299abstractfree full text
0.41600177.11504857.html.plaintext.txt	341	muallem 2001 aberrant cftr dependent hco3 transport mutations associated cystic fibrosis nature 41094 97isimedline
0.41600177.11504857.html.plaintext.txt	342	welsh 1996 effect cystic fibrosis associated mutations fourth intracellular loop cystic fibrosis transmembrane conductance regulator j
0.41600177.11504857.html.plaintext.txt	343	chem 27121279 21284abstractfree full text
0.41600177.11504857.html.plaintext.txt	344	gadsby 2000 severed channels probe regulation gating cystic fibrosis transmembrane conductance regulator cytoplasmic domains j
0.41600177.11504857.html.plaintext.txt	345	physiol 116477 500abstractfree full text
0.41600177.11504857.html.plaintext.txt	346	cramb 2000 expression duplicate nak atpase beta1 isoform european eel anguilla anguilla
0.41600177.11504857.html.plaintext.txt	347	physiol 279r222 r229abstractfree full text
0.41600177.11504857.html.plaintext.txt	348	porteous 2000 genomic sequence analysis fugu rubripes cftr flanking genes 60 kb region conserving synteny 800 kb human chromosome 7 genome res 101194 1203abstractfree full text
0.41600177.11504857.html.plaintext.txt	349	bevins 1991 cross species analysis cystic fibrosis transmembrane conductance regulator
0.41600177.11504857.html.plaintext.txt	350	potential functional domains regulatory sites j
0.41600177.11504857.html.plaintext.txt	351	chem 26622761 22769abstractfree full text
0.41600177.11504857.html.plaintext.txt	352	1999 happens deltaf508 vivo j
0.41600177.11504857.html.plaintext.txt	353	invest 1031369 1370free full text
0.41600177.11504857.html.plaintext.txt	354	shull 1992 cloning sequence analysis rat cystic fibrosis transmembrane conductance regulator
0.41600177.11504857.html.plaintext.txt	355	physiol 262l779 l784abstractfree full text
0.41600177.11504857.html.plaintext.txt	356	1978 cases parsimony compatibility methods positively misleading syst
0.41600177.11504857.html.plaintext.txt	357	nairn 1999 control cftr gating phosphorylation nucleotide hydrolysis physiol
0.41600177.11504857.html.plaintext.txt	358	riordan 2001 localization sequences within c terminal domain cftr impact maturation stability j
0.41600177.11504857.html.plaintext.txt	359	chem 2761291 1298abstractfree full text
0.41600177.11504857.html.plaintext.txt	360	goossens 2000 screening practices mutations cftr gene abcc7 hum
0.41600177.11504857.html.plaintext.txt	361	mutat 15135 149isimedline
0.41600177.11504857.html.plaintext.txt	362	smith 1991 maturation function cystic fibrosis transmembrane conductance regulator variants bearing mutations putative nucleotide binding domains 1 2 mol
0.41600177.11504857.html.plaintext.txt	363	biol 113886 3893isimedline
0.41600177.11504857.html.plaintext.txt	364	lukacs 1999 c terminal truncations destabilize cystic fibrosis transmembrane conductance regulator without impairing biogenesis
0.41600177.11504857.html.plaintext.txt	365	chem 27421873 21877abstractfree full text
0.41600177.11504857.html.plaintext.txt	366	1992 abc transporters microorganisms man annu
0.41600177.11504857.html.plaintext.txt	367	rose 1998 model nucleotide binding domains abc transporters based large domain aspartate aminotransferase proteins 30275 286isimedline
0.41600177.11504857.html.plaintext.txt	368	1998 impact ancestral tetraploidy antibody heterogeneity salmonid fishes immunol
0.41600177.11504857.html.plaintext.txt	369	kim 1998 crystal structure atp binding subunit abc transporter nature 396703 707isimedline
0.41600177.11504857.html.plaintext.txt	370	tummler 1992 cystic fibrosis allele encoding missense mutations nucleotide binding folds cystic fibrosis transmembrane conductance regulator hum
0.41600177.11504857.html.plaintext.txt	371	tsui 1989 identification cystic fibrosis gene genetic analysis science 2451073 1080isimedline
0.41600177.11504857.html.plaintext.txt	372	beaudet 1990 benign missense variations cystic fibrosis gene
0.41600177.11504857.html.plaintext.txt	373	genet 47611 615isimedline
0.41600177.11504857.html.plaintext.txt	374	1983 rare variant alleles light neutral theory mol
0.41600177.11504857.html.plaintext.txt	375	1994 aspects historiques et heuristiques de lichtyologie systematique cybium 18339 430
0.41600177.11504857.html.plaintext.txt	376	hanrahan 2000 molecular determinants anion selectivity cystic fibrosis transmembrane conductance regulator chloride channel pore biophys
0.41600177.11504857.html.plaintext.txt	377	j 782973 2982abstractfree full text
0.41600177.11504857.html.plaintext.txt	378	hanrahan 1998 non pore lining amino acid side chains influence anion selectivity human cftr cl channel expressed mammalian cell lines j
0.41600177.11504857.html.plaintext.txt	379	physiol 5121 16abstractfree full text
0.41600177.11504857.html.plaintext.txt	380	hartenberger 1993 monophyly polyphyly order rodentia possible conflict morphological molecular interpretations j
0.41600177.11504857.html.plaintext.txt	381	kaczmarek 1991 identification localization dogfish homolog human cystic fibrosis transmembrane conductance regulator j
0.41600177.11504857.html.plaintext.txt	382	chem 26622749 22754abstractfree full text
0.41600177.11504857.html.plaintext.txt	383	veeze 1998 cystic fibrosis like disease unrelated cystic fibrosis transmembrane conductance regulator hum
0.41600177.11504857.html.plaintext.txt	384	genet 102582 586isimedline
0.41600177.11504857.html.plaintext.txt	385	malaga trillo 1999 vertebrate genomics fishy tales hox genes curr
0.41600177.11504857.html.plaintext.txt	386	biol 9r210 r213isimedline
0.41600177.11504857.html.plaintext.txt	387	cutting 2000 killifish model study role cftr absorptive secretory epithelia abstract
0.41600177.11504857.html.plaintext.txt	388	cutting 1998 mutation cystic fibrosis transmembrane conductance regulator gene associated elevated sweat chloride concentrations absence cystic fibrosis hum
0.41600177.11504857.html.plaintext.txt	389	genet 7729 735abstractfree full text
0.41600177.11504857.html.plaintext.txt	390	cutting 2000 effects cystic fibrosis congenital bilateral absence vas deferens associated mutations cystic fibrosis transmembrane conductance regulator mediated regulation separate channels
0.41600177.11504857.html.plaintext.txt	391	genet 661485 1495isimedline
0.41600177.11504857.html.plaintext.txt	392	cutting 2001 pdz binding motif essential sufficient localize c terminus cftr apical membrane j
0.41600177.11504857.html.plaintext.txt	393	cell sci 114719 726abstractfree full text
0.41600177.11504857.html.plaintext.txt	394	ames 1991 structural model nucleotide binding conserved component periplasmic permeases proc
0.41600177.11504857.html.plaintext.txt	395	14 co authors 2000 pdz interacting domain cystic fibrosis transmembrane conductance regulator required functional expression apical plasma membrane j
0.41600177.11504857.html.plaintext.txt	396	chem 27527069 27074abstractfree full text
0.41600177.11504857.html.plaintext.txt	397	1999 differential function two nucleotide binding domains cystic fibrosis transmembrane conductance regulator biochim
0.41600177.11504857.html.plaintext.txt	398	acta 1461263 274isimedline
0.41600177.11504857.html.plaintext.txt	399	kirk 1999 cftr chloride channel regulation interdomain interaction science 286544 548abstractfree full text
0.41600177.11504857.html.plaintext.txt	400	wyss 1986 higher level relationships recent eutherian orders morphological evidence cladistics 2257 287
0.41600177.11504857.html.plaintext.txt	401	harris 1999 analysis dnase hypersensitive site located 20
0.41600177.11504857.html.plaintext.txt	402	9 kb upstream cftr gene eur
0.41600177.11504857.html.plaintext.txt	403	biochem 266431 443abstractfree full text
0.41600177.11504857.html.plaintext.txt	404	1993 must computer package management utilities sequences trees nucleic acids res 215264 5272abstract
0.41600177.11504857.html.plaintext.txt	405	1997 rodent monophyly pitfalls molecular phylogenies j
0.41600177.11504857.html.plaintext.txt	406	welsh 1996 function xenopus cystic fibrosis transmembrane conductance regulator cftr cl channels use human xenopus chimeras investigate pore properties cftr j
0.41600177.11504857.html.plaintext.txt	407	chem 27125184 25191abstractfree full text
0.41600177.11504857.html.plaintext.txt	408	welsh 1993 effect deletion mutations function cftr chloride channels receptors channels 1221 232isimedline
0.41600177.11504857.html.plaintext.txt	409	14 co authors 1989 identification cystic fibrosis gene cloning characterization complementary dna science 2451066 1073isimedline
0.41600177.11504857.html.plaintext.txt	410	ramsay 1999 first putative sequence alterations minimal cftr promoter region j
0.41600177.11504857.html.plaintext.txt	411	genet 36263 264free full text
0.41600177.11504857.html.plaintext.txt	412	15 co authors 1989 identification cystic fibrosis gene chromosome walking jumping science 2451059 1065isimedline
0.41600177.11504857.html.plaintext.txt	413	nei 1987 neighbor joining method new method reconstructing phylogenetic trees mol
0.41600177.11504857.html.plaintext.txt	414	engelhardt 1996 developmental expression patterns cftr ferret tracheal surface airway submucosal gland epithelia
0.41600177.11504857.html.plaintext.txt	415	riordan 1996 disease associated mutations fourth cytoplasmic loop cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing chloride channel activity j
0.41600177.11504857.html.plaintext.txt	416	chem 27115139 15145abstractfree full text
0.41600177.11504857.html.plaintext.txt	417	welsh 1999 structure function cftr chloride channel physiol
0.41600177.11504857.html.plaintext.txt	418	ames 1991 structure function analysis histidine permease comparison cystic fibrosis mutations j
0.41600177.11504857.html.plaintext.txt	419	chem 26618714 18719abstractfree full text
0.41600177.11504857.html.plaintext.txt	420	mckinley 2000 role cftr seawater adaptation atlantic salmon abstract comp
0.41600177.11504857.html.plaintext.txt	421	higgins 1998 divergent cftr homologue highly regulated salt transport euryhaline teleost f
0.41600177.11504857.html.plaintext.txt	422	physiol 274c715 c723isimedline
0.41600177.11504857.html.plaintext.txt	423	1999 paup phylogenetic analysis using parsimony methods
0.41600177.11504857.html.plaintext.txt	424	sarkadi 1999 nucleotide occlusion human cystic fibrosis transmembrane conductance regulator
0.41600177.11504857.html.plaintext.txt	425	different patterns two nucleotide binding domains j
0.41600177.11504857.html.plaintext.txt	426	chem 27412209 12212abstractfree full text
0.41600177.11504857.html.plaintext.txt	427	yamashita 1999 two distinct isoforms cdna encoding rainbow trout androgen receptors j
0.41600177.11504857.html.plaintext.txt	428	chem 2745674 5680abstractfree full text
0.41600177.11504857.html.plaintext.txt	429	11 co authors 1991 cloning mouse homolog human cystic fibrosis transmembrane conductance regulator gene genomics 10301 307isimedline
0.41600177.11504857.html.plaintext.txt	430	harris 1995 molecular analysis ovine cystic fibrosis transmembrane conductance regulator gene proc
0.41600177.11504857.html.plaintext.txt	431	higgins 1992 identification developmental expression xenopus laevis cystic fibrosis transmembrane conductance regulator gene hum
0.41600177.11504857.html.plaintext.txt	432	denamur 1997 phylogenetic analysis cystic fibrosis transmembrane conductance regulator gene mammalian species argues development rabbit model cystic fibrosis mol
0.41600177.11504857.html.plaintext.txt	433	schmidtke 1992 missense variation cftr gene codon 507 hum
0.41600177.11504857.html.plaintext.txt	434	1999 genesis cystic fibrosis lung disease j
0.41600177.11504857.html.plaintext.txt	435	invest 103309 312free full text
0.41600177.11504857.html.plaintext.txt	436	dean 1998 genomic dna sequence rhesus m
0.41600177.11504857.html.plaintext.txt	437	mulatta cystic fibrosis cftr gene mamm
0.41600177.11504857.html.plaintext.txt	438	genome 9301 305isimedline
0.41600177.11504857.html.plaintext.txt	439	beaudet 1991 molecular cloning sequence analysis murine cdna cystic fibrosis transmembrane conductance regulator genomics 10547 550isimedline
0.41600177.11504857.html.plaintext.txt	440	eto 1999 japanese patient homozygous h1085r mutation cftr gene presents severe form cystic fibrosis clin
0.41600177.11504857.html.plaintext.txt	441	genet 56173 175isimedline
0.41600177.11504857.html.plaintext.txt	442	guggino 2000 two halves cftr form dual pore ion channel j
0.41600177.11504857.html.plaintext.txt	443	chem 27510030 10034abstractfree full text
0.41600177.11504857.html.plaintext.txt	444	dong 1998 efficient expression cftr function adeno associated virus vectors carry shortened cftr genes proc
0.41600177.11504857.html.plaintext.txt	445	usa 9510158 10163abstractfree full text
0.41600177.11504857.html.plaintext.txt	446	accepted publication may 23 2001
0.4653881.10601334.html.plaintext.txt	0	stress associated endoplasmic reticulum protein 1 serp1ribosome associated membrane protein 4 ramp4 stabilizes membrane proteins stress facilitates subsequent glycosylation atsushi yamaguchiac osamu horibc david m
0.4653881.10601334.html.plaintext.txt	1	sternd enno hartmanne satoshi ogawabc masaya tohyamaac department anatomy neuroscience graduate school medicine osaka university suita city osaka 565 0871 japan b department anatomy iii kanazawa university school medicine kanazawa city ishikawa 290 8640 japan c core research evolutional science technology japan science technology tokyo 105 japan d department surgery department physiology cellular biophysics college physicians surgeons columbia university new york new york 10032 e abteilung biochemie ii zentrum biochemie und moleculare zellbiologie georg august universitat 37073 gottingen germany
0.4653881.10601334.html.plaintext.txt	2	correspondence osamu hori department anatomy iii kanazawa university medical school 13 1 takara machi kanazawa city ishikawa 290 8640 japan
0.4653881.10601334.html.plaintext.txt	3	tel81 76 265 2162 fax81 76 234 4222 e mailosamuhatnanat
0.4653881.10601334.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	5	application differential display cultured rat astrocytes subjected hypoxia allowed cloning novel cdna termed stress associated endoplasmic reticulum protein 1 serp1
0.4653881.10601334.html.plaintext.txt	6	expression serp1 enhanced vitro hypoxia andor reoxygenation forms stress causing accumulation unfolded proteins endoplasmic reticulum er stress vivo middle cerebral artery occlusion rats
0.4653881.10601334.html.plaintext.txt	7	serp1 cdna encodes 66 amino acid polypeptide found identical ribosome associated membrane protein 4 ramp4 bearing 29 identity yeast suppressor secy 6 protein ysy6p suggesting participation pathways controlling membrane protein biogenesis er
0.4653881.10601334.html.plaintext.txt	8	cultured 293 cells subjected er stress overexpression serp1ramp4 suppressed aggregation andor degradation newly synthesized integral membrane proteins subsequently facilitated glycosylation stress removed
0.4653881.10601334.html.plaintext.txt	9	serp1ramp4 interacted sec61 sec61ss subunits translocon molecular chaperon calnexin
0.4653881.10601334.html.plaintext.txt	10	furthermore sec61 sec61ss serp1ramp4 found associate newly synthesized integral membrane proteins stress
0.4653881.10601334.html.plaintext.txt	11	results suggest stabilization membrane proteins response stress involves concerted action rescue unit er membrane comprised serp1ramp4 components translocon molecular chaperons er
0.4653881.10601334.html.plaintext.txt	12	key words hypoxia endoplasmic reticulum stress translocon aggregationdegradation refolding
0.4653881.10601334.html.plaintext.txt	13	introduction top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	14	ischemic stress due hypoxemia alone hypoxemia followed reperfusion one relevant environmental challenges accompanies spectrum disorders associated vascular dysfunction aging
0.4653881.10601334.html.plaintext.txt	15	central nervous system typifies complexities cellular response ischemia
0.4653881.10601334.html.plaintext.txt	16	ischemia neuronal function compromised often resulting loss cell viability due least part extracellular accumulation excitatory amino acids disordered calcium homeostasis choi 1995 rothman olney 1995
0.4653881.10601334.html.plaintext.txt	17	subsequent reperfusion exacerbates injury formation reactive oxygen species attack membranous proteinaceous cellular constituents compromising functions mccord 1987 solenski et al
0.4653881.10601334.html.plaintext.txt	18	cellular response ischemia occurs many levels including modulation gene expression
0.4653881.10601334.html.plaintext.txt	19	context 80 different mrnas identified ischemic brain review see koistinaho hokfelt 1997 encode proximal distal regulators cellular stress response immediate early gene products apoptosis associated proteins stress proteins cytokines growth factors
0.4653881.10601334.html.plaintext.txt	20	although undoubtedly contribute pathways underlying neuronal death others probably represent adaptive responses promoting cellular survival response stress
0.4653881.10601334.html.plaintext.txt	21	contrast extraordinary vulnerability neurons ischemic stress astrocytes unique ability tolerate even proliferate conditions assigning central role immediate cellular response later events associated tissue remodelling hertz 1982
0.4653881.10601334.html.plaintext.txt	22	potential astrocytes orchestrate events central nervous system triggered ischemic stress led us analyze response hypoxia h1 hypoxia followed reoxygenation r using brain derived rat astrocytes order simulate ischemia ischemiareperfusion respectively hori et al
0.4653881.10601334.html.plaintext.txt	23	found astrocytes subjected environmental perturbations display upregulation stress proteins glucose regulated protein grp 78 grp94 heat shock protein hsp 72 heme oxygenase type 1 release neurotrophic cytokine il 6 maeda et al
0.4653881.10601334.html.plaintext.txt	24	dissection differential gene expression astrocytes exposed hr allowed cloning three novel cdnas encoding novel stress protein oxygen regulated protein orp 150 b rat homologue drosophila splicing factor tra2 ra301 c novel vesicle transporter ra410 matsuo et al
0.4653881.10601334.html.plaintext.txt	25	probe mechanisms astrocytes participate response ischemic stress cloned novel stress associated er protein termed serp1 differential display applied primary cultures astrocytes exposed h
0.4653881.10601334.html.plaintext.txt	26	compared homeostatic conditions serp1 expression upregulated vivo vitro response h r including induction brain ischemia well conditions associated accumulation unfolded proteins endoplasmic reticulum er stress
0.4653881.10601334.html.plaintext.txt	27	serp1 found identical ribosome associated membrane protein 4 ramp4 bearing 30 homology yeast suppressor secy 6 protein ysy6p suggesting participation pathways controlling biogenesis secretory membrane proteins er
0.4653881.10601334.html.plaintext.txt	28	cultured 293 cells subjected er stress overexpression serp1ramp4 suppressed aggregation andor degradation integral membrane proteins stress facilitates glycosylation stress
0.4653881.10601334.html.plaintext.txt	29	serp1ramp4 interacted directly sec61 sec61ss subunits translocon sec61 complex gorlich et al
0.4653881.10601334.html.plaintext.txt	30	1992 gorlich rapoport 1993 calnexin membrane protein molecular chaperon er associates folding intermediates glycoprotein ou et al
0.4653881.10601334.html.plaintext.txt	31	immunoprecipitation demonstrate binding newly synthesized integral membrane proteins sec61 sec61ss serp1ramp4
0.4653881.10601334.html.plaintext.txt	32	results suggest stabilization membrane proteins response stress involves concerted action rescue unit er membrane appears comprised serp1ramp4 well components translocon molecular chaperons er
0.4653881.10601334.html.plaintext.txt	33	materials methods top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	34	cell culture conditions hr stresses astrocytes isolated cerebral cortex e18 rat embryos using minor modification previously described methods mccarthy de vellis 1980
0.4653881.10601334.html.plaintext.txt	35	brief cerebral hemispheres obtained e18 brains meninges carefully removed
0.4653881.10601334.html.plaintext.txt	36	brain tissue digested papain worthington biochemical corp
0.4653881.10601334.html.plaintext.txt	37	37 degrees c 15 min plated 175 cm2 culture flasks two brainsflask
0.4653881.10601334.html.plaintext.txt	38	cells grown mem 10 fcs 10 d agitated strongly shaking platform separate astrocytes microglia oligodendroglia
0.4653881.10601334.html.plaintext.txt	39	cells replated 150 mm diam dishes grown additional 7 d
0.4653881.10601334.html.plaintext.txt	40	cultures used experiments comprised 95 astrocytes based morphological fibroblast like appearance formation cobblestone cell layer immunohistochemical detection glial fibrillary acidic protein gfap anti gfap antibody sigma chemical co
0.4653881.10601334.html.plaintext.txt	41	cells achieved confluence medium replaced serum free mem cultures subjected h indicated times 22 h using incubator equipped h chamber coy laboratory products described ogawa et al
0.4653881.10601334.html.plaintext.txt	42	using chamber ambient oxygen tension culture medium bathing cells 8 10 torr ogawa et al
0.4653881.10601334.html.plaintext.txt	43	experiments cells returned ambient atmosphere h incubated 4 h r
0.4653881.10601334.html.plaintext.txt	44	experiments cells maintained normoxia exposed either calcium ionophore a23187 1 microm 8 h sigma chemical co
0.4653881.10601334.html.plaintext.txt	45	tunicamycin 1 microgml 8 h sigma chemical co
0.4653881.10601334.html.plaintext.txt	46	hydrogen peroxide 80 microm 4 h wako chemicals
0.4653881.10601334.html.plaintext.txt	47	alternatively cultures subjected heat shock 42 degrees c 2 h returned 37 degrees c incubated additional 2 h
0.4653881.10601334.html.plaintext.txt	48	293 cells bhk cells cultured dmem transfected indicated expression vectors described
0.4653881.10601334.html.plaintext.txt	49	differential display total rna extracted cultured astrocytes subjected normoxia h 20 h using qiagen rneasy kit differential display performed described liang pardee 1992
0.4653881.10601334.html.plaintext.txt	50	brief rt pcr avian myeloblastosis virus reverse transcriptase amersham pharmacia biotech 300 random primers 12 21 oligonucleotides used prepare cdnas
0.4653881.10601334.html.plaintext.txt	51	pcr products separated acrylamide gel 6 electrophoresis cdna bands interests cut gel
0.4653881.10601334.html.plaintext.txt	52	cloning cdnas pgem vector promega dna sequencing performed using dna sequencer model 377 applied biosystems
0.4653881.10601334.html.plaintext.txt	53	differential expression candidate genes h versus normoxia confirmed northern blotting using 32p radiolabeled cdnas probes
0.4653881.10601334.html.plaintext.txt	54	cloning rat human serp1ramp4 cdnas one cdna fragments obtained differential display termed t41 used screen adult cdna library lambda zapii cdna library stratagene
0.4653881.10601334.html.plaintext.txt	55	3 kb obtained spanning entire open reading frame orf polyadenylation signal strands sequenced
0.4653881.10601334.html.plaintext.txt	56	sequence searches comparisons carried using several databases including national center biotechnology information fasta blast molecular analysis systems embl genbankddbj
0.4653881.10601334.html.plaintext.txt	57	human serp1ramp4 cdna included complete orf rat serp1ramp4 obtained human expression sequence tag est clone image consortium
0.4653881.10601334.html.plaintext.txt	58	dna sequencing performed strands clone
0.4653881.10601334.html.plaintext.txt	59	northern blot analysis total rna 10 15 microg isolated cultured astrocytes rat tissues separated agaroseformaldehyde 1 gels transferred onto immobilon n membranes millipore
0.4653881.10601334.html.plaintext.txt	60	cdna fragment serp1ramp4 labeled 32p random hexamer procedure specific activity 0
0.4653881.10601334.html.plaintext.txt	61	5 3 x 109 cpm microg dna used probe membranes immobilized rna
0.4653881.10601334.html.plaintext.txt	62	5x sds 1 h membranes subjected autoradiography
0.4653881.10601334.html.plaintext.txt	63	northern blots also performed rat sec61 human sec61ss see rat grp78 cloned pcr specific primers rat hsp72 imuta et al
0.4653881.10601334.html.plaintext.txt	64	1998 human orp150 kuwabara et al
0.4653881.10601334.html.plaintext.txt	65	1996 human oligosaccaryltransferase ost cloned pcr specific primers cdna fragments probes
0.4653881.10601334.html.plaintext.txt	66	expression serp1ramp4 ischemic brain unilateral middle cerebral artery mca occlusion performed male sprague dawley rats 250 g described garcia et al
0.4653881.10601334.html.plaintext.txt	67	12 h ischemia rats killed brains frozen 80 degrees c
0.4653881.10601334.html.plaintext.txt	68	serial coronal sections cut serp1ramp4 mrna detected situ hybridization using previously described techniques matsuo et al
0.4653881.10601334.html.plaintext.txt	69	brief sense antisense riboprobes serp1ramp4 vitro transcribed rat serp1ramp4 cdna inserted pgem vector
0.4653881.10601334.html.plaintext.txt	70	linearizing vector ncoi sense probe spei antisense probe reaction mixtures incubated 35sutp neg 039h dupont nen sp6 t7 rna polymerase promega
0.4653881.10601334.html.plaintext.txt	71	brain sections hybridized either sense antisense probes washed dried subjected autoradiography
0.4653881.10601334.html.plaintext.txt	72	2 d later films developed brain images examined
0.4653881.10601334.html.plaintext.txt	73	sections slides covered photographic emulsion eastman kodak co
0.4653881.10601334.html.plaintext.txt	74	2 wk developed analyzed dark field microscopy
0.4653881.10601334.html.plaintext.txt	75	serp1ramp4 antigen also detected immunoprecipitation followed western blotting anti serp1ramp4 antibody described
0.4653881.10601334.html.plaintext.txt	76	plasmid construction generation antibodies serp1ramp4 cdna encoding complete orf amplified pcr using primers tagged flag epitope nh2 terminus cloned pcdna3 invitrogen
0.4653881.10601334.html.plaintext.txt	77	rat sec61 human sec61ss cdnas cloned described gorlich et al
0.4653881.10601334.html.plaintext.txt	78	1994 hemagglutinin ha tagged amplified pcr ligated pcdna3
0.4653881.10601334.html.plaintext.txt	79	constructs sequenced transfection studies see
0.4653881.10601334.html.plaintext.txt	80	anti human sec61ss antibody generously provided dr
0.4653881.10601334.html.plaintext.txt	81	rapoport harvard university boston ma
0.4653881.10601334.html.plaintext.txt	82	reagents detect receptor advanced glycation endproducts rage protein level prepared described neeper et al
0.4653881.10601334.html.plaintext.txt	83	antibodies cdna cd8 kindly provided dr
0.4653881.10601334.html.plaintext.txt	84	kazunori imaizumi osaka university medical school osaka japan
0.4653881.10601334.html.plaintext.txt	85	production anti serp1ramp4 antibodies detection serp1ramp4 protein obtain antibody reactive serp1ramp4 peptide sequence ctqrgnvaktsrnapeek containing extra cysteine residue nh2 terminus synthesized conjugated keyhole limpet hemocyanin
0.4653881.10601334.html.plaintext.txt	86	rabbits immunized conventional methods
0.4653881.10601334.html.plaintext.txt	87	high titer antibody obtained antiserum affinity purified using column immobilized synthetic peptide proton kit 1 multiple peptide systems
0.4653881.10601334.html.plaintext.txt	88	detecting serp1ramp4 protein cultured astrocytes 293 cells transfected pcdna3flag tagged serp1ramp4 lysed 1 np 4010 mm tris ph 7
0.4653881.10601334.html.plaintext.txt	89	6 150 mm nacl 1 mm edta 1 mm pmsf 10 microgml aprotinin immunoprecipitation western blotting performed using rabbit anti serp1ramp4 antibody mouse anti flag antibody
0.4653881.10601334.html.plaintext.txt	90	sites primary antibody binding determined enhanced chemiluminescence method amersham pharmacia biotech using alkaline phosphatase conjugated secondary antibodies
0.4653881.10601334.html.plaintext.txt	91	immunoblotting molecules used specific antibodies epitope general procedure serp1ramp4 used
0.4653881.10601334.html.plaintext.txt	92	immunocytochemical analysis bhk cells assess subcellular localization serp1ramp4 bhk cells transiently transfected overexpress flag tagged serp1ramp4 ysy6p subjected double immunostaining mouse anti flag sigma chemical co
0.4653881.10601334.html.plaintext.txt	93	rabbit anti protein disulfide isomerase pdi antibodies latter kindly provided dr
0.4653881.10601334.html.plaintext.txt	94	ryuichi masaki kansai medical university osaka japan akagi et al
0.4653881.10601334.html.plaintext.txt	95	sites primary antibody binding visualized using tritc conjugated anti mouse antibody sigma chemical co
0.4653881.10601334.html.plaintext.txt	96	fitc conjugated anti rabbit antibody sigma chemical co
0.4653881.10601334.html.plaintext.txt	97	studies rage detected using rabbit anti rage igg followed fitc conjugated anti rabbit antibody
0.4653881.10601334.html.plaintext.txt	98	effect serp1ramp4 stabilization glycosylation membrane proteins induction cell stress 293 bhk cells transiently transfected expression constructs rage cd8 2 microg dnaml alone pcdnaserp1ramp4 2 microg dnaml using lipofectamine life technologies inc
0.4653881.10601334.html.plaintext.txt	99	indicated er stress induced addition calcium ionophore a23187 1 microgml tunicamycin 1 microm
0.4653881.10601334.html.plaintext.txt	100	overnight incubation stabilization membrane proteins rage cd8 analyzed immunoblotting immunoprecipitation latter pulse chase labeling
0.4653881.10601334.html.plaintext.txt	101	metabolic labeling accomplished addition 35smethionine american radiolabeled chemicals culture medium 0
0.4653881.10601334.html.plaintext.txt	102	25 mciml followed incubation 30 min methionine free dmem 1 h chase period complete medium
0.4653881.10601334.html.plaintext.txt	103	control experiment stabilization ib stress conditions also studied using anti ib antibody santa cruz biotechnology inc
0.4653881.10601334.html.plaintext.txt	104	antiubiquitin antibody stressgen biotechnologies corp
0.4653881.10601334.html.plaintext.txt	105	used characterize smear rage antigen stress condition
0.4653881.10601334.html.plaintext.txt	106	experiments cells released stress overnight incubation tunicamycin 1 microm
0.4653881.10601334.html.plaintext.txt	107	medium replaced tunicamycin free medium glycosylation rage analyzed metabolic labeling 35smethionine 0
0.4653881.10601334.html.plaintext.txt	108	25 mciml 3 h followed immunoprecipitation anti rage antibody
0.4653881.10601334.html.plaintext.txt	109	interaction serp1ramp4 sec61 complex molecular chaperons membrane protein rage 293 cells 5 x 106 cells transfected expression constructs flag tagged serp1ramp4 membrane protein rage see
0.4653881.10601334.html.plaintext.txt	110	overnight incubation cultures lysed 1 np 40 2 deoxycholate latter followed dnase treatment10 mm tris ph 7
0.4653881.10601334.html.plaintext.txt	111	6 150 mm nacl 1 mm edta 1 mm pmsf 10 microgml aprotinin immunoprecipitation performed various antibodies anti flag sigma chemical co
0.4653881.10601334.html.plaintext.txt	112	anti sec61 anti sec61ss anti rage neeper et al
0.4653881.10601334.html.plaintext.txt	113	1995 anti grp78 stressgen biotechnologies corp
0.4653881.10601334.html.plaintext.txt	114	anti orp150 anticalnexin stressgen biotechnologies corp
0.4653881.10601334.html.plaintext.txt	115	immunoprecipitates subjected sds page immunoblotted indicated antibodies
0.4653881.10601334.html.plaintext.txt	116	cross linking disuccinimidyl suberate dss pierce performed membrane fractions isolated 293 cells cotransfected expression constructs serp1ramp4 ha tagged sec61ss described schmidt et al
0.4653881.10601334.html.plaintext.txt	117	brief 107 cells homogenized dounce homogenizer 0
0.4653881.10601334.html.plaintext.txt	118	25 m sucrose 10 mm acetic acid 10 mm triethanolamine 1 mm edta ph 7
0.4653881.10601334.html.plaintext.txt	119	4 1 mm pmsf centrifuged 1000 g 10 min
0.4653881.10601334.html.plaintext.txt	120	supernatant spun 10000 g 30 min supernatant second spinning subjected final centrifugation 100000 g 60 min clarify cytosolic fraction
0.4653881.10601334.html.plaintext.txt	121	cross linking carried incubating membrane fractions 1 mm dss pbs 1 h
0.4653881.10601334.html.plaintext.txt	122	coimmunoprecipitation co ip performed described
0.4653881.10601334.html.plaintext.txt	123	laser densitometric analysis laser densitometric analysis performed standardize results western northern blotting quality one software pdi inc
0.4653881.10601334.html.plaintext.txt	124	described previously tsukamoto et al
0.4653881.10601334.html.plaintext.txt	125	results top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	126	identification serp1ramp4 cultured rat astrocytes exposed h rt pcr differentially expressed amplicon 400 bp termed t41 identified
0.4653881.10601334.html.plaintext.txt	127	northern analysis using cdna probe total rna harvested hypoxic astrocytes confirmed selective upregulation compared normoxia see led us clone full length cdna
0.4653881.10601334.html.plaintext.txt	128	rat brain cdna library screened 2
0.4653881.10601334.html.plaintext.txt	129	3 kb cdna clone obtained contained single orf polyadenylation signal
0.4653881.10601334.html.plaintext.txt	130	cdna encoded protein 66 amino acids termed serp1 including putative transmembrane spanning domain cooh terminus figure 1
0.4653881.10601334.html.plaintext.txt	131	based sequence homology database searches serp1 displayed 29 identity amino acid level yeast protein ysy6p identified high copy suppressor secysec61 mutant sakaguchi et al
0.4653881.10601334.html.plaintext.txt	132	human caenorhabditis elegans homologues serp1 encoded est clones showed 100 53 identities respectively
0.4653881.10601334.html.plaintext.txt	133	found serp1 identical ribosome associated membrane protein termed ramp4 copurified sec61 complex gorlich rapoport 1993
0.4653881.10601334.html.plaintext.txt	134	elegans serp1 cdna sequences obtained emblgenbankddbj accession nos
0.4653881.10601334.html.plaintext.txt	135	ab018546 ab022427 z81095 respectively
0.4653881.10601334.html.plaintext.txt	136	view larger version 6k figure 1
0.4653881.10601334.html.plaintext.txt	137	amino acid sequence rat human serp1
0.4653881.10601334.html.plaintext.txt	138	putative transmembrane domain underlined sequence used raising antibodies indicated box
0.4653881.10601334.html.plaintext.txt	139	expression serp1ramp4 homeostatic conditions response cell stress northern blotting total rna harvested rat tissues demonstrated similar levels serp1ramp4 transcripts range normal organs whereas heart lung muscle displayed lower levels mrna figure 2
0.4653881.10601334.html.plaintext.txt	140	cultured astrocytes exposed h showed time dependent increase serp1ramp4 transcripts although occurred relatively long term oxygen deprivation figure 2 b top h12 h22
0.4653881.10601334.html.plaintext.txt	141	cultures returned ambient environment hypoxia r increase serp1ramp4 mrna kept least 4 h figure 2 b top hr
0.4653881.10601334.html.plaintext.txt	142	levels serp1ramp4 mrna h hr compared sec61 complex sec61 sec61ss molecular chaperons er grp78 orp150 latter known induced h types er stress figure 2 b top
0.4653881.10601334.html.plaintext.txt	143	transcripts sec61 sec61ss increased manner paralleling serp1ramp4 whereas grp78 orp150 displayed enhanced expression earlier times began decline soon replacement normoxia
0.4653881.10601334.html.plaintext.txt	144	quantification northern analysis demonstrated serp1ramp4 grp78 mrnas increased 5
0.4653881.10601334.html.plaintext.txt	145	0 fold h compared normoxia respectively figure 2 b bottom
0.4653881.10601334.html.plaintext.txt	146	view larger version 108k figure 2
0.4653881.10601334.html.plaintext.txt	147	expression serp1ramp4 vivo vitro
0.4653881.10601334.html.plaintext.txt	148	distribution serp1 mrna normal rat organs
0.4653881.10601334.html.plaintext.txt	149	total rna 12 microglane indicated organ adult male rat applied lane
0.4653881.10601334.html.plaintext.txt	150	b brain h heart lu lung l liver k kidney spleen m muscle testes
0.4653881.10601334.html.plaintext.txt	151	lower panel shows ethidium bromide staining gel
0.4653881.10601334.html.plaintext.txt	152	b expression serp1ramp4 mrna hr comparison translocon sec61 sec61ss molecular chaperons orp150 grp78
0.4653881.10601334.html.plaintext.txt	153	cultured rat astrocytes subjected h 12 h h12 22 h h22 h 22 h followed r 4 h hr amount total rna 15 microglane used northern analysis
0.4653881.10601334.html.plaintext.txt	154	sixth panel shows ethidium bromide staining gel
0.4653881.10601334.html.plaintext.txt	155	c expression serp1ramp4 grp78 hsp72 mrna astrocytes subjected forms stress
0.4653881.10601334.html.plaintext.txt	156	total rna 10 microglane cultured rat astrocytes treated a23187 1 microm tunicamycin 1 microgml tu hydrogen peroxide 80 microm h2o2 heat shock 42 degrees c hs without treatment c used northern blotting detect serp1ramp4 transcripts
0.4653881.10601334.html.plaintext.txt	157	middle panel shows ethidium bromide staining gel
0.4653881.10601334.html.plaintext.txt	158	d expression serp1ramp4 protein cultured rat astrocytes exposed h hr er stress
0.4653881.10601334.html.plaintext.txt	159	protein extracts cultured rat astrocytes 107 cellscondition exposed h h22 h followed r hr left panel treated a23187 1 microm tunicamycin 1 microgml tu immunoprecipitated anti serp1ramp4 antibody subjected western blotting antibody
0.4653881.10601334.html.plaintext.txt	160	binding primary antibody detected enhanced chemiluminescence method
0.4653881.10601334.html.plaintext.txt	161	migration simultaneously run molecular mass standards indicated far left kd
0.4653881.10601334.html.plaintext.txt	162	quantification serp1ramp4 mrna grp78 mrna serp1ramp4 antigen performed laser densitometry expressed fold increase intensity condition compared normoxic control results quantification shown graphs bottom b c d
0.4653881.10601334.html.plaintext.txt	163	mean plus minus sd three experiments shown
0.4653881.10601334.html.plaintext.txt	164	treatment normoxic cultures tunicamycin a23187 result accumulation unfolded polypeptides within er bush et al
0.4653881.10601334.html.plaintext.txt	165	8 fold increase serp1ramp4 transcripts respectively whereas hydrogen peroxide hsp without effect figure 2 c
0.4653881.10601334.html.plaintext.txt	166	accompanying hr er stress induced elevation serp1ramp4 mrna five sixfold increase serp1ramp4 antigen 10 kd shown using immunoprecipitation followed immunoblotting anti serp1 antibody figure 2 d
0.4653881.10601334.html.plaintext.txt	167	immunostaining bhk cells transiently transfected flag tagged serp1ramp4 displayed overlapping distribution serp1ramp4 antigen er marker pdi figure 3 c
0.4653881.10601334.html.plaintext.txt	168	although serp1ramp4 putative n glycosylation site nh2 terminus treatment serp1ramp4 transfected cells tunicamycin incubation serp1ramp4 protein endoglycosidase h revealed change serp1ramp4 respect either subcellular distribution migration sds page suggesting glycosylation occurred data shown
0.4653881.10601334.html.plaintext.txt	169	view larger version 42k figure 3
0.4653881.10601334.html.plaintext.txt	170	immunostaining bhk cells transfected flag tagged pcdnaserp1ramp4 using anti flag antibody anti pdi antibody b c
0.4653881.10601334.html.plaintext.txt	171	serp1ramp4 transfected bhk cells fixed 0
0.4653881.10601334.html.plaintext.txt	172	1 np 404 paraformaldehyde solution subjected immunostaining protocol see text
0.4653881.10601334.html.plaintext.txt	173	sites primary antibody binding visualized tritc conjugated anti mouse antibody flag epitope fitc conjugated anti rabbit antibody pdi b using detection systems c
0.4653881.10601334.html.plaintext.txt	174	upper panels show lower magnification lower panels higher magnification
0.4653881.10601334.html.plaintext.txt	175	note two epitopes colocalize throughout interior even peripheral regions cells
0.4653881.10601334.html.plaintext.txt	176	extend studies serp1ramp4 expression response oxygen deprivation vivo distribution serp1ramp4 transcripts expression serp1ramp4 antigen assessed rat brain mca occlusion
0.4653881.10601334.html.plaintext.txt	177	situ hybridization showed increased serp1ramp4 transcripts especially periischemic penumbral region compared lower levels expression nonischemic areas figure 4
0.4653881.10601334.html.plaintext.txt	178	microautoradiography suggested induction serp1ramp4 transcripts occurred neurons astrocytes ischemic hemisphere figure 4 b
0.4653881.10601334.html.plaintext.txt	179	immunoprecipitation followed western blotting anti serp1ramp4 antibody confirmed 5
0.4653881.10601334.html.plaintext.txt	180	7 fold induction serp1ramp4 antigen rat ischemic brain figure 4 c
0.4653881.10601334.html.plaintext.txt	181	view larger version 26k figure 4
0.4653881.10601334.html.plaintext.txt	182	expression serp1ramp4 ischemic rat brain
0.4653881.10601334.html.plaintext.txt	183	brain ischemia induced rats unilateral left mca occlusion
0.4653881.10601334.html.plaintext.txt	184	12 h ischemia rats killed brain slices studied situ hybridization b riboprobes derived serp1 cdna detect serp1ramp4 transcripts
0.4653881.10601334.html.plaintext.txt	185	serp1ramp4 antigen also studied homogenates brain samples using immunoprecipitation followed western blotting anti serp1ramp4 antibody c
0.4653881.10601334.html.plaintext.txt	186	b shows microautoradiogram boxed area displaying enhanced serp1ramp4 mrna periischemic penumbral region
0.4653881.10601334.html.plaintext.txt	187	c shows induction serp1ramp4 protein level ischemic brain
0.4653881.10601334.html.plaintext.txt	188	c control hemisphere ischemic hemisphere
0.4653881.10601334.html.plaintext.txt	189	migration simultaneously run molecular mass standards indicated left side kd
0.4653881.10601334.html.plaintext.txt	190	quantification serp1ramp4 antigen ischemic brain c right showed fold increase mean plus minus sd three experiments
0.4653881.10601334.html.plaintext.txt	191	effect serp1ramp4 stabilization membrane proteins response er stress effect serp1ramp4 processing two integral membrane glycoproteins rage neeper et al
0.4653881.10601334.html.plaintext.txt	192	1992 cd8 studied cotransfecting 293 cells expression vectors along pcdnaserp1ramp4
0.4653881.10601334.html.plaintext.txt	193	transient transfection cultures pcdna3rage followed treatment cells tunicamycin figure 5 a23187 data shown resulted trapping rage er followed degradation
0.4653881.10601334.html.plaintext.txt	194	similar results observed cd8 overexpressed cultures treated drugs
0.4653881.10601334.html.plaintext.txt	195	intracellular levels rage analyzed immunoblotting figure 5 b metabolic labeling 35smethionine followed immunoprecipitation figure 5 c
0.4653881.10601334.html.plaintext.txt	196	293 cells overexpressing rage exposed tunicamycin a23187 showed decrease amount rage antigen 58 36 respectively compared quiescent cultures mr 55 kd glycosylated form 52 kd unglycosylated form well poorly defined smear rage immunoreactivity upper portion membrane latter likely due aggregation rage figure 5 b lanes 2 3 andor several rapidly migrating immunoreactive bands consistent occurrence degradation figure 5 b lane 3
0.4653881.10601334.html.plaintext.txt	197	immunoprecipitation cell lysates anti rage antibody followed western blotting antiubiquitin antibody showed smear rage immunoreactivity includes polyubiquitinated rage data shown
0.4653881.10601334.html.plaintext.txt	198	although cotransfection quiescent 293 cells pcdna3rage pcdna3serp1ramp4 apparent effect rage antigen figure 5 b lane 4 overexpression serp1ramp4 tunicamycin a23187 treated cultures increased intensity major rage band 80 86 intensity untreated controls respectively
0.4653881.10601334.html.plaintext.txt	199	furthermore higher lower molecular weight immunoreactive rage bands disappeared cotransfectants overexpressing rage serp1ramp4 figure 5 b lanes 5 6
0.4653881.10601334.html.plaintext.txt	200	contrast overexpression sec61ss instead serp1ramp4 similar effect rage overexpression serp1ramp4 stabilize cytosolic proteins ib also undergoes degradation response stress conditions study data shown
0.4653881.10601334.html.plaintext.txt	201	view larger version 60k figure 5
0.4653881.10601334.html.plaintext.txt	202	effect serp1ramp4 stabilization refolding membrane proteins er stress
0.4653881.10601334.html.plaintext.txt	203	subcellular localization rage control tunicamycin treated cells
0.4653881.10601334.html.plaintext.txt	204	rage transfected bhk cells fixed 0
0.4653881.10601334.html.plaintext.txt	205	1 np 404 paraformaldehyde subjected immunostaining rabbit anti rage antibody primary antibody fitc conjugated anti rabbit igg secondary antibody
0.4653881.10601334.html.plaintext.txt	206	addition tunicamycin caused rage distributed mainly perinuclear region
0.4653881.10601334.html.plaintext.txt	207	b western blotting anti rage igg using cell extracts rage transfected 293 cells without cotransfection pcdnaserp1ramp4 treatment tunicamycin a23187 top quantification intensity rage immunoreactive bands percentage intensity bands control rage transfected cultures bottom
0.4653881.10601334.html.plaintext.txt	208	mean plus minus sd three experiments shown
0.4653881.10601334.html.plaintext.txt	209	lane 1 rage transfection alone lane 2 rage transfection plus tunicamycin lane 3 rage transfection plus a23187 lane 4 rage plus serp1ramp4 cotransfection lane 5 rage plus serp1ramp4 cotransfection plus tunicamycin lane 6 rage plus serp1ramp4 cotransfection plus a23187
0.4653881.10601334.html.plaintext.txt	210	c immunoprecipitation either anti rage anti cd8 igg metabolic labeling 30 min alone additional chasing 60 min top quantification intensity corresponding rage cd8 immunoreactive bands percentage band control rage cd8 transfected cultures bottom
0.4653881.10601334.html.plaintext.txt	211	mean plus minus sd three experiments shown
0.4653881.10601334.html.plaintext.txt	212	lane 1 transfection pcdna3rage pcdna3cd8 alone lane 2 transfection lane 1 followed treatment tunicamycin lane 3 transfection lane 1 followed treatment a23187 lane 4 transfection lane 1 followed cotransfection pcdnaserp1ramp4 treatment tunicamycin lane 5 transfection lane 1 followed cotransfection pcdnaserp1ramp4 treatment a23187
0.4653881.10601334.html.plaintext.txt	213	d metabolic labeling rage transfected 293 cells quenching tunicamycin treatment
0.4653881.10601334.html.plaintext.txt	214	control cells lane 4 treated tunicamycin cotransfected pcdna3serp1ramp4
0.4653881.10601334.html.plaintext.txt	215	cultures transfected cotransfected constructs encoding rage andor serp1
0.4653881.10601334.html.plaintext.txt	216	glycosylated unglycosylated forms rage indicated cho cho
0.4653881.10601334.html.plaintext.txt	217	293 cells transfected pcdna3rage labeled 35smethionine 30 min treatment cell cultures tunicamycin a23187
0.4653881.10601334.html.plaintext.txt	218	immunoprecipitation rage resulted appearance expected immunoreactive species figure 5 c top
0.4653881.10601334.html.plaintext.txt	219	however rage present 60 min chase period substantially reduced tunicamycin a23187 treated cells 32 5 untreated control respectively presumably due degradation figure 5 c lanes 2 3
0.4653881.10601334.html.plaintext.txt	220	cotransfection pcdnaserp1ramp4 along pcdna3rage maintained least part levels rage cells exposed tunicamycin figure 5 c lane 4 73 untreated control a23187 figure 5 c lane 5 60 untreated control
0.4653881.10601334.html.plaintext.txt	221	similar results obtained pcdna3cd8 transfected instead pcdna3rage figure 5 c
0.4653881.10601334.html.plaintext.txt	222	effect serp1ramp4 glycosylation membrane proteins er stress view enhanced expression serp1ramp4 h r homology yeast protein ysy6p sakaguchi et al
0.4653881.10601334.html.plaintext.txt	223	1991 studies performed assess contribution serp1ramp4 protein refolding glycosylation stress
0.4653881.10601334.html.plaintext.txt	224	serp1ramp4 overexpression detectable effect glycosylation rage presence tunicamycin figure 5b figure c
0.4653881.10601334.html.plaintext.txt	225	however metabolic labeling 35smethionine 3 h using pcdna3rage transfected 293 cells quenching tunicamycin treatment demonstrated serp1ramp4 overexpression stabilized unglycosylated rage also facilitated least part glycosylation rage figure 5 d lanes 2 3 24 total rage glycosylated
0.4653881.10601334.html.plaintext.txt	226	effects serp1ramp4 overexpression stress due induction ost complex enzymes required n linked glycosylation data shown
0.4653881.10601334.html.plaintext.txt	227	interactions serp1ramp4 rage sec61 complex molecular chaperons analyze mechanism underlying chaperon like functions serp1ramp4 stabilizing facilitating glycosylation membrane proteins er stress first studied interaction serp1ramp4 integral membrane protein rage
0.4653881.10601334.html.plaintext.txt	228	however co ip 293 cells transfected pcdna3rage pcdna3serp1ramp4 show complex comprised molecules either normal stress conditions
0.4653881.10601334.html.plaintext.txt	229	next binding serp1ramp4 sec61 complex examined since ramp4 originally copurified sec61 complex gorlich rapoport 1993
0.4653881.10601334.html.plaintext.txt	230	co ip study using whole cell lysates np 40 containing buffer figure 6 co ip cross linking membrane fractions figure 6 b revealed serp1ramp4 formed stable complex sec61ss transfected cells endogenous conditions
0.4653881.10601334.html.plaintext.txt	231	figure 6 b lane 4 two major bands 42 27 kd may represent heterotrimer heterodimer sec61ss serp1ramp4 complex based molecular masses molecules
0.4653881.10601334.html.plaintext.txt	232	noted transfection cells pcdna3serp1ramp4 resulted least 10 times higher expression proteins based immunoprecipitation western blotting data shown
0.4653881.10601334.html.plaintext.txt	233	rule possibility sec61ss formed complex serp1ramp4 dissociation sec61 complex np 40 containing buffer similar co ip studies performed cell lysates made presence deoxycholate figure 6 c
0.4653881.10601334.html.plaintext.txt	234	conditions sec61ss also sec61 coimmunoprecipitated serp1ramp4
0.4653881.10601334.html.plaintext.txt	235	view larger version 34k figure 6
0.4653881.10601334.html.plaintext.txt	236	interaction serp1ramp4 rage sec61 complex molecular chaperon calnexin
0.4653881.10601334.html.plaintext.txt	237	c f 293 cells transfected cotransfected constructs encoding flag serp1ramp4 andor rage co ip performed indicated antibodies lysis cultures buffer containing np 40 d e deoxycholate c f
0.4653881.10601334.html.plaintext.txt	238	b co ip study cross linking membrane fractions 293 cells cotransfected pcdna3flag serp1 ramp4 pcdna3ha sec61ss
0.4653881.10601334.html.plaintext.txt	239	cross linking performed dss described text co ip carried using anti flag anti ha antibodies
0.4653881.10601334.html.plaintext.txt	240	migration simultaneously run molecular mass standards indicated left kd
0.4653881.10601334.html.plaintext.txt	241	formation complex rage sec61 complex also studied co ip sec61ss rage complex detected response stress np 40 deoxycholate containing buffer although sec61 rage binding detected presence deoxycholate figure 6d figure e
0.4653881.10601334.html.plaintext.txt	242	serp1ramp4 also became associated calnexin membrane protein molecular chaperon er figure 6 f
0.4653881.10601334.html.plaintext.txt	243	interaction occurred control endogenous conditions overexpression serp1ramp4
0.4653881.10601334.html.plaintext.txt	244	co ip studies 10 15 sec61ss coimmunoprecipitated serp1 unglycosylated rage respectively data shown
0.4653881.10601334.html.plaintext.txt	245	discussion top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	246	key facet cellular response environmental stress imposed oxygen deprivation appears induction molecular chaperons
0.4653881.10601334.html.plaintext.txt	247	context previous studies laboratories demonstrated induction molecular chaperons er grp78 grp94 novel 150 kd polypeptide termed orp150 lowenstein et al
0.4653881.10601334.html.plaintext.txt	248	1996 hypoxic ischemic conditions
0.4653881.10601334.html.plaintext.txt	249	suppression orp150 transcripts oxygen deprived cultures human embryonic kidney cells increased vulnerability h induced apoptosis ozawa et al
0.4653881.10601334.html.plaintext.txt	250	1999 suggesting stress response er might important role adaptation ischemic challenge
0.4653881.10601334.html.plaintext.txt	251	current studies describe another polypeptide serp1 whose expression increased hr although induction preceded molecular chaperons er participates er stress response due accumulation unfolded proteins er
0.4653881.10601334.html.plaintext.txt	252	serp1 encodes polypeptide localized er comprised 66 amino acids identical ramp4
0.4653881.10601334.html.plaintext.txt	253	ramp4 originally copurified core component protein translocation machinery er sec61 complex recently reported ramp4 controls glycosylation major histocompatbility complex class ii associated invariant chain schroder et al
0.4653881.10601334.html.plaintext.txt	254	sec61 complex composed ss subunits assemble channel nascent proteins enter er gorlich et al
0.4653881.10601334.html.plaintext.txt	255	putative transmembrane spanning domain cooh terminus probably anchors serp1ramp4 er membrane
0.4653881.10601334.html.plaintext.txt	256	orientation serp1ramp4 er likely present nh2 terminus cytosol predicted previous studies similar proteins hartmann et al
0.4653881.10601334.html.plaintext.txt	257	1993 consistent apparent lack glycosylation putative n glycosylation site serp1ramp4 nh2 terminus
0.4653881.10601334.html.plaintext.txt	258	serp1ramp4 displays homology yeast ysy6p identified based capacity suppress defect protein export secy sec61 homologue bacteria mutant sakaguchi et al
0.4653881.10601334.html.plaintext.txt	259	identity serp1 ramp4 homology serp1 ysy6 well induction serp1 response er stress mrna protein levels suggested hypothesis serp1 might participate biosynthesis degradation secretory membrane proteins
0.4653881.10601334.html.plaintext.txt	260	evaluate effect serp1ramp4 protein processing experiments performed address whether serp1ramp4 effect stabilization refolding membrane proteins stress conditions
0.4653881.10601334.html.plaintext.txt	261	induction er stress tunicamycin a23187 293 cells promoted aggregation degradation two integral membrane proteins rage cd8 members ig superfamily cell surface molecules single transmembrane spanning domain
0.4653881.10601334.html.plaintext.txt	262	cotransfection 293 cells overexpress serp1ramp4 prevented accelerated aggregation degradation rage cd8 setting er stress figure 5b figure c
0.4653881.10601334.html.plaintext.txt	263	although yet clear whether effects serp1ramp4 occurred directly preventing degradation membrane proteins promoting refolding er results support latter concept serp1ramp4 facilitate least part glycosylation integral membrane proteins er er stress relieved figure 5 d without induction ost
0.4653881.10601334.html.plaintext.txt	264	co ip cross linking studies revealed serp1ramp4 interacts sec61 sec61ss subunits bind rage analogy membrane proteins response cellular perturbation figure 6 e
0.4653881.10601334.html.plaintext.txt	265	important note serp1ramp4 likely interact er proteins addition sec61 sec61ss indicated presence several bands immunoblotting serp1ramp4 cross linking figure 6 b
0.4653881.10601334.html.plaintext.txt	266	however previous cross linking study ramp4 detected complex sec61ss kalies et al
0.4653881.10601334.html.plaintext.txt	267	speculate reason difference results likely derive use different cross linking agents
0.4653881.10601334.html.plaintext.txt	268	1998 used bis maleimidohexane depends optimal juxtaposition cysteines whereas study used dss interact sulfhydryl groups
0.4653881.10601334.html.plaintext.txt	269	serp1ramp4 coprecipitated calnexin figure 6 f membrane protein molecular chaperon er known associate folding intermediates glycoproteins monomeric glycoproteins believed play major role quality control apparatus er ou et al
0.4653881.10601334.html.plaintext.txt	270	together results suggest stabilization membrane proteins er stress involves concerted action rescue unit er membrane comprised serp1ramp4 components translocon sec61 sec61ss er chaperons calnexin
0.4653881.10601334.html.plaintext.txt	271	increased expression components sec61 complex begins relatively late h 12 h sustained r
0.4653881.10601334.html.plaintext.txt	272	suggests induction sec61 complex probably integral role increased biosynthesis luminal membrane proteins replacement damaged stress
0.4653881.10601334.html.plaintext.txt	273	noteworthy expression serp1ramp4 parallels components sec61 complex luminal er chaperons declines r
0.4653881.10601334.html.plaintext.txt	274	may indicate functions sec61 complex serp1ramp4 de novo protein synthesis tightly coupled
0.4653881.10601334.html.plaintext.txt	275	considerations underline importance studies determine detailed function serp1ramp4 context cell stress contribution serp1ramp4 cellular processing native polypeptides disease related proteins cystic fibrosis transmembrane conductance regulator cftr bebok et al
0.4653881.10601334.html.plaintext.txt	276	1995 amyloid beta precursor protein app coor et al
0.4653881.10601334.html.plaintext.txt	277	hori contributed equally work
0.4653881.10601334.html.plaintext.txt	278	1 abbreviations used paper co ip coimmunoprecipitation dss disuccinimidyl suberate grp glucose regulated protein h hypoxia ha hemagglutinin hsp heat shock protein mca middle cerebral artery orf open reading frame orp oxygen regulated protein ost oligosaccaryltransferase pdi protein disulfide isomerase r reoxygenation rage receptor advanced glycation endproducts ramp ribosome associated membrane protein serp stress associated endoplasmic reticulum protein ysy6p yeast suppressor secy 6 protein
0.4653881.10601334.html.plaintext.txt	279	acknowledgements top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	280	rapoport providing anti sec61 anti sec61ss antibodies
0.4653881.10601334.html.plaintext.txt	281	kazunori imaizumi ryuichi masaki providing cdnas andor antibodies cd8 pdi
0.4653881.10601334.html.plaintext.txt	282	masao sakaguchi kyusyu university fukuoka japan koreaki ito kyoto university kyoto japan providing information yeast ysy6p dr
0.4653881.10601334.html.plaintext.txt	283	naoya sato osaka university giving valuable suggestions
0.4653881.10601334.html.plaintext.txt	284	submitted 6 july 1999 revised 18 october 1999 accepted 1 november 1999
0.4653881.10601334.html.plaintext.txt	285	references top abstract introduction materials methods results discussion acknowledgements references
0.4653881.10601334.html.plaintext.txt	286	distribution protein disulfide isomerase rat hepatocytes
0.4653881.10601334.html.plaintext.txt	287	cytochem 361533 1542abstract
0.4653881.10601334.html.plaintext.txt	288	mechanism underlying cystic fibrosis transmembrane conductance regulator transport endoplasmic reticulum proteasome includes sec61ss cytosolic deglycosylated intermediary
0.4653881.10601334.html.plaintext.txt	289	27329873 29878abstractfree full text
0.4653881.10601334.html.plaintext.txt	290	progression ischemic injury infarct following middle cerebral artery occlusion rat
0.4653881.10601334.html.plaintext.txt	291	predicting orientation eukaryotic membrane spanning proteins
0.4653881.10601334.html.plaintext.txt	292	2nd ed new york plenum press 603 661
0.4653881.10601334.html.plaintext.txt	293	ss subunit sec61 complex facilitates cotranslational protein transport interacts signal peptidase translocation
0.4653881.10601334.html.plaintext.txt	294	141887 894abstractfree full text
0.4653881.10601334.html.plaintext.txt	295	altered gene expression brain ischemia
0.4653881.10601334.html.plaintext.txt	296	class membrane proteins c terminal anchor
0.4653881.10601334.html.plaintext.txt	297	purification characterization novel stress protein 150 kda oxygen regulated protein orp150 cultured rat astrocytes expression ischemic mouse brain
0.4653881.10601334.html.plaintext.txt	298	hypoxiareoxygenation mediated induction interleukin 6 paracrine mechanism potentially enhancing neuron survival
0.4653881.10601334.html.plaintext.txt	299	cloning novel rna binding poly peptide ra301 induced hypoxiareoxygenation
0.4653881.10601334.html.plaintext.txt	300	27028216 28222abstractfree full text
0.4653881.10601334.html.plaintext.txt	301	cloning putative vesicle transport related protein ra410 cultured rat astrocytes expression ischemic rat brain
0.4653881.10601334.html.plaintext.txt	302	27216438 16444abstractfree full text
0.4653881.10601334.html.plaintext.txt	303	preparation separate astroglial oligodendroglial cell cultures rat cerebral tissue
0.4653881.10601334.html.plaintext.txt	304	cloning expression cell surface receptor advanced glycosylation end products proteins
0.4653881.10601334.html.plaintext.txt	305	26714998 15004abstractfree full text
0.4653881.10601334.html.plaintext.txt	306	hypoxia modulates barrier coagulant function cultures bovine endothelium
0.4653881.10601334.html.plaintext.txt	307	150 kda oxygen regulated protein orp150 suppressed hypoxia induced apoptotic cell death
0.4653881.10601334.html.plaintext.txt	308	2746397 6404abstractfree full text
0.4653881.10601334.html.plaintext.txt	309	yeast gene suppresses defect protein transport secy mutant e
0.4653881.10601334.html.plaintext.txt	310	endothelial cell binding site advanced glycation end products consists complex integral membrane protein lactoferrin like polypeptide
0.4653881.10601334.html.plaintext.txt	311	2699882 9888abstractfree full text
0.4653881.10601334.html.plaintext.txt	312	control glycosylation mhc class ii associated invariant chain translocon associated ramp4
0.4653881.10601334.html.plaintext.txt	313	184804 4815abstractfree full text
0.4653881.10601334.html.plaintext.txt	314	differential hydroxylation salicylate core penumbra regions focal reversible cerebral ischemia
0.4653881.10601334.html.plaintext.txt	315	stroke 282545 2552abstractfree full text
0.4653881.10601334.html.plaintext.txt	316	150 kd oxygen regulated protein expressed human atherosclerotic plaques allows mononuclear phagocytes withstand cellular stress exposure hypoxia modified low density lipoprotein
0.4653881.10601334.html.plaintext.txt	317	981930 1941abstractfree full text
0.4653881.10601334.html.plaintext.txt	318	promotion transferrin folding cyclic interaction calnexin calreticulin
0.4653881.10601334.html.plaintext.txt	319	165420 5432abstractfree full text
0.4653881.10601334.html.plaintext.txt	320	molecular architecture er translocase probed chemical crosslinking sss1p complementary fragments sec61p
0.4653881.10601334.html.plaintext.txt	321	164549 4559abstractfree full text
0.54181886.9915789.html.plaintext.txt	0	evidence endoplasmic reticulum er associated degradation cystic fibrosis transmembrane conductance regulator linked retrograde translocation er membrane ximing xiong elaine chong william r
0.54181886.9915789.html.plaintext.txt	1	department molecular cellular engineering department medicine university pennsylvania philadelphia pennsylvania 19104
0.54181886.9915789.html.plaintext.txt	2	abstract top abstract introduction references
0.54181886.9915789.html.plaintext.txt	3	ubiquitin proteasome pathway implicated degradation newly synthesized misfolded unassembled proteins endoplasmic reticulum er
0.54181886.9915789.html.plaintext.txt	4	using cell free reticulocyte lysate system examined relationship biosynthesis er associated degradation cystic fibrosis transmembrane conductance regulator cftr polytopic protein 12 predicted transmembrane segments
0.54181886.9915789.html.plaintext.txt	5	results provide direct evidence full length glycosylated membrane integrated cftr substrate degradation degradation involves polyubiquitination cytosolic proteolytic activity
0.54181886.9915789.html.plaintext.txt	6	cftr ubiquitination temperature atp dependent
0.54181886.9915789.html.plaintext.txt	7	degradation significantly inhibited edta apyrase proteasome inhibitors hemin mg132
0.54181886.9915789.html.plaintext.txt	8	degradation inhibited lesser extent clasto lactacystin lactone alln n tosyl l phenylalanine chloromethyl ketone relatively unaffected lactacystin n tosyl lysyl chloromethyl ketone
0.54181886.9915789.html.plaintext.txt	9	presence hemin polyubiquitinated cftr remained tightly associated er microsomes
0.54181886.9915789.html.plaintext.txt	10	however membrane bound ubiquitinated cftr could subsequently degraded trichloroacetic acid soluble fragments upon incubation hemin free atp containing lysate
0.54181886.9915789.html.plaintext.txt	11	thus er associated degradation cftr occurs via membrane bound rather cytosolic intermediate likely involves recruitment degradation machinery er membrane
0.54181886.9915789.html.plaintext.txt	12	data suggest model degradation polytopic proteins cftr coupled retrograde translocation removal polypeptide lipid bilayer
0.54181886.9915789.html.plaintext.txt	13	introduction top abstract introduction references
0.54181886.9915789.html.plaintext.txt	14	rough endoplasmic reticulum er1 facilitates translocation membrane integration folding oligomeric assembly proteins found secretory pathway eukaryotic cells 1 4
0.54181886.9915789.html.plaintext.txt	15	er also functions recognize misfolded unassembled proteins prevent exit golgi complex 5 7 process termed er associated degradation erad 8
0.54181886.9915789.html.plaintext.txt	16	substrates erad like secretory transmembrane proteins initially targeted translocated across er membrane via sec61 translocon complex 1 2
0.54181886.9915789.html.plaintext.txt	17	however aberrantly folded proteins selectively translocated back cytosol undergo ubiquitination degradation cytosolic proteases 9 11
0.54181886.9915789.html.plaintext.txt	18	certain erad substrates major histocompatibility complex class heavy chains 10 12 13 unglycosylated prepro factor undergo complete retrograde translocation soluble cytosolic form prior degradation 8
0.54181886.9915789.html.plaintext.txt	19	contrast mutant forms carboxypeptidase y unassembled cell receptor subunits translocate back cytosol remain associated cytoplasmic face er membrane 14 15
0.54181886.9915789.html.plaintext.txt	20	cases generation cytosolic intermediates thought occur via retrograde transport sec61 translocon complex 9 11
0.54181886.9915789.html.plaintext.txt	21	ubiquitin proteasome pathway also involved er associated degradation polytopic proteins
0.54181886.9915789.html.plaintext.txt	22	yeast mutants defective ubiquitin conjugating enzymes proteasome subunits show decreased degradation mutant forms sec61p 16 17 resident er protein 10 predicted transmembrane segments 18
0.54181886.9915789.html.plaintext.txt	23	erad may also play role ensuring proper protein levels er suggested mevalonate mediated regulation 3 hydroxy 3 methylglutaryl coenzyme reductase 19 21
0.54181886.9915789.html.plaintext.txt	24	cystic fibrosis transmembrane conductance regulator cftr plasma membrane protein approximately 80 wild type protein 100 common mutant forms degraded prior reaching golgi complex 22 23
0.54181886.9915789.html.plaintext.txt	25	recent studies demonstrated er associated degradation cftr also requires intact ubiquitin conjugation pathway likely involves 26 proteasome 24 25
0.54181886.9915789.html.plaintext.txt	26	underlying reasons cftr degradation remain unknown proposed majority wild type cftr like mutant cftr recognized er quality control machinery fails fold properly 26 29
0.54181886.9915789.html.plaintext.txt	27	degradation polytopic proteins cytosolic proteases poses particular problem multiple transmembrane tm segments must removed membrane
0.54181886.9915789.html.plaintext.txt	28	unclear whether polytopic proteins like secretory bitopic transmembrane proteins proceed cytosolic intermediates prior degradation
0.54181886.9915789.html.plaintext.txt	29	one possibility proteasome might degrade cytosolic peptide loops leaving lumenal andor transmembrane segments degraded proteases 7 30
0.54181886.9915789.html.plaintext.txt	30	alternatively degradation might coupled process retrograde translocation
0.54181886.9915789.html.plaintext.txt	31	distinguish among possibilities necessary define temporal relationship recognition retrograde translocation degradation events involved polytopic protein er degradation
0.54181886.9915789.html.plaintext.txt	32	regard cell free system reconstitutes erad attractive readily amenable physical pharmacological manipulation
0.54181886.9915789.html.plaintext.txt	33	using system sato et al
0.54181886.9915789.html.plaintext.txt	34	31 recently demonstrated cftr could ubiquitinated cotranslationally indicating initial recognition events er degradation might occur early lifetime polytopic protein
0.54181886.9915789.html.plaintext.txt	35	current study use similar cell free system demonstrate cftr ubiquitination also occur protein synthesis n linked glycosylation membrane integration completed
0.54181886.9915789.html.plaintext.txt	36	also able separate process ubiquitination degradation show ubiquitinated cftr remains tightly associated er membrane degraded trichloroacetic acid soluble peptide fragments
0.54181886.9915789.html.plaintext.txt	37	cftr degradation therefore physically localized er
0.54181886.9915789.html.plaintext.txt	38	results consistent model cytosolic degradation machinery recruited er membrane polyubiquitinated substrates suggest degradation occurs coincident polypeptide removal lipid bilayer
0.54181886.9915789.html.plaintext.txt	39	materials alln tpck tlck hemin bovine ubiquitin anti bovine ubiquitin antibody 14c methylated lysozyme purchased sigma
0.54181886.9915789.html.plaintext.txt	40	protease inhibitor mixture 4 2 aminoethylbenzenesulfonyl fluoride aprotinin e 64 edta leupeptin mg132 lactacystin clasto lactacystin lactone purchased calbiochem
0.54181886.9915789.html.plaintext.txt	41	nucleotide triphosphates creatine phosphate creatine kinase dithiothreitol dtt purchased boehringer mannheim
0.54181886.9915789.html.plaintext.txt	42	anti cftr antisera raised synthetic peptides corresponding residues 45 65 n terminus 680 700 r domain 1458 1476 c terminus babco berkeley ca
0.54181886.9915789.html.plaintext.txt	43	regents purchased sigma unless otherwise stated
0.54181886.9915789.html.plaintext.txt	44	rabbit reticulocyte lysate translation prepared fresh rabbit reticulocytes induced acetylphenylhydrazine treatment described previously 32 stored 80 degrees c
0.54181886.9915789.html.plaintext.txt	45	prior freezing hemin added final concentration 40 microm
0.54181886.9915789.html.plaintext.txt	46	degradation experiments rrl either purchased green hectare farm oregon wi prepared described previously 32 without addition hemin
0.54181886.9915789.html.plaintext.txt	47	although degradation efficiency varied different preparations rrl consistent differences observed different rrl sources
0.54181886.9915789.html.plaintext.txt	48	prepare atp depleted rrl reticulocytes washed three times ice cold phosphate buffered saline resuspended krebs ringer phosphate medium lacking glucose incubated 0
0.54181886.9915789.html.plaintext.txt	49	2 mm 24 dinitrophenol 20 mm 2 deoxyglucose 37 degrees c 90 min 33
0.54181886.9915789.html.plaintext.txt	50	reticulocytes washed twice phosphate buffered saline lysed adding 1
0.54181886.9915789.html.plaintext.txt	51	samples centrifuged 15000 rpm 30 min beckman ja17 rotor supernatant
0.54181886.9915789.html.plaintext.txt	52	rrl stored 80 degrees c
0.54181886.9915789.html.plaintext.txt	53	methylated ubiquitin prepared reductive methylation described previously 34
0.54181886.9915789.html.plaintext.txt	54	bovine ubiquitin incubated room temperature 20 h 12 mm formaldehyde 20 mm cyanoborohydride followed additional hour fresh reagents
0.54181886.9915789.html.plaintext.txt	55	reaction dialyzed 48 h 10 mm hepes 5 mm mgcl2 3 mm dtt concentrated 10 mgml using centricon number 3 filter
0.54181886.9915789.html.plaintext.txt	56	cell free transcriptiontranslation cftr mrna transcribed vitro 40 degrees c 1 h reactions containing 0
0.54181886.9915789.html.plaintext.txt	57	4 mgml plasmid dna plasmid pspcftr35 40 mm tris ph 7
0.54181886.9915789.html.plaintext.txt	58	5 mm gpppg amersham pharmacia biotech 10 mm dtt 0
0.54181886.9915789.html.plaintext.txt	59	75 unitml rnase inhibitor promega madison wi 0
0.54181886.9915789.html.plaintext.txt	60	4 unitml sp6 rna polymerase new england biolabs beverly ma
0.54181886.9915789.html.plaintext.txt	61	transcript stored frozen 80 degrees c
0.54181886.9915789.html.plaintext.txt	62	translation performed 24 25 degrees c 2 h reaction containing 20 transcription mixture 40 nuclease treated rabbit reticulocyte lysate 20 emix final concentration 400 microgml creatine kinase 0
0.54181886.9915789.html.plaintext.txt	63	2 microl rnase inhibitor promega 10 mm tris ph 7
0.54181886.9915789.html.plaintext.txt	64	5 100 mm koac 2 mm mgcl2 2 mm dtt
0.54181886.9915789.html.plaintext.txt	65	emix contains 5 mm atp 5 mm gtp 60 mm creatine phosphate 0
0.54181886.9915789.html.plaintext.txt	66	2 mm 19 essential amino acids except methionine 5 microci microl tran35s label icn pharmaceuticals irvine ca
0.54181886.9915789.html.plaintext.txt	67	canine pancreas microsomal membranes prepared described elsewhere 36 added start translation final concentration a280 8
0.54181886.9915789.html.plaintext.txt	68	experiments except fig
0.54181886.9915789.html.plaintext.txt	69	1a aurin tricarboxylic acid 0
0.54181886.9915789.html.plaintext.txt	70	1 mm added translation mixture 15 min synchronize translation reduce synthesis partial length chains
0.54181886.9915789.html.plaintext.txt	71	membrane pelleting floatation experiments puromycin hcl final concentration 1 mm added 110 min ensure nascent chains released ribosomes
0.54181886.9915789.html.plaintext.txt	72	carbonate extraction translation products incubated 0
0.54181886.9915789.html.plaintext.txt	73	5 30 min ice described 37
0.54181886.9915789.html.plaintext.txt	74	samples centrifuged 180000 x g 30 min membrane pellets dissolved directly sds loading buffer
0.54181886.9915789.html.plaintext.txt	75	supernatants precipitated 20 trichloroacetic acid pelleted 16000 x g 15 min washed acetone dissolved sds loading buffer
0.54181886.9915789.html.plaintext.txt	76	immunoprecipitation rrl aliquots diluted directly 1 ml ice cold buffer 0
0.54181886.9915789.html.plaintext.txt	77	1 m nacl 1 triton x 100 2 mm edta 0
0.54181886.9915789.html.plaintext.txt	78	1 mm phenylmethylsulfonyl fluoride 0
0.54181886.9915789.html.plaintext.txt	79	0 preincubated antisera 10 30 min prior addition 5 microl protein affi gel bio rad
0.54181886.9915789.html.plaintext.txt	80	cftr antisera nonimmune antisera used 11000 dilution
0.54181886.9915789.html.plaintext.txt	81	ubiquitin antibody used 1200 dilution similar amounts ig present reactions
0.54181886.9915789.html.plaintext.txt	82	samples mixed 4 degrees c 6 10 h washed three times buffer twice 0
0.54181886.9915789.html.plaintext.txt	83	0 taken sds loading buffer
0.54181886.9915789.html.plaintext.txt	84	degradation assay translation mixture layered onto 0
0.54181886.9915789.html.plaintext.txt	85	1 m kcl 5 mm mgcl2 1 mm dtt centrifuged 180000 x g 10 min
0.54181886.9915789.html.plaintext.txt	86	membranes resuspended ice cold 0
0.54181886.9915789.html.plaintext.txt	87	1 m kcl 5 mm mgcl2 1 mm dtt one half original translation volume
0.54181886.9915789.html.plaintext.txt	88	degradation reaction assembled ice included 20 resuspended membranes 72 reticulocyte lysate final concentration 10 mm tris ph 7
0.54181886.9915789.html.plaintext.txt	89	5 1 mm atp 5 mm mgcl2 12 mm creatine phosphate 3 mm dtt 80 microgml creatine kinase
0.54181886.9915789.html.plaintext.txt	90	indicated rrl replaced water proteasome inhibitors added
0.54181886.9915789.html.plaintext.txt	91	atp depleted rrl atp creatine phosphate omitted
0.54181886.9915789.html.plaintext.txt	92	degradation mixture incubated 37 degrees c aliquots added directly loading buffer sds page enhance nen life sceince products fluorography autoradiography
0.54181886.9915789.html.plaintext.txt	93	autoradiograms scanned agfa studioscan ii transmission scanner using adobe photoshop software
0.54181886.9915789.html.plaintext.txt	94	quantitation autoradiograms performed using amersham pharmacia biotech dts scanning densitometer precalibrated kodak photographic step tablet eastman kodak co
0.54181886.9915789.html.plaintext.txt	95	trichloroacetic acid soluble counts quantitated precipitating degradation mixture 20 trichloroacetic acid incubating ice 30 min pelleting 16000 x g 15 min counting supernatants 10 volumes ready safe scintillation fluid beckman fullerton ca beckman ls6500 scintillation counter
0.54181886.9915789.html.plaintext.txt	96	vesicle pelleting floatation microsomal membranes translation mixture pelleted resuspended incubated atp containing rrl presence 40 microm hemin described
0.54181886.9915789.html.plaintext.txt	97	pelleting experiments aliquots rrlhemin mixture taken specified time points kcl triton x 100 added indicated mixture incubated ice 30 min pelleted 0
0.54181886.9915789.html.plaintext.txt	98	equivalent fractions pellet supernatant resuspended directly sds loading buffer analyzed sds page
0.54181886.9915789.html.plaintext.txt	99	floatation experiments aliquots rrlhemin mixture diluted 10 volumes 2
0.54181886.9915789.html.plaintext.txt	100	5 5 mm mgcl2 1 mm dtt 2
0.54181886.9915789.html.plaintext.txt	101	100 microl samples incubated ice 30 min overlaid 300 microl 1
0.54181886.9915789.html.plaintext.txt	102	1 m kcl 4 mm mgcl2 10 mm tris ph 7
0.54181886.9915789.html.plaintext.txt	103	5 1 mm dtt overlaid 200 microl 0
0.54181886.9915789.html.plaintext.txt	104	solutions centrifuged 350000 x g 2 h tla 100
0.54181886.9915789.html.plaintext.txt	105	55 microl aliquots taken top bottom mixed 180 microl 0
0.54181886.9915789.html.plaintext.txt	106	1 m sucrose buffer samples repelleted 170000 x g 10 min prior addition sds loading buffer autoradiography
0.54181886.9915789.html.plaintext.txt	107	vitro cftr biogenesis examine steps cftr degradation native er membranes first characterized expression full length cftr protein cell free rrl system
0.54181886.9915789.html.plaintext.txt	108	translation plasmid pspcftr 35 absence er derived microsomal membranes generated polypeptide migrating 160 kda fig
0.54181886.9915789.html.plaintext.txt	109	translation product shifted 6 kda size rough microsomes added start translation consistent addition two n linked core carbohydrates predicted consensus sites fourth extracytoplasmic loop
0.54181886.9915789.html.plaintext.txt	110	presence full length cftr confirmed immunoprecipitation peptide specific antisera raised n terminus r domain c terminus epitopes
0.54181886.9915789.html.plaintext.txt	111	carbonate extraction translation products demonstrated vitro synthesized cftr fully integrated er membrane
0.54181886.9915789.html.plaintext.txt	112	thus rrl system capable efficiently reconstituting early events cftr biosynthesis processing agreement results reported sato et al
0.54181886.9915789.html.plaintext.txt	113	test stability newly synthesized cftr er membrane cyclohexamide added 2 h translation samples incubated additional 4 h fig
0.54181886.9915789.html.plaintext.txt	114	24 degrees c cftr remarkably stable whereas 37 degrees c cftr rapidly converted high molecular weight hmw complex estimated size 450 kda t12 30 min
0.54181886.9915789.html.plaintext.txt	115	convenience large complex subsequently referred hmw complex 170 kda band referred full length cftr
0.54181886.9915789.html.plaintext.txt	116	view larger version 93k fig
0.54181886.9915789.html.plaintext.txt	117	expression cftr rabbit reticulocyte lysate
0.54181886.9915789.html.plaintext.txt	118	cftr cdna plasmid pspcftr35 translated transcription linked rrl translation system 24 degrees c 90 min described experimental procedures
0.54181886.9915789.html.plaintext.txt	119	canine pancreas microsomal membranes present translation lanes except lane 1
0.54181886.9915789.html.plaintext.txt	120	lanes 1 2 7 represent total translation products analyzed sds page
0.54181886.9915789.html.plaintext.txt	121	translation products immunoprecipitated nonimmune sera lane 6 peptide specific antisera raised n terminus lane 3 r domain lane 4 c terminus lane 5 cftr
0.54181886.9915789.html.plaintext.txt	122	carbonate extraction translation products lane 7 incubated ph 7
0.54181886.9915789.html.plaintext.txt	123	5 carb supernatant pellet p fractions analyzed directly
0.54181886.9915789.html.plaintext.txt	124	b cftr translation carried except aurin tricarboxylic acid 0
0.54181886.9915789.html.plaintext.txt	125	1 mm cyclohexamide added 15 min 2 h start translation respectively
0.54181886.9915789.html.plaintext.txt	126	following addition cyclohexamide aliquots removed specified time points analyzed directly sds page
0.54181886.9915789.html.plaintext.txt	127	atp dependent conversion cftr hmw complex determine requirements conversion cftr hmw complex cftr translated rrl microsomal membranes collected pelleting sucrose cushion fig
0.54181886.9915789.html.plaintext.txt	128	microsomes resuspended incubated 37 degrees c sucrose buffer containing atp lanes 1 5 rrl supplemented atp regeneration system lanes 6 10 atp depleted rrl lanes 11 15 atp depleted rrl supplemented additional atp lanes 15 20
0.54181886.9915789.html.plaintext.txt	129	specified time points samples analyzed directly sds page
0.54181886.9915789.html.plaintext.txt	130	presence buffer alone atp depleted rrl 70 full length cftr remained intact 4 h incubation fig
0.54181886.9915789.html.plaintext.txt	131	however microsomal membranes incubated fresh rrl containing atp atp depleted rrl supplemented additional atp full length cftr rapidly converted hmw complex t12 30 min subsequently disappeared next 4 h
0.54181886.9915789.html.plaintext.txt	132	results consistent two step process full length cftr initially converted hmw complex via atp dependent mechanism hmw complex substrate degradation
0.54181886.9915789.html.plaintext.txt	133	view larger version 51k fig
0.54181886.9915789.html.plaintext.txt	134	vitro degradation cftr via hmw intermediate
0.54181886.9915789.html.plaintext.txt	135	cftr translated 2 h rrl fig
0.54181886.9915789.html.plaintext.txt	136	1b microsomal membranes pelleted 0
0.54181886.9915789.html.plaintext.txt	137	5 m sucrose cushion resuspended 0
0.54181886.9915789.html.plaintext.txt	138	1 m sucrose buffer described experimental procedures
0.54181886.9915789.html.plaintext.txt	139	membranes incubated 37 degrees c buffer lanes 1 5 rrl containing atp regeneration system lanes 6 10 atp depleted rrl lanes 11 15 atp depleted rrl containing atp regeneration system lanes 16 20
0.54181886.9915789.html.plaintext.txt	140	specified time points aliquots removed tube analyzed directly sds page
0.54181886.9915789.html.plaintext.txt	141	b autoradiograms digitized band intensities full length cftr hmw complex quantitated normalized amount full length cftr present 0 plotted time point
0.54181886.9915789.html.plaintext.txt	142	closed open symbols represent cftr hmw complex respectively
0.54181886.9915789.html.plaintext.txt	143	cftr hmw complex polyubiquitinated noted degradation cftr hmw complex fig
0.54181886.9915789.html.plaintext.txt	144	2 contrasted results fig
0.54181886.9915789.html.plaintext.txt	145	1b complex accumulated time
0.54181886.9915789.html.plaintext.txt	146	one difference two experiments cftr translation performed presence hemin required co factor protein expression rrl 38 aurin tricarboxylic acid inhibitor protein synthesis initiation
0.54181886.9915789.html.plaintext.txt	147	compounds inhibit atp dependent degradation ubiquitinated substrates rrl
0.54181886.9915789.html.plaintext.txt	148	results together requirement atp cytosol suggested hmw complex might represent polyubiquitinated cftr
0.54181886.9915789.html.plaintext.txt	149	microsomal membranes containing newly synthesized cftr therefore incubated fresh rrl supplemented bovine ubiquitin 40 microm hemin
0.54181886.9915789.html.plaintext.txt	150	aliquots immunoprecipitated anti bovine ubiquitin antisera analyzed sds page specified time points
0.54181886.9915789.html.plaintext.txt	151	3a hmw complex full length cftr reactive anti ubiquitin antisera lanes 11 15
0.54181886.9915789.html.plaintext.txt	152	reactivity observed immunoprecipitation performed nonimmune sera nis lanes 6 10 bovine ubiquitin omitted lysate data shown
0.54181886.9915789.html.plaintext.txt	153	confirm cftr ubiquitination microsomes containing newly synthesized cftr incubated rrl presence methylated ubiquitin blocks sequential addition ubiquitin molecules preventing isopeptide bond formation ubiquitin residue lys 48
0.54181886.9915789.html.plaintext.txt	154	conditions observed dose dependent inhibition rate hmw complex formation fig
0.54181886.9915789.html.plaintext.txt	155	taken together data demonstrate sequential covalent addition multiple ubiquitin molecules contributes formation cftr hmw complex
0.54181886.9915789.html.plaintext.txt	156	view larger version 91k fig
0.54181886.9915789.html.plaintext.txt	157	vitro ubiquitination cftr
0.54181886.9915789.html.plaintext.txt	158	microsomal membranes containing newly synthesized cftr resuspended 0
0.54181886.9915789.html.plaintext.txt	159	1 m sucrose buffer incubated 37 degrees c rrl containing 40 microm hemin 0
0.54181886.9915789.html.plaintext.txt	160	4 mgml bovine ubiquitin methylated ubiquitin b
0.54181886.9915789.html.plaintext.txt	161	times indicated samples immunoprecipitated nonimmune sera nis lanes 6 10 anti ubiquitin antisera lanes 11 15 analyzed directly lanes 1 5 b lanes
0.54181886.9915789.html.plaintext.txt	162	inhibition cftr hmw complex degradation proteasome inhibitors next examined ability protease inhibitors influence disappearance cftr hmw complex
0.54181886.9915789.html.plaintext.txt	163	inhibitors serine cysteine metalloproteases essentially effect rate disappearance either full length cftr hmw complex fig
0.54181886.9915789.html.plaintext.txt	164	contrast hemin mg132 known inhibitors proteasome resulted significant delay disappearance hmw complex particularly early time points fig
0.54181886.9915789.html.plaintext.txt	165	quantitation autoradiograms revealed hemin effectively blocked 60 hmw complex degradation
0.54181886.9915789.html.plaintext.txt	166	contrast mg132 alln tpck slowed prevent hmw complex disappearance
0.54181886.9915789.html.plaintext.txt	167	surprisingly little inhibition observed lactacystin tlck
0.54181886.9915789.html.plaintext.txt	168	results suggested either certain proteasome inhibitors might relatively inactive rrl system alternatively degradation ubiquitinated cftr might involve additional protease activities
0.54181886.9915789.html.plaintext.txt	169	distinguish possibilities therefore examined effect proteasome inhibitors degradation methylated lysozyme known substrate 26 proteasome
0.54181886.9915789.html.plaintext.txt	170	subsequent experiments rate extent protein degradation quantitated measuring conversion cftr andor lysozyme trichloroacetic acid soluble peptide fragments
0.54181886.9915789.html.plaintext.txt	171	view larger version 66k fig
0.54181886.9915789.html.plaintext.txt	172	effect protease inhibitors cftr degradation
0.54181886.9915789.html.plaintext.txt	173	microsomal membranes containing newly synthesized cftr collected incubated rrl presence protease inhibitor mixture consisting 500 microm 4 2 aminoethylbenzenesulfonyl fluoride 150 nm aprotinin 1 microm e 64 0
0.54181886.9915789.html.plaintext.txt	174	5 mm edta 1 microm leupeptin individual proteasome inhibitors indicated concentrations b
0.54181886.9915789.html.plaintext.txt	175	time point aliquots mixed directly sds loading buffer analyzed page
0.54181886.9915789.html.plaintext.txt	176	c cftr hmw complex quantitated time point densitometry normalized amount cftr present 0 plotted function time
0.54181886.9915789.html.plaintext.txt	177	data shown representative results multiple experiments
0.54181886.9915789.html.plaintext.txt	178	5 26 14clysozyme 65 newly synthesized cftr degraded trichloroacetic acid soluble peptide fragments within 3 h rrl
0.54181886.9915789.html.plaintext.txt	179	lysozyme degradation inhibited approximately 90 presence 40 microm hemin 10 mm edta consistent previous studies 39
0.54181886.9915789.html.plaintext.txt	180	hemin also resulted formation hmw complex containing 14clysozyme data shown
0.54181886.9915789.html.plaintext.txt	181	contrast specific proteasome inhibitor lactacystin well active metabolite clasto lactacystin lactone little effect lysozyme degradation 10 inhibition
0.54181886.9915789.html.plaintext.txt	182	conditions cftr degradation inhibited approximately 80 presence edta atp hydrolyzing enzyme apyrase
0.54181886.9915789.html.plaintext.txt	183	hemin inhibited cftr degradation 56 lactacystin clasto lactacystin lactone inhibited cftr degradation 20 35 respectively
0.54181886.9915789.html.plaintext.txt	184	latter experiments lactacystin based inhibitors preincubated rrl 30 60 min prior addition cftr containing microsomal membranes
0.54181886.9915789.html.plaintext.txt	185	experiments demonstrate specific lactacystin based proteasome inhibitors relatively inactive blocking degradation ubiquitinated substrates rrl
0.54181886.9915789.html.plaintext.txt	186	also noted significant amount cftr degradation rrl 35 40 appears proceed hemin insensitive pathway distinct utilized lysozyme
0.54181886.9915789.html.plaintext.txt	187	view larger version 22k fig
0.54181886.9915789.html.plaintext.txt	188	degradation lysozyme cftr
0.54181886.9915789.html.plaintext.txt	189	degradation mixtures assembled described legend fig
0.54181886.9915789.html.plaintext.txt	190	2 added resuspended microsomal membranes containing cftr 14clysozyme 0
0.54181886.9915789.html.plaintext.txt	191	hemin 40 microm edta 10 mm apyrase 0
0.54181886.9915789.html.plaintext.txt	192	1 unit microl added 0 indicated
0.54181886.9915789.html.plaintext.txt	193	lactacystin 100 microm clasto lactacystin lactone 100 microm preincubated rrl 30 60 min prior assembling reaction
0.54181886.9915789.html.plaintext.txt	194	aliquots precipitated 20 trichloroacetic acid soluble counts calculated following formula counts released cn c0t c0 cn soluble counts time point c0 soluble counts 0 total counts per aliquot
0.54181886.9915789.html.plaintext.txt	195	results represent average plus minus
0.54181886.9915789.html.plaintext.txt	196	two six separate experiments
0.54181886.9915789.html.plaintext.txt	197	ubiquitinated cftr remains tightly associated er membrane sixty five percent vitro synthesized cftr protein degraded trichloroacetic acid soluble fragments within 3 h incubation rrl fig
0.54181886.9915789.html.plaintext.txt	198	degradation could restricted solely large cytosolic peptide loops
0.54181886.9915789.html.plaintext.txt	199	n terminus nucleotide binding domains r domain loops contain 47 total methionine residues 40
0.54181886.9915789.html.plaintext.txt	200	rather data indicate proteolytic machinery also gains access small cytosolic loops possibly lumenal andor transmembrane regions protein
0.54181886.9915789.html.plaintext.txt	201	thus prior coincident degradation cftr likely extracted membrane
0.54181886.9915789.html.plaintext.txt	202	therefore tested whether ubiquitinated hmw complex already targeted degradation ubiquitin conjugating enzymes might undergo retrograde translocation cytosolic intermediate
0.54181886.9915789.html.plaintext.txt	203	ubiquitinated cftr complexes generated incubation rrl presence hemin vesicles collected pelleting sucrose cushion
0.54181886.9915789.html.plaintext.txt	204	6a cftr cftr hmw complex nearly quantitatively recovered microsome pellet absence detergent
0.54181886.9915789.html.plaintext.txt	205	addition preincubation cftr containing microsomes high salt 1
0.54181886.9915789.html.plaintext.txt	206	1 m kcl failed extract full length cftr hmw complex supernatant fraction fig
0.54181886.9915789.html.plaintext.txt	207	thus ubiquitinated cftr behave cytosolic peripheral membrane protein
0.54181886.9915789.html.plaintext.txt	208	view larger version 74k fig
0.54181886.9915789.html.plaintext.txt	209	cftr containing microsomes incubated rrl presence hemin
0.54181886.9915789.html.plaintext.txt	210	times specified aliquots analyzed directly lanes 1 4 pelleted 0
0.54181886.9915789.html.plaintext.txt	211	5 m sucrose buffer lanes 5 9 incubated ice 1 triton x 100 30 min prior pelleting lanes 10 14
0.54181886.9915789.html.plaintext.txt	212	pellets dissolved directly sds loading buffer
0.54181886.9915789.html.plaintext.txt	213	b aliquots rrl degradation mixture taken specified times analyzed directly sds loading buffer lanes 1 3 incubated 30 min ice following addition kcl final concentrations indicated lanes 4 21
0.54181886.9915789.html.plaintext.txt	214	samples pelleted 0
0.54181886.9915789.html.plaintext.txt	215	5 m sucrose buffer equal fractions pellet supernatant analyzed sds page
0.54181886.9915789.html.plaintext.txt	216	6 rule possibility hmw ubiquitinated cftr might also pelleted large detergent sensitive protein complex
0.54181886.9915789.html.plaintext.txt	217	therefore tested whether hmw complex physically associated er membrane floatation
0.54181886.9915789.html.plaintext.txt	218	aliquots rrl containing newly synthesized cftr andor polyubiquitinated cftr diluted 2 m sucrose layered beneath discontinuous sucrose gradient centrifuged 2 h described experimental procedures fig
0.54181886.9915789.html.plaintext.txt	219	half samples ribosomes first stripped membranes incubation kcledta fig
0.54181886.9915789.html.plaintext.txt	220	secretory protein bovine prolactin 41 used standard determine location microsomal membranes gradient
0.54181886.9915789.html.plaintext.txt	221	full length cftr polyubiquitinated complex exhibited floatation pattern secretory control
0.54181886.9915789.html.plaintext.txt	222	thus absence degradation cftr remained membrane associated long ubiquitination occurred
0.54181886.9915789.html.plaintext.txt	223	following ribosome stripping edtakcl microsomes uniformly partitioned lighter fractions
0.54181886.9915789.html.plaintext.txt	224	however ribosome removal detectable effect dislocation ubiquitinated cftr er membrane
0.54181886.9915789.html.plaintext.txt	225	view larger version 41k fig
0.54181886.9915789.html.plaintext.txt	226	microsomal membranes containing newly synthesized cftr bovine prolactin incubated 37 degrees c rrl degradation mixture 0 20 120 min presence hemin
0.54181886.9915789.html.plaintext.txt	227	samples mixed final concentration 2 m sucrose layered beneath discontinuous sucrose gradient centrifuged 350000 x g 2 h described experimental procedures
0.54181886.9915789.html.plaintext.txt	228	6 m added prior centrifugation
0.54181886.9915789.html.plaintext.txt	229	aliquots taken top bottom gradient lanes 1 10 respectively
0.54181886.9915789.html.plaintext.txt	230	hmw complex cftr prolactin control indicated
0.54181886.9915789.html.plaintext.txt	231	degradation membrane bound ubiquitinated cftr test whether membrane bound cftr remained substrate degradation simply protease resistant aggregate cftr containing microsomes incubated rrl presence hemin allow accumulation ubiquitinated intermediate
0.54181886.9915789.html.plaintext.txt	232	vesicles isolated sequential time points reincubated presence absence fresh rrl degradation cftr monitored release trichloroacetic acid soluble counts
0.54181886.9915789.html.plaintext.txt	233	8a 70 total cftr degraded trichloroacetic acid soluble counts following 3 h incubation atp containing rrl
0.54181886.9915789.html.plaintext.txt	234	vesicles collected 20 min preincubation hemin containing rrl resuspended fresh rrl lacking hemin 56 total cftr subsequently degraded
0.54181886.9915789.html.plaintext.txt	235	degradation remained sensitive hemin edta
0.54181886.9915789.html.plaintext.txt	236	incubation cftr hemin containing rrl longer periods time
0.54181886.9915789.html.plaintext.txt	237	1 2 h resulted near complete conversion 90 full length protein hmw complex prior experiments data shown
0.54181886.9915789.html.plaintext.txt	238	even 2 h preincubation 57 total cftr protein still able degraded upon removal hemin
0.54181886.9915789.html.plaintext.txt	239	experiments degradation polyubiquitinated cftr thus 80 efficient degradation newly synthesized protein
0.54181886.9915789.html.plaintext.txt	240	furthermore longer preincubation times reversible component cftr degradation became progressively sensitive inhibition 2 h preincubation hemin edta blocked degradation polyubiquitinated cftr approximately 90
0.54181886.9915789.html.plaintext.txt	241	microsomes containing pre ubiquitinated cftr similarly resuspended incubated presence buffer alone fig
0.54181886.9915789.html.plaintext.txt	242	8b degradation hmw polyubiquitinated cftr observed
0.54181886.9915789.html.plaintext.txt	243	view larger version 16k fig
0.54181886.9915789.html.plaintext.txt	244	degradation preubiquitinated cftr
0.54181886.9915789.html.plaintext.txt	245	cftr containing microsomal membranes incubated rrl presence hemin indicated
0.54181886.9915789.html.plaintext.txt	246	time point samples pelleted 0
0.54181886.9915789.html.plaintext.txt	247	5 m sucrose buffer resuspended fresh rrl presence absence hemin edta
0.54181886.9915789.html.plaintext.txt	248	aliquots precipitated 20 trichloroacetic acid indicated times percent soluble counts released determined scintillation counting
0.54181886.9915789.html.plaintext.txt	249	b samples pelleted 0
0.54181886.9915789.html.plaintext.txt	250	5 m sucrose buffer presence absence 1 mm atp resuspended 10 mm tris 5 mm mgcl2 3 mm dtt 80 microgml creatine kinase without 1 mm atp12 mm creatine phosphate
0.54181886.9915789.html.plaintext.txt	251	time scale graph based 0 starting rrl degradation mixture
0.54181886.9915789.html.plaintext.txt	252	20 60 120 min graphs base line soluble counts reflect percent counts released rrl presence hemin
0.54181886.9915789.html.plaintext.txt	253	total trichloroacetic acid soluble counts plotted therefore represent counts released initial incubation plus counts released following resuspension reincubation microsomes
0.54181886.9915789.html.plaintext.txt	254	together results demonstrate inhibitory effects hemin cftr degradation reversible ii membrane bound ubiquitinated cftr remains substrate degradation iii cftr degradation like ubiquitination requires presence atp cytosolic factors iv degradation physically localized er membrane likely occurs coincident removal least portion cftr lipid bilayer
0.54181886.9915789.html.plaintext.txt	255	er primary site cellular quality control involved recognition disposal misfolded unassembled proteins 5
0.54181886.9915789.html.plaintext.txt	256	initially proposed er proteases responsible degrading er substrates recent evidence indicates erad mediated largely cytosolic proteases including 26 proteasome 6 7
0.54181886.9915789.html.plaintext.txt	257	topologic disparity substrate degradation machinery resulted reevaluation protein movement er compartment 6
0.54181886.9915789.html.plaintext.txt	258	appears translocation across er membrane bidirectional process regulated part folded state given protein substrate
0.54181886.9915789.html.plaintext.txt	259	whereas nascent secretory transmembrane proteins targeted translocated across andor integrated er membrane er translocation machinery 2 42 proteins fail fold properly may also recognized er quality control machinery transported er back cytosol 6 9 10 15
0.54181886.9915789.html.plaintext.txt	260	observations raised important questions regarding process retrograde transport across er membrane
0.54181886.9915789.html.plaintext.txt	261	stage biogenesis protein substrates identified recognition events target proteins back translocon andor facilitate movement cytosol retrograde transport coupled process degradation current study address issues developing vitro system reconstitutes de novo synthesis er associated degradation polytopic protein cftr
0.54181886.9915789.html.plaintext.txt	262	full length glycosylated membrane integrated cftr substrate atp dependent ubiquitination
0.54181886.9915789.html.plaintext.txt	263	addition polyubiquitinated cftr remained tightly associated er membrane degraded trichloroacetic acid soluble peptide fragments
0.54181886.9915789.html.plaintext.txt	264	thus ubiquitination precedes retrograde translocation degradation polytopic proteins cftr physically localized er membrane rather cytosol proposed secretory transmembrane substrates 8 10 13
0.54181886.9915789.html.plaintext.txt	265	results consistent model cftr degradation tightly coupled removal polypeptide lipid bilayer
0.54181886.9915789.html.plaintext.txt	266	least 65 35smethionine labeled cftr degraded trichloroacetic acid soluble fragments consistent proteasomal degradation resulting polypeptides 6 9 residues length 43
0.54181886.9915789.html.plaintext.txt	267	small fraction full length cftr approximately 10 15 remained intact nearly experiments extent degradation individual cftr polypeptides actually approached 80
0.54181886.9915789.html.plaintext.txt	268	thus cftr degradation could limited large cytosolic regions containing n terminus nucleotide binding domains r domain together comprise 61 total mass 47 methionine residues 40
0.54181886.9915789.html.plaintext.txt	269	cytosolic loops within 8 15 residues membrane cleaved degradation full length cftr polypeptide chains would liberate 60 total cftr methionine trichloroacetic acid soluble fraction 40
0.54181886.9915789.html.plaintext.txt	270	therefore seems likely proteolytic machinery proteasome might participate removal cftr lipid bilayer gain access transmembrane segments andor lumenal peptide regions
0.54181886.9915789.html.plaintext.txt	271	possibility supported observation proteasome like particles physically localized cytosolic surface er membrane 44 ii results cftr degradation occurs via membrane bound rather cytosolic intermediate
0.54181886.9915789.html.plaintext.txt	272	retrograde translocation cftr occurred sec61 translocon extraction lipid bilayer could potentially involve reverse process membrane integration namely lateral movement tm segments membrane back translocation channel cytosol 45 46
0.54181886.9915789.html.plaintext.txt	273	study provides additional support ubiquitin proteasome pathway involved er associated degradation cftr unclear different proteasome inhibitors exhibited different effects cftr degradation
0.54181886.9915789.html.plaintext.txt	274	lactacystin clasto lactacystin lactone covalently inactivate active site threonine residue 5 subunit 20 proteasome subunit x mammalian proteasome 47 48 relatively minor effects cftr degradation determined either disappearance cftr hmw complex fig
0.54181886.9915789.html.plaintext.txt	275	4 generation trichloroacetic acid soluble fragments fig
0.54181886.9915789.html.plaintext.txt	276	interesting clasto lactacystin lactone active form lactacystin inactivated glutathione cells 49 50
0.54181886.9915789.html.plaintext.txt	277	observation neither lactacystin lactone form inhibited degradation lysozyme known proteasome substrate suggests rrl capable rendering agents inactive even preincubated absence exogenous reducing agents
0.54181886.9915789.html.plaintext.txt	278	know results reported differ qu et al
0.54181886.9915789.html.plaintext.txt	279	51 demonstrated 20 microm lactacystin inhibited degradation 1 antitrypsin lysozyme similar rrl system
0.54181886.9915789.html.plaintext.txt	280	however results consistent two different preparations lactacystin multiple inhibitor concentrations 100 microm
0.54181886.9915789.html.plaintext.txt	281	possible differences reflect varying amounts proteasome different rrl preparations
0.54181886.9915789.html.plaintext.txt	282	potent inhibitors cftr degradation edta apyrase hemin
0.54181886.9915789.html.plaintext.txt	283	edta hemin shown previously inhibit degradation proteasome substrates rrl stabilizing hmw ubiquitin conjugates 39 52 53
0.54181886.9915789.html.plaintext.txt	284	hemin heme precursor exerts pleiotropic effects rrl
0.54181886.9915789.html.plaintext.txt	285	stimulatory effect protein translation 38 proposed mediated inactivation translation factor eif 2 possibly inhibiting endogenous rrl kinase 54 55
0.54181886.9915789.html.plaintext.txt	286	addition hemin directly inhibits atpase activities purified 19 proteasome regulatory complex pa700 well 26 proteasome 56
0.54181886.9915789.html.plaintext.txt	287	catalytic core 20 proteasome cannot accommodate folded ubiquitinated polypeptides proposed atpases contained within 19 regulatory subunit required substrate unfolding well deubiquitination 43 48 56 59
0.54181886.9915789.html.plaintext.txt	288	therefore likely hemin inhibits proteasome mediated cftr degradation blocking atpase activity thereby preventing cftr unfolding andor deubiquitination
0.54181886.9915789.html.plaintext.txt	289	cftr unfolding required removal bilayer mechanism would explain accumulation membrane bound polyubiquitinated cftr observed current study
0.54181886.9915789.html.plaintext.txt	290	results rule possibility additional peptidase activities either er lumen within membrane also participate cftr degradation suggested previously 25 60
0.54181886.9915789.html.plaintext.txt	291	one candidate signal peptidase complex er localized protease capable cleaving transmembrane proteins 61 free signal peptides 30 sites located within plane lipid bilayer
0.54181886.9915789.html.plaintext.txt	292	interestingly cftr contains cryptic signal peptidase cleavage sites within adjacent tm segments n terminus hydrophobic domain 62 63
0.54181886.9915789.html.plaintext.txt	293	similar proteases facilitated cftr degradation tm segments small peptide loops could potentially released membrane
0.54181886.9915789.html.plaintext.txt	294	mechanism might explain significant amount cftr degradation atp independent hemin insensitive
0.54181886.9915789.html.plaintext.txt	295	also possible membrane bound hmw complex might actually consist polyubiquitinated cftr cleavage products degraded ubiquitin proteasome pathway
0.54181886.9915789.html.plaintext.txt	296	cell free systems significantly enhanced understanding protein folding 64 translocation 2
0.54181886.9915789.html.plaintext.txt	297	however yet know whether folded state newly synthesized cftr rrl system found er cells whether mechanism cftr recognition er quality control machinery vitro vivo
0.54181886.9915789.html.plaintext.txt	298	processing rrl system limited early events occur er membrane possible cftr might require specialized cellular components limiting rrl andor canine pancreas microsomes
0.54181886.9915789.html.plaintext.txt	299	recently rrl yeast derived cell free systems used examine degradation secretory transmembrane proteins 8 51 including cftr 31
0.54181886.9915789.html.plaintext.txt	300	observation 85 90 newly synthesized wild type cftr degraded rrl system consistent studies demonstrate wild type cftr also degraded er membrane intact cells 22 23
0.54181886.9915789.html.plaintext.txt	301	addition preliminary experiments laboratory demonstrated polytopic proteins expressed rrl system human p glycoprotein aquaporin water channels much stable cftr
0.54181886.9915789.html.plaintext.txt	302	2 studies indicate rapid cftr degradation vitro simply cell free artifact rather reflects specific structural features recognized er quality control machinery
0.54181886.9915789.html.plaintext.txt	303	vitro systems rrl thus likely provide versatile tool investigating events cellular machinery involved er associated degradation
0.54181886.9915789.html.plaintext.txt	304	case cftr may also provide screening assays identify compounds improve folding trafficking efficiency
0.54181886.9915789.html.plaintext.txt	305	marks members skach laboratory helpful comments
0.54181886.9915789.html.plaintext.txt	306	work supported grants gm53457 dk51818 national institutes health north american cystic fibrosis foundation
0.54181886.9915789.html.plaintext.txt	307	costs publication article defrayed part payment page charges
0.54181886.9915789.html.plaintext.txt	308	article must therefore hereby marked advertisement accordance 18 u
0.54181886.9915789.html.plaintext.txt	309	section 1734 solely indicate fact
0.54181886.9915789.html.plaintext.txt	310	correspondence addressed
0.54181886.9915789.html.plaintext.txt	311	present address division molecular medicine 3181 sw sam jackson park rd
0.54181886.9915789.html.plaintext.txt	312	nrc 3 oregon health sciences university portland 97201
0.54181886.9915789.html.plaintext.txt	313	503 494 7322 fax 503 494 7368 e mail skachwatohsu
0.54181886.9915789.html.plaintext.txt	314	abbreviations used er endoplasmic reticulum erad er associated degradation cftr cystic fibrosis transmembrane conductance regulator dtt dithiothreitol hmw high molecular weight rrl rabbit reticulocyte lysate alln n acetyl l leucyl l leucinyl norleucinal tpck n tosyl l phenylalanine chloromethyl ketone tlck n tosyl lysyl chloromethyl ketone tm transmembrane page polyacrylamide gel electrophoresis
0.54181886.9915789.html.plaintext.txt	315	skach unpublished observations
0.54181886.9915789.html.plaintext.txt	316	references top abstract introduction references rapoport
0.54181886.9915789.html.plaintext.txt	317	8 499 504crossrefmedline order article via infotrieve johnson
0.54181886.9915789.html.plaintext.txt	318	1997 cell 91 675 682crossref helenius
0.54181886.9915789.html.plaintext.txt	319	cellular proteolytic systems ciechanover
0.54181886.9915789.html.plaintext.txt	320	137 160 wiley liss new york brodsky j
0.54181886.9915789.html.plaintext.txt	321	7 151 155crossref sommer
0.54181886.9915789.html.plaintext.txt	322	11 1227 1233abstractfree full text mccracken
0.54181886.9915789.html.plaintext.txt	323	132 291 298abstract plemper r
0.54181886.9915789.html.plaintext.txt	324	1997 nature 388 891 895crossrefmedline order article via infotrieve wiertz e
0.54181886.9915789.html.plaintext.txt	325	1996 nature 384 432 438crossrefmedline order article via infotrieve pilon m
0.54181886.9915789.html.plaintext.txt	326	16 4540 4548abstractfree full text hughes e
0.54181886.9915789.html.plaintext.txt	327	94 1896 1901abstractfree full text wiertz e
0.54181886.9915789.html.plaintext.txt	328	1996 cell 84 769 779medline order article via infotrieve yu h
0.54181886.9915789.html.plaintext.txt	329	272 20800 20804abstractfree full text hiller m
0.54181886.9915789.html.plaintext.txt	330	1996 science 273 1725 1728abstractfree full text biederer
0.54181886.9915789.html.plaintext.txt	331	15 2069 2076abstract sommer
0.54181886.9915789.html.plaintext.txt	332	1993 nature 365 176 197crossrefmedline order article via infotrieve wilkinson b
0.54181886.9915789.html.plaintext.txt	333	271 25590 25597abstractfree full text roitelman j
0.54181886.9915789.html.plaintext.txt	334	267 25264 25273abstractfree full text edwards p
0.54181886.9915789.html.plaintext.txt	335	258 7272 7275abstractfree full text hampton r
0.54181886.9915789.html.plaintext.txt	336	cell 7 2029 2044abstract cheng
0.54181886.9915789.html.plaintext.txt	337	1990 cell 63 827 834medline order article via infotrieve ward c
0.54181886.9915789.html.plaintext.txt	338	269 25710 25718abstractfree full text ward c
0.54181886.9915789.html.plaintext.txt	339	1995 cell 83 121 128medline order article via infotrieve jensen
0.54181886.9915789.html.plaintext.txt	340	1995 cell 83 129 136medline order article via infotrieve qu b
0.54181886.9915789.html.plaintext.txt	341	272 15739 15744abstractfree full text qu b
0.54181886.9915789.html.plaintext.txt	342	271 7261 7264abstractfree full text lukacs g
0.54181886.9915789.html.plaintext.txt	343	13 6076 6086abstract zhang f
0.54181886.9915789.html.plaintext.txt	344	5 180 183medline order article via infotrieve lyko f
0.54181886.9915789.html.plaintext.txt	345	270 19873 19878abstractfree full text sato
0.54181886.9915789.html.plaintext.txt	346	273 7189 7192abstractfree full text jackson r
0.54181886.9915789.html.plaintext.txt	347	96 50 74medline order article via infotrieve ciechanover
0.54181886.9915789.html.plaintext.txt	348	81 1100 1105medline order article via infotrieve hershko
0.54181886.9915789.html.plaintext.txt	349	128 1079 1086medline order article via infotrieve hasegawa h
0.54181886.9915789.html.plaintext.txt	350	1992 science 258 1477 1479medline order article via infotrieve walter p
0.54181886.9915789.html.plaintext.txt	351	96 84 93medline order article via infotrieve fujiki y
0.54181886.9915789.html.plaintext.txt	352	93 97 102abstract beuzard y
0.54181886.9915789.html.plaintext.txt	353	70 1022 1026abstract hough r
0.54181886.9915789.html.plaintext.txt	354	261 2400 2408abstractfree full text riordan j
0.54181886.9915789.html.plaintext.txt	355	1989 science 245 1066 1072medline order article via infotrieve sasavage n
0.54181886.9915789.html.plaintext.txt	356	257 678 681abstractfree full text rapoport
0.54181886.9915789.html.plaintext.txt	357	15 355 358medline order article via infotrieve lowe j
0.54181886.9915789.html.plaintext.txt	358	1995 science 268 533 539medline order article via infotrieve rivett
0.54181886.9915789.html.plaintext.txt	359	40 1165 1172abstractfree full text martoglio b
0.54181886.9915789.html.plaintext.txt	360	1995 cell 81 207 214medline order article via infotrieve h
0.54181886.9915789.html.plaintext.txt	361	1996 cell 85 369 378medline order article via infotrieve fenteany g
0.54181886.9915789.html.plaintext.txt	362	1995 science 268 726 731medline order article via infotrieve groll m
0.54181886.9915789.html.plaintext.txt	363	1997 nature 386 463 471crossrefmedline order article via infotrieve dick l
0.54181886.9915789.html.plaintext.txt	364	271 7273 7276abstractfree full text dick l
0.54181886.9915789.html.plaintext.txt	365	272 182 188abstractfree full text qu d
0.54181886.9915789.html.plaintext.txt	366	chem 271 22971 22975 etlinger j
0.54181886.9915789.html.plaintext.txt	367	78 6845 6848abstract farrell j
0.54181886.9915789.html.plaintext.txt	368	1977 cell 11 187 200medline order article via infotrieve lenz j
0.54181886.9915789.html.plaintext.txt	369	1977 nature 266 191 193medline order article via infotrieve hoffman l
0.54181886.9915789.html.plaintext.txt	370	271 32538 32545abstractfree full text eytan e
0.54181886.9915789.html.plaintext.txt	371	268 4668 4674abstractfree full text lam y
0.54181886.9915789.html.plaintext.txt	372	1997 nature 385 737 740crossrefmedline order article via infotrieve pickart c
0.54181886.9915789.html.plaintext.txt	373	11 1055 1066abstractfree full text amara j
0.54181886.9915789.html.plaintext.txt	374	109 3315 3324abstract mullins c
0.54181886.9915789.html.plaintext.txt	375	270 17139 17147abstractfree full text lu y
0.54181886.9915789.html.plaintext.txt	376	273 568 576abstractfree full text xiong x
0.54181886.9915789.html.plaintext.txt	377	100 1079 1088abstractfree full text hartl f
0.54181886.9915789.html.plaintext.txt	378	19 20 25crossrefmedline order article via infotrieve
0.54181886.9915789.html.plaintext.txt	379	copyright 1999 american society biochemistry molecular biology inc
0.41277942.10069998.html.plaintext.txt	0	chemokine expression cf epithelia implications role cftr rantes expression lisa m
0.41277942.10069998.html.plaintext.txt	1	schwiebert12 kim estell1 stacie m
0.41277942.10069998.html.plaintext.txt	2	1 department physiology biophysics 2 gregory fleming james cystic fibrosis research center university alabama birmingham alabama 35294
0.41277942.10069998.html.plaintext.txt	3	abstract top abstract introduction methods results discussion references
0.41277942.10069998.html.plaintext.txt	4	delineate mechanisms facilitate leukocyte migration cystic fibrosis cf lung expression chemokines including interleukin 8 il 8 monocyte chemoattractant protein 1 mcp 1 rantes compared cf non cf airway epithelia
0.41277942.10069998.html.plaintext.txt	5	findings presented herein demonstrate either basal conditions tumor necrosis factor tnf andor interferon ifn stimulated conditions consistent pattern differences secretion il 8 mcp 1 cf non cf epithelial cells observed
0.41277942.10069998.html.plaintext.txt	6	contrast cf epithelial cells expressed detectable rantes protein mrna basal conditions stimulated tnf andor ifn p 0
0.41277942.10069998.html.plaintext.txt	7	05 unlike non cf counterparts
0.41277942.10069998.html.plaintext.txt	8	correction cf transmembrane conductance regulator cftr defect cf airway epithelial cells restored induction rantes protein mrna tnf combination ifn p 0
0.41277942.10069998.html.plaintext.txt	9	05 little effect il 8 mcp 1 production compared mock controls
0.41277942.10069998.html.plaintext.txt	10	transfection studies utilizing rantes promoter constructs suggested cftr activates rantes promoter via nuclear factor b mediated pathway
0.41277942.10069998.html.plaintext.txt	11	together results suggest 1 rantes expression altered cf epithelia 2 epithelial expression rantes il 8 mcp 1 dependent cftr
0.41277942.10069998.html.plaintext.txt	12	epithelial cells cystic fibrosis cystic fibrosis transmembrane conductance regulator inflammation
0.41277942.10069998.html.plaintext.txt	13	introduction top abstract introduction methods results discussion references
0.41277942.10069998.html.plaintext.txt	14	cystic fibrosis cf lethal inherited disorder caused mutations cf transmembrane conductance regulator cftr gene 23
0.41277942.10069998.html.plaintext.txt	15	cftr gene encodes 180 kda glycosylated protein functions low conductance camp regulated chloride channel 23
0.41277942.10069998.html.plaintext.txt	16	progressive pulmonary tissue damage hallmark cf however pancreatic liver intestinal dysfunction also characteristic cf
0.41277942.10069998.html.plaintext.txt	17	cf lung disease phenotype includes thick mucus secretion bacterial colonization airway pseudomonas aeruginosa
0.41277942.10069998.html.plaintext.txt	18	recent reports suggest cf lung may exhibit exaggerated immune response 19 even absence bacterial infection 1 12
0.41277942.10069998.html.plaintext.txt	19	cf associated airway inflammation characterized profound influx neutrophils lung however types leukocytes including eosinophils monocytes implicated cf airway inflammation
0.41277942.10069998.html.plaintext.txt	20	2 detected presence highly activated eosinophils lungs transplanted deceased cf patients
0.41277942.10069998.html.plaintext.txt	21	moreover koller co workers 13 observed increased levels eosinophilic cationic protein serum sputum cf patients compared healthy nonatopic donors
0.41277942.10069998.html.plaintext.txt	22	authors also demonstrated cf eosinophils increased propensity degranulate vitro compared eosinophils isolated control subjects patients bronchial asthma 15
0.41277942.10069998.html.plaintext.txt	23	addition previous studies reported monocytes derived cf patients increased metabolic level 34 36 generate increased levels inflammatory mediators including elastase superoxide compared non cf monocytes 9 22 36
0.41277942.10069998.html.plaintext.txt	24	airway epithelial cells described classically barrier cells involved ion fluid homeostasis
0.41277942.10069998.html.plaintext.txt	25	cells respond variety environmental stimuli resulting alteration cellular functions ion transport movement airway secretions
0.41277942.10069998.html.plaintext.txt	26	addition airway epithelial cells may act immune effector cells response endogenous exogenous stimuli
0.41277942.10069998.html.plaintext.txt	27	several studies shown airway epithelial cells express secrete variety inflammatory mediators including chemokines interleukin 8 il 8 monocyte chemoattractant protein 1 mcp 1 rantes regulated activation normal cell expressed presumably secreted reviewed ref
0.41277942.10069998.html.plaintext.txt	28	il 8 belongs c x c subfamily chemokines displays four highly conserved cysteine amino acid residues first two separated one nonconserved residue
0.41277942.10069998.html.plaintext.txt	29	contrast mcp 1 rantes belong c c subfamily exhibits two adjacent cysteine amino acid residues
0.41277942.10069998.html.plaintext.txt	30	chemokine subfamilies exhibit cell selectivity respect chemoattraction
0.41277942.10069998.html.plaintext.txt	31	members c x c subfamily primarily target neutrophils whereas various members c c subfamily target monocytes lymphocytes eosinophils basophils
0.41277942.10069998.html.plaintext.txt	32	specifically il 8 mediates neutrophil chemotaxis however mcp 1 mediates monocyte basophil chemotaxis activation
0.41277942.10069998.html.plaintext.txt	33	rantes induces chemotaxis eosinophils monocytes cd45 ro memory lymphocytes
0.41277942.10069998.html.plaintext.txt	34	expression chemokines airway epithelial cells implicates cells facilitating leukocyte migration associated airway inflammatory diseases cf
0.41277942.10069998.html.plaintext.txt	35	despite recent advances understanding cellular molecular basis cf mechanisms initiate maintain cf associated airway inflammation remain ill defined
0.41277942.10069998.html.plaintext.txt	36	attempt understand mechanisms trigger recruitment leukocytes cf lung present study examines expression il 8 mcp 1 rantes cf airway epithelial cells
0.41277942.10069998.html.plaintext.txt	37	results presented herein demonstrate presence andor absence proinflammatory cytokines cf airway epithelial cells express chemokines il 8 mcp 1 yet little rantes
0.41277942.10069998.html.plaintext.txt	38	moreover results suggest complementation cf epithelial cells wild type cftr wt cftr correct cftr defect restored cytokine induction rantes expression via nuclear factor b nf b mediated pathway effect il 8 mcp 1 expression cells
0.41277942.10069998.html.plaintext.txt	39	methods top abstract introduction methods results discussion references
0.41277942.10069998.html.plaintext.txt	40	experiments employed following non cf epithelial cells airway epithelial cell lines beas2b bronchial american type culture collection atcc manassas va 16hbe14o bronchial gift dr
0.41277942.10069998.html.plaintext.txt	41	dieter gruenert university california san francisco ca ref
0.41277942.10069998.html.plaintext.txt	42	5 a549 alveolar type ii atcc pancreatic carcinoma cell line panc 1 atcc
0.41277942.10069998.html.plaintext.txt	43	following cf epithelial cells utilized airway epithelial cell lines ib3 1 bronchial f508w1282x compound heterozygote gift dr
0.41277942.10069998.html.plaintext.txt	44	pam zeitlin johns hopkins university baltimore md ref
0.41277942.10069998.html.plaintext.txt	45	37 cfbe41o bronchial f508 homozygote gift dr
0.41277942.10069998.html.plaintext.txt	46	5 cfte29o tracheal f508 homozygote gift dr
0.41277942.10069998.html.plaintext.txt	47	5 pancreatic adenocarcinoma cell line cfpac 1 f508 homozygote atcc
0.41277942.10069998.html.plaintext.txt	48	primary cf f508 homozygous non cf airway epithelial cells derived human bronchi nasal polyps provided dr
0.41277942.10069998.html.plaintext.txt	49	sorscher gregory fleming james cystic fibrosis research center university alabama birmingham al ref
0.41277942.10069998.html.plaintext.txt	50	john engelhardt university iowa iowa city ia ref
0.41277942.10069998.html.plaintext.txt	51	nael mccarty emory university atlanta ga ref
0.41277942.10069998.html.plaintext.txt	52	cells grown vitrogen 100 collagen palo alto ca coated flasks vitrogen 100 contains mixture collagen types iv
0.41277942.10069998.html.plaintext.txt	53	airway epithelial cells cultured lhc 8 medium biofluids rockville md containing 5 fcs 1 penicillin streptomycin 0
0.41277942.10069998.html.plaintext.txt	54	pancreatic cells maintained mem d valine medium gibco brl life technologies grand island ny containing 5 fcs 1 penicillin streptomycin 0
0.41277942.10069998.html.plaintext.txt	55	correction cftr defect cf epithelial cells
0.41277942.10069998.html.plaintext.txt	56	cfpac 1 cells transduced previously virus containing wt cftr control virus mock included studies ref
0.41277942.10069998.html.plaintext.txt	57	7 gregory fleming james cystic fibrosis research center
0.41277942.10069998.html.plaintext.txt	58	ib3 1 cells transiently transfected follows
0.41277942.10069998.html.plaintext.txt	59	cells grown vitrogen 100 coated wells 12 well plate medium cfpac 1 mem d valine ib3 1 lhc 8 containing 5 fcs 1 penicillin streptomycin 0
0.41277942.10069998.html.plaintext.txt	60	50 confluence cells incubated low serum opti mem medium gibco brl containing lipofectamine plus 6 microgwell gibco brl prsv wt cftr ref
0.41277942.10069998.html.plaintext.txt	61	erik schwiebert university alabama birmingham al psv galactosidase reporter plasmid 0
0.41277942.10069998.html.plaintext.txt	62	5 microgwell promega pgreen lantern 1 green fluorescence protein gfp gibco brl psv galactosidase reporter plasmid 0
0.41277942.10069998.html.plaintext.txt	63	5 microgml mock control 6 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	64	incubation 2 ml mem d valine lhc 8 medium containing 5 fcs added well cells cultured additional 48 h analysis
0.41277942.10069998.html.plaintext.txt	65	determine percentage cells transfected transiently gfp positive gfp negative mock transfected cells counted using fluorescence microscope transfection percentages normally ranged 40 50
0.41277942.10069998.html.plaintext.txt	66	mock wt cftr transfected cells analyzed relative transfection efficiency using galactosidase reporter assay system promega according manufacturers protocols
0.41277942.10069998.html.plaintext.txt	67	wt cftr function complemented ib3 1 cfpac 1 cells monitored via chloride efflux described previously 27
0.41277942.10069998.html.plaintext.txt	68	analysis il 8 mcp 1 rantes protein expression
0.41277942.10069998.html.plaintext.txt	69	analyze il 8 mcp 1 rantes protein expression cells cultured presence absence tumor necrosis factor tnf 100 ngml r d systems minneapolis mn andor interferon ifn 100 ngml r d systems 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	70	culture supernatants harvested prepared elisa il 8 mcp 1 rantes protein content r d systems cells harvested counted account differences cell number
0.41277942.10069998.html.plaintext.txt	71	elisas performed according manufacturers protocol limits detection 3 pgml
0.41277942.10069998.html.plaintext.txt	72	analysis il 8 mcp 1 rantes mrna expression
0.41277942.10069998.html.plaintext.txt	73	analyze il 8 mcp 1 rantes mrna expression cells cultured presence absence tnf 100 ngml andor ifn 100 ngml 2 il 8 mcp 1 18 rantes h 37 degrees c
0.41277942.10069998.html.plaintext.txt	74	culture total rna isolated cells trizol gibco brl prepared northern blot analysis
0.41277942.10069998.html.plaintext.txt	75	northern blot analysis 10 microg total rna electrophoresed formaldehyde containing gel transferred nitrocellulose genescreen plus amersham arlington heights il
0.41277942.10069998.html.plaintext.txt	76	blots prehybridized buffer containing 50 formamide 2 x pipes buffer 0
0.41277942.10069998.html.plaintext.txt	77	5 sds denatured salmon sperm dna 100 microgml sigma chemical st
0.41277942.10069998.html.plaintext.txt	78	louis mo 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	79	blots hybridized dna fragment specific il 8 mcp 1 rantes randomly labeled random prime labeling kit promega 32pdatp 5 x 105 counts min1 ml1 new england nuclear boston ma 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	80	hybridization blots washed 2 x ssc 0
0.41277942.10069998.html.plaintext.txt	81	03 m trisodium citrate 2h2o ph 7
0.41277942.10069998.html.plaintext.txt	82	0 15 min room temperature 2 x ssc 1 sds 15 min 65 degrees c 0
0.41277942.10069998.html.plaintext.txt	83	1 x ssc 15 min room temperature
0.41277942.10069998.html.plaintext.txt	84	blots prepared autoradiography
0.41277942.10069998.html.plaintext.txt	85	control differences loading blots stripped 0
0.41277942.10069998.html.plaintext.txt	86	0 sds heated 100 degrees c 15 min hybridized glyceraldehyde 3 phosphate dehydrogenase probe described
0.41277942.10069998.html.plaintext.txt	87	results analyses quantitated densitometry
0.41277942.10069998.html.plaintext.txt	88	analysis rantes promoter activity
0.41277942.10069998.html.plaintext.txt	89	analyze rantes promoter activity constructs containing portions rantes promoter ligated luciferase reporter gene generated provided dr
0.41277942.10069998.html.plaintext.txt	90	hiro moriuchi national institutes health bethesda md 17
0.41277942.10069998.html.plaintext.txt	91	4 kb 5 noncoding sequence rantes gene 1
0.41277942.10069998.html.plaintext.txt	92	4rantes cloned pgl2 basic promega
0.41277942.10069998.html.plaintext.txt	93	2rantes site directed mutation nf b binding site within noncoding sequence designated b confirmed via dddna sequencing 17
0.41277942.10069998.html.plaintext.txt	94	ib3 1 cells cotransfected psv galactosidase prsv wt cftr pgl2 basic 1
0.41277942.10069998.html.plaintext.txt	95	5 microgml presence lipofectamine plus described correction cftr defect cf epithelial cells
0.41277942.10069998.html.plaintext.txt	96	parallel experiments ib3 1 cells cotransfected psv galactosidase pgreen lantern gfp respective rantes promoter construct mock controls 0
0.41277942.10069998.html.plaintext.txt	97	transfection cells cultured presence absence tnf combination ifn 100 ngml 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	98	cells harvested luciferase activity monitored via dual luciferase reporter assay system promega according manufacturers protocol
0.41277942.10069998.html.plaintext.txt	99	percentage cells transfected transiently determined via gfp expression described ranged 40 50 relative transfection efficiency assessed via measurement galactosidase activity
0.41277942.10069998.html.plaintext.txt	100	results top abstract introduction methods results discussion references
0.41277942.10069998.html.plaintext.txt	101	il 8 expression cf non cf airway epithelial cells
0.41277942.10069998.html.plaintext.txt	102	cf associated inflammation characterized profound influx neutrophils lung
0.41277942.10069998.html.plaintext.txt	103	determine whether epithelial cells contribute cf airway inflammation increased expression neutrophil chemoattractant il 8 expression il 8 compared cf non cf airway epithelial cells vitro
0.41277942.10069998.html.plaintext.txt	104	specifically il 8 expression analyzed non cf airway epithelial cell lines beas2b 16hbe14o a549 cf airway epithelial cell lines ib3 1 cfbe41o cfte29o
0.41277942.10069998.html.plaintext.txt	105	ib3 1 heterozygous f508 cftr mutation f508w1282x whereas cfbe41o cfte29o homozygous f508 cftr mutation
0.41277942.10069998.html.plaintext.txt	106	il 8 expression also compared primary cf non cf airway epithelial cells cf primary cells homozygous f508 cftr mutation
0.41277942.10069998.html.plaintext.txt	107	analyses epithelial cells cultured presence absence proinflammatory cytokines tnf ifn cytokines shown previously upregulate chemokine expression airway epithelial cells 33
0.41277942.10069998.html.plaintext.txt	108	moreover increased levels tnf detected bronchioalveolar lavage fluid balf collected cf patients 26
0.41277942.10069998.html.plaintext.txt	109	1 beas2b cells expressed il 8 protein basal conditions 20 ng106 cells tnf combination ifn stimulated twofold increase il 8 protein expression cells fig
0.41277942.10069998.html.plaintext.txt	110	16hbe14o a549 cells also expressed il 8 protein basal conditions 0
0.41277942.10069998.html.plaintext.txt	111	tnf stimulation 16hbe14o a549 cells induced 10 100 fold increase il 8 protein expression cells 2 20 ng106 cells ifn either effect a549 inhibited il 8 expression 16hbe14o fig
0.41277942.10069998.html.plaintext.txt	112	cf airway epithelial cell lines ib3 1 cfbe41o cfte29o expressed low levels il 8 protein 0 0
0.41277942.10069998.html.plaintext.txt	113	5 ng106 cells basal conditions il 8 expression cells enhanced 3 80 fold presence tnf alone tnf combination ifn 1
0.41277942.10069998.html.plaintext.txt	114	comparison cf non cf primary airway epithelial cells expressed greater amounts il 8 protein 80 ng106 cells basal conditions respective cell lines fig
0.41277942.10069998.html.plaintext.txt	115	interestingly tnf together ifn significantly affect il 8 protein expression cells fig
0.41277942.10069998.html.plaintext.txt	116	northern blot analysis cf non cf airway epithelial cell lines primary cells described cultured presence absence tnf andor ifn revealed il 8 mrna expression data shown paralleled pattern il 8 protein expression observed cells fig
0.41277942.10069998.html.plaintext.txt	117	overall data suggest cf non cf airway epithelial cells express il 8 presence absence tnf ifn levels consistent
0.41277942.10069998.html.plaintext.txt	118	view larger version 30k fig
0.41277942.10069998.html.plaintext.txt	119	cystic fibrosis cf non cf epithelial cells express varied levels interleukin 8 il 8 protein
0.41277942.10069998.html.plaintext.txt	120	non cf cf airway epithelial cell lines primary cells b stimulated without tumor necrosis factor tnf andor interferon ifn 100 ngml 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	121	culture cells harvested counted supernatants analyzed il 8 protein content via il 8 specific elisa
0.41277942.10069998.html.plaintext.txt	122	results reported ng il 8106 cells n 6 9
0.41277942.10069998.html.plaintext.txt	123	05 compared carrier control
0.41277942.10069998.html.plaintext.txt	124	mcp 1 expression cf non cf airway epithelial cells
0.41277942.10069998.html.plaintext.txt	125	monocytes derived cf patients reported exhibit increased metabolic level 34 36 generate increased levels inflammatory mediators elastase superoxide compared non cf monocytes 9 22 36
0.41277942.10069998.html.plaintext.txt	126	determine whether cf airway epithelial cells express monocyte chemoattracting activating agent mcp 1 mcp 1 expression compared cf non cf airway epithelial cell lines primary cells vitro
0.41277942.10069998.html.plaintext.txt	127	2 beas2b cells expressed mcp 1 protein basal conditions 16 ng106 cells tnf combination ifn enhanced expression approximately twofold 26 ng106 cells
0.41277942.10069998.html.plaintext.txt	128	comparison 16hbe14o a549 cells expressed little mcp 1 protein absence stimuli fig
0.41277942.10069998.html.plaintext.txt	129	interestingly tnf andor ifn induced 60 140 fold increase mcp 1 protein expression a549 cells yet effect mcp 1 expression 16hbe14o cells fig
0.41277942.10069998.html.plaintext.txt	130	cf cell lines cfbe41o ib3 1 expressed detectable mcp 1 protein basal conditions however cfte29o cells expressed 5 ng106 cells basal conditions fig
0.41277942.10069998.html.plaintext.txt	131	tnf ifn alone effect mcp 1 protein expression cfbe41o cfte29o cells yet induced expression ib3 1 cells 20 ng106 cells tnf combination ifn enhanced mcp 1 protein expression 2
0.41277942.10069998.html.plaintext.txt	132	5 ng106 cells cfbe41o cells
0.41277942.10069998.html.plaintext.txt	133	contrast neither cf non cf primary airway epithelial cells expressed mcp 1 protein basal conditions fig
0.41277942.10069998.html.plaintext.txt	134	however tnf together ifn induced significant increase mcp 1 expression cf cells 18 ng106 cells non cf cells 42 ng106 cells
0.41277942.10069998.html.plaintext.txt	135	northern blot analysis cf non cf airway epithelial cell lines primary cells described cultured presence absence tnf andor ifn revealed mcp 1 mrna expression data shown paralleled pattern mcp 1 protein expression observed cells fig
0.41277942.10069998.html.plaintext.txt	136	taken together findings indicate although cf non cf primary airway epithelial cells expressed significantly different levels mcp 1 presence absence tnf ifn respective cell lines express consistent levels mcp 1
0.41277942.10069998.html.plaintext.txt	137	view larger version 33k fig
0.41277942.10069998.html.plaintext.txt	138	cf non cf epithelial cells express varied levels monocyte chemoattractant protein 1 mcp 1
0.41277942.10069998.html.plaintext.txt	139	non cf cf airway epithelial cell lines primary cells b stimulated without tnf andor ifn 100 ngml 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	140	culture cells harvested counted supernatants analyzed mcp 1 protein content via mcp 1 specific elisa
0.41277942.10069998.html.plaintext.txt	141	results reported ng il 8106 cells n 6 9
0.41277942.10069998.html.plaintext.txt	142	05 compared carrier control
0.41277942.10069998.html.plaintext.txt	143	rantes expression cf non cf airway epithelial cells
0.41277942.10069998.html.plaintext.txt	144	recent studies suggest eosinophils may play role progressive tissue damage observed cf lung 2
0.41277942.10069998.html.plaintext.txt	145	determine whether cf epithelial cells express eosinophil chemoattractant rantes rantes expression compared cf non cf airway epithelial cells vitro
0.41277942.10069998.html.plaintext.txt	146	specifically levels rantes compared basal tnf andor ifn stimulated conditions non cf airway epithelial cell lines beas2b 16hbe14o a549 cf airway epithelial cell lines cfbe41o ib3 1 cfte29o well non cf cf primary airway epithelial cells
0.41277942.10069998.html.plaintext.txt	147	3a beas2b a549 expressed low levels rantes protein 1 ng106 cells basal conditions stimulated ifn tnf induced rantes protein expression 12 ng106 cells a549 cells
0.41277942.10069998.html.plaintext.txt	148	however tnf combination ifn induced significant increase rantes protein expression beas2b cells 14 ng106 cells 31 35 a549 cells 28 ng106 cells fig
0.41277942.10069998.html.plaintext.txt	149	3a reported previously 16
0.41277942.10069998.html.plaintext.txt	150	interestingly 16hbe14o cells expressed rantes constitutively 6 ng106 cells tnf andor ifn effect rantes expression cells fig
0.41277942.10069998.html.plaintext.txt	151	contrast cfbe41o ib3 1 cfte29o cells expressed detectable rantes protein basal conditions presence tnf andor ifn fig
0.41277942.10069998.html.plaintext.txt	152	comparison non cf cf primary airway epithelial cells expressed detectable rantes protein absence stimuli fig
0.41277942.10069998.html.plaintext.txt	153	tnf combination ifn stimulated rantes protein expression non cf cells 33 ng106 cells yet proinflammatory cytokines significant effect cf cells fig
0.41277942.10069998.html.plaintext.txt	154	results suggest cf airway epithelial cells express detectable rantes protein compared non cf controls basal cytokine stimulated conditions
0.41277942.10069998.html.plaintext.txt	155	view larger version 25k fig
0.41277942.10069998.html.plaintext.txt	156	cf airway epithelial cells express rantes protein
0.41277942.10069998.html.plaintext.txt	157	non cf cf bronchial epithelial cell lines primary cells b cultured presence absence tnf andor ifn 100 ngml 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	158	culture supernatants collected analyzed via rantes specific elisa cells harvested counted account differences cell number
0.41277942.10069998.html.plaintext.txt	159	results reported ng rantes protein106 cells n 6 9
0.41277942.10069998.html.plaintext.txt	160	compare rantes mrna expression non cf cf airway epithelia non cf airway epithelial cell lines beas2b a549 16hbe14o cf airway epithelial cell lines ib3 1 cfbe41o cfte29o well non cf cf primary airway epithelial cells cultured presence absence tnf andor ifn analyzed mrna expression via northern blot analysis
0.41277942.10069998.html.plaintext.txt	161	4 tnf combination ifn stimulated significant levels rantes mrna expression 6 fold basal levels beas2b cells tnf ifn alone effect rantes expression cells
0.41277942.10069998.html.plaintext.txt	162	however tnf alone together ifn induced significant increase 2 fold 7 fold basal levels respectively rantes mrna expression non cf airway epithelial cell line a549 fig
0.41277942.10069998.html.plaintext.txt	163	interestingly 16hbe14o cells exhibited significant levels rantes mrna expression absence presence tnf andor ifn fig
0.41277942.10069998.html.plaintext.txt	164	contrast ib3 1 cfbe41o cfte29o cells expressed detectable rantes mrna presence absence tnf andor ifn fig
0.41277942.10069998.html.plaintext.txt	165	importantly non cf cf primary airway epithelial cells yielded patterns rantes mrna expression similar observed respective cell lines
0.41277942.10069998.html.plaintext.txt	166	tnf together ifn stimulated significant increase rantes mrna expression 5 fold basal levels non cf cells yet failed stimulate rantes mrna expression cf cells fig
0.41277942.10069998.html.plaintext.txt	167	together findings indicate cf airway epithelial cells express detectable rantes mrna compared non cf counterparts
0.41277942.10069998.html.plaintext.txt	168	view larger version 49k fig
0.41277942.10069998.html.plaintext.txt	169	cf airway epithelial cells express rantes mrna
0.41277942.10069998.html.plaintext.txt	170	non cf cf airway epithelial cell lines primary cells cultured without tnf andor ifn described fig
0.41277942.10069998.html.plaintext.txt	171	stimulation cells harvested total rna isolated analyzed via northern blot analysis
0.41277942.10069998.html.plaintext.txt	172	northern blots probed cdna fragment specific rantes
0.41277942.10069998.html.plaintext.txt	173	blots stripped reprobed glyceraldehyde 3 phosphate dehydrogenase gapdh mrna expression account difference loading
0.41277942.10069998.html.plaintext.txt	174	representative autoradiograms densitometric results b 3 separate experiments shown
0.41277942.10069998.html.plaintext.txt	175	lane 1 carrier control lane 2 tnf lane 3 ifn lane 4 tnf ifn
0.41277942.10069998.html.plaintext.txt	176	densitometric results reported fold induction rantes mrna compared carrier controls
0.41277942.10069998.html.plaintext.txt	177	il 8 mcp 1 rantes expression non cf cf pancreatic epithelial cells
0.41277942.10069998.html.plaintext.txt	178	determine whether pattern il 8 mcp 1 rantes expression observed cf airway epithelial cells exhibited epithelial cells derived cf affected organ systems lung il 8 mcp 1 rantes expression compared non cf cf pancreatic epithelial cell lines presence absence tnf ifn
0.41277942.10069998.html.plaintext.txt	179	non cf pancreatic epithelial cell line panc 1 cf pancreatic cell line cfpac 1 f508 homozygote utilized studies
0.41277942.10069998.html.plaintext.txt	180	5 panc 1 cells cultured tnf alone together ifn expressed increased levels il 8 protein 11 6 ng106 cells respectively
0.41277942.10069998.html.plaintext.txt	181	interestingly cfpac 1 cells expressed approximately eightfold il 8 protein 9 ng106 cells basal conditions non cf counterpart tnf alone tnf together ifn enhanced il 8 protein expression cfpac 1 cells 23 ng106 cells fig
0.41277942.10069998.html.plaintext.txt	182	similar pattern il 8 mrna expression observed panc 1 cfpac 1 cells data shown
0.41277942.10069998.html.plaintext.txt	183	contrast panc 1 cells expressed mcp 1 protein constitutively 20 24 ng106 cells tnf andor ifn effect mcp 1 protein expression cells fig
0.41277942.10069998.html.plaintext.txt	184	interestingly cfpac 1 cells expressed significantly less mcp 1 protein 3 5 ng106 cells non cf counterpart tnf andor ifn effect fig
0.41277942.10069998.html.plaintext.txt	185	similar pattern mcp 1 mrna expression observed panc 1 cfpac 1 cells data shown
0.41277942.10069998.html.plaintext.txt	186	together results demonstrate cf non cf pancreatic epithelial cells display different pattern il 8 mcp 1 expression observed cf non cf airway epithelial cells described
0.41277942.10069998.html.plaintext.txt	187	view larger version 21k fig
0.41277942.10069998.html.plaintext.txt	188	cf non cf pancreatic cells express il 8 mcp 1 rantes differentially
0.41277942.10069998.html.plaintext.txt	189	cf non cf pancreatic epithelial cells cultured presence absence tnf andor ifn 100 ngml 18 h 37 degrees c
0.41277942.10069998.html.plaintext.txt	190	supernatants collected cells harvested counted control differences cell number supernatants analyzed via elisa il 8 mcp 1 b rantes c protein content
0.41277942.10069998.html.plaintext.txt	191	results reported ng protein106 cells n 3
0.41277942.10069998.html.plaintext.txt	192	interestingly cf non cf pancreatic epithelial cells exhibited pattern rantes expression similar observed cf non cf airway epithelial cells
0.41277942.10069998.html.plaintext.txt	193	specifically panc 1 cells expressed increased levels 20 25 ng106 cells rantes protein fig
0.41277942.10069998.html.plaintext.txt	194	6 stimulated tnf alone combination ifn low levels rantes protein 1 ng106 cells mrna observed basal conditions presence ifn alone
0.41277942.10069998.html.plaintext.txt	195	cfpac 1 cells however expressed little detectable rantes protein fig
0.41277942.10069998.html.plaintext.txt	196	6 presence absence tnf andor ifn
0.41277942.10069998.html.plaintext.txt	197	findings parallel pattern rantes expression observed non cf cf airway epithelial cells findings demonstrate epithelial cells derived multiple cf affected organs express significantly lower amounts rantes non cf counterparts
0.41277942.10069998.html.plaintext.txt	198	view larger version 47k fig
0.41277942.10069998.html.plaintext.txt	199	cf pancreatic cells express rantes mrna
0.41277942.10069998.html.plaintext.txt	200	cf non cf pancreatic epithelial cells stimulated without tnf andor ifn described fig
0.41277942.10069998.html.plaintext.txt	201	cells harvested total rna isolated analyzed via northern blotting described fig
0.41277942.10069998.html.plaintext.txt	202	representative autoradiograms densitometric results b 3 separate experiments shown
0.41277942.10069998.html.plaintext.txt	203	densitometric results reported fold induction rantes mrna compared panc 1 carrier controls
0.41277942.10069998.html.plaintext.txt	204	lane 1 carrier control lane 2 tnf lane 3 ifn lane 4 tnf ifn
0.41277942.10069998.html.plaintext.txt	205	role cftr regulation il 8 mcp 1 rantes expression
0.41277942.10069998.html.plaintext.txt	206	determine whether cftr directly modulates chemokine expression epithelial cells cf epithelial cell lines cfpac 1 ib3 1 complemented either wt cftr correct mutant cftr phenotype mock control analyzed il 8 mcp 1 rantes expression presence absence tnf andor ifn
0.41277942.10069998.html.plaintext.txt	207	specifically cfpac 1 cells transduced previously engineered plj virus containing either wt cftr mock control 7 ib3 1 cells transiently transfected plasmid carrying either wt cftr mock control utilized studies 8
0.41277942.10069998.html.plaintext.txt	208	wt cftr function complemented cfpac 1 ib3 1 cells monitored via chloride efflux described previously 27
0.41277942.10069998.html.plaintext.txt	209	cell type complemented wt cftr displayed least twofold increase chloride efflux activity presence camp nucleotide analogs compared mock controls data shown results suggest wt cftr expressed functional complemented cfpac 1 ib3 1 cells
0.41277942.10069998.html.plaintext.txt	210	transient transfection ib3 1 cells wt cftr alter protein mrna expression il 8 mcp 1 either basal cytokine stimulated conditions compared mock controls data shown
0.41277942.10069998.html.plaintext.txt	211	similarly cfpac 1 cells transduced virus containing wt cftr expressed equivalent levels il 8 mcp 1 protein mrna tnf andor ifn enhance il 8 mcp 1 expression mock control levels data shown
0.41277942.10069998.html.plaintext.txt	212	contrast cfpac 1 ib3 1 cells complemented wt cftr displayed significant increase rantes protein expression cfpac 1 3
0.41277942.10069998.html.plaintext.txt	213	4 ng106 cells 7 fold ib3 1 1
0.41277942.10069998.html.plaintext.txt	214	3 ng106 cells 2 fold cultured presence tnf combination ifn compared respective mock controls fig
0.41277942.10069998.html.plaintext.txt	215	cfpac 1 containing wt cftr also displayed significant increase rantes mrna stimulated simultaneously tnf ifn 9 fold greater mock control fig
0.41277942.10069998.html.plaintext.txt	216	significant difference rantes expression observed wt cftr complemented cfpac 1 ib3 1 cells respective mock controls basal conditions stimulated tnf ifn separately figs
0.41277942.10069998.html.plaintext.txt	217	findings taken together results presented demonstrate cftr modulates expression rantes il 8 mcp 1 protein mrna levels
0.41277942.10069998.html.plaintext.txt	218	view larger version 17k fig
0.41277942.10069998.html.plaintext.txt	219	cf epithelial cells complemented wild type cf transmembrane conductance regulator wt cftr express rantes protein presence tnf ifn
0.41277942.10069998.html.plaintext.txt	220	complemented ib3 1 cfpac 1 b cells cultured presence absence tnf andor ifn described fig
0.41277942.10069998.html.plaintext.txt	221	supernatants collected analyzed via rantes specific elisa cells harvested counted account differences cell number
0.41277942.10069998.html.plaintext.txt	222	results reported fold induction rantes protein relative respective mock controls n 3 6
0.41277942.10069998.html.plaintext.txt	223	view larger version 45k fig
0.41277942.10069998.html.plaintext.txt	224	cf epithelial cells complemented wt cftr express rantes mrna presence tnf ifn
0.41277942.10069998.html.plaintext.txt	225	cfpac 1 cells complemented wt cftr mock control cultured presence absence tnf andor ifn described fig
0.41277942.10069998.html.plaintext.txt	226	total rna isolated analyzed via northern blot analysis described fig
0.41277942.10069998.html.plaintext.txt	227	representative autoradiograms densitometric results b 3 separate experiments shown
0.41277942.10069998.html.plaintext.txt	228	densitometric results reported fold induction rantes mrna compared respective mock controls
0.41277942.10069998.html.plaintext.txt	229	lane 1 carrier control lane 2 tnf lane 3 ifn lane 4 tnf ifn
0.41277942.10069998.html.plaintext.txt	230	effect wt cftr rantes promoter activity
0.41277942.10069998.html.plaintext.txt	231	rantes gene expression reported regulated level transcription mrna stability 25
0.41277942.10069998.html.plaintext.txt	232	therefore delineate role cftr rantes mrna expression transfection assays utilizing rantes promoter constructs fused luciferase reporter gene performed ib3 1 cf airway epithelial cells complemented wt cftr respective mock controls rantes promoter constructs generated provided dr
0.41277942.10069998.html.plaintext.txt	233	4 kb 5 noncoding sequence rantes gene cloned pgl2 basic promega 1
0.41277942.10069998.html.plaintext.txt	234	4 kb region 5 deletion mutations region site directed mutation nf b binding site region fig
0.41277942.10069998.html.plaintext.txt	235	9 ib3 1 cells transfected complete 1
0.41277942.10069998.html.plaintext.txt	236	4 kb rantes promoter construct absence wt cftr displayed low reporter activity presence absence tnf ifn
0.41277942.10069998.html.plaintext.txt	237	contrast ib3 1 cells transfected 1
0.41277942.10069998.html.plaintext.txt	238	4 kb rantes promoter construct together wt cftr displayed approximately fourfold increase reporter activity presence tnf ifn compared unstimulated controls fig
0.41277942.10069998.html.plaintext.txt	239	determine regions rantes promoter essential cftr mediated activation 5 deletions rantes promoter construct analyzed
0.41277942.10069998.html.plaintext.txt	240	interestingly ib3 1 cells transfected 0
0.41277942.10069998.html.plaintext.txt	241	4 kb rantes promoter construct either absence presence wt cftr exhibited increased reporter activity basal conditions suggesting negative regulatory element exists upstream deletion activity responsive effects tnf ifn fig
0.41277942.10069998.html.plaintext.txt	242	however ib3 1 cells transfected 0
0.41277942.10069998.html.plaintext.txt	243	4 kb rantes promoter construct displayed pattern activity similar observed complete 1
0.41277942.10069998.html.plaintext.txt	244	specifically ib3 1 cells transfected 0
0.41277942.10069998.html.plaintext.txt	245	2 kb rantes promoter construct together wt cftr exhibited fourfold increase reporter activity stimulated tnf combination ifn compared unstimulated mock controls fig
0.41277942.10069998.html.plaintext.txt	246	findings indicate transcription factor binding sites located within 300 bp upstream 0
0.41277942.10069998.html.plaintext.txt	247	2 kb construct activator protein 1 signal transducer activator transcription stat nuclear factor activated cells nf fig
0.41277942.10069998.html.plaintext.txt	248	9a mediate constitutive activation rantes promoter however binding sites within 0
0.41277942.10069998.html.plaintext.txt	249	2 kb construct including nuclear factor il 6 nf b fig
0.41277942.10069998.html.plaintext.txt	250	9a confer wt cftr modulation rantes promoter activation
0.41277942.10069998.html.plaintext.txt	251	nf b implicated essential factor tnf andor ifn mediated induction rantes gene expression 17 21
0.41277942.10069998.html.plaintext.txt	252	determine whether wt cftr modulates rantes promoter activation via nf b ib3 1 cells transfected complete 1
0.41277942.10069998.html.plaintext.txt	253	4 kb rantes promoter construct containing mutant nf b site b wt cftr mock control
0.41277942.10069998.html.plaintext.txt	254	9c ib3 1 cells transfected wt cftr b rantes promoter construct responsive effects tnf andor ifn observed intact 1
0.41277942.10069998.html.plaintext.txt	255	taken together results suggest presence tnf ifn wt cftr modulates activation rantes promoter airway epithelial cells via nf b mediated pathway
0.41277942.10069998.html.plaintext.txt	256	view larger version 21k fig
0.41277942.10069998.html.plaintext.txt	257	wt cftr modulates rantes promoter activation presence tnf ifn
0.41277942.10069998.html.plaintext.txt	258	4 kb 5 noncoding sequence rantes gene modified ref
0.41277942.10069998.html.plaintext.txt	259	17 showing mutant nuclear factor b nf b binding site b
0.41277942.10069998.html.plaintext.txt	260	rantes promoter constructs containing 1
0.41277942.10069998.html.plaintext.txt	261	2r 5 noncoding sequence b utilized
0.41277942.10069998.html.plaintext.txt	262	b ib3 1 cells transfected transiently 1
0.41277942.10069998.html.plaintext.txt	263	2r wt cftr mock control
0.41277942.10069998.html.plaintext.txt	264	c ib3 1 cells transfected transiently 1
0.41277942.10069998.html.plaintext.txt	265	4r b construct wt cftr mock control
0.41277942.10069998.html.plaintext.txt	266	cells cultured presence absence tnf ifn described fig
0.41277942.10069998.html.plaintext.txt	267	3 harvested counted processed reporter activity
0.41277942.10069998.html.plaintext.txt	268	results reported relative reporter activity compared unstimulated mock controls n 3 5
0.41277942.10069998.html.plaintext.txt	269	discussion top abstract introduction methods results discussion references
0.41277942.10069998.html.plaintext.txt	270	present study performed delineate role airway epithelium leukocyte recruitment associated cf airway inflammation
0.41277942.10069998.html.plaintext.txt	271	data presented herein demonstrate cf non cf airway epithelial cells presence absence proinflammatory cytokines tnf ifn expressed levels il 8 mcp 1 consistent therefore data suggest differences exist expression molecules cf non cf cells
0.41277942.10069998.html.plaintext.txt	272	sharp contrast however cf epithelial cells expressed little rantes protein mrna compared non cf controls
0.41277942.10069998.html.plaintext.txt	273	although cf non cf epithelial cells derived pancreas another cf affected organ exhibited pattern il 8 mcp 1 expression differed respective airway epithelial counterparts pattern rantes expression cf pancreatic epithelial cells expressed detectable rantes protein mrna compared non cf controls
0.41277942.10069998.html.plaintext.txt	274	importantly insertion wt cftr cf airway pancreatic epithelial cells correct cftr defect restored rantes protein mrna expression presence tnf ifn via nf b mediated pathway however correction cftr defect effect il 8 mcp 1 expression cells
0.41277942.10069998.html.plaintext.txt	275	together results demonstrate 1 cytokine induced rantes expression altered cf epithelia 2 epithelial gene expression rantes il 8 mcp 1 dependent cftr
0.41277942.10069998.html.plaintext.txt	276	studies presented herein performed presence absence tnf andor ifn p
0.41277942.10069998.html.plaintext.txt	277	26 detected elevated levels tnf sputum cf patients infected p
0.41277942.10069998.html.plaintext.txt	278	study concluded high concentrations proinflammatory cytokines including tnf may contribute localized neutrophil dominated inflammatory state observed cf airway 26
0.41277942.10069998.html.plaintext.txt	279	second increasing evidence suggests exaggerated inflammatory response may exist cf lung presence absence bacterial infection
0.41277942.10069998.html.plaintext.txt	280	12 demonstrated airway inflammation may occur appearance bacterial pathogens cf patients
0.41277942.10069998.html.plaintext.txt	281	investigators examined balf control cf infants results demonstrated significant increase number neutrophils il 8 levels balf cf infants negative cultures common bacterial cf related pathogens including p
0.41277942.10069998.html.plaintext.txt	282	aeruginosa staphylococcus aureus compared normal controls
0.41277942.10069998.html.plaintext.txt	283	contrast armstrong co workers 1 reported early onset airway inflammation cf infants due presence respiratory pathogens previously diagnosed
0.41277942.10069998.html.plaintext.txt	284	studies demonstrated increased neutrophil numbers il 8 levels balf cf infants correlate bacteria andor viral infection
0.41277942.10069998.html.plaintext.txt	285	however authors also showed uninfected cf infants greater number balf neutrophils normal controls suggesting enhanced airway inflammatory response occurs cf patients 1
0.41277942.10069998.html.plaintext.txt	286	19 reported il 8 levels markedly elevated balf infected cf patients compared levels infected uninfected controls even standardization il 8 concentrations bacterial counts
0.41277942.10069998.html.plaintext.txt	287	although studies presented herein indicate cf non cf airway epithelial cell lines express inconsistent differences levels il 8 mcp 1 presence absence tnf ifn mere expression chemokines implicates cf epithelia leukocyte migration observed cf associated airway inflammation
0.41277942.10069998.html.plaintext.txt	288	moreover observation cf non cf airway epithelial cells expressed comparable levels il 8 presence absence proinflammatory cytokines together observation complementation cf epithelial cells alter il 8 expression cells suggests 1 enhanced il 8 expression cf airway epithelial cells source increased il 8 levels detected uninfected cf patient balf 2 cytokine induced epithelial il 8 expression regulated independently cftr
0.41277942.10069998.html.plaintext.txt	289	findings contradict previous studies reported increased il 8 expression cf airway epithelial cells presence absence proinflammatory stimuli 24 30
0.41277942.10069998.html.plaintext.txt	290	ruef co workers 24 demonstrated cf airway epithelial cell line jmecf15 secreted il 8 absence stimuli expression enhanced presence il 1
0.41277942.10069998.html.plaintext.txt	291	analyses single cf epithelial cell line authors concluded local production il 8 cf epithelial cells may trigger significant upregulation airway inflammation cf 24
0.41277942.10069998.html.plaintext.txt	292	30 reported recently cf airway epithelial cell lines ib3 1 2cf expressed significantly il 8 protein non cf epithelial cell lines beas2b normal human primary bronchial epithelial cells presence tnf il 1 wt cftr complemented ib3 1 cell line c38 expressed il 8 levels similar expressed non cf cells
0.41277942.10069998.html.plaintext.txt	293	however authors examined two cf epithelial cell lines compare il 8 expression cf non cf primary airway epithelial cells importantly demonstrate complemented cell line c38 exhibited wt cftr activity 30
0.41277942.10069998.html.plaintext.txt	294	inability cf epithelial cells express rantes protein mrna suggests cells recruit eosinophils cf lung via particular c c chemokine
0.41277942.10069998.html.plaintext.txt	295	airway epithelial cells shown express c c chemokines rantes including eotaxin 20 mcp 4 32 may facilitate eosinophil migration
0.41277942.10069998.html.plaintext.txt	296	end unable detect eotaxin expression cf non cf primary airway epithelial cells however observed non cf pancreatic epithelial cell line panc 1 expresses eotaxin response tnf alone together ifn whereas cf counterpart cfpac 1 l
0.41277942.10069998.html.plaintext.txt	297	schwiebert unpublished observations
0.41277942.10069998.html.plaintext.txt	298	recent report stellato et al
0.41277942.10069998.html.plaintext.txt	299	32 authors demonstrated cf airway epithelial cell line ib3 1 expressed mcp 1 mrna presence tnf combination ifn
0.41277942.10069998.html.plaintext.txt	300	however level mcp 4 mrna expression ib3 1 cells significantly lower observed non cf airway epithelial cell lines beas2b a549 stimulated manner 32
0.41277942.10069998.html.plaintext.txt	301	14 observed rantes levels balf cf patients significantly lower rantes levels balf asthmatics
0.41277942.10069998.html.plaintext.txt	302	report suggests expression rantes cell types express chemokine including lymphocytes macrophages may depressed cf lung
0.41277942.10069998.html.plaintext.txt	303	present unclear role rantes may play improving cf associated airway inflammation andor bacterial clearance cf lung
0.41277942.10069998.html.plaintext.txt	304	rantes gene expression appears regulated level transcription 3 untranslated region rantes mrna contain au repeat element suggesting rantes mrna expression regulated level mrna stability 25
0.41277942.10069998.html.plaintext.txt	305	results reported herein demonstrate tnf ifn synergize induction rantes expression cf epithelial cells complemented wt cftr wt cftr modulates rantes promoter activation via nf b
0.41277942.10069998.html.plaintext.txt	306	nf b transcription factor family composed c rel nf b1 p50 nf b2 p52 rela p65 relb reviewed ref
0.41277942.10069998.html.plaintext.txt	307	members family form homo heterodimers retained cytoplasm unactivated cells interaction members ib inhibitor family members ib family include ib ib ibr 3
0.41277942.10069998.html.plaintext.txt	308	tnf reported induce rapid phosphorylation subsequent degradation ib allowing nf b translocate nucleus activate transcription 3
0.41277942.10069998.html.plaintext.txt	309	interestingly recent paper ray co workers 21 suggests rantes il 8 differentially regulated nf b
0.41277942.10069998.html.plaintext.txt	310	authors reported overexpression ibr alveolar epithelial cell line a549 sequesters p50 homodimers thereby facilitating binding unique nf b rel complex rantes b region binding turn triggered rapid 50 100 fold induction rantes upon cytokine stimulation compared control cells 21
0.41277942.10069998.html.plaintext.txt	311	however ibr overexpression a549 cells enhance gene expression chemokine il 8 21
0.41277942.10069998.html.plaintext.txt	312	possible loss cftr activity
0.41277942.10069998.html.plaintext.txt	313	loss chloride transport cf epithelial cells may alter activity transcription factors nf b subsequent induction rantes gene expression
0.41277942.10069998.html.plaintext.txt	314	several studies linked activity ion channels immune responses vivo 10 11 29
0.41277942.10069998.html.plaintext.txt	315	cahalan lewis 4 hypothesize activating kinase regulated chloride channels cftr may result depolarization membrane potential thereby may suppress mitogen stimulated calcium influx
0.41277942.10069998.html.plaintext.txt	316	18 demonstrated adding permeable camp analog lymphocytes suppressed calcium influx nf mediated gene expression il 2 response cell receptor activation
0.41277942.10069998.html.plaintext.txt	317	activity transcription factors nf including c fos also linked membrane depolarization calcium influx 29
0.41277942.10069998.html.plaintext.txt	318	defining cellular molecular mechanisms trigger migration leukocytes cf lung critical understanding pathophysiology disease
0.41277942.10069998.html.plaintext.txt	319	moreover determining cftr regulates expression chemokines rantes understanding airway inflammation general
0.41277942.10069998.html.plaintext.txt	320	schleimer encouragement drs
0.41277942.10069998.html.plaintext.txt	321	etty benveniste john engelhardt nael mccarty hiro moriuchi erik m
0.41277942.10069998.html.plaintext.txt	322	schwiebert theresa strong assistance
0.41277942.10069998.html.plaintext.txt	323	sorscher department physiology biophysics gregory fleming james cystic fibrosis research center continued support
0.41277942.10069998.html.plaintext.txt	324	work funded grants cystic fibrosis foundation american lung association
0.41277942.10069998.html.plaintext.txt	325	costs publication article defrayed part payment page charges
0.41277942.10069998.html.plaintext.txt	326	article must therefore hereby marked advertisement accordance 18 u
0.41277942.10069998.html.plaintext.txt	327	1734 solely indicate fact
0.41277942.10069998.html.plaintext.txt	328	address reprint requests l
0.41277942.10069998.html.plaintext.txt	329	physiology biophysics mccallum bldg
0.41277942.10069998.html.plaintext.txt	330	966 university alabama birmingham 1918 university blvd
0.41277942.10069998.html.plaintext.txt	331	received 29 july 1998 accepted final form 4 december 1998
0.41277942.10069998.html.plaintext.txt	332	references top abstract introduction methods results discussion references
0.41277942.10069998.html.plaintext.txt	333	lower airway inflammation infants young children cystic fibrosis
0.41277942.10069998.html.plaintext.txt	334	156 1197 1204 1997abstractfree full text
0.41277942.10069998.html.plaintext.txt	335	lymphocytes activated eosinophils airway mucosa fatal asthma cystic fibrosis
0.41277942.10069998.html.plaintext.txt	336	nfb ib proteins new discoveries insights
0.41277942.10069998.html.plaintext.txt	337	regulation chloride channels lymphocytes
0.41277942.10069998.html.plaintext.txt	338	current topics membranes edited w
0.41277942.10069998.html.plaintext.txt	339	san diego ca academic 1994 p
0.41277942.10069998.html.plaintext.txt	340	cftr expression chloride secretion polarized immortal human bronchial epithelial cells
0.41277942.10069998.html.plaintext.txt	341	method rapid detection recombinant cftr gene therapy cystic fibrosis
0.41277942.10069998.html.plaintext.txt	342	correction cystic fibrosis defect vitro retrovirus mediated gene transfer
0.41277942.10069998.html.plaintext.txt	343	cell 62 1227 1233 1990medline
0.41277942.10069998.html.plaintext.txt	344	two cystic fibrosis transmembrane conductance regulator mutations different effects pulmonary phenotype regulation outwardly rectified chloride currents
0.41277942.10069998.html.plaintext.txt	345	usa 92 6832 6836 1995abstract
0.41277942.10069998.html.plaintext.txt	346	increased elastase production peripheral blood monocytes cystic fibrosis patients
0.41277942.10069998.html.plaintext.txt	347	activation nuclear factor b via cell receptor requires raf kinase ca2 influx
0.41277942.10069998.html.plaintext.txt	348	functional synergy raf calcineurin
0.41277942.10069998.html.plaintext.txt	349	157 5277 5283 1996abstract
0.41277942.10069998.html.plaintext.txt	350	ion channels ca2 signaling reporter gene expression antigen specific mouse cells
0.41277942.10069998.html.plaintext.txt	351	159 1628 1638 1997abstract
0.41277942.10069998.html.plaintext.txt	352	early pulmonary inflammation infants cystic fibrosis
0.41277942.10069998.html.plaintext.txt	353	151 1075 1082 1995abstract
0.41277942.10069998.html.plaintext.txt	354	eosinophilic activation cystic fibrosis
0.41277942.10069998.html.plaintext.txt	355	thorax 49 496 499 1994abstract
0.41277942.10069998.html.plaintext.txt	356	cytokine concentrations sputum patients cystic fibrosis relation eosinophil activity
0.41277942.10069998.html.plaintext.txt	357	155 1050 1054 1997abstract
0.41277942.10069998.html.plaintext.txt	358	increased degranulation eosinophil neutrophil granulocytes cystic fibrosis
0.41277942.10069998.html.plaintext.txt	359	glucocorticoid inhibition rantes expression human lung epithelial cells
0.41277942.10069998.html.plaintext.txt	360	nuclear factor b potently regulates promoter activity rantes chemokine blocks hiv infection
0.41277942.10069998.html.plaintext.txt	361	158 3483 3491 1997abstract
0.41277942.10069998.html.plaintext.txt	362	intracellular calcium dependence gene expression single lymphocytes
0.41277942.10069998.html.plaintext.txt	363	usa 91 2873 2877 1994abstract
0.41277942.10069998.html.plaintext.txt	364	nasal bronchioalveolar lavage fluid cytokines early cystic fibrosis
0.41277942.10069998.html.plaintext.txt	365	cloning human eosinophil chemoattractant eotaxin
0.41277942.10069998.html.plaintext.txt	366	97 604 612 1996abstractfree full text
0.41277942.10069998.html.plaintext.txt	367	selective regulation cytokine induced rantes gene expression lung epithelial cells overexpression ibr
0.41277942.10069998.html.plaintext.txt	368	272 20191 20197 1997abstractfree full text
0.41277942.10069998.html.plaintext.txt	369	increased monocyte oxidase activity cystic fibrosis heterozygotes homozygotes
0.41277942.10069998.html.plaintext.txt	370	identification cystic fibrosis gene cloning characterization complementary dna
0.41277942.10069998.html.plaintext.txt	371	science 245 1066 1073 1989medline
0.41277942.10069998.html.plaintext.txt	372	regulation cytokine secretion cystic fibrosis airway epithelial cells
0.41277942.10069998.html.plaintext.txt	373	human cell specific molecule member new gene family
0.41277942.10069998.html.plaintext.txt	374	141 1018 1025 1988abstractfree full text
0.41277942.10069998.html.plaintext.txt	375	cytokines neutrophil dominated airway inflammation patients cystic fibrosis
0.41277942.10069998.html.plaintext.txt	376	chloride channel chloride conductance regulator domains cftr
0.41277942.10069998.html.plaintext.txt	377	usa 95 2674 2679 1998abstractfree full text
0.41277942.10069998.html.plaintext.txt	378	epithelium target glucocorticoid action treatment asthma
0.41277942.10069998.html.plaintext.txt	379	membrane depolarization calcium induce c fos transcription via phosphorylation transcription factor creb
0.41277942.10069998.html.plaintext.txt	380	neuron 4 571 582 1990medline
0.41277942.10069998.html.plaintext.txt	381	exaggerated inflammatory response cf airway epithelial cells abstract
0.41277942.10069998.html.plaintext.txt	382	expression chemokine rantes human bronchial epithelial cell line
0.41277942.10069998.html.plaintext.txt	383	modulation cytokines glucocorticoids
0.41277942.10069998.html.plaintext.txt	384	production novel c c chemokine mcp 4 airway cells comparison biological activity c c chemokines
0.41277942.10069998.html.plaintext.txt	385	99 926 936 1997abstractfree full text
0.41277942.10069998.html.plaintext.txt	386	philadelphia lippincott 1997 p
0.41277942.10069998.html.plaintext.txt	387	monocytes cystic fibrosis responsiveness microbial stimuli
0.41277942.10069998.html.plaintext.txt	388	expression rantes human bronchial epithelial cells vitro vivo effect corticosteroids
0.41277942.10069998.html.plaintext.txt	389	primary host defense abnormality involving monocytes macrophages underlie pathogenesis lung disease cystic fibrosis med
0.41277942.10069998.html.plaintext.txt	390	hypotheses 8 527 542 1982medline
0.41277942.10069998.html.plaintext.txt	391	cystic fibrosis bronchial epithelial cell line immortalization adeno 12 sv40 infection
0.41277942.10069998.html.plaintext.txt	392	vivo analysis fluid transport cystic fibrosis airway epithelia bronchial xenografts
0.41277942.10069998.html.plaintext.txt	393	39 c1326 c1335 1996abstractfree full text
0.41277942.10069998.html.plaintext.txt	394	j physiol cell physiol 2763c700 c710 0002 951399 5
0.41277942.10069998.html.plaintext.txt	395	00 copyright 1999 american physiological society
0.4332927.11121385.html.plaintext.txt	0	improved oxygenation promotes cftr maturation trafficking mdck monolayers zsuzsanna bebok12 albert tousson3 lisa m
0.4332927.11121385.html.plaintext.txt	1	departments 1 medicine 4 physiology biophysics 3 cell biology 2 gregory fleming james cystic fibrosis research center university alabama birmingham birmingham alabama 35294 0005
0.4332927.11121385.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references
0.4332927.11121385.html.plaintext.txt	3	culturing airway epithelial cells apical media removed air liquid interface shown enhance cystic fibrosis transmembrane conductance regulator cftr mediated cl secretory current
0.4332927.11121385.html.plaintext.txt	4	thus hypothesized cellular oxygenation may modulate cftr expression
0.4332927.11121385.html.plaintext.txt	5	tested notion using type madin darby canine kidney cells endogenously express low levels cftr
0.4332927.11121385.html.plaintext.txt	6	growing monolayers cells 4 5 days air liquid interface caused 50 fold increase forskolin stimulated cl current compared conventional submerged controls
0.4332927.11121385.html.plaintext.txt	7	assaying possible changes cftr immunoprecipitation immunocytochemical localization revealed cftr appeared immature 140 kda form intracellularly conventional cultures
0.4332927.11121385.html.plaintext.txt	8	contrast monolayers grown air liquid interface possessed cftr protein accompanied increases toward mature 170 kda form apical membrane staining
0.4332927.11121385.html.plaintext.txt	9	culturing submerged monolayers 95 o2 produced similar improvements cl current cftr protein air liquid interface culture increasing po2 2
0.4332927.11121385.html.plaintext.txt	10	5 20 air liquid interface cultures yielded graded enhancements
0.4332927.11121385.html.plaintext.txt	11	together data indicate improved cellular oxygenation increase endogenous cftr maturation andor trafficking
0.4332927.11121385.html.plaintext.txt	12	cystic fibrosis cellular polarization hypoxia cell culture methods
0.4332927.11121385.html.plaintext.txt	13	introduction top abstract introduction materials methods results discussion references
0.4332927.11121385.html.plaintext.txt	14	cystic fibrosis transmembrane conductance regulator cftr epithelial anion channel requires camp dependent phosphorylation plus intracellular atp open 19 46 50
0.4332927.11121385.html.plaintext.txt	15	channels normally expressed apical membranes epithelial cells lining airways intestines pancreatic ducts kidney tubules 19 46 33 56
0.4332927.11121385.html.plaintext.txt	16	mutations gene coding cftr impair epithelial cl hco3 transport cause cystic fibrosis cf
0.4332927.11121385.html.plaintext.txt	17	cf patients 90 allele coding mutant cftr lacks phenylalanine 508 position 19 46
0.4332927.11121385.html.plaintext.txt	18	f508 cftr retains function protein kinase atp regulated anion channel 9 absent plasma membranes cells used heterologous expression 6 14
0.4332927.11121385.html.plaintext.txt	19	hence many cf patients expected benefit increased f508 cftr expression
0.4332927.11121385.html.plaintext.txt	20	34 35 identified important caveat regarding heterologous expression cftr
0.4332927.11121385.html.plaintext.txt	21	specifically showed wild type cftr present plasma membranes ht 29 intestinal epithelial cells unless cells confluent polarized
0.4332927.11121385.html.plaintext.txt	22	furthermore change cftr localization cell surface mediated change transcription translation since polarized nonpolarized ht 29 cells contained similar amounts cftr mrna protein 34 35
0.4332927.11121385.html.plaintext.txt	23	data suggest trafficking cftr apical cell surface highly regulated
0.4332927.11121385.html.plaintext.txt	24	also number reports showing detectable amounts endogenous cftr protein present apical membranes epithelial cells f508 homozygous cf patients 14 15 28 44 49 62
0.4332927.11121385.html.plaintext.txt	25	thus likely additional factors regulate endogenous cftr maturation cell surface localization epithelial cells
0.4332927.11121385.html.plaintext.txt	26	aims study test hypothesis gain insight regarding endogenous cftr expression may increased
0.4332927.11121385.html.plaintext.txt	27	growing primary immortalized airway epithelial cells filters nearly apical fluid removed shown cause six eightfold increase cftr mediated anion secretion compared conventional submerged controls 30 52
0.4332927.11121385.html.plaintext.txt	28	maneuver referred air liquid interface culture 27 31 36 41 43 air interface culture 30 52
0.4332927.11121385.html.plaintext.txt	29	mediator responsible increased cl hco3 secretory response following air liquid interface culture possible effects cftr remains unknown
0.4332927.11121385.html.plaintext.txt	30	since conventional cell cultures hypoxic 8 12 40 59 hypothesized improved cellular oxygenation may enhance cftr expression
0.4332927.11121385.html.plaintext.txt	31	used subclone madin darby canine kidney mdck cell line model test hypothesis
0.4332927.11121385.html.plaintext.txt	32	mdck cells american type culture collection 23 consist least two strains types 38 45
0.4332927.11121385.html.plaintext.txt	33	type mdck cells form high resistance monolayers demonstrate small cl secretory currents following addition camp mediated agonists whereas type ii mdck cells form low resistance monolayers respond camp 5 32 45 51
0.4332927.11121385.html.plaintext.txt	34	recent studies indicate type clones endogenously express small amounts cftr conventional culture conditions 32
0.4332927.11121385.html.plaintext.txt	35	thus subclones type mdck cells may provide good model test possible enhancement cftr expression
0.4332927.11121385.html.plaintext.txt	36	present study show culturing type mdck cells air liquid interface caused 50 fold increase forskolin stimulated cl secretion period 4 5 days culture
0.4332927.11121385.html.plaintext.txt	37	basis observation tested notion increased cl secretory response mediated enhanced cftr expression
0.4332927.11121385.html.plaintext.txt	38	finally exposed submerged air liquid interface cultures varying amounts o2 determine whether effects air liquid interface culture mediated improved oxygenation
0.4332927.11121385.html.plaintext.txt	39	data presented show increasing oxygen hypoxic atmospheric levels markedly enhanced cftr maturation apical membrane localization
0.4332927.11121385.html.plaintext.txt	40	observations important implications since cultured cells 39 47 53 59 cf patients 18 24 57 often hypoxic
0.4332927.11121385.html.plaintext.txt	41	materials methods top abstract introduction materials methods results discussion references
0.4332927.11121385.html.plaintext.txt	42	mdck aa7 cells culture methods
0.4332927.11121385.html.plaintext.txt	43	obtained type mdck subclone mdck aa7 16 38 university alabama birmingham cystic fibrosis research center
0.4332927.11121385.html.plaintext.txt	44	physiology east tennessee state univ
0.4332927.11121385.html.plaintext.txt	45	also kindly provided mdck aa7 cells study 16
0.4332927.11121385.html.plaintext.txt	46	grew cells mem containing earles salts l glutamine nonessential amino acids gibco brl grand island ny supplemented 10 fetal bovine serum atlanta biologicals norcross ga hyclone logan ut 23
0.4332927.11121385.html.plaintext.txt	47	medium aspirated replaced 2 day intervals
0.4332927.11121385.html.plaintext.txt	48	cells passaged pretreatment ca2 mg2 free phosphate buffered saline pbs contained 1 mm edta 20 30 min followed 10 min incubation pbs plus 0
0.4332927.11121385.html.plaintext.txt	49	dispersed cells seeded density 2 7 x 104 cellscm2 0
0.4332927.11121385.html.plaintext.txt	50	45 microm millicell ha filters millipore bedford ma 0
0.4332927.11121385.html.plaintext.txt	51	40 microm falcon pet filters becton dickinson franklin lakes nj use experiments
0.4332927.11121385.html.plaintext.txt	52	mdck aa7 cells maintained fluid sides 1 wk seeding permit monolayer formation
0.4332927.11121385.html.plaintext.txt	53	thereafter apical media gently aspirated replaced
0.4332927.11121385.html.plaintext.txt	54	previous studies shown airway cells grown conditions remained hydrated thin 15 microm fluid layer 27
0.4332927.11121385.html.plaintext.txt	55	filters maintained conventional submerged culture serve controls
0.4332927.11121385.html.plaintext.txt	56	initial studies cells grown humidified incubator contained 5 co2 95 room air 37 degrees c
0.4332927.11121385.html.plaintext.txt	57	later experiments filters cultured sealed plastic chambers gassed daily mixtures 5 co2 2
0.4332927.11121385.html.plaintext.txt	58	2 12 20 95 o2 plus balance n2 test possible effects cellular oxygenation
0.4332927.11121385.html.plaintext.txt	59	reductions po2 verified testing media instrumentation laboratory 1640 blood gas analyzer
0.4332927.11121385.html.plaintext.txt	60	transepithelial short circuit current measurements
0.4332927.11121385.html.plaintext.txt	61	filters mounted modified ussing chambers jims instruments iowa city ia bathed sides identical hepes buffered saline solutions contained mm 130 nacl 5 sodium pyruvate 4 kcl 1 cacl2 1 mgcl2 5 d glucose 5 hepes naoh ph 7
0.4332927.11121385.html.plaintext.txt	62	bath solutions stirred vigorously gassed room air
0.4332927.11121385.html.plaintext.txt	63	solution temperature maintained 37 degrees c
0.4332927.11121385.html.plaintext.txt	64	short circuit current isc measurements obtained using epithelial voltage clamp vcc 600 physiologic instruments san diego ca
0.4332927.11121385.html.plaintext.txt	65	10 mv pulse 1 duration imposed every 100 monitor transepithelial resistance rt calculated using ohms law
0.4332927.11121385.html.plaintext.txt	66	amiloride 100 microm routinely added apical solutions abolish na absorption 3
0.4332927.11121385.html.plaintext.txt	67	forskolin 10 microm added bathing solutions stimulate camp mediated cl secretion 51
0.4332927.11121385.html.plaintext.txt	68	cl secretory currents identified basis activation forskolin sensitivity basolateral bacl2 5 mm bumetanide 10 microm ouabain 100 microm 1 5 10 51
0.4332927.11121385.html.plaintext.txt	69	drugs added small volume concentrated stock solution
0.4332927.11121385.html.plaintext.txt	70	5 m ouabain 10 mm stocks made water
0.4332927.11121385.html.plaintext.txt	71	forskolin 10 mm dissolved ethanol bumetanide 3 mm dissolved 0
0.4332927.11121385.html.plaintext.txt	72	methods used immunoprecipitate cftr previously described detail 2 42
0.4332927.11121385.html.plaintext.txt	73	briefly cells washed ice cold pbs contained 1 mm cacl2 mgcl2 lysed buffer contained 150 mm nacl 20 mm hepes 1 mm edta 1 nonidet p 40 supplemented protease inhibitor cocktail complete mini boehringer mannheim indianapolis
0.4332927.11121385.html.plaintext.txt	74	protein concentration determined using protein assay reagent bio rad
0.4332927.11121385.html.plaintext.txt	75	lysates contained 300 microg total protein immunoprecipitated 4 degrees c 2 h using anti cftr cooh terminal monoclonal antibody genzyme framington ma protein g agarose beads boehringer mannheim
0.4332927.11121385.html.plaintext.txt	76	immunoprecipitated proteins phosphorylated using 32patp dupont nen plus catalytic subunit camp dependent protein kinase promega separated 6 polyacrylamide gels novex
0.4332927.11121385.html.plaintext.txt	77	gels placed phosphoscreen analyzed phosphorimager molecular dynamics
0.4332927.11121385.html.plaintext.txt	78	images processed using iplab spectrum software signal analytics
0.4332927.11121385.html.plaintext.txt	79	cftr localization confocal immunofluorescence microscopy
0.4332927.11121385.html.plaintext.txt	80	mdck aa7 cells grown transparent cyclopore filters falcon
0.4332927.11121385.html.plaintext.txt	81	two primary anti cftr antibodies used rabbit polyclonal antibody first nucleotide binding domain nbd kindly provided dr
0.4332927.11121385.html.plaintext.txt	82	alabama birmingham 2 42 monoclonal antibody specific regulatory domain r domain genzyme
0.4332927.11121385.html.plaintext.txt	83	monolayers probed anti nbd antibody fixed initially methanol 20 degrees c
0.4332927.11121385.html.plaintext.txt	84	monolayers probed anti r domain antibody underwent preliminary fixation methanolacetic acid 31 20 degrees c
0.4332927.11121385.html.plaintext.txt	85	formaldehyde 3 pbs used complete fixation specimens
0.4332927.11121385.html.plaintext.txt	86	nonspecific protein binding blocked 1 wtvol bovine serum albumin
0.4332927.11121385.html.plaintext.txt	87	oregon green labeled anti rabbit igg texas red x labeled anti mouse igg molecular probes used secondary antibodies
0.4332927.11121385.html.plaintext.txt	88	samples counterstained nuclear dye bisbenzimide
0.4332927.11121385.html.plaintext.txt	89	filters cut folded cell side mounting enable cross sectional views 35
0.4332927.11121385.html.plaintext.txt	90	cftr immunolocalization examined using olympus ix70 inverted epifluorescence microscope equipped step motor filter wheel assembly ludl electronics products hawthorn ny 83000 filter set chroma technology brattleboro vt
0.4332927.11121385.html.plaintext.txt	91	images captured sensys cooled charge coupled device high resolution digital camera photometrics tucson az
0.4332927.11121385.html.plaintext.txt	92	partial deconvolution images performed using iplab spectrum software scanalytics fairfax va
0.4332927.11121385.html.plaintext.txt	93	analysis cftr mrna rt pcr
0.4332927.11121385.html.plaintext.txt	94	total rna isolated filter grown mdck aa7 monolayers using trizol gibco brl
0.4332927.11121385.html.plaintext.txt	95	contamination genomic dna eliminated using 1 u dnase gibco brl per microgram total rna
0.4332927.11121385.html.plaintext.txt	96	one microgram dnase treated rna reverse transcribed reaction contained 200 u moloney murine leukemia virus rt gibco brl 0
0.4332927.11121385.html.plaintext.txt	97	5 mm dntp 25 u rnase inhibitor rnasin promega madison wi
0.4332927.11121385.html.plaintext.txt	98	cdna samples amplified cftr reaction contained 0
0.4332927.11121385.html.plaintext.txt	99	2 microg cdna 1 u taq polymerase perkin elmer norwalk ct 200 microm dntp 20 pmol following pcr primers 5 gag gac act gct cct aca c 3 5 cag att agc ccc atg agg ag 3 gibco brl
0.4332927.11121385.html.plaintext.txt	100	primers span region cftr nt 531 778
0.4332927.11121385.html.plaintext.txt	101	reactions cftr cycled follows initial melt 95 degrees c 5 min 40 cycles 95 degrees c 1 min 58 degrees c 1 min 72 degrees c 2 min final extension 72 degrees c 10 min
0.4332927.11121385.html.plaintext.txt	102	expected size cftr product 248 bp
0.4332927.11121385.html.plaintext.txt	103	amplified cdna products housekeeping gene actin control
0.4332927.11121385.html.plaintext.txt	104	amplification actin consisted mixing 0
0.4332927.11121385.html.plaintext.txt	105	2 microg cdna sample 1 u taq polymerase perkin elmer 200 mm dntp 20 pmol pcr primers 5 tga cgg ggt cac cca cac tgt gcc cat cta 3 5 cta gaa gca ttg cgg tgg acg atg gag gg 3 gibco brl
0.4332927.11121385.html.plaintext.txt	106	primers span nucleotides 2133 2822 actin cdna
0.4332927.11121385.html.plaintext.txt	107	pcr reactions actin cycled initial melt 95 degrees c 5 min 30 cycles 95 degrees c 30 46 degrees c 1 min 72 degrees c 1 min final extension 72 degrees c 10 min
0.4332927.11121385.html.plaintext.txt	108	expected fragment size actin product 690 bp
0.4332927.11121385.html.plaintext.txt	109	salts buffers reagents purchased sigma aldrich unless otherwise noted
0.4332927.11121385.html.plaintext.txt	110	aqueous solutions made milli q water millipore
0.4332927.11121385.html.plaintext.txt	111	results top abstract introduction materials methods results discussion references
0.4332927.11121385.html.plaintext.txt	112	air liquid interface culture induces large cl secretory response mdck aa7 monolayers
0.4332927.11121385.html.plaintext.txt	113	figure 1 compares representative isc records mdck aa7 monolayers grown either apical side submerged culture medium solid line apical air liquid interface 4 days dashed line
0.4332927.11121385.html.plaintext.txt	114	forskolin 10 microm added sides increase cellular camp 43
0.4332927.11121385.html.plaintext.txt	115	forskolin stimulated currents inhibited basolateral addition either barium 5 mm see fig
0.4332927.11121385.html.plaintext.txt	116	1 bumetanide 10 microm shown ouabain 100 microm shown
0.4332927.11121385.html.plaintext.txt	117	effects forskolin barium bumetanide ouabain indicate forskolin stimulated isc provides direct measure electrogenic cl secretion 1 5 10 45 51 52 60
0.4332927.11121385.html.plaintext.txt	118	results also agree previous studies type mdck cells 5 45 51
0.4332927.11121385.html.plaintext.txt	119	electrogenic na absorption contribute isc since apical amiloride 100 microm effect isc added fig
0.4332927.11121385.html.plaintext.txt	120	1 forskolin shown
0.4332927.11121385.html.plaintext.txt	121	filters produced records shown fig
0.4332927.11121385.html.plaintext.txt	122	1 seeded 5 x 104 cellscm2 cultured standard conditions 1 wk
0.4332927.11121385.html.plaintext.txt	123	one monolayer exposed air liquid interface 4 days apical fluid removed replaced monolayer remained submerged 2
0.4332927.11121385.html.plaintext.txt	124	thus imposition apical air liquid interface 4 days markedly enhanced forskolin stimulated cl secretion
0.4332927.11121385.html.plaintext.txt	125	view larger version 9k fig
0.4332927.11121385.html.plaintext.txt	126	comparison forskolin stimulated short circuit current isc across madin darby canine kidney mdck aa7 monolayer cultured 4 days apical air liquid interface dashed line paired medium submerged control solid line
0.4332927.11121385.html.plaintext.txt	127	millicell ha filters attached monolayers bathed sides identical hepes buffered saline solutions voltage clamped 0 mv described materials methods
0.4332927.11121385.html.plaintext.txt	128	amiloride 100 microm used abolish possible isc due active na absorption 3
0.4332927.11121385.html.plaintext.txt	129	forskolin 10 microm added sides increase cellular camp stimulate electrogenic cl secretion 52
0.4332927.11121385.html.plaintext.txt	130	added basolateral bacl2 5 mm inhibit cl secretory currents 1
0.4332927.11121385.html.plaintext.txt	131	amiloride forskolin bacl2 present continuously bathing solutions following addition
0.4332927.11121385.html.plaintext.txt	132	maximum isc response 1 microacm2 monolayer culture fluid submerged compared 47
0.4332927.11121385.html.plaintext.txt	133	2 microacm2 monolayer cultured air liquid interface
0.4332927.11121385.html.plaintext.txt	134	experiment repeated 60 times similar results also see fig
0.4332927.11121385.html.plaintext.txt	135	figure 2 summarizes relationships forskolin stimulated isc basal rt number days monolayers grown air liquid interface
0.4332927.11121385.html.plaintext.txt	136	time paired submerged controls n 24 behaved similarly plotted day 0
0.4332927.11121385.html.plaintext.txt	137	figure 2 left shows growing mdck aa7 cells apical air liquid interface caused 50 fold increase forskolin stimulated cl secretion plateaued days 4 5
0.4332927.11121385.html.plaintext.txt	138	contrast control monolayers grown conventional technique possessed relatively small forskolin stimulated currents 0
0.4332927.11121385.html.plaintext.txt	139	enhanced response observed air liquid interface grown monolayers compared cells grown conventional culture suggests cftr cl channel activity increased
0.4332927.11121385.html.plaintext.txt	140	view larger version 13k fig
0.4332927.11121385.html.plaintext.txt	141	forskolin stimulated short circuit current isc forskolin basal transepithelial resistance rt plotted function number days monolayers cultured apical media removed air liquid interface
0.4332927.11121385.html.plaintext.txt	142	isc forskolin calculated difference basal resting isc maximum isc evoked forskolin 10 microm
0.4332927.11121385.html.plaintext.txt	143	1 materials methods details regarding experimental design conditions
0.4332927.11121385.html.plaintext.txt	144	rt calculated magnitude current pulse arising 10 mv change holding potential using ohms law
0.4332927.11121385.html.plaintext.txt	145	basal rt forskolin addition provides estimate junctional resistance
0.4332927.11121385.html.plaintext.txt	146	time paired controls n 24 behaved similarly low forskolin stimulated isc 0
0.4332927.11121385.html.plaintext.txt	147	4 microacm2 high rt 2250 plus minus 650 cm2
0.4332927.11121385.html.plaintext.txt	148	data combined plotted initial day 0 points n 7 points error bars depict sd
0.4332927.11121385.html.plaintext.txt	149	comparison amount biochemical form subcellular localization cftr
0.4332927.11121385.html.plaintext.txt	150	one possible explanation results shown previous section growth air liquid interface increased number cftr cl channels apical membranes
0.4332927.11121385.html.plaintext.txt	151	initial test hypothesis immunoprecipitation used determine whether air liquid interface culture effect amount andor biochemical properties cftr
0.4332927.11121385.html.plaintext.txt	152	figure 3 compares immunoprecipitated cftr derived conventional fluid immersed monolayers fluid cftr obtained air interface monolayers air
0.4332927.11121385.html.plaintext.txt	153	cftr immunoprecipitated filter grown t84 cells served control 1 10
0.4332927.11121385.html.plaintext.txt	154	submerged mdck aa7 monolayers expressed small amount cftr
0.4332927.11121385.html.plaintext.txt	155	furthermore much protein submerged monolayers electrophoretic mobility corresponding 140 kda molecular weight protein
0.4332927.11121385.html.plaintext.txt	156	contrast mdck aa7 monolayers grown air liquid interface 5 days showed increase total cftr protein level well shift toward higher molecular weight 170 kda
0.4332927.11121385.html.plaintext.txt	157	previous studies indicate 140 kda band b form cftr represents immature core glycosylated protein whereas 170 kda band c form fully glycosylated 6 14
0.4332927.11121385.html.plaintext.txt	158	thus increase total amount cftr protein increase molecular weight following air liquid interface culture suggest 50 fold increase forskolin stimulated isc mediated least part enhanced maturation
0.4332927.11121385.html.plaintext.txt	159	view larger version 41k fig
0.4332927.11121385.html.plaintext.txt	160	immunoprecipitation cystic fibrosis transmembrane conductance regulator cftr lysates mdck aa7 cells grown either fluid submerged fluid air liquid interface air 5 days
0.4332927.11121385.html.plaintext.txt	161	32p phosphorylated cftr immunoprecipitates derived equivalent amounts lysates either mdck aa7 monolayers cultured 2 conditions control t84 cells using anti cftr cooh terminal antibody
0.4332927.11121385.html.plaintext.txt	162	treated mdck aa7 air liquid interface lysate preimmune serum negative control
0.4332927.11121385.html.plaintext.txt	163	samples analyzed 6 polyacrylamide sds gel
0.4332927.11121385.html.plaintext.txt	164	data representative 4 experiments
0.4332927.11121385.html.plaintext.txt	165	next performed immunocytochemistry digital confocal microscopy gain insight regarding possible changes cftr staining patterns following air liquid interface culture
0.4332927.11121385.html.plaintext.txt	166	figure 4 compares monolayers cultured either conventionally submerged exposed air liquid interface 6 days
0.4332927.11121385.html.plaintext.txt	167	basis immunoprecipitation data shown fig
0.4332927.11121385.html.plaintext.txt	168	3 previous studies 2 6 14 46 expected cftr located intracellularly mdck aa7 monolayers grown using conventional methodology
0.4332927.11121385.html.plaintext.txt	169	indeed punctate cftr immunofluorescence localized within perinuclear compartment submerged cells
0.4332927.11121385.html.plaintext.txt	170	together results shown figs
0.4332927.11121385.html.plaintext.txt	171	3 4 suggest cftr protein translated fully processed andor trafficked cell surface submerged monolayers
0.4332927.11121385.html.plaintext.txt	172	4 right air liquid interface shows considerable amounts cftr present apical membranes mdck aa7 monolayers grown without apical media 6 days
0.4332927.11121385.html.plaintext.txt	173	view larger version 110k fig
0.4332927.11121385.html.plaintext.txt	174	cftr immunolocalization monolayers either grown conventional conditions submerged 13 days submerged 1 wk followed apical air liquid interface 6 days
0.4332927.11121385.html.plaintext.txt	175	used 2 different primary antibodies raised cftr labeled r domain nucleotide binding domain nbd
0.4332927.11121385.html.plaintext.txt	176	anti cftr antibodies labeled either texas red x r domain oregon green 488 nuclei counterstained blue bisbenzimide
0.4332927.11121385.html.plaintext.txt	177	fixed immunologically stained monolayers folded permit cross sectional views shown en face views
0.4332927.11121385.html.plaintext.txt	178	images obtained magnification bar 40 microm
0.4332927.11121385.html.plaintext.txt	179	analysis cftr mrna submerged air liquid interface monolayers rt pcr
0.4332927.11121385.html.plaintext.txt	180	performed semiquantitative rt pcr analysis determine whether air interface culture augmented cftr transcription
0.4332927.11121385.html.plaintext.txt	181	figure 5 shows representative results
0.4332927.11121385.html.plaintext.txt	182	triplicate monolayers assayed cftr mrna either 2 4 days growth apical air liquid interface air
0.4332927.11121385.html.plaintext.txt	183	compared time matched triplicate fluid submerged monolayers fluid
0.4332927.11121385.html.plaintext.txt	184	mdck aa7 monolayers contained low levels cftr mrna compared control 16hbe14o airway cells 60
0.4332927.11121385.html.plaintext.txt	185	results consistent studies showing low levels cftr mrna detected native epithelial cells 55 61
0.4332927.11121385.html.plaintext.txt	186	furthermore data presented fig
0.4332927.11121385.html.plaintext.txt	187	5 show 50 fold increase forskolin stimulated isc figs
0.4332927.11121385.html.plaintext.txt	188	1 2 change cftr protein figs
0.4332927.11121385.html.plaintext.txt	189	3 4 observed air liquid interface culture accompanied 50 fold enhancement cftr mrna
0.4332927.11121385.html.plaintext.txt	190	data consistent changes cftr mobility cellular localization shown previous section strongly implicate posttranscriptional mechanism
0.4332927.11121385.html.plaintext.txt	191	view larger version 57k fig
0.4332927.11121385.html.plaintext.txt	192	expression cftr mrna submerged fluid vs
0.4332927.11121385.html.plaintext.txt	193	air liquid interface air mdck aa7 cultures determined rt pcr
0.4332927.11121385.html.plaintext.txt	194	cdna derived triplicate mdck aa7 monolayers amplified cftr specific primers spanning region nt 531 778 248 bp fragment
0.4332927.11121385.html.plaintext.txt	195	cdna derived 16hbe14o airway cell line amplified cftr positive control lane reaction containing template included negative control lane
0.4332927.11121385.html.plaintext.txt	196	samples also amplified actin 690 bp fragment control rna degradation dnase treatment reverse transcription
0.4332927.11121385.html.plaintext.txt	197	m lanes containing 100 bp markers
0.4332927.11121385.html.plaintext.txt	198	improvements forskolin stimulated isc cftr expression oxygen mediated
0.4332927.11121385.html.plaintext.txt	199	removing fluid apical surface epithelial cells give rise transepithelial hydrostatic pressure gradient decrease luminal volume possibly dry irritate monolayer increase apical cytokines permit oxygen reach cells
0.4332927.11121385.html.plaintext.txt	200	test hypothesis improved cellular oxygenation mediates increase cftr maturation cell surface expression cultured submerged mdck aa7 monolayers humidified atmosphere containing 95 o2 plus 5 co2 5 6 days
0.4332927.11121385.html.plaintext.txt	201	figure 6 compares representative records monolayers grown identical conditions except culture atmosphere contained either 95 o2 dashed line room o2 solid line
0.4332927.11121385.html.plaintext.txt	202	forskolin activated current observed following 5 6 days incubation 95 oxygen 48 plus minus 4 microacm2 n 6 markedly elevated compared control
0.4332927.11121385.html.plaintext.txt	203	results 95 o2 comparable paired control 5 6 day responses air liquid interface cultures 40
0.4332927.11121385.html.plaintext.txt	204	since monolayers grown identical conditions except fivefold increase po2 conclude increased oxygen mediates 50 fold increase cl secretion
0.4332927.11121385.html.plaintext.txt	205	immunoprecipitation immunolocalization cftr revealed culturing submerged monolayers 95 oxygen produced similar changes mobility cellular localization cftr air liquid interface culture data shown also refer fig
0.4332927.11121385.html.plaintext.txt	206	view larger version 9k fig
0.4332927.11121385.html.plaintext.txt	207	fivefold increase atmospheric o2 enhances cftr mediated isc across submerged mdck aa7 monolayers
0.4332927.11121385.html.plaintext.txt	208	records show 2 representative experiments comparing effect forskolin 10 microm isc across submerged filters cultured either 95 oxygen 5 co2 5 days dashed line room air plus 5 co2 solid line
0.4332927.11121385.html.plaintext.txt	209	monolayers submerged 200 microl media apical side corresponding depth 2
0.4332927.11121385.html.plaintext.txt	210	experiment repeated 6 times similar results see text
0.4332927.11121385.html.plaintext.txt	211	additional details regarding experimental design methods provided legend fig
0.4332927.11121385.html.plaintext.txt	212	data demonstrate cftr cell surface expression increased improved oxygenation mdck aa7 cells
0.4332927.11121385.html.plaintext.txt	213	however certain data shown fig
0.4332927.11121385.html.plaintext.txt	214	enhancement occurs hypoxic normoxic hyperoxic levels
0.4332927.11121385.html.plaintext.txt	215	thus grew air liquid interface cultures atmospheres containing 2
0.4332927.11121385.html.plaintext.txt	216	2 12 20 o2 plus 5 co2 balance n2 4 5 days
0.4332927.11121385.html.plaintext.txt	217	figure 7 summarizes data functional studies
0.4332927.11121385.html.plaintext.txt	218	plot shows forskolin stimulated isc increased graded manner range po2 tested
0.4332927.11121385.html.plaintext.txt	219	results obtained submerged monolayers l plotted comparison
0.4332927.11121385.html.plaintext.txt	220	parallel studies performed assay possible dose dependent effects cftr protein using immunoprecipitation representative gel presented fig
0.4332927.11121385.html.plaintext.txt	221	data show increasing po2 enhanced 170 kda form cftr
0.4332927.11121385.html.plaintext.txt	222	oxygen dependence increase cftr glycosylation quantified densitometry shown fig
0.4332927.11121385.html.plaintext.txt	223	using change cftr function fig
0.4332927.11121385.html.plaintext.txt	224	8 bioassay suggests conventional cultures mdck aa7 cells hypoxic
0.4332927.11121385.html.plaintext.txt	225	finally data demonstrate cftr maturation function cell surface increased pathophysiological physiological levels cellular oxygenation
0.4332927.11121385.html.plaintext.txt	226	view larger version 14k fig
0.4332927.11121385.html.plaintext.txt	227	isc forskolin demonstrates graded response increased oxygenation
0.4332927.11121385.html.plaintext.txt	228	air liquid interface cultures mdck aa7 exposed atmospheres contained 2
0.4332927.11121385.html.plaintext.txt	229	point represents mean 5 experiments error bars show sd
0.4332927.11121385.html.plaintext.txt	230	response conventional submerged monolayers l plotted comparison
0.4332927.11121385.html.plaintext.txt	231	refer materials methods legend fig
0.4332927.11121385.html.plaintext.txt	232	1 additional information regarding experimental conditions design
0.4332927.11121385.html.plaintext.txt	233	view larger version 52k fig
0.4332927.11121385.html.plaintext.txt	234	cftr protein maturation shows graded response increased o2 air liquid interface cultures
0.4332927.11121385.html.plaintext.txt	235	top panel shows cftr immunoprecipitated equivalent amounts lysates mdck aa7 cells cultured air liquid interface atmospheres contained 2
0.4332927.11121385.html.plaintext.txt	236	2 12 20 o2 refer fig
0.4332927.11121385.html.plaintext.txt	237	immunoprecipitated protein submerged monolayers l plotted comparison
0.4332927.11121385.html.plaintext.txt	238	control experiment atmospheric 20 o2 performed 7 times increase higher mobility form cftr figure typical refer lane 12 o2 fig
0.4332927.11121385.html.plaintext.txt	239	densitometry used quantify increase cftr protein maturation 170 kda form shown bottom
0.4332927.11121385.html.plaintext.txt	240	reducing apical media volume culture increases forskolin stimulated isc
0.4332927.11121385.html.plaintext.txt	241	since cftr maturation cell surface expression augmented oxygen mdck aa7 cells predict forskolin stimulated isc increase volume apical media decreased
0.4332927.11121385.html.plaintext.txt	242	prediction based notion apical media acts barrier oxygen diffusion refer discussion
0.4332927.11121385.html.plaintext.txt	243	tested hypothesis growing mdck aa7 cells 6 days 40 80 160 300 microl apical mem assaying forskolin stimulated isc
0.4332927.11121385.html.plaintext.txt	244	data summarized fig
0.4332927.11121385.html.plaintext.txt	245	indeed cftr mediated isc isc forskolin increased decreasing volumes media left plot isc forskolin function volume1 suggestive linear relationship right
0.4332927.11121385.html.plaintext.txt	246	minimum depth tested permitted maximum current 0
0.4332927.11121385.html.plaintext.txt	247	moreover data show even modest changes media volume
0.4332927.11121385.html.plaintext.txt	248	20 microl markedly altered measure cftr activity
0.4332927.11121385.html.plaintext.txt	249	thus identified important caveat regarding study endogenous cftr expression using conventional cell culture technique
0.4332927.11121385.html.plaintext.txt	250	view larger version 10k fig
0.4332927.11121385.html.plaintext.txt	251	relationship apical fluid volume cftr mediated cl secretory response
0.4332927.11121385.html.plaintext.txt	252	grew monolayers 40 80 160 300 microl medium apical side 6 days surface area 0
0.4332927.11121385.html.plaintext.txt	253	left panel plots forskolin stimulated isc function apical media volume
0.4332927.11121385.html.plaintext.txt	254	results air liquid interface cultures shown comparison
0.4332927.11121385.html.plaintext.txt	255	define relationship plotted forskolin stimulated isc function apical fluid volume1 shown right
0.4332927.11121385.html.plaintext.txt	256	line illustrates fit data simple linear regression r 0
0.4332927.11121385.html.plaintext.txt	257	point represents mean error bars represent sd 4 experiments
0.4332927.11121385.html.plaintext.txt	258	discussion top abstract introduction materials methods results discussion references
0.4332927.11121385.html.plaintext.txt	259	hypoxia conditions culture important consequences regarding cftr trafficking function
0.4332927.11121385.html.plaintext.txt	260	large unstirred layer medium overlaying cells culture limits amount oxygen available cellular respiration
0.4332927.11121385.html.plaintext.txt	261	figure 10 illustrates partial pressure o2 vary linear relation media depth d given steady state
0.4332927.11121385.html.plaintext.txt	262	relationship derived simple force flow relation
0.4332927.11121385.html.plaintext.txt	263	ficks law 1 flow oxygen jo2 units milliliters per minute per cm2 cells directly proportional difference po2 air media interface po2air cells po2cell o2 diffusion constant krough water 37 degrees c k 3
0.4332927.11121385.html.plaintext.txt	264	4 x 105 53 inversely related media depth d
0.4332927.11121385.html.plaintext.txt	265	since oxygen flow jo2 consumption r equivalent steady state rearrangement eq
0.4332927.11121385.html.plaintext.txt	266	1 yields 2 stevens 53 derived equation estimated rate oxygen consumption freshly isolated confluent hepatocytes r 1
0.4332927.11121385.html.plaintext.txt	267	6 x 104 ml o2min calculated fluid depth exceed 0
0.4332927.11121385.html.plaintext.txt	268	34 mm maintain cellular po2 within low normal range
0.4332927.11121385.html.plaintext.txt	269	indeed monolayers l cells cultured excess depth shown hypoxic polarographic analysis 59
0.4332927.11121385.html.plaintext.txt	270	recently ostrowski nettesheim 41 varied media overlaying airway cells found maximum depth permitting airway ciliogenesis 0
0.4332927.11121385.html.plaintext.txt	271	5 mm consistent value calculated stevens 0
0.4332927.11121385.html.plaintext.txt	272	34 well results shown fig
0.4332927.11121385.html.plaintext.txt	273	view larger version 13k fig
0.4332927.11121385.html.plaintext.txt	274	model illustrating expected relationship partial pressure oxygen po2 cell culture fluid media depth d
0.4332927.11121385.html.plaintext.txt	275	model based linear force flow relation e
0.4332927.11121385.html.plaintext.txt	276	ficks law assumes oxygen diffusion utilization reached steady state
0.4332927.11121385.html.plaintext.txt	277	maneuvers improve oxygenation cultures either stirring overlaying fluid layer using rocking shaker 12 47 rolling bottle 20 reducing medium depth air liquid interface 27 30 36 41 43 52 54 enhance cellular growth proliferation differentiation variety cells
0.4332927.11121385.html.plaintext.txt	278	hypoxia also important functional consequences
0.4332927.11121385.html.plaintext.txt	279	example monolayers kidney proximal tubule epithelial cells gluconeogenic 39 ammoniagenic 8 observed vivo cells cultured presence increased oxygen levels
0.4332927.11121385.html.plaintext.txt	280	similarly pancreatic cells shown release insulin normoxic cultures 13
0.4332927.11121385.html.plaintext.txt	281	data contained present study demonstrate improved cellular oxygenation markedly augments cftr function maturation localization model cell line
0.4332927.11121385.html.plaintext.txt	282	assuming mdck aa7 cells consume oxygen similar rate hepatic 53 llc pk1 8 3t3 53 l cells 59 eq
0.4332927.11121385.html.plaintext.txt	283	2 predicts confluent mdck aa7 monolayers submerged conventional conditions
0.4332927.11121385.html.plaintext.txt	284	expect either removing apical media culturing monolayers approximate fivefold increase oxygen restore cellular po2 approximately normoxic levels 53
0.4332927.11121385.html.plaintext.txt	285	indeed maneuvers caused similar increases cftr mediated isc cell surface expression
0.4332927.11121385.html.plaintext.txt	286	however data exclude alternative hypothesis conventional cultures normoxic effects 95 o2 mediated hyperoxia 58
0.4332927.11121385.html.plaintext.txt	287	thus exposed air liquid interface cultures varying po2 figs
0.4332927.11121385.html.plaintext.txt	288	use cftr bioassay indicates conventional mdck aa7 cultures hypoxic predicted eq
0.4332927.11121385.html.plaintext.txt	289	furthermore data show cftr maturation function varies physiological oxygenation
0.4332927.11121385.html.plaintext.txt	290	interestingly increase po2 arterial venous blood may cause two threefold enhancement cftr expression
0.4332927.11121385.html.plaintext.txt	291	comparing cftr expression cell lines
0.4332927.11121385.html.plaintext.txt	292	one question arises study conventional culture conditions nearly abolish cftr expression mdck aa7 cells whereas t84 cells grown identical conditions express high levels mature cftr protein refer fig
0.4332927.11121385.html.plaintext.txt	293	3 one possible explanation comes previous studies dickman mandel 12 others showing poor oxygenation culture favors proliferation growth cells enhanced glycolysis 4 12 37 40
0.4332927.11121385.html.plaintext.txt	294	selection evolution vitro expected driven media formulated high glucose 25 mm containing substrates oxidative phosphorylation
0.4332927.11121385.html.plaintext.txt	295	indeed t84 cells express mitochondria
0.4332927.11121385.html.plaintext.txt	296	hence differences metabolism considered future studies wild type mutant cftr
0.4332927.11121385.html.plaintext.txt	297	moreover ability air liquid interface culture increase camp dependent cl secretion limited mdck aa7 cells
0.4332927.11121385.html.plaintext.txt	298	augmented cl secretory response following air liquid interface culture observed three cell lines calu 3 52 mdck aa7 article several t84 clones venglarik unpublished data well primary cultures airway epithelial cells ref
0.4332927.11121385.html.plaintext.txt	299	30 venglarik unpublished data
0.4332927.11121385.html.plaintext.txt	300	observation cftr expressing epithelial cells derived airways kidney colon respond similarly air liquid interface culture suggestive relationship oxygen tension cl secretion vivo
0.4332927.11121385.html.plaintext.txt	301	also likely mediator cellular mechanisms underlying enhanced cl secretory isc
0.4332927.11121385.html.plaintext.txt	302	hence study provides important new insight regarding relationship cellular oxygenation cftr maturation trafficking identifies model cell line investigate underlying mechanisms
0.4332927.11121385.html.plaintext.txt	303	possible role metabolism cftr expression
0.4332927.11121385.html.plaintext.txt	304	previous studies show vectorial transport reduced conditions decrease oxidative phosphorylation presumably preserve cellular integrity 717
0.4332927.11121385.html.plaintext.txt	305	therefore favor hypothesis oxygen induced increase cftr expression mdck aa7 cells may also related improved metabolism
0.4332927.11121385.html.plaintext.txt	306	others shown decreasing cellular atpadp ratio acutely limit cl secretion reducing open probability cftr cl channels 19 50
0.4332927.11121385.html.plaintext.txt	307	results presented article suggestive long term mechanism whereby decrease oxygen reduce number cftr channels present apical membrane
0.4332927.11121385.html.plaintext.txt	308	adaption may help conserve energy either prolonged periods moderate hypoxia conditions atp consumed either vectorial transport metabolic pathways 17
0.4332927.11121385.html.plaintext.txt	309	already evidence air liquid interface culture markedly increases oxidative phosphorylation primary cultures bovine airway cells 31
0.4332927.11121385.html.plaintext.txt	310	mdck aa7 cells provide convenient model future studies investigating precise relationship cellular metabolism cftr expression
0.4332927.11121385.html.plaintext.txt	311	identified important source variability cftr cell surface localization may explain cells f508 cftr plasma membranes others none
0.4332927.11121385.html.plaintext.txt	312	indeed many freshly isolated epithelial cells cultured epithelial cells grown air liquid interface functionally biochemically detectable levels f508 cftr cell surface 14 28 44 49 60 62 whereas conventional cultures 6 11 21 25
0.4332927.11121385.html.plaintext.txt	313	49 first demonstrate 180 kda form f508 cftr expressed apical membranes primary immortalized cf cell lines 49
0.4332927.11121385.html.plaintext.txt	314	basis oxygen dependence wild type cftr expression mdck aa7 cells consider likely variation f508 cftr cell surface expression due hypoxic culture conditions
0.4332927.11121385.html.plaintext.txt	315	furthermore although evidence maturation trafficking f508 cftr may defective heterologous systems 6 little known regarding processes normally regulate cftr biogenesis
0.4332927.11121385.html.plaintext.txt	316	data show oxygen modulate endogenous cftr expression posttranscriptionally
0.4332927.11121385.html.plaintext.txt	317	oxygen known regulate expression several proteins level 22 26 29 48
0.4332927.11121385.html.plaintext.txt	318	example normoxia promotes translation andor folding cytochrome c oxidase 22 hypoxia abolishes ubiquitin mediated proteolysis hypoxia inducible factor 1 26 48 stabilizes plasma membrane form glucose transporter glut 3 29
0.4332927.11121385.html.plaintext.txt	319	increased synthesis decreased degradation extended half life three possible mechanisms o2 enhanced cftr expression
0.4332927.11121385.html.plaintext.txt	320	unable detect augmented synthesis cftr air liquid interface cultures mdck aa7 cells using 35s met pulse chase analysis data shown
0.4332927.11121385.html.plaintext.txt	321	hence speculate increased levels fully glycosylated 170 kda cftr may due increased maturation andor stability apical plasma membrane
0.4332927.11121385.html.plaintext.txt	322	already evidence suggest normoxia causes apical membranes differentiate functionally 47 morphologically 30 41
0.4332927.11121385.html.plaintext.txt	323	thus possible improvement cftr biogenesis mediated global mechanism designed regulate composition andor architecture apical membranes differentiation
0.4332927.11121385.html.plaintext.txt	324	finally many cf patients hypoxic due mucus plugs small airways progressive loss lung function 18 24 57
0.4332927.11121385.html.plaintext.txt	325	f508 cftr cell surface expression depends oxygenation may correlation nasal potential difference pulmonary function among subset cf patients
0.4332927.11121385.html.plaintext.txt	326	indeed two recent reports show basal nasal potential difference similar nonaffected controls subpopulation cf patients normal pulmonary function 18 24
0.4332927.11121385.html.plaintext.txt	327	although results somewhat controversial consistent studies localizing mutant cftr near apical membranes f508 homozygous patients 14 44 49 60 62
0.4332927.11121385.html.plaintext.txt	328	thus cf patients least one f508 allele
0.4332927.11121385.html.plaintext.txt	329	92 total cf population may benefit maneuvers improve tissue oxygenation drugs mimic oxygen signaling pathways cftr expressing epithelial cells
0.4332927.11121385.html.plaintext.txt	330	eric sorscher access labs support encouragement
0.4332927.11121385.html.plaintext.txt	331	tom ecay kim barrett eric schwiebert generously providing mdck aa7 t84 16hbe14o cell lines respectively drs
0.4332927.11121385.html.plaintext.txt	332	eric sorscher kevin kirk cathy fuller critique earlier versions article
0.4332927.11121385.html.plaintext.txt	333	gerhard giebisch anonymous reviewer suggesting vary po2 air liquid interface cultures
0.4332927.11121385.html.plaintext.txt	334	work supported cystic fibrosis foundation vengi97 rdp464 national heart lung blood institute grant hl 46943
0.4332927.11121385.html.plaintext.txt	335	address reprint requests correspondence c
0.4332927.11121385.html.plaintext.txt	336	environmental health sciences school public health univ
0.4332927.11121385.html.plaintext.txt	337	alabama birmingham 793 mccallum birmingham al 35294 0005 e mail cjvatuab
0.4332927.11121385.html.plaintext.txt	338	costs publication article defrayed part payment page charges
0.4332927.11121385.html.plaintext.txt	339	article must therefore hereby marked advertisement accordance 18 u
0.4332927.11121385.html.plaintext.txt	340	section 1734 solely indicate fact
0.4332927.11121385.html.plaintext.txt	341	received 9 april 1999 accepted final form 24 august 2000
0.4332927.11121385.html.plaintext.txt	342	references top abstract introduction materials methods results discussion references
0.4332927.11121385.html.plaintext.txt	343	barrett ke cohn ja huott pa wasserman si dharmsathaphorn k
0.4332927.11121385.html.plaintext.txt	344	immune related intestinal chloride secretion
0.4332927.11121385.html.plaintext.txt	345	effect adenosine t84 cell line
0.4332927.11121385.html.plaintext.txt	346	j physiol cell physiol 258 c902 c912 1990abstractfree full text
0.4332927.11121385.html.plaintext.txt	347	bebok z venglarik cj panczel z jilling kirk kl sorscher ej
0.4332927.11121385.html.plaintext.txt	348	activation f508 cftr epithelial monolayer
0.4332927.11121385.html.plaintext.txt	349	j physiol cell physiol 275 c599 c607 1998abstractfree full text
0.4332927.11121385.html.plaintext.txt	350	amiloride molecular probe sodium transport tissues cells
0.4332927.11121385.html.plaintext.txt	351	j physiol cell physiol 242 c131 c145 1982abstract
0.4332927.11121385.html.plaintext.txt	352	apparent heterogeneity leukemic lymphocytic cell lines
0.4332927.11121385.html.plaintext.txt	353	adv exp med biol 316 393 398 1992medline
0.4332927.11121385.html.plaintext.txt	354	brown cda rugg el simmons nl
0.4332927.11121385.html.plaintext.txt	355	loop diuretic inhibition adrenaline stimulated cl secretion cultured epithelium renal origin mdck
0.4332927.11121385.html.plaintext.txt	356	q j exp physiol 71 183 193 1986isimedline
0.4332927.11121385.html.plaintext.txt	357	cheng sh gregory rj marshall j paul souza dw white ga oriordan cr smith ae
0.4332927.11121385.html.plaintext.txt	358	defective intracellular transport processing molecular basis cystic fibrosis
0.4332927.11121385.html.plaintext.txt	359	cell 63 827 834 1990isimedline
0.4332927.11121385.html.plaintext.txt	360	cohen jj barac nieto m
0.4332927.11121385.html.plaintext.txt	361	renal metabolism relation renal function
0.4332927.11121385.html.plaintext.txt	362	bethesda md physiol soc 1973 sect 8 vol p
0.4332927.11121385.html.plaintext.txt	363	cole la scheid jm tannen rl
0.4332927.11121385.html.plaintext.txt	364	induction mitochondrial metabolism ph modulated ammoniagenesis rocking llc pk1 cells
0.4332927.11121385.html.plaintext.txt	365	j physiol cell physiol 251 c293 c298 1986abstractfree full text
0.4332927.11121385.html.plaintext.txt	366	dalemans w barbry p champigny g jallat dott k dreyer d crystal rg parirani lecocq jp lazdunski m
0.4332927.11121385.html.plaintext.txt	367	altered chloride channel kinetics associated delta f508 mutation
0.4332927.11121385.html.plaintext.txt	368	nature 354 526 528 1991isimedline
0.4332927.11121385.html.plaintext.txt	369	darmsathaphorn k mcroberts ja mandel kg tisdale ld masui h
0.4332927.11121385.html.plaintext.txt	370	human colonic tumor cell line maintains vectorial electrolyte transport
0.4332927.11121385.html.plaintext.txt	371	j physiol gastrointest liver physiol 246 g204 g208 1984abstractfree full text
0.4332927.11121385.html.plaintext.txt	372	demolombe baro laurent m hongre pavirani escande d
0.4332927.11121385.html.plaintext.txt	373	abnormal subcellular localization mutated cftr protein cystic fibrosis epithelial cell line
0.4332927.11121385.html.plaintext.txt	374	eur j cell biol 65 214 219 1994isimedline
0.4332927.11121385.html.plaintext.txt	375	glycolytic oxidative metabolism primary renal proximal tubule cultures
0.4332927.11121385.html.plaintext.txt	376	j physiol cell physiol 257 c333 c340 1989abstractfree full text
0.4332927.11121385.html.plaintext.txt	377	dionne ke cole ck yarmush ml
0.4332927.11121385.html.plaintext.txt	378	effect oxygen isolated pancreatic tissue
0.4332927.11121385.html.plaintext.txt	379	asaio trans 35 739 741 1989medline
0.4332927.11121385.html.plaintext.txt	380	happens f508 vivo j clin invest 103 1369 1370 1999free full text
0.4332927.11121385.html.plaintext.txt	381	dupuit f kalin n brezillon hinnrasky j tummler b puchelle e
0.4332927.11121385.html.plaintext.txt	382	cftr differentiation markers expression non cf delta f508 homozygous cf nasal epithelium
0.4332927.11121385.html.plaintext.txt	383	j clin invest 96 1601 1611 1995isimedline
0.4332927.11121385.html.plaintext.txt	384	basal lamina formation epithelial cell lines correlates laminin chain synthesis secretion
0.4332927.11121385.html.plaintext.txt	385	exp cell res 203 32 38 1992isimedline
0.4332927.11121385.html.plaintext.txt	386	kidney int 51 381 385 1997isimedline
0.4332927.11121385.html.plaintext.txt	387	fajac hubert d bienvenu richard thiriez b matran r kaplan jc dallall santucci j dusser dj
0.4332927.11121385.html.plaintext.txt	388	relationship nasal potential difference respiratory function adults cystic fibrosis
0.4332927.11121385.html.plaintext.txt	389	eur respir j 12 1295 1300 1998abstractfree full text
0.4332927.11121385.html.plaintext.txt	390	cftr j physiol cell physiol 263 c267 c286 1992abstractfree full text
0.4332927.11121385.html.plaintext.txt	391	organotypic monolayer cultures nervous tissue
0.4332927.11121385.html.plaintext.txt	392	j neurosci methods 4 329 342 1981isimedline
0.4332927.11121385.html.plaintext.txt	393	gilbert jadot m leontieva e wattiaux deconinck wattiaux r
0.4332927.11121385.html.plaintext.txt	394	f508 cftr localizes endoplasmic reticulum golgi intermediate compartment cystic fibrosis cells
0.4332927.11121385.html.plaintext.txt	395	exp cell res 242 144 152 1998isimedline
0.4332927.11121385.html.plaintext.txt	396	oxygen control cytochrome c oxidase synthesis isolated mitochondria saccharomyces cervisiae
0.4332927.11121385.html.plaintext.txt	397	nature 255 238 240 1975isimedline
0.4332927.11121385.html.plaintext.txt	398	hay r caputo j chen tr macy m mcclintock p reid y editors
0.4332927.11121385.html.plaintext.txt	399	american type culture collection catalogue cell lines hybridomas 7th ed
0.4332927.11121385.html.plaintext.txt	400	rockville md american type culture collection 1992 p
0.4332927.11121385.html.plaintext.txt	401	ho lp samways jm porteous dj
0.4332927.11121385.html.plaintext.txt	402	correlation nasal potential difference measurements genotype clinical conditions patients cystic fibrosis
0.4332927.11121385.html.plaintext.txt	403	eur respir j 10 2018 2022 1997abstractfree full text
0.4332927.11121385.html.plaintext.txt	404	jefferson dm valentich jd marini fc grubman sa iannuzzi mc dorkin hl li m klinger kw welsh mj
0.4332927.11121385.html.plaintext.txt	405	expression normal cystic fibrosis phenotypes continuous airway epithelial cell lines
0.4332927.11121385.html.plaintext.txt	406	j physiol lung cell mol physiol 259 l496 l505 1990abstractfree full text
0.4332927.11121385.html.plaintext.txt	407	jiang bh semenza gl bauer c marti hh
0.4332927.11121385.html.plaintext.txt	408	hypoxia inducible factor 1 levels vary exponentially physiologically relevant range o2 tension
0.4332927.11121385.html.plaintext.txt	409	j physiol cell physiol 271 c1172 c1180 1996abstractfree full text
0.4332927.11121385.html.plaintext.txt	410	johnson lg dickman kg moore kl mandel lj boucher rc
0.4332927.11121385.html.plaintext.txt	411	enhanced na transport air liquid interface culture system
0.4332927.11121385.html.plaintext.txt	412	j physiol lung cell mol physiol 264 l560 l565 1993abstractfree full text
0.4332927.11121385.html.plaintext.txt	413	kalin n claass sommer m puchelle e tummler b
0.4332927.11121385.html.plaintext.txt	414	f508 cftr protein expression tissues patients cystic fibrosis
0.4332927.11121385.html.plaintext.txt	415	j clin invest 103 1379 1389 1999abstractfree full text
0.4332927.11121385.html.plaintext.txt	416	khayatt za mccall al klip
0.4332927.11121385.html.plaintext.txt	417	unique mechanism glut3 glucose transporter regulation prolonged energy demand increased protein half life
0.4332927.11121385.html.plaintext.txt	418	biochem j 333 713 718 1998isimedline
0.4332927.11121385.html.plaintext.txt	419	kondo m finkbeiner widdicombe jh
0.4332927.11121385.html.plaintext.txt	420	simple technique culture highly differentiated cells dog tracheal epithelium
0.4332927.11121385.html.plaintext.txt	421	j physiol lung cell mol physiol 261 l106 l117 1991abstractfree full text
0.4332927.11121385.html.plaintext.txt	422	kondo m tamaoki j sakai kameyama kanoh konno k
0.4332927.11121385.html.plaintext.txt	423	increased oxidative metabolism cow tracheal epithelial cells cultured air liquid interface
0.4332927.11121385.html.plaintext.txt	424	j respir cell mol biol 16 62 68 1997abstract
0.4332927.11121385.html.plaintext.txt	425	mohamed ferguson d seibert fs cai hm kartner n grinstein riordan jr lukacs gl
0.4332927.11121385.html.plaintext.txt	426	functional expression apical localization cystic fibrosis transmembrane conductance regulator mdck cells
0.4332927.11121385.html.plaintext.txt	427	biochem j 322 259 265 1997isimedline
0.4332927.11121385.html.plaintext.txt	428	morales mm carroll tp morita schwiebert em devuyst o wilson pd lopes ag stanton ba dietz hc cutting gr guggino wb
0.4332927.11121385.html.plaintext.txt	429	wild type functional isoform cftr expressed kidney
0.4332927.11121385.html.plaintext.txt	430	j physiol renal fluid electrolyte physiol 270 f1038 f1048 1996abstractfree full text
0.4332927.11121385.html.plaintext.txt	431	morris ap cunningham sa benos dj frizzell ra
0.4332927.11121385.html.plaintext.txt	432	cellular differentiation required camp ca2 dependent cl secretion colonic epithelial cells expressing high levels cystic fibrosis transmembrane conductance regulator
0.4332927.11121385.html.plaintext.txt	433	j biol chem 267 5575 5583 1992abstractfree full text
0.4332927.11121385.html.plaintext.txt	434	morris ap cunningham sa tousson benos dj frizzell ra
0.4332927.11121385.html.plaintext.txt	435	polarization dependent apical membrane cftr targeting underlies camp stimulated cl secretion epithelial cells
0.4332927.11121385.html.plaintext.txt	436	j physiol cell physiol 266 c254 c268 1994abstractfree full text
0.4332927.11121385.html.plaintext.txt	437	munson l wilkinson je schlafer dh
0.4332927.11121385.html.plaintext.txt	438	effects substrata polarization bovine endometrial epithelial cells vitro
0.4332927.11121385.html.plaintext.txt	439	cell tissue res 261 155 161 1990isimedline
0.4332927.11121385.html.plaintext.txt	440	nash rw mckay bs burke jm
0.4332927.11121385.html.plaintext.txt	441	response cultured human retinal pigment epithelium hypoxia comparison cell types
0.4332927.11121385.html.plaintext.txt	442	invest ophthalmol vis sci 35 2850 2856 1994abstract
0.4332927.11121385.html.plaintext.txt	443	nichols ge lovejoy jc borgman ca sanders jm young ww jr
0.4332927.11121385.html.plaintext.txt	444	isolation characterization two types mdck epithelial cell clones based glycosphingolipid pattern
0.4332927.11121385.html.plaintext.txt	445	biochim biophys acta 887 1 12 1986isimedline
0.4332927.11121385.html.plaintext.txt	446	nowak g schnellmann rg
0.4332927.11121385.html.plaintext.txt	447	improved culture conditions stimulate gluconeogenesis primary cultures renal proximal tubule cells
0.4332927.11121385.html.plaintext.txt	448	j physiol cell physiol 268 c1053 c1061 1995abstractfree full text
0.4332927.11121385.html.plaintext.txt	449	cultured rat hepatocytes adapt cellular glycolytic activity adenylate energy status tissue oxygen tension influences extracellular matrix components insulin glucagon
0.4332927.11121385.html.plaintext.txt	450	j cell physiol 160 358 366 1994isimedline
0.4332927.11121385.html.plaintext.txt	451	ostrowski le nettesheim p
0.4332927.11121385.html.plaintext.txt	452	inhibition ciliated cell differentiation fluid submersion
0.4332927.11121385.html.plaintext.txt	453	exp lung res 21 957 970 1995isimedline
0.4332927.11121385.html.plaintext.txt	454	peng sommerfelt m logan j huang z jilling kirk k hunter e sorscher e
0.4332927.11121385.html.plaintext.txt	455	one step affinity isolation recombinant protein using baculovirusinsect cell expression system
0.4332927.11121385.html.plaintext.txt	456	protein expr purif 4 95 100 1993isimedline
0.4332927.11121385.html.plaintext.txt	457	prunieras m regnier m woodley d
0.4332927.11121385.html.plaintext.txt	458	methods cultivation keratinocytes air liquid interface
0.4332927.11121385.html.plaintext.txt	459	j invest dermatol 81 28s 33s 1983abstract
0.4332927.11121385.html.plaintext.txt	460	reddy mm bell cl quinton pm
0.4332927.11121385.html.plaintext.txt	461	cystic fibrosis affects specific cell type sweat duct secretory coil
0.4332927.11121385.html.plaintext.txt	462	j physiol cell physiol 273 c426 c433 1997abstractfree full text
0.4332927.11121385.html.plaintext.txt	463	richardson jcw scalera v simmons nl
0.4332927.11121385.html.plaintext.txt	464	identification two strains mdck cells resemble separate nephron tubule segments
0.4332927.11121385.html.plaintext.txt	465	biochim biophys acta 673 26 36 1981isimedline
0.4332927.11121385.html.plaintext.txt	466	cystic fibrosis current topics volume edited dodge ja brock djh widdicombe jh
0.4332927.11121385.html.plaintext.txt	467	sahai cole la clarke dl tannen rl
0.4332927.11121385.html.plaintext.txt	468	rocking promotes differentiated properties llc pk1 cells improved oxygenation
0.4332927.11121385.html.plaintext.txt	469	j physiol cell physiol 256 c1064 c1069 1989abstractfree full text
0.4332927.11121385.html.plaintext.txt	470	hypoxia inducible factor 1 hif 1 protein rapidly degraded ubiquitin proteasome system normoxic conditions
0.4332927.11121385.html.plaintext.txt	471	j biol chem 272 22642 22647 1997abstractfree full text
0.4332927.11121385.html.plaintext.txt	472	sarkadi b bauzon d huckle wr earp hs berry suchindran h price em olson jc boucher rc scarborough ga
0.4332927.11121385.html.plaintext.txt	473	biochemical characterization cystic fibrosis transmembrane conductance regulator normal cystic fibrosis epithelial cells
0.4332927.11121385.html.plaintext.txt	474	j biol chem 267 2087 2095 1992abstractfree full text
0.4332927.11121385.html.plaintext.txt	475	schultz bd venglarik cj bridges rj frizzell ra
0.4332927.11121385.html.plaintext.txt	476	regulation cftr channel gating adp atp analogs
0.4332927.11121385.html.plaintext.txt	477	j gen physiol 105 329 361 1994abstract
0.4332927.11121385.html.plaintext.txt	478	chloride secretion stimulated prostaglandin e1 forskolin canine renal epithelial cell line
0.4332927.11121385.html.plaintext.txt	479	j physiol lond 432 459 472 1991abstract
0.4332927.11121385.html.plaintext.txt	480	singh m krouse m moon wine jj
0.4332927.11121385.html.plaintext.txt	481	basal isc calu 3 human airway cells bicarbonate dependent cl secretion
0.4332927.11121385.html.plaintext.txt	482	j physiol lung cell mol physiol 272 l690 l698 1997abstractfree full text
0.4332927.11121385.html.plaintext.txt	483	oxygen requirements liver cells vitro
0.4332927.11121385.html.plaintext.txt	484	nature 206 199 1965isimedline
0.4332927.11121385.html.plaintext.txt	485	stoppini l buchs pa muller d
0.4332927.11121385.html.plaintext.txt	486	simple method organotypic cultures nervous tissue
0.4332927.11121385.html.plaintext.txt	487	j neurosci methods 37 173 182 1991isimedline
0.4332927.11121385.html.plaintext.txt	488	trapnell bc chu cs paakko pk banks tc yoshimura k ferrans vj chernik ms crystal rg
0.4332927.11121385.html.plaintext.txt	489	expression cystic fibrosis transmembrane conductance regulator gene respiratory tract normal individuals individuals cystic fibrosis
0.4332927.11121385.html.plaintext.txt	490	proc natl acad sci usa 88 6565 6569 1991abstract
0.4332927.11121385.html.plaintext.txt	491	vandorpe d kizer n ciampollino f moyer b karlson k guggino wb stanton ba
0.4332927.11121385.html.plaintext.txt	492	cftr mediates electrogenic chloride secretion mouse inner medullary collecting duct mimcd k2 cells
0.4332927.11121385.html.plaintext.txt	493	j physiol cell physiol 269 c683 c689 1995abstract
0.4332927.11121385.html.plaintext.txt	494	vinchinsky ep pennathur das r nicholson b minor m kleman k higashino lubin
0.4332927.11121385.html.plaintext.txt	495	inadequate erythroid response hypoxia cystic fibrosis
0.4332927.11121385.html.plaintext.txt	496	j pediatr 105 15 21 1984isimedline
0.4332927.11121385.html.plaintext.txt	497	wendt ch towle h sharma r duvick kawakami k gick g ingbar dh
0.4332927.11121385.html.plaintext.txt	498	regulation na k atpase gene expression hyperoxia mdck cells
0.4332927.11121385.html.plaintext.txt	499	j physiol cell physiol 274 c256 c264 1998
0.4332927.11121385.html.plaintext.txt	500	oxygen environment respiratory oscillations cultured mammalian cells
0.4332927.11121385.html.plaintext.txt	501	nature 251 317 319 1974isimedline
0.4332927.11121385.html.plaintext.txt	502	yamaya m finkbeiner chun sy widdicombe jh
0.4332927.11121385.html.plaintext.txt	503	differentiated structure function cultures human tracheal epithelium
0.4332927.11121385.html.plaintext.txt	504	j physiol lung cell mol physiol 262 l713 l724 1992abstractfree full text
0.4332927.11121385.html.plaintext.txt	505	yoshimura k nakamura h trapnell bc dalemans w pavirani lecocq jp crystal rg
0.4332927.11121385.html.plaintext.txt	506	cystic fibrosis gene housekeeping type promoter expressed low levels cells epithelial origin
0.4332927.11121385.html.plaintext.txt	507	j biol chem 266 9140 9144 1991abstractfree full text
0.4332927.11121385.html.plaintext.txt	508	zeitlin pl crawford lu l woel cohen donowitz m montrose mh hamosh cutting gr gruenert d
0.4332927.11121385.html.plaintext.txt	509	cftr protein processing primary cultured epithelia
0.4332927.11121385.html.plaintext.txt	510	proc natl acad sci usa 89 344 347 1992abstract
0.4332927.11121385.html.plaintext.txt	511	j physiol cell physiol 2801c135 c145 0363 614301 5
0.4332927.11121385.html.plaintext.txt	512	00 copyright 2001 american physiological society
0.46872106.9688865.html.plaintext.txt	0	rapid communication glutathione permeability cftr paul linsdell john w
0.46872106.9688865.html.plaintext.txt	1	department physiology mcgill university montreal quebec canada h3g 1y6
0.46872106.9688865.html.plaintext.txt	2	abstract top abstract introduction methods results discussion references
0.46872106.9688865.html.plaintext.txt	3	cystic fibrosis transmembrane conductance regulator cftr forms ion channel permeable cl larger organic anions
0.46872106.9688865.html.plaintext.txt	4	show using macroscopic current recording excised membrane patches anionic antioxidant tripeptide glutathione permeant cftr channel
0.46872106.9688865.html.plaintext.txt	5	permeability may account high concentrations glutathione measured surface fluid coats airway epithelial cells
0.46872106.9688865.html.plaintext.txt	6	furthermore loss pathway glutathione transport may contribute reduced levels glutathione observed airway surface fluid cystic fibrosis patients suggested contribute oxidative stress observed lung cystic fibrosis
0.46872106.9688865.html.plaintext.txt	7	suggest release glutathione airway surface fluid may novel function cftr
0.46872106.9688865.html.plaintext.txt	8	cystic fibrosis chloride channel lung defense airway surface fluid multidrug resistance protein cystic fibrosis transmembrane conductance regulator
0.46872106.9688865.html.plaintext.txt	9	introduction top abstract introduction methods results discussion references
0.46872106.9688865.html.plaintext.txt	10	cystic fibrosis cf caused mutations single gene one encodes cf transmembrane conductance regulator cftr
0.46872106.9688865.html.plaintext.txt	11	cftr member atp binding cassette abc family membrane transport proteins forms phosphorylation atp dependent cl channel 3 4
0.46872106.9688865.html.plaintext.txt	12	remains unclear reduced epithelial cl permeability caused functional absence cftr leads complexity symptoms seen cf lung disease
0.46872106.9688865.html.plaintext.txt	13	coupled structural similarity cftr abc proteins long hinted cftr may also perform function
0.46872106.9688865.html.plaintext.txt	14	anionic tripeptide glutathione glutamyl cysteinyl glycine gsh important extracellular antioxidant lung 1 20
0.46872106.9688865.html.plaintext.txt	15	airway surface fluid asf contains 400 microm gsh 50 times concentration found plasma 100 times found extracellular fluid many tissues 1 5 17 20
0.46872106.9688865.html.plaintext.txt	16	source high concentration gsh found asf unknown 20
0.46872106.9688865.html.plaintext.txt	17	interestingly concentration gsh asf greatly reduced cf 16 may exacerbate severe oxidative stress results chronic inflammation cf lung 19
0.46872106.9688865.html.plaintext.txt	18	indeed antioxidant therapy cf previously suggested 2 16 19
0.46872106.9688865.html.plaintext.txt	19	recently demonstrated broad range large organic anions able permeate cftr cl channel cytoplasmic side membrane suggested release anions asf might novel physiological function cftr 11
0.46872106.9688865.html.plaintext.txt	20	show gsh oxidized glutathione gssg permeate cftr intracellular solution
0.46872106.9688865.html.plaintext.txt	21	results suggest cftr addition role cl channel may function permeation pathway gsh released asf
0.46872106.9688865.html.plaintext.txt	22	function would suggest previously unidentified link cftr lung antioxidant defense
0.46872106.9688865.html.plaintext.txt	23	loss gsh permeation pathway may contribute pathogenesis cf
0.46872106.9688865.html.plaintext.txt	24	methods top abstract introduction methods results discussion references
0.46872106.9688865.html.plaintext.txt	25	macroscopic cftr current recordings carried inside membrane patches excised baby hamster kidney cells stably expressing cftr described detail elsewhere 9 11
0.46872106.9688865.html.plaintext.txt	26	briefly channels activated exposure cytoplasmic face excised patches 40 60 nm protein kinase catalytic subunit pka plus 1 mm mgatp
0.46872106.9688865.html.plaintext.txt	27	current traces shown background leak current recorded addition pka digitally subtracted described previously 9 11
0.46872106.9688865.html.plaintext.txt	28	current traces filtered 100 hz using eight pole bessel filter digitized 250 hz analyzed using pclamp6 computer software axon instruments foster city ca
0.46872106.9688865.html.plaintext.txt	29	recording solutions contained mm 150 nacl 2 mgcl2 10 tes 154 nagsh na2gssg plus 2 mgoh2 10 tes
0.46872106.9688865.html.plaintext.txt	30	solutions adjusted ph 7
0.46872106.9688865.html.plaintext.txt	31	pipette solution contain cl pipette ag agcl wire protected nacl containing agar bridge inside pipette
0.46872106.9688865.html.plaintext.txt	32	voltages corrected measured liquid junction potentials 12 mv existing dissimilar pipette bath solutions
0.46872106.9688865.html.plaintext.txt	33	chemicals obtained sigma st
0.46872106.9688865.html.plaintext.txt	34	louis mo except 44 dinitrostilbene 22 disulfonic acid dnds pfaltz bauer waterbury ct glibenclamide glyburide calbiochem la jolla ca
0.46872106.9688865.html.plaintext.txt	35	macroscopic current voltage v relationships constructed using depolarizing voltage ramp protocols described previously 9 11
0.46872106.9688865.html.plaintext.txt	36	current reversal potential erev estimated fitting polynomial function v relationship used estimate permeability p ratios according equations 1 2 f faraday constant r gas constant temperature
0.46872106.9688865.html.plaintext.txt	37	block cftr cl current gsh gssg analyzed using woodhull model voltage dependent block 21 3 amplitude current remaining presence blocker i0 control unblocked current amplitude b blocker concentration v membrane potential kdv voltage dependent dissociation constant voltage dependence given 4 z apparent valence blocking ion
0.46872106.9688865.html.plaintext.txt	38	experiments carried room temperature 21 23 degrees c
0.46872106.9688865.html.plaintext.txt	39	values presented means plus minus se
0.46872106.9688865.html.plaintext.txt	40	results top abstract introduction methods results discussion references
0.46872106.9688865.html.plaintext.txt	41	broad range large organic anions able carry current cftr present intracellular solution 11
0.46872106.9688865.html.plaintext.txt	42	pka stimulated v relationships obtained gsh fig
0.46872106.9688865.html.plaintext.txt	43	1b intracellular solution cl extracellular solution bi ionic conditions indicated large anions permeant cftr mean permeabilities according eqs
0.46872106.9688865.html.plaintext.txt	44	1d measurably permeant present extracellular solution bi ionic conditions
0.46872106.9688865.html.plaintext.txt	45	asymmetric permeability similar previously observed number large organic anions 11
0.46872106.9688865.html.plaintext.txt	46	asymmetry abolished substances lock cftr channels open state pyrophosphate ppi 11
0.46872106.9688865.html.plaintext.txt	47	1 c d addition 10 mm ppi intracellular solution stimulated influx gsh gssg extracellular solution
0.46872106.9688865.html.plaintext.txt	48	properties gsh gssg permeation similar described previously number different large organic anions 11
0.46872106.9688865.html.plaintext.txt	49	discussed detail elsewhere 11 reasons disruption asymmetric permeability caused ppi currently known may involve inhibition atp hydrolysis dependent transitions different channel open states
0.46872106.9688865.html.plaintext.txt	50	mean relative permeability gsh gssg different conditions calculated according eqs
0.46872106.9688865.html.plaintext.txt	51	1 2 see methods summarized fig
0.46872106.9688865.html.plaintext.txt	52	note permeability divalent anion gssg low compared gsh large monovalent anions fig
0.46872106.9688865.html.plaintext.txt	53	view larger version 23k fig
0.46872106.9688865.html.plaintext.txt	54	asymmetric glutathione gsh oxidized glutathione gssg permeation cystic fibrosis transmembrane conductance regulator cftr
0.46872106.9688865.html.plaintext.txt	55	d example current voltage v relationships recorded either gsh gssg present intracellular extracellular solution bi ionic conditions stated individual panel
0.46872106.9688865.html.plaintext.txt	56	cftr currents consistently much smaller intracellular gssg ionic conditions studied reasons unknown
0.46872106.9688865.html.plaintext.txt	57	v relationships shown d used calculate mean permeabilities gsh e gssg f present intracellular solution extracellular solution bi ionic conditions
0.46872106.9688865.html.plaintext.txt	58	numbers parentheses number patches examined
0.46872106.9688865.html.plaintext.txt	59	permeability ratios shown gsh gssg extracellular solution absence pyrophosphate ppi maximum values since reversal potential observed conditions voltage range studied
0.46872106.9688865.html.plaintext.txt	60	actual permeabilities conditions likely considerably lower may zero see ref
0.46872106.9688865.html.plaintext.txt	61	suggestion intracellular large organic anions permeant cftr simply transported cftr regulated transport process supported finding currents carried large anions inhibited cftr open channel blockers dnds glibenclamide 11
0.46872106.9688865.html.plaintext.txt	62	dnds glibenclamide also blocked current carried intracellular gsh bi ionic conditions fig
0.46872106.9688865.html.plaintext.txt	63	suggests gsh cl share common permeation pathway cftr previously suggested large anions 11
0.46872106.9688865.html.plaintext.txt	64	view larger version 14k fig
0.46872106.9688865.html.plaintext.txt	65	blocker sensitivity gsh efflux
0.46872106.9688865.html.plaintext.txt	66	typical examples v relationships recorded bi ionic conditions intracellular gsh extracellular cl control immediately addition 200 microm 44 dinitrostilbene 22 disulfonate dnds n 4 patches 60 microm glibenclamide glib n 3 patches intracellular solution
0.46872106.9688865.html.plaintext.txt	67	gsh gssg able permeate cftr cl channel pore might also expected act open channel blockers cftr cl current
0.46872106.9688865.html.plaintext.txt	68	indeed large organic anions gluconate glutamate permeant cftr present intracellular solution 11 also low affinity blockers cl permeation channel 10
0.46872106.9688865.html.plaintext.txt	69	3 addition gsh 5 mm gssg 10 mm intracellular solution reduced macroscopic cftr cl current recorded 150 mm nacl present sides membrane
0.46872106.9688865.html.plaintext.txt	70	block intracellular gsh gssg immediate readily reversible consistent open channel block mechanism
0.46872106.9688865.html.plaintext.txt	71	analysis blocking effects gsh gssg using woodhull model 21 see methods suggested kd0 15
0.46872106.9688865.html.plaintext.txt	72	02 n 5 gsh kd0 23
0.46872106.9688865.html.plaintext.txt	73	thus although affinity channel block two anions relatively low least 20 times higher estimated intracellular gluconate glutamate ions membrane potential 0 mv 600 1100 mm respectively ref
0.46872106.9688865.html.plaintext.txt	74	ability intracellular gsh gssg act blockers cftr cl current consistent able enter pore intracellular end
0.46872106.9688865.html.plaintext.txt	75	view larger version 12k fig
0.46872106.9688865.html.plaintext.txt	76	block cftr cl currents gsh gssg
0.46872106.9688865.html.plaintext.txt	77	example v relationships recorded symmetrical cl containing solutions control immediately addition 5 mm gsh 10 mm gssg intracellular solution
0.46872106.9688865.html.plaintext.txt	78	discussion top abstract introduction methods results discussion references
0.46872106.9688865.html.plaintext.txt	79	despite early skepticism due structure cftr conclusively proven cl channel
0.46872106.9688865.html.plaintext.txt	80	reduced transepithelial cl transport thought primary defect cf 15 however link reduced cl permeability pathogenesis cf lung disease remains unclear
0.46872106.9688865.html.plaintext.txt	81	previously suggested cftr may fulfill another direct transport role allowing efflux broad range large organic anions cytoplasm 11
0.46872106.9688865.html.plaintext.txt	82	based present results propose potential physiological substrate transport pathway important antioxidant molecule gsh
0.46872106.9688865.html.plaintext.txt	83	ability gsh permeate cftr suggests direct link cftr antioxidant defense lung
0.46872106.9688865.html.plaintext.txt	84	gsh synthesized cytoplasm levels 1 10 mm typical 17
0.46872106.9688865.html.plaintext.txt	85	high concentrations gsh 400 microm also found asf healthy individuals 1
0.46872106.9688865.html.plaintext.txt	86	propose gsh may released asf via cftr emphasizing role cftr determining asf composition 18
0.46872106.9688865.html.plaintext.txt	87	cytoplasmic concentrations gsh high passive permeation pathway would presumably sufficient mediate release amounts gsh asf
0.46872106.9688865.html.plaintext.txt	88	loss gsh transport pathway may contribute cf lung disease
0.46872106.9688865.html.plaintext.txt	89	levels gsh greatly reduced asf cf patients 16 potentially exacerbating oxidant stress results neutrophil dominated inflammation cf lung 16 19
0.46872106.9688865.html.plaintext.txt	90	gsh levels asf also reduced idiopathic pulmonary fibrosis adult respiratory distress syndrome increased cigarette smokers clinical evidence lung disease 16
0.46872106.9688865.html.plaintext.txt	91	gsh gssg transport cftr suggests functional similarity cftr structurally related abc proteins multidrug resistance protein mrp canalicular multispecific organic anion transporter cmoat also known mrp2
0.46872106.9688865.html.plaintext.txt	92	mrp cmoat mediate atp dependent export large intracellular organic anions particular glutathione conjugates 6 14
0.46872106.9688865.html.plaintext.txt	93	gssg substrate mrp cmoat mediated transport 8 14
0.46872106.9688865.html.plaintext.txt	94	unconjugated gsh may transported cmoat 14 thought transported mrp 8 however may act cosubstrate mrp mediated transport unconjugated compounds 12 13
0.46872106.9688865.html.plaintext.txt	95	potential functional overlap cftr abc proteins particular interest since suggested mrp may able functionally substitute cftr lung alleviate cf symptoms 7
0.46872106.9688865.html.plaintext.txt	96	results suggest functional substitution may due restoration gsh gsh conjugate transport
0.46872106.9688865.html.plaintext.txt	97	thank jie liao maintaining cell cultures drs
0.46872106.9688865.html.plaintext.txt	98	elizabeth cowley david eidelman comments manuscript
0.46872106.9688865.html.plaintext.txt	99	work supported canadian cystic fibrosis foundation ccff canadian medical research council mrc national institute diabetes digestive kidney diseases
0.46872106.9688865.html.plaintext.txt	100	linsdell ccff postdoctoral fellow
0.46872106.9688865.html.plaintext.txt	101	costs publication article defrayed part payment page charges
0.46872106.9688865.html.plaintext.txt	102	article must therefore hereby marked advertisement accordance 18 u
0.46872106.9688865.html.plaintext.txt	103	1734 solely indicate fact
0.46872106.9688865.html.plaintext.txt	104	address reprint requests p
0.46872106.9688865.html.plaintext.txt	105	montreal quebec canada h3g 1y6
0.46872106.9688865.html.plaintext.txt	106	received 6 march 1998 accepted final form 14 april 1998
0.46872106.9688865.html.plaintext.txt	107	references top abstract introduction methods results discussion references
0.46872106.9688865.html.plaintext.txt	108	normal alveolar epithelial lining fluid contains high levels glutathione
0.46872106.9688865.html.plaintext.txt	109	63 152 157 1987abstractfree full text
0.46872106.9688865.html.plaintext.txt	110	oxidants respiratory tract epithelial injury pathogenesis strategies therapeutic intervention
0.46872106.9688865.html.plaintext.txt	111	cftr chloride channel mammalian heart
0.46872106.9688865.html.plaintext.txt	112	function dysfunction cftr chloride channel
0.46872106.9688865.html.plaintext.txt	113	ion channels genetic diseases edited d
0.46872106.9688865.html.plaintext.txt	114	glutathione concentrations rat lung bronchoalveolar lavage fluid effects hyperoxia
0.46872106.9688865.html.plaintext.txt	115	transport glutathione conjugates glucuronides multidrug resistance proteins mrp1 mrp2
0.46872106.9688865.html.plaintext.txt	116	induction antitumoral drugs proteins functionally complement cftr novel therapy cystic fibrosis lancet 350 711 712 1997medline
0.46872106.9688865.html.plaintext.txt	117	atp dependent glutathi one disulfide transport mediated mrp gene encoded conjugate export pump
0.46872106.9688865.html.plaintext.txt	118	disulphonic stilbene block cystic fibrosis transmembrane conductance regulator cl channels expressed mammalian cell line regulation critical pore residue
0.46872106.9688865.html.plaintext.txt	119	flickery block single cftr chloride channels intracellular anions osmolytes
0.46872106.9688865.html.plaintext.txt	120	40 c628 c634 1996abstractfree full text
0.46872106.9688865.html.plaintext.txt	121	adenosine triphosphate dependent asymmetry anion permeation cystic fibrosis transmembrane conductance regulator chloride channel
0.46872106.9688865.html.plaintext.txt	122	111 601 614 1998abstractfree full text
0.46872106.9688865.html.plaintext.txt	123	multidrug resistance protein mrp mediated transport leukotriene c4 chemotherapeutic agents membrane vesicles
0.46872106.9688865.html.plaintext.txt	124	demonstration glutathione dependent vincristine transport
0.46872106.9688865.html.plaintext.txt	125	271 9675 9682 1996abstractfree full text
0.46872106.9688865.html.plaintext.txt	126	atp dependent transport aflatoxin b1 glutathione conjugates product multidrug resistance protein mrp gene
0.46872106.9688865.html.plaintext.txt	127	51 1034 1041 1997abstractfree full text
0.46872106.9688865.html.plaintext.txt	128	hepatobiliary secretion organic compounds molecular mechanisms membrane transport
0.46872106.9688865.html.plaintext.txt	129	acta 1241 215 268 1995medline
0.46872106.9688865.html.plaintext.txt	130	cystic fibrosis disease electrolyte transport
0.46872106.9688865.html.plaintext.txt	131	4 2709 2717 1990abstractfree full text
0.46872106.9688865.html.plaintext.txt	132	systemic deficiency glutathione cystic fibrosis
0.46872106.9688865.html.plaintext.txt	133	compartmentation glutathione implications study toxicity disease
0.46872106.9688865.html.plaintext.txt	134	cystic fibrosis airway epithelia fail kill bacteria abnormal airway surface fluid
0.46872106.9688865.html.plaintext.txt	135	cell 85 229 236 1996medline
0.46872106.9688865.html.plaintext.txt	136	oxidative stress cystic fibrosis occur matter adv
0.46872106.9688865.html.plaintext.txt	137	cellular glutathione turnover vitro emphasis type ii pneumocytes
0.46872106.9688865.html.plaintext.txt	138	10 1392 1400 1997abstractfree full text
0.46872106.9688865.html.plaintext.txt	139	ionic blockage sodium channels nerve
0.46872106.9688865.html.plaintext.txt	140	61 687 708 1973abstractfree full text
0.46872106.9688865.html.plaintext.txt	141	j physiol cell physiol 2751c323 c326 0002 951398 5
0.46872106.9688865.html.plaintext.txt	142	00 copyright 1998 american physiological society
0.4255241.9755043.html.plaintext.txt	0	editorial focus focus exocytosis involved activation cl secretion via cftr calu 3 airway epithelial cells william b
0.4255241.9755043.html.plaintext.txt	1	department physiology pediatrics johns hopkins university school medicine baltimore maryland 21205
0.4255241.9755043.html.plaintext.txt	2	article top article references
0.4255241.9755043.html.plaintext.txt	3	rapid changes salt water movement occur many epithelial tissues respond quickly alterations overall salt water balance
0.4255241.9755043.html.plaintext.txt	4	example amount cl secreted shark rectal gland vary greatly response changes external environment 4
0.4255241.9755043.html.plaintext.txt	5	rapidly change rate transport epithelial cells regulate transport rates specific ion channels pumps carriers
0.4255241.9755043.html.plaintext.txt	6	regulation commonly occurs either affecting activity individual transport process andor number transport entities plasma membrane
0.4255241.9755043.html.plaintext.txt	7	activity many ion channels regulated voltage extracellular ligands intracellular signal transduction mechanisms 6
0.4255241.9755043.html.plaintext.txt	8	thus many ion channels easily switched match needs rapidly changing physiological process
0.4255241.9755043.html.plaintext.txt	9	cftr excellent example highly regulated cl channel 2
0.4255241.9755043.html.plaintext.txt	10	activity cftr controlled coordination two processes phosphorylation several sites primarily within regulatory domain followed atp binding hydrolysis nucleotide binding domains
0.4255241.9755043.html.plaintext.txt	11	two processes act together switch regulate channel opening 3
0.4255241.9755043.html.plaintext.txt	12	contrast clear cut cases inserted plasma membrane activity variety transporters difficult regulate
0.4255241.9755043.html.plaintext.txt	13	cases effective way modulate transepithelial transport alter number transporters plasma membrane
0.4255241.9755043.html.plaintext.txt	14	example well known mature aquaporin water channels move water unregulated fashion 1
0.4255241.9755043.html.plaintext.txt	15	modulate overall transepithelial water transport renal collecting duct vesicles containing aquaporin 2 water channels rapidly inserted plasma membrane following activation antidiuretic hormone 8
0.4255241.9755043.html.plaintext.txt	16	specific question addressed article focus whether exocytosis involved activation cl secretion via cftr human airway serous cell line calu 3
0.4255241.9755043.html.plaintext.txt	17	serous cells located primarily submucosal glands human airway known express cftr
0.4255241.9755043.html.plaintext.txt	18	overall question much function cftr dependent insertion plasma membrane answered phrase depends
0.4255241.9755043.html.plaintext.txt	19	cftr expressed variety tissues including airway pancreas gastrointestinal tract heart kidney participates ion transport 5
0.4255241.9755043.html.plaintext.txt	20	thus much cftr mediated transport controlled exocytosis may depend critically organ considered
0.4255241.9755043.html.plaintext.txt	21	moreover cultured cells studied may also depend degree differentiation cells
0.4255241.9755043.html.plaintext.txt	22	example current article focus ref
0.4255241.9755043.html.plaintext.txt	23	c913 issue loffing colleagues demonstrate exocytosis cftr containing vesicles involved activation cl secretion calu 3 cells
0.4255241.9755043.html.plaintext.txt	24	similarly exocytic delivery cftr occur gallbladder epithelium 14
0.4255241.9755043.html.plaintext.txt	25	presumably tissues activation resident cftr sufficient regulate transport
0.4255241.9755043.html.plaintext.txt	26	tissues shark rectal gland bronchial epithelial cells transporting cell lines madin darby canine kidney mdck ii a6 camp increases amount cftr apical cell membrane 7 9 11 13
0.4255241.9755043.html.plaintext.txt	27	t84 cells colonic epithelial cell line results conflicting suggesting either culture conditions may affect machinery camp dependent exocytosis cftr 12 15 methodological difficulties localizing cftr plasma membrane make difficult detect exocytosis cftr
0.4255241.9755043.html.plaintext.txt	28	thus question much role exocytosis plays regulating transport cftr t84 cells still unresolved
0.4255241.9755043.html.plaintext.txt	29	loffing colleagues 10 speculate serous cells airway high basal rates cl antibiotic secretion
0.4255241.9755043.html.plaintext.txt	30	may require high levels cftr present times support high level transport
0.4255241.9755043.html.plaintext.txt	31	given cftr highly regulated phosphorylation atp binding hydrolysis tissues need control function rapidly moving cftr plasma membrane via exocytosis one may speculate stimulation transport via cftr increasing number channels though exocytosis may occur tissues shark rectal gland large rapid changes transport occur
0.4255241.9755043.html.plaintext.txt	32	report funded grants national heart lung blood institute national institute diabetes digestive kidney diseases cystic fibrosis foundation
0.4255241.9755043.html.plaintext.txt	33	references top article references
0.4255241.9755043.html.plaintext.txt	34	aquaporin chip archetypal molecular water channel
0.4255241.9755043.html.plaintext.txt	35	265 renal fluid electrolyte physiol
0.4255241.9755043.html.plaintext.txt	36	34 f463 f476 1993abstractfree full text
0.4255241.9755043.html.plaintext.txt	37	demonstration cftr chloride channel alteration anion selectivity
0.4255241.9755043.html.plaintext.txt	38	science 253 202 205 1991medline
0.4255241.9755043.html.plaintext.txt	39	cystic fibrosis transmembrane conductance regulator atp
0.4255241.9755043.html.plaintext.txt	40	mechanism control hyperosmotic nacl rich secretion rectal gland squalus acanthias
0.4255241.9755043.html.plaintext.txt	41	32 c267 c286 1992abstractfree full text
0.4255241.9755043.html.plaintext.txt	42	regulation tubular transport via ion channels
0.4255241.9755043.html.plaintext.txt	43	camp regulated trafficking epitope tagged cftr
0.4255241.9755043.html.plaintext.txt	44	vasoactive intestinal peptide forskolin genistein increase apical cftr trafficking rectal gland spiny dogfish squalus acanthias
0.4255241.9755043.html.plaintext.txt	45	acute regulation cftr trafficking intact epithelium
0.4255241.9755043.html.plaintext.txt	46	101 737 745 1998abstractfree full text
0.4255241.9755043.html.plaintext.txt	47	exocytosis involved activation cl secretion via cftr calu 3 airway epithelial cells
0.4255241.9755043.html.plaintext.txt	48	44 c913 c920 1998abstractfree full text
0.4255241.9755043.html.plaintext.txt	49	vesicle targeting ion secretion epithelial cells implications cystic fibrosis
0.4255241.9755043.html.plaintext.txt	50	cell surface labeling cftr t84 cells
0.4255241.9755043.html.plaintext.txt	51	33 c491 c498 1993abstractfree full text
0.4255241.9755043.html.plaintext.txt	52	rapid endocytosis cystic fibrosis transmembrane conductance regulator chloride channel
0.4255241.9755043.html.plaintext.txt	53	usa 91 5192 5196 1994abstract
0.4255241.9755043.html.plaintext.txt	54	polarized expression camp activated chloride channels isolated epithelial cells
0.4255241.9755043.html.plaintext.txt	55	40 c1574 c1582 1996abstractfree full text
0.4255241.9755043.html.plaintext.txt	56	apical recruitment cftr 84 cells dependent camp microtubules ca2 microfilaments
0.4255241.9755043.html.plaintext.txt	57	109 1325 1334 1996abstractfree full text
0.4255241.9755043.html.plaintext.txt	58	j physiol cell physiol 2754c911 c912 0002 951398 5
0.4255241.9755043.html.plaintext.txt	59	00 copyright 1998 american physiological society
0.65036243.12777252.html.plaintext.txt	0	role regulated cftr trafficking epithelial secretion carol
0.65036243.12777252.html.plaintext.txt	1	department cell biology physiology university pittsburgh school medicine pittsburgh pennsylvania 15261
0.65036243.12777252.html.plaintext.txt	2	abstract top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	3	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	4	summary appendix references focus review regulated trafficking cystic fibrosis transmembrane conductance regulator cftr distal compartments protein secretory pathway question changes cftr cellular distribution may impact functions polarized epithelial cells
0.65036243.12777252.html.plaintext.txt	5	summarize data concerning cellular localization activity cftr attempt synthesize often conflicting results functional studies regulated endocytosis exocytosis cftr expressing cells
0.65036243.12777252.html.plaintext.txt	6	instances findings inconsistent regulated cftr trafficking may result use overexpression systems nonphysiological experimental conditions
0.65036243.12777252.html.plaintext.txt	7	nevertheless judging data transporters appropriate cellular context necessary support regulated cftr trafficking even epithelial cells
0.65036243.12777252.html.plaintext.txt	8	discovery disease mutations influence cftr trafficking distal secretory recycling compartments provides support concept regulated cftr recycling contributes normal epithelial function including control apical cftr channel density epithelial protein secretion
0.65036243.12777252.html.plaintext.txt	9	finally propose molecular mechanisms regulated cftr endocytosis exocytosis based cftr interactions proteins particularly whose primary function membrane trafficking
0.65036243.12777252.html.plaintext.txt	10	models provide testable hypotheses may lead elucidation cftr trafficking mechanisms permit experimental manipulation polarized epithelial cells
0.65036243.12777252.html.plaintext.txt	11	cystic fibrosis transmembrane conductance regulator membrane traffic chloride channel protein secretion
0.65036243.12777252.html.plaintext.txt	12	cystic fibrosis transmembrane conductance regulator cftr responsible camp activated anion conductance epithelial cell apical membranes
0.65036243.12777252.html.plaintext.txt	13	principal apical conductance pathway cftr anion channel involved camp dependent cl bicarbonate secretion airway intestinal epithelia exocrine glands
0.65036243.12777252.html.plaintext.txt	14	also influences activity conductive pathways either linked regulatory interactions electrochemical coupling influences driving forces ion transport 49 93
0.65036243.12777252.html.plaintext.txt	15	subsequent cloning cftr gene methods situ hybridization development antibodies cftr permitted characterization distribution variety tissues 52 104 107
0.65036243.12777252.html.plaintext.txt	16	results generally correlated presence camppka stimulated anion secretory processes various epithelial tissues identified earlier studies using physiological methods
0.65036243.12777252.html.plaintext.txt	17	mutations gene encoding cftr produce cystic fibrosis cf whereas hyperactivity transport pathway underlies secretory diarrheas
0.65036243.12777252.html.plaintext.txt	18	cf disease arises reduced density andor activity cftr apical membranes secretory epithelial cells airways exocrine pancreas salivary glands reproductive tissues intestines
0.65036243.12777252.html.plaintext.txt	19	regulated cftr conductance pathway also important normal functions several absorptive cells including epithelia lining airway surface sweat gland ducts general review see ref
0.65036243.12777252.html.plaintext.txt	20	subject review cftr trafficking distal portion protein secretory pathway lies trans golgi network plasma membrane
0.65036243.12777252.html.plaintext.txt	21	historically studies pathway motivated question whether would possible explain manifestations cf disease basis missing anion conductance apical membranes epithelial cells
0.65036243.12777252.html.plaintext.txt	22	accordingly functional roles cftr primary role apical membrane anion conductance pathway proposed contribute cf pathology
0.65036243.12777252.html.plaintext.txt	23	include disease associated changes regulated protein secretion 65 chemistry macromolecular secretions 22 33 90 properties airway microenvironment lead bacterial colonization cf airways 89
0.65036243.12777252.html.plaintext.txt	24	although attention numerous investigators focused cftr trafficking distal protein secretory pathway possible contributor complexity cf disease consensus regarding importance intracellular cftr function process regulated cftr trafficking within subcellular domain yet emerge
0.65036243.12777252.html.plaintext.txt	25	integral membrane protein cftr reside least transiently compartments protein secretory pathway migrates toward cell surface
0.65036243.12777252.html.plaintext.txt	26	thus one expect find cftr membranes endoplasmic reticulum er golgi endosomal lysosomal compartments epithelial cells fig
0.65036243.12777252.html.plaintext.txt	27	although question cftr channels function regulated conductance pathway resident apical membrane numerous studies see cftr localization cells also indicated significant quantity mature
0.65036243.12777252.html.plaintext.txt	28	post golgi cftr contained within intracellular compartments cftr within compartments functional 9 78 camp stimulation modulate distribution cftr compartments plasma membrane see regulated cftr traffic
0.65036243.12777252.html.plaintext.txt	29	therefore issue whether apical cl conductance due regulation gating membrane resident cftr channels whether results insertion cftr channels membrane processes occur
0.65036243.12777252.html.plaintext.txt	30	want know extent forms cftr regulation linked mechanistically trafficking cftr contributes overall conductance response
0.65036243.12777252.html.plaintext.txt	31	view larger version 36k fig
0.65036243.12777252.html.plaintext.txt	32	intracellular locations cystic fibrosis transmembrane conductance regulator cftr maturation plasma membrane insertion degradation
0.65036243.12777252.html.plaintext.txt	33	properly folded nascent cftr leaves rough endoplasmic reticulum travels golgi undergoes glycosylation mature band c protein
0.65036243.12777252.html.plaintext.txt	34	mature cftr leaves golgi vesicles travel directly apical plasma membrane recycling endosome
0.65036243.12777252.html.plaintext.txt	35	cftr containing vesicles continually traffic recycling endosomes plasma membrane rates trafficking protein distribution determined cell type differentiation phosphorylation conditions
0.65036243.12777252.html.plaintext.txt	36	cftr eventually follows late endosome lysosome pathway degradation
0.65036243.12777252.html.plaintext.txt	37	misfolded cftr mutants significant wild type nascent cftrs degraded proteosome
0.65036243.12777252.html.plaintext.txt	38	area cftr cell biology among contentious unresolved subjects cf research continues
0.65036243.12777252.html.plaintext.txt	39	relatively recent review subject bradbury 10 argued disparate conclusions regarding regulation distribution cftr plasma membrane intracellular compartments might reconciled regulated cftr trafficking property specific epithelial cells
0.65036243.12777252.html.plaintext.txt	40	studies showing lack cftr trafficking generally performed fibroblasts
0.65036243.12777252.html.plaintext.txt	41	nevertheless four years bradbury review literature clarified
0.65036243.12777252.html.plaintext.txt	42	accordingly task bringing synthesis conflicting data set easy one
0.65036243.12777252.html.plaintext.txt	43	yet feel possible attempt add understanding control plasma membrane cftr density critical issue cf disease
0.65036243.12777252.html.plaintext.txt	44	cftr localization cells top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	45	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	46	summary appendix references review primarily concerned steadystate distribution cftr plasma membrane intracellular compartments effect camppka mediated stimulation distribution
0.65036243.12777252.html.plaintext.txt	47	methods used determine cellular cftr localization relied primarily detection antibodies cultured cells tissue sections
0.65036243.12777252.html.plaintext.txt	48	studies employed functional assays subsequent cell fractionation others relied expression epitope tagged green fluorescent protein gfp cftr fusion proteins method locating exogenously expressed cftr
0.65036243.12777252.html.plaintext.txt	49	cellular targets studies included polarized non polar cells
0.65036243.12777252.html.plaintext.txt	50	detection reliable cftr signal often required overexpression normally low abundance protein heterologous systems
0.65036243.12777252.html.plaintext.txt	51	location mature cftr band c
0.65036243.12777252.html.plaintext.txt	52	biochemical standpoint prevailing view core glycosylated immature band b cftr localized er whereas complex glycosylated mature band c cftr present primarily compartments distal golgi including apical membrane
0.65036243.12777252.html.plaintext.txt	53	contrast many heterologous expression systems relatively little band b observed immunoblot epithelial cells expressing cftr endogenously steady state
0.65036243.12777252.html.plaintext.txt	54	example ratio band c b calu 3 airway cells 10 100
0.65036243.12777252.html.plaintext.txt	55	indicates cftr expressed endogenously epithelial cells located distal compartments protein secretory pathway
0.65036243.12777252.html.plaintext.txt	56	first reported studies cftr localization performed cos 7 cells transiently expressing cftr showed weak diffuse plasma membrane staining pattern
0.65036243.12777252.html.plaintext.txt	57	signal intracellular probably due protein overexpression 23
0.65036243.12777252.html.plaintext.txt	58	polarized epithelial cells express cftr endogenously t84 ht29 caco 2 airway epithelia signal located unambiguously apical membrane domain 27 28
0.65036243.12777252.html.plaintext.txt	59	staining detected basolateral membrane little perinuclear staining cftr observed epithelial monolayers implying little cftr present er steady state consistent low levels band b
0.65036243.12777252.html.plaintext.txt	60	27 highlighted importance localizing cftr within epithelial cells express protein endogenously
0.65036243.12777252.html.plaintext.txt	61	study mostly intracellular location exogenously expressed cftr found non polar hela 3t3 cells
0.65036243.12777252.html.plaintext.txt	62	central question concerning issue regulated cftr trafficking whether protein contributes plasma membrane anion conductance present strictly apical plasma membranes epithelial cells whether present also subapical post golgi compartment mobilized cell surface stimulation
0.65036243.12777252.html.plaintext.txt	63	related issue whether cftr stable plasma membrane undergoes recycling intracellular compartments
0.65036243.12777252.html.plaintext.txt	64	regard rapid rate cftr endocytosis cell surface observed epithelial nonepithelial systems 13 61 85
0.65036243.12777252.html.plaintext.txt	65	studies used biotinylation procedures monitor rate cftr internalization cell surface
0.65036243.12777252.html.plaintext.txt	66	t84 cells estimated 50 cell surface cftr retrieved within minutes 85 chinese hamster ovary cho cells internalization rate 5 per minute 61
0.65036243.12777252.html.plaintext.txt	67	rates endocytosis different constitutively recycling receptors transferrin ldl
0.65036243.12777252.html.plaintext.txt	68	findings together estimated 24 48 h half life mature plasma membrane cftr 7 41 indicate virtually cftr internalized endocytosis must returned plasma membrane recyclingexocytic pathway
0.65036243.12777252.html.plaintext.txt	69	presence rapid cftr recycling pathway minimal requirement regulated insertion retrieval model controls cellular cftr distribution
0.65036243.12777252.html.plaintext.txt	70	thus question whether cftr undergoes trafficking plasma membrane whether process contributes change distribution cftr plasma membrane intracellular compartments response camppka regulation
0.65036243.12777252.html.plaintext.txt	71	addition kinetic considerations presence cftr endosomes steady state conditions established use combination biochemical techniques functional assays rely cftrs anion channel activity
0.65036243.12777252.html.plaintext.txt	72	12 resolved cftr early stages endosomal retrieval within clathrin coated vesicles epithelial cells
0.65036243.12777252.html.plaintext.txt	73	cftr demonstrated present compartment immunoblot
0.65036243.12777252.html.plaintext.txt	74	removal clathrin lattice uncoatase fusion resulting membranes planar lipid bilayers currents biophysical regulatory properties characteristic cftr observed
0.65036243.12777252.html.plaintext.txt	75	clathrin removal necessary prerequisite reconstitution cftr definitely component endocytic compartment
0.65036243.12777252.html.plaintext.txt	76	additional studies demonstrated rapid endocytosis cftr cell surface depends clathrin mediated pathways cftr significantly internalized caveolae 11 85
0.65036243.12777252.html.plaintext.txt	77	several transport andor channel proteins found internalize via clathrin dependent endocytosis including aquaporin 2 aqp 2 101 nah exchanger 3 nhe3 24 renal outer medulla k channels romk 114 epithelial na channels enac 96
0.65036243.12777252.html.plaintext.txt	78	recent studies mechanism cftr endocytosis see functional studies endocytosis indicate direct physical interaction cftr plasma membrane adapter complex making cftr specific target endocytic machinery
0.65036243.12777252.html.plaintext.txt	79	methods demonstrating presence cftr endosomes relied ability cftr provide pathway anion transport parallels vacuolar h atpase
0.65036243.12777252.html.plaintext.txt	80	60 allowed cho cells expressing cftr take ph sensitive dye fitc dextran endosomes rate dissipation ph gradient across endosomal membranes stimulated addition proton ionophore
0.65036243.12777252.html.plaintext.txt	81	intact cells ph gradient dissipation limited counterion
0.65036243.12777252.html.plaintext.txt	82	activation camp production elicited twofold increase rate ph change cells expressing cftr parental mock transfected cells
0.65036243.12777252.html.plaintext.txt	83	results duplicated microsomes isolated cells
0.65036243.12777252.html.plaintext.txt	84	biwersi verkman 9 used similar method monitoring endosomal ph cftr transfected 3t3 cells t84 cells endogenously expressing cftr
0.65036243.12777252.html.plaintext.txt	85	treatment cells forskolin microsome isolation produced approximately twofold increase rate subsequently measured ph gradient dissipation effect microsomes isolated nontransfected f508 cftr expressing 3t3 cells
0.65036243.12777252.html.plaintext.txt	86	data also consistent presence functional cftr endosomes principle could contribute cftr recycling
0.65036243.12777252.html.plaintext.txt	87	using immunofluorescence confocal microscopy detection cellular cftr investigators generated data arrive somewhat divergent conclusions respect importance regulated cftr trafficking
0.65036243.12777252.html.plaintext.txt	88	one side issue study lehrich et al
0.65036243.12777252.html.plaintext.txt	89	55 shark rectal gland tissue expresses cftr high levels endogenously
0.65036243.12777252.html.plaintext.txt	90	investigators used quantitative confocal microscopy show cftr immunofluorescence extended apical membrane subapical supernuclear regions cell stimulation secretagogues overall depth cftr signal decreased 50
0.65036243.12777252.html.plaintext.txt	91	similar conclusions reached histogram cftr fluorescence intensity function distance apical membrane quantitated
0.65036243.12777252.html.plaintext.txt	92	camp agonist effects cftr distribution imposed perfused intact rectal glands fixation reversible
0.65036243.12777252.html.plaintext.txt	93	whether shift fluorescence signal represents insertion vesicles containing cftr apical membrane remains unknown however findings consistent acute hormonal regulation cftr trafficking intact epithelial tissue
0.65036243.12777252.html.plaintext.txt	94	1 2 used immunofluorescence microscopy quantify cellular location cftr rat small intestine influence camp dependent agonists distribution
0.65036243.12777252.html.plaintext.txt	95	vasoactive intestinal peptide vip elicited bicarbonate rich fluid secretory response isolated perfused intestinal loops elicited within time frame redistribution cftr apical membrane domain
0.65036243.12777252.html.plaintext.txt	96	cftr association apical membrane quantified colocalization f actin brush border marker
0.65036243.12777252.html.plaintext.txt	97	duodenal villus cells vip elicited reversible threefold increase brush border associated cftr redistributed cftr within cell apex brush border within 30 min
0.65036243.12777252.html.plaintext.txt	98	studies confirmed immunoelectron microscopic methods see immunoelectron microscopy
0.65036243.12777252.html.plaintext.txt	99	results provide support physiological role camp induced cftr containing membrane traffic regulation apical anion conductance native endogenously expressing epithelium
0.65036243.12777252.html.plaintext.txt	100	investigators reached different conclusions respect regulated cftr trafficking
0.65036243.12777252.html.plaintext.txt	101	70 expressed gfp cftr fusion protein mdck type epithelial cells used quantitative confocal fluorescence microscopy cell surface biotinylation determine effect camp stimulation apical membrane cftr localization
0.65036243.12777252.html.plaintext.txt	102	findings showed camp stimulate detectable gfp cftr translocation intracellular compartments apical membrane along apical basal gfp fluorescence gradient extended throughout cell
0.65036243.12777252.html.plaintext.txt	103	cells camp regulate gfp cftr endocytosis determined apical biotinylation subsequent immunoprecipitation
0.65036243.12777252.html.plaintext.txt	104	likewise disruption microtubules colchicine affect camp stimulation cl secretion expression gfp cftr apical membrane
0.65036243.12777252.html.plaintext.txt	105	thus authors concluded camp stimulates cftr mediated cl secretion mdck type cells activating channels resident apical membrane
0.65036243.12777252.html.plaintext.txt	106	regulated cftr trafficking event may lacking cell type however also reasonable ask whether exogenous expression cftr driven cmv promoter leads saturation regulated trafficking pathways see functional studies exocytosis
0.65036243.12777252.html.plaintext.txt	107	related study 58 involving measurements cellular cftr immunolocalization endogenously expressing calu 3 epithelia fluorescence confocal microscopy detected change apical cftr staining upon camp stimulation
0.65036243.12777252.html.plaintext.txt	108	surface biotinylation experiments reported study 58 also showed stimulation dependent increase apical membrane cftr
0.65036243.12777252.html.plaintext.txt	109	two biotinylated proteins detected cftr antibody precipitation following biotinylation equal intensity 200 220 kda molecular size
0.65036243.12777252.html.plaintext.txt	110	yet others demonstrated immunoblot cftr calu 3 cells shows typical pattern predominant band c 150 180 kda relatively little band b latter presumably intracellular c
0.65036243.12777252.html.plaintext.txt	111	thus clear biotin labeled proteins identified experiments cftr
0.65036243.12777252.html.plaintext.txt	112	possible differences conclusions drawn fluorescence measurements native cultured epithelial cells stem variations distribution cftr subapical compartments nonstimulated conditions
0.65036243.12777252.html.plaintext.txt	113	studies native secretory tissues shark rectal gland rat intestine apical fluorescence signal extended cell sufficiently detect clear change distribution stimulation
0.65036243.12777252.html.plaintext.txt	114	mdck cells expressing gfp cftr 70 even deeper distribution expressed protein may reflect deposition nonphysiological compartments described earlier article
0.65036243.12777252.html.plaintext.txt	115	given quantitative limitations gfp visualization 7 moleculespixel 79 may necessary express cftr nonphysiological levels obtain cftr signal
0.65036243.12777252.html.plaintext.txt	116	calu 3 cells 58 cftr signal much densely localized apical membrane domain
0.65036243.12777252.html.plaintext.txt	117	nevertheless reasonable ask whether band apical fluorescence detected epithelial cross sections resolve apical membrane cftr present nearby subapical recycling pool
0.65036243.12777252.html.plaintext.txt	118	consideration point spread function fluorescence intensity variation distance suggests structures separated 0
0.65036243.12777252.html.plaintext.txt	119	2 microm resolved using light microscopy
0.65036243.12777252.html.plaintext.txt	120	thus immunofluorescence even coupled confocal microscopy may lack ability resolve fluorescence signals membrane vesicles diameter 0
0.65036243.12777252.html.plaintext.txt	121	1 microm less components cftr recycling pathway
0.65036243.12777252.html.plaintext.txt	122	vesicle size expectation based neurosecretory regulated trafficking vesicles see appendix
0.65036243.12777252.html.plaintext.txt	123	example intracellular glut 4 staining thin section immunoelectron microscopy localized vesiculotubular structures 50 70 nm diameter 62
0.65036243.12777252.html.plaintext.txt	124	thus possible different conclusions light microscopic level may emerge different cellular distributions intracellular cftr trafficking compartments constituents see consequences regulated cftr trafficking
0.65036243.12777252.html.plaintext.txt	125	results several studies using immunoelectron microscopic methods consistent subapical population post golgi cftr c
0.65036243.12777252.html.plaintext.txt	126	86 used immunogold labeling localize cftr vesicles present beneath plasma membrane human airway epithelial cells
0.65036243.12777252.html.plaintext.txt	127	also observed vesicles process fusion retrieval plasma membrane
0.65036243.12777252.html.plaintext.txt	128	immunogold labeling cftr expressing l cells sf9 cells also demonstrated presence cftr beneath plasma membrane well rough er 26
0.65036243.12777252.html.plaintext.txt	129	studies striated duct rat submandibular gland cells webster et al
0.65036243.12777252.html.plaintext.txt	130	107 showed immunogold labeling cftr along apical membrane well numerous subapical membrane vesicles
0.65036243.12777252.html.plaintext.txt	131	estimates labeling density suggested cftr present subapical intracellular compartments plasma membrane resting conditions
0.65036243.12777252.html.plaintext.txt	132	cftr labeled vesicles also stained antibodies transferrin receptor rab4 two endosomal markers indicating vesicles likely part endosomalrecycling pathway cftr
0.65036243.12777252.html.plaintext.txt	133	fluorescence measurements ameen et al
0.65036243.12777252.html.plaintext.txt	134	1 performed rat small intestine confirmed immunoelectron microscopy
0.65036243.12777252.html.plaintext.txt	135	cftr identified subapical vesicles several intestinal cell types including cells crypt brunner glands subpopulation villar cells cftr expression predominated called cftr high expressors che cells
0.65036243.12777252.html.plaintext.txt	136	camp stimulation elicited two threefold increase cftr labeling apical microvilli che cells response cholera toxin providing evidence regulated insertion cftr apical membranes native epithelium
0.65036243.12777252.html.plaintext.txt	137	42 examined apical membrane domain cftr localization function cftr expression level
0.65036243.12777252.html.plaintext.txt	138	earlier study 43 investigators showed cftr located plasma membrane could discriminated intracellular cftr using nonpermeabilized mdck cells expressing extracellular epitope tagged cftr flag m2 epitope added 4th extracellular loop cftr amino acid 901
0.65036243.12777252.html.plaintext.txt	139	found camp stimulation increased cell surface signal cftr two threefold steady state
0.65036243.12777252.html.plaintext.txt	140	recent studies induced cftr expression using recombinant adenovirus encoded m2 901cftr
0.65036243.12777252.html.plaintext.txt	141	virally expressed flag tagged cftr functional could detected apical surface forskolin stimulated polarized mdck type ii cells immunofluorescence performed nonpermeabilized epithelial monolayers
0.65036243.12777252.html.plaintext.txt	142	low multiplicity infection moi
0.65036243.12777252.html.plaintext.txt	143	lower cftr expression level forskolin stimulated insertion m2 901cftr apical membrane higher moi m2 901cftr expression levels agonist dependent increase surface expression could detected
0.65036243.12777252.html.plaintext.txt	144	immunoelectron microscopy confirmed redistribution cftr apical membrane upon forskolin stimulation lower cftr expression levels demonstrated apically inserted cftr originated population subapical vesicles
0.65036243.12777252.html.plaintext.txt	145	results similar obtained use immunoelectron microscopy calu 3 cells endogenously expressing cftr two threefold increase apical cftr observed response acute forskolin stimulation hug mj frizzell ra unpublished observation
0.65036243.12777252.html.plaintext.txt	146	observations howard et al
0.65036243.12777252.html.plaintext.txt	147	42 may reconcile least prior conflicting reports regarding effect camp stimulation cftr trafficking
0.65036243.12777252.html.plaintext.txt	148	show high level cftr expression obtained using strong promoters example 70 saturate pathways regulated cftr trafficking even epithelial systems
0.65036243.12777252.html.plaintext.txt	149	also oocytes cftr trafficking signal camp induced increase membrane capacitance saturated cftr expression level elevated injection rna 102
0.65036243.12777252.html.plaintext.txt	150	inappropriate trafficking aqp 2 relation actions dominant negative aqp 2 mutants also observed high protein expression levels 51
0.65036243.12777252.html.plaintext.txt	151	later article discuss candidate protein interactions may mediate regulated cftr trafficking apical membrane
0.65036243.12777252.html.plaintext.txt	152	cells express different levels relevant traffic regulatory proteins likely contribution regulated cftr trafficking total anion conductance opposed regulated gating membrane resident cftr vary different epithelial nonepithelial systems
0.65036243.12777252.html.plaintext.txt	153	regulated cftr traffic top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	154	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	155	summary appendix references functional studies endocytosis
0.65036243.12777252.html.plaintext.txt	156	concept cf gene product may play role regulated membrane trafficking new
0.65036243.12777252.html.plaintext.txt	157	implication defective mucin glycoprotein secretion found cf airways organs 64 67 cf gene product identified would involved somehow control protein secretory processes
0.65036243.12777252.html.plaintext.txt	158	secretion mucin several cftr expressing tissues stimulated camp 65 camppka regulatory pathways also control cftr gating reasonable anticipate protein secretion exocytosis may lead also increase numbers cftr channels plasma membrane fig
0.65036243.12777252.html.plaintext.txt	159	first studies implicated cftr function regulated endocytosis performed colonic pancreatic epithelial cell lines latter transduced express cftr using retrovirus vectors
0.65036243.12777252.html.plaintext.txt	160	13 14 measured detergent sensitive horseradish peroxidase fitc dextran uptake monitor fluid phase endocytosis t84 cfpac 1 cells
0.65036243.12777252.html.plaintext.txt	161	found camp significantly inhibited fluid phase endocytosis pancreatic cells depended expression wild type wt cftr
0.65036243.12777252.html.plaintext.txt	162	camp inhibition endocytic activity observed parental cfpac 1 cells transduced empty vector
0.65036243.12777252.html.plaintext.txt	163	similar 60 inhibition endocytosis observed camp stimulation endogenous cftr expressing t84 13 9hteo cells 94
0.65036243.12777252.html.plaintext.txt	164	t84 cells pkc stimulation affect either basal endocytosis inhibitory effect elicited camp stimulation
0.65036243.12777252.html.plaintext.txt	165	methods employing biotinylation cell surface also demonstrated cftr internalization inhibited camppka
0.65036243.12777252.html.plaintext.txt	166	85 biotinylated carbohydrate residues extracellular surface t84 cells using nhs biotin
0.65036243.12777252.html.plaintext.txt	167	subsequent immunoprecipitation radioisotope labeling cftr use 32patp pka performed distinguish cftr cell surface intracellular compartments
0.65036243.12777252.html.plaintext.txt	168	workers found apical membrane cftr rapidly internalized t84 cells half time 3 min showed camp decreased internalization rate extent similar found prior studies fluid phase endocytosis 60 inhibition
0.65036243.12777252.html.plaintext.txt	169	also showed internalization rate g551d cftr similar wild type protein interestingly endocytosis affected camp
0.65036243.12777252.html.plaintext.txt	170	finding suggested either channel activity cftr related ability retrieved cell surface altered structure g551d mutant precludes regulation gating trafficking
0.65036243.12777252.html.plaintext.txt	171	difficult detect change total amount cftr cell surface using method prince et al
0.65036243.12777252.html.plaintext.txt	172	even short times 1 min 12 increase apical membrane cftr detected
0.65036243.12777252.html.plaintext.txt	173	however use vitro phosphorylation detect cftr biotinylation immunoprecipitation may influenced existing phosphorylation status protein thus compromising surface cftr detection
0.65036243.12777252.html.plaintext.txt	174	cftr already phosphorylated agonist subsequent cftr signal would reduced phosphorylation sites already occupied
0.65036243.12777252.html.plaintext.txt	175	method avoids complication employs second cftr antibody detect biotinylated cftr avoids potential back phosphorylation reduce signal
0.65036243.12777252.html.plaintext.txt	176	approach also demonstrates forskolin induced inhibition cftr endocytosis depletion protein intracellular compartments consequent increase plasma membrane cftr 61
0.65036243.12777252.html.plaintext.txt	177	studies documenting presence functional cftr endosomes extended show role cftr postendocytic membrane trafficking
0.65036243.12777252.html.plaintext.txt	178	8 implicated role cftr camp stimulated endosome endosome fusion
0.65036243.12777252.html.plaintext.txt	179	labeled endosomes cftr expressing control 3t3 cells fluorophores fluorescence signal would detected endosomes separately labeled cell populations fused one another
0.65036243.12777252.html.plaintext.txt	180	investigators asked whether presence cftr endosomes stimulation camp influenced fusion process
0.65036243.12777252.html.plaintext.txt	181	endosomes nonstimulated cftr expressing cells fused rate differ observed control cells expressing cftr
0.65036243.12777252.html.plaintext.txt	182	endosomes isolated cftr expressing cells stimulated forskolin however showed 2
0.65036243.12777252.html.plaintext.txt	183	abolished endosomal cl depletion suggesting cftr mediated cl flux conformational changes cftr associated cl conduction somehow contribute process
0.65036243.12777252.html.plaintext.txt	184	data consistent concept cftr stimulation alter membrane traffic endosomal recycling pathways
0.65036243.12777252.html.plaintext.txt	185	recent findings able establish certain structural features cftr govern rapid removal cell surface
0.65036243.12777252.html.plaintext.txt	186	84 weixel bradbury 109 demonstrated internalization cftr via clathrin dependent mechanisms depends presence yxx motif bulky hydrophobic residue cftr cooh terminus
0.65036243.12777252.html.plaintext.txt	187	similar tyrosine based endocytic motifs present proteins rapidly retrieved cell surface see ref
0.65036243.12777252.html.plaintext.txt	188	vivo cross linking vitro pull assays showed cftr binds plasma membrane endocytic adaptor complex ap 2
0.65036243.12777252.html.plaintext.txt	189	cftr cooh terminus able bind ap 2 bind golgi specific adaptor complex ap 1
0.65036243.12777252.html.plaintext.txt	190	mutation tyrosine residue position 1424 cftr significantly reduced ability isolated cftr cooh terminus bind ap 2
0.65036243.12777252.html.plaintext.txt	191	ydsi sequence cftr interacts specifically micro2 subunit ap 2 108 site implicated adapter binding similar endocytic motifs 74
0.65036243.12777252.html.plaintext.txt	192	protein binding studies showed cooh terminus binds selectively adapter subunit
0.65036243.12777252.html.plaintext.txt	193	cells expressing either dominant negative micro2 cftr lacking tyrosine based internalization motif cooh terminus y1424a fail endocytose cftr efficiently
0.65036243.12777252.html.plaintext.txt	194	studies indicate interaction cftrs cooh terminus ap 2 guides clathrin mediated endocytic pathway observed many cell surface receptors
0.65036243.12777252.html.plaintext.txt	195	although studies provide compelling evidence specific protein interactions mediate cftr retrieval cell surface yet provide indication process may regulated camppka
0.65036243.12777252.html.plaintext.txt	196	speculated possible mechanisms regulated cftr endocytosis see mechanisms regulated cftr trafficking perpetrator bystander fig
0.65036243.12777252.html.plaintext.txt	197	view larger version 30k fig
0.65036243.12777252.html.plaintext.txt	198	model molecular interactions regulating endocytosis cftr
0.65036243.12777252.html.plaintext.txt	199	cooh terminus phosphorylated asterisks cftr free bind adapter protein complex ap 2 limiting internalization
0.65036243.12777252.html.plaintext.txt	200	b phosphorylated ap 2 adapter see text associates plasma membrane cooh terminus dephosphorylated cftr
0.65036243.12777252.html.plaintext.txt	201	small blue bubbles indicate cftr site ap 2 binding
0.65036243.12777252.html.plaintext.txt	202	binding ap 2 plasma membrane initiates assembly clathrin lattice structure simplified 2 dimensional representation
0.65036243.12777252.html.plaintext.txt	203	c ap 2 bound cftr sequestered forming clathrin coated pit
0.65036243.12777252.html.plaintext.txt	204	d clathrin coated vesicle internalized coat adaptor proteins shed
0.65036243.12777252.html.plaintext.txt	205	functional studies exocytosis
0.65036243.12777252.html.plaintext.txt	206	13 cftr dependent endocytosis also examined cftr dependent exocytic recycling cell surface
0.65036243.12777252.html.plaintext.txt	207	monitor exocytosis plasma membranes pulse labeled biotinylated lectin wga removal bath cells allowed take lectin intracellular compartments
0.65036243.12777252.html.plaintext.txt	208	remaining cell surface wga blocked unlabeled avidin various times recycling internalized wga cell surface assayed using texas red labeled avidin
0.65036243.12777252.html.plaintext.txt	209	cells expressing wt cftr recycling exocytosis internalized marker increased approximately threefold forskolin whereas camp stimulation effect wga recycling either parental cfpac 1 cell line empty vector controls
0.65036243.12777252.html.plaintext.txt	210	importantly studies showed camp responsive recyclingexocytosis required cftr expression
0.65036243.12777252.html.plaintext.txt	211	similar findings obtained human airway cell lines 94 recyclingexocytosis monitored release previously internalized fitc dextran fluid phase marker endocytosis human airway cells
0.65036243.12777252.html.plaintext.txt	212	treatment cells expressing wt cftr camp analog elicited increased release fitc dextran accompanied increases membrane capacitance monitored whole cell patch clamp measurements
0.65036243.12777252.html.plaintext.txt	213	trafficking cftr dependent camp effect membrane capacitance recyclingexocytosis airway cells derived cf patient
0.65036243.12777252.html.plaintext.txt	214	investigators concluded camp stimulates exocytosis cftr cl conductance normal cf cells stimulating delivery cftr channels intracellular pool plasma membrane
0.65036243.12777252.html.plaintext.txt	215	much effort determine whether camp stimulates cftr dependent membrane trafficking employed measurements membrane capacitance cells express cftr endogenously cells cftr expression induced
0.65036243.12777252.html.plaintext.txt	216	studies summarized table 1 tabulates methods conditions experimental results studies
0.65036243.12777252.html.plaintext.txt	217	discussed diversity methods conditions used may contribute variable outcome
0.65036243.12777252.html.plaintext.txt	218	measurement stimulated capacitance cftr expressing tissue
0.65036243.12777252.html.plaintext.txt	219	previous work nonepithelial cell lines e
0.65036243.12777252.html.plaintext.txt	220	cho cells failed show cftr camp dependent membrane trafficking 29 47 suggesting machinery regulated cftr recycling may expressed epithelial cells
0.65036243.12777252.html.plaintext.txt	221	however studies xenopus oocytes generally shown good correlation camp stimulation cftr currents increases membrane capacitance 81 102 105
0.65036243.12777252.html.plaintext.txt	222	studies takahashi et al
0.65036243.12777252.html.plaintext.txt	223	102 apparent changes cell surface area stimulation determined membrane capacitance measurements confirmed using blinded measurements membrane morphometry stimulated nonstimulated cells
0.65036243.12777252.html.plaintext.txt	224	addition recruitment cftr cell surface demonstrated using epitope tagged m2 901cftr labeling nonpermeabilized cells 81
0.65036243.12777252.html.plaintext.txt	225	together findings consistent exocytic insertion cftr oocyte plasma membrane camp stimulation
0.65036243.12777252.html.plaintext.txt	226	cell surface immunofluorescence studies peters et al
0.65036243.12777252.html.plaintext.txt	227	81 suggested low level cftr expression plasma membrane nonstimulated oocytes
0.65036243.12777252.html.plaintext.txt	228	fluorescence levels near background absence stimulation
0.65036243.12777252.html.plaintext.txt	229	data suggested recruitment cftr cell surface significant component cftr current stimulation system
0.65036243.12777252.html.plaintext.txt	230	however conclusion assumes flag cftr labeling approach detect low levels cell surface cftr
0.65036243.12777252.html.plaintext.txt	231	although technically difficult would optimal determine dose response relation camp dependent cell surface cftr labeling independent parameter corresponding change membrane capacitance
0.65036243.12777252.html.plaintext.txt	232	possible example threshold level cftr residing plasma membrane cannot detected method underestimating levels cftr cell surface basal conditions
0.65036243.12777252.html.plaintext.txt	233	however concern compromise data obtained three different methods consistent stimulation dependent recruitment cftr surface cells
0.65036243.12777252.html.plaintext.txt	234	electrophysiological aspects studies confirmed work weber et al
0.65036243.12777252.html.plaintext.txt	235	105 used impedance analysis assess membrane conductance capacitance correlated changes parameters induced camp
0.65036243.12777252.html.plaintext.txt	236	agreement prior reports 81 102 camp stimulation cftr expressing oocytes evoked significant increases current capacitance observed noninjected f508 expressing cells
0.65036243.12777252.html.plaintext.txt	237	injection rp camp specific camp antagonist abolished effects camp stimulation current capacitance
0.65036243.12777252.html.plaintext.txt	238	interestingly less specific pka inhibitors kt5720 h8 prolonged overnight exposure primarily blocked capacitance increases evoked camp less effect corresponding current activation
0.65036243.12777252.html.plaintext.txt	239	however reagents shown alter cytoskeletal properties
0.65036243.12777252.html.plaintext.txt	240	example kt5720 induces microtubule rearrangement inhibition mitogen activated protein kinase 76 h8 shown alter cytoskeletal protein phosphorylation inhibition pkc 63
0.65036243.12777252.html.plaintext.txt	241	would interesting explore actions less selective kinase inhibitors produce cytoskeletal disruption may account inhibitory effects membrane trafficking
0.65036243.12777252.html.plaintext.txt	242	106 showed microtubule disruption markedly inhibits current capacitance increases evoked camp cftr expressing oocytes similar conclusions reached cftr expressing epithelial cells 103
0.65036243.12777252.html.plaintext.txt	243	although two groups independently demonstrated camp dependent changes membrane capacitance parameters indicative regulated cftr trafficking xenopus oocytes using different analytic methods liu et al
0.65036243.12777252.html.plaintext.txt	244	57 arrived different conclusion
0.65036243.12777252.html.plaintext.txt	245	employed cftr construct containing cysteine substitution postulated cftr conduction pathway arrive conclusion essentially conductance activation camp oocytes due cftr channels already present plasma membrane
0.65036243.12777252.html.plaintext.txt	246	approach relied changes conductance induced treatment cftr mutant cysteine reactive methanethiosulfonate mts reagents whose effects attributed altered charge shielding properties cftr conduction pathway
0.65036243.12777252.html.plaintext.txt	247	oocytes treated briefly 2 trimethylammoniumethyl methanethiosulfonate mtset positively charged modifier little 20 camp activation activated channels behaved properties already modified
0.65036243.12777252.html.plaintext.txt	248	mtset demonstrated systems cell impermeant data suggest modified channels must already present cell surface
0.65036243.12777252.html.plaintext.txt	249	findings consistent lack regulated cftr redistribution oocytes need negate results prior studies two reasons
0.65036243.12777252.html.plaintext.txt	250	first study used cftr expression levels based conductance 5 10 times higher prior work capacitance measurements made
0.65036243.12777252.html.plaintext.txt	251	discussed earlier article overexpression cftr saturate pathways available regulated trafficking
0.65036243.12777252.html.plaintext.txt	252	consistent idea takahashi et al
0.65036243.12777252.html.plaintext.txt	253	102 observed increasing cftr expression levels increased cftr currents corresponding capacitance changes plateaued regulated trafficking pathways saturated
0.65036243.12777252.html.plaintext.txt	254	constitutive delivery cftr plasma membrane high expression levels would limit ones ability detect population trafficking channels
0.65036243.12777252.html.plaintext.txt	255	57 measure membrane capacitance cell surface cftr measure cftr trafficking
0.65036243.12777252.html.plaintext.txt	256	nevertheless facile explanation differences carefully performed studies cited
0.65036243.12777252.html.plaintext.txt	257	determined using mts cftr modification together capacitance measurements surface cftr labeling whether high cftr expression levels would account results
0.65036243.12777252.html.plaintext.txt	258	two recent studies performed mammalian epithelial cells endogenously express cftr reported negative findings respect changes membrane capacitance camp stimulation
0.65036243.12777252.html.plaintext.txt	259	independent assay studies also employed fm 1 43 dye labeling attempt monitor membrane addition plasma membrane would result exocytosis stimulated camp
0.65036243.12777252.html.plaintext.txt	260	21 membrane capacitance measured calu 3 airway cells imposing alternating sinusoidal square voltage waveforms monitoring resulting currents assess membrane capacitance conductance
0.65036243.12777252.html.plaintext.txt	261	calculated capacitance changes induced camp insignificant
0.65036243.12777252.html.plaintext.txt	262	addition found increase steady state plasma membrane labeling fm 1 43 cells stimulated camp fluorescence measurements
0.65036243.12777252.html.plaintext.txt	263	enhanced dye labeling fluorescence intensity would expected additional membrane exposed cell surface result exocytosis
0.65036243.12777252.html.plaintext.txt	264	thus authors concluded camp stimulate cftr currents increasing cftr trafficking plasma membrane stimulates membrane resident cftr channels calu 3 cells
0.65036243.12777252.html.plaintext.txt	265	similar study chang et al
0.65036243.12777252.html.plaintext.txt	266	20 used sinusoidal voltage current phase lag analysis estimate cell capacitance fluorescence measurements fm 1 43 membrane dye labeling colonic ht29 cl
0.65036243.12777252.html.plaintext.txt	267	19a airway 14hbeo cells express cftr endogenously
0.65036243.12777252.html.plaintext.txt	268	outcome airway cell line similar study chen et al
0.65036243.12777252.html.plaintext.txt	269	detectable camp induced changes membrane capacitance fm dye labeling
0.65036243.12777252.html.plaintext.txt	270	ht29 cells increases membrane capacitance camp stimulation occurred endocytosis blocked use dynamin antibody
0.65036243.12777252.html.plaintext.txt	271	authors indicated absence change without dynamin inhibition may result parallel increases exocytosis endocytosis stimulation
0.65036243.12777252.html.plaintext.txt	272	net increase membrane area
0.65036243.12777252.html.plaintext.txt	273	20 despite sophisticated methodologies employed two significant shortcomings preclude definitive conclusions regarding regulated cftr trafficking systems
0.65036243.12777252.html.plaintext.txt	274	first studies performed room temperature condition known impair regulated membrane traffic variety systems
0.65036243.12777252.html.plaintext.txt	275	example release amylase pancreatic exocrine cells decreased 70 25 degrees c compared normal temperature
0.65036243.12777252.html.plaintext.txt	276	release insulin rat pancreatic islets markedly inhibited 25 degrees c 90 reduction membrane capacitance response stimulation q10 11
0.65036243.12777252.html.plaintext.txt	277	addition camp regulated aqp 2 recycling renal cells blocked 20 degrees c 38
0.65036243.12777252.html.plaintext.txt	278	indeed recent data collected laboratory 45 indicate studies performed 37 degrees c calu 3 cells using either sinusoidal waveform analysis current transient analysis show 1 pf increase membrane capacitance basal membrane capacitance averages 20 pf response camp stimulation parallels increase membrane conductance
0.65036243.12777252.html.plaintext.txt	279	identical recordings made room temperature 5 10 mm egta pipette solution conditions chen chang studies camp elicited significant increase membrane capacitance
0.65036243.12777252.html.plaintext.txt	280	interesting early recordings capacitance changes airway cells 94 showed camp dependent increases 23 degrees c table 1 however experiments employed low egta concentrations ca buffering normal resting levels recording pipette
0.65036243.12777252.html.plaintext.txt	281	thus recording conditions consistent
0.65036243.12777252.html.plaintext.txt	282	assays fm dye labeling also performed room temperature conducted using protocol insensitive small increases membrane area
0.65036243.12777252.html.plaintext.txt	283	cells labeled steady state intensity fm dye fluorescence intensity monitored camp stimulation
0.65036243.12777252.html.plaintext.txt	284	however increase plasma membrane area induced camp 3 basal membrane area suggested capacitance measurements 37 degrees c ref
0.65036243.12777252.html.plaintext.txt	285	46 signal would detected steady state dye labeling
0.65036243.12777252.html.plaintext.txt	286	rather subsequent stimulation necessary wash dye agonist membrane minimize plasma membrane background staining
0.65036243.12777252.html.plaintext.txt	287	permits visualization dye retrieved subsequent endocytosis labeled plasma membrane assuming cell recovers original area following reversal stimulation
0.65036243.12777252.html.plaintext.txt	288	recent studies laboratory performed 37 degrees c demonstrated measurements performed manner indicate fm 1 43 labeling increased camp stimulation calu 3 45
0.65036243.12777252.html.plaintext.txt	289	protocol used studies chen et al
0.65036243.12777252.html.plaintext.txt	290	20 similar methods employed monitor secretory granule release systems incorporate large amounts membrane cell surface stimulation e
0.65036243.12777252.html.plaintext.txt	291	pancreatic acinar cells generally response stimulation cellular calcium rise 36
0.65036243.12777252.html.plaintext.txt	292	systems addition membrane increase fm dye signal steady state easily demonstrated ht29 16e cells stimulation mucin secretion ca dependent agonists bertrand ca laboisse c hopfer u bridges rj frizzell ra unpublished observations
0.65036243.12777252.html.plaintext.txt	293	estimates numbers cftr channels intracellular vesicles obtained using data derived calu 3 cell oocyte measurements provided appendix
0.65036243.12777252.html.plaintext.txt	294	important assumptions calculations include single channel parameters assumed vesicle radius 100 nm
0.65036243.12777252.html.plaintext.txt	295	calculations based reported values membrane current capacitance changes patch clamp studies camp stimulated cells 46 102
0.65036243.12777252.html.plaintext.txt	296	calculations assumptions yield estimates 1 10 channels per vesicle systems likely provide one order magnitude estimate channel density
0.65036243.12777252.html.plaintext.txt	297	mean oocyte current capacitance changes reported weber et al
0.65036243.12777252.html.plaintext.txt	298	105 approximately fourfold smaller takahashi study 102 calculated outcome would unaffected
0.65036243.12777252.html.plaintext.txt	299	110 estimated number na dependent glucose transporters per oocyte vesicle 10 20 based freeze fracture scanning electron microscopy
0.65036243.12777252.html.plaintext.txt	300	size imaged oocyte vesicles 100 120 nm
0.65036243.12777252.html.plaintext.txt	301	value 1 10 cftrs per vesicle instructive considering whether one able visualize vesicular gfp cftr light microscopic methods
0.65036243.12777252.html.plaintext.txt	302	discussed earlier article sensitivity gfp detection 79 together considerations suggests cftr density single transport vesicle near limit detection
0.65036243.12777252.html.plaintext.txt	303	worth emphasizing source cftr current generation whether membrane resident inserted channels need black white issue
0.65036243.12777252.html.plaintext.txt	304	systems plasma membrane cftr currents likely arise stimulation membrane resident channels acutely trafficked cftr channels proportions may differ among cell types experimental conditions see consequences regulated cftr trafficking
0.65036243.12777252.html.plaintext.txt	305	data studies regulated trafficking glut 4 aqp 2 indicate undergo recycling even basal conditions 15 17
0.65036243.12777252.html.plaintext.txt	306	stimulation rate coefficients steps involved recycling proteins altered changing distribution increase number transporters andor channels plasma membrane
0.65036243.12777252.html.plaintext.txt	307	presumably regulated cftr recycling behaves similarly
0.65036243.12777252.html.plaintext.txt	308	appears true cftr cellular background support regulated glut 4 aqp 2 trafficking important
0.65036243.12777252.html.plaintext.txt	309	thus expression glut 4 nonmuscle nonadipose derived cells eliminates insulin regulated redistribution glut 4 40 44
0.65036243.12777252.html.plaintext.txt	310	similarly aqp 2 endogenous expression vas deferens results constitutive apical membrane localization channel found camppka regulated internal compartment renal epithelia effect stimulation apical channel density 99
0.65036243.12777252.html.plaintext.txt	311	requirement proper cellular context likely also characterize regulated trafficking cftr
0.65036243.12777252.html.plaintext.txt	312	aqp 2 data suggest differences exist epithelial nonepithelial cells also epithelial systems
0.65036243.12777252.html.plaintext.txt	313	conclusion underscores need determine cellular components provide proper context
0.65036243.12777252.html.plaintext.txt	314	mechanisms regulated cftr trafficking perpetrator bystander top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	315	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	316	summary appendix references studies discussed provide mechanistic basis cftr dependent proteins regulatory events involved control cftr distribution apical membrane
0.65036243.12777252.html.plaintext.txt	317	positive reports regulated cftr trafficking increased exocytosis decreased endocytosis increased endosome fusion indicated events require expression cftr stimulation camppka
0.65036243.12777252.html.plaintext.txt	318	addition exception xenopus oocytes processes appear epithelial cell specific
0.65036243.12777252.html.plaintext.txt	319	view relatively recent discovery extensive interactions cftr proteins speculation regarding possible molecular mechanisms governing least trafficking reactions seems warranted
0.65036243.12777252.html.plaintext.txt	320	although firm conclusions cannot drawn stage principal value models propose suggest testable hypotheses may lead understanding mechanism
0.65036243.12777252.html.plaintext.txt	321	moreover contention importance regulated cftr trafficking anion secretion continue generate controversy mechanistic basis understood extent manipulated experimentally e
0.65036243.12777252.html.plaintext.txt	322	manner identification adapter protein interactions cftr provided mechanistic basis cftr endocytosis
0.65036243.12777252.html.plaintext.txt	323	physical interaction cftr cooh terminus micro2 subunit ap 2 adapter complex indicated results recent studies 108 suggests model like shown fig
0.65036243.12777252.html.plaintext.txt	324	2 pka mediated regulation endocytosis
0.65036243.12777252.html.plaintext.txt	325	scheme based observations concerning inherently rapid rate cftr dependent endocytosis inhibitory effect camp process 13 14 61 85
0.65036243.12777252.html.plaintext.txt	326	assumes cftr normally endocytosed rapid rate interaction ap 2 adapter complex ydsi motif cooh terminus
0.65036243.12777252.html.plaintext.txt	327	recent data indicate interaction requires also phosphorylation micro2 subunit facilitates ap 2 interactions membrane lipids 25
0.65036243.12777252.html.plaintext.txt	328	2 implies pka mediated inhibition cftr endocytosis may result occlusion obstruction adapter protein binding site cooh terminus cftr phosphorylation event
0.65036243.12777252.html.plaintext.txt	329	example could result yet unidentified physical interaction phosphorylated r domain cooh terminal tail adapters bind could mediated another interacting protein whose association cooh terminus proportional cftr phosphorylation
0.65036243.12777252.html.plaintext.txt	330	key feature model relies phosphorylation dependent accessibility cooh terminus site adapter protein binding
0.65036243.12777252.html.plaintext.txt	331	second possibility yxx motif altered phosphorylation
0.65036243.12777252.html.plaintext.txt	332	species cftrs sequence described ydsi motif highly conserved 108
0.65036243.12777252.html.plaintext.txt	333	although conform canonical pka consensus sequence possible y2 serine phosphorylated pka another kinase acts disrupt adapter binding motif
0.65036243.12777252.html.plaintext.txt	334	possibility amp kinase implicated binding region cftr 39 involved phosphorylation ydsi internalization motif requires evaluation
0.65036243.12777252.html.plaintext.txt	335	however function kinase presumably downregulate cftr metabolic stress would expected promote inhibit cftr retrieval
0.65036243.12777252.html.plaintext.txt	336	nevertheless phosphorylation event near site could reduce endocytic rate cftr parallel activation channel gating
0.65036243.12777252.html.plaintext.txt	337	remains determined whether mechanism account finding made epithelial nonepithelial systems 13 14 85 94 pka phosphorylation inhibits cftr endocytosis leading retention channel cell surface
0.65036243.12777252.html.plaintext.txt	338	determines ability cftr enter regulated opposed constitutive fig
0.65036243.12777252.html.plaintext.txt	339	1 secretory pathway progression cell surface xenopus oocytes redistribution cftr intracellular plasma membrane compartments demonstrable immunofluorescence measurements discussed
0.65036243.12777252.html.plaintext.txt	340	data interpreted suggest cftr stabilized kinetically intracellular compartment nonstimulated conditions
0.65036243.12777252.html.plaintext.txt	341	therefore reasonable ask structural features cftr provides entry regulated secretory pathway basal conditions
0.65036243.12777252.html.plaintext.txt	342	cftr carries regulatory domain phosphorylation domain stimulates channel gating trafficking
0.65036243.12777252.html.plaintext.txt	343	therefore logical ask whether r domain responsible entry cftr regulated pathway
0.65036243.12777252.html.plaintext.txt	344	purpose cftr lacking r domain expressed two injected rnas corresponding cftr half molecule n tm1 nbd1 tm2 nbd2 c 56
0.65036243.12777252.html.plaintext.txt	345	oocytes expressing constructs showed spontaneous currents quantitatively similar stimulated currents cells expressing wt cftr augmented camp stimulation
0.65036243.12777252.html.plaintext.txt	346	addition change membrane capacitance stimulation indicating regulated cftr trafficking required r domain
0.65036243.12777252.html.plaintext.txt	347	direct targeting r cftr plasma membrane cells consistent concept nonphosphorylated r domain may allow cftr access regulated intracellular compartment cftr within compartment redistributed plasma membrane r domain phosphorylated
0.65036243.12777252.html.plaintext.txt	348	therefore reasonable ask following mediators process protein interactions involving r domain govern movement cftr regulated trafficking pathway
0.65036243.12777252.html.plaintext.txt	349	although questions cannot answered certainty present relatively recent discovery kirk colleagues 72 73 cftr interacts physically functionally syntaxin 1a s1a suggests soluble n ethylmaleimide sensitive factor attachment protein receptor snare proteins candidates participation regulated trafficking process
0.65036243.12777252.html.plaintext.txt	350	interaction s1a nh2 terminus cftr 73 81 inhibition cftr currents s1a overexpression 72 interpreted consequence direct interaction s1a cftr reduces open probability 20
0.65036243.12777252.html.plaintext.txt	351	however addition peters et al
0.65036243.12777252.html.plaintext.txt	352	81 showed s1a overexpression decreased density cftr channels plasma membrane
0.65036243.12777252.html.plaintext.txt	353	concluded disruption snare complex formation overexpressed s1a interfered cftr trafficking presumably exocytosis
0.65036243.12777252.html.plaintext.txt	354	regards functional involvement syntaxin cftr reason discount one mechanism favor syntaxin may regulate cftr gating also function component machinery brings cftr plasma membrane may act regulator process
0.65036243.12777252.html.plaintext.txt	355	might snare proteins involved regulated cftr exocytosis pose answer question recount several observations
0.65036243.12777252.html.plaintext.txt	356	first kirk laboratory shown nh2 terminus cftr s1a binds also interacts proximal portion r domain protein binding studies 71
0.65036243.12777252.html.plaintext.txt	357	series basic amino acid residues nh2 terminus thought mediate association
0.65036243.12777252.html.plaintext.txt	358	mutation residues altered magnitude kinetics cftr current stimulation oocytes decreased open probability single cftr channels 34 perhaps interfering nh2 terminus r domain interactions influence cftr gating
0.65036243.12777252.html.plaintext.txt	359	nh2 terminus also site s1a binding 73
0.65036243.12777252.html.plaintext.txt	360	thus possible nh2 terminus r domain interactions influence association cftr s1a affects ability s1a interact proteins necessary cftr trafficking
0.65036243.12777252.html.plaintext.txt	361	relation another possible scenario recently reported physical functional interactions another synaptic terminal protein cysteine string protein csp cftr 115
0.65036243.12777252.html.plaintext.txt	362	csp resident synaptic vesicles knockout interferes regulated neurotransmitter release 116 s1a knockout 111
0.65036243.12777252.html.plaintext.txt	363	protein binding studies csp interacted cftr nh2 terminus r domain
0.65036243.12777252.html.plaintext.txt	364	seems likely interactions s1a csp nh2 terminus additional interactions nh2 terminus csp r domain may provide means linking proteins involved regulated membrane trafficking regulatory phosphorylation status r domain similar general concept proposal regulated cftr endocytosis
0.65036243.12777252.html.plaintext.txt	365	according model shown fig
0.65036243.12777252.html.plaintext.txt	366	3 phosphorylation r domain would alter protein interactions manner would lead snare protein associations appropriate fusion cftr containing vesicles plasma membrane
0.65036243.12777252.html.plaintext.txt	367	also interest csp bind several snare proteins including s1a syntaxin 4 vesicle associated membrane protein 2 vamp 2 csp proposed modulator snare protein interactions 19
0.65036243.12777252.html.plaintext.txt	368	according concept nh2 terminus r domain interactions within cftr alter single channel properties may also couple phosphorylation dependent activation cftr channel gating proteins regulate cftr trafficking
0.65036243.12777252.html.plaintext.txt	369	possible protein csp ability interact snare proteins one hand nh2 terminus r domain cftr provides transduction mechanism coupling cftr channel activation channel trafficking mediated snare machinery
0.65036243.12777252.html.plaintext.txt	370	view larger version 28k fig
0.65036243.12777252.html.plaintext.txt	371	model molecular interactions regulating exocytosis activation cftr
0.65036243.12777252.html.plaintext.txt	372	basal conditions cftr distributed apical plasma membrane subapical vesicles derived recycling endosome
0.65036243.12777252.html.plaintext.txt	373	nh2 terminus cftr binds syntaxin 1a tethers vesicles close plasma membrane
0.65036243.12777252.html.plaintext.txt	374	cysteine string protein csp localized cftr containing vesicles apical membrane domain binds r domain
0.65036243.12777252.html.plaintext.txt	375	blue bubbles indicate cftr site syntaxin binding interaction regions proteins depicted small boxes
0.65036243.12777252.html.plaintext.txt	376	b stimulation camp activates pka phosphorylating asterisks r domain csp
0.65036243.12777252.html.plaintext.txt	377	r domain phosphorylation may disrupt binding syntaxin nh2 terminus also interacts r domain see text
0.65036243.12777252.html.plaintext.txt	378	csp r domain interactions may also altered phosphorylation csp may act chaperone snare protein interactions involving syntaxin 1a free bind vesicle associated membrane protein vamp members snare complex shown
0.65036243.12777252.html.plaintext.txt	379	cftr plasma membrane active gating syntaxin sensitive
0.65036243.12777252.html.plaintext.txt	380	c snare complex facilitates fusion cftr vesicle plasma membrane inserting active cftr channels d increasing cftr channel density
0.65036243.12777252.html.plaintext.txt	381	consequences regulated cftr trafficking top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	382	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	383	summary appendix references cftr channel density
0.65036243.12777252.html.plaintext.txt	384	obvious consequence regulated cftr insertionretrieval processes distribution cftr intracellular compartments apical plasma membrane vary agonist stimulation
0.65036243.12777252.html.plaintext.txt	385	analogy process examples transporters whose overall plasma membrane activity modulated trafficking vasopressin stimulated aqp 2 water channel insulin dependent glut 4 transporter cited throughout article
0.65036243.12777252.html.plaintext.txt	386	cftr doubt gating channel regulated phosphorylation channel already present plasma membrane
0.65036243.12777252.html.plaintext.txt	387	trafficking cftr also regulated control insertionretrieval common mechanism regulation transporters slow activation kinetics
0.65036243.12777252.html.plaintext.txt	388	control channel number would provide amplification secretory response agonist preserving option sequester cftr within compartment cannot affect plasma membrane cl conductance
0.65036243.12777252.html.plaintext.txt	389	high intracellular salt levels deleterious cells whose intracellular ionic composition volume must closely regulated 30
0.65036243.12777252.html.plaintext.txt	390	addition contribution trafficking events anion secretion may vary differentiation status epithelium 6 37
0.65036243.12777252.html.plaintext.txt	391	found example cftr epithelial cells find way plasma membrane tight junctions formed cells polarize 68
0.65036243.12777252.html.plaintext.txt	392	epithelium developing cells may utilize regulated trafficking means fine tune apical cl conductance expression levels transporters metabolic regulatory components overall secretory absorptive ion movements depend expressed appropriate levels
0.65036243.12777252.html.plaintext.txt	393	stage mature cell may find reasonable better anchor cftr plasma membrane virtue pdz domain 69 97 interactions shift balance channel distribution favor plasma membrane
0.65036243.12777252.html.plaintext.txt	394	yet even well differentiated native epithelia significant cftr trafficking signals demonstrated see regulated cftr traffic
0.65036243.12777252.html.plaintext.txt	395	know mechanistic viewpoint protein interactions mediate cftr trafficking events able determine balance achieved may perturbed counter effects disease
0.65036243.12777252.html.plaintext.txt	396	disease related mutations influence cftr trafficking distal compartments protein secretory pathway identified
0.65036243.12777252.html.plaintext.txt	397	probably true mutations proteins control general trafficking pathways would negative selective advantage may lethal however cftr mutations influence trafficking described
0.65036243.12777252.html.plaintext.txt	398	several reports indicated half life f508 cftr plasma membrane perhaps post golgi compartments markedly reduced relative wt cftr
0.65036243.12777252.html.plaintext.txt	399	using functional measurements cftr activity cho cells lukacs et al
0.65036243.12777252.html.plaintext.txt	400	59 found plasma membrane currents associated f508 cftr recruited cell surface low temperature decayed half time 4 h whereas functional half life wt cftr currents 24 h
0.65036243.12777252.html.plaintext.txt	401	41 measured half life f508 vs
0.65036243.12777252.html.plaintext.txt	402	wt cftr plasma membrane llc pk1 cells using cell surface biotinylation streptavidin mediated isolation immunoblot analysis
0.65036243.12777252.html.plaintext.txt	403	mutant cftr brought cell surface use combination low temperature butyrate preincubation
0.65036243.12777252.html.plaintext.txt	404	found half life plasma membrane f508 cftr 4 h whereas corresponding half life wt cftr exceeded 48 h cells
0.65036243.12777252.html.plaintext.txt	405	camp dependent iodide efflux correlated cftr expression cell surface
0.65036243.12777252.html.plaintext.txt	406	authors concluded f508 cftr rapidly internalized perhaps targeted degradation pathway
0.65036243.12777252.html.plaintext.txt	407	parallel study sharma et al
0.65036243.12777252.html.plaintext.txt	408	95 reached similar conclusion
0.65036243.12777252.html.plaintext.txt	409	mutant cftr encouraged escape er use combination reduced temperature chemical chaperone glycerol treatment
0.65036243.12777252.html.plaintext.txt	410	observed also rapid degradation rate f508 cftr attribute decreased conformational stability protein susceptible aggregation protease digestion
0.65036243.12777252.html.plaintext.txt	411	authors favor concept folding defects cftr mutant persist mature post golgi protein studies agree lacks normal channel gating kinetics open probability c
0.65036243.12777252.html.plaintext.txt	412	92 leads rapid degradation perhaps ubiquitin proteasome pathways
0.65036243.12777252.html.plaintext.txt	413	also possible view model regulated cftr endocytosis illustrated fig
0.65036243.12777252.html.plaintext.txt	414	2 rapid degradation f508 cftr reflects rapid endocytic rate 41 95 increasing exposure degradation mechanisms
0.65036243.12777252.html.plaintext.txt	415	evident findings altered stability mutant cftr distal trafficking pathways require attention rescue f508 cftr er degradation pathways achievable therapeutic target cf disease
0.65036243.12777252.html.plaintext.txt	416	another interesting disease mutation influences distal pathway cftr trafficking identified silvis et al
0.65036243.12777252.html.plaintext.txt	417	investigators searched mutation database disease mutations may lead increased cftr endocytosis creation endocytic motif
0.65036243.12777252.html.plaintext.txt	418	n287y mutant resides second intracellular loop cftr results mild disease expressed combination f508 cftr
0.65036243.12777252.html.plaintext.txt	419	mutant exhibit folding defect n287y wt cftrs showed similar maturation kinetics
0.65036243.12777252.html.plaintext.txt	420	however roughly 50 mutant plasma membrane steady state relative wt cftr
0.65036243.12777252.html.plaintext.txt	421	increased colocalization mutant endocytic marker eea1 suggested mutation alters distribution cftr plasma membrane intracellular compartments
0.65036243.12777252.html.plaintext.txt	422	cl transport reduced proportion altered cell surface cftr single channel properties n287y similar wt cftr
0.65036243.12777252.html.plaintext.txt	423	biotinylation experiments showed n287y cftr internalized approximately twice fast wt cftr expected alter distribution plasma membrane intracellular compartments
0.65036243.12777252.html.plaintext.txt	424	findings provide evidence disease mutations primary defect lies altered kinetics cftr recycling plasma membrane resulting subnormal apical membrane cftr levels
0.65036243.12777252.html.plaintext.txt	425	intracellular cftr channel function
0.65036243.12777252.html.plaintext.txt	426	second consequence regulated cftr trafficking intracellular cftr distribution may vary secretory status epithelium
0.65036243.12777252.html.plaintext.txt	427	despite indications intracellular cftr channels activated camppka 9 77 model barasch et al
0.65036243.12777252.html.plaintext.txt	428	5 suggesting vesicular cftr activity alters internal compartment ph cellular glycoprotein processing bacterial colonization supported subsequent studies 32 35 60 83
0.65036243.12777252.html.plaintext.txt	429	nevertheless fundamental need resolving causes increased bacterial adherence cf cells glycoprotein secretory products preferential binding p
0.65036243.12777252.html.plaintext.txt	430	aeruginosa undersialylated cf mucins 16 31 48 53 91 113
0.65036243.12777252.html.plaintext.txt	431	findings argue deletion cftr distal secretory pathway influences epithelial cell surface chemistry
0.65036243.12777252.html.plaintext.txt	432	properties cf cells secretions could affected cftr dependent membrane trafficking events intracellular compartments well plasma membrane domain
0.65036243.12777252.html.plaintext.txt	433	8 demonstrated cftr promotes endosome endosome fusion plasma membrane cftr redistribution required cftr expression camp stimulation
0.65036243.12777252.html.plaintext.txt	434	presence cftr internal membranes alters patterns posttranslational glycoprotein modification changing compartmentation enzymes substrates involved processes 78 surface chemistry cf cells may affected
0.65036243.12777252.html.plaintext.txt	435	issue related discussion concerns role cftr epithelial tissue protein secretory activity largely suggested data mcpherson colleagues 65 67 examined mucin amylase secretion salivary glands control cf patients
0.65036243.12777252.html.plaintext.txt	436	metabolic incorporation isotopic label carbohydrate residues mucins used quantitate secretory rates
0.65036243.12777252.html.plaintext.txt	437	results showed adrenergic stimulation mucin amylase secretion reduced 60 submandibular salivary glands derived cf subjects
0.65036243.12777252.html.plaintext.txt	438	extensive series studies showed alterations signal transduction mechanisms responsible difference mucin content control cf glands similar
0.65036243.12777252.html.plaintext.txt	439	recently similar results obtained using salivary glands cftr knockout mice 67
0.65036243.12777252.html.plaintext.txt	440	camp dependent secretory component secretion impaired
0.65036243.12777252.html.plaintext.txt	441	66 performed experiments type several human airway cell lines
0.65036243.12777252.html.plaintext.txt	442	demonstrated independent regulation 14c labeled glycoconjugate secretion pka pkc pathways
0.65036243.12777252.html.plaintext.txt	443	pka agonist isoproterenol increased mucin release 40 control cells effect virtually eliminated reduced 3 stimulation cells derived cf subjects
0.65036243.12777252.html.plaintext.txt	444	difference pkc mediated secretion control cf cell lines detected similar observations bradbury et al
0.65036243.12777252.html.plaintext.txt	445	13 camp regulated membrane trafficking t84 cells
0.65036243.12777252.html.plaintext.txt	446	moreover attenuated pka response cf airway cells could restored adenovirus mediated cftr expression
0.65036243.12777252.html.plaintext.txt	447	results suggest cftr play important role camp mediated glycoconjugate secretion
0.65036243.12777252.html.plaintext.txt	448	although explicitly implicating cftr mucin release studies kuver et al
0.65036243.12777252.html.plaintext.txt	449	54 demonstrated camp dependent regulation protein mucin secretion cftr expressing canine gallbladder epithelial cells
0.65036243.12777252.html.plaintext.txt	450	cftr detected immunostaining mucin granule membranes
0.65036243.12777252.html.plaintext.txt	451	studies may implications epithelial protein secretion yilla et al
0.65036243.12777252.html.plaintext.txt	452	112 examined influence vacuolar h atpase inhibition constitutive protein secretory pathway hepg2 cells
0.65036243.12777252.html.plaintext.txt	453	although treatment concanamycin b influence er golgi transit kinetics protein traffic golgi plasma membrane significantly impaired
0.65036243.12777252.html.plaintext.txt	454	secretion albumin 1 antitrypsin transferrin delayed processing n linked glycans sialyltransferases inhibited resulting secretion less extensively modified glycoproteins
0.65036243.12777252.html.plaintext.txt	455	study implicates intracellular compartment acidification sialylation n linked glycan modification secreted glycoproteins rate protein secretion
0.65036243.12777252.html.plaintext.txt	456	related study jilling kirk 50 demonstrated camp increased secretion several proteins including 1 antitrypsin apical basolateral compartment t84 cells
0.65036243.12777252.html.plaintext.txt	457	effect cl dependent resulted also increase protein sialylation
0.65036243.12777252.html.plaintext.txt	458	involvement cftr regulated exocytosis could underlie differences protein secretion observed studies cells andor tissues derived normal cf patients cf knockout mice
0.65036243.12777252.html.plaintext.txt	459	understand reasons ability cftr alter membrane traffic may become apparent underlying mechanisms involved progression cftr different compartments certain features common
0.65036243.12777252.html.plaintext.txt	460	critical question regard concerns exit cftr protein er
0.65036243.12777252.html.plaintext.txt	461	reasons thinking along lines include common features controlling vesicle transit along compartments secretory pathway e
0.65036243.12777252.html.plaintext.txt	462	combination snare coat protein associations often involve interactions cargo conveyed 3
0.65036243.12777252.html.plaintext.txt	463	recent findings regarding csp interactions cftr 115 also may provide example common trafficking events may occur early later components protein secretory pathway
0.65036243.12777252.html.plaintext.txt	464	csp regulates exocytosis neurosecretory cells implications similar role cftr exocytosis discussed
0.65036243.12777252.html.plaintext.txt	465	addition csp plays role cftr maturation er
0.65036243.12777252.html.plaintext.txt	466	csp antibodies co precipitate large proportion band b cftr localize csp protein er addition presence apical domain
0.65036243.12777252.html.plaintext.txt	467	major influence csp overexpression disruption biogenesis mature cftr band c
0.65036243.12777252.html.plaintext.txt	468	csp hsc70 binding protein also binds cftr likely csp serves cftr co chaperone
0.65036243.12777252.html.plaintext.txt	469	csp overexpression may decrease cftr biogenesis prolonging association hsc70 lead cftr degradation 88
0.65036243.12777252.html.plaintext.txt	470	much work needs done determine role csp cftr maturation interesting speculate steps involved egress nascent cftr er regulated compartment distal secretory pathway plasma membrane may involve similar protein interactions
0.65036243.12777252.html.plaintext.txt	471	therefore identifying mechanisms underlying stage specific cftr trafficking events may also shed light traffic occurring compartments cell
0.65036243.12777252.html.plaintext.txt	472	summary top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	473	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	474	summary appendix references active field study discussion leaves several issues unresolved
0.65036243.12777252.html.plaintext.txt	475	balance good evidence epithelial cells exhibit regulated cftr trafficking mechanism increase density cftr channels cell surface
0.65036243.12777252.html.plaintext.txt	476	process may contribute camp dependent secretion proteins contained within trafficking compartment
0.65036243.12777252.html.plaintext.txt	477	results show lack regulated cftr trafficking may attributable use overexpression systems nonphysiological experimental conditions
0.65036243.12777252.html.plaintext.txt	478	yet findings cannot similarly rationalized may reflect need expression right set interacting proteins perhaps yet unidentified
0.65036243.12777252.html.plaintext.txt	479	finding disease mutations influence cftr trafficking events distal protein secretory pathway thereby contribute cf phenotype supports concept regulated cftr recycling important normal epithelial function
0.65036243.12777252.html.plaintext.txt	480	era cftr interactions proteins particularly recognized traffic regulatory components beginning shed light potential mechanism regulated cftr trafficking
0.65036243.12777252.html.plaintext.txt	481	suggest testable hypotheses figs
0.65036243.12777252.html.plaintext.txt	482	2 3 regarding manner cftr phosphorylation may alter protein interactions thereby affect distribution cftr apical membrane intracellular compartments
0.65036243.12777252.html.plaintext.txt	483	yet likely controversy regarding significance process continue identify specific components cftr dependent trafficking machinery permitting expression activity modulated experimentally polarized epithelial cells ultimately organism
0.65036243.12777252.html.plaintext.txt	484	appendix top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	485	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	486	summary appendix references calculated cftr channel density transport vesicles reported 46 102 changes whole cell current capacitance cftr stimulation camp shown
0.65036243.12777252.html.plaintext.txt	487	common values cftr single channel parameters used estimate channel number
0.65036243.12777252.html.plaintext.txt	488	relationship among membrane current capacitance increase numbers active cftr channels fused vesicles
0.65036243.12777252.html.plaintext.txt	489	pertinent equations number active cftr channels nc fused vesicles nv
0.65036243.12777252.html.plaintext.txt	490	im measured membrane current calu 3 cell 500 pa xenopus oocyte 4 microa po open probability cftr channel 0
0.65036243.12777252.html.plaintext.txt	491	4 conductance cftr channel 8 ps v vm vr membrane potential minus reversal potential 20 mv1
0.65036243.12777252.html.plaintext.txt	492	cm measured increase membrane capacitance calu 3 cell 0
0.65036243.12777252.html.plaintext.txt	493	9 pf xenopus oocyte 80 nf cs specific capacitance biological membrane 1 microfcm2 rg radius spherical vesicle 100 nm
0.65036243.12777252.html.plaintext.txt	494	channel density calu 3 vesicle 7800716 11 channelsvesicle
0.65036243.12777252.html.plaintext.txt	495	channel density oocyte vesicle 1 channelvesicle
0.65036243.12777252.html.plaintext.txt	496	acknowledgments thank neil
0.65036243.12777252.html.plaintext.txt	497	bradbury comments manuscript janet zambotti assistance preparation
0.65036243.12777252.html.plaintext.txt	498	work authors laboratories supported national institute diabetes digestive kidney diseases grants dk 54814 dk 56490 cystic fibrosis foundation
0.65036243.12777252.html.plaintext.txt	499	footnotes address reprint requests correspondence r
0.65036243.12777252.html.plaintext.txt	500	cell biology physiology univ
0.65036243.12777252.html.plaintext.txt	501	pittsburgh school medicine s362 bst 3500 terrace st
0.65036243.12777252.html.plaintext.txt	502	pittsburgh pa 15261 e mail frizzellatpitt
0.65036243.12777252.html.plaintext.txt	503	1 reversal potential oocyte experiments determined estimated
0.65036243.12777252.html.plaintext.txt	504	vesicle diameter 100 nm number channels per vesicle increases proportionately
0.65036243.12777252.html.plaintext.txt	505	references top abstract cftr localization cells regulated cftr traffic mechanisms regulated cftr
0.65036243.12777252.html.plaintext.txt	506	consequences regulated cftr
0.65036243.12777252.html.plaintext.txt	507	summary appendix references 1
0.65036243.12777252.html.plaintext.txt	508	ameen na alexis j salas p
0.65036243.12777252.html.plaintext.txt	509	cellular localization cystic fibrosis transmembrane conductance regulator mouse intestinal tract
0.65036243.12777252.html.plaintext.txt	510	histochem cell biol 114 69 75 2000
0.65036243.12777252.html.plaintext.txt	511	ameen na martensson b bourguinon l marino c isenberg j mclaughlin ge
0.65036243.12777252.html.plaintext.txt	512	cftr channel insertion apical surface rat duodenal villus epithelial cells upregulated vip vivo
0.65036243.12777252.html.plaintext.txt	513	j cell sci 112 887 894 1999
0.65036243.12777252.html.plaintext.txt	514	aridor m bannykh si rowe balch
0.65036243.12777252.html.plaintext.txt	515	cargo modulate copii vesicle formation endoplasmic reticulum
0.65036243.12777252.html.plaintext.txt	516	j biol chem 274 4389 4399 1999
0.65036243.12777252.html.plaintext.txt	517	atia f zeiske w van driessche w
0.65036243.12777252.html.plaintext.txt	518	secretory apical cl channels a6 cells possible control cell ca2 camp
0.65036243.12777252.html.plaintext.txt	519	pflugers arch 438 344 353 1999
0.65036243.12777252.html.plaintext.txt	520	barasch j kiss b prince saiman l gruenert d al awqati q
0.65036243.12777252.html.plaintext.txt	521	defective acidification intracellular organelles cystic fibrosis
0.65036243.12777252.html.plaintext.txt	522	bebok z tousson schwiebert lm venglarik cj
0.65036243.12777252.html.plaintext.txt	523	improved oxygenation promotes cftr maturation trafficking mdck monolayers
0.65036243.12777252.html.plaintext.txt	524	j physiol cell physiol 280 c135 c145 2001
0.65036243.12777252.html.plaintext.txt	525	benharouga m haaardt m kartner n lukacs gl
0.65036243.12777252.html.plaintext.txt	526	cooh terminal truncations promote proteasome dependent degradation mature cystic fibrosis transmembrane conductance regulator post golgi compartments
0.65036243.12777252.html.plaintext.txt	527	j cell biol 153 957 970 2001
0.65036243.12777252.html.plaintext.txt	528	biwersi j emans n verkman
0.65036243.12777252.html.plaintext.txt	529	cystic fibrosis transmembrane conductance regulator activation stimulates endosome fusion vivo
0.65036243.12777252.html.plaintext.txt	530	proc natl acad sci usa 93 12484 12489 1996
0.65036243.12777252.html.plaintext.txt	531	functional cftr endosomal compartment cftr expressing fibroblasts t84 cells
0.65036243.12777252.html.plaintext.txt	532	j physiol cell physiol 266 c149 c156 1994
0.65036243.12777252.html.plaintext.txt	533	intracellular cftr localization function
0.65036243.12777252.html.plaintext.txt	534	physiol rev 79 s175 s191 1999
0.65036243.12777252.html.plaintext.txt	535	bradbury na clark ja watkins sc widnell cc smith hs bridges rj
0.65036243.12777252.html.plaintext.txt	536	characterization internalization pathways cystic fibrosis transmembrane conductance regulator
0.65036243.12777252.html.plaintext.txt	537	j physiol lung cell mol physiol 276 l659 l668 1999
0.65036243.12777252.html.plaintext.txt	538	bradbury na cohn ja venglarik cj bridges rj
0.65036243.12777252.html.plaintext.txt	539	biochemical biophysical identification cystic fibrosis transmembrane conductance regulator chloride channels components endocytic clathrin coated vesicles
0.65036243.12777252.html.plaintext.txt	540	j biol chem 269 8296 8302 1994
0.65036243.12777252.html.plaintext.txt	541	bradbury na jilling berta g sorscher ej bridges rj kirk kl
0.65036243.12777252.html.plaintext.txt	542	regulation plasma membrane recycling cftr
0.65036243.12777252.html.plaintext.txt	543	bradbury na jilling kirk kl bridges rj
0.65036243.12777252.html.plaintext.txt	544	regulated endocytosis chloride secretory epithelial cell line
0.65036243.12777252.html.plaintext.txt	545	j physiol cell physiol 262 c752 c759 1992
0.65036243.12777252.html.plaintext.txt	546	brown d katsura gustafson ce
0.65036243.12777252.html.plaintext.txt	547	cellular mechanisms aquaporin trafficking
0.65036243.12777252.html.plaintext.txt	548	j physiol renal physiol 275 f328 f331 1998
0.65036243.12777252.html.plaintext.txt	549	bryan r kube d perez david p prince
0.65036243.12777252.html.plaintext.txt	550	production cftr r domain leads increased levels asialogm1 increased pseudomonas aeruginosa binding epithelial cells
0.65036243.12777252.html.plaintext.txt	551	j respir cell mol biol 19 269 277 1998
0.65036243.12777252.html.plaintext.txt	552	bryant nj govers r james de
0.65036243.12777252.html.plaintext.txt	553	regulated transport glucose transporter glut4
0.65036243.12777252.html.plaintext.txt	554	bulteau l derand r mettey y metaye morris mr mcneilly cm folli c galietta lj zegarra moran o pereira mm jougla c dormer rl vierfond jm joffre m becq f
0.65036243.12777252.html.plaintext.txt	555	properties cftr activated xanthine derivative x 33 human airway calu 3 cells
0.65036243.12777252.html.plaintext.txt	556	j physiol cell physiol 279 c1925 c1937 2000
0.65036243.12777252.html.plaintext.txt	557	chamberlain lh burgoyne rd
0.65036243.12777252.html.plaintext.txt	558	cysteine string protein chaperone synapse
0.65036243.12777252.html.plaintext.txt	559	j neurochem 74 1781 1789 2000
0.65036243.12777252.html.plaintext.txt	560	chang sy di naren ap palfrey hc kirk kl nelson dj
0.65036243.12777252.html.plaintext.txt	561	mechanisms cftr regulation syntaxin 1a pka
0.65036243.12777252.html.plaintext.txt	562	j cell sci 115 783 791 2002
0.65036243.12777252.html.plaintext.txt	563	chen p hwant gc gillis kd
0.65036243.12777252.html.plaintext.txt	564	relationship camp ca2 transport cftr plasma membrane
0.65036243.12777252.html.plaintext.txt	565	j gen physiol 118 135 144 2001
0.65036243.12777252.html.plaintext.txt	566	cheng pw sherman jm boat tf bruce m
0.65036243.12777252.html.plaintext.txt	567	quantitation radiolabeled mucous glycoproteins secreted tracheal explants
0.65036243.12777252.html.plaintext.txt	568	anal biochem 117 301 306 1981
0.65036243.12777252.html.plaintext.txt	569	cheng sh gregory rj marshall j paul souza dw white ga oriordan cr smith ae
0.65036243.12777252.html.plaintext.txt	570	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.65036243.12777252.html.plaintext.txt	571	chow cw khurana woodside m grinstein orlowski j
0.65036243.12777252.html.plaintext.txt	572	epithelial nah exchanger nhe3 internalized clathrin mediated pathway
0.65036243.12777252.html.plaintext.txt	573	j biol chem 274 37551 37558 1999
0.65036243.12777252.html.plaintext.txt	574	collins bm mccoy aj kent hm evans pr owen dj
0.65036243.12777252.html.plaintext.txt	575	molecular architecture functional model endocytic ap2 complex
0.65036243.12777252.html.plaintext.txt	576	dalemans w hinnrasky j slos p dreyer d fuchey c pavirani puchelle e
0.65036243.12777252.html.plaintext.txt	577	immunocytochemical analysis reveals differences subcellular localization normal delta phe508 recombinant cystic fibrosis transmembrane conductance regulator
0.65036243.12777252.html.plaintext.txt	578	exp cell res 201 235 240 1992
0.65036243.12777252.html.plaintext.txt	579	denning gm ostedgaard ls cheng sh smith ae welsh mj
0.65036243.12777252.html.plaintext.txt	580	localization cystic fibrosis transmembrane conductance regulator chloride secretory epithelia
0.65036243.12777252.html.plaintext.txt	581	j clin invest 89 339 340 1992
0.65036243.12777252.html.plaintext.txt	582	denning gm ostedgaard ls welsh mj
0.65036243.12777252.html.plaintext.txt	583	abnormal localization cystic fibrosis transmembrane conductance regulator primary cultures cystic fibrosis airway epithelia
0.65036243.12777252.html.plaintext.txt	584	j cell biol 118 551 559 1992
0.65036243.12777252.html.plaintext.txt	585	dho grinstein foskett jk
0.65036243.12777252.html.plaintext.txt	586	plasma membrane recycling cftr expressing cho cells
0.65036243.12777252.html.plaintext.txt	587	biochim biophys acta 1225 78 82 1993
0.65036243.12777252.html.plaintext.txt	588	dmitrieva ni michea lf rocha gm burg mb
0.65036243.12777252.html.plaintext.txt	589	cell cycle delay apoptosis response osmotic stress
0.65036243.12777252.html.plaintext.txt	590	comp biochem physiol 130 411 420 2001
0.65036243.12777252.html.plaintext.txt	591	dosanjh lencer w brown d ausiello da stow jl
0.65036243.12777252.html.plaintext.txt	592	heterologous expression f508 cftr results decreased sialylation membrane glycoconjugates
0.65036243.12777252.html.plaintext.txt	593	j physiol cell physiol 266 c360 c366 1994
0.65036243.12777252.html.plaintext.txt	594	dunn kw park j semrad ce gelman dl shevell mcgraw te
0.65036243.12777252.html.plaintext.txt	595	regulation endocytic trafficking acidification independent cystic fibrosis transmembrane regulator
0.65036243.12777252.html.plaintext.txt	596	j biol chem 269 5336 5345 1994
0.65036243.12777252.html.plaintext.txt	597	frates rc jr kaizu tt last ja
0.65036243.12777252.html.plaintext.txt	598	mucus glycoproteins secreted respiratory epithelial tissue cystic fibrosis patients
0.65036243.12777252.html.plaintext.txt	599	pediatr res 17 30 34 1983
0.65036243.12777252.html.plaintext.txt	600	fu j ji hl naren ap kirk kl
0.65036243.12777252.html.plaintext.txt	601	cluster negative charges amino terminal tail cftr regulates atp dependent channel gating
0.65036243.12777252.html.plaintext.txt	602	j physiol 536 459 470 2001
0.65036243.12777252.html.plaintext.txt	603	gibson ga hill wg weisz oa
0.65036243.12777252.html.plaintext.txt	604	evidence acidification hypothesis cystic fibrosis
0.65036243.12777252.html.plaintext.txt	605	j physiol cell physiol 279 c1088 c1099 2000
0.65036243.12777252.html.plaintext.txt	606	giovannucci dr yule di stuenkel el
0.65036243.12777252.html.plaintext.txt	607	optical measurement stimulus evoked membrane dynamics single pancreatic acinar cells
0.65036243.12777252.html.plaintext.txt	608	j physiol cell physiol 275 c732 c739 1998
0.65036243.12777252.html.plaintext.txt	609	greger r thiele ii warth r bleich m
0.65036243.12777252.html.plaintext.txt	610	stimulation nacl secretion vitro perfused rectal gland tubules squalus acanthias increase membrane capacitance pflugers arch 436 538 544 1998
0.65036243.12777252.html.plaintext.txt	611	focus exocytosis involved activation c1 secretion via cftr calu 3 airway epithelial cells
0.65036243.12777252.html.plaintext.txt	612	j physiol cell physiol 275 c911 c912 1998
0.65036243.12777252.html.plaintext.txt	613	gustafson ce katsura mckee m bouley r casanova je brown d
0.65036243.12777252.html.plaintext.txt	614	recycling aqp2 occurs temperature bafilomycin sensitive trans golgi associated compartment
0.65036243.12777252.html.plaintext.txt	615	j physiol renal physiol 278 f317 f326 2000
0.65036243.12777252.html.plaintext.txt	616	hallows kr raghuram v kemp witters la foskett jk
0.65036243.12777252.html.plaintext.txt	617	inhibition cystic fibrosis transmembrane conductance regulator novel interaction metabolic sensor amp activated protein kinase
0.65036243.12777252.html.plaintext.txt	618	j clin invest 105 1711 1721 2000
0.65036243.12777252.html.plaintext.txt	619	haney pm slot jw piper rc james de mueckler m
0.65036243.12777252.html.plaintext.txt	620	intracellular targeting insulin regulatable glucose transporter glut4 isoform specific independent cell type
0.65036243.12777252.html.plaintext.txt	621	j cell biol 114 689 699 1991
0.65036243.12777252.html.plaintext.txt	622	heda gd tanwani m marino cr
0.65036243.12777252.html.plaintext.txt	623	f508 mutation shortens biochemical half life plasma membrane cftr polarized epithelial cells
0.65036243.12777252.html.plaintext.txt	624	j physiol cell physiol 280 c166 c174 2001
0.65036243.12777252.html.plaintext.txt	625	howard m jiang x stolz db hill wg johnson ja watkins sc frizzell ra bruton cm robbins pd weisz oa
0.65036243.12777252.html.plaintext.txt	626	forskolin induced apical membrane insertion virally expressed epitope tagged cftr polarized mdck cells
0.65036243.12777252.html.plaintext.txt	627	j physiol cell physiol 279 c375 c382 2000
0.65036243.12777252.html.plaintext.txt	628	howard m jilling duvall m
0.65036243.12777252.html.plaintext.txt	629	camp regulated trafficking epitope tagged cftr
0.65036243.12777252.html.plaintext.txt	630	kidney int 49 1642 1648 1996
0.65036243.12777252.html.plaintext.txt	631	hudson aw ruiz m birnbaum mj
0.65036243.12777252.html.plaintext.txt	632	isoform specific subcellular targeting glucose transporters mouse fibroblasts
0.65036243.12777252.html.plaintext.txt	633	j cell biol 116 785 797 1992
0.65036243.12777252.html.plaintext.txt	634	hug mj bertrand ca frizzell ra
0.65036243.12777252.html.plaintext.txt	635	camp increases fm 1 43 labeled membrane uptake calu 3 cells abstract
0.65036243.12777252.html.plaintext.txt	636	pediatr pulmonol 34 240 2002
0.65036243.12777252.html.plaintext.txt	637	hug mj sun f frizzell ra
0.65036243.12777252.html.plaintext.txt	638	camp increases membrane conductance membrane capacitance calu 3 cells abstract
0.65036243.12777252.html.plaintext.txt	639	pediatr pulmonol 28 183 1999
0.65036243.12777252.html.plaintext.txt	640	hug mj thiele ie greger r
0.65036243.12777252.html.plaintext.txt	641	role exocytosis activation chloride conductance chinese hamster ovary cells cho stably expressing cftr
0.65036243.12777252.html.plaintext.txt	642	pflugers arch 434 779 784 1997
0.65036243.12777252.html.plaintext.txt	643	imundo l barasch j prince al awqati q
0.65036243.12777252.html.plaintext.txt	644	cystic fibrosis epithelial cells regulator pathogenic bacteria apical surface
0.65036243.12777252.html.plaintext.txt	645	proc natl acad sci usa 92 3019 3023 1995
0.65036243.12777252.html.plaintext.txt	646	jentsch tj stein v weinreich f zdebik aa
0.65036243.12777252.html.plaintext.txt	647	molecular structure physiological function chloride channels
0.65036243.12777252.html.plaintext.txt	648	physiol rev 82 503 568 2002
0.65036243.12777252.html.plaintext.txt	649	cyclic amp chloride dependent regulation apical constitutive secretory pathway colonic epithelial cells
0.65036243.12777252.html.plaintext.txt	650	j biol chem 271 4381 4387 1996
0.65036243.12777252.html.plaintext.txt	651	importance aquaporin 2 expression levels genotype phenotype studies nephrogenic diabetes insipidus
0.65036243.12777252.html.plaintext.txt	652	j physiol renal physiol 279 f778 f784 2000
0.65036243.12777252.html.plaintext.txt	653	kartner n augustinas o jensen tj naismith al riordan jr
0.65036243.12777252.html.plaintext.txt	654	mislocation f508 cftr cystic fibrosis sweat gland
0.65036243.12777252.html.plaintext.txt	655	krivan hc ginsburg v roberts dd
0.65036243.12777252.html.plaintext.txt	656	pseudomonas aeruginosa pseudomonas cepacia isolated cystic fibrosis patients bind specifically gangliotetraosylceramide asialo gm1 gangliotriaosylceramide asialo gm2
0.65036243.12777252.html.plaintext.txt	657	arch biochem biophys 260 493 496 1988
0.65036243.12777252.html.plaintext.txt	658	kuver r klinkspoor jh osborne wr lee sp
0.65036243.12777252.html.plaintext.txt	659	mucous granule exocytosis cftr expression gallbladder epithelium
0.65036243.12777252.html.plaintext.txt	660	glycobiology 10 149 157 2000
0.65036243.12777252.html.plaintext.txt	661	lehrich rw aller sg webster p marino cr forrest jn
0.65036243.12777252.html.plaintext.txt	662	vasoactive intestinal peptide forskolin genistein increase apical cftr trafficking rectal gland spiny dogfish squalus acanthias
0.65036243.12777252.html.plaintext.txt	663	acute regulation cftr trafficking intact epithelium
0.65036243.12777252.html.plaintext.txt	664	j clin invest 101 737 745 1998
0.65036243.12777252.html.plaintext.txt	665	lewarchik cm peters kw qi j dudley r frizzell ra
0.65036243.12777252.html.plaintext.txt	666	r domain regulation cftr trafficking abstract
0.65036243.12777252.html.plaintext.txt	667	pediatr pulmonol 30 176 2000
0.65036243.12777252.html.plaintext.txt	668	liu x smith ss sun f dawson dc
0.65036243.12777252.html.plaintext.txt	669	cftr covalent modification cysteine substituted channels expressed xenopus oocytes shows activation due opening channels resident plasma membrane
0.65036243.12777252.html.plaintext.txt	670	j gen physiol 118 433 446 2001
0.65036243.12777252.html.plaintext.txt	671	loffing j moyer bd mccoy d stanton ba
0.65036243.12777252.html.plaintext.txt	672	exocytosis involved activation cl secretion via cftr calu 3 airway epithelial cells
0.65036243.12777252.html.plaintext.txt	673	j physiol cell physiol 275 c913 c920 1998
0.65036243.12777252.html.plaintext.txt	674	lukacs gl chang xb bear c kartner n mohamed riordan jr grinstein
0.65036243.12777252.html.plaintext.txt	675	f508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.65036243.12777252.html.plaintext.txt	676	determination functional half lives transfected cells
0.65036243.12777252.html.plaintext.txt	677	j biol chem 268 592 598 1993
0.65036243.12777252.html.plaintext.txt	678	lukacs gl chang xb kartner n rotstein od riordan jr grinstein
0.65036243.12777252.html.plaintext.txt	679	cystic fibrosis transmembrane regulator present functional endosomes
0.65036243.12777252.html.plaintext.txt	680	role determinant endosomal ph
0.65036243.12777252.html.plaintext.txt	681	j biol chem 267 14568 14672 1992
0.65036243.12777252.html.plaintext.txt	682	lukacs gl segal g kartner n grinstein zhang f
0.65036243.12777252.html.plaintext.txt	683	constitutive internalization cystic fibrosis transmembrane conductance regulator occurs via clathrin dependent endocytosis regulated protein phosphorylation
0.65036243.12777252.html.plaintext.txt	684	biochem j 328 353 361 1997
0.65036243.12777252.html.plaintext.txt	685	malide d ramm g cushman sw slot jw
0.65036243.12777252.html.plaintext.txt	686	immunoelectron microscopic evidence glut4 translocation explains stimulation glucose transport isolated rat white adipose cells
0.65036243.12777252.html.plaintext.txt	687	j cell sci 113 4203 4210 2000
0.65036243.12777252.html.plaintext.txt	688	mangoura d sogos v dawson g
0.65036243.12777252.html.plaintext.txt	689	phorbol esters pkc signaling regulate proliferation vimentin cytoskeleton assembly glutamine synthetase activity chick embryo cerebrum astrocytes culture
0.65036243.12777252.html.plaintext.txt	690	brain res dev brain res 87 1 11 1995
0.65036243.12777252.html.plaintext.txt	691	cystic fibrosis defect stimulus response coupling
0.65036243.12777252.html.plaintext.txt	692	trends biochem sci 13 10 13 1988
0.65036243.12777252.html.plaintext.txt	693	mcpherson ma pereira mm russell d mcneilly cm morris rm stratford fl dormer rl
0.65036243.12777252.html.plaintext.txt	694	cftr mediated protein secretion defect pharmacological correction
0.65036243.12777252.html.plaintext.txt	695	pflugers arch 443 s121 s126 2001
0.65036243.12777252.html.plaintext.txt	696	mergey m lemnaouar m veissiere d perricaudet m gruenert dc picard j capeau j brahimi horn mc paul
0.65036243.12777252.html.plaintext.txt	697	cftr gene transfer corrects defective glycoconjugate secretion human cf epithelial tracheal cells
0.65036243.12777252.html.plaintext.txt	698	j physiol lung cell mol physiol 269 l855 l864 1995
0.65036243.12777252.html.plaintext.txt	699	mills cl dorin jr davidson dj porteus dj alton ew dormer rl mcpherson ma
0.65036243.12777252.html.plaintext.txt	700	decreased beta adrenergic stimulation glycoprotein secretion cf mice submandibular glands reversal methylxanthine ibmx
0.65036243.12777252.html.plaintext.txt	701	biochem biophys res commun 215 674 81 1995
0.65036243.12777252.html.plaintext.txt	702	morris ap cunningham sa tousson benos dj frizzell ra
0.65036243.12777252.html.plaintext.txt	703	polarization dependent apical membrane cftr targeting underlies camp stimulated cl secretion epithelial cells
0.65036243.12777252.html.plaintext.txt	704	j physiol cell physiol 266 c254 c268 1994
0.65036243.12777252.html.plaintext.txt	705	moyer bd duhaime m shaw c denton j reynolds d karlson kh pfeiffer j wang mickle je milewski m cutting gr guggino wb li m stanton ba
0.65036243.12777252.html.plaintext.txt	706	pdz interacting domain cystic fibrosis transmembrane conductance regulator required functional expression apical plasma membrane
0.65036243.12777252.html.plaintext.txt	707	j biol chem 275 27069 27074 2000
0.65036243.12777252.html.plaintext.txt	708	moyer bd loffing j schwiebert em loffing cueni d halpin pa karlson kh ismailov ii guggino wb langford gm stanton ba
0.65036243.12777252.html.plaintext.txt	709	membrane trafficking cystic fibrosis gene product cystic fibrosis transmembrane conductance regulator tagged green fluorescent protein madin darby canine kidney cells
0.65036243.12777252.html.plaintext.txt	710	j biol chem 273 21759 21768 1998
0.65036243.12777252.html.plaintext.txt	711	naren ap cormet boyaka e fu j villain m blalock je quick mw kirk kl
0.65036243.12777252.html.plaintext.txt	712	cftr chloride channel regulation interdomain interaction
0.65036243.12777252.html.plaintext.txt	713	naren ap nelson dj xie w jovov b pevsner j bennett mk benos dj quick mw kirk kl
0.65036243.12777252.html.plaintext.txt	714	regulation cftr chloride channels syntaxin munc18 isoforms
0.65036243.12777252.html.plaintext.txt	715	naren ap quick mw collawn jf nelson dj kirk kl
0.65036243.12777252.html.plaintext.txt	716	syntaxin 1a inhibits cftr chloride channels means domain specific protein protein interactions
0.65036243.12777252.html.plaintext.txt	717	proc natl acad sci usa 95 10972 10977 1998
0.65036243.12777252.html.plaintext.txt	718	nesterov carter re sorkina gill gn sorkin
0.65036243.12777252.html.plaintext.txt	719	inhibition receptor binding function clathrin adaptor protein ap 2 dominant negative mutant mu2 subunit effects endocytosis
0.65036243.12777252.html.plaintext.txt	720	niwa k shibuya kanno
0.65036243.12777252.html.plaintext.txt	721	temperature dependence processes proximal distal glucose induced ca2i rise stimulus secretion coupling rat pancreatic islets
0.65036243.12777252.html.plaintext.txt	722	biol signals 5 30 43 1996
0.65036243.12777252.html.plaintext.txt	723	olsen mk reszka aa abraham
0.65036243.12777252.html.plaintext.txt	724	kt5720 u 98017 inhibit mapk alter cytoskeleton cell morphology
0.65036243.12777252.html.plaintext.txt	725	j cell physiol 176 525 536 1998
0.65036243.12777252.html.plaintext.txt	726	cystic fibrosis transmembrane conductance regulator associated atp adenosine 3 phosphate 5 phosphosulfate channels endoplasmic reticulum plasma membranes
0.65036243.12777252.html.plaintext.txt	727	j biol chem 272 7746 7751 1997
0.65036243.12777252.html.plaintext.txt	728	mutant f508 cystic fibrosis transmembrane conductance regulator cl channel functional retained endoplasmic reticulum mammalian cells
0.65036243.12777252.html.plaintext.txt	729	j biol chem 270 12347 12350 1995
0.65036243.12777252.html.plaintext.txt	730	paterson gh knobel sm sharif wd kain sr piston dw
0.65036243.12777252.html.plaintext.txt	731	use green fluorescent protein mutants quantitative fluorescence microscopy
0.65036243.12777252.html.plaintext.txt	732	biophys j 73 2782 2790 1997
0.65036243.12777252.html.plaintext.txt	733	pearse bm smith cj owen dj
0.65036243.12777252.html.plaintext.txt	734	clathrin coat construction endocytosis
0.65036243.12777252.html.plaintext.txt	735	curr opin struct biol 10 220 228 2000
0.65036243.12777252.html.plaintext.txt	736	peters w qi jj watkins sc frizzell ra
0.65036243.12777252.html.plaintext.txt	737	syntaxin 1a inhibits regulated cftr trafficking xenopus oocytes
0.65036243.12777252.html.plaintext.txt	738	j physiol cell physiol 277 c174 c180 1999
0.65036243.12777252.html.plaintext.txt	739	role cftr airway disease
0.65036243.12777252.html.plaintext.txt	740	physiol rev 79 s215 s255 1999
0.65036243.12777252.html.plaintext.txt	741	poschet jf boucher jc tatterson l skidmore j van dyke rw deretic v
0.65036243.12777252.html.plaintext.txt	742	molecular basis defective glycosylation pseudomonas pathogenesis cystic fibrosis lung
0.65036243.12777252.html.plaintext.txt	743	proc natl acad sci usa 98 13972 13977 2001
0.65036243.12777252.html.plaintext.txt	744	prince ls peter k hatton sr zaliauskiene l cotlin lf clancy jp marchase rb collawn jf
0.65036243.12777252.html.plaintext.txt	745	efficient endocytosis cystic fibrosis transmembrane conductance regulator requires tyrosine based signal
0.65036243.12777252.html.plaintext.txt	746	j biol chem 274 3602 3609 1999
0.65036243.12777252.html.plaintext.txt	747	prince ls workman rb jr marchase rb
0.65036243.12777252.html.plaintext.txt	748	rapid endocytosis cystic fibrosis transmembrane conductance regulator chloride channel
0.65036243.12777252.html.plaintext.txt	749	proc natl acad sci usa 91 5192 5196 1994
0.65036243.12777252.html.plaintext.txt	750	puchelle e gaillard d ploton d hinnrasky j fuchey c boutterin mc jacquot j dreyer d pavirani dalemans w
0.65036243.12777252.html.plaintext.txt	751	differential localization cystic fibrosis transmembrane conductance regulator normal cystic fibrosis airway epithelium
0.65036243.12777252.html.plaintext.txt	752	j respir cell mol biol 7 485 491 1992
0.65036243.12777252.html.plaintext.txt	753	renstrom e eliasson l bokvist k rorsman p
0.65036243.12777252.html.plaintext.txt	754	cooling inhibits exocytosis single mouse pancreatic b cells suppression granule mobilization
0.65036243.12777252.html.plaintext.txt	755	sodium 4 phenylbutyrate downregulates hsc70 implications intracellular trafficking f508 cftr
0.65036243.12777252.html.plaintext.txt	756	j physiol cell physiol 278 c259 c267 2000
0.65036243.12777252.html.plaintext.txt	757	pseudomonas aeruginosa pili bind asialogm1 increased surface cystic fibrosis epithelial cells
0.65036243.12777252.html.plaintext.txt	758	j clin invest 92 1875 1880 1993
0.65036243.12777252.html.plaintext.txt	759	glycosylation cystic fibrosis transmembrane conductance regulator
0.65036243.12777252.html.plaintext.txt	760	respir res 2 276 279 2001
0.65036243.12777252.html.plaintext.txt	761	terminal glycosylation cystic fibrosis
0.65036243.12777252.html.plaintext.txt	762	biochim biophys acta 1455 241 253 1999
0.65036243.12777252.html.plaintext.txt	763	schultz bd bridges rj frizzell ra
0.65036243.12777252.html.plaintext.txt	764	rescue dysfunctional f508 cftr chloride activity ibmx
0.65036243.12777252.html.plaintext.txt	765	schwiebert em benos dj egan stutts mj guggino wb
0.65036243.12777252.html.plaintext.txt	766	cftr conductance regulator well chloride channel
0.65036243.12777252.html.plaintext.txt	767	physiol rev 79 s145 s166 1999
0.65036243.12777252.html.plaintext.txt	768	schwiebert em gesek f ercolani l wjasow c gruenert dc karlson k stanton ba
0.65036243.12777252.html.plaintext.txt	769	heterotrimeric g proteins vesicle trafficking cftr cl channels
0.65036243.12777252.html.plaintext.txt	770	j physiol cell physiol 267 c272 c281 1994
0.65036243.12777252.html.plaintext.txt	771	sharma m benharouga m hu w lukacs gl
0.65036243.12777252.html.plaintext.txt	772	conformational temperature sensitive stability defects f508 cystic fibrosis transmembrane conductance regulator post endoplasmic reticulum compartments
0.65036243.12777252.html.plaintext.txt	773	j biol chem 276 8942 8950 2001
0.65036243.12777252.html.plaintext.txt	774	shimkets ra lifton rp canessa cm
0.65036243.12777252.html.plaintext.txt	775	activity epithelial sodium channel regulated clathrin mediated endocytosis
0.65036243.12777252.html.plaintext.txt	776	j biol chem 272 25537 25541 1997
0.65036243.12777252.html.plaintext.txt	777	short db trotter kw reczek d kreda sm bretscher boucher rc stutts mj milgram sl
0.65036243.12777252.html.plaintext.txt	778	apical pdz protein anchors cystic fibrosis transmembrane conductance regulator cytoskeleton
0.65036243.12777252.html.plaintext.txt	779	j biol chem 273 19797 19801 1998
0.65036243.12777252.html.plaintext.txt	780	silvis mr picciano ja bertrand c weixel k bridges rj bradbury na
0.65036243.12777252.html.plaintext.txt	781	mutation cystic fibrosis transmembrane conductance regulator generates novel internalization sequence enhances endocytic rates
0.65036243.12777252.html.plaintext.txt	782	j biol chem 278 11554 11560 2003
0.65036243.12777252.html.plaintext.txt	783	stevens al breton gustafson ce bouley r nelson rd kohan de brown d
0.65036243.12777252.html.plaintext.txt	784	aquaporin 2 vasopressin independent constitutive apical membrane protein rat vas deferens
0.65036243.12777252.html.plaintext.txt	785	j physiol cell physiol 278 c791 c802 2000
0.65036243.12777252.html.plaintext.txt	786	sun f hug mj lewarchik cm yun c bradbury na frizzell ra
0.65036243.12777252.html.plaintext.txt	787	e3karp mediates association ezrin protein kinase cystic fibrosis transmembrane conductance regulator airway cells
0.65036243.12777252.html.plaintext.txt	788	j biol chem 275 29539 29546 2000
0.65036243.12777252.html.plaintext.txt	789	sun x van hoek huang y bouley r mclaughlin m brown d
0.65036243.12777252.html.plaintext.txt	790	aquaporin 2 localization clathrin coated pits inhibition endocytosis dominant negative dynamin
0.65036243.12777252.html.plaintext.txt	791	j physiol renal physiol 282 f998 f1011 2002
0.65036243.12777252.html.plaintext.txt	792	takahashi watkins sc howard mb frizzell ra
0.65036243.12777252.html.plaintext.txt	793	cftr dependent membrane insertion linked stimulation cftr chloride conductance
0.65036243.12777252.html.plaintext.txt	794	j physiol cell physiol 271 c1887 c1894 1996
0.65036243.12777252.html.plaintext.txt	795	tousson fuller cm benos dj
0.65036243.12777252.html.plaintext.txt	796	apical recruitment cftr 84 cells dependent camp microtubules ca2 microfilaments
0.65036243.12777252.html.plaintext.txt	797	j cell sci 109 1325 1334 1996
0.65036243.12777252.html.plaintext.txt	798	vivo cell specific expression cystic fibrosis transmembrane conductance regulator
0.65036243.12777252.html.plaintext.txt	799	weber wm cuppens h cassiman j j clauss w van driessche w
0.65036243.12777252.html.plaintext.txt	800	capacitance measurements reveal different pathways activation cftr
0.65036243.12777252.html.plaintext.txt	801	pflugers arch 438 561 569 1999
0.65036243.12777252.html.plaintext.txt	802	weber wm segal vankeerberghen cassiman jj van driessche w
0.65036243.12777252.html.plaintext.txt	803	different activation mechanisms cystic fibrosis transmembrane conductance regulator expressed xenopus laevis oocytes
0.65036243.12777252.html.plaintext.txt	804	comp biochem physiol 139 521 531 2001
0.65036243.12777252.html.plaintext.txt	805	webster p vanacore l nairn ac marino cr
0.65036243.12777252.html.plaintext.txt	806	subcellular localization cftr endosomes ductal epithelium
0.65036243.12777252.html.plaintext.txt	807	j physiol cell physiol 267 c340 c348 1994
0.65036243.12777252.html.plaintext.txt	808	mu2 binding directs cystic fibrosis transmembrane conductance regulator clathrin mediated endocytic pathway
0.65036243.12777252.html.plaintext.txt	809	j biol chem 276 46251 46259 2001
0.65036243.12777252.html.plaintext.txt	810	carboxyl terminus cystic fibrosis transmembrane conductance regulator binds ap 2 clathrin adaptors
0.65036243.12777252.html.plaintext.txt	811	j biol chem 275 3655 3660 2000
0.65036243.12777252.html.plaintext.txt	812	wright em hirsch jr loo dd zampighi ga
0.65036243.12777252.html.plaintext.txt	813	regulation naglucose cotransporters
0.65036243.12777252.html.plaintext.txt	814	j exp biol 200 287 293 1997
0.65036243.12777252.html.plaintext.txt	815	wu mn fergestad lloyd te y broadie k bellen hj
0.65036243.12777252.html.plaintext.txt	816	syntaxin 1a interacts multiple exocytic proteins regulate neurotransmitter release vivo
0.65036243.12777252.html.plaintext.txt	817	yilla m tan ito k milwa k ploegh hl
0.65036243.12777252.html.plaintext.txt	818	involvement vacuolar h atpases secretory pathway hepg2 cells
0.65036243.12777252.html.plaintext.txt	819	j biol chem 268 19092 19100 1993
0.65036243.12777252.html.plaintext.txt	820	zar h saiman l quittell l prince
0.65036243.12777252.html.plaintext.txt	821	binding pseudomonas aeruginosa respiratory epithelial cells patients various mutations cystic fibrosis transmembrane regulator
0.65036243.12777252.html.plaintext.txt	822	j pediatr 126 230 233 1995
0.65036243.12777252.html.plaintext.txt	823	zeng wz babich v ortega b quigley r white sj welling pa huang cl
0.65036243.12777252.html.plaintext.txt	824	evidence endocytosis romk potassium channel via clathrin coated vesicles
0.65036243.12777252.html.plaintext.txt	825	j physiol renal physiol 283 f630 f639 2002
0.65036243.12777252.html.plaintext.txt	826	zhang h peters kw sun f marino cr lang j burgoyne rd frizzell ra
0.65036243.12777252.html.plaintext.txt	827	cysteine string protein interacts modulates maturation cftr
0.65036243.12777252.html.plaintext.txt	828	j biol chem 277 28948 28958 2002
0.65036243.12777252.html.plaintext.txt	829	zinsmaier ke hofbauer heimbeck g pflugfelder go buchner buchner e
0.65036243.12777252.html.plaintext.txt	830	cysteine string protein expressed retina brain drosophila
0.65036243.12777252.html.plaintext.txt	831	j neurogenet 7 15 29 1990
0.57130253.12538638.html.plaintext.txt	0	rockefeller university press 0021 952520031157 5
0.57130253.12538638.html.plaintext.txt	1	00 journal cell biology volume 160 number 2 157 163 report
0.57130253.12538638.html.plaintext.txt	2	traffic independent function sar1pcopii machinery proteasomal sorting cystic fibrosis transmembrane conductance regulator lianwu fu elizabeth sztul
0.57130253.12538638.html.plaintext.txt	3	department cell biology university alabama birmingham birmingham al 35294
0.57130253.12538638.html.plaintext.txt	4	cell biology mclm room 668 1530 3rd ave
0.57130253.12538638.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods references newly synthesized proteins fold correctly er targeted er associated protein degradation erad distinct sorting mechanisms soluble erad substrates require er golgi transport retrieval degradation whereas transmembrane erad substrates retained er
0.57130253.12538638.html.plaintext.txt	6	retained transmembrane proteins often sequestered specialized er subdomains relevance sequestration proteasomal degradation explored
0.57130253.12538638.html.plaintext.txt	7	used yeast saccharomyces cerevisiae model erad substrate cystic fibrosis transmembrane conductance regulator cftr explore whether cftr sequestered degradation identify molecular machinery regulating sequestration analyze relationship sequestration degradation
0.57130253.12538638.html.plaintext.txt	8	report cftr sequestered er subdomains containing chaperone kar2p sequestration cftr degradation disrupted sec12ts strain mutant guanine nucleotide exchange factor sar1p sec13ts strain mutant sec13p component copii sec23ts strain mutant sec23p component copii grown restrictive temperature
0.57130253.12538638.html.plaintext.txt	9	function sar1pcopii machinery cftr sequestration degradation independent role er golgi traffic
0.57130253.12538638.html.plaintext.txt	10	propose sar1pcopii mediated sorting cftr er subdomains essential entry proteasomal degradation pathway
0.57130253.12538638.html.plaintext.txt	11	findings reveal new aspect degradative mechanism suggest functional crosstalk secretory degradative pathways
0.57130253.12538638.html.plaintext.txt	12	key words er sorting proteasomal degradation cftr erad yeast
0.57130253.12538638.html.plaintext.txt	13	introduction top abstract introduction results discussion materials methods references quality control newly synthesized membrane proteins occurs er ellgaard helenius 2001
0.57130253.12538638.html.plaintext.txt	14	incorrectly folded proteins targeted er associated protein degradation erad eliminated ubiquitin proteasome pathway brodsky mccracken 1999
0.57130253.12538638.html.plaintext.txt	15	proteasomal degradation occurs cytoplasm erad substrates must retrotranslocated er cytoplasm digestion
0.57130253.12538638.html.plaintext.txt	16	cellular machinery involved sorting translocation erad substrates active investigation
0.57130253.12538638.html.plaintext.txt	17	one key requirements fully competent early secretory pathway mutations proteins involved er golgi traffic cause disorganization er structure inhibit erad taxis et al
0.57130253.12538638.html.plaintext.txt	18	sec61psec63p translocon plemper et al
0.57130253.12538638.html.plaintext.txt	19	1997 auxiliary proteins der1p knop et al
0.57130253.12538638.html.plaintext.txt	20	1996 der3phrd1p bordallo wolf 1999 hrd3 hampton et al
0.57130253.12538638.html.plaintext.txt	21	1996 shown required retrotranslocation erad substrates
0.57130253.12538638.html.plaintext.txt	22	addition subset molecular chaperones calnexin mccracken brodsky 1996 bip plemper et al
0.57130253.12538638.html.plaintext.txt	23	2001 p97 rabinovich et al
0.57130253.12538638.html.plaintext.txt	24	2002 participate selecting erad substrates
0.57130253.12538638.html.plaintext.txt	25	evidence indicates two distinct mechanisms participate directing different substrates erad vashist et al
0.57130253.12538638.html.plaintext.txt	26	soluble erad substrates carboxy peptidase y cpy pra khn require functional transport er golgi caldwell et al
0.57130253.12538638.html.plaintext.txt	27	2001 degradation proteins delayed er golgi traffic inhibited sec18 1 sec12 4 strains
0.57130253.12538638.html.plaintext.txt	28	additional components encoded per17 vashist et al
0.57130253.12538638.html.plaintext.txt	29	2001 erv14 erv29 caldwell et al
0.57130253.12538638.html.plaintext.txt	30	2001 appear essential degradation soluble erad substrates appear function regulating er golgi transport specific soluble proteins
0.57130253.12538638.html.plaintext.txt	31	contrast degradation membrane erad substrates mutant forms ste6p yor1p sec61p vph1p cystic fibrosis transmembrane conductance regulator cftr seem unaffected sec18 1 sec12 4 sec21 1 per17 1 erv14 erv29 mutations loayza et al
0.57130253.12538638.html.plaintext.txt	32	findings suggest transmembrane erad substrates enter post er compartments secretory pathway degradation
0.57130253.12538638.html.plaintext.txt	33	agreement soluble erad substrates detected post er transport vesicles whereas transmembrane erad substrates excluded vashist et al
0.57130253.12538638.html.plaintext.txt	34	exact pathway degradation transmembrane erad substrates er unclear evidence suggest least retained proteins sorted specialized er subdomains degradation kamhi nesher et al
0.57130253.12538638.html.plaintext.txt	35	unknown molecular mechanisms regulate sequestration erad substrates whether sequestration required er retrotranslocation proteasomal degradation
0.57130253.12538638.html.plaintext.txt	36	explore questions used yeast saccharomyces cerevisiae mutant strains defective sar1pcopii sorting machinery known erad substrate cftr model system
0.57130253.12538638.html.plaintext.txt	37	sar1pcopii mediated selection er proteins secretory traffic one best understood mechanisms selective recruitment proteins er antonny schekman 2001
0.57130253.12538638.html.plaintext.txt	38	copii sorting initiated sar1p small gtpase veldhuisen et al
0.57130253.12538638.html.plaintext.txt	39	1997 activated sec12p mediated guanine nucleotide exchange
0.57130253.12538638.html.plaintext.txt	40	sar1p gtp bound state associates er membrane recruits sec23psec24p copii complex subsequently sec13psec31p copii complex membrane review see barlowe 2000
0.57130253.12538638.html.plaintext.txt	41	assembly copii coat er budding structures coupled selection transmembrane proteins nascent budding structures eventually bud er transport vesicles
0.57130253.12538638.html.plaintext.txt	42	copii function examined date exclusively context secretory traffic
0.57130253.12538638.html.plaintext.txt	43	cftr chloride channel present apical surface epithelial cells lining respiratory intestinal exocrine tissues kirk 2000
0.57130253.12538638.html.plaintext.txt	44	mammalian cells 20 newly synthesized wild type cftr folds correctly transported er plasma membrane secretory pathway whereas remaining 80 cftr degraded er ubiquitin proteasome pathway jensen et al
0.57130253.12538638.html.plaintext.txt	45	mammalian cells cftr sequestered er subdomains degradation inhibition proteasomal activity chemical inhibitors overtaxing proteolytic capacity overexpressing cftr leads retrotranslocation cftr er accumulation cytosolic aggresomes johnston et al
0.57130253.12538638.html.plaintext.txt	46	yeast majority newly synthesized cftr also degraded ubiquitin proteasome pathway contrast mammalian cells cftr yeast delivered aggresomes appears sequestered er subdomains degradation kiser et al
0.57130253.12538638.html.plaintext.txt	47	report sar1pcopii machinery functions sorting cftr er subdomains proteasomal degradation sorting required cftr entry degradative pathway
0.57130253.12538638.html.plaintext.txt	48	function sar1pcopii involve er golgi traffic
0.57130253.12538638.html.plaintext.txt	49	results support model sar1pcopii machinery participates sorting proteins anterograde secretory pathway degradative pathway
0.57130253.12538638.html.plaintext.txt	50	findings raise possibility newly synthesized proteins subjected sar1pcopii sorting mechanism irrespective ultimate secretory degradative fate
0.57130253.12538638.html.plaintext.txt	51	results discussion top abstract introduction results discussion materials methods references gfp tagged cftr bona fide erad substrate yeast provide substrate studies generated construct containing egfp fused frame nh2 terminus human cftr yeast expression vector copper inducible promoter
0.57130253.12538638.html.plaintext.txt	52	1 egfp cftr detected immunoprecipitation anti cftr antibody anti gfp antibody copper induction wild type yeast carrying egfp cftr plasmid fig
0.57130253.12538638.html.plaintext.txt	53	1 lanes 1 4 yeast carrying empty vector fig
0.57130253.12538638.html.plaintext.txt	54	egfp cftr seen sample precipitated anti f1ss antibody
0.57130253.12538638.html.plaintext.txt	55	mobility egfp cftr 175 kd appropriate chimera egfp 27 kd full length human cftr 145 kd
0.57130253.12538638.html.plaintext.txt	56	view larger version 26k figure 1
0.57130253.12538638.html.plaintext.txt	57	egfp cftr represents yeast erad substrate
0.57130253.12538638.html.plaintext.txt	58	yeast transformed pcu426cup1 egfp cftr lane pcu426cup1egfp cftr egfp cftr lanes induced labeled 35smethionine 20 min lysed
0.57130253.12538638.html.plaintext.txt	59	lysates immunoprecipitated anti cftr anti f1ss anti gfp pabs
0.57130253.12538638.html.plaintext.txt	60	band 175 kd appropriate chimera egfp cftr immunoprecipitated anti cftr anti gfp antibodies cells expressing egfp cftr
0.57130253.12538638.html.plaintext.txt	61	b wild type pre1 1 ubc6 yeast transformed pcu426cup1egfp cftr induced pulse labeled 35smethionine 20 min
0.57130253.12538638.html.plaintext.txt	62	equal amount culture taken chase time lysed lysates immunoprecipitated anti cftr antibody
0.57130253.12538638.html.plaintext.txt	63	relative intensities egfp cftr bands quantitated
0.57130253.12538638.html.plaintext.txt	64	egfp cftr stabilized pre1 1 ubc6 strains
0.57130253.12538638.html.plaintext.txt	65	ensure egfp cftr behaves erad substrate examined degradation rate mutant strains lacking either functional proteasome subunit pre1 1 ubiquitin conjugation enzyme ubc6
0.57130253.12538638.html.plaintext.txt	66	proteins previously shown required degradation cftr tagged cooh terminus gfp kiser et al
0.57130253.12538638.html.plaintext.txt	67	1 b egfp cftr wild type yeast digested rapidly half life 10 15 min fig
0.57130253.12538638.html.plaintext.txt	68	1 b slightly rapidly previously published 20 min kiser et al
0.57130253.12538638.html.plaintext.txt	69	cftr appears degraded yeast kiser et al
0.57130253.12538638.html.plaintext.txt	70	2001 opposed mammalian cells 20 transported plasma membrane
0.57130253.12538638.html.plaintext.txt	71	possible yeast sufficient machinery efficiently fold overexpressed cftr even correctly folded cftr read yeast defective
0.57130253.12538638.html.plaintext.txt	72	contrast rapid degradation wild type yeast egfp cftr remains stable pre1 1 mutant yeast even 90 min chase half life egfp cftr ubc6 strain extended 40 min
0.57130253.12538638.html.plaintext.txt	73	egfp cftr construct degraded ubiquitin proteasome pathway yeast use erad substrate test sar1pcopii involvement proteasomal targeting
0.57130253.12538638.html.plaintext.txt	74	egfp cftr sorted subcompartments er degradation previous studies shown cftr tagged cooh terminus gfp kiser et al
0.57130253.12538638.html.plaintext.txt	75	2001 degraded integral membrane protein colocalizes er chaperone kar2p punctate er structures degradation
0.57130253.12538638.html.plaintext.txt	76	analyze egfp cftr construct first tested association membranes
0.57130253.12538638.html.plaintext.txt	77	2 egfp cftr detected exclusively membrane pellet fraction medium speed centrifugation indicating degraded membrane associated form
0.57130253.12538638.html.plaintext.txt	78	view larger version 47k figure 2
0.57130253.12538638.html.plaintext.txt	79	egfp cftr localization depends functional sar1pcopii machinery
0.57130253.12538638.html.plaintext.txt	80	yeast expressing egfp cftr subjected membrane fractionation
0.57130253.12538638.html.plaintext.txt	81	sample fraction processed sds page transferred nitrocellulose membrane immunoblotted anti cftr antibody
0.57130253.12538638.html.plaintext.txt	82	supernatant high speed centrifugation
0.57130253.12538638.html.plaintext.txt	83	p1 p2 p3 pellets low speed medium speed high speed centrifugation respectively
0.57130253.12538638.html.plaintext.txt	84	egfp cftr recovered exclusively membrane fraction
0.57130253.12538638.html.plaintext.txt	85	b wild type yeast expressing egfp cftr grown log phase processed immunofluorescence using anti kar2p anti kex2p antibodies incubated fluorescent dye fm 4 64 45 min 0 degrees c followed 1 h 24 degrees c stain vacuole
0.57130253.12538638.html.plaintext.txt	86	egfp cftr colocalizes er marker kar2p
0.57130253.12538638.html.plaintext.txt	87	c wild type yeast transformed pcu426cup1 egfp cftr pcu426cup1egfp cftr egfp cftr grown log phase induced processed immunofluorescence anti kar2p antibodies insets electron microscopy
0.57130253.12538638.html.plaintext.txt	88	kar2p shows typical er localization egfp cftr cells distributes punctate structures egfp cftr cells
0.57130253.12538638.html.plaintext.txt	89	cells without egfp cftr contain normal er arrows cells expressing egfp cftr show accumulation membranous elements arrowheads
0.57130253.12538638.html.plaintext.txt	90	d wild type ubc6 sec18 1ts sec23 1ts yeast transformed pcu426cup1egfp cftr grown log phase induced permissive 24 degrees c restrictive 39 degrees c temperature
0.57130253.12538638.html.plaintext.txt	91	live yeast imaged fluorescence microscopy
0.57130253.12538638.html.plaintext.txt	92	egfp cftr localizes er subdomains wild type ubc6 sec18 1ts yeast grown permissive restrictive temperatures
0.57130253.12538638.html.plaintext.txt	93	egfp cftr localizes er subdomains sec23 1ts yeast grown permissive temperature diffusely distributed throughout er sec23 1ts yeast grown restrictive temperature
0.57130253.12538638.html.plaintext.txt	94	performed immunofluorescence known organellar markers localize egfp cftr
0.57130253.12538638.html.plaintext.txt	95	2 b egfp cftr detected small punctate structures containing late golgi marker kex2p preuss et al
0.57130253.12538638.html.plaintext.txt	96	result agrees findings cftr expressed yeast undergoes er type n glycosylation undergo golgi type oligosaccharide modifications kiser et al
0.57130253.12538638.html.plaintext.txt	97	egfp cftr detected plasma membrane colocalize fluorescent dye fm 4 64 fig
0.57130253.12538638.html.plaintext.txt	98	2 b shown transported endosomal unpublished data vacuolar compartments yeast function incubation time temperature vida emr 1995 minimal colocalization vacuole due bleed strong egfp cftr signal visible cells without egfp cftr
0.57130253.12538638.html.plaintext.txt	99	lack vacuolar localization consistent lack degradation cftr via pep4pprb1p vacuolar proteases kiser et al
0.57130253.12538638.html.plaintext.txt	100	egfp cftr detected relatively large punctate structures contain kar2p fig
0.57130253.12538638.html.plaintext.txt	101	punctate kar2p distribution egfp cftr expressing yeast distinct normal cage like perinuclear localization control yeast paddon et al
0.57130253.12538638.html.plaintext.txt	102	effects egfp cftr expression intracellular morphology analyzed electron microscopy yeast transformed either empty egfp cftr containing plasmids
0.57130253.12538638.html.plaintext.txt	103	2 c normal nuclear membrane sub plasma membrane er structures evident control cell arrows agreement published images zhang et al
0.57130253.12538638.html.plaintext.txt	104	contrast egfp cftr cell shows clusters membranous structures proximity perinuclear er arrowheads
0.57130253.12538638.html.plaintext.txt	105	higher magnification shows accumulations tubular vesicular elements morphologically analogous er extensions observed yeast expressing cftr zhang et al
0.57130253.12538638.html.plaintext.txt	106	relative size clusters average diameter 0
0.57130253.12538638.html.plaintext.txt	107	5 1 microm corresponds approximate size fluorescent kar2pegfp cftr puncta
0.57130253.12538638.html.plaintext.txt	108	significantly membrane amplification induced cftr zhang et al
0.57130253.12538638.html.plaintext.txt	109	2001 egfp cftr work distinct multi layered er karmellae induced expression hmg coa reductase koning et al
0.57130253.12538638.html.plaintext.txt	110	together data suggest egfp cftr localizes subdomains er network represent penultimate stations degradation
0.57130253.12538638.html.plaintext.txt	111	results also imply sequestration er domains efficient subsequent removal degradation
0.57130253.12538638.html.plaintext.txt	112	functional sar1pcopii machinery required sorting egfp cftr er subdomains determine sar1pcopii machinery participates sorting egfp cftr examined localization copii function disrupted
0.57130253.12538638.html.plaintext.txt	113	first tested localization egfp cftr wild type ubc6 sec18 1 yeast strains grown 24 degrees c permissive temperature strains defective copii components grown 39 degrees c restrictive temperature strains defective copii components
0.57130253.12538638.html.plaintext.txt	114	2 d egfp cftr wild type strain remains punctate spots temperatures
0.57130253.12538638.html.plaintext.txt	115	similarly pattern egfp cftr ubc6 strain defective proteasomal degradation analogous wild type strain
0.57130253.12538638.html.plaintext.txt	116	strongly suggests egfp cftr sorted punctate structure maintained targeted ubiquitination degradation
0.57130253.12538638.html.plaintext.txt	117	data together finding cftr remains sequestered kar2p containing subdomains yeast strain pre1 1pre2 2 defective proteasomal degradation zhang et al
0.57130253.12538638.html.plaintext.txt	118	2001 suggest catalytic activity ubiquitin conjugating enzyme ubc6p sufficient remove egfp cftr er subdomains ubiquitination proteasomal degradation tightly coupled
0.57130253.12538638.html.plaintext.txt	119	punctate egfp cftr pattern observed sec18 1 strain grown either temperature indicating block vesicular fusion er golgi protein transport significantly affect egfp cftr sequestration
0.57130253.12538638.html.plaintext.txt	120	analysis egfp cftr localization sec23 1ts strain kuehn et al
0.57130253.12538638.html.plaintext.txt	121	1998 showed significant temperature dependent changes fig
0.57130253.12538638.html.plaintext.txt	122	permissive temperature egfp cftr sequestered er subdomains restrictive temperature egfp cftr diffusely distributed throughout er pattern characteristic er proteins compare enlargement kar2p staining inset fig
0.57130253.12538638.html.plaintext.txt	123	similar results obtained yeast strains mutant components sar1pcopii machinery described analyzed unpublished data
0.57130253.12538638.html.plaintext.txt	124	functional sar1pcopii machinery required egfp cftr degradation uncover whether sar1pcopii machinery also involved cftr degradation compared degradation rate egfp cftr permissive 24 degrees c restrictive 39 degrees c temperature yeast mutant sar1pcopii components
0.57130253.12538638.html.plaintext.txt	125	wild type strain egfp cftr degraded rapidly temperatures half life 10 15 min fig
0.57130253.12538638.html.plaintext.txt	126	temperature sensitive strain sec12 4ts defective catalyzing gdpgtp exchange sar1p restrictive temperature due p73l mutation barlowe schekman 1993
0.57130253.12538638.html.plaintext.txt	127	egfp cftr degraded rapidly sec12 4ts strain permissive temperature half life 10 min analogous wild type strain fig
0.57130253.12538638.html.plaintext.txt	128	contrast degradation rate delayed significantly yeast shifted restrictive temperature half life extending 40 45 min threefold increase compared permissive temperature
0.57130253.12538638.html.plaintext.txt	129	temperature sensitive strains sec23 1ts sec13 1ts salama et al
0.57130253.12538638.html.plaintext.txt	130	1997 defective restrictive temperature due s382l mutation yoshihisa et al
0.57130253.12538638.html.plaintext.txt	131	1993 mutation yet identified respectively
0.57130253.12538638.html.plaintext.txt	132	cases copii function compromised
0.57130253.12538638.html.plaintext.txt	133	egfp cftr degraded rapidly sec23 1ts sec13 1ts strains permissive temperature half lives 15 min fig
0.57130253.12538638.html.plaintext.txt	134	contrast degradation rates significantly delayed strains restrictive temperatures half life 50 min
0.57130253.12538638.html.plaintext.txt	135	significant inhibition egfp cftr degradation suggests functional copii machinery required proteasomal degradation egfp cftr
0.57130253.12538638.html.plaintext.txt	136	view larger version 50k figure 3
0.57130253.12538638.html.plaintext.txt	137	egfp cftr degradation depends functional sar1pcopii machinery
0.57130253.12538638.html.plaintext.txt	138	wild type sec12 4ts b sec23 1ts c sec13 1ts d sec18 1ts e yeast transformed pcu426cup1egfp cftr
0.57130253.12538638.html.plaintext.txt	139	yeast grown log phase induced permissive temperature
0.57130253.12538638.html.plaintext.txt	140	equal amount culture pulse labeled 35smethionine 20 min either 24 degrees c 39 degrees c
0.57130253.12538638.html.plaintext.txt	141	equal amount culture taken indicated chase times used prepare cell lysates
0.57130253.12538638.html.plaintext.txt	142	lysates immunoprecipitated anti cftr anti cpy sec18 1ts antibody
0.57130253.12538638.html.plaintext.txt	143	relative intensities egfp cftr bands quantitated
0.57130253.12538638.html.plaintext.txt	144	egfp cftr degradation significantly inhibited inactivation sec12p sec23p sec13p
0.57130253.12538638.html.plaintext.txt	145	must stressed egfp cftr like transmembrane erad substrates enter er golgi recycling degradative pathway
0.57130253.12538638.html.plaintext.txt	146	like previously characterized cftr kiser et al
0.57130253.12538638.html.plaintext.txt	147	2001 egfp cftr degraded normal kinetics permissive restrictive temperatures sec18 1 strain fig
0.57130253.12538638.html.plaintext.txt	148	strain defective sec18p function shown block maturation vacuolar cpy restrictive temperature fig
0.57130253.12538638.html.plaintext.txt	149	together results indicate er golgi transport recycling required egfp cftr degradation
0.57130253.12538638.html.plaintext.txt	150	findings suggest novel role sar1pcopii sorting machinery
0.57130253.12538638.html.plaintext.txt	151	addition selecting correctly folded substrates forward secretory pathway schekman orci 1996 bannykh et al
0.57130253.12538638.html.plaintext.txt	152	2000 selecting misfolded soluble erad substrates er golgi recycling degradative pathway vashist et al
0.57130253.12538638.html.plaintext.txt	153	2001 sar1pcopii also sorts misfolded substrates subdomains er subsequently degraded
0.57130253.12538638.html.plaintext.txt	154	machinery sort proteins three distinct pathways common sorting mechanism correctly folded misfolded membrane proteins presents spatial problem classes must occupy distinct regions er
0.57130253.12538638.html.plaintext.txt	155	likely additional targeting mechanisms coordinate sar1pcopii direct proteins er exit retention
0.57130253.12538638.html.plaintext.txt	156	appears primary distinction made level packaging copii vesicles although correctly folded soluble transmembrane proteins secretory traffic misfolded soluble erad substrates er golgi recycling degradative traffic sorted copii vesicles misfolded transmembrane erad substrates excluded vashist et al
0.57130253.12538638.html.plaintext.txt	157	evidence transmembrane erad substrates prevented entry copii vesicles retained er action luminal er proteins
0.57130253.12538638.html.plaintext.txt	158	example mutants transmembrane atpase pma1p appear retained degraded er action protein disulfide isomerase related protein eps1p wang chang 1999
0.57130253.12538638.html.plaintext.txt	159	similarly retention transmembrane h2a precursor er determined pentapeptide sequence present luminal side er shenkman et al
0.57130253.12538638.html.plaintext.txt	160	addition erad substrates retained binding calnexin
0.57130253.12538638.html.plaintext.txt	161	shown calnexin binds wild type folding compromised f508cftr er association f508cftr prolonged might facilitate er retention pind et al
0.57130253.12538638.html.plaintext.txt	162	erad substrates also retained association translocon loayza et al
0.57130253.12538638.html.plaintext.txt	163	cytoplasmic chaperones may also participate er retention brodsky et al
0.57130253.12538638.html.plaintext.txt	164	finding strains inactivated cytosolic hsp70 ssa1p sort cftr er subdomains supports view er sequestration requires coordinate action sar1pcopii accessory factors
0.57130253.12538638.html.plaintext.txt	165	sar1pcopii likely participate secretory degradative pathways supported data obtained whole genome microarray analysis many genes involved secretory traffic found upr targets travers et al
0.57130253.12538638.html.plaintext.txt	166	initially regulation viewed means increase traffic er golgi recycling degradative pathway soluble erad substrates caldwell et al
0.57130253.12538638.html.plaintext.txt	167	however work suggests regulation also means increase components required er sequestration transmembrane erad substrates
0.57130253.12538638.html.plaintext.txt	168	specifically relevant analysis regulation sec12 sec13 sec24
0.57130253.12538638.html.plaintext.txt	169	thus may upr mediated regulation genes may cellular strategy remove protein er exporting additionally might promote sorting retained proteins toward degradation
0.57130253.12538638.html.plaintext.txt	170	materials methods top abstract introduction results discussion materials methods references antibodies plasmids anti cftr nbd1 pab described previously bebok et al
0.57130253.12538638.html.plaintext.txt	171	david bedwell university alabama birmingham birmingham al
0.57130253.12538638.html.plaintext.txt	172	anti kar2p pab gift dr
0.57130253.12538638.html.plaintext.txt	173	jeffrey brodsky university pittsburgh pittsburgh pa
0.57130253.12538638.html.plaintext.txt	174	anti kex2p mab gift dr
0.57130253.12538638.html.plaintext.txt	175	vytas bankaitis university north carolina chapel hill chapel hill nc
0.57130253.12538638.html.plaintext.txt	176	anti cooh terminal cftr mab purchased usbiological
0.57130253.12538638.html.plaintext.txt	177	anti cpy antibody purchased molecular probes inc
0.57130253.12538638.html.plaintext.txt	178	goat anti rat anti mouse antibodies conjugated fluorescein isothiocyanate rhodamine purchased jackson immunoresearch laboratories
0.57130253.12538638.html.plaintext.txt	179	generate inducible construct expressing gfp tagged cftr yeast pegfp cftr plasmid moyer et al
0.57130253.12538638.html.plaintext.txt	180	1998 first digested sacii treated klenow fragment followed digestion nhei
0.57130253.12538638.html.plaintext.txt	181	prsetbegfp plasmid provided dr
0.57130253.12538638.html.plaintext.txt	182	david bedwell first digested hindiii treated klenow fragment followed digestion nhei
0.57130253.12538638.html.plaintext.txt	183	egfp containing fragment prsetbegfp cftr containing fragment pegfp cftr gel purified ligated transformed eschericia coli
0.57130253.12538638.html.plaintext.txt	184	resulting plasmid digested nhei ecorv treated klenow fragment
0.57130253.12538638.html.plaintext.txt	185	egfp cftr containing fragment gel purified cloned smai site pcu426cup1 labbe thiele 1999
0.57130253.12538638.html.plaintext.txt	186	final construct sequenced ensure correct open reading frame
0.57130253.12538638.html.plaintext.txt	187	yeast strains cty182 mata ura3 52 his3 200 lys2 80 cty252 mata ura3 52 sec12 4ts cty253 mata ura3 52 sec13 1ts cty260 mat ura3 52 leu2 3 112 sec23 1ts gift dr
0.57130253.12538638.html.plaintext.txt	188	yhi29w mata ura3 leu2 3 112 his3 11 15 cans gal1 yhi291 mata pre1 1 ura3 leu2 3 112 his3 11 15 cans gal1 ywo0346 mat ura3 1 leu2 3 112 his3 11 15 ade2 1 ocre trp1 1 can1 100 ubc6leu2 gift dr
0.57130253.12538638.html.plaintext.txt	189	dieter wolf universitat stuttgart stuttgart germany
0.57130253.12538638.html.plaintext.txt	190	sey6210 mat ura3 52 leu2 3 112 his3 200 trp1 901 lys2 801 suc2 9 sey5186 mat sec18 1 ura3 52 leu2 3 112 gal gift dr
0.57130253.12538638.html.plaintext.txt	191	yeast media prepared described previously rose et al
0.57130253.12538638.html.plaintext.txt	192	unless specified experiments cultures grown minimum 5 6 generations a600 1
0.57130253.12538638.html.plaintext.txt	193	fractionation immunofluorescence electron microscopy yeast expressing egfp cftr fractionated described previously paddon et al
0.57130253.12538638.html.plaintext.txt	194	brief cells grown exponential phase converted spheroplasts using yeast lytic enzyme icn biomedicals presence 20 mm potassium phosphate buffer ph 7
0.57130253.12538638.html.plaintext.txt	195	spheroplasts washed disrupted using dounce homogenizer 25 mm hepes naoh buffer ph 7
0.57130253.12538638.html.plaintext.txt	196	4 plus protease inhibitors sigma aldrich
0.57130253.12538638.html.plaintext.txt	197	cell lysates centrifuged 4 degrees c 500 g 10 min resulting supernatant spun 25000 g 15 min
0.57130253.12538638.html.plaintext.txt	198	resulting supernatant centrifuged 150000 g 1 h
0.57130253.12538638.html.plaintext.txt	199	pellet spin washed hepes buffer saved p1 p2 p3 respectively
0.57130253.12538638.html.plaintext.txt	200	protein concentration measured using detergent compatible protein assay kit bio rad laboratories
0.57130253.12538638.html.plaintext.txt	201	immunofluorescent studies yeast grown synthetic complete medium lacking uracil od600 1
0.57130253.12538638.html.plaintext.txt	202	yeast fixed adding formaldehyde 3 incubating either 24 degrees c 39 degrees c 30 min
0.57130253.12538638.html.plaintext.txt	203	cells harvested washed twice 0
0.57130253.12538638.html.plaintext.txt	204	5 potassium phosphate buffer containing 1
0.57130253.12538638.html.plaintext.txt	205	cell walls digested adding ss mercaptoethanol 0
0.57130253.12538638.html.plaintext.txt	206	incubating 30 degrees c 1 h cells washed twice sorbitol buffer applied polylysine coated coverslips allowed settle rt 20 min
0.57130253.12538638.html.plaintext.txt	207	cells refixed 3 formaldehyde 5 min followed quenching 50 mm nh4cl 5 min
0.57130253.12538638.html.plaintext.txt	208	cells permeabilized 0
0.57130253.12538638.html.plaintext.txt	209	1 triton x 100 10 min washed twice 5 min blocking buffer pbs containing 0
0.57130253.12538638.html.plaintext.txt	210	cells incubated overnight primary antibody diluted 15000 anti kar2p antibody 12000 anti kex2p antibody
0.57130253.12538638.html.plaintext.txt	211	coverslips washed three times blocking buffer
0.57130253.12538638.html.plaintext.txt	212	cells incubated secondary antibody 1 h washed
0.57130253.12538638.html.plaintext.txt	213	coverslips mounted slides 91 glycerolpbs 0
0.57130253.12538638.html.plaintext.txt	214	images acquired inverted microscope axiovert 30 carl zeiss microimaging inc
0.57130253.12538638.html.plaintext.txt	215	iplab spectrum software signal analytics corp
0.57130253.12538638.html.plaintext.txt	216	used control image acquisition
0.57130253.12538638.html.plaintext.txt	217	yeast containing either empty plasmid egfp cftr containing plasmid grown a600 0
0.57130253.12538638.html.plaintext.txt	218	5 induced copper 2 h processed electron microscopy described previously kaiser schekman 1990
0.57130253.12538638.html.plaintext.txt	219	grids examined electron microscope model 100cx jeol usa inc
0.57130253.12538638.html.plaintext.txt	220	pulse chase labeling immunoprecipitation yeast grown overnight log phase 24 degrees c synthetic complete medium supplemented appropriate amino acids
0.57130253.12538638.html.plaintext.txt	221	egfp cftr expression induced 100 microm cuso4 2 h labbe thiele 1999
0.57130253.12538638.html.plaintext.txt	222	total 32 od600 u cells harvested 3 od600 u time point resuspended 4 ml synthetic complete medium plus 100 microm cuso4
0.57130253.12538638.html.plaintext.txt	223	culture separated two parts incubated shaking 24 degrees c 39 degrees c 10 min
0.57130253.12538638.html.plaintext.txt	224	cells labeled 200 microci 35smethionine trans35s label icn biomedicals 20 min
0.57130253.12538638.html.plaintext.txt	225	label chased 40 microl chasing mixture 1 mgml methionine 1 mgml cysteine 15 yeast extract
0.57130253.12538638.html.plaintext.txt	226	4 ml samples collected 0 15 30 60 90 min added 25 microl 100 tca 5 final tca concentration
0.57130253.12538638.html.plaintext.txt	227	samples mixed placed ice 20 min washed twice ice cold acetone
0.57130253.12538638.html.plaintext.txt	228	cells resuspended lysis buffer 50 mm tris hcl ph 7
0.57130253.12538638.html.plaintext.txt	229	5 sds protease inhibitors broken vortexing glass beads
0.57130253.12538638.html.plaintext.txt	230	egfp cftr immunoprecipitated total cell lysate using polyclonal anti nbd1 cftr antibody 1250 dilutions
0.57130253.12538638.html.plaintext.txt	231	immunoprecipitates separated 6 sds page analyzed phosphorimager molecular dynamics inc
0.57130253.12538638.html.plaintext.txt	232	egfp cftr signal quantified using imagequant software molecular dynamics inc
0.57130253.12538638.html.plaintext.txt	233	relative amounts calculated plotted using excel software microsoft
0.57130253.12538638.html.plaintext.txt	234	cpy analysis pulse chase done lysates immunoprecipitated anti cpy antibodies
0.57130253.12538638.html.plaintext.txt	235	immunoprecipitates resolved 10 sds page analyzed
0.57130253.12538638.html.plaintext.txt	236	sds page immunoblotting samples resolved 6 sds page described previously bebok et al
0.57130253.12538638.html.plaintext.txt	237	gels electrotransferred nitrocellulose membrane immunoblotted anti cooh terminal cftr mab described previously bebok et al
0.57130253.12538638.html.plaintext.txt	238	footnotes abbreviations used paper cftr cystic fibrosis transmembrane conductance regulator cpy carboxy peptidase y erad er associated protein degradation
0.57130253.12538638.html.plaintext.txt	239	acknowledgments thank drs
0.57130253.12538638.html.plaintext.txt	240	jeffrey brodsky eric sorscher dave bedwell gergely lukacs helpful suggestions drs
0.57130253.12538638.html.plaintext.txt	241	bruce stanton eric schwiebert dieter wolf davis ng essential reagents
0.57130253.12538638.html.plaintext.txt	242	also thank ratnakar josyula ed philips help electron microscopy
0.57130253.12538638.html.plaintext.txt	243	submitted 15 october 2002revised 6 december 2002accepted 9 december 2002
0.57130253.12538638.html.plaintext.txt	244	references top abstract introduction results discussion materials methods references
0.57130253.12538638.html.plaintext.txt	245	er export public transportation copii coach
0.57130253.12538638.html.plaintext.txt	246	traffic pattern cystic fibrosis transmembrane regulator early exocytic pathway
0.57130253.12538638.html.plaintext.txt	247	traffic cops early secretory pathway
0.57130253.12538638.html.plaintext.txt	248	sec12 encodes guanine nucleotide exchange factor essential transport vesicle budding er
0.57130253.12538638.html.plaintext.txt	249	mechanism underlying cystic fibrosis transmembrane conductance regulator transport endoplasmic reticulum proteasome includes sec61beta cytosolic deglycosylated intermediary
0.57130253.12538638.html.plaintext.txt	250	ring h2 finger motif essential function der3hrd1 endoplasmic reticulum associated protein degradation yeast saccharomyces cerevisiae
0.57130253.12538638.html.plaintext.txt	251	er protein quality control proteasome mediated protein degradation
0.57130253.12538638.html.plaintext.txt	252	requirement molecular chaperones endoplasmic reticulum associated protein degradation demonstrates protein export import mechanistically distinct
0.57130253.12538638.html.plaintext.txt	253	degradation endoplasmic reticulum er quality control substrates requires transport er golgi
0.57130253.12538638.html.plaintext.txt	254	er quality control towards understanding molecular level
0.57130253.12538638.html.plaintext.txt	255	principal role proteasome endoplasmic reticulum associated degradation misfolded intracellular cystic fibrosis transmembrane conductance regulator
0.57130253.12538638.html.plaintext.txt	256	role 26s proteasome hrd genes degradation 3 hydroxy 3 methylglutaryl coa reductase integral endoplasmic reticulum membrane protein
0.57130253.12538638.html.plaintext.txt	257	multiple proteolytic systems including proteasome contribute cftr processing
0.57130253.12538638.html.plaintext.txt	258	aggresomes cellular response misfolded proteins
0.57130253.12538638.html.plaintext.txt	259	distinct sets sec genes govern transport vesicle formation fusion early secretory pathway
0.57130253.12538638.html.plaintext.txt	260	novel quality control compartment derived endoplasmic reticulum
0.57130253.12538638.html.plaintext.txt	261	mutational disruption plasma membrane trafficking saccharomyces cerevisiae yor1p homologue mammalian multidrug resistance protein
0.57130253.12538638.html.plaintext.txt	262	new paradigms cftr chloride channel regulation
0.57130253.12538638.html.plaintext.txt	263	expression degradation cystic fibrosis transmembrane conductance regulator saccharomyces cerevisiae
0.57130253.12538638.html.plaintext.txt	264	der1 novel protein specifically required endoplasmic reticulum degradation yeast
0.57130253.12538638.html.plaintext.txt	265	different subcellular localization saccharomyces cerevisiae hmg coa reductase isozymes elevated levels corresponds distinct endoplasmic reticulum membrane proliferations
0.57130253.12538638.html.plaintext.txt	266	copii cargo interactions direct protein sorting er derived transport vesicles
0.57130253.12538638.html.plaintext.txt	267	copper ion inducible repressible promoter systems yeast
0.57130253.12538638.html.plaintext.txt	268	ste6p mutants defective exit endoplasmic reticulum er reveal aspects er quality control pathway saccharomyces cerevisiae
0.57130253.12538638.html.plaintext.txt	269	assembly er associated protein degradation vitro dependence cytosol calnexin atp
0.57130253.12538638.html.plaintext.txt	270	membrane trafficking cystic fibrosis gene product cystic fibrosis transmembrane conductance regulator tagged green fluorescent protein madin darby canine kidney cells
0.57130253.12538638.html.plaintext.txt	271	molecular chaperones yeast endoplasmic reticulum maintain solubility proteins retrotranslocation degradation
0.57130253.12538638.html.plaintext.txt	272	analysis localization ste6cftr chimeras saccharomyces cerevisiae model cystic fibrosis defect cftr delta f508
0.57130253.12538638.html.plaintext.txt	273	participation endoplasmic reticulum chaperone calnexin p88 ip90 biogenesis cystic fibrosis transmembrane conductance regulator
0.57130253.12538638.html.plaintext.txt	274	mutant analysis links translocon bip retrograde protein transport er degradation
0.57130253.12538638.html.plaintext.txt	275	characterization saccharomyces golgi complex cell cycle immunoelectron microscopy
0.57130253.12538638.html.plaintext.txt	276	aaa atpase p97cdc48p cytosolic chaperone required endoplasmic reticulum associated protein degradation
0.57130253.12538638.html.plaintext.txt	277	cystic fibrosis disease misprocessing cystic fibrosis transmembrane conductance regulator glycoprotein
0.57130253.12538638.html.plaintext.txt	278	methods yeast genetics laboratory course manual
0.57130253.12538638.html.plaintext.txt	279	cold spring harbor laboratory cold spring harbor ny
0.57130253.12538638.html.plaintext.txt	280	sec31 encodes essential component copii coat required transport vesicle budding endoplasmic reticulum
0.57130253.12538638.html.plaintext.txt	281	endoplasmic reticulum quality control asialoglycoprotein receptor h2a involves determinant retention retrieval
0.57130253.12538638.html.plaintext.txt	282	coat proteins vesicle budding
0.57130253.12538638.html.plaintext.txt	283	er golgi traffic prerequisite efficient er degradation
0.57130253.12538638.html.plaintext.txt	284	functional genomic analyses reveal essential coordination unfolded protein response er associated degradation
0.57130253.12538638.html.plaintext.txt	285	distinct retrieval retention mechanisms required quality control endoplasmic reticulum protein folding
0.57130253.12538638.html.plaintext.txt	286	isolation analysis functional homologues secretion related sar1 gene saccharomyces cerevisiae aspergillus niger trichoderma reesei
0.57130253.12538638.html.plaintext.txt	287	new vital stain visualizing vacuolar membrane dynamics endocytosis yeast
0.57130253.12538638.html.plaintext.txt	288	eps1 novel pdi related protein involved er quality control yeast
0.57130253.12538638.html.plaintext.txt	289	degradation cftr ubiquitin proteasome pathway
0.57130253.12538638.html.plaintext.txt	290	requirement gtpase activating protein vesicle budding endoplasmic reticulum
0.57130253.12538638.html.plaintext.txt	291	hsp70 molecular chaperone facilitates endoplasmic reticulum associated protein degradation cystic fibrosis transmembrane conductance regulator yeast
0.45175216.11381082.html.plaintext.txt	0	cooh terminal truncations promote proteasome dependent degradation mature cystic fibrosis transmembrane conductance regulator post golgi compartments mohamed benharougaab martin haardtab norbert kartnerc gergely l
0.45175216.11381082.html.plaintext.txt	1	lukacsab program lung cell biology hospital sick children toronto m5g 1x8 ontario canada b department laboratory medicine pathobiology university toronto toronto m5g 1x8 ontario canada c department pharmacology university toronto toronto m5g 1x8 ontario canada
0.45175216.11381082.html.plaintext.txt	2	lukacs program lung cell biology hospital sick children 555 university ave
0.45175216.11381082.html.plaintext.txt	3	toronto m5g 1x8 ontario canada
0.45175216.11381082.html.plaintext.txt	4	tel416 813 5125 fax416 813 5771 e mailglukacsatsickkids
0.45175216.11381082.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	6	impaired biosynthetic processing cystic fibrosis cf transmembrane conductance regulator cftr camp regulated chloride channel constitutes common cause cf
0.45175216.11381082.html.plaintext.txt	7	recently identified distinct category mutation caused premature stop codons frameshift mutations manifests diminished expression cooh terminally truncated cftr cell surface
0.45175216.11381082.html.plaintext.txt	8	although biosynthetic processing plasma membrane targeting truncated cftrs preserved turnover complex glycosylated mutant sixfold faster wild type wt counterpart
0.45175216.11381082.html.plaintext.txt	9	destabilization truncated cftr coincides enhanced susceptibility proteasome dependent degradation post golgi compartments globally plasma membrane specifically determined pulse chase analysis conjunction cell surface biotinylation
0.45175216.11381082.html.plaintext.txt	10	proteolytic cleavage full length complex glycosylated wt degradation intermediates derived t70 wt cftr requires endolysosomal proteases
0.45175216.11381082.html.plaintext.txt	11	enhanced protease sensitivity vitro decreased thermostability complex glycosylated t70 cftr vivo suggest structural destabilization may account increased proteasome susceptibility short residence time cell surface
0.45175216.11381082.html.plaintext.txt	12	turn responsible least part phenotypic manifestation cf
0.45175216.11381082.html.plaintext.txt	13	propose proteasome ubiquitin pathway may involved peripheral quality control partially unfolded membrane proteins well
0.45175216.11381082.html.plaintext.txt	14	key words cystic fibrosis lysosomal proteolysis structural destabilization functional complementation ubiquitination
0.45175216.11381082.html.plaintext.txt	15	introduction top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	16	newly synthesized secretory membrane proteins must attain native conformation spontaneously assistance er resident cytosolic chaperones export er
0.45175216.11381082.html.plaintext.txt	17	er quality control mechanism assures functionally incompetent misfolded unassembled oligomeric proteins retained targeted proteolysis via er associated degradation erad1 pathway hurtley helnius 1989 brodsky mccracken 1997 bonifacino weismann 1998 ellgaard et al
0.45175216.11381082.html.plaintext.txt	18	erad involves recognition dislocation proteolysis misfolded polypeptides 26s proteasome multicatalytic enzyme complex localized cytoplasm nucleus baumeister et al
0.45175216.11381082.html.plaintext.txt	19	1998 bonifacino weismann 1998 brodsky mccracken 1999 plemper wolf 1999
0.45175216.11381082.html.plaintext.txt	20	atp dependent cleavage process facilitated multiple ubiquitin attachments amino groups lysine residues substrate catalyzed cascade enzymatic reactions involving ubiquitin activating e1 conjugating e2 enzymes addition ubiquitin protein ligases e3 hershko ciechanover 1998
0.45175216.11381082.html.plaintext.txt	21	trafficking defects recognized underlying mechanism growing number genetic diseases including cystic fibrosis cf diabetes insipidus 1 antitrypsin deficiency thomas et al
0.45175216.11381082.html.plaintext.txt	22	1995 bonifacino weismann 1998 hershko ciechanover 1998 aridor balch 1999 kopito 1999 schwartz ciechanover 1999
0.45175216.11381082.html.plaintext.txt	23	cf prevalent recessive genetic disorder caucasian population caused dysfunction cf transmembrane conductance regulator cftr member atp binding cassette transport protein family riordan et al
0.45175216.11381082.html.plaintext.txt	24	cftr camp stimulated cl channel residing predominantly cell surface less abundantly endosomal compartment bradbury 1999
0.45175216.11381082.html.plaintext.txt	25	channel consists two homologous halves comprised six transmembrane helices nucleotide binding domain nbd1 nbd2 connected regulatory domain riordan et al
0.45175216.11381082.html.plaintext.txt	26	complex multidomain structure conceivably renders posttranslational folding wild type wt cftr inefficient
0.45175216.11381082.html.plaintext.txt	27	approximately 70 newly synthesized wt cftr trapped er core glycosylated folding intermediate apparent molecular weight 150 000 degraded t12 30 min erad
0.45175216.11381082.html.plaintext.txt	28	proteasome activity responsible least part degradation co posttranslationally ubiquitinated incompletely folded cftr er jensen et al
0.45175216.11381082.html.plaintext.txt	29	however inhibition proteasomes failed promote processing core glycosylated wt well f508 cftr jensen et al
0.45175216.11381082.html.plaintext.txt	30	20 30 newly synthesized cftr enters secretory pathway atp dependent conformational maturation lukacs et al
0.45175216.11381082.html.plaintext.txt	31	1998 assisted cytosolic er resident chaperones yang et al
0.45175216.11381082.html.plaintext.txt	32	processing high mannose type n linked glycan complex type oligosaccharides cismedial golgi region reflected decreased electrophoretic mobility 180 kd providing convenient method monitor trafficking cftr cheng et al
0.45175216.11381082.html.plaintext.txt	33	1994 ward kopito 1994 riordan 1999
0.45175216.11381082.html.plaintext.txt	34	folded complex glycosylated cftr slow turnover vivo t12 12 h also displays conformation resistant proteolysis vitro zhang et al
0.45175216.11381082.html.plaintext.txt	35	posttranslational folding conformational maturation cftr independent er golgi vesicular transport implying complex glycosylation prerequisite attain native conformation lukacs et al
0.45175216.11381082.html.plaintext.txt	36	1994 ward kopito 1994 zhang et al
0.45175216.11381082.html.plaintext.txt	37	majority cf associated point mutations including common f508 cftr impair biosynthetic processing disrupting posttranslational folding er welsh smith 1993 zielenski tsui 1995 riordan 1999
0.45175216.11381082.html.plaintext.txt	38	recently identified mechanistically distinct category mutation caused premature terminations frameshift mutations cf gene haardt et al
0.45175216.11381082.html.plaintext.txt	39	although er processing cooh terminally truncated cftr variants missing last 70 82 amino acid residues t70 t82 cftr similar wt form biological half life complex glycosylated mutants sixfold shorter wt counterpart haardt et al
0.45175216.11381082.html.plaintext.txt	40	although proteolytic elimination mechanism processing mutants entrapped er extensively studied welsh smith 1993 kopito 1999 riordan 1999 cellular processes responsible short residence time truncated cftr post golgi compartments remained obscure
0.45175216.11381082.html.plaintext.txt	41	show deletion cooh terminus renders complex glycosylated truncated cftr highly susceptible proteasome dependent proteolysis post golgi compartments including plasma membrane
0.45175216.11381082.html.plaintext.txt	42	structural destabilization demonstrated increased protease susceptibility vitro diminished thermostability complex glycosylated mutants vivo may serve signal premature proteolysis
0.45175216.11381082.html.plaintext.txt	43	contrast lysosomal proteolysis appears represent rate limiting step degradation complex glycosylated wt cftr
0.45175216.11381082.html.plaintext.txt	44	results reveal novel aspect proteasome dependent degradation pathway elimination nonnative cftr escape er quality control
0.45175216.11381082.html.plaintext.txt	45	materials methods top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	46	plasmids influenza hemagglutinin ha epitope attached nh2 terminus ubiquitin using pcr mutagenesis cdna yeast ubiquitin template provided dr
0.45175216.11381082.html.plaintext.txt	47	haguenauer tsapis jacques monod university paris vii paris france
0.45175216.11381082.html.plaintext.txt	48	generate tac lamp1 chimera extracellular transmembrane segment interleukin 2 receptor tac fused cytoplasmic tail lamp 1
0.45175216.11381082.html.plaintext.txt	49	constructs sequenced verify errors introduced
0.45175216.11381082.html.plaintext.txt	50	cdna encoding tac tac tcr provided dr
0.45175216.11381082.html.plaintext.txt	51	bonifacino national institutes health bethesda md
0.45175216.11381082.html.plaintext.txt	52	tac tac tcr tac lamp1 stably transfected bhk 21 cells using pnut expression cassette haardt et al
0.45175216.11381082.html.plaintext.txt	53	cell lines transfections mixtures stably transfected bhk 21 cells expressing wt truncated cftr missing last 26 70 82 98 amino acid residues t26 t70 t82 t98 cftr respectively tac tac tcr tac lamp1 generated maintained described haardt et al
0.45175216.11381082.html.plaintext.txt	54	intestinal epithelia t84 caco 2 expressing endogenous cftr cultured described lukacs et al
0.45175216.11381082.html.plaintext.txt	55	cos 1 cells transiently transfected lipofectamine haardt et al
0.45175216.11381082.html.plaintext.txt	56	electrophoresis immunoblotting cells washed ice cold pbs lysed ripa buffer 150 mm nacl 20 mm tris hcl 1 triton x 100 0
0.45175216.11381082.html.plaintext.txt	57	0 containing 5 microgml leupeptin pepstatin 10 mm iodoacetamide 1 mm pmsf 4 degrees c
0.45175216.11381082.html.plaintext.txt	58	nuclei unbroken cells removed centrifugation 15000 g 15 min 4 degrees c
0.45175216.11381082.html.plaintext.txt	59	proteins denatured laemmli sample buffer separated sds page transferred nitrocellulose membrane
0.45175216.11381082.html.plaintext.txt	60	immunoblotting performed described previously using mouse monoclonal l12b4 m3a7 anti cftr antibodies abs kartner et al
0.45175216.11381082.html.plaintext.txt	61	1992 mouse monoclonal anti ha covance antiubiquitin abs santa cruz biotechnology inc
0.45175216.11381082.html.plaintext.txt	62	primary abs visualized horseradish peroxidase conjugated sheep anti mouse igg enhanced chemiluminescence ecl western blot kit amersham pharmacia biotech
0.45175216.11381082.html.plaintext.txt	63	metabolic pulse chase labeling immunoprecipitation bhk cos 1 cells pulse labeled presence 35smethionine 35scysteine 0
0.45175216.11381082.html.plaintext.txt	64	25 mciml amersham pharmacia biotech chased complete medium specified time 37 degrees c
0.45175216.11381082.html.plaintext.txt	65	cftr immunoprecipitated mixture m3a7 l12b4 anti cftr abs described lukacs et al
0.45175216.11381082.html.plaintext.txt	66	duration pulse chase periods withdrawals samples indicated schematic figures
0.45175216.11381082.html.plaintext.txt	67	radioactivity associated cftr visualized fluorography quantified phosphorimager pdi using imagequant software haardt et al
0.45175216.11381082.html.plaintext.txt	68	cell surface biotinylation determine expression levels wt truncated cftr cell surface early endosome bhk cells metabolically labeled steady state overnight rinsed h buffer 154 mm nacl 10 mm hepes 3 mm kcl 1 mm mgcl2 0
0.45175216.11381082.html.plaintext.txt	69	1 mm cacl2 10 mm glucose ph 7
0.45175216.11381082.html.plaintext.txt	70	cells biotinylated presence 1 mgml sulphosuccinimidyl 2 biotinamidoethyl 13 dithiopropionate ez link sulfo nhs ss biotin pierce chemical co
0.45175216.11381082.html.plaintext.txt	71	h buffer 37 degrees c lukacs et al
0.45175216.11381082.html.plaintext.txt	72	cells washed ice cold pbs supplemented 0
0.45175216.11381082.html.plaintext.txt	73	1 mm cacl2 solubilized ripa buffer
0.45175216.11381082.html.plaintext.txt	74	biotinylated cftr isolated immunoprecipitation m3a7 l12b4 anti cftr abs streptavidin sepharose sigma aldrich
0.45175216.11381082.html.plaintext.txt	75	biotinylated cftr visualized fluorography radioactivity measured phosphorimage analysis
0.45175216.11381082.html.plaintext.txt	76	subcellular fractionation cells washed ice cold pbs three times resuspended homogenization medium 0
0.45175216.11381082.html.plaintext.txt	77	25 m sucrose 10 mm hepes 1 mm edta 1 mm dtt ph 7
0.45175216.11381082.html.plaintext.txt	78	2 supplemented 5 microgml leupeptin 5 microgml pepstatin 2 mm pmsf
0.45175216.11381082.html.plaintext.txt	79	cho bq1 cho k1 caco 2 t84 cells homogenized nitrogen cavitation described zhang et al
0.45175216.11381082.html.plaintext.txt	80	1998 whereas bhk cells homogenized dounce homogenizer
0.45175216.11381082.html.plaintext.txt	81	sedimentation unbroken cells nuclei 2500 g 5 min 4 degrees c mitochondria pelleted centrifugation 10000 g 10 min 4 degrees c postnuclear supernatant
0.45175216.11381082.html.plaintext.txt	82	microsomes fractionated self forming percoll density gradient 25 percoll 0
0.45175216.11381082.html.plaintext.txt	83	25 m sucrose 10 mm hepes 1 mm edta 5 microgml leupeptin 5 microgml pepstatin ph 7
0.45175216.11381082.html.plaintext.txt	84	density profile gradient verified density marker beads sigma aldrich fractions downloaded described lukacs et al
0.45175216.11381082.html.plaintext.txt	85	experiments lysosomes labeled fluid phase marker fluorescein dextran 0
0.45175216.11381082.html.plaintext.txt	86	5 mgml 70 kd molecular probes overnight chased full medium 3 h
0.45175216.11381082.html.plaintext.txt	87	alkaline phosphatase ss glucoronidase mannosidase ii activity specific markers plasma membrane lysosomes golgi regions respectively measured described lukacs et al
0.45175216.11381082.html.plaintext.txt	88	fluorescence associated fractions determined fluorescence spectrophotometry presence 0
0.45175216.11381082.html.plaintext.txt	89	limited proteolysis bhk cells expressing wt t70 cftr incubated presence cycloheximide 100 microgml ensure degradation core glycosylated wt t70 cftr lukacs et al
0.45175216.11381082.html.plaintext.txt	90	isolation er golgi complex plasma membrane enriched microsomes performed described zhang et al
0.45175216.11381082.html.plaintext.txt	91	5 mgml digested hse medium 10 mm hepes 0
0.45175216.11381082.html.plaintext.txt	92	6 presence indicated concentration trypsin proteinase k 15 min 4 degrees c zhang et al
0.45175216.11381082.html.plaintext.txt	93	proteolysis terminated addition 1 mm pmsf
0.45175216.11381082.html.plaintext.txt	94	samples immediately denatured 2x laemmli sample buffer 37 degrees c 20 min probed immunoblot analysis
0.45175216.11381082.html.plaintext.txt	95	measurement camp stimulated iodide conductance plasma membrane plasma membrane camp dependent halide conductance bhk cells expressing t70 cftr determined iodide efflux described mohamed et al
0.45175216.11381082.html.plaintext.txt	96	iodide efflux initiated replacing loading buffer efflux medium composed 136 mm nitrate place iodide
0.45175216.11381082.html.plaintext.txt	97	extracellular medium replaced every minute efflux buffer 1 ml
0.45175216.11381082.html.plaintext.txt	98	steady state reached intracellular camp level raised agonists 10 microm forskolin 0
0.45175216.11381082.html.plaintext.txt	99	2 mm isobutyl methyl xanthane achieve maximal phosphorylation t70 cftr
0.45175216.11381082.html.plaintext.txt	100	collection efflux medium resumed additional 6 9 min
0.45175216.11381082.html.plaintext.txt	101	amount iodide sample determined iodide selective electrode orion
0.45175216.11381082.html.plaintext.txt	102	results top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	103	cell surface delivery truncated cftr preserved demonstrated previously steady state expression level complex glycosylated cftr missing last 70 82 98 amino acids designated t70 t82 t98 cftr decreased 90 compared wt cftr heterologous expression systems haardt et al
0.45175216.11381082.html.plaintext.txt	104	contrast deletion last 26 amino acid residues t26 cftr without effect mickle et al
0.45175216.11381082.html.plaintext.txt	105	also shown neither translational rate biosynthetic maturation t70 t82 cftr significantly impaired er transient cos 1 haardt et al
0.45175216.11381082.html.plaintext.txt	106	1999 stable bhk expression systems benharouga m
0.45175216.11381082.html.plaintext.txt	107	proposed contrast prevalent cf associated processing mutations e
0.45175216.11381082.html.plaintext.txt	108	f508 cftr compromise biogenesis cftr destabilization mature form distal stages biosynthetic endocytic pathway accounts phenotypic manifestation truncated cftr haardt et al
0.45175216.11381082.html.plaintext.txt	109	examine whether impaired plasma membrane targeting complex glycosylated truncated cftr attribute accelerated degradation efficacy cell surface delivery mutant determined first
0.45175216.11381082.html.plaintext.txt	110	bhk cells constitutively expressing wt truncated cftr metabolically labeled 35smethionine 35scysteine overnight cell surface exposed cftr covalently tagged sulfo nhs ss biotin
0.45175216.11381082.html.plaintext.txt	111	solubilization immunoprecipitation cftr biotinylated polypeptides isolated streptavidin sepharose visualized fluorography separation sds page fig 1
0.45175216.11381082.html.plaintext.txt	112	phosphorimage analysis revealed abundance biotinylated t70 t82 t98 cftr 5 8 relative wt t26 cftr mixture clones fig 1 b
0.45175216.11381082.html.plaintext.txt	113	steady state level complex glycosylated t70 t82 t98 cftr pool also diminished 5 10 relative wt t26 cftr determined quantitative western blotting using l12b4 m3a7 anti cftr abs fig 1b fig c
0.45175216.11381082.html.plaintext.txt	114	complex core glycosylated forms wt truncated cftr could distinguished distinct electrophoretic mobility well endoglycosidase h sensitivity described previously shown fig 1c fig d cheng et al
0.45175216.11381082.html.plaintext.txt	115	parallel decrease size complex glycosylated biotinylated pools truncated cftr suggests plasma membrane targeting largely preserved
0.45175216.11381082.html.plaintext.txt	116	confirm notion cell surface delivery newly synthesized t70 cftr measured
0.45175216.11381082.html.plaintext.txt	117	view larger version 46k figure 1
0.45175216.11381082.html.plaintext.txt	118	steady state expression cell surface targeting wt truncated cftr
0.45175216.11381082.html.plaintext.txt	119	expression level biotinylated cftr
0.45175216.11381082.html.plaintext.txt	120	identical number bhk 21 cells expressing wt t26 t70 t82 t98 cftr metabolically labeled overnight 35smethionine 35scysteine
0.45175216.11381082.html.plaintext.txt	121	plasma membrane proteins biotinylated 1 mgml sulfo nhs ss biotin 60 min 37 degrees c isolated immunoprecipitation l12b4 m3a7 anti cftr abs streptavidin sepharose top
0.45175216.11381082.html.plaintext.txt	122	10 immunoprecipitate directly loaded bottom
0.45175216.11381082.html.plaintext.txt	123	avoid clonal variations experiments shown c carried mixture clones
0.45175216.11381082.html.plaintext.txt	124	sulfo nhs ss biotin remains membrane impermeant labeling indicated lack biotinylated core glycosylated forms
0.45175216.11381082.html.plaintext.txt	125	complex core glycosylated cftr indicated black white arrowheads respectively
0.45175216.11381082.html.plaintext.txt	126	b expression level wt truncated cftr cell surface biotinylated post er compartments complex glycosylated
0.45175216.11381082.html.plaintext.txt	127	radioactivity biotinylated cftr measured phosphorimage analysis experiments described legend
0.45175216.11381082.html.plaintext.txt	128	level complex glycosylated cftr determined densitometry immunoblots c
0.45175216.11381082.html.plaintext.txt	129	data represent means plus minus sem n 3 expressed percentage wt designated 100
0.45175216.11381082.html.plaintext.txt	130	c expression wt t26 t70 t82 t98 cftr bhk 21 cells
0.45175216.11381082.html.plaintext.txt	131	cftr expression cell lysate assessed immunoblotting using l12b4 m3a7 anti cftr abs
0.45175216.11381082.html.plaintext.txt	132	bhk lane contains lysate parental cells
0.45175216.11381082.html.plaintext.txt	133	d glycosidase sensitivity complex core glycosylated wt t70 cftr
0.45175216.11381082.html.plaintext.txt	134	cell lysates incubated presence absence endoglycosidase h endo h peptide n glycosidase f pngase f 3 h 37 degrees c
0.45175216.11381082.html.plaintext.txt	135	polypeptides separated sds page probed l12b4 anti cftr ab
0.45175216.11381082.html.plaintext.txt	136	complex core deglycosylated cftr indicated black white hatched arrowheads respectively
0.45175216.11381082.html.plaintext.txt	137	e targeting efficiency newly synthesized cftr cell surface
0.45175216.11381082.html.plaintext.txt	138	pulse labeling wt t70 cftr 20 min plasma membrane insertion channels determined biotinylation 1 h chase 37 degrees c using freshly dissolved sulfo nhs ss biotin 1 mgml every 15 min
0.45175216.11381082.html.plaintext.txt	139	biotinylated cftr precipitated l12b4 m3a7 abs isolated streptavidin sepharose biot
0.45175216.11381082.html.plaintext.txt	140	labeled cftr visualized fluorography
0.45175216.11381082.html.plaintext.txt	141	monitor pulse labeling total cftr pools 10 precipitate loaded directly lysate
0.45175216.11381082.html.plaintext.txt	142	wt t70 cftr pulse labeled 15 min molecules arrived cell surface biotinylated 1 h chase
0.45175216.11381082.html.plaintext.txt	143	biotinylated cftr affinity isolated visualized fluorography fig 1 e biot
0.45175216.11381082.html.plaintext.txt	144	radioactivity biotinylated forms quantified phosphorimage analysis expressed percentage respective pulse labeled core glycosylated cftr fig 1 e lysate
0.45175216.11381082.html.plaintext.txt	145	cell surface targeting efficiency t70 cftr 74 plus minus 4 mean plus minus sem n 4 wt cftr
0.45175216.11381082.html.plaintext.txt	146	since measurement compounded rapid degradation complex glycosylated t70 cftr t12 1
0.45175216.11381082.html.plaintext.txt	147	5 2 h see also fig 6 b haardt et al
0.45175216.11381082.html.plaintext.txt	148	1999 calculated targeting efficiency t70 cftr represents underestimate suggests plasma membrane delivery complex glycosylated t70 cftr largely preserved
0.45175216.11381082.html.plaintext.txt	149	view larger version 70k figure 2
0.45175216.11381082.html.plaintext.txt	150	role lysosomal proteases metabolism truncated wt cftr
0.45175216.11381082.html.plaintext.txt	151	pulse labeling t70 t82 t98 cftr expressors bhk cells chased 2 h ensure conversion core glycosylated form complex glycosylated cftr 37 degrees c
0.45175216.11381082.html.plaintext.txt	152	subsequent chase performed presence nh4cl 15 mm
0.45175216.11381082.html.plaintext.txt	153	bafilomycin b baf b 2 microm leupeptin plus pepstatin leupep 50 microgml present entire pulse chase
0.45175216.11381082.html.plaintext.txt	154	cftr immunoprecipitated visualized fluorography
0.45175216.11381082.html.plaintext.txt	155	b radioactivity remaining complex glycosylated t70 t82 t98 cftr chase quantified phosphorimage analysis experiments shown expressed percentage initial amount present 2 h chase
0.45175216.11381082.html.plaintext.txt	156	data represent means plus minus sem n 3
0.45175216.11381082.html.plaintext.txt	157	c effect chathepsin inhibitors expression level truncated cftr
0.45175216.11381082.html.plaintext.txt	158	bhk transfectants incubated without leupeptin pepstatin 50 microgml 4 h
0.45175216.11381082.html.plaintext.txt	159	equal amounts protein probed immunoblotting described legend fig 1 c
0.45175216.11381082.html.plaintext.txt	160	d metabolic stability tac bhk cells
0.45175216.11381082.html.plaintext.txt	161	turnover tac determined presence absence leupeptin pepstatin 50 microgml
0.45175216.11381082.html.plaintext.txt	162	metabolically labeled cells chased indicated time tac isolated immunoprecipitation visualized fluorography
0.45175216.11381082.html.plaintext.txt	163	e f metabolic stability complex glycosylated wt cftr determined stably transfected cho cells presence nh4cl 15 mm chloroquin 200 microm leupeptin plus pepstatin leupep 50 microgml described b
0.45175216.11381082.html.plaintext.txt	164	statistical analysis performed samples subjected 20 h chase f
0.45175216.11381082.html.plaintext.txt	165	data means plus minus sem n 3
0.45175216.11381082.html.plaintext.txt	166	view larger version 39k figure 3
0.45175216.11381082.html.plaintext.txt	167	effect leupeptin pepstatin metabolism wt t70 cftr lysosomes
0.45175216.11381082.html.plaintext.txt	168	separation subcellular organelles percoll density gradient
0.45175216.11381082.html.plaintext.txt	169	postnuclear supernatants wt t70 cftr expressing bhk cells fractionated 25 percoll density gradient described materials methods
0.45175216.11381082.html.plaintext.txt	170	organellar distribution established activity specific marker enzymes plasma membrane alkaline phosphatase p golgi mannosidase ii mann ii lysosomes ss glucuronidase ss gluc described previously lukacs et al
0.45175216.11381082.html.plaintext.txt	171	enrichment lysosomes high density fractions confirmed accumulation fluorescein dextran 70 kd 1
0.45175216.11381082.html.plaintext.txt	172	5 mgml well overnight labeling 3 h chase
0.45175216.11381082.html.plaintext.txt	173	b bhk cells expressing wt t70 cftr treated leupeptin pepstatin overnight 50 microgml 4 h 100 microgml respectively
0.45175216.11381082.html.plaintext.txt	174	microsomes isolated percoll density gradient fractions 5 13 15 18 comprising majority lysosomes plasma membrane golgi regions endosomes respectively pooled
0.45175216.11381082.html.plaintext.txt	175	equal amounts 50 microg protein loaded probed nbd1 l12b4 nbd2 m3a7 specific anti cftr abs using ecl
0.45175216.11381082.html.plaintext.txt	176	view larger version 90k figure 4
0.45175216.11381082.html.plaintext.txt	177	biochemical rescue complex glycosylated form truncated cftr
0.45175216.11381082.html.plaintext.txt	178	b complex glycosylated truncated cftr stabilized proteasome inhibitors
0.45175216.11381082.html.plaintext.txt	179	bhk cells expressing t70 t82 t98 cftr metabolically labeled chased presence lactacystin lac 10 microm mg132 mg 10 microm
0.45175216.11381082.html.plaintext.txt	180	stability complex glycosylated form monitored immunoprecipitation fluorography
0.45175216.11381082.html.plaintext.txt	181	radioactivity remaining complex glycosylated cftr measured phosphorimage analysis expressed percentage amount 2 h chase b
0.45175216.11381082.html.plaintext.txt	182	data means plus minus sem n 3 4
0.45175216.11381082.html.plaintext.txt	183	c d rule lactacystin 10 microm delays degradation complex glycosylated form promoting biosynthesis conversion core glycosylated form cells treated lactacystin pulse labeling c conversion core complex glycosylated t70 d
0.45175216.11381082.html.plaintext.txt	184	protocol provided similar inhibition complex glycosylated turnover reported
0.45175216.11381082.html.plaintext.txt	185	indicated bfa 5 microgml included prevent conversion residual core glycosylated form d e
0.45175216.11381082.html.plaintext.txt	186	e g comparison turnover rate folded wt t70 cftr er post golgi compartments
0.45175216.11381082.html.plaintext.txt	187	pulse labeling bhk transfectants fully mature core glycosylated t70 wt cftr accumulated er bfa 5 microgml 2 h chase
0.45175216.11381082.html.plaintext.txt	188	disappearance folded core glycosylated form monitored subsequent 15 h chase presence bfa expressed percentage amount detected 2 h chase f g
0.45175216.11381082.html.plaintext.txt	189	stability complex glycosylated t70 wt cftr representing post golgi pools determined described
0.45175216.11381082.html.plaintext.txt	190	view larger version 53k figure 5
0.45175216.11381082.html.plaintext.txt	191	functional rescue t70 cftr lactacystin exerted selective inhibition proteasomes
0.45175216.11381082.html.plaintext.txt	192	protease inhibitors effect disposal maturation efficiency core glycosylated t70 cftr
0.45175216.11381082.html.plaintext.txt	193	pulse labeled 20 min bhk transfectants chased presence lactacystin 10 microm mg 132 10 microm leupeptin pepstatin 50 microgml indicated
0.45175216.11381082.html.plaintext.txt	194	t70 cftr visualized immunoprecipitation fluorography
0.45175216.11381082.html.plaintext.txt	195	phosphorimage analysis showed none drug significantly delayed degradation core glycosylated form shown
0.45175216.11381082.html.plaintext.txt	196	b lactacystin 10 microm leupeptin pepstatin 50 microgml impedes degradation core glycosylated tac tcr
0.45175216.11381082.html.plaintext.txt	197	stable transfectants pulse labeled 15 min chased presence indicated drugs
0.45175216.11381082.html.plaintext.txt	198	fluorography performed described legend fig 2 d
0.45175216.11381082.html.plaintext.txt	199	c degradation tac lamp1 chimera sensitive inhibition vacuolar h atpase bafilomycin b baf b
0.45175216.11381082.html.plaintext.txt	200	bhk cells stably expressing tac lamp1 labeled 30 min chased 2 h
0.45175216.11381082.html.plaintext.txt	201	addition nh4cl 10 mm bafilomycin b 2 microm mg132 10 microm cells chased additional 3 h tac lamp1 isolated immunoprecipitation
0.45175216.11381082.html.plaintext.txt	202	d effect lactacystin mg132 steady state expression mutant cftr
0.45175216.11381082.html.plaintext.txt	203	equal amounts whole cell lysate obtained cells exposed lactacystin lac 10 microm mg132 10 microm 3 h separated sds page immunoblotted l12b4 anti cftr ab
0.45175216.11381082.html.plaintext.txt	204	complex core glycosylated cftr indicated black white arrowheads respectively
0.45175216.11381082.html.plaintext.txt	205	e functional rescue t70 cftr lactacystin
0.45175216.11381082.html.plaintext.txt	206	camp activated halide conductance t70 cftr expressing bhk cells measured iodide efflux assay absence control presence lactacystin treatment lac 10 microm 3 h
0.45175216.11381082.html.plaintext.txt	207	data points averages triplicate determinations show difference iodide release presence absence protein kinase agonist cocktail 10 microm forskolin 0
0.45175216.11381082.html.plaintext.txt	208	view larger version 41k figure 6
0.45175216.11381082.html.plaintext.txt	209	residence time cell surface biotinylated wt t70 cftr
0.45175216.11381082.html.plaintext.txt	210	metabolic labeling complex glycosylated wt t70 cftr cell surface resident proteins biotinylated 45 min chased indicated time complete medium
0.45175216.11381082.html.plaintext.txt	211	biotinylated cftr immunoprecipitated l12b4 m3a7 anti cftr abs isolated streptavidin sepharose top
0.45175216.11381082.html.plaintext.txt	212	comparison 10 immunoprecipitate loaded fluorography bottom
0.45175216.11381082.html.plaintext.txt	213	b turnover rates biotinylated wt t70 cftr
0.45175216.11381082.html.plaintext.txt	214	radioactivity incorporated biotinylated cftr measured phosphorimage analysis expressed percentage initial label
0.45175216.11381082.html.plaintext.txt	215	data represent means plus minus sem n 3
0.45175216.11381082.html.plaintext.txt	216	c d proteasome inhibitors delay degradation biotinylated t70 cftr
0.45175216.11381082.html.plaintext.txt	217	radioactivity remaining biotinylated t70 cftr measured pulse chase experiments 4 h chase absence presence lactacystin lac 10 microm mg132 mg 10 microm phosphorimage analysis
0.45175216.11381082.html.plaintext.txt	218	data expressed percentage amount remaining control t70 cftr represent means plus minus sem n 3
0.45175216.11381082.html.plaintext.txt	219	contribution endolysosomal proteases turnover complex glycosylated wt truncated cftr light efficient clathrin dependent internalization cftr prince et al
0.45175216.11381082.html.plaintext.txt	220	1997 bradbury 1999 proteolysis plasma membrane resident atp binding cassette transporters vacuolarlysosomal compartments loayza michaelis 1998 hicke 1999 katzmann et al
0.45175216.11381082.html.plaintext.txt	221	1999 hypothesized cooh terminal truncations may interfere recycling cftr lead premature endolysosomal proteolysis
0.45175216.11381082.html.plaintext.txt	222	test hypothesis disposal rate metabolically labeled complex glycosylated t70 t82 cftr measured presence lysosomal protease inhibitors allowing conversion core complex glycosylated form fig 2
0.45175216.11381082.html.plaintext.txt	223	degradation rate unaltered upon exposing cells nh4cl chloroquin bafilomycin b agents inhibit endolysosomal proteolysis dissipating acidic luminal ph interfering cargo delivery fig 2 b
0.45175216.11381082.html.plaintext.txt	224	similarly leupeptin pepstatin inhibitors cathepsins b h l n seglen 1983 negligible effect degradation rate fig 2a fig b steady state expression truncated cftrs fig 2 c
0.45175216.11381082.html.plaintext.txt	225	contrast drugs stabilized interleukin 2 receptor chain tac targeted lysosomal degradation fig 2 d hemar et al
0.45175216.11381082.html.plaintext.txt	226	1995 validating efficacy suggesting initial proteolysis truncated cftr largely independent endolysosomal proteases
0.45175216.11381082.html.plaintext.txt	227	pulse chase analysis revealed disposal complex glycosylated wt cftr mitigated nh4cl chloroquin fig 2e fig f
0.45175216.11381082.html.plaintext.txt	228	examine discordant role lysosomal proteases wt t70 cftr degradation subcellular fractionation performed enrichment short lived proteolytic intermediates may difficult detect treating cells cathepsin inhibitors
0.45175216.11381082.html.plaintext.txt	229	heavy light microsomes containing predominantly lysosomes golgi complex plasma membrane endosomes respectively isolated percoll density gradient fig 3
0.45175216.11381082.html.plaintext.txt	230	although cathepsin inhibitors stabilized complex glycosylated wt cftr 7 10 fold lysosomes well light density fraction modest accumulation t70 cftr could documented immunoblot analysis fig 3 b
0.45175216.11381082.html.plaintext.txt	231	similar results obtained lysosomes isolated calcium precipitation method data shown kawashima et al
0.45175216.11381082.html.plaintext.txt	232	surprisingly leupeptin pepstatin provoked accumulation degradation intermediates wt t70 cftr predominantly lysosomes fig 3 b
0.45175216.11381082.html.plaintext.txt	233	inhibitors also provoked appearance breakdown products isolated lysosomes intestinal epithelia caco 2 t84 expressing cftr endogenously implying lysosomal proteolysis cannot attributed heterologous overexpession data shown
0.45175216.11381082.html.plaintext.txt	234	considering cathepsin inhibitors unable promote er processing core glycosylated form lukacs et al
0.45175216.11381082.html.plaintext.txt	235	1994 ward kopito 1994 results suggest endolysosomal proteases essential elimination complex glycosylated full length wt cftr
0.45175216.11381082.html.plaintext.txt	236	addition endolysosomal proteases appear involved processing proteolytic intermediates derived t70 wt cftr
0.45175216.11381082.html.plaintext.txt	237	proteasome dependent degradation complex glycosylated truncated cftr 26s proteasome responsible degradation misfolded polypeptides recognized er quality control short lived cytosolic plasma membrane proteins ligand induced internalization hochstrasser 1996 bonifacino weismann 1998 hershko ciechanover 1998 brodsky mccracken 1999 plemper wolf 1999 schwartz ciechanover 1999
0.45175216.11381082.html.plaintext.txt	238	reveal involvement 26s proteasome metabolism truncated cftr impact peptide aldehyde mg 132 cbz leu leu leucinal lactacystin specific irreversible inhibitor 20s subunit assessed fenteany et al
0.45175216.11381082.html.plaintext.txt	239	disappearance complex glycosylated core glycosylated t70 t82 t98 cftr inhibited 2
0.45175216.11381082.html.plaintext.txt	240	1 fold respectively lactacystin drug present pulse labeling chase fig 4a fig b fig 5
0.45175216.11381082.html.plaintext.txt	241	mg132 exerted less pronounced effect fig 4 b
0.45175216.11381082.html.plaintext.txt	242	comparable inhibition observed lactacystin added pulse labeling fig 4 c 2 h chase fig 4 d
0.45175216.11381082.html.plaintext.txt	243	latter protocol ensured augmented conversion core complex glycosylated form attributable lactacystin effect
0.45175216.11381082.html.plaintext.txt	244	similarly preventing er golgi complex transport residual core glycosylated t70 cftr brefeldin bfa failed influence inhibitory effect lactacystin fig 4 d substantiating notion disposal complex glycosylated mutants delayed rather escape core glycosylated form facilitated lactacystin
0.45175216.11381082.html.plaintext.txt	245	fact neither lactacystin mg 132 promoted processing core glycosylated t70 cftr fig 5 similarly cftr mutations identified nbd1 jensen et al
0.45175216.11381082.html.plaintext.txt	246	maturation efficiency t70 cftr 20 plus minus 2 n 9 negligibly increased presence lactacystin 23 plus minus 4 n 4
0.45175216.11381082.html.plaintext.txt	247	deletion cooh terminus destabilizes cftr exclusively post golgi compartments retention folded t70 cftr er would protect degradation
0.45175216.11381082.html.plaintext.txt	248	taking advantage fact bfa provoke accumulation folded cftr er without interfering erad stability folded t70 cftr measured elimination immature core glycosylated form fig 4 e
0.45175216.11381082.html.plaintext.txt	249	turnover folded core glycosylated t70 cftr fourfold slower t12 7 h complex glycosylated t70 cftr t12 1
0.45175216.11381082.html.plaintext.txt	250	contrast er retention marginally increased half life wt cftr t12 14 h vs
0.45175216.11381082.html.plaintext.txt	251	11 h fig 4 g underlining previous observations destabilization t70 cftr primarily manifests distal stage secretory pathway
0.45175216.11381082.html.plaintext.txt	252	similar stabilization observed upon retaining complex glycosylated t70 cftr distal golgi region aluminum fluoride benharouga m
0.45175216.11381082.html.plaintext.txt	253	lukacs unpublished observation
0.45175216.11381082.html.plaintext.txt	254	rule cross talks lysosomal proteasomal degradation pathway account stabilization complex glycosylated t70 cftr specificity drugs examined bhk cells expressing tac tcr tac lamp1 chimeras
0.45175216.11381082.html.plaintext.txt	255	although former polypeptide substrate erad bonifacino et al
0.45175216.11381082.html.plaintext.txt	256	1990 latter targeted lysosomal proteolysis marks et al
0.45175216.11381082.html.plaintext.txt	257	anticipated proteasome inhibitors mitigated disappearance tac tcr tac lamp1 whereas bafilomycin b proteasome inhibitors stabilized tac lamp1 fig 5b fig c
0.45175216.11381082.html.plaintext.txt	258	consistent notion proteasome activity accounts least part proteolysis complex glycosylated truncated cftr proteasome inhibitors increased steady state level complex glycosylated t70 t82 t98 cftr two fourfold according densitometric analysis immunoblots fig 5 d
0.45175216.11381082.html.plaintext.txt	259	also reflected elevated camp activated anion conductance plasma membrane fig 5 e
0.45175216.11381082.html.plaintext.txt	260	lactacystin treatment significantly increased protein kinase stimulated iodide release bhk cells constitutively expressing t70 cftr compared nontreated cells fig 5 e
0.45175216.11381082.html.plaintext.txt	261	proteasome dependent turnover cell surface resident t70 cftr investigate influence proteasome inhibitors residence time truncated cftr cell surface turnover biotinylated t70 cftr measured pulse chase technique
0.45175216.11381082.html.plaintext.txt	262	half life biotinylated t70 cftr sevenfold shorter t12 1
0.45175216.11381082.html.plaintext.txt	263	lactacystin mg132 inhibited turnover biotinylated t70 cftr 2
0.45175216.11381082.html.plaintext.txt	264	observation provides direct support hypothesis proteasomes directly indirectly involved proteolysis complex glycosylated t70 cftr cell surface endosomal compartments fig 6c fig d
0.45175216.11381082.html.plaintext.txt	265	ubiquitination complex glycosylated t70 cftr since recognition substrates destined destruction proteasome requires polyubiquitin modification hershko ciechanover 1998 laney hochstrasser 1999 plemper wolf 1999 hirsh ploegh 2000 examined whether t70 cftr subjected ubiquitin attachments
0.45175216.11381082.html.plaintext.txt	266	cos 1 cells transiently cotransfected plasmids encoding wt t70 cftr ha tagged ubiquitin ha ub
0.45175216.11381082.html.plaintext.txt	267	ha ub detected monoclonal anti ha ab immunoprecipitated t70 cftr
0.45175216.11381082.html.plaintext.txt	268	abundance high molecular weight immunoreactive polypeptides augmented lactacystin mg132 suggesting proteasome activity involved degradation polyubiquitinated t70 cftr fig 7 top lanes 8 10
0.45175216.11381082.html.plaintext.txt	269	similar results obtained monitoring conjugation endogenous ub monoclonal anti ub ab fig 7 middle lanes 6 10
0.45175216.11381082.html.plaintext.txt	270	ubiquitinated t70 cftr could detected cells expressing t70 cftr ha ub individually fig 7 top lanes 3 7 mock transfection fig 7 lanes 1 3 validating specificity assay
0.45175216.11381082.html.plaintext.txt	271	discriminate whether polyubiquitinated t70 cftr derived core andor complex glycosylated t70 cftr jensen et al
0.45175216.11381082.html.plaintext.txt	272	1999 double immunoprecipitation metabolically labeled t70 cftr performed
0.45175216.11381082.html.plaintext.txt	273	view larger version 100k figure 7
0.45175216.11381082.html.plaintext.txt	274	proteasome inhibitors induce accumulation polyubiquitinated t70 cftr
0.45175216.11381082.html.plaintext.txt	275	cos 1 cells transiently expressing ha ub t70 cftr combination treated mg132 mg 10 microm lactacystin lac 10 microm 3 h 37 degrees c
0.45175216.11381082.html.plaintext.txt	276	equal amounts cellular proteins immunoprecipitated l12b4 m3a7 anti cftr abs immunoblotted mouse monoclonal anti ha top antiubiquitin middle ab
0.45175216.11381082.html.plaintext.txt	277	expression t70 cftr verified probing 10 cell lysate l12b4 anti cftr ab bottom
0.45175216.11381082.html.plaintext.txt	278	b detection polyubiquitinated complex glycosylated t70 cftr
0.45175216.11381082.html.plaintext.txt	279	pulse labeling 20 min t70 cftr expressing t70 nontransfected mock bhk cells degradation core glycosylated t70 cftr ensured 2 h chase
0.45175216.11381082.html.plaintext.txt	280	additional 2 h chase performed presence mg132 mg 10 microm leupeptin pepstatin leupep 50 microgml lanes 4 5
0.45175216.11381082.html.plaintext.txt	281	cftr ubiquitin conjugates isolated sequential immunoprecipitation ip using l12b4 m3a7 abs first antiubiquitin ab top middle visualized fluorography
0.45175216.11381082.html.plaintext.txt	282	processing pulse labeled t70 cftr pool monitored visualizing 10 cftr immunoprecipitate bottom
0.45175216.11381082.html.plaintext.txt	283	c detection polyubiquitinated complex glycosylated t70 cftr cos 1 cells
0.45175216.11381082.html.plaintext.txt	284	experimental protocols described b performed transiently transfected cos 1 cells expressing t70 cftr ha ub
0.45175216.11381082.html.plaintext.txt	285	incubation protease inhibitors extended 4 h indicated lactacystin lac used 20 microm
0.45175216.11381082.html.plaintext.txt	286	second immunoprecipitation done anti ha abs
0.45175216.11381082.html.plaintext.txt	287	stably transfected bhk cells pulse labeled 20 min chased 2 h ensure elimination core glycosylated t70 cftr verified fluorography fig 7 b bottom lanes 1 2 see also fig 4 d
0.45175216.11381082.html.plaintext.txt	288	second set samples separation ubiquitinated adducts achieved sequential immunoprecipitation anti cftr anti ub ab
0.45175216.11381082.html.plaintext.txt	289	results show negligible amount polyubiquitinated core glycosylated t70 cftr persisted initial 2 h chase fig 7 b top bottom lanes 1 2
0.45175216.11381082.html.plaintext.txt	290	contrast radioactivity appeared high molecular weight polyubiquitinated t70 cftr mg132 present last 2 h chase fig 7 b top lane 4
0.45175216.11381082.html.plaintext.txt	291	accumulation polyubiquitinated t70 cftr pronounced cos 1 cells transiently coexpressing t70 cftr ha ub fig 7 c
0.45175216.11381082.html.plaintext.txt	292	likely due higher immunoprecipitation efficiency anti ha ab
0.45175216.11381082.html.plaintext.txt	293	ubiquitinated conjugates detectable upon inhibition lysosomal proteolysis mock transfected cells fig 7 b top middle c
0.45175216.11381082.html.plaintext.txt	294	considering turnover complex glycosylated core glycosylated t70 cftr sensitive proteasome inhibitors core glycosylated form largely eliminated proteasome inhibition conclude least fraction polyubiquitinated t70 cftr originates complex glycosylated t70 cftr
0.45175216.11381082.html.plaintext.txt	295	although cannot rule small amount polyubiquitinated t70 cftr derived core glycosylated form following observations substantiate notion complex glycosylated t70 cftr form ubiquitinated adducts
0.45175216.11381082.html.plaintext.txt	296	ubiquitinated complex glycosylated form visualized anti ub abs separation core complex glycosylated forms immunoprecipitation anti cftr abs wheat germ agglutinin affinity chromatography data shown
0.45175216.11381082.html.plaintext.txt	297	furthermore coexpression dominant negative k48rub t70 cftr delayed disposal complex glycosylated mutant cftr data shown
0.45175216.11381082.html.plaintext.txt	298	deletion cooh terminal tail structurally destabilizes cftr nonnative partially denatured soluble proteins subjected ubiquitination andor proteasome mediated degradation pacifici et al
0.45175216.11381082.html.plaintext.txt	299	1998 laney hochstrasser 1999
0.45175216.11381082.html.plaintext.txt	300	similar scenario may prevail t70 cftr cooh terminal tail engaged structural stabilization cftr post er compartment
0.45175216.11381082.html.plaintext.txt	301	large body evidence demonstrates existence intra intermolecular interactions cftr seibert et al
0.45175216.11381082.html.plaintext.txt	302	compare conformational stability complex glycosylated wt t70 cftr situ protease susceptibility vivo thermostability assays performed
0.45175216.11381082.html.plaintext.txt	303	conformation cytosolic domains probed limited proteolytic digestion conjunction immunoblotting method implemented reveal conformational difference wt f508 cftr zhang et al
0.45175216.11381082.html.plaintext.txt	304	intact microsomes isolated differential centrifugation bhk cells enriched complex glycosylated wt t70 cftr cyclohexamide chase subjected limited proteolysis presence increasing concentration trypsin
0.45175216.11381082.html.plaintext.txt	305	immunoblot analysis proteolytic fragments l12b4 anti cftr ab recognizing nbd1 demonstrates distinct proteolytic digestion pattern moderate reproducibly increased protease sensitivity complex glycosylated t70 cftr compared wt cftr fig 8
0.45175216.11381082.html.plaintext.txt	306	similar results obtained proteinase k using nbd2 specific m3a7 anti cftr ab data shown indicating nbd2 also nbd1 conformation altered upon truncating cooh terminus
0.45175216.11381082.html.plaintext.txt	307	view larger version 47k figure 8
0.45175216.11381082.html.plaintext.txt	308	protease susceptibility native wt t70 cftr
0.45175216.11381082.html.plaintext.txt	309	treating cells cyclohexamide 100 microgml 2
0.45175216.11381082.html.plaintext.txt	310	5 h 37 degrees c deplete core glycosylated forms microsomes isolated differential centrifugation bhk 21 cells stably expressing wt t70 cftr
0.45175216.11381082.html.plaintext.txt	311	microsomes subjected limited proteolysis indicated concentrations trypsin 15 min 4 degrees c
0.45175216.11381082.html.plaintext.txt	312	proteolytic digestion pattern probed l12b4 anti cftr ab ecl
0.45175216.11381082.html.plaintext.txt	313	complex glycosylated t70 cftr conformationally unstable anticipated polypeptide vivo thermostability would compromised
0.45175216.11381082.html.plaintext.txt	314	temperature dependence turnover complex glycosylated wt t70 cftr compared metabolic pulse chase studies
0.45175216.11381082.html.plaintext.txt	315	turnover complex glycosylated t70 cftr fivefold faster 40 degrees c t12 0
0.45175216.11381082.html.plaintext.txt	316	5 h 37 degrees c t12 2
0.45175216.11381082.html.plaintext.txt	317	sharp contrast turnover wt cftr marginally affected 40 degrees c t12 10
0.45175216.11381082.html.plaintext.txt	318	15 h 37 degrees c fig 9b fig d
0.45175216.11381082.html.plaintext.txt	319	simplest interpretation data intrinsic structural instability t70 cftr becomes apparent elevated temperature leading thermodenaturation proteolysis whereas compact tertiary structures wt cftr resistant unfolding
0.45175216.11381082.html.plaintext.txt	320	view larger version 30k figure 9
0.45175216.11381082.html.plaintext.txt	321	thermostability complex glycosylated wt t70 cftr vivo
0.45175216.11381082.html.plaintext.txt	322	b temperature dependent turnover complex glycosylated t70 wt cftr
0.45175216.11381082.html.plaintext.txt	323	metabolic stability pulse labeled complex glycosylated t70 wt cftr monitored described legend fig 4
0.45175216.11381082.html.plaintext.txt	324	chase conducted 26 degrees c 37 degrees c 40 degrees c
0.45175216.11381082.html.plaintext.txt	325	c d disappearance kinetics complex glycosylated t70 wt cftr determined phosphorimage analysis experiments shown b
0.45175216.11381082.html.plaintext.txt	326	data means plus minus sem n 3
0.45175216.11381082.html.plaintext.txt	327	discussion top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	328	combination transcriptional cotranslational posttranslational mechanisms contributes er quality control preventing misfolded secretory membrane proteins traversing secretory pathway ellgaard et al
0.45175216.11381082.html.plaintext.txt	329	nevertheless several examples demonstrate fidelity er quality control far perfect
0.45175216.11381082.html.plaintext.txt	330	nonfunctional polypeptides escape er retention whereas mutants partially fully preserved biological function trapped causing severe human diseases cf alpha 1 protease inhibitor deficiency thomas et al
0.45175216.11381082.html.plaintext.txt	331	1995 zielenski tsui 1995 aridor balch 1999 schwartz ciechanover 1999
0.45175216.11381082.html.plaintext.txt	332	nonnative polypeptides could also generated post er compartments result unfolding upon environmental stresses mutations compromise native form stability goldenberg 1992 pacifici et al
0.45175216.11381082.html.plaintext.txt	333	1993 parsell lindquist 1993 sitte et al
0.45175216.11381082.html.plaintext.txt	334	little known mechanism responsible degradation abnormal membrane proteins post er compartments
0.45175216.11381082.html.plaintext.txt	335	mammalian cells aggregated furin incompletely assembled golgi coronavirus e1 mutant connexin32 destined lysosomal degradation golgi region without reaching cell surface armstrong et al
0.45175216.11381082.html.plaintext.txt	336	post er quality control mechanism appears responsible targeting vacuolar degradation mutant plasma membrane atpase late golgi protease kex2 model protein comprising secretory invertase nh2 terminus lambda repressor saccharomyces cerevisiae wilcox et al
0.45175216.11381082.html.plaintext.txt	337	1992 chang fink 1995 hong et al
0.45175216.11381082.html.plaintext.txt	338	aggregation unoccupied class ii major histocompatibility complex molecules cross linking cell surface membrane proteins transferrin receptor evoke preferential lysosomal targeting degradation weissman et al
0.45175216.11381082.html.plaintext.txt	339	although examples illustrate nonnative membrane protein targeted lysosomal proteolysis either arrival cell surface internalization complex glycosylated truncated cftr distinct intracellular fate
0.45175216.11381082.html.plaintext.txt	340	presented compelling evidence indicating dramatically decreased expression level residence time complex glycosylated truncated cftr cannot attributed missorting lysosomal degradation trans golgi endosomal compartment
0.45175216.11381082.html.plaintext.txt	341	instead truncated cftr targeted plasma membrane comparable efficiency wt counterpart fig 1
0.45175216.11381082.html.plaintext.txt	342	turnover total cell surface biotinylated t70 cftr pools insensitive inhibitors endolysosomal proteases
0.45175216.11381082.html.plaintext.txt	343	contrast weak bases cathepsin inhibitors stabilized full length form degradation intermediates wt cftr transfected cells well epithelia highlighting multiple role endolysosomal proteolysis turnover wt cftr fig 2 fig 3
0.45175216.11381082.html.plaintext.txt	344	several criteria used establish proteasomes involved accelerated metabolism truncated cftr post golgi compartments including cell surface
0.45175216.11381082.html.plaintext.txt	345	first degradation rates complex glycosylated t70 82 98 cftr delayed presence lactacystin specific inhibitor proteasome fenteany et al
0.45175216.11381082.html.plaintext.txt	346	second dramatic extension plasma membrane residence time biotinylated t70 cftr evoked lactacystin fig 6 implying proteasomes indispensable proteolysis truncated cftr cell surface andor endosomal compartment
0.45175216.11381082.html.plaintext.txt	347	since proteasome inhibitors impact degradation tac lamp1 indirect effect lactacystin lysosomal proteolysis could precluded fig 5
0.45175216.11381082.html.plaintext.txt	348	third mg132 lactacystin evoked accumulation polyubiqutinated adducts complex glycosylated t70 cftr consistent notion fraction t70 cftr tagged polyubiquitin chains degradation fig 7
0.45175216.11381082.html.plaintext.txt	349	finally mg132 lactacystin partially restored expression level complex glycosylated t70 t82 t98 cftr well plasma membrane camp activated chloride conductance t70 cftr transfectants without facilitating biogenesis mutants fig 5d fig e
0.45175216.11381082.html.plaintext.txt	350	although observations indicate proteasome activity one rate limiting steps turnover full length complex glycosylated t70 cftr proteasome inhibitors failed restore mutant stability wt cftr
0.45175216.11381082.html.plaintext.txt	351	could explained incomplete inhibition proteasome activity andor involvement presently unidentified proteolytic mechanisms
0.45175216.11381082.html.plaintext.txt	352	cooh terminal tail cftr might confer stability mature cftr several mechanisms combination thereof
0.45175216.11381082.html.plaintext.txt	353	deletion cooh terminus comprising postsynaptic density 95 disc large zonula occludens 1 binding motif 1476dtrl ensures association cftr ebp 50 ezrin radixin moesin binding phosphoprotein 50 vitro vivo may facilitate lysosomal degradation compromising endosomal sorting recycling hall et al
0.45175216.11381082.html.plaintext.txt	354	similar paradigm proposed accelerated degradation ss2 adrenergic receptor upon preventing binding ebp 50 cao et al
0.45175216.11381082.html.plaintext.txt	355	however possibility appears unlikely since steady state expression level turnover rate cftr variant lacking cooh terminal 26 amino acid residues normal mickle et al
0.45175216.11381082.html.plaintext.txt	356	neither aggregation t70 cftr trans golgi early endosomes target mutant lysosomal degradation
0.45175216.11381082.html.plaintext.txt	357	finally absence cooh terminal tail may structurally destabilize folded cftr increasing portion nonnative molecules susceptible proteolysis
0.45175216.11381082.html.plaintext.txt	358	evidence suggests nonnative states soluble polypeptides induced mutations thermal chemical denaturation lead accelerated degradation parsell lindquist 1993 hershko ciechanover 1998 brodsky mccracken 1999 plemper wolf 1999 paradigm may apply degradation nonnative plasma membrane proteins including truncated cftr well
0.45175216.11381082.html.plaintext.txt	359	based enhanced protease susceptibility decreased vivo thermostability t70 cftr fig 8 fig 9 speculate structural destabilization native form induced disrupting interactions cooh terminus
0.45175216.11381082.html.plaintext.txt	360	using various yeast screening assays site directed mutagenesis deg 1 proteolytic motif mat2 transcription factor established ubiquitin conjugating enzymes ubc6 ubc7 recognize hydrophobic stretches exposed hydrophobic surfaces amphipathic helices sadis et al
0.45175216.11381082.html.plaintext.txt	361	similar motifs normally buried inside globular domains cftr inserted membrane plane may serve recognition signals
0.45175216.11381082.html.plaintext.txt	362	support notion decreased plasma membrane residence time impaired expression level ss2 2a adrenergic receptors also attributed structural destabilization gether et al
0.45175216.11381082.html.plaintext.txt	363	1997 wilson limbird 2000
0.45175216.11381082.html.plaintext.txt	364	however mechanism responsible downregulation g protein coupled receptors could partially rescued ligand stabilization remained obscure
0.45175216.11381082.html.plaintext.txt	365	key question remains resolved whether ubiquitination prerequisite proteasome dependent degradation mutant cftr cell surface endosomal compartment
0.45175216.11381082.html.plaintext.txt	366	several tyrosine kinase g protein coupled receptors observed undergo ligand induced ubiquitination downregulation via lysosomal andor proteasomal degradation bonifacino weismann 1998 hershko ciechanover 1998 hicke 1999 strous govers 1999
0.45175216.11381082.html.plaintext.txt	367	ubiquitination also appears necessary sufficient induce internalization downregulation plasma membrane receptors transporters e
0.45175216.11381082.html.plaintext.txt	368	fur4 gap1 ste2 ste3 ste6 via vacuolar proteolysis yeast hicke 1999
0.45175216.11381082.html.plaintext.txt	369	constitutive downregulation epithelial sodium channel enac association nedd4 ubiquitin ligase proposed follow similar degradation route contrast unassembled subunits channel degraded proteasome dependent mechanism er staub et al
0.45175216.11381082.html.plaintext.txt	370	since covalent noncovalent attachment ubiquitins serve degradation signal plasma membrane proteins via internalization govers et al
0.45175216.11381082.html.plaintext.txt	371	2000 one possible scenario augmented ubiquitination cftr associated protein facilitates internalization mutant
0.45175216.11381082.html.plaintext.txt	372	hand light multiple tyrosine dileucine based endocytic signals cftr ubiquitin attachment may prerequisite endocytosis lukacs et al
0.45175216.11381082.html.plaintext.txt	373	consistent dispensable nature ubiquitination downregulation ss2 adrenergic mutant m2 muscarinic receptors proceed without endocytosis presumably direct association proteasome andor presently unidentified proteases jockers et al
0.45175216.11381082.html.plaintext.txt	374	1999 wilson limbird 2000
0.45175216.11381082.html.plaintext.txt	375	recognition 26s proteasome p700 subunit able degrade nonnative polypeptides lacking polyubiquitin conjugates supports notion ubiquitin independent degradation mechanism cannot ruled murakami 1992 braun et al
0.45175216.11381082.html.plaintext.txt	376	importantly degradation pathways mutually exclusive may function parallel
0.45175216.11381082.html.plaintext.txt	377	since retrograde translocation t70 cftr via translocon unlikely occur post golgi compartments xiong et al
0.45175216.11381082.html.plaintext.txt	378	1999 coordinated action multiple proteolytic systems invoked resolve topological problem disposing transmembrane segments exofacial loops t70 cftr
0.45175216.11381082.html.plaintext.txt	379	degradation appears initiated unfolding cytosolic domains proteasome dependent manner
0.45175216.11381082.html.plaintext.txt	380	biochemical well functional rescue cell surface resident t70 wt cftr data shown proteasome inhibitors substantiate hypothesis
0.45175216.11381082.html.plaintext.txt	381	whereas initial cleavage mature wt cftr opposed mutant relies activity lysosmal proteases subsequent degradation wt t70 cftr converges endolysosomes demonstrated overlapping proteolytic fragmentation pattern presence cathepsin inhibitors fig 3 b
0.45175216.11381082.html.plaintext.txt	382	although truncated cftr one first mutant plasma membrane proteins subjected sequential proteasomal lysosomal breakdown coordinated action proteolytic systems without precedent
0.45175216.11381082.html.plaintext.txt	383	although lysosomes proteasomes involved constitutive ligand induced disposal connexin43 renal napi cotransporter pdgf ss receptor respectively mori et al
0.45175216.11381082.html.plaintext.txt	384	1998 recognition mechanism substrates proteasome remains unknown
0.45175216.11381082.html.plaintext.txt	385	considering deletion cooh terminal tail appears destabilize cftr structurally propose ubiquitin proteasome pathway may play role recognition elimination t70 cftr also nonnative partially unfolded plasma membrane proteins
0.45175216.11381082.html.plaintext.txt	386	1 abbreviations used paper ab antibody bfa brefeldin cf cystic fibrosis cftr cf transmembrane conductance regulator erad er associated degradation ha hemagglutinin ha ub ha tagged ubiquitin nbd nuclear binding domain wild type wt
0.45175216.11381082.html.plaintext.txt	387	acknowledgements top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	388	haguenauer tsapis jacques monod university paris vii paris france j
0.45175216.11381082.html.plaintext.txt	389	bonifacino national institutes health bethesda md m
0.45175216.11381082.html.plaintext.txt	390	fukuda burnham institute la jolla ca generous gifts cdna
0.45175216.11381082.html.plaintext.txt	391	weissman helpful suggestions j
0.45175216.11381082.html.plaintext.txt	392	szapor critical reading manuscript
0.45175216.11381082.html.plaintext.txt	393	work supported medical research council canada canadian cystic fibrosis foundation national institutes health national institute diabetes digestive kidney diseases
0.45175216.11381082.html.plaintext.txt	394	instrumentation covered part block term grant ontario thoracic society
0.45175216.11381082.html.plaintext.txt	395	benharouga supported canadian cystic fibrosis foundation postdoctoral fellowship
0.45175216.11381082.html.plaintext.txt	396	lukacs scholar medical research council canada
0.45175216.11381082.html.plaintext.txt	397	submitted 3 november 2000 revised 30 march 2001 accepted 30 march 2001
0.45175216.11381082.html.plaintext.txt	398	references top abstract introduction materials methods results discussion acknowledgements references
0.45175216.11381082.html.plaintext.txt	399	invariant chain cleavage peptide loading major histocompatibility complex class ii vesicles
0.45175216.11381082.html.plaintext.txt	400	lysosomal sorting mutants coronavirus e1 protein golgi membane protein
0.45175216.11381082.html.plaintext.txt	401	er associated proteasome mediated protein degradation two topologically restricted events came together
0.45175216.11381082.html.plaintext.txt	402	er protein quality control proteasome mediated protein degradation
0.45175216.11381082.html.plaintext.txt	403	targeting yeast plasma membrane h atpase novel gene ast1 prevents mislocalization mutant atpase vacuole
0.45175216.11381082.html.plaintext.txt	404	setting standards quality control secretory pathway
0.45175216.11381082.html.plaintext.txt	405	science 2861882 1888abstractfree full text
0.45175216.11381082.html.plaintext.txt	406	structural instability constitutively active g protein coupled receptor
0.45175216.11381082.html.plaintext.txt	407	2722587 2590abstractfree full text
0.45175216.11381082.html.plaintext.txt	408	degradation signals ubiquitin system proteolysis saccharomyces cerevisiae
0.45175216.11381082.html.plaintext.txt	409	172759 2766abstractfree full text
0.45175216.11381082.html.plaintext.txt	410	mutational analysis protein folding stability
0.45175216.11381082.html.plaintext.txt	411	identification novel ubiquitin conjugation motif required ligand induced internalization growth hormone receptor
0.45175216.11381082.html.plaintext.txt	412	1828 36abstractfree full text
0.45175216.11381082.html.plaintext.txt	413	c terminal truncations destabilize cftr without impairing biogenesis
0.45175216.11381082.html.plaintext.txt	414	27421873 21877abstractfree full text
0.45175216.11381082.html.plaintext.txt	415	c terminal motif found beta2 adrenergic receptor p2y1 receptor cystic fibrosis transmembrane conductance regulator determines binding nah exchanger regulatory factor family pdz proteins
0.45175216.11381082.html.plaintext.txt	416	958496 8501abstractfree full text
0.45175216.11381082.html.plaintext.txt	417	endocytosis interleukin 2 receptors human lymphocytes distinct intracellular localization fate receptor ss chains
0.45175216.11381082.html.plaintext.txt	418	pathway targeting soluble misfolded proteins yeast vacuole
0.45175216.11381082.html.plaintext.txt	419	protein oligomerization endoplasmic reticulum
0.45175216.11381082.html.plaintext.txt	420	ss2 adrenergic receptor regulation
0.45175216.11381082.html.plaintext.txt	421	evidence pathway require endocytosis
0.45175216.11381082.html.plaintext.txt	422	27428900 28908abstractfree full text
0.45175216.11381082.html.plaintext.txt	423	mutational disruption plasma membrane trafficking saccharomyces cerevisiae yor1p homologue mammalian multidrug resistance protein
0.45175216.11381082.html.plaintext.txt	424	192998 3009abstractfree full text
0.45175216.11381082.html.plaintext.txt	425	biosynthesis degradation cftr
0.45175216.11381082.html.plaintext.txt	426	role ubiquitin proteasome system vacuolar degradation ste6p factor transporter saccharomyces cerevisiae
0.45175216.11381082.html.plaintext.txt	427	18779 789abstractfree full text
0.45175216.11381082.html.plaintext.txt	428	perturbation hsp90 interaction nascent cftr prevents maturation accelerates degradation protesome
0.45175216.11381082.html.plaintext.txt	429	176879 6887abstractfree full text
0.45175216.11381082.html.plaintext.txt	430	df508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.45175216.11381082.html.plaintext.txt	431	26821592 21598abstractfree full text
0.45175216.11381082.html.plaintext.txt	432	conformational maturation cftr mutant counterpart df508 occurs er requires atp
0.45175216.11381082.html.plaintext.txt	433	protein targeting tyrosine di leucine based signals evidence distinct saturable components
0.45175216.11381082.html.plaintext.txt	434	hdj 2hsc70 chaperone pair facilitates early steps cftr biogenesis
0.45175216.11381082.html.plaintext.txt	435	181492 1505abstractfree full text
0.45175216.11381082.html.plaintext.txt	436	chemical denaturation modification ovalbumin alters dependence ubiquitin conjugation class 1 antigen presentation
0.45175216.11381082.html.plaintext.txt	437	mutation cystic fibrosis transmembrane conductance regulator gene associated elevated sweat chloride concentration absence cystic fibrosis
0.45175216.11381082.html.plaintext.txt	438	7729 735abstractfree full text
0.45175216.11381082.html.plaintext.txt	439	degradation process ligand stimulated platelet derived growth factor ss receptor involves ubiquitin proteasome proteolytic pathway
0.45175216.11381082.html.plaintext.txt	440	27029447 29452abstractfree full text
0.45175216.11381082.html.plaintext.txt	441	pdz interacting domain cftr required functional expression apical plasma membrane
0.45175216.11381082.html.plaintext.txt	442	27527069 27074abstractfree full text
0.45175216.11381082.html.plaintext.txt	443	ornithine decarboxylase degraded 26s proteasome without ubiquitination
0.45175216.11381082.html.plaintext.txt	444	cftr chloride channel regulation interdomain interaction
0.45175216.11381082.html.plaintext.txt	445	science 286544 548abstractfree full text
0.45175216.11381082.html.plaintext.txt	446	functional r domain cystic fibrosis transmembrane conductance regulator predominantly unstructured solution
0.45175216.11381082.html.plaintext.txt	447	usa 975657 5662abstractfree full text
0.45175216.11381082.html.plaintext.txt	448	hydrophobicity signal selective degradation hydroxyl radical modified hemoglobin multicatalytic proteinase complex proteasome
0.45175216.11381082.html.plaintext.txt	449	26815405 15411abstractfree full text
0.45175216.11381082.html.plaintext.txt	450	parathyroid hormone leads lysosomal degradation renal type ii napi cotransporter
0.45175216.11381082.html.plaintext.txt	451	usa 951909 1914abstractfree full text
0.45175216.11381082.html.plaintext.txt	452	participation endoplasmic reticulum chaperone calnexin p88 ip90 biogenesis cystic fibrosis transmembrane conductance regulator
0.45175216.11381082.html.plaintext.txt	453	26912784 12788abstractfree full text
0.45175216.11381082.html.plaintext.txt	454	rapid endocytosis cystic fibrosis transmembrane conductance regulator chloride channel
0.45175216.11381082.html.plaintext.txt	455	efficient endocytosis cftr requires tyrosine based signal
0.45175216.11381082.html.plaintext.txt	456	2743602 3609abstractfree full text
0.45175216.11381082.html.plaintext.txt	457	synthetic signals ubiquitin dependent proteolysis
0.45175216.11381082.html.plaintext.txt	458	ubiquitin proteasome pathway pathogenesis human diseases
0.45175216.11381082.html.plaintext.txt	459	cytoplasmic loop three cystic fibrosis transmembrane conductance regulator contributes regulation chloride channel activity
0.45175216.11381082.html.plaintext.txt	460	27115139 15145abstractfree full text
0.45175216.11381082.html.plaintext.txt	461	monoubiquitin carries novel internalization signal appended activated receptors
0.45175216.11381082.html.plaintext.txt	462	19187 198abstractfree full text
0.45175216.11381082.html.plaintext.txt	463	apical pdz protein anchors cftr cytoskeleton
0.45175216.11381082.html.plaintext.txt	464	27319797 19801abstractfree full text
0.45175216.11381082.html.plaintext.txt	465	regulation stability function epithelial na channel enac ubiquitination
0.45175216.11381082.html.plaintext.txt	466	166325 6336abstractfree full text
0.45175216.11381082.html.plaintext.txt	467	recognition misfolding proteins pa700 regulatory subcomplex 26 proteasome
0.45175216.11381082.html.plaintext.txt	468	2755565 5572abstractfree full text
0.45175216.11381082.html.plaintext.txt	469	ubiquitin proteasome system endocytosis
0.45175216.11381082.html.plaintext.txt	470	1121417 1423abstractfree full text
0.45175216.11381082.html.plaintext.txt	471	cystic fibrosis mutations lead carboxyl terminal fragments highlight early biogenesis step cftr
0.45175216.11381082.html.plaintext.txt	472	27519577 19584abstractfree full text
0.45175216.11381082.html.plaintext.txt	473	intracellular transport assembly degradation wild type disease linked mutant gap junction proteins
0.45175216.11381082.html.plaintext.txt	474	cell 111933 1946abstractfree full text
0.45175216.11381082.html.plaintext.txt	475	intracellular turnover cystic fibrosis transmembrane conductance regulator
0.45175216.11381082.html.plaintext.txt	476	26925710 25718abstractfree full text
0.45175216.11381082.html.plaintext.txt	477	exposure k562 cells anti receptor monoclonal antibody okt9 results rapid redistribution enhanced degradation transferrin receptor
0.45175216.11381082.html.plaintext.txt	478	posttranslational quality control folding refolding degrading proteins
0.45175216.11381082.html.plaintext.txt	479	science 2861888 1893abstractfree full text
0.45175216.11381082.html.plaintext.txt	480	mutation tyrosine localization signal cytosolic tail yeast kex2 protease disrupts golgi retention results default transport vacuole
0.45175216.11381082.html.plaintext.txt	481	aggregation determinant protein fate post golgi compartments role luminal domain furin lysosomal targeting
0.45175216.11381082.html.plaintext.txt	482	1391735 1745abstractfree full text
0.45175216.11381082.html.plaintext.txt	483	evidence endoplasmic reticulum er associated degradation cftr linked retrograde translocation er membrane
0.45175216.11381082.html.plaintext.txt	484	2742616 2624abstractfree full text
0.45175216.11381082.html.plaintext.txt	485	common variant cystic fibrosis transmembrane conductance regulator recognized hsp70 degraded pre golgi nonlysosomal compartment
0.44193757.12482874.html.plaintext.txt	0	transcriptional adaptation cystic fibrosis transmembrane conductance regulator deficiency yan xu jean c
0.44193757.12482874.html.plaintext.txt	1	divisions pulmonary biology developmental biology pediatric informatics pulmonary medicine cincinnati childrens hospital medical center cincinnati ohio 45229 3039
0.44193757.12482874.html.plaintext.txt	2	received publication october 8 2002 revised form november 13 2002
0.44193757.12482874.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references
0.44193757.12482874.html.plaintext.txt	4	cystic fibrosis commonly inherited lethal pulmonary disorder caucasians caused mutations cystic fibrosis transmembrane conductance regulator gene cftr
0.44193757.12482874.html.plaintext.txt	5	identify genomic responses presence absence cftr pulmonary tissues vivo microarray analyses lung mrnas performed whole lung tissue mice lacking cftr expressing mouse cftr cftr
0.44193757.12482874.html.plaintext.txt	6	whereas histology lungs cftr cftr mice indistinguishable statistically significant increases relative abundance 29 decreases 25 rnas identified rna microarray analysis
0.44193757.12482874.html.plaintext.txt	7	rnas whose expression consistently altered absence cftr functional classes genes influencing gene transcription inflammation intracellular trafficking signal transduction ion transport identified
0.44193757.12482874.html.plaintext.txt	8	rnas encoding transcription factor ccaat enhancer binding protein cebp interleukin il 1 known regulate cftr expression induced perhaps indicating adaptation lack cftr
0.44193757.12482874.html.plaintext.txt	9	rnas mediating lung inflammation including calgranulin s100 family members il 1 il 4 increased
0.44193757.12482874.html.plaintext.txt	10	likewise expression several membrane transport proteins interact directly cftr increased suggesting cftr protein complexes initiate genomic responses
0.44193757.12482874.html.plaintext.txt	11	absence cftr influenced expression genes modulating diverse pulmonary cell functions may ameliorate contribute pathogenesis cf
0.44193757.12482874.html.plaintext.txt	12	introduction top abstract introduction materials methods results discussion references
0.44193757.12482874.html.plaintext.txt	13	cystic fibrosis cf1 common lethal inherited pulmonary disorder caused mutations cystic fibrosis transmembrane conductance regulator cftr 1
0.44193757.12482874.html.plaintext.txt	14	800 distinct mutations cftr gene associated clinical diseases characteristic cystic fibrosis 2
0.44193757.12482874.html.plaintext.txt	15	whereas many organs affected cf morbidity mortality disease primarily related mucus accumulation recurrent infections excessive inflammation lung
0.44193757.12482874.html.plaintext.txt	16	whereas pathogenesis cf fully understood abnormalities cyclic amp dependent chloride secretion excessive sodium reuptake epithelial cells related cftr deficiency thought alter fluid homeostasis airway surface liquid leading dehydration impaired mucociliary clearance infection see ref
0.44193757.12482874.html.plaintext.txt	17	elucidation primary structure cftr myriad functions numerous interactions cellular proteins ascribed cftr
0.44193757.12482874.html.plaintext.txt	18	thus addition role cftr regulation camp dependent chloride transport protein may play pleotropic roles many cellular processes interacting cytoskeleton membrane transport proteins well receptors protein routing degradation machinery 2
0.44193757.12482874.html.plaintext.txt	19	number studies support concept excessive inflammatory responses occur cf lung mechanisms underlying abnormalities clarified
0.44193757.12482874.html.plaintext.txt	20	changes levels il 8 proteins mediating inflammatory signaling including nfb inos associated cf presence absence infection raising possibility abnormalities cftr may constitutively alter pathways mediating inflammation 4 6
0.44193757.12482874.html.plaintext.txt	21	lung cftr distributed primarily apical regions airway submucosal gland epithelial cells 7
0.44193757.12482874.html.plaintext.txt	22	abundance cellular sites expression cftr strongly influenced developmental spatial humoral factors supporting concept expression function cftr regulated transcriptional post transcriptional levels
0.44193757.12482874.html.plaintext.txt	23	despite extensive study precise role cftr pathogenesis cf disease remains poorly understood
0.44193757.12482874.html.plaintext.txt	24	clinical level severity cf disease highly variable even among individuals bearing identical mutations supporting concept environmental hereditary factors may influence severity disorder 2
0.44193757.12482874.html.plaintext.txt	25	clinical observations observations demonstrating strain differences severity cf phenotype cftr gene targeting mutation mice 8 support concept expression cftr function cellular processes may influenced many genes pathways intensifying mollifying cf disease various organs
0.44193757.12482874.html.plaintext.txt	26	morbidity mortality patients cf strongly associated pulmonary disease caused mucous accumulation inflammation infection however deletion cftr mice cause significant pulmonary disease suggesting expression alternative channels complementary genes maintains pulmonary homeostasis mouse
0.44193757.12482874.html.plaintext.txt	27	whereas numerous vitro vivo models developed study cftr analysis genomic responses presence absence cftr complicated heterogeneity cell models culture conditions may influence cell function gene expression independently cftr
0.44193757.12482874.html.plaintext.txt	28	direct rna analysis pulmonary tissue humans cf complicated nearly ubiquitous severe pulmonary infections may secondarily modify cellular responses gene expression complicating identification responses cftr vivo
0.44193757.12482874.html.plaintext.txt	29	present study undertook experiments identify rnas influenced presence absence cftr vivo seeking identify genes pathways interact compensate cftr maintain pulmonary function
0.44193757.12482874.html.plaintext.txt	30	study stereotypic genomic responses lack cftr observed pulmonary tissues absence infection disease
0.44193757.12482874.html.plaintext.txt	31	materials methods top abstract introduction materials methods results discussion references
0.44193757.12482874.html.plaintext.txt	32	transgenic mice bearing null mutation cftr cftr generally succumb intestinal disease weanling period 9
0.44193757.12482874.html.plaintext.txt	33	generate healthy mice deficient cftr human cftr cdna expressed intestinal epithelium control intestinal fatty acid binding protein gene promoter ifabp fully correcting small intestinal pathology supporting normal postnatal survival cftr mice 10
0.44193757.12482874.html.plaintext.txt	34	ifabp hcftr mcftr mice maintained mixed fvbn c57bl6 background without evidence gastrointestinal pulmonary disease nearly decade laboratory
0.44193757.12482874.html.plaintext.txt	35	histological andbiochemical studies identified overt pathology lung tissue mice compared cftr expressing littermate controls 10 11
0.44193757.12482874.html.plaintext.txt	36	mice maintained filtered microisolator cages
0.44193757.12482874.html.plaintext.txt	37	sentinal mice free mouse pathogens
0.44193757.12482874.html.plaintext.txt	38	lungs adult ifabp hcftr mcftr control mice free bacterial pathogens colonization assessed quantitative culture lung homogenates blood agar plates
0.44193757.12482874.html.plaintext.txt	39	rna preparation matings fabp hcftrmcftr mice wild type fvbn mcftr mice used produce f1 fabp hcftrmcftr mice
0.44193757.12482874.html.plaintext.txt	40	mice crossed generate f2 offspring littermates genotyped choosing fabp hcftrmcftr hcftrmcftr mice use rna comparisons
0.44193757.12482874.html.plaintext.txt	41	minimize potential influence strain differences colony lung rna isolated sex matched littermates 3 6 11 weeks age
0.44193757.12482874.html.plaintext.txt	42	rna also isolated lungs surviving cftrhcftr cftr littermates 3 weeks age comparison bearing ifabp hcftr transgene
0.44193757.12482874.html.plaintext.txt	43	cftr mice heterozygous targeted mcftr gene
0.44193757.12482874.html.plaintext.txt	44	lungs sex matched littermates carefully dissected conducting airways mediastinal structures removed
0.44193757.12482874.html.plaintext.txt	45	rna cdna synthesis microarray analysis performed pairs minimize technical variability related rna isolation hybridization conditions
0.44193757.12482874.html.plaintext.txt	46	lungs homogenized trizol reagent invitrogen using methods recommended manufacturer
0.44193757.12482874.html.plaintext.txt	47	genotyping performed using following primers primers mcftr pcr forward primer intron 9 5 aggggctcgctcttctttgtgaac 3 reverse primer intron 10 5 tggctgtctgcttcctgactatgg 3 neomycin resistance gene pcr forward primer 5 cacaacagacaatcggctgct 3 reverse primer 5 acagttcggctggcgcgag 3 hcftr pcr forward primer exon 9 5 aaacttctaatggtgatgacag 3 reverse primer exon 11 5 agaaattcttgctcgttgac 3
0.44193757.12482874.html.plaintext.txt	48	validation rnas rt pcr changes selected rna levels identified microarray analysis validated rt pcr using light cyclertm regular thermocycler followed gel electrophoresis
0.44193757.12482874.html.plaintext.txt	49	studies lung rnas isolated described
0.44193757.12482874.html.plaintext.txt	50	cdnas generated reverse transcription pcr analysis performed using following primers kir 4
0.44193757.12482874.html.plaintext.txt	51	2 forward 5 ctttgagtttgtgcctgtggtttc 3 reverse 5 gctgtgtgatttggtagtgcgg 3 human cftr mouse cftr forward 5 tgcttccctacagagtcatcaacgg 3 reverse 5 cacaggatttcccacaacgcagag 3 actin normalization forward 5 tggaatcctgcggcatccatgaac reverse 5 taaaacgcagctcagtaacagtccg 3 glyceraldehyde 3 phosphate dehydrogenase forward 5 cttcaccaccatggagaaggc 3 reverse 5 ggcatggactgtggtcatgag 3 ccaat enhancer binding protein cebp forward 5 cgcaacaacatcgctgtg 3 reverse 5 gggctgggcagttttttg 3 tnf aip 3 forward 5 gcacgaatacaagaaatggcagg 3 reverse 5 ggcataaaggctgagtgttcacg 3 grin 2d forward 5 ccttctttgccgtcatctttcttgc 3 reverse 5 aaacttcaggggtgggtattgctcc 3
0.44193757.12482874.html.plaintext.txt	52	rna microarray data analysis total rna subjected reverse transcription using oligodt t7 promoter sequences attached followed second strand cdna synthesis
0.44193757.12482874.html.plaintext.txt	53	antisera crna amplified biotinylated using t7 rna polymerase prior hybridization affymetrix genechip mouse u74av2 using affymetrix recommended protocol 12 13
0.44193757.12482874.html.plaintext.txt	54	affymetrix microarray suite version 5
0.44193757.12482874.html.plaintext.txt	55	0 used scan quantitate genechips using default scan settings
0.44193757.12482874.html.plaintext.txt	56	intensity data collected chip scaled target intensity 1500 results analyzed using microarray suite genespring 5
0.44193757.12482874.html.plaintext.txt	57	cdnas hybridized u74av2 chips affymetrix inc
0.44193757.12482874.html.plaintext.txt	58	hybridization data normalized ccaat enhancer binding protein two step process remove minimize systemic sources variation chip gene level
0.44193757.12482874.html.plaintext.txt	59	specifically chip normalized distribution genes chip control variation samples
0.44193757.12482874.html.plaintext.txt	60	rna mcftr mice normalized specific control
0.44193757.12482874.html.plaintext.txt	61	sex age matched mcftr littermates
0.44193757.12482874.html.plaintext.txt	62	data transformed log ratio analysis symmetry distribution
0.44193757.12482874.html.plaintext.txt	63	changes mrnas identified combination distribution analysis jmp4 sas institute inc
0.44193757.12482874.html.plaintext.txt	64	welch analysis variance
0.44193757.12482874.html.plaintext.txt	65	outlier box quartile box plots used identify outliers definition outlier upper quartile 1
0.44193757.12482874.html.plaintext.txt	66	5 interquartile range outlier lower quartile 1
0.44193757.12482874.html.plaintext.txt	67	significant changes calculated welch test p 0
0.44193757.12482874.html.plaintext.txt	68	adjusted p values calculated westfall young permutation correction false positives genespring 4
0.44193757.12482874.html.plaintext.txt	69	comparisons genotype age groups performed using one way analysis variance
0.44193757.12482874.html.plaintext.txt	70	identify genes differentially expressed cftr genotype regardless age hierarchical k means clustering used identify consistent changes gene expression response lack cftr three time points
0.44193757.12482874.html.plaintext.txt	71	candidate rnas filtered basis reproducibility absolute intensity
0.44193757.12482874.html.plaintext.txt	72	mean standard deviation coefficient variation calculated replicate
0.44193757.12482874.html.plaintext.txt	73	replicates coefficient variations 50 deleted analysis
0.44193757.12482874.html.plaintext.txt	74	genes whose expression level detection eliminated experimental noise
0.44193757.12482874.html.plaintext.txt	75	pathway literature analysis selected genes subjected intensive search identify biological function associated regulatory pathways
0.44193757.12482874.html.plaintext.txt	76	u74av2 annotation data base system identifiers constructed array elements associated genbanktm accession numbers
0.44193757.12482874.html.plaintext.txt	77	gene description functional categories biological processes molecular functions cellular components protein domain literature information identified
0.44193757.12482874.html.plaintext.txt	78	information resources included netaffy www
0.44193757.12482874.html.plaintext.txt	79	com source search genome www5
0.44193757.12482874.html.plaintext.txt	80	educgi binsmdsource blast ncbi locus link mouse human homolog search www
0.44193757.12482874.html.plaintext.txt	81	gov gene ontology data base www
0.44193757.12482874.html.plaintext.txt	82	differentially expressed genes classified functional categories based gene ontology definition
0.44193757.12482874.html.plaintext.txt	83	determine functional category overrepresented selected gene list binomial probability calculated category using entire u74av2 contains 12488 mice genes reference data set
0.44193757.12482874.html.plaintext.txt	84	binomial probability defined following
0.44193757.12482874.html.plaintext.txt	85	1 returns probability getting k successes n trials probability p given population u74av2
0.44193757.12482874.html.plaintext.txt	86	potential proteinprotein proteindna interactions identified using published literature information
0.44193757.12482874.html.plaintext.txt	87	lung histology immunohistochemistry lungs postnatal animals inflation fixed 4 paraformaldehyde 25 cm h2o pressure via tracheal cannula
0.44193757.12482874.html.plaintext.txt	88	lung tissue processed according standard methods embedded paraffin
0.44193757.12482874.html.plaintext.txt	89	procedures immunostaining previously described 14
0.44193757.12482874.html.plaintext.txt	90	rabbit monoclonal antibody 110 kda mac 3 antigen used 140000 identify alveolar macrophages bd pharmingen san diego ca
0.44193757.12482874.html.plaintext.txt	91	results top abstract introduction materials methods results discussion references
0.44193757.12482874.html.plaintext.txt	92	histology immunohistochemistry lung histology adult ifabp hcftr cftr ifabp hcftr cftr cftr control mice different fig
0.44193757.12482874.html.plaintext.txt	93	evidence pulmonary inflammation infection remodeling
0.44193757.12482874.html.plaintext.txt	94	mac 3 staining used identify alveolar macrophages
0.44193757.12482874.html.plaintext.txt	95	numbers histology alveolar macrophages altered mcftr
0.44193757.12482874.html.plaintext.txt	96	view larger version 133k fig
0.44193757.12482874.html.plaintext.txt	97	normal lung histology cftr mice
0.44193757.12482874.html.plaintext.txt	98	lung tissue obtained inflation fixation ifabp hcftr mcftr mice b d ifabp hcftr mcftr littermates c 3 months age
0.44193757.12482874.html.plaintext.txt	99	lung histology staining hematoxylin eosin b mac 3 antibody c d marker alveolar macrophages altered cftr mice
0.44193757.12482874.html.plaintext.txt	100	identification gene responses lung cftr deletion identify genes responsive cftr lung rnas ifabp hcftr mcftr ifabp hcftr mcftr mcftr mcftr littermates age 3 6 11 weeks age compared
0.44193757.12482874.html.plaintext.txt	101	microarray analyses performed duplicate rna isolated 3 6 weeks age
0.44193757.12482874.html.plaintext.txt	102	data 10 affymetrix murine genome u74av2 chips normalized statistical differences cftr deficient cftr control cftr mice identified
0.44193757.12482874.html.plaintext.txt	103	differences related age identified outlier analysis andor unpaired test
0.44193757.12482874.html.plaintext.txt	104	normalization normal distributions observed intensity data lung tissue obtained ages
0.44193757.12482874.html.plaintext.txt	105	lung rna data 3 week old mcftr mcftr mice lacking ifabp hcftr transgene similarly distributed bearing fabp hcftr gene therefore included analysis
0.44193757.12482874.html.plaintext.txt	106	identify rnas differentially expressed response cftr regardless age mcftr mcftr data separated two groups
0.44193757.12482874.html.plaintext.txt	107	log ratio distribution outlier plot combined data set represented fig
0.44193757.12482874.html.plaintext.txt	108	total 1977 outliers identified 12442 genesexpressed sequence tags analyzed
0.44193757.12482874.html.plaintext.txt	109	abundance 848 rnas increased 1129 decreased
0.44193757.12482874.html.plaintext.txt	110	welch test together westfall young step permutation narrowed number differentially expressed rnas 315
0.44193757.12482874.html.plaintext.txt	111	hierarchical clustering used visualize classify data set fig
0.44193757.12482874.html.plaintext.txt	112	data shown two dimensional matrix identify groups genes similar expression patterns show remarkably ordered gene expression profiles 315 selected genes
0.44193757.12482874.html.plaintext.txt	113	chip level top dendrogram rnas influenced cftr formed two distinct groups
0.44193757.12482874.html.plaintext.txt	114	within group samples collected age matched pairs closely related different ages suggesting age also influenced gene expression
0.44193757.12482874.html.plaintext.txt	115	rna level dendrogram left side genes clearly separated two major groups mrnas increased decreased mcftr mice
0.44193757.12482874.html.plaintext.txt	116	genes filtered consistency differences expression levels across time points coefficient variation 50 absolute intensity 243 90 genes called absent affymetrix software 243 data set
0.44193757.12482874.html.plaintext.txt	117	additional filters reduced number rnas 54 29 consistently increased 25 decreased mcftr compared mcftr littermates tables ii
0.44193757.12482874.html.plaintext.txt	118	expression profiles 54 genes shown fig
0.44193757.12482874.html.plaintext.txt	119	4 demonstrating consistent patterns expression cftr responsive rnas regardless age
0.44193757.12482874.html.plaintext.txt	120	view larger version 28k fig
0.44193757.12482874.html.plaintext.txt	121	distribution lung rnas mcftr mcftr mice
0.44193757.12482874.html.plaintext.txt	122	left panel histogram log ratio gene frequency
0.44193757.12482874.html.plaintext.txt	123	right panel outlier box plot
0.44193757.12482874.html.plaintext.txt	124	ends dashed lines denoted x y markers outliers identified respective quartiles
0.44193757.12482874.html.plaintext.txt	125	view larger version 47k fig
0.44193757.12482874.html.plaintext.txt	126	two dimensional hierarchial clustering 315 genesexpressed sequence tag significantly altered response presence absence mcftr
0.44193757.12482874.html.plaintext.txt	127	intensity red green color range indicates regulated regulated rnas respectively
0.44193757.12482874.html.plaintext.txt	128	row represents single gene
0.44193757.12482874.html.plaintext.txt	129	column represents particular experimental condition
0.44193757.12482874.html.plaintext.txt	130	box represents normalized rna intensity value
0.44193757.12482874.html.plaintext.txt	131	clustering performed upgma
0.44193757.12482874.html.plaintext.txt	132	similarity measures assessed utilizing euclidean distance
0.44193757.12482874.html.plaintext.txt	133	view table table genes regulated mcftr versus mcftr mice
0.44193757.12482874.html.plaintext.txt	134	view table table ii genes regulated mcftr mice
0.44193757.12482874.html.plaintext.txt	135	view larger version 31k fig
0.44193757.12482874.html.plaintext.txt	136	expression profile chart hierarchical clustering b 54 selected rnas consistently altered response lack cftr regardless age
0.44193757.12482874.html.plaintext.txt	137	hierarchical clustering performed upgma
0.44193757.12482874.html.plaintext.txt	138	data normalized using trimmed mean z score calculations
0.44193757.12482874.html.plaintext.txt	139	profile chart data normalized pairwise control
0.44193757.12482874.html.plaintext.txt	140	y axis normalized intensity log scale x axis represents experimental ages
0.44193757.12482874.html.plaintext.txt	141	red lines represent profiles lung rnas increased cftr mice
0.44193757.12482874.html.plaintext.txt	142	green lines represent profiles regulated rnas
0.44193757.12482874.html.plaintext.txt	143	differentially expressed genes classified according known predicted functions
0.44193757.12482874.html.plaintext.txt	144	gene annotated assigned functional category
0.44193757.12482874.html.plaintext.txt	145	simplify calculation assumed genes category could fit binomial distribution
0.44193757.12482874.html.plaintext.txt	146	binomial probability calculated category using entire u74av2 reference data set
0.44193757.12482874.html.plaintext.txt	147	inflammatory response represented category rnas increased mcftr mice
0.44193757.12482874.html.plaintext.txt	148	among rnas whose abundance increased lack cftr influencing inflammation transcription transport highly represented consisted group functional categories quite distinct whose expression decreased mcftr mice tables iii
0.44193757.12482874.html.plaintext.txt	149	view table table iii functional categories gene list
0.44193757.12482874.html.plaintext.txt	150	potential influence fabp hcftr transgene rna expression also assessed using welch test three ages
0.44193757.12482874.html.plaintext.txt	151	differentially regulated rnas identified analysis gastrointestinal corrected mice similarly affected mcftr mice demonstrating lack effect ifabp hcftr subset genes
0.44193757.12482874.html.plaintext.txt	152	genes whose expression independently altered ifabp hcftr transgene included 7 rnas decreased 11 increased
0.44193757.12482874.html.plaintext.txt	153	differences levels expression modest less 1
0.44193757.12482874.html.plaintext.txt	154	view table table iv effect fabp hcftr lung gene expression lung rna samples ifabp hcftrcftr
0.44193757.12482874.html.plaintext.txt	155	gut corrected gc compared cftr lacking ifarp hcftr transgene
0.44193757.12482874.html.plaintext.txt	156	ratio defined r gcngc gc ngc r ngcgc gc ngc
0.44193757.12482874.html.plaintext.txt	157	validation selected mrnas validate responsive rnas identified microarray analyses real time rt pcr performed
0.44193757.12482874.html.plaintext.txt	158	mrna levels normalized using actin glyceraldehyde 3 phosphate dehydrogenase
0.44193757.12482874.html.plaintext.txt	159	2 kcnj15 cebp tnf aip 3 grin 2d mrna significantly increased cftr mice compared control littermates fig
0.44193757.12482874.html.plaintext.txt	160	expected murine cftr detectable rt pcr mcftr mice hcftr mrna detected lung ifabp hcftr bearing mice
0.44193757.12482874.html.plaintext.txt	161	view larger version 19k fig
0.44193757.12482874.html.plaintext.txt	162	real time pcr analysis grin 2d kir4
0.44193757.12482874.html.plaintext.txt	163	2 b cebp c tnf aip 3 d
0.44193757.12482874.html.plaintext.txt	164	lung mrna abundance determined rt pcr using light cyclertm tissue mcftr open mcftr mice black
0.44193757.12482874.html.plaintext.txt	165	values normalized actin glyceraldehyde 3 phosphate dehydrogenase rnas represent mean plus minus
0.44193757.12482874.html.plaintext.txt	166	n 56 determinations differences assessed paired test
0.44193757.12482874.html.plaintext.txt	167	discussion top abstract introduction materials methods results discussion references
0.44193757.12482874.html.plaintext.txt	168	absence cftr caused stereotypic changes gene expression lungs cftr mice absence detectable infection inflammation
0.44193757.12482874.html.plaintext.txt	169	cellular responses cftr included enhanced expression transcription factors signaling pathways known influence cftr gene expression il 1 cebp
0.44193757.12482874.html.plaintext.txt	170	likewise expression rnas modulating inflammation ion transport protein trafficking degradation altered indicating number cellular pathways may compensate mediate cftr dependent functions turn may maintain normal pulmonary homeostasis cftr mice alternatively influence cf phenotype following response pathogens
0.44193757.12482874.html.plaintext.txt	171	absence cftr initiates reproducible changes lung gene expression may modify inflammation host defense cellular functions likely contribute mollify pathogenesis pulmonary disease cf
0.44193757.12482874.html.plaintext.txt	172	strain known influence pulmonary findings cf mice 8 transgenic mice presently studied generated mixed fvbn c57 bl6 background lung rna compared sex matched littermates various ages
0.44193757.12482874.html.plaintext.txt	173	extensive data set utilized identify cftr dependent changes gene expression present throughout development absence inflammation seeking identify pathways influenced primarily cftr rather sex strain age secondary phenomena
0.44193757.12482874.html.plaintext.txt	174	expected expression mcftr detected gastrointestinal corrected mcftr mice consistent previous findings 10
0.44193757.12482874.html.plaintext.txt	175	histologic analyses performed presently previously demonstrated structural abnormalities infection inflammation lungs mice maintained vivarium 10 11 supporting concept changes gene expression related cftr age lung disease
0.44193757.12482874.html.plaintext.txt	176	analysis arrays prepared pairs mcftr mice mcftr littermates lacking ifabp hcftr transgene confirmed microarray findings demonstrating lack mcftr mrna lungs mcftr rna changes independent ifabp hcftr transgene
0.44193757.12482874.html.plaintext.txt	177	expression genes modulating cftr expression number genes known influence cftr expression enhanced lungs cftr mice including cebp il 1 suggesting cftr cells responded enhancing levels rnas encoding transcription factors pathways may compensate lack cftr
0.44193757.12482874.html.plaintext.txt	178	il 1 increased cftr gene transcription epithelial cells vitro 15 cis acting elements binding cebp ccaat enhancer sites c fos ap 1 elements present promoter enhancer regions mouse cftr gene 16 17
0.44193757.12482874.html.plaintext.txt	179	previous studies demonstrated cebp directly enhanced cftr gene transcription vitro 18 thus increased cebp expression may represent potential compensatory response cftr deficiency turn may influence expression genes unrelated cftr
0.44193757.12482874.html.plaintext.txt	180	expression c fos also increased mcftr mice
0.44193757.12482874.html.plaintext.txt	181	whereas ap 1 sites identified hcftr promoter precise role c fos regulation cftr clarified although treatment various cell types phorbol esters decreased cftr gene transcription vitro 18
0.44193757.12482874.html.plaintext.txt	182	cebp c fos activate inhibit expression numerous genes share cis active elements cftr gene changes activity may broadly influence gene expression perhaps inadvertently linking cftr deficiency expression genes whose activities directly related cftr protein function
0.44193757.12482874.html.plaintext.txt	183	rna encoding tnf aip 3 zinc finger transcription factor also increased cftr mice linking transcription responses lack cftr
0.44193757.12482874.html.plaintext.txt	184	considerable interest tnf aip 3 rna induced either il 1 tnf
0.44193757.12482874.html.plaintext.txt	185	tnf aip 3 inhibited nfb translocation vitro may represent compensatory response increased expression il 1 seen cftr mice 19
0.44193757.12482874.html.plaintext.txt	186	jak 3 nuclear receptor subfamily 2 interferon regulatory factor 1 rnas decreased cftr mice
0.44193757.12482874.html.plaintext.txt	187	rnas encode transcription factors regulate various pathways involved inflammation may therefore represent responses proinflammatory proteins induced cftr mice essence secondarily responsive initial compensatory changes
0.44193757.12482874.html.plaintext.txt	188	enhanced expression genes modulating inflammation genes involved inflammation overly represented among rnas induced distinct decreased lungs cftr mice table iii
0.44193757.12482874.html.plaintext.txt	189	prominent among genes whose expression increased family calcium binding proteins termed calgranulins s100a8 s100a9 calbindin d9k
0.44193757.12482874.html.plaintext.txt	190	s100a8 expressed primarily macrophages monocytes expression enhanced various cytokines including tnf il 1 interferon 20 21
0.44193757.12482874.html.plaintext.txt	191	family peptides expressed various cell types share potent chemoattractant activities stimulating inflammatory cell trafficking
0.44193757.12482874.html.plaintext.txt	192	increased expression s100a8 calgranulin previously demonstrated alveolar macrophages cftr mutant mice authors suggesting increased s100a8 may contribute enhanced inflammatory responses seen absence cftr 22
0.44193757.12482874.html.plaintext.txt	193	expression s100a8 alveolar macrophages induced tnf interferon il 1 mediated least part ap 1 dependent pathways 20
0.44193757.12482874.html.plaintext.txt	194	chitinase mrna also consistently increased lungs cftr mice
0.44193757.12482874.html.plaintext.txt	195	acidic chitinase small peptide containing mammalian lectin domain binds complex carbohydrates surfaces microbial pathogens including fungi
0.44193757.12482874.html.plaintext.txt	196	like s100 family proteins chitinase family members also expressed alveolar macrophages lung 23
0.44193757.12482874.html.plaintext.txt	197	thus decreased mcftr initiated changes expression gene expressed primarily alveolar macrophages
0.44193757.12482874.html.plaintext.txt	198	remains unclear whether responses mediated direct effects cftr alveolar macrophages altered cellular signaling initiated lack cftr epithelial pulmonary cells secondarily alters macrophage activity
0.44193757.12482874.html.plaintext.txt	199	intense neutrophilic infiltration increased il 8 production strongly associated cf lung disease humans 2
0.44193757.12482874.html.plaintext.txt	200	increased il 8 neutrophilic infiltrates observed bronchoalveolar lavage fluid cf patients absence documented pulmonary infection 4
0.44193757.12482874.html.plaintext.txt	201	although remains possible antecedent resolved infections may contributed increased inflammation observed cf observations support concept cf associated increased susceptibility pulmonary inflammation
0.44193757.12482874.html.plaintext.txt	202	present study il 1 il 4 csf 1 receptor rnas increased may contribute proinflammatory milieu
0.44193757.12482874.html.plaintext.txt	203	il 1 enhances cftr gene transcription induces inflammation known stimulate production s100 calgranulins perhaps indicating network genes influenced cftr il 1
0.44193757.12482874.html.plaintext.txt	204	il 4 potent inflammatory mediator enhances inflammation mucous production airway epithelia
0.44193757.12482874.html.plaintext.txt	205	transgenic animals expressing il 4 animal models il 4 induced developed severe goblet cell hyperplasia increased mucous production inflammatory cell infiltrates 24 findings typically found patients cystic fibrosis
0.44193757.12482874.html.plaintext.txt	206	csf 3r rna encoding receptor mediates monocytic cell migration proliferation activity response csf 3 g csf increased 3 4 fold cftr mice 25
0.44193757.12482874.html.plaintext.txt	207	thus taken together expression number genes many influenced il 1 mediating inflammation induced lungs cftr mice
0.44193757.12482874.html.plaintext.txt	208	despite increased expression proinflammatory molecules evidence inflammation lung cftr mice perhaps indicating normal homeostasis maintained complex responses lung lack cftr
0.44193757.12482874.html.plaintext.txt	209	presence stereotypic changes expression many genes suggests presence single ameliorating gene example alternative chloride channel fully explain physiologic adjustment lung cftr mice
0.44193757.12482874.html.plaintext.txt	210	present unclear whether proinflammatory responses secondary changes expression function cftr epithelial cells turn modulate cell signaling cytokine production lung
0.44193757.12482874.html.plaintext.txt	211	alternatively absence cftr alveolar macrophages may alter expression genes mediating inflammation cells
0.44193757.12482874.html.plaintext.txt	212	considerable interest changes rnas modifying inflammation altered lungs mcftr mice absence detectable bacterial infection inflammation supporting concept transcriptional adjustment cftr deficiency suffices maintain normal pulmonary homeostasis mouse vivo
0.44193757.12482874.html.plaintext.txt	213	alternatively levels expression proinflammatory molecules may adequate cause histologically detectable inflammation
0.44193757.12482874.html.plaintext.txt	214	remains unclear whether adjustments gene expression may turn render cftr mice susceptible inflammation following infection injury
0.44193757.12482874.html.plaintext.txt	215	changes nfb tnf dependent pathways rnas encoding number proteins involved tnf signaling nfb activation also induced cftr mice
0.44193757.12482874.html.plaintext.txt	216	abundance tnf aip 3 mrna zinc finger transcription protein protein whose expression induced tnf il 1 increased cftr mice
0.44193757.12482874.html.plaintext.txt	217	tnf aip 3 inhibits nfb activity target genes 19 may represent response proinflammatory milieu established cftr lung
0.44193757.12482874.html.plaintext.txt	218	peg 3 protein regulates induction nfb following tnf stimulation also increased providing support transcriptional relationships cftr deficiency activity nfb 26
0.44193757.12482874.html.plaintext.txt	219	recent studies schroeder et al
0.44193757.12482874.html.plaintext.txt	220	27 support concept cftr required regulation nfb serving pattern associated molecular recognition molecule following pulmonary exposure pseudomonas aeruginosa
0.44193757.12482874.html.plaintext.txt	221	study nfb activation nuclear trafficking deficient cf cells
0.44193757.12482874.html.plaintext.txt	222	taken together observation il 1 mediated transcription cftr gene transcription dependent upon nfb important pathway mediating inflammation appears influenced cftr
0.44193757.12482874.html.plaintext.txt	223	present microarray analysis cftr deficiency associated increased claudin 8 decreased gap junction connexin 37
0.44193757.12482874.html.plaintext.txt	224	decreased expression gap junction proteins cx43 40 37 32 decreased gap junction communication observed various vitro cell systems exposure proinflammatory cytokines 28
0.44193757.12482874.html.plaintext.txt	225	observed changes rnas mediating cell adhesion increased expression il 1 seen cftr mice consistent findings absence cftr il 1 tnf failed inhibit cell communication via gap junctions
0.44193757.12482874.html.plaintext.txt	226	previous studies demonstrated cftr required uncoupling gap functions epithelial cells inflammation process may restrict spread pathogens signaling among adjacent cells
0.44193757.12482874.html.plaintext.txt	227	interest test whether cell adhesion mediated claudins also linked pathogenesis cf
0.44193757.12482874.html.plaintext.txt	228	changes protein degradation pathways several genes involved protein degradation altered absence cftr compared normal
0.44193757.12482874.html.plaintext.txt	229	proteosome 26 subunit psmc3 major proteolytic component ubiquitin dependent proteosome
0.44193757.12482874.html.plaintext.txt	230	proteosome 26 regulates degradation proteins influencing cell cycle oncogenesis transcription immunity including cftr 29 30
0.44193757.12482874.html.plaintext.txt	231	proteosome composed two subcomplexes 20 proteosome pa700
0.44193757.12482874.html.plaintext.txt	232	psmc3 expression modestly significantly increased 1
0.44193757.12482874.html.plaintext.txt	233	contrast pa28 psme3 activator 20 proteosome decreased 1
0.44193757.12482874.html.plaintext.txt	234	observations consistent previous findings proinflammatory cytokines including tnf interferon increased expression 26 proteosome activators pa28 31 whereas expression pa28 decreased interferon 32
0.44193757.12482874.html.plaintext.txt	235	rna encoding adaptor protein complex ap 2 1 subunit ap2a1 protein involved formation intracellular transport vesicles also decreased absence cftr
0.44193757.12482874.html.plaintext.txt	236	cftr co precipitates adaptin 33
0.44193757.12482874.html.plaintext.txt	237	recent studies demonstrated c terminal domain cftr binds ap 2 adaptor complex form clathrin coated vesicles mediates cftr internalization 34
0.44193757.12482874.html.plaintext.txt	238	adp ribosylation factor 5 belongs family gtp binding proteins play important roles control membrane trafficking including formation secretory vesicles trans golgi network endosomal vesicle plasma membrane fusion 35
0.44193757.12482874.html.plaintext.txt	239	recent studies support concept cftr regulates endosomal fusion vesicular trafficking 36 37 indicating potential relationships cftr actions adp ribosylation factor 5
0.44193757.12482874.html.plaintext.txt	240	another gene functional category represented kinesin3 mrna decreased lungs cftr mice
0.44193757.12482874.html.plaintext.txt	241	transport proteins influenced cftr rnas encoding several transmembrane transport proteins receptors also altered lungs cftr mice including solute carrier 38 member 4 potassium inwardly rectifying channel kir 4
0.44193757.12482874.html.plaintext.txt	242	2 kcnj 15 glutamate receptor grin 2d naturietic peptide receptor 3 npr 3 3 adrenergic receptor adrb 3
0.44193757.12482874.html.plaintext.txt	243	thus expression number membrane transport proteins influenced cftr perhaps representing compensatory responses defects cftr mediated transport activity
0.44193757.12482874.html.plaintext.txt	244	2 grin 2d rnas increased 2 3 fold cftr mice
0.44193757.12482874.html.plaintext.txt	245	2 expressed respiratory epithelial cells sites similar cftr 38
0.44193757.12482874.html.plaintext.txt	246	2 regulates cation transport upon chloride transport via cftr chloride channels may influenced
0.44193757.12482874.html.plaintext.txt	247	surprisingly evidence interactions cftr kir family members known bind via pdz binding domains interactions channel interacting pdz domain protein 39
0.44193757.12482874.html.plaintext.txt	248	likewise precedence pdz dependent interactions among glutamate receptors cftr kir family members 40
0.44193757.12482874.html.plaintext.txt	249	thus lack cftr enhanced expression number membrane proteins may interact cftr via pdz domains perhaps indicating cftr protein complexes may initiate changes gene expression
0.44193757.12482874.html.plaintext.txt	250	findings support concept cftr interacts numerous membrane transport proteins support model activity alternative cl transporter alone suffices compensate lack cftr pulmonary cells cftr mice
0.44193757.12482874.html.plaintext.txt	251	regulation cell receptors cftr natriuretic peptide receptor c npr 3 nprc increased 2 fold cftr mice
0.44193757.12482874.html.plaintext.txt	252	natriuretic peptides comprise family 3 structurally related molecules atrial anp brain bnp c type cnp whose functions cgmp dependent 41 42
0.44193757.12482874.html.plaintext.txt	253	among cnp increased ciliary beat mucociliary clearance airway epithelial cells activated cftr dependent chloride transport 42
0.44193757.12482874.html.plaintext.txt	254	natriuretic peptides regulate cytokine stimulated production via binding npr 3 43
0.44193757.12482874.html.plaintext.txt	255	deficient production observed respiratory epithelial cells ifabp hcftr cftr mice increased expression npr 3 cftr mice may represent compensatory response influencing airway clearance nitric oxide production via cgmp 44
0.44193757.12482874.html.plaintext.txt	256	contrast transportreceptors induced adrb3 g protein coupled transmembrane protein mediating camp production decreased cftr mice
0.44193757.12482874.html.plaintext.txt	257	adrb3 co expressed cftr airway epithelium 45 may functionally coupled cftr via camp independent pathways 46
0.44193757.12482874.html.plaintext.txt	258	2 adrenergic receptors directly interact cftr via nah exchanger regulatory factor form signal transduction complex 47
0.44193757.12482874.html.plaintext.txt	259	co regulation adrb3 cftr may indicate proteins interact closely structural functional levels finding may linked important role adrenergic stimulation camp activation chloride transport mediated cftr
0.44193757.12482874.html.plaintext.txt	260	altered expression rnas encoding cftr interacting proteins surprisingly analysis rna influenced cftr identified number proteins directly indirectly interact cftr via protein protein interactions
0.44193757.12482874.html.plaintext.txt	261	list included proteins involved protein trafficking degradation proteosome 26 pa28 subunits adaptin ion transport kcnj15 grin 2d receptors npr 3 adrb3
0.44193757.12482874.html.plaintext.txt	262	interaction cftr many proteins occurs via pdz binding domains mediate protein protein complex formation
0.44193757.12482874.html.plaintext.txt	263	finding expression cftr interacting proteins altered lungs cftr mice suggests cftr influences networks signaling transport activities cell cells respond cftr deficiency via transcriptional responses cftr protein complexes rather cftr per se
0.44193757.12482874.html.plaintext.txt	264	changes gene expression bystander effects whereas genomic responses may compensate lack cftr mrna represent compensation cftr function responses may secondary mediated pathways directly related action cftr per se
0.44193757.12482874.html.plaintext.txt	265	alterations cytokine production changes transcription factor activity caused absence cftr may secondarily change behavior numerous cell types may turn contribute pathogenesis cf lung disease processes direct functions cftr
0.44193757.12482874.html.plaintext.txt	266	cftr known form membrane associated cyclic nucleotide activated cl channel interacts numerous cellular proteins changes gene expression may indicate cells sense cftr protein cftr dependent activity cftr protein complexes initiate transcriptional responses related unrelated cftr function
0.44193757.12482874.html.plaintext.txt	267	present unclear whether sensor chloride ion presence cftr cftr protein complexes intracellular membrane compartments functions cftr
0.44193757.12482874.html.plaintext.txt	268	likewise hierarchy interrelatedness networks rna responses cftr deficiency remain unraveled
0.44193757.12482874.html.plaintext.txt	269	maintenance pulmonary homeostasis mcftr mouse associated complex adaptive responses gene expression
0.44193757.12482874.html.plaintext.txt	270	cftr influenced rnas encoding transcription factors ion channels membrane receptors cytokines intracellular trafficking proteins
0.44193757.12482874.html.plaintext.txt	271	finally cftr altered expression number proteins interact cftr via protein protein interactions perhaps representing transcriptional responses functions mediated cftr protein complexes fig
0.44193757.12482874.html.plaintext.txt	272	diversity genes whose expression altered cftr support concept addition regulation cl transport cftr plays diverse roles multiple cellular functions
0.44193757.12482874.html.plaintext.txt	273	present findings support hypothesis pulmonary homeostasis cftr mouse maintained complex genomic responses lack cftr rather action single alternative cl channel
0.44193757.12482874.html.plaintext.txt	274	finally genes pathways identified study provide new links cftr cellular processes may influence pathogenesis cf lung disease
0.44193757.12482874.html.plaintext.txt	275	view larger version 40k fig
0.44193757.12482874.html.plaintext.txt	276	molecular pathways networks influenced cftr
0.44193757.12482874.html.plaintext.txt	277	model proposed lack cftr initiates expression genes known enhance cftr expression il 1 cebp secondarily modulating inflammation 1 2
0.44193757.12482874.html.plaintext.txt	278	increased expression cytokines il 4 il 1 cytokine receptor csf 3r may influence inflammation 2 well expression genes modulating protein trafficking degradation cell cell communication 3 5
0.44193757.12482874.html.plaintext.txt	279	abundance rna chemoattractant peptides calgranulin family enhanced perhaps contributing proinflammatory environment within lung 2
0.44193757.12482874.html.plaintext.txt	280	cftr altered expression rnas encoding transport proteins membrane receptors likely interact cftr via pdz domains 6 7 supporting concept pulmonary cells respond lack cftr cftr complexes regulating expression cftr partners
0.44193757.12482874.html.plaintext.txt	281	alterations pathways regulating second messengers including camp via 3 adrenergic receptor adrb3 observed 7
0.44193757.12482874.html.plaintext.txt	282	absence cftr also influenced expression genes mediating endocytosis membrane recycling regulated secretion 4 8 9
0.44193757.12482874.html.plaintext.txt	283	thank theresa richardson technical support
0.44193757.12482874.html.plaintext.txt	284	work supported cystic fibrosis foundation national institutes health grant hl56387
0.44193757.12482874.html.plaintext.txt	285	costs publication article defrayed part payment page charges
0.44193757.12482874.html.plaintext.txt	286	article must therefore hereby marked advertisement accordance 18 u
0.44193757.12482874.html.plaintext.txt	287	section 1734 solely indicate fact
0.44193757.12482874.html.plaintext.txt	288	correspondence addressed cincinnati childrens hospital medical center divisions neonatology pulmonary biology 3333 burnet ave
0.44193757.12482874.html.plaintext.txt	289	513 636 4830 fax 513 636 7868 e mail jeff
0.44193757.12482874.html.plaintext.txt	290	published jbc papers press december 12 2002 doi 10
0.44193757.12482874.html.plaintext.txt	291	abbreviations used cf cystic fibrosis cftr cystic fibrosis transmembrane conductance regulator il interleukin ifabp intestinal fatty acid binding protein gene promoter rt reverse transcriptase cebp ccaat enhancer binding protein tnf tumor necrosis factor csf colony stimulating factor npr 3 naturietic peptide receptor 3 adrb 3 adrenergic receptor
0.44193757.12482874.html.plaintext.txt	292	references top abstract introduction materials methods results discussion references 1
0.44193757.12482874.html.plaintext.txt	293	1989 science 245 1066 1073medline order article via infotrieve 2
0.44193757.12482874.html.plaintext.txt	294	2001 metabolic molecular basis inherited disease scriver c
0.44193757.12482874.html.plaintext.txt	295	5121 5188 mcgraw hill new york 3
0.44193757.12482874.html.plaintext.txt	296	cell 8 149 158medline order article via infotrieve 4
0.44193757.12482874.html.plaintext.txt	297	101 2598 2605abstractfree full text 6
0.44193757.12482874.html.plaintext.txt	298	276 l466 l473abstractfree full text 7
0.44193757.12482874.html.plaintext.txt	299	93 737 749medline order article via infotrieve 8
0.44193757.12482874.html.plaintext.txt	300	12 280 287medline order article via infotrieve 9
0.44193757.12482874.html.plaintext.txt	301	1992 science 257 1083 1088medline order article via infotrieve 10
0.44193757.12482874.html.plaintext.txt	302	1994 science 266 1705 1708medline order article via infotrieve 11
0.44193757.12482874.html.plaintext.txt	303	165 3941 3950abstractfree full text 12
0.44193757.12482874.html.plaintext.txt	304	27 48 54crossrefmedline order article via infotrieve 13
0.44193757.12482874.html.plaintext.txt	305	61 3124 3130abstractfree full text 14
0.44193757.12482874.html.plaintext.txt	306	277 22743 22749abstractfree full text 15
0.44193757.12482874.html.plaintext.txt	307	276 15441 15444abstractfree full text 16
0.44193757.12482874.html.plaintext.txt	308	270 28848 28857abstractfree full text 17
0.44193757.12482874.html.plaintext.txt	309	268 19070 19075abstractfree full text 19
0.44193757.12482874.html.plaintext.txt	310	145 1471 1482abstractfree full text 20
0.44193757.12482874.html.plaintext.txt	311	21 134 140crossrefmedline order article via infotrieve 21
0.44193757.12482874.html.plaintext.txt	312	164 4916 4923abstractfree full text 22
0.44193757.12482874.html.plaintext.txt	313	164 3870 3877abstractfree full text 23
0.44193757.12482874.html.plaintext.txt	314	276 6770 6778abstractfree full text 24
0.44193757.12482874.html.plaintext.txt	315	93 7821 7825abstractfree full text 25
0.44193757.12482874.html.plaintext.txt	316	1990 cell 61 341 350medline order article via infotrieve 26
0.44193757.12482874.html.plaintext.txt	317	18 287 291medline order article via infotrieve 27
0.44193757.12482874.html.plaintext.txt	318	99 6907 6912abstractfree full text 28
0.44193757.12482874.html.plaintext.txt	319	158 1775 1784abstractfree full text 29
0.44193757.12482874.html.plaintext.txt	320	274 22123 22126free full text 30
0.44193757.12482874.html.plaintext.txt	321	277 11709 11714abstractfree full text 31
0.44193757.12482874.html.plaintext.txt	322	277 16528 16537abstractfree full text 32
0.44193757.12482874.html.plaintext.txt	323	1997 genes cells 2 195 211abstractfree full text 33
0.44193757.12482874.html.plaintext.txt	324	cell 12 2907 2920abstractfree full text 34
0.44193757.12482874.html.plaintext.txt	325	276 46251 46259abstractfree full text 35
0.44193757.12482874.html.plaintext.txt	326	273 21431 21434free full text 36
0.44193757.12482874.html.plaintext.txt	327	93 12484 12489abstractfree full text 37
0.44193757.12482874.html.plaintext.txt	328	277 13959 13965abstractfree full text 38
0.44193757.12482874.html.plaintext.txt	329	95 313 316crossrefmedline order article via infotrieve 39
0.44193757.12482874.html.plaintext.txt	330	7 49 58crossrefmedline order article via infotrieve 40
0.44193757.12482874.html.plaintext.txt	331	11 161 172crossrefmedline order article via infotrieve 41
0.44193757.12482874.html.plaintext.txt	332	137 347 359medline order article via infotrieve 42
0.44193757.12482874.html.plaintext.txt	333	265 l598 l605abstractfree full text 43
0.44193757.12482874.html.plaintext.txt	334	7 438 448crossrefmedline order article via infotrieve 44
0.44193757.12482874.html.plaintext.txt	335	94 2604 2608abstractfree full text 45
0.44193757.12482874.html.plaintext.txt	336	274 6107 6113abstractfree full text 47
0.44193757.12482874.html.plaintext.txt	337	308 963 973crossrefmedline order article via infotrieve
0.44193757.12482874.html.plaintext.txt	338	copyright 2003 american society biochemistry molecular biology inc
0.42004547.11287314.html.plaintext.txt	0	increased functional cell surface expression cftr f508 cftr anthracycline doxorubicin rangan maitra1 collin m
0.42004547.11287314.html.plaintext.txt	1	1 departments pharmacology toxicology 2 physiology dartmouth medical school hanover new hampshire 03755 3835
0.42004547.11287314.html.plaintext.txt	2	abstract top abstract introduction methods results discussion references
0.42004547.11287314.html.plaintext.txt	3	cystic fibrosis cf disease caused mutations within cystic fibrosis transmembrane conductance regulator cftr gene
0.42004547.11287314.html.plaintext.txt	4	common mutation f508 accounts 70 cf alleles results protein defective folding trafficking cell surface
0.42004547.11287314.html.plaintext.txt	5	however f508 cftr functional properly localized
0.42004547.11287314.html.plaintext.txt	6	report single noncytotoxic dose anthracycline doxorubicin dox 0
0.42004547.11287314.html.plaintext.txt	7	25 microm significantly increased total cellular cftr protein expression cell surface cftr protein expression cftr associated chloride secretion cultured t84 epithelial cells
0.42004547.11287314.html.plaintext.txt	8	dox treatment also increased f508 cftr cell surface expression f508 cftr associated chloride secretion stably transfected madin darby canine kidney cells
0.42004547.11287314.html.plaintext.txt	9	results suggest anthracycline analogs may useful clinical treatment cf
0.42004547.11287314.html.plaintext.txt	10	trafficking chloride secretion
0.42004547.11287314.html.plaintext.txt	11	introduction top abstract introduction methods results discussion references
0.42004547.11287314.html.plaintext.txt	12	cystic fibrosis transmembrane conductance regulator cftr camp protein kinase regulated chloride channel found apical membranes polarized epithelial cells 10
0.42004547.11287314.html.plaintext.txt	13	mutations within gene lead cf phenotype ultimately results premature death primarily combination chronic lung infections loss pulmonary function pancreatic insufficiency 5
0.42004547.11287314.html.plaintext.txt	14	genetic disease among prevalent human population occurring 1 2500 caucasian live births
0.42004547.11287314.html.plaintext.txt	15	cftr member structurally related atp binding cassette family transmembrane transport proteins whose members include p glycoprotein pgp mdr1 gene product multidrug resistance associated protein related multidrug resistance proteins sulfonylurea receptor 21
0.42004547.11287314.html.plaintext.txt	16	850 individual cftr mutations leading cf phenotype described important f508 phenylalanine deletion amino acid position 508 seen 70 cf patients
0.42004547.11287314.html.plaintext.txt	17	f508 cftr mutation results improper folding trafficking cftr protein leading degradation endoplasmic reticulum 26s proteosome machinery cell 23
0.42004547.11287314.html.plaintext.txt	18	however importantly mutant protein folded expressed membrane experimental cell culture techniques glycerol 20 low temperature treatments 3 functions normally chloride channel
0.42004547.11287314.html.plaintext.txt	19	moreover estimated restoration functional cftr expression 10 normal levels would sufficient ameliorate symptoms disease vivo 19
0.42004547.11287314.html.plaintext.txt	20	thus great interest development strategies enhance f508 cftr cell surface expression may clinically useful treatment cf patients
0.42004547.11287314.html.plaintext.txt	21	evidence coregulation pgp cftr epithelial cells although mechanism level overlapping regulation currently unknown 2
0.42004547.11287314.html.plaintext.txt	22	previous work laboratory demonstrated transcriptional posttranscriptional effects low dose noncytotoxic treatments cancer chemotherapy drugs mitomycin c mmc doxorubicin dox expression pgp various cell lines mouse vivo model 6 7
0.42004547.11287314.html.plaintext.txt	23	therefore hypothesized cftr expression might also modified related drugs similar treatment conditions
0.42004547.11287314.html.plaintext.txt	24	recently demonstrated mmc increased total protein cell surface functional expression wild type cftr ht 29 t84 human colon cells 15a
0.42004547.11287314.html.plaintext.txt	25	study investigated effects dox cftr f508 cftr expression
0.42004547.11287314.html.plaintext.txt	26	report low dose dox 0
0.42004547.11287314.html.plaintext.txt	27	25 microm significantly increased functional cell surface expression cftr f508 cftr t84 madin darby canine kidney mdck cells respectively primarily result posttranscriptional effects
0.42004547.11287314.html.plaintext.txt	28	methods top abstract introduction methods results discussion references
0.42004547.11287314.html.plaintext.txt	29	human colon adenocarcinoma t84 cells american type culture collection manassas va maintained dmemf 12 media life technology rockville md containing l glutamine supplemented 10 fetal bovine serum fbs antibiotics life technology
0.42004547.11287314.html.plaintext.txt	30	isogenic line mdckc 7 cells stably expressing green fluorescent protein gfp tagged nh2 terminus f508 cftr mdckf508 created fashion similar cell line expressing gfp tagged nh2 terminus cftr mdckcftr described elsewhere 17 18
0.42004547.11287314.html.plaintext.txt	31	cell line parental mdck c7 cells maintained minimum essential media mem life technology supplemented
0.42004547.11287314.html.plaintext.txt	32	3 mgml g418 sulfate sigma st
0.42004547.11287314.html.plaintext.txt	33	louis mo added mdckf508 media maintaining selection pressure
0.42004547.11287314.html.plaintext.txt	34	immunoblot analysis rt pcr following drug treatment cells grown six well plates costar cambridge ma confluence washed pbs treated without 0
0.42004547.11287314.html.plaintext.txt	35	completed media replenished cells harvested various time points
0.42004547.11287314.html.plaintext.txt	36	short circuit current measurements cell surface biotinylations cells cultured transwell type filters corning ithaca ny
0.42004547.11287314.html.plaintext.txt	37	medium completely changed every 24 h experiments performed 14 days postseeding
0.42004547.11287314.html.plaintext.txt	38	total rna t84 cells isolated using triazol reagent life technology
0.42004547.11287314.html.plaintext.txt	39	one microgram total rna t84 cells reverse transcribed using rna pcr core kit perkin elmer foster city ca 20 microl total volume
0.42004547.11287314.html.plaintext.txt	40	cdnas divided two equal aliquots amplified using 0
0.42004547.11287314.html.plaintext.txt	41	5 microl amplitaq dna polymerase 5 u microl 20 pm upper lower primers specific human cftr upper 5 cct gaa cct gat gac aca ct 3 lower 5 taa aac tgc gac aac tgc ta 3 1
0.42004547.11287314.html.plaintext.txt	42	25 microl 5 microm 18s rna specific primers competimers ambion austin tx ratio 3
0.42004547.11287314.html.plaintext.txt	43	prior titration experiments ensured amplification cftr 18s rna products within linear range
0.42004547.11287314.html.plaintext.txt	44	cdna products separated electrophoresis 1 agarose gels life technology stained ethidium bromide confirm proper product sizes
0.42004547.11287314.html.plaintext.txt	45	cells treated solvent dox washed cold pbs scraped small volume lysis buffer 50 mm tris hcl ph 6
0.42004547.11287314.html.plaintext.txt	46	8 150 mm nacl 1 nonidet p 40 containing protease inhibitor cocktail roche biochemicals indianapolis
0.42004547.11287314.html.plaintext.txt	47	protein extracted samples 30 min incubation ice intermediate vortexing frozen 70 degrees c
0.42004547.11287314.html.plaintext.txt	48	protein sample quantified bichinchoninic acid assay pierce rockford il
0.42004547.11287314.html.plaintext.txt	49	sds page performed 4 15 minigels using 50 microg protein lysate per lane
0.42004547.11287314.html.plaintext.txt	50	proteins separated transferred polyvinylidene difluoride membrane millipore bedford ma 120 ma 1 h towbins transfer buffer 25 mm tris 192 mm glycine 12 methanol
0.42004547.11287314.html.plaintext.txt	51	transfer blots blocked probed sequentially first polyclonal a2 rabbit anti cftr antisera 25 generously provided dr
0.42004547.11287314.html.plaintext.txt	52	skach oregon health sciences institute overnight 4 degrees c horseradish peroxidase hrp labeled anti rabbit secondary polyclonal antibody amersham piscataway nj
0.42004547.11287314.html.plaintext.txt	53	membranes washed six times pbs 0
0.42004547.11287314.html.plaintext.txt	54	3 tween 20 pbst room temperature 10 min
0.42004547.11287314.html.plaintext.txt	55	blots developed enhanced chemiluminescence ecl blaze substrate pierce exposed film
0.42004547.11287314.html.plaintext.txt	56	cell surface biotinylation immunoprecipitation
0.42004547.11287314.html.plaintext.txt	57	t84 cells biotinylated apical plasma membrane commercially available biotinylation kit roche biochemicals
0.42004547.11287314.html.plaintext.txt	58	treatment 4 degrees c lc biotin hydrazide cells washed cold pbs harvested lysis buffer ice total protein sample quantified described
0.42004547.11287314.html.plaintext.txt	59	two hundred micrograms protein sample immunoprecipitated using polyclonal a2 rabbit anti cftr antisera 11000 protein agarose roche biochemicals
0.42004547.11287314.html.plaintext.txt	60	beads washed pbst immunoreactive proteins separated sds page detected streptavidin hrp ecl described
0.42004547.11287314.html.plaintext.txt	61	f508 cftr expressing mdck cells immunoprecipitated similarly immunoblotted using monoclonal anti gfp antibody clontech laboratories palo alto ca
0.42004547.11287314.html.plaintext.txt	62	experiments cftr immunoprecipitated a2 described detected m3a7 monoclonal anti cftr antibody 12 generous gift dr
0.42004547.11287314.html.plaintext.txt	63	riordan mayo institute scottsdale az
0.42004547.11287314.html.plaintext.txt	64	measurement short circuit current
0.42004547.11287314.html.plaintext.txt	65	short circuit current isc measured across monolayers t84 cells grown filters
0.42004547.11287314.html.plaintext.txt	66	cells treated dox 0
0.42004547.11287314.html.plaintext.txt	67	25 microm 24 h beginning 14 days seeding media changed remove residual drug isc measurement
0.42004547.11287314.html.plaintext.txt	68	isc measured cells presence amiloride 105 m apical solution block potential contribution sodium transport isc
0.42004547.11287314.html.plaintext.txt	69	presence amiloride 8 4 chlorophenylthio camp cpt camp stimulated isc t84 cells equivalent electrogenic cl secretion 1
0.42004547.11287314.html.plaintext.txt	70	cftr antagonist diphenylamino carboxylic acid dpc clhco exchange inhibitor 44 diisothiocyanostilbene 22 disulfonic acid dids added previously described 1 17
0.42004547.11287314.html.plaintext.txt	71	bath solutions maintained 37 degrees c stirred bubbling 5 co2 95 air
0.42004547.11287314.html.plaintext.txt	72	current output voltage clamp digitized tl 1 dma interface analog digital converter axon instruments foster city ca
0.42004547.11287314.html.plaintext.txt	73	data collection analysis done axotape 2
0.42004547.11287314.html.plaintext.txt	74	experiments cells bathed fbs free mem solution containing mm 116 nacl 116 nahco3 3 kcl 2 mgcl2 0
0.42004547.11287314.html.plaintext.txt	75	fluorescent chloride efflux assay
0.42004547.11287314.html.plaintext.txt	76	cells grown confluence six well plates loaded 10 mm n ethoxycarbonylmethyl 6 methoxyquinolinium bromide mqae molecular probes eugene overnight described detail previously 24
0.42004547.11287314.html.plaintext.txt	77	briefly cells incubated chloride containing nitrate free buffer chloride concentration equilibration inside outside cells background fluorescence recorded 3 min
0.42004547.11287314.html.plaintext.txt	78	buffer changed chloride free nitrate containing buffer
0.42004547.11287314.html.plaintext.txt	79	buffers contained 100 microm cpt camp roche biochemicals stimulate cftr
0.42004547.11287314.html.plaintext.txt	80	presence chloride mqae caged probes fluorescence quenched
0.42004547.11287314.html.plaintext.txt	81	upon changing chloride free nitrate containing buffer chloride gradient established results rapid exchange chloride nitrate cells
0.42004547.11287314.html.plaintext.txt	82	first minutes rate increase free mqae fluorescence proportional number chloride channels membrane
0.42004547.11287314.html.plaintext.txt	83	increase mqae fluorescence monitored 20 min buffer exchange
0.42004547.11287314.html.plaintext.txt	84	rates chloride efflux calculated slopes fluorescence curves first 3 min
0.42004547.11287314.html.plaintext.txt	85	cytofluor ii plate reader perseptive biosystems framingham ma equipped 360 nm excitation460 nm emission filter set used measure mqae fluorescence cells
0.42004547.11287314.html.plaintext.txt	86	densitometric quantification image processing carried using adobe photoshop adobe software san jose ca nih image national institutes health bethesda md software packages
0.42004547.11287314.html.plaintext.txt	87	statistical analyses performed using instat prism software graphpad software san diego ca
0.42004547.11287314.html.plaintext.txt	88	results top abstract introduction methods results discussion references
0.42004547.11287314.html.plaintext.txt	89	effects dox cftr expression t84 cells
0.42004547.11287314.html.plaintext.txt	90	experiments described except fig
0.42004547.11287314.html.plaintext.txt	91	2c cells treated 0
0.42004547.11287314.html.plaintext.txt	92	25 microm dox 24 h caused overt cytotoxicity change cell viability measured trypan blue exclusion assay
0.42004547.11287314.html.plaintext.txt	93	dose 20 fold lower half maximal lethal concentration lc50 dox cells j
0.42004547.11287314.html.plaintext.txt	94	effects dox cftr mrna expression examined t84 cells semiquantitative rt pcr assay
0.42004547.11287314.html.plaintext.txt	95	treatment cells 24 h 0
0.42004547.11287314.html.plaintext.txt	96	25 microm dox little effect steady state cftr mrna expression fig
0.42004547.11287314.html.plaintext.txt	97	contrast dox treatment significantly altered cftr protein levels
0.42004547.11287314.html.plaintext.txt	98	24 h dox treatment increased cftr protein approximately twofold fig
0.42004547.11287314.html.plaintext.txt	99	2 c particularly c band represents mature fully glycosylated form cftr fig
0.42004547.11287314.html.plaintext.txt	100	dose response time course studies indicated optimal treatment 0
0.42004547.11287314.html.plaintext.txt	101	increase cftr protein also observed immunoprecipitation a2 antibody subsequent immunoblotting second cftr specific monoclonal antibody m3a7 fig
0.42004547.11287314.html.plaintext.txt	102	view larger version 20k fig
0.42004547.11287314.html.plaintext.txt	103	effects doxorubicin dox cystic fibrosis transmembrane conductance regulator cftr mrna expression t84 cells
0.42004547.11287314.html.plaintext.txt	104	25 microm dox 6 24 h shown vehicle 24 h control con
0.42004547.11287314.html.plaintext.txt	105	total rna cells isolated analyzed cftr mrna steady state expression rt pcr described methods
0.42004547.11287314.html.plaintext.txt	106	representative gel image rt pcr analysis
0.42004547.11287314.html.plaintext.txt	107	18s rrna expression shown sample comparison
0.42004547.11287314.html.plaintext.txt	108	b densitometry analysis rt pcr experiments
0.42004547.11287314.html.plaintext.txt	109	quantitiation performed described methods cftr value normalized values 18s rrna
0.42004547.11287314.html.plaintext.txt	110	bar represents mean se values 3 6 independent samples
0.42004547.11287314.html.plaintext.txt	111	statistically significant differences among treatment groups anova ad hoc pairwise comparison
0.42004547.11287314.html.plaintext.txt	112	view larger version 22k fig
0.42004547.11287314.html.plaintext.txt	113	effects dox cftr protein expression t84 cells
0.42004547.11287314.html.plaintext.txt	114	cells treated dox 0
0.42004547.11287314.html.plaintext.txt	115	25 microm vehicle con total protein isolated described methods
0.42004547.11287314.html.plaintext.txt	116	representative immunoblotting total cellular protein control dox treated cells 24 h polyclonal a2 antibody
0.42004547.11287314.html.plaintext.txt	117	arrows indicate positions b c forms cftr based relative mobilities
0.42004547.11287314.html.plaintext.txt	118	b time course effects dox cftr expression
0.42004547.11287314.html.plaintext.txt	119	western blotting performed various time points dox treatment indicated cftr bands quantified densitometry
0.42004547.11287314.html.plaintext.txt	120	bar represents mean se densitometry values total cftr 3 separate samples time point
0.42004547.11287314.html.plaintext.txt	121	significant difference control p 0
0.42004547.11287314.html.plaintext.txt	122	01 anova ad hoc pairwise comparison
0.42004547.11287314.html.plaintext.txt	123	c dose response effects dox cftr expression
0.42004547.11287314.html.plaintext.txt	124	western blotting performed 24 h dox treatment indicated cftr bands quantified densitometry
0.42004547.11287314.html.plaintext.txt	125	bar represents mean se densitometry values total cftr 3 separate samples time point
0.42004547.11287314.html.plaintext.txt	126	significant difference control p 0
0.42004547.11287314.html.plaintext.txt	127	01 anova ad hoc pairwise comparison
0.42004547.11287314.html.plaintext.txt	128	d immunoprecipitation cftr total cellular protein samples a2 antibody followed western blotting detection using monoclonal m3a7 antibody cftr control dox treated 24 h samples immunoprecipitation pra sepharose protein control yb1 immunoprecipitation nonspecific anti yb1 antibody
0.42004547.11287314.html.plaintext.txt	129	e densitometry blot c b
0.42004547.11287314.html.plaintext.txt	130	significant difference control p 0
0.42004547.11287314.html.plaintext.txt	131	f representative blot following cell surface biotinylation apical membrane control dox treated cells 24 h followed immunoprecipitation cftr detection using horseradish peroxidase conjugated streptavidin described methods
0.42004547.11287314.html.plaintext.txt	132	g densitometric analysis biotinylation experiments shown e
0.42004547.11287314.html.plaintext.txt	133	bar represents mean se values 3 separate samples
0.42004547.11287314.html.plaintext.txt	134	significant difference control p 0
0.42004547.11287314.html.plaintext.txt	135	assess whether dox specifically increased membrane cftr expression performed selective cell surface biotinylation apical membrane proteins followed immunoprecipitation cftr specific polyclonal antibody detection using hrp conjugated streptavidin
0.42004547.11287314.html.plaintext.txt	136	2 f g dox treated cells compared control cells approximately twofold increase levels plasma membrane associated cftr detected single 170 kda band mature c band immunoblots fig
0.42004547.11287314.html.plaintext.txt	137	taken together experiments indicate dox treatment t84 cells leads enhanced cftr protein expression cell surface
0.42004547.11287314.html.plaintext.txt	138	experiments conducted assess whether increased plasma membrane expression cftr resulted enhanced chloride secretion t84 cells
0.42004547.11287314.html.plaintext.txt	139	used mqae fluorescence based assay 24 h dox treatment increased chloride permeability approximately twofold relative control shown fig
0.42004547.11287314.html.plaintext.txt	140	electrogenic chloride secretion also measured across monolayers t84 cells fig
0.42004547.11287314.html.plaintext.txt	141	dox treatment increased cftr associated chloride secretion approximately twofold compared control
0.42004547.11287314.html.plaintext.txt	142	thus used two different assays cftr function dox significantly increased cftr mediated chloride permeability association increased levels membrane associated cftr cells
0.42004547.11287314.html.plaintext.txt	143	view larger version 20k fig
0.42004547.11287314.html.plaintext.txt	144	effects dox cftr associated chloride secretion t84 cells
0.42004547.11287314.html.plaintext.txt	145	two different assays used demonstrate effects dox 0
0.42004547.11287314.html.plaintext.txt	146	25 microm 24 h functional cell surface expression endogenous human cftr t84 cells described methods
0.42004547.11287314.html.plaintext.txt	147	representative data n ethoxycarbonylmethyl 6 methoxyquinolinium bromide mqae fluorescence assay demonstrating change fluorescence recorded time
0.42004547.11287314.html.plaintext.txt	148	slope tracing linear portion curve used generate data shown b solid line dox dotted line control
0.42004547.11287314.html.plaintext.txt	149	b effects dox camp stimulated chloride permeability measured chloride sensitive fluorescent probe mqae
0.42004547.11287314.html.plaintext.txt	150	values expressed rate change mqae fluorescence linear portion curve shown
0.42004547.11287314.html.plaintext.txt	151	values significantly different control p 0
0.42004547.11287314.html.plaintext.txt	152	c representative data ussing chamber assay demonstrating change short circuit current used generate data shown d see methods
0.42004547.11287314.html.plaintext.txt	153	dpc diphenylamino carboxylic acid dids 44 diisothiocyanostilbene 22 difulsonic acid
0.42004547.11287314.html.plaintext.txt	154	d effects dox short circuit current isc measured ussing chamber assay
0.42004547.11287314.html.plaintext.txt	155	values represent change isc measured microampcm2 shown c
0.42004547.11287314.html.plaintext.txt	156	bar represents mean se values obtained 6 independent monolayers
0.42004547.11287314.html.plaintext.txt	157	values significantly different control p 0
0.42004547.11287314.html.plaintext.txt	158	effects dox f508 cftr expression mdck cells
0.42004547.11287314.html.plaintext.txt	159	effects dox treatment functional cell surface expression cftr folding mutant f508 cftr assessed techniques
0.42004547.11287314.html.plaintext.txt	160	cftr associated chloride secretion measured ussing chamber across monolayers parental mdck c7 cells two isogenic mdck cell lines stably expressing either gfp tagged human cftr human gfp f508 cftr
0.42004547.11287314.html.plaintext.txt	161	dox treatment effect chloride secretion mdck c7 parental cells fig
0.42004547.11287314.html.plaintext.txt	162	however mdck cells expressing mutant gfp f508 cftr dox treatment caused 2
0.42004547.11287314.html.plaintext.txt	163	3 fold increase cftr mediated chloride secretion compared untreated control cells fig
0.42004547.11287314.html.plaintext.txt	164	increase gfp f508 cftr expression confirmed western blotting cells fig
0.42004547.11287314.html.plaintext.txt	165	important note control level chloride secretion cells similar parental mdck cells expressing canine cftr fig
0.42004547.11287314.html.plaintext.txt	166	4a suggesting essentially little functional f508 cftr expression plasma membrane cells dox treatment
0.42004547.11287314.html.plaintext.txt	167	view larger version 24k fig
0.42004547.11287314.html.plaintext.txt	168	effects dox cftr f508 cftr associated chloride secretion f508 cftr protein expression parental madin darby canine kidney mdck c7 cells independently derived cell lines stably expressing green fluorescent protein gfp tagged human cftr f508 cftr
0.42004547.11287314.html.plaintext.txt	169	cells treated dox 0
0.42004547.11287314.html.plaintext.txt	170	25 microm 24 h isc protein expression assayed described methods figs
0.42004547.11287314.html.plaintext.txt	171	dox effects isc parental mdck cells wt stably transfected mdck cells expressing cftr cftr f508 cftr df508
0.42004547.11287314.html.plaintext.txt	172	bar represents mean se values obtained 6 independent samples
0.42004547.11287314.html.plaintext.txt	173	values significantly different control p 0
0.42004547.11287314.html.plaintext.txt	174	b c dox effects cftr expression detected western blots cells treated analyzed expression human wild type gfp cftr b gfp f508 cftr c described methods fig
0.42004547.11287314.html.plaintext.txt	175	d dox effects gfp f508 cftr protein expression determined immunoprecipitation
0.42004547.11287314.html.plaintext.txt	176	cells treated described analyzed immunoprecipitation anti cftr polyclonal antibody a2 detection using anti gfp antibody described methods fig
0.42004547.11287314.html.plaintext.txt	177	arrows indicate positions gfp f508 cftr fusion proteins
0.42004547.11287314.html.plaintext.txt	178	interestingly dox effect chloride secretion mdck cell line expressing wild type human gfp cftr fig
0.42004547.11287314.html.plaintext.txt	179	also effect expression determined western blotting fig
0.42004547.11287314.html.plaintext.txt	180	reason lack effect either canine human wild type cftr experiments clear since wild type cftr expression affected t84 cells figs
0.42004547.11287314.html.plaintext.txt	181	may due already high level expression cftr mdck cells demonstrated fivefold increase chloride secretion compared parental mdck cells expressing canine form fig
0.42004547.11287314.html.plaintext.txt	182	conversely may mdck cells two distinct pathways normal mutant cftr protein trafficking latter dox sensitive
0.42004547.11287314.html.plaintext.txt	183	several previous experimental cell culture procedures high concentrations glycerol low temperature incubation treatment xanthine drug cpx shown able increase functional cell surface f508 cftr expression 3 4 14
0.42004547.11287314.html.plaintext.txt	184	interestingly treatments appear affect wild type cftr expression cells suggesting agents targeting alternative pathway specific mutant misfolded protein rather general trafficking cftr proteins 3 4 14
0.42004547.11287314.html.plaintext.txt	185	thus may differences efficiency wild type cftr expression cells e
0.42004547.11287314.html.plaintext.txt	186	cftr may follow alternative pathway t84 cells therefore available rescue dox treatment compared mdck cells
0.42004547.11287314.html.plaintext.txt	187	event doxs lack effect functional expression endogenous canine cftr parental mdck cells expression stably expressed normal human gfp cftr suggests change chloride current gfp f508 cftr mdck cells principally result substantially increased cell surface expression gfp f508 cftr essentially undetectable functional level
0.42004547.11287314.html.plaintext.txt	188	confirm isc western results examined changes gfp f508 cftr expression mdck cells immunoprecipitation
0.42004547.11287314.html.plaintext.txt	189	4d dox increased expression f508 cftr protein cells
0.42004547.11287314.html.plaintext.txt	190	large glycoproteins typically migrate reduced rate denaturing gels result mature c band gfp f508 cftr detected 240 kda rather 210 kda predicted
0.42004547.11287314.html.plaintext.txt	191	laboratory previously demonstrated similar migration pattern wild type gfp cftr 17
0.42004547.11287314.html.plaintext.txt	192	taken together results demonstrate noncytotoxic dose dox substantially increase functional cell surface expression f508 cftr epithelial cells
0.42004547.11287314.html.plaintext.txt	193	discussion top abstract introduction methods results discussion references
0.42004547.11287314.html.plaintext.txt	194	report single noncytotoxic dose dox increased amount functional cftr plasma membrane t84 cells amount functional f508 cftr plasma membrane mdck cells
0.42004547.11287314.html.plaintext.txt	195	t84 cells appeared principally posttranscriptional effect little effect cftr mrna expression
0.42004547.11287314.html.plaintext.txt	196	cell models dox caused significant increase total cellular cftr protein levels proportionate increase cftr associated chloride secretion
0.42004547.11287314.html.plaintext.txt	197	results suggest analogs may identified clinically useful ameliorating cf disease phenotype human cf patients
0.42004547.11287314.html.plaintext.txt	198	purpose studies obtain proof principle class drugs
0.42004547.11287314.html.plaintext.txt	199	although exact mechanistic basis behind effect currently investigated one possibility dox increases stability f508 cftr nascent forms allowing fold properly
0.42004547.11287314.html.plaintext.txt	200	dox may alter kinetics f508 cftr biogenesis influencing interaction nascent protein cellular chaperones
0.42004547.11287314.html.plaintext.txt	201	previous reports indicate heat shock cognate protein hsc70 facilitates early steps f508 cftr biogenesis appear important maturation protein 22 compounds capable altering association facilitate f508 cftr 9 expression chloride secretion
0.42004547.11287314.html.plaintext.txt	202	another possibility dox directly interacts alters folding stability trafficking f508 cftr biogenesis
0.42004547.11287314.html.plaintext.txt	203	example mutations pgp alter folding plasma membrane trafficking including mutation comparable f508 cftr corrected treatment cells pgp substrate drugs 15
0.42004547.11287314.html.plaintext.txt	204	authors proposed drugs acted chemical chaperones interact pgp allow proper folding nascent molecule functional mature form
0.42004547.11287314.html.plaintext.txt	205	similar phenomenon could occur f508 cftr although study indicated effect treatments f508 cftr expression indicating effect pgp specific
0.42004547.11287314.html.plaintext.txt	206	however anthracycline analogs tested study
0.42004547.11287314.html.plaintext.txt	207	drugs also described capable altering cftr pgp protein levels
0.42004547.11287314.html.plaintext.txt	208	example butyrate compounds shown capable stimulating pgp 16 cftr 18 protein expression
0.42004547.11287314.html.plaintext.txt	209	found another cancer chemotherapy drug mitomycin c also increased functional cell surface expression cftr t84 ht 29 cells although effects modest dox r
0.42004547.11287314.html.plaintext.txt	210	alternatively dox may inhibit degradation misfolded f508 cftr might favor proper folding maturation
0.42004547.11287314.html.plaintext.txt	211	however previous studies kopito colleagues 11 23 demonstrated inhibition 26s proteosomal degradation pathway per se enhance f508 cftr folding rather leads aggregation
0.42004547.11287314.html.plaintext.txt	212	proteolytic pathways involved cftr degradation 8 possibility cannot completely ruled
0.42004547.11287314.html.plaintext.txt	213	possibilities remain explored future studies
0.42004547.11287314.html.plaintext.txt	214	perhaps interestingly recent clinical observation made 13 cf patient f508 cftr mutation one allele g673x stop mutation allele fibrosarcoma
0.42004547.11287314.html.plaintext.txt	215	patient demonstrated significantly improved lung function inhibition pseudomonas aeruginosa infection combination chemotherapy cyclophosphamide anthracycline epirubicin
0.42004547.11287314.html.plaintext.txt	216	intriguing clinical observation investigated systematically cf cancer patients receiving chemotherapy
0.42004547.11287314.html.plaintext.txt	217	study dox treatment regimen significant f508 cftr effects observed 0
0.42004547.11287314.html.plaintext.txt	218	25 microm promising clinical pharmacology perspective
0.42004547.11287314.html.plaintext.txt	219	dox concentration 20 fold lower lc50 cell systems suggesting one might also able achieve effects vivo comparably low dose well used cancer chemotherapy elicit significant nontarget toxicity
0.42004547.11287314.html.plaintext.txt	220	dox unlikely useful cf clinical setting due cumulative systemic toxicity
0.42004547.11287314.html.plaintext.txt	221	however likely given thousands anthracyclines derivatives developed characterized past 50 years analogs discovered developed share beneficial properties dox increasing f508 cftr expression avoiding cumulative toxicities
0.42004547.11287314.html.plaintext.txt	222	long term goal research develop clinically useful drugs systemic treatment cf patients aim ameliorating disease phenotype
0.42004547.11287314.html.plaintext.txt	223	givan help flow cytometry
0.42004547.11287314.html.plaintext.txt	224	work supported grants national institutes health b
0.42004547.11287314.html.plaintext.txt	225	stanton cystic fibrosis foundation b
0.42004547.11287314.html.plaintext.txt	226	hamilton also partially supported norris cotton cancer center r
0.42004547.11287314.html.plaintext.txt	227	maitra partially supported research grant j
0.42004547.11287314.html.plaintext.txt	228	hamilton bristol myers squibb
0.42004547.11287314.html.plaintext.txt	229	address reprint requests correspondence j
0.42004547.11287314.html.plaintext.txt	230	pharmacology toxicology dartmouth medical school 7650 remsen hanover nh 03755 3835 e mail josh
0.42004547.11287314.html.plaintext.txt	231	costs publication article defrayed part payment page charges
0.42004547.11287314.html.plaintext.txt	232	article must therefore hereby marked advertisement accordance 18 u
0.42004547.11287314.html.plaintext.txt	233	section 1734 solely indicate fact
0.42004547.11287314.html.plaintext.txt	234	received 1 february 2000 accepted final form 17 november 2000
0.42004547.11287314.html.plaintext.txt	235	references top abstract introduction methods results discussion references
0.42004547.11287314.html.plaintext.txt	236	positive negative regulation chloride secretion t84 cells
0.42004547.11287314.html.plaintext.txt	237	j physiol cell physiol 265 c859 c868 1993abstractfree full text
0.42004547.11287314.html.plaintext.txt	238	breuer w slotki ausiello da cabantchik iz
0.42004547.11287314.html.plaintext.txt	239	induction multidrug resistance downregulates expression cftr colon epithelial cells
0.42004547.11287314.html.plaintext.txt	240	j physiol cell physiol 265 c1711 c1715 1993abstractfree full text
0.42004547.11287314.html.plaintext.txt	241	denning gm anderson mp amara jf marshall j smith ae welsh mj
0.42004547.11287314.html.plaintext.txt	242	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.42004547.11287314.html.plaintext.txt	243	nature 358 761 764 1992isimedline
0.42004547.11287314.html.plaintext.txt	244	drumm ml wilkinson dj smit ls worrell rt strong tv frizzell ra dawson dc collins fs
0.42004547.11287314.html.plaintext.txt	245	chloride conductance expressed f508 mutant cftrs xenopus oocytes
0.42004547.11287314.html.plaintext.txt	246	science 254 1797 1799 1991isimedline
0.42004547.11287314.html.plaintext.txt	247	genotype phenotype correlation cystic fibrosis patients
0.42004547.11287314.html.plaintext.txt	248	ann biol clin paris 54 235 241 1996isimedline
0.42004547.11287314.html.plaintext.txt	249	ihnat ma lariviere jp warren aj la ronde n blaxall jrn pierre km turpie bw hamilton jw
0.42004547.11287314.html.plaintext.txt	250	suppression p glycoprotein expression multidrug resistance dna cross linking agents
0.42004547.11287314.html.plaintext.txt	251	clin cancer res 3 1339 1346 1997abstract
0.42004547.11287314.html.plaintext.txt	252	ihnat ma nervi anthony sp kaltreider rc warren aj pesce ca davis sa lariviere jp hamilton jw
0.42004547.11287314.html.plaintext.txt	253	effects mitomycin c carboplatin pretreatment multidrug resistance associated p glycoprotein expression subsequent suppression tumor growth doxorubicin paclitaxel human metastatic breast cancer xenografted nude mice
0.42004547.11287314.html.plaintext.txt	254	oncol res 11 303 310 1999isimedline
0.42004547.11287314.html.plaintext.txt	255	jensen tj loo ma pind williams db goldberg al riordon jr
0.42004547.11287314.html.plaintext.txt	256	multiple proteolytic systems including proteosome contribute cftr processing
0.42004547.11287314.html.plaintext.txt	257	cell 83 129 135 1995isimedline
0.42004547.11287314.html.plaintext.txt	258	jiang c fang sl xiao yf oconnor sp nadler sg lee dw jefferson dm kaplan jm smith ae cheng sh
0.42004547.11287314.html.plaintext.txt	259	partial restoration camp stimulated cftr chloride channel activity f508 cells deoxyspergualin
0.42004547.11287314.html.plaintext.txt	260	j physiol cell physiol 275 c171 c178 1998abstractfree full text
0.42004547.11287314.html.plaintext.txt	261	biogenesis traffic function cystic fibrosis transmembrane conductance regulator
0.42004547.11287314.html.plaintext.txt	262	int rev cytol 172 193 241 1997isimedline
0.42004547.11287314.html.plaintext.txt	263	johnston ja ward cl kopito rr
0.42004547.11287314.html.plaintext.txt	264	aggresomes cellular response misfolded proteins
0.42004547.11287314.html.plaintext.txt	265	j cell biol 143 1883 1898 1998abstractfree full text
0.42004547.11287314.html.plaintext.txt	266	characterization polyclonal monoclonal antibodies cystic fibrosis transmembrane conductance regulator
0.42004547.11287314.html.plaintext.txt	267	methods enzymol 292 629 652 1998isimedline
0.42004547.11287314.html.plaintext.txt	268	lallemand jy stoven v annereau jp boucher j blanquet barthe j lenoir g
0.42004547.11287314.html.plaintext.txt	269	induction antitumoral drugs proteins functionally complement cftr novel therapy cystic fibrosis lancet 350 711 712 1997isimedline
0.42004547.11287314.html.plaintext.txt	270	li c ramjeesingh m reyes e jensen chang x rommens jm bear ce
0.42004547.11287314.html.plaintext.txt	271	cystic fibrosis mutation f508 influence chloride channel activity cftr
0.42004547.11287314.html.plaintext.txt	272	nat genet 3 311 316 1993isimedline
0.42004547.11287314.html.plaintext.txt	273	correction defective protein kinesis human p glycoprotein mutants substrates modulators
0.42004547.11287314.html.plaintext.txt	274	j biol chem 272 709 712 1997abstractfree full text
0.42004547.11287314.html.plaintext.txt	275	maitra r shaw cm stanton ba hamilton jw
0.42004547.11287314.html.plaintext.txt	276	functional enhancement cftr expression mitomycin c
0.42004547.11287314.html.plaintext.txt	277	morrow cs nakagawa m goldsmith madden mj cowan kh
0.42004547.11287314.html.plaintext.txt	278	reversible transcriptional activation mdr1 sodium butyrate treatment human colon cancer cells
0.42004547.11287314.html.plaintext.txt	279	j biol chem 269 10739 10746 1994abstractfree full text
0.42004547.11287314.html.plaintext.txt	280	moyer bd loffing j schwiebert em loffing cueni d halpin pa karlson kh ismailov ii guggino wb langford gm stanton ba
0.42004547.11287314.html.plaintext.txt	281	membrane trafficking cystic fibrosis gene product cystic fibrosis transmembrane conductance regulator tagged green fluorescent protein madin darby canine kidney cells
0.42004547.11287314.html.plaintext.txt	282	j biol chem 273 21759 21768 1998abstractfree full text
0.42004547.11287314.html.plaintext.txt	283	moyer bd loffing cueni d loffing j reynolds d stanton ba
0.42004547.11287314.html.plaintext.txt	284	butyrate increases apical membrane cftr reduces chloride secretion mdck cells
0.42004547.11287314.html.plaintext.txt	285	j physiol renal physiol 277 f271 f276 1999abstractfree full text
0.42004547.11287314.html.plaintext.txt	286	pilewski jm frizzell ra
0.42004547.11287314.html.plaintext.txt	287	role cftr airway disease
0.42004547.11287314.html.plaintext.txt	288	physiol rev 79 s215 s255 1999medline
0.42004547.11287314.html.plaintext.txt	289	sato ward cl krouse wine jj kopito rr
0.42004547.11287314.html.plaintext.txt	290	glycerol reverses misfolding phenotype common cystic fibrosis mutation
0.42004547.11287314.html.plaintext.txt	291	j biol chem 271 635 638 1996abstractfree full text
0.42004547.11287314.html.plaintext.txt	292	atp binding cassette abc transport systems functional structural aspects atp hydrolyzing subunitsdomains
0.42004547.11287314.html.plaintext.txt	293	fems microbiol rev 22 1 20 1998isimedline
0.42004547.11287314.html.plaintext.txt	294	strickland e qu bh millen l thomas pj
0.42004547.11287314.html.plaintext.txt	295	molecular chaperone hsc70 assists vitro folding n terminal nucleotide binding domain cystic fibrosis transmembrane conductance regulator
0.42004547.11287314.html.plaintext.txt	296	j biol chem 272 25421 25424 1997abstractfree full text
0.42004547.11287314.html.plaintext.txt	297	ward cl omura kopito rr
0.42004547.11287314.html.plaintext.txt	298	degradation cftr ubiquitin proteosome pathway
0.42004547.11287314.html.plaintext.txt	299	cell 83 121 127 1995isimedline
0.42004547.11287314.html.plaintext.txt	300	microplate assay measuring chloride ion channel activity
0.42004547.11287314.html.plaintext.txt	301	anal biochem 241 51 58 1996isimedline
0.42004547.11287314.html.plaintext.txt	302	xiong x bragin widdicombe jh cohn j skach wr
0.42004547.11287314.html.plaintext.txt	303	structural cues involved endoplasmic reticulum degradation g85e g91r mutant cystic fibrosis transmembrane conductance regulator
0.42004547.11287314.html.plaintext.txt	304	j clin invest 100 1079 1088 1997abstractfree full text
0.42004547.11287314.html.plaintext.txt	305	j physiol cell physiol 2805c1031 c1037 0363 614301 5
0.42004547.11287314.html.plaintext.txt	306	00 copyright 2001 american physiological society
0.42343527.15028554.html.plaintext.txt	0	domain mimic increases f508 cftr trafficking restores camp stimulated anion secretion cystic fibrosis epithelia lane l
0.42343527.15028554.html.plaintext.txt	1	gawenis1 tzyh chang hwang2 nancy m
0.42343527.15028554.html.plaintext.txt	2	departments 1biomedical sciences 2medical physiology pharmacology dalton cardiovascular research center university missouri columbia missouri 65211
0.42343527.15028554.html.plaintext.txt	3	submitted 5 august 2003 accepted final form 10 march 2004
0.42343527.15028554.html.plaintext.txt	4	abstract top abstract materials methods results discussion grants references major disease causing mutation cystic fibrosis transmembrane conductance regulator cftr deletion phenylalanine 508 f508 adversely affects processing plasma membrane targeting cftr
0.42343527.15028554.html.plaintext.txt	5	conditions predicted stabilize protein folding f508 cftr capable trafficking plasma membrane retains camp regulated anion channel activity
0.42343527.15028554.html.plaintext.txt	6	overexpression one factor increases cftr trafficking therefore hypothesized expression domain mimic first nucleotide binding fold nbf1 cftr
0.42343527.15028554.html.plaintext.txt	7	site f508 may sufficient overwhelm quality control process otherwise stabilize f508 cftr thereby restore camp stimulated anion secretion
0.42343527.15028554.html.plaintext.txt	8	epithelial cells expressing recombinant f508 human hcftr expression wild type nbf1 increased amount core glycosylated mature protein greater extent expression f508 nbf1
0.42343527.15028554.html.plaintext.txt	9	expression wild type nbf1 f508 hcftr cells increased whole cell cl current density 50 cells expressing wild type hcftr
0.42343527.15028554.html.plaintext.txt	10	expression nbf1 polarized epithelial monolayers f508f508 cystic fibrosis mouse mgef restored camp stimulated transepithelial anion secretion monolayers cftr null mouse mgen
0.42343527.15028554.html.plaintext.txt	11	restoration anion secretion sustained nbf1 expressing mgef 30 passages whereas mgen corrected hcftr progressively lost anion secretion capability
0.42343527.15028554.html.plaintext.txt	12	conclude expression nbf1 domain mimic may useful correction f508 cftr protein trafficking defect cystic fibrosis epithelia
0.42343527.15028554.html.plaintext.txt	13	protein processing mouse retrovirus gene therapy
0.42343527.15028554.html.plaintext.txt	14	major disease causing mutation cystic fibrosis cf transmembrane conductance regulator cftr protein deletion phenylalanine position 508 f508 predicted cytoplasmic domain known first nucleotide binding fold nbf1
0.42343527.15028554.html.plaintext.txt	15	approximately 70 cf patients homozygous f508 cftr 90 carry least one f508 cftr allele compound heterozygotes 11
0.42343527.15028554.html.plaintext.txt	16	nascent wild type human hcftr translated core glycosylated endoplasmic reticulum er
0.42343527.15028554.html.plaintext.txt	17	fraction core glycosylated hcftr protein 25 40 refs
0.42343527.15028554.html.plaintext.txt	18	36 48 transported golgi apparatus glycosylation modified form mature hcftr targeted plasma membrane 5
0.42343527.15028554.html.plaintext.txt	19	wild type hcftr functions cyclic nucleotide regulated anion channel serves number transport functions including regulation ion transport proteins membrane recycling phenomena 2 8
0.42343527.15028554.html.plaintext.txt	20	contrast wild type hcftr nearly f508 hcftr retained er core glycosylated form sorted ubiquitin proteasome protein degradation pathway instead golgi apparatus 5 25
0.42343527.15028554.html.plaintext.txt	21	believed improper folding mutant protein recognized proteins comprising cellular quality control mechanism retains misfolded proteins degradation 44
0.42343527.15028554.html.plaintext.txt	22	chaperone proteins also involved processing hcftr least two proteins hsp70 calnexin bind f508 hcftr greater avidity wild type hcftr 39
0.42343527.15028554.html.plaintext.txt	23	process recognition quality control machinery conformation misfolded f508 hcftr elucidated
0.42343527.15028554.html.plaintext.txt	24	epithelia homozygous f508 mutation retention degradation mutant hcftr essentially eliminates capacity cyclic nucleotide regulated anion secretion believed deficit fundamental pathogenesis disease 38
0.42343527.15028554.html.plaintext.txt	25	defective processing f508 hcftr least partially reversible
0.42343527.15028554.html.plaintext.txt	26	studies cells expressing recombinant f508 hcftr tissues cultured transgenic f508 murine mcftr mice shown fraction mutant protein undergoes biosynthetic maturation cells grown subphysiological temperatures 26 degrees c 13
0.42343527.15028554.html.plaintext.txt	27	studies f508 hcftr expressing cells treated chemical chaperones glycerol dimethyl sulfoxide dmso organic cellular osmolytes myo inositol betaine also found increased maturation f508 hcftr result attributed stabilization mutant protein 1 3 22 52
0.42343527.15028554.html.plaintext.txt	28	overexpression mutant protein either transfection treatment butyrate results trafficking f508 hcftr plasma membrane 4 40
0.42343527.15028554.html.plaintext.txt	29	observations important therapeutic implications f508 hcftr plasma membrane retains capacity cyclic nucleotide regulated anion channel 13
0.42343527.15028554.html.plaintext.txt	30	studies cell free systems indicate stimulated f508 hcftr may channel kinetics similar wild type hcftr 23 31 42 whereas cell patch studies measure reduced channel kinetic activity compared wild type hcftr 12 20 24
0.42343527.15028554.html.plaintext.txt	31	even f508 cftr reduced function shorter membrane residence 32 previous studies suggest small amount 10 15 f508 cftr activity membrane required restore epithelial function moderate disease 15 26
0.42343527.15028554.html.plaintext.txt	32	combined recent pharmacological studies showing f508 hcftr channel activity significantly enhanced treatment compounds 8 cyclopentyl 13 dipropylxanthine cpx genistein class iii phosphodiesterase inhibitors 28 clear correcting f508 hcftr trafficking viable strategy treating cf
0.42343527.15028554.html.plaintext.txt	33	recent studies shown expression polypeptides representing structural domain protein
0.42343527.15028554.html.plaintext.txt	34	domain mimics predictably alter posttranslational processing protein
0.42343527.15028554.html.plaintext.txt	35	expression minigene encoding carboxy terminus human ether go go related gene shown rescue carboxy terminal truncation mutant misprocessing 29
0.42343527.15028554.html.plaintext.txt	36	another study 6 mer peptide mimic reactive center loop 1 antitrypsin used block pathological polymerization z variant mutation protein 35
0.42343527.15028554.html.plaintext.txt	37	regard cftr expression polypeptide representing nbf1 plus regulatory r domain hcftr shown inhibit activity enac epithelial na channel reputedly regulated cftr 45
0.42343527.15028554.html.plaintext.txt	38	nbf1 domain hcftr location f508 well several processing mutants 46 nbf1 domain may serve checkpoint recognition cellular quality control machinery alternatively may function critical intramolecular interaction stabilizes hcftr structure within er
0.42343527.15028554.html.plaintext.txt	39	therefore hypothesized expression nbf1 domain may sufficient increase f508 cftr activity epithelial cells
0.42343527.15028554.html.plaintext.txt	40	nbf1 domain cftr well conserved among mammalian species 17 mouse deletion f508 results mcftr processing defect recapitulates fundamental cellular defect f508 homozygous cf patients 16 50
0.42343527.15028554.html.plaintext.txt	41	present study heterologous cell systems expressing recombinant f508 hcftr epithelial monolayers f508 cftr homozygous mouse used test hypothesis expression nbf1 domain mimic increases trafficking f508 cftr restores camp stimulated anion secretion
0.42343527.15028554.html.plaintext.txt	42	materials methods top abstract materials methods results discussion grants references cell culture
0.42343527.15028554.html.plaintext.txt	43	mouse mammary epithelial cell lines c127 expressing wild type hcftr f508 hcftr empty plasmid obtained courtesy genzyme cambridge ma maintained plastic culture flasks using dulbeccos modified eagles medium dmem high glucose supplemented 10 volvol fetal bovine serum fbs 200 microgml geneticin
0.42343527.15028554.html.plaintext.txt	44	sv40 lt antigen immortalized mouse gallbladder epithelial cells derived mcftr knockout cftr mouse
0.42343527.15028554.html.plaintext.txt	45	mgen cell line f508 mcftr f508cftrf508cftr mouse
0.42343527.15028554.html.plaintext.txt	46	mouse strains purposes maintained c57bl6j background
0.42343527.15028554.html.plaintext.txt	47	cell lines grown transwell col permeable supports corning costar cambridge ma hams f 12 medium containing 1 microgml insulin 7
0.42343527.15028554.html.plaintext.txt	48	5 microgml transferrin 1 microm hydrocortisone 30 nm triiodothyronine 2
0.42343527.15028554.html.plaintext.txt	49	5 ngml epidermal growth factor 10 ngml endothelial cell growth substance supplemented 11 3t3 fibroblast conditioned dmem containing 2 volvol fbs previously described 9
0.42343527.15028554.html.plaintext.txt	50	stable expression nbf domain mimics
0.42343527.15028554.html.plaintext.txt	51	noti restriction endonuclease site flanked cdna constructs wild type nbf1 f508 nbf1 coding amino acids 429 591 full length hcftr flag epitope dykddddk inserted carboxy terminus prepared previously described 6
0.42343527.15028554.html.plaintext.txt	52	constructs subcloned zeocin selectable vectors pzeosv pcdna3
0.42343527.15028554.html.plaintext.txt	53	c127 cell lines transfected nbf1 construct plasmids electroporation selected medium containing 200 microgml zeocin
0.42343527.15028554.html.plaintext.txt	54	clones isolated 2 wk electroporation
0.42343527.15028554.html.plaintext.txt	55	stable expression nbf1 construct polarized mgef mgen epithelial cell lines passages 3 16 noti flanked construct subcloned retroviral vector plxsnz
0.42343527.15028554.html.plaintext.txt	56	john olsen university north carolina engineered zeocin resistance form proviral component nbf1 lxsnz
0.42343527.15028554.html.plaintext.txt	57	positive control hcftr cdna introduced plasmid produce proviral component hcftr lxsnz
0.42343527.15028554.html.plaintext.txt	58	transfection capo4 precipitation nbf1 lxsnz hcftr lxsnz plxsnz empty vector control virus packaging cell line pa317 led production replication defective virus
0.42343527.15028554.html.plaintext.txt	59	virus stock supernatant used infect mgef mgen cells subsequently selected medium containing 200 microgml zeocin
0.42343527.15028554.html.plaintext.txt	60	transfected cell lines screened expression nbf1 constructs rt pcr essentially described previously 19 utilizing gene specific primer 5 ggatccactggagcaggcaag 3 combination primer specific flag epitope nbf1 domain mimic 5 atcatcgtcgtctttgtagtc 3
0.42343527.15028554.html.plaintext.txt	61	c127 cells grown glass coverslips whole cell patch clamp recordings described previously 47
0.42343527.15028554.html.plaintext.txt	62	briefly cl gradient established following solutions pipette mm 85 aspartic acid 5 pyruvic acid 10 egta 10 hepes 20 tetraethylammonium cl 5 tris 10 mgatp 2 mgcl2 5
0.42343527.15028554.html.plaintext.txt	63	4 csoh bath mm 145 nacl 5 glucose 5 hepes 2 mgcl2 1 cacl2 5 kcl 20 sucrose ph 7
0.42343527.15028554.html.plaintext.txt	64	outward current generated cl influx observed holding potential 0 mv activation cftr
0.42343527.15028554.html.plaintext.txt	65	holding current 0 mv normalized membrane capacitance yield current density
0.42343527.15028554.html.plaintext.txt	66	current traces response voltage pulses plus minus 100 mv 20 mv increments filtered 1 khz built four pole bessel filter digitized 2 khz itc 16 interface instrutech great neck ny
0.42343527.15028554.html.plaintext.txt	67	mgen mgef cells cultured rat tail collagen membrane covering 4
0.42343527.15028554.html.plaintext.txt	68	5 mm diameter aperture polycarbonate cups previously described 10
0.42343527.15028554.html.plaintext.txt	69	bioelectric measurements made voltage clamp conditions intermittent voltage spikes calculate transepithelial resistance ohms law
0.42343527.15028554.html.plaintext.txt	70	preparations bathed luminal basolateral surfaces warmed 37 degrees c oxygenated krebs bicarbonate ringer kbr solution containing mm 115 nacl 4 k2hpo4 0
0.42343527.15028554.html.plaintext.txt	71	2 cacl2 10 glucose ph 7
0.42343527.15028554.html.plaintext.txt	72	ion substitution studies gluconate sulfate replaced cl n trishydroxymethylmethyl 2 aminoethanesulfonic acid tes replaced hco3 tetramethylammonium tma replaced na equimolar basis
0.42343527.15028554.html.plaintext.txt	73	detection hcftr f508 hcftr glycosylation status immunoprecipitation 32p labeling
0.42343527.15028554.html.plaintext.txt	74	detection hcftr glycosylation status performed described gregory et al
0.42343527.15028554.html.plaintext.txt	75	cultured cells 1 confluent 25 flask homogenized 1 ml lysis buffer 50 mm tris ph 7
0.42343527.15028554.html.plaintext.txt	76	4 150 mm nacl 10 mm mgcl2 1 volvol triton x 100 1 wtvol 3 3 cholamidopropyldimethylammonio 1 propanesulfonate chaps 1 mm pefabloc 10 microgml aprotinin
0.42343527.15028554.html.plaintext.txt	77	low speed centrifugation remove insoluble material 14000 g cftr immunoprecipitated 1
0.42343527.15028554.html.plaintext.txt	78	5 microg monoclonal antibody m3a7 27 recognizes epitope within nbf2 domain genzyme addition protein agarose beads
0.42343527.15028554.html.plaintext.txt	79	tumbling 2 h 4 degrees c beads washed three times lysis buffer incubated vitro phosphorylation buffer containing 25 mu protein kinase 0
0.42343527.15028554.html.plaintext.txt	80	2 mm ratp 50 microci 32patp 10 min 30 degrees c
0.42343527.15028554.html.plaintext.txt	81	washing remove unincorporated 32patp bound phosphorylated protein eluted beads sds page sample buffer room temperature 1 h
0.42343527.15028554.html.plaintext.txt	82	total protein separated sds page 4 20 gels dried autoradiographed 1 7 days
0.42343527.15028554.html.plaintext.txt	83	densitometric measurements performed kodak image station 2000r rochester ny 1d image analysis software
0.42343527.15028554.html.plaintext.txt	84	forskolin genistein 5 nitro 2 3 phenylpropylaminobenzoate nppb diluted dmso stock concentrations 10 10 100 mm respectively
0.42343527.15028554.html.plaintext.txt	85	amiloride diluted stock concentration 10 mm distilled water
0.42343527.15028554.html.plaintext.txt	86	reagents obtained either sigma st
0.42343527.15028554.html.plaintext.txt	87	louis mo fisher scientific springfield nj
0.42343527.15028554.html.plaintext.txt	88	data expressed means plus minus se
0.42343527.15028554.html.plaintext.txt	89	data two treatment groups compared two tailed students test assuming equal variances
0.42343527.15028554.html.plaintext.txt	90	data two treatment groups compared one way anova post hoc student newman keuls test
0.42343527.15028554.html.plaintext.txt	91	probability value p 0
0.42343527.15028554.html.plaintext.txt	92	05 considered statistically significant
0.42343527.15028554.html.plaintext.txt	93	results top abstract materials methods results discussion grants references expression nbf1 domain mimics increases f508 hcftr protein trafficking reconstitutes camp stimulated whole cell cl currents
0.42343527.15028554.html.plaintext.txt	94	basis observation overexpression increases cftr trafficking 4 hypothesized expression nbf1 domain mimics f508 hcftr expressing cells may produce excess nbf1 polypeptides would either competitively inhibit quality control proteins retain degrade f508 hcftr processing reconstitute domain interactions may permit fraction f508 hcftr fully processed
0.42343527.15028554.html.plaintext.txt	95	c127 cells expressing f508 hcftr transfected either f508 nbf1 wild type nbf1 domains assayed hcftr expression immunoprecipitation 32p labeling
0.42343527.15028554.html.plaintext.txt	96	method mature fully processed cftr band c electrophoreses 180 kda whereas immature unprocessed cftr band b runs 160 kda
0.42343527.15028554.html.plaintext.txt	97	1a wild type hcftr expressed c127 cells lane 1 processed high molecular mass band c form indicative glycosylation chain modifications occurring trans golgi network
0.42343527.15028554.html.plaintext.txt	98	apparent dominance band c hcftr typical cells immunoprecipitation 32p labeling technique
0.42343527.15028554.html.plaintext.txt	99	1a lanes 2 5 coexpressing f508 hcftr f508 nbf1 domain mimic uniformly expressed nascent core glycosylated forms unprocessed hcftr
0.42343527.15028554.html.plaintext.txt	100	band b expressed small amounts fully glycosylated hcftr
0.42343527.15028554.html.plaintext.txt	101	density band b shown fig
0.42343527.15028554.html.plaintext.txt	102	1a lanes 2 5 typical f508 c127 cells transfected n 20 data shown
0.42343527.15028554.html.plaintext.txt	103	surprisingly clonal cell lines coexpressing f508 hcftr wild type nbf1 domain mimic fig
0.42343527.15028554.html.plaintext.txt	104	1a lanes 6 8 expressed greater amounts fully processed core glycosylated f508 hcftr suggesting wild type nbf1 domain mimic stabilizes f508 cftr protein throughout processing membrane trafficking
0.42343527.15028554.html.plaintext.txt	105	view larger version 29k fig
0.42343527.15028554.html.plaintext.txt	106	immunoblot analysis whole cell cl current densities phenylalanine 508 deleted f508 human h cystic fibrosis transmembrane conductance regulator cftr transfected c127 cells coexpressing first nucleotide binding fold nbf1 domain mimics
0.42343527.15028554.html.plaintext.txt	107	lane 1 cells expressing wild type wt hcftr lanes 2 5 f508 hcftr cell lines coexpressing f508 f nbf1 lanes 6 8 f508 hcftr cell lines coexpressing wild type nbf1
0.42343527.15028554.html.plaintext.txt	108	b relative contribution band c pixel intensity profilelane wt hcftr f508 hcftr cell lines coexpressing f508 nbf1 n 4 f508 hcftr cell lines coexpressing wild type nbf1 n 3 data
0.42343527.15028554.html.plaintext.txt	109	relative intensity calculated pixel intensity band ccombined pixel intensity bands b c correction background lane
0.42343527.15028554.html.plaintext.txt	110	significantly different f nbf1
0.42343527.15028554.html.plaintext.txt	111	c whole cell patch clamp measurements cl current density papf normalize differences cell size c127 epithelial cell transfectants
0.42343527.15028554.html.plaintext.txt	112	data collected cell treatment cocktail containing 2 microm forskolin 100 microm genistein
0.42343527.15028554.html.plaintext.txt	113	wt f508 c127 cell lines expressing full length wt f508 hcftr respectively f50827 degrees c c127 cells expressing f508 hcftr maintained 27 degrees c 48 h experimentation nbf1 wild type nbf1 domain mimic
0.42343527.15028554.html.plaintext.txt	114	bars labeled different letters significantly different
0.42343527.15028554.html.plaintext.txt	115	whole cell patch clamp analysis used investigate cl current density cell clones showing maximal increase f508 hcftr maturation coexpression wild type nbf1 domain mimic
0.42343527.15028554.html.plaintext.txt	116	open probabilities wild type hcftr f508 hcftr greatly enhanced presence forskolin plus genistein 23 whole cell cl current density used estimate activity functional channels plasma membrane
0.42343527.15028554.html.plaintext.txt	117	positive controls cells expressing wild type hcftr cells expressing f508 hcftr exposed processing permissive temperature conditions 27 degrees c 48 h also assayed comparison
0.42343527.15028554.html.plaintext.txt	118	earlier studies using cells expressing recombinant f508 hcftr showed temperature induced band c expression correlates positively whole cell cl current efflux 13 21
0.42343527.15028554.html.plaintext.txt	119	1c c127 cells expressing wild type hcftr demonstrate whole cell cl current density severalfold greater cells expressing f508 hcftr
0.42343527.15028554.html.plaintext.txt	120	cells expressing f508 hcftr grown temperature permissive f508 hcftr trafficking plasma membrane cl current density 50 wild type hcftr expressing cells
0.42343527.15028554.html.plaintext.txt	121	importantly clonal f508 hcftr cell lines expressing wild type nbf1 showed increased cl current density similar magnitude temperature corrected f508 hcftr cells
0.42343527.15028554.html.plaintext.txt	122	expression nbf1 domain mimic f508f508 cftr murine epithelial monolayers reconstitutes camp stimulated anion secretion
0.42343527.15028554.html.plaintext.txt	123	studies described demonstrate coexpression nbf1 domain mimic increase plasma membrane activity f508 hcftr epithelial cell line expressing recombinant protein driven nonnative promoter
0.42343527.15028554.html.plaintext.txt	124	level f508 hcftr expression affect trafficking cell 4 asked whether expression nbf1 domain mimic would also improve plasma membrane trafficking endogenously expressed f508 cftr polarized epithelium
0.42343527.15028554.html.plaintext.txt	125	extensive search unable identify human f508f508 cftr epithelial cell line retained ability form polarized epithelial monolayers express significant levels endogenous f508 hcftr protein retroviral transfection studies
0.42343527.15028554.html.plaintext.txt	126	previous studies demonstrated defects processing plasma membrane expression f508 mcftr homolog murine epithelia recapitulate defects f508 hcftr 16 epithelial cell line mgef developed transformation gallbladder epithelia f508f508 cftr mutant mouse model transfected nbf1 domain mimic 50
0.42343527.15028554.html.plaintext.txt	127	shown short circuit current isc trace ussing chamber experiment fig
0.42343527.15028554.html.plaintext.txt	128	2a expression nbf1 domain mimic mgef epithelial monolayer increased basal isc means n 9 monolayers nbf1 18
0.42343527.15028554.html.plaintext.txt	129	zeomycin resistance gene zeo 6
0.42343527.15028554.html.plaintext.txt	130	05 importantly yielded distinct isc response forskolin stimulation compared mgef cells transduced empty vector control plxsnz
0.42343527.15028554.html.plaintext.txt	131	subsequent treatment monolayer cftr channel blocker nppb inhibited camp stimulated isc large fraction basal isc
0.42343527.15028554.html.plaintext.txt	132	although ionic basis residual isc investigated previous studies indicate presence ca2 activated anion channel apical membrane mge epithelial cells 9
0.42343527.15028554.html.plaintext.txt	133	negative control mcftr null cell line mgen developed transformation gallbladder epithelium cftr knockout mouse also transfected nbf1 construct comparison nbf1 expressing mgef cells
0.42343527.15028554.html.plaintext.txt	134	expression nbf1 domain mimic mgen cells slightly increased basal isc means n 5 monolayers nbf1 4
0.42343527.15028554.html.plaintext.txt	135	however contrast camp induced isc responses nbf1 expressing mgef cells expression nbf1 domain mimic mgen cells restore isc response camp stimulation see cumulative data fig
0.42343527.15028554.html.plaintext.txt	136	positive control transfection selection procedure hcftr expressed cftr mgen cell line transduction process used nbf1 expressing cell lines
0.42343527.15028554.html.plaintext.txt	137	expression hcftr mgen cell monolayers resulted significantly greater basal isc mean n 7 monolayers hcftr 6
0.42343527.15028554.html.plaintext.txt	138	1c greater stimulation isc forskolin treatment mgen cells transduced plxsnz
0.42343527.15028554.html.plaintext.txt	139	view larger version 26k fig
0.42343527.15028554.html.plaintext.txt	140	short circuit current isc measurements f508f508 mgef murine mcftr null mgen epithelial monolayers
0.42343527.15028554.html.plaintext.txt	141	isc recording mgef cells expressing either selectable zeomycin resistance gene zeo nbf1 zeo nbf1
0.42343527.15028554.html.plaintext.txt	142	repetitive upward current deflections result applied voltage 2 mv used measure transepithelial resistance
0.42343527.15028554.html.plaintext.txt	143	treatments arrows sequential additions luminal bath 10 microm forskolin forsk 100 microm 5 nitro 2 3 phenylpropylaminobenzoate nppb
0.42343527.15028554.html.plaintext.txt	144	b comparison maximal isc change isc 10 microm forskolin treatment mgef mgen cell lines transfected zeo nbf1 zeo nbf1 wild type hcftr
0.42343527.15028554.html.plaintext.txt	145	significantly different mgen zeo mgef zeo n 5 9
0.42343527.15028554.html.plaintext.txt	146	c ion substitution studies isc induced treatment 10 microm forskolin mgef cells expressing nbf1 zeo nbf1
0.42343527.15028554.html.plaintext.txt	147	kbr krebs bicarbonate ringer solution
0.42343527.15028554.html.plaintext.txt	148	significantly different kbr n 4 9
0.42343527.15028554.html.plaintext.txt	149	camp stimulated isc nbf1 expressing f508 homozygous mgef monolayers could result either electrogenic cation na absorption electrogenic anion cl hco3 secretion ion substitution studies used investigate ionic basis camp stimulated isc nbf1 expressing mgef cell line
0.42343527.15028554.html.plaintext.txt	150	2c substitution na impermeant cation tma mucosal bath significantly affect camp stimulated isc response compared response standard kbr solution
0.42343527.15028554.html.plaintext.txt	151	subsequent addition 10 microm amiloride mucosal solution nbf1 expressing mgef cells bathed standard kbr solution also affect magnitude camp stimulated isc change isc 0
0.42343527.15028554.html.plaintext.txt	152	findings indicated camp induced isc response transduced cell line due electrogenic na absorption
0.42343527.15028554.html.plaintext.txt	153	contrast cl hco3 substituted impermeant anions mucosal serosal bathing solutions camp stimulated isc nbf1 expressing mgef cell monolayers nearly eliminated
0.42343527.15028554.html.plaintext.txt	154	together evidence camp stimulated isc response nbf1 expressing mgef cells sensitive nppb see fig
0.42343527.15028554.html.plaintext.txt	155	2a findings consistent conclusion stimulated isc represents f508 cftr mediated anion secretion
0.42343527.15028554.html.plaintext.txt	156	camp stimulated isc maintained successive passages nbf1 expressing mgef epithelial cell line
0.42343527.15028554.html.plaintext.txt	157	previous studies showed expression recombinant cftr induce downregulation cftr gene adversely affect cell proliferation 41
0.42343527.15028554.html.plaintext.txt	158	therefore compared stability isc response nbf1 expressing mgef cell line hcftr expressing mgen cell line measuring camp stimulated isc response monolayers successive passages two cell lines
0.42343527.15028554.html.plaintext.txt	159	3 nbf1 expressing mgef cell monolayers maintained almost identical magnitude camp stimulated isc response 30 passages passaged every 4 7 days
0.42343527.15028554.html.plaintext.txt	160	contrast magnitude camp stimulated isc progressively decreased hcftr transfected mgen cells successive passages essentially absent passage 9
0.42343527.15028554.html.plaintext.txt	161	view larger version 13k fig
0.42343527.15028554.html.plaintext.txt	162	comparison maximal isc resulting treatment 10 microm forskolin mgen cell line expressing hcftr mgef cell line expressing nbf1 successive passages
0.42343527.15028554.html.plaintext.txt	163	cell lines passaged approximately per week
0.42343527.15028554.html.plaintext.txt	164	data point represents average experiments 2 5 monolayers
0.42343527.15028554.html.plaintext.txt	165	discussion top abstract materials methods results discussion grants references misfolded cftr protein discriminated stringent quality control process retains protein within er directs cytosolic ubiquitinationproteosomal pathway 44
0.42343527.15028554.html.plaintext.txt	166	20 wild type cftr little f508 cftr completes process yield functional channels plasma membrane 48
0.42343527.15028554.html.plaintext.txt	167	neither action f508 mutation disrupts yield correctly folded cftr molecular features misfolded protein recognized abnormal known
0.42343527.15028554.html.plaintext.txt	168	present study based premise nbf1 domain
0.42343527.15028554.html.plaintext.txt	169	location f508 several mutations affect cftr processing 46 may key molecular component involved successful processing cftr
0.42343527.15028554.html.plaintext.txt	170	expressing wild type nbf1 domain mimic increased amounts fully glycosylated f508 cftr observed camp stimulated anion secretion restored epithelial cells expressing recombinant f508 hcftr
0.42343527.15028554.html.plaintext.txt	171	furthermore expression wild type nbf1 also increased camp stimulated anion secretion polarized epithelial monolayers expressing endogenous f508 mcftr
0.42343527.15028554.html.plaintext.txt	172	together results indicate one function nbf1 domain mimic increase f508 hcftr trafficking plasma membrane
0.42343527.15028554.html.plaintext.txt	173	restoration camp stimulated anion secretion f508 cftr expressing epithelial cells yielded bioelectrical responses characteristics consistent activation f508 cftr conductance
0.42343527.15028554.html.plaintext.txt	174	studies f508 hcftr cells expressing nbf1 genistein forskolin treatment increased whole cell cl currents 50 exhibited c127 cells stably expressing wild type cftr
0.42343527.15028554.html.plaintext.txt	175	difference whether due reduced open probability numbers membrane channels similar observed f508 hcftr cells exposed reduced ambient temperature increased expression mutant cftr 4 13 16 40
0.42343527.15028554.html.plaintext.txt	176	studies polarized mgef monolayers expressing nbf1 macroscopic isc response forskolin treatment activated slower rate compared mgen cells expressing wild type hcftr data shown might reflect characteristic f508 cftr protein attenuates protein kinase phosphorylation dependent activation 47
0.42343527.15028554.html.plaintext.txt	177	however contrast c127 cells absolute magnitude camp induced isc nbf1 expressing mgef monolayers approximately mgen monolayers expressing recombinant hcftr
0.42343527.15028554.html.plaintext.txt	178	variance may reflect differences activities recombinant vs
0.42343527.15028554.html.plaintext.txt	179	endogenous cftr channel result inherent differences f508 cftr properties two species 30
0.42343527.15028554.html.plaintext.txt	180	interestingly basal isc nbf1 expressing mgef mgen cells elevated compared zeocin expressing control monolayers
0.42343527.15028554.html.plaintext.txt	181	change consistent previous demonstrations expression nbf1 yields transmembrane configuration peptide increase basal halide permeability mammalian cell lines 7 19
0.42343527.15028554.html.plaintext.txt	182	however similar findings nbf1 expressing mgen cells expression nbf1 domain result camp regulated anion permeability
0.42343527.15028554.html.plaintext.txt	183	present study restoration camp regulated anion secretion required nbf1 coexpression f508 cftr expressing epithelial cells
0.42343527.15028554.html.plaintext.txt	184	expression cytosolic domain mimics previously used alter specific intra intermolecular interactions within cells
0.42343527.15028554.html.plaintext.txt	185	pioneering work lefkowitz coworkers 33 used domain mimics disrupt interactions plasma membrane receptors g proteins coupled phospholipase c activation
0.42343527.15028554.html.plaintext.txt	186	recently domain mimic expressed via minigene used rescue misprocessing carboxy terminal truncation mutant human ether go go related protein 29 domain peptide used selectively mask portions mutant 1 antitrypsin prevent posttranslational polymerization within hepatocytes 35
0.42343527.15028554.html.plaintext.txt	187	regard cftr exogenous copies r domain shown interact full length cftr modify gating behavior channel activity 34
0.42343527.15028554.html.plaintext.txt	188	domain mimics cftr integral membrane protein syntaxin 1a used modify channel activity demonstrate direct protein protein interaction 37
0.42343527.15028554.html.plaintext.txt	189	furthermore peptide mimics used demonstrate binding interactions nbf1 r domain cftr could partially disrupted introduction f508 mutation 6
0.42343527.15028554.html.plaintext.txt	190	given findings present study previous observations expression recombinant f508 cftr 4 40 least two mechanisms postulated would result increased processing f508 cftr beyond er
0.42343527.15028554.html.plaintext.txt	191	first expression recombinant nbf1 may overwhelm quality control system involved retention degradation mutant protein
0.42343527.15028554.html.plaintext.txt	192	similar process could postulated plasma membrane appearance f508 hcftr mutant protein overexpressed heterologous cell systems 4 40
0.42343527.15028554.html.plaintext.txt	193	mechanism would predict competitive binding perhaps specific chaperone proteins proteases thereby allowing escape mutant protein er
0.42343527.15028554.html.plaintext.txt	194	however evidence weakens case proposed mechanism
0.42343527.15028554.html.plaintext.txt	195	measures protein expression c127 cells indicated clones expressing wild type nbf1 likely greater expression fully processed f508 cftr compared clones expressing f508 nbf1 peptide fig
0.42343527.15028554.html.plaintext.txt	196	seems contrary prediction f508 nbf1 would efficacious competing quality control proteins
0.42343527.15028554.html.plaintext.txt	197	furthermore although possible concentration recombinant nbf1 quality control binding sites far exceeds needed discern differences two domain mimics estimates nbf1 peptide concentration 5 ng microl cell pellets based detection flag epitope m2 monoclonal antibody well millimolar concentrations typically necessary inhibit proteases chemical inhibitors 25 49
0.42343527.15028554.html.plaintext.txt	198	second potential mechanism nbf1 expression may lead increased processing f508 cftr coexpression additional nbf1 peptides may bind immature f508 cftr stabilize structure er
0.42343527.15028554.html.plaintext.txt	199	example peptide interaction r domain f508 cftr may mask site misfolded protein recognized quality control machinery additional copies nbf1 may temporarily interact f508 cftr catalyze folding reaction results properly folded protein
0.42343527.15028554.html.plaintext.txt	200	given recent evidence mature cftr protein may dimerize plasma membrane 51 seems plausible cooperation different cftr monomers may necessary correct folding interaction may mimicked nbf1 domain peptides
0.42343527.15028554.html.plaintext.txt	201	although precise mechanism resulting increased expression f508 cftr plasma membrane using coexpression nbf1 peptides remains speculative significant aspect present study suggests refinement therapeutic approaches correcting f508 cftr processing
0.42343527.15028554.html.plaintext.txt	202	one major drawback use viral vectors adeno associated virus 2 gene therapy packaging capacity virus limited large gene like cftr leaves little capacity promoter sequences 14
0.42343527.15028554.html.plaintext.txt	203	thus modification strategy instead transfect nbf1 domain attractive small size construct 0
0.42343527.15028554.html.plaintext.txt	204	5 kb would improve packaging efficiency
0.42343527.15028554.html.plaintext.txt	205	furthermore two biological advantages using nbf1 domain transduction therapy envisioned
0.42343527.15028554.html.plaintext.txt	206	first expression f508 cftr driven endogenous promoter may avoid consequences cftr overexpression epithelium e
0.42343527.15028554.html.plaintext.txt	207	reduced cell proliferation potential 41
0.42343527.15028554.html.plaintext.txt	208	second advantage nbf1 peptide less likely toxic full length channel protein inadvertently expressed nontarget tissues
0.42343527.15028554.html.plaintext.txt	209	nbf1 construct fused protein transduction domain 43 may also useful peptide therapy especially smallest effective subunit nbf1 defined
0.42343527.15028554.html.plaintext.txt	210	thus basis observations present study therapeutic approach correcting basic protein processing defect f508 cftr refined focus nbf1 domain mimics alter trafficking mutant protein
0.42343527.15028554.html.plaintext.txt	211	grants top abstract materials methods results discussion grants references study supported cystic fibrosis foundation grants clarke99p0 clarke99g0 national institute diabetes digestive kidney diseases grant dk 48816 l
0.42343527.15028554.html.plaintext.txt	212	acknowledgments acknowledge technical assistance julie schultz shenghui hu
0.42343527.15028554.html.plaintext.txt	213	gruis pioneer hi bred international inc
0.42343527.15028554.html.plaintext.txt	214	suite 800 po box 14453 des moines ia 50306 3453
0.42343527.15028554.html.plaintext.txt	215	footnotes address reprint requests correspondence l
0.42343527.15028554.html.plaintext.txt	216	clarke 324d dalton cardiovascular research center research park drive univ
0.42343527.15028554.html.plaintext.txt	217	missouri columbia columbia mo 65211 e mail clarkelatmissouri
0.42343527.15028554.html.plaintext.txt	218	costs publication article defrayed part payment page charges
0.42343527.15028554.html.plaintext.txt	219	article must therefore hereby marked advertisement accordance 18 u
0.42343527.15028554.html.plaintext.txt	220	section 1734 solely indicate fact
0.42343527.15028554.html.plaintext.txt	221	1 abstract presented 16th annual north american cystic fibrosis conference reported coexpression f508 cftr amino terminal fragment cftr amino acids 1 633 induced maturation f508 cftr cos7 cells cormet boyaka ea kirk kl
0.42343527.15028554.html.plaintext.txt	222	trans complementation 508 cftr amino terminal fragment cftr
0.42343527.15028554.html.plaintext.txt	223	pediatr pulmonol suppl 24 183 2002
0.42343527.15028554.html.plaintext.txt	224	references top abstract materials methods results discussion grants references 1
0.42343527.15028554.html.plaintext.txt	225	bebok z venglarik cj panczel z jilling kirk kl sorscher ej
0.42343527.15028554.html.plaintext.txt	226	activation f508 cftr epithelial monolayer
0.42343527.15028554.html.plaintext.txt	227	j physiol cell physiol 275 c599 c607 1998
0.42343527.15028554.html.plaintext.txt	228	bradbury na jilling berta g sorscher ej bridges rj kirk kl
0.42343527.15028554.html.plaintext.txt	229	regulation plasma membrane recycling cftr
0.42343527.15028554.html.plaintext.txt	230	cheng sh fang zabner j marshall j piraino schiavi sc jefferson dm welsh mj smith ae
0.42343527.15028554.html.plaintext.txt	231	glycerol reverses misfolding phenotype common cystic fibrosis mutation
0.42343527.15028554.html.plaintext.txt	232	j biol chem 271 635 638 1996
0.42343527.15028554.html.plaintext.txt	233	cheng sh fang sl zabner j marshall j piraino schiavi sc jefferson dm welsh mj smith ae
0.42343527.15028554.html.plaintext.txt	234	functional activation cystic fibrosis trafficking mutant f508 cftr overexpression
0.42343527.15028554.html.plaintext.txt	235	j physiol lung cell mol physiol 268 l615 l624 1995
0.42343527.15028554.html.plaintext.txt	236	cheng sh gregory rj marshall j paul souza dw white ga oriordan cr smith ae
0.42343527.15028554.html.plaintext.txt	237	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.42343527.15028554.html.plaintext.txt	238	ciaccia av pitterle dm price em
0.42343527.15028554.html.plaintext.txt	239	domain domain interactions cftr abstract
0.42343527.15028554.html.plaintext.txt	240	pediatr pulmonol suppl 10 180 1994
0.42343527.15028554.html.plaintext.txt	241	clancy jp hong js bebok z king sa demolombe bedwell dm sorscher ej
0.42343527.15028554.html.plaintext.txt	242	cystic fibrosis transmembrane conductance regulator cftr nucleotide binding domain 1 nbd 1 cftr truncated within nbd 1 target epithelial plasma membrane increase anion permeability
0.42343527.15028554.html.plaintext.txt	243	biochemistry 37 15222 15230 1998
0.42343527.15028554.html.plaintext.txt	244	cftr required camp inhibition intestinal na absorption cystic fibrosis mouse model
0.42343527.15028554.html.plaintext.txt	245	j physiol gastrointest liver physiol 270 g259 g267 1996
0.42343527.15028554.html.plaintext.txt	246	clarke ll harline mc ortero ma glover gg garrad rc krugh b walker nm gonzalez fa turner jt weisman ga
0.42343527.15028554.html.plaintext.txt	247	desensitization p2y2 receptor activated transepithelial anion secretion
0.42343527.15028554.html.plaintext.txt	248	j physiol cell physiol 276 c777 c787 1999
0.42343527.15028554.html.plaintext.txt	249	clarke ll paradiso mason sj boucher rc
0.42343527.15028554.html.plaintext.txt	250	effects bradykinin na cl transport human nasal epithelium
0.42343527.15028554.html.plaintext.txt	251	j physiol cell physiol 262 c644 c655 1992
0.42343527.15028554.html.plaintext.txt	252	cystic fibrosis molecular biology therapeutic implications
0.42343527.15028554.html.plaintext.txt	253	dalemans w barbry p champigny g jallat dott k dreyer d crystal rg pavirani lecocq jp lazdunski m
0.42343527.15028554.html.plaintext.txt	254	altered chloride ion channel kinetics associated f508 cystic fibrosis mutation
0.42343527.15028554.html.plaintext.txt	255	denning gm anderson mp amara j marshall j smith ae welsh mj
0.42343527.15028554.html.plaintext.txt	256	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.42343527.15028554.html.plaintext.txt	257	dong jy fan pd frizzell ra
0.42343527.15028554.html.plaintext.txt	258	quantitative analysis packaging capacity recombinant adeno associated virus
0.42343527.15028554.html.plaintext.txt	259	hum gene ther 7 2101 2112 1996
0.42343527.15028554.html.plaintext.txt	260	dorin jr stevenson bj fleming alton ew dickinson p porteous dj
0.42343527.15028554.html.plaintext.txt	261	long term survival exon 10 insertional cystic fibrosis mutant mouse consequence low level residual wild type cftr gene expression
0.42343527.15028554.html.plaintext.txt	262	mamm genome 5 465 472 1994
0.42343527.15028554.html.plaintext.txt	263	french pj van doorninck jh peters rh verbeek e ameen na marino cr de jonge hr bijman j scholte bj
0.42343527.15028554.html.plaintext.txt	264	f508 mutation mouse cystic fibrosis transmembrane conductance regulator results temperature sensitive processing defect vivo
0.42343527.15028554.html.plaintext.txt	265	j clin invest 98 1304 1312 1996
0.42343527.15028554.html.plaintext.txt	266	gasparini p nunes v dognini m estivill x
0.42343527.15028554.html.plaintext.txt	267	high conservation sequences involved cystic fibrosis mutations five mammalian species
0.42343527.15028554.html.plaintext.txt	268	genomics 10 1070 1072 1991
0.42343527.15028554.html.plaintext.txt	269	gregory rj cheng sh rich dp marshall j paul hehir k ostedgaard ls klinger kw welsch mj smith ae
0.42343527.15028554.html.plaintext.txt	270	expression characterization cystic fibrosis transmembrane conductance regulator
0.42343527.15028554.html.plaintext.txt	271	nucleotide binding folds cystic fibrosis transmembrane conductance regulator extracellularly accessible
0.42343527.15028554.html.plaintext.txt	272	biochemistry 36 7739 7745 1997
0.42343527.15028554.html.plaintext.txt	273	haws c nepomuceno ib krouse wakelee h law xia y nguyen h wine jj
0.42343527.15028554.html.plaintext.txt	274	f508 cftr channels kinetics activation forskolin potentiation xanthines
0.42343527.15028554.html.plaintext.txt	275	j physiol cell physiol 270 c1544 c1555 1996
0.42343527.15028554.html.plaintext.txt	276	surface expression cystic fibrosis transmembrane conductance regulator mutant f508 markedly upregulated combination treatment sodium butyrate low temperature
0.42343527.15028554.html.plaintext.txt	277	biochem biophys res commun 271 659 664 2000
0.42343527.15028554.html.plaintext.txt	278	howard m fischer h roux j santos bc gullans sr yancey ph welch wj
0.42343527.15028554.html.plaintext.txt	279	mammalian osmolytes nitrosoglutathione promote f508 cystic fibrosis transmembrane conductance regulator cftr protein maturation function
0.42343527.15028554.html.plaintext.txt	280	j biol chem 278 35159 35167 2003
0.42343527.15028554.html.plaintext.txt	281	hwang tc wang f yang ich reenstra ww
0.42343527.15028554.html.plaintext.txt	282	genistein potentiates wild type f508 cftr channel activity
0.42343527.15028554.html.plaintext.txt	283	j physiol cell physiol 273 c988 c998 1997
0.42343527.15028554.html.plaintext.txt	284	molecular pharmacology cftr cl channel
0.42343527.15028554.html.plaintext.txt	285	trends pharmacol sci 20 448 453 1999
0.42343527.15028554.html.plaintext.txt	286	jensen tj loo ma pind williams db goldberg al riordan jr
0.42343527.15028554.html.plaintext.txt	287	multiple proteolytic systems including proteasome contribute cftr processing
0.42343527.15028554.html.plaintext.txt	288	johnson lg olsen jc sarkadi b moore kl swanstrom r boucher rc
0.42343527.15028554.html.plaintext.txt	289	efficiency gene transfer restoration normal airway epithelial function cystic fibrosis
0.42343527.15028554.html.plaintext.txt	290	kartner n augustinas o jensen tj naismith al riordan jr
0.42343527.15028554.html.plaintext.txt	291	mislocalization delta f508 cftr cystic fibrosis sweat gland
0.42343527.15028554.html.plaintext.txt	292	kelley tj al nakkash l cotton cu drumm ml
0.42343527.15028554.html.plaintext.txt	293	activation endogenous f508 cystic fibrosis transmembrane conductance regulator phosphodiesterase inhibition
0.42343527.15028554.html.plaintext.txt	294	j clin invest 98 513 520 1996
0.42343527.15028554.html.plaintext.txt	295	kupershmidt yang chanthaphaychith wang z towbin ja roden dm
0.42343527.15028554.html.plaintext.txt	296	defective human ether go go related gene trafficking linked endoplasmic reticulum retention signal c terminus
0.42343527.15028554.html.plaintext.txt	297	j biol chem 277 27442 27448 2002
0.42343527.15028554.html.plaintext.txt	298	lansdell ka delaney sj lunn dp thomson sa sheppard dn wainwright bj
0.42343527.15028554.html.plaintext.txt	299	comparison gating behaviour human murine cystic fibrosis transmembrane conductance regulator cl channels expressed mammalian cells
0.42343527.15028554.html.plaintext.txt	300	j physiol 508 379 392 1998
0.42343527.15028554.html.plaintext.txt	301	li c ramjeesingh m reyes e jensen tj chang xb rommens jm bear ce
0.42343527.15028554.html.plaintext.txt	302	cystic fibrosis mutation f508 influence chloride channel activity cftr
0.42343527.15028554.html.plaintext.txt	303	lukacs gl chang xb bear c kartner n mohamed riordan jr grinstein
0.42343527.15028554.html.plaintext.txt	304	f508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.42343527.15028554.html.plaintext.txt	305	j biol chem 268 21592 21598 1993
0.42343527.15028554.html.plaintext.txt	306	luttrell lm ostrowski j cotecchia kendall h lefkowitz rj
0.42343527.15028554.html.plaintext.txt	307	antagonism catecholamine receptor signaling expression cytoplasmic domains receptors
0.42343527.15028554.html.plaintext.txt	308	science 259 1453 1456 1993
0.42343527.15028554.html.plaintext.txt	309	ma j zhao j drumm ml xie j davis pb
0.42343527.15028554.html.plaintext.txt	310	function r domain cystic fibrosis transmembrane conductance regulator chloride channel
0.42343527.15028554.html.plaintext.txt	311	j biol chem 272 28133 28141 1997
0.42343527.15028554.html.plaintext.txt	312	mahadeva r dafforn tr carrell rw lomas da
0.42343527.15028554.html.plaintext.txt	313	6 mer peptide selectively anneals pathogenic serpin conformation blocks polymerization
0.42343527.15028554.html.plaintext.txt	314	implications prevention z 1 antitrypsin related cirrhosis
0.42343527.15028554.html.plaintext.txt	315	j biol chem 277 6771 6774 2002
0.42343527.15028554.html.plaintext.txt	316	marshall j fang ostedgaard ls oriordan cr ferrara d amara jf hoppe h scheule rk welsh mj smith ae cheng sh
0.42343527.15028554.html.plaintext.txt	317	stoichiometry recombinant cystic fibrosis transmembrane conductance regulator epithelial cells functional reconstitution cells vitro
0.42343527.15028554.html.plaintext.txt	318	j biol chem 269 2987 2995 1994
0.42343527.15028554.html.plaintext.txt	319	naren ap quick mw collawn jf nelson dj kirk kl
0.42343527.15028554.html.plaintext.txt	320	syntaxin 1a inhibits cftr chloride channels means domain specific protein protein interactions
0.42343527.15028554.html.plaintext.txt	321	proc natl acad sci usa 95 10972 10977 1998
0.42343527.15028554.html.plaintext.txt	322	role cftr airway disease
0.42343527.15028554.html.plaintext.txt	323	physiol rev 79 s215 s255 1999
0.42343527.15028554.html.plaintext.txt	324	pind riordan jr williams db
0.42343527.15028554.html.plaintext.txt	325	participation endoplasmic reticulum chaperone calnexin p88 ip90 biogenesis cystic fibrosis transmembrane conductance regulator
0.42343527.15028554.html.plaintext.txt	326	j biol chem 269 12784 12788 1994
0.42343527.15028554.html.plaintext.txt	327	pilot clinical trial oral sodium 4 phenylbutyrate buphenyl f508 homozygous cystic fibrosis patients partial restoration nasal epithelial cftr function
0.42343527.15028554.html.plaintext.txt	328	j respir crit care med 157 484 490 1998
0.42343527.15028554.html.plaintext.txt	329	schiavi sc abdelkader n reber pennington narayana r mcpherson jm smith ae hoppe h iv cheng sh
0.42343527.15028554.html.plaintext.txt	330	biosynthetic growth abnormalities associated high level expression cftr heterologous cells
0.42343527.15028554.html.plaintext.txt	331	j physiol cell physiol 270 c341 c351 1996
0.42343527.15028554.html.plaintext.txt	332	schultz bd frizzell ra bridges rj
0.42343527.15028554.html.plaintext.txt	333	rescue dysfunctional f508 cftr chloride channel activity ibmx
0.42343527.15028554.html.plaintext.txt	334	j membr biol 170 51 66 1999
0.42343527.15028554.html.plaintext.txt	335	schwarze sr ho vocero akbani dowdy sf
0.42343527.15028554.html.plaintext.txt	336	vivo protein transduction delivery biologically active protein mouse
0.42343527.15028554.html.plaintext.txt	337	science 285 1569 1572 1999
0.42343527.15028554.html.plaintext.txt	338	defects processing trafficking cystic fibrosis transmembrane conductance regulator
0.42343527.15028554.html.plaintext.txt	339	kidney int 57 825 831 2000
0.42343527.15028554.html.plaintext.txt	340	stutts mj canessa cm olsen jc hamrick m cohn ja rossier bc boucher rc
0.42343527.15028554.html.plaintext.txt	341	cftr camp dependent regulator sodium channels
0.42343527.15028554.html.plaintext.txt	342	spectrum cystic fibrosis mutations
0.42343527.15028554.html.plaintext.txt	343	trends genet 8 392 398 1992
0.42343527.15028554.html.plaintext.txt	344	wang f zeltwanger hu su hwang tc
0.42343527.15028554.html.plaintext.txt	345	deletion phenylalanine 508 causes attenuated phosphorylation dependent activation cftr chloride channels
0.42343527.15028554.html.plaintext.txt	346	j physiol 524 637 648 2000
0.42343527.15028554.html.plaintext.txt	347	intracellular turnover cystic fibrosis transmembrane conductance regulator
0.42343527.15028554.html.plaintext.txt	348	inefficient processing rapid degradation wild type mutant proteins
0.42343527.15028554.html.plaintext.txt	349	j biol chem 296 25710 25718 1994
0.42343527.15028554.html.plaintext.txt	350	ward cl omura kopito rr
0.42343527.15028554.html.plaintext.txt	351	degradation cftr ubiquitin proteasome pathway
0.42343527.15028554.html.plaintext.txt	352	zeiher bg eichwald e zabner j smith ap puga pb mccray pb capecchi mr welsh mj thomas kr
0.42343527.15028554.html.plaintext.txt	353	mouse model f508 allele cystic fibrosis
0.42343527.15028554.html.plaintext.txt	354	j clin invest 96 2051 2064 1995
0.42343527.15028554.html.plaintext.txt	355	zerhusen b zhao jy xie jx davis pb ma jj
0.42343527.15028554.html.plaintext.txt	356	single conductance pore chloride ions formed two cystic fibrosis transmembrane conductance regulator molecules
0.42343527.15028554.html.plaintext.txt	357	j biol chem 274 7627 7630 1999
0.42343527.15028554.html.plaintext.txt	358	zhang xm wang xt yue h leung sw thibodeau ph thomas pj guggino se
0.42343527.15028554.html.plaintext.txt	359	organic solutes rescue functional defect f508 cystic fibrosis transmembrane conductance regulator
0.42343527.15028554.html.plaintext.txt	360	j biol chem 278 51232 51243 2003
0.42343527.15028554.html.plaintext.txt	361	article abstract full text pdf versions article 2871c192 recent 00337
0.42343527.15028554.html.plaintext.txt	362	2003v1 alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager search citing articles isi web science 1 google scholar articles clarke l
0.42343527.15028554.html.plaintext.txt	363	articles citing article pubmed pubmed citation articles clarke l
0.42343527.15028554.html.plaintext.txt	364	home help feedback subscriptions archive search table contents visit aps journals online copyright 2004 american physiological society
0.4301281.9466991.html.plaintext.txt	0	tissue specific vivo transcription start sites human murine cystic fibrosis genes
0.4301281.9466991.html.plaintext.txt	1	nuffield department clinical biochemistry imperial cancer research fund laboratories institute molecular medicine university oxford john radcliffe hospital oxford ox3 9ds uk
0.4301281.9466991.html.plaintext.txt	2	received june 20 1997 revised accepted december 15 1997
0.4301281.9466991.html.plaintext.txt	3	vivo transcription start sites human cystic fibrosis transmembrane conductance regulator gene cftr murine homologue cftr mapped range tissues using technique 5prime rapid amplification cdna ends 5prime race
0.4301281.9466991.html.plaintext.txt	4	first vivo transcription start sites cftr cftr reported
0.4301281.9466991.html.plaintext.txt	5	distinct tissue specific patterns cftr start site usage identified mouse human
0.4301281.9466991.html.plaintext.txt	6	particular striking variation position murine cftr transcription start site seen along length intestinal tract different start sites utilized ileum duodenum
0.4301281.9466991.html.plaintext.txt	7	humans distinct transcription start sites utilized adult foetal lungs
0.4301281.9466991.html.plaintext.txt	8	addition novel 5prime untranslated exon murine cftr denoted exon 1 identified shown expressed exclusively mouse testis
0.4301281.9466991.html.plaintext.txt	9	expression exon 1 containing cftr transcripts shown mrna situ hybridization confined germ cells regulated spermatogenesis
0.4301281.9466991.html.plaintext.txt	10	cystic fibrosis common autosomal recessive disease characterized intestinal blockages exocrine pancreatic insufficiency male infertility progressive degenerative lung disease 1
0.4301281.9466991.html.plaintext.txt	11	diverse symptoms result mutation single gene cystic fibrosis transmembrane conductance regulator cftr 23 product functions camp regulated low conductance chloride channel 4
0.4301281.9466991.html.plaintext.txt	12	cftr exhibits complex patterns tissue specific expression expressed low levels specialized epithelial cells intestinal crypts airway submucosal glands pancreatic ducts sweat gland ducts male reproductive tract 5 8
0.4301281.9466991.html.plaintext.txt	13	addition observed patterns expression indicate cftr expression regulated hormones 9 development differentiation 81011
0.4301281.9466991.html.plaintext.txt	14	although patterns regulated cftr gene expression well known surprisingly little known genetic elements transcription factors regulate tissue specific expression cftr
0.4301281.9466991.html.plaintext.txt	15	mouse human cftr genes promoters resemble housekeeping genes 12 14 observation inconsistent tissue cell type specificity cftr expression
0.4301281.9466991.html.plaintext.txt	16	knowledge position cftr transcription start site utilized cftr expressing cells vivo prerequisite understanding regulation cftr promoter
0.4301281.9466991.html.plaintext.txt	17	cftr transcription start sites previously mapped number immortalized cell lines 121315 cannot concluded identical sites used vivo
0.4301281.9466991.html.plaintext.txt	18	present study used 5prime rapid amplification cdna ends 5prime race approach map accurately transcription start sites human cftr murine homologue cftr range primary tissues
0.4301281.9466991.html.plaintext.txt	19	distinct tissue specific patterns transcription start site usage observed
0.4301281.9466991.html.plaintext.txt	20	implications findings regard regulation cftr expression discussed
0.4301281.9466991.html.plaintext.txt	21	results identification murine cftr transcription start sites 5prime race
0.4301281.9466991.html.plaintext.txt	22	order identify major vivo cftr transcription start sites utilized mouse primary tissues performed 5prime race total rna isolated adult mouse lungs ileum duodenum testis uterus kidney also 16 day old foetal mouse lungs
0.4301281.9466991.html.plaintext.txt	23	first strand cdna synthesis performed using cftr specific primer mc6r table 1
0.4301281.9466991.html.plaintext.txt	24	cdnas homopolymer tailed subjected two successive rounds hemi nested pcr amplification anchor primer complementary homopolymer tail cftr specific nested primers mc5r mc2
0.4301281.9466991.html.plaintext.txt	25	discrete 5prime race products amplified mouse tissue fig
0.4301281.9466991.html.plaintext.txt	26	1 shows representative experiments
0.4301281.9466991.html.plaintext.txt	27	5prime race products excised either sequenced directly cloned vector pt7 blue novagen sequenced
0.4301281.9466991.html.plaintext.txt	28	positions observed transcription initiation sites numbered relative initiating methionine codon cftr open reading frame orf position 1 shown schematically figure 2 summarized table 2
0.4301281.9466991.html.plaintext.txt	29	single major transcription start sites observed mouse adult lung 82 kidney 75 uterus 72 16 day old mouse foetal lung 72
0.4301281.9466991.html.plaintext.txt	30	variation cftr transcription start site usage seen along length mouse intestinal tract two start sites observed mouse duodenum 60 19 whereas two different major start sites mapped mouse ileum 72 75 corresponding abundant 5prime race products amplified tissue fig
0.4301281.9466991.html.plaintext.txt	31	addition major start sites number minor transcription start sites observed ileum kidney uterus
0.4301281.9466991.html.plaintext.txt	32	minor 5prime race products ileum isolated found correspond transcription start sites positions 27 216 255
0.4301281.9466991.html.plaintext.txt	33	representative 5prime race pcr experiments performed mouse tissue cdna samples
0.4301281.9466991.html.plaintext.txt	34	tissue dc tailed cdna samples tdt paired negative control cdna samples homopolymer tailed subjected identical pcr amplification
0.4301281.9466991.html.plaintext.txt	35	testis b l adult lung fl foetal lung ileum d duodenum u uterus k kidney
0.4301281.9466991.html.plaintext.txt	36	lane m contains 100 bp ladder promega intense band corresponding 500 bp
0.4301281.9466991.html.plaintext.txt	37	700 bp murine cftr 5prime flanking genomic sequence spanning exons 1 1 intervening intron
0.4301281.9466991.html.plaintext.txt	38	nucleotide sequence numbered relative first base initiation codon cftr orf
0.4301281.9466991.html.plaintext.txt	39	exons shown upper case first 17 amino acids cftr predicted amino acid sequence short upstream orf shown single letter code
0.4301281.9466991.html.plaintext.txt	40	bent arrows indicate relative positions cftr transcription start sites utilized mouse tissues
0.4301281.9466991.html.plaintext.txt	41	l adult lung fl foetal lung testis ileum d duodenum u uterus k kidney
0.4301281.9466991.html.plaintext.txt	42	oligonucleotide primers used reverse transcription pcr primer exon sequence hc6r 6 5prime ccagctctctgatctctgtacttcatcatc hc5r 5 5prime ttatctagaacacggcttgacagc hc2r 2 5prime tttggtatatgtctgacaattccaggcgct hc3r 3 5prime acatcgccgaagggcattaatgagtttagg mc6r 6 5prime gcagctctttgatctctgtacttcaccatg mc5r 5 5prime gttcaggttgttggaaagaagactaacaa mc2
0.4301281.9466991.html.plaintext.txt	43	1r 2 5prime acaagtggtcagctgaatcagcagaagggg
0.4301281.9466991.html.plaintext.txt	44	cftr transcription start sites mapped pcr based technique one start site observed absolute values assigned percentage transcript initiating sites
0.4301281.9466991.html.plaintext.txt	45	however conclude abundant products correspond major transcription start sites cftr collectively minor 5prime race products constitute 10 cftr transcripts tissue
0.4301281.9466991.html.plaintext.txt	46	importantly two major start sites mapped ileum 72 75 used approximately equal frequency two start sites mapped duodenum 60 19 used 41 ratio respectively
0.4301281.9466991.html.plaintext.txt	47	finally relative intensities 5prime race products foetal adult lung correspond well known regulation cftr expression adult mouse lung tissue unpublished data
0.4301281.9466991.html.plaintext.txt	48	positions major murine cftr transcription start sites utilized mouse tissues numbered relative initiation codon cftr open reading frame 1 tissue major start sites minor start sites testis 549 lung 82 foetal lung 72 duodenum 19 60 ileum 75 72 27 216 255 kidney 75 uterus 72
0.4301281.9466991.html.plaintext.txt	49	positions human cftr transcription start sites numbered relative cftr translation initiation codon 1 tissue position start site adult lung 69 foetal lung 132 intestine 69 intestine 114 pancreas 68 identification human cftr transcription start sites 5prime race
0.4301281.9466991.html.plaintext.txt	50	significant amount tissue specific variation pattern cftr transcription start site usage observed mouse
0.4301281.9466991.html.plaintext.txt	51	order investigate whether similar variation cftr transcription start site usage also occurs human tissues performed 5prime race rna isolated human whole small intestine whole pancreas whole adult lung whole foetal lung pooled 29 specimens age range 18 28 weeks tissues represent major sites cftr expression relevant cf disease pathology
0.4301281.9466991.html.plaintext.txt	52	first strand cdna synthesis performed using cftr specific primer hc6r table 1
0.4301281.9466991.html.plaintext.txt	53	cdnas homopolymer tailed subjected two successive rounds hemi nested pcr amplification anchor primer complementary homopolymer tail cftr specific nested primers hc5r either hc2r hc3r table 1
0.4301281.9466991.html.plaintext.txt	54	discrete 5prime race pcr products amplified human tissue fig
0.4301281.9466991.html.plaintext.txt	55	3 shows representative experiments
0.4301281.9466991.html.plaintext.txt	56	5prime race products excised gel purified sequenced directly
0.4301281.9466991.html.plaintext.txt	57	positions transcription initiation sites numbered relative initiating methionine codon cftr orf position 1 shown schematically figure 4 summarized table 3
0.4301281.9466991.html.plaintext.txt	58	mapping transcription start sites cftr gene samples human tissue total rna
0.4301281.9466991.html.plaintext.txt	59	tissue analysed paired samples dc tailed cdna tdt negative control tdt cdna subjected identical hemi nested pcr amplification
0.4301281.9466991.html.plaintext.txt	60	first round pcr amplification performed anchor primer cftr specific primer hc5r second round pcr amplification performed anchor primer hc2r except performed anchor primer hc3r
0.4301281.9466991.html.plaintext.txt	61	l lung whole small intestine p pancreas fl foetal lung m 100 bp dna ladder
0.4301281.9466991.html.plaintext.txt	62	sequence 5prime flanking region human cftr gene
0.4301281.9466991.html.plaintext.txt	63	nucleotide sequence numbered relative translation codon 1 initiation codon double underlined
0.4301281.9466991.html.plaintext.txt	64	bent arrows indicate positions cftr transcription start sites position site tissue mapped shown
0.4301281.9466991.html.plaintext.txt	65	fl foetal lungs l adult lungs whole small intestine p pancreas
0.4301281.9466991.html.plaintext.txt	66	5prime race products amplified adult lung foetal lung pancreas corresponded single transcription initiation sites positions 69 132 68 respectively whilst two 5prime race products amplified small intestine corresponded start sites positions 69 114
0.4301281.9466991.html.plaintext.txt	67	limited availability human tissues possible determine whether two alternative start sites represent variation start site usage along length human intestinal tract case murine cftr whether alternative start sites used different cftr expressing cell types along length intestine e
0.4301281.9466991.html.plaintext.txt	68	epithelial cells lining intestinal crypt versus poorly characterized cftr expressing cells intestinal villus 1617
0.4301281.9466991.html.plaintext.txt	69	results vivo transcription mapping study broadly consistent previously published data immortalized cell lines single transcription start sites utilized adult lung 69 pancreas 68 one start sites identified intestine 69 close major cftr start sites mapped colonic epithelial adenocarcinoma cell lines t84 ht 29 caco 2 121315
0.4301281.9466991.html.plaintext.txt	70	however none multiple minor start sites observed t84 ht 29 caco 2 cells appear used cftr expressing cells vivo
0.4301281.9466991.html.plaintext.txt	71	observation distinct cftr transcription start sites utilized adult 69 foetal lungs 132 intriguing given previously reported developmental regulation cftr expression lung 101118
0.4301281.9466991.html.plaintext.txt	72	cftr mrna levels substantially higher foetal lungs adult lungs cftr expression declining dramatically birth although precise age regulation occurs known
0.4301281.9466991.html.plaintext.txt	73	possible switch transcription initiation 132 site 69 site correlates particular stage lung development
0.4301281.9466991.html.plaintext.txt	74	correlation pattern cftr transcription start site usage level cftr mrna expression previously reported cftr expressing cell lines suggesting mechanism cftr regulation operates level start site selection 15
0.4301281.9466991.html.plaintext.txt	75	data suggest similar mechanism might operate human lung development
0.4301281.9466991.html.plaintext.txt	76	identification novel exon murine cftr
0.4301281.9466991.html.plaintext.txt	77	figure 1 shows major 5prime race product 420 bp amplified mouse testis
0.4301281.9466991.html.plaintext.txt	78	dna sequencing revealed pcr product extended cftr exon 2 splice junction exon 1 contained 161 bp cftr exon 1 154 bp unknown sequence named exon 1
0.4301281.9466991.html.plaintext.txt	79	comparison sequence major 5prime race product testis upstream genomic sequence murine cftr 19 confirmed existence exon 1 distinct untranslated exon indicated major transcription start site cftr mouse testis position 549 relative initiating methionine codon cftr orf fig
0.4301281.9466991.html.plaintext.txt	80	intron 285 bp separates exon 1 exon 1 sequences splice donor splice acceptor sites obeying invariant gt ag rule 20 exon 1exon 1 splice junction
0.4301281.9466991.html.plaintext.txt	81	position exon 1exon 1 boundary polyadenylated rna mouse testis confirmed performing independent rt pcr amplification mouse testis first strand cdna primed oligodt shown
0.4301281.9466991.html.plaintext.txt	82	exon 1 expression testis specific
0.4301281.9466991.html.plaintext.txt	83	tissue specificity exon 1 expression investigated using dual probe rnase protection assay simultaneously detected cftr exon 1 internal cftr sequence cftr exons 10 12 base pairs 1580 1865 samples mouse tissue total rna
0.4301281.9466991.html.plaintext.txt	84	cftr exon 10 12 expression detected tissues examined exception pancreas fig
0.4301281.9466991.html.plaintext.txt	85	5 agreement previous observations cftr expressed extremely low levels rodent pancreas 521
0.4301281.9466991.html.plaintext.txt	86	significant levels exon 1 expression observed testis fig
0.4301281.9466991.html.plaintext.txt	87	amounts protected fragment quantitated using molecular dynamics phosphoimaging cassette imagequant software comparison relevant standard curve known amounts rna sense strands shown
0.4301281.9466991.html.plaintext.txt	88	approximately 95 cftr transcripts expressed murine testis contain exon 1 whilst mouse tissues examined 5 cftr transcripts contained exon 1
0.4301281.9466991.html.plaintext.txt	89	simultaneous detection cftr exons 10 12 cftr exon 1 single samples mouse tissue total rna dual probe rnase protection analysis
0.4301281.9466991.html.plaintext.txt	90	lane 1 ileum lane 2 duodenum lane 3 ovaryoviduct lane 4 uterus lane 5 testis lane 6 pancreas lane 7 adult lung lane 8 16 day foetal lung lane 9 salivary gland
0.4301281.9466991.html.plaintext.txt	91	lane 10 represents yeast rna negative control
0.4301281.9466991.html.plaintext.txt	92	expected positions two protected fragments indicated
0.4301281.9466991.html.plaintext.txt	93	germ cell specific expression cftr exon 1
0.4301281.9466991.html.plaintext.txt	94	cftr exhibits cell type specific pattern expression murine testis levels expression varying different stages spermatogenesis 22
0.4301281.9466991.html.plaintext.txt	95	cftr expressed first pachytene spermatocytes expression maintained cells undergo meiotic division produce round spermatids declining round spermatids elongate 22
0.4301281.9466991.html.plaintext.txt	96	order determine whether cftr exon 1 shows cell type specific pattern expression examined vivo expression cftr exon 1 mouse testis mrna situ hybridization
0.4301281.9466991.html.plaintext.txt	97	series consecutive sections adult mouse testis hybridized probes specific exon 1 fig
0.4301281.9466991.html.plaintext.txt	98	6 internal region cftr data shown
0.4301281.9466991.html.plaintext.txt	99	identical patterns cell type specific expression observed probes demonstrating expression exon 1 containing cftr transcript regulated stages spermatogenesis agreement previous observations cftr expression mouse testis 22
0.4301281.9466991.html.plaintext.txt	100	cell type specific expression cftr mrna adult mouse testis examined situ hydridization
0.4301281.9466991.html.plaintext.txt	101	series consecutive sections adult mouse testis hybridized 35s labelled cftr 1 antisense sense probes
0.4301281.9466991.html.plaintext.txt	102	brightfield view haemotoxylin eosin stained section mouse testis hybridized 35s labelled cftr 1 antisense probe
0.4301281.9466991.html.plaintext.txt	103	b darkfield view section
0.4301281.9466991.html.plaintext.txt	104	c hybridized 35s labelled cftr 1 sense probe
0.4301281.9466991.html.plaintext.txt	105	cftr expression human testis reported extremely low associated particular cell type particular stage spermatogenesis strikingly different rodent expression pattern 23
0.4301281.9466991.html.plaintext.txt	106	nevertheless existence human equivalent testis specific murine cftr exon 1 investigated performing 5prime race pcr order identify cftr transcription start site utilized adult human testis
0.4301281.9466991.html.plaintext.txt	107	5prime race procedure repeated total three times cftr specific product bands could amplified
0.4301281.9466991.html.plaintext.txt	108	positive control cftr expression human testis confirmed rt pcr using internal cftr primer set shown
0.4301281.9466991.html.plaintext.txt	109	concluded therefore level cftr expression human testis extremely low detectable rt pcr low level expression limit detection 5prime race due latter methods inherently lower sensitivity
0.4301281.9466991.html.plaintext.txt	110	thus position cftr start site utilized adult human testis remains unknown conclusions drawn regarding expression human equivalent murine cftr exon 1 human testis
0.4301281.9466991.html.plaintext.txt	111	study mapped vivo transcription start sites human cftr murine homologue cftr
0.4301281.9466991.html.plaintext.txt	112	using sensitive 5prime race technique able map cftr start sites number different mouse human tissues
0.4301281.9466991.html.plaintext.txt	113	first vivo cftr transcription start sites mapped species
0.4301281.9466991.html.plaintext.txt	114	case murine cftr use distinct tissue specific transcription start sites leads production cftr transcripts differ length 5prime untranslated regions 5prime utrs
0.4301281.9466991.html.plaintext.txt	115	observation distinct transcription start sites used different tissues suggests tissue specific regulation cftr expression may part operate level transcription start site selection
0.4301281.9466991.html.plaintext.txt	116	analysis primary sequence 5prime flanking region murine cftr provides clues tissue specific start site selection might achieved
0.4301281.9466991.html.plaintext.txt	117	sequence likely correspond tata box element could found upstream vivo transcription start sites identified murine cftr fig
0.4301281.9466991.html.plaintext.txt	118	however table 4 illustrates sequences surrounding three cftr transcription start sites 82 site utilized lung 60 19 sites utilized duodenum similar consensus sequence mammalian initiator inr element pypya1ntapypy suggested maintain fidelity transcription initiation promoters devoid tata boxes 24
0.4301281.9466991.html.plaintext.txt	119	likely therefore inr dependent mechanism responsible directing formation transcription pre initiation complex tissues
0.4301281.9466991.html.plaintext.txt	120	sequence context murine cftr transcription start sites
0.4301281.9466991.html.plaintext.txt	121	case transcription start site 1 underlined position start site sequence context inr consensus pypya1ntapypy 549 agaagga 82 gcattga 75 cctggtc 72 ggtcctg 60 ccagatg 19 tcattgc
0.4301281.9466991.html.plaintext.txt	122	tissue specific variation position cftr start site also observed human tissues
0.4301281.9466991.html.plaintext.txt	123	notably distinct start sites appear used adult foetal lungs
0.4301281.9466991.html.plaintext.txt	124	however exact position cftr transcription start site relative translation initiation codon appear conserved equivalent tissues mice humans suggesting precise mechanisms responsible correct start site selection conserved cross species
0.4301281.9466991.html.plaintext.txt	125	perhaps surprising given apparent lack primary nucleic acid sequence homology mouse human proximal promoter regions 1925
0.4301281.9466991.html.plaintext.txt	126	identification testis specific untranslated exon murine cftr exon 1 implies cftr expression tissue control testis specific alternative promoter
0.4301281.9466991.html.plaintext.txt	127	murine cftr falls group genes demonstrating cell type specific expression testis expression regulated spermatogenesis 22
0.4301281.9466991.html.plaintext.txt	128	genes group include many whose protein products thought play particular role complex process spermatogenesis reviewed 26 potential role cftr chloride channel spermatogenesis suggested 22
0.4301281.9466991.html.plaintext.txt	129	genes cftr expressed post meiotically testis tissues often produce testis specific transcripts generated use testis specific promoters altered polyadenylation andor tissue specific alternative exon splicing 26
0.4301281.9466991.html.plaintext.txt	130	shown testis specific cftr transcript generated use alternative promoter alternative splicing 5prime utr include exon 1 extreme 5prime end transcript
0.4301281.9466991.html.plaintext.txt	131	vast majority 95 cftr transcripts mouse testis contain additional untranslated exon implying important role exon 1 regard either function cftr testis regulation cftr expression tissue
0.4301281.9466991.html.plaintext.txt	132	latter alternative would appear plausible number genes expressed post meiotically rodent testis exhibit negative translational regulation mediated binding regulatory proteins specific 5prime utr sequences reviewed 27
0.4301281.9466991.html.plaintext.txt	133	one families germ cell specific proteins proposed mediate translational regulation testis y box proteins 28
0.4301281.9466991.html.plaintext.txt	134	y box proteins may function dna binding transcription factors bind specific cis acting y box promoter elements rna binding proteins mediate translational regulation via mrna masking vertebrate gametes 29
0.4301281.9466991.html.plaintext.txt	135	context interesting note y box consensus sequence previously suggested act positive regulator transcription murine cftr promoter 14 contained within exon 1 thus present exclusively 5prime utr testis specific cftr transcripts
0.4301281.9466991.html.plaintext.txt	136	another feature murine cftr 5prime flanking region suggests translational regulation may general mechanism controlling cftr expression
0.4301281.9466991.html.plaintext.txt	137	additional aug codon present position 58 upstream cftr orf fig
0.4301281.9466991.html.plaintext.txt	138	upstream aug precedes short upstream orf uorf recognized translation machinery would produce small peptide five amino acids length
0.4301281.9466991.html.plaintext.txt	139	uorf present 5prime utr cftr transcripts initiating upstream position 58 including major cftr transcripts expressed lung foetal lung ileum kidney uterus testis
0.4301281.9466991.html.plaintext.txt	140	upstream aug occurs weak kozak context neither critical purine position 3 g position 4 present 30 whereas aug cftr orf occurs much stronger kozak context 31
0.4301281.9466991.html.plaintext.txt	141	scanning model predicts translation usually initiate first aug favourable kozak context 30
0.4301281.9466991.html.plaintext.txt	142	nevertheless interaction translation machinery upstream aug may effect reducing translation efficiency cftr orf
0.4301281.9466991.html.plaintext.txt	143	presence short uorf would therefore predicted reduce translation efficiency major cftr transcripts expressed lungs ileum testis expressed duodenum uorf absent 5prime utr duodenum transcript initiating position 19 close m7g cap site exert effect transcript initiating position 60 31
0.4301281.9466991.html.plaintext.txt	144	thus use distinct transcription start sites expression cftr might also modulated translational level
0.4301281.9466991.html.plaintext.txt	145	identification major cftr transcription start sites utilized vivo essential prerequisite understanding function cftr promoter
0.4301281.9466991.html.plaintext.txt	146	possible define promoter elements transcription factors mechanisms directing complex patterns vivo cftr expression
0.4301281.9466991.html.plaintext.txt	147	materials methods sources mouse tissues total rna preparation
0.4301281.9466991.html.plaintext.txt	148	human rna samples purchased clontech
0.4301281.9466991.html.plaintext.txt	149	mouse tissues pooled six male six female adult mice strain mf1
0.4301281.9466991.html.plaintext.txt	150	foetal lung tissue pooled three 16 day old foetuses removed single timed pregnant female
0.4301281.9466991.html.plaintext.txt	151	total rna isolated using guanidinium thiocyanateacid phenol chloroform extraction method 32
0.4301281.9466991.html.plaintext.txt	152	5prime race performed using adaptation method frohman 33
0.4301281.9466991.html.plaintext.txt	153	first strand cdna synthesis performed 2 microg total rna using 10 pmol primer mc6r table 1 200 u superscript ii reverse transcriptase brl
0.4301281.9466991.html.plaintext.txt	154	rna template strands digested 2 u rnase h brl first strand cdnas purified using qiaquik pcr purification columns qiagen homopolymer tailed using 0
0.4301281.9466991.html.plaintext.txt	155	2 mm dctp 20 u terminal transferase promega
0.4301281.9466991.html.plaintext.txt	156	cdnas purified using qiaquik columns subjected two rounds hemi nested pcr amplifications using primers mc5r mc2
0.4301281.9466991.html.plaintext.txt	157	1r 5prime race anchor primer specific homopolymer tail purchased brl 10 pmol primer 2
0.4301281.9466991.html.plaintext.txt	158	5 u amplitaq gold polymerase perkin elmer per pcr reaction
0.4301281.9466991.html.plaintext.txt	159	5prime race products either sequenced directly ligated vector pt7 blue recombinant plasmids sequenced
0.4301281.9466991.html.plaintext.txt	160	sequencing reactions performed using amplitaq dye terminator cycle sequencing kit applied biosystems analysed abi prism 377 automated sequencer
0.4301281.9466991.html.plaintext.txt	161	dual probe rnase protection assays performed using rpa ii system ambion
0.4301281.9466991.html.plaintext.txt	162	two probes used detect different regions single cftr mrna first cftr 10 12 corresponded internal region cftr spanning exons 10 12 base pairs 1580 1865 cftr cdna 19 vector bluescript ks stratagene second cftr 1 contained 150 bp mouse cftr exon 1 50 bp race anchor primer sequence amplified mouse testis major 5prime race product pcr using anchor primer gibco brl primer mc 1r 5prime accgtggccaatctgcgggacttagaaccc cloned bluescript sk stratagene
0.4301281.9466991.html.plaintext.txt	163	bluescript vectors contain opposing t3 t7 promoters allow synthesis 32p labelled antisense rna probes control unlabelled sense strand rnas vitro transcription
0.4301281.9466991.html.plaintext.txt	164	samples 20 microg mouse tissue total rna hybridized overnight equal excess amounts 0
0.4301281.9466991.html.plaintext.txt	165	32p labelled antisense cftr 1 cftr 10 12 probes
0.4301281.9466991.html.plaintext.txt	166	following rnase digestion precipitation protected products resolved 6 denaturing polyacrylamide gels visualized exposure kodak x omat ar film
0.4301281.9466991.html.plaintext.txt	167	situ hybridization performed essentially described previously 17
0.4301281.9466991.html.plaintext.txt	168	probes specific two regions mouse cftr used situ localization cftr mrna first cftr 10 13 corresponded fragment cftr exons 10 13 bases 1580 2108 cftr cdna 19 vector bluescript ks second cftr 1 used rnase protection
0.4301281.9466991.html.plaintext.txt	169	probes cloned bluescript vectors containing opposing t3 t7 promoters generation 35sutp labelled sense antisense strand rna probes vitro transcription
0.4301281.9466991.html.plaintext.txt	170	cryostat tissue sections 10 microm hybridized overnight 35s labelled single stranded rna probes 50 formamide 55 60 degrees c
0.4301281.9466991.html.plaintext.txt	171	sections digested rnase remove excess probe single stranded rna washed stringency 0
0.4301281.9466991.html.plaintext.txt	172	slides dipped kodak ntb 2 emulsion exposed 2 weeks 4 degrees c developed counterstained haematoxylin eosin
0.4301281.9466991.html.plaintext.txt	173	sections photographed brightfield darkfield illumination using nikon optiphot 2 microscope equipped nikon ufx dx automatic camera
0.4301281.9466991.html.plaintext.txt	174	multiple tissue sections hybridized either sense antisense probes two regions cftr cases results seen consistent probe
0.4301281.9466991.html.plaintext.txt	175	searches genbank database look sequence homology performed using fasta gcg program
0.4301281.9466991.html.plaintext.txt	176	supported wellcome trust prize studentship
0.4301281.9466991.html.plaintext.txt	177	beit memorial research fellowship
0.4301281.9466991.html.plaintext.txt	178	additional support work came cystic fibrosis research trust icrf eu henry smith foundation university oxford
0.4301281.9466991.html.plaintext.txt	179	howard hughes international research scholar
0.4301281.9466991.html.plaintext.txt	180	eds metabolic basis inherited disease
0.4301281.9466991.html.plaintext.txt	181	1989 identification cystic fibrosis gene chromosome walking jumping
0.4301281.9466991.html.plaintext.txt	182	1989 identification cystic fibrosis gene cloning characterization complementary dna
0.4301281.9466991.html.plaintext.txt	183	1992 purification functional reconstitution cystic fibrosis transmembrane conductance regulator cftr
0.4301281.9466991.html.plaintext.txt	184	1991 vivo cell specific expression cystic fibrosis transmembrane conductance regulator
0.4301281.9466991.html.plaintext.txt	185	1991 immunocytochemical localisation cystic fibrosis gene product cftr
0.4301281.9466991.html.plaintext.txt	186	1992 submucosal glands predominant site cftr expression human bronchus
0.4301281.9466991.html.plaintext.txt	187	1992 multidrug resistance cystic fibrosis genes complementary patterns epithelial expression
0.4301281.9466991.html.plaintext.txt	188	1993 stimulation cystic fibrosis transmembrane conductance regulator expression estrogen vivo
0.4301281.9466991.html.plaintext.txt	189	1993 expression cystic fibrosis gene human foetal tissues
0.4301281.9466991.html.plaintext.txt	190	1993 cell specific localization cftr mrna shows developmentally regulated expression human foetal tissues
0.4301281.9466991.html.plaintext.txt	191	1991 cystic fibrosis gene housekeeping type promoter expressed low levels cells epithelial origin
0.4301281.9466991.html.plaintext.txt	192	1991 characterization cystic fibrosis transmembrane conductance regulator promoter region
0.4301281.9466991.html.plaintext.txt	193	1994 analysis mouse rat cftr promoter regions
0.4301281.9466991.html.plaintext.txt	194	1993 characterisation cystic fibrosis transmembrane conductance regulator promoter region
0.4301281.9466991.html.plaintext.txt	195	1995 unique subset rat human intestinal villus cells express human cystic fibrosis transmembrane conductance regulator
0.4301281.9466991.html.plaintext.txt	196	gastroenterology 108 1016 1023
0.4301281.9466991.html.plaintext.txt	197	1994 localization cystic fibrosis transmembrane conductance regulator mrna human gastrointestinal tract situ hybridisation
0.4301281.9466991.html.plaintext.txt	198	1992 localization cystic fibrosis transmembrane conductance regulator mrna human foetal lung tissue situ hybridisation
0.4301281.9466991.html.plaintext.txt	199	1991 cloning mouse homolog human cystic fibrosis transmembrane conductance regulator gene
0.4301281.9466991.html.plaintext.txt	200	1982 catalogue splice junction sequences
0.4301281.9466991.html.plaintext.txt	201	1992 expression chromosomal localisation murine cystic fibrosis transmembrane conductance regulator
0.4301281.9466991.html.plaintext.txt	202	1993 cftr expression regulated cycle seminiferous epithelium oestrus cycle rodents
0.4301281.9466991.html.plaintext.txt	203	1994 differential cellular expression cystic fibrosis transmembrane regulator human reproductive tissues
0.4301281.9466991.html.plaintext.txt	204	1994 dna sequence requirements transcriptional initiator activity mammalian cells
0.4301281.9466991.html.plaintext.txt	205	1997 phylogenetic analysis cystic fibrosis transmembrane conductance regulator gene mammalian species argues development rabbit model cystic fibrosis
0.4301281.9466991.html.plaintext.txt	206	1990 post meiotic gene expression
0.4301281.9466991.html.plaintext.txt	207	1995 translational control spermatogenesis
0.4301281.9466991.html.plaintext.txt	208	1994 structural functional properties evolutionarily ancient y box family nucleic acid binding proteins
0.4301281.9466991.html.plaintext.txt	209	1993 mouse y box protein msy1 associated paternal mrna spermatocytes
0.4301281.9466991.html.plaintext.txt	210	1991 analysis vertebrate mrna sequences intimations translational control
0.4301281.9466991.html.plaintext.txt	211	1991 structural features eukaryotic mrnas modulate initiation translation
0.4301281.9466991.html.plaintext.txt	212	1987 single step method rna isolation guanidinium thiocyanate phenol chloroform extraction
0.4301281.9466991.html.plaintext.txt	213	1988 rapid production full length cdnas rare transcripts amplification using single gene specific oligonucleotide primer
0.4301281.9466991.html.plaintext.txt	214	correspondence addressed present address school biomolecular biomedical science griffith university brisbane queensland 4111 australia
0.4301281.9466991.html.plaintext.txt	215	au present address mrc clinical sciences centre imperial college school medicine hammersmith hospital du cane road london w12 0nn uk
0.4301281.9466991.html.plaintext.txt	216	tel 44 181 383 8335 fax 44 181 383 8337 email chigginsrpms
0.4301281.9466991.html.plaintext.txt	217	uk page run oxford university press great clarendon street oxford ox2 6dp part oup journalscomments feedback www adminatoup
0.4301281.9466991.html.plaintext.txt	218	uk u d last modification 14 feb 1998copyright oxford university press 1998
0.43087202.9530112.html.plaintext.txt	0	electrodiffusional atp movement cystic fibrosis transmembrane conductance regulator horacio f
0.43087202.9530112.html.plaintext.txt	1	borkan4 yihan wang4 ignacio l
0.43087202.9530112.html.plaintext.txt	2	1 renal unit massachusetts general hospital east charlestown 02129 2 department medicine harvard medical school boston 02115 4 renal section boston medical center boston 02118 5 genzyme corporation framingham massachusetts 01701 3 departamento de quimica general e inorganica facultad de farmacia y bioquimica universidad de buenos aires 1113 buenos aires argentina
0.43087202.9530112.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references
0.43087202.9530112.html.plaintext.txt	4	expression cystic fibrosis transmembrane conductance regulator cftr least one member atp binding cassette family transport proteins p glycoprotein associated electrodiffusional movement nucleotide atp
0.43087202.9530112.html.plaintext.txt	5	evidence directly implicating cftr expression atp channel activity however still missing
0.43087202.9530112.html.plaintext.txt	6	reported reconstitution lipid bilayer highly purified cftr human epithelial origin enables permeation cl atp
0.43087202.9530112.html.plaintext.txt	7	similar previously reported data vivo atp currents cftr expressing cells reconstituted channels displayed competition cl atp multiple conductance states presence cl atp
0.43087202.9530112.html.plaintext.txt	8	purified cftr mediated atp currents activated protein kinase atp 1 mm intracellular side molecule inhibited diphenylamine 2 carboxylate glibenclamide anti cftr antibodies
0.43087202.9530112.html.plaintext.txt	9	absence cftr mediated electrodiffusional atp movement may thus relevant component pleiotropic cystic fibrosis phenotype
0.43087202.9530112.html.plaintext.txt	10	adenosine 5 triphosphate channels adenosine 5 triphosphate binding cassette transporters nucleotide transport
0.43087202.9530112.html.plaintext.txt	11	introduction top abstract introduction materials methods results discussion references
0.43087202.9530112.html.plaintext.txt	12	cystic fibrosis transmembrane conductance regulator cftr supports atp dependent cl channel activity 3 14
0.43087202.9530112.html.plaintext.txt	13	however controversy still exists whether functional feature cftr sufficient explain complete pathophysiology disease 7
0.43087202.9530112.html.plaintext.txt	14	cellular epithelial cystic fibrosis cf phenotype example associated dysfunctional phospholipase a2 activity deranged arachidonic acid metabolism 10 24 abnormally increased apical epithelial na permeability 6 regulated cftr 26
0.43087202.9530112.html.plaintext.txt	15	expression cftr also associated recovery outwardly rectifying cl channel activity cf cells 12 autocoid mechanism entailing release cellular atp turn helps modulate cell responses 23
0.43087202.9530112.html.plaintext.txt	16	disparate observations unlikely stem altered cl conductance
0.43087202.9530112.html.plaintext.txt	17	alternate paradigms explain various features cf phenotype currently sought
0.43087202.9530112.html.plaintext.txt	18	cftr implicated release cellular atp 18 23 electrodiffusional atp movement 17 22 23 however studies failed detect electrodiffusional atp movement preparations containing functional cftr 13 21
0.43087202.9530112.html.plaintext.txt	19	report revisited question whether cftr capable permeating atp
0.43087202.9530112.html.plaintext.txt	20	highly purified functional human epithelial recombinant cftr 14 reconstituted lipid bilayer addition protein kinase pka atp elicited diphenylamine 2 carboxylate dpc inhibitable cl atp permeable ion channel activity agreement previous findings intact cells 9 22 23
0.43087202.9530112.html.plaintext.txt	21	present data indicate atp transfer cftr may require adjacent transmembrane structure allow permeation nucleotide
0.43087202.9530112.html.plaintext.txt	22	materials methods top abstract introduction materials methods results discussion references
0.43087202.9530112.html.plaintext.txt	23	recombinant human epithelial cftr obtained baculovirus infected sf9 insect cell membranes according oriordan et al
0.43087202.9530112.html.plaintext.txt	24	briefly cftr purified small 2
0.43087202.9530112.html.plaintext.txt	25	6 x 6 cm 30 ml ceramic hydroxyapatite column equilibration buffer containing 10 mm sodium phosphate buffer ph 6
0.43087202.9530112.html.plaintext.txt	26	15 sodium dodecyl sulfate sds 5 mm dithiothreitol dtt eluted linear gradient 100 600 mm sodium phosphate 0
0.43087202.9530112.html.plaintext.txt	27	15 sds 5 mm dtt originally described 3
0.43087202.9530112.html.plaintext.txt	28	superdex column chromatography 0
0.43087202.9530112.html.plaintext.txt	29	25 lithium dodecyl sulfate also used facilitate purification larger quantities mg insect cftr 14
0.43087202.9530112.html.plaintext.txt	30	cases purified cftr obtained cftr expressing chinese hamster ovary cho cells cells grown microcarriers harvested washed sodium phosphate buffered saline pbs lysed buffer containing protease inhibitors details see ref
0.43087202.9530112.html.plaintext.txt	31	supernatant processed obtain membrane suspension pelleted 100000 g 60 min
0.43087202.9530112.html.plaintext.txt	32	supernatant containing solubilized cftr purified immunoaffinity resins prepared monoclonal antibody mab 13 1 mab 24 1 genzyme framingham ma activated sodium periodate coupled hydrazide avidgel unisyn technologies 50 mm sodium acetate ph 5
0.43087202.9530112.html.plaintext.txt	33	immunoaffinity chromatography performed incubation cftr containing membranes 25 ml 15 ml resin least 3 h 4 degrees c
0.43087202.9530112.html.plaintext.txt	34	collection flow resin rinsed 100 ml wash buffer containing 150 mm nacl 50 mm trishydroxymethylaminomethane tris hcl ph 8
0.43087202.9530112.html.plaintext.txt	35	0 1 mm edta 1 sodium cholate remove nonspecifically bound proteins
0.43087202.9530112.html.plaintext.txt	36	cftr eluted resin using elution buffer 150 mm nacl 50 mm tris hcl ph 7
0.43087202.9530112.html.plaintext.txt	37	4 1 mm edta 10 glycerol 0
0.43087202.9530112.html.plaintext.txt	38	5 sodium cholate containing 5 mgml appropriate peptide antigen synthesized qcb hopkinton ma
0.43087202.9530112.html.plaintext.txt	39	fractions containing cftr pooled concentrated using centricell 20 final concentration 1 mgml 500 microl
0.43087202.9530112.html.plaintext.txt	40	cftr purified using either gel filtration ion exchange chromatography 14
0.43087202.9530112.html.plaintext.txt	41	gel filtration chromatography performed superdex 200 hr 1030 column preequilibrated 150 mm nacl 50 mm tris hcl 1 mm edta 10 glycerol 0
0.43087202.9530112.html.plaintext.txt	42	immunoaffinity purified cftr 200 microl applied column fractions collected cftr detected sds polyacrylamide gel electrophoresis followed silver staining
0.43087202.9530112.html.plaintext.txt	43	fractions pooled concentrated cftr quantitated enzyme linked immunosorbent assay details see ref
0.43087202.9530112.html.plaintext.txt	44	cases ion exchange chromatography used 50 ml column deae sepharose equilibrated 10 mm k2hpo4 10 glycerol 0
0.43087202.9530112.html.plaintext.txt	45	05 lysophosphatidylcholine ph 7
0.43087202.9530112.html.plaintext.txt	46	stripped membranes 100 mg solubilized buffer resulting 100000 g supernatant applied column
0.43087202.9530112.html.plaintext.txt	47	cftr bound deae sepharose conditions
0.43087202.9530112.html.plaintext.txt	48	extensive washing resin equilibration buffer linear gradient 10 150 mm k2hpo4 applied
0.43087202.9530112.html.plaintext.txt	49	cftr eluted column 60 85 mm k2hpo4 14
0.43087202.9530112.html.plaintext.txt	50	purified cftr obtained insect sf9 cells subjected 4 20 sds gradient gel electrophoresis identify potential protein contaminants ranging size 1 300 kda
0.43087202.9530112.html.plaintext.txt	51	electrophoresis stopped bromophenol blue dye front reached bottom gel
0.43087202.9530112.html.plaintext.txt	52	gel overstained silver enhance sensitivity
0.43087202.9530112.html.plaintext.txt	53	molecular size estimated using markers obtained gibco brl grand island ny
0.43087202.9530112.html.plaintext.txt	54	detection cftr immunoblot analysis
0.43087202.9530112.html.plaintext.txt	55	mouse mammary carcinoma c127i cells transfected human epithelial cftr wt1 cells harvested washing ice cold ca2 free pbs 5 ml scraped rubber policeman centrifuged resuspended ice cold lysis buffer containing 1 triton x 100 0
0.43087202.9530112.html.plaintext.txt	56	5 np 40 150 mm nacl 10 mm tris hcl ph 7
0.43087202.9530112.html.plaintext.txt	57	5 1 mm ethylene glycol bis aminoethyl ether nnnn tetraacetic acid egta 1 mm edta 0
0.43087202.9530112.html.plaintext.txt	58	25 mm sodium vanadate 10 microgml phenylmethylsulfonyl fluoride 10 microgml aprotinin sonicated
0.43087202.9530112.html.plaintext.txt	59	purified cftr sf9 cells prepared indicated
0.43087202.9530112.html.plaintext.txt	60	protein determination performed using bio rad assay bio rad richmond ca
0.43087202.9530112.html.plaintext.txt	61	briefly sample mixed dilution buffer final concentrations 62
0.43087202.9530112.html.plaintext.txt	62	5 2 sds 10 glycerol 50 mm dtt heated 5 min 60 degrees c
0.43087202.9530112.html.plaintext.txt	63	proteins separated 7
0.43087202.9530112.html.plaintext.txt	64	5 sds polyacrylamide gel transferred polyvinylidene difluoride membranes prewetted methanol soaked transfer buffer 15 min
0.43087202.9530112.html.plaintext.txt	65	membranes blocked 5 dried milk 0
0.43087202.9530112.html.plaintext.txt	66	5 nonimmune goat serum tbst 50 mm tris hcl ph 7
0.43087202.9530112.html.plaintext.txt	67	blots probed one two cftr mab 0
0.43087202.9530112.html.plaintext.txt	68	5 1 microgml mab 13 1 mab 24 1 genzyme tbst containing 1 bovine serum albumin 36 48 h 4 degrees c
0.43087202.9530112.html.plaintext.txt	69	three washings tbst membranes incubated peroxidase labeled goat anti mouse antibody sigma 1 h 25 degrees c
0.43087202.9530112.html.plaintext.txt	70	immunoreactive bands detected enzyme linked chemiluminescence kirkegaard perry gaithersburg md
0.43087202.9530112.html.plaintext.txt	71	reconstitution cftr phospholipid vesicles
0.43087202.9530112.html.plaintext.txt	72	immunoaffinity purified cftr concentrated described reconstituted using modification procedure described bear et al
0.43087202.9530112.html.plaintext.txt	73	aliquot containing known amount cftr 15 20 microgml added 100 microl solution containing 15 mm n 2 hydroxyethylpiperazine n 2 ethanesulfonic acid hepes ph 7
0.43087202.9530112.html.plaintext.txt	74	5 mm egta also containing 1 mg sonicated phospholipid mixture phosphatidylethanolamine phosphatidylserine phosphatidylcholine ergosterol 5212 molar ratio 1 sodium cholate
0.43087202.9530112.html.plaintext.txt	75	40 min incubation ice mixture dialyzed 4 degrees c 24 h 15 mm hepes 0
0.43087202.9530112.html.plaintext.txt	76	dialysis continued daily changes buffer additional 3 days buffer without sodium cholate
0.43087202.9530112.html.plaintext.txt	77	sample dialyzed 15 mm hepes 0
0.43087202.9530112.html.plaintext.txt	78	5 mm egta 150 mm sodium isethionate ph 7
0.43087202.9530112.html.plaintext.txt	79	resulting proteoliposomes quickly frozen 80 degrees c thawed sonicated 5 bath sonicator lab supplies hicksville ny
0.43087202.9530112.html.plaintext.txt	80	cases reconstitution cftr containing proteoliposomes conducted without freezing thawing avoid potential denaturing protein
0.43087202.9530112.html.plaintext.txt	81	purified cftr either transfected sf9 cho cells reconstituted lipid bilayer reconstitution system previously used assess cftr mediated cl channel activity 3 14
0.43087202.9530112.html.plaintext.txt	82	reconstituted protein either fused lipid bilayer reconstitution proteoliposomes techniques previously described 3 14 applied directly lipid bilayer elution sephadex g 50 fine column remove denaturing sds
0.43087202.9530112.html.plaintext.txt	83	reconstitution cftr conditions conducted follows
0.43087202.9530112.html.plaintext.txt	84	glass rod used painting lipid bilayer dipped consecutively cftr containing eluent lipid mixture used forming bilayer
0.43087202.9530112.html.plaintext.txt	85	cftr containing mixture used break repaint lipid bilayer
0.43087202.9530112.html.plaintext.txt	86	test lack detergent contamination potential source spurious ion channel activity equivalent samples sds also eluted sephadex g 50 column andor incorporated bilayer indicated
0.43087202.9530112.html.plaintext.txt	87	none eluate sds fractions tested showed nonspecific leak conductance either absence presence pka
0.43087202.9530112.html.plaintext.txt	88	thus reconstituted cftr channel activity correlated presence protein either contaminant sds protein degradation products eluted protein
0.43087202.9530112.html.plaintext.txt	89	experiments also conducted membrane preparations cftr expressing wt1 cells 22 data shown
0.43087202.9530112.html.plaintext.txt	90	either proteoliposomes containing purified cftr cftr mixed lipid components fused planar lipid bilayers painting onto 0
0.43087202.9530112.html.plaintext.txt	91	1 mm hole 13 mm polystyrene cuvette warner instrument hamden ct described alvarez 2
0.43087202.9530112.html.plaintext.txt	92	phospholipid composition lipid bilayers 1 palmitoyl 2 oleyl sn glycero 3 phosphoethanolamine 1 palmitoyl 2 oleyl sn glycero 3 phosphocholine oleyl sn glycero 3 phosphatidylserine 721 volvolvol avanti polar lipids alabaster al n decane aldrich chemical milwaukee wi final concentration 14 6 0
0.43087202.9530112.html.plaintext.txt	93	cftr eluted sephadex g 50 fine collected final concentration 1
0.43087202.9530112.html.plaintext.txt	94	initial cis trans solutions usually contained respectively 10 mm 3 n morpholinopropanesulfonic acid mops 20 microm cacl2 ph 7
0.43087202.9530112.html.plaintext.txt	95	however solutions varied different experiments indicated
0.43087202.9530112.html.plaintext.txt	96	single channel recordings purified cftr
0.43087202.9530112.html.plaintext.txt	97	input signals acquired pc 501a patchwhole cell clamp amplifier via 10 g head stage lipid bilayers warner instrument
0.43087202.9530112.html.plaintext.txt	98	output currents low pass filtered 500 hz eight pole bessel filter frequency devices haverhill ma digitized 37 khz 14 bits vr 10b digital data recorder instrutech great neck ny stored videocassette recorder jvc fairfield nj analysis pclamp 6
0.43087202.9530112.html.plaintext.txt	99	3 axon instruments foster city ca
0.43087202.9530112.html.plaintext.txt	100	single channel tracings gaussian filtered 100 200 hz display purposes analyzed per patch clamp protocols
0.43087202.9530112.html.plaintext.txt	101	unless otherwise stated values n given text numbers individual current measurements necessarily reflect numbers experiments analyzed
0.43087202.9530112.html.plaintext.txt	102	calculation perm selectivity ratio asymmetrical atpcl conditions
0.43087202.9530112.html.plaintext.txt	103	calculate atp cl perm selectivity ratio patppcl asymmetrical conditions atpcl single channel conductances current divided holding potential vh best fitted goldman hodgkin katz ghk equation species trans compartment j species cis compartment represent cl atp depending locations either side membrane vh mv zi zj charges species j respectively ci cj concentrations j respectively
0.43087202.9530112.html.plaintext.txt	104	pi pj represent permeability coefficients species j respectively zifvhrt zjfvhrt f r faradays constant gas constant absolute temperature respectively
0.43087202.9530112.html.plaintext.txt	105	cases mgatp used fitted z 2 tris atp used instead fitted z 4
0.43087202.9530112.html.plaintext.txt	106	atp salts mgatp tris atp sigma added stock solutions 100 mm distilled water
0.43087202.9530112.html.plaintext.txt	107	catalytic subunit adenosine 35 cyclic monophosphate camp dependent protein kinase pka sigma used final concentrations ranging 75 252 nm
0.43087202.9530112.html.plaintext.txt	108	cl channel blocker dpc fluka chemical ronkonkoma ny kept 100 fold stock solution 20 mm 50 water ethanol
0.43087202.9530112.html.plaintext.txt	109	44 diisothiocyanostilbene 22 disulfonic acid sigma glibenclamide rbi natick ma kept 10 mm stock solutions 100 dimethyl sulfoxide
0.43087202.9530112.html.plaintext.txt	110	mab raised amino acids 729 736 regulatory domain r domain cftr mab 13 1 genzyme directly diluted 1100 intracellular bathing solution stock solution 292 microgml
0.43087202.9530112.html.plaintext.txt	111	inactive antibody obtained preheating cftr antibody 30 min 100 degrees c
0.43087202.9530112.html.plaintext.txt	112	results top abstract introduction materials methods results discussion references
0.43087202.9530112.html.plaintext.txt	113	cl atp currents highly purified human epithelial cftr
0.43087202.9530112.html.plaintext.txt	114	assess role cftr electrodiffusional atp transfer human epithelial cftr expressed purified either sf9 insect mammalian cho cells 14 functionally reconstituted lipid bilayer system measure ion channel activity reported previously 3 14
0.43087202.9530112.html.plaintext.txt	115	summarized data various experimental conditions preparations used shown table 1
0.43087202.9530112.html.plaintext.txt	116	purified material either cho data shown sf9 cells fig
0.43087202.9530112.html.plaintext.txt	117	1 14 reconstituted chamber containing either 50 mm kcl 100 mm mgatp data shown 75 mm mgcl2 100 mm tris atp fig
0.43087202.9530112.html.plaintext.txt	118	2a cis trans compartments respectively
0.43087202.9530112.html.plaintext.txt	119	compartments contained 10 mm mops ph 7
0.43087202.9530112.html.plaintext.txt	120	4 cis compartment also contained 200 nm pka
0.43087202.9530112.html.plaintext.txt	121	eight nine experiments kclmgatp seven nine experiments mgcl2tris atp displayed anion selective channel activity pka addition cis side chamber
0.43087202.9530112.html.plaintext.txt	122	latter conditions currents observed directions fig
0.43087202.9530112.html.plaintext.txt	123	2a least two distinct discernible single channel conductances 8
0.43087202.9530112.html.plaintext.txt	124	32 ps n 7 respectively fig
0.43087202.9530112.html.plaintext.txt	125	reversal potentials er 2
0.43087202.9530112.html.plaintext.txt	126	29 mv n 7 thus consistent patpp cl 0
0.43087202.9530112.html.plaintext.txt	127	2 smaller larger conductances respectively
0.43087202.9530112.html.plaintext.txt	128	values close agreement patppcl values previously obtained whole cell single channel currents cftr expressing cells calculated respective conductances symmetrical concentrations two ions range 0
0.43087202.9530112.html.plaintext.txt	129	indication cftr molecule may implicated atp transport suggested observation addition active heat inactivated anti cftr r domain antibody 13 1 genzyme inhibited simultaneously almost completely cl atp currents highly purified cftr fig
0.43087202.9530112.html.plaintext.txt	130	2c five five experiments tested
0.43087202.9530112.html.plaintext.txt	131	data suggest cftr incorporation lipid reconstitution chamber indeed functional oriented expected pka activation sites cis side membrane
0.43087202.9530112.html.plaintext.txt	132	view table table 1
0.43087202.9530112.html.plaintext.txt	133	observation channel activity various cftr preparations
0.43087202.9530112.html.plaintext.txt	134	view larger version 58k fig
0.43087202.9530112.html.plaintext.txt	135	purity cystic fibrosis transmembrane conductance regulator cftr reconstituted preparations
0.43087202.9530112.html.plaintext.txt	136	purified cftr material sf9 cells obtained indicated materials methods used reconstitution studies subjected silver staining following electrophoresis 4 20 gradient sds polyacrylamide gel
0.43087202.9530112.html.plaintext.txt	137	dye front preserved retain low molecular mass proteins
0.43087202.9530112.html.plaintext.txt	138	presence band complex running 140 kda observed 0
0.43087202.9530112.html.plaintext.txt	139	3 microg lane 2 purified cftr
0.43087202.9530112.html.plaintext.txt	140	close agreement previously reported data 14
0.43087202.9530112.html.plaintext.txt	141	left lane molecular mass markers
0.43087202.9530112.html.plaintext.txt	142	b immunolabeling cftr conducted monoclonal antibody mab 13 1 cftr either purified material sf9 cells membranes either subconfluent fully confluent cftr expressing wt1 cells
0.43087202.9530112.html.plaintext.txt	143	top arrow indicates fully mature
0.43087202.9530112.html.plaintext.txt	144	lower arrow indicates nonglycosylated cftr
0.43087202.9530112.html.plaintext.txt	145	higher molecular mass cftr complexes also observed sf9 material
0.43087202.9530112.html.plaintext.txt	146	view larger version 42k fig
0.43087202.9530112.html.plaintext.txt	147	cl atp currents purified human epithelial cftr
0.43087202.9530112.html.plaintext.txt	148	purified cftr reconstituted lipid bilayer chamber containing 10 mm mops ph 7
0.43087202.9530112.html.plaintext.txt	149	0 mm mgatp 75 mm mgcl2 cis side chamber trans side contained 100 mm tris atp buffer composition
0.43087202.9530112.html.plaintext.txt	150	cftr always incorporated cis chamber also contained protein kinase pka 200 nm
0.43087202.9530112.html.plaintext.txt	151	holding potentials vh indicated top right tracing driven trans chamber
0.43087202.9530112.html.plaintext.txt	152	b current voltage v relationships common conductance states channels observed presence 75 mm mgcl2 100 mm tris atp
0.43087202.9530112.html.plaintext.txt	153	cl atp readily permeable conditions
0.43087202.9530112.html.plaintext.txt	154	solid lines best fits experimental points using goldman hodgkin katz ghk equation
0.43087202.9530112.html.plaintext.txt	155	dashed lines linear fits experimental data slopes single channel conductances calculated see table 2
0.43087202.9530112.html.plaintext.txt	156	smaller conductance represented 25 larger one thus least four levels could recognized particular 40 mv
0.43087202.9530112.html.plaintext.txt	157	c cl positive potentials left atp currents negative potentials right inhibited addition cis side monoclonal antibody mab 13 1 regulatory domain human epithelial cftr
0.43087202.9530112.html.plaintext.txt	158	antibody addition open probability single channels changed 0
0.43087202.9530112.html.plaintext.txt	159	5 positive potentials left 0
0.43087202.9530112.html.plaintext.txt	160	02 negative potentials right
0.43087202.9530112.html.plaintext.txt	161	histograms beside tracings indicate increment frequency closed state indicated c arrow antibody addition
0.43087202.9530112.html.plaintext.txt	162	channels observed displayed characteristics remarkably similar previously published data showing cftr associated channel activity cell attached conditions 9
0.43087202.9530112.html.plaintext.txt	163	single channel currents seemed correspond simultaneous gating smaller conductance states channel case four fig
0.43087202.9530112.html.plaintext.txt	164	subconductance states atp currents purified human epithelial cftr observed 3 3 experiments indicated currents driven 100 mm tris atp
0.43087202.9530112.html.plaintext.txt	165	least four identical current levels could recognized although channel gated complex four levels
0.43087202.9530112.html.plaintext.txt	166	expanded tracings indicated channel levels crept fig
0.43087202.9530112.html.plaintext.txt	167	3b seemingly even smaller channel currents indicated third tracing consistent conductance 4
0.43087202.9530112.html.plaintext.txt	168	view larger version 34k fig
0.43087202.9530112.html.plaintext.txt	169	subconductance states atp currents purified human epithelial cftr
0.43087202.9530112.html.plaintext.txt	170	purified cftr reconstituted lipid bilayer chamber containing 10 mm mops ph 7
0.43087202.9530112.html.plaintext.txt	171	0 mm mgatp 75 mm mgcl2 cis side chamber trans side contained 100 mm tris atp buffer composition
0.43087202.9530112.html.plaintext.txt	172	cftr always incorporated cis chamber also contained pka 200 nm
0.43087202.9530112.html.plaintext.txt	173	vh 40 mv thus indicating atp currents
0.43087202.9530112.html.plaintext.txt	174	least 4 identical current levels could recognized although channel gated complex 4 levels
0.43087202.9530112.html.plaintext.txt	175	b expanded tracing indicated solid bar
0.43087202.9530112.html.plaintext.txt	176	channel levels crept asterisks seemingly even smaller channel currents indicated third tracing consistent conductance 4
0.43087202.9530112.html.plaintext.txt	177	data representative 3 experiments
0.43087202.9530112.html.plaintext.txt	178	effect low atp cl conductance purified cftr
0.43087202.9530112.html.plaintext.txt	179	determine role cl single channel permeability atp experiments also conducted presence low cis 5 10 mm mgatp high n methyl d glucamine chloride 300 mm trans compartment fig
0.43087202.9530112.html.plaintext.txt	180	compartments also contained 10 mm mops ph 7
0.43087202.9530112.html.plaintext.txt	181	4 cis compartment contained 200 nm pka
0.43087202.9530112.html.plaintext.txt	182	ion channel activity observed unitary conductances 22
0.43087202.9530112.html.plaintext.txt	183	interestingly ion channel activity also observed positive potentials indicating sizable permeability 10 mm mgatp identical results obtained either absence cis mops replacement hepes
0.43087202.9530112.html.plaintext.txt	184	er values two channel conductances highly similar 15
0.43087202.9530112.html.plaintext.txt	185	3 indicating patppcl order 9
0.43087202.9530112.html.plaintext.txt	186	9 obtained fitting data ghk equation fig
0.43087202.9530112.html.plaintext.txt	187	similar conditions higher conductance state cftr 511 plus minus 58
0.43087202.9530112.html.plaintext.txt	188	1 ps n 7 also observed albeit rarely similar er patppcl 15
0.43087202.9530112.html.plaintext.txt	189	presence 300 mm cis cl 6 mm trans mgatp ionic gradients thus reversed single channel conductance purified cftr 26
0.43087202.9530112.html.plaintext.txt	190	50 ps n 16 er 16
0.43087202.9530112.html.plaintext.txt	191	98 mv n 16 patppcl 17
0.43087202.9530112.html.plaintext.txt	192	data suggest cftr may highly sensitive external atp phenomenon require examination
0.43087202.9530112.html.plaintext.txt	193	view larger version 22k fig
0.43087202.9530112.html.plaintext.txt	194	electrodiffusional cl atp movement purified cftr
0.43087202.9530112.html.plaintext.txt	195	purified cftr incorporated cis chamber reconstituted lipid bilayer chamber containing cis side 10 mm mops ph 7
0.43087202.9530112.html.plaintext.txt	196	4 10 mm mgatp 75 nm pka trans side chamber contained 300 mm n methyl d glucamine chloride nmgcl buffer composition
0.43087202.9530112.html.plaintext.txt	197	vh driven trans chamber kept 150 mv channel activation evident
0.43087202.9530112.html.plaintext.txt	198	tracing representative cl channel activity observed 29 52 experiments
0.43087202.9530112.html.plaintext.txt	199	b v relationship 2 common conductance states channel
0.43087202.9530112.html.plaintext.txt	200	solid lines fits experimental values n 4 different experiments goldman hodgkin katz equation
0.43087202.9530112.html.plaintext.txt	201	dashed lines best linear fits experimental data
0.43087202.9530112.html.plaintext.txt	202	atp channel activity absence cl
0.43087202.9530112.html.plaintext.txt	203	single atp channel activity cftr also determined complete absence cl fig
0.43087202.9530112.html.plaintext.txt	204	cis 10 mm mgatp trans 100 mm mgatp similar buffer conditions atp channel currents observed fig
0.43087202.9530112.html.plaintext.txt	205	5 b single channel conductance 32
0.43087202.9530112.html.plaintext.txt	206	addition cis cl however reduced conductance atp channel currents fig
0.43087202.9530112.html.plaintext.txt	207	occasionally channel conductance 235 plus minus 40
0.43087202.9530112.html.plaintext.txt	208	4 mv n 5 statistically different theoretical er mgatp2 rtzf lnatpcisatptrans 29
0.43087202.9530112.html.plaintext.txt	209	1 mv atpcis atptrans cis trans concentrations atp respectively see fig
0.43087202.9530112.html.plaintext.txt	210	thus possible either atp4 theoretical er 14 mv makes contribution ionic conductance cftr presence mgatp cftr also permeable mg2
0.43087202.9530112.html.plaintext.txt	211	either case cftr preparation permeable atp determined replacing atp salts
0.43087202.9530112.html.plaintext.txt	212	presence trans 100 mm tris atp cis 10 mm mgatp single atp channel conductance 38
0.43087202.9530112.html.plaintext.txt	213	1 ps n 13 similar seen presence mgatp
0.43087202.9530112.html.plaintext.txt	214	er shifted however 52
0.43087202.9530112.html.plaintext.txt	215	0 mv n 13 consistent strong difference permeabilities free mg2 complexed atp
0.43087202.9530112.html.plaintext.txt	216	findings indicate although cftr capable cl permeation ability preferentially move cl atp may depend driving force intracellular nucleotide atp also atp species patppcl intracellular cl concentration
0.43087202.9530112.html.plaintext.txt	217	physiological intracellular conditions 5 mm atp 30 mm cl atp transport may favored however electrochemical gradient multivalent atp 1000 fold higher cl 18 22
0.43087202.9530112.html.plaintext.txt	218	view larger version 28k fig
0.43087202.9530112.html.plaintext.txt	219	electrodiffusional atp movement purified cftr absence cl
0.43087202.9530112.html.plaintext.txt	220	purified cftr incorporated cis chamber reconstituted lipid bilayer chamber containing cis side 10 mm mops ph 7
0.43087202.9530112.html.plaintext.txt	221	4 10 mm mgatp 75 nm pka trans side 100 mm mgatp buffer composition
0.43087202.9530112.html.plaintext.txt	222	vh driven trans chamber kept 150 mv channel activation evident
0.43087202.9530112.html.plaintext.txt	223	channel activity also present positive vh thus indicating atp currents 10 mm mgatp
0.43087202.9530112.html.plaintext.txt	224	tracing bottom left shows expansion segment marked bold line tracing top
0.43087202.9530112.html.plaintext.txt	225	histogram bottom right corresponds expanded section
0.43087202.9530112.html.plaintext.txt	226	tracings representative 16 25 experiments
0.43087202.9530112.html.plaintext.txt	227	b purified cftr single atp channels often displayed subconductance states compare b middle bottom
0.43087202.9530112.html.plaintext.txt	228	ndiv indicates number 128 sample point bins per division
0.43087202.9530112.html.plaintext.txt	229	c top left v relationships single channel currents asymmetrical mgatp
0.43087202.9530112.html.plaintext.txt	230	two distinct main conductance states observed condition
0.43087202.9530112.html.plaintext.txt	231	solid lines fits experimental data ghk equation
0.43087202.9530112.html.plaintext.txt	232	dashed lines best linear fits experimental points slopes indicated
0.43087202.9530112.html.plaintext.txt	233	c top right replacement trans mgatp equimolar concentration tris atp shifted er value single channel conductance indicating free mg2 complexed atp may different permeabilities 7 7 experiments
0.43087202.9530112.html.plaintext.txt	234	c bottom v relationship expansion c top left clearly indicate predicted er z 2 right z 3 middle z 4 left obtained fitting ghk equation experimental data using asymmetrical mgatp 10 vs
0.43087202.9530112.html.plaintext.txt	235	100 mm larger 235 ps smaller 32
0.43087202.9530112.html.plaintext.txt	236	d presence 10 mm cis mgatp 100 mm trans mgatp addition cis nmgcl 50 mm reduced single channel currents
0.43087202.9530112.html.plaintext.txt	237	change shown 2 channels top middle whose main conductance state defined current amplitude channel closed bottom
0.43087202.9530112.html.plaintext.txt	238	single channel opening bottom left decreased main conductance state 25 ps 11
0.43087202.9530112.html.plaintext.txt	239	7 ps bottom right b addition cis cl
0.43087202.9530112.html.plaintext.txt	240	data representative 2 experiments
0.43087202.9530112.html.plaintext.txt	241	discussion top abstract introduction materials methods results discussion references
0.43087202.9530112.html.plaintext.txt	242	expression cftr recently associated otherwise unapparent permeation atp
0.43087202.9530112.html.plaintext.txt	243	phenomenon observed camp induced release atp cftr expressing cells physiological conditions 18 well electrophysiological studies highly nonphysiological conditions 22 determined nevertheless channellike nature pka induced atp movement single molecule level 17 22 23
0.43087202.9530112.html.plaintext.txt	244	agreement observation camp activation associated extrusion atp wild type 18 508 cftr expressing cells 8
0.43087202.9530112.html.plaintext.txt	245	molecular steps associated atp movement cftr expressing cells however unequivocally determined
0.43087202.9530112.html.plaintext.txt	246	although simplest possible explanation findings implicate cftr channel responsible atp permeable pathway direct evidence support claim still lacking
0.43087202.9530112.html.plaintext.txt	247	atp permeable channels cftr expressing cells may reflection endogenous functional channel proteins regulated distinct cftr
0.43087202.9530112.html.plaintext.txt	248	example expression mammalian 1 drosophila melanogaster 5 p glycoproteins cftr congeners atp binding cassette abc family transport proteins associated expression atp channel activity thus raising possibility transport proteins cftr present certain preparations
0.43087202.9530112.html.plaintext.txt	249	least one recent report demonstrated osmotically stimulated electrodiffusional atp movement human hepatoma cells seemingly devoid cftr 28
0.43087202.9530112.html.plaintext.txt	250	direct role cftr atp movement also questioned recent reports failed detect atp permeable channel activity cells preparations containing cftr 13 21
0.43087202.9530112.html.plaintext.txt	251	however studies also failed detect atp channel activity inconsistent atp release associated cftr expression 18 23
0.43087202.9530112.html.plaintext.txt	252	raises possibility presence putative atp permeable pathways cftr expressing preparations may largely depend cellular tissue model study andor nature atp complexes driven
0.43087202.9530112.html.plaintext.txt	253	alternate possibilities however may also entail critical experimental conditions determining atp movement previously expected
0.43087202.9530112.html.plaintext.txt	254	previous study failed detect atp release cftr expressing cells 27 example may simply failed meet technological parameters suitable detecting expected amounts atp released extracellular milieu 18
0.43087202.9530112.html.plaintext.txt	255	furthermore possibility certain conditions electroneutral atp complexes driven channel structures cannot yet ruled
0.43087202.9530112.html.plaintext.txt	256	report revisited question whether cftr responsible atp movement
0.43087202.9530112.html.plaintext.txt	257	reconstituted cftr displayed atp channel activity either absence presence cl
0.43087202.9530112.html.plaintext.txt	258	several including large conductance states also observed see summary results table 2 agreement original vivo observations 9 22
0.43087202.9530112.html.plaintext.txt	259	studies 5 ps 50 ps atp channel observed
0.43087202.9530112.html.plaintext.txt	260	least two groups observed single channel atp currents associated cftr expression similar low 5 ps conductance 16 17 23
0.43087202.9530112.html.plaintext.txt	261	issue single atp channel conductance cftr may confounded observation cl atp modify others movement thus changing single channel conductance ions either direction 22
0.43087202.9530112.html.plaintext.txt	262	presence extracellular 100 mm mgatp 140 mm intracellular cl single atp channel conductances rectified limiting conductance 24
0.43087202.9530112.html.plaintext.txt	263	22 different observed single channel conductance either ion alone 22
0.43087202.9530112.html.plaintext.txt	264	furthermore recent study also detected cl channel rectification cftr striking departure established paradigm cftr behavior 15
0.43087202.9530112.html.plaintext.txt	265	report also summarizes previous data literature indicating single channel conductances 7 13 ps previously attributed cftr ref
0.43087202.9530112.html.plaintext.txt	266	view table table 2
0.43087202.9530112.html.plaintext.txt	267	frequent single channel conductances
0.43087202.9530112.html.plaintext.txt	268	present report addition cis cl n methyl d glucamine chloride 50 mm presence 10 mm mgatp reduced cftr single channel conductance 25 11
0.43087202.9530112.html.plaintext.txt	269	5d condition similar previously reported values cftr associated cl movement 13
0.43087202.9530112.html.plaintext.txt	270	finding suggests cl atp may compete conductance pore channel originally reported intact cells 22
0.43087202.9530112.html.plaintext.txt	271	reconstituted cftr atp channel activity readily inhibited anti r domain cftr antibody mab 13 1 genzyme agreement previous reports intact cells 19
0.43087202.9530112.html.plaintext.txt	272	possibility functional cftr required regulate atp channels cftr however cannot easily ruled since indicated recent studies failed detect atp permeable channel activity preparations containing cftr 13 21
0.43087202.9530112.html.plaintext.txt	273	least one study conducted purified cftr preparation similar one presented report 13
0.43087202.9530112.html.plaintext.txt	274	thus likely possibility activated cftr indeed permeable cl may behave atp selective ion channel certain circumstances see
0.43087202.9530112.html.plaintext.txt	275	also noted reports exactly mimic present previous studies
0.43087202.9530112.html.plaintext.txt	276	found pka activation cftr example readily observed 15 18 experiments experiments tested daily fresh batches pka
0.43087202.9530112.html.plaintext.txt	277	however certain experimental conditions namely use older pka prepared 24 h experiments cftr activation cl free conditions also required presence sustained holding potentials 100 150 mv 41 82 experiments
0.43087202.9530112.html.plaintext.txt	278	finding may actually explain previous failed attempts obtain single atp channel currents reconstituted cftr pka absent 21 suggests possibility adjacent structures cftr may also required proper channel activation vivo 19
0.43087202.9530112.html.plaintext.txt	279	although reason required voltage activation cftr presence pka yet unknown unprecedented atp transport abc transporters
0.43087202.9530112.html.plaintext.txt	280	concerning electrodiffusional atp movement murine mdr1 gene product p glycoprotein 1 example observed double mutation channel protein either nucleotide binding domain rendered mutated p glycoprotein completely unable spontaneously release cellular atp
0.43087202.9530112.html.plaintext.txt	281	however voltage activation reestablished atp transport interestingly cl channel activity associated protein well 1
0.43087202.9530112.html.plaintext.txt	282	similar findings also recently observed d
0.43087202.9530112.html.plaintext.txt	283	melanogaster mdr gene products mdr65 mdr49 p glycoprotein homologues also voltage activated 5
0.43087202.9530112.html.plaintext.txt	284	although unlikely activation process physiological significance raises interesting possibility relevant intracellular factors absent purified cftr preparation may required proper pka activation cftr
0.43087202.9530112.html.plaintext.txt	285	circumstances however voltage stimulation induce atp permeable channel activity absence pka
0.43087202.9530112.html.plaintext.txt	286	present data also dispel common misconception size atp transported channel molecule
0.43087202.9530112.html.plaintext.txt	287	solution atp takes various conformations interacting counterions mg2 11
0.43087202.9530112.html.plaintext.txt	288	however one conformation observed mgatp2 complex relevant moiety associated molecules bind andor hydrolyze atp 4 11
0.43087202.9530112.html.plaintext.txt	289	average planar diameter mgatp complex conditions 5 see fig
0.43087202.9530112.html.plaintext.txt	290	6 least similar smaller expected diameter cftr permeable anion details see fig
0.43087202.9530112.html.plaintext.txt	291	thus atp size constraint movement cftr provided either free complexed mg2
0.43087202.9530112.html.plaintext.txt	292	counterion atp complexes larger sizes however may reflect different interactions cftr
0.43087202.9530112.html.plaintext.txt	293	recent paper 13 reporting purified cftr tested failed detect atp transport suggested k2atp salt used study actually blocked cl movement cftr
0.43087202.9530112.html.plaintext.txt	294	k almost nine times larger mg2 larger k2atp moiety likely blocking agent cftr channel activity
0.43087202.9530112.html.plaintext.txt	295	agreement expected undetectable 0
0.43087202.9530112.html.plaintext.txt	296	14 ps k2atp single channel conductance assuming monovalent salt minimum size calculated extrapolating single channel conductance 26
0.43087202.9530112.html.plaintext.txt	297	2 ps obtained present study function counterionic radius mgatp complex
0.43087202.9530112.html.plaintext.txt	298	view larger version 35k fig
0.43087202.9530112.html.plaintext.txt	299	models free mg2 complexed atp
0.43087202.9530112.html.plaintext.txt	300	scaled color models mg2 complexed atp mgatp2 b d free atp c created chem3dpro molecular modeling system version 3
0.43087202.9530112.html.plaintext.txt	301	0 1990 cambridge scientific computing cambridge ma
0.43087202.9530112.html.plaintext.txt	302	c atoms solid purple o atoms solid red p atoms striped red h atoms light blue
0.43087202.9530112.html.plaintext.txt	303	mg atom indicated green striped ball bottom left center b extreme left d
0.43087202.9530112.html.plaintext.txt	304	b show phosphate groups covered respective oxygen atoms left molecule
0.43087202.9530112.html.plaintext.txt	305	c d 3 dimensional perspectives indicating pyridine ring toward front molecule
0.43087202.9530112.html.plaintext.txt	306	molecule either model largely oblong
0.43087202.9530112.html.plaintext.txt	307	shorter diameter drawn steric distance n1 n3 pyridine ring 2
0.43087202.9530112.html.plaintext.txt	308	46 longer diameter drawn c2 p17 5
0.43087202.9530112.html.plaintext.txt	309	thus phosphates encircle adenine moiety using ribose hinge position coordinated nucleoside also surrounding oxygens
0.43087202.9530112.html.plaintext.txt	310	comparison n1 n3 distance mgatp2 found identical free atp
0.43087202.9530112.html.plaintext.txt	311	however arrangement phosphates surrounding adenine moiety completely different distance c4 o25 0
0.43087202.9530112.html.plaintext.txt	312	addition distance c2 p17 5
0.43087202.9530112.html.plaintext.txt	313	18 c2 p18 mgatp2 thus suggesting although models similar diameters mgatp seems longer free atp
0.43087202.9530112.html.plaintext.txt	314	structures minimized structural errors minimal energy conformations
0.43087202.9530112.html.plaintext.txt	315	furthermore also important realize ether bonds either model computed 1
0.43087202.9530112.html.plaintext.txt	316	0 despite fact bond orders high energy phosphates significantly shorter order 0
0.43087202.9530112.html.plaintext.txt	317	41 thus suggesting much smaller 3 dimensional structures 20
0.43087202.9530112.html.plaintext.txt	318	model free atp however almost identical although without structural minimization stryers biochemistry ref
0.43087202.9530112.html.plaintext.txt	319	329 although possible conformations mgatp2 ref
0.43087202.9530112.html.plaintext.txt	320	352 explored molecules
0.43087202.9530112.html.plaintext.txt	321	reconstituted cftr mediated electrodiffusional movement cl atp displayed several conductance states may related clustering cftr complexes perm selectivity properties
0.43087202.9530112.html.plaintext.txt	322	ion seems modify permeability properties may due either competition one another conductance pore channel possibility ions distinct mutually interactive permeable pathways
0.43087202.9530112.html.plaintext.txt	323	phenomenon require investigation
0.43087202.9530112.html.plaintext.txt	324	interestingly however cis concentration cl trans concentration atp modified single channel conductance cftr
0.43087202.9530112.html.plaintext.txt	325	conclusion present data consistent likely exclusive possibility cftr permeates atp
0.43087202.9530112.html.plaintext.txt	326	close agreement previous reports indicating wild type cftr 9 17 22 23 508 cftr 8 may involved atp movement vivo
0.43087202.9530112.html.plaintext.txt	327	contaminant channels permeable atp distinct cftr cannot ruled although finding preparations different degrees purification cftr including purified protein show functional characteristics similar identical observed vivo strongly suggest direct role channel protein atp movement
0.43087202.9530112.html.plaintext.txt	328	additional studies including mutational analysis channel protein required however assess relevance cftr mediated atp transport context cl vs
0.43087202.9530112.html.plaintext.txt	329	atp transport importantly onset reversal cf phenotype
0.43087202.9530112.html.plaintext.txt	330	yi wang assistance analysis structural models atp
0.43087202.9530112.html.plaintext.txt	331	address reprint requests h
0.43087202.9530112.html.plaintext.txt	332	cantiello renal unit massachusetts general hospital east 149 13th st
0.43087202.9530112.html.plaintext.txt	333	received 16 may 1997 accepted final form 26 november 1997
0.43087202.9530112.html.plaintext.txt	334	references top abstract introduction materials methods results discussion references
0.43087202.9530112.html.plaintext.txt	335	multidrug resistance mdr1 gene product functions atp channel
0.43087202.9530112.html.plaintext.txt	336	usa 90 312 316 1993abstract
0.43087202.9530112.html.plaintext.txt	337	set bilayer system
0.43087202.9530112.html.plaintext.txt	338	ion channel reconstitution edited c
0.43087202.9530112.html.plaintext.txt	339	purification functional reconstitution cystic fibrosis transmembrane conductance regulator cftr
0.43087202.9530112.html.plaintext.txt	340	cell 68 809 818 1992medline
0.43087202.9530112.html.plaintext.txt	341	closed conformation highly flexible protein structure e
0.43087202.9530112.html.plaintext.txt	342	coli adenylate kinase bound amp amppnp
0.43087202.9530112.html.plaintext.txt	343	proteins 19 183 198 1994medline
0.43087202.9530112.html.plaintext.txt	344	expression drosophila melanogaster p glycoproteins associated atp channel activity
0.43087202.9530112.html.plaintext.txt	345	40 c1527 c1538 1996abstractfree full text
0.43087202.9530112.html.plaintext.txt	346	evidence reduced cl increased na permeability cystic fibrosis human primary cell cultures
0.43087202.9530112.html.plaintext.txt	347	unified theory cystic fibrosis lung disease
0.43087202.9530112.html.plaintext.txt	348	cystic fibrosis horizons edited d
0.43087202.9530112.html.plaintext.txt	349	nucleotide transport cystic fibrosis transmembrane conductance regulator
0.43087202.9530112.html.plaintext.txt	350	external atp activates cystic fibrosis transmembrane conductance regulator
0.43087202.9530112.html.plaintext.txt	351	269 11224 11232 1994abstractfree full text
0.43087202.9530112.html.plaintext.txt	352	pathological regulation arachidonic acid release cystic fibrosis putative basic defect
0.43087202.9530112.html.plaintext.txt	353	usa 83 9202 9206 1986abstract
0.43087202.9530112.html.plaintext.txt	354	structural chemical properties atp metal complexes solution
0.43087202.9530112.html.plaintext.txt	355	biological actions extracellular atp edited g
0.43087202.9530112.html.plaintext.txt	356	defective regulation outwardly rectifying cl channels protein kinase corrected insertion cftr
0.43087202.9530112.html.plaintext.txt	357	nature 358 531 536 1992medline
0.43087202.9530112.html.plaintext.txt	358	purified cystic fibrosis transmembrane conductance regulator cftr function atp channel
0.43087202.9530112.html.plaintext.txt	359	271 11623 11626 1996abstractfree full text
0.43087202.9530112.html.plaintext.txt	360	purification characterization recombinant cystic fibrosis transmembrane conductance regulator chinese hamster ovary insect cells
0.43087202.9530112.html.plaintext.txt	361	270 17033 17043 1995abstractfree full text
0.43087202.9530112.html.plaintext.txt	362	rectification whole cell cystic fibrosis transmembrane conductance regulator chloride current
0.43087202.9530112.html.plaintext.txt	363	37 c636 c646 1995abstractfree full text
0.43087202.9530112.html.plaintext.txt	364	mutant delta f508 cystic fibrosis transmembrane conductance regulator cl channel functional retained endoplasmic reticulum mammalian cells
0.43087202.9530112.html.plaintext.txt	365	270 12347 12350 1995abstractfree full text
0.43087202.9530112.html.plaintext.txt	366	cystic fibrosis transmembrane conductance regulator associated atp adenosine 3 phosphate 5 phosphosulfate channels endoplasmic reticulum plasma membranes
0.43087202.9530112.html.plaintext.txt	367	272 7746 7751 1997abstractfree full text
0.43087202.9530112.html.plaintext.txt	368	cellular atp release cystic fibrosis transmembrane conductance regulator
0.43087202.9530112.html.plaintext.txt	369	39 c538 c545 1996abstractfree full text
0.43087202.9530112.html.plaintext.txt	370	camp independent regulation cftr actin cytoskeleton
0.43087202.9530112.html.plaintext.txt	371	37 c1552 c1561 1995abstractfree full text
0.43087202.9530112.html.plaintext.txt	372	new york interscience 1963 p
0.43087202.9530112.html.plaintext.txt	373	failure cystic fibrosis transmembrane conductance regulator conduct atp
0.43087202.9530112.html.plaintext.txt	374	science 271 1876 1879 1996abstract
0.43087202.9530112.html.plaintext.txt	375	cystic fibrosis transmembrane conductance regulator cftr dual atp chloride channel
0.43087202.9530112.html.plaintext.txt	376	269 20584 20591 1994abstractfree full text
0.43087202.9530112.html.plaintext.txt	377	cftr regulates outwardly rectifying chloride channels autocrine mechanism involving atp
0.43087202.9530112.html.plaintext.txt	378	cell 81 1063 1073 1995medline
0.43087202.9530112.html.plaintext.txt	379	relation defective regulation arachidonic acid release symptoms cystic fibrosis
0.43087202.9530112.html.plaintext.txt	380	cftr camp dependent regulator sodium channels
0.43087202.9530112.html.plaintext.txt	381	science 269 847 850 1995medline
0.43087202.9530112.html.plaintext.txt	382	effect camp intracellular extracellular atp content cl secreting epithelia 3t3 fibroblasts
0.43087202.9530112.html.plaintext.txt	383	269 17853 17857 1994abstractfree full text
0.43087202.9530112.html.plaintext.txt	384	autocrine signaling atp release represents novel mechanism cell volume regulation
0.43087202.9530112.html.plaintext.txt	385	usa 93 12020 12025 1996abstractfree full text
0.43087202.9530112.html.plaintext.txt	386	ajp cell physiol 2743c799 c809 0363 614398 5
0.43087202.9530112.html.plaintext.txt	387	00 copyright 1998 american physiological society
0.5272462.14570915.html.plaintext.txt	0	modulation mature cystic fibrosis transmembrane regulator protein pdz domain protein cal jie cheng hua wang william b
0.5272462.14570915.html.plaintext.txt	1	department physiology johns hopkins university school medicine baltimore maryland 21205
0.5272462.14570915.html.plaintext.txt	2	received publication august 5 2003 revised form october 6 2003
0.5272462.14570915.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references previously identified cystic fibrosis transmembrane regulator cftr interacting protein cal demonstrated cal modulates cftr plasma membrane expression retaining cftr within cell
0.5272462.14570915.html.plaintext.txt	4	report addition regulating membrane expression cal also regulates expression mature cftr
0.5272462.14570915.html.plaintext.txt	5	co expression hemagglutinin tagged myc tagged cal green fluorescent protein gfp cftr cos 7 cells causes dose dependent reduction mature gfp cftr independent tags
0.5272462.14570915.html.plaintext.txt	6	bafilomycin a1 lysosomal proton pump inhibitor increases mature gfp cftr confirming previous reports lysosomal degradation mature cftr
0.5272462.14570915.html.plaintext.txt	7	importantly bafilomycin a1 reverses cal mediated cftr degradation
0.5272462.14570915.html.plaintext.txt	8	proteasome inhibitor mg132 hand reverse effect cal
0.5272462.14570915.html.plaintext.txt	9	cal effect cftr maturation suggesting exerts effects mature cftr
0.5272462.14570915.html.plaintext.txt	10	co expression cal enhances degradation cftr
0.5272462.14570915.html.plaintext.txt	11	showed previously cal reduces half life cftr cell surface
0.5272462.14570915.html.plaintext.txt	12	show expression dominant negative dynamin 2 k44a large gtpase inhibitor known inhibit clathrin mediated endocytosis vesicle formation golgi increases cell surface cftr measured surface biotinylation
0.5272462.14570915.html.plaintext.txt	13	importantly dynamin 2 k44a also restores cell surface cftr cal overexpressing cells partially blocks cal mediated degradation mature cftr
0.5272462.14570915.html.plaintext.txt	14	data suggest model cal retains cftr cell targets cftr degradation
0.5272462.14570915.html.plaintext.txt	15	introduction top abstract introduction experimental procedures results discussion references cystic fibrosis common lethal genetic disease caused autosomal recessive mutations cystic fibrosis transmembrane regulator cftr1 1 2
0.5272462.14570915.html.plaintext.txt	16	best known probably primary defect cystic fibrosis salt water transport plasma membranes epithelial cells lining organs lung pancreas liver intestines sweat duct reproductive systems 3
0.5272462.14570915.html.plaintext.txt	17	cftr membrane protein belongs atp binding cassette transport family
0.5272462.14570915.html.plaintext.txt	18	functions camp dependent protein kinase atp regulated cl channel 4 well regulatory protein epithelial sodium channel 5 channels 6 putative receptor pseudomonas aeruginosa 7
0.5272462.14570915.html.plaintext.txt	19	well characterized functions cftr require correct synthesis maturation trafficking endoplasmic reticulum er golgi cell surface
0.5272462.14570915.html.plaintext.txt	20	misfolded proteins recognized er quality control system targeted degradation er associated degradation 8
0.5272462.14570915.html.plaintext.txt	21	immature wild type cftr folded inefficiently er large fraction degraded reaching plasma membrane 9
0.5272462.14570915.html.plaintext.txt	22	folded efficiently traffics golgi acquires complex glycosylation characteristic mature cftr
0.5272462.14570915.html.plaintext.txt	23	common mutation cf f508cftr misfolded protein recognized er translocated cytosol degraded 26 proteasome 9
0.5272462.14570915.html.plaintext.txt	24	thus predominant majority f508 never matures traffics plasma membrane
0.5272462.14570915.html.plaintext.txt	25	degradation mature cftr less well understood
0.5272462.14570915.html.plaintext.txt	26	10 found lysosome proteasome involved
0.5272462.14570915.html.plaintext.txt	27	found lysosomal inhibitors increase half life mature wild type cftr baby hamster kidney cells transfected cftr endogenous cftr caco 2 t84 cells
0.5272462.14570915.html.plaintext.txt	28	interestingly c terminal truncation mutants traffic lysosome
0.5272462.14570915.html.plaintext.txt	29	instead degraded proteasome 10
0.5272462.14570915.html.plaintext.txt	30	thus cftr appears enter different degradative pathways depending signals within c terminus
0.5272462.14570915.html.plaintext.txt	31	cftr possesses type c terminal pdz psd 95dlgzo 1 binding motif
0.5272462.14570915.html.plaintext.txt	32	several pdz domain proteins known interact cftr include nhe rfebp 50 cap70 cal cftr associated ligand 11 15
0.5272462.14570915.html.plaintext.txt	33	c terminal tail cftr plays potential regulatory role modulating cl channel activity
0.5272462.14570915.html.plaintext.txt	34	adding recombinant nhe rf cap70 fusion proteins cytoplasmic side cftr vitro increases activity cftr 15 16
0.5272462.14570915.html.plaintext.txt	35	addition nhe rf anchors cftr cytoskeleton stabilizing cell surface cftr 13 17
0.5272462.14570915.html.plaintext.txt	36	nhe rf related protein e3karp link camp dependent protein kinase cftr 13 18
0.5272462.14570915.html.plaintext.txt	37	moreover nhe rf shown link 2 adrenergic receptor cftr 19
0.5272462.14570915.html.plaintext.txt	38	formation macromolecular complexes facilitates efficiency activation cftr
0.5272462.14570915.html.plaintext.txt	39	cal also known pist pdz domain protein interacting specifically tc10 gopc golgi associated pdz coiled coil motif containing fig fused glioblastoma 11 20 22 cftr interacting pdz domain protein associates predominantly golgi apparatus
0.5272462.14570915.html.plaintext.txt	40	overexpression cal reduces cftr chloride currents mammalian cells decreasing expression cftr plasma membrane 11
0.5272462.14570915.html.plaintext.txt	41	effect cal overcome nhe rf restores plasma membrane expression cftr
0.5272462.14570915.html.plaintext.txt	42	cal favors retention cftr within cell whereas nhe rf favors surface expression competing cal binding cftr 11
0.5272462.14570915.html.plaintext.txt	43	interestingly overexpression cal also reduces amount cftr 23
0.5272462.14570915.html.plaintext.txt	44	findings point role cal intracellular trafficking cftr
0.5272462.14570915.html.plaintext.txt	45	consistent notion cal interacts proteins involved membrane vesicle trafficking snare protein syntaxin 6 small gtpase tc10 20 22
0.5272462.14570915.html.plaintext.txt	46	furthermore cal also interacts potentially regulates intracellular trafficking wnt receptors frizzled 5 8 neural members epidermal growth factor receptor family calebngc 21 24 chloride channel clc 3b 23
0.5272462.14570915.html.plaintext.txt	47	recently pdz domain interactions found involved trafficking plasma membrane proteins plasma membrane
0.5272462.14570915.html.plaintext.txt	48	example synapse associated protein 102 involved delivery n methyl d aspartate receptors cell surface 25
0.5272462.14570915.html.plaintext.txt	49	addition nhe rf regulates 2 adrenergic receptor recycling plasma membrane 26
0.5272462.14570915.html.plaintext.txt	50	addition pdz domain c tail cftr contains motifs endocytosis
0.5272462.14570915.html.plaintext.txt	51	tyrosine motif c terminus cftr binds directly micro light chain ap2 complex involved sorting cftr endocytosis clathrin coated pits 27
0.5272462.14570915.html.plaintext.txt	52	surface cftr endocytosed rapidly
0.5272462.14570915.html.plaintext.txt	53	example within 5 min 50 cftr plasma membrane endocytosed via ap2 clathrin coated pits
0.5272462.14570915.html.plaintext.txt	54	cftr contained within endosomes either recycled back plasma membrane degraded lysosome
0.5272462.14570915.html.plaintext.txt	55	surface cftr long half life 24 48h majority cftr must recycled back cell surface instead targeted lysosome degradation
0.5272462.14570915.html.plaintext.txt	56	clear process regulated
0.5272462.14570915.html.plaintext.txt	57	study examined role cal expression mature cftr protein
0.5272462.14570915.html.plaintext.txt	58	found cal regulates expression mature cftr mechanisms bafilomycin a1 dynamin 2 sensitive
0.5272462.14570915.html.plaintext.txt	59	experimental procedures top abstract introduction experimental procedures results discussion references cell culture transfection african green monkey kidney cells cos 7 obtained american type tissue culture maintained dmem 20 mm l glutamine 100 unitml penicillin 100 microgml streptomycin 10 fetal calf serum
0.5272462.14570915.html.plaintext.txt	60	media components purchased invitrogen
0.5272462.14570915.html.plaintext.txt	61	cos 7 cells transfected using lipofectamine 2000 invitrogen according manufacturers instructions
0.5272462.14570915.html.plaintext.txt	62	immunoblotting cells harvested processed described previously 11
0.5272462.14570915.html.plaintext.txt	63	briefly cells solubilized lysis buffer 50 mm nacl 150 mm tris hcl ph 7
0.5272462.14570915.html.plaintext.txt	64	4 1 nonidet p 40 complete protease inhibitor roche applied sciences
0.5272462.14570915.html.plaintext.txt	65	cell lysates spun 14000 x g 15 min 4 degrees c pellet insoluble material
0.5272462.14570915.html.plaintext.txt	66	supernatants subjected sds page western blotting followed ecl amersham biosciences
0.5272462.14570915.html.plaintext.txt	67	chemiluminescence signal polyvinylidene difluoride membrane directly captured fujifilm las 1000 plus system 1300000 pixel cooled ccd camera 3
0.5272462.14570915.html.plaintext.txt	68	quantification carried within linear range using image gauge version 3
0.5272462.14570915.html.plaintext.txt	69	gfp cftr dyn2 gfp detected polyclonal gfp antibody 11000 bd biosciences boston ma
0.5272462.14570915.html.plaintext.txt	70	ha cal detected monoclonal ha antibody 12000 roche applied sciences
0.5272462.14570915.html.plaintext.txt	71	tubulin detected monoclonal tubulin antibody 1 1000 sigma
0.5272462.14570915.html.plaintext.txt	72	surface biotinylation surface biotinylation cftr plasma membrane described previously 11
0.5272462.14570915.html.plaintext.txt	73	briefly cell surface proteins labeled cell impermeable ez linktm sulfo nhs ss biotin sulfosuccinimidyl 2 biotinamidoethyl 13 dithiopropionate pierce 4 degrees c 15 min
0.5272462.14570915.html.plaintext.txt	74	cell surface proteins isolated incubating immobilized neutravidin beads 4 degrees c 2 h pierce catalog number 53151
0.5272462.14570915.html.plaintext.txt	75	bound proteins eluted 2x laemmli sample buffer supplemented 100 mm dithiothreitol 42 degrees c 30 min
0.5272462.14570915.html.plaintext.txt	76	eluted proteins subjected sds page western blotting followed ecl amersham biosciences
0.5272462.14570915.html.plaintext.txt	77	gfp cftr detected polyclonal gfp antibody 11000 bd biosciences
0.5272462.14570915.html.plaintext.txt	78	pulse chase cos 7 cells washed twice methioninecysteine free dmem incubated 30 min methioninecysteine free dmem
0.5272462.14570915.html.plaintext.txt	79	cells incubated methioninecysteine free dmem containing tran 35s label 250 microciml 30 min
0.5272462.14570915.html.plaintext.txt	80	subsequently cells washed extensively dmem containing 10 mm unlabeled methionine 10 mm unlabeled cysteine chased solution indicated times
0.5272462.14570915.html.plaintext.txt	81	radiolabeled cftr immunoprecipitated m3a7 l12b14 monoclonal antibodies upstate waltham ma separated 7
0.5272462.14570915.html.plaintext.txt	82	5 sds page dried visualized autoradiography
0.5272462.14570915.html.plaintext.txt	83	radioactive signal dried sds page scanned fujifilm bas 100 system fujifilm
0.5272462.14570915.html.plaintext.txt	84	quantification carried within linear range using image gauge version 3
0.5272462.14570915.html.plaintext.txt	85	confocal microscopy cos 7 cells plated glass coverslips 1 day transfection
0.5272462.14570915.html.plaintext.txt	86	cells fixed 4 paraformaldehyde permeabilized 0
0.5272462.14570915.html.plaintext.txt	87	2 nonidet p 40 1 day post transfection
0.5272462.14570915.html.plaintext.txt	88	nonspecific binding sites blocked 5 normal goat serum
0.5272462.14570915.html.plaintext.txt	89	cells stained anti ha monoclonal antibody 12000 roche applied sciences 5 normal goat serum washed 1 bovine serum albumin incubated goat anti mouse cy3 secondary antibodies 1 normal goat serum 1200 jackson immunoresearch west grove pa
0.5272462.14570915.html.plaintext.txt	90	gfp signal detected fluorescence
0.5272462.14570915.html.plaintext.txt	91	specimens mounted viewed ultraview spinning disk confocal microscope perkinelmer life sciences
0.5272462.14570915.html.plaintext.txt	92	calculation degradation percentage bafilomycin a1 sensitive cftr degradation calculated follows cftrbafilomycin a1 treated cftruntreatedcftrbafilomycin a1 treated x 100
0.5272462.14570915.html.plaintext.txt	93	statistical analysis data presented means plus minus
0.5272462.14570915.html.plaintext.txt	94	statistical significance determined students test
0.5272462.14570915.html.plaintext.txt	95	assigned significance p 0
0.5272462.14570915.html.plaintext.txt	96	results top abstract introduction experimental procedures results discussion references expression mature cftr protein influenced cal co expression cal reduces total cellular cftr 23
0.5272462.14570915.html.plaintext.txt	97	confirm observations co transfected gfp cftr cos 7 cells different concentrations either ha myc tagged cal
0.5272462.14570915.html.plaintext.txt	98	gfp cftr previously shown single channel properties intracellular trafficking patterns similar wild type cftr 28
0.5272462.14570915.html.plaintext.txt	99	1 depicts steady state levels cftr ha cal tubulin used assess protein loading
0.5272462.14570915.html.plaintext.txt	100	note cftr resolves two bands well known correspond upper mature c band fully glycosylated lower immature b band core glycosylated cftr 29
0.5272462.14570915.html.plaintext.txt	101	note expression either type tagged cal construct significantly reduced steady state levels mature band cftr assayed 48 h post transfection
0.5272462.14570915.html.plaintext.txt	102	consistent previous results 23 effects cal mature cftr dose dependent independent epitope tags
0.5272462.14570915.html.plaintext.txt	103	results argue cal regulates cftr mature protein specific fashion
0.5272462.14570915.html.plaintext.txt	104	example abundance tubulin cytoskeleton protein affected either ha cal fig
0.5272462.14570915.html.plaintext.txt	105	likewise co expression ha cal myc cal affect expression gfp cytosolic protein gfp frizzled 4 membrane protein data shown
0.5272462.14570915.html.plaintext.txt	106	neither gfp frizzled 4 binds cal 11
0.5272462.14570915.html.plaintext.txt	107	gfp tagged proteins used cytomegalovirus promoters eliminating nonspecific effect promoter activity
0.5272462.14570915.html.plaintext.txt	108	addition nhe rf effect abundance mature cftr 11 23
0.5272462.14570915.html.plaintext.txt	109	data suggest cal regulate gfp cftr reducing transcription see pulse chase experiments later acting gfp moiety fusion proteins
0.5272462.14570915.html.plaintext.txt	110	view larger version 34k fig
0.5272462.14570915.html.plaintext.txt	111	dose dependent degradation cftr cal
0.5272462.14570915.html.plaintext.txt	112	cos 7 cells co transfected gfp cftr 3 microg ha cal indicated
0.5272462.14570915.html.plaintext.txt	113	cells lysed 48 h post transfection
0.5272462.14570915.html.plaintext.txt	114	proteins cell lysates separated sds page
0.5272462.14570915.html.plaintext.txt	115	b cos 7 cells co transfected gfp cftr 3 microgdish myc cal indicated
0.5272462.14570915.html.plaintext.txt	116	gfp cftr detected western blotting using anti gfp polyclonal antibody
0.5272462.14570915.html.plaintext.txt	117	ha cal myc cal detected western blotting using anti ha anti myc monoclonal antibodies respectively
0.5272462.14570915.html.plaintext.txt	118	tubulin detected western blotting using anti tubulin monoclonal antibody demonstrate equal loading total cell lysates
0.5272462.14570915.html.plaintext.txt	119	c averages experiments described b
0.5272462.14570915.html.plaintext.txt	120	filled circles values cells co transfected ha cal
0.5272462.14570915.html.plaintext.txt	121	open circles values cells co transfected myc cal
0.5272462.14570915.html.plaintext.txt	122	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	123	05 versus cells transfected 6 microgdish cal n 3
0.5272462.14570915.html.plaintext.txt	124	verify results effect cal cftr investigated cells stably expressing low level cftr
0.5272462.14570915.html.plaintext.txt	125	cell line created transfecting cos 7 cells gfp cftr followed selection expansion isolated g418 resistant colonies
0.5272462.14570915.html.plaintext.txt	126	one resultant clone 4f2 obtained expressed one tenth gfp cftr cells transiently transfected 3 microg gfp cftr100 mm dish data shown
0.5272462.14570915.html.plaintext.txt	127	cells ha cal also reduced steady state levels cftr fig
0.5272462.14570915.html.plaintext.txt	128	view larger version 25k fig
0.5272462.14570915.html.plaintext.txt	129	bafilomycin a1 reverses cal mediated reduction cftr
0.5272462.14570915.html.plaintext.txt	130	cos 7 cells co transfected gfp cftr ha cal
0.5272462.14570915.html.plaintext.txt	131	either lysosome inhibitor bafilomycin a1 1 microm proteasome inhibitor mg132 10 microm added 24 h post transfection
0.5272462.14570915.html.plaintext.txt	132	cells lysed proteins detected western blotting described legend fig
0.5272462.14570915.html.plaintext.txt	133	b percentage bafilomycin a1 sensitive cftr degradation calculated portion cftr protected bafilomycin a1 see experimental procedures
0.5272462.14570915.html.plaintext.txt	134	data means three experiments
0.5272462.14570915.html.plaintext.txt	135	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	136	c cos 7 cell line 4f2 stably expressing low amount gfp cftr transfected ha cal 6 microgdish
0.5272462.14570915.html.plaintext.txt	137	bafilomycin a1 1 microm added 24 h post transfection
0.5272462.14570915.html.plaintext.txt	138	cells lysed proteins detected described
0.5272462.14570915.html.plaintext.txt	139	d percentage bafilomycin a1 sensitive cftr degradation 4f2
0.5272462.14570915.html.plaintext.txt	140	data means three experiments
0.5272462.14570915.html.plaintext.txt	141	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	142	degradation cftr influenced cal investigate role lysosome proteasome cal mediated regulation cftr examined effect respective inhibitors
0.5272462.14570915.html.plaintext.txt	143	2a treatment bafilomycin a1 lysosomal proton pump inhibitor 30 increases steady state protein levels cftr
0.5272462.14570915.html.plaintext.txt	144	data combined previous findings obtained lysosome blocking agents 10 11 suggest lysosomal degradation important process regulating mature cftr abundance
0.5272462.14570915.html.plaintext.txt	145	important study bafilomycin a1 reverses cal mediated reduction mature cftr fig
0.5272462.14570915.html.plaintext.txt	146	fig 2a first third lanes shows typical effect cal mature cftr
0.5272462.14570915.html.plaintext.txt	147	absence bafilomycin a1 cal transfected cells significantly less mature cftr cells transfected cal fig
0.5272462.14570915.html.plaintext.txt	148	importantly 24 48 h bafilomycin a1 treatment effect cal significantly reduced fig
0.5272462.14570915.html.plaintext.txt	149	effect bafilomycin likely underestimated
0.5272462.14570915.html.plaintext.txt	150	cal induced reduction mature cftr expected take place prior addition bafilomycin midway 24 h posttransfection
0.5272462.14570915.html.plaintext.txt	151	thus cal induced reduction mature cftr expected take place prior addition bafilomycin
0.5272462.14570915.html.plaintext.txt	152	2b depicts extent cftr bafilomycin a1 sensitivity see experimental procedures
0.5272462.14570915.html.plaintext.txt	153	24 48 h posttransfection 27
0.5272462.14570915.html.plaintext.txt	154	85 cftr bafilomycin sensitive
0.5272462.14570915.html.plaintext.txt	155	contrast cells transfected 6 microg ha cal100 mm dish 49
0.5272462.14570915.html.plaintext.txt	156	62 cftr bafilomycin sensitive p 0
0.5272462.14570915.html.plaintext.txt	157	reversal cal mediated reduction mature cftr bafilomycin a1 also reproduced stable cell line 4f2 fig
0.5272462.14570915.html.plaintext.txt	158	importantly transfection ha cal leads increase extent bafilomycin a1 sensitive degradation cftr fig
0.5272462.14570915.html.plaintext.txt	159	results strongly suggested cal plays key role regulating bafilomycin a1 sensitive degradation cftr
0.5272462.14570915.html.plaintext.txt	160	hand treating cal transfected cells proteasome inhibitor mg132 rescue mature gfp cftr fig
0.5272462.14570915.html.plaintext.txt	161	2a back control levels observed absence cal
0.5272462.14570915.html.plaintext.txt	162	contrast bafilomycin a1 treatment presence cal mg132 actually reduced levels mature cftr
0.5272462.14570915.html.plaintext.txt	163	observed several investigators proteasome inhibition increase maturation cftr 31 32
0.5272462.14570915.html.plaintext.txt	164	mg132 increase immature cftr nonidet p 40 lysates probably blocking proteosomal degradation leads accumulation cftr detergent insoluble polyubiquitinated form immature cftr 32
0.5272462.14570915.html.plaintext.txt	165	failure mg132 inhibit cal reduction mature cftr evidence cal function downstream proteosome influence degradation mature cftr
0.5272462.14570915.html.plaintext.txt	166	effect cal cftr maturation steady state level mature cftr determined new protein synthesis trafficking maturation cftr er golgi well post golgi degradation
0.5272462.14570915.html.plaintext.txt	167	eliminate possibility addition enhancing degradation mature cftr lysosome cal decreases cftr synthesis andor maturation examined synthesis maturation cftr metabolic labeling pulse chase experiments
0.5272462.14570915.html.plaintext.txt	168	3a cos 7 cells transfected gfp cftr without ha cal metabolically pulse labeled 35smethionine cysteine 30 min 16 h post transfection
0.5272462.14570915.html.plaintext.txt	169	cells chased medium supplemented unlabeled methionine cysteine 1 4 h follow maturation cftr
0.5272462.14570915.html.plaintext.txt	170	3a band b newly synthesized cftr er appears first
0.5272462.14570915.html.plaintext.txt	171	newly synthesized cftr converted mature cftr band c upper band cftr folds inefficiently band b degraded er associated degradation 8
0.5272462.14570915.html.plaintext.txt	172	3 shows gfp cftr matures similarly whether transfected transfected cal
0.5272462.14570915.html.plaintext.txt	173	therefore cal exerts effects mature cftr affect synthesis trafficking golgi
0.5272462.14570915.html.plaintext.txt	174	test hypothesis directly effect cal mature cftr examined
0.5272462.14570915.html.plaintext.txt	175	gfp cftr becomes fully mature chasing 4 h fig
0.5272462.14570915.html.plaintext.txt	176	significant difference amount cftr cal transfected untransfected cells 40990 plus minus 1840 versus 39284 plus minus 1464 arbitrary unitdish p 0
0.5272462.14570915.html.plaintext.txt	177	mature cftr followed cells chased additional 16 h
0.5272462.14570915.html.plaintext.txt	178	3c less 35s labeled mature cftr 16 h cells transfected ha cal transfected ha cal confirming role cal degradation mature cftr
0.5272462.14570915.html.plaintext.txt	179	hand bafilomycin a1 added 4 h absence cal followed 16 h chase labeled cftr remains 16 h compared remaining absence cal bafilomycin a1 suggesting degradation inhibited
0.5272462.14570915.html.plaintext.txt	180	note labeled cftr remaining cal transfected cells presence bafilomycin cal transfected cells absence bafilomycin
0.5272462.14570915.html.plaintext.txt	181	importantly fraction mature cftr sensitive bafilomycin a1 statistically larger presence cal versus control 50
0.5272462.14570915.html.plaintext.txt	182	01 indicating cal enhancing degradation mature cftr
0.5272462.14570915.html.plaintext.txt	183	taken together data suggest cal affect early cftr biosynthesis er maturation mature cftr
0.5272462.14570915.html.plaintext.txt	184	cal retains cftr intracellularly regulates mature cftr likely enhancing degradation post golgi compartments
0.5272462.14570915.html.plaintext.txt	185	view larger version 20k fig
0.5272462.14570915.html.plaintext.txt	186	cal enhances degradation mature cftr blocked bafilomycin a1
0.5272462.14570915.html.plaintext.txt	187	cos 7 cells transfected gfp cftr ha cal
0.5272462.14570915.html.plaintext.txt	188	cells metabolically labeled 30 min 35smethionine 16 h post transfection
0.5272462.14570915.html.plaintext.txt	189	cells chased normal medium supplemented unlabeled cysteine methionine 1 4 h indicated
0.5272462.14570915.html.plaintext.txt	190	b quantification 35smethionine labeled cftr described
0.5272462.14570915.html.plaintext.txt	191	filled symbols transfected cftr alone
0.5272462.14570915.html.plaintext.txt	192	open symbols co transfected gfp cftr ha cal
0.5272462.14570915.html.plaintext.txt	193	circles immature cftr band b
0.5272462.14570915.html.plaintext.txt	194	triangles mature cftr band c
0.5272462.14570915.html.plaintext.txt	195	data represented percentages radioactivity cpm 0 h band b percentages radioactivity cpm 4 h band c
0.5272462.14570915.html.plaintext.txt	196	data mean three experiments
0.5272462.14570915.html.plaintext.txt	197	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	198	c 4 h chase cftr maturation complete
0.5272462.14570915.html.plaintext.txt	199	cells treated bafilomycin a1 indicated chased additional 16 h
0.5272462.14570915.html.plaintext.txt	200	longer exposure used allow visualization
0.5272462.14570915.html.plaintext.txt	201	d percentage bafilomycin a1 sensitive cftr degradation
0.5272462.14570915.html.plaintext.txt	202	data means three experiments described c
0.5272462.14570915.html.plaintext.txt	203	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	204	cal mediates mature cftr vesicle formation involving dynamin 2 large gtpase dynamin 2 controls pinching clathrin coated endocytic vesicles plasma membrane perhaps budding vesicles golgi 33
0.5272462.14570915.html.plaintext.txt	205	dominant negative dynamin 2 aa dyn2k44a blocks endocytosis wide variety membrane proteins 34 also known affect integrity golgi cell types 35
0.5272462.14570915.html.plaintext.txt	206	4 shows effects gfp tagged dyn2k44a wild type dyn2 cftr cell surface expression assayed surface biotinylation
0.5272462.14570915.html.plaintext.txt	207	dyn2k44a gfp dyn2 gfp co transfected gfp cftr either without ha cal
0.5272462.14570915.html.plaintext.txt	208	cell surface cftr labeled cell impermeable ez linktm sulfo nhs ss biotin 4 degrees c isolated neutravidin beads detected western blotting polyclonal gfp antibodies
0.5272462.14570915.html.plaintext.txt	209	dyn2 gfp effect cell surface cftr whereas dyn2k44a gfp increased cell surface expression gfp cftr
0.5272462.14570915.html.plaintext.txt	210	increased cell surface expression mature cftr dynamin mutant consistent previous reports clathrin coated pits mediate endocytosis cftr 36 37
0.5272462.14570915.html.plaintext.txt	211	importantly dyn2k44a gfp inhibits ability cal reduce surface expression cftr thereby restoring surface expression gfp cftr cells expressing ha cal fig
0.5272462.14570915.html.plaintext.txt	212	view larger version 45k fig
0.5272462.14570915.html.plaintext.txt	213	dynamin cal affect cftr surface expression
0.5272462.14570915.html.plaintext.txt	214	cos 7 cells transfected gfp cftr ha cal dyn2 gfp dominant negative dyn2k44a gfp
0.5272462.14570915.html.plaintext.txt	215	forty eight hours post transfection cell surface proteins labeled membrane impermeable sulfo nhs ss biotin 4 degrees c
0.5272462.14570915.html.plaintext.txt	216	cell surface proteins isolated neutravidin beads fractionated sds page detected western blotting using gfp polyclonal antibody
0.5272462.14570915.html.plaintext.txt	217	b averages three experiments described
0.5272462.14570915.html.plaintext.txt	218	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	219	05 versus cells transfected cal alone
0.5272462.14570915.html.plaintext.txt	220	next examined whether dyn2k44a gfp affects cal mediated effects levels mature cftr
0.5272462.14570915.html.plaintext.txt	221	cells co transfected gfp cftr increasing amounts ha cal presence absence transfected dyn2k44a gfp fig
0.5272462.14570915.html.plaintext.txt	222	dynamin mutant significantly affect levels mature cftr arguing large effect mutant maturation cftr golgi
0.5272462.14570915.html.plaintext.txt	223	ha cal reduces mature gfp cftr dose dependent manner
0.5272462.14570915.html.plaintext.txt	224	importantly dyn2k44a gfp partially reverses reduction mature gfp cftr fig
0.5272462.14570915.html.plaintext.txt	225	clear whether incomplete reversal due incomplete co transfection three plasmids whether portion cal mediated effect mature cftr occurs via dynamin insensitive pathway
0.5272462.14570915.html.plaintext.txt	226	however taken together lack effect cal maturation cftr fig
0.5272462.14570915.html.plaintext.txt	227	3 data provide support notion degradation cftr post golgi compartments enhanced cal causing regulation mature cftr
0.5272462.14570915.html.plaintext.txt	228	view larger version 35k fig
0.5272462.14570915.html.plaintext.txt	229	dominant negative dynamin 2 partially blocks cal mediated effects mature cftr
0.5272462.14570915.html.plaintext.txt	230	cos 7 cells transfected gfp cftr ha cal dominant negative dyn2k44a gfp
0.5272462.14570915.html.plaintext.txt	231	total mature cftr isolated detected western blotting using gfp polyclonal antibody described legend fig
0.5272462.14570915.html.plaintext.txt	232	b averages three experiments described
0.5272462.14570915.html.plaintext.txt	233	error bars standard deviations
0.5272462.14570915.html.plaintext.txt	234	dyn2k44a transfected cells differ significantly untransfected cells
0.5272462.14570915.html.plaintext.txt	235	05 versus cells transfected 6 microg cal
0.5272462.14570915.html.plaintext.txt	236	05 versus cells transfected 9 microg cal
0.5272462.14570915.html.plaintext.txt	237	dominant negative dynamin 2 redistributes subcellular localization cal cal predominantly expressed golgi apparatus particularly trans golgi network tgn 11
0.5272462.14570915.html.plaintext.txt	238	study subcellular localization cal examined effect dominant negative dynamin 2 subcellular distribution cal confocal microscopy
0.5272462.14570915.html.plaintext.txt	239	cos 7 cells grown coverslips transfected ha cal dyn2 gfp dyn2k44a gfp
0.5272462.14570915.html.plaintext.txt	240	reported previously others also shown cal located perinuclear region cell 11 20 21
0.5272462.14570915.html.plaintext.txt	241	6b shows dyn2 gfp expressed uniformly cos 7 cells
0.5272462.14570915.html.plaintext.txt	242	dyn2k44a gfp hand distinctly different punctuate expression pattern fig
0.5272462.14570915.html.plaintext.txt	243	6c consistent previous report mutant blocks clathrin coat mediated endocytosis arrested clathrin coated pits plasma membrane 38
0.5272462.14570915.html.plaintext.txt	244	whereas co expression wild type dyn2 effect distribution cal fig
0.5272462.14570915.html.plaintext.txt	245	6 d f expression dyn2k44a redistributes cal sites co localized dyn2k44a fig
0.5272462.14570915.html.plaintext.txt	246	6 g transfected ha cal dyn2k44a gfp retain typical golgi localization cal
0.5272462.14570915.html.plaintext.txt	247	results significant show cal traffics golgi arrested cell periphery progression blocked dyn2k44a
0.5272462.14570915.html.plaintext.txt	248	view larger version 70k fig
0.5272462.14570915.html.plaintext.txt	249	dynamin 2 dominant negative mutant redistributes cal
0.5272462.14570915.html.plaintext.txt	250	cos 7 cells singly transfected ha cal wild type dyn2 gfp b dominant negative dyn2k44a gfp c top row doubly transfected ha cal dyn2 gfp d f middle row ha cal dyn2k44a gfp g bottom row
0.5272462.14570915.html.plaintext.txt	251	cal detected monoclonal antibody ha epitope red dyn2 visualized green fluorescence green confocal microscope
0.5272462.14570915.html.plaintext.txt	252	cal typically expressed golgi apparatus
0.5272462.14570915.html.plaintext.txt	253	wild type dyn2 effect intracellular localization
0.5272462.14570915.html.plaintext.txt	254	dyn2k44a redistributes co localizes cal
0.5272462.14570915.html.plaintext.txt	255	discussion top abstract introduction experimental procedures results discussion references paper report co expression cftr interacting protein cal regulates expression mature cftr protein
0.5272462.14570915.html.plaintext.txt	256	previously identified cal novel cftr interacting protein showed co expression cal retains cftr intracellular compartment decreasing cell surface expression cftr 11
0.5272462.14570915.html.plaintext.txt	257	show cal causes dose dependent reduction total amount mature cftr fig
0.5272462.14570915.html.plaintext.txt	258	proton pump inhibitor bafilomycin a1 reverses cal mediated reduction mature cftr fig
0.5272462.14570915.html.plaintext.txt	259	transfection cal leads increase extent bafilomycin a1 sensitive degradation cftr fig
0.5272462.14570915.html.plaintext.txt	260	proteasomal inhibitor mg132 hand reverse effect cal fig
0.5272462.14570915.html.plaintext.txt	261	pulse chase experiments indicate cal effect cftr maturation suggesting exerts effect mature cftr fig
0.5272462.14570915.html.plaintext.txt	262	3 enhancing degradation mature cftr
0.5272462.14570915.html.plaintext.txt	263	previously shown cal reduces half life cftr cell surface 11
0.5272462.14570915.html.plaintext.txt	264	co expression dominant negative mutant dynamin 2 dyn2k44a gfp cal cftr restores cell surface cftr partially blocks cal mediated degradation mature cftr figs
0.5272462.14570915.html.plaintext.txt	265	data suggest model cal retains cftr cell targets mature cftr degradation via mechanisms involving post golgi vesicle formation trafficking
0.5272462.14570915.html.plaintext.txt	266	intracellular retention degradation mature cftr cal contributes cal mediated regulation cftr
0.5272462.14570915.html.plaintext.txt	267	date enzymatic activity identified cal
0.5272462.14570915.html.plaintext.txt	268	examining protein domains motifs suggests cal scaffolding protein multiple protein binding domains
0.5272462.14570915.html.plaintext.txt	269	like scaffolding proteins cal operates adaptor couple multiple proteins
0.5272462.14570915.html.plaintext.txt	270	pdz domain binds cftr second coiled coil domain binds small gtpase tc10 snare protein syntaxin 6 20 22
0.5272462.14570915.html.plaintext.txt	271	tc10 syntaxin 6 known involved intracellular trafficking
0.5272462.14570915.html.plaintext.txt	272	tc10 member rho gtpase family
0.5272462.14570915.html.plaintext.txt	273	adipose tissues tc10 involved regulating trafficking insulin stimulated glucose transporter glut4 plasma membrane
0.5272462.14570915.html.plaintext.txt	274	adaptor protein cal likely link cftr intracellular trafficking processes carried tc10 syntaxin 6 cftr expressing epithelial tissues
0.5272462.14570915.html.plaintext.txt	275	steady state cal localized golgi complex particularly tgn cytosol
0.5272462.14570915.html.plaintext.txt	276	tc10 localized plasma membrane intracellular vesicles syntaxin 6 primarily golgi endosomes
0.5272462.14570915.html.plaintext.txt	277	cftr spans compartments
0.5272462.14570915.html.plaintext.txt	278	proteins work concert cftr must physically interact
0.5272462.14570915.html.plaintext.txt	279	one possibility interact interface respective compartments
0.5272462.14570915.html.plaintext.txt	280	alternatively one proteins could cycle among different compartments
0.5272462.14570915.html.plaintext.txt	281	example cal may traffic tgngolgi plasma membrane endosomes lysosome may traffic directly tgn lysosome
0.5272462.14570915.html.plaintext.txt	282	6 depicts evidence supporting notion
0.5272462.14570915.html.plaintext.txt	283	data show expression dominant negative dynamin 2 mutant redistributes cal cell periphery punctuate structures co localize mutant dynamin 2
0.5272462.14570915.html.plaintext.txt	284	circumstance cal arrested sites dynamin regulates vesicle budding fig
0.5272462.14570915.html.plaintext.txt	285	dynamin 2 mutant dyn2k44a well known inhibit endocytosis affect golgi 33 35
0.5272462.14570915.html.plaintext.txt	286	observation dynamin 2 mutant dyn2k44a enhances surface expression mature cftr large effect total amount mature cftr supports notion primary effect dyn2k44a post golgi
0.5272462.14570915.html.plaintext.txt	287	thus likely cal traffic cftr past golgi target cftr degradation either endocytosis plasma membrane via direct trafficking post golgi compartment lysosome
0.5272462.14570915.html.plaintext.txt	288	however important note data exclude ways regulating mature protein cell surface expression cftr
0.5272462.14570915.html.plaintext.txt	289	evidence cal involved trafficking tissues epithelia suggested two recent papers
0.5272462.14570915.html.plaintext.txt	290	neuronal cal contributes pathology lurcher mice 39
0.5272462.14570915.html.plaintext.txt	291	lurcher mutant mice ataxic degeneration cortex cerebella
0.5272462.14570915.html.plaintext.txt	292	constitutive activation glurd2lc receptor causes inward current death purkinje cells
0.5272462.14570915.html.plaintext.txt	293	neuronal cal additional 8 amino acids beginning second coiled coil domain
0.5272462.14570915.html.plaintext.txt	294	cal binds glurd2 beclin1 links receptor activation autophagy cell death 39
0.5272462.14570915.html.plaintext.txt	295	autophagy involves trafficking membrane compartments lysosome degradation
0.5272462.14570915.html.plaintext.txt	296	therefore cal maybe involved lysosomal trafficking autophagy
0.5272462.14570915.html.plaintext.txt	297	information function cal came knockout mouse experiments 40
0.5272462.14570915.html.plaintext.txt	298	cal knockout mice males infertile
0.5272462.14570915.html.plaintext.txt	299	mature sperm male mice missing cal lack acrosome specialized lysosomal structure derived golgi required oocyte activation
0.5272462.14570915.html.plaintext.txt	300	normal mice cal located tgn tgn derived vesicles round spermatids
0.5272462.14570915.html.plaintext.txt	301	data suggest cal involved acrosome biogenesis perhaps facilitating protein cargo transport organelle
0.5272462.14570915.html.plaintext.txt	302	new therapies development promote f508 cftr maturation
0.5272462.14570915.html.plaintext.txt	303	interfering degradation f508 cftr post golgi compartments may attractive method boost levels mature cftr
0.5272462.14570915.html.plaintext.txt	304	current study suggests method accomplish inhibiting degradation mature cftr
0.5272462.14570915.html.plaintext.txt	305	importantly specific way blocking interaction cal cftr may potentially allow cftr trafficked plasma membrane
0.5272462.14570915.html.plaintext.txt	306	footnotes work supported cystic fibrosis foundation research development programs w
0.5272462.14570915.html.plaintext.txt	307	national institutes health grants dk 48977 w
0.5272462.14570915.html.plaintext.txt	308	costs publication article defrayed part payment page charges
0.5272462.14570915.html.plaintext.txt	309	article must therefore hereby marked advertisement accordance 18 u
0.5272462.14570915.html.plaintext.txt	310	section 1734 solely indicate fact
0.5272462.14570915.html.plaintext.txt	311	correspondence addressed
0.5272462.14570915.html.plaintext.txt	312	410 955 7166 fax 410 955 0461 e mail wgugginoatbs
0.5272462.14570915.html.plaintext.txt	313	1 abbreviations used cftr cystic fibrosis transmembrane regulator nhe rf nah exchanger regulatory factor dyn2 dynamin 2 gfp green fluorescent protein ha hemagglutinin er endoplasmic reticulum dmem dulbeccos modified eagles medium tgn trans golgi network snare soluble nsf attachment protein receptors
0.5272462.14570915.html.plaintext.txt	314	acknowledgments thank dr
0.5272462.14570915.html.plaintext.txt	315	mcniven dynamin 2 aa constructs dyn2 gfp dyn2k44a gfp
0.5272462.14570915.html.plaintext.txt	316	carolyn machamer laura roman helpful discussions
0.5272462.14570915.html.plaintext.txt	317	peying fong critical reading manuscript
0.5272462.14570915.html.plaintext.txt	318	references top abstract introduction experimental procedures results discussion references kerem b
0.5272462.14570915.html.plaintext.txt	319	1989 science 245 1073 1080medline order article via infotrieve riordan j
0.5272462.14570915.html.plaintext.txt	320	1989 science 245 1066 1073medline order article via infotrieve rosenstein b
0.5272462.14570915.html.plaintext.txt	321	33 83 84crossref sheppard d
0.5272462.14570915.html.plaintext.txt	322	79 s23 s45medline order article via infotrieve stutts m
0.5272462.14570915.html.plaintext.txt	323	1995 science 269 847 850medline order article via infotrieve schwiebert e
0.5272462.14570915.html.plaintext.txt	324	79 s145 s166medline order article via infotrieve pier g
0.5272462.14570915.html.plaintext.txt	325	94 12088 12093abstractfree full text kopito r
0.5272462.14570915.html.plaintext.txt	326	79 s167 s173medline order article via infotrieve benharouga m
0.5272462.14570915.html.plaintext.txt	327	70 229 243medline order article via infotrieve benharouga m
0.5272462.14570915.html.plaintext.txt	328	153 957 970abstractfree full text cheng j
0.5272462.14570915.html.plaintext.txt	329	277 3520 3529abstractfree full text hall r
0.5272462.14570915.html.plaintext.txt	330	95 8496 8501abstractfree full text short d
0.5272462.14570915.html.plaintext.txt	331	273 19797 19801abstractfree full text wang
0.5272462.14570915.html.plaintext.txt	332	427 103 108crossrefmedline order article via infotrieve wang
0.5272462.14570915.html.plaintext.txt	333	2000 cell 103 169 179medline order article via infotrieve raghuram v
0.5272462.14570915.html.plaintext.txt	334	98 1300 1305abstractfree full text swiatecka urban
0.5272462.14570915.html.plaintext.txt	335	277 40099 40105abstractfree full text sun f
0.5272462.14570915.html.plaintext.txt	336	275 29539 29546abstractfree full text naren
0.5272462.14570915.html.plaintext.txt	337	100 342 346abstractfree full text charest
0.5272462.14570915.html.plaintext.txt	338	276 29456 29465abstractfree full text yao r
0.5272462.14570915.html.plaintext.txt	339	286 771 778crossrefmedline order article via infotrieve neudauer c
0.5272462.14570915.html.plaintext.txt	340	280 541 547crossrefmedline order article via infotrieve gentzsch m
0.5272462.14570915.html.plaintext.txt	341	278 6440 6449abstractfree full text hassel b
0.5272462.14570915.html.plaintext.txt	342	278 40136 40143abstractfree full text sans n
0.5272462.14570915.html.plaintext.txt	343	6 520 530crossref cao
0.5272462.14570915.html.plaintext.txt	344	1999 nature 401 286 290crossrefmedline order article via infotrieve weixel k
0.5272462.14570915.html.plaintext.txt	345	443 s70 s74crossrefmedline order article via infotrieve moyer b
0.5272462.14570915.html.plaintext.txt	346	273 21759 21768abstractfree full text cheng
0.5272462.14570915.html.plaintext.txt	347	1990 cell 63 827 834medline order article via infotrieve bowman e
0.5272462.14570915.html.plaintext.txt	348	85 7972 7976abstract jensen
0.5272462.14570915.html.plaintext.txt	349	1995 cell 83 129 135medline order article via infotrieve ward c
0.5272462.14570915.html.plaintext.txt	350	1995 cell 83 121 127medline order article via infotrieve conner
0.5272462.14570915.html.plaintext.txt	351	2003 nature 422 37 44crossrefmedline order article via infotrieve mcniven m
0.5272462.14570915.html.plaintext.txt	352	25 115 120crossrefmedline order article via infotrieve cao h
0.5272462.14570915.html.plaintext.txt	353	113 1993 2002abstractfree full text lukacs g
0.5272462.14570915.html.plaintext.txt	354	328 353 361medline order article via infotrieve bradbury n
0.5272462.14570915.html.plaintext.txt	355	276 l659 l668medline order article via infotrieve damke h
0.5272462.14570915.html.plaintext.txt	356	127 915 934abstract yue z
0.5272462.14570915.html.plaintext.txt	357	2002 neuron 35 921 933medline order article via infotrieve yao r
0.5272462.14570915.html.plaintext.txt	358	99 11211 11216abstractfree full text
0.5620728.10666019.html.plaintext.txt	0	editorial focus focus sodium 4 phenylbutyrate downregulates hsc70 implications intracellular trafficking f508 cftr neil
0.5620728.10666019.html.plaintext.txt	1	cystic fibrosis research center department cell biology physiology university pittsburgh school medicine pittsburgh pennsylvania 15261
0.5620728.10666019.html.plaintext.txt	2	article top article references
0.5620728.10666019.html.plaintext.txt	3	ability newly synthesized proteins particularly oligomeric multidomain proteins fold unique three dimensional structures vivo dependent amino acid sequence activities enzymes molecular chaperone proteins catalyze folding 9
0.5620728.10666019.html.plaintext.txt	4	evidence accumulating many human diseases caused improper folding nascent polypeptides achieve final three dimensional structure
0.5620728.10666019.html.plaintext.txt	5	proteins either inactive altered activity result inappropriate folding case marfan syndrome familiar hypercholesterolemia mislocalized due trafficking defects arising abnormal folding case tay sachs disease 1 antitrypsin deficiency
0.5620728.10666019.html.plaintext.txt	6	mutations cystic fibrosis transmembrane conductance regulator cftr give rise cystic fibrosis cf common lethal autosomal genetic disease caucasians
0.5620728.10666019.html.plaintext.txt	7	deletion codon phenylalanine 508 f508 accounts 70 disease causing cf alleles 11 yields protein unable exit endoplasmic reticulum er traffic plasma membrane functions normally ion channel
0.5620728.10666019.html.plaintext.txt	8	available evidence suggests nascent f508 cftr temperature sensitive protein 4 adopts slightly altered protein conformation
0.5620728.10666019.html.plaintext.txt	9	recognized er quality control mechanisms abnormal leading er retention 3 see also ref
0.5620728.10666019.html.plaintext.txt	10	6 ultimately degradation ubiquitin proteosome pathway 7
0.5620728.10666019.html.plaintext.txt	11	retention appears least part due cellular chaperones heat shock protein hsc70 calnexin 10 17
0.5620728.10666019.html.plaintext.txt	12	question shield dissociate mutant cftr molecules er quality control machinery allow exit plasma membrane focus research several cf laboratories
0.5620728.10666019.html.plaintext.txt	13	f508 cftr retains regulated chloride channel activity 16 correcting folding andor preventing er retention mutant cftr chaperones may therapeutic benefit treatment cf
0.5620728.10666019.html.plaintext.txt	14	attempts pharmacologically manipulate folding f508 cftr included use protein stabilizing reagents chemical chaperones glycerol trimethylamine n oxide well deuterated water 2 14
0.5620728.10666019.html.plaintext.txt	15	indeed evidence suggests approaches facilitate exit f508 cftr er insertion apical plasma membrane vivo
0.5620728.10666019.html.plaintext.txt	16	previous publication rubenstein colleagues 12 shown sodium 4 phenylbutyrate 4pba similarly facilitates exit f508 cftr er though mechanism action remained elusive
0.5620728.10666019.html.plaintext.txt	17	previous work shown f508 cftr remains associated cellular chaperone hsc70 much greater extent wild type cftr 17 association may direct mutant cftr ubiquitin dependent degradation pathway 1
0.5620728.10666019.html.plaintext.txt	18	current article focus ref
0.5620728.10666019.html.plaintext.txt	19	13 see page c259 issue rubenstein zeitlin demonstrate association mutant cftr heat shock protein hsc70 reduced exposing cells 4pba
0.5620728.10666019.html.plaintext.txt	20	mechanistically appears 4pba inhibits interaction f508 cftr hsc70 allowing mutant cftr escape targeting degradation facilitating exit er
0.5620728.10666019.html.plaintext.txt	21	4pba appears downregulating expression hsc70 protein mrna level thereby limiting amount hsc70 available bind cftr
0.5620728.10666019.html.plaintext.txt	22	hypothesis consistent observations cheng colleagues 5 utilized deoxyspergualin compound affect hsc70 protein levels competitively inhibits peptide binding hsc70 partially restore cftr function heterologous cells expressing f508 cftr
0.5620728.10666019.html.plaintext.txt	23	would appear however efficacious effects inhibiting cftr chaperone interactions limited hsc70 since perturbation cftr hsc90 interactions shown accelerate cftr degradation 8
0.5620728.10666019.html.plaintext.txt	24	manipulating cftr folding chemical chaperones appear readily feasible context cf patient
0.5620728.10666019.html.plaintext.txt	25	however preventing recognition misfolded cftr abnormal may amenable pharmacological strategies
0.5620728.10666019.html.plaintext.txt	26	thus current article rubenstein zeitlin offers exciting insight one might able disrupt cellular chaperone dependent retention mutant cftr molecules er allowing insertion plasma membrane
0.5620728.10666019.html.plaintext.txt	27	moreover 4pba deoxyspergualin approved drugs urea cycle disorders antitumorimmunosuppression respectively
0.5620728.10666019.html.plaintext.txt	28	indeed clinical trials using 4pba suggested small significant improvement nasal epithelial chloride transport f508 homozygous cf patients
0.5620728.10666019.html.plaintext.txt	29	however observations fully realized therapies several questions must addressed
0.5620728.10666019.html.plaintext.txt	30	example much mutant cftr must escape er quality control machinery effect clinical benefit studies cheng colleagues 5 would argue amount mutant cftr required reach plasma membrane provide measurable camp sensitive chloride conductive pathway less detected mature cftr protein biochemical methods
0.5620728.10666019.html.plaintext.txt	31	however since f508 cftr retain full wild type function even reaching plasma membrane pharmacological activation plasmalemmal resident mutant cftr may still required 15 16
0.5620728.10666019.html.plaintext.txt	32	remains determined impact perturbation er quality control machinery protein folding processing pathways proteins expressed cell
0.5620728.10666019.html.plaintext.txt	33	addition hsc70 cellular functions including atp dependent uncoating clathrin coated vesicles endocytic pathway targeting proteins lysosomal degradation
0.5620728.10666019.html.plaintext.txt	34	unclear effects alterations hsc70 activity would intracellular processes
0.5620728.10666019.html.plaintext.txt	35	nevertheless ability screen large libraries compounds drugs disrupt cftr hsc70 interactions may fruitful providing pharmacological therapy cf
0.5620728.10666019.html.plaintext.txt	36	report funded grants national institute diabetes digestive kidney diseases cystic fibrosis foundation
0.5620728.10666019.html.plaintext.txt	37	address reprint requests correspondence n
0.5620728.10666019.html.plaintext.txt	38	bradbury s306 bst south dept
0.5620728.10666019.html.plaintext.txt	39	cell biology physiology 3500 terrace st
0.5620728.10666019.html.plaintext.txt	40	pittsburgh school medicine pittsburgh pa 15261 e mail nabradatpitt
0.5620728.10666019.html.plaintext.txt	41	references top article references
0.5620728.10666019.html.plaintext.txt	42	ubiquitin dependent degradation certain protein substrates vitro requires molecular chaperone hsc70
0.5620728.10666019.html.plaintext.txt	43	272 9002 9010 1997abstractfree full text
0.5620728.10666019.html.plaintext.txt	44	chemical chaperones correct mutant phenotype f508 cystic fibrosis transmembrane conductance regulator protein
0.5620728.10666019.html.plaintext.txt	45	cell stress chaperones 1 117 125 1996isimedline
0.5620728.10666019.html.plaintext.txt	46	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.5620728.10666019.html.plaintext.txt	47	cell 63 827 834 1990isimedline
0.5620728.10666019.html.plaintext.txt	48	processing mutant cystic fibrosis transmembrane regulator temperature sensitive
0.5620728.10666019.html.plaintext.txt	49	partial restoration camp stimulated cftr chloride channel activity f508 cells deoxyspergualin
0.5620728.10666019.html.plaintext.txt	50	275 c171 c178 1998abstractfree full text
0.5620728.10666019.html.plaintext.txt	51	f508 cftr protein expression tissues patients cystic fibrosis
0.5620728.10666019.html.plaintext.txt	52	103 1379 1389 1999abstractfree full text
0.5620728.10666019.html.plaintext.txt	53	biosynthesis degradation cftr
0.5620728.10666019.html.plaintext.txt	54	perturbation hsp90 interaction nascent cftr prevents maturation accelerates degradation proteosome
0.5620728.10666019.html.plaintext.txt	55	17 6879 6887 1998abstractfree full text
0.5620728.10666019.html.plaintext.txt	56	chaperone assisted protein folding
0.5620728.10666019.html.plaintext.txt	57	participation endoplasmic reticulum chaperone calnexin p88 ip90 biogenesis cystic fibrosis transmembrane conductance regulator
0.5620728.10666019.html.plaintext.txt	58	269 12784 12788 1994abstractfree full text
0.5620728.10666019.html.plaintext.txt	59	identification cystic fibrosis gene cloning characterization complementary dna
0.5620728.10666019.html.plaintext.txt	60	science 245 1059 1065 1989isimedline
0.5620728.10666019.html.plaintext.txt	61	vitro pharmacologic restoration cftr mediated chloride transport sodium 4 phenylbutyrate cystic fibrosis epithelial cells containing f508 cftr
0.5620728.10666019.html.plaintext.txt	62	100 2457 2465 1997abstractfree full text
0.5620728.10666019.html.plaintext.txt	63	sodium 4 phenylbutyrate downregulates hsc70 implications intracellular trafficking f508 cftr
0.5620728.10666019.html.plaintext.txt	64	278 c259 c267 2000abstractfree full text
0.5620728.10666019.html.plaintext.txt	65	glycerol reverses misfolding phenotype common cystic fibrosis mutation
0.5620728.10666019.html.plaintext.txt	66	271 635 638 1996abstractfree full text
0.5620728.10666019.html.plaintext.txt	67	pharmacology cftr chloride channel activity
0.5620728.10666019.html.plaintext.txt	68	rescue dysfunctional f508 cftr chloride channel activity ibmx
0.5620728.10666019.html.plaintext.txt	69	170 51 66 1999isimedline
0.5620728.10666019.html.plaintext.txt	70	common variant cystic fibrosis transmembrane conductance regulator recognized hsp70 degraded pre golgi nonlysosomal compartment
0.5620728.10666019.html.plaintext.txt	71	usa 90 9480 9484 1993abstract
0.5620728.10666019.html.plaintext.txt	72	j physiol cell physiol 2782c257 c258 0363 614300 5
0.5620728.10666019.html.plaintext.txt	73	00 copyright 2000 american physiological society
0.44163495.16170155.html.plaintext.txt	0	binding serum response factor cystic fibrosis transmembrane conductance regulator carg like elements new potential cftr transcriptional regulation pathway celine rene magali taulan florence iral julien doudement aurore lhonore12 catherine gerbon jacques demaille3 mireille claustres marie catherine romey
0.44163495.16170155.html.plaintext.txt	1	laboratoire de genetique moleculaire et chromosomique institut universitaire de recherche clinique montpellier france 1laboratoire de proliferation et differentiation cellulaire institut de genetique humaine montpellier france 2laboratoire de genetique moleculaire institut de recherches cliniques de montreal quebec canada 3centre de sequencage genomique institut de genetique humaine montpellier france
0.44163495.16170155.html.plaintext.txt	2	correspondence addressed
0.44163495.16170155.html.plaintext.txt	3	tel 33 4 67 41 53 60 fax 33 4 67 41 53 65 email marie catherine
0.44163495.16170155.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references cftr expression tightly controlled complex network ubiquitous tissue specific cis elements trans factors
0.44163495.16170155.html.plaintext.txt	5	better understand mechanisms regulate transcription cftr examined transcription factors specifically bind cftr carg like motif previously shown modulate cftr expression
0.44163495.16170155.html.plaintext.txt	6	gel mobility shift assays chromatin immunoprecipitation analyses demonstrated cftr carg like motif binds serum response factor vitro vivo
0.44163495.16170155.html.plaintext.txt	7	transient co transfections various srf expression vector including dominant negative forms small interfering rna demonstrated srf significantly increases cftr transcriptional activity bronchial epithelial cells
0.44163495.16170155.html.plaintext.txt	8	mutagenesis studies suggested addition srf co factors yin yang 1 yy1 previously shown bind cftr promoter potentially involved cftr regulation
0.44163495.16170155.html.plaintext.txt	9	show functional interplay srf yy1 might provide interesting perspectives characterize underlying molecular mechanism basal cftr transcriptional activity
0.44163495.16170155.html.plaintext.txt	10	furthermore identification multiple carg binding sites highly conserved cftr untranslated regions form specific srf complexes provides direct evidence considerable role srf cftr transcriptional regulation specialized epithelial lung cells
0.44163495.16170155.html.plaintext.txt	11	introduction top abstract introduction materials methods results discussion references expression cystic fibrosis transmembrane conductance regulator cftr gene occurs subset specialized cells epithelial origin 1 3 tightly regulated temporally spatially 45
0.44163495.16170155.html.plaintext.txt	12	however clear mechanism responsible regulation yet reported part due complexity non coding regions structure cftr gene
0.44163495.16170155.html.plaintext.txt	13	despite absence tata element transcription cftr gene may initiated several discrete start sites 67 including tissue specific 8
0.44163495.16170155.html.plaintext.txt	14	intact ccaat consensus also required accurate transcript initiation 9
0.44163495.16170155.html.plaintext.txt	15	basal camp mediated regulation cftr transcription involve weak camp response element cre nucleotide consensus 1011 tandem consensus inverted ccaat element y box 9
0.44163495.16170155.html.plaintext.txt	16	addition cftr transcription may modulated additional overlapping cis acting elements including polymorphic yy1 site located human minimal cftr promoter 12
0.44163495.16170155.html.plaintext.txt	17	cftr promoter activity may enhanced exogenous transfected nf b via binding 1103 b element 13
0.44163495.16170155.html.plaintext.txt	18	cftr expression also regulated interactions factors involved remodeling chromatin structure cdpcut hgcn5 14
0.44163495.16170155.html.plaintext.txt	19	none cis acting elements confers tissue specific control cftr expression several studies focused identifying potential regulatory elements lie mainly outside coding region
0.44163495.16170155.html.plaintext.txt	20	extensive analyses chromatin structure identified multiple clusters dnase hypersensitive sites dhss 1516 contain tissue specific enhancer elements 1718
0.44163495.16170155.html.plaintext.txt	21	multiple binding sites tissue specific transcription factor called hnf1 recently identified various dhs core modulate likewise cftr expression 19
0.44163495.16170155.html.plaintext.txt	22	despite extensive studies transcriptional regulatory networks cftr expression remain unraveled
0.44163495.16170155.html.plaintext.txt	23	current model regulation human cftr expression proposes multiple transcription factors interact previously reported polymorphic composite cis acting elements encompassing carg like motif 1220
0.44163495.16170155.html.plaintext.txt	24	carg box ccat6gg originally defined core component serum response element sre found 5 region immediate early response genes c fos 21 many muscle specific gene promoters 22
0.44163495.16170155.html.plaintext.txt	25	dna element binds serum response factor srf highly regulated interactive transcription factor phylogenetically conserved belongs mads box family proteins mcm1 agamous deficiens srf 23
0.44163495.16170155.html.plaintext.txt	26	although srf particularly enriched skeletal cardiac smooth muscle lineages 2425 also expressed variety human cell lines distinct tissue origins 26 lesser extent ectoderm derived tissue gastric epithelium 27
0.44163495.16170155.html.plaintext.txt	27	interestingly shown drosophila srf homolog expressed subset tracheal cells regulates cytoplasmic outgrowth terminal branching tracheal system 28
0.44163495.16170155.html.plaintext.txt	28	hence suggested srf plays essential role formation respiratory system
0.44163495.16170155.html.plaintext.txt	29	moreover recently shown srf involved myofibroblast differentiation lung damage 29
0.44163495.16170155.html.plaintext.txt	30	therefore hypothesized trans acting factors interacting carg like motif srf could important cftr expression regulation
0.44163495.16170155.html.plaintext.txt	31	provided evidence srf expressed bronchial epithelial cell expressing endogenous cftr protein
0.44163495.16170155.html.plaintext.txt	32	use combined gel mobility shift chromatin immunoprecipitation chip assays first demonstrated srf protein binds vitro vivo cftr minimal promoter region spanning carg like motif
0.44163495.16170155.html.plaintext.txt	33	mutagenic studies transient co transfections experiments showed srf alone sufficient transactivate cftr gene
0.44163495.16170155.html.plaintext.txt	34	upon mutations cftr carg like element promoter activity severely decreased potentially implying yy1 co repressor
0.44163495.16170155.html.plaintext.txt	35	given yy1 well defined role transcriptional regulation sre dependent promoters 30 33 explored putative role yy1 cftr promoter activity demonstrated functional interplay factor srf
0.44163495.16170155.html.plaintext.txt	36	finally stringent silico structural analysis identified additional multiple near consensus carg sites within highly conserved promoter intronic regions cftr gene
0.44163495.16170155.html.plaintext.txt	37	also documented existence srf containing protein complexes numerous predicted cftr carg like elements
0.44163495.16170155.html.plaintext.txt	38	taken together data obtained classify cftr novel srf target gene subject modest significant srf activation open gate investigate srf may involved regulation cftr gene expression
0.44163495.16170155.html.plaintext.txt	39	materials methods top abstract introduction materials methods results discussion references cell culture human bronchial epithelial cells beas2b a549 expressing endogenous cftr kindly provided dr marc chanson department pediatrics laboratory clinical investigation switzerland
0.44163495.16170155.html.plaintext.txt	40	beas2b a549 cells maintained high glucose dmem 4500 mgl d glucose invitrogen corporation supplemented 10 fetal bovine serum fbs eurobio france 5 mm l glutamine
0.44163495.16170155.html.plaintext.txt	41	c2c12 myoblasts grown dmem supplemented 10 fbs 5 mm l glutamine
0.44163495.16170155.html.plaintext.txt	42	cell cultures supplemented 100 u ml 1 penicillin 100 mg ml 1 streptomycin maintained 37 degrees c 5 co2
0.44163495.16170155.html.plaintext.txt	43	positive negative controls different assays cells used study included colon adenocarcinoma caco 2 cell line ecacc functional cftr 3435 normal monkey kidney fibroblast like cos 7 cell line atcc express cftr 3637 maintained dmem supplemented fbs incubated conditions
0.44163495.16170155.html.plaintext.txt	44	plasmids constructs original luciferase expression vector pgl3 basic containing wild type human cftr minimal promoter described previously 12
0.44163495.16170155.html.plaintext.txt	45	study putative composite cis acting element located 108 major transcription initiation site human cftr promoter 38 cftr carg like motif either mutated consensus carg box degenerated motif
0.44163495.16170155.html.plaintext.txt	46	mutations introduced wt pgl3 plasmid using oligonucleotide directed mutagenesis system quickchangetmsite directed mutagenesis kit stratagene according manufacturers instructions
0.44163495.16170155.html.plaintext.txt	47	mutagenesis primers depicted table 1
0.44163495.16170155.html.plaintext.txt	48	presence mutations sequence fidelity verified dideoxynucleotide sequencing
0.44163495.16170155.html.plaintext.txt	49	introduced mutation loss improvement transcription factor binding activity checked vitro assays
0.44163495.16170155.html.plaintext.txt	50	3xsre fos tata luciferase reporter construct kindly provided r
0.44163495.16170155.html.plaintext.txt	51	hipskind institut de genetique moleculaire montpellier france
0.44163495.16170155.html.plaintext.txt	52	expression vectors encoding either human wild type srf phiv srf srf dominant negative form deleted essential part dna binding domain dbd phiv dn generously given d
0.44163495.16170155.html.plaintext.txt	53	trouche laboratoire de biologie moleculaire eucaryote toulouse france
0.44163495.16170155.html.plaintext.txt	54	another dominant negative srf mutant phiv dbd constructed pcr amplification srf fragment spanning dbd flanked hindiii hincii sites facilitate cloning expression vector
0.44163495.16170155.html.plaintext.txt	55	pcr performed using phiv dbd srf primers listed table 1 10 ng srf expression vector 200 microm dntp 0
0.44163495.16170155.html.plaintext.txt	56	5 u taq dna polymerase perkin elmer inc
0.44163495.16170155.html.plaintext.txt	57	1x reaction buffer provided manufacturer
0.44163495.16170155.html.plaintext.txt	58	transilent human control sirna vector transilenttm human srf sirna vector catalog
0.44163495.16170155.html.plaintext.txt	59	sr1038 purchased panomics
0.44163495.16170155.html.plaintext.txt	60	expression vectors encoding either pcmv yy1 pcdna3 yy1 generously provided e
0.44163495.16170155.html.plaintext.txt	61	view table table 1 sequences oligonucleotides
0.44163495.16170155.html.plaintext.txt	62	transient transfections cells seeded density 200 000 cells2 ml medium plated 6 well dishes nunclone merck eurolab inc
0.44163495.16170155.html.plaintext.txt	63	culturing period 24 h cells transfected polyfect transfection reagent qiagen corporation france according manufacturers recommendations
0.44163495.16170155.html.plaintext.txt	64	transient transfection used 1
0.44163495.16170155.html.plaintext.txt	65	8 microg plasmid reporter 0
0.44163495.16170155.html.plaintext.txt	66	2 microg internal control prl sv40 containing renilla luciferase promega corporation
0.44163495.16170155.html.plaintext.txt	67	pgl3 basic vector lacking eukaryotic promoter enhancer sequences used negative control
0.44163495.16170155.html.plaintext.txt	68	48 h luciferase activity evaluated dual luciferase reporter assay system promega corporation described previously 12
0.44163495.16170155.html.plaintext.txt	69	luminescence measurements performed luminoskan ascent luminometer thermolabsystem corporation france
0.44163495.16170155.html.plaintext.txt	70	firefly luciferase activity normalized renilla luciferase activity
0.44163495.16170155.html.plaintext.txt	71	luciferase activities represent least three independent experiments construct tested triplicate per experiment
0.44163495.16170155.html.plaintext.txt	72	luciferase activity data expressed means plus minus sd computed results obtained set transfection experiments
0.44163495.16170155.html.plaintext.txt	73	minimize possibility errors dna amplification least two independently constructed clones tested
0.44163495.16170155.html.plaintext.txt	74	co transfection assays unless otherwise indicated 1
0.44163495.16170155.html.plaintext.txt	75	8 microgof luciferase reporter 1 2 microg expression vector used
0.44163495.16170155.html.plaintext.txt	76	transfection sirna performed using lipofectamine 2000 invitrogen 2
0.44163495.16170155.html.plaintext.txt	77	cells transfected cftr promoter plasmid reporter luciferase activity determined described
0.44163495.16170155.html.plaintext.txt	78	aliquots cell lysates used western blotting confirm specificity level srf protein knockdown
0.44163495.16170155.html.plaintext.txt	79	preparation whole cell proteins nuclear extracts recombinant protein production cftr immunodetection analyses beas2b a549 c2c12 cos 7 caco 2 cells treated 5 mm sodium phenylbutyrate previously reported increase cftr 39 scraped lysis buffer 50 mm tris hcl 1 np 40 40 mm beta glycerophosphate 120 mm nacl supplemented protease inhibitors 1 mm phenylmethylsulfonyl fluoride pmsf 1 mm dtt 1 microg microl aprotinin leupeptin pepstatin
0.44163495.16170155.html.plaintext.txt	80	nuclear extracts prepared using nuclear extraction kit according procedure recommended supplier panomics ozyme france
0.44163495.16170155.html.plaintext.txt	81	protein concentrations determined using bio rad protein assay kit bsa standard based classical bradford method
0.44163495.16170155.html.plaintext.txt	82	pgex srf plasmid generous gift d
0.44163495.16170155.html.plaintext.txt	83	trouche laboratoire de biologie moleculaire eucaryote used protein expression
0.44163495.16170155.html.plaintext.txt	84	gst srf fusion protein purified escherichia coli described previously 40
0.44163495.16170155.html.plaintext.txt	85	purity concentration protein samples estimated sds page
0.44163495.16170155.html.plaintext.txt	86	electrophoretic mobility shift assay emsa supershifts oligonucleotides probes synthesized corresponding cftr carg like element mutant versions carg motif either mutated consensus box disrupted
0.44163495.16170155.html.plaintext.txt	87	oligonucleotide sequences listed table 2
0.44163495.16170155.html.plaintext.txt	88	single stranded complementary oligonucleotides containing studied sequences annealed end labeled 32patp 5000 cimmol purified described previously 12
0.44163495.16170155.html.plaintext.txt	89	mobility assay conditions specifically optimized binding srf
0.44163495.16170155.html.plaintext.txt	90	binding reaction carried total volume 20 microl containing 2 ng 30 000 c
0.44163495.16170155.html.plaintext.txt	91	labeled probe 10 microl binding buffer 2x 0
0.44163495.16170155.html.plaintext.txt	92	25 microg polydi dc amersham pharmacia used non specific competitor 5 12 microg nuclear extracts 100 1000 ng gst srf fusion chimera protein
0.44163495.16170155.html.plaintext.txt	93	emsa competition antibody interference assays proteins incubated either cold specific competitors wt sre oligonucleotides see table 2 unspecific competitor gata oligonucleotide see table 2 purified antibodies anti srf sc 335x anti yy1 sc 1703x anti ha santa cruz biotechnology inc
0.44163495.16170155.html.plaintext.txt	94	tebu france 20 min addition labeled probes
0.44163495.16170155.html.plaintext.txt	95	incubation 30 min room temperature complexes resolved 5 acrylamidebisacrylamide 291 native gel containing 0
0.44163495.16170155.html.plaintext.txt	96	view table table 2 ologonuc leotides used emsa analysis
0.44163495.16170155.html.plaintext.txt	97	formaldehyde cross linking chromatin immunoprecipitation beas2b a549 cells proteins cross linked dna adding formaldehyde final concentration 1 10 min 37 degrees c
0.44163495.16170155.html.plaintext.txt	98	fixed cells prepared immunoprecipitation using protocol chip assay kit upstate biotechnology inc
0.44163495.16170155.html.plaintext.txt	99	euromedex france minor modifications
0.44163495.16170155.html.plaintext.txt	100	cells resuspended 1 ml cold phosphate buffered saline pbs pelleted centrifugation lysed 800 microl sds lysis buffer 1 sds 10 mm edta 50 mm tris hcl ph 8
0.44163495.16170155.html.plaintext.txt	101	1 containing protease inhibitors 1 mm pmsf 1 microgmlaprotinin 1 microgml pepstatina
0.44163495.16170155.html.plaintext.txt	102	incubation ice 10 min cross linked chromatin sheared sonication following conditions eight times 10 40 maximum power diluted 10 fold chip dilution buffer 0
0.44163495.16170155.html.plaintext.txt	103	1 167 mm nacl protease inhibitors
0.44163495.16170155.html.plaintext.txt	104	aliquots containing 20 microl aliquot used control show total input dna
0.44163495.16170155.html.plaintext.txt	105	chromatin solution precleared 80 microl salmon sperm dnaprotein agarose 50 slurry upstate biotechnology inc
0.44163495.16170155.html.plaintext.txt	106	1 h 4 degrees c agitation subsequently incubated 4 degrees c rotating stand overnight either 3 microl anti srf antibody sc 335x santa cruz biotechnology inc
0.44163495.16170155.html.plaintext.txt	107	irrelevant antibody anti ha
0.44163495.16170155.html.plaintext.txt	108	immune complexes precipitated addition 60 microl salmon sperm dnaprotein agarose incubated 4 degrees c 1 h low speed spinning
0.44163495.16170155.html.plaintext.txt	109	precipitates washed 1 ml low salt buffer high salt buffer licl buffer twice 1x te according manufacturers recommendations upstate biotechnology inc
0.44163495.16170155.html.plaintext.txt	110	cross links reversed addition 20 microl 5 m nacl incubation 65 degrees c overnight
0.44163495.16170155.html.plaintext.txt	111	samples treated proteinase k phenol chloroform extracted ethanol precipitated resuspended 30 microl sterile water
0.44163495.16170155.html.plaintext.txt	112	pcr analysis carried using primers different regions human cftr promoter additional controls promoter regions number genes either silent ss globin least one functional carg element ss actin
0.44163495.16170155.html.plaintext.txt	113	sequences pcr primers listed table 1
0.44163495.16170155.html.plaintext.txt	114	45 cycles amplification pcr products separated 1
0.44163495.16170155.html.plaintext.txt	115	8 agarose gels visualized ethidium bromide staining uv transillumination
0.44163495.16170155.html.plaintext.txt	116	reverse transcriptase pcr total rna epithelial cells beas2b a549 myoblasts c2c12 fibroblasts cos 7 isolated using sv total rna isolation system promega france
0.44163495.16170155.html.plaintext.txt	117	reverse transcription performed 3 microg total rna 300 ng random hexamers invitrogen corporation 10 mm dntps 1 microl rnasin rnase inhibitor promega 2 microl dtt 0
0.44163495.16170155.html.plaintext.txt	118	1 m 4 microl first strand buffer invitrogen 200 u m mlv rt invitrogen nuclease free water promega final reaction volume 20 microl
0.44163495.16170155.html.plaintext.txt	119	rna template control reaction without rt included
0.44163495.16170155.html.plaintext.txt	120	rt reaction condition h2o template reaction included additional negative control
0.44163495.16170155.html.plaintext.txt	121	reaction mixture incubated first 10 min 25 degrees c 40 min 42 degrees c followed heat inactivation step 72 degrees c 3 min
0.44163495.16170155.html.plaintext.txt	122	aliquots containing 1 microl cdna synthesis reaction mixture used pcr analyses
0.44163495.16170155.html.plaintext.txt	123	expression level srf mrna analyzed pcr amplification endogenous hypoxanthine phosphorybosyl transferase hprt gene used internal control
0.44163495.16170155.html.plaintext.txt	124	amplification mixture included either 10 pmol srf specific primer 10 pmol hprt specific primer 1
0.44163495.16170155.html.plaintext.txt	125	5 u amplitaq polymerase applied biosystem corporation nuclease free water promega 25 microl volume
0.44163495.16170155.html.plaintext.txt	126	amplification performed initial denaturation step 95 degrees c 5 min followed 35 cycles 30 95 degrees c denaturation 60 52 degrees c annealing 2 min extension 72 degrees c
0.44163495.16170155.html.plaintext.txt	127	amplification cftr performed described previously 41
0.44163495.16170155.html.plaintext.txt	128	rt pcr products separated 8 non denaturing polyacrylamide gel stained ethidium bromide
0.44163495.16170155.html.plaintext.txt	129	ensure sequence cdna products derived srf cftr rt pcr analyses correspond respective published sequences cdna bands purified prepared dideoxy dna sequencing
0.44163495.16170155.html.plaintext.txt	130	controls included rna preparations monkey kidney fibroblasts cos 7 negative cftr expression 3637
0.44163495.16170155.html.plaintext.txt	131	western blot analysis twenty five microgram protein extracts except otherwise indicated resolved 10 except otherwise indicated sds polyacrylamide gel transferred onto nitrocellulose membrane except otherwise indicated
0.44163495.16170155.html.plaintext.txt	132	membranes ponceau stained ensure sample integrity
0.44163495.16170155.html.plaintext.txt	133	briefly membranes blocked 5 skim milk pbs supplemented 0
0.44163495.16170155.html.plaintext.txt	134	01 tween 20 incubated diluted primary antibodies 5 skim milk 15000 diluted anti srf abs sc 335x sc 25290x purchased santa cruz 11000 diluted anti cftr ab 24
0.44163495.16170155.html.plaintext.txt	135	1 r d system 12500 diluted anti ss actin antibody ac 15 sigma 12500 diluted anti ss tubulin antibody t6074 sigma overnight
0.44163495.16170155.html.plaintext.txt	136	membranes washed incubated appropriate horseradish peroxidase hrp conjugated secondary antibody 115 000 pbs 5 milk
0.44163495.16170155.html.plaintext.txt	137	membranes reacted chemiluminescence reagent ecl roche diagnostic described manufacturer subsequently exposed biomax photographic film kodak corporation
0.44163495.16170155.html.plaintext.txt	138	protein levels actin housekeeping gene except otherwise stated assayed internal control protein loading
0.44163495.16170155.html.plaintext.txt	139	indirect immunofluorescence a549 beas2b c2c12 cos 7 cells plated lab tektmii cc2tm chamber slidetm systems nalge nunc 1 day immunohistochemical analysis
0.44163495.16170155.html.plaintext.txt	140	cells fixed permeabilized 4 paraformaldehyde 0
0.44163495.16170155.html.plaintext.txt	141	1 triton x 100 respectively 20 min durations room temperature
0.44163495.16170155.html.plaintext.txt	142	non specific binding sites blocked 1 bsa pbs 1 h
0.44163495.16170155.html.plaintext.txt	143	cells subsequently incubated primary antibodies diluted 1100 pbs bsa
0.44163495.16170155.html.plaintext.txt	144	antibodies used included clone l12b4 upstate biotechnology anti cftr antibody known recognize human rat mouse bovine cftrs 42 h 300 a11 anti srf antibody sc 13029 sc 25290 santa cruz
0.44163495.16170155.html.plaintext.txt	145	specificity anti cftr antibody described previously 4344 also verified using cftr positive human caco 2 cell line 3435
0.44163495.16170155.html.plaintext.txt	146	nuclear counterstaining dapi sc 3598 santa cruz applied concentration 15000
0.44163495.16170155.html.plaintext.txt	147	cells washed pbs bsa incubated either donkey anti rabbit fluorescein isothiocyanate conjugated fitc donkey anti mouse cy3tm conjugated secondary antibody jackson immunoresearch laboratory inc
0.44163495.16170155.html.plaintext.txt	148	diluted 1200 1 h room temperature
0.44163495.16170155.html.plaintext.txt	149	cells washed twice pbs bsa pbs mounted dakocytomation fluorescent mounting medium dakocytomation
0.44163495.16170155.html.plaintext.txt	150	indirect immunofluorescence examined inverted leica dmr microscope leica microsystemes sas
0.44163495.16170155.html.plaintext.txt	151	final images processed using adobe photoshop 7
0.44163495.16170155.html.plaintext.txt	152	statistical analyses transfection data expressed mean plus minus se
0.44163495.16170155.html.plaintext.txt	153	paired comparisons made using students test
0.44163495.16170155.html.plaintext.txt	154	data considered statistically significant p 0
0.44163495.16170155.html.plaintext.txt	155	graphical data statistical analyses generated graphpad prism software version 3
0.44163495.16170155.html.plaintext.txt	156	densitometric analysis performed using computerized densitometry imagequanttl v
0.44163495.16170155.html.plaintext.txt	157	0 software amersham biosciences
0.44163495.16170155.html.plaintext.txt	158	densitometric values transcript protein bands determined areas equal size reported normalized arbitrary units relatives expression either hprt gene actin protein set 1 except otherwise indicated
0.44163495.16170155.html.plaintext.txt	159	computational analyses computer program consite httpwww
0.44163495.16170155.html.plaintext.txt	160	org particularly suited analysis large genomic sequences used identify putative carg binding sites within promoter intronic regions human cftr gene
0.44163495.16170155.html.plaintext.txt	161	com used verify predictions minimize false negatives positives
0.44163495.16170155.html.plaintext.txt	162	prevent possible bias introduced palindromic internally repetitive cis regulatory elements overlapping matches including opposite dna strands defined single match
0.44163495.16170155.html.plaintext.txt	163	assess importance putative carg elements identified non coding regions human cftr gene performed multiple sequence alignments
0.44163495.16170155.html.plaintext.txt	164	human cynomolgus gibbon squirrel monkey rabbit pig sheep cow sequences aligned using clustalw global alignment tool httpclustalw
0.44163495.16170155.html.plaintext.txt	165	gap open extension penalties set 15 6
0.44163495.16170155.html.plaintext.txt	166	66 respectively sequence delay divergence 30 dna transition weight 0
0.44163495.16170155.html.plaintext.txt	167	results top abstract introduction materials methods results discussion references cftr minimal promoter region encompassing cftr carg like element remarkably conserved search cis acting elements involved cftr gene expression regulation previously performed silico search transcription factor binding sites 46 reported human minimal cftr promoter contains carg like motif localized 108 bp upstream major transcription initiation start site 38
0.44163495.16170155.html.plaintext.txt	168	far described carg box elements found regulatory regions immediate early genes 47 muscle specific genes 22 confirmed first binding site prediction using two algorithms alibaba httpwww
0.44163495.16170155.html.plaintext.txt	169	com consite httpclustalw
0.44163495.16170155.html.plaintext.txt	170	shown figure 1a cftr carg like element sequence gcat6gg diverges slightly 5 published srf consensus sequence ccat6gg 2237
0.44163495.16170155.html.plaintext.txt	171	however divergence similar observed smooth muscle gamma actin promoter demonstrated bind srf 48
0.44163495.16170155.html.plaintext.txt	172	view larger version 29k figure 1 cross species comparison cftr carg like element
0.44163495.16170155.html.plaintext.txt	173	visualization consensus carg binding site pop window containing information srf transcription factor obtained silico analysis performed consite tool
0.44163495.16170155.html.plaintext.txt	174	b detailed alignment view carg like element including region human cftr minimal promoter seven orthologous sequences cynomolgus gibbon squirrel monkey rabbit pig sheep cow
0.44163495.16170155.html.plaintext.txt	175	dashes indicate gaps introduced maximize alignment
0.44163495.16170155.html.plaintext.txt	176	sequence represented classical text representation nucleotide assigned color colored red c blue g green black
0.44163495.16170155.html.plaintext.txt	177	numberings cynomolgus sequence indicated according major human transcription initiation site
0.44163495.16170155.html.plaintext.txt	178	left panel phylogenetic relationships different species illustrated rooted tree directly derived clustalw program
0.44163495.16170155.html.plaintext.txt	179	right panel humanspecies homologies indicated
0.44163495.16170155.html.plaintext.txt	180	accession number cftr genomic sequence indicated species name brackets bold characters
0.44163495.16170155.html.plaintext.txt	181	human cftr carg like motif noted cynomolgus sequence
0.44163495.16170155.html.plaintext.txt	182	assess putative functional importance cftr carg like binding site used orthogonal approach deducing regulatory elements considering orthologous cftr minimal promoter regions several mammalian species representing primates artiodactylia lagomorpha orders
0.44163495.16170155.html.plaintext.txt	183	comparison humanspecies homologies carried using clustalw multiple cftr sequence alignments according numerous alignment parameters described previously 49
0.44163495.16170155.html.plaintext.txt	184	consistent previous studies 5051 showed human minimal cftr promoter remarkably conserved across orders studied figure 1b right panel
0.44163495.16170155.html.plaintext.txt	185	found cftr carg like element conserved within primates species studied also within pig within sheep cow rabbit species substitutions occur middle carg like motif figure 1b
0.44163495.16170155.html.plaintext.txt	186	data consistent previous cftr promoter phylogenetic work identified two types regulatory elements conserved species non consensus cre positions 0
0.44163495.16170155.html.plaintext.txt	187	1 kb relative atg species specific elements 300 bp purine
0.44163495.16170155.html.plaintext.txt	188	py stretch present rodents 50
0.44163495.16170155.html.plaintext.txt	189	bronchial epithelial expression srf could previously identify srf binding cftr carg like element even though anti srf antibody used 12 asked whether srf mainly described highly expressed muscle cells also present epithelial cell lines
0.44163495.16170155.html.plaintext.txt	190	measure expression levels srf mrnas used rt pcr based procedure previously described davis et al
0.44163495.16170155.html.plaintext.txt	191	reverse transcribed control hypoxanthine phosphorybosyl transferase hprt housekeeping gene amplified
0.44163495.16170155.html.plaintext.txt	192	amplification srf bronchial epithelial cells myoblasts yielded fragment size 651 bp figure 2a full length srf transcript produced rt pcr human hearts 52
0.44163495.16170155.html.plaintext.txt	193	453 bp band corresponding srf lacking exon 5 srf5 detected c2c12 myoblast line figure 2a
0.44163495.16170155.html.plaintext.txt	194	ensure bands result pcr artifact genomic contamination samples negative controls exclusion rt rna cdna synthesis included assay
0.44163495.16170155.html.plaintext.txt	195	expected pcr product appeared either rt template omitted figure 2a
0.44163495.16170155.html.plaintext.txt	196	densitometric analysis revealed bronchial epithelial cells contained appreciable amount srf mrna
0.44163495.16170155.html.plaintext.txt	197	nuclear extracts a549 beas2b c2c12 cells electrophoresed assayed western blotting anti srf antibody reported recognize four isoforms protein 52
0.44163495.16170155.html.plaintext.txt	198	shown figure 2b found robust expression 67 kda band based molecular mass corresponds full length srf srf fl cell lines examined
0.44163495.16170155.html.plaintext.txt	199	consistent wit rt pcr analysis 57 kda band corresponding srf5 detected c2c12 myoblast line
0.44163495.16170155.html.plaintext.txt	200	control checked ss actin levels figure 2b
0.44163495.16170155.html.plaintext.txt	201	densitometric analysis western blot revealed apparent difference expression level srf proteins myoblasts epithelial cells figure 2b
0.44163495.16170155.html.plaintext.txt	202	subsequent western blot analyses parallel blots probed secondary antibody band detected data shown thus confirming bands indeed specific srf
0.44163495.16170155.html.plaintext.txt	203	evidence a549 beas2b c2c12 cells express relatively large amounts srf cell lines assessed indirect immunofluorescence labeling
0.44163495.16170155.html.plaintext.txt	204	similar staining pattern noted bronchial epithelial cells myoblasts figure 2c rows c
0.44163495.16170155.html.plaintext.txt	205	nuclei stained blue dapi
0.44163495.16170155.html.plaintext.txt	206	negative control staining detected primary antibody omitted figure 2c row d
0.44163495.16170155.html.plaintext.txt	207	consistent studies reporting srf ubiquitously expressed variety cell types 262753 srf expression studies demonstrated human srf gene expressed bronchial epithelial cells
0.44163495.16170155.html.plaintext.txt	208	view larger version 25k figure 2 bronchial epithelial expression srf
0.44163495.16170155.html.plaintext.txt	209	detection srf hprt transcripts bronchial epithelial myoblast cell lines rt pcr analysis
0.44163495.16170155.html.plaintext.txt	210	total rnas isolated a549 beas2b c2c12 cells indicated reverse transcribed random hexamers pcr amplified srf hprt primers
0.44163495.16170155.html.plaintext.txt	211	amplified products directly stained bromide ethidium non denaturing polyacrylamide gel
0.44163495.16170155.html.plaintext.txt	212	expected size pcr products given left transcript
0.44163495.16170155.html.plaintext.txt	213	negative controls noted follow rt absence reverse transcriptase rna h2o template reaction
0.44163495.16170155.html.plaintext.txt	214	densitometric analysis srf bands intensity performed relative hprt mrna expression c2c12 myoblasts
0.44163495.16170155.html.plaintext.txt	215	b western blot analysis nuclear extracts prepared epithelial myoblast lines
0.44163495.16170155.html.plaintext.txt	216	extract 25 microg separated sdspage 10 western blotted using anti srf ab
0.44163495.16170155.html.plaintext.txt	217	relative mass kilodaltons indicated alongside
0.44163495.16170155.html.plaintext.txt	218	control proteins loading sds page anti ss actin ab used western blot
0.44163495.16170155.html.plaintext.txt	219	numbers ss actin panel indicate densitometric values total srf bands normalized corresponding ss actin bands expressed relative c2c12 controls bands set 1
0.44163495.16170155.html.plaintext.txt	220	c a549 beas2b c2c12 cells rows b c respectively grown coverslips fixed subjected indirect immunofluorescence anti srf ab
0.44163495.16170155.html.plaintext.txt	221	left panel cells stained fitc conjugated secondary antibody green
0.44163495.16170155.html.plaintext.txt	222	middle panel cells counterstained dapi blue nuclear staining
0.44163495.16170155.html.plaintext.txt	223	right panel shown merge srf immunostaining dapi
0.44163495.16170155.html.plaintext.txt	224	row d background immunofluorescence obtained absence primary antibody
0.44163495.16170155.html.plaintext.txt	225	srf binds cftr carg like element carg box found regulatory regions many muscle specific genes also located center sres 54 forms core binding site srf 55 attempted determine whether srf binds cftr carg like element sequence
0.44163495.16170155.html.plaintext.txt	226	performed two series bandshift experiments
0.44163495.16170155.html.plaintext.txt	227	first incubated 32p labelled wt oligonucleotide corresponding cftr carg like element sequence indicated table 2 bacterially expressed srf
0.44163495.16170155.html.plaintext.txt	228	shown figure 3a lane 3 emsa revealed recombinant srf wt duplex
0.44163495.16170155.html.plaintext.txt	229	shown figure 3a lane 5 bands defined cftr carg like srf complex disappeared 100 fold molar excess specific competitor containing consensus sre motif derived human c fos promoter 56 added
0.44163495.16170155.html.plaintext.txt	230	contrast competition irrelevant oligonucleotide noted uc appear significantly alter complex suggesting specificity binding lane 6
0.44163495.16170155.html.plaintext.txt	231	confirm precisely identity protein binding minimal cftr promoter 121 83 bp bacterially expressed srf preincubated anti srf antibody incubation 32p labelled probe
0.44163495.16170155.html.plaintext.txt	232	shown figure 3a lane 4 bands corresponding cftr carg like srf complex disappeared slowly migrating bands appeared anti srf antibody added
0.44163495.16170155.html.plaintext.txt	233	verify antibody specificity control experiments performed either absence srf protein figure 3a lane 7 presence irrelevant antibody figure 3a lane 8
0.44163495.16170155.html.plaintext.txt	234	results demonstrate cftr carg like element bona fide srf binding site
0.44163495.16170155.html.plaintext.txt	235	second performed additional emsa wt oligonucleotide main binding target nuclear extracts epithelial muscle cells figure 3b
0.44163495.16170155.html.plaintext.txt	236	three nucleoprotein complexes formed nuclear extracts beas2b c2c12 cells wt probe five complexes detected a549 cells
0.44163495.16170155.html.plaintext.txt	237	nuclear protein complex designated upper case relative nuclear lysate followed roman numeral indicating position gels
0.44163495.16170155.html.plaintext.txt	238	binding specificity different complexes examined competition analyses specific non specific unlabeled oligonucleotides figure 3b lanes 2 4
0.44163495.16170155.html.plaintext.txt	239	although non specific binding activities observed complexes bii biii aiii av ci cii ciii efficiently competed excess wt c fos sre unlabeled specific competitors indicating binding specificity figure 3b lanes 2 3 respectively
0.44163495.16170155.html.plaintext.txt	240	control experiments including irrelevant oligonucleotide reveal change electrophoretic profiles figure 3b lanes 4
0.44163495.16170155.html.plaintext.txt	241	evaluate whether srf protein contributes formation nucleoprotein complexes interacting cftr derived srf site used specific antibody srf protein
0.44163495.16170155.html.plaintext.txt	242	although incubation anti srf antibody apparently failed give discrete supershift various sources nuclear proteins significant decrease specific complexes observed figure 3b lanes 6
0.44163495.16170155.html.plaintext.txt	243	effect seemed specific none nuclear protein complexes supershifted abolished non specific antibody used figure 3b lanes 7
0.44163495.16170155.html.plaintext.txt	244	control experiments containing anti srf antiserum radiolabeled wt oligonucleotide reveal binding activities figure 3b lanes 8
0.44163495.16170155.html.plaintext.txt	245	addition supershift assays performed radiolabeled c fos sre oligonucleotide instead wt probe showed bands corresponding sre srf complex disappeared slowly migrating bands appeared figure 3b lane 10
0.44163495.16170155.html.plaintext.txt	246	absence supershift specific wt binding complexes figure 3d lanes 6 may explained epitope recognized anti srf antibody part located near cftr carg like dna binding site
0.44163495.16170155.html.plaintext.txt	247	antibody binding would compete dna binding resulting significant decrease total disappearance carg like complexes rather supershifted complexes
0.44163495.16170155.html.plaintext.txt	248	alternatively interaction cftr carg like dna binding site srf protein insufficiently strong could stable one observed sre probe figure 3b lane 10 detected supershift gel retardation assays
0.44163495.16170155.html.plaintext.txt	249	one hand dna binding proteins potentially part complex could interfere antibodys access srf protein
0.44163495.16170155.html.plaintext.txt	250	taken together emsa studies establish srf binding carg like box within minimal promoter human cftr gene
0.44163495.16170155.html.plaintext.txt	251	view larger version 36k figure 3 srf component cftr carg like binding complexes
0.44163495.16170155.html.plaintext.txt	252	emsas performed radiolabeled oligonucleotide encompassing studied cftr carg like motif noted wt see table 2 bacterially expressed srf lane 3
0.44163495.16170155.html.plaintext.txt	253	competition assays carried using 100 fold molar excess two specific competitors noted wt sre lanes 2 5 respectively
0.44163495.16170155.html.plaintext.txt	254	uc lane 6 indicates unspecific competitor used negative control
0.44163495.16170155.html.plaintext.txt	255	supershift assays carried using either specific antibody lane 4 irrelevant antibody lane 8
0.44163495.16170155.html.plaintext.txt	256	arrow ss indicates ab supershifted complex
0.44163495.16170155.html.plaintext.txt	257	neither retarded supershifted complexes found 32p labeled wt double stranded oligonucleotide incubated either binding buffer lane 1 specific anti srf antibody absence purified srf protein lane 7
0.44163495.16170155.html.plaintext.txt	258	b emsas performed wt 32p labeled probe absence proteins lanes 1 nuclear extracts lanes 5 isolated beas2b upper panel a549 middle panel c2c12 cells lower panel
0.44163495.16170155.html.plaintext.txt	259	three five nuclear protein complexes detected designated cell type dependent upper case left autoradiograms
0.44163495.16170155.html.plaintext.txt	260	binding reaction mixtures included 100 fold molar excess indicated cold probes lanes 2 4
0.44163495.16170155.html.plaintext.txt	261	immunologic assays performed either anti srf ab lanes 6 anti ha irrelevant antiserum lanes 7
0.44163495.16170155.html.plaintext.txt	262	control 32p labeled wt probe incubated anti srf ab without nuclear extracts lanes 8
0.44163495.16170155.html.plaintext.txt	263	additional control experiments radiolabeled sre double stranded oligonucleotide corresponding sre binding site c fos promoter subjected emsas nuclear extracts beas2b cells upper panel absence lane 9 presence anti srf antiserum lane 10
0.44163495.16170155.html.plaintext.txt	264	nuclear protein complexes significantly decreased supershifted anti srf ab indicated
0.44163495.16170155.html.plaintext.txt	265	srf binds carg like motif cftr minimal promoter within intact chromatin physiological conditions although extensive evidence srf bind carg like elements vitro assays involved transcriptional regulation carg elements reporter assays cultured cells typical epithelioid morphology 53 lack direct evidence involvement srf transcription endogenous cftr gene within context intact chromatin
0.44163495.16170155.html.plaintext.txt	266	directly address whether srf also binds vivo chip carried bronchial epithelial cells
0.44163495.16170155.html.plaintext.txt	267	purpose dna binding proteins beas2b epithelial cells covalently linked genomic dna treatment cells formaldehyde
0.44163495.16170155.html.plaintext.txt	268	cross linked chromatin immunoprecipitated either specific irrelevant antibodies anti srf anti ha respectively
0.44163495.16170155.html.plaintext.txt	269	precipitated chromatin dna purified amplified pcr specific primers target sequences table 1
0.44163495.16170155.html.plaintext.txt	270	promoter ss globin gene lacks carg elements used negative control figure 4 row
0.44163495.16170155.html.plaintext.txt	271	skeletal ss actin promoter sequence contains least consensus srf binding site used positive control figure 4 row b
0.44163495.16170155.html.plaintext.txt	272	expected pcr signals obtained dnaprotein adducts immunoprecipitated anti srf antibody beas2b figure 4 rows b c lane 1 a549 data shown epithelial cell lines
0.44163495.16170155.html.plaintext.txt	273	contrast negative controls immunoprecipitation performed irrelevant antibody figure 4 rows c lane 3 without antibody figure 4 rows c lane 2 show pcr signal
0.44163495.16170155.html.plaintext.txt	274	results reproduced several independently isolated chip populations
0.44163495.16170155.html.plaintext.txt	275	data show cftr carg like binding site identified within cftr minimal promoter binds srf vivo bronchial cell lines
0.44163495.16170155.html.plaintext.txt	276	view larger version 14k figure 4 chip analysis srf binding endogenous cftr minimal promoter
0.44163495.16170155.html.plaintext.txt	277	chromatin immunoprecipitation carried described materials methods
0.44163495.16170155.html.plaintext.txt	278	sheared dnaprotein complexes immunoprecipitated using either anti srf ab irrelevant anti ha ab
0.44163495.16170155.html.plaintext.txt	279	pcr carried detect endogenous carg regions immunoprecipitated chromatin fragments
0.44163495.16170155.html.plaintext.txt	280	target promoter sequences indicated follow row ss globin row b ss actin row c cftr
0.44163495.16170155.html.plaintext.txt	281	lane 1 shows amplification target sequences immunoprecipitated chromatin fragments anti srf ab
0.44163495.16170155.html.plaintext.txt	282	lanes 2 3 pcr amplification control samples without ab irrelevant ab
0.44163495.16170155.html.plaintext.txt	283	lane 4 shows amplification 1100 dilution samples total input dna immunoprecipitation
0.44163495.16170155.html.plaintext.txt	284	human minimal cftr promoter shows activity epithelial muscular cells srf transcription factor thought mainly mediate tissue specific transcription muscular cells first assessed activity minimal cftr promoter epithelial muscular cell types
0.44163495.16170155.html.plaintext.txt	285	therefore addressed ability wt pgl3 construct previously described 12 drive expression beas2b a549 c2c12 cells
0.44163495.16170155.html.plaintext.txt	286	shown figure 5a efficient transcription cftr promoter could readily observed three cell lines compared monkey kidney fibroblasts cos 7 negative cftr expression 3637
0.44163495.16170155.html.plaintext.txt	287	surprisingly activity minimal cftr promoter c2c12 cells 4 5
0.44163495.16170155.html.plaintext.txt	288	5 times higher observed beas2b a549 cells respectively
0.44163495.16170155.html.plaintext.txt	289	although expression cftr protein previously evidenced muscle cells 57 59 never investigated mouse c2c12 myoblasts
0.44163495.16170155.html.plaintext.txt	290	therefore investigated cftr expression mrna protein levels
0.44163495.16170155.html.plaintext.txt	291	examine cftr mrna expression mouse myoblasts c2c12 total rna isolated epithelial non epithelial cells analyzed via rt pcr cftr specific primers table 1
0.44163495.16170155.html.plaintext.txt	292	shown figure 5b pcr product cftr seen cos 7 cells expected cftr amplified product obtained epithelial a549 beas2b muscular c2c12 cell lines
0.44163495.16170155.html.plaintext.txt	293	product detected absence reverse transcriptase rna noted rt rna respectively
0.44163495.16170155.html.plaintext.txt	294	although hprt pcr control showed non equivalent amounts cdna used different pcrs densitometric analysis revealed c2c12 cells contained appreciable amount cftr mrna
0.44163495.16170155.html.plaintext.txt	295	determination cftr expression c2c12 myoblasts conducted western blot analysis figure 5c
0.44163495.16170155.html.plaintext.txt	296	caco 2 cells used positive control cos 7 negative control
0.44163495.16170155.html.plaintext.txt	297	shown figure 5c mature fully glycosylated band c cftr observed a549 beas2b c2c12 cells core glycosylated band b cftr occurred molecular mass subset cell lines indicative potential variations glycosylation process
0.44163495.16170155.html.plaintext.txt	298	rule possibility antibodies cross reactivity non specific labeling indirect immunofluorescence analysis performed another anti cftr antibody l12b4 figure 5d
0.44163495.16170155.html.plaintext.txt	299	expected caco 2 cell line used positive control showed strong immunoreactivity cftr protein figure 5d row d
0.44163495.16170155.html.plaintext.txt	300	contrast expected cos 7 cells used negative control stain anti cftr antibody figure 5d row e
0.44163495.16170155.html.plaintext.txt	301	staining detected primary antibody omitted figure 5d row f
0.44163495.16170155.html.plaintext.txt	302	comparison immunofluorescence images epithelial figure 5d row b d muscular figure 5d row c cells provides evidence cftr significantly expressed c2c12 myoblasts
0.44163495.16170155.html.plaintext.txt	303	however indirect immunofluorescence experiments performed permeabilized cells distinguish cftr located apical membrane cftr located vesicular pool beneath apical membrane
0.44163495.16170155.html.plaintext.txt	304	findings together transcriptional activities presented suggest minimal cftr promoter might contain tissue specific enhancers well repressive cis regulatory elements ability mitigate activity cftr promoter epithelial non epithelial lineages
0.44163495.16170155.html.plaintext.txt	305	cf affects mainly epithelial tissues beas2b consistently yielded higher enhancer activity a549 restricted subsequent studies bronchial epithelial cell line
0.44163495.16170155.html.plaintext.txt	306	view larger version 25k figure 5 analysis cftr minimal promoter activity cftr expression
0.44163495.16170155.html.plaintext.txt	307	cftr minimal promoter activities beas2b a549 c2c12 cos 7 cell lines
0.44163495.16170155.html.plaintext.txt	308	8 microg wt pgl3 construct co transfected together 0
0.44163495.16170155.html.plaintext.txt	309	2 microg internal control prl sv40 containing renilla luciferase
0.44163495.16170155.html.plaintext.txt	310	empty pgl3 basic vector transfected negative control
0.44163495.16170155.html.plaintext.txt	311	normalized luciferase values illustrated relative light units
0.44163495.16170155.html.plaintext.txt	312	mean two independent plasmids preps experiment standard errors shown
0.44163495.16170155.html.plaintext.txt	313	experimental value luciferase activity represented mean plus minus sd four separate experiments triplicates
0.44163495.16170155.html.plaintext.txt	314	b rt pcr analysis cftr mrna expression
0.44163495.16170155.html.plaintext.txt	315	total rna harvested indicated cell lines subjected pcr described materials methods
0.44163495.16170155.html.plaintext.txt	316	cdna derived cos 7 used negative control
0.44163495.16170155.html.plaintext.txt	317	samples without reverse transcriptase noted rt h2o template reaction noted rna used additional negative controls
0.44163495.16170155.html.plaintext.txt	318	samples also amplified hprt control rna degradation dnase treatment reverse transcription
0.44163495.16170155.html.plaintext.txt	319	densitometric analysis cftr bands intensity performed relative hprt mrna expression beas2b bronchial epithelial cells
0.44163495.16170155.html.plaintext.txt	320	whole cell proteins extracts prepared indicated cells subjected electrophoresis 7 sds page gel transferred supported pvdf membrane
0.44163495.16170155.html.plaintext.txt	321	cftr immunoreactivity detected using 24
0.44163495.16170155.html.plaintext.txt	322	1 anti cftr ab primary antibody
0.44163495.16170155.html.plaintext.txt	323	positions core glycosylated band b mature fully glycosylated cftr band c indicated arrows right
0.44163495.16170155.html.plaintext.txt	324	numbers ss actin panel indicate intensity values integrated optical densities mature immature cftr bands normalized corresponding ss actin bands expressed relative beas2b controls bands set 1
0.44163495.16170155.html.plaintext.txt	325	d indirect immunofluorescence analysis
0.44163495.16170155.html.plaintext.txt	326	a549 beas2b c2c12 caco 2 cos 7 cells rows e respectively fixed permeabilized stained l12b4 anti cftr ab followed appropriate secondary antibody described materials methods
0.44163495.16170155.html.plaintext.txt	327	left panel cells stained cy3 conjugated secondary antibody red
0.44163495.16170155.html.plaintext.txt	328	middle panel cells counterstained dapi blue nuclear staining
0.44163495.16170155.html.plaintext.txt	329	right panel shown merge cftr immunostaining dapi
0.44163495.16170155.html.plaintext.txt	330	row f background immunofluorescence obtained absence primary antibody
0.44163495.16170155.html.plaintext.txt	331	effects srf proximal cftr promoter assess whether srf protein might affect cftr transcriptional regulation took two related approaches
0.44163495.16170155.html.plaintext.txt	332	first co transfected either exogenous full length srf truncated srf mutants wild type cftr minimal promoter
0.44163495.16170155.html.plaintext.txt	333	second utilized sirna approach ask whether reduction endogenous srf levels could affect basal cftr activation
0.44163495.16170155.html.plaintext.txt	334	luciferase assays carried beas2b cells using indicated srf expression vectors wt pgl3luciferase reporter construct figure 6b left panel
0.44163495.16170155.html.plaintext.txt	335	3xsre fos tata luciferase reporter gene used positive control transcriptional activity highly dependent srf binding figure 6b right panel
0.44163495.16170155.html.plaintext.txt	336	expected synthetic promoter containing several consensus sres markedly significantly activated 2 fold forced expression full length srf protein phiv srf figure 6b right panel truncated srf mutants either containing amino acids 133 264 corresponding dna binding domain srf phiv dbd srf deleted amino acids 153 165 essential part dna binding phiv dn srf induced modest significant decrease sre activity 10 30 respectively
0.44163495.16170155.html.plaintext.txt	337	srf expression vectors transiently co transfected wt pgl3 luciferase reporter construct trans activator effect srf notably reduced
0.44163495.16170155.html.plaintext.txt	338	indeed overexpression full length dominant negative phiv dn srf srf proteins resulted 50 increased 30 decreased luciferase activity respectively figure 6b left panel
0.44163495.16170155.html.plaintext.txt	339	unexpectedly inconsistent previous study 60 phiv dbd srf construct induced 40 increase wt pgl3 luciferase activity
0.44163495.16170155.html.plaintext.txt	340	results disparity may explained fact c fos promoter study 60 assessed dbd srf domain activity via microinjection corresponding truncated srf polypeptide
0.44163495.16170155.html.plaintext.txt	341	perhaps best explanation increased activity dna binding domain srf also called mads box sufficient transcriptional activation srf dependent genes mediates interactions accessory co activators 61
0.44163495.16170155.html.plaintext.txt	342	results suggest neither regions outside mads box n c terminal appear essential transactivation cftr promoter srf
0.44163495.16170155.html.plaintext.txt	343	view larger version 24k figure 6 effect srf activity carg containing cftr minimal promoter
0.44163495.16170155.html.plaintext.txt	344	schematic representation different srf constructs analyzed
0.44163495.16170155.html.plaintext.txt	345	srf fragments shown cloned phiv expression vector indicated materials methods
0.44163495.16170155.html.plaintext.txt	346	position mads box containing dna binding domain dimerization domain srf depicted black rectangle
0.44163495.16170155.html.plaintext.txt	347	wt srf construct encodes human full length srf open reading frame
0.44163495.16170155.html.plaintext.txt	348	dbd srf construct encodes dna binding domain srf
0.44163495.16170155.html.plaintext.txt	349	dn srf deletion construct encodes full length srf deleted essential part dna binding
0.44163495.16170155.html.plaintext.txt	350	b expression exogenous srf beas2b cells
0.44163495.16170155.html.plaintext.txt	351	cells co transfected wt pgl3 luciferase reporter plasmid left panel together empty phiv vector phiv srf phiv dbd srf phiv dn srf constructs indicated bar diagram
0.44163495.16170155.html.plaintext.txt	352	positive control 3xsre luciferase reporter plasmid used
0.44163495.16170155.html.plaintext.txt	353	experiment renilla luciferase expression plasmid included normalize transfection efficiency
0.44163495.16170155.html.plaintext.txt	354	reporter plasmid luciferase activity mean plus minus se derived 4 7 different transfection experiments performed triplicate
0.44163495.16170155.html.plaintext.txt	355	errors bars indicate standard deviations
0.44163495.16170155.html.plaintext.txt	356	luciferase activity value 100 assigned samples co transfected indicated reporter plasmid empty phiv expression vector
0.44163495.16170155.html.plaintext.txt	357	statistical significance referred differences activity obtained empty expression vector
0.44163495.16170155.html.plaintext.txt	358	c effects srf sirna cftr promoter activity expression beas2b epithelial cells
0.44163495.16170155.html.plaintext.txt	359	left panel beas2b cells co transfected either human control sirna vector plasmid encoding srf sirna indicated
0.44163495.16170155.html.plaintext.txt	360	forty eight hours following transfection total proteins harvested analyzed western blotting
0.44163495.16170155.html.plaintext.txt	361	densitometric analysis showed substantial decrease endogenous srf
0.44163495.16170155.html.plaintext.txt	362	right panel luciferase activity value 100 assigned samples co transfected control sirna
0.44163495.16170155.html.plaintext.txt	363	establish role srf mediating increase cftr gene transcription performed sirna experiments figure 6c
0.44163495.16170155.html.plaintext.txt	364	demonstrate efficacy specific srf sirna construct beas2b cells co transfected either control srf sirna plasmids western blots performed analyze levels srf cells
0.44163495.16170155.html.plaintext.txt	365	densitometric analysis western blot showed endogenous srf levels strongly reduced presence srf sirna plasmid figure 6c left panel
0.44163495.16170155.html.plaintext.txt	366	control srf sirna plasmids co transfected beas2b cells either wt pgl3 3xsre luciferase reporter construct
0.44163495.16170155.html.plaintext.txt	367	shown figure 6c right panel reduction endogenous srf protein level decreased activity wild type cftr promoter 3xsre fos tata luciferase reporter constructs 25
0.44163495.16170155.html.plaintext.txt	368	taken together findings indicate endogenous srf bronchial epithelial cells normally function transcriptional coactivator carg mediated transactivation
0.44163495.16170155.html.plaintext.txt	369	however found srf activated cftr promoter less well sre containing synthetic promoter suggesting carg like element mediated cftr transcriptional activation probably required bridging co activating factors
0.44163495.16170155.html.plaintext.txt	370	carg like element contained human minimal cftr promoter important sufficient basal transcriptional activity beas2b cells assess transcriptional relevance carg like binding sequence cftr minimal promoter mutants performed create either consensus carg element degenerated motif table 1
0.44163495.16170155.html.plaintext.txt	371	used d upper case c upper case designate degenerated carg motifs consensus carg elements respectively
0.44163495.16170155.html.plaintext.txt	372	ensure efficacy mutations abrogating transcription factor binding first performed series emsa experiments carg mutant wt probe table 2
0.44163495.16170155.html.plaintext.txt	373	expected based sequence analysis mutations resulting degenerated carg motifs d1 d2 d3 d4 mutants completely abolished srf binding activity figure 7a lanes 1 4 compared srf wt complexes figure 7a lane 5
0.44163495.16170155.html.plaintext.txt	374	addition probes containing consensus carg boxes c1 c2 c3 c4 c5 mutants bound srf strongly nuclear extracts prepared beas2b figure 7a lanes 6 10
0.44163495.16170155.html.plaintext.txt	375	inclusion anti srf antibody partially abolished srf binding activity resulted slower mobility band confirming identity binding protein figure 7a lane 11
0.44163495.16170155.html.plaintext.txt	376	minimal cftr promoter constructs bearing consensus disrupted carg boxes tested transient transfection assays beas2b cells figure 7b
0.44163495.16170155.html.plaintext.txt	377	compared luciferase activity resulting wt pgl3 construct variable increases reporter activity observed d1 d2 d3 d4 mutant constructs disrupted carg motif transiently transfected
0.44163495.16170155.html.plaintext.txt	378	hand mutations create consensus carg element result either reducing increasing transcriptional activity figure 7b
0.44163495.16170155.html.plaintext.txt	379	consistent preceding gel shift results revealing uncharacterized proteindna complex slightly slower mobility variable intensity compared srf dna complex finer mutagenesis studies suggest co activators co repressors might interact studied promoter sequences
0.44163495.16170155.html.plaintext.txt	380	taken together data demonstrated cftr carg like element alone sufficient confer basal transcriptional activation cftr gene
0.44163495.16170155.html.plaintext.txt	381	view larger version 51k figure 7 cftr carg like element sufficient basal transcriptional activity beas2b cells
0.44163495.16170155.html.plaintext.txt	382	emsa analysis nuclear extracts srf protein enriched beas2b cells using mutated labeled oligonucleotide probes sequences listed table 2
0.44163495.16170155.html.plaintext.txt	383	ab srf included indicated lane 10
0.44163495.16170155.html.plaintext.txt	384	arrow ss indicates supershifted complexes
0.44163495.16170155.html.plaintext.txt	385	b basal transcriptional activity carg variants cftr promoter
0.44163495.16170155.html.plaintext.txt	386	luciferase activity obtained wt pgl3 luciferase construct defined 100 relative luciferase activities mutant constructs expressed percentage value
0.44163495.16170155.html.plaintext.txt	387	firefly luciferase activity normalized respect renilla luciferase activity
0.44163495.16170155.html.plaintext.txt	388	errors bars indicate standard deviations
0.44163495.16170155.html.plaintext.txt	389	functional antagonism srf yy1 competition cftr carg like binding means establishing role srf binding carg boxes mediating either cftr enhancer silencer activity observed different minimal cftr promoter mutants performed additional computational analyses
0.44163495.16170155.html.plaintext.txt	390	sequence analysis carg boxes immediate flanking sequences showed c1 c3 c4 constructs contain consensus binding sites number transcription factors addition srf including transcription factor yy1
0.44163495.16170155.html.plaintext.txt	391	findings previous work 12 particularly evoked interest examine role yy1 srf mediated cftr transcriptional activity
0.44163495.16170155.html.plaintext.txt	392	first set experiments evaluated whether yy1 factor contributes formation nucleoprotein complexes interacting wt c1 c3 c4 radiolabeled probes
0.44163495.16170155.html.plaintext.txt	393	shown figure 8a incubation specific anti yy1 antibody resulted either significant decrease total disappearance complexes normally formed carg boxes component beas2b nuclear extracts establishing dna binding yy1 sequences tested
0.44163495.16170155.html.plaintext.txt	394	expected control experiment performed radiolabeled probe d2 devoid yy1 binding site anti yy1 antiserum reveal change electrophoretic profiles indicating specificity yy1 binding
0.44163495.16170155.html.plaintext.txt	395	thus emsas demonstrated cftr carg like wt probe consensus carg elements c1 c3 c4 served binding site least two distinct nuclear factors namely srf yy1 bronchial epithelial cells
0.44163495.16170155.html.plaintext.txt	396	view larger version 43k figure 8 functional interplay srf yy1
0.44163495.16170155.html.plaintext.txt	397	yy1 binding cftr carg elements
0.44163495.16170155.html.plaintext.txt	398	nuclear extracts beas2b cells incubated 32p labelled oligonucleotide probe containing either carg like noted wt consensus carg box noted c1 c3 c4 presence absence specific antibody raised yy1 indicated
0.44163495.16170155.html.plaintext.txt	399	d2 contain neither carg element yy1 site included negative control
0.44163495.16170155.html.plaintext.txt	400	arrows indicate position yy1
0.44163495.16170155.html.plaintext.txt	401	b mutually exclusive dna binding activity yy1 versus srf cftr carg site
0.44163495.16170155.html.plaintext.txt	402	labeled carg oligonucleotides used panel incubated yy1 transfected beas2b nuclear extracts 5 microg presence increasing amounts bacterial purified srf 100 1000 ng
0.44163495.16170155.html.plaintext.txt	403	arrows indicate position srf yy1
0.44163495.16170155.html.plaintext.txt	404	c functional antagonism srf yy1
0.44163495.16170155.html.plaintext.txt	405	beas2b transfected constructs containing either cftr carg like element noted wt consensus cftr carg boxes noted c1 c3 c4 presence srf andor yy1 expression vectors
0.44163495.16170155.html.plaintext.txt	406	luciferase activities normalized transfection efficiency renilla luciferase used internal control
0.44163495.16170155.html.plaintext.txt	407	luciferase activity value 100 assigned samples co transfected indicated reporter plasmid empty expression vector
0.44163495.16170155.html.plaintext.txt	408	mean plus minus sd least three independent experiments represented
0.44163495.16170155.html.plaintext.txt	409	determine whether interaction two factors target dna cftr carg like consensus carg sequence either mutually inclusive exclusive emsas conducted using bacterially expressed srf nuclear extracts prepared beas2b cells transfected yy1 expression vector source yy1 dna binding activity
0.44163495.16170155.html.plaintext.txt	410	shown figure 8b yy1 binding complex significantly reduced increasing srf binding activity suggesting mutually exclusive binding carg sites
0.44163495.16170155.html.plaintext.txt	411	consistent studies 3262 emsas results suggested working hypothesis srf yy1 likely act functional competitors cftr promoter activity
0.44163495.16170155.html.plaintext.txt	412	since minimal cftr promoter activated srf knowing previous studies 30 33 yy1 negatively regulates promoter containing carg elements seemed logical first assess whether yy1 could also repress cftr promoter
0.44163495.16170155.html.plaintext.txt	413	asked whether carg like binding site cftr promoter acted negative regulatory elements
0.44163495.16170155.html.plaintext.txt	414	several cftr promoter reporter constructs containing either carg like namely wt consensus carg element c1 c3 c4 co transfected srf andor yy1 expression vectors beas2b cells
0.44163495.16170155.html.plaintext.txt	415	shown figure 8c co transfections srf alone resulted 1
0.44163495.16170155.html.plaintext.txt	416	5 2 fold luciferase activation forced expression yy1 protein caused strong decrease reporter activities 50 75 control luciferase value
0.44163495.16170155.html.plaintext.txt	417	therefore wanted determine functional relationship factors cftr activity regulation
0.44163495.16170155.html.plaintext.txt	418	transient co transfections analysis combination protein expression vectors showed expression srf either restore figure 8c panel wt c4 reporter constructs slightly raised yy1 repressed reporter activities figure 8c panel c1 c3 reporter constructs
0.44163495.16170155.html.plaintext.txt	419	findings consistent results obtained co transfections performed yy1 expression vector alone previous alpha actin promoter studies 30 33 yy1 acted strong repressor
0.44163495.16170155.html.plaintext.txt	420	taken together data suggested functional antagonism srf yy1 dna binding competition
0.44163495.16170155.html.plaintext.txt	421	identification multiple carg binding sites non coding regions human cftr gene assessment putative functional importance assess putative importance carg motifs human cftr expression regulation performed silico inspection additional sequences upstream minimal promoter intronic regions
0.44163495.16170155.html.plaintext.txt	422	four carg binding sites found cftr promoter regions seven intronic regions
0.44163495.16170155.html.plaintext.txt	423	distribution positions putative binding sites srf shown figure 9a
0.44163495.16170155.html.plaintext.txt	424	confirm computational predictions used several approaches
0.44163495.16170155.html.plaintext.txt	425	first nucleotide regions harboring predicted cis acting elements analyzed conservation cow physiologically relevant transcription factor binding sites frequently conserved non coding regions orthologous genes 4963
0.44163495.16170155.html.plaintext.txt	426	second srf binding sites tested emsas also one chip
0.44163495.16170155.html.plaintext.txt	427	view larger version 61k figure 9 cftr gene untranslated regions contain multiple srf binding sites carg boxes
0.44163495.16170155.html.plaintext.txt	428	schematic drawing cftr gene shows exons circles location putative carg boxes non coding regions including identified minimal cftr promoter
0.44163495.16170155.html.plaintext.txt	429	b cftr gene non coding regions encompassing putative carg elements analyzed conservation cow
0.44163495.16170155.html.plaintext.txt	430	species homology positions conserved sequence within bac clones indicated reported recent work 49
0.44163495.16170155.html.plaintext.txt	431	c comparative binding srf cftr carg boxes
0.44163495.16170155.html.plaintext.txt	432	promoter intronic carg box containing oligonucleotide see table 2 radiolabeled purified described materials methods
0.44163495.16170155.html.plaintext.txt	433	upper panel binding reaction performed bacterially expressed srf
0.44163495.16170155.html.plaintext.txt	434	ab srf included indicated
0.44163495.16170155.html.plaintext.txt	435	arrow indicates specific dna srf complexes ss indicates ab supershifted complexes
0.44163495.16170155.html.plaintext.txt	436	lower panel emsa analysis nuclear extracts beas2b cells using mutated labeled oligonucleotide probes
0.44163495.16170155.html.plaintext.txt	437	d chip analysis srf binding endogenous carg regions
0.44163495.16170155.html.plaintext.txt	438	lane 1 shows amplification target sequence immunoprecipitated chromatin fragments anti srf ab
0.44163495.16170155.html.plaintext.txt	439	target sequence encompasses carg element located 2373 bp minimal cftr promoter
0.44163495.16170155.html.plaintext.txt	440	lane 2 shows pcr amplification control sample without ab
0.44163495.16170155.html.plaintext.txt	441	lane 3 shows amplification 1100 dilution samples total input dna immunoprecipitation
0.44163495.16170155.html.plaintext.txt	442	showed predicted carg elements occur highly conserved cftr non coding regions figure 9b may contain tissue specific transcription factors 5
0.44163495.16170155.html.plaintext.txt	443	provided evidence majority silico predicted carg motifs form specific dna protein complexes bacterially expressed srf protein figure 9c left panel
0.44163495.16170155.html.plaintext.txt	444	also demonstrated using beas2b nuclear extracts supershift assays carg elements bound vitro srf protein figure 9c right panel lanes 1 3 7 9
0.44163495.16170155.html.plaintext.txt	445	finally additional chip experiments indicated tested carg element located 2373 bp cftr promoter bound srf chromatin intact cultured beas2b cells figure 9d lane 1
0.44163495.16170155.html.plaintext.txt	446	collectively findings support concept srf may play key role cftr expression regulation via binding multiple cftr carg elements
0.44163495.16170155.html.plaintext.txt	447	discussion top abstract introduction materials methods results discussion references great strides made cftr research emphasis structure function protein incremental advances achieved field transcriptional regulation
0.44163495.16170155.html.plaintext.txt	448	previous works 1220 identified polymorphic carg like site showed naturally occurring sequence variation motif may enhance basal cftr transcriptional activity
0.44163495.16170155.html.plaintext.txt	449	goal present study better characterize human cftr promoter region encompassing carg like element
0.44163495.16170155.html.plaintext.txt	450	comparisons nucleotide sequences cftr promoter region eight mammalian species representing three different orders primates artiodactyla lagomorpha revealed high levels conservation minimal promoter region described previously 64
0.44163495.16170155.html.plaintext.txt	451	however carg like element gcta6gg conform authentic carg box ccta6gg absent three species sheep cow rabbit
0.44163495.16170155.html.plaintext.txt	452	even though motif occurs subset input sequences necessarily mean functional importance
0.44163495.16170155.html.plaintext.txt	453	instances cis regulatory elements species specific already reported cftr gene 50
0.44163495.16170155.html.plaintext.txt	454	generally well known transcription factors tolerate one type nucleotide given position binding site
0.44163495.16170155.html.plaintext.txt	455	instances substitutions central core carg element highly conserved contact points srf terminal ends impairing srf binding previously reported 4865 68
0.44163495.16170155.html.plaintext.txt	456	taken together data support notion cftr carg like element possible important implication cftr transcriptional regulation
0.44163495.16170155.html.plaintext.txt	457	interestingly analysis srf expression revealed relatively high expression levels srf protein bronchial epithelial cells figure 2 shown differentiated epithelial cells 27
0.44163495.16170155.html.plaintext.txt	458	accumulating evidence supports concept srf could contribute cftr expression regulation
0.44163495.16170155.html.plaintext.txt	459	addition regulating growth responsive genes numerous muscle specific genes 2269 srf also described key trans binding factor various important physiological events
0.44163495.16170155.html.plaintext.txt	460	example srf shown regulate pulmonary development drosophila 28 promote re epithelialization muscular structure restoration gastric ulcer healing 70 recently involved regulation endoplasmic reticulum targeted gene 67
0.44163495.16170155.html.plaintext.txt	461	therefore relevant examine potential role srf cftr transcriptional activity
0.44163495.16170155.html.plaintext.txt	462	present study demonstrated cftr carg like element forms specific dna protein complexes include srf protein part complex vitro vivo figures 3 4
0.44163495.16170155.html.plaintext.txt	463	investigated expression driven proximal human cftr promoter pgl3 construct epithelial myoblasts lines
0.44163495.16170155.html.plaintext.txt	464	results transient transfections 3xsre fos tata wt pgl3 luciferase reporter genes showed human minimal cftr promoter encompassing carg like motif sufficient drive expression cell types figure 5
0.44163495.16170155.html.plaintext.txt	465	consistent studies showing cftr expression smooth muscle tissue 7172 results demonstrated human cftr minimal promoter ability drive expression muscle lineages
0.44163495.16170155.html.plaintext.txt	466	transient co transfections analyses performed full length dominant negative srf forms expression vectors also specific srf sirna constructs figure 6 panels b c provide first evidence positive role srf protein regulation human cftr promoter
0.44163495.16170155.html.plaintext.txt	467	however srf induced cftr transactivation though significant relatively modest
0.44163495.16170155.html.plaintext.txt	468	data results finer mutagenesis studies presented figure 7 support concept srf alone sufficient drive basal expression cftr gene
0.44163495.16170155.html.plaintext.txt	469	suggested previous studies 73 75 likely additional factors might required optimally drive cftr promoter well specify cell type restricted expression
0.44163495.16170155.html.plaintext.txt	470	since yy1 previously shown bind cftr promoter 12 subset sres serve binding sites yy1 30 33 first evaluated candidate srf mediated cftr transcriptional activity
0.44163495.16170155.html.plaintext.txt	471	data analysis suggests functional antagonism srf yy1 binding competition cftr carg like box
0.44163495.16170155.html.plaintext.txt	472	however analysis combinatorial co transfection studies presented figure 8c suggests functional interplay srf yy1 alone sufficient account basal cftr transcriptional activation
0.44163495.16170155.html.plaintext.txt	473	studies necessary determine whether another player might involved functional interplay accounted basal transcriptional cftr activity observed beas2b bronchial epithelial cells
0.44163495.16170155.html.plaintext.txt	474	interestingly showed addition carg like element defined minimal promoter cftr gene three carg motifs located 5 end gene seven present intronic regions figure 9
0.44163495.16170155.html.plaintext.txt	475	also evidenced srf binding carg elements endogenous cftr gene context intact chromatin figures 4 9d
0.44163495.16170155.html.plaintext.txt	476	although role distal carg boxes yet assessed findings major importance since shown optimal activity srf dependent target genes may require number carg boxes including defined intronic region 666776
0.44163495.16170155.html.plaintext.txt	477	moreover already suggested actin promoters 3274 perhaps presence multiple carg elements cftr gene cooperative binding events might essential srf prevent yy1 binding cftr promoter
0.44163495.16170155.html.plaintext.txt	478	clearly studies needed directly investigate role multiple carg elements transcriptional regulation cftr gene
0.44163495.16170155.html.plaintext.txt	479	taken together results demonstrated first time human cftr promoter novel srf target gene subject modest significant srf activation partially due functional antagonism yy1 srf mutually exclusive dna binding activities yy1 versus srf cftr carg like site
0.44163495.16170155.html.plaintext.txt	480	critical question thus might srf contribute orchestrating cell restricted context dependent programs cftr gene expression findings investigations date clearly indicate presence several different underlying mechanisms srf dependent transcriptional activation represented figure 10
0.44163495.16170155.html.plaintext.txt	481	might include association srf variety cell restricted co factors noted gray bubbles figure 10 mrtf highly expressed epithelial cells lung kidney colon testis mrtf b also expressed smooth muscle cells 77 ternary complex factors p62 sap 1 2578 remodeling chromatin co factors hat dependent manner creb binding protein 79
0.44163495.16170155.html.plaintext.txt	482	addition well known binding srf carg box induces acute bend dna bending may vary changing base compositions across carg box 80
0.44163495.16170155.html.plaintext.txt	483	bending probably facilitate interactions proteins already involved cftr expression regulation nf b 13 cebp 9 described interacting srf 81
0.44163495.16170155.html.plaintext.txt	484	finally ras related gtpases family rac rhoa cdc42 might critical role activation srf 82
0.44163495.16170155.html.plaintext.txt	485	indeed reported rhoa induced srf activation occurs phenomenon actin treadmilling restricted carg dependent genes adjacent ets binding sites e
0.44163495.16170155.html.plaintext.txt	486	smooth muscle cell restricted carg genes 8384
0.44163495.16170155.html.plaintext.txt	487	moreover shown activation srf may mediated nf b cebp transcription factors 81
0.44163495.16170155.html.plaintext.txt	488	view larger version 33k figure 10 schematic model depicting potential mechanism might contribute epithelial specific regulation cftr gene
0.44163495.16170155.html.plaintext.txt	489	model arrows bubbles marked gray indicate multiple potential srf mediated regulation pathways protein protein interaction potential induction ras related gtpases cascades
0.44163495.16170155.html.plaintext.txt	490	blue pink bubbles indicate trans factors identified study contribute basal cftr transcriptional activity
0.44163495.16170155.html.plaintext.txt	491	black double arrow shows functional antagonism yy1 srf identified study cftr carg like element characterization
0.44163495.16170155.html.plaintext.txt	492	data provide foundation studies regulation cftr unable rational design functional studies including various strategies aiming dissect different regulation pathways
0.44163495.16170155.html.plaintext.txt	493	acknowledgements study supported grants french associations vaincre la mucoviscidose vlm fondation pour la recherche medicale frm
0.44163495.16170155.html.plaintext.txt	494	supported phd fellowship grants vlm
0.44163495.16170155.html.plaintext.txt	495	particularly indebted
0.44163495.16170155.html.plaintext.txt	496	lamb continuous support
0.44163495.16170155.html.plaintext.txt	497	critical reading manuscript
0.44163495.16170155.html.plaintext.txt	498	carnac many valuable discussions suggestions
0.44163495.16170155.html.plaintext.txt	499	authors also thank investigators mentioned materials methods kind gifts crucial reagents
0.44163495.16170155.html.plaintext.txt	500	funding pay open access publication charges article provided centre national de la recherche scientifique cnrs
0.44163495.16170155.html.plaintext.txt	501	footnotes authors wish known opinion first three authors regarded joint first authors
0.44163495.16170155.html.plaintext.txt	502	references top abstract introduction materials methods results discussion references crawford
0.44163495.16170155.html.plaintext.txt	503	1991 immunocytochemical localization cystic fibrosis gene product cftr proc
0.44163495.16170155.html.plaintext.txt	504	usa 88 9262 9266abstractfree full text
0.44163495.16170155.html.plaintext.txt	505	1992 localization cystic fibrosis transmembrane conductance regulator chloride secretory epithelia j
0.44163495.16170155.html.plaintext.txt	506	89 339 349isimedline
0.44163495.16170155.html.plaintext.txt	507	1992 submucosal glands predominant site cftr expression human bronchus nature genet
0.44163495.16170155.html.plaintext.txt	508	2 240 248crossrefisimedline
0.44163495.16170155.html.plaintext.txt	509	1993 cftr expression regulated cycle seminiferous epithelium oestrous cycle rodents nature genet
0.44163495.16170155.html.plaintext.txt	510	3 157 164crossrefisimedline
0.44163495.16170155.html.plaintext.txt	511	2003 alternative 5 exons cftr gene show developmental regulation hum
0.44163495.16170155.html.plaintext.txt	512	12 759 769abstractfree full text
0.44163495.16170155.html.plaintext.txt	513	1991 cystic fibrosis gene housekeeping type promoter expressed low levels cells epithelial origin j
0.44163495.16170155.html.plaintext.txt	514	266 9140 9144abstractfree full text
0.44163495.16170155.html.plaintext.txt	515	1993 characterization cystic fibrosis transmembrane conductance regulator promoter region
0.44163495.16170155.html.plaintext.txt	516	chromatin context tissue specificity j
0.44163495.16170155.html.plaintext.txt	517	268 15912 15921abstractfree full text
0.44163495.16170155.html.plaintext.txt	518	1998 tissue specific vivo transcription start sites human murine cystic fibrosis genes hum
0.44163495.16170155.html.plaintext.txt	519	7 363 369abstractfree full text
0.44163495.16170155.html.plaintext.txt	520	1995 transcription cystic fibrosis transmembrane conductance regulator requires ccaat like element basal camp mediated regulation j
0.44163495.16170155.html.plaintext.txt	521	270 28848 28857abstractfree full text
0.44163495.16170155.html.plaintext.txt	522	1996 characterization camp response element cystic fibrosis transmembrane conductance regulator gene promoter j
0.44163495.16170155.html.plaintext.txt	523	271 31869 31877abstractfree full text
0.44163495.16170155.html.plaintext.txt	524	1995 basal expression cystic fibrosis transmembrane conductance regulator gene dependent protein kinase activity proc
0.44163495.16170155.html.plaintext.txt	525	usa 92 7560 7564abstractfree full text
0.44163495.16170155.html.plaintext.txt	526	2000 naturally occurring sequence variation creates yy1 element associated increased cystic fibrosis transmembrane conductance regulator gene expression j
0.44163495.16170155.html.plaintext.txt	527	275 3561 3567abstractfree full text
0.44163495.16170155.html.plaintext.txt	528	2001 nf kappa b mediates regulation cftr gene expression calu 3 cells interleukin 1beta j
0.44163495.16170155.html.plaintext.txt	529	276 9486 9491abstractfree full text
0.44163495.16170155.html.plaintext.txt	530	1999 transcriptional repression cystic fibrosis transmembrane conductance regulator gene mediated ccaat displacement proteincut homolog associated histone deacetylation j
0.44163495.16170155.html.plaintext.txt	531	274 7803 7815abstractfree full text
0.44163495.16170155.html.plaintext.txt	532	1996 regulatory element intron 1 cystic fibrosis transmembrane conductance regulator gene j
0.44163495.16170155.html.plaintext.txt	533	271 9947 9954abstractfree full text
0.44163495.16170155.html.plaintext.txt	534	2000 multiple potential intragenic regulatory elements cftr gene genomics 64 90 96crossrefisimedline
0.44163495.16170155.html.plaintext.txt	535	2001 element intron 1 cftr gene augments intestinal expression vivo hum
0.44163495.16170155.html.plaintext.txt	536	10 1455 1464abstractfree full text
0.44163495.16170155.html.plaintext.txt	537	2002 evaluation potential regulatory elements identified dnase hypersensitive sites cftr gene eur
0.44163495.16170155.html.plaintext.txt	538	269 553 559abstractfree full text
0.44163495.16170155.html.plaintext.txt	539	2004 hnf1alpha involved tissue specific regulation cftr gene expression biochem
0.44163495.16170155.html.plaintext.txt	540	378 909 918crossrefisimedline
0.44163495.16170155.html.plaintext.txt	541	1999 complex allele 102t as549rt g associated milder forms cystic fibrosis allele s549rt g alone hum
0.44163495.16170155.html.plaintext.txt	542	105 145 150crossrefisimedline
0.44163495.16170155.html.plaintext.txt	543	1986 identification protein binding site mediates transcriptional response c fos gene serum factors cell 46 567 574crossrefisimedline
0.44163495.16170155.html.plaintext.txt	544	2003 serum response factor toggling disparate programs gene expression j
0.44163495.16170155.html.plaintext.txt	545	35 577 593crossrefisimedline
0.44163495.16170155.html.plaintext.txt	546	1995 mads box family transcription factors eur
0.44163495.16170155.html.plaintext.txt	547	1998 developmentally regulated expression serum response factor plays key role control smooth muscle specific genes dev
0.44163495.16170155.html.plaintext.txt	548	194 18 37crossrefisimedline
0.44163495.16170155.html.plaintext.txt	549	2003 serum response factor function dysfunction smooth muscle respir
0.44163495.16170155.html.plaintext.txt	550	137 223 235crossrefisi
0.44163495.16170155.html.plaintext.txt	551	1996 analysis srf sap 1 elk 1 transcripts proteins human cell lines febs lett
0.44163495.16170155.html.plaintext.txt	552	391 247 251crossrefisimedline
0.44163495.16170155.html.plaintext.txt	553	2002 expression serum response factor normal rat gastric mucosa j
0.44163495.16170155.html.plaintext.txt	554	53 289 294isimedline
0.44163495.16170155.html.plaintext.txt	555	1996 pruned gene encodes drosophila serum response factor regulates cytoplasmic outgrowth terminal branching tracheal system development 122 1353 1362abstractfree full text
0.44163495.16170155.html.plaintext.txt	556	2003 involvement serum response factor isoforms myofibroblast differentiation bleomycin induced lung injury
0.44163495.16170155.html.plaintext.txt	557	29 583 590abstractfree full text
0.44163495.16170155.html.plaintext.txt	558	2000 evolution cis acting elements 5 flanking regions vertebrate actin genes j
0.44163495.16170155.html.plaintext.txt	559	1995 yy1 facilitates association serum response factor c fos serum response element mol
0.44163495.16170155.html.plaintext.txt	560	biol 15 5975 5982abstract
0.44163495.16170155.html.plaintext.txt	561	1997 competition negative acting yy1 versus positive acting serum response factor tinman homologue nkx 2
0.44163495.16170155.html.plaintext.txt	562	5 regulates cardiac alpha actin promoter activity mol
0.44163495.16170155.html.plaintext.txt	563	11 812 822abstractfree full text
0.44163495.16170155.html.plaintext.txt	564	1997 competitive mechanism carg element regulation yy1 srf implications assessment phox1mhox transcription factor interactions carg elements dna cell biol 16 653 661isimedline
0.44163495.16170155.html.plaintext.txt	565	1997 functional expression apical localization cystic fibrosis transmembrane conductance regulator mdck cells biochem
0.44163495.16170155.html.plaintext.txt	566	j 322 259 265isimedline
0.44163495.16170155.html.plaintext.txt	567	1999 characterization internalization pathways cystic fibrosis transmembrane conductance regulator
0.44163495.16170155.html.plaintext.txt	568	276 l659 l668isimedline
0.44163495.16170155.html.plaintext.txt	569	1998 characterization cftr expression chloride channel activity human endothelia
0.44163495.16170155.html.plaintext.txt	570	physiol 275 c1555 c1564isimedline
0.44163495.16170155.html.plaintext.txt	571	2002 ablation internalization signals carboxyl terminal tail cystic fibrosis transmembrane conductance regulator enhances cell surface expression j
0.44163495.16170155.html.plaintext.txt	572	277 49952 49957abstractfree full text
0.44163495.16170155.html.plaintext.txt	573	1991 characterization promoter region cystic fibrosis transmembrane conductance regulator gene j
0.44163495.16170155.html.plaintext.txt	574	266 24471 24476abstractfree full text
0.44163495.16170155.html.plaintext.txt	575	1995 functional activation cystic fibrosis trafficking mutant delta f508 cftr overexpression
0.44163495.16170155.html.plaintext.txt	576	physiol 268 l615 l624isimedline
0.44163495.16170155.html.plaintext.txt	577	1994 transcription factors elk 1 serum response factor interact direct protein protein contacts mediated short region elk 1 mol
0.44163495.16170155.html.plaintext.txt	578	1996 transcript analysis cftr frameshift mutations lymphocytes using reverse transcription polymerase chain reaction technique protein truncation test hum
0.44163495.16170155.html.plaintext.txt	579	98 328 332crossrefisimedline
0.44163495.16170155.html.plaintext.txt	580	1992 mislocalization delta f508 cftr cystic fibrosis sweat gland nature genet
0.44163495.16170155.html.plaintext.txt	581	1 321 327crossrefisimedline
0.44163495.16170155.html.plaintext.txt	582	2004 antibodies cftr studies j
0.44163495.16170155.html.plaintext.txt	583	2004 comparison 14 antibodies biochemical detection cystic fibrosis transmembrane conductance regulator protein mol
0.44163495.16170155.html.plaintext.txt	584	probes 18 235 242crossrefisimedline
0.44163495.16170155.html.plaintext.txt	585	1994 clustal w improving sensitivity progressive multiple sequence alignment sequence weighting positions specific gap penalties weight matrix choice nucleic acids res
0.44163495.16170155.html.plaintext.txt	586	1999 first putative sequence alterations minimal cftr promoter region j
0.44163495.16170155.html.plaintext.txt	587	36 263 264free full text
0.44163495.16170155.html.plaintext.txt	588	1991 primary response genes induced growth factors tumor promoters annu
0.44163495.16170155.html.plaintext.txt	589	60 281 319crossrefisimedline
0.44163495.16170155.html.plaintext.txt	590	2002 transforming growth factor beta induction smooth muscle cell phenotype requires transcriptional post transcriptional control serum response factor j
0.44163495.16170155.html.plaintext.txt	591	277 6287 6295abstractfree full text
0.44163495.16170155.html.plaintext.txt	592	2003 evaluation gene targeting homologous recombination ovine somatic cells mol
0.44163495.16170155.html.plaintext.txt	593	66 115 125crossrefisimedline
0.44163495.16170155.html.plaintext.txt	594	1997 cross species characterization promoter region cystic fibrosis transmembrane conductance regulator gene reveals multiple levels regulation biochem
0.44163495.16170155.html.plaintext.txt	595	327 651 662isimedline
0.44163495.16170155.html.plaintext.txt	596	2003 comparative genomic analysis cow pig human cftr genes identifies potential intronic regulatory elements genomics 81 628 639crossrefisimedline
0.44163495.16170155.html.plaintext.txt	597	2002 increased expression alternatively spliced dominant negative isoform srf human failing hearts
0.44163495.16170155.html.plaintext.txt	598	282 h1521 h1533abstractfree full text
0.44163495.16170155.html.plaintext.txt	599	2002 high activity serum response factor mesenchymal transition epithelial tumor cells regulated rhoa signaling j
0.44163495.16170155.html.plaintext.txt	600	277 29490 29495abstractfree full text
0.44163495.16170155.html.plaintext.txt	601	1996 expression serum response factor gene regulated serum response factor binding sites j
0.44163495.16170155.html.plaintext.txt	602	271 16535 16543abstractfree full text
0.44163495.16170155.html.plaintext.txt	603	1992 serum response element trends
0.44163495.16170155.html.plaintext.txt	604	17 423 426crossrefisimedline
0.44163495.16170155.html.plaintext.txt	605	1992 functional antagonism yy1 serum response factor mol
0.44163495.16170155.html.plaintext.txt	606	1995 cftr chloride channel mammalian heart annu
0.44163495.16170155.html.plaintext.txt	607	57 387 416crossrefisimedline
0.44163495.16170155.html.plaintext.txt	608	1996 expression regulation chloride channels neonatal rat cardiomyocytes mol
0.44163495.16170155.html.plaintext.txt	609	biochem 157 129 135isimedline
0.44163495.16170155.html.plaintext.txt	610	2004 regulation cystic fibrosis transmembrane conductance regulator channel beta adrenergic agonists vasoactive intestinal peptide rat smooth muscle cells role vasorelaxation j
0.44163495.16170155.html.plaintext.txt	611	chem 279 21160 21168abstractfree full text
0.44163495.16170155.html.plaintext.txt	612	1993 expression purification dna binding domain srf srf db part dna binding protein act dominant negative mutant vivo exp
0.44163495.16170155.html.plaintext.txt	613	209 208 215crossrefisimedline
0.44163495.16170155.html.plaintext.txt	614	1994 serum regulated transcription serum response factor srf novel role dna binding domain embo j
0.44163495.16170155.html.plaintext.txt	615	2002 increased actin polymerization reduces inhibition serum response factor activity yin yang 1 biochem
0.44163495.16170155.html.plaintext.txt	616	j 364 547 554crossrefisimedline
0.44163495.16170155.html.plaintext.txt	617	2000 human mouse genome comparisons locate regulatory sites nature genet
0.44163495.16170155.html.plaintext.txt	618	26 225 228crossrefisimedline
0.44163495.16170155.html.plaintext.txt	619	1994 analysis mouse rat cftr promoter regions hum
0.44163495.16170155.html.plaintext.txt	620	1998 evolutionarily conserved promoter region containing carg like elements crucial smooth muscle myosin heavy chain gene expression circ
0.44163495.16170155.html.plaintext.txt	621	82 566 575abstractfree full text
0.44163495.16170155.html.plaintext.txt	622	2000 serum response factor dependent regulation smooth muscle calponin gene j
0.44163495.16170155.html.plaintext.txt	623	275 9814 9822abstractfree full text
0.44163495.16170155.html.plaintext.txt	624	2005 akap12alpha atypical serum response factor dependent target gene j
0.44163495.16170155.html.plaintext.txt	625	280 4125 4134abstractfree full text
0.44163495.16170155.html.plaintext.txt	626	2003 myod distal regulatory region contains srf binding carg element required myod expression skeletal myoblasts muscle regeneration mol
0.44163495.16170155.html.plaintext.txt	627	cell 14 2151 2162abstractfree full text
0.44163495.16170155.html.plaintext.txt	628	1995 journey surface cell fos regulation sre embo j
0.44163495.16170155.html.plaintext.txt	629	14 4905 4913isimedline
0.44163495.16170155.html.plaintext.txt	630	2004 serum response factor promotes re pithelialization muscular structure restoration gastric ulcer healing gastroenterology 126 1809 1818crossrefisimedline
0.44163495.16170155.html.plaintext.txt	631	2004 regulation cystic fibrosis transmembrane conductance regulator channel beta adrenergic agonists vip rat smooth muscle cells role vasorelaxation j
0.44163495.16170155.html.plaintext.txt	632	chem 279 21160 21168abstractfree full text
0.44163495.16170155.html.plaintext.txt	633	2004 cardiac expression cystic fibrosis transmembrane conductance regulator involves novel exon 1 usage produce unique amino terminal protein j
0.44163495.16170155.html.plaintext.txt	634	279 15877 15887abstractfree full text
0.44163495.16170155.html.plaintext.txt	635	1990 combination closely associated positive negative cis acting promoter elements regulates transcription skeletal alpha actin gene mol
0.44163495.16170155.html.plaintext.txt	636	10 528 538isimedline
0.44163495.16170155.html.plaintext.txt	637	1991 activation skeletal alpha actin gene transcription cooperative formation serum response factor binding complexes positive cis acting promoter serum response elements displaces negative acting nuclear factor enriched replicating myoblasts nonmyogenic cells mol
0.44163495.16170155.html.plaintext.txt	638	11 5090 5100isimedline
0.44163495.16170155.html.plaintext.txt	639	1994 avian cardiac alpha actin promoter regulated pair complex elements composed e boxes serum response elements bind positive negative acting factors j
0.44163495.16170155.html.plaintext.txt	640	chem 269 12731 12740abstractfree full text
0.44163495.16170155.html.plaintext.txt	641	1999 regulation smooth muscle alpha actin expression vivo dependent carg elements within 5 first intron promoter regions circ
0.44163495.16170155.html.plaintext.txt	642	84 852 861abstractfree full text
0.44163495.16170155.html.plaintext.txt	643	2002 potentiation serum response factor activity family myocardin related transcription factors proc
0.44163495.16170155.html.plaintext.txt	644	usa 99 14855 14860abstractfree full text
0.44163495.16170155.html.plaintext.txt	645	2001 crystal structure ternary sap 1srfc fos sre dna complex j
0.44163495.16170155.html.plaintext.txt	646	314 495 506crossrefisimedline
0.44163495.16170155.html.plaintext.txt	647	2002 histone acetylation recruitment serum responsive factor creb binding protein onto sm22 promoter sm22 gene expression circ
0.44163495.16170155.html.plaintext.txt	648	90 858 865abstractfree full text
0.44163495.16170155.html.plaintext.txt	649	1995 structure serum response factor core bound dna nature 376 490 498crossrefisimedline
0.44163495.16170155.html.plaintext.txt	650	1999 activation serum response factor rhoa mediated nuclear factor kappab cebp transcription factors j
0.44163495.16170155.html.plaintext.txt	651	274 8506 8515abstractfree full text
0.44163495.16170155.html.plaintext.txt	652	1995 rho family gtpases rhoa rac1 cdc42hs regulate transcriptional activation srf cell 81 1159 1170crossrefisimedline
0.44163495.16170155.html.plaintext.txt	653	1999 signal regulated activation serum response factor mediated changes actin dynamics cell 98 159 169crossrefisimedline
0.44163495.16170155.html.plaintext.txt	654	2001 differential usage signal transduction pathways defines two types serum response factor target gene j
0.44163495.16170155.html.plaintext.txt	655	276 24531 24539abstractfree full text
0.44163495.16170155.html.plaintext.txt	656	1997 lim protein lmo2 bridging molecule assembling erythroid dna binding complex includes tal1 e47 gata 1 ldb1nli proteins embo j
0.44163495.16170155.html.plaintext.txt	657	16 3145 3157abstractfree full text
0.44163495.16170155.html.plaintext.txt	658	article abstract print pdf 1396k screen pdf 662k alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager request permissions commercial re use guidelinesfor open access nar content google scholar articles rene c
0.44163495.16170155.html.plaintext.txt	659	pubmed pubmed citation articles rene c
0.44163495.16170155.html.plaintext.txt	660	online issn 1362 4962 print issn 0305 1048 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.49680814.11404239.html.plaintext.txt	0	special topic cftr trafficking signaling respiratory epithelium bruce r
0.49680814.11404239.html.plaintext.txt	1	department environmental occupational health graduate school public health university pittsburgh pittsburgh pennsylvania 15238
0.49680814.11404239.html.plaintext.txt	2	introduction top introduction molecular chaperones
0.49680814.11404239.html.plaintext.txt	3	research cystic fibrosis cf remains leading edge investigations employing human genetics molecular cellular biology
0.49680814.11404239.html.plaintext.txt	4	12 years since discovery gene encoding cf transmembrane conductance regulator cftr cl channel 14 translation efforts clinically remarkable includes 1 identification almost 1000 different mutations httpwww
0.49680814.11404239.html.plaintext.txt	5	cacftr including 70 phenylalanine deletion f508 led successful clinical detection individuals family history even completion human genome project 2 20 trials human cf gene therapy involving dosing nose airways 2 22
0.49680814.11404239.html.plaintext.txt	6	rapid progress however belies complexity cftr gene pathophysiology cf
0.49680814.11404239.html.plaintext.txt	7	cftr unique member atp binding cassette transporter gene family 1 conducts cl 2 transports substrates across membranes nonconductive fashion e
0.49680814.11404239.html.plaintext.txt	8	facilitates atp release 3 regulates ion channel proteins e
0.49680814.11404239.html.plaintext.txt	9	positive regulation outwardly rectifying cl channels negative regulation na channels 4 regulates intracellular compartment acidification protein processing 18
0.49680814.11404239.html.plaintext.txt	10	complexity led authors categorize defects cf respiratory epithelium primary dehydration associated dysfunctional cl transport secondary hyperabsorption na tertiary enhanced binding pseudomonas aeruginosa proinflammatory environment
0.49680814.11404239.html.plaintext.txt	11	fundamental diversity awareness minor mutations e
0.49680814.11404239.html.plaintext.txt	12	f508 single amino acid deletion within 1480 amino acid protein result profound pathological phenotype cf 23
0.49680814.11404239.html.plaintext.txt	13	case f508 missense mutation results mutant cftr believed fold improperly defects biosynthesis trafficking result little surface cftr
0.49680814.11404239.html.plaintext.txt	14	mutations cftr lead genotypic phenotypic changes span range cftr membrane cftr reaches membrane respond appropriate stimuli conduct cl 6
0.49680814.11404239.html.plaintext.txt	15	adding complexity recent report describing tissue specific changes impairment f508 processing 10
0.49680814.11404239.html.plaintext.txt	16	mutations overlap pdz interacting domains cooh terminus cftr required polarization cftr apical membrane respiratory epithelium 13 may underscore cftr regulation ion channels affecting relationship accessory proteins linker proteins regulatory cofactors
0.49680814.11404239.html.plaintext.txt	17	accordingly research biosynthesis trafficking wild type mutated cftr forefront cf investigations
0.49680814.11404239.html.plaintext.txt	18	although defect cl conductance critical pathology cf respiratory epithelia contributions alterations vesicle trafficking protein processing immune function clearly contribute pathogenesis maintenance cf 18
0.49680814.11404239.html.plaintext.txt	19	efforts underlie disparities genotype phenotype cf suggest addition nucleotide repair gene therapy aminoglycoside dependent restoration readthrough full length cftr pharmacotherapy targeted toward improved biosynthesis mutated cftr may useful adjunct approach treatment cf 24
0.49680814.11404239.html.plaintext.txt	20	molecular chaperones biosynthesis cftr top introduction molecular chaperones
0.49680814.11404239.html.plaintext.txt	21	importance providing mechanistic support pharmacologically affecting maturation cf placed context current molecular physiological understanding roles various chaperones cftr brodsky 4 issue american journal physiology lung cellular molecular physiology
0.49680814.11404239.html.plaintext.txt	22	steps proper folding cftr quality control mechanism endoplasmic reticulum trafficking requisite association various chaperones outlined brodsky reference made three original articles special topic
0.49680814.11404239.html.plaintext.txt	23	mechanisms sodium 4 phenylbutyrate may modulator chaperones presented rubenstein lyons 17 choo kang zeitlin 5 vivo efficacy chemical chaperone trimethylamine oxide restoration defective cl conductance critical target tissue intestinal epithelium cftr null mutant mice presented fischer et al
0.49680814.11404239.html.plaintext.txt	24	collective work strongly supports concept small molecules useful alternative adjunct therapies disorders protein folding 23 24
0.49680814.11404239.html.plaintext.txt	25	proinflammatory profile cf epithelia top introduction molecular chaperones
0.49680814.11404239.html.plaintext.txt	26	critical aspect cf chronic airway inflammation several groups provided support dysregulation inflammatory response intrinsic component phenotype
0.49680814.11404239.html.plaintext.txt	27	editorial blackwell et al
0.49680814.11404239.html.plaintext.txt	28	1 accompanies manuscript weber et al
0.49680814.11404239.html.plaintext.txt	29	21 highlights central role unregulated nuclear factor nf b proinflammatory cytokine profile cells expressing mutated cftr
0.49680814.11404239.html.plaintext.txt	30	regard blocking production nf b may alternative rational therapeutic approach cf therapy
0.49680814.11404239.html.plaintext.txt	31	addition enhanced cytokine interleukin 8 tumor necrosis factor production oxidative stress appears component cf epithelia
0.49680814.11404239.html.plaintext.txt	32	previous vitro work 9 11 showed cftr associated transport glutathione gsh
0.49680814.11404239.html.plaintext.txt	33	current special topic gao et al
0.49680814.11404239.html.plaintext.txt	34	8 show cl channel forming peptide n k4 m2glyr increased cl secretion gsh efflux human cf airway epithelial cell line suggesting apical cl conductance necessarily cftr function per se coupled gsh efflux
0.49680814.11404239.html.plaintext.txt	35	20 report issue gsh decreased epithelial lining fluid cftr deficient mice imbalance antioxidant defense cftr deficient mice evident
0.49680814.11404239.html.plaintext.txt	36	data extend previous observations gsh decreased airway fluid humans cftr 16 aerosol delivery gsh may useful therapy cf 15
0.49680814.11404239.html.plaintext.txt	37	gsh cellular defense mechanisms may indeed represent rational therapeutic strategy cf
0.49680814.11404239.html.plaintext.txt	38	serine protease sensitive sodium hyperabsorption human airway epithelium top introduction molecular chaperones
0.49680814.11404239.html.plaintext.txt	39	noted na hyperabsorption critical secondary like phenomenon cf epithelia
0.49680814.11404239.html.plaintext.txt	40	although mechanism coupling hyperabsorption cftr mutations remains unknown extracellular serine protease mediated signaling pathway identified 19 activates amiloride sensitive na channel
0.49680814.11404239.html.plaintext.txt	41	special topic issue bridges et al
0.49680814.11404239.html.plaintext.txt	42	3 show human bronchial epithelial cells sensitive aprotinin
0.49680814.11404239.html.plaintext.txt	43	using kunitz domain aprotinin pharmacophore show bay 39 9437 recombinant kunitz type serine protease inhibitor decreased na absorption non cf cf human bronchial epithelia
0.49680814.11404239.html.plaintext.txt	44	editors note top introduction molecular chaperones
0.49680814.11404239.html.plaintext.txt	45	first series special topics appear routinely american journal physiology lung cellular molecular physiology
0.49680814.11404239.html.plaintext.txt	46	purpose special calls highlight areas significant interest respiratory biology soliciting input broad research community fast tracking submitted manuscripts review process publishing separate heading
0.49680814.11404239.html.plaintext.txt	47	case call papers cftr trafficking signaling respiratory epithelium initially appeared july 2000 12
0.49680814.11404239.html.plaintext.txt	48	led seven manuscripts two accompanying editorials appear current issue
0.49680814.11404239.html.plaintext.txt	49	remarkable timely turnaround peer review testimony importance topic enthusiasm authors reviewers bring information readership
0.49680814.11404239.html.plaintext.txt	50	special topic section collection papers accepted special call manuscripts editor
0.49680814.11404239.html.plaintext.txt	51	see journal web site information next call
0.49680814.11404239.html.plaintext.txt	52	address reprint requests correspondence b
0.49680814.11404239.html.plaintext.txt	53	environmental occupational health graduate school public health univ
0.49680814.11404239.html.plaintext.txt	54	pittsburgh pittsburgh pa 15238 e mail brucepatpitt
0.49680814.11404239.html.plaintext.txt	55	costs publication article defrayed part payment page charges
0.49680814.11404239.html.plaintext.txt	56	article must therefore hereby marked advertisement accordance 18 u
0.49680814.11404239.html.plaintext.txt	57	section 1734 solely indicate fact
0.49680814.11404239.html.plaintext.txt	58	references top introduction molecular chaperones
0.49680814.11404239.html.plaintext.txt	59	blackwell ts stecenko aa christman jw
0.49680814.11404239.html.plaintext.txt	60	dysregulated nf b activation cystic fibrosis evidence primary inflammatory disorder
0.49680814.11404239.html.plaintext.txt	61	j physiol lung cell mol physiol 281 l69 l70 2001free full text
0.49680814.11404239.html.plaintext.txt	62	status gene therapy cystic fibrosis lung disease
0.49680814.11404239.html.plaintext.txt	63	j clin invest 103 441 445 1999free full text
0.49680814.11404239.html.plaintext.txt	64	bridges rj newton bb pilewski jm devor dc poll ct hall rl
0.49680814.11404239.html.plaintext.txt	65	na transport normal cf human bronchial epithelial cells inhibited bay 39 9437
0.49680814.11404239.html.plaintext.txt	66	j physiol lung cell mol physiol 281 l16 l23 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	67	chaperoning maturation cystic fibrosis transmembrane conductance regulator
0.49680814.11404239.html.plaintext.txt	68	j physiol lung cell mol physiol 281 l39 l42 2001free full text
0.49680814.11404239.html.plaintext.txt	69	choo kang lr zeitlin pl
0.49680814.11404239.html.plaintext.txt	70	induction hsp70 promotes f508 cftr trafficking
0.49680814.11404239.html.plaintext.txt	71	j physiol lung cell mol physiol 281 l58 l68 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	72	happens f508 vivo j clin invest 103 1369 1370 1999free full text
0.49680814.11404239.html.plaintext.txt	73	fischer h fukuda n barbry p illek b sartori c matthay ma
0.49680814.11404239.html.plaintext.txt	74	partial restoration defective chloride conductance f508 cf mice chemical chaperone trimethylamine oxide
0.49680814.11404239.html.plaintext.txt	75	j physiol lung cell mol physiol 281 l52 l57 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	76	gao l broughman jr iwamoto tomich jm venglarik cj forman hj
0.49680814.11404239.html.plaintext.txt	77	synthetic chloride channel restores glutathione secretion cystic fibrosis airway epithelia
0.49680814.11404239.html.plaintext.txt	78	j physiol lung cell mol physiol 281 l24 l30 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	79	gao l kim kj yankaskas jb forman hj
0.49680814.11404239.html.plaintext.txt	80	abnormal glutathione transport cystic fibrosis airway epithelia
0.49680814.11404239.html.plaintext.txt	81	j physiol lung cell mol physiol 277 l113 l118 1999abstractfree full text
0.49680814.11404239.html.plaintext.txt	82	kalin n claas sommer m puchelle e tummler b
0.49680814.11404239.html.plaintext.txt	83	f508 cftr protein expression tissues patients cystic fibrosis
0.49680814.11404239.html.plaintext.txt	84	j clin invest 103 1379 1389 1999abstractfree full text
0.49680814.11404239.html.plaintext.txt	85	lindsell p hanrahan jw
0.49680814.11404239.html.plaintext.txt	86	glutathione permeability cftr
0.49680814.11404239.html.plaintext.txt	87	j physiol cell physiol 275 c323 c326 1998abstractfree full text
0.49680814.11404239.html.plaintext.txt	88	call papers cftr trafficking signaling respiratory epithelium
0.49680814.11404239.html.plaintext.txt	89	j physiol lung cell mol physiol 279 l1 2000free full text
0.49680814.11404239.html.plaintext.txt	90	moyer bd denton j karlson kh reynolds d wang mickle je milewski m cutting gr guggino wb li m stanton ba
0.49680814.11404239.html.plaintext.txt	91	pdz interacting domain cftr apical membrane polarization signal
0.49680814.11404239.html.plaintext.txt	92	j clin invest 104 1353 1361 1999abstractfree full text
0.49680814.11404239.html.plaintext.txt	93	riordan jr rommens jm kerem b alon n rozmahel r grzelczak z zielinski j lok plavsic n chou jl drumm ml iannuzzi mc collins fs tsui lc
0.49680814.11404239.html.plaintext.txt	94	identification cystic fibrosis gene cloning characterization complementary cdna
0.49680814.11404239.html.plaintext.txt	95	science 245 1066 1073 1989isimedline
0.49680814.11404239.html.plaintext.txt	96	roum jh borok z mcelvaney ng grimes gj bokser ad buhl r crystal rg
0.49680814.11404239.html.plaintext.txt	97	glutathione aerosol suppresses lung epithelial surface inflammatory cell derived oxidants cystic fibrosis
0.49680814.11404239.html.plaintext.txt	98	j appl physiol 87 438 443 1999abstractfree full text
0.49680814.11404239.html.plaintext.txt	99	roum jh buhl r mcelvaney ng borok z crystal rg
0.49680814.11404239.html.plaintext.txt	100	systemic deficiency glutathione cystic fibrosis
0.49680814.11404239.html.plaintext.txt	101	j appl physiol 75 2419 2424 1993abstract
0.49680814.11404239.html.plaintext.txt	102	rubenstein rc lyons bm
0.49680814.11404239.html.plaintext.txt	103	sodium 4 phenylbutyrate downregulates hsc70 expression facilitating mrna degradation
0.49680814.11404239.html.plaintext.txt	104	j physiol lung cell mol physiol 281 l43 l51 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	105	schweibert em benos dj egan stutts mj guggino wb
0.49680814.11404239.html.plaintext.txt	106	cftr conductance regulator well chloride channel
0.49680814.11404239.html.plaintext.txt	107	physiol rev 79 s145 s166 1999medline
0.49680814.11404239.html.plaintext.txt	108	vallet v chraibi gaeggeler hp horisberger jd rossier bc
0.49680814.11404239.html.plaintext.txt	109	epithelial serine protease activates amiloride sensitive sodium channel
0.49680814.11404239.html.plaintext.txt	110	nature 389 607 610 1997isimedline
0.49680814.11404239.html.plaintext.txt	111	velsor lw van heeckeren day bj
0.49680814.11404239.html.plaintext.txt	112	antioxidant imbalance lungs cystic fibrosis transmembrane conductance regulator protein mutant mice
0.49680814.11404239.html.plaintext.txt	113	j physiol lung cell mol physiol 281 l31 l38 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	114	weber aj soong g bryan r saba prince
0.49680814.11404239.html.plaintext.txt	115	activation nf b airway epithelial cells dependent cftr trafficking cl channel function
0.49680814.11404239.html.plaintext.txt	116	j physiol lung cell mol physiol 281 l71 l78 2001abstractfree full text
0.49680814.11404239.html.plaintext.txt	117	gene transfer cystic fibrosis
0.49680814.11404239.html.plaintext.txt	118	j clin invest 104 1165 1166 1999free full text
0.49680814.11404239.html.plaintext.txt	119	j clin invest 105 853 854 2000free full text
0.49680814.11404239.html.plaintext.txt	120	novel pharmacologic therapies cystic fibrosis
0.49680814.11404239.html.plaintext.txt	121	j clin invest 103 447 452 1999free full text
0.49680814.11404239.html.plaintext.txt	122	j physiol lung cell mol physiol 2811l13 l15 1040 060501 5
0.49680814.11404239.html.plaintext.txt	123	00 copyright 2001 american physiological society article full text pdf alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager google scholar articles pitt b
0.49680814.11404239.html.plaintext.txt	124	articles citing article pubmed pubmed citation articles pitt b
0.49680814.11404239.html.plaintext.txt	125	home help feedback subscriptions archive search table contents visit aps journals online
0.45434183.11809721.html.plaintext.txt	0	temporal regulation cftr expression ovine lung development implications cf gene therapy fiona c
0.45434183.11809721.html.plaintext.txt	1	broackes carter nathalie mouchel deborah gill1 stephen hyde1 john bassett2 ann harris
0.45434183.11809721.html.plaintext.txt	2	paediatric molecular genetics institute molecular medicine oxford university john radcliffe hospital oxford ox3 9ds uk 1nuffield department clinical laboratory sciences oxford university john radcliffe hospital oxford ox3 9du uk 2growth development unit field laboratory oxford university oxford ox2 8qj uk
0.45434183.11809721.html.plaintext.txt	3	received september 10 2001 revised accepted november 13 2001
0.45434183.11809721.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references cystic fibrosis transmembrane conductance regulator cftr protein small conductance chloride ion channel may interact directly channels including epithelial sodium channel enac
0.45434183.11809721.html.plaintext.txt	5	cftr known abundant airway epithelium second trimester human development birth
0.45434183.11809721.html.plaintext.txt	6	could consequence change function respiratory epithelium chloride secretion sodium absorption near term
0.45434183.11809721.html.plaintext.txt	7	alternatively might reflect additional role cftr developing airway epithelium
0.45434183.11809721.html.plaintext.txt	8	though lung epithelia cf fetuses infants rarely show gross histological abnormalities often evidence inflammation
0.45434183.11809721.html.plaintext.txt	9	aim establish whether cftr expression levels correlated specific developmental stages differentiated functions ovine fetal lung
0.45434183.11809721.html.plaintext.txt	10	evaluated cftr expression using quantitative assay mrna 14 time points gestation showed highest levels start second trimester followed gradual decline term
0.45434183.11809721.html.plaintext.txt	11	contrast enac expression increased start third trimester
0.45434183.11809721.html.plaintext.txt	12	results support role cftr differentiation respiratory epithelium suggest expression levels merely reflecting major changes sodiumchloride bulk flow close term
0.45434183.11809721.html.plaintext.txt	13	observations may significant implications likely success cf gene therapy postnatal lung
0.45434183.11809721.html.plaintext.txt	14	introduction top abstract introduction results discussion materials methods references cystic fibrosis transmembrane conductance regulator cftr gene encodes small conductance camp activated chloride ion channel 1
0.45434183.11809721.html.plaintext.txt	15	cftr protein located primarily apical membranes epithelial cells within respiratory digestive systems
0.45434183.11809721.html.plaintext.txt	16	1000 disease associated mutations defined cftr gene www
0.45434183.11809721.html.plaintext.txt	17	ca majority associated characteristic airway disease pancreatic insufficiency male infertility elevated levels sodium chloride sweat
0.45434183.11809721.html.plaintext.txt	18	difficult explain mutations single small conductance epithelial chloride channel cause pleiotropic manifestations disease though complex picture emerging cftr interacts directly indirectly additional proteins
0.45434183.11809721.html.plaintext.txt	19	cftr known regulate ion channels including epithelial sodium channel enac 2 volume activated chloride channel 3
0.45434183.11809721.html.plaintext.txt	20	cftr may also involved cellular processes example membrane recycling 45 apoptosis 67
0.45434183.11809721.html.plaintext.txt	21	relatively little attention given progression cf disease utero though affects postnatal pathology may relevance likely success gene therapy
0.45434183.11809721.html.plaintext.txt	22	initial pathology cf exhibited pancreas early second trimester gestation proteinaceous material starts obstruct ductal tree 89
0.45434183.11809721.html.plaintext.txt	23	perhaps surprising since cftr expressed epithelia start second trimester human development cftr expression levels high mid trimester pancreas 10 12
0.45434183.11809721.html.plaintext.txt	24	tissues cftr expression levels show little fluctuation second trimester gestation postnatal life
0.45434183.11809721.html.plaintext.txt	25	however cftr appears developmentally regulated human sheep lung epithelium 11 13 high expression levels fetal life contrast much lower abundance cftr mrna birth adulthood
0.45434183.11809721.html.plaintext.txt	26	significance regulation cftr expression major focus work
0.45434183.11809721.html.plaintext.txt	27	since feasible investigate human lung development utero used sheep provide useful model human lung development 14
0.45434183.11809721.html.plaintext.txt	28	sheep lung anatomically similar human mouse submucosal glands throughout cartilagenous airway
0.45434183.11809721.html.plaintext.txt	29	expression pattern cftr sheep similar humans temporally spatially shown ovine cftr gene sequence shows close homology human gene 1415
0.45434183.11809721.html.plaintext.txt	30	expression cftr human sheep lung development far assessed primarily means situ hybridization 1112 northern blotting 1013 reverse transcriptase polymerase chain reaction rt pcr 1013
0.45434183.11809721.html.plaintext.txt	31	cftr expression levels high lung second trimester gestation low postnatally
0.45434183.11809721.html.plaintext.txt	32	date developmental expression cftr examined limited number time points data accurately quantitative
0.45434183.11809721.html.plaintext.txt	33	aim evaluate cftr expression specific time points throughout gestation using real time quantitative rt pcr assay provided taqman technology
0.45434183.11809721.html.plaintext.txt	34	generated developmental profile cftr mrna sheep particular attention regulation cftr respiratory system
0.45434183.11809721.html.plaintext.txt	35	profile identified key gestational ages cftr expression maximal hence targeting potential utero therapies might benefit
0.45434183.11809721.html.plaintext.txt	36	results top abstract introduction results discussion materials methods references semi quantitative rt pcr cftr preliminary experiments cftr expression ovine gestation evaluated semi quantitative rt pcr
0.45434183.11809721.html.plaintext.txt	37	primers c2r c2l 16 span exon 13 cftr cdna used reverse transcribe amplify cftr rna samples extracted ovine tissues 52 66 83 94 108 129 143 days gestation 147 term days 2 days post term
0.45434183.11809721.html.plaintext.txt	38	subunit c ovine atp synthase 17 used reference standard rt pcr reactions
0.45434183.11809721.html.plaintext.txt	39	developmental profile cftr mrna lung tissue fig
0.45434183.11809721.html.plaintext.txt	40	1 shows decline 83 days gestation mid trimester term
0.45434183.11809721.html.plaintext.txt	41	since semi quantitative rt pcr limited power providing accurate data relative expression levels gene used real time taqman rt pcr quantify precise developmental expression ovine cftr lung
0.45434183.11809721.html.plaintext.txt	42	view larger version 41k figure 1
0.45434183.11809721.html.plaintext.txt	43	developmental expression cftr ovine airway
0.45434183.11809721.html.plaintext.txt	44	ovine lung samples 52 66 83 94 108 129 143 days gestation g 147 days term 2 days post term pt
0.45434183.11809721.html.plaintext.txt	45	semi quantitative rt pcr using cftr primers c2r c2l yielding 792 bp fragment ovine atp synthase primers f1 r1 producing 530 bp fragment
0.45434183.11809721.html.plaintext.txt	46	fragments separated 1
0.45434183.11809721.html.plaintext.txt	47	5 agarose gel stained ethidium bromide
0.45434183.11809721.html.plaintext.txt	48	validation real time cftr rt pcr assay target region ovine cftr gene chosen generating taqman amplifying primers probe covered boundary exons 6a 6b
0.45434183.11809721.html.plaintext.txt	49	since cftr gene known exhibit range alternatively spliced forms number species 18 necessary confirm aberrant transcripts lacking parts exons 6a 6b produced ovine gene
0.45434183.11809721.html.plaintext.txt	50	conventional rt pcr carried using primers spanning exons 4 7 alternative transcripts lacking exons 6a 6b detected rna lung mid gestation birth pancreas small intestine salivary gland colon 2 days birth data shown
0.45434183.11809721.html.plaintext.txt	51	results suggested real time taqman rt pcr assay targeted exon 6a6b boundary would accurately reflect total cftr mrna transcription
0.45434183.11809721.html.plaintext.txt	52	real time rt pcr cftr mrna ovine fetal tissues real time rt pcr assay ovine cftr mrna optimized reproducibility established
0.45434183.11809721.html.plaintext.txt	53	values obtained reactions template omitted consistently fell range standard curve 0
0.45434183.11809721.html.plaintext.txt	54	standard curves highly reproducible ovine cftr ribosomal rna assays r2 0
0.45434183.11809721.html.plaintext.txt	55	99 genomic contribution rt pcr reactions 0
0.45434183.11809721.html.plaintext.txt	56	two series experiments performed first evaluated cftr expression ovine lung tissues throughout developmental time course second evaluated cftr expression eight ovine tissues 83 108 days gestation 2 days post term
0.45434183.11809721.html.plaintext.txt	57	developmental expression ovine cftr lung developmental profile cftr expression lung showed gradual fall mrna levels though 147 days gestation fig
0.45434183.11809721.html.plaintext.txt	58	values 52 days gestation end first trimester 75 fold higher birth
0.45434183.11809721.html.plaintext.txt	59	66 days cftr mrna levels reduced 4
0.45434183.11809721.html.plaintext.txt	60	5 fold increasing 74 80 days
0.45434183.11809721.html.plaintext.txt	61	levels peaked 80 days gestation gradual decline toward birth negligible levels expression 4 days term 143 days birth
0.45434183.11809721.html.plaintext.txt	62	two days parturition levels cftr mrna increased slightly expression level maintained 2 weeks age adult sheep tissue
0.45434183.11809721.html.plaintext.txt	63	experiments performed three times samples analysed triplicate
0.45434183.11809721.html.plaintext.txt	64	evaluate variation cftr expression levels individuals specific time points samples analysed sib pair 74 days gestation half sib pair 2 days birth
0.45434183.11809721.html.plaintext.txt	65	cases cftr expression levels significantly different 74 days p 0
0.45434183.11809721.html.plaintext.txt	66	86 two tailed student test
0.45434183.11809721.html.plaintext.txt	67	view larger version 15k figure 2
0.45434183.11809721.html.plaintext.txt	68	developmental expression cftr ovine airway
0.45434183.11809721.html.plaintext.txt	69	quantitative rt pcr using abi prism 7700 sequence detection system
0.45434183.11809721.html.plaintext.txt	70	ovine lung samples 52 66 74 80 83 90 94 108 129 143 days gestation g 147 days term 2 14 days post term pt adult
0.45434183.11809721.html.plaintext.txt	71	mean values triplicate assays expressed percentage cftr mrna lung 83 days
0.45434183.11809721.html.plaintext.txt	72	data derived ct values threshold cycle statistically significant increase emission first detected produced abi prism 7700 sequence detection system cftr assay normalized 18s ribosomal rna
0.45434183.11809721.html.plaintext.txt	73	error bars represent sd values
0.45434183.11809721.html.plaintext.txt	74	developmental expression ovine cftr organs developmental expression ovine cftr pancreas small intestine colon trachea salivary gland kidney muscle evaluated three different time points 83 108 days gestation 2 days post term fig
0.45434183.11809721.html.plaintext.txt	75	muscle provided negative control expected negligible amounts cftr mrna expression three time points experiments
0.45434183.11809721.html.plaintext.txt	76	experiments performed three times samples analysed triplicate
0.45434183.11809721.html.plaintext.txt	77	view larger version 25k figure 3
0.45434183.11809721.html.plaintext.txt	78	developmental expression cftr ovine tissues
0.45434183.11809721.html.plaintext.txt	79	quantitative rt pcr using abi prism 7700 sequence detection system
0.45434183.11809721.html.plaintext.txt	80	ovine tissue samples pancreas small intestine colon lung trachea salivary gland kidney muscle 83 108 days gestation g 2 days post term pt
0.45434183.11809721.html.plaintext.txt	81	mean values triplicate assays expressed percentage cftr mrna lung 83 days
0.45434183.11809721.html.plaintext.txt	82	data derived ct values produced abi prism 7700 sequence detection system cftr assay normalized 18s ribosomal rna
0.45434183.11809721.html.plaintext.txt	83	error bars represent sd values
0.45434183.11809721.html.plaintext.txt	84	first quantitative data enable comparison cftr expression levels tissues one species
0.45434183.11809721.html.plaintext.txt	85	confirm observation levels cftr mrna pancreas digestive system significantly higher least 5 fold lung epithelium even time maximal expression respiratory system
0.45434183.11809721.html.plaintext.txt	86	observation greater levels cftr mrna colon small intestine probably unique feature sheep digestive system data show opposite distribution human intestine 11
0.45434183.11809721.html.plaintext.txt	87	glandular organs pancreas lung salivary gland similar pattern expression characterized higher expression early gestation followed decline towards birth levels maintained 2 days post term
0.45434183.11809721.html.plaintext.txt	88	cftr mrna levels higher pancreas salivary gland lung
0.45434183.11809721.html.plaintext.txt	89	trachea cftr mrna levels comparable values lung gestation rose 2 days post term
0.45434183.11809721.html.plaintext.txt	90	small intestine expressed lower levels cftr mrna birth comparison 2 days birth
0.45434183.11809721.html.plaintext.txt	91	colon initially expressed high amounts cftr mrna decreased slightly mid gestation rising high level birth
0.45434183.11809721.html.plaintext.txt	92	cftr mrna expression ovine kidney low declines 83 2 days post term
0.45434183.11809721.html.plaintext.txt	93	developmental expression ovine enac lung cftr enac ion channels thought interact directly 2 hence pertinent evaluate also developmental expression enac ovine lung
0.45434183.11809721.html.plaintext.txt	94	assays performed using conventional rt pcr rather real time taqman rt pcr due lack full sequence information ovine enac reported alternative splicing gene 19
0.45434183.11809721.html.plaintext.txt	95	marked contrast cftr expression subunit enac low ovine lung 52 days gestation gradually rises 108 129 143 147 term days gestation much higher levels 2 days post term adult lung fig
0.45434183.11809721.html.plaintext.txt	96	subunit c atp synthase used reference standard 17 semi quantitative rt pcr reactions
0.45434183.11809721.html.plaintext.txt	97	view larger version 36k figure 4
0.45434183.11809721.html.plaintext.txt	98	developmental expression enac ovine airway
0.45434183.11809721.html.plaintext.txt	99	ovine lung samples 52 66 83 94 108 129 143 days gestation g 147 days term 2 14 days post term pt adult
0.45434183.11809721.html.plaintext.txt	100	semi quantitative rt pcr using enac primers enaf enar yielding 373 bp fragment ovine atp synthase primers f1 r1 producing 530 bp fragment
0.45434183.11809721.html.plaintext.txt	101	fragments separated 1
0.45434183.11809721.html.plaintext.txt	102	5 agarose gel stained ethidium bromide
0.45434183.11809721.html.plaintext.txt	103	discussion top abstract introduction results discussion materials methods references shown using semi quantitative quantitative rt pcr high levels cftr expression seen second trimester ovine fetal lung decrease gradually term rather declining suddenly near parturition
0.45434183.11809721.html.plaintext.txt	104	detection significant cftr expression lung development low levels birth confirms previous observations humans sheep 11 13
0.45434183.11809721.html.plaintext.txt	105	13 showed rt pcr northern blots cftr mrna expression ovine fetal lung far higher birth adulthood high levels seen 70 days ovine gestation comparable cftr mrna mid trimester human fetuses
0.45434183.11809721.html.plaintext.txt	106	however previous data evaluate cftr expression throughout gestation
0.45434183.11809721.html.plaintext.txt	107	gradual decline cftr observed ovine fetal lung development could accounted least two explanations
0.45434183.11809721.html.plaintext.txt	108	either percentage cells express cftr within lung epithelium decrease time levels expression within cell type gradually decreases
0.45434183.11809721.html.plaintext.txt	109	basis previous data would expect former explanation correct
0.45434183.11809721.html.plaintext.txt	110	postnatal human lung epithelium significant cftr expression limited specific cells within serous portion submucosal glands individual cells airway surface epithelium 2021
0.45434183.11809721.html.plaintext.txt	111	contrast apparent expression cftr mrna majority cells fetal lung epithelium 11
0.45434183.11809721.html.plaintext.txt	112	furthermore human trachea cftr expression seen intermediate diffuse first trimester situ hybridization 11
0.45434183.11809721.html.plaintext.txt	113	second trimester cftr mrna expression reduced limited subset cells epithelia trachea third trimester individual cells expressed cftr high levels 12
0.45434183.11809721.html.plaintext.txt	114	high levels cftr mrna expression observed situ hybridization pancreas small intestine colon early gestational age humans 11
0.45434183.11809721.html.plaintext.txt	115	expression levels remain constant throughout gestation contrast lung expression patterns
0.45434183.11809721.html.plaintext.txt	116	temporal spatial expression cftr mrna ovine small intestine pancreas colon salivary gland kidney muscle seen experiments closely parallel human gene 13
0.45434183.11809721.html.plaintext.txt	117	however quantitative assays show contrast human cftr gene expressed higher level crypts small intestine colon ovine cftr mrna abundant colonic epithelium
0.45434183.11809721.html.plaintext.txt	118	may reflect functional differences ruminant digestive system
0.45434183.11809721.html.plaintext.txt	119	interest decline cftr expression observed ovine fetal lung 83 days gestation 2 days birth also seen pancreas salivary gland
0.45434183.11809721.html.plaintext.txt	120	cftr may significant role development differentiation glandular tissues
0.45434183.11809721.html.plaintext.txt	121	physiological implications gradual decline lung cftr expression levels gestation warrant discussion
0.45434183.11809721.html.plaintext.txt	122	fetal lung filled high chloride low ph fluid distinct amniotic fluid
0.45434183.11809721.html.plaintext.txt	123	chloride actively secreted lung epithelium lung lumen development chloride ion channel cftr protein could contribute process
0.45434183.11809721.html.plaintext.txt	124	however chloride conductances cftr likely important fetal lung fluid secretion since cf associated hypoplastic lungs birth
0.45434183.11809721.html.plaintext.txt	125	furthermore profile cftr expression gestation correspond changes lung liquid secretion 2223
0.45434183.11809721.html.plaintext.txt	126	postnatally major ion flows across airway epithelium uptake sodium
0.45434183.11809721.html.plaintext.txt	127	lung liquid begins reabsorbed ovine lung epithelium 140 days gestation
0.45434183.11809721.html.plaintext.txt	128	sodium reabsorption achieved primarily sodium channels located apical surface lung epithelium main one enac 24
0.45434183.11809721.html.plaintext.txt	129	recent data shown enac inhibited cftr probably interacts directly 22526
0.45434183.11809721.html.plaintext.txt	130	gradual decline cftr mrna levels protein would compatible enabling enac activity
0.45434183.11809721.html.plaintext.txt	131	furthermore shown abundance enac transcripts inversely proportional levels cftr mrna developing ovine lung second trimester hence expression genes encoding two ion channels may also coordinately regulated
0.45434183.11809721.html.plaintext.txt	132	additional possibility cftr expression fetal lung epithelium important yet undefined functional role normal lung development
0.45434183.11809721.html.plaintext.txt	133	though birth lung pathology usually evident cf absence functional cftr protein developing lung reported produce pro inflammatory state 27
0.45434183.11809721.html.plaintext.txt	134	increased levels interleukin 8 observed airway surface fluid human cf fetal tracheal grafts implanted severe combined immunodeficient scid mice
0.45434183.11809721.html.plaintext.txt	135	though apparent pro inflammatory state epithelia result directly histological abnormalities challenge pseudomonas aeruginosa provoked exaggerated immune response resulting sloughing epithelial cells increased leukocyte activity thereby increasing likelihood bacterial colonization 27
0.45434183.11809721.html.plaintext.txt	136	high levels cftr expression early gestation may correspond important function cftr protein unique developmental stage
0.45434183.11809721.html.plaintext.txt	137	periods high low cftr expression defined correspond distinct developmental phases sheep lung
0.45434183.11809721.html.plaintext.txt	138	relatively high levels cftr mrna expression observed pseudoglandular phase 40 80 days sheep gestation bronchial tree acini form
0.45434183.11809721.html.plaintext.txt	139	developmental progression canalicular phase 80 120 days gestation differentiation type ii epithelial cells occurs cftr mrna levels begin decline remain low birth
0.45434183.11809721.html.plaintext.txt	140	28 shown overexpression cftr lungs wild type mice 15 16 days corresponding late pseudoglandular early canalicular developmental stages advanced epithelial cell proliferation differentiation
0.45434183.11809721.html.plaintext.txt	141	furthermore investigators suggested transient expression cftr cf mice following intramniotic injection adeno cftr cdna 15 16 days mouse gestation corrected lethal intestinal disease 29
0.45434183.11809721.html.plaintext.txt	142	expression profile cftr developing sheep lung consistent data mouse suggest crucial role cftr lung epithelial maturation
0.45434183.11809721.html.plaintext.txt	143	observations may important implications current attempts treat cf airway disease postnatal gene therapy
0.45434183.11809721.html.plaintext.txt	144	materials methods top abstract introduction results discussion materials methods references ovine tissue collection accurately timed sheep breeding programme established
0.45434183.11809721.html.plaintext.txt	145	sheep breeds used cross ram poll dorset ewes suffolk mule cross
0.45434183.11809721.html.plaintext.txt	146	ewes killed anaesthetic overdose
0.45434183.11809721.html.plaintext.txt	147	tissue collected fetuses lambs time points 52 66 74 80 83 90 94 108 129 143 days gestation term 147 days 2 days 2 weeks birth
0.45434183.11809721.html.plaintext.txt	148	time points one ewe killed however 74 days ewe carrying one fetus evaluated separately 2 days post term two ewes sacrificed
0.45434183.11809721.html.plaintext.txt	149	tissues snap frozen liquid nitrogen cryotubes nunc stored liquid nitrogen
0.45434183.11809721.html.plaintext.txt	150	extraction rna ovine tissues tissue homogenized glass homogenizers rna prepared guanidinium thiocyanate extraction 30
0.45434183.11809721.html.plaintext.txt	151	following ethanol precipitation samples stored 20 degrees c
0.45434183.11809721.html.plaintext.txt	152	rna pellet resuspended nuclease free water od260 determined
0.45434183.11809721.html.plaintext.txt	153	volumes adjusted concentration 100 250 ng microl aliquoting storage 20 degrees c
0.45434183.11809721.html.plaintext.txt	154	rt pcr ovine cftr enac rt pcrs carried previously described chalkley harris 16 across region encompassing exons 4 4s3r 5 ggaatgcagatgagaatagc 3 7 a1l 5 gctccaagagagtcatacca 3 ascertain whether alternative splicing exons 6a 6b occurred
0.45434183.11809721.html.plaintext.txt	155	semi quantitative rt pcr cftr cdna synthesis primed 3 primer c2l 5 tcttcacttatttccaagcc 3
0.45434183.11809721.html.plaintext.txt	156	cdna generated using superscript life technologies 42 degrees c 1 h pcr performed 5 primer c2r 16 5 agcagtatacaaagatgctg 3 c2l 94 degrees c 5 min 30 cycles 94 degrees c 1 min 60 degrees c 1 min 72 degrees c 1 min followed final cycle extension 72 degrees c 5 min
0.45434183.11809721.html.plaintext.txt	157	primer concentrations 10 ng microl
0.45434183.11809721.html.plaintext.txt	158	subunit c sheep mitochondrial atp synthase coamplified control total rna using primers f1 r1 concentrations 0
0.45434183.11809721.html.plaintext.txt	159	semi quantitative rt pcr ovine enac reactions carried described cftr using primers subunit enac subunit
0.45434183.11809721.html.plaintext.txt	160	5 primer 5 ctgctacactttcaacgaca 3 3 primer 5 ctccttgatcatgctctcct 3 used 5 ng microl primers ovine atp synthase used 0
0.45434183.11809721.html.plaintext.txt	161	5 ng microl annealing temperature pcr 65 degrees c extension time 5 min
0.45434183.11809721.html.plaintext.txt	162	real time quantitative rt pcr taqman using abi prism 7700 sequence detection system applied biosystems primer probe sequences designed using ovine cftr cdna sequence genbank accession
0.45434183.11809721.html.plaintext.txt	163	u20418 abi primerexpress 1
0.45434183.11809721.html.plaintext.txt	164	ovine cftr 5 primer located exon 6a 5 aagccgggttagggaaaatg 3
0.45434183.11809721.html.plaintext.txt	165	3 primer located exon 6b 5 tgccttaactgattggatattttcaa 3 ovine cftr taqman probe 5 cattgatctttccagctctctgatctctgtacttcat 3 contained reporter dye fam 5 end quencher dye tamra 3 end
0.45434183.11809721.html.plaintext.txt	166	18s rrna primer probes 5 primer 5 cggctaccacatccaaggaa 3 3 primer 5 gctggaattaccgcggct 3 5 vic 3 tamra modified probe 5 tgctggcaccagacttgccctc 3 supplied applied biosystems
0.45434183.11809721.html.plaintext.txt	167	one step rt pcr approach adopted quantitative analysis
0.45434183.11809721.html.plaintext.txt	168	independent assays performed experimental sample determine levels cftr mrna 18s rrna
0.45434183.11809721.html.plaintext.txt	169	variations rna loading samples controlled normalizing levels cftr mrna levels 18s rrna
0.45434183.11809721.html.plaintext.txt	170	cftr rt pcr assays 25 microl final volume performed using taqman gold rt pcr kit applied biosystems contained 1x buffer 7
0.45434183.11809721.html.plaintext.txt	171	3 mm datp dctp dgtp 0
0.45434183.11809721.html.plaintext.txt	172	2 u microl rnase inhibitor 300 nm 5 3 primers 100 nm probe included 5 microl experimental total rna template
0.45434183.11809721.html.plaintext.txt	173	18s rrna assays identical composition except reactions contained 5
0.45434183.11809721.html.plaintext.txt	174	experimental total rna samples diluted 10 ng microl cftr assays 0
0.45434183.11809721.html.plaintext.txt	175	01 ng microl 18s rrna assays
0.45434183.11809721.html.plaintext.txt	176	reactions carried microamp optical 96 well plates covered microamp optical caps applied biosystems
0.45434183.11809721.html.plaintext.txt	177	taqman rt conditions 48 degrees c 30 min followed amplitaq gold activation 95 degrees c 10 min 40 pcr cycles 95 degrees c 15 60 degrees c 1 min
0.45434183.11809721.html.plaintext.txt	178	data analysed using abi sequence detector software version 1
0.45434183.11809721.html.plaintext.txt	179	relative standard curves cftr 18s rrna levels generated seven sequential 5 fold dilutions common arbitrary sample lung rna 83 days gestation
0.45434183.11809721.html.plaintext.txt	180	determined arbitrary values cftr divided appropriate 18s rrna value give expression ratio
0.45434183.11809721.html.plaintext.txt	181	ratio expressed percentage one chosen sample calibrator
0.45434183.11809721.html.plaintext.txt	182	experiments total rna 83 days gestation used calibrator sample
0.45434183.11809721.html.plaintext.txt	183	standards experimental samples assayed three times sample analysed triplicate experiment
0.45434183.11809721.html.plaintext.txt	184	reaction controls performed omitted rt andor template rna
0.45434183.11809721.html.plaintext.txt	185	standard curves fitted linear regression goodness fit reported coefficient determination r2
0.45434183.11809721.html.plaintext.txt	186	acknowledgements thank cliff hanson frances knight david smith sytse henstra debbie harrison andrew rose ian pringle assistance
0.45434183.11809721.html.plaintext.txt	187	work funded vaincre la mucoviscidose cystic fibrosis trust
0.45434183.11809721.html.plaintext.txt	188	receipt medical research council postgraduate studentship
0.45434183.11809721.html.plaintext.txt	189	footnotes correspondence addressed
0.45434183.11809721.html.plaintext.txt	190	fax 44 1865 222626 email aharrismolbiol
0.45434183.11809721.html.plaintext.txt	191	references top abstract introduction results discussion materials methods references 1 riordanj
0.45434183.11809721.html.plaintext.txt	192	1989 identification cystic fibrosis gene cloning characterization complementary dna
0.45434183.11809721.html.plaintext.txt	193	1995 cftr camp dependent regulator sodium channels
0.45434183.11809721.html.plaintext.txt	194	1995 cftr regulates outwardly rectifying chloride channels autocrine mechanism involving atp
0.45434183.11809721.html.plaintext.txt	195	1992 regulation plasma membrane recycling cftr
0.45434183.11809721.html.plaintext.txt	196	1996 cftr involved membrane endocytosis fluid phase receptor mediated endocytosis human respiratory epithelial cells
0.45434183.11809721.html.plaintext.txt	197	1996 mutant cystic fibrosis transmembrane conductance regulator inhibits acidification apoptosis c127 cells possible relevance cystic fibrosis
0.45434183.11809721.html.plaintext.txt	198	1999 fas fas ligand expression cystic fibrosis airway epithelium
0.45434183.11809721.html.plaintext.txt	199	1986 prenatal diagnosis 200 pregnancies 1 4 risk cystic fibrosis
0.45434183.11809721.html.plaintext.txt	200	1997 cystic fibrosis pancreas involvement muc6 mucin obstruction pancreatic ducts
0.45434183.11809721.html.plaintext.txt	201	1991 expression cystic fibrosis gene human development
0.45434183.11809721.html.plaintext.txt	202	1993 expression cystic fibrosis gene human foetal tissues
0.45434183.11809721.html.plaintext.txt	203	1993 cell specific localization cftr mrna shows developmentally regulated expression human fetal tissues
0.45434183.11809721.html.plaintext.txt	204	1995 molecular analysis ovine cystic fibrosis transmembrane conductance regulator gene
0.45434183.11809721.html.plaintext.txt	205	1997 towards ovine model cystic fibrosis
0.45434183.11809721.html.plaintext.txt	206	2001 sheep genome contributes localization control elements human gene complex regulatory mechanisms
0.45434183.11809721.html.plaintext.txt	207	1991 cystic fibrosis patient homozygous g85e mutation mild disease
0.45434183.11809721.html.plaintext.txt	208	1993 characterization expressed genes subunit c mitochondrial atp synthase sheep ceroid lipofuscinosis
0.45434183.11809721.html.plaintext.txt	209	1994 analysis mutations alternative splicing patterns cftr gene using mrna derived nasal epithelial cells
0.45434183.11809721.html.plaintext.txt	210	1998 cloning functional studies splice variants subunit amiloride sensitive na channel
0.45434183.11809721.html.plaintext.txt	211	1992 submucosal glands predominant site cftr expression human bronchus
0.45434183.11809721.html.plaintext.txt	212	1994 expression cystic fibrosis gene adult human lung
0.45434183.11809721.html.plaintext.txt	213	1986 decline lung liquid volume labor fetal lambs
0.45434183.11809721.html.plaintext.txt	214	1997 lung liquid production rates volumes decrease labor healthy fetal sheep
0.45434183.11809721.html.plaintext.txt	215	1994 amiloride sensitive epithelial na channel made three homologous subunits
0.45434183.11809721.html.plaintext.txt	216	2000 epithelial sodium channels regulate cystic fibrosis transmembrane conductance regulator chloride channels xenopus oocytes
0.45434183.11809721.html.plaintext.txt	217	2000 cytosolic termini ss enac subunits involved functional interactions cystic fibrosis transmembrane conductance regulator epithelial sodium channel
0.45434183.11809721.html.plaintext.txt	218	2000 inflammation infection naive human cystic fibrosis airway grafts
0.45434183.11809721.html.plaintext.txt	219	2000 cftr modulates lung secretory cell proliferation differentiation
0.45434183.11809721.html.plaintext.txt	220	1997 reversal cystic fibrosis phenotype mice gene therapy utero
0.45434183.11809721.html.plaintext.txt	221	1979 isolation biologically active ribonucleic acid sources enriched ribonuclease
0.45434183.11809721.html.plaintext.txt	222	biochemistry 18 5294 5299
0.41579112.11404243.html.plaintext.txt	0	editorial focus chaperoning maturation cystic fibrosis transmembrane conductance regulator jeffrey l
0.41579112.11404243.html.plaintext.txt	1	department biological sciences university pittsburgh pittsburgh pennsylvania 15260
0.41579112.11404243.html.plaintext.txt	2	article top article references
0.41579112.11404243.html.plaintext.txt	3	endoplasmic reticulum er serves way station biogenesis nearly every integral membrane secreted protein synthesized eukaryotic cells
0.41579112.11404243.html.plaintext.txt	4	primary role facilitate folding nascent polypeptides
0.41579112.11404243.html.plaintext.txt	5	thus plentiful among er resident proteins 1 enzymes catalyze conformational rearrangements protein disulfide isomerase peptidylprolyl isomerase 2 enzymes chemically modify nascent polypeptide signal sequence peptidase oligosaccharyl transferase 3 molecules retain polypeptide soluble aggregation free state
0.41579112.11404243.html.plaintext.txt	6	factors constituting last group molecular chaperones many first identified heat shock proteins hsps synthesis induced cells exposed high temperatures stresses
0.41579112.11404243.html.plaintext.txt	7	however hsps cellular homologs constitutively produced named heat shock cognate proteins hscs
0.41579112.11404243.html.plaintext.txt	8	hsc hsp molecular chaperones defined molecular masses kda plentiful class found every cell type molecular mass 70 kda
0.41579112.11404243.html.plaintext.txt	9	hsp70 hsc70 hydrolyze atp concomitant binding release polypeptide substrates atpase activities may activated another group chaperones 21 33 known hsp40 dnaj homologs
0.41579112.11404243.html.plaintext.txt	10	cases hsp40 cochaperone delivers polypeptide substrate hsp70 hsc70 17 37
0.41579112.11404243.html.plaintext.txt	11	use variety vitro techniques hsc70 hsp70 chaperones shown bind preferentially short stretches amino acids overall hydrophobic character 3 13 31
0.41579112.11404243.html.plaintext.txt	12	motifs normally buried within core native protein may become solvent accessible protein folding upon protein denaturation
0.41579112.11404243.html.plaintext.txt	13	thus hsc70 hsp70 chaperones ideally suited aid unfolded proteins en route native conformations limiting protein aggregation
0.41579112.11404243.html.plaintext.txt	14	deletion phenylalanine position 508 cystic fibrosis cf transmembrane conductance regulator cftr common mutation associated cf 27
0.41579112.11404243.html.plaintext.txt	15	cftr likely functions chloride channel plasma membrane airway epithelial cells cells containing f508 variant either lack harbor variable amounts protein plasma membrane 7 16
0.41579112.11404243.html.plaintext.txt	16	wild type f508 mutant form cftr translocated er membrane time protein folding commence
0.41579112.11404243.html.plaintext.txt	17	however vitro studies qu colleagues 25 26 suggest efficiency f508 cftr folding severely impaired compared wild type protein
0.41579112.11404243.html.plaintext.txt	18	also shown f508 mutant protein unable undergo atp dependent conformational change er 20 40
0.41579112.11404243.html.plaintext.txt	19	consistent inability f508 cftr fold efficiently incubation cells expressing mutant lower temperatures condition may favor protein folding andor stability permits variant traffic plasma membrane active 10 albeit reduced open probability half life 9 11 19
0.41579112.11404243.html.plaintext.txt	20	contrast cftr folding retarded er protein becomes substrate er associated degradation quality control mechanism degrades aberrant proteins secretory pathway 4
0.41579112.11404243.html.plaintext.txt	21	degradation cftr like er associated degradation substrates requires ubiquitinylation delivery multicatalytic cytoplasmic proteasome 14 36 38
0.41579112.11404243.html.plaintext.txt	22	although significant proportion even wild type cftr degraded nearly f508 mutant destroyed therefore cells expressing mutant form protein phenotypically null
0.41579112.11404243.html.plaintext.txt	23	f508 cftr unable attain native conformation er come surprise interacts molecular chaperones
0.41579112.11404243.html.plaintext.txt	24	specifically cytoplasmic hsc70 hsp90 luminal ca2 binding chaperone calnexin cytoplasmic hsp40 homolog hdj2 coprecipitated cftr 18 22 24 39
0.41579112.11404243.html.plaintext.txt	25	hsc70 hdj2 also prevent vitro aggregation first nucleotide binding domain cftr 22 34 domain phenylalanine position 508 resides
0.41579112.11404243.html.plaintext.txt	26	although wild type folded cftr released chaperones transit er golgi apparatus hsc70 calnexin remain bound mutant degradation ensues 24 39
0.41579112.11404243.html.plaintext.txt	27	hsc70 interacting factor chip recently shown facilitate degradation immature forms cftr 23
0.41579112.11404243.html.plaintext.txt	28	one interpretation combined data chaperone cftr complexes represent folding intermediates
0.41579112.11404243.html.plaintext.txt	29	several human diseases arise defects protein folding 4 35 devastating effects widespread occurrence cf profound amount information available mechanisms molecular chaperones modulation protein folding chaperone activity attempted small molecules genetic manipulations
0.41579112.11404243.html.plaintext.txt	30	example demonstrated welch 5 kopito 32 laboratories f508 cftr expressing cells incubated glycerol polyol known stabilize proteins vitro contain er matured forms cftr display camp forskolin activated plasma membrane chloride transport hallmark functional cftr
0.41579112.11404243.html.plaintext.txt	31	glycerol also facilitates vitro folding first nucleotide binding domain lacking phenylalanine position 508 preventing pathway intermediates forming 25
0.41579112.11404243.html.plaintext.txt	32	f508 cftr expressing cells incubated trimethylamine oxide tmao osmotic stabilizer found sharks protect proteins urea denaturation exhibit similar properties 5
0.41579112.11404243.html.plaintext.txt	33	compounds tmao glycerol commonly known chemical chaperones
0.41579112.11404243.html.plaintext.txt	34	another means alter protein folding vivo modulation intracellular chaperone concentration
0.41579112.11404243.html.plaintext.txt	35	28 showed sodium 4 phenylbutyrate 4pba ammonia scavenger approved treatment urea cycle disorders known transcriptional regulator permits fraction f508 cftr mature bronchial epithelial cell lines primary nasal epithelial cells patients cf
0.41579112.11404243.html.plaintext.txt	36	maturation mutant coincides camp stimulated plasma membrane cl conductance treated cells
0.41579112.11404243.html.plaintext.txt	37	determine molecular basis 4pba mediated rescue f508 cftr phenotype immunoprecipitations performed examine amount cftr associated hsc70 4pba dose dependent decrease amount cftr hsc70 complex observed 30
0.41579112.11404243.html.plaintext.txt	38	hsc70 shown facilitate ubiquitination several test proteins vitro 2 authors suggested hsc70 targets cftr degradation 4pba unknown mechanism reduces amount complex cftr delivered proteasome
0.41579112.11404243.html.plaintext.txt	39	studies described support concept using chaperone modulation means rectify pathophysiology associated f508 cftr
0.41579112.11404243.html.plaintext.txt	40	three papers issue american journal physiology lung cellular molecular physiology 8 12 29 represent significant leap understanding molecular basis chaperone modulation ultimate hope interventions may become clinically relevant cf
0.41579112.11404243.html.plaintext.txt	41	building previous studies rubenstein lyons 29 show mechanism 4pba downregulates hsc70 levels decrease stability hsc70 mrna
0.41579112.11404243.html.plaintext.txt	42	although hsc70 mrna known relatively unstable 4pba appears accelerate degradation
0.41579112.11404243.html.plaintext.txt	43	coincident acceleration mrna degradation 40 reduction amount hsc70 evident
0.41579112.11404243.html.plaintext.txt	44	mechanism occurs unknown shown inhibiting initiation yeast hsc70 translation leads rapid destruction message 1
0.41579112.11404243.html.plaintext.txt	45	large number translation poisons known many first isolated antibiotics hypothesis tested
0.41579112.11404243.html.plaintext.txt	46	4pba modulate hsc70 levels although previous data 30 suggested new work choo kang zeitlin 8 indicates 4pba raises hsp70 levels leading increased hsp70 f508 cftr complex formation f508 cftr maturation
0.41579112.11404243.html.plaintext.txt	47	one concern phenomenon may arise secondary effect decreasing hsc70 levels see turn could induce general heat shock stress response
0.41579112.11404243.html.plaintext.txt	48	however authors show cftr maturation also facilitated selectively increasing intracellular levels hsp70 transient transfection hsp70 expression vector
0.41579112.11404243.html.plaintext.txt	49	combined studies suggest modulating levels thus activities hsc70 hsp70 enhances cftr maturation
0.41579112.11404243.html.plaintext.txt	50	also point complexity hsp70 hsc70 function cell
0.41579112.11404243.html.plaintext.txt	51	hsp70 facilitates protein folding homolog
0.41579112.11404243.html.plaintext.txt	52	hsc70 targets misfolded protein degradation
0.41579112.11404243.html.plaintext.txt	53	previous data suggest multiple chaperones bind coordinately nascent polypeptides
0.41579112.11404243.html.plaintext.txt	54	although functions many chaperones likely redundant seems logical subset required folding another subset necessary protein degradation
0.41579112.11404243.html.plaintext.txt	55	one group fails fold polypeptide another readily available target substrate destruction
0.41579112.11404243.html.plaintext.txt	56	activities unique sets chaperones may defined action hsp40dnaj cochaperones regulate hsp70 hsc70 function
0.41579112.11404243.html.plaintext.txt	57	cases folding degradation targeting activities may reside one chaperone complex
0.41579112.11404243.html.plaintext.txt	58	example hsp90 proposed facilitate cftr maturation degradation 18
0.41579112.11404243.html.plaintext.txt	59	another means catalyze cftr folding use chemical chaperones attack shown promise vitro model systems described
0.41579112.11404243.html.plaintext.txt	60	determine whether approach feasible animal system fischer et al
0.41579112.11404243.html.plaintext.txt	61	12 examined whether tmao corrects f508 cftr trafficking defect mice
0.41579112.11404243.html.plaintext.txt	62	severity defect associated f508 form cftr prevalent rodent intestine measurements rectal potential difference rpd undertaken control mice lacking cftr f508 cftr mice
0.41579112.11404243.html.plaintext.txt	63	administration tmao 24 h subcutaneous injection reveals significant increases forskolin activated rpd hyperpolarization control f508 cftr mice consistent partial rescue folding defects associated wild type mutant proteins
0.41579112.11404243.html.plaintext.txt	64	promising clinical perspective observation administering flavinoid apigenin cftr activator increases forskolin activated rpd f508 cftr expressing mouse
0.41579112.11404243.html.plaintext.txt	65	result supports promise combined therapeutic attacks may present best option lessen pathophysiology cf
0.41579112.11404243.html.plaintext.txt	66	combining small molecule activators cftr function warranted particularly case concentrations tmao used studies quite high physiological effects prolonged administration tmao unknown
0.41579112.11404243.html.plaintext.txt	67	might chaperone based therapies become clinically relevant generalized spectrum diseases arise protein misfolding corrective effects glycerol 4 pba maturation secretion another conformational disease causing protein z variant antitrypsin recently reported burrows et al
0.41579112.11404243.html.plaintext.txt	68	addition chaperone modulators currently examined ability correct misfolded proteins
0.41579112.11404243.html.plaintext.txt	69	15 deoxyspergualin known hsc70 effector immunosuppressant increases camp stimulated plasma membrane cl channel activity f508 cftr expressing cells 15
0.41579112.11404243.html.plaintext.txt	70	however increase er matured forms f508 cftr could observed 15 deoxyspergualin treatment small amount mutant likely trafficked plasma membrane yielded desired activity
0.41579112.11404243.html.plaintext.txt	71	nevertheless advent combinatorial chemistry defined methods examine protein folding chaperone action molecular level suspect see new convergence chemical cell biological biophysical tools geared combat variety human diseases
0.41579112.11404243.html.plaintext.txt	72	address reprint requests correspondence j
0.41579112.11404243.html.plaintext.txt	73	biological sciences 267 crawford hall univ
0.41579112.11404243.html.plaintext.txt	74	pittsburgh pittsburgh pa 15260 e mail jbrodskyatpitt
0.41579112.11404243.html.plaintext.txt	75	references top article references
0.41579112.11404243.html.plaintext.txt	76	upf1 upf2 proteins mediate normal yeast mrna degradation translation initiation limited
0.41579112.11404243.html.plaintext.txt	77	nucleic acids res 26 2433 2441 1998abstractfree full text
0.41579112.11404243.html.plaintext.txt	78	berkovich b stancovski mayer blumenfeld n laszlo schwartz al ciechanover
0.41579112.11404243.html.plaintext.txt	79	ubiquitin dependent degradation certain protein substrates vitro requires molecular chaperone hsc70
0.41579112.11404243.html.plaintext.txt	80	j biol chem 272 9002 9010 1997abstractfree full text
0.41579112.11404243.html.plaintext.txt	81	blond elguindi cwirla se dower wj lipshutz rj sprang sr sambrook jf gething mj
0.41579112.11404243.html.plaintext.txt	82	affinity panning library peptides displayed bacteriophages reveals binding specificity bip
0.41579112.11404243.html.plaintext.txt	83	cell 75 717 728 1993isimedline
0.41579112.11404243.html.plaintext.txt	84	brodsky jl mccracken aa
0.41579112.11404243.html.plaintext.txt	85	er protein quality control proteasome mediated protein degradation
0.41579112.11404243.html.plaintext.txt	86	semin cell dev biol 10 507 513 1999isimedline
0.41579112.11404243.html.plaintext.txt	87	brown cr hong brown lq biwersi j verkman welch wj
0.41579112.11404243.html.plaintext.txt	88	chemical chaperones correct mutant phenotype delta f508 cystic fibrosis transmembrane conductance regulator protein
0.41579112.11404243.html.plaintext.txt	89	cell stress chaperones 1 117 125 1996isimedline
0.41579112.11404243.html.plaintext.txt	90	burrows jaj willis lk perlmutter dh
0.41579112.11404243.html.plaintext.txt	91	chemical chaperones mediate increased secretion mutant 1 antitrypsin 1 z potential pharmacological strategy prevention liver injury emphysema 1 deficiency
0.41579112.11404243.html.plaintext.txt	92	proc natl acad sci usa 97 1796 1801 2000abstractfree full text
0.41579112.11404243.html.plaintext.txt	93	cheng sh gregory rj marshall j paul souza dw white ga oriordan cr smith ae
0.41579112.11404243.html.plaintext.txt	94	defective intracellular transport processing cftr molecular basis cystic fibrosis
0.41579112.11404243.html.plaintext.txt	95	cell 63 827 834 1990isimedline
0.41579112.11404243.html.plaintext.txt	96	choo kang lr zeitlin pl
0.41579112.11404243.html.plaintext.txt	97	induction hsp70 promotes f508 cftr trafficking
0.41579112.11404243.html.plaintext.txt	98	j physiol lung cell mol physiol 281 l58 l68 2001abstractfree full text
0.41579112.11404243.html.plaintext.txt	99	dalemans w barbry p champigny g jallat dott k dreyer d crystal rg pavirani lecocq jp lazdunski m
0.41579112.11404243.html.plaintext.txt	100	altered chloride ion channel kinetics associated delta f508 cystic fibrosis mutation
0.41579112.11404243.html.plaintext.txt	101	nature 354 526 528 1991isimedline
0.41579112.11404243.html.plaintext.txt	102	denning gm anderson mp amara jf marshall j smith ae welsh mj
0.41579112.11404243.html.plaintext.txt	103	processing mutant cystic fibrosis transmembrane conductance regulator temperature sensitive
0.41579112.11404243.html.plaintext.txt	104	nature 358 761 764 1992isimedline
0.41579112.11404243.html.plaintext.txt	105	drumm ml wilkinson dj smit ls worrell rt strong tv frizell ra dawson dc collins fs
0.41579112.11404243.html.plaintext.txt	106	chloride conductance expressed delta f508 mutant cftrs xenopus oocytes
0.41579112.11404243.html.plaintext.txt	107	science 254 1797 1799 1991isimedline
0.41579112.11404243.html.plaintext.txt	108	fischer h fukuda n barbry p illek b sartori c matthay ma
0.41579112.11404243.html.plaintext.txt	109	partial restoration defective chloride conductance f508 cf mice chemical chaperone trimethylamine oxide
0.41579112.11404243.html.plaintext.txt	110	j physiol lung cell mol physiol 281 l52 l57 2001abstractfree full text
0.41579112.11404243.html.plaintext.txt	111	flynn gc pohl j flocco mt rothman je
0.41579112.11404243.html.plaintext.txt	112	peptide binding specificity molecular chaperone bip
0.41579112.11404243.html.plaintext.txt	113	nature 353 726 730 1991isimedline
0.41579112.11404243.html.plaintext.txt	114	jensen tj loo ma pind williams db goldberg al riordan jr
0.41579112.11404243.html.plaintext.txt	115	multiple proteolytic systems including proteasome contribute cftr processing
0.41579112.11404243.html.plaintext.txt	116	cell 83 129 135 1995isimedline
0.41579112.11404243.html.plaintext.txt	117	jiang c fang sl xiao yf oconnor sp nadler sg lee dw jefferson dm kaplan jm smith ae cheng sh
0.41579112.11404243.html.plaintext.txt	118	partial restoration camp stimulated cftr chloride channel activity f508 cells deoxyspergualin
0.41579112.11404243.html.plaintext.txt	119	j physiol cell physiol 275 c171 c178 1998abstractfree full text
0.41579112.11404243.html.plaintext.txt	120	kalin n claass sommer m puchelle e tummler b
0.41579112.11404243.html.plaintext.txt	121	f508 cftr protein expression tissue patients cystic fibrosis
0.41579112.11404243.html.plaintext.txt	122	j clin invest 10 1379 1389 1999
0.41579112.11404243.html.plaintext.txt	123	langer lu c echols h flanagan j hayer mk hartl fu
0.41579112.11404243.html.plaintext.txt	124	successive action dnak dnaj groel along pathway chaperone mediated folding
0.41579112.11404243.html.plaintext.txt	125	nature 356 683 689 1992isimedline
0.41579112.11404243.html.plaintext.txt	126	loo ma jensen tj cui l hou y chang xb riordan jr
0.41579112.11404243.html.plaintext.txt	127	perturbation hsp90 interaction nascent cftr prevents maturation accelerates degradation proteasome
0.41579112.11404243.html.plaintext.txt	128	embo j 17 6879 6887 1998abstractfree full text
0.41579112.11404243.html.plaintext.txt	129	lukacs gl chang xb bear c kartner n mohamed riordan jr grinstein
0.41579112.11404243.html.plaintext.txt	130	delta f508 mutation decreases stability cystic fibrosis transmembrane conductance regulator plasma membrane
0.41579112.11404243.html.plaintext.txt	131	determination functional half lives transfected cells
0.41579112.11404243.html.plaintext.txt	132	j biol chem 268 21592 21598 1993abstractfree full text
0.41579112.11404243.html.plaintext.txt	133	lukacs gl mohamed kartner n chang xb riordan jr grinstein
0.41579112.11404243.html.plaintext.txt	134	conformational maturation cftr mutant counterpart delta f508 occurs endoplasmic reticulum requires atp
0.41579112.11404243.html.plaintext.txt	135	embo j 13 6076 6086 1994abstract
0.41579112.11404243.html.plaintext.txt	136	mccarty js buchberger reinstein j bukau b
0.41579112.11404243.html.plaintext.txt	137	role atp functional cycle dnak chaperone system
0.41579112.11404243.html.plaintext.txt	138	j mol biol 249 126 137 1995isimedline
0.41579112.11404243.html.plaintext.txt	139	meacham gc lu z king sorscher e tousson cyr dm
0.41579112.11404243.html.plaintext.txt	140	hdj 2hsc70 chaperone pair facilitates early steps cftr biogenesis
0.41579112.11404243.html.plaintext.txt	141	embo j 18 1492 1505 1999abstractfree full text
0.41579112.11404243.html.plaintext.txt	142	meacham gc patterson c zhang w younger jm cyr dm
0.41579112.11404243.html.plaintext.txt	143	hsc70 co chaperone chip targets immature cftr proteasomal degradation
0.41579112.11404243.html.plaintext.txt	144	nat cell biol 3 100 105 2001isimedline
0.41579112.11404243.html.plaintext.txt	145	pind riordan jr williams db
0.41579112.11404243.html.plaintext.txt	146	participation endoplasmic reticulum chaperone calnexin p88 ip90 biogenesis cystic fibrosis transmembrane conductance regulator
0.41579112.11404243.html.plaintext.txt	147	j biol chem 269 12784 12788 1994abstractfree full text
0.41579112.11404243.html.plaintext.txt	148	qu bh strickland eh thomas pj
0.41579112.11404243.html.plaintext.txt	149	localization suppression kinetic defect cystic fibrosis transmembrane conductance regulator folding
0.41579112.11404243.html.plaintext.txt	150	j biol chem 272 15739 15744 1997abstractfree full text
0.41579112.11404243.html.plaintext.txt	151	alteration cystic fibrosis transmembrane conductance regulator folding pathway
0.41579112.11404243.html.plaintext.txt	152	j biol chem 271 7261 7264 1996abstractfree full text
0.41579112.11404243.html.plaintext.txt	153	riordan jr rommens jm kerem b alon n rozmahel r grzelczak z zielenski j lok plavsic n chou jl drumm ml ianuzzi mc collin fs tsui lc
0.41579112.11404243.html.plaintext.txt	154	identification cystic fibrosis gene cloning characterization complementary dna
0.41579112.11404243.html.plaintext.txt	155	science 245 1066 1073 1989isimedline
0.41579112.11404243.html.plaintext.txt	156	rubenstein rc egan zeitlin pl
0.41579112.11404243.html.plaintext.txt	157	vitro pharmacologic restoration cftr mediated chloride transport sodium 4 phenylbutyrate cystic fibrosis epithelial cells containing delta f508 cftr
0.41579112.11404243.html.plaintext.txt	158	j clin invest 100 2457 2465 1997abstractfree full text
0.41579112.11404243.html.plaintext.txt	159	rubenstein rc lyons bm
0.41579112.11404243.html.plaintext.txt	160	sodium 4 phenylbutyrate downregulates hsc70 expression facilitating mrna degradation
0.41579112.11404243.html.plaintext.txt	161	j physiol lung cell mol physiol 281 l43 l51 2001abstractfree full text
0.41579112.11404243.html.plaintext.txt	162	rubenstein rc zeitlin pl
0.41579112.11404243.html.plaintext.txt	163	sodium 4 phenylbutyrate downregulates hsc70 implications intracellular trafficking f508 cftr
0.41579112.11404243.html.plaintext.txt	164	j physiol cell physiol 278 c259 c267 2000abstractfree full text
0.41579112.11404243.html.plaintext.txt	165	rudiger germeroth l schneider mergener j bukau b
0.41579112.11404243.html.plaintext.txt	166	substrate specificity dnak chaperone determined scanning cellulose bound peptide libraries
0.41579112.11404243.html.plaintext.txt	167	embo j 16 1501 1507 2000abstractfree full text
0.41579112.11404243.html.plaintext.txt	168	sato ward cl krouse wine jj kopito rr
0.41579112.11404243.html.plaintext.txt	169	glycerol reverses misfolding phenotype common cystic fibrosis mutation
0.41579112.11404243.html.plaintext.txt	170	j biol chem 271 635 638 1996abstractfree full text
0.41579112.11404243.html.plaintext.txt	171	schmid d baici gehring h christen p
0.41579112.11404243.html.plaintext.txt	172	kinetics molecular chaperone action
0.41579112.11404243.html.plaintext.txt	173	science 263 971 973 1994isimedline
0.41579112.11404243.html.plaintext.txt	174	strickland e qu bh millen l thomas pj
0.41579112.11404243.html.plaintext.txt	175	molecular chaperone hsc70 assists vitro folding n terminal nucleotide binding domain cystic fibrosis transmembrane conductance regulator
0.41579112.11404243.html.plaintext.txt	176	j biol chem 272 25421 25424 1997abstractfree full text
0.41579112.11404243.html.plaintext.txt	177	thomas pj qu bh pedersen pl
0.41579112.11404243.html.plaintext.txt	178	defective protein folding basis human disease
0.41579112.11404243.html.plaintext.txt	179	trends biochem sci 20 456 459 1995isimedline
0.41579112.11404243.html.plaintext.txt	180	ward cl omura kopito rr
0.41579112.11404243.html.plaintext.txt	181	degradation cftr ubiquitin proteasome pathway
0.41579112.11404243.html.plaintext.txt	182	cell 83 121 127 1995isimedline
0.41579112.11404243.html.plaintext.txt	183	wickner hoskins j mckenney k
0.41579112.11404243.html.plaintext.txt	184	function dnaj dnak chaperones origin specific dna binding repa
0.41579112.11404243.html.plaintext.txt	185	nature 350 165 167 1991isimedline
0.41579112.11404243.html.plaintext.txt	186	xiong x chong e skach wr
0.41579112.11404243.html.plaintext.txt	187	evidence endoplasmic reticulum er associated degradation cystic fibrosis transmembrane conductance regulator linked retrograde translocation er membrane
0.41579112.11404243.html.plaintext.txt	188	j biol chem 274 2616 2624 1999abstractfree full text
0.41579112.11404243.html.plaintext.txt	189	yang y janich cohn ja wilson jm
0.41579112.11404243.html.plaintext.txt	190	common variant cystic fibrosis transmembrane conductance regulator recognized hsp70 degraded pre golgi nonlysosomal compartment
0.41579112.11404243.html.plaintext.txt	191	proc natl acad sci usa 90 9480 9484 1993abstract
0.41579112.11404243.html.plaintext.txt	192	zhang f kartner n lukacs gl
0.41579112.11404243.html.plaintext.txt	193	limited proteolysis probe arrested conformational maturation f508 cftr
0.41579112.11404243.html.plaintext.txt	194	nat struct biol 5 180 183 1998isimedline
0.41579112.11404243.html.plaintext.txt	195	j physiol lung cell mol physiol 2811l39 l42 1040 060501 5
0.41579112.11404243.html.plaintext.txt	196	00 copyright 2001 american physiological society
0.56830734.9843756.html.plaintext.txt	0	themes genetic disorders membrane transportii
0.56830734.9843756.html.plaintext.txt	1	regulation cftr small molecules including hco3 beate illek12 horst fischer1 terry e
0.56830734.9843756.html.plaintext.txt	2	1 childrens hospital oakland research institute oakland 94609 2 department molecular cell biology university california berkeley california 94720
0.56830734.9843756.html.plaintext.txt	3	abstract top abstract introduction references
0.56830734.9843756.html.plaintext.txt	4	cystic fibrosis cf affects number epithelial tissues including gastrointestinal tract
0.56830734.9843756.html.plaintext.txt	5	goal review summarize data related regulation protein product cf gene cf transmembrane conductance regulator cftr variety small molecules
0.56830734.9843756.html.plaintext.txt	6	surge interest discovering small molecules could exogenously added cells tissues regulate cftr could potentially used alone combination genetic approaches therapy cf
0.56830734.9843756.html.plaintext.txt	7	discuss apparent mechanisms action genistein milrinone 8 cyclopentyl 13 dipropylxanthine ibmx ns 004 several appear interact directly one nucleotide binding domains cftr
0.56830734.9843756.html.plaintext.txt	8	also discuss hco3 interacts cftr permeating anion potential regulator cl permeation cftr ion channel
0.56830734.9843756.html.plaintext.txt	9	likely complicated interactions cl hco3 secretion ions cftr anion exchanger intestinal cells may yield role cftr regulation intestinal hco3 secretion well intra extracellular ph
0.56830734.9843756.html.plaintext.txt	10	cystic fibrosis cystic fibrosis transmembrane conductance regulator pharmacology epithelial transport chloride secretion
0.56830734.9843756.html.plaintext.txt	11	introduction top abstract introduction references
0.56830734.9843756.html.plaintext.txt	12	cystic fibrosis cf common fatal genetic disease caucasian population incidence 1 2500 live births carrier frequency 1 25
0.56830734.9843756.html.plaintext.txt	13	disease caused mutations cf transmembrane conductance regulator cftr 30 functions camp activated cl channel
0.56830734.9843756.html.plaintext.txt	14	cellular level cftr dysfunction results defective camp regulated cl conductance primarily cells epithelial origin 27
0.56830734.9843756.html.plaintext.txt	15	although lung disease primary cause mortality cf patients significant proportion morbidity directly attributed gastrointestinal complications
0.56830734.9843756.html.plaintext.txt	16	duodenum jejunum ileum colon express high levels cftr mrna 30
0.56830734.9843756.html.plaintext.txt	17	immunocytochemical analysis also demonstrated high cftr protein expression luminal surfaces along intestine 7
0.56830734.9843756.html.plaintext.txt	18	small intestine cf patients exhibits decreased cl fluid secretion results meconium ileus lower water content higher viscosity compared non cf patients 10 cf newborns accumulation mucus intestinal obstructions primarily ileocecum large intestine 20 adult patients see ref
0.56830734.9843756.html.plaintext.txt	19	intestinal pathophysiology appears hallmark recently developed transgenic cf mouse models
0.56830734.9843756.html.plaintext.txt	20	ileocecum large intestine appear common sites intestinal blockade whereas jejunal obstructions occur less frequently 13
0.56830734.9843756.html.plaintext.txt	21	thus cftr plays important role intestinal secretion
0.56830734.9843756.html.plaintext.txt	22	secretion controlled multiple hormones nerve cell transmitters couple activation cftr well ion channels transporters required generate transepithelial secretion
0.56830734.9843756.html.plaintext.txt	23	phosphorylation cftr protein kinases pk dephosphorylation protein phosphatases pp considered major way cftr cl channel activity physiologically regulated
0.56830734.9843756.html.plaintext.txt	24	addition normal gating cycle opening closing cftr requires atp binding hydrolysis two nucleotide binding domains nbds cftr see ref
0.56830734.9843756.html.plaintext.txt	25	atp concentration likely maintained constant cells therefore significant physiological regulator
0.56830734.9843756.html.plaintext.txt	26	addition phosphorylationdephosphorylation atp binding hydrolysis investigators searched exogenous compounds potential therapeutic activators mutant cftr protein found cf patients
0.56830734.9843756.html.plaintext.txt	27	figure 1 shows chemical structures several small molecules discussed review
0.56830734.9843756.html.plaintext.txt	28	small molecules appear bind directly one nbds cftr cftr prephosphorylated increase open probability channel
0.56830734.9843756.html.plaintext.txt	29	first portion review pharmacological regulation cftr small molecules discuss work showing genistein 8 cyclopentyl 13 dipropylxanthine dpcpx ibmx xanthines ns 004 seem operate way
0.56830734.9843756.html.plaintext.txt	30	addition discuss phosphodiesterase pde inhibitor milrinone also stimulates cftr mechanism less well characterized
0.56830734.9843756.html.plaintext.txt	31	view larger version 14k fig
0.56830734.9843756.html.plaintext.txt	32	chemical structures compounds discussed text
0.56830734.9843756.html.plaintext.txt	33	dpcpx 8 cyclopentyl 13 dipropylxanthine
0.56830734.9843756.html.plaintext.txt	34	second portion review hco3 permeation possible regulation cftr mediated cl currents discuss question hco3 permeation potential regulation cftr
0.56830734.9843756.html.plaintext.txt	35	controversial area research
0.56830734.9843756.html.plaintext.txt	36	secretory epithelia secrete cl hco3 cftr seems involved critical way still poorly understood
0.56830734.9843756.html.plaintext.txt	37	discuss data relevant question whether key role cftr conduct hco3 play sort permissive role hco3 secretion adjacent anion exchanger requires cl cells luminal aspect exchange cellular hco3
0.56830734.9843756.html.plaintext.txt	38	alternatively cftr could also required keep cellular cl concentration low enough cl enters cell exchanger exchanges cellular hco3
0.56830734.9843756.html.plaintext.txt	39	also discuss possibility hco3 may regulate activity cftr altering permeation cl due multi ion pore behavior cftr
0.56830734.9843756.html.plaintext.txt	40	pharmacological regulation cftr small molecules
0.56830734.9843756.html.plaintext.txt	41	genistein member large class naturally occurring flavonoids
0.56830734.9843756.html.plaintext.txt	42	flavonoids potent genistein activating cftr 19 focus genistein investigated thoroughly
0.56830734.9843756.html.plaintext.txt	43	genistein potent activator cftr e
0.56830734.9843756.html.plaintext.txt	44	20 22 activating mechanism debated
0.56830734.9843756.html.plaintext.txt	45	genistein seem operate activation protein kinase pka pkc pkg increases intracellular camp ca2 cgmp concentrations 21 32
0.56830734.9843756.html.plaintext.txt	46	genistein well known tyrosine kinase ptk inhibitor two ptk inhibitors tyrphostin 47 tyrphostin b42 also stimulated cftr genistein stimulated channel activity blocked tyrosine phosphatase inhibitor vanadate 21 32
0.56830734.9843756.html.plaintext.txt	47	however several ptk inhibitors tyrphostin a23 tyrphostin a51 erbstatin analog herbimycin failed stimulate cftr 20
0.56830734.9843756.html.plaintext.txt	48	genistein also stimulated cftr equally well gtp poor substrate tyrosine kinases used replacement atp 10
0.56830734.9843756.html.plaintext.txt	49	results suggested genistein activated cftr blocking pp inactivation rates cftr currents camp removal markedly decreased genistein 20 cftr phosphorylated amino acids genistein raise camp concentration forskolin 29
0.56830734.9843756.html.plaintext.txt	50	recent data indicated likely explanation stimulatory effect genistein direct binding nbd phosphorylated cftr
0.56830734.9843756.html.plaintext.txt	51	genistein directly open cftr channels genistein stimulate cftr atp camp depleted monolayers 22
0.56830734.9843756.html.plaintext.txt	52	similarly genistein activation cftr excised patches required atp prior phosphorylation pka 10
0.56830734.9843756.html.plaintext.txt	53	addition genistein stimulated phosphatase resistant thiophosphorylated cftr even presence pki block pka vo4 block pp 10 39
0.56830734.9843756.html.plaintext.txt	54	kinetic analysis indicated genistein concentration 35 microm induced prolonged openings cftr similar effect nonhydrolyzable atp analog whereas genistein concentration 35 microm caused prolonged closed times 38
0.56830734.9843756.html.plaintext.txt	55	attractive model stimulatory inhibitory effects genistein cftr gadsby et al
0.56830734.9843756.html.plaintext.txt	56	model 11 proposes atp binding hydrolysis nbd1 control channel opening closing low phosphorylation levels atp hydrolysis nbd1 opened highly phosphorylated cftr channel atp binding nbd2 stabilize open state
0.56830734.9843756.html.plaintext.txt	57	hydrolysis nucleotide nbd2 terminates stabilization
0.56830734.9843756.html.plaintext.txt	58	agents interfere atp hydrolysis nbd2 e
0.56830734.9843756.html.plaintext.txt	59	5 adenylylimidodiphosphate amp pnp pyrophosphate induce prolonged burst opening
0.56830734.9843756.html.plaintext.txt	60	genistein competitive inhibitor atp binding ptk inhibitor constant 13
0.56830734.9843756.html.plaintext.txt	61	7 microm atp binding proteins crystal structure analysis src family tyrosine kinase hck revealed structurally related flavone cftr activator quercetin 19 localized binding site adenine ring amp pnp atp 34
0.56830734.9843756.html.plaintext.txt	62	considering sequence homology shared walker type binding motifs ptk nbds cftr therefore seems possible genistein competes atp binding sites cftr possibly nbd2 10 thereby slowing atp hydrolysis preventing cftr channel closure
0.56830734.9843756.html.plaintext.txt	63	unlikely genistein activates cftr binding src kinase would require activation tyrosine kinase genistein blocks tyrosine kinases
0.56830734.9843756.html.plaintext.txt	64	might also proposed higher concentrations genistein inhibit cftr competing atp nbd1 may lower affinity genistein binding prevent cftr opening
0.56830734.9843756.html.plaintext.txt	65	substituted benzimidazolone ns 004 effects quite similar exhibited genistein
0.56830734.9843756.html.plaintext.txt	66	1 1 microm f508 cftr 10 microm without raising camp concentration also presence pka inhibitor 12 necessary pretreat cells forskolin patch excision observe cftr channel activation ns 004
0.56830734.9843756.html.plaintext.txt	67	addition drug caused active cftr channels increase activity effect added channel rundown indicating ns 004 required phosphorylated cftr
0.56830734.9843756.html.plaintext.txt	68	ns 004 inhibit vitro pp activity
0.56830734.9843756.html.plaintext.txt	69	thus although ns 004 thought operate directly opening cftr 12 drug may use mechanism similar genistein increase open probabilities phosphorylated active channels without affecting either pk pp
0.56830734.9843756.html.plaintext.txt	70	cardiotonic drug milrinone inhibitor cgmp inhibited pde class iii pde selected several drugs inhibiting pde isozymes 23
0.56830734.9843756.html.plaintext.txt	71	pde inhibitors raise cellular camp concentration cftr activated increases camp concentration assumed milrinone also ibmx see stimulate cftr raising camp
0.56830734.9843756.html.plaintext.txt	72	however exact mechanisms determined
0.56830734.9843756.html.plaintext.txt	73	milrinone activated normal f508 cftr transformed nasal epithelial cells 24 combination forskolin milrinone milrinone alone increased potential difference across nasal epithelium f508 cftr mice vivo transgenic mice lacking cftr 24
0.56830734.9843756.html.plaintext.txt	74	milrinone activated cftr even cells maximally stimulated forskolin camp agonist indicating drug likely effects stimulate production camp
0.56830734.9843756.html.plaintext.txt	75	ibmx dpcpx xanthine derivatives
0.56830734.9843756.html.plaintext.txt	76	ibmx inhibitor pde broad specificity
0.56830734.9843756.html.plaintext.txt	77	despite broad use pde inhibitor seems unlikely ibmx works solely via mechanism
0.56830734.9843756.html.plaintext.txt	78	ibmx activated cftr even cells maximally stimulated forskolin camp agonist 23
0.56830734.9843756.html.plaintext.txt	79	although substituted xanthine derivatives activated cftr correlation effects cftr cellular camp atp concentrations 4
0.56830734.9843756.html.plaintext.txt	80	also found use fluorescence assay pka activity opposed measurements camp concentration using ria forskolin caused fibroblasts raise camp concentration high level pka activity saturated maximally binding camp ibmx indeed raised camp concentration effect increase pka activity b
0.56830734.9843756.html.plaintext.txt	81	machen unpublished observations
0.56830734.9843756.html.plaintext.txt	82	therefore seems likely stimulatory effects ibmx cftr due combined effects raise camp pka saturated also block pp directly bind cftr
0.56830734.9843756.html.plaintext.txt	83	xanthine derivative dpcpx adenosine a1 antagonist may selectivity f508 cftr compared effects wild type cftr
0.56830734.9843756.html.plaintext.txt	84	dpcpx stimulates f508 cftr channels variety epithelial fibroblast cells 8 15
0.56830734.9843756.html.plaintext.txt	85	cells correction cf defect transfection cftr gene rendered transfected cells insensitive dpcpx
0.56830734.9843756.html.plaintext.txt	86	contrast dpcpx stimulated recombinant cftr channels hek cell microsomal membranes incorporated planar lipid layers 2
0.56830734.9843756.html.plaintext.txt	87	effects dpcpx seemed due effect a1 receptors northern analysis showed dpcpx sensitive cell line cfpac 1 a1 receptor mrna another xanthine analog 13 diallyl 8 cyclohexylxanthine dax potent cftr activator poor a1 adenosine receptor antagonist
0.56830734.9843756.html.plaintext.txt	88	using rapid membrane filtration assay cohen et al
0.56830734.9843756.html.plaintext.txt	89	6 reported dpcpx bound nbd1 f508 cftr dissociation constant kd 1
0.56830734.9843756.html.plaintext.txt	90	0 nm affinity 17 times higher nbd1 wild type cftr kd 17
0.56830734.9843756.html.plaintext.txt	91	0 nm rank order among different xanthines dax dpcpx caffeine da dpcpx adenosine ibmx 2 thio dpcpx
0.56830734.9843756.html.plaintext.txt	92	results consistent unique binding site dpcpx related xanthines nbd1 cftr vicinity f508 2
0.56830734.9843756.html.plaintext.txt	93	dpcpx 25 fold potent ibmx potentiating f508 cftr mechanism elevation intracellular camp concentration 15
0.56830734.9843756.html.plaintext.txt	94	stimulation cftr dpcpx dax required prephosphorylated cftr 2
0.56830734.9843756.html.plaintext.txt	95	thus dpcpx likely xanthines including ibmx genistein ns 004 seemed activate prephosphorylated cftr binding directly cftr
0.56830734.9843756.html.plaintext.txt	96	dpcpx appeared bind nbd1 rather nbd2 also seemed selective f508 cftr wild type cftr
0.56830734.9843756.html.plaintext.txt	97	pharmacological stimulation mutant cftr therapeutic potential
0.56830734.9843756.html.plaintext.txt	98	common mutation cf f508 cftr leads trafficking impaired protein gets degraded cell 40
0.56830734.9843756.html.plaintext.txt	99	mutations lead trafficking competent misfunctional proteins e
0.56830734.9843756.html.plaintext.txt	100	appears mutants different misfunctions need selective treatments
0.56830734.9843756.html.plaintext.txt	101	example genistein failed activate f508 cftr cf bronchial epithelial cells 22 addition genistein camp agonists nih3t3 cells overexpressing f508 cftr caused strong synergistic activation 18
0.56830734.9843756.html.plaintext.txt	102	alternatively cf nasal epithelial cells treated 4 phenylbutyrate low temperature increase expression f508 cftr membrane 31 40 genistein potent stimulant 9
0.56830734.9843756.html.plaintext.txt	103	addition trafficking competent g551d cftr mutant expressed fibroblasts stimulated combination genistein forskolin forskolin alone ineffective 9
0.56830734.9843756.html.plaintext.txt	104	data indicate genistein targets cftr mutants present plasma membrane
0.56830734.9843756.html.plaintext.txt	105	ns 004 especially dpcpx also shown activate f508 cftr
0.56830734.9843756.html.plaintext.txt	106	ibmx produced small cftr related secretory response jejunum cecum rectum g551d mice effect nasal epithelium 36
0.56830734.9843756.html.plaintext.txt	107	ns 004 restored near normal channel activity p574h cftr mild trafficking impaired mutation nbd1 3
0.56830734.9843756.html.plaintext.txt	108	results suggest addition direct effects cftr drugs may also effects increase number channel proteins found membrane
0.56830734.9843756.html.plaintext.txt	109	also important remember may tissue specific effects drugs epithelial cells require concomitant activity basolateral k channels secrete fluid efficiently
0.56830734.9843756.html.plaintext.txt	110	hco3 permeation possible regulation cftr mediated cl currents
0.56830734.9843756.html.plaintext.txt	111	background role cftr hco3 secretion across intestine
0.56830734.9843756.html.plaintext.txt	112	hco3 secretion key function occurs stomach pancreas small large intestine
0.56830734.9843756.html.plaintext.txt	113	hco3 secretion particularly important duodenum protect intestinal mucosa damage large amounts acid stomach 1
0.56830734.9843756.html.plaintext.txt	114	transepithelial secretion hco3 likely involves concerted activities apical anion channel clhco3 exchange hco3 uptake across basolateral membrane andor production hco3 intracellular carbonic anhydrase activity
0.56830734.9843756.html.plaintext.txt	115	paracellular pathway may also contribute since transepithelial gradient hco3 favoring secretion occurs
0.56830734.9843756.html.plaintext.txt	116	electrogenic hco3 secretion activated secretagogues increase intracellular camp cgmp ca2 concentrations 1 hco3 secretion required presence cftr segments small intestine mice 16 17 33
0.56830734.9843756.html.plaintext.txt	117	however specific mechanisms involved remains mystery
0.56830734.9843756.html.plaintext.txt	118	use ph stat method combination inhibitors anion exchange cftr recent work 5 duodenum normal cftr knockout mice shows cftr may contributed hco3 secretion two ways directly conducting hco3 lumen also indirectly conducting cl lumen could recycled back cell via anion exchange hco3
0.56830734.9843756.html.plaintext.txt	119	cftr expressed highest levels crypts 7 electrogenic hco3 secretion predicted occur primarily region
0.56830734.9843756.html.plaintext.txt	120	contrast cftr expressed lower levels carbonic anhydrase activity expressed higher levels villus epithelium cftr coupled clhco3 exchange activity may primarily localized villus
0.56830734.9843756.html.plaintext.txt	121	cftr conduct hco3 patch clamp studies showed hco3 conducted cftr nih3t3 cells recombinantly expressing wild type cftr 26 permeability ratio cl hco3 0
0.56830734.9843756.html.plaintext.txt	122	similar measurements also presented recently linsdell et al
0.56830734.9843756.html.plaintext.txt	123	25 found permeability ratio cl hco3 0
0.56830734.9843756.html.plaintext.txt	124	also measured cftr mediated permeation hco3 across apical membrane calu 3 monolayers conductance ratios camp stimulated hco3 cl currents 0
0.56830734.9843756.html.plaintext.txt	125	thus hco3 cl permeability conductance ratios cftr ranged 0
0.56830734.9843756.html.plaintext.txt	126	role cftrs function hco3 conductor also suggested cf models using variety methods comparing wild type cftr expressing cells f508 cftr expressing cf cells 22 35 wild type cftr knockout mice cftr 5 13 17 33
0.56830734.9843756.html.plaintext.txt	127	reports suggested possibility defect hco3 secretion cftr may contribute pathophysiology cf pulmonary disease 22 35
0.56830734.9843756.html.plaintext.txt	128	contrast experiments showed cftr conducts hco3 quinton reddy 28 p
0.56830734.9843756.html.plaintext.txt	129	quinton personal communication showed using microelectrode methods intact sweat ducts hco3 equally impermeant cftr gluconate
0.56830734.9843756.html.plaintext.txt	130	contradiction remains unresolved
0.56830734.9843756.html.plaintext.txt	131	cftr contribute cytosolic andor extracellular ph regulation cftr permeant hco3 expected contribute movements hco3 cell thereby alter ph cell extracellular fluids
0.56830734.9843756.html.plaintext.txt	132	nih3t3 cells expressing exogenous cftr showed forskolin stimulated changes ph absent cells expressing f508 cftr 26
0.56830734.9843756.html.plaintext.txt	133	data also presented biliary epithelial cells showing cftr may regulate activity anion exchanger alter cytosolic ph regulatory ability cells 14 contrast recently compared cytosolic ph regulation cf cftr corrected nasal cells found apparent differences l
0.56830734.9843756.html.plaintext.txt	134	possible explanation cells expressed nah clhco3 exchange na hco3 cotransport mechanisms much prominent cftr regulating cytosolic ph
0.56830734.9843756.html.plaintext.txt	135	thus cells express prominent activity transporters regulate cytosolic ph conductive pathway hco3 across cftr might minor importance cytosolic ph regulation
0.56830734.9843756.html.plaintext.txt	136	however cftr might still contribute importantly accumulation hco3 poorly buffered apicalluminal fluid
0.56830734.9843756.html.plaintext.txt	137	anions regulate cl permeation cftr well described thiocyanate scn highly permeant across cftr mixtures cl scn used conductance cftr decreases 37
0.56830734.9843756.html.plaintext.txt	138	effect interpreted terms multi ion pore behavior cftr
0.56830734.9843756.html.plaintext.txt	139	interactions anions within pore lead anomalous effects
0.56830734.9843756.html.plaintext.txt	140	also halide anion permeated blocked cftr
0.56830734.9843756.html.plaintext.txt	141	similarly shown f hco3 added apical surface reduced cl conductance cftr calu 3 cells illek machen unpublished observations
0.56830734.9843756.html.plaintext.txt	142	vivo cl hco3 present cytosol similar concentrations driven membrane potential pore cftr suggesting ions may compete common binding sites permeation path thus affect permeation
0.56830734.9843756.html.plaintext.txt	143	could particularly important tissues secrete large amounts hco3
0.56830734.9843756.html.plaintext.txt	144	summary role cftr hco3 secretion
0.56830734.9843756.html.plaintext.txt	145	exact role cftr hco3 permeation physiological conditions likely depends relative expression cftr hco3 channels hco3 transporters paracellular permeability hco3
0.56830734.9843756.html.plaintext.txt	146	addition cell lumen electrochemical driving forces cl hco3 determine ion movements across luminal cell membrane tight junctions
0.56830734.9843756.html.plaintext.txt	147	cftr appears important hco3 conductance also way direct indirect regulator adjacent anion exchange e
0.56830734.9843756.html.plaintext.txt	148	source luminal cl may exchange cellular hco3 andor means keeping cellular cl concentration low enough anion exchanger operates hco3 secretion mechanism
0.56830734.9843756.html.plaintext.txt	149	many cftr expressing epithelia including intestine pancreas liver exhibit different gradients cl hco3 along length organ relationships also affected anatomic structures
0.56830734.9843756.html.plaintext.txt	150	apologize whose work unable quote due space limitations
0.56830734.9843756.html.plaintext.txt	151	second series invited articles genetic disorders membrane transport
0.56830734.9843756.html.plaintext.txt	152	study laboratories supported grants national institutes health r01 dk 51799 cystic fibrosis research inc
0.56830734.9843756.html.plaintext.txt	153	cystic fibrosis foundation grant illek96f0 commercial endowment childrens hospital oakland
0.56830734.9843756.html.plaintext.txt	154	address reprint requests
0.56830734.9843756.html.plaintext.txt	155	molecular cell biology univ
0.56830734.9843756.html.plaintext.txt	156	california berkeley ca 94720
0.56830734.9843756.html.plaintext.txt	157	references top abstract introduction references
0.56830734.9843756.html.plaintext.txt	158	gastroduodenal mucosal protection
0.56830734.9843756.html.plaintext.txt	159	73 823 857 1993abstractfree full text
0.56830734.9843756.html.plaintext.txt	160	direct activation cystic fibrosis transmembrane conductance regulator channels 8 cyclopentyl 13 dipropylxanthine cpx 13 diallyl 8 cyclohexylxanthine dax
0.56830734.9843756.html.plaintext.txt	161	273 5727 5734 1998abstractfree full text
0.56830734.9843756.html.plaintext.txt	162	change gating mode leading increased intrinsic cl channel activity compensates defective processing cystic fibrosis mutant corresponding mild form disease
0.56830734.9843756.html.plaintext.txt	163	structural basis specificity potency xanthine derivatives activators cftr chloride channel
0.56830734.9843756.html.plaintext.txt	164	dual role cftr camp stimulated hco3 secretion across murine duodenum
0.56830734.9843756.html.plaintext.txt	165	37 g718 g726 1998abstractfree full text
0.56830734.9843756.html.plaintext.txt	166	8 cyclopentyl 13 dipropylxanthine xanthines differentially bind wild type f508 first nucleotide binding fold nbf 1 domains cystic fibrosis transmembrane conductance regulator
0.56830734.9843756.html.plaintext.txt	167	biochemistry 36 6455 6461 1997medline
0.56830734.9843756.html.plaintext.txt	168	immunocytochemical localization cystic fibrosis gene product cftr
0.56830734.9843756.html.plaintext.txt	169	usa 88 9262 9266 1991abstract
0.56830734.9843756.html.plaintext.txt	170	a1 adenosine receptor antagonists activate chloride efflux cystic fibrosis cells
0.56830734.9843756.html.plaintext.txt	171	usa 89 5562 5566 1992abstract
0.56830734.9843756.html.plaintext.txt	172	effects genistein disease causing mutant cftrs abstract
0.56830734.9843756.html.plaintext.txt	173	genistein activates cftr cl channels via tyrosine kinase protein phosphatase independent mechanism
0.56830734.9843756.html.plaintext.txt	174	42 c747 c753 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	175	cftr chloride channel mammalian heart
0.56830734.9843756.html.plaintext.txt	176	substituted benzimidazolone ns 004 opener cystic fibrosis chloride channel
0.56830734.9843756.html.plaintext.txt	177	269 10983 10986 1994abstractfree full text
0.56830734.9843756.html.plaintext.txt	178	intestinal physiology pathology gene targeted mouse models cystic fibrosis
0.56830734.9843756.html.plaintext.txt	179	36 g258 g266 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	180	regulation chloridebicarbonate exchange activity wild type mutant cftr
0.56830734.9843756.html.plaintext.txt	181	f508 cftr channels kinetics activation forskolin potentiation xanthines
0.56830734.9843756.html.plaintext.txt	182	39 c1544 c1555 1996abstractfree full text
0.56830734.9843756.html.plaintext.txt	183	schaffalitzky de muckadell m
0.56830734.9843756.html.plaintext.txt	184	acid stimulated duodenal bicarbonate secretion involves cftr mediated transport pathway mice
0.56830734.9843756.html.plaintext.txt	185	gastroenterology 113 533 541 1997medline
0.56830734.9843756.html.plaintext.txt	186	schaffalitzky de muckadell m
0.56830734.9843756.html.plaintext.txt	187	cftr mediates camp ca2 activated duodenal epithelial hco3 secretion
0.56830734.9843756.html.plaintext.txt	188	35 g872 g878 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	189	genistein potentiates wild type f508 cftr channel activity
0.56830734.9843756.html.plaintext.txt	190	42 c988 c998 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	191	flavonoids stimulate cl conductance human airway epithelium vitro vivo
0.56830734.9843756.html.plaintext.txt	192	19 l902 l910 1998abstractfree full text
0.56830734.9843756.html.plaintext.txt	193	alternate stimulation apical cftr genistein epithelia
0.56830734.9843756.html.plaintext.txt	194	39 c265 c275 1996abstractfree full text
0.56830734.9843756.html.plaintext.txt	195	camp independent activation cftr cl channels tyrosine kinase inhibitor genistein
0.56830734.9843756.html.plaintext.txt	196	37 c886 c893 1995abstractfree full text
0.56830734.9843756.html.plaintext.txt	197	camp genistein stimulate hco3 conductance cftr human airway epithelia
0.56830734.9843756.html.plaintext.txt	198	16 l752 l761 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	199	cftr mediated chloride permeability regulated type iii phosphodiesterases airway epithelial cells
0.56830734.9843756.html.plaintext.txt	200	vivo activation cystic fibrosis transmembrane conductance regulator mutant f508 murine nasal epithelium
0.56830734.9843756.html.plaintext.txt	201	usa 94 2604 2608 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	202	permeability wild type mutant cystic fibrosis transmembrane conductance regulator chloride channels polyatomic anions
0.56830734.9843756.html.plaintext.txt	203	110 355 364 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	204	bicarbonate conductance ph regulatory capability cystic fibrosis transmembrane conductance regulator
0.56830734.9843756.html.plaintext.txt	205	usa 91 5340 5344 1994abstract
0.56830734.9843756.html.plaintext.txt	206	defective epithelial ion transport cystic fibrosis
0.56830734.9843756.html.plaintext.txt	207	35 726 730 1989abstractfree full text
0.56830734.9843756.html.plaintext.txt	208	cl conductance acid secretion human sweat duct
0.56830734.9843756.html.plaintext.txt	209	cftr chloride channel activation genistein role serinethreonine protein phosphatases
0.56830734.9843756.html.plaintext.txt	210	40 c650 c657 1996abstractfree full text
0.56830734.9843756.html.plaintext.txt	211	identification cystic fibrosis gene cloning characterization complementary dna
0.56830734.9843756.html.plaintext.txt	212	science 245 1066 1073 1989medline
0.56830734.9843756.html.plaintext.txt	213	vitro pharmacologic restoration cftr mediated chloride transport sodium 4 phenylbutyrate cystic fibrosis epithelial cells containing f508 cftr
0.56830734.9843756.html.plaintext.txt	214	100 2457 2465 1997abstractfree full text
0.56830734.9843756.html.plaintext.txt	215	genistein tyrphostin 47 stimulate cftr mediated cl secretion t84 cell monolayers
0.56830734.9843756.html.plaintext.txt	216	32 g874 g882 1995abstractfree full text
0.56830734.9843756.html.plaintext.txt	217	functional cftr protein required mouse intestinal camp cgmp ca2 dependent hco3 secretion
0.56830734.9843756.html.plaintext.txt	218	crystal structure src family tyrosine kinase hck
0.56830734.9843756.html.plaintext.txt	219	nature 385 602 609 1997medline
0.56830734.9843756.html.plaintext.txt	220	camp stimulates bicarbonate secretion across normal cystic fibrosis airway epithelia
0.56830734.9843756.html.plaintext.txt	221	effect ibmx alkaline phosphatase inhibitors cl secretion g551d cystic fibrosis mutant mice
0.56830734.9843756.html.plaintext.txt	222	43 c492 c499 1998abstractfree full text
0.56830734.9843756.html.plaintext.txt	223	multi ion pore behaviour cftr chloride channel
0.56830734.9843756.html.plaintext.txt	224	nature 366 79 82 1993medline
0.56830734.9843756.html.plaintext.txt	225	actions genistein cystic fibrosis transmembrane conductance regulator channel gating
0.56830734.9843756.html.plaintext.txt	226	evidence two binding sites opposite effects
0.56830734.9843756.html.plaintext.txt	227	111 477 490 1998abstractfree full text
0.56830734.9843756.html.plaintext.txt	228	direct action genistein cftr
0.56830734.9843756.html.plaintext.txt	229	molecular mechanisms cftr chloride channel dysfunction cystic fibrosis
0.56830734.9843756.html.plaintext.txt	230	cell 73 1251 1254 1993medline
0.56830734.9843756.html.plaintext.txt	231	j physiol gastroint liver physiol 2756g1221 g1226 0002 951398 5
0.56830734.9843756.html.plaintext.txt	232	00 copyright 1998 american physiological society
